PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Osborne, LR; Soder, S; Shi, XM; Pober, B; Costa, T; Scherer, SW; Tsui, LC				Osborne, LR; Soder, S; Shi, XM; Pober, B; Costa, T; Scherer, SW; Tsui, LC			Hemizygous deletion of the syntaxin 1A gene in individuals with Williams syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							7Q11.23; CHANNELS; SNAP-25; LOCUS		HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; YALE UNIV, SCH MED, NEW HAVEN, CT USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University			Scherer, Stephen W./B-3785-2013; Tsui, Lap-chee/A-1081-2010	Scherer, Stephen W./0000-0002-8326-1999; 				BELLUGI U, 1990, AM J MED GENET, P115; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; DILTS CV, 1990, AM J MED GENET, P126; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; GILBERTDUSSARDIER B, 1995, AM J HUM GENET, V56, P542; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; HESS EJ, 1992, J NEUROSCI, V12, P2865; Jagadish MN, 1997, BIOCHEM J, V321, P151, DOI 10.1042/bj3210151; MORRIS CA, 1993, AM J MED GENET, V47, P478, DOI 10.1002/ajmg.1320470409; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; Peoples R, 1996, AM J HUM GENET, V58, P1370; Pober BR, 1996, CHILD ADOL PSYCH CL, V5, P929, DOI 10.1016/S1056-4993(18)30341-9; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; SADLER LS, 1993, AM J MED GENET, V47, P468, DOI 10.1002/ajmg.1320470406; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; Wang YK, 1997, HUM MOL GENET, V6, P465, DOI 10.1093/hmg/6.3.465; ZHANG RE, 1995, GENE, V159, P293, DOI 10.1016/0378-1119(95)00152-V	22	67	68	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					449	452		10.1086/514850	http://dx.doi.org/10.1086/514850			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311751	Green Published, Bronze			2022-12-18	WOS:A1997XX70100024
J	CavalliSforza, LL; Minch, E				CavalliSforza, LL; Minch, E			Paleolithic and neolithic lineages in the European mitochondrial gene pool	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DNA SEQUENCES; POPULATIONS; ORIGIN				CavalliSforza, LL (corresponding author), STANFORD UNIV, SCH MED, DEPT GENET, MED CTR, MS-5120, STANFORD, CA 94305 USA.			RICHARDS, MARTIN/0000-0003-3118-0967				Bendall KE, 1996, AM J HUM GENET, V59, P1276; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza L. L., 1986, AFRICAN PYGMIES; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Hewlett B. S., 1996, CULTURAL DIVERSITY 2, P215; HORAI S, 1990, AM J HUM GENET, V46, P828; JORDE LB, 1995, AM J HUM GENET, V57, P523; Linares AR, 1996, ANN HUM GENET, V60, P401, DOI 10.1111/j.1469-1809.1996.tb00438.x; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; Richards M, 1996, AM J HUM GENET, V59, P185; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Semino O, 1996, AM J HUM GENET, V59, P964; SLATKIN M, 1991, GENETICS, V129, P555; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702	21	67	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					247	251		10.1016/S0002-9297(07)64303-1	http://dx.doi.org/10.1016/S0002-9297(07)64303-1			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9246011	Green Published, Bronze			2022-12-18	WOS:A1997XM72800039
J	Mancini, D; Singh, S; Ainsworth, P; Rodenhiser, D				Mancini, D; Singh, S; Ainsworth, P; Rodenhiser, D			Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION; HEREDITARY RETINOBLASTOMA; P53 GENE; CHROMATIN STRUCTURE; GERMLINE MUTATIONS; MAMMALIAN-CELLS; EXPRESSION; BINDING; SENSITIVITY; SPECTRUM	A wide spectrum of mutations, ranging from point mutations to large deletions, have been described in the retinoblastoma gene (RB1). Mutations have been found throughout the gene; however, these genetic alterations do not appear to be homogeneously distributed. In particular, a significant proportion of disease-causing mutations result in the premature termination of protein synthesis, and the majority of these mutations occur as C-->T transitions at CpG dinucleotides (CpGs). Such recurrent CPG mutations, including those found in RB1, are likely the result of the deamination of 5-methylcytosine within these CpGs. In the present study, we used the sodium-bisulfite conversion method to detect cytosine methylation in representative exons of RB1. We analyzed DNA from a variety of tissues and specifically targeted CGA codons in RB1, where recurrent premature termination mutations have been reported. We found that DNA methylation within RB1 exons 8, 14, 25, and 27 appeared to be restricted to CpGs, including six CGA codons. Other codons containing methylated cytosines have not been reported to be mutated. Therefore, disease-causing mutations at CpGs in RB1 appear to be determined by several factors, including the constitutive presence of DNA methylation at cytosines within CpGs, the specific codon within which the methylated cytosine is located, and the particular region of the gene within which that codon resides.	CHILDRENS HOSP WESTERN ONTARIO, CHRI, MOL MED GENET PROGRAM, LONDON HLTH SCI CTR, LONDON, ON N6C 2V5, CANADA; UNIV WESTERN ONTARIO, DEPT PAEDIAT, LONDON, ON, CANADA; UNIV WESTERN ONTARIO, DEPT ZOOL, LONDON, ON, CANADA; UNIV WESTERN ONTARIO, DEPT BIOCHEM, LONDON, ON, CANADA	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)								Andrews JD, 1996, HUM MOL GENET, V5, P503, DOI 10.1093/hmg/5.4.503; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BLANQUET V, 1995, HUM MOL GENET, V4, P383, DOI 10.1093/hmg/4.3.383; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Graessmann M, 1993, EXS, V64, P404; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GREGER V, 1994, HUM GENET, V94, P491; HENSON JW, 1994, ANN NEUROL, V36, P714, DOI 10.1002/ana.410360505; HOGG A, 1993, P NATL ACAD SCI USA, V90, P7351, DOI 10.1073/pnas.90.15.7351; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; LETEURTRE F, 1994, J BIOL CHEM, V269, P7893; Lohmann DR, 1996, AM J HUM GENET, V58, P940; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; McArthur M, 1996, EMBO J, V15, P1705, DOI 10.1002/j.1460-2075.1996.tb00516.x; Nan XS, 1996, MOL CELL BIOL, V16, P414; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; POGRIBNY IP, 1995, CARCINOGENESIS, V16, P2863, DOI 10.1093/carcin/16.11.2863; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Rodenhiser D, 1996, ONCOGENE, V12, P2623; Rodenhiser DI, 1997, MUTAT RES-FUND MOL M, V373, P185, DOI 10.1016/S0027-5107(96)00171-6; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; TASHEVA ES, 1993, SOMAT CELL MOLEC GEN, V19, P275, DOI 10.1007/BF01233075; Tate P, 1996, NAT GENET, V12, P205, DOI 10.1038/ng0296-205; TORNALETTI S, 1995, ONCOGENE, V10, P1493; VanOrsouw NJ, 1996, HUM MOL GENET, V5, P755, DOI 10.1093/hmg/5.6.755; WENG A, 1995, MOL CELL BIOL, V15, P572, DOI 10.1128/MCB.15.1.572; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	42	67	70	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					80	87		10.1086/513898	http://dx.doi.org/10.1086/513898			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245987	Bronze, Green Published			2022-12-18	WOS:A1997XM72800014
J	Christensen, K; Mitchell, LE				Christensen, K; Mitchell, LE			Familial recurrence-pattern analysis of nonsyndromic isolated cleft palate - A Danish registry study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR-ALPHA; GENETICALLY COMPLEX TRAITS; LINKAGE STRATEGIES; LIP; GENE; ASSOCIATION; LOCI; MODE	The finding of an association between genetic variation at the transforming growth-factor alpha (TGFA) locus and nonsyndromic isolated cleft palate (CP) represents a potentially important breakthrough in our understanding of this condition. The present study was undertaken to assess the feasibility of detecting linkage to putative CP-susceptibility loci, such as TGFA. To this end, the familial recurrence pattern for CP was evaluated to determine the most likely mode of inheritance for this condition. The study took advantage of the high ascertainment and uniform registration of CP in Denmark. In addition, the study utilized estimates of familial recurrence that were obtained by register linkage and, hence, were not subject to either recall bias or the potentially biasing influence of nonresponders. The recurrence risks for first-, second-, and third-degree relatives of 1,364 nonsyndromic CP probands were estimated to be 2.74% (72/2,628), 0.28% (3/1,068), and 0.00% (0/360), respectively. These estimates are close to published estimates based on questionnaire and interview data. The population prevalence for nonsyndromic CP was, however, found to be considerable higher than usually reported (0.058% [1,456/ 2,523,023]). Analyses of these and previously published data, using the method presented by Risch, indicated that major-locus or additive multilocus inheritance of CP is unlikely. The familiar recurrence pattern was, however, consistent with CP being determined by several interacting loci. Under such a model, a single locus accounting for more than a sixfold increase in the risk to first-degree relatives of CP probands is unlikely, whereas a single locus accounting for a threefold increase provided a good fit to the data. Such a locus could be detected in a realistic sample of affected sib pairs.	ODENSE UNIV, SCH MED, ODENSE, DENMARK; ST LOUIS UNIV, SCH PUBL HLTH, DEPT COMMUNITY HLTH, ST LOUIS, MO 63103 USA	University of Southern Denmark; Saint Louis University	Christensen, K (corresponding author), AARHUS UNIV, STENO INST PUBL HLTH, DEPT EPIDEMIOL & SOCIAL MED, DANISH EPIDEMIOL SCI CTR RES UNIT, DK-8000 AARHUS C, DENMARK.		Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292				ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BIXLER D, 1971, Clinical Genetics, V2, P155; BONAITI C, 1982, J MED GENET, V19, P8, DOI 10.1136/jmg.19.1.8; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHRISTENSEN K, 1993, AM J MED GENET, V47, P910, DOI 10.1002/ajmg.1320470620; CHRISTENSEN K, 1995, NEW ENGL J MED, V333, P161, DOI 10.1056/NEJM199507203330305; CHRISTENSEN K, 1992, AM J HUM GENET, V51, P654; CHRISTENSEN K, 1993, CLEFT PALATE-CRAN J, V30, P469, DOI 10.1597/1545-1569(1993)030<0469:ICPIDM>2.3.CO;2; CHRISTENSEN K, 1994, CLIN GENET, V46, P329; DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FARRALL M, 1993, AM J HUM GENET, V52, P434; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; GOLDBERG R, 1993, AM J MED GENET, V45, P313, DOI 10.1002/ajmg.1320450307; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; PRADAT P, 1994, GENET EPIDEMIOL, V11, P131, DOI 10.1002/gepi.1370110204; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; SANDER A, 1995, AM J HUM GENET, V56, P310; SHAW GM, 1994, AM J HUM GENET S, V55, P4165; SHIANG R, 1993, AM J HUM GENET, V53, P836; SHIELDS ED, 1981, CLIN GENET, V20, P13; WOOLF CM, 1963, AM J HUM GENET, V15, P209	26	67	67	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					182	190						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554055				2022-12-18	WOS:A1996TL69700022
J	Jarvik, GP; Larson, EB; Goddard, K; Kukull, WA; Schellenberg, GD; Wijsman, EM				Jarvik, GP; Larson, EB; Goddard, K; Kukull, WA; Schellenberg, GD; Wijsman, EM			Influence of apolipoprotein e genotype on the transmission of Alzheimer disease in a community-based sample	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGREGATION ANALYSIS; E POLYMORPHISM; RISK-FACTORS; GENE; CHROMOSOME-14; FAMILIES; MODELS; TRAITS; ALLELE	The E4 allele of the apolipoprotein E locus (APOE) has been found to be an important predictor of Alzheimer disease (AD). However, linkage analysis has not clarified the role of APOE in the transmission of AD. The results of the current study provide evidence that the pattern of transmission of memory disorders differs in nuclear families in which the AD-affected proband did carry an epsilon 4 allele versus those families in which the AD-affected proband did not carry an E4 allele. Further, risk of AD due to APOE genotype in the probands is modified by family history of memory disorders, suggesting gene-by-gene interactions. Family history remained a significant predictor of AD for affected probands with some, but not all, APOE genotypes in a logistic regression analysis. Though nonadditive in the prediction of AD, APOE genotype and family history acted additively in the prediction of age at AD onset. The results of complex segregation analysis were inconsistent with Mendelian segregation of memory disorders both in families of affected probands who did or did not carry an E4 allele, yet these two groups had significantly different parameter estimates for their transmission models. These results are consistent with gene-by-gene interactions, but also could result from common elements in the familial environment.	UNIV WASHINGTON,MED CTR,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DIV GERONTOL & GERIATR MED,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DEPT HLTH SERV,SEATTLE,WA 98195; VET AFFAIRS MED CTR,CTR GERIATR RES & CLIN,SEATTLE,WA 98108	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; Kukull, Walter/0000-0001-8761-9014	NATIONAL INSTITUTE ON AGING [R01AG007584, U01AG006781] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05135, AG 07584, AG 06781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAILEYWILSON JE, 1987, SAGE STATISTICAL ANA; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; Elston R C, 1981, Adv Hum Genet, V11, P63; Elston R.C., 1981, ADV HUM GENET, V11, P372; ELSTON RC, 1986, 7TH P INT C HUM GEN; FARRER LA, 1991, AM J HUM GENET, V48, P1026; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goddard KAB, 1995, GENET EPIDEMIOL, V12, P759, DOI 10.1002/gepi.1370120638; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; HIXSON JE, 1990, J LIPID RES, V31, P545; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; JARVIK GP, 1994, NAT GENET, V8, P115, DOI 10.1038/ng1094-115a; KUKULL WA, 1992, NEUROLOGY, V42, P607, DOI 10.1212/WNL.42.3.607; Larson E B, 1990, Aging (Milano), V2, P404; LEVYLAHAD E, 1995, NATURE, V269, P973; LEVYLAHAD E, 1995, NATURE, V269, P970; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; MCGUFFIN P, 1991, ETHICAL ISSUES MOL G, P42; MENDEZ MF, 1992, NEUROLOGY, V42, P770, DOI 10.1212/WNL.42.4.770; MORTON NE, 1971, AM J HUM GENET, V23, P602; PAIRITZ G, 1988, AM J HUM GENET, V43, P311; PAYAMI H, 1994, AM J HUM GENET, V54, P650; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; RAO VS, 1994, AM J HUM GENET, V55, P991; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SING CF, 1985, AM J HUM GENET, V37, P268; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; TSAI MS, 1994, AM J HUM GENET, V54, P643; VANCE MAP, 1991, AM J HUM GENET, V48, P1034; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; YU CE, 1994, AM J HUM GENET, V54, P631; 1994, STATISTICAL ANAL GEN; 1991, SPSS STATISTICAL ALG	42	67	69	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					191	200						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554056				2022-12-18	WOS:A1996TL69700023
J	BARTELS, CF; ZELINSKI, T; LOCKRIDGE, O				BARTELS, CF; ZELINSKI, T; LOCKRIDGE, O			MUTATION AT CODON-322 IN THE HUMAN ACETYLCHOLINESTERASE (ACHE) GENE ACCOUNTS FOR YT BLOOD-GROUP POLYMORPHISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-SERUM-CHOLINESTERASE; HUMAN-ERYTHROCYTE ACETYLCHOLINESTERASE; MEMBRANE; PROTEIN; SYSTEM; IDENTIFICATION; NOMENCLATURE; TRANSCRIPTS; EXPRESSION; SEQUENCES	Acetylcholinesterase is present in innervated tissues, where its function is to terminate nerve impulse transmission. It is also found in the red blood cell membrane, where its function is unknown. We report the first genetic variant of human acetylcholinesterase and support the identity of acetylcholinesterase as the YT blood group antigen. DNA sequencing shows that the wild-type sequence of acetylcholinesterase with His322 (CAC) is the YT1 blood group antigen and that the rare variant of acetylcholinesterase with Asn322 (AAC) is the YT2 blood group antigen. Two additional point mutations in the acetylcholinesterase gene do not affect the amino acid sequence of the mature enzyme.	UNIV NEBRASKA,MED CTR,EPPLEY INST,600 S 42D ST,OMAHA,NE 68198; UNIV MANITOBA,RH LAB,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Nebraska System; University of Nebraska Medical Center; University of Manitoba					NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 36727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANSTEE DJ, 1990, VOX SANG, V58, P1, DOI 10.1111/j.1423-0410.1990.tb02049.x; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; BARTELS CF, 1992, AM J HUM GENET, V50, P1104; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; DUTTACHOUDHURY TA, 1984, J BIOL CHEM, V259, P5653; EATON BR, 1956, BRIT J HAEMATOL, V2, P333, DOI 10.1111/j.1365-2141.1956.tb06707.x; FOURNIER D, 1989, J MOL BIOL, V210, P15, DOI 10.1016/0022-2836(89)90287-8; GETMAN DK, 1992, AM J HUM GENET, V51, P170; GILES CM, 1967, VOX SANG, V13, P171, DOI 10.1111/j.1423-0410.1967.tb03946.x; GNATT A, 1990, CANCER RES, V50, P1983; HADA T, 1992, INTERNAL MED, V31, P357, DOI 10.2169/internalmedicine.31.357; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; LEVENE C, 1987, TRANSFUSION, V27, P471, DOI 10.1046/j.1537-2995.1987.27688071697.x; LEWIS M, 1990, VOX SANG, V58, P152; LEWIS M, 1987, VOX SANG, V53, P52, DOI 10.1111/j.1423-0410.1987.tb04914.x; LEWIS M, 1958, J LAB CLIN MED, V52, P163; LI Y, 1991, J BIOL CHEM, V266, P23083; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; MCGUIRE MC, 1989, P NATL ACAD SCI USA, V86, P953, DOI 10.1073/pnas.86.3.953; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; MUTERO A, 1992, J BIOL CHEM, V267, P1695; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RACE RR, 1975, BLOOD GROUPS MAN, P379; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SHOWS TB, 1987, CYTOGENET CELL GENET, V46, P11; SIKORAV JL, 1988, EMBO J, V7, P2983, DOI 10.1002/j.1460-2075.1988.tb03161.x; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SPRING FA, 1992, BLOOD, V80, P2136; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TELEN MJ, 1990, BLOOD, V75, P1404; TELEN MJ, 1992, CLIN RES, V40, P170; VENGELENTYLER V, 1983, TRANSFUSION, V23, P114, DOI 10.1046/j.1537-2995.1983.23283172845.x; WHITTAKER M, 1986, MONOGRAPHS HUMAN GEN, V11; WURZEL HA, 1968, VOX SANG, V15, P304, DOI 10.1111/j.1423-0410.1968.tb01765.x; ZELINSKI T, 1991, GENOMICS, V11, P165, DOI 10.1016/0888-7543(91)90113-S	41	67	76	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					928	936						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488842				2022-12-18	WOS:A1993LB88900010
J	BRAUN, A; KAMMERER, S; CLEVE, H; LOHRS, U; SCHWARZ, HP; KUHNLE, U				BRAUN, A; KAMMERER, S; CLEVE, H; LOHRS, U; SCHWARZ, HP; KUHNLE, U			TRUE HERMAPHRODITISM IN A 46,XY INDIVIDUAL, CAUSED BY A POSTZYGOTIC SOMATIC POINT MUTATION IN THE MALE GONADAL SEX-DETERMINING LOCUS (SRY) - MOLECULAR-GENETICS AND HISTOLOGICAL-FINDINGS IN A SPORADIC CASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TESTIS-DETERMINING FACTOR; Y-CHROMOSOME; DETERMINING REGION; XX MALES; PSEUDOAUTOSOMAL BOUNDARY; XY FEMALE; ZFY; PROTEIN; DIFFERENTIATION; EXPRESSION	Recently, the gene for the determination of maleness has been identified in the sex-determining region on the short arm of the Y chromosome (SRY) between the Y-chromosomal pseudoautosomal boundary (PABY) and the ZFY gene locus. Experiments with transgenic mice confirmed that SRY is a part of the testis-determining factor (TDF). We describe a sporadic case of a patient with intersexual genitalia and the histological finding of ovotestes in the gonad, which resembles the mixed type of gonadal tissue without primordial follicle structures. The karyotype of the patient was 46,XY. By PCR amplification, we tested for the presence of PABY, SRY, and ZFY by using DNA isolated from peripheral blood leukocytes and for the presence of SRY by using DNA obtained from histological gonadal slices. The SRY products of both DNA preparations were further analyzed by direct sequencing. All three parts of the sex-determining region of the Y chromosome could be amplified from leukocytic DNA. The patient's and the father's SRY sequences were identical with the published sequence. In the SRY PCR product of gonadal DNA, the wild-type and two point mutations were present in the patient's sequence, simulating a heterozygous state of a Y-chromosomal gene: one of the mutations was silent, while the other encoded for a nonconservative amino acid substitution from leucine to histidine. Subcloning procedures showed that the two point mutations always occurred together. The origin of the patient's intersexuality is a postzygotic mutation of the SRY occurring in part of the gonadal tissue. This event caused the loss of the testis-determining function in affected cells.	UNIV MUNICH, CHILDRENS HOSP, DEPT PATHOL, W-8000 MUNICH 2, GERMANY; UNIV MUNICH, CHILDRENS HOSP, DEPT ENDOCRINOL, W-8000 MUNICH 2, GERMANY	University of Munich; University of Munich	BRAUN, A (corresponding author), UNIV MUNICH, CHILDRENS HOSP, INST ANTHROPOL & HUMAN GENET, RICHARD WAGNER STR 10-1, W-8000 MUNICH 2, GERMANY.							AARONSON IA, 1985, BRIT J UROL, V57, P775, DOI 10.1111/j.1464-410X.1985.tb07052.x; ABBAS NE, 1990, HUM GENET, V84, P356; AFFARA NA, 1987, NUCLEIC ACIDS RES, V15, P7325, DOI 10.1093/nar/15.18.7325; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BRAUN A, 1992, HUM GENET, V89, P401; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHAPELLE AD, 1972, AM J HUM GENET, V24, P71; COOKE NE, 1986, HUM GENET, V73, P225, DOI 10.1007/BF00401232; DELACHAPELLE A, 1987, DEVELOPMENT, V101, P33; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FERGUSONSMITH MA, 1990, LANCET, V336, P809, DOI 10.1016/0140-6736(90)93270-Y; FERGUSONSMITH MA, 1990, HUM GENET, V84, P198; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; KASDAN R, 1973, NEW ENGL J MED, V288, P539, DOI 10.1056/NEJM197303152881102; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LIBRIK L, 1972, J PEDIATR-US, V80, P1060, DOI 10.1016/S0022-3476(72)80029-5; MCKELVIE P, 1987, Pediatric Pathology, V7, P31; MCLAREN A, 1990, NATURE, V346, P216, DOI 10.1038/346216a0; NAKAGOME Y, 1991, AM J MED GENET, V41, P112, DOI 10.1002/ajmg.1320410127; OVERZIER C, 1961, INTERSEXUALITAT; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; PEREIRA ET, 1991, J MED GENET, V28, P591, DOI 10.1136/jmg.28.9.591; RAMSAY M, 1988, AM J HUM GENET, V43, P4; ROSENBERG HS, 1963, J CLIN ENDOCR METAB, V23, P203, DOI 10.1210/jcem-23-2-203; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SKORDIS NA, 1987, J PEDIATR-US, V110, P244, DOI 10.1016/S0022-3476(87)80162-2; SWYER GIM, 1955, BMJ-BRIT MED J, V2, P709, DOI 10.1136/bmj.2.4941.709; TAZAKI H, 1964, Keio J Med, V13, P143; Van Niekerk WA, 1981, INTERSEX CHILD, V8, P80; VANNIEKERK WA, 1981, HUM GENET, V58, P117, DOI 10.1007/BF00284158; VILAIN E, 1992, AM J HUM GENET, V50, P1008	37	67	71	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					578	585						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447323				2022-12-18	WOS:A1993KR72000015
J	DURNER, M; GREENBERG, DA; HODGE, SE				DURNER, M; GREENBERG, DA; HODGE, SE			INTERFAMILIAL AND INTRAFAMILIAL HETEROGENEITY - EFFECTIVE SAMPLING STRATEGIES AND COMPARISON OF ANALYSIS-METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; SEGREGATION ANALYSIS; AFFECTIVE-DISORDERS; 2-LOCUS MODELS; LINKAGE DATA; SCHIZOPHRENIA; CHROMOSOME-5; SIMULATION; PEDIGREE; MARKERS	Heterogeneity, both inter- and intrafamilial, represents a serious problem in linkage studies of common complex diseases. In this study we simulated different scenarios with families who phenotypically have identical diseases but who genotypically have two different forms of the disease (both forms genetic). We examined the proportion of families displaying intrafamilial heterogeneity, as a function of mode of inheritance, gene frequency, penetrance, and sampling strategies. Furthermore, we compared two different ways of analyzing linkage in these data sets: a two-locus (2L) analysis versus a one-locus (SL) analysis combined with an admixture test. Data were simulated with tight linkage between one disease locus and a marker locus; the other disease locus was not linked to a marker. Our findings are as follows: (1) In contrast to what has been proposed elsewhere to minimize heterogeneity, sampling only "high-density" pedigrees will increase the proportion of families with intrafamilial heterogeneity, especially when the two forms are relatively close in frequency. (2) When one form is dominant and one is recessive, this sampling strategy will greatly decrease the proportions of families with a recessive form and may therefore make it more difficult to detect linkage to the recessive form. (3) An SL analysis combined with an admixture test achieves about the same lod scores and estimate of the recombination fraction as does a 2L analysis. Also, a 2L analysis of a sample of families with intrafamilial heterogeneity does not perform significantly better than an SL analysis. (4) Bilineal pedigrees have little effect on the mean maximum lod score and mean maximum recombination fraction, and therefore there is little danger that including these families will lead to a false exclusion of linkage.	MT SINAI MED CTR,DEPT PSYCHIAT,BOX 1229,1 GUSTAVE LEVY PL,NEW YORK,NY 10029; MT SINAI MED CTR,DEPT BIOMATH,NEW YORK,NY 10029; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10027; COLUMBIA UNIV,DEPT BIOSTAT,NEW YORK,NY 10027; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775, R01DK031813, R55DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31813, DK31775] Funding Source: Medline; NINDS NIH HHS [NS27941] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; GOLDIN LR, 1991, EUR ARCH PSY CLIN N, V240, P182, DOI 10.1007/BF02190761; GOLDIN LR, IN PRESS NEW GENETIC; GREENBERG DA, 1984, AM J HUM GENET, V36, P167; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, IN PRESS ARCH GEN PS; HODGE SE, 1983, AM J HUM GENET, V35, P1139; HODGE SE, IN PRESS GENET EPIDE; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LANDER ES, 1988, NATURE, V336, P105, DOI 10.1038/336105a0; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; MARTINEZ MM, 1989, AM J HUM GENET, V44, P552; MERIKANGAS KR, 1989, ARCH GEN PSYCHIAT, V46, P1137; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1959, AM J HUM GENET, V11, P1; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; OTT J, 1974, AM J HUM GENET, V26, P588; REGIER DA, 1989, REQUEST APPLICATIONS; RISCH N, 1982, ANN HUM GENET, V46, P153, DOI 10.1111/j.1469-1809.1982.tb00706.x; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106	28	67	67	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					859	870						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415227				2022-12-18	WOS:A1992JQ66700020
J	VONECKARDSTEIN, A; FUNKE, H; SCHULTE, M; ERREN, M; SCHULTE, H; ASSMANN, G				VONECKARDSTEIN, A; FUNKE, H; SCHULTE, M; ERREN, M; SCHULTE, H; ASSMANN, G			NONSYNONYMOUS POLYMORPHIC SITES IN THE APOLIPOPROTEIN (APO) A-IV GENE ARE ASSOCIATED WITH CHANGES IN THE CONCENTRATION OF APO B-CONTAINING AND APO A-I-CONTAINING LIPOPROTEINS IN A NORMAL POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-PLASMA; CHOLESTEROL ACYLTRANSFERASE; MOLECULAR-BASIS; ACTIVATION; LECITHIN; BINDING; PROTEIN; CELLS; SUBSTITUTIONS; FREQUENCY	The aims of this study were to detect polymorphic sites in the apolipoprotein (apo) A-IV gene, to establish their frequencies, to determine potential haplotypes, and to investigate the role of these polymorphisms in lipid metabolism. A sequencing study of four individuals led to the identification of two synonymous mutations (codons 9 and 54) and three nonsynonymous mutations (Val-8 --> Met, Gln360 --> His, and Thr347 --> Ser) and of a VNTR polymorphism within a series of three or four CTGT repeats in the noncoding region of exon 3. Frequencies of these polymorphisms were determined in 291 students by using naturally occurring (BstEII for the synonymous mutation in codon 54, HinfI for Thr347 --> Ser, and Fnu4HI for Gln360 --> His) or artificially introduced restriction-enzyme cutting sites (BstEII for the synonymous mutation in codon 9 and MamI for Val-8 --> Met), subsequent to PCR amplification. The four-base deletion / insertion polymorphism and its localization cis or trans to the mutations in codons 347 and 360 were studied by direct sequencing of PCR-amplified DNA from 87 students. Frequencies of the rarer alleles were .007 for apo A-IV-8:Met, .04 for the synonymous mutation in codon 9, .14 for the synonymous mutation in codon 54, .16 for apo A-IV347:Ser, .07 for apo A-IV360:His, and .39 for the four-base of insertion. Apo A-IV360:His in all cases was cis-localized to the (CTGT)3 repeat and apo A-IV347:Thr; and apo A-IV347:Ser was cis-localized to the (CTGT)4 repeat and apo A-IV360:Gln. Four haplotypes formed from these three polymorphic sites were thus found. The apo A-IV347:Ser allele was associated both with significantly lower plasma apo B concentrations in both sexes and with significantly lower LDL-cholesterol concentrations in men. Heterozygous carriers of apo A-IV360:His exhibited significantly higher concentrations of LDL-cholesterol and lower Lp(a) concentrations, compared with apo A-IV360:Gln homozygotes. We could not confirm the previously reported association of apo A-IV360:His with elevated HDL-cholesterol concentrations. In the population, the Val-8 --> Met polymorphism was not associated with significantly different lipid concentrations, but in a family study the Met-8 allele was associated with lower HDL-cholesterol and higher LDL-cholesterol concentrations. In conclusion, our results indicate an important role of the apo A-IV gene locus in the metabolism of apo B and, to a lesser extent, apo A-I containing lipoproteins.			VONECKARDSTEIN, A (corresponding author), UNIV MUNSTER,INST KLIN CHEM & LAB MED,ALBERT SCHWEITZER STR 33,W-4400 MUNSTER,GERMANY.							ANATHARAMIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95; ASSMANN G, 1989, METABOLIC BASIS INHE, P1267; ASSMANN G, 1986, PROCAM TRIAL PROSPEC; ASSMANN G, 1990, CURR OPIN LIPIDOL, V1, P105; BEISIEGEL U, 1979, EUR J BIOCHEM, V93, P601, DOI 10.1111/j.1432-1033.1979.tb12860.x; BISGAIER CL, 1985, J LIPID RES, V26, P11; BOERWINKLE E, 1990, NUCLEIC ACIDS RES, V18, P4966, DOI 10.1093/nar/18.16.4966; CHEN CH, 1985, BIOCHIM BIOPHYS ACTA, V836, P279, DOI 10.1016/0005-2760(85)90131-6; COLEMAN RT, 1986, MOL BIOL MED, V3, P213; DEKNIJFF P, 1988, J LIPID RES, V29, P1621; DVORIN E, 1986, J BIOL CHEM, V261, P5714; EICHNER JE, 1989, GENET EPIDEMIOL, V6, P493, DOI 10.1002/gepi.1370060404; ELSHOURBAGY NA, 1987, J BIOL CHEM, V262, P7973; FERRELL RE, 1990, J LIPID RES, V31, P131; FRANCONE OL, 1989, J BIOL CHEM, V264, P7066; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; FUNKE H, 1991, J CLIN INVEST, V87, P375; GHISELLI G, 1985, BIOCHEM BIOPH RES CO, V139, P122; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HANIS CL, 1991, HUM GENET, V86, P323; HAYDEN MR, 1987, AM J HUM GENET, V40, P421; JUNEJA RK, 1989, ANIM GENET, V20, P59; KARATHANASIS SK, 1986, P NATL ACAD SCI USA, V83, P8457, DOI 10.1073/pnas.83.22.8457; KARATHANASIS SK, 1985, P NATL ACAD SCI USA, V82, P6374, DOI 10.1073/pnas.82.19.6374; KUMAR R, 1988, ONCOGENE, V3, P647; KUMAR R, 1989, ONCOGENE RES, V1, P235; LEFEVRE M, 1989, LIPIDS, V24, P1035, DOI 10.1007/BF02544075; LOHSE P, 1990, CIRCULATION, V82, P425; LOHSE P, 1990, J BIOL CHEM, V265, P10061; LOHSE P, 1990, J BIOL CHEM, V265, P12734; LOHSE P, 1991, J BIOL CHEM, V266, P13513; Lohse P., 1991, CURR OPIN LIPIDOL, V2, P90; MAHLEY RW, 1990, CURRENT OPINION LIPI, V1, P87; MCCARTHY BJ, 1991, CURR OPIN LIPIDOL, V2, P81; MENZEL HJ, 1990, HUM GENET, V84, P344; MENZEL HJ, 1988, HUM GENET, V79, P368; MENZEL HJ, 1982, J LIPID RES, V23, P915; NOWICKA G, 1990, J LIPID RES, V31, P1947; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANDKAMP M, 1990, CLIN CHEM, V36, P20; SANDKAMP M, 1988, J CLIN CHEM CLIN BIO, V26, P685; SAVION N, 1988, ARTERIOSCLEROSIS, V8, P178, DOI 10.1161/01.ATV.8.2.178; STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; STEINMETZ A, 1985, J BIOL CHEM, V260, P2258; TENKANEN H, 1991, ARTERIOSCLER THROMB, V11, P851, DOI 10.1161/01.ATV.11.4.851; UTERMANN G, 1979, EUR J BIOCHEM, V99, P333, DOI 10.1111/j.1432-1033.1979.tb13261.x; WEINBERG RB, 1990, J BIOL CHEM, V265, P18372; WEINBERG RB, 1983, J LIPID RES, V24, P52; WEINBERG RB, 1990, BIOCHIM BIOPHYS ACTA, V1044, P255, DOI 10.1016/0005-2760(90)90311-K; WEINBERG RB, 1990, J BIOL CHEM, V265, P8081; WEISGRABER KH, 1978, BIOCHEM BIOPH RES CO, V85, P287, DOI 10.1016/S0006-291X(78)80041-2; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0	56	67	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1992	50	5					1115	1128						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR473	1349197				2022-12-18	WOS:A1992HR47300027
J	HELLIWELL, TR; ELLIS, JM; MOUNTFORD, RC; APPLETON, RE; MORRIS, GE				HELLIWELL, TR; ELLIS, JM; MOUNTFORD, RC; APPLETON, RE; MORRIS, GE			A TRUNCATED DYSTROPHIN LACKING THE C-TERMINAL DOMAINS IS LOCALIZED AT THE MUSCLE MEMBRANE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKER MUSCULAR-DYSTROPHY; MONOCLONAL-ANTIBODIES; SKELETAL-MUSCLE; MOLECULAR-BASIS; DUCHENNE; PROTEIN; DELETION; ISOFORMS; SEQUENCE; REGIONS	A Duchenne muscular dystrophy patient who displayed near-normal dystrophin staining at the sarcolemma with N-terminal, but not with C-terminal, anti-dystrophin monoclonal antibodies was found to have a frameshift deletion of exons 42 and 43. This deletion introduces an early termination codon, and a 225-kD protein was detected by western blotting with N-terminal antibodies only. The results suggest that an N-terminal truncated dystrophin fragment encoded by exons 1-41 is able to associate with the muscle cell membrane. The current idea that the C-terminal domains of dystrophin are important or essential for its integration with the sarcolemma may have to be reexamined in the light of these observations.	NE WALES INST,DIV RES,DEESIDE CH5 4BR,CLWYD,WALES; UNIV LIVERPOOL,LIVERPOOL ROYAL HOSP,DEPT PATHOL,LIVERPOOL L69 3BX,ENGLAND; ROYAL LIVERPOOL CHILDRENS HOSP,LIVERPOOL L7 7DG,MERSEYSIDE,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND	Glyndwr University; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Manchester				Helliwell, Timothy/0000-0003-2112-4128				ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BULMAN DE, 1991, AM J HUM GENET, V48, P295; CARPENTER S, 1990, MUSCLE NERVE, V13, P376, DOI 10.1002/mus.880130503; ELLIS JM, 1990, LANCET, V336, P881, DOI 10.1016/0140-6736(90)92392-U; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GINJAAR IB, 1989, LANCET, V2, P1212; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; MAN NT, 1990, FEBS LETT, V262, P237, DOI 10.1016/0014-5793(90)80199-S; MAN NT, 1990, FEBS LETT, V272, P109, DOI 10.1016/0014-5793(90)80460-Z; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NICHOLSON LVB, 1990, ACTA NEUROPATHOL, V80, P239, DOI 10.1007/BF00294640; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; READ AP, 1988, HUM GENET, V80, P152, DOI 10.1007/BF00702859; ROBERTS RG, 1990, LANCET, V336, P1523, DOI 10.1016/0140-6736(90)93305-9; SHIMIZU T, 1988, P JPN ACAD B-PHYS, V64, P205, DOI 10.2183/pjab.64.205; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; VAINZOF M, 1991, J NEUROL SCI, V101, P141, DOI 10.1016/0022-510X(91)90038-9; ZATZ M, 1989, AM J MED GENET, V32, P438, DOI 10.1002/ajmg.1320320336	26	67	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					508	514						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539591				2022-12-18	WOS:A1992HH97400008
J	SIRUGO, G; KEATS, B; FUJITA, R; DUCLOS, F; PUROHIT, K; KOENIG, M; MANDEL, JL				SIRUGO, G; KEATS, B; FUJITA, R; DUCLOS, F; PUROHIT, K; KOENIG, M; MANDEL, JL			FRIEDREICH ATAXIA IN LOUISIANA ACADIANS - DEMONSTRATION OF A FOUNDER EFFECT BY ANALYSIS OF MICROSATELLITE-GENERATED EXTENDED HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARKER LOCI D9S5; LINKAGE DISEQUILIBRIUM; GENETIC HOMOGENEITY; CHROMOSOME-9; FAMILIES; RFLP; IDENTIFICATION; MUTATIONS; GENOME; PCR	Eleven Acadian families with Friedreich ataxia (FA) who were from southwest Louisiana were studied with a series of polymorphic markers spanning 310 kb in the D9S5-D9S15 region previously shown to be tightly linked to the disease locus. In particular, three very informative microsatellites were tested. Evidence for a strong founder effect was found, since a specific extended haplotype spanning 230 kb from 26P (D9S5) to MCT112 (D9S15) was present on 70% of independent FA chromosomes and only once (6%) on the normal ones. There was no evident correlation between haplotypes and clinical expression. The typing of an additional microsatellite (GS4) located 80 kb from MCT112 created a divergence of the main FA-linked haplotype, generating four minor and one major haplotype. A similar split was observed with GS4 in a patient homozygous for a rare 26P-to-MCT112 haplotype. These results suggest that GS4 is a flanking marker for the disease locus, although other interpretations are possible.	FAC MED STRASBOURG,INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,NEW ORLEANS,LA 70112	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Louisiana State University System			Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016	Fujita, Ricardo/0000-0002-9617-5109				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P526, DOI 10.1017/S0317167100034995; BRASSEAUX CA, 1987, FOUNDING NEW ACADIA, P1765; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; COX NJ, 1988, AM J HUM GENET, V43, P495; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FUJITA R, 1991, GENOMICS, V10, P915, DOI 10.1016/0888-7543(91)90179-I; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; FUJITA R, UNPUB A 530 KB YAC C; FUJIWARA TM, 1989, AM J HUM GENET, V44, P327; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KEATS BJB, 1989, AM J MED GENET, V33, P266, DOI 10.1002/ajmg.1320330224; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; ORZECHOWSKI HD, 1987, NUCLEIC ACIDS RES, V15, P6310, DOI 10.1093/nar/15.15.6310; OUDET C, 1991, AM J HUM GENET, V49, P311; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; RICHTER A, 1990, AM J HUM GENET S, V47, pA144; ROZEN R, 1990, AM J HUM GENET, V47, P606; WALLIS J, 1990, HUM GENET, V85, P98; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WILKES D, 1991, GENOMICS, V9, P90, DOI 10.1016/0888-7543(91)90224-3	27	67	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					559	566						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1347194				2022-12-18	WOS:A1992HH97400015
J	THEIN, SL; WINICHAGOON, P; HESKETH, C; BEST, S; FUCHAROEN, S; WASI, P; WEATHERALL, DJ				THEIN, SL; WINICHAGOON, P; HESKETH, C; BEST, S; FUCHAROEN, S; WASI, P; WEATHERALL, DJ			THE MOLECULAR-BASIS OF BETA-THALASSEMIA IN THAILAND - APPLICATION TO PRENATAL-DIAGNOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAHIDOL UNIV,SIRIRAJ HOSP,DEPT MED,DIV HEMATOL,BANGKOK 10700,THAILAND	Mahidol University	THEIN, SL (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.		Best, Steve/A-7531-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034408] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 34408] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANGASTINIOTIS MA, 1981, LANCET, V1, P369; BUNGE FN, 1981, AREA HDB SERIES; CHAN V, 1987, AM J HUM GENET, V41, P678; CHAN V, 1988, BLOOD, V72, P1420; CHAN V, 1989, BLOOD, V74, P2304; FUCHAROEN S, 1989, J BIOL CHEM, V264, P7780; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; FUCHAROEN S, 1989, HUM GENET, V84, P41, DOI 10.1007/BF00210668; HALL DGE, 1987, HIST S E ASIA; KAZAZIAN HH, 1986, BLOOD, V68, P964; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; LAIG M, 1989, HUM GENET, V84, P47, DOI 10.1007/BF00210669; OLD JM, 1989, MOL BIOL MED, V6, P55; ORKIN SH, 1984, J BIOL CHEM, V259, P8679; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; ROSATELLI C, 1985, LANCET, V1, P241; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; THEIN SL, 1988, BRIT J HAEMATOL, V70, P225, DOI 10.1111/j.1365-2141.1988.tb02468.x; THEIN SL, 1987, J MED GENET, V24, P110, DOI 10.1136/jmg.24.2.110; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WINICHAGOON P, 1989, HUM GENET, V82, P389; YANG KG, 1989, BRIT J HAEMATOL, V72, P73, DOI 10.1111/j.1365-2141.1989.tb07655.x	27	67	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					369	375						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2393018				2022-12-18	WOS:A1990DX22300001
J	ENDO, H; HASEGAWA, K; NARISAWA, K; TADA, K; KAGAWA, Y; OHTA, S				ENDO, H; HASEGAWA, K; NARISAWA, K; TADA, K; KAGAWA, Y; OHTA, S			DEFECTIVE GENE IN LACTIC-ACIDOSIS - ABNORMAL PYRUVATE-DEHYDROGENASE EL ALPHA-SUBUNIT CAUSED BY A FRAME SHIFT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JICHI MED SCH,DEPT BIOCHEM,MINAMIKAWACHI,TOCHIGI 32904,JAPAN; TOHOKU UNIV,DEPT BIOCHEM GENET,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,SCH MED,DEPT PEDIAT,SENDAI,MIYAGI 980,JAPAN	Jichi Medical University; Tohoku University; Tohoku University								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BIRD AG, 1981, NATURE, V289, P300, DOI 10.1038/289300a0; BLASS JP, 1979, NEUROLOGY, V29, P280, DOI 10.1212/WNL.29.3.280; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; HO L, 1986, J CLIN INVEST, V78, P844, DOI 10.1172/JCI112651; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KOIKE K, 1988, P NATL ACAD SCI USA, V85, P41, DOI 10.1073/pnas.85.1.41; Koike M., 1976, ADV BIOPHYS, V9, P182; Maniatis T., 1982, MOL CLONING; MCKAY N, 1986, EUR J PEDIATR, V144, P445, DOI 10.1007/BF00441736; MEIRLEIR LD, 1988, J BIOL CHEM, V263, P1991; MIYABAYASHI S, 1985, EUR J PEDIATR, V143, P278, DOI 10.1007/BF00442301; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176; Utter M F, 1980, Birth Defects Orig Artic Ser, V16, P289	21	67	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					358	364						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T3535	2537010				2022-12-18	WOS:A1989T353500008
J	LEDLEY, FD; LUMETTA, MR; ZOGHBI, HY; VANTUINEN, P; LEDBETTER, SA; LEDBETTER, DH				LEDLEY, FD; LUMETTA, MR; ZOGHBI, HY; VANTUINEN, P; LEDBETTER, SA; LEDBETTER, DH			MAPPING OF HUMAN METHYLMALONYL COA MUTASE (MUT) LOCUS ON CHROMOSOME-6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	LEDLEY, FD (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030, USA.			Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [R29 HD24186, K11 HD00684] Funding Source: Medline; BHP HRSA HHS [DH20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000684, R29HD024186] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BHP HRSA HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CHEN SH, 1986, SOMAT CELL MOLEC GEN, V12, P303, DOI 10.1007/BF01570790; FENTON WA, 1984, J BIOL CHEM, V259, P6616; FENTON WA, 1982, ARCH BIOCHEM BIOPHYS, V214, P815, DOI 10.1016/0003-9861(82)90088-1; FENTON WA, 1987, P NATL ACAD SCI USA, V84, P1421, DOI 10.1073/pnas.84.5.1421; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; KOLHOUSE JF, 1981, P NATL ACAD SCI-BIOL, V78, P7737, DOI 10.1073/pnas.78.12.7737; KOLHOUSE JF, 1980, J BIOL CHEM, V255, P2708; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; LEDLEY FD, 1987, SOMAT CELL MOLEC GEN, V13, P575, DOI 10.1007/BF01534499; LEDLEY FD, 1984, NEW ENGL J MED, V311, P1015, DOI 10.1056/NEJM198410183111604; LEDLEY FD, IN PRESS P NATL ACAD; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; MELLMAN IS, 1979, P NATL ACAD SCI USA, V76, P405, DOI 10.1073/pnas.76.1.405; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; NAYLOR SL, 1983, P NATL ACAD SCI-BIOL, V80, P5027, DOI 10.1073/pnas.80.16.5027; ROSENBERG LE, 1983, METABOLIC BASIS INHE, P474; SU TS, 1984, AM J HUM GENET, V36, P954; WATKINS D, 1986, AM J HUM GENET, V39, P404; WILLARD HF, 1978, AM J HUM GENET, V30, P1; WILLARD HF, 1980, J CLIN INVEST, V65, P690, DOI 10.1172/JCI109715	23	67	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1988	42	6					839	846						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N5197	2897160				2022-12-18	WOS:A1988N519700006
J	LANGE, K; GORADIA, TM				LANGE, K; GORADIA, TM			AN ALGORITHM FOR AUTOMATIC GENOTYPE ELIMINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,MIT,DIV HLTH SCI & TECHNOL,BOSTON,MA 02115	Harvard University; Massachusetts Institute of Technology (MIT)	LANGE, K (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024, USA.				NHLBI NIH HHS [HL07505] Funding Source: Medline; NIADDK NIH HHS [AM33329] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM033329] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Conneally P M, 1980, Adv Hum Genet, V10, P209; Elston R C, 1981, Adv Hum Genet, V11, P63; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; LANGE K, 1983, HUM HERED, V33, P291, DOI 10.1159/000153393; LANGE K, 1985, PROGRAMS PEDIGREE AN; OTT J, 1984, ANAL HUMAN GENETIC L; Thompson EA, 1986, PEDIGREE ANAL HUMAN	7	67	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1987	40	3					250	256						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0854	3578274				2022-12-18	WOS:A1987H085400005
J	SPARKES, RS; DIZIKES, GJ; KLISAK, I; GRODY, WW; MOHANDAS, T; HEINZMANN, C; ZOLLMAN, S; LUSIS, AJ; CEDERBAUM, SD				SPARKES, RS; DIZIKES, GJ; KLISAK, I; GRODY, WW; MOHANDAS, T; HEINZMANN, C; ZOLLMAN, S; LUSIS, AJ; CEDERBAUM, SD			THE GENE FOR HUMAN-LIVER ARGINASE (ARG1) IS ASSIGNED TO CHROMOSOME BAND 6Q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PEDIAT,TORRANCE,CA 90509	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	SPARKES, RS (corresponding author), UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED,LOS ANGELES,CA 90024, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD006576] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-06576, HD-07032, HD-05615] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADCOCK MW, 1984, J BIOL CHEM, V259, P3471; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; CEDERBAUM SD, 1979, PEDIATR RES, V13, P827, DOI 10.1203/00006450-197907000-00007; DAS TK, 1974, BRIT J NUTR, V32, P353, DOI 10.1079/BJN19740088; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DIZIKES G J, 1984, American Journal of Human Genetics, V36, p135S; DIZIKES G J, 1985, American Journal of Human Genetics, V37, pA152; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FODOR EJB, 1977, BIOCHEM BIOPH RES CO, V77, P1478, DOI 10.1016/S0006-291X(77)80145-9; GLASS RD, 1973, J BIOL CHEM, V248, P5785; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HERZFELD A, 1976, BIOCHEM J, V153, P469, DOI 10.1042/bj1530469; KUCHERLAPATI RS, 1975, CYTOGENET CELL GENET, V14, P362, DOI 10.1159/000130384; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MOHANDAS T, 1980, CYTOGENET CELL GENET, V28, P116, DOI 10.1159/000131519; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; NAYLOR SL, 1978, P NATL ACAD SCI USA, V75, P6159, DOI 10.1073/pnas.75.12.6159; NUZUM CT, 1971, SCIENCE, V172, P1042, DOI 10.1126/science.172.3987.1042; RATNER S, 1960, ARCH BIOCHEM BIOPHYS, V91, P280, DOI 10.1016/0003-9861(60)90502-6; REDDI PK, 1975, ENZYME, V20, P305, DOI 10.1159/000458952; SCHIMKE RT, 1963, J BIOL CHEM, V238, P1012; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPECTOR EB, 1982, BIOCHEM MED METAB B, V28, P165, DOI 10.1016/0006-2944(82)90067-9; SPECTOR EB, 1983, PEDIATR RES, V17, P941, DOI 10.1203/00006450-198312000-00003; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; WALSER M, 1983, METABOLIC BASIS INHE, P402; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	29	67	67	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1986	39	2					186	193						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E1459	3752085				2022-12-18	WOS:A1986E145900004
J	MORTON, CC; KIRSCH, IR; TAUB, R; ORKIN, SH; BROWN, JA				MORTON, CC; KIRSCH, IR; TAUB, R; ORKIN, SH; BROWN, JA			LOCALIZATION OF THE BETA-GLOBIN GENE BY CHROMOSOMAL INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NATL NAVAL MED CTR,NCI,NAVAL MED ONCOL BRANCH,BETHESDA,MD 20814; CHILDRENS HOSP MED CTR,DEPT PEDIAT,DIV HEMATOL & ONCOL,BOSTON,MA 02115; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Harvard University; Boston Children's Hospital; Virginia Commonwealth University	MORTON, CC (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017088] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-07492, GM-17088] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; ATWOOD KC, 1975, CYTOGENET CELL GENET, V14, P229, DOI 10.1159/000130350; CHEUNG SW, 1977, CELL BIOL INT REP, V1, P255, DOI 10.1016/0309-1651(77)90050-9; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DEISSEROTH A, 1978, P NATL ACAD SCI USA, V75, P1456, DOI 10.1073/pnas.75.3.1456; DELACHAPELLE A, 1983, NUCLEIC ACIDS RES, V11, P1133, DOI 10.1093/nar/11.4.1133; DEMARTINVILLE B, 1983, NATURE, V305, P641, DOI 10.1038/305641a0; DONLON TA, 1984, CYTOGENET CELL GENET, V37, P455; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; ERIKSON J, 1982, P NATL ACAD SCI-BIOL, V79, P5611, DOI 10.1073/pnas.79.18.5611; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P197, DOI 10.1159/000130809; FRITSCH EF, 1979, NATURE, V279, P598, DOI 10.1038/279598a0; GERHARD DS, 1981, P NATL ACAD SCI-BIOL, V78, P3755, DOI 10.1073/pnas.78.6.3755; GERHARD DS, 1984, CYTOGENET CELL GENET, V37, P478; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HARNDEN DG, 1981, CYTOGENET CELL GENET, V31, P1; HARPER ME, 1982, AM J HUM GENET, V34, P227; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARPER ME, 1983, AM J HUM GENET, V35, P565; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HUERRE C, 1983, NATURE, V305, P638, DOI 10.1038/305638a0; JEFFREYS AJ, 1979, NATURE, V281, P606, DOI 10.1038/281606a0; JHANWAR SC, 1983, P NATL ACAD SCI-BIOL, V80, P4794, DOI 10.1073/pnas.80.15.4794; KANDA N, 1983, P NATL ACAD SCI-BIOL, V80, P4069, DOI 10.1073/pnas.80.13.4069; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; LEBO RV, 1979, P NATL ACAD SCI USA, V76, P5804, DOI 10.1073/pnas.76.11.5804; MALCOLM S, 1981, ANN HUM GENET, V45, P135, DOI 10.1111/j.1469-1809.1981.tb00315.x; MALCOLM S, 1982, P NATL ACAD SCI-BIOL, V79, P4957, DOI 10.1073/pnas.79.16.4957; MEYERS DA, 1984, CYTOGENET CELL GENET, V37, P540; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MORTON CC, 1984, SCIENCE, V223, P173, DOI 10.1126/science.6691143; MORTON CC, UNPUB DETECTION LOCA; NAYLOR SL, 1982, AM J HUM GENET, V34, pA165; NEEL BG, 1982, P NATL ACAD SCI-BIOL, V79, P7842, DOI 10.1073/pnas.79.24.7842; PIRASTU M, 1983, J CLIN INVEST, V72, P602, DOI 10.1172/JCI111008; PRICE PM, 1972, NATURE, V237, P340, DOI 10.1038/237340a0; PRICE PM, 1975, FED PROC, V34, P2227; PRICE PM, 1975, CYTOGENET CELL GENET, V14, P395, DOI 10.1159/000130392; RYAN J, 1983, P NATL ACAD SCI-BIOL, V80, P4460, DOI 10.1073/pnas.80.14.4460; SANDBERG AA, 1981, CHROMOSOMES HUMAN CA, P323; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SEABRIGH.M, 1971, LANCET, V2, P971; SPURR NK, 1984, CYTOGENET CELL GENET, V37, P590; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TRENT JM, 1982, P NATL ACAD SCI-BIOL, V79, P7809, DOI 10.1073/pnas.79.24.7809; ZABEL BU, 1982, AM J HUM GENET, V34, pA153; ZABEL BU, 1984, CYTOGENET CELL GENET, V37, P615	52	67	67	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	3					576	585						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SY119	6587773				2022-12-18	WOS:A1984SY11900007
J	PAGON, RA; HALL, JG; DAVENPORT, SLH; AASE, J; NORWOOD, TH; HOEHN, HW				PAGON, RA; HALL, JG; DAVENPORT, SLH; AASE, J; NORWOOD, TH; HOEHN, HW			ABNORMAL SKIN FIBROBLAST CYTOGENETICS IN 4 DYSMORPHIC PATIENTS WITH NORMAL LYMPHOCYTE CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195; UNIV NEW MEXICO,DEPT PEDIAT,ALBUQUERQUE,NM 87131; UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DIV MED GENET,SEATTLE,WA 98195; CHILDRENS ORTHOPED HOSP & MED CTR,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of New Mexico; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	PAGON, RA (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195, USA.			Hall, Judith G./0000-0001-5062-491X				ATKINS LEONARD, 1966, JMED GENET, V3, P134, DOI 10.1136/jmg.3.2.134; BOOK JA, 1962, ACTA GENET STAT MED, V12, P193; DEBRAYRITZEN P, 1974, REV NEUROL-FRANCE, V130, P357; deGrouchy J, 1969, BIRTH DEFECTS, V5, P74; ELLIS JR, 1963, NATURE, V198, P411, DOI 10.1038/198411a0; FERRIER P, 1964, LANCET, V1, P80; GOLDSTEIN DE, 1977, J PEDIATR-US, V90, P604, DOI 10.1016/S0022-3476(77)80378-8; HABERLANDT W, 1973, J GENET HUM, V21, P215; HARNDEN DG, 1976, SOMAT CELL GENET, V2, P55, DOI 10.1007/BF01539242; HOEHN H, 1975, CYTOGENET CELL GENET, V15, P282, DOI 10.1159/000130526; JENKINS ME, 1971, AM J DIS CHILD, V122, P80, DOI 10.1001/archpedi.1971.02110010116024; KAVA HW, 1968, FERTIL STERIL, V19, P835; KENNY GE, 1975, MICROBIOLOGY, P32; KOSZTOLANYI G, 1976, EUR J PEDIATR, V123, P293, DOI 10.1007/BF00444650; LADDA RL, 1977, DEV MED CHILD NEUROL, V19, P668; LITTLEFIELD LG, 1975, AM J HUM GENET, V27, P190; MARTIN GM, 1970, LAB INVEST, V23, P86; NEU RL, 1969, PEDIATRICS, V43, P623; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PALLISTER PD, 1976, LANCET, V1, P431; PASSARGE E, 1974, METHODS HUMAN CYTOGE, P198; PORTER I H, 1969, Journal of Medical Genetics, V6, P310, DOI 10.1136/jmg.6.3.310; PURVISSMITH S, 1976, EXCERPTA MEDICA  297, P148; RIDLER MAC, 1965, BRIT J PSYCHIAT, V111, P183, DOI 10.1192/bjp.111.471.183; SCHINZEL A, 1974, HELV PAEDIATR ACTA, V29, P531; SCHMID W, 1967, CYTOGENETICS, V6, P145, DOI 10.1159/000129935; SCHNEIDER EL, 1974, SCIENCE, V184, P477, DOI 10.1126/science.184.4135.477; SEHESTED J, 1974, HUMANGENETIK, V21, P55, DOI 10.1007/BF00278565; STALDER GR, 1963, LANCET, V1, P1379; SUMMITT RL, 1977, EUR J PEDIATR, V125, P169, DOI 10.1007/BF00480593; TAYLOR AI, 1970, NATURE, V227, P163, DOI 10.1038/227163a0; WARKANY J, 1964, PEDIATRICS, V33, P290; ZELLWEGER H, 1966, HUMANGENETIK, V4, P323	33	67	70	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	1					54	61						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GR115	155399				2022-12-18	WOS:A1979GR11500007
J	MACMAHON, B; PUGH, TF				MACMAHON, B; PUGH, TF			SEX RATIO OF WHITE BIRTHS IN THE UNITED STATES DURING THE WORLD WAR 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAUMGARTNER L, 1949, AJPH, V39, P1549; Ciocco A., 1938, HUM BIOL, V10, P36; Lowe CR, 1951, BR J SOC MED, V5, P91; Lowe CR, 1950, BR J SOC MED, V4, P75; Macmahon B, 1953, BRIT J PREV SOC MED, V7, P83; Martin WJ, 1943, LANCET, V2, P807; McMahan CA, 1951, MILBANK MEML FUND Q, V29, P273, DOI 10.2307/3348407; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531; 1949, METROPOLITAN LIFE IN, V30, P5; 1939, METROPOLITAN LIFE IN, V20, P1	10	67	68	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1954	6	2					284	292						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YB733	13158334				2022-12-18	WOS:A1954YB73300010
J	Myers, SM; Challman, TD; Bernier, R; Bourgeron, T; Chung, WK; Constantino, JN; Eichler, EE; Jacquemont, S; Miller, DT; Mitchell, KJ; Zoghbi, HY; Martin, CL; Ledbetter, DH				Myers, Scott M.; Challman, Thomas D.; Bernier, Raphael; Bourgeron, Thomas; Chung, Wendy K.; Constantino, John N.; Eichler, Evan E.; Jacquemont, Sebastien; Miller, David T.; Mitchell, Kevin J.; Zoghbi, Huda Y.; Martin, Christa Lese; Ledbetter, David H.			Insufficient Evidence for "Autism-Specific" Genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTELLECTUAL DISABILITY; SPECTRUM DISORDER; MUTATIONS; RISK; COMMON; RARE; INTELLIGENCE; METAANALYSIS; INDIVIDUALS; GENETICS	Despite evidence that deleterious variants in the same genes are implicated across multiple neurodevelopmental and neuropsychiatric disorders, there has been considerable interest in identifying genes that, when mutated, confer risk that is largely specific for autism spectrum disorder (ASD). Here, we review the findings and limitations of recent efforts to identify relatively "autism-specific" genes, efforts which focus on rare variants of large effect size that are thought to account for the observed phenotypes. We present a divergent interpretation of published evidence; discuss practical and theoretical issues related to studying the relationships between rare, large-effect deleterious variants and neurodevelopmental phenotypes; and describe potential future directions of this research. We argue that there is currently insufficient evidence to establish meaningful ASD specificity of any genes based on large-effect rare-variant data.	[Myers, Scott M.; Challman, Thomas D.; Martin, Christa Lese; Ledbetter, David H.] Geisinger Autism & Dev Med Inst, Danville, PA 17822 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Bourgeron, Thomas] Univ Paris, Inst Pasteur, Human Genet & Cognit Funct Unit, UMR 3571 CNRS, Paris 75015, France; [Chung, Wendy K.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10032 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY 10032 USA; [Constantino, John N.] Washington Univ, Res Ctr, Sch Med, Dept Psychiat Intellectual & Dev Disabil, St Louis, MO 63120 USA; [Constantino, John N.] Washington Univ, Sch Med, Res Ctr, Dept Pediat Intellectual & Dev Disabil, St Louis, MO 63120 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Jacquemont, Sebastien] Univ Montreal, St Justine Hosp, Dept Pediat, Res Ctr, Montreal, PQ H4A 3J1, Canada; [Miller, David T.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin D02 PN40, Ireland; [Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin D02 PN40, Ireland; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Harvard University; Boston Children's Hospital; Trinity College Dublin; Trinity College Dublin; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Myers, SM; Ledbetter, DH (corresponding author), Geisinger Autism & Dev Med Inst, Danville, PA 17822 USA.	smyers1@geisinger.edu; dhledbetter@geisinger.edu	Jacquemont, Sebastien/AAS-5060-2021; Myers, Scott/AAE-6398-2019	Jacquemont, Sebastien/0000-0001-6838-8767; 	National Institute of Mental Health (NIMH); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the US National Institutes of Health (NIH) [R01MH074090, R01MH107431, U01MH11970510]; Institut Pasteur, Universite de Paris, Fondation BettencourtSchueller; Simons Foundation Autism Research Initiative; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD087011]; NIH [MH101221, U41 HG006834]; Canadian Institute of Health Research Canada Research Chair, Canadian Institute of Health [400528]; NIMH [U01 MH119690-01]	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the US National Institutes of Health (NIH); Institut Pasteur, Universite de Paris, Fondation BettencourtSchueller; Simons Foundation Autism Research Initiative; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research Canada Research Chair, Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Hermela Shimelis for assistance with the Geisinger DBD Genes Database data and the creation of Figure 1. Thiswork was supported, inpart, by the National Institute of Mental Health (NIMH) and Eunice Kennedy Shriver National Institute of Child Health and Human Development of the US National Institutes of Health (NIH), under award numbers R01MH074090, R01MH107431, and U01MH11970510 (D.H.L., C.L.M., S.M.M.); Institut Pasteur, Universite de Paris, Fondation BettencourtSchueller (T.B.); the Simons Foundation Autism Research Initiative (W.K.C.); the Eunice Kennedy Shriver National Institute of Child Health and Human Development award number U54 HD087011 (J.N.C.); NIH grant MH101221(E.E.E.); and the Canadian Institute of Health Research Canada Research Chair, Canadian Institute of Health Research award number 400528, and NIMH award number U01 MH119690-01 (S.J.). E.E.E. is an investigator of the Howard Hughes Medical Institute. D.T.M. receives an honorarium to serve on the Medical GeneticsCommittee of the Simons Foundation Powering Autism Research (SPARK) project and receives salary support from NIH grant U41 HG006834 (a Unified Clinical Genomics Database). H.Y.Z. is an investigator of the Howard HughesMedical Institute.	American Psychiatric Association, 2012, DSM 5; [Anonymous], 2013, LANCET NEUROL, V12, P323, DOI 10.1016/S1474-4422(13)70063-2; Bai D, 2019, JAMA PSYCHIAT, V76, P1035, DOI 10.1001/jamapsychiatry.2019.1411; Bergen SE, 2019, AM J PSYCHIAT, V176, P29, DOI 10.1176/appi.ajp.2018.17040467; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Braun KVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124120; Clark LA, 2017, PSYCHOL SCI PUBL INT, V18, P72, DOI 10.1177/1529100617727266; Clarke TK, 2016, MOL PSYCHIATR, V21, P419, DOI 10.1038/mp.2015.12; Coe BP, 2019, NAT GENET, V51, P106, DOI 10.1038/s41588-018-0288-4; Constantino J. N., 2005, SOCIAL RESPONSIVENES; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Douard E., 2020, BIORXIV, DOI [10.1101/2020.03.09.979815, DOI 10.1101/2020.03.09.979815]; Douzgou S, 2019, CLIN GENET, V96, P72, DOI 10.1111/cge.13554; Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gonzalez-Mantilla AJ, 2016, JAMA PSYCHIAT, V73, P275, DOI 10.1001/jamapsychiatry.2015.2692; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Guo H, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0247-z; Halvardson J, 2016, J MED GENET, V53, P697, DOI 10.1136/jmedgenet-2016-103814; Hoang N, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0066-3; Hoekstra RA, 2010, AM J MED GENET B, V153B, P994, DOI 10.1002/ajmg.b.31066; Huguet G, 2018, JAMA PSYCHIAT, V75, P447, DOI 10.1001/jamapsychiatry.2018.0039; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Iakoucheva LM, 2019, CELL, V178, P1287, DOI 10.1016/j.cell.2019.07.037; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Jensen M., 2019, BIORXIV, DOI [10.1101/715755, DOI 10.1101/715755]; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lilienfeld SO, 2016, ANNU REV CLIN PSYCHO, V12, P435, DOI 10.1146/annurev-clinpsy-021815-093122; Maljaars J, 2012, AUTISM, V16, P487, DOI 10.1177/1362361311402857; Markon KE, 2011, PSYCHOL BULL, V137, P856, DOI 10.1037/a0023678; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Moreno-De-Luca A, 2015, JAMA PSYCHIAT, V72, P119, DOI 10.1001/jamapsychiatry.2014.2147; Niemi MEK, 2018, NATURE, V562, P268, DOI 10.1038/s41586-018-0566-4; O'Donovan MC, 2016, NAT MED, V22, P1214, DOI 10.1038/nm.4196; Olszewski AK, 2014, RES DEV DISABIL, V35, P3582, DOI 10.1016/j.ridd.2014.08.034; Pierpont ME, 2018, CIRCULATION, V138, pE653, DOI 10.1161/CIR.0000000000000606; Pizzo L, 2019, GENET MED, V21, P816, DOI 10.1038/s41436-018-0266-3; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Sanders SJ, 2019, NAT MED, V25, P1477, DOI 10.1038/s41591-019-0581-5; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Satterstrom FK, 2019, NAT NEUROSCI, V22, P1961, DOI 10.1038/s41593-019-0527-8; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Simmons JM, 2014, MAMM GENOME, V25, P23, DOI 10.1007/s00335-013-9476-9; Srivastava S, 2019, GENET MED, V21, P2413, DOI 10.1038/s41436-019-0554-6; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Stessman HAF, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0278-z; Sullivan PF, 2019, CELL, V177, P162, DOI 10.1016/j.cell.2019.01.015; Tansey KE, 2016, MOL PSYCHIATR, V21, P1085, DOI 10.1038/mp.2015.143; Thurm A, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00526; Tick B, 2016, J CHILD PSYCHOL PSYC, V57, P585, DOI 10.1111/jcpp.12499; Tikhodeyev ON, 2019, BEHAV GENET, V49, P259, DOI 10.1007/s10519-019-09950-1; Vogt G, 2015, J BIOSCIENCES, V40, P159, DOI 10.1007/s12038-015-9506-8; Wang Lijun, 2019, Liver Res, V3, P3, DOI 10.1016/j.livres.2019.02.001; Wang WD, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00258; Warrier V, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0558-4; Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863; Xie S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0154; Zarrei M, 2019, NPJ GENOM MED, V4, DOI 10.1038/s41525-019-0098-3	63	66	66	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2020	106	5					587	595		10.1016/j.ajhg.2020.04.004	http://dx.doi.org/10.1016/j.ajhg.2020.04.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LK8FQ	32359473	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000531096100001
J	Fassad, MR; Shoemark, A; Legendre, M; Hirst, RA; Koll, F; le Borgne, P; Louis, B; Daudvohra, F; Patel, MP; Thomas, L; Dixon, M; Burgoyne, T; Hayes, J; Nicholson, AG; Cullup, T; Jenkins, L; Carr, SB; Aurora, P; Lemullois, M; Aubusson-Fleury, A; Papon, JF; O'Callaghan, C; Amselem, S; Hogg, C; Escudier, E; Tassin, AM; Mitchison, HM				Fassad, Mahmoud R.; Shoemark, Amelia; Legendre, Marie; Hirst, Robert A.; Koll, France; le Borgne, Pierrick; Louis, Bruno; Daudvohra, Farheen; Patel, Mitali P.; Thomas, Lucie; Dixon, Mellisa; Burgoyne, Thomas; Hayes, Joseph; Nicholson, Andrew G.; Cullup, Thomas; Jenkins, Lucy; Carr, Siobhan B.; Aurora, Paul; Lemullois, Michel; Aubusson-Fleury, Anne; Papon, Jean-Francois; O'Callaghan, Christopher; Amselem, Serge; Hogg, Claire; Escudier, Estelle; Tassin, Anne-Marie; Mitchison, Hannah M.			Mutations in Outer Dynein Arm Heavy Chain DNAH9 Cause Motile Cilia Defects and Situs Inversus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSKINESIA; DIAGNOSIS; GENETICS; GENES	Motile cilia move body fluids and gametes and the beating of cilia lining the airway epithelial surfaces ensures that they are kept clear and protected from inhaled pathogens and consequent respiratory infections. Dynein motor proteins provide mechanical force for cilia beating. Dynein mutations are a common cause of primary ciliary dyskinesia (PCD), an inherited condition characterized by deficient mucociliary clearance and chronic respiratory disease coupled with laterality disturbances and subfertility. Using next-generation sequencing, we detected mutations in the ciliary outer dynein arm (ODA) heavy chain gene DNAH9 in individuals from PCD clinics with situs inversus and in one case male infertility. DNAH9 and its partner heavy chain DNAH5 localize to type 2 ODAs of the distal cilium and in DNAH9-mutated nasal respiratory epithelial cilia we found a loss of DNAH9/DNAH5-containing type 2 ODAs that was restricted to the distal cilia region. This confers a reduced beating frequency with a subtle beating pattern defect affecting the motility of the distal cilia portion. 3D electron tomography ultrastructural studies confirmed regional loss of ODAs from the distal cilium, manifesting as either loss of whole ODA or partial loss of ODA volume. Paramecium DNAH9 knockdown confirms an evolutionarily conserved function for DNAH9 in cilia motility and ODA stability. We find that DNAH9 is widely expressed in the airways, despite DNAH9 mutations appearing to confer symptoms restricted to the upper respiratory tract. In summary, DNAH9 mutations reduce cilia function but some respiratory mucociliary clearance potential may be retained, widening the PCD disease spectrum.	[Fassad, Mahmoud R.; Patel, Mitali P.; Mitchison, Hannah M.] UCL, Genet & Genom Med Programme, UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Fassad, Mahmoud R.] Alexandria Univ, Med Res Inst, Dept Human Genet, 165 El Horreya Ave El Hadra, Alexandria 21561, Egypt; [Shoemark, Amelia; Daudvohra, Farheen; Dixon, Mellisa; Burgoyne, Thomas; Carr, Siobhan B.; Hogg, Claire] Royal Brompton & Harefield NHS Trust, PCD Diagnost Team, London SW3 6NP, England; [Shoemark, Amelia; Daudvohra, Farheen; Dixon, Mellisa; Burgoyne, Thomas; Carr, Siobhan B.; Hogg, Claire] Royal Brompton & Harefield NHS Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Shoemark, Amelia] Univ Dundee, Sch Med, Dundee DD2 4BF, Scotland; [Legendre, Marie; Thomas, Lucie; Amselem, Serge; Escudier, Estelle] Hop Armand Trousseau, AP HP, Dept Genet Med, F-75012 Paris, France; [Legendre, Marie; Thomas, Lucie; Amselem, Serge; Escudier, Estelle] Sorbonne Univ, Paris 06, INSERM, UMR S933, F-75005 Paris, France; [Hirst, Robert A.; Hayes, Joseph; O'Callaghan, Christopher] Univ Leicester, Ctr PCD Diag & Res, Dept Infect Immun & Inflammat, RKCSB, Leicester LE2 7LX, Leics, England; [Koll, France; le Borgne, Pierrick; Lemullois, Michel; Aubusson-Fleury, Anne; Tassin, Anne-Marie] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell, CEA,CNRS, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France; [Louis, Bruno] Univ Paris Est, Fac Med Creteil, INSERM, U955,Equipe 13, F-94010 Creteil, France; [Nicholson, Andrew G.] Royal Brompton & Harefield NHS Trust, Histopathol Dept, London SW3 6NP, England; [Cullup, Thomas; Jenkins, Lucy] Great Ormond St Hosp Children NHS Fdn Trust, Reg Mol Genet Lab, Queen Sq, London WC1N 3BH, England; [Aurora, Paul; O'Callaghan, Christopher] UCL, Dept Resp, Crit Care & Anaesthesia Unit, Great Ormond St Inst Child Hlth, Guilford St, London WC1N 1EH, England; [Aurora, Paul] Great Ormond St Hosp Sick Children, Dept Paediat Resp Med, London WC1N 3JH, England; [Papon, Jean-Francois] Hop Bicetre, AP HP, Serv Otorhinolaryngol & Chirurg Cervicomaxillofac, F-94275 Le Kremlin Bicetre, France	University of London; University College London; Egyptian Knowledge Bank (EKB); Alexandria University; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of Dundee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Leicester; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Mitchison, HM (corresponding author), UCL, Genet & Genom Med Programme, UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England.	h.mitchison@ucl.ac.uk	Hirst, Robert/AAD-1649-2022; Louis, Bruno/AGB-7050-2022; Fassad, Mahmoud/J-5769-2019; Burgoyne, Thomas/HCI-9054-2022; Legendre, Marie/AAD-7018-2021; Shoemark, Amelia/I-4068-2019; Louis, Bruno C/R-1862-2018	Louis, Bruno/0000-0001-9587-9932; Fassad, Mahmoud/0000-0003-2568-8326; Burgoyne, Thomas/0000-0002-8428-720X; Legendre, Marie/0000-0003-2178-0846; Shoemark, Amelia/0000-0001-7360-6060; Louis, Bruno C/0000-0001-9587-9932; Mitchison, Hannah/0000-0002-3163-6293; THOMAS, Lucie/0000-0001-6998-590X	Fondation pour la Recherche Medicale [DEQ20120323689]; Legs Poix from the Chancellerie des Universites; Action Medical Research [GN2101]; Great Ormond Street Children's Charity [V4515, V1299, V2217]; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; British Council Newton-Mosharafa Fund; Ministry of Higher Education, Egypt; COST Action STSM [BM1407]; Investissements d'Avenir (RaDiCo program) [ANR-10-COHO-0003]; National Institute of Health Research; Health Education England; COST Action BEAT-PCD: Better Evidence to Advance Therapeutic options for PCD network [BM1407]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Legs Poix from the Chancellerie des Universites; Action Medical Research; Great Ormond Street Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; British Council Newton-Mosharafa Fund; Ministry of Higher Education, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); COST Action STSM; Investissements d'Avenir (RaDiCo program); National Institute of Health Research(National Institute for Health Research (NIHR)); Health Education England; COST Action BEAT-PCD: Better Evidence to Advance Therapeutic options for PCD network	We are grateful to the families who participated in this study and thank the UK PCD Family Support Group for their continued support. We thank Ms. Dani Lee and Prof. Chris O'Callaghan (UCL Great Ormond Street Institute of Child Health) for help with assessment of Paramecium motility, Dr. Jane Hayward with genetic analysis, and Dr. Dale Moulding (GOS-ICH Confocal Microscopy Core Facility) for imaging assistance. We thank Catherine Faucon (Service d'Anatomopathologie, Hopital intercommunal, Creteil, France) for her great technical assistance in TEM studies. Work by M. Legendre, S.A., and E.E. is supported by grants from the Fondation pour la Recherche Medicale (DEQ20120323689) and the Legs Poix from the Chancellerie des Universites and from the Investissements d'Avenir (RaDiCo program; ANR-10-COHO-0003). Other funding for this study was provided by Action Medical Research (GN2101; H.M.M.) and Great Ormond Street Children's Charity grant (V4515; H.M.M.) and Leadership awards (V1299, V2217; H.M.M.). We acknowledge support from the NIHR Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. M.R.F. is supported by the British Council Newton-Mosharafa Fund and the Ministry of Higher Education, Egypt. Work by A.S. is independent research funded by a postdoctoral research fellowship from the National Institute of Health Research and Health Education England. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute of Health Research, or the Department of Health. The authors participate in the COST Action BEAT-PCD: Better Evidence to Advance Therapeutic options for PCD network (BM1407) and this work was supported by two BM1407 COST Action STSM Grants awarded to M.R.F. and P.L.B. The authors alone are responsible for the content and writing of the paper.	Bartoloni L, 2001, GENOMICS, V72, P21, DOI 10.1006/geno.2000.6462; Bottier M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005552; Burgoyne T, 2012, AM J RESP CELL MOL, V47, P800, DOI 10.1165/rcmb.2011-0440OC; Chilvers MA, 2003, THORAX, V58, P333, DOI 10.1136/thorax.58.4.333; Dizier MH, 2016, EUR RESPIR J, V47, P1072, DOI 10.1183/13993003.00849-2015; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Fassad MR, 2018, AM J HUM GENET, V102, P956, DOI 10.1016/j.ajhg.2018.03.024; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Horani A, 2016, PAEDIATR RESPIR REV, V18, P18, DOI 10.1016/j.prrv.2015.09.001; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; King S. M., 2016, COLD SPRING HARB PER, V8, P8; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Linck RW, 2016, J ASSIST REPROD GEN, V33, P141, DOI 10.1007/s10815-016-0652-1; Loges NT, 2018, AM J HUM GENET, V103, P995, DOI 10.1016/j.ajhg.2018.10.020; Lucas JS, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01090-2016; Lucas JS, 2014, ARCH DIS CHILD, V99, P850, DOI 10.1136/archdischild-2013-304831; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Oltean A, 2018, AM J RESP CELL MOL, V59, P511, DOI 10.1165/rcmb.2017-0436OC; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Reed W, 2000, AM J RESP CELL MOL, V23, P734, DOI 10.1165/ajrcmb.23.6.4045; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Shoemark A., 2018, EUR RESPIR J, V51, P51; Viswanadha R., 2017, COLD SPRING HARB PER, V9, P9; Wallmeier J, 2016, AM J HUM GENET, V99, P460, DOI 10.1016/j.ajhg.2016.06.014	27	66	68	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					984	994		10.1016/j.ajhg.2018.10.016	http://dx.doi.org/10.1016/j.ajhg.2018.10.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30471717	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000452535600012
J	Loges, NT; Antony, D; Maver, A; Deardorff, MA; Gulec, EY; Gezdirici, A; Nothe-Menchen, T; Hoben, IM; Jelten, L; Frank, D; Werner, C; Tebbe, J; Wu, KM; Goldmuntz, E; Cuturilo, G; Krock, B; Ritter, A; Hjeij, R; Bakey, Z; Pennekamp, P; Dworniczak, B; Brunner, H; Peterlin, B; Tanidir, C; Olbrich, H; Omran, H; Schmidts, M				Loges, Niki T.; Antony, Dinu; Maver, Ales; Deardorff, Matthew A.; Gulec, Elif Yylmaz; Gezdirici, Alper; Noethe-Menchen, Tabea; Hoeben, Inga M.; Jelten, Lena; Frank, Diana; Werner, Claudius; Tebbe, Johannes; Wu, Kaman; Goldmuntz, Elizabeth; Cuturilo, Goran; Krock, Bryan; Ritter, Alyssa; Hjeij, Rim; Bakey, Zeineb; Pennekamp, Petra; Dworniczak, Bernd; Brunner, Han; Peterlin, Borut; Tanidir, Cansaran; Olbrich, Heike; Omran, Heymut; Schmidts, Miriam			Recessive DNAH9 Loss-of-Function Mutations Cause Laterality Defects and Subtle Respiratory Ciliary-Beating Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; BODY ASYMMETRY; COMMON-CAUSE; DYSKINESIA; OUTER; RANDOMIZATION; HETEROTAXY; HEART; NEPHRONOPHTHISIS; IDENTIFICATION	Dysfunction of motile monocilia, altering the leftward flow at the embryonic node essential for determination of left-right body asymmetry, is a major cause of laterality defects. Laterality defects are also often associated with reduced mucociliary clearance caused by defective multiple motile cilia of the airway and are responsible for destructive airway disease. Outer dynein arms (ODAs) are essential for ciliary beat generation, and human respiratory cilia contain different ODA heavy chains (HCs): the panaxonemally distributed gamma-HC DNAH5, proximally located beta-HC DNAH11 (defining ODA type 1), and the distally localized beta-HC DNAH9 (defining ODA type 2). Here we report loss-of-function mutations in DNAH9 in five independent families causing situs abnormalities associated with subtle respiratory ciliary dysfunction. Consistent with the observed subtle respiratory phenotype, high-speed video microscopy demonstrates distally impaired ciliary bending in DNAH9 mutant respiratory cilia. DNAH9-deficient cilia also lack other ODA components such as DNAH5, DNAI1, and DNAI2 from the distal axonemal compartment, demonstrating an essential role of DNAH9 for distal axonemal assembly of ODAs type 2. Yeast two-hybrid and co-immunoprecipitation analyses indicate interaction of DNAH9 with the ODA components DNAH5 and DNAI2 as well as the ODA-docking complex component CCDC114. We further show that during ciliogenesis of respiratory cilia, first proximally located DNAH11 and then distally located DNAH9 is assembled in the axoneme. We propose that the beta-HC paralogs DNAH9 and DNAH11 achieved specific functional roles for the distinct axonemal compartments during evolution with human DNAH9 function matching that of ancient beta-HCs such as that of the unicellular Chlamydomonas reinhardtii.	[Loges, Niki T.; Noethe-Menchen, Tabea; Hoeben, Inga M.; Jelten, Lena; Frank, Diana; Werner, Claudius; Tebbe, Johannes; Hjeij, Rim; Pennekamp, Petra; Dworniczak, Bernd; Olbrich, Heike; Omran, Heymut] Univ Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Antony, Dinu; Wu, Kaman; Bakey, Zeineb; Brunner, Han; Schmidts, Miriam] Radboud Univ Nijmegen, Med Ctr, Human Genet Dept, Genome Res Div, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands; [Antony, Dinu; Wu, Kaman; Bakey, Zeineb; Brunner, Han; Schmidts, Miriam] Radboud Inst Mol Life Sci, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands; [Antony, Dinu; Bakey, Zeineb; Schmidts, Miriam] Freiburg Univ, Univ Hosp Freiburg, Fac Med, Ctr Pediat & Adolescent Med, Mathildenstr 1, D-79112 Freiburg, Germany; [Maver, Ales; Peterlin, Borut] UMC Ljubljana, Clin Inst Med Genet, Slajmerjeva 4, Ljubljana 1000, Slovenia; [Deardorff, Matthew A.; Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Dept Pediat & Pathol, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.; Ritter, Alyssa] Univ Penn, Perelman Sch Med, Lab Med, Philadelphia, PA 19104 USA; [Gulec, Elif Yylmaz; Gezdirici, Alper] Univ Hlth Sci, Kanuni Sultan Suleyman Training & Res Hosp, Dept Med Genet, TR-34303 Istanbul, Turkey; [Goldmuntz, Elizabeth; Ritter, Alyssa] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Cuturilo, Goran] Univ Childrens Hosp, Dept Med Genet, Belgrade 11000, Serbia; [Krock, Bryan] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Krock, Bryan] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Tanidir, Cansaran] Univ Hlth Sci, Mehmet Akif Ersoy Thorac & Cardiovasc Surg Train, Dept Pediat Cardiol, TR-34303 Istanbul, Turkey	University of Munster; Radboud University Nijmegen; University of Freiburg; University Medical Centre Ljubljana; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Belgrade; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Omran, H (corresponding author), Univ Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.; Schmidts, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Human Genet Dept, Genome Res Div, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands.; Schmidts, M (corresponding author), Radboud Inst Mol Life Sci, Geert Grootepl Zuid 10, NL-6525 KL Nijmegen, Netherlands.; Schmidts, M (corresponding author), Freiburg Univ, Univ Hosp Freiburg, Fac Med, Ctr Pediat & Adolescent Med, Mathildenstr 1, D-79112 Freiburg, Germany.	heymut.omran@ukmuenster.de; miriam.schmidts@uniklinik-freiburg.de	Noethe-Menchen, Tabea/AAW-1667-2021; Yılmaz Gulec, Elif/GPS-8141-2022; Gezdirici, Alper/AAG-5480-2019; Yilmaz Gulec, Elif/X-2778-2018; Gezdirici, Alper/W-8459-2018; Schmidts, Miriam/A-3777-2012	Noethe-Menchen, Tabea/0000-0002-0571-6767; Yılmaz Gulec, Elif/0000-0003-0872-3898; Gezdirici, Alper/0000-0002-2432-9279; Yilmaz Gulec, Elif/0000-0003-0872-3898; Gezdirici, Alper/0000-0002-2432-9279; Schmidts, Miriam/0000-0002-1714-6749; Omran, Heymut/0000-0003-0282-6765; Hjeij, Rim/0000-0003-1464-7289	Deutsche Forschungsgemeinschaft (DFG) [OM6/7, OM6/8, OM6/10, CRC1140 KIDGEM, KFO 326, OL450/1, HJ7/1-1]; IZKF Muenster [Om2/009/12, Om/015/16]; European Union seventh FP [305404]; "Innovative Medical Research'' of the University of Muenster Medical School [I-LO121517]; RIMLS Nijmegen (Hypatia tenure track fellowship); European Research Council (ERC StG TREATCilia) [716344]; German PCD; Radboudumc	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF Muenster; European Union seventh FP; "Innovative Medical Research'' of the University of Muenster Medical School; RIMLS Nijmegen (Hypatia tenure track fellowship); European Research Council (ERC StG TREATCilia); German PCD; Radboudumc	We thank the PCD-affected individuals and their families for their participation and acknowledge the German PCD support group Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V. We thank A. Dorissen, D. Ernst, S. Helms, M. Herting, A. Robbers, L. Schwiddessen, F.J. Seesing, M. Tekaat, K. Wohlgemuth, and C. Westermann for excellent technical work. We also thank Dr. Alper Guzeltas, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Department of Pediatric Cardiology, 34303 Istanbul, Turkey and Dr. Helen Bornaun, Cardiology Department, Health Sciences University, Kanuni Sultan Suleyman Research and Training Hospital, Istanbul, Turkey for the diagnosis and referral of the individual MS_SI46 II.1 for genetic workup. The authors would like to thank the Genome Aggregation Database and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/. This work was supported by the Deutsche Forschungsgemeinschaft OM6/7, OM6/8, OM6/10, and DFG KFO 326 (H. Omran), OL450/1 (H. Olbrich), and HJ7/1-1 (R.H.), by the IZKF Muenster to H. Omran (Om2/009/12 and Om/015/16), the European Union seventh FP under GA Nr. 305404, project BESTCILIA (H. Omran), and "Innovative Medical Research'' of the University of Muenster Medical School to N.T.L. (I-LO121517). M.S. acknowledges funding from Radboudumc and RIMLS Nijmegen (Hypatia tenure track fellowship), the Deutsche Forschungsgemeinschaft (DFG CRC1140 KIDGEM), and the European Research Council (ERC StG TREATCilia, grant no. 716344).	Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bataille S, 2011, AM J KIDNEY DIS, V58, P456, DOI 10.1053/j.ajkd.2011.05.015; Behan L, 2016, EUR RESPIR J, V47, P1103, DOI 10.1183/13993003.01551-2015; Beydon N, 2015, PEDIATR PULM, V50, P1374, DOI 10.1002/ppul.23167; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Edelbusch C, 2017, HUM MUTAT, V38, P964, DOI 10.1002/humu.23261; Fassad MR, 2018, AM J HUM GENET, V103, P984, DOI 10.1016/j.ajhg.2018.10.016; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Guimier A, 2015, NAT GENET, V47, P1260, DOI 10.1038/ng.3376; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hoben IM, 2018, AM J HUM GENET, V102, P973, DOI 10.1016/j.ajhg.2018.03.025; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Jackson CL, 2016, EUR RESPIR J, V47, P837, DOI 10.1183/13993003.00749-2015; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kollmar M, 2016, MOL BIOL EVOL, V33, P3249, DOI 10.1093/molbev/msw213; Leigh Margaret W, 2013, Ann Am Thorac Soc, V10, P574, DOI 10.1513/AnnalsATS.201305-110OC; Lin AE, 2014, AM J MED GENET A, V164, P2581, DOI 10.1002/ajmg.a.36695; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Ma LJ, 2012, CARDIOL YOUNG, V22, P194, DOI 10.1017/S1047951111001181; Marthin JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057262; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Mohapatra B, 2009, HUM MOL GENET, V18, P861, DOI 10.1093/hmg/ddn411; Morelli SH, 2001, AM J MED GENET, V101, P388, DOI 10.1002/ajmg.1221; Munye MM, 2017, AM J PHYSIOL-LUNG C, V312, pL258, DOI 10.1152/ajplung.00471.2016; NHLBI Exome Sequencing Project (ESP), EX SEQ PROJ ESP; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Oltean A, 2018, AM J RESP CELL MOL, V59, P511, DOI 10.1165/rcmb.2017-0436OC; Omran H, 2009, METHOD CELL BIOL, V91, P123, DOI 10.1016/S0091-679X(08)91007-4; Paff T, 2018, HUM MUTAT, V39, P653, DOI 10.1002/humu.23403; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Piperno G., 1982, Progress in Clinical and Biological Research, V80, P95; PORTER ME, 1994, J CELL BIOL, V126, P1495, DOI 10.1083/jcb.126.6.1495; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Vetrini F, 2016, AM J HUM GENET, V99, P886, DOI 10.1016/j.ajhg.2016.07.011; Wallmeier J, 2016, AM J HUM GENET, V99, P460, DOI 10.1016/j.ajhg.2016.06.014; Werner Claudius, 2015, Cilia, V4, P2, DOI 10.1186/s13630-014-0011-8; Wilkes DE, 2008, CELL MOTIL CYTOSKEL, V65, P342, DOI 10.1002/cm.20264; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC	53	66	67	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					995	1008		10.1016/j.ajhg.2018.10.020	http://dx.doi.org/10.1016/j.ajhg.2018.10.020			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30471718	hybrid, Green Published			2022-12-18	WOS:000452535600013
J	Cannon, ME; Mohlke, KL				Cannon, Maren E.; Mohlke, Karen L.			Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							GENOME-WIDE ASSOCIATION; CAUSAL VARIANTS; RARE VARIANTS; ALLELIC HETEROGENEITY; REGULATORY VARIANTS; GENETIC-VARIATION; FETAL-HEMOGLOBIN; MAPPING BIASES; RISK; CHROMATIN	Genome-wide association studies (GWASs) have identified thousands of loci associated with hundreds of complex diseases and traits, and progress is being made toward elucidating the causal variants and genes underlying these associations. Functional characterization of mechanisms at GWAS loci is a multi-faceted challenge. Challenges include linkage disequilibrium and allelic heterogeneity at each locus, the noncoding nature of most loci, and the time and cost needed for experimentally evaluating the potential mechanistic contributions of genes and variants. AsGWAS sample sizes increase, more loci are identified, and the complexities of individual loci emerge. Loci can consist of multiple association signals, each of which can reflect the influence of multiple variants, inseparable by association analyses. Each signal within a locus can influence the same or different target genes. Experimental studies of genes and variants can differ on the basis of cell type, cellular environment, or other context-specific variables. In this review, we describe the complexity of mechanisms at GWAS loci-including multiple signals, multiple variants, and/or multiple genes-and the implications these complexities hold for experimental study design and interpretation of GWAS mechanisms.	[Cannon, Maren E.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	mohlke@med.unc.edu			National Institutes of Health [F31 HL127984, U01 DK105561, R01 DK 093757, R01 DK072193]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL127984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK105561, R01DK093757, R01DK072193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank James Davis, Cassandra Spracklen, Chelsea Raulerson, and Kevin Currin for helpful discussion and feedback. This work was supported by National Institutes of Health grants F31 HL127984, U01 DK105561, R01 DK 093757, and R01 DK072193.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Betts JA, 2017, AM J HUM GENET, V101, P255, DOI 10.1016/j.ajhg.2017.07.007; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Buchkovich ML, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0117-x; Cannon ME, 2017, G3-GENES GENOM GENET, V7, P3217, DOI 10.1534/g3.117.300088; Castel SE, 2018, NAT GENET, V50, P1327, DOI 10.1038/s41588-018-0192-y; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Choi JY, 2017, NAT GENET, V49, P1326, DOI 10.1038/ng.3927; Civelek M, 2017, AM J HUM GENET, V100, P428, DOI 10.1016/j.ajhg.2017.01.027; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Crawford NG, 2017, SCIENCE, V358, P887, DOI 10.1126/science.aan8433; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Datta AS, 2016, BRIEF BIOINFORM, V17, P657, DOI 10.1093/bib/bbv072; Davis JP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007079; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dixit S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15183; Dobbyn A, 2018, AM J HUM GENET, V102, P1169, DOI 10.1016/j.ajhg.2018.04.011; Duan JB, 2014, AM J HUM GENET, V95, P744, DOI 10.1016/j.ajhg.2014.11.001; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Flister MJ, 2013, GENOME RES, V23, P1996, DOI 10.1101/gr.160283.113; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Gallagher MD, 2017, AM J HUM GENET, V101, P643, DOI 10.1016/j.ajhg.2017.09.004; Gamazon ER, 2018, NAT GENET, V50, P956, DOI 10.1038/s41588-018-0154-4; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gosalia N, 2017, NUCLEIC ACIDS RES, V45, P10393, DOI 10.1093/nar/gkx730; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Guo C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7069; Gupta RM, 2017, CELL, V170, P522, DOI 10.1016/j.cell.2017.06.049; Gusev A, 2018, NAT GENET, V50, P538, DOI 10.1038/s41588-018-0092-1; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Harvey CT, 2015, BIOINFORMATICS, V31, P1235, DOI 10.1093/bioinformatics/btu802; Hoffmann TJ, 2018, NAT GENET, V50, P401, DOI 10.1038/s41588-018-0064-5; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Iotchkova V, 2018, NON TRADITIONAL REF, DOI [10.1101/085738, DOI 10.1101/085738]; Jansen R, 2017, HUM MOL GENET, V26, P1444, DOI 10.1093/hmg/ddx043; Jian XQ, 2014, GENET MED, V16, P497, DOI 10.1038/gim.2013.176; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khetarpal SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002393; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumasaka N., 2017, BIORXIV, DOI [10.1101/227389, DOI 10.1101/227389]; Legare ME, 2000, GENOME RES, V10, P42; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Manor O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003396; Martin JS, 2017, BIOINFORMATICS, V33, P3793, DOI 10.1093/bioinformatics/btx359; Mondal AK, 2010, J CLIN ENDOCR METAB, V95, P1450, DOI 10.1210/jc.2009-2064; Montefiori LE, 2018, ELIFE, V7, DOI 10.7554/eLife.35788; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Mousas A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006925; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Risca VI, 2015, TRENDS GENET, V31, P357, DOI 10.1016/j.tig.2015.03.010; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roman TS, 2017, DIABETES, V66, P2521, DOI 10.2337/db17-0464; Roman TS, 2015, AM J HUM GENET, V97, P801, DOI 10.1016/j.ajhg.2015.10.016; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schmidt EM, 2015, BIOINFORMATICS, V31, P2601, DOI 10.1093/bioinformatics/btv201; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; She R, 2018, CELL, V172, P478, DOI 10.1016/j.cell.2017.12.015; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Spisak S, 2015, NAT MED, V21, P1357, DOI 10.1038/nm.3975; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Sung YJ, 2018, AM J HUM GENET, V102, P375, DOI 10.1016/j.ajhg.2018.01.015; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thibodeau SN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9653; Thomsen SK, 2016, DIABETES, V65, P3805, DOI 10.2337/db16-0361; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Veturi Y, 2018, BIOCOMPUT-PAC SYM, P228; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang YL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1519-9; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; Wen XQ, 2016, AM J HUM GENET, V98, P1114, DOI 10.1016/j.ajhg.2016.03.029; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	127	66	66	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					637	653		10.1016/j.ajhg.2018.10.001	http://dx.doi.org/10.1016/j.ajhg.2018.10.001			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30388398	Green Published, Bronze			2022-12-18	WOS:000448942100002
J	Starita, LM; Islam, MM; Banerjee, T; Adamovich, AI; Gullingsrud, J; Fields, S; Shendure, J; Parvin, JD				Starita, Lea M.; Islam, Muhtadi M.; Banerjee, Tapahsama; Adamovich, Aleksandra I.; Gullingsrud, Justin; Fields, Stanley; Shendure, Jay; Parvin, Jeffrey D.			A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIANTS; E3 LIGASE; TUMOR SUPPRESSION; CLASSIFICATION; IDENTIFICATION; BINDING	Loss-of-function pathogenic variants in BRCA1 confer a predisposition to breast and ovarian cancer. Genetic testing for sequence changes in BRCA1 frequently reveals a missense variant for which the impact on cancer risk and on the molecular function of BRCA1 is unknown. Functional BRCA1 is required for the homology-directed repair (HDR) of double-strand DNA breaks, a critical activity for maintaining genome integrity and tumor suppression. Here, we describe a multiplex HDR reporter assay for concurrently measuring the effects of hundreds of variants of BRCA1 for their role in DNA repair. Using this assay, we characterized the effects of 1,056 amino acid substitutions in the first 192 residues of BRCA1. Benchmarking these results against variants with known effects on DNA repair function or on cancer predisposition, we demonstrate accurate discrimination of loss-of-function versus benign missense variants. We anticipate that this assay can be used to functionally characterize BRCA1 missense variants at scale, even before the variants are observed in results from genetic testing.	[Starita, Lea M.; Gullingsrud, Justin; Fields, Stanley; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Starita, Lea M.; Shendure, Jay] Brotman Baty Inst Precis Med, Seattle, WA 98195 USA; [Islam, Muhtadi M.; Banerjee, Tapahsama; Adamovich, Aleksandra I.; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Fields, Stanley] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Fields, Stanley; Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Parvin, Jeffrey D.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA	University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Brotman Baty Inst Precis Med, Seattle, WA 98195 USA.; Parvin, JD (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.; Parvin, JD (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA.	shendure@u.washinton.edu; jeffrey.parvin@osumc.edu	Banerjee, Tapahsama/GNP-2785-2022; Shendure, Jay/AAU-3684-2021; Parvin, Jeffrey D/C-8955-2009	Banerjee, Tapahsama/0000-0002-4358-7740; 	National Institutes of Health [P41GM103533, DP1HG007811-05]; Basser Center for BRCA (Basser BRCA1 Innovation Award); Pelotonia cancer training fellowship; Brotman Baty Institute for Precision Medicine; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basser Center for BRCA (Basser BRCA1 Innovation Award); Pelotonia cancer training fellowship; Brotman Baty Institute for Precision Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jason Underwood and Katy Munson of the University of Washington PacBio Sequencing Services for their assistance with long-read sequencing, Ronald Hause and Alan Rubin for their helpful suggestions regarding statistical methods, Martin Kircher for his help with the analysis of long read sequences, Ethan Ahler for his assistance with figures, and the Ohio State University Comprehensive Cancer Center Analytical Cytometry Shared Resource for the sorting of GFP<SUP>+</SUP> thorn cells. This work was supported by National Institutes of Health grants to S.F. (Biomedical Technology Research Resource project P41GM103533) and J.S. (Director's Pioneer Award DP1HG007811-05) and by the Basser Center for BRCA (Basser BRCA1 Innovation Award to J.D.P.). S.F. and J.S. are investigators of the Howard Hughes Medical Institute. M.M.I. was supported by a Pelotonia cancer training fellowship. This study was funded in part by the Brotman Baty Institute for Precision Medicine.	Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Couch FJ, 2017, JAMA ONCOL, V3, P1190, DOI 10.1001/jamaoncol.2017.0424; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Harrison SM, 2017, GENET MED, V19, P1096, DOI 10.1038/gim.2017.14; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Kitzman JO, 2015, NAT METHODS, V12, P203, DOI [10.1038/NMETH.3223, 10.1038/nmeth.3223]; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee C, 2015, HUM MUTAT, V36, P1205, DOI 10.1002/humu.22902; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10086; Majithia AR, 2016, NAT GENET, V48, P1570, DOI 10.1038/ng.3700; Matreyek KA, 2018, NAT GENET, V50, P874, DOI 10.1038/s41588-018-0122-z; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Murray ML, 2011, GENET MED, V13, P998, DOI 10.1097/GIM.0b013e318226fc15; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Sweet K, 2010, BREAST CANCER RES TR, V119, P737, DOI 10.1007/s10549-009-0438-6; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Welsh JL, 2017, ANN SURG ONCOL, V24, P3067, DOI 10.1245/s10434-017-5959-3; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304	34	66	66	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					498	508		10.1016/j.ajhg.2018.07.016	http://dx.doi.org/10.1016/j.ajhg.2018.07.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30219179	Green Published, Bronze			2022-12-18	WOS:000446312200004
J	Sung, YJ; Winkler, TW; de Las Fuentes, L; Bentley, AR; Brown, MR; Kraja, AT; Schwander, K; Ntalla, I; Guo, XQ; Franceschini, N; Lu, YC; Cheng, CY; Sim, XL; Vojinovic, D; Marten, J; Musani, SK; Li, CW; Feitosa, MF; Kilpelainen, TO; Richard, MA; Noordam, R; Aslibekyan, S; Aschard, H; Bartz, TM; Dorajoo, R; Liu, YM; Manning, AK; Rankinen, T; Smith, AV; Tajuddin, SM; Tayo, BO; Warren, HR; Zhao, W; Zhou, YH; Matoba, N; Sofer, T; Alver, M; Amini, M; Boissel, M; Chai, JF; Chen, X; Divers, J; Gandin, I; Gao, C; Giulianini, F; Goel, A; Harris, SE; Hartwig, FP; Horimoto, ARVR; Hsu, FC; Jackson, AU; Kahonen, M; Kasturiratne, A; Kuhnel, B; Leander, K; Lee, WJ; Lin, KH; Luan, JA; McKenzie, CA; He, MA; Nelson, CP; Rauramaa, R; Schupf, N; Scott, RA; Sheu, WHH; Stancakova, A; Takeuchi, F; van der Most, PJ; Varga, TV; Wang, HM; Wang, YJ; Ware, EB; Weiss, S; Wen, WQ; Yanek, LR; Zhang, WH; Zhao, JH; Afaq, S; Alfred, T; Amin, N; Arking, D; Aung, T; Barr, RG; Bielak, LF; Boerwinkle, E; Bottinger, EP; Braund, PS; Brody, JA; Broeckel, U; Cabrera, CP; Cade, B; Yu, CZ; Campbell, A; Canouil, M; Chakravarti, A; Chauhan, G; Christensen, K; Cocca, M; Collins, FS; Connell, JM; de Mutsert, R; de Silva, HJ; Debette, S; Dorr, M; Duan, Q; Eaton, CB; Ehret, G; Evangelou, E; Faul, JD; Fisher, VA; Forouhi, NG; Franco, OH; Friedlander, Y; Gao, H; Gigante, B; Graff, M; Gu, CC; Gu, DF; Gupta, P; Hagenaars, SP; Harris, TB; He, J; Heikkinen, S; Heng, CK; Hirata, M; Hofman, A; Howard, BV; Hunt, S; Irvin, MR; Jia, YC; Joehanes, R; Justice, AE; Katsuya, T; Kaufman, J; Kerrison, ND; Khor, CC; Koh, WP; Koistinen, HA; Komulainen, P; Kooperberg, C; Krieger, JE; Kubo, M; Kuusisto, J; Langefeld, CD; Langenberg, C; Launer, LJ; Lehne, B; Lewis, CE; Li, YZ; Lim, SH; Lin, S; Liu, CT; Liu, JJ; Liu, JM; Liu, K; Liu, YH; Loh, M; Lohman, KK; Long, JR; Louie, T; Magi, R; Mahajan, A; Meitinger, T; Metspalu, A; Milani, L; Momozawa, Y; Morris, AP; Mosley, TH; Munson, P; Murray, AD; Nalls, MA; Nasri, U; Norris, JM; North, K; Ogunniyi, A; Padmanabhan, S; Palmas, WR; Palmer, ND; Pankow, JS; Pedersen, NL; Peters, A; Peyser, PA; Polasek, O; Raitakari, OT; Renstrom, F; Rice, TK; Ridker, PM; Robino, A; Robinson, JG; Rose, LM; Rudan, I; Sabanayagam, C; Salako, BL; Sandow, K; Schmidt, CO; Schreiner, PJ; Scott, WR; Seshadri, S; Sever, P; Sitlani, CM; Smith, JA; Snieder, H; Starr, JM; Strauch, K; Tang, H; Taylor, KD; Teo, YY; Tham, YC; Ultterlinden, AG; Waldenberger, M; Wang, LH; Wang, YX; Bin Wei, W; Williams, C; Wilson, G; Wojczynski, MK; Yao, J; Yuan, JM; Zonderman, AB; Becker, DM; Boehnke, M; Bowden, DW; Chambers, JC; Chen, YDI; de Faire, U; Deary, IJ; Esko, T; Farrall, M; Forrester, T; Franks, PW; Freedman, BI; Froguel, P; Gasparini, P; Gieger, C; Horta, BL; Hung, YJ; Jonas, JB; Kato, N; Kooner, JS; Laakso, M; Lehtimaki, T; Liang, KW; Magnusson, PKE; Newman, AB; Oldehinkel, AJ; Pereira, AC; Redline, S; Rettig, R; Samani, NJ; Scott, J; Shu, XO; van der Harst, P; Wagenknecht, LE; Wareham, NJ; Watkins, H; Weir, DR; Wickremasinghe, AR; Wu, TC; Zheng, W; Kamatani, Y; Laurie, CC; Bouchard, C; Cooper, RS; Evans, MK; Gudnason, V; Kardia, SLR; Kritchevsky, SB; Levy, D; O'Connell, JR; Psaty, BM; van Dam, RM; Sims, M; Arnett, DK; Mook-Kanamori, DO; Kelly, TN; Fox, ER; Hayward, C; Fornage, M; Rotimi, CN; Province, MA; van Duijn, CM; Tai, ES; Wong, TY; Loos, RJF; Reiner, AP; Rotter, JI; Zhu, XF; Bierut, LJ; Gauderman, WJ; Caulfield, MJ; Elliott, P; Rice, K; Munroe, PB; Morrison, AC; Cupples, LA; Rao, DC; Chasman, DI				Sung, Yun J.; Winkler, Thomas W.; de las Fuentes, Lisa; Bentley, Amy R.; Brown, Michael R.; Kraja, Aldi T.; Schwander, Karen; Ntalla, Ioanna; Guo, Xiuqing; Franceschini, Nora; Lu, Yingchang; Cheng, Ching-Yu; Sim, Xueling; Vojinovic, Dina; Marten, Jonathan; Musani, Solomon K.; Li, Changwei; Feitosa, Mary F.; Kilpelainen, Tuomas O.; Richard, Melissa A.; Noordam, Raymond; Aslibekyan, Stella; Aschard, Hugues; Bartz, Traci M.; Dorajoo, Rajkumar; Liu, Yongmei; Manning, Alisa K.; Rankinen, Tuomo; Smith, Albert Vernon; Tajuddin, Salman M.; Tayo, Bamidele O.; Warren, Helen R.; Zhao, Wei; Zhou, Yanhua; Matoba, Nana; Sofer, Tamar; Alver, Maris; Amini, Marzyeh; Boissel, Mathilde; Chai, Jin Fang; Chen, Xu; Divers, Jasmin; Gandin, Ilaria; Gao, Chuan; Giulianini, Franco; Goel, Anuj; Harris, Sarah E.; Hartwig, Fernando Pires; Horimoto, Andrea R. V. R.; Hsu, Fang-Chi; Jackson, Anne U.; Kahonen, Mika; Kasturiratne, Anuradhani; Kuhnel, Brigitte; Leander, Karin; Lee, Wen-Jane; Lin, Keng-Hung; Luan, Jian' An; McKenzie, Colin A.; He Meian; Nelson, Christopher P.; Rauramaa, Rainer; Schupf, Nicole; Scott, Robert A.; Sheu, Wayne H. H.; Stancakova, Alena; Takeuchi, Fumihiko; van der Most, Peter J.; Varga, Tibor V.; Wang, Heming; Wang, Yajuan; Ware, Erin B.; Weiss, Stefan; Wen, Wanqing; Yanek, Lisa R.; Zhang, Weihua; Zhao, Jing Hua; Afaq, Saima; Alfred, Tamuno; Amin, Najaf; Arking, Dan; Aung, Tin; Barr, R. Graham; Bielak, Lawrence F.; Boerwinkle, Eric; Bottinger, Erwin P.; Braund, Peter S.; Brody, Jennifer A.; Broeckel, Ulrich; Cabrera, Claudia P.; Cade, Brian; Yu Caizheng; Campbell, Archie; Canouil, Mickael; Chakravarti, Aravinda; Chauhan, Ganesh; Christensen, Kaare; Cocca, Massimiliano; Collins, Francis S.; Connell, John M.; de Mutsert, Renee; de Silva, H. Janaka; Debette, Stephanie; Dorr, Marcus; Duan, Qing; Eaton, Charles B.; Ehret, Georg; Evangelou, Evangelos; Faul, Jessica D.; Fisher, Virginia A.; Forouhi, Nita G.; Franco, Oscar H.; Friedlander, Yechiel; Gao, He; Gigante, Bruna; Graff, Misa; Gu, C. Charles; Gu, Dongfeng; Gupta, Preeti; Hagenaars, Saskia P.; Harris, Tamara B.; He, Jiang; Heikkinen, Sami; Heng, Chew-Kiat; Hirata, Makoto; Hofman, Albert; Howard, Barbara V.; Hunt, Steven; Irvin, Marguerite R.; Jia, Yucheng; Joehanes, Roby; Justice, Anne E.; Katsuya, Tomohiro; Kaufman, Joel; Kerrison, Nicola D.; Khor, Chiea Chuen; Koh, Woon-Puay; Koistinen, Heikki A.; Komulainen, Pirjo; Kooperberg, Charles; Krieger, Jose E.; Kubo, Michiaki; Kuusisto, Johanna; Langefeld, Carl D.; Langenberg, Claudia; Launer, Lenore J.; Lehne, Benjamin; Lewis, Cora E.; Li, Yize; Lim, Sing Hui; Lin, Shiow; Liu, Ching-Ti; Liu, Jianjun; Liu, Jingmin; Liu, Kiang; Liu, Yeheng; Loh, Marie; Lohman, Kurt K.; Long, Jirong; Louie, Tin; Magi, Reedik; Mahajan, Anubha; Meitinger, Thomas; Metspalu, Andres; Milani, Lili; Momozawa, Yukihide; Morris, Andrew P.; Mosley, Thomas H., Jr.; Munson, Peter; Murray, Alison D.; Nalls, Mike A.; Nasri, Ubaydah; Norris, Jill M.; North, Kari; Ogunniyi, Adesola; Padmanabhan, Sandosh; Palmas, Walter R.; Palmer, Nicholette D.; Pankow, James S.; Pedersen, Nancy L.; Peters, Annette; Peyser, Patricia A.; Polasek, Ozren; Raitakari, Olli T.; Renstrom, Frida; Rice, Treva K.; Ridker, Paul M.; Robino, Antonietta; Robinson, Jennifer G.; Rose, Lynda M.; Rudan, Igor; Sabanayagam, Charumathi; Salako, Babatunde L.; Sandow, Kevin; Schmidt, Carsten O.; Schreiner, Pamela J.; Scott, William R.; Seshadri, Sudha; Sever, Peter; Sitlani, Colleen M.; Smith, Jennifer A.; Snieder, Harold; Starr, John M.; Strauch, Konstantin; Tang, Hua; Taylor, Kent D.; Teo, Yik Ying; Tham, Yih Chung; Ultterlinden, Andre G.; Waldenberger, Melanie; Wang, Lihua; Wang, Ya X.; Bin Wei, Wen; Williams, Christine; Wilson, Gregory; Wojczynski, Mary K.; Yao, Jie; Yuan, Jian-Min; Zonderman, Alan B.; Becker, Diane M.; Boehnke, Michael; Bowden, Donald W.; Chambers, John C.; Chen, Yii-Der Ida; de Faire, Ulf; Deary, Ian J.; Esko, Tonu; Farrall, Martin; Forrester, Terrence; Franks, Paul W.; Freedman, Barry I.; Froguel, Philippe; Gasparini, Paolo; Gieger, Christian; Horta, Bernardo Lessa; Hung, Yi-Jen; Jonas, Jost B.; Kato, Norihiro; Kooner, Jaspal S.; Laakso, Markku; Lehtimaki, Terho; Liang, Kae-Woei; Magnusson, Patrik K. E.; Newman, Anne B.; Oldehinkel, Albertine J.; Pereira, Alexandre C.; Redline, Susan; Rettig, Rainer; Samani, Nilesh J.; Scott, James; Shu, Xiao-Ou; van der Harst, Pim; Wagenknecht, Lynne E.; Wareham, Nicholas J.; Watkins, Hugh; Weir, David R.; Wickremasinghe, Ananda R.; Wu, Tangchun; Zheng, Wei; Kamatani, Yoichiro; Laurie, Cathy C.; Bouchard, Claude; Cooper, Richard S.; Evans, Michele K.; Gudnason, Vilmundur; Kardia, Sharon L. R.; Kritchevsky, Stephen B.; Levy, Daniel; O'Connell, Jeff R.; Psaty, Bruce M.; van Dam, Rob M.; Sims, Mario; Arnett, Donna K.; Mook-Kanamori, Dennis O.; Kelly, Tanika N.; Fox, Ervin R.; Hayward, Caroline; Fornage, Myriam; Rotimi, Charles N.; Province, Michael A.; van Duijn, Cornelia M.; Tai, E. Shyong; Wong, Tien Yin; Loos, Ruth J. F.; Reiner, Alex P.; Rotter, Jerome I.; Zhu, Xiaofeng; Bierut, Laura J.; Gauderman, W. James; Caulfield, Mark J.; Elliott, Paul; Rice, Kenneth; Munroe, Patricia B.; Morrison, Alanna C.; Cupples, L. Adrienne; Rao, Dabeeru C.; Chasman, Daniel I.		CHARGE NeurologyWorking Grp; COGENT-Kidney Consortium; Giant Consortium; Lifelines Cohort Study	A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-ENVIRONMENT INTERACTION; INTIMA-MEDIA THICKNESS; FALSE DISCOVERY RATE; BODY-MASS INDEX; ASSOCIATION ANALYSIS; COMMON VARIANTS; METAANALYSIS; DISEASE; OBESITY; JOINT	Genome-wide association analysis advanced understanding of blood pressure (BP), a major risk factor for vascular conditions such as coronary heart disease and stroke. Accounting for smoking behavior may help identify BP loci and extend our knowledge of its genetic architecture. We performed genome-wide association meta-analyses of systolic and diastolic BP incorporating gene-smoking interactions in 610,091 individuals. Stage 1 analysis examined similar to 18.8 million SNPs and small insertion/deletion variants in 129,913 individuals from four ancestries (European, African, Asian, and Hispanic) with follow-up analysis of promising variants in 480,178 additional individuals from five ancestries. We identified 15 loci that were genome-wide significant (p < 5 x 10(-8)) in stage 1 and formally replicated in stage 2. A combined stage 1 and 2 meta-analysis identified 66 additional genome-wide significant loci (13, 35, and 18 loci in European, African, and trans-ancestry, respectively). A total of 56 known BP loci were also identified by our results (p < 5 x 10(-8)). Of the newly identified loci, ten showed significant interaction with smoking status, but none of them were replicated in stage 2. Several loci were identified in African ancestry, highlighting the importance of genetic studies in diverse populations. The identified loci show strong evidence for regulatory features and support shared pathophysiology with cardiometabolic and addiction traits. They also highlight a role in BP regulation for biological candidates such as modulators of vascular structure and function (CDKN1B, BCAR1-CFDP1, PXDN, EEA1), ciliopathies (SDCCAG8, RPGRIP1L), telomere maintenance (TNKS, PINX1, AKTIP), and central dopaminergic signaling MSRA, EBF2).	[Sung, Yun J.; Schwander, Karen; Gu, C. Charles; Li, Yize; Rice, Treva K.; Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Winkler, Thomas W.] Univ Regensburg, Dept Genet Epidemiol, D-93051 Regensburg, Germany; [de las Fuentes, Lisa] Washington Univ, Cardiovasc Div, Dept Med, St Louis, MO 63110 USA; [Bentley, Amy R.; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Brown, Michael R.; Morrison, Alanna C.] Univ Texas Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Kraja, Aldi T.; Feitosa, Mary F.; Lin, Shiow; Wang, Lihua; Williams, Christine; Wojczynski, Mary K.; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, Dept Genet, St Louis, MO 63108 USA; [Ntalla, Ioanna; Warren, Helen R.; Cabrera, Claudia P.; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Clin Pharmacol, London EC1M 6BQ, England; [Guo, Xiuqing; Jia, Yucheng; Liu, Yeheng; Nasri, Ubaydah; Sandow, Kevin; Taylor, Kent D.; Yao, Jie; Chen, Yii-Der Ida; Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Dept Pediat, Genom Outcomes, Torrance, CA 90502 USA; [Franceschini, Nora; Graff, Misa; Justice, Anne E.; North, Kari] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Lu, Yingchang; Alfred, Tamuno; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Cheng, Ching-Yu; Aung, Tin; Gupta, Preeti; Lim, Sing Hui; Sabanayagam, Charumathi; Tham, Yih Chung; Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 169856, Singapore; [Cheng, Ching-Yu; Aung, Tin; Sabanayagam, Charumathi; Wong, Tien Yin] Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program Eye ACP, Singapore 169857, Singapore; [Cheng, Ching-Yu; Aung, Tin; Wong, Tien Yin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117597, Singapore; [Sim, Xueling; Liu, Jianjun; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Sim, Xueling; Liu, Jianjun; Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Singapore 117549, Singapore; [Vojinovic, Dina; Amin, Najaf; Franco, Oscar H.; Hofman, Albert; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol, Med Ctr, Rotterdam, Netherlands; [Marten, Jonathan; Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Musani, Solomon K.; Sims, Mario] Univ Mississippi, Med Ctr, Dept Med, Jackson Heart Study, Jackson, MS 39213 USA; [Li, Changwei] Univ Giorgia, Athens Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Kilpelainen, Tuomas O.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2100 Copenhagen, Denmark; [Kilpelainen, Tuomas O.] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Richard, Melissa A.; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Noordam, Raymond] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, NL-2300 RC Leiden, Netherlands; [Aslibekyan, Stella; Irvin, Marguerite R.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Aschard, Hugues] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Aschard, Hugues] Inst Pasteur, Ctr Bioinformat Biostat & Biol Integrat C3BI, F-75015 Paris, France; [Bartz, Traci M.] Univ Washington, Biostat & Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Dorajoo, Rajkumar; Khor, Chiea Chuen; Liu, Jianjun; Teo, Yik Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Liu, Yongmei; Divers, Jasmin; Hsu, Fang-Chi; Langefeld, Carl D.; Lohman, Kurt K.] Wake Forest Sch Med, Dept Publ Hlth Sci, Div Biostat Sci, Winston Salem, NC 27157 USA; [Manning, Alisa K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Manning, Alisa K.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Rankinen, Tuomo; Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Tajuddin, Salman M.; Evans, Michele K.] NIA, Hlth Dispar Res Sect, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Warren, Helen R.; Cabrera, Claudia P.; Caulfield, Mark J.] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Zhao, Wei; Ware, Erin B.; Bielak, Lawrence F.; Peyser, Patricia A.; Smith, Jennifer A.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Zhou, Yanhua; Fisher, Virginia A.; Liu, Ching-Ti; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Matoba, Nana; Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Sofer, Tamar; Louie, Tin; Laurie, Cathy C.; Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98105 USA; [Alver, Maris; Magi, Reedik; Metspalu, Andres; Milani, Lili; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Amini, Marzyeh; van der Most, Peter J.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 Groningen, Netherlands; [Boissel, Mathilde; Canouil, Mickael; Froguel, Philippe] Univ Lille, Inst Pasteur Lille, European Genom Inst Diabet EGID, CNRS,UMR 8199, F-59000 Lille, France; [Chai, Jin Fang; Koh, Woon-Puay; van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Chen, Xu; Pedersen, Nancy L.; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Gandin, Ilaria; Cocca, Massimiliano; Gasparini, Paolo] Univ Trieste, Dept Med Sci, I-34137 Trieste, Italy; [Gao, Chuan] Wake Forest Sch Med, Dept Mol Genet, Winston Salem, NC 27157 USA; [Gao, Chuan] Wake Forest Sch Med, Genom Program, Winston Salem, NC 27157 USA; [Giulianini, Franco; Ridker, Paul M.; Rose, Lynda M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, Oxon, England; [Goel, Anuj; Mahajan, Anubha; Morris, Andrew P.; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Ctr Human Genet, Oxford OX3 7BN, England; [Harris, Sarah E.; Hagenaars, Saskia P.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Harris, Sarah E.] Univ Edinburgh, MRC, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hartwig, Fernando Pires; Horta, Bernardo Lessa] Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96020220 Pelotas, RS, Brazil; [Horimoto, Andrea R. V. R.; Krieger, Jose E.; Pereira, Alexandre C.] Univ Sao Paulo, Inst Heart, Dept Cardiol, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Kahonen, Mika] Univ Tampere, Fac Med & Life Sci, Dept Clin Physiol, Tampere 33014, Finland; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kasturiratne, Anuradhani; Wickremasinghe, Ananda R.] Univ Kelaniya, Dept Publ Hlth, Ragama, Sri Lanka; [Kuhnel, Brigitte; Waldenberger, Melanie; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Kuhnel, Brigitte; Peters, Annette; Waldenberger, Melanie] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Leander, Karin; Gigante, Bruna; de Faire, Ulf; Giant Consortium] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Lee, Wen-Jane] Tunghai Univ, Dept Social Work, Taichung Vet Gen Hosp, Dept Med Res, Taichung 40705, Taiwan; [Lin, Keng-Hung] Taichung Vet Gen Hosp, Dept Opthalmol, Taichung 40705, Taiwan; [Luan, Jian' An; Scott, Robert A.; Zhao, Jing Hua; Forouhi, Nita G.; Kerrison, Nicola D.; Langenberg, Claudia; Wareham, Nicholas J.] Univ Cambridge, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England; [McKenzie, Colin A.; Forrester, Terrence] Univ West Indies, Res Inst Trop Med, Trop Metab Res Unit, JMAAW15, Mona, Jamaica; [He Meian; Yu Caizheng; Wu, Tangchun] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, Sch Publ Hlth, Wuhan, Hubei, Peoples R China; [He Meian; Yu Caizheng; Wu, Tangchun] Huazhong Univ Sci & Technol, State Key Lab Environm Hlth Incubating, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Nelson, Christopher P.; Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Nelson, Christopher P.; Braund, Peter S.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Rauramaa, Rainer; Komulainen, Pirjo] Kuopio Res Inst Exercise Med, Fdn Res Hlth Exercise & Nutr, Kuopio 70100, Finland; [Schupf, Nicole] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, Taub Inst Res Alzheimer Dis Aging Brain, New York, NY 10032 USA; [Sheu, Wayne H. H.] Taichung Vet Gen Hosp, Dept Internal Med, Endocrinol & Metab, Taichung 40705, Taiwan; [Sheu, Wayne H. H.; Liang, Kae-Woei] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Sheu, Wayne H. H.] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Sheu, Wayne H. H.] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40705, Taiwan; [Stancakova, Alena] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio 70210, Finland; [Takeuchi, Fumihiko; Kato, Norihiro] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo 1628655, Japan; [Varga, Tibor V.; Renstrom, Frida; Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, S-20502 Malmo, Skane, Sweden; [Wang, Heming; Wang, Yajuan; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Ware, Erin B.] Univ Michigan, Inst Social Res, Res Ctr Grp Dynam, Ann Arbor, MI 48104 USA; [Weiss, Stefan] Univ Med, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Weiss, Stefan] Ernst Moritz Arndt Univ Greifswald, D-17487 Greifswald, Germany; [Weiss, Stefan; Dorr, Marcus; Schmidt, Carsten O.; Rettig, Rainer] DZHK German Cen ter Cardiovasc Res, Partner Site Greifswald, D-17475 Greifswald, Germany; [Wen, Wanqing; Long, Jirong; Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37203 USA; [Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Univ, Dept Med, GeneSTAR Res Program, Gen Internal Med,Sch Med, Baltimore, MD 21287 USA; [Zhang, Weihua; Afaq, Saima; Evangelou, Evangelos; Gao, He; Lehne, Benjamin; Loh, Marie; Scott, William R.; Chambers, John C.; Elliott, Paul] Imperial Coll London, Dept Epidemiol & Biostat, London W2 1PG, England; [Zhang, Weihua; Chambers, John C.; Kooner, Jaspal S.] Ealing Gen Hosp, Dept Cardiol, Ealing UB1 3HW, Middx, England; [Arking, Dan] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10032 USA; [Boerwinkle, Eric] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Brody, Jennifer A.; Sitlani, Colleen M.] Univ Washington, Cardiovasc Hlth Res Unit, Med, Seattle, WA 98101 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Pediat Med & Physiol, Sect Genom Pediat, Milwaukee, WI 53226 USA; [Cade, Brian; Redline, Susan] Brigham & Womens Hosp, Sleep Med & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Campbell, Archie] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Chakravarti, Aravinda; Ehret, Georg] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Chauhan, Ganesh; CHARGE NeurologyWorking Grp] Indian Inst Schience, Ctr Brain Res, Bangalore 560012, Karnataka, India; [Christensen, Kaare] Univ Southern Denmark, Inst Publ Hlth, Danish Aging Res Ctr, Odense, Denmark; [Collins, Francis S.; COGENT-Kidney Consortium] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [de Mutsert, Renee; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; [de Silva, H. Janaka] Univ Kelaniya, Dept Med, Ragama, Sri Lanka; [Debette, Stephanie] Univ Bordeaux, Neuroepidemiol, U1219, INSERM, Bordeaux, France; [Debette, Stephanie] Univ Hosp, Dept Neurol, Bordeaux, France; [Debette, Stephanie] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dorr, Marcus] Univ Med Greifswald, Dept Internal Med B, D-17475 Greifswald, Germany; [Duan, Qing] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Eaton, Charles B.] Brown Univ, Alpert Med Sch, Dept Family Med & Epidemiol, Providence, RI 02860 USA; [Ehret, Georg] Geneva Univ Hosp, Dept Med Specialties, Div Cardiol, CH-1211 Geneva, Switzerland; [Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Survey Res Ctr, Inst Social Res, Ann Arbor, MI 48104 USA; [Friedlander, Yechiel] Hebrew Univ Jerusalem, Hadassah Med Ctr, Braun Sch Publ Hlth, IL-91120 Jerusalem, Israel; [Gao, He; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Gu, Dongfeng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Epidemiol,State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing, Peoples R China; [Hagenaars, Saskia P.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD USA; [He, Jiang; Kelly, Tanika N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Heikkinen, Sami] Univ Eastern Finland, Inst Biomed, Kuopio 70211, Finland; [Heng, Chew-Kiat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Heng, Chew-Kiat] Khoo Teck Puat Natl Univ, Natl Univ Hlth Syst, Childrens Med Inst, Singapore 119228, Singapore; [Hirata, Makoto] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Technol,Minato Ku, Tokyo 1088639, Japan; [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD 20782 USA; [Howard, Barbara V.] Georgetown Howard Univ, Ctr Clin & Translat Sci, Washington, DC 20057 USA; [Howard, Barbara V.] Georgetown Howard Univ, Dept Med, Washington, DC 20057 USA; [Hunt, Steven] Univ Utah, Dept Internal Med, Cardiovasc Genet, Salt Lake City, UT 84108 USA; [Hunt, Steven] Weill Cornell Med Qatar, Doha, Qatar; [Joehanes, Roby] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Hebrew SeniorLife, Boston, MA 02131 USA; [Joehanes, Roby; Seshadri, Sudha; Levy, Daniel; Cupples, L. Adrienne] NHLBI, Framingham Heart Study, NIH, Bethesda, MD 20982 USA; [Katsuya, Tomohiro] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Suita, Osaka 5650871, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Geriatr & Gen Med, Suita, Osaka 5650871, Japan; [Kaufman, Joel] Univ Washington, Dept Occupat & Environm Med Program, Epidemiol, Seattle, WA 98105 USA; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Biochem, Singapore 117596, Singapore; [Koh, Woon-Puay; Tai, E. Shyong] Duke NUS Med Sch, Singapore 169857, Singapore; [Koistinen, Heikki A.] Natl Inst Hlth & Welf, Dept Hlth, Helsinki 00271, Finland; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Helsinki 00029, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr, Endocrinol, Helsinki 00029, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland; [Kooperberg, Charles; Reiner, Alex P.] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Publ Hlth, Seattle, WA 98109 USA; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Inst Clin Med Internal Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio 70210, Finland; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35205 USA; [Lifelines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, Lifelines Cohort Study, NL-9700 RB Groningen, Netherlands; [Liu, Jingmin] Fred Hutchinson Canc Res Ctr, WHI CCC, Seattle, WA 98115 USA; [Liu, Kiang] Northwestern Univ, Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Loh, Marie] Agcy Sci Technol & Res, Translat Lab Genet Med, Singapore 138648, Singapore; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80333 Munich, Germany; [Momozawa, Yukihide] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3GL, Merseyside, England; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Med, Geriatr, Jackson, MS 39216 USA; [Munson, Peter] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Murray, Alison D.] Univ Aberdeen, Inst Med Sci, Aberdeen Biomed Imaging Ctr, Aberdeen AB25 2ZD, Scotland; [Nalls, Mike A.] Data Tecn Int, Glen Echo, MD 20812 USA; [Nalls, Mike A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Norris, Jill M.] Colorado Sch Publ, Dept Epidemiol Hlth, Aurora, CO 80045 USA; [Ogunniyi, Adesola; Salako, Babatunde L.] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Palmas, Walter R.] Columbia Univ, Dept Med, Internal Med, New York, NY 10032 USA; [Palmer, Nicholette D.; Bowden, Donald W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Pankow, James S.; Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Peters, Annette] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-85764 Neuherberg, Germany; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20521, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20520, Finland; [Renstrom, Frida] Umea Univ, Dept Biobank Res, S-90187 Umea, Sweden; [Robino, Antonietta] IRCCS Burlo, Med Genet, I-34137 Garofolo, Italy; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol & Med, Iowa City, IA 52242 USA; [Rudan, Igor] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9AG, Midlothian, Scotland; [Schmidt, Carsten O.] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Scott, William R.; Kooner, Jaspal S.; Scott, James] Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Sever, Peter] Imperial Coll London, Int Ctr Circulatory Hlth, London W2 1PG, England; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Fac Med, IBE, Chair Genet Epidemiol, D-81377 Munich, Germany; [Tang, Hua] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Teo, Yik Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Teo, Yik Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 176, Singapore; [Ultterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Wang, Ya X.] Capital Med Univ, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol, Beijing 100730, Peoples R China; [Bin Wei, Wen; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China; [Wilson, Gregory] Jackson State Univ, Dept Publ Hlth, Jackson Heart Study, Jackson, MS 39213 USA; [Yuan, Jian-Min; Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA 15232 USA; [Zonderman, Alan B.] NIA, Lab Epidemiol & Populat Sci, Behav Epidemiol Sect, NIH, Baltimore, MD 21224 USA; [Esko, Tonu] MIT, Broad Inst, Boston, MA 02142 USA; [Esko, Tonu] Harvard Univ, Boston, MA 02142 USA; [Franks, Paul W.] Harvard Univ, Dept Nutr, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Vasterbotten, Sweden; [Freedman, Barry I.] Wake Forest Sch Med, Dept Internal Med, Div Nephrol, Winston Salem, NC 27157 USA; [Froguel, Philippe] Imperial Coll London, Dept Genom Common Dis, London W12 0NN, England; [Gasparini, Paolo] Sidra, Div Expt Genet, Doha 26999, Qatar; [Gieger, Christian] German Ctr Diabet Res DZD eV, D-85764 Neuherberg, Germany; [Hung, Yi-Jen] Natl Def Med Ctr, Triserv Gen Hosp, Endocrinol & Metab, Taipei 11490, Taiwan; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-68167 Mannheim, Germany; [Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Lehtimaki, Terho] Univ Tampere, Fac Med & Lifes Sci, Finnish Cardiovasc Res Ctr Tampere, Dept Clin Chem, Tampere 33014, Finland; [Liang, Kae-Woei] Taichung Vet Gen Hosp, Cardiovasc Ctr, Taichung 40705, Taiwan; [Liang, Kae-Woei] China Med Univ, Dept Med, Taichung 40705, Taiwan; [Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Pereira, Alexandre C.] Harvard Med Sch, Genet, Boston, MA 02115 USA; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, D-17495 Greifswald, Germany; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Kritchevsky, Stephen B.] Wake Forest Sch Med, Dept Internal Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Winston Salem, NC 27157 USA; [Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [O'Connell, Jeff R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [O'Connell, Jeff R.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Psaty, Bruce M.] Univ Washington, Epidemiol Med & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA 98101 USA; [van Dam, Rob M.; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore; [Arnett, Donna K.] Univ Kentucky, Coll Publ, Deans Off, Lexington, KY 40536 USA; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, NL-2300 RC Leiden, Netherlands; [Fox, Ervin R.] Univ Mississippi, Med Ctr, Dept Med, Cardiol, Jackson, MS 39216 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Dept Med, Genom Outcomes, Torrance, CA 90502 USA; [Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Gauderman, W. James] Univ Southern Calif, Prevent Med, Div Biostat, Los Angeles, CA 90032 USA; [Munroe, Patricia B.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London EC1M 6BQ, England	Washington University (WUSTL); University of Regensburg; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Washington University (WUSTL); University of London; Queen Mary University London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; University of Mississippi; University of Mississippi Medical Center; Novo Nordisk Foundation; University of Copenhagen; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Health Science Center Houston; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard T.H. Chan School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Washington; University of Washington Seattle; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Wake Forest University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Loyola University Chicago; University of London; Queen Mary University London; University of Michigan System; University of Michigan; Boston University; RIKEN; University of Washington; University of Washington Seattle; University of Tartu; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; National University of Singapore; Karolinska Institutet; University of Trieste; Wake Forest University; Wake Forest University; Harvard University; Brigham & Women's Hospital; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Edinburgh; University of Edinburgh; Universidade Federal de Pelotas; Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tampere University; Tampere University; Tampere University Hospital; University Kelaniya; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet; Taichung Veterans General Hospital; Tunghai University; Taichung Veterans General Hospital; University of Cambridge; University West Indies Mona Jamaica; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Columbia University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; National Chung Hsing University; University of Eastern Finland; National Center for Global Health & Medicine - Japan; Lund University; Case Western Reserve University; University of Michigan System; University of Michigan; Ernst Moritz Arndt Universitat Greifswald; German Centre for Cardiovascular Research; Vanderbilt University; Johns Hopkins University; Imperial College London; Johns Hopkins University; Columbia University; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; Medical College of Wisconsin; Harvard University; Brigham & Women's Hospital; University of Edinburgh; Johns Hopkins University; Indian Institute of Science (IISC) - Bangalore; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Dundee; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University Kelaniya; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Boston University; Greifswald Medical School; University of North Carolina; University of North Carolina Chapel Hill; Brown University; University of Geneva; University of Ioannina; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; Hadassah University Medical Center; Imperial College London; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tulane University; Tulane University; University of Eastern Finland; National University of Singapore; National University of Singapore; University of Tokyo; MedStar Health Research Institute; Utah System of Higher Education; University of Utah; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew SeniorLife; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Osaka University; Osaka University; University of Washington; University of Washington Seattle; National University of Singapore; National University of Singapore; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; RIKEN; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Alabama System; University of Alabama Birmingham; University of Groningen; Fred Hutchinson Cancer Center; Northwestern University; Feinberg School of Medicine; Agency for Science Technology & Research (A*STAR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; RIKEN; University of Liverpool; University of Mississippi; University of Mississippi Medical Center; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Ibadan; University of Glasgow; Columbia University; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Split; University of Turku; University of Turku; Umea University; University of Iowa; University of Edinburgh; Greifswald Medical School; Imperial College London; Boston University; Imperial College London; University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Stanford University; National University of Singapore; National University of Singapore; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Capital Medical University; Capital Medical University; Jackson State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Umea University; Wake Forest University; Imperial College London; Sidra Medical & Research Center; National Defense Medical Center; Tri-Service General Hospital; Ruprecht Karls University Heidelberg; Tampere University; Taichung Veterans General Hospital; China Medical University Taiwan; University of Groningen; Harvard University; Harvard Medical School; Greifswald Medical School; University of Groningen; Wake Forest University; Wake Forest University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; Kaiser Permanente; National University of Singapore; University of Kentucky; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Mississippi; University of Mississippi Medical Center; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Washington University (WUSTL); University of Southern California; University of London; Queen Mary University London	Sung, YJ (corresponding author), Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA.; Chasman, DI (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA.	yunju@wustl.edu; dchasman@research.bwh.harvard.edu	Waldenberger, Melanie/B-5355-2014; Bouchard, Claude/A-7637-2009; Loos, Ruth J F/Q-2862-2016; He, Jiang/AAF-5303-2020; Stancakova, Alena/AAN-6723-2020; Evans, Michele Kim/AAE-4776-2019; Gudnason, Vilmundur/AAE-7126-2019; Magnusson, Patrik KE/C-4458-2017; Debette, Stephanie/T-4946-2019; Sabanayagam, Charumathi/C-1294-2011; Horta, Bernardo/A-7604-2008; Raitakari, Olli/AAQ-7389-2021; Deary, Ian J/C-6297-2009; Franks, Paul/AAA-3300-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Schmidt, Carsten Oliver/AAH-2778-2019; Varga, Tibor/AAE-8035-2020; wang, YA XING/K-9671-2016; Yu, Caizheng/AAQ-9031-2021; Liu, Jianjun/AAK-4989-2020; EHRET, Georg B/A-9532-2009; Rankinen, Tuomo/N-1984-2017; Christensen, Kaare/C-2360-2009; Bouchard, Claude/AAE-2035-2019; Cade, Brian/J-6770-2019; Manning, Alisa Knodle/ABC-7711-2021; Krieger, Jose E/C-3117-2011; CHAUHAN, GANESH/AAI-5110-2021; Heikkinen, Sami P/L-1460-2013; Dörr, Marcus/F-1919-2010; Polasek, Ozren/B-6002-2011; Campbell, Archie/AAZ-1757-2021; Lehtimäki, Terho/AAD-1094-2022; Gandin, Ilaria/B-2634-2017; Chung, Yih/AIF-2414-2022; Wong, Tien Yin/AAC-9724-2020; Kilpeläinen, Tuomas/F-8569-2012; Feitosa, Mary F/K-8044-2012; Sim, Xueling/AAZ-6652-2020; , Jennifer/AAD-8336-2019; Chen, Xu/I-6829-2016; Canouil, Mickaël/L-6657-2018; Hartwig, Fernando/AAG-5578-2020; Gigante, Bruna/I-9252-2012; Leander, Karin/C-7261-2017; van Dam, Rob M/F-9674-2010; Franco, Óscar H/ABE-2305-2020; Mägi, Reedik/AAJ-9679-2021; Levy, Daniel/ABF-6873-2021; Zhu, Xiaofeng/O-6874-2019; Rudan, Igor/I-1467-2012; Cocca, Massimiliano/J-2951-2018; Evangelou, Evangelos/C-3033-2013; Smith, Albert Vernon/AHC-3838-2022; Loos, Ruth/GON-5877-2022; Li, Yize/HCI-9317-2022; Sander-Effron, Samuel/AAX-2231-2020; Gasparini, Paolo/B-6173-2014; Kaufman, Joel D/B-5761-2008; Li, Yize/ABB-9226-2021; Pereira, Alexandre/HHN-1038-2022; zhang, weihua/GXV-1334-2022; Langenberg, Claudia/ABG-9067-2021; Bierut, Laura Jean/W-6806-2019; Levy, Daniel/ABB-2752-2021; Cheng, Ching-Yu/Y-2229-2019; FROGUEL, Philippe/O-6799-2017; Rotter, Jerome/AAY-6598-2021; Peters, Annette/A-6117-2011; Milani, Lili/N-1097-2019; Robino, Antonietta/K-9398-2016; Koistinen, Heikki/J-7313-2016; Gu, C. Charles/A-7934-2010	Waldenberger, Melanie/0000-0003-0583-5093; Bouchard, Claude/0000-0002-0048-491X; Loos, Ruth J F/0000-0002-8532-5087; He, Jiang/0000-0002-8286-9652; Stancakova, Alena/0000-0002-1375-0252; Gudnason, Vilmundur/0000-0001-5696-0084; Magnusson, Patrik KE/0000-0002-7315-7899; Debette, Stephanie/0000-0001-8675-7968; Sabanayagam, Charumathi/0000-0002-4042-4719; Horta, Bernardo/0000-0001-9843-412X; Deary, Ian J/0000-0002-1733-263X; Schmidt, Carsten Oliver/0000-0001-5266-9396; wang, YA XING/0000-0003-2749-7793; Liu, Jianjun/0000-0002-3255-3019; EHRET, Georg B/0000-0002-5730-0675; Christensen, Kaare/0000-0002-5429-5292; Cade, Brian/0000-0003-1424-0673; Krieger, Jose E/0000-0001-5464-1792; Heikkinen, Sami P/0000-0002-6083-2402; Dörr, Marcus/0000-0001-7471-475X; Polasek, Ozren/0000-0002-5765-1862; Lehtimäki, Terho/0000-0002-2555-4427; Gandin, Ilaria/0000-0003-3196-2491; Chung, Yih/0000-0002-6752-797X; Wong, Tien Yin/0000-0002-8448-1264; Kilpeläinen, Tuomas/0000-0002-8349-3028; Feitosa, Mary F/0000-0002-0933-2410; Sim, Xueling/0000-0002-1233-7642; Chen, Xu/0000-0002-7299-3238; Canouil, Mickaël/0000-0002-3396-4549; Leander, Karin/0000-0002-1404-9222; van Dam, Rob M/0000-0002-7354-8734; Franco, Óscar H/0000-0002-4606-4929; Levy, Daniel/0000-0003-1843-8724; Rudan, Igor/0000-0001-6993-6884; Cocca, Massimiliano/0000-0002-1127-7596; Evangelou, Evangelos/0000-0002-5488-2999; Smith, Albert Vernon/0000-0003-1942-5845; Kaufman, Joel D/0000-0003-4174-9037; Li, Yize/0000-0003-1074-281X; Langenberg, Claudia/0000-0002-5017-7344; Bierut, Laura Jean/0000-0002-9952-4810; Cheng, Ching-Yu/0000-0003-0655-885X; FROGUEL, Philippe/0000-0003-2972-0784; Peters, Annette/0000-0001-6645-0985; Milani, Lili/0000-0002-5323-3102; Forouhi, Nita/0000-0002-5041-248X; Weiss, Stefan/0000-0002-3553-4315; Tajuddin, Salman M./0000-0002-7919-8528; Scott, William/0000-0001-5467-114X; Dorajoo, Rajkumar/0000-0001-6608-2051; Pedersen, Nancy/0000-0001-8057-3543; Seshadri, Sudha/0000-0001-6135-2622; Goel, Anuj/0000-0003-2307-4021; Morrison, Alanna/0000-0001-6381-4296; Robino, Antonietta/0000-0003-2152-2353; Loh, Marie/0000-0003-3626-8466; Sofer, Tamar/0000-0001-8520-8860; Kerrison, Nicola/0000-0002-1471-953X; Vojinovic, Dina/0000-0001-5744-0232; Cupples, L. Adrienne/0000-0003-0273-7965; Liu, Ching-Ti/0000-0002-0703-0742; de las Fuentes, Lisa/0000-0002-4689-325X; Noordam, Raymond/0000-0001-7801-809X; Matoba, Nana/0000-0001-5329-0134; Gasparini, Paolo/0000-0002-0859-0856; Caulfield, Mark/0000-0001-9295-3594; Boissel, Mathilde/0000-0001-5719-8749; Franks, Paul/0000-0002-0520-7604; Justice, Anne/0000-0002-8903-8712; Tai, E Shyong/0000-0003-2929-8966; Smith, Jennifer Ann/0000-0002-3575-5468; Van Duijn, Cornelia/0000-0002-2374-9204; Wang, Yajuan (Megan)/0000-0002-3284-9012; Murray, Alison/0000-0003-4915-4847; Elliott, Paul/0000-0002-7511-5684; Koistinen, Heikki/0000-0001-7870-070X; Gigante, Bruna/0000-0003-4508-7990; Nelson, Christopher/0000-0001-8025-2897; V. Varga, Tibor/0000-0002-2383-699X; Zhu, Xiaofeng/0000-0003-0037-411X; Kahonen, Mika/0000-0002-4510-7341; Gu, C. Charles/0000-0002-8527-8145; Schreiner, Pamela/0000-0002-9920-6257; Padmanabhan, Sandosh/0000-0003-3869-5808; Long, Jirong/0000-0002-7433-9766; Chauhan, Ganesh/0000-0002-8564-5021	U.S. National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health [R01HL118305]; NHLBI [K25HL121091]; NATIONAL CANCER INSTITUTE [P01CA196569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117078, U01HL130114, K25HL121091, R00HL130580, K01HL135405, R01HL105756, T32HL007055, R01HL118305, R21HL123677] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, U01DK062370, P30DK072488, P30DK020572, R01DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG054076, U01AG009740, U01AG023746] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD012765] Funding Source: NIH RePORTER; British Heart Foundation [SP/13/2/30111] Funding Source: researchfish; Medical Research Council [MC_PC_13046, G0601966, MC_PC_U127561128, MR/L01632X/1, MC_UP_1605/7, MR/K002414/1, G0600237, MR/K026992/1, MC_PC_13048, MR/L01341X/1, UKDRI-5001, MR/K006584/1, MC_UU_12015/5, MR/R023484/1, MC_UU_00007/10, G0700704B, MC_UU_12015/1, G0700931, G9521010, HDR-2002] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136, NF-SI-0617-10149, NF-SI-0512-10113, NF-SI-0512-10135, NF-SI-0617-10154, NF-SI-0513-10059] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Kilpel�inen Group] Funding Source: researchfish; MRC [UKDRI-5001, MC_UU_00007/10, G0601966, MR/K002414/1, MR/L01632X/1, G9521010, MR/L01341X/1, MC_UP_1605/7, MR/R023484/1, G0700931, MC_UU_12015/1, G0600237, MC_PC_U127561128, MC_UU_12015/5] Funding Source: UKRI	U.S. National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The various Gene-Lifestyle Interaction projects, including this one, are largely supported by a grant from the U.S. National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health, R01HL118305. A Career Development Award (K25HL121091), also from the NHLBI, enabled Y.J.S. to lead this project. Full set of study-specific funding sources and acknowledgments appear in the Supplemental Note.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ambatipudi S, 2016, EPIGENOMICS-UK, V8, P599, DOI 10.2217/epi-2016-0001; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aschard H, 2010, HUM HERED, V70, P292, DOI 10.1159/000323318; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bis JC, 2011, NAT GENET, V43, P940, DOI 10.1038/ng.920; Boardman-Pretty F, 2015, CIRC-CARDIOVASC GENE, V8, P696, DOI 10.1161/CIRCGENETICS.115.001062; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Butt HZ, 2010, EUR J VASC ENDOVASC, V40, P17, DOI 10.1016/j.ejvs.2010.04.012; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; CROFT JB, 1990, AM J MED GENET, V36, P37, DOI 10.1002/ajmg.1320360109; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Del Greco FM, 2011, HUM MOL GENET, V20, P1660, DOI 10.1093/hmg/ddr035; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Hemerich D, 2015, ATHEROSCLEROSIS, V243, P466, DOI 10.1016/j.atherosclerosis.2015.10.017; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Husson H, 2016, HUM MOL GENET, V25, P2245, DOI 10.1093/hmg/ddw093; IMBS JL, 1975, EUR J PHARMACOL, V33, P151, DOI 10.1016/0014-2999(75)90150-8; Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6; Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013; Justice AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14977; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kawaguchi T, 2010, BIOCHEM BIOPH RES CO, V391, P1336, DOI 10.1016/j.bbrc.2009.12.045; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Kirk E. P., 2017, CIRC-CARDIOVASC GENE, V10, P10; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Levran O, 2015, PHARMACOGENOMICS, V16, P1329, DOI [10.2217/PGS.15.86, 10.2217/pgs.15.86]; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li XX, 2001, HYPERTENSION, V38, P303, DOI 10.1161/01.HYP.38.3.303; Liang JJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006728; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; MANN SJ, 1991, JAMA-J AM MED ASSOC, V265, P2226, DOI 10.1001/jama.265.17.2226; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manning AK, 2011, GENET EPIDEMIOL, V35, P11, DOI 10.1002/gepi.20546; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marples D, 1998, AM J PHYSIOL-RENAL, V274, pF384, DOI 10.1152/ajprenal.1998.274.2.F384; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Primatesta P, 2001, HYPERTENSION, V37, P187, DOI 10.1161/01.HYP.37.2.187; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rao DC, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001649; Reilly D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085369; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Sakata M, 2002, BRAIN RES, V928, P194, DOI 10.1016/S0006-8993(01)03402-3; Schueler M, 2016, J MED GENET, V53, P208, DOI 10.1136/jmedgenet-2015-103304; Setsuta K, 2014, INT J CARDIOL, V176, P1323, DOI 10.1016/j.ijcard.2014.07.150; Shi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171446; Simms RJ, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/527137; Singh R, 2013, HUM MUTAT, V34, P1221, DOI 10.1002/humu.22360; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stoynev N, 2014, J CARDIOVASC MED, V15, P702, DOI 10.2459/JCM.0b013e32835dbcc8; Stratigopoulos G, 2014, CELL METAB, V19, P767, DOI 10.1016/j.cmet.2014.04.009; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Sung YJ, 2016, GENET EPIDEMIOL, V40, P404, DOI 10.1002/gepi.21978; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Swan GE, 2006, AM J MED GENET B, V141B, P354, DOI 10.1002/ajmg.b.30315; Taylor A, 2014, J NEURAL TRANSM, V121, P105, DOI 10.1007/s00702-013-1065-2; Tchetgen EJT, 2011, EPIDEMIOLOGY, V22, P257, DOI 10.1097/EDE.0b013e31820877c5; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Tyrrell J, 2017, INT J EPIDEMIOL, V46, P559, DOI 10.1093/ije/dyw337; Voorman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019416; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler TW, 2015, BIOINFORMATICS, V31, P259, DOI 10.1093/bioinformatics/btu621; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Young AI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12724; Yu KY, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0416-y; Zee RYL, 2011, CLIN CHIM ACTA, V412, P199, DOI 10.1016/j.cca.2010.10.003; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	98	66	67	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					375	400		10.1016/j.ajhg.2018.01.015	http://dx.doi.org/10.1016/j.ajhg.2018.01.015			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29455858	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000426469600011
J	Tang, HB; Kirkness, EF; Lippert, C; Biggs, WH; Fabani, M; Guzman, E; Ramakrishnan, S; Lavrenko, V; Kakaradov, B; Hou, C; Hicks, B; Heckerman, D; Och, FJ; Caskey, CT; Venter, JC; Telenti, A				Tang, Haibao; Kirkness, Ewen F.; Lippert, Christoph; Biggs, William H.; Fabani, Martin; Guzman, Ernesto; Ramakrishnan, Smriti; Lavrenko, Victor; Kakaradov, Boyko; Hou, Claire; Hicks, Barry; Heckerman, David; Och, Franz J.; Caskey, C. Thomas; Venter, J. Craig; Telenti, Amalio			Profiling of Short-Tandem-Repeat Disease Alleles in 12,632 Human Whole Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERSONAL GENOMES; SEQUENCING DATA; RAPID DETECTION; MUTATION-RATE; GENE; EXPANSIONS; VARIANTS; INDELS	Short tandem repeats (STRs) are hyper-mutable sequences in the humangenome. They are often used in forensics and population genetics and are also the underlying cause of many genetic diseases. There are challenges associated with accurately determining the length polymorphismof STR loci in thegenomeby next-generation sequencing (NGS). In particular, accurate detection of pathological STRexpansion is limited by the sequence read length during whole-genome analysis. We developed TREDPARSE, a software package that incorporates various cues from read alignment and paired-end distance distribution, as well as a sequence stutter model, in a probabilistic framework to infer repeat sizes for genetic loci, and we used this software to infer repeat sizes for 30 known disease loci. Using simulated data, we show that TREDPARSE outperforms other available software. We sampled the full genome sequences of 12,632 individuals to an average read depth of approximately 303 to 403 with Illumina HiSeq X. We identified 138 individuals with risk alleles at 15 STR disease loci. We validated a representative subset of the samples (n = 19) by Sanger and by Oxford Nanopore sequencing. Additionally, we validated the STR calls against knownallele sizes in a set of GeT-RM reference cell-line materials (n = 6). Several STR loci that are entirely guanine or cytosines (G or C) have insufficient read evidence for inference and therefore could not be assayed precisely by TREDPARSE. TREDPARSE extends the limit of STR size detection beyond the physical sequence read length. This extension is critical because many of the disease risk cutoffs are close to or beyond the short sequence read length of 100 to 150 bases.	[Tang, Haibao; Lippert, Christoph; Ramakrishnan, Smriti; Lavrenko, Victor; Hicks, Barry; Heckerman, David; Och, Franz J.] Human Longev, Mountain View, CA 94041 USA; [Kirkness, Ewen F.; Biggs, William H.; Fabani, Martin; Guzman, Ernesto; Kakaradov, Boyko; Hou, Claire; Venter, J. Craig; Telenti, Amalio] Human Longev, San Diego, CA 92121 USA; [Caskey, C. Thomas] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Venter, JC; Telenti, A (corresponding author), Human Longev, San Diego, CA 92121 USA.	jcventer@jcvi.org; atelenti@humanlongevity.com	Telenti, Amalio/AAY-1674-2021; Tang, Haibao/A-6715-2011	Tang, Haibao/0000-0002-3460-8570; Lavrenko, Victor/0000-0002-2106-8173				Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Baudhuin LM, 2017, CLIN CHEM, V63, P632, DOI 10.1373/clinchem.2016.261420; Bolton KA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-795; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; de Die-Smulders CEM, 2013, HUM REPROD UPDATE, V19, P304, DOI 10.1093/humupd/dms058; Delatycki MB, 1998, J MED GENET, V35, P713, DOI 10.1136/jmg.35.9.713; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doi K, 2014, BIOINFORMATICS, V30, P815, DOI 10.1093/bioinformatics/btt647; Dolzhenko E., 2016, DETECTION LONG REPEA; Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57; Fan Hao, 2007, Genomics Proteomics & Bioinformatics, V5, P7, DOI 10.1016/S1672-0229(07)60009-6; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P97; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hardwick SA, 2017, NAT REV GENET, V18, P473, DOI 10.1038/nrg.2017.44; Hares DR, 2015, FORENSIC SCI INT-GEN, V17, P33, DOI 10.1016/j.fsigen.2015.03.006; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Helgason A, 2015, NAT GENET, V47, P453, DOI 10.1038/ng.3171; Huang MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13321; Kojima Kaname, 2016, BMC Genomics, V17, P991; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maat-Kievit A, 2001, J Med Genet, V38, pE12, DOI 10.1136/jmg.38.4.e12; Cao MD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1313; Pellegrini M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S3; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Press MO, 2014, TRENDS GENET, V30, P504, DOI 10.1016/j.tig.2014.07.008; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Ummat A, 2014, BIOINFORMATICS, V30, P3491, DOI 10.1093/bioinformatics/btu437; Willems T, 2016, AM J HUM GENET, V98, P919, DOI 10.1016/j.ajhg.2016.04.001; Zhang W, 2007, EJSO-EUR J SURG ONC, V33, P529, DOI 10.1016/j.ejso.2006.11.027; Zhao MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082138; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	41	66	69	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					700	715		10.1016/j.ajhg.2017.09.013	http://dx.doi.org/10.1016/j.ajhg.2017.09.013			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100084	Green Published, hybrid			2022-12-18	WOS:000414251600004
J	Haack, TB; Ignatius, E; Calvo-Garrido, J; Iuso, A; Isohanni, P; Maffezzini, C; Lonnqvist, T; Suomalainen, A; Gorza, M; Kremer, LS; Graf, E; Hartig, M; Berutti, R; Paucar, M; Svenningsson, P; Stranneheim, H; Brandberg, G; Wedell, A; Kurian, MA; Hayflick, SA; Venco, P; Tiranti, V; Strom, TM; Dichgans, M; Horvath, R; Holinski-Feder, E; Freyer, C; Meitinger, T; Prokisch, H; Senderek, J; Wredenberg, A; Carroll, CJ; Klopstock, T				Haack, Tobias B.; Ignatius, Erika; Calvo-Garrido, Javier; Iuso, Arcangela; Isohanni, Pirjo; Maffezzini, Camilla; Lonnqvist, Tuula; Suomalainen, Anu; Gorza, Matteo; Kremer, Laura S.; Graf, Elisabeth; Hartig, Monika; Berutti, Riccardo; Paucar, Martin; Svenningsson, Per; Stranneheim, Henrik; Brandberg, Goran; Wedell, Anna; Kurian, Manju A.; Hayflick, Susan A.; Venco, Paola; Tiranti, Valeria; Strom, Tim M.; Dichgans, Martin; Horvath, Rita; Holinski-Feder, Elke; Freyer, Christoph; Meitinger, Thomas; Prokisch, Holger; Senderek, Jan; Wredenberg, Anna; Carroll, Christopher J.; Klopstock, Thomas			Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P62/SQSTM1; MUTATIONS; MITOPHAGY; PARKIN; P62; MITOCHONDRIA; PROTEIN; RECEPTORS; DISEASE; CANCER	SQSTM1 (sequestosome 1; also known as p62) encodes a multidomain scaffolding protein involved in various key cellular processes, including the removal of damaged mitochondria by its function as a selective autophagy receptor. Heterozygous variants in SQSTMI have been associated with Paget disease of the bone and might contribute to neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Using exome sequencing, we identified three different biallelic loss-of-function variants in SQSTMI in nine affected individuals from four families with a childhood- or adolescence-onset neurodegenerative disorder characterized by gait abnormalities, ataxia, dysarthria, dystonia, vertical gaze palsy, and cognitive decline. We confirmed absence of the SQSTMl/p62 protein in affected individuals' fibroblasts and found evidence of a defect in the early response to mitochondrial depolarization and autophagosome formation. Our findings expand the SQSTMI-associated phenotypic spectrum and lend further support to the concept of disturbed selective autophagy pathways in neurodegenerative diseases.	[Haack, Tobias B.; Iuso, Arcangela; Hartig, Monika; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Iuso, Arcangela; Gorza, Matteo; Kremer, Laura S.; Graf, Elisabeth; Berutti, Riccardo; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Ignatius, Erika; Isohanni, Pirjo; Suomalainen, Anu; Carroll, Christopher J.] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00290 Helsinki, Finland; [Ignatius, Erika; Isohanni, Pirjo; Lonnqvist, Tuula] Univ Helsinki, Dept Child Neurol, Childrens Hosp, Helsinki 00029, Finland; [Ignatius, Erika; Isohanni, Pirjo; Lonnqvist, Tuula] Helsinki Univ Hosp, Helsinki 00029, Finland; [Calvo-Garrido, Javier; Stranneheim, Henrik; Wedell, Anna] Karolinska Inst, Sci Life Lab, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Maffezzini, Camilla; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Paucar, Martin; Svenningsson, Per] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Stranneheim, Henrik; Wedell, Anna; Freyer, Christoph; Wredenberg, Anna] Karolinska Inst, Ctr Inherited Metab Dis, S-17176 Stockholm, Sweden; [Brandberg, Goran] Falu Iasarett, Dept Pediat, S-79182 Falun, Sweden; [Kurian, Manju A.] UCL, Inst Child Hlth, Neurosci Unit, London WC1N 3BG, England; [Kurian, Manju A.] Great Ormond St Hosp Sick Children, Dept Paediat Neurol, London WC1N 3BG, England; [Hayflick, Susan A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Hayflick, Susan A.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Hayflick, Susan A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Venco, Paola; Tiranti, Valeria] IRCCS Fdn Neurol Inst C Besta, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Unit Mol Neurogenet, I-20126 Milan, Italy; [Dichgans, Martin] Univ Munich, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Dichgans, Martin; Meitinger, Thomas; Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Dichgans, Martin; Klopstock, Thomas] DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany; [Horvath, Rita; Holinski-Feder, Elke] MGZ Med Genet Ctr, D-80335 Munich, Germany; [Horvath, Rita] Newcastle Univ, Inst Genet Med, MRC Ctr Neuromuscular Dis, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Senderek, Jan; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Falun Hospital; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Newcastle University - UK; University of Munich	Haack, TB (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.; Haack, TB (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.; Klopstock, T (corresponding author), Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.; Klopstock, T (corresponding author), DZNE German Ctr Neurodegenerat Dis, D-80336 Munich, Germany.; Klopstock, T (corresponding author), Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.	tobias.haack@helmholtz-muenchen.de; tklopsto@med.lmu.de	Carroll, Christopher/AAV-8023-2021; Dichgans, Martin/HCH-3247-2022; Calvo-Garrido, Javier/AAA-5344-2020; Senderek, Jan/F-8405-2015; Horvath, Rita/AAY-7042-2020; Svenningsson, Per JL/K-5210-2014; Tiranti, Valeria/AFN-5783-2022; Meitinger, Thomas/O-1318-2015; Carroll, Christopher/AAJ-6185-2021	Dichgans, Martin/0000-0002-0654-387X; Senderek, Jan/0000-0002-8263-1783; Tiranti, Valeria/0000-0002-3584-7338; Carroll, Christopher/0000-0002-2814-6955; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Calvo Garrido, Javier/0000-0002-7786-2800; Horvath, Rita/0000-0002-9841-170X; Ignatius, Erika/0000-0002-3574-6510; Meitinger, Thomas/0000-0002-8838-8403; Kremer, Laura/0000-0002-1647-7538; Maffezzini, Camilla/0000-0002-0397-1609; Wredenberg, Anna/0000-0002-2500-6121; Freyer, Christoph/0000-0003-0418-1673; Prokisch, Holger/0000-0003-2379-6286	German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET) [01GM1113A-E]; E-Rare project GENOMIT [01GM1207]; Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]; European Commission 7th Framework Programme (FP7, HEALTH-F2), TIRCON [277984]; Arvo and Lea Ylppo Foundation; Foundation for Pediatric Research; Helsinki University research grant; Sigrid Juselius Foundation; Aatos and Jane Erkko Foundation; Academy of Finland; Wellcome Trust [109915/Z/15/Z]; Medical Research Council (UK) [G1000848]; European Research Council [309548]; Swedish Research Council [VR521-2012-2571, K2014-54X-20642-13-3]; Stockholm County Council [K0176-2012, 20140053]; Swedish Foundation for Strategic Research [ICA 12-0017]; Knut & Alice Wallenberg Foundation [KAW 20130026]; Swedish Brain Foundation [FO2015-0146]; "Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks [GTB12001J]; Eurobiobank Network; Deutsche Forschungsgemeinschaft (German Research Foundation) within Munich Cluster for Systems Neurology [EXC 1010 SyNergy]; Medical Research Council [G1000848] Funding Source: researchfish; Action Medical Research [1722] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [ICH1031] Funding Source: researchfish; MRC [G1000848] Funding Source: UKRI	German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Juniorverbund in der Systemmedizin "mitOmics"; European Commission 7th Framework Programme (FP7, HEALTH-F2), TIRCON; Arvo and Lea Ylppo Foundation; Foundation for Pediatric Research; Helsinki University research grant; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Aatos and Jane Erkko Foundation; Academy of Finland(Academy of Finland); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Brain Foundation; "Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks(Fondazione Telethon); Eurobiobank Network; Deutsche Forschungsgemeinschaft (German Research Foundation) within Munich Cluster for Systems Neurology(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the families for their participation and Dr. Boriana Buchner, Dr. Ivan Karin, and Dr. Benedikt Schoser for their support in phenotyping. This study was supported by the German Bundesministerium fur Bildung and Forschung (BMBF) through the German Network for Mitochondrial Disorders (mitoNET; 01GM1113A-E to T.M., H.P., and T.K.), the E-Rare project GENOMIT (01GM1207 to T.M. and H.P.), the Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C to T.B.H.), as well as the European Commission 7th Framework Programme (FP7/2007-2013, HEALTH-F2-2011, grant agreement No. 277984, TIRCON). E.I. was supported by the Arvo and Lea Ylppo Foundation, P.I. by Foundation for Pediatric Research, and C.J.C. by a Helsinki University research grant. A.S. acknowledges support of Sigrid Juselius Foundation, Aatos and Jane Erkko Foundation, and Academy of Finland. R.H. is a Wellcome Trust Investigator (109915/Z/15/Z) and was supported by the Medical Research Council (UK) (G1000848) and the European Research Council (309548). Additional support came from The Swedish Research Council (VR521-2012-2571 to A. Wredenberg and K2014-54X-20642-13-3 to A. Wedell), Stockholm County Council (K0176-2012 to A. Wredenberg, and 20140053 to A. Wedell), Swedish Foundation for Strategic Research (ICA 12-0017 to A. Wredenberg), Knut & Alice Wallenberg Foundation (KAW 20130026 to A. Wredenberg and A. Wedell), and The Swedish Brain Foundation (FO2015-0146). A. Wredenberg is a Ragnar Soderberg fellow (M77/13). We acknowledge the "Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks (grant GTB12001J) and the Eurobiobank Network. This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy) to T.M. and T.K.	Babu JR, 2008, J NEUROCHEM, V106, P107, DOI 10.1111/j.1471-4159.2008.05340.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bucelli RC, 2015, NEUROLOGY, V85, P665, DOI 10.1212/WNL.0000000000001864; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kremer LS, 2016, AM J HUM GENET, V98, P358, DOI 10.1016/j.ajhg.2015.12.009; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Manford AG, 2015, MOL CELL, V60, P1, DOI 10.1016/j.molcel.2015.09.016; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Rea SL, 2014, EXP CELL RES, V325, P27, DOI 10.1016/j.yexcr.2014.01.020; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Stranneheim H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1090; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94	28	66	66	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					735	743		10.1016/j.ajhg.2016.06.026	http://dx.doi.org/10.1016/j.ajhg.2016.06.026			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545679	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000383114800019
J	Fenwick, AL; Kliszczak, M; Cooper, F; Murray, J; Sanchez-Pulido, L; Twigg, SRF; Goriely, A; McGowan, SJ; Miller, KA; Taylor, IB; Logan, C; Bozdogan, S; Danda, S; Dixon, J; Elsayed, SM; Elsobky, E; Gardham, A; Hoffer, MJV; Koopmans, M; McDonald-McGinn, DM; Santen, GWE; Savarirayan, R; de Silva, D; Vanakker, O; Wall, SA; Wilson, LC; Yuregir, OO; Zackai, EH; Ponting, CP; Jackson, AP; Wilkie, AOM; Niedzwiedz, W; Bicknell, LS				Fenwick, Aimee L.; Kliszczak, Maciej; Cooper, Fay; Murray, Jennie; Sanchez-Pulido, Luis; Twigg, Stephen R. F.; Goriely, Anne; McGowan, Simon J.; Miller, Kerry A.; Taylor, Indira B.; Logan, Clare; Bozdogan, Sevcan; Danda, Sumita; Dixon, Joanne; Elsayed, Solaf M.; Elsobky, Ezzat; Gardham, Alice; Hoffer, Mariette J. V.; Koopmans, Marije; McDonald-McGinn, Donna M.; Santen, Gijs W. E.; Savarirayan, Ravi; de Silva, Deepthi; Vanakker, Olivier; Wall, Steven A.; Wilson, Louise C.; Yuregir, Ozge Ozalp; Zackai, Elaine H.; Ponting, Chris P.; Jackson, Andrew P.; Wilkie, Andrew O. M.; Niedzwiedz, Wojciech; Bicknell, Louise S.		WGS500 Consortium	Mutations in CDC45, Encoding an Essential Component of the Pre-initiation Complex, Cause Meier-Gorlin Syndrome and Craniosynostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; MINICHROMOSOME MAINTENANCE; PROTEIN; GROWTH; GENE; HELICASE; MCM2-7; RECQL4; DEFICIENCY	DNA replication precisely duplicates the genome to ensure stable inheritance of genetic information. Impaired licensing of origins of replication during the G(1) phase of the cell cycle has been implicated in Meier-Gorlin syndrome (MGS), a disorder defined by the triad of short stature, microtia, and a/hypoplastic patellae. Biallelic partial loss-of-function mutations in multiple components of the pre-replication complex (preRC; ORC1, ORC4, ORC6, CDT1, or CDC6) as well as de novo stabilizing mutations in the licensing inhibitor, GMNN, cause MGS. Here we report the identification of mutations in CDC45 in 15 affected individuals from 12 families with MGS and/or craniosynostosis. CDC45 encodes a component of both the pre-initiation (preIC) and CMG helicase complexes, required for initiation of DNA replication origin firing and ongoing DNA synthesis during S-phase itself, respectively, and hence is functionally distinct from previously identified MGS-associated genes. The phenotypes of affected individuals range from syndromic coronal craniosynostosis to severe growth restriction, fulfilling diagnostic criteria for Meier-Gorlin syndrome. All mutations identified were biallelic and included synonymous mutations altering splicing of physiological CDC45 transcripts, as well as amino acid substitutions expected to result in partial loss of function. Functionally, mutations reduce levels of full-length transcripts and protein in subject cells, consistent with partial loss of CDC45 function and a predicted limited rate of DNA replication and cell proliferation. Our findings therefore implicate the preIC as an additional protein complex involved in the etiology of MGS and connect the core cellular machinery of genome replication with growth, chondrogenesis, and cranial suture homeostasis.	[Fenwick, Aimee L.; Kliszczak, Maciej; Twigg, Stephen R. F.; Goriely, Anne; Miller, Kerry A.; Taylor, Indira B.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, England; [Kliszczak, Maciej; Niedzwiedz, Wojciech] Univ Oxford, Dept Oncol, MRC Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Cooper, Fay; Murray, Jennie; Sanchez-Pulido, Luis; Logan, Clare; Ponting, Chris P.; Jackson, Andrew P.; Bicknell, Louise S.] Univ Edinburgh, IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [McGowan, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Bozdogan, Sevcan] Mersin Univ, Dept Med Genet, TR-33343 Cukurova, Turkey; [Danda, Sumita] Christian Med Coll & Hosp, Dept Clin Genet, Vellore 632004, Tamil Nadu, India; [Dixon, Joanne] Christchurch Hosp, Genet Hlth Serv NZ South Isl Hub, Canterbury 8140, New Zealand; [Elsayed, Solaf M.; Elsobky, Ezzat] Ain Shams Univ, Childrens Hosp, Cairo 11566, Egypt; [Gardham, Alice; Wilson, Louise C.] Great Ormond St Hosp Sick Children, Great Ormond St Hosp Children NHS Fdn Trust, North East Thames Reg Genet Serv, London WC1N 3JH, England; [Hoffer, Mariette J. V.; Koopmans, Marije; Santen, Gijs W. E.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [McDonald-McGinn, Donna M.; Zackai, Elaine H.] Childrens Hosp Philadelphia, Clin Genet, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Savarirayan, Ravi] Univ Melbourne, Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [de Silva, Deepthi] Univ Kelaniya, Fac Med, Dept Physiol, Ragama 11010, Gampaha Gq, Sri Lanka; [Vanakker, Olivier] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Wall, Steven A.; Wilkie, Andrew O. M.] John Radcliffe Hosp, Oxford Univ Hosp NHS Fdn Trust, Dept Plast & Reconstruct Surg, Craniofacial Unit, Oxford OX3 9DU, England; [Yuregir, Ozge Ozalp] Adana Numune Training & Res Hosp, Genet Diag Ctr, TR-01170 Adana, Turkey; [Bicknell, Louise S.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9016, Otago, New Zealand	University of Oxford; University of Oxford; University of Edinburgh; University of Oxford; Mersin University; Christian Medical College & Hospital (CMCH) Vellore; Christchurch Hospital New Zealand; Egyptian Knowledge Bank (EKB); Ain Shams University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Murdoch Children's Research Institute; University of Melbourne; University Kelaniya; Ghent University; Ghent University Hospital; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Adana Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; University of Otago	Niedzwiedz, W (corresponding author), Univ Oxford, Dept Oncol, MRC Weatherall Inst Mol Med, Oxford OX3 9DS, England.; Bicknell, LS (corresponding author), Univ Edinburgh, IGMM, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.; Bicknell, LS (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin 9016, Otago, New Zealand.	wojciech.niedzwiedz@imm.ox.ac.uk; louise.bicknell@otago.ac.nz	Jackson, Andrew P/D-3442-2009; Bicknell, Louise/AAL-8003-2020; Twigg, Stephen/AAU-1135-2021; McDonald-McGinn, Donna/L-8643-2019; Wilkie, Andrew/AAC-3820-2020; Elsayed, Solaf/AAJ-7898-2020; Goriely, Anne/AAR-1133-2020; Vanakker, Olivier M./AAN-2900-2021; Bicknell, Louise/GLR-4215-2022; Ponting, Chris/AAV-2621-2021; Knight, Julian Charles/W-2399-2019	Jackson, Andrew P/0000-0002-8739-2646; Twigg, Stephen/0000-0001-5024-049X; Wilkie, Andrew/0000-0002-2972-5481; Elsayed, Solaf/0000-0003-3054-9929; Vanakker, Olivier M./0000-0003-4491-0332; Bicknell, Louise/0000-0001-6899-9322; Knight, Julian Charles/0000-0002-0377-5536; niedzwiedz, wojciech/0000-0002-8518-6304; Goriely, Anne/0000-0001-9229-7216; McDonald-McGinn, Donna/0000-0003-4077-250X; McGowan, Simon/0000-0001-9720-1914; Jones, Aimee/0000-0003-0279-1814; Cooper, Fay/0000-0002-5340-619X; Logan, Clare/0000-0003-4323-1602; Sanchez Pulido, Luis/0000-0002-2300-8502	Medical Research Council (MRC); WIMM Strategic Alliance [G0902418, MC_UU_12025]; European Research Council (ERC) [281847]; Lister Institute for Preventative Medicine; Medical Research Scotland; Royal Society of New Zealand Rutherford Discovery Fellowship; Department of Health, UK; Quality, Improvement, Development and Initiative Scheme (QIDIS); Newlife Foundation for Disabled Children [SG/14-15/10]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; Wellcome Trust [093329, 102731]; Medical Research Council [G0902418, MC_UU_12008/1, MC_PC_U127580972] Funding Source: researchfish; MRC [G0902418, MC_UU_12008/1, MC_PC_U127580972] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WIMM Strategic Alliance; European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventative Medicine; Medical Research Scotland; Royal Society of New Zealand Rutherford Discovery Fellowship(Royal Society of New Zealand); Department of Health, UK; Quality, Improvement, Development and Initiative Scheme (QIDIS); Newlife Foundation for Disabled Children; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families and clinicians for their participation, the IGMM core sequencing service, staff at the High-Throughput Genomics facility at the Wellcome Trust Centre for Human Genetics (Oxford) for Illumina sequencing, Tim Forshew and Francesco Marass for primer design, and Sue Butler, John Frankland, and Tim Rostron for help with cell culture and DNA sequencing. This work was supported by funding from the Medical Research Council (MRC) (A.P.J., L.S.-P., C.P.P., W.N.) and through the WIMM Strategic Alliance (G0902418 and MC_UU_12025), the European Research Council (ERC, 281847) (A.P.J.), the Lister Institute for Preventative Medicine (A.P.J.), Medical Research Scotland (L.S.B.), Royal Society of New Zealand Rutherford Discovery Fellowship (L.S.B.), the Department of Health, UK, Quality, Improvement, Development and Initiative Scheme (QIDIS) (A.O.M.W.), Newlife Foundation for Disabled Children (SG/14-15/10 to A.O.M.W.), National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (A.O.M.W.), and the Wellcome Trust (Project Grant 093329 to A.O.M.W. and S.R.F.T.; Investigator Award 102731 to A.O.M.W.).	Ali FA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10708; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Bongers EMHF, 2001, AM J MED GENET, V102, P115, DOI 10.1002/ajmg.1452; Burrage LC, 2015, AM J HUM GENET, V97, P904, DOI 10.1016/j.ajhg.2015.11.006; Casey JP, 2012, J MED GENET, V49, P242, DOI 10.1136/jmedgenet-2012-100803; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Costa A, 2014, ELIFE, V3, DOI 10.7554/eLife.03273; de Munnik SA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0322-x; de Munnik SA, 2012, EUR J HUM GENET, V20, P598, DOI 10.1038/ejhg.2011.269; Delio M, 2013, AM J HUM GENET, V92, P439, DOI 10.1016/j.ajhg.2013.01.018; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Di Perna R, 2013, BIOCHEM J, V454, P333, DOI 10.1042/BJ20130059; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.M115.699801, 10.1074/jbc.A115.699801]; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hopwood B, 1996, P NATL ACAD SCI USA, V93, P12309, DOI 10.1073/pnas.93.22.12309; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Krastanova I, 2012, J BIOL CHEM, V287, P4121, DOI 10.1074/jbc.M111.285395; Kukimoto I, 1999, EUR J BIOCHEM, V265, P936, DOI 10.1046/j.1432-1327.1999.00791.x; Li NN, 2015, NATURE, V524, P186, DOI 10.1038/nature14685; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Miyake S, 1998, GENES CELLS, V3, P157, DOI 10.1046/j.1365-2443.1998.00177.x; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Newell NE, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0671-4; On KF, 2014, EMBO J, V33, P605, DOI 10.1002/embj.201387369; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schmidt U, 2008, BIOCHEM J, V409, P169, DOI 10.1042/BJ20070872; Schwartz S, 2009, NUCLEIC ACIDS RES, V37, pW189, DOI 10.1093/nar/gkp320; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siitonen HA, 2009, EUR J HUM GENET, V17, P151, DOI 10.1038/ejhg.2008.154; Stiff T, 2013, PLOS GENET, V9, DOI [10.1371/journal.pgen.1003360, 10.1371/journal.pone.0058239]; Szambowska A, 2014, NUCLEIC ACIDS RES, V42, P2308, DOI 10.1093/nar/gkt1217; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Wakamatsu T, 2011, J BIOL CHEM, V286, P2807, DOI 10.1074/jbc.M110.161596; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Yoshida K, 2004, ONCOGENE, V23, P58, DOI 10.1038/sj.onc.1206987; Yoshida K, 2001, MOL CELL BIOL, V21, P4598, DOI 10.1128/MCB.21.14.4598-4603.2001; Yuan ZN, 2016, NAT STRUCT MOL BIOL, V23, P217, DOI 10.1038/nsmb.3170; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	57	66	71	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					125	138		10.1016/j.ajhg.2016.05.019	http://dx.doi.org/10.1016/j.ajhg.2016.05.019			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27374770	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-18	WOS:000381616600010
J	Reyes, A; Melchionda, L; Nasca, A; Carrara, F; Lamantea, E; Zanolini, A; Lamperti, C; Fang, MY; Zhang, JG; Ronchi, D; Bonato, S; Fagiolari, G; Moggio, M; Ghezzi, D; Zeviani, M				Reyes, Aurelio; Melchionda, Laura; Nasca, Alessia; Carrara, Franco; Lamantea, Eleonora; Zanolini, Alice; Lamperti, Costanza; Fang, Mingyan; Zhang, Jianguo; Ronchi, Dario; Bonato, Sara; Fagiolari, Gigliola; Moggio, Maurizio; Ghezzi, Daniele; Zeviani, Massimo			RNASEH1 Mutations Impair mtDNA Replication and Cause Adult-Onset Mitochondrial Encephalomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA REPLICATION; H1; POLYMERASE; EXPRESSION; SUBUNIT; DISEASE; CELLS; MICE	Chronic progressive external ophthalmoplegia (CPEO) is common in mitochondrial disorders and is frequently associated with multiple mtDNA deletions. The onset is typically in adulthood, and affected subjects can also present with general muscle weakness. The underlying genetic defects comprise autosomal-dominant or recessive mutations in several nuclear genes, most of which play a role in mtDNA replication. Next-generation sequencing led to the identification of compound-heterozygous RNASEH1 mutations in two singleton subjects and a homozygous mutation in four siblings. RNASEH1, encoding ribonuclease H1 (RNase H1), is an endonuclease that is present in both the nucleus and mitochondria and digests the RNA component of RNA-DNA hybrids. Unlike mitochondria, the nucleus harbors a second ribonuclease (RNase H2). All affected individuals first presented with CPEO and exercise intolerance in their twenties, and these were followed by muscle weakness, dysphagia, and spino-cerebellar signs with impaired gait coordination, dysmetria, and dysarthria. Ragged-red and cytochrome c oxidase (COX)-negative fibers, together with impaired activity of various mitochondrial respiratory chain complexes, were observed in muscle biopsies of affected subjects. Western blot analysis showed the virtual absence of RNase H1 in total lysate from mutant fibroblasts. By an in vitro assay, we demonstrated that altered RNase H1 has a reduced capability to remove the RNA from RNA-DNA hybrids, confirming their pathogenic role. Given that an increasing amount of evidence indicates the presence of RNA primers during mtDNA replication, this result might also explain the accumulation of mtDNA deletions and underscores the importance of RNase H1 for mtDNA maintenance.	[Reyes, Aurelio; Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Melchionda, Laura; Nasca, Alessia; Carrara, Franco; Lamantea, Eleonora; Zanolini, Alice; Lamperti, Costanza; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy; [Fang, Mingyan; Zhang, Jianguo] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Ronchi, Dario; Bonato, Sara] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neurol Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy; [Fagiolari, Gigliola; Moggio, Maurizio] Univ Milan, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Neuromuscular Unit,Neurosci Sect,Dino Ferrari Ctr, I-20122 Milan, Italy	IRCCS Istituto Neurologico Besta; Beijing Genomics Institute (BGI); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.	daniele.ghezzi@istituto-besta.it; mdz21@mrc-mbu.cam.ac.uk	Ghezzi, Daniele/J-7873-2016; lamperti, costanza/J-8801-2016; Lamantea, Eleonora/J-8339-2016; Zeviani, Massimo/AAU-2632-2021; Ronchi, Dario/K-8011-2016; Nasca, Alessia/K-2227-2016; Ronchi, Dario/O-4138-2019; Fang, Mingyan/B-8505-2017; Fang, Mingyan/M-9171-2019	Ghezzi, Daniele/0000-0002-6564-3766; lamperti, costanza/0000-0002-2280-2253; Lamantea, Eleonora/0000-0001-5090-6028; Zeviani, Massimo/0000-0002-9067-5508; Ronchi, Dario/0000-0002-6093-9816; Nasca, Alessia/0000-0002-0640-9929; Ronchi, Dario/0000-0002-6093-9816; Fang, Mingyan/0000-0001-7185-6445; Zhang, Jianguo/0000-0003-0723-1701	"Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks [GTB12001J]; EurobiobanK Network; Medical Research Council; Pierfranco and Luisa Mariani Foundation; Telethon [GGP11011]; Italian Ministry of Health [GR2010-2316392]; European Research Council [FP7-322424]; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish; MRC [MC_UP_1002/1] Funding Source: UKRI	"Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks(Fondazione Telethon); EurobiobanK Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pierfranco and Luisa Mariani Foundation; Telethon(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the "Cell Lines and DNA Bank of Paediatric Movement Disorders and Neurodegenerative Diseases" of the Telethon Network of Genetic Biobanks (grant GTB12001J) and the EurobiobanK Network. This work was supported by the Medical Research Council, the Pierfranco and Luisa Mariani Foundation, Telethon grant GGP11011, the Italian Ministry of Health (grant GR2010-2316392), and European Research Council advanced grant FP7-322424.	Alla NR, 2012, FEBS J, V279, P4492, DOI 10.1111/febs.12035; Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091; Cerritelli SM, 1998, GENOMICS, V53, P300, DOI 10.1006/geno.1998.5497; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971; Kazak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062340; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Lamperti C, 2009, Acta Myol, V28, P2; Nicholls TJ, 2014, HUM MOL GENET, V23, P6147, DOI 10.1093/hmg/ddu336; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196; Reyes A, 2009, METHODS MOL BIOL, V554, P15, DOI 10.1007/978-1-59745-521-3_2; Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014; Ruhanen H, 2011, BBA-MOL CELL RES, V1813, P2000, DOI 10.1016/j.bbamcr.2011.08.008; Stewart JD, 2011, BBA-MOL BASIS DIS, V1812, P321, DOI 10.1016/j.bbadis.2010.11.012; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wu HJ, 2001, J BIOL CHEM, V276, P23547, DOI 10.1074/jbc.M009676200; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392	22	66	67	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					186	193		10.1016/j.ajhg.2015.05.013	http://dx.doi.org/10.1016/j.ajhg.2015.05.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26094573	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000358189500017
J	Ebarasi, L; Ashraf, S; Bierzynska, A; Gee, HY; McCarthy, HJ; Lovric, S; Sadowski, CE; Pabst, W; Vega-Warner, V; Fang, H; Koziell, A; Simpson, MA; Dursun, I; Serdaroglu, E; Levy, S; Saleem, MA; Hildebrandt, F; Majumdar, A				Ebarasi, Lwaki; Ashraf, Shazia; Bierzynska, Agnieszka; Gee, Heon Yung; McCarthy, Hugh J.; Lovric, Svjetlana; Sadowski, Carolin E.; Pabst, Werner; Vega-Warner, Virginia; Fang, Humphrey; Koziell, Ania; Simpson, Michael A.; Dursun, Ismail; Serdaroglu, Erkin; Levy, Shawn; Saleem, Moin A.; Hildebrandt, Friedhelm; Majumdar, Arindam			Defects of CRB2 Cause Steroid-Resistant Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMERULAR SLIT DIAPHRAGM; ZEBRAFISH; NEPHRIN; IDENTIFICATION; MUTATIONS; SPECTRUM	Nephrotic syndrome (NS), the association of gross proteinuria, hypoalbuminaemia, edema, and hyperlipidemia, can be clinically divided into steroid-sensitive (SSNS) and steroid-resistant (SRNS) forms. SRNS regularly progresses to end-stage renal failure. By homozygosity mapping and whole exome sequencing, we here identify recessive mutations in Crumbs homolog 2 (CRB2) in four different families affected by SRNS. Previously, we established a requirement for zebrafish crb2b, a conserved regulator of epithelial polarity, in podocyte morphogenesis. By characterization of a loss-of-function mutation in zebrafish crb2b, we now show that zebrafish crb2b is required for podocyte foot process arborization, slit diaphragm formation, and proper nephrin trafficking. Furthermore, by complementation experiments in zebrafish, we demonstrate that CRB2 mutations result in loss of function and therefore constitute causative mutations leading to NS in humans. These results implicate defects in podocyte apico-basal polarity in the pathogenesis of NS.	[Ebarasi, Lwaki; Majumdar, Arindam] Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Ebarasi, Lwaki] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Ashraf, Shazia; Gee, Heon Yung; Lovric, Svjetlana; Sadowski, Carolin E.; Pabst, Werner; Fang, Humphrey; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Div Nephrol, Boston Childrens Hosp, Boston, MA 02115 USA; [Bierzynska, Agnieszka; McCarthy, Hugh J.; Saleem, Moin A.] Univ Bristol, Childrens & Acad Renal Unit, Bristol BS1 5NB, Avon, England; [Vega-Warner, Virginia] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Koziell, Ania] Kings Coll London, Dept Expt Immunobiol Med & Mol Genet, Guys Hosp, London SE1 9RT, England; [Simpson, Michael A.] Kings Coll London, Guys Hosp, London SE1 9RT, England; [Dursun, Ismail] Erciyes Univ, Dept Pediat Nephrol, TR-38039 Kayseri, Turkey; [Dursun, Ismail] Erciyes Univ, Dept Rheumatol, TR-38039 Kayseri, Turkey; [Serdaroglu, Erkin] Dr Behcet Uz Children Hosp, Dept Pediat Nephrol, TR-35210 Izmir, Turkey; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Uppsala University; Karolinska Institutet; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Bristol; University of Michigan System; University of Michigan; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Erciyes University; Erciyes University; Izmir Dr Behcet Uz Children's Disease & Surgery Training & Research Hospital; HudsonAlpha Institute for Biotechnology; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Div Nephrol, Boston Childrens Hosp, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu; arindam.majumdar@igp.uu.se	Serdaroglu, Erkin/N-3838-2019; Gee, Heon Yung/K-7781-2019; Serdaroglu, Erkin/E-9547-2016; Dursun, Ismail/AAN-5016-2020; Dursun, Ismail/AAW-7097-2020; Simpson, Michael/F-4737-2011	Serdaroglu, Erkin/0000-0002-6863-8866; Gee, Heon Yung/0000-0002-8741-6177; Serdaroglu, Erkin/0000-0002-6863-8866; Bierzynska, Agnieszka/0000-0002-7878-6096; Simpson, Michael/0000-0002-8539-8753; Levy, Shawn/0000-0002-1369-5740; Saleem, Moin/0000-0002-9808-4518; Ebarasi, Lwaki/0000-0001-7767-196X	NIH [DK076683, DK086542]; Nephcure Foundation; NephCure-ASN Foundation; HEFC; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Kids Kidney Research; Kidney Research UK; British Kidney Patients Association; MRC [G0800571] Funding Source: UKRI; Kidney Research UK [RP45/2008] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0800571] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086542, R01DK076683] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nephcure Foundation; NephCure-ASN Foundation; HEFC; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK)); British Kidney Patients Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge the late Michelle Winn (Duke University) for initial attempts at finding human CRB2 mutations. We thank Markus Affolter and Hans Georg Belting for the alpha-Pdxl2 antibody. Special thanks to Lars Holmgren (Karolinska Institute) and Lena Claesson-Welsh (Uppsala University) for their overall support and encouragement. We thank Leslie Steed for clinical samples, Giselbert Hauptmann and Iris Sol for zebrafish care, and Katarina Garpenstrand and Johan Ledin at the SciLife zebrafish, Uppsala University. The authors also thank the families who contributed to this study. This research was supported by grants from the NIH to F.H. (DK076683, DK086542) and by the Nephcure Foundation to F.H. H.Y.G. is supported by the NephCure-ASN Foundation Kidney Research grant. F.H. is an Investigator of the Howard Hughes Medical Institute and the Warren E. Grupe Professor. A.K. is supported by a HEFC Senior Clinical Lectureship. The research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, Kids Kidney Research, Kidney Research UK, and the British Kidney Patients Association. We would like to acknowledge RADAR, the UK SRNS study group, especially Dr. Larissa Kerecuk for participation and support. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	Alves CH, 2013, HUM MOL GENET, V22, P35, DOI 10.1093/hmg/dds398; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; [Anonymous], 1981, KIDNEY INT, V20, P765; Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Benoit G, 2010, PEDIATR NEPHROL, V25, P1621, DOI 10.1007/s00467-010-1495-0; Bujakowska K, 2012, HUM MUTAT, V33, P306, DOI 10.1002/humu.21653; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Fukasawa H, 2009, J AM SOC NEPHROL, V20, P1491, DOI 10.1681/ASN.2008101117; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Jao Li-En, 2008, Briefings in Functional Genomics & Proteomics, V7, P427, DOI 10.1093/bfgp/eln038; Katoh M, 2004, INT J ONCOL, V24, P743; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Lovric S, 2014, CLIN J AM SOC NEPHRO, V9, P1109, DOI 10.2215/CJN.09010813; Mekahli D, 2009, PEDIATR NEPHROL, V24, P1525, DOI 10.1007/s00467-009-1138-5; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Satoh D, 2014, J BIOCHEM, V156, P115, DOI 10.1093/jb/mvu022; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007	23	66	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					153	161		10.1016/j.ajhg.2014.11.014	http://dx.doi.org/10.1016/j.ajhg.2014.11.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557779	Green Published, Bronze			2022-12-18	WOS:000347707800012
J	Colin, E; Cong, EH; Mollet, G; Guichet, A; Gribouval, O; Arrondel, C; Boyer, O; Daniel, L; Gubler, MC; Ekinci, Z; Tsimaratos, M; Chabrol, B; Boddaert, N; Verloes, A; Chevrollier, A; Gueguen, N; Desquiret-Dumas, V; Ferre, M; Procaccio, V; Richard, L; Funalot, B; Moncla, A; Bonneau, D; Antignac, C				Colin, Estelle; Cong, Evelyne Huynh; Mollet, Geraldine; Guichet, Agnes; Gribouval, Olivier; Arrondel, Christelle; Boyer, Olivia; Daniel, Laurent; Gubler, Marie-Claire; Ekinci, Zelal; Tsimaratos, Michel; Chabrol, Brigitte; Boddaert, Nathalie; Verloes, Alain; Chevrollier, Arnaud; Gueguen, Naig; Desquiret-Dumas, Valerie; Ferre, Marc; Procaccio, Vincent; Richard, Laurence; Funalot, Benoit; Moncla, Anne; Bonneau, Dominique; Antignac, Corinne			Loss-of-Function Mutations in WDR73 Are Responsible for Microcephaly and Steroid-Resistant Nephrotic Syndrome: Galloway-Mowat Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIFFUSE MESANGIAL SCLEROSIS; PROTEINS; PODOCYTES; WDR62; GLOMERULOPATHY; ARCHITECTURE; EXPRESSION; POLARITY; GROWTH; PLCE1	Galloway-Mowat syndrome is a rare autosomal-recessive condition characterized by nephrotic syndrome associated with microcephaly and neurological impairment. Through a combination of autozygosity mapping and whole-exome sequencing, we identified WDR73 as a gene in which mutations cause Galloway-Mowat syndrome in two unrelated families. WDR73 encodes a WD40-repeat-containing protein of unknown function. Here, we show that WDR73 was present in the brain and kidney and was located diffusely in the cytoplasm during interphase but relocalized to spindle poles and astral microtubules during mitosis. Fibroblasts from one affected child and WDR73-depleted podocytes displayed abnormal nuclear morphology, low cell viability and alterations of the microtubule network. These data suggest that WDR73 plays a crucial role in the maintenance of cell architecture and cell survival. Altogether, WDR73 mutations cause Galloway-Mowat syndrome in a particular subset of individuals presenting with late-onset nephrotic syndrome, postnatal microcephaly, severe intellectual disability and homogenous brain MRI features. WDR73 is another example of a gene involved in a disease affecting both the kidney glomerulus and the CNS.	[Colin, Estelle; Guichet, Agnes; Chevrollier, Arnaud; Gueguen, Naig; Desquiret-Dumas, Valerie; Ferre, Marc; Procaccio, Vincent; Bonneau, Dominique] Angers Univ Hosp, Dept Biochem & Genet, F-49933 Angers, France; [Colin, Estelle; Chevrollier, Arnaud; Gueguen, Naig; Desquiret-Dumas, Valerie; Ferre, Marc; Procaccio, Vincent; Bonneau, Dominique] Univ Nantes Angers Le Mans, CNRS 6214, F-49000 Angers, France; [Colin, Estelle; Chevrollier, Arnaud; Gueguen, Naig; Desquiret-Dumas, Valerie; Ferre, Marc; Procaccio, Vincent; Bonneau, Dominique] Univ Nantes Angers Le Mans, INSERM 1083, F-49000 Angers, France; [Cong, Evelyne Huynh; Mollet, Geraldine; Gribouval, Olivier; Arrondel, Christelle; Boyer, Olivia; Gubler, Marie-Claire; Antignac, Corinne] INSERM, Lab Inherited Kidney Dis, UMR 1163, F-75015 Paris, France; [Cong, Evelyne Huynh; Mollet, Geraldine; Gribouval, Olivier; Arrondel, Christelle; Boyer, Olivia; Gubler, Marie-Claire; Boddaert, Nathalie; Antignac, Corinne] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Boyer, Olivia; Gubler, Marie-Claire] Hop Necker Enfants Malad, AP HP, Dept Pediat Nephrol, F-75015 Paris, France; [Daniel, Laurent] Timone Hosp, Assistance Publ Hop Marseille, Dept Pathol, F-13385 Marseille, France; [Ekinci, Zelal] Kocaeli Univ, Fac Med, Dept Pediat Nephrol, TR-41380 Kocaeli, Turkey; [Tsimaratos, Michel] Timone Hosp, Assistance Publ Hop Marseille, Dept Pediat Nephrol, F-13385 Marseille, France; [Chabrol, Brigitte] Timone Hosp, Assistance Publ Hop Marseille, Dept Pediat Neurol, F-13385 Marseille, France; [Boddaert, Nathalie] Hop Necker Enfants Malad, AP HP, Dept Pediat Radiol, F-75015 Paris, France; [Verloes, Alain] Hop Robert Debre, AP HP, Dept Genet, F-75015 Paris, France; [Verloes, Alain] Univ Paris Diderot, F-75015 Paris, France; [Richard, Laurence; Funalot, Benoit] Limoges Univ Hosp, Dept Neurol, F-87000 Limoges, France; [Richard, Laurence; Funalot, Benoit] Limoges Univ Hosp, Dept Biochem, F-87000 Limoges, France; [Richard, Laurence; Funalot, Benoit] Limoges Univ Hosp, Dept Genet, F-87000 Limoges, France; [Moncla, Anne] Timone Hosp, Assistance Publ Hop Marseille, Dept Genet, F-13385 Marseille, France; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Kocaeli University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Limoges; CHU Limoges; CHU Limoges; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Antignac, C (corresponding author), INSERM, Lab Inherited Kidney Dis, UMR 1163, F-75015 Paris, France.	corinne.antignac@inserm.fr	Tsimaratos, Michel/AAS-5740-2021; boddaert, nathalie/GWV-2865-2022; ANTIGNAC, Corinne/H-8945-2017; Mollet, Geraldine/E-8049-2017; LENAERS, Guy/K-2421-2015; colin, estelle/AAI-2447-2019; colin, estelle/K-6398-2015; CHEVROLLIER, Arnaud/K-2853-2015; Boyer, Olivia Gillion/H-9469-2017; CHEVROLLIER, Arnaud/P-6630-2019; FERRE, Marc/B-4103-2010; CHEVROLLIER, Arnaud/GSD-3887-2022; Naig, Gueguen/K-2699-2015; /AAK-8500-2021; Bonneau, Dominique/K-6110-2015; Gribouval, Olivier/A-7689-2015; Desquiret-Dumas, Valérie/K-2695-2015; Procaccio, Vincent/M-2596-2015; daniel, laurent/R-2826-2016; ARRONDEL, Christelle/H-8908-2017	Tsimaratos, Michel/0000-0001-6027-0721; ANTIGNAC, Corinne/0000-0002-9934-4940; Mollet, Geraldine/0000-0003-4685-5736; LENAERS, Guy/0000-0003-2736-3349; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Boyer, Olivia Gillion/0000-0002-3957-1359; CHEVROLLIER, Arnaud/0000-0002-5135-6643; FERRE, Marc/0000-0001-8265-7249; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Naig, Gueguen/0000-0002-3094-8121; Gribouval, Olivier/0000-0003-0238-8224; Funalot, Benoit/0000-0001-6352-6518; Desquiret-Dumas, Valerie/0000-0001-9551-9400; Bonneau, Dominique/0000-0002-6886-0969; daniel, laurent/0000-0002-7539-0109; boddaert, nathalie/0000-0003-0991-7774; Gubler, Marie-Claire/0000-0002-3526-5661; ARRONDEL, Christelle/0000-0001-9522-4186; procaccio, Vincent/0000-0002-1537-4684	Agence Nationale de la Recherche [ANR-12-BSV1-0033.01]; European Union [305608-EURenOmics]; "Investments for the Future" program [ANR-10-IAHU-01]; Angers University Hospital; Ministere de l'Education Nationale de la Recherche et de la Technologie	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); "Investments for the Future" program; Angers University Hospital; Ministere de l'Education Nationale de la Recherche et de la Technologie	We thank Moin A. Saleem for kindly providing the conditionally immortalized human podocyte cell line. We greatly acknowledge the Necker Institute cell-imaging facility for providing expert knowledge on confocal microscopy. We are grateful to Integragen for exome sequencing. We thank Gisele Froment, Didier Negre, and Caroline Costa from the lentivector production facility Structure Federative de Recherche Biosciences Gerland-Lyon Sud (UMS3444/US8). We thank all the individuals with Galloway-Mowat syndrome and their families for their participation in this study. We thank Kalman Tory and Sophie Saunier for helpful discussions. Financial support for this work was provided by grants from the Agence Nationale de la Recherche (GenPod project ANR-12-BSV1-0033.01), the European Union's Seventh Framework Programme (FP7/2007-2013/no305608-EURenOmics), and the "Investments for the Future" program (ANR-10-IAHU-01) to C.A., from the Angers University Hospital to E.C., and from the Ministere de l'Education Nationale de la Recherche et de la Technologie to E.H.C.	Akchurin O., 2014, PEDIAT NEPHROL; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Dietrich A, 2008, PEDIATR NEPHROL, V23, P1779, DOI 10.1007/s00467-008-0880-4; Ekstrand JJ, 2012, PEDIATR NEUROL, V47, P129, DOI 10.1016/j.pediatrneurol.2012.04.011; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; FRIEDE RL, 1973, ACTA NEUROPATHOL, V23, P48, DOI 10.1007/BF00689004; GALLOWAY W H, 1968, Journal of Medical Genetics, V5, P319, DOI 10.1136/jmg.5.4.319; Gbadegesin R, 2008, NEPHROL DIAL TRANSPL, V23, P1291, DOI 10.1093/ndt/gfm759; Gerlitz G, 2013, CELL MOL LIFE SCI, V70, P1255, DOI 10.1007/s00018-012-1200-5; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Gilbert RD, 2009, KIDNEY INT, V75, P415, DOI 10.1038/ki.2008.573; Hazza I, 1999, Saudi J Kidney Dis Transpl, V10, P171; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Huynh Cong E., 2014, J AM SOC NEPHROL, DOI 10.1681; Kang L, 2005, PRENATAL DIAG, V25, P159, DOI 10.1002/pd.1099; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Lewis TL, 2013, J CELL BIOL, V202, P837, DOI 10.1083/jcb.201305098; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Mahuzier A, 2012, J CELL BIOL, V198, P927, DOI 10.1083/jcb.201111009; Meyers KEC, 1999, AM J MED GENET, V82, P257, DOI 10.1002/(SICI)1096-8628(19990129)82:3<257::AID-AJMG12>3.0.CO;2-7; Mollet G, 2009, J AM SOC NEPHROL, V20, P2181, DOI 10.1681/ASN.2009040379; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Pezzella M, 2010, SEIZURE-EUR J EPILEP, V19, P132, DOI 10.1016/j.seizure.2009.12.002; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; Recino A, 2010, BIOCHEM J, V430, P207, DOI 10.1042/BJ20100883; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sartelet H, 2008, PATHOL RES PRACT, V204, P401, DOI 10.1016/j.prp.2007.12.007; Sistani L, 2013, KIDNEY INT, V83, P63, DOI 10.1038/ki.2012.321; Steiss JO, 2005, NEUROPEDIATRICS, V36, P332, DOI 10.1055/s-2005-872842; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093999; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065705; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yu CS, 2012, ONCOL REP, V28, P949, DOI 10.3892/or.2012.1882; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	42	66	71	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					637	648		10.1016/j.ajhg.2014.10.011	http://dx.doi.org/10.1016/j.ajhg.2014.10.011			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25466283	Green Published, Bronze			2022-12-18	WOS:000346623100001
J	Thomas, AC; Williams, H; Seto-Salvia, N; Bacchelli, C; Jenkins, D; O'Sullivan, M; Mengrelis, K; Ishida, M; Ocaka, L; Chanudet, E; James, C; Lescai, F; Anderson, G; Morrogh, D; Ryten, M; Duncan, AJ; Pai, YJ; Saraiva, JM; Ramos, F; Farren, B; Saunders, D; Vernay, B; Gissen, P; Straatmaan-Iwanowska, A; Baas, F; Wood, NW; Hersheson, J; Houlden, H; Hurst, J; Scott, R; Bitner-Glindzicz, M; Moore, GE; Sousa, SB; Stanier, P				Thomas, Anna C.; Williams, Hywel; Seto-Salvia, Nuria; Bacchelli, Chiara; Jenkins, Dagan; O'Sullivan, Mary; Mengrelis, Konstantinos; Ishida, Miho; Ocaka, Louise; Chanudet, Estelle; James, Chela; Lescai, Francesco; Anderson, Glenn; Morrogh, Deborah; Ryten, Mina; Duncan, Andrew J.; Pai, Yun Jin; Saraiva, Jorge M.; Ramos, Fabiana; Farren, Bernadette; Saunders, Dawn; Vernay, Bertrand; Gissen, Paul; Straatmaan-Iwanowska, Anna; Baas, Frank; Wood, Nicholas W.; Hersheson, Joshua; Houlden, Henry; Hurst, Jane; Scott, Richard; Bitner-Glindzicz, Maria; Moore, Gudrun E.; Sousa, Sergio B.; Stanier, Philip			Mutations in SNX14 Cause a Distinctive Autosomal-Recessive Cerebellar Ataxia and Intellectual Disability Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; COPY-NUMBER VARIATION; DNA-SEQUENCING DATA; SORTING NEXIN; DEVELOPMENTAL DELAY; HUMAN BRAIN; GENE; DISEASE; GENOME; BIOGENESIS	Intellectual disability and cerebellar atrophy occur together in a large number of genetic conditions and are frequently associated with microcephaly and/or epilepsy. Here we report the identification of causal mutations in Sorting Nexin 14 (SNX14) found in seven affected individuals from three unrelated consanguineous families who presented with recessively inherited moderate-severe intellectual disability, cerebellar ataxia, early-onset cerebellar atrophy, sensorineural hearing loss, and the distinctive association of progressively coarsening facial features, relative macrocephaly, and the absence of seizures. We used homozygosity mapping and whole-exome sequencing to identify a homozygous nonsense mutation and an in-frame multiexon deletion in two families. A homozygous splice site mutation was identified by Sanger sequencing of SNX14 in a third family, selected purely by phenotypic similarity. This discovery confirms that these characteristic features represent a distinct and recognizable syndrome. SNX14 encodes a cellular protein containing Phox (PX) and regulator of G protein signaling (RGS) domains. Weighted gene coexpression network analysis predicts that SNX14 is highly coexpressed with genes involved in cellular protein metabolism and vesicle-mediated transport. All three mutations either directly affected the PX domain or diminished SNX14 levels, implicating a loss of normal cellular function. This manifested as increased cytoplasmic vacuolation as observed in cultured fibroblasts. Our findings indicate an essential role for SNX14 in neural development and function, particularly in development and maturation of the cerebellum.	[Thomas, Anna C.; Williams, Hywel; Seto-Salvia, Nuria; Bacchelli, Chiara; Jenkins, Dagan; O'Sullivan, Mary; Mengrelis, Konstantinos; Ishida, Miho; Ocaka, Louise; Chanudet, Estelle; James, Chela; Lescai, Francesco; Duncan, Andrew J.; Pai, Yun Jin; Vernay, Bertrand; Gissen, Paul; Straatmaan-Iwanowska, Anna; Bitner-Glindzicz, Maria; Moore, Gudrun E.; Sousa, Sergio B.; Stanier, Philip] UCL Inst Child Hlth, London WC1N 1EH, England; [Williams, Hywel; Bacchelli, Chiara; Ocaka, Louise; Chanudet, Estelle; James, Chela; Lescai, Francesco] UCL Inst Child Hlth, Ctr Translat Om GOSgene, London WC1N 1EH, England; [Lescai, Francesco] Aarhus Univ, Dept Biomed, iPSYCH, DK-8000 Aarhus, Denmark; [Anderson, Glenn] Great Ormond St Hosp Sick Children, Histopathol Dept, London WC1N 3JH, England; [Morrogh, Deborah] NE Thames Reg Genet Lab Serv, London WC1N 3BH, England; [Ryten, Mina; Wood, Nicholas W.; Hersheson, Joshua; Houlden, Henry] UCL Inst Neurol, London WC1N 3BG, England; [Ryten, Mina] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Saraiva, Jorge M.; Ramos, Fabiana; Sousa, Sergio B.] Ctr Hosp Coimbra, Hosp Pediat, Serv Genet Med, P-3000602 Coimbra, Portugal; [Saraiva, Jorge M.; Ramos, Fabiana; Sousa, Sergio B.] Univ Coimbra, P-3000602 Coimbra, Portugal; [Saraiva, Jorge M.] Univ Coimbra, Fac Med, Univ Clin Pediat, P-3000602 Coimbra, Portugal; [Farren, Bernadette; Saunders, Dawn; Hurst, Jane; Scott, Richard; Bitner-Glindzicz, Maria] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands	University of London; University College London; University of London; University College London; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Universidade de Coimbra; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam	Sousa, SB (corresponding author), UCL Inst Child Hlth, London WC1N 1EH, England.	sbsousa@chc.min-saude.pt; p.stanier@ucl.ac.uk	Houlden, Henry J/C-1532-2008; e, Chanudet/N-4064-2015; Seto-Salvia, Nuria/K-4546-2014; Williams, Hywel/AAL-2440-2021; Baas, Frank/F-9574-2010; Bitner-Glindzicz, Maria/A-4231-2009; Wood, Nicholas W/C-2505-2009; Moore, Gudrun/A-2092-2009; Ryten, Mina/Q-8419-2016; Stanier, Philip/C-1593-2008; O'Sullivan, Mary/U-3763-2017	Houlden, Henry J/0000-0002-2866-7777; Seto-Salvia, Nuria/0000-0002-3753-0027; Williams, Hywel/0000-0001-7758-0312; Baas, Frank/0000-0003-3912-5428; Wood, Nicholas W/0000-0002-9500-3348; Stanier, Philip/0000-0001-9340-8117; O'Sullivan, Mary/0000-0002-8700-6047; Ramos, Fabiana/0000-0001-7780-9762; Gissen, Paul/0000-0002-9712-6122; Lescai, Francesco/0000-0002-6399-9101; Vernay, Bertrand/0000-0002-7843-3872; Moore, Gudrun/0000-0002-2099-3420; Saraiva, Jorge Manuel/0000-0002-7232-3509; james, chela/0000-0003-3996-0909	Fundacao para a Ciencia e Tecnologia [SFRH/BD/46778/2008]; Wellbeing of Women; MRC; Sparks; National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; Joshua Deeth foundation; NIHR BRC; NIHR BRC at Great Ormond Street Hospital for Children NHS Foundation Trust; MRC [MR/K01417X/1, MR/L009978/1, MR/J004758/1, G0802462, G0802760, G108/638, G1001253] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/L009978/1, G0802760, MR/J004758/1, G108/638, MR/K01417X/1, G1001253, G0802462] Funding Source: researchfish; National Institute for Health Research [ACF-2007-18-011, ACF-2012-17-017] Funding Source: researchfish; Brain Research UK [UCCHoulden] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellbeing of Women(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sparks; National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Institute of Child Health; Joshua Deeth foundation; NIHR BRC; NIHR BRC at Great Ormond Street Hospital for Children NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Brain Research UK	We would like to thank the families who contributed to this study. We would also like to thank the expert assistance of Kerra Pearce (UCL Genomics) for running the SNP genotyping arrays, Osama Alsmadi and Dinu Antony for exome sequencing at The Dasman Diabetes Institute Genome Centre (Kuwait City), and Manuela Grazina (Faculty of Medicine, University of Coimbra) and Biljana Lukovic (Chemical Pathology, Great Ormond Street Hospital for Children) for providing an affected individual's fibroblast culture. P.S. is supported by the Great Ormond Street Hospital Children's Charity. S.B.S. was supported by Fundacao para a Ciencia e Tecnologia (SFRH/BD/46778/2008). A.C.T. is a Wellbeing of Women Research Associate, G.E.M.'s Fetal Growth and Development research group is supported by Wellbeing of Women, MRC, Sparks and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) at Great Ormond Street Hospital for Children NHS Foundation Trust, and UCL Institute of Child Health. F.B. is supported by the Joshua Deeth foundation. We thank the additional members of the GOSgene Scientific Advisory Board (Philip Beales, Robert Kleta, Horia Stanesku, Nicholas Lench, Bobby Gaspar, Michael Hubank, and Ella Stupka). GOS-gene is supported by the NIHR BRC at Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Institute of Child Health. This report is independent research by the NIHR BRC Funding Scheme. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y; Ba W, 2013, EXP CELL RES, V319, P2368, DOI 10.1016/j.yexcr.2013.05.033; Bin Z, 2004, MOL BIOL CELL, V15, P5538, DOI 10.1091/mbc.E04-06-0446; Boczonadi V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5287; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; D'Arrigo S, 2005, J CHILD NEUROL, V20, P859, DOI 10.1177/08830738050200110101; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Elmali F, 2012, PEDIATR NEUROL, V46, P307, DOI 10.1016/j.pediatrneurol.2012.02.016; Evereklioglu C, 2002, CLEFT PALATE-CRAN J, V39, P208, DOI 10.1597/1545-1569(2002)039<0208:CAIATP>2.0.CO;2; Ezgu F, 2014, CLIN GENET, V86, P74, DOI 10.1111/cge.12230; Huang HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098383; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Konopka G, 2011, WIRES SYST BIOL MED, V3, P628, DOI 10.1002/wsbm.139; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee Kyung-Min, 2013, Exp Neurobiol, V22, P133, DOI 10.5607/en.2013.22.3.133; Lowry RB, 2013, MOL SYNDROMOL, V4, P280, DOI 10.1159/000354038; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Namavar Y, 2011, EUR J HUM GENET, V19, P724, DOI 10.1038/ejhg.2011.8; Pangrazio A, 2013, J BONE MINER RES, V28, P1041, DOI 10.1002/jbmr.1849; Philip N, 2003, J MED GENET, V40, P441, DOI 10.1136/jmg.40.6.441; Poretti A, 2008, EUR J PAEDIATR NEURO, V12, P155, DOI 10.1016/j.ejpn.2007.07.010; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Sousa SB, 2014, AM J MED GENET A, V164, P10, DOI 10.1002/ajmg.a.36235; Strehle EM, 2003, GENET TEST, V7, P113, DOI 10.1089/109065703322146795; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; TURLEAU C, 1988, CLIN GENET, V34, P38; Van Esch H, 2010, J MED GENET, V47, P717, DOI 10.1136/jmg.2010.077586; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Waterham HR, 2012, BBA-MOL BASIS DIS, V1822, P1430, DOI 10.1016/j.bbadis.2012.04.006; Wentzel C, 2010, MOL SYNDROMOL, V1, P75, DOI 10.1159/000314025; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zheng B, 2006, P NATL ACAD SCI USA, V103, P16776, DOI 10.1073/pnas.0607974103; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	50	66	68	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					611	621		10.1016/j.ajhg.2014.10.007	http://dx.doi.org/10.1016/j.ajhg.2014.10.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439728	Green Published, hybrid			2022-12-18	WOS:000344845000012
J	Gee, HY; Ashraf, S; Wan, XY; Vega-Warner, V; Esteve-Rudd, J; Lovric, S; Fang, H; Hurd, TW; Sadowski, CE; Allen, SJ; Otto, EA; Korkmaz, E; Washburn, J; Levy, S; Williams, DS; Bakkaloglu, SA; Zolotnitskaya, A; Ozaltin, F; Zhou, WB; Hildebrandt, F				Gee, Heon Yung; Ashraf, Shazia; Wan, Xiaoyang; Vega-Warner, Virginia; Esteve-Rudd, Julian; Lovric, Svjetlana; Fang, Humphrey; Hurd, Toby W.; Sadowski, Carolin E.; Allen, Susan J.; Otto, Edgar A.; Korkmaz, Emine; Washburn, Joseph; Levy, Shawn; Williams, David S.; Bakkaloglu, Sevcan A.; Zolotnitskaya, Anna; Ozaltin, Fatih; Zhou, Weibin; Hildebrandt, Friedhelm			Mutations in EMP2 Cause Childhood-Onset Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPITHELIAL MEMBRANE PROTEIN-2; SURFACE EXPRESSION; CAVEOLAE	Nephrotic syndrome (NS) is a genetically heterogeneous group of diseases that are divided into steroid-sensitive NS (SSNS) and steroid-resistant NS (SRNS). SRNS inevitably leads to end-stage kidney disease, and no curative treatment is available. To date, mutations in more than 24 genes have been described in Mendelian forms of SRNS; however, no Mendelian form of SSNS has been described. To identify a genetic form of SSNS, we performed homozygosity mapping, whole-exome sequencing, and multiplex PCR followed by next-generation sequencing. We thereby detected biallelic mutations in EMP2 (epithelial membrane protein 2) in four individuals from three unrelated families affected by SRNS or SSNS. We showed that EMP2 exclusively localized to glomeruli in the kidney. Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of mutated EMP2 in human NS. At the cellular level, we showed that knockdown of EMP2 in podocytes and endothelial cells resulted in an increased amount of CAVEOLIN-1 and decreased cell proliferation. Our data therefore identify EMP2 mutations as causing a recessive Mendelian form of SSNS.	[Gee, Heon Yung; Ashraf, Shazia; Lovric, Svjetlana; Fang, Humphrey; Sadowski, Carolin E.; Hildebrandt, Friedhelm] Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Gee, Heon Yung; Ashraf, Shazia; Lovric, Svjetlana; Fang, Humphrey; Sadowski, Carolin E.; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wan, Xiaoyang; Vega-Warner, Virginia; Allen, Susan J.; Otto, Edgar A.; Zhou, Weibin] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Esteve-Rudd, Julian; Williams, David S.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hurd, Toby W.] Univ Edinburgh, Inst Genet & Mol Med, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Korkmaz, Emine; Ozaltin, Fatih] Hacettepe Univ, Nephrogenet Lab, Fac Med, TR-06100 Ankara, Turkey; [Washburn, Joseph] Univ Michigan, Biomed Res Core Facil, Ann Arbor, MI 48109 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Bakkaloglu, Sevcan A.] Gazi Univ, Dept Pediat Nephrol, Fac Med, TR-06570 Ankara, Turkey; [Zolotnitskaya, Anna] New York Med Coll, Valhalla, NY 10595 USA; [Ozaltin, Fatih] Hacettepe Univ, Dept Pediat Nephrol, Fac Med, TR-06100 Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Ctr Biobanking & Genom, TR-06100 Ankara, Turkey; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Edinburgh; Hacettepe University; University of Michigan System; University of Michigan; HudsonAlpha Institute for Biotechnology; Gazi University; New York Medical College; Hacettepe University; Hacettepe University; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu	Gee, Heon Yung/K-7781-2019; Bakkaloglu, Sevcan/AAE-9884-2021	Gee, Heon Yung/0000-0002-8741-6177; Wan, Xiaoyang/0000-0002-8871-2015; Otto, Edgar/0000-0002-2387-9973; Levy, Shawn/0000-0002-1369-5740	NIH [DK076683, DK086542, DK090917, DK091405, EY07042]; Nephcure Foundation; European Commission [2012-305608]; Scientific and Technological Research Council of Turkey [TUBITAK 108S417]; Hacettepe University Infrastructure Project [06A101008, 011A101003]; NATIONAL EYE INSTITUTE [R01EY013408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090917, R00DK091405, RC1DK086542, R01DK076683] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nephcure Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Hacettepe University Infrastructure Project(Hacettepe University); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the families who contributed to this study. We thank David M. Briscoe (Boston Children's Hospital) for materials and helpful discussion. This research was supported by NIH grants to F.H. (DK076683 and DK086542), E.A.O. (DK090917), W.Z. (DK091405), and D.S.W. (EY07042) and by a Nephcure Foundation grant (to F.H.). F.O. was supported by the European Commission Seventh Framework Programme (EURenOmics, 2012-305608), the Scientific and Technological Research Council of Turkey (TUBITAK 108S417), and the Hacettepe University Infrastructure Project (06A101008 and 011A101003). H.Y.G. is a research fellow of the American Society of Nephrology. W.Z. is a Carl W. Gottschalk Scholar. D.S.W is a Jules and Doris Stein Research to Prevent Blindness Professor. F.H. is an investigator of the Howard Hughes Medical Institute, and Warren E. Grupe is a professor of pediatrics at the Harvard Medical School.	[Anonymous], 1978, Kidney Int, V13, P159; Benoit G, 2010, PEDIATR NEPHROL, V25, P1621, DOI 10.1007/s00467-010-1495-0; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Forbes A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702117200; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hinkes BG, 2007, PEDIATRICS, V119, pE907, DOI 10.1542/peds.2006-2164; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; Morales SA, 2013, INVEST OPHTH VIS SCI, V54, P2367, DOI 10.1167/iovs.12-11013; Moriyama T, 2011, J CLIN PATHOL, V64, P504, DOI 10.1136/jcp.2010.087023; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Sorensson J, 2002, J AM SOC NEPHROL, V13, P2639, DOI 10.1097/01.ASN.0000033277.32822.23; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Taylor V, 1996, GENE, V175, P115, DOI 10.1016/0378-1119(96)00134-5; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2004, MOL BIOL CELL, V15, P2073, DOI 10.1091/mbc.E03-07-0488	24	66	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					884	890		10.1016/j.ajhg.2014.04.010	http://dx.doi.org/10.1016/j.ajhg.2014.04.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24814193	Green Published, Bronze			2022-12-18	WOS:000337331200008
J	Srour, M; Chitayat, D; Caron, V; Chassaing, N; Bitoun, P; Patry, L; Cordier, MP; Capo-Chichi, JM; Francannet, C; Calvas, P; Ragge, N; Dobrzeniecka, S; Hamdan, FF; Rouleau, GA; Tremblay, A; Michaud, JL				Srour, Myriam; Chitayat, David; Caron, Veronique; Chassaing, Nicolas; Bitoun, Pierre; Patry, Lysanne; Cordier, Marie-Pierre; Capo-Chichi, Jose-Mario; Francannet, Christine; Calvas, Patrick; Ragge, Nicola; Dobrzeniecka, Sylvia; Hamdan, Fadi F.; Rouleau, Guy A.; Tremblay, Andre; Michaud, Jacques L.			Recessive and Dominant Mutations in Retinoic Acid Receptor Beta in Cases with Microphthalmia and Diaphragmatic Hernia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATTHEW-WOOD-SYNDROME; STRA6 MUTATIONS; MOUSE FETUSES; ANOPHTHALMIA; ANOPHTHALMIA/MICROPHTHALMIA; ABNORMALITIES; MALFORMATIONS; TERATOGENICITY; MORPHOGENESIS; VARIANTS	Anophthalmia and/or microphthalmia, pulmonary hypoplasia, diaphragmatic hernia, and cardiac defects are the main features of PDAC syndrome. Recessive mutations in STRA6, encoding a membrane receptor for the retinol-binding protein, have been identified in some cases with PDAC syndrome, although many cases have remained unexplained. Using whole-exome sequencing, we found that two PDAC-syndrome-affected siblings, but not their unaffected sibling, were compound heterozygous for nonsense (c.355C>T [p.Arg119*]) and frameshift (c.1201_1202insCT [p.Ile403Serfs*15]) mutations in retinoic acid receptor beta (RARB). Transfection studies showed that p.Arg119* and p.Ile403Serfs*15 altered RARB had no transcriptional activity in response to ligands, confirming that the mutations induced a loss of function. We then sequenced RARB in 15 subjects with anophthalmia and/or microphthalmia and at least one other feature of PDAC syndrome. Surprisingly, three unrelated subjects with microphthalmia and diaphragmatic hernia showed de novo missense mutations affecting the same codon; two of the subjects had the c.1159C>T (Arg387Cys) mutation, whereas the other one carried the c.1159C>A (p.Arg387Ser) mutation. We found that compared to the wild-type receptor, p.Arg387Ser and p.Arg387Cys altered RARB induced a 2- to 3-fold increase in transcriptional activity in response to retinoic acid ligands, suggesting a gain-of-function mechanism. Our study thus suggests that both recessive and dominant mutations in RARB cause anophthalmia and/or microphthalmia and diaphragmatic hernia, providing further evidence of the crucial role of the retinoic acid pathway during eye development and organogenesis.	[Srour, Myriam; Caron, Veronique; Patry, Lysanne; Capo-Chichi, Jose-Mario; Hamdan, Fadi F.; Tremblay, Andre; Michaud, Jacques L.] Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada; [Chitayat, David] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Chitayat, David] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Chassaing, Nicolas; Calvas, Patrick] Ctr Hosp Univ Toulouse, Hop Purpan, Serv Genet Med, F-31059 Toulouse, France; [Chassaing, Nicolas; Calvas, Patrick] Univ Toulouse 3, Equipe Accueil 4555, F-31000 Toulouse, France; [Bitoun, Pierre] Ctr Hosp Univ Paris Nord, Hop Jean Verdier, AP HP, F-93140 Bondy, France; [Cordier, Marie-Pierre] Hosp Civils Lyon, Serv Genet, F-69677 Bron, France; [Francannet, Christine] Hop Hotel Dieu, Serv Genet Med, F-63058 Clermont Ferrand, France; [Ragge, Nicola] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England; [Ragge, Nicola] Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England; [Dobrzeniecka, Sylvia; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Lyon; CHU Clermont Ferrand; Oxford Brookes University; Birmingham Women's Hospital; McGill University	Michaud, JL (corresponding author), Ctr Hosp Univ St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada.	jacques.michaud@recherche-ste-justine.qc.ca		spiegelman, dan/0000-0003-4971-8868; Capo-Chichi, Jose-Mario/0000-0002-7440-3633; Bitoun, Pierre/0000-0001-6557-6826	Canadian Institute for Health Research; Canadian Institutes of Health Research [MOP 106499]; French Ministry of Health [PHRC 09 109 01]; Retina France	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); French Ministry of Health; Retina France	J.L.M. is a National Scientist of the Fonds de Recherche du Quebec - Sante. M.S. holds a clinician-scientist award from the Canadian Institute for Health Research. We wish to thank the members of the bioinformatic analysis team of Reseau de Medecine Genetique Appliquee du Quebec (Alexandre Dionne-Laporte, Dan Spiegelman, Edouard Henrion, and Ousmane Diallo) for the analysis of the exome sequencing data. This research was funded by a grant from the Canadian Institutes of Health Research (MOP 106499) to J.L.M. and by grants from the Clinical Research Hospital Program from the French Ministry of Health (PHRC 09 109 01) and Retina France to N.C.	BALKAN W, 1992, DEV BIOL, V151, P622, DOI 10.1016/0012-1606(92)90200-Z; Berryer MH, 2013, HUM MUTAT, V34, P385, DOI 10.1002/humu.22248; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chassaing N, 2013, CLIN GENET, V83, P244, DOI 10.1111/j.1399-0004.2012.01904.x; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Chitayat D, 2007, AM J MED GENET A, V143A, P1268, DOI 10.1002/ajmg.a.31788; Coles GL, 2013, P NATL ACAD SCI USA, V110, pE1898, DOI 10.1073/pnas.1222797110; Demers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007728; Desai TJ, 2006, DEV BIOL, V291, P12, DOI 10.1016/j.ydbio.2005.10.045; Farboud B, 2004, MOL ENDOCRINOL, V18, P2839, DOI 10.1210/me.2004-0236; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Ghyselinck NB, 1997, INT J DEV BIOL, V41, P425; Glass CK, 2000, GENE DEV, V14, P121; Greer JJ, 2003, PEDIATR RES, V53, P726, DOI 10.1203/01.PDR.0000062660.12769.E6; Hunker CM, 2006, BIOCHEM BIOPH RES CO, V340, P967, DOI 10.1016/j.bbrc.2005.12.099; Kallen B, 1996, INT J EPIDEMIOL, V25, P1009, DOI 10.1093/ije/25.5.1009; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Loureiro KD, 2005, AM J MED GENET A, V136A, P117, DOI 10.1002/ajmg.a.30744; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Ozeki H, 1999, EXP EYE RES, V68, P223, DOI 10.1006/exer.1998.0591; Ozeki H, 1998, JPN J OPHTHALMOL, V42, P162, DOI 10.1016/S0021-5155(97)00134-2; PADMANABHAN R, 1981, ACTA ANAT, V110, P291; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Shaw GM, 2005, AM J MED GENET A, V137A, P36, DOI 10.1002/ajmg.a.30840; Shi HH, 2012, ECOTOXICOLOGY, V21, P1465, DOI 10.1007/s10646-012-0900-9; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White T, 2008, MOL VIS, V14, P2458; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Zhou GM, 2001, MOL VIS, V7, P253	35	66	68	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					765	772		10.1016/j.ajhg.2013.08.014	http://dx.doi.org/10.1016/j.ajhg.2013.08.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075189	Green Published, Bronze			2022-12-18	WOS:000326305600019
J	Aschard, H; Chen, JB; Cornelis, MC; Chibnik, LB; Karlson, EW; Kraft, P				Aschard, Hugues; Chen, Jinbo; Cornelis, Marilyn C.; Chibnik, Lori B.; Karlson, Elizabeth W.; Kraft, Peter			Inclusion of Gene-Gene and Gene-Environment Interactions Unlikely to Dramatically Improve Risk Prediction for Complex Diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER RISK; SINGLE-NUCLEOTIDE POLYMORPHISMS; RHEUMATOID-ARTHRITIS; DISCRIMINATORY ACCURACY; COMMON DISEASES; ROC CURVE; VARIANTS; MODELS; SUSCEPTIBILITY	Genome-wide association studies have identified hundreds of common genetic variants associated with the risk of multifactorial diseases. However, their impact on discrimination and risk prediction is limited. It has been suggested that the identification of gene-gene (G-G) and gene-environment (G-E) interactions would improve disease prediction and facilitate prevention. We conducted a simulation study to explore the potential improvement in discrimination if G-G and G-E interactions exist and are known. We used three diseases (breast cancer, type 2 diabetes, and rheumatoid arthritis) as motivating examples. We show that the inclusion of G-G and G-E interaction effects in risk-prediction models is unlikely to dramatically improve the discrimination ability of these models.	[Aschard, Hugues; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Aschard, Hugues; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chen, Jinbo] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Cornelis, Marilyn C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chibnik, Lori B.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Karlson, Elizabeth W.] Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Aschard, H (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	haschard@hsph.harvard.edu		Chibnik, Lori/0000-0001-6293-806X	Fondation Bettencourt Schueller;  [R21 DK084529];  [2P01CA87969-11];  [AR049880];  [P60 AR047782]; NATIONAL CANCER INSTITUTE [P01CA087969, U19CA148065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049880, P60AR047782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084529] Funding Source: NIH RePORTER	Fondation Bettencourt Schueller; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants R21 DK084529, 2P01CA87969-11, AR049880, and P60 AR047782 and by the Fondation Bettencourt Schueller.	Bookman E.B., 2011, GENET EPIDEMIOL; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cornelis MC, 2012, AM J EPIDEMIOL, V175, P191, DOI 10.1093/aje/kwr368; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Costenbader KH, 2006, AM J MED, V119, P503, DOI 10.1016/j.amjmed.2005.09.053; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hughes DA, 2004, PHARMACOGENETICS, V14, P335, DOI 10.1097/00008571-200406000-00002; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Karlson EW, 2009, ARTHRITIS RHEUM-US, V60, P641, DOI 10.1002/art.24350; Karlson EW, 2004, ARTHRITIS RHEUM-US, V50, P3458, DOI 10.1002/art.20621; Khoury MJ, 2004, GENET MED, V6, P38, DOI 10.1097/01.GIM.0000105751.71430.79; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindstrom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017142; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Mechanic L.E., 2011, GENET EPIDEMIOL; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Milne RL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2797; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore S.C., 2011, OBESITY; Mukherjee B, 2012, AM J EPIDEMIOL, V175, P177, DOI 10.1093/aje/kwr367; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pepe M.S., 2003, STAT EVALUATION MED; Pepe MS, 2008, JNCI-J NATL CANCER I, V100, P978, DOI 10.1093/jnci/djn215; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi L, 2010, CURR OPIN LIPIDOL, V21, P31, DOI 10.1097/MOL.0b013e3283346cb6; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rose G., 1992, STRATEGY PREVENTIVE; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; SIEMIATYCKI J, 1981, INT J EPIDEMIOL, V10, P383, DOI 10.1093/ije/10.4.383; So HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001230; Spitz MR, 2009, J NATL CANCER I, V101, P1731, DOI 10.1093/jnci/djp394; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Thomas DC, 2012, AM J EPIDEMIOL, V175, P203, DOI 10.1093/aje/kwr365; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849	66	66	69	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					962	972		10.1016/j.ajhg.2012.04.017	http://dx.doi.org/10.1016/j.ajhg.2012.04.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22633398	Green Published, Bronze			2022-12-18	WOS:000305262600003
J	Caputo, V; Cianetti, L; Niceta, M; Carta, C; Ciolfi, A; Bocchinfuso, G; Carrani, E; Dentici, ML; Biamino, E; Belligni, E; Garavelli, L; Boccone, L; Melis, D; Andria, G; Gelb, BD; Stella, L; Silengo, M; Dallapiccola, B; Tartaglia, M				Caputo, Viviana; Cianetti, Luciano; Niceta, Marcello; Carta, Claudio; Ciolfi, Andrea; Bocchinfuso, Gianfranco; Carrani, Eugenio; Dentici, Maria Lisa; Biamino, Elisa; Belligni, Elga; Garavelli, Livia; Boccone, Loredana; Melis, Daniela; Andria, Generoso; Gelb, Bruce D.; Stella, Lorenzo; Silengo, Margherita; Dallapiccola, Bruno; Tartaglia, Marco			A Restricted Spectrum of Mutations in the SMAD4 Tumor-Suppressor Gene Underlies Myhre Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GELEOPHYSIC DYSPLASIA; JUVENILE POLYPOSIS; FEMALE; PROTEINS; DEFECTS; CANCER; MICE	Myhre syndrome is a developmental disorder characterized by reduced growth, generalized muscular hypertrophy, facial dysmorphism, deafness, cognitive deficits, joint stiffness, and skeletal anomalies. Here, by performing exome sequencing of a single affected individual and coupling the results to a hypothesis-driven filtering strategy, we establish that heterozygous mutations in SMAD4, which encodes for a transducer mediating transforming growth factor beta and bone morphogenetic protein signaling branches, underlie this rare Mendelian trait. Two recurrent de novo SMAD4 mutations were identified in eight unrelated subjects. Both mutations were missense changes altering Ile500 within the evolutionary conserved MAD homology 2 domain, a well known mutational hot spot in malignancies. Structural analyses suggest that the substituted residues are likely to perturb the binding properties of the mutant protein to signaling partners. Although SMAD4 has been established as a tumor suppressor gene somatically mutated in pancreatic, gastrointestinal, and skin cancers, and germline loss-of-function lesions and deletions of this gene have been documented to cause disorders that predispose individuals to gastrointestinal cancer and vascular dysplasias, the present report identifies a previously unrecognized class of mutations in the gene with profound impact on development and growth.	[Caputo, Viviana; Cianetti, Luciano; Niceta, Marcello; Carta, Claudio; Ciolfi, Andrea; Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Bocchinfuso, Gianfranco; Stella, Lorenzo] Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy; [Carrani, Eugenio] Ist Super Sanita, Serv Informat Documentaz Biblioteca & Att Editori, I-00161 Rome, Italy; [Dentici, Maria Lisa; Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, I-00165 Rome, Italy; [Biamino, Elisa; Belligni, Elga; Silengo, Margherita] Univ Torino, Dipartimento Sci Pediat, I-10126 Turin, Italy; [Garavelli, Livia] Ist Ric & Cura Carattere Sci Arcispedale Santa Ma, Dipartimento Ostetr Ginecol & Pediat, Genet Clin, I-42123 Reggio Emilia, Italy; [Boccone, Loredana] Osped Microcitem, Clin Pediat 2, I-09121 Cagliari, Italy; [Melis, Daniela; Andria, Generoso] Univ Naples Federico II, Fac Med & Chirurg, Dipartimento Pediat, I-80131 Naples, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Stella, Lorenzo] IRCCS, I-86077 Pozzilli, IS, Italy	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Turin; University of Naples Federico II; Icahn School of Medicine at Mount Sinai	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it	Niceta, Marcello/V-1557-2019; Garavelli, Livia/AAA-8132-2021; Dentici, Maria Lisa/AAC-7654-2022; Bocchinfuso, Gianfranco/E-9014-2011; Tartaglia, Marco/K-2955-2018; Melis, Daniela/AAD-3623-2019; Carta, Claudio/A-7305-2013; Stella, Lorenzo/A-7996-2010; Ciolfi, Andrea/J-4954-2018; andria, generoso/V-7172-2019; Dallapiccola, Bruno/K-8692-2016	Niceta, Marcello/0000-0003-4766-7753; Garavelli, Livia/0000-0002-7684-3982; Dentici, Maria Lisa/0000-0002-9505-5906; Bocchinfuso, Gianfranco/0000-0002-5556-7691; Tartaglia, Marco/0000-0001-7736-9672; Melis, Daniela/0000-0002-9458-3926; Carta, Claudio/0000-0003-3545-198X; Stella, Lorenzo/0000-0002-5489-7381; Ciolfi, Andrea/0000-0002-6191-0978; Dallapiccola, Bruno/0000-0002-5031-1013; Boccone, Loredana/0000-0002-0168-0322; Silengo, Margherita/0000-0002-6255-1532	Telethon-Italy [GGP10020]; Associazione Italiana per la Ricerca sul Cancro [8803]; Collaborazione Italia-USA; Italian Ministry of Health (Ricerca Corrente)	Telethon-Italy(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Collaborazione Italia-USA; Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	We are indebted to the families who participated in the study, the physicians who referred the subjects, and Valentina Fodale, Francesca Pantaleoni, Viviana Cordeddu, and Serenella Venanzi (Istituto Superiore di Sanita, Rome, Italy) for experimental support. We thank the colleagues at the SIDBAE (Istituto Superiore di Sanita) for information technology support. This research was funded by grants from Telethon-Italy (GGP10020), Associazione Italiana per la Ricerca sul Cancro Investigator Grant 2009 (8803), and "Collaborazione Italia-USA" to M.T, and Italian Ministry of Health (Ricerca Corrente 2011) to B.D and M.T.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ATTISANO L, 2001, GENOME BIOL, V2, P3010, DOI DOI 10.1186/GB-2001-2-8-REVIEWS3010; Bachmann-Gagescu R, 2011, CLIN DYSMORPHOL, V20, P156, DOI 10.1097/MCD.0b013e3283468043; Becerra-Solano LE, 2008, CLIN DYSMORPHOL, V17, P113, DOI 10.1097/MCD.0b013e3282f52828; BOTTANI A, 1995, AM J MED GENET, V59, P523, DOI 10.1002/ajmg.1320590423; Burglen L, 2003, J MED GENET, V40, P546, DOI 10.1136/jmg.40.7.546; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Descotte V., 2008, INBORN ERRORS DEV, P358; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Figuera LE, 1996, AM J MED GENET, V65, P361, DOI 10.1002/(SICI)1096-8628(19961111)65:4<361::AID-AJMG25>3.0.CO;2-R; Fontaine JF, 2011, NUCLEIC ACIDS RES, V39, pW455, DOI 10.1093/nar/gkr246; Gallione C, 2010, AM J MED GENET A, V152A, P333, DOI 10.1002/ajmg.a.33206; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Lindor NM, 2009, AM J MED GENET A, V149A, P798, DOI 10.1002/ajmg.a.32719; Lopez-Cardona MG, 2004, CLIN DYSMORPHOL, V13, P91, DOI 10.1097/00019605-200404000-00007; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McGowan R, 2011, EUR J MED GENET, V54, pE553, DOI 10.1016/j.ejmg.2011.07.001; Moustakas A, 2001, J CELL SCI, V114, P4359; MYHRE SA, 1981, CLIN GENET, V20, P1; Newfeld SJ, 1999, GENETICS, V152, P783; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Qin B, 1999, STRUCTURE, V7, P1493, DOI 10.1016/S0969-2126(00)88340-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rulli I, 2005, AM J MED GENET A, V134A, P100, DOI 10.1002/ajmg.a.30444; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Titomanlio L, 2001, AM J MED GENET, V103, P163, DOI 10.1002/ajmg.1517; van Steensel MAM, 2005, AM J MED GENET A, V139A, P127, DOI 10.1002/ajmg.a.30988; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902; Zhang HB, 1996, DEVELOPMENT, V122, P2977	46	66	67	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					161	169		10.1016/j.ajhg.2011.12.011	http://dx.doi.org/10.1016/j.ajhg.2011.12.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22243968	Green Published, hybrid			2022-12-18	WOS:000299409100017
J	Widen, E; Ripatti, S; Cousminer, DL; Surakka, I; Lappalainen, T; Jarvelin, MR; Eriksson, JG; Raitakari, O; Salomaa, V; Sovio, U; Hartikainen, AL; Pouta, A; McCarthy, MI; Osmond, C; Kajantie, E; Lehtimaki, T; Viikari, J; Kahonen, M; Tyler-Smith, C; Freimer, N; Hirschhorn, JN; Peltonen, L; Palotie, A				Widen, Elisabeth; Ripatti, Samuli; Cousminer, Diana L.; Surakka, Ida; Lappalainen, Tuuli; Jaervelin, Marjo-Riitta; Eriksson, Johan G.; Raitakari, Olli; Salomaa, Veikko; Sovio, Ulla; Hartikainen, Anna-Liisa; Pouta, Anneli; McCarthy, Mark I.; Osmond, Clive; Kajantie, Eero; Lehtimaki, Terho; Viikari, Jorma; Kahonen, Mika; Tyler-Smith, Chris; Freimer, Nelson; Hirschhorn, Joel N.; Peltonen, Leena; Palotie, Aarno			Distinct Variants at LIN28B Influence Growth in Height from Birth to Adulthood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS-INDEX; SEQUENCE VARIANTS; CARDIOVASCULAR RISK; POSITIVE SELECTION; GENETIC-REGULATION; PUBERTAL GROWTH; YOUNG FINNS; AGE; MENARCHE	We have studied the largely unknown genetic underpinnings of height growth by using a unique resource of longitudinal childhood height data available in Finnish population cohorts. After applying GWAS mapping of potential genes influencing pubertal height growth followed by further characterization of the genetic effects on complete postnatal growth trajectories, we have identified strong association between variants near LIN28B and pubertal growth (rs7759938; female p = 4.0 x 10(-9), male p = 1.5 x 10(-4), combined p = 5.0 x 10(-11), n = 5038). Analysis of growth during early puberty confirmed an effect on the timing of the growth spurt. Correlated SNPs have previously been implicated as influencing both adult stature and age at menarche, the same alleles associating with taller height and later age of menarche in other studies as with later pubertal growth here. Additionally, a partially correlated LIN28B SNP, rs314277, has been associated previously with final height. Testing both rs7759938 and rs314277 (pairwise r(2) = 0.29) for independent effects on postnatal growth in 8903 subjects indicated that the pubertal timing-associated marker rs7759938 affects prepubertal growth in females (p = 7 x 10(-5)) and final height in males (p = 5 x 10(-4)), whereas rs314277 has sex-specific effects on growth (p for interaction = 0.005) that were distinct from those observed at rs7759938. In conclusion, partially correlated variants at LIN28B tag distinctive, complex, and sex-specific height-growth-regulating effects, influencing the entire period of postnatal growth. These findings imply a critical role for LIN28B in the regulation of human growth.	[Widen, Elisabeth; Ripatti, Samuli; Cousminer, Diana L.; Surakka, Ida; Lappalainen, Tuuli; Peltonen, Leena; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Ripatti, Samuli; Surakka, Ida; Eriksson, Johan G.; Salomaa, Veikko; Pouta, Anneli; Kajantie, Eero; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Lappalainen, Tuuli] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Lappalainen, Tuuli] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Jaervelin, Marjo-Riitta; Sovio, Ulla] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki 00029, Finland; [Eriksson, Johan G.] Univ Helsinki, Biomedicum Helsinki, Folkhalsan Res Ctr, FIN-00014 Helsinki, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20520 Turku, Finland; [Hartikainen, Anna-Liisa] Univ Oulu, Dept Obstet & Gynecol, SF-90220 Oulu, Finland; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Osmond, Clive] Univ Southampton, MRC Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; [Viikari, Jorma] Univ Turku, Dept Med, FIN-20520 Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, FIN-20520 Turku, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33521, Finland; [Lehtimaki, Terho; Kahonen, Mika] Tampere Univ Hosp, Tampere 33521, Finland; [Tyler-Smith, Chris; Peltonen, Leena; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Freimer, Nelson] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Freimer, Nelson] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.; Peltonen, Leena; Palotie, Aarno] Harvard & MIT, Broad Inst, Cambridge, MA 02142 USA	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Geneva; Imperial College London; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Turku; University of Turku; University of Oulu; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Southampton; Tampere University; Tampere University Hospital; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Wellcome Trust Sanger Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Widen, E (corresponding author), Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland.	elisabeth.widen@helsinki.fi	Lappalainen, Tuuli/AAE-6532-2020; Lehtimäki, Terho/AAD-1094-2022; Sovio, Ulla/H-8532-2019; Ripatti, Samuli/H-9446-2014; Raitakari, Olli/AAQ-7389-2021; McCarthy, Mark/M-3763-2015	Lappalainen, Tuuli/0000-0002-7746-8109; Lehtimäki, Terho/0000-0002-2555-4427; Sovio, Ulla/0000-0002-0799-1105; Ripatti, Samuli/0000-0002-0504-1202; Surakka, Ida/0000-0002-6669-5541; McCarthy, Mark/0000-0002-4393-0510; Kahonen, Mika/0000-0002-4510-7341; Palotie, Aarno/0000-0002-2527-5874; Osmond, Clive/0000-0002-9054-4655; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	European Community [FP7/2007-2013]; ENGAGE; Wellcome Trust [89061/Z/09/Z, WT089062]; European Commission [QLG2-CT-2002-01254]; Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics) [129680, 120315, 129287, 134839, 77841, 117832, 201888, 129494]; Social Insurance Institution of Finland, Turku University Foundation, Kuopio, Tampere; Turku University Hospital; Emil Aaltonen Foundation; Juho Vainio Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Medical Research Council [G0500539];  [HEALTH-F4-2007-201413]; Medical Research Council [U1475000004] Funding Source: researchfish	European Community(European Commission); ENGAGE; Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics)(Academy of Finland); Social Insurance Institution of Finland, Turku University Foundation, Kuopio, Tampere; Turku University Hospital; Emil Aaltonen Foundation; Juho Vainio Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded and/or partly funded through the European Community's Seventh Framework Programme (FP7/2007-2013); by the ENGAGE project; by grant agreement HEALTH-F4-2007-201413; by the Wellcome Trust (grants 89061/Z/09/Z and WT089062); by the European Commission under the programme "Quality of Life and Management of the Living Resources" of the 5th Framework Programme (QLG2-CT-2002-01254); by the Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics, grant 129680, grants 120315, 129287, and 134839 to E.W., grants 77841, 117832, and 201888 to OR., and grant 129494 to V.S.); by the Social Insurance Institution of Finland, Turku University Foundation, Kuopio, Tampere, and Turku University Hospital Medical Funds; by the Emil Aaltonen Foundation; by the Juho Vainio Foundation; by the Finnish Foundation of Cardiovascular Research; by the Finnish Cultural Foundation; and by the Medical Research Council (studentship grant G0500539 to U.S.). CT-S. is supported by The Wellcome Trust.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; FISCHBEIN S, 1977, ANN HUM BIOL, V4, P417, DOI 10.1080/03014467700002401; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Heistaro S., 2008, METHODOLOGY REPORT H; KAPRIO J, 1995, HUM BIOL, V67, P739; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Lappalainen T, 2010, EUR J HUM GENET, V18, P471, DOI 10.1038/ejhg.2009.184; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lettre G, 2009, CURR OPIN PEDIATR, V21, P515, DOI 10.1097/MOP.0b013e32832c6dce; Luo ZC, 2000, AM J EPIDEMIOL, V152, P125, DOI 10.1093/aje/152.2.125; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Okasha M, 2002, BEST PRACT RES CL EN, V16, P225, DOI 10.1053/beem.2002.0204; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Palmert MR, 2001, J CLIN ENDOCR METAB, V86, P2364, DOI 10.1210/jc.86.6.2364; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Perry RJ, 2008, CLIN ENDOCRINOL, V68, P4; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; SHARMA JC, 1983, ANN HUM BIOL, V10, P163, DOI 10.1080/03014468300006301; Silventoinen K, 2008, AM J HUM BIOL, V20, P292, DOI 10.1002/ajhb.20717; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Taponen S, 2004, J CLIN ENDOCR METAB, V89, P2114, DOI 10.1210/jc.2003-031720; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wehkalampi K, 2008, AM J HUM BIOL, V20, P417, DOI 10.1002/ajhb.20748; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	39	66	69	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					773	782		10.1016/j.ajhg.2010.03.010	http://dx.doi.org/10.1016/j.ajhg.2010.03.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20398887	hybrid, Green Published			2022-12-18	WOS:000278045300013
J	Edvardson, S; Shaag, A; Zenvirt, S; Erlich, Y; Hannon, GJ; Shanske, AL; Gomori, JM; Ekstein, J; Elpeleg, O				Edvardson, Simon; Shaag, Avraham; Zenvirt, Shamir; Erlich, Yaniv; Hannon, Gregory J.; Shanske, Alan L.; Gomori, John Moshe; Ekstein, Joseph; Elpeleg, Orly			Joubert Syndrome 2 (JBTS2) in Ashkenazi Jews Is Associated with a TMEM216 Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALFORMATION; DISORDERS; CAPTURE; GENE	Patients with Joubert syndrome 2 (JBTS2) suffer from a neurological disease manifested by psychomotor retardation, hypotonia, ataxia, nystagmus, and oculomotor apraxia and variably associated with dysmorphism, as well as retinal and renal involvement. Brain MRI results show cerebellar vermis hypoplasia and additional anomalies of the fourth ventricle, corpus callosum, and occipital cortex. The disease has previously been mapped to the centromeric region of chromosome 11. Using homozygosity mapping in 13 patients from eight Ashkenazi Jewish families, we identified a homozygous Mutation, R12L, in the TMEM216 gene, in all affected individuals. Thirty individuals heterozygous for the Mutation were detected among 2766 anonymous Ashkenazi Jews, indicating it carrier rate of 1:92. Given the small size of the TMEM216 gene relative to other JBTS genes, its sequence analysis is warranted in all JBTS patients, especially those who stiffer from associated anomalies.	[Shaag, Avraham; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Edvardson, Simon] Hadassah Hebrew Univ, Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel; [Zenvirt, Shamir; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Gomori, John Moshe] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, IL-91120 Jerusalem, Israel; [Erlich, Yaniv; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Erlich, Yaniv; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Ekstein, Joseph] Dor Yeshorim, Brooklyn, NY 11219 USA; [Shanske, Alan L.] Albert Einstein Coll Med, Childrens Hosp Montefiore, Ctr Craniofacial Disorders, Bronx, NY 10461 USA; [Ekstein, Joseph] Dor Yeshorim, IL-97774 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore	Elpeleg, O (corresponding author), Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	elpeleg@cc.huji.ac.il	Hannon, Gregory/AAB-3568-2019	Edvardson, Simon/0000-0003-2878-1278				Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Doherty D, 2009, SEMIN PEDIATR NEUROL, V16, P143, DOI 10.1016/j.spen.2009.06.002; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Haug K, 2000, AM J MED GENET, V91, P135, DOI 10.1002/(SICI)1096-8628(20000313)91:2<135::AID-AJMG11>3.0.CO;2-1; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; KING MD, 1984, ARCH DIS CHILD, V59, P709, DOI 10.1136/adc.59.8.709; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Satran D, 1999, AM J MED GENET, V86, P459; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217	19	66	70	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					93	97		10.1016/j.ajhg.2009.12.007	http://dx.doi.org/10.1016/j.ajhg.2009.12.007			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20036350	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000274471200011
J	Teresi, RE; Zbuk, KM; Pezzolesi, MG; Waite, KA; Eng, C				Teresi, Rosemary E.; Zbuk, Kevin M.; Pezzolesi, Marcus G.; Waite, Kristin A.; Eng, Charis			Cowden syndrome - affected patients with PTEN promoter mutations demonstrate abnormal protein translation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RILEY-RUVALCABA-SYNDROME; SYNDROME PLEASE STAND; TUMOR-SUPPRESSOR; SECONDARY STRUCTURE; PPAR-GAMMA; EXPRESSION; GENE; BREAST; TRANSCRIPTION; PHOSPHATASE	Germline mutations of PTEN (phosphatase and tensin homolog deleted on chromosome 10) are associated with the multihamartomatous disorder Cowden syndrome (CS). Moreover, patients with CS with germline PTEN promoter mutations have aberrant PTEN protein expression and an increased frequency of breast cancer. Here, we examined the downstream effect of five PTEN promoter variants (-861G/T, -853C/G, -834C/T, -798G/C, and -764G/A) that are not within any known cis- acting regulatory elements. Clinically, all five of these patients have been given diagnoses of breast, thyroid, and/or endometrial cancer. We demonstrated that protein binding to the PTEN promoter (-893 to -755) was not altered in the five variants when compared with the wild- type (WT) promoter. However, reporter assays indicated that three of the variants (-861G/T, -853C/G, and -764G/A) demonstrated an similar to 50% decrease in luciferase activity compared with the WT construct. PTEN messenger RNA (mRNA) levels were not altered in these variants, whereas secondary structure predictions indicated that different PTEN 5' untranslated region transcript-folding patterns exist in three variants, suggesting an inhibition of protein translation. This was confirmed by PTEN protein analysis. These data indicate that variants causing large mRNA secondary structure alterations result in an inhibition of protein translation and a decrease in PTEN protein expression. These data emphasize the importance of PTEN promoter nucleotide variations and their ability to lead to CS progression by a novel regulatory mechanism. Importantly, these patients have a high prevalence of breast, thyroid, and endometrial malignancies; thus, understanding of the mechanism of PTEN dysfunction in these patients will lead to more-sensitive molecular diagnostic and predictive testing and, ultimately, to rational targeted therapies to treat or prevent malignancy.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Eng, C (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Waite, Kristin/AAB-1031-2021	Eng, Charis/0000-0002-3693-5145				Bonofiglio D, 2005, CLIN CANCER RES, V11, P6139, DOI 10.1158/1078-0432.CCR-04-2453; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; GORLIN RJ, 1992, AM J MED GENET, V44, P307, DOI 10.1002/ajmg.1320440309; Grabe Niels, 2002, In Silico Biology, V2, pS1; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Pezzolesi MG, 2007, HUM MOL GENET, V16, P1058, DOI 10.1093/hmg/ddm053; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Ries LAG, 2003, SEER CANC STAT REV 1; Sarquis MS, 2006, AM J HUM GENET, V79, P23, DOI 10.1086/504392; Saxena A, 2006, J MED GENET, V43, P470, DOI 10.1136/jmg.2005.036244; SCHUNG J, 1997, CBILTR19971001V00 U; Sheng XY, 2002, BIOCHEM BIOPH RES CO, V292, P422, DOI 10.1006/bbrc.2002.6662; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Svitkin YV, 2001, RNA, V7, P1743; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Teresi RE, 2006, INT J CANCER, V118, P2390, DOI 10.1002/ijc.21799; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Witman Patricia M, 2006, Adv Dermatol, V22, P157, DOI 10.1016/j.yadr.2006.08.002; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	41	66	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					756	767		10.1086/521051	http://dx.doi.org/10.1086/521051			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847000	Green Published, Bronze			2022-12-18	WOS:000249307600016
J	Pezzolesi, MG; Li, Y; Zhou, XP; Pilarski, R; Shen, L; Eng, C				Pezzolesi, Marcus G.; Li, Yan; Zhou, Xiao-Ping; Pilarski, Robert; Shen, Lei; Eng, Charis			Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR PTEN; SYNDROME PLEASE STAND; LINKAGE DISEQUILIBRIUM; GERMLINE MUTATION; PROTEUS-SYNDROME; GENE-EXPRESSION; GENOTYPE DATA; PROMOTER; POPULATION; CANCER	Phosphatase and tensin homolog deleted on chromosome 10 ( PTEN) encodes a tumor-suppressor phosphatase frequently mutated in both sporadic and heritable forms of human cancer. Germline mutations are associated with a number of heritable cancer syndromes that are jointly referred to as the "PTEN hamartoma tumor syndrome" (PHTS) and include Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome, and Proteus-like syndrome. Germline PTEN mutations have been identified in a significant proportion of patients with PHTS; however, there are still many individuals with classic diagnostic features for whom mutations have yet to be identified. To address this, we took a haplotype-based approach and investigated the association of specific genomic regions of the PTEN locus with PHTS. We found this locus to be characterized by three distinct haplotype blocks 33 kb, 65 kb, and 43 kb in length. Comparisons of the haplotype distributions for all three blocks differed significantly among patients with PHTS and controls (P = .0098, P < .0001, and P < .0001 for blocks 1, 2, and 3, respectively). "Rare" haplotype blocks and extended haplotypes account for two-to-threefold more PHTS chromosomes than control chromosomes. PTEN mutation-negative patients are strongly associated with a haplotype block spanning a region upstream of PTEN and the gene's first intron (P = .0027). Furthermore, allelic combinations contribute to the phenotypic complexity of this syndrome. Taken together, these data suggest that specific haplotypes and rare alleles underlie the disease etiology in these sample populations; constitute low-penetrance, modifying loci; and, specifically in the case of patients with PHTS for whom traditional mutations have yet to be identified, may harbor pathogenic variant(s) that have escaped detection by standard PTEN mutation-scanning methodologies.	Cleveland Clin Fdn, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA; Ohio State Univ, Div Biostat, Sch Publ Hlth, Columbus, OH 43210 USA; Ohio State Univ, Clin Canc Genet Program, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,NE 50, Cleveland, OH 44195 USA.	engc@ccf.org	Pilarski, Robert/X-3256-2019; Pilarski, Robert/E-3871-2011	Eng, Charis/0000-0002-3693-5145				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Carethers JM, 1998, CANCER RES, V58, P2724; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Greenwood TA, 2003, GENOMICS, V82, P511, DOI 10.1016/S0888-7543(03)00142-3; Haiman CA, 2006, CANCER EPIDEM BIOMAR, V15, P1021, DOI 10.1158/1055-9965.EPI-05-0896; Hamilton JA, 2000, BRIT J CANCER, V82, P1671; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; LEWONTIN RC, 1964, GENETICS, V50, P757; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffeld A, 2006, BRIT J DERMATOL, V154, P1194, DOI 10.1111/j.1365-2133.2006.07196.x; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhang L, 2006, AM J MED GENET B, V141B, P10, DOI 10.1002/ajmg.b.30240; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	33	66	68	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					923	934		10.1086/508943	http://dx.doi.org/10.1086/508943			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033968	Green Published, Bronze			2022-12-18	WOS:000241667400013
J	Kolehmainen, J; Wilkinson, R; Lehesjoki, AE; Chandler, K; Kivitie-Kallio, S; Clayton-Smith, J; Traskelin, AL; Waris, L; Saarinen, A; Khan, J; Gross-Tsur, V; Traboulsi, EI; Warburg, M; Fryns, JP; Norio, R; Black, GCM; Manson, FDC				Kolehmainen, J; Wilkinson, R; Lehesjoki, AE; Chandler, K; Kivitie-Kallio, S; Clayton-Smith, J; Traskelin, AL; Waris, L; Saarinen, A; Khan, J; Gross-Tsur, V; Traboulsi, EI; Warburg, M; Fryns, JP; Norio, R; Black, GCM; Manson, FDC			Delineation of Cohen syndrome following a large-scale genotype-phenotype screen	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-HISTORY; JEWISH TYPE; FINNISH	Cohen syndrome is an autosomal recessive condition associated with developmental delay, facial dysmorphism, pigmentary retinopathy, and neutropenia. The pleiotropic phenotype, combined with insufficient clinical data, often leads to an erroneous diagnosis and has led to confusion in the literature. Here, we report the results of a comprehensive genotype-phenotype study on the largest cohort of patients with Cohen syndrome assembled to date. We found 22 different COH1 mutations, of which 19 are novel, in probands identified by our diagnostic criteria. In addition, we identified another three novel mutations in patients with incomplete clinical data. By contrast, no COH1 mutations were found in patients with a provisional diagnosis of Cohen syndrome who did not fulfill the diagnostic criteria ("Cohen-like" syndrome). This study provides a molecular confirmation of the clinical phenotype associated with Cohen syndrome and provides a basis for laboratory screening that will be valuable in its diagnosis.	Univ Helsinki, Biomedicum Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Family Federat Finland, Dept Med Genet, Helsinki, Finland; Univ Manchester, Acad Unit Ophthalmol, Manchester, Lancs, England; Univ Manchester, Acad Unit Med Genet, Manchester, Lancs, England; Univ Manchester, Reg Genet Serv, Manchester, Lancs, England; Univ Manchester, Ctr Mol Med, Manchester, Lancs, England; Shaare Zedek Med Ctr, Neuropediat Unit, Jerusalem, Israel; Cole Eye Inst, Ctr Genet Eye Dis, Cleveland, OH USA; Univ Copenhagen, Glostrup Hosp, Ctr Disabled Persons, Glostrup, Denmark; Univ Louvain, Ctr Human Genet, Louvain, Belgium	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Family Federation of Finland; University of Manchester; University of Manchester; University of Manchester; University of Manchester; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Copenhagen	Lehesjoki, AE (corresponding author), Univ Helsinki, Biomedicum Helsinki, Ctr Neurosci, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	anna-elina.lehesjoki@helsinki.fi	Traboulsi, Elias/AAY-7443-2020; Manson, Forbes/G-2222-2015; Black, Graeme/K-7374-2015	Manson, Forbes/0000-0002-8342-660X; Seitsonen, Anne/0000-0001-5488-0291; Wilkinson, Robert/0000-0003-2706-316X; Black, Graeme/0000-0001-8727-6592	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA 16058, P30 CA016058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandler KE, 2003, J MED GENET, V40, P233, DOI 10.1136/jmg.40.4.233; Chandler KE, 2002, AM J MED GENET, V111, P453, DOI 10.1002/ajmg.10611; Chandler KE, 2002, BRIT J OPHTHALMOL, V86, P1395, DOI 10.1136/bjo.86.12.1395; COHEN MM, 1973, J PEDIATR-US, V83, P280; Kivitie-Kallio S, 2001, AM J MED GENET, V102, P125, DOI 10.1002/1096-8628(20010801)102:2<125::AID-AJMG1439>3.0.CO;2-0; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; KONDO I, 1990, AM J MED GENET, V37, P109, DOI 10.1002/ajmg.1320370126; NORIO R, 1984, CLIN GENET, V25, P1; Norio R, 2003, HUM GENET, V112, P441, DOI 10.1007/s00439-002-0875-3; SACK J, 1986, ISRAEL J MED SCI, V22, P766	10	66	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					122	127		10.1086/422197	http://dx.doi.org/10.1086/422197			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15141358	Green Published, Bronze			2022-12-18	WOS:000222031300015
J	Soragna, D; Vettori, A; Carraro, G; Marchioni, E; Vazza, G; Bellini, S; Tupler, R; Savoldi, F; Mostacciuolo, ML				Soragna, D; Vettori, A; Carraro, G; Marchioni, E; Vazza, G; Bellini, S; Tupler, R; Savoldi, F; Mostacciuolo, ML			A locus for migraine without aura maps on chromosome 14q21.2-q22.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; GTP CYCLOHYDROLASE-I; TYPICAL MIGRAINE; LOD SCORES; GENE; SUSCEPTIBILITY; ASSOCIATION; MUTATIONS; 19P13; LINKAGE	Migraine is a common and disabling neurological disease of unknown origin characterized by a remarkable clinical variability. It shows strong familial aggregation, suggesting that genetic factors are involved in its pathogenesis. Different approaches have been used to elucidate this hereditary component, but a unique transmission model and causative gene(s) have not yet been identified. We report clinical and molecular data from a large Italian pedigree in which migraine without aura (MO) segregates as an autosomal dominant trait. After exclusion of any association between MO and the known familial hemiplegic migraine and migraine with aura loci, we performed a genomewide linkage analysis using 482 polymorphic microsatellite markers. We obtained significant evidence of linkage between the MO phenotype and the marker D14S978 on 14q22.1 (maximum two-point LOD score of 3.70, at a recombination fraction of 0.01). Multipoint parametric analysis (maximum LOD score of 5.25 between markers D14S976 and D14S978) and haplotype construction showed strong evidence of linkage in a region of 10 cM flanked by markers D14S1027 and D14S980 on chromosome 14q21.2-q22.3. These results indicate the first evidence of a genetic locus associated with MO on chromosome 14.	Univ Pavia, IRCCS, Dept Neurol Sci, Neurol Inst C Mondino, I-27100 Pavia, Italy; Univ Pavia, Dept Gen Biol & Med Genet, I-27100 Pavia, Italy; Univ Padua, Dept Biol, Padua, Italy; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA	IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Pavia; University of Padua; University of Massachusetts System; University of Massachusetts Worcester	Soragna, D (corresponding author), Univ Pavia, IRCCS, Dept Neurol Sci, Neurol Inst C Mondino, Via Palestro 3, I-27100 Pavia, Italy.		Vettori, Andrea/J-3951-2014; Carraro, Giovanni/Q-5485-2018; Tupler, Rossella/C-9500-2015; Mostacciuolo, Maria Luisa/A-2397-2014	Vettori, Andrea/0000-0003-4958-0619; Carraro, Giovanni/0000-0002-0155-9434; Tupler, Rossella/0000-0002-3797-1789; Marchioni, Enrico/0000-0003-0414-8128; Carraro, Gianni/0000-0003-0824-7692	Telethon [E.1252] Funding Source: Medline	Telethon(Fondazione Telethon)		Ai XB, 1999, MOL CELL NEUROSCI, V14, P506, DOI 10.1006/mcne.1999.0798; CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; Del Zompo M, 1998, NEUROLOGY, V51, P781, DOI 10.1212/WNL.51.3.781; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Gervil M, 1999, ANN NEUROL, V46, P606, DOI 10.1002/1531-8249(199910)46:4<606::AID-ANA8>3.0.CO;2-O; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hargreaves RJ, 1999, CAN J NEUROL SCI, V26, pS12, DOI 10.1017/S0317167100000147; *HEAD CLASS COMM I, 1988, CLASS DIAGN CRIT HEA, pS1; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; HOVATTA I, 1994, GENOMICS, V23, P707, DOI 10.1006/geno.1994.1563; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Jones KW, 2001, GENOMICS, V78, P150, DOI 10.1006/geno.2001.6665; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lea RA, 2002, NEUROGENETICS, V4, P17, DOI 10.1007/s10048-001-0125-1; Lea RA, 2000, NEUROGENETICS, V3, P35; MAY A, 1995, HUM GENET, V96, P604, DOI 10.1007/BF00197420; McCarthy LC, 2001, GENOMICS, V78, P135, DOI 10.1006/geno.2001.6647; MOCHI M, 1993, CEPHALALGIA, V13, P389, DOI 10.1046/j.1468-2982.1993.1306389.x; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, NEUROLOGY, V50, P1428, DOI 10.1212/WNL.50.5.1428; Ogilvie A, 1998, CEPHALALGIA, V18, P23, DOI 10.1046/j.1468-2982.1998.1801023.x; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PARDO J, 1995, CEPHALALGIA, V15, P200, DOI 10.1046/j.1468-2982.1995.015003200.x; Peroutka SJ, 1997, NEUROLOGY, V49, P201, DOI 10.1212/WNL.49.1.201; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x; RUSSELL MB, 1995, HUM GENET, V96, P726, DOI 10.1007/BF00210307; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stewart WF, 1997, ANN NEUROL, V41, P166, DOI 10.1002/ana.410410207; Terwindt GM, 2001, NEUROLOGY, V56, P1028, DOI 10.1212/WNL.56.8.1028; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Werner ER, 1996, REV PHYSIOL BIOCH P, V127, P97, DOI 10.1007/BFb0048266; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; Witter K, 1996, GENE, V171, P285, DOI 10.1016/0378-1119(95)00886-1; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	43	66	67	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					161	167		10.1086/345298	http://dx.doi.org/10.1086/345298			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474141	Green Published, Bronze			2022-12-18	WOS:000180186800016
J	Good, DA; Busfield, F; Fletcher, BH; Duffy, DL; Kesting, JB; Andersen, J; Shaw, JTE				Good, DA; Busfield, F; Fletcher, BH; Duffy, DL; Kesting, JB; Andersen, J; Shaw, JTE			Linkage of Paget disease of bone to a novel region on human chromosome 18q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL EXPANSILE OSTEOLYSIS; GENETIC-LINKAGE; TRANSCRIPTIONAL REPRESSION; AGGREGATION; RECEPTOR; HLA; DNA	Paget disease of bone (PDB) is characterized by increased osteoclast activity and localized abnormal bone remodeling. PDB has a significant genetic component, with evidence of linkage to chromosomes 6p21.3 (PDB1) and 18q21-22 (PDB2) in some pedigrees. There is evidence of genetic heterogeneity, with other pedigrees showing negative linkage to these regions. TNFRSF11A, a gene that is essential for osteoclast formation and that encodes receptor activator of nuclear factor-kappa B (RANK), has been mapped to the PDB2 region. TNFRSF11A mutations that segregate in pedigrees with either familial expansile osteolysis or familial PDB have been identified; however, linkage studies and mutation screening have excluded the involvement of RANK in the majority of patients with PDB. We have excluded linkage, both to PDB1 and to PDB2, in a large multigenerational pedigree with multiple family members affected by PDB. We have conducted a genomewide scan of this pedigree, followed by fine mapping and multipoint analysis in regions of interest. The peak two-point LOD scores from the genomewide scan were 2.75, at D7S507, and 1.76, at D18S70. Multipoint and haplotype analysis of markers flanking D7S507 did not support linkage to this region. Haplotype analysis of markers flanking D18S70 demonstrated a haplotype segregating with PDB in a large subpedigree. This subpedigree had a significantly lower age at diagnosis than the rest of the pedigree (51.2 +/- 8.5 vs. 64.2 +/- 9.7 years; P = .0012). Linkage analysis of this subpedigree demonstrated a peak two-point LOD score of 4.23, at marker D18S1390 (theta = 0), and a peak multipoint LOD score of 4.71, at marker D18S70. Our data are consistent with genetic heterogeneity within the pedigree and indicate that 18q23 harbors a novel susceptibility gene for PDB.	Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia; Princess Alexandra Hosp, Dept Radiol, Div Nucl Med, Brisbane, Qld 4102, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Shaw, JTE (corresponding author), Princess Alexandra Hosp, Dept Endocrinol & Diabet, Ipswich Rd, Brisbane, Qld 4102, Australia.	joanne_shaw@health.qld.gov.au	Duffy, David L/B-7392-2013	Duffy, David L/0000-0001-7227-632X				ALROY I, 1995, MOL CELL BIOL, V15, P5789; Cody JD, 1997, AM J HUM GENET, V61, P1117, DOI 10.1086/301601; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DETHERIDGE FM, 1982, BRIT MED J, V285, P1005, DOI 10.1136/bmj.285.6347.1005; Ewen KR, 2000, AM J HUM GENET, V67, P727, DOI 10.1086/303048; FOTINO M, 1977, TRANSPLANT P, V9, P1867; Galson DL, 2000, J BONE MINER RES, V15, pS219; GARDNER MJ, 1978, BRIT MED J, V2, P1436, DOI 10.1136/bmj.2.6149.1436-d; Good D, 2001, J BONE MINER RES, V16, P33, DOI 10.1359/jbmr.2001.16.1.33; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; HADJIPAVLOU A, 1992, CANCER-AM CANCER SOC, V70, P2802, DOI 10.1002/1097-0142(19921215)70:12<2802::AID-CNCR2820701213>3.0.CO;2-N; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Kormas N., 2000, Bone (New York), V27, p25S; KRANE S, 1986, CALCIFIED TISSUE INT, V38, P309, DOI 10.1007/BF02555742; Laurin N, 1999, AM J HUM GENET, V65, pA258; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; Mc Kusick V.A., 1972, HERITABLE DISORDERS, P718; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOORE SB, 1988, TISSUE ANTIGENS, V31, P69, DOI 10.1111/j.1399-0039.1988.tb02065.x; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Nellissery MJ, 1998, AM J HUM GENET, V63, P817, DOI 10.1086/302019; Ooi CG, 1997, POSTGRAD MED J, V73, P69, DOI 10.1136/pgmj.73.856.69; OSTERBERG PH, 1988, J BONE JOINT SURG BR, V70, P255, DOI 10.1302/0301-620X.70B2.3346299; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao DC, 2000, HUM HERED, V50, P34, DOI 10.1159/000022889; ROSENBAUM HD, 1969, RADIOLOGY, V92, P959, DOI 10.1148/92.5.959; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SIRIS ES, 1991, J BONE MINER RES, V6, P495; Siris ES, 1998, J BONE MINER RES, V13, P1061, DOI 10.1359/jbmr.1998.13.7.1061; STOFFEL M, 1992, NAT GENET, V2, P153, DOI 10.1038/ng1092-153; TILYARD MW, 1982, AUST NZ J MED, V12, P498, DOI 10.1111/j.1445-5994.1982.tb03830.x; Towers TL, 1999, MOL CELL BIOL, V19, P4191; WALLACE RGH, 1989, CLIN ORTHOP RELAT R, P265; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Yamada T, 1996, POLYM REACT ENG, V4, P1	37	66	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2002	70	2					517	525		10.1086/338658	http://dx.doi.org/10.1086/338658			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	511FQ	11742440	Green Published, Bronze			2022-12-18	WOS:000173254300022
J	Okano, Y; Asada, M; Fujimoto, A; Ohtake, A; Murayama, K; Hsiao, KJ; Choeh, K; Yang, YL; Cao, QX; Reichardt, JKV; Niihira, S; Imamura, T; Yamano, T				Okano, Y; Asada, M; Fujimoto, A; Ohtake, A; Murayama, K; Hsiao, KJ; Choeh, K; Yang, YL; Cao, QX; Reichardt, JKV; Niihira, S; Imamura, T; Yamano, T			A genetic factor for age-related cataract: Identification and characterization of a novel galactokinase variant, "Osaka," in Asians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR CHARACTERIZATION; GALACTOSE METABOLISM; JAPANESE PATIENTS; GAL OPERON; DEFICIENCY; MUTATIONS; POLYMORPHISM; CLONING; HUMANS	Galactokinase (GALK) deficiency is an autosomal recessive disorder characterized by hypergalactosemia and cataract formation. Through mass screening of newborn infants, we identified a novel and prevalent GALK variant (designated here as the "Osaka" variant) associated with an A198V mutation in three infants with mild GALK deficiency. GALK activity and the amount of immunoreactive protein in the mutant were both 20% of normal construct in expression analysis. The K-m values for galactose and ATP-Mg2+ in erythrocytes with homozygous A198V were similar to those of the healthy adult control subjects. A population study for A198V revealed prevalences of 4.1% in Japanese and 2.8% in Koreans, lower incidence in Taiwanese and Chinese, no incidence in blacks and whites from the United States, and a significantly high frequency (7.8%; P<.023) in Japanese individuals with bilateral cataract. This variant probably originated in Japanese and Korean ancestors and is one of the genetic factors that causes cataract in elderly individuals.	Osaka City Univ, Grad Sch Med, Dept Pediat, Abeno Ku, Osaka 5458585, Japan; Osaka City Environm & Publ Hlth Assoc, Osaka, Japan; Osaka City Univ, Fac Human Life Sci, Dept Human Dev & Welf, Osaka 5458585, Japan; Saitama Med Sch, Dept Pediat, Moroyama, Saitama, Japan; Saitama Med Sch, Dept Ophthalmol, Moroyama, Saitama, Japan; Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan; Eulji Med Coll, Dept Pediat, Taejon, South Korea; Peking Univ, Hosp 1, Dept Pediat, Peking, Peoples R China; Shanghai Children Hosp, Neonatal Screening Ctr, Shanghai, Peoples R China; Univ So Calif, Kech Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA USA; Univ So Calif, Kech Sch Med, Inst Med Genet, Los Angeles, CA USA	Osaka Metropolitan University; Osaka Metropolitan University; Saitama Medical University; Saitama Medical University; National Yang Ming Chiao Tung University; Eulji University; Peking University; University of Southern California; University of Southern California	Okano, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Pediat, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.			Reichardt, Juergen/0000-0001-6458-2773; Ohtake, Akira/0000-0003-1147-3113				ADAMS CW, 1988, J BACTERIOL, V170, P203, DOI 10.1128/jb.170.1.203-212.1988; Aoki K, 1988, Acta Paediatr Jpn, V30, P429; Asada M, 1999, J HUM GENET, V44, P377, DOI 10.1007/s100380050182; ASHINO J, 1995, HUM MUTAT, V6, P36, DOI 10.1002/humu.1380060108; Bergsma DJ, 1996, GENOME RES, V6, P980, DOI 10.1101/gr.6.10.980; Bhatnagar R, 1989, Dev Ophthalmol, V17, P93; BIRLOUEZARAGON I, 1993, J NUTR, V123, P1370; COUET C, 1991, J AM COLL NUTR, V10, P79; DEBOUCK C, 1985, NUCLEIC ACIDS RES, V13, P1841, DOI 10.1093/nar/13.6.1841; ELSAS LJ, 1994, AM J HUM GENET, V54, P1030; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hirokawa H, 1999, EUR J HUM GENET, V7, P757, DOI 10.1038/sj.ejhg.5200368; ICHIBA Y, 1989, JPN J PEDIAT, V42, P579; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Kalaydjieva L, 1999, AM J HUM GENET, V65, P1299, DOI 10.1086/302611; Kolosha V, 2000, HUM MUTAT, V15, P447; LIN HC, 1994, HUM GENET, V93, P167; LIN HC, 1995, HUM GENET, V95, P353; MAGNANI M, 1982, HUM HERED, V32, P329, DOI 10.1159/000153319; MONTELEO.JA, 1971, AM J MED, V50, P403, DOI 10.1016/0002-9343(71)90230-0; NG WG, 1965, J LAB CLIN MED, V66, P115; RINALDI E, 1984, LANCET, V1, P355; Sasaki K, 1987, Dev Ophthalmol, V15, P28; Segal S, 1995, METABOLIC MOL BASIS, P967; SHINBUEHRING YS, 1977, CLIN CHIM ACTA, V74, P1, DOI 10.1016/0009-8981(77)90379-5; Simonelli F, 1992, Metab Pediatr Syst Ophthalmol (1985), V15, P53; Simonelli F, 1989, Dev Ophthalmol, V17, P82; SIMOONS FJ, 1982, DIGEST DIS SCI, V27, P257, DOI 10.1007/BF01296925; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P269; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; STAMBOLIAN D, 1986, INVEST OPHTH VIS SCI, V27, P429; STAMBOLIAN D, 1995, NAT GENET, V10, P307, DOI 10.1038/ng0795-307; TEDESCO TA, 1977, AM J HUM GENET, V29, P240; TEDESCO TA, 1972, SCIENCE, V178, P176, DOI 10.1126/science.178.4057.176; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620	35	66	68	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1036	1042		10.1086/319512	http://dx.doi.org/10.1086/319512			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11231902	Bronze, Green Published			2022-12-18	WOS:000167666000023
J	DeWan, AT; Arnett, DK; Atwood, LD; Province, MA; Lewis, CE; Hunt, SC; Eckfeldt, J				DeWan, AT; Arnett, DK; Atwood, LD; Province, MA; Lewis, CE; Hunt, SC; Eckfeldt, J			A genome scan for renal function among hypertensives: The HyperGEN study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-D GENE; CREATININE CLEARANCE; COMPLEX TRAITS; DISEASE; RISK; POLYMORPHISM; LOCALIZATION; CLONING; LINKAGE; MARKER	Decreased renal function is often a complication of hypertension. Although it has been suggested that the response of the kidney to hypertension has an underlying genetic component, there is limited information suggesting that specific genetic regions or candidate genes contribute to the variability in creatinine clearance, a commonly used measure of kidney function. As part of the Hypertension Genetic Epidemiology Network (HyperGEN) study, creatinine clearance measurements were assessed in a large biracial sample of hypertensive siblings (466 African American subjects and 634 white subjects in 215 and 265 sibships, respectively). All participants were hypertensive before the age of 60 years, and the mean age of the siblings was 52 years among the African American subjects and 61 years among the white subjects. Two residual models were created for creatinine clearance: a minimally adjusted model (which included age and age(2)) and a fully adjusted model (which included age, age(2), lean body mass, pulse rate, pulse pressure, hormone-replacement therapy, educational status, and physical activity). Standardized residuals were calculated separately for men and women in both racial groups. The heritability of the residual creatinine clearance was 17% and 18% among the African American and white subjects, respectively. We conducted multipoint variance components linkage analysis using GENEHUNTER2 and 387 anonymous markers (Cooperative Human Linkage Center screening set 8). The best evidence for linkage in African American subjects was found on chromosome 3 (LOD = 3.61 at 214.6 cM, 3q27) with the fully adjusted model, and the best evidence in white subjects was found on chromosome 3 (LOD = 3.36 at 115.1 cM) with the minimally adjusted model. Positional candidate genes that are contained in and around the region on chromosome 3 (214.6 cM) that may contribute to renal function include enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (EHHADH) and apo lipoprotein D (ApoD). These findings suggest there may be genetic regions related to the variability of creatinine clearance among hypertensive individuals.	Univ Minnesota, Div Epidemiol, Minneapolis, MN 55454 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA; Washington Univ, Div Biostat, St Louis, MO USA; Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah	Arnett, DK (corresponding author), Univ Minnesota, Div Epidemiol, 1300 S 2nd St,Suite 300, Minneapolis, MN 55454 USA.	arnett@epi.umn.edu		DeWan, Andrew/0000-0002-7679-8704	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054471, R01HL055673, U10HL054509, U10HL054473, U01HL054509, U01HL054496, U01HL054472, U10HL054471, U01HL054473, U10HL054495, U10HL054472, U10HL054496, U01HL054495] Funding Source: NIH RePORTER; NHLBI NIH HHS [U10 HL054472, U01 HL054472, U01 HL054471, U01 HL054496, U10 HL54471, U01 HL054473, R01 HL055673, U01 HL054495, U10 HL054471, U10 HL054496, U10 HL054495, U10 HL054509, U01 HL054509, U10 HL54472, U10 HL054473, R01 HL55673] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1981, ATHEROSCLEROSIS, V39, P395, DOI 10.1016/0021-9150(81)90025-3; BAKER WA, 1994, DIABETIC MED, V11, P947, DOI 10.1111/j.1464-5491.1994.tb00252.x; BAKER WA, 1991, P 14 INT DIAB FED C, P220; BAUMANN TJ, 1987, CLIN PHARMACY, V6, P393; BLYTHE WB, 1991, AM J KIDNEY DIS, V18, P33, DOI 10.1016/S0272-6386(12)80287-3; Brown DM, 1996, NAT GENET, V12, P44, DOI 10.1038/ng0196-44; BROWN MA, 1992, J HYPERTENS, V10, P701; Campese V M, 1996, Ethn Health, V1, P145; CUSI D, 1993, AM J KIDNEY DIS, V21, P2, DOI 10.1016/0272-6386(93)70092-D; DEWARDENER HE, 1990, CLIN SCI, V79, P193, DOI 10.1042/cs0790193; DRAYNA D, 1986, J BIOL CHEM, V261, P6535; DRAYNA DT, 1987, DNA-J MOLEC CELL BIO, V6, P199, DOI 10.1089/dna.1987.6.199; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; FIELDING PE, 1980, P NATL ACAD SCI-BIOL, V77, P3327, DOI 10.1073/pnas.77.6.3327; GIOVANNETTI S, 1991, NEPHRON, V59, P11, DOI 10.1159/000186510; HOEFLER G, 1994, GENOMICS, V19, P60, DOI 10.1006/geno.1994.1013; Jaimes E, 1996, CURR OPIN CARDIOL, V11, P471, DOI 10.1097/00001573-199609000-00004; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEBEL M, 1991, CLIN INVEST MED, V14, P525; Lezin ES, 1999, HYPERTENSION, V34, P187, DOI 10.1161/01.HYP.34.2.187; LINDEMAN RD, 1984, KIDNEY INT, V26, P861, DOI 10.1038/ki.1984.229; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; PORTH CM, 1994, PATHOPHYSIOLOGY CONC, pCH32; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; ROSTAND SG, 1982, NEW ENGL J MED, V306, P1276, DOI 10.1056/NEJM198205273062106; Seedat YK, 1999, J HUM HYPERTENS, V13, P747, DOI 10.1038/sj.jhh.1000911; TIERNEY WM, 1989, AM J KIDNEY DIS, V13, P485, DOI 10.1016/S0272-6386(89)80006-X; Tyni T, 1997, PEDIATR PATHOL LAB M, V17, P427, DOI 10.1080/107710497174732; VANLENTE F, 1989, CLIN CHEM, V35, P2326; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Williams RR, 2000, ANN EPIDEMIOL, V10, P389, DOI 10.1016/S1047-2797(00)00063-6; Woolfson RG, 1996, KIDNEY INT, V50, P717, DOI 10.1038/ki.1996.370	34	66	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					136	144		10.1086/316927	http://dx.doi.org/10.1086/316927			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115379	Green Published, Bronze			2022-12-18	WOS:000166399900012
J	Liede, A; Metcalfe, K; Hanna, D; Hoodfar, E; Snyder, C; Durham, C; Lynch, HT; Narod, SA				Liede, A; Metcalfe, K; Hanna, D; Hoodfar, E; Snyder, C; Durham, C; Lynch, HT; Narod, SA			Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWISH WOMEN; BREAST-CANCER FAMILIES; PSYCHOLOGICAL DISTRESS; DECISION-MAKING; PROSTATE-CANCER; OVARIAN CANCER; SUSCEPTIBILITY; INDIVIDUALS; RISKS; MEN	To date, the concerns of men at risk of inheriting a BRCA1 mutation or a BRCA2 mutation have received little attention, It had been anticipated that few men would be interested in predictive testing when a BRCA mutation was identified in their family. However, these men are often affected emotionally by diagnoses of breast cancer in their relatives and may themselves harbor fears that cancer will develop. Male carriers of BRCA1/2 mutations are at increased risk of development of cancers of several types, including those of the breast and prostate. We conducted an evaluation of the needs and experiences of 59 male carriers of BRCA1/2 mutations followed at either the University of Toronto or Creighton University. We assessed their motivations for seeking genetic counseling and testing, involvement in family discussions of breast and ovarian cancer, risk perception, changes in cancer-screening practices, and overall satisfaction with the genetic-counseling process. The principal motivation for seeking genetic counseling was concern for their daughters. The majority (88%) of men participated in family conversations about breast and ovarian cancer, and 47% participated in conversations about prophylactic surgery. Most men believed that they were at increased risk of development of cancer (prostate, breast, colorectal, and skin cancers). However, fewer than one-half (43%) of the men with no previous diagnosis of cancer stated that their prostate cancer-surveillance practices had changed after they had received genetic test results. More than one-half (55%) had intrusive thoughts about their cancer risk. Although levels of satisfaction were high, practitioners should be aware of (a) potential pressures influencing men to request predictive testing, (b) the difficulties that men encounter in establishing surveillance regimens for breast and prostate cancer, and (c) the general lack of information about men's particular experiences in the medical community.	Univ Toronto, Ctr Res Womens Hlth, Toronto, ON, Canada; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA	University of Toronto; Creighton University	Narod, SA (corresponding author), 790 Bay St,Suite 750A, Toronto, ON M5G 1N8, Canada.		Narod, Steven A/AAA-6112-2022	Metcalfe, Kelly/0000-0003-1803-2169				Audrain J, 1998, J CLIN ONCOL, V16, P133, DOI 10.1200/JCO.1998.16.1.133; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Bleiker EMA, 1997, PATIENT EDUC COUNS, V32, P107, DOI 10.1016/S0738-3991(97)00067-0; Borg A, 2000, INT J CANCER, V85, P796; Botkin JR, 1996, J NATL CANCER I, V88, P872, DOI 10.1093/jnci/88.13.872; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; DudokdeWit AC, 1998, AM J MED GENET, V75, P62, DOI 10.1002/(SICI)1096-8628(19980106)75:1<62::AID-AJMG14>3.0.CO;2-Q; DUDOKDEWIT AC, 1996, PSYCHO-ONCOL, V5, P251; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Fobair P, 1997, J PSYCHOSOC ONCOL, V15, P123; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Green J, 1997, J Genet Couns, V6, P45, DOI 10.1023/A:1025611818643; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; Kelly P T, 1992, Semin Oncol Nurs, V8, P288, DOI 10.1016/0749-2081(92)90042-2; Lehrer S, 1998, BRIT J CANCER, V78, P771, DOI 10.1038/bjc.1998.576; Lerman C, 1997, JNCI-J NATL CANCER I, V89, P148, DOI 10.1093/jnci/89.2.148; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Lerman C, 1997, J CONSULT CLIN PSYCH, V65, P414, DOI 10.1037/0022-006X.65.3.414; Lerman C, 1998, J CLIN ONCOL, V16, P1650, DOI 10.1200/JCO.1998.16.5.1650; LERMAN C, 1995, AM J MED GENET, V57, P385, DOI 10.1002/ajmg.1320570304; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; LERMAN C, 1997, SAN ANT BREAST CANC; Lynch HT, 1997, CANCER, V79, P2219, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y; Lynch HT, 1999, CANCER GENET CYTOGEN, V109, P91, DOI 10.1016/S0165-4608(98)00165-4; McAllister MF, 1998, J MED GENET, V35, P739, DOI 10.1136/jmg.35.9.739; Metcalfe KA, 2000, J MED GENET, V37, P866, DOI 10.1136/jmg.37.11.866; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Nastiuk KL, 1999, PROSTATE, V40, P172; Richards M P, 1995, J Genet Couns, V4, P219, DOI 10.1007/BF01408411; Smith KR, 1999, CANCER EPIDEM BIOMAR, V8, P385; STADLER MP, 1998, J GENET COUNS, V7, P279; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Vezina A, 2000, BRIT J CANCER, V83, P463, DOI 10.1054/bjoc.2000.1249; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	36	66	66	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1494	1504		10.1086/316907	http://dx.doi.org/10.1086/316907			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11063672	Bronze, Green Published			2022-12-18	WOS:000165607600014
J	Mukhopadhyay, N; Almasy, L; Schroeder, M; Mulvihill, WP; Weeks, DE				Mukhopadhyay, N; Almasy, L; Schroeder, M; Mulvihill, WP; Weeks, DE			Mega2, a data-handling program for facilitating genetic linkage and association analyses.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Pittsburgh, Pittsburgh, PA USA; Stanford Univ, Stanford, CA 94305 USA; Carleton Coll, Northfield, MN 55057 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; Carleton College			Weeks, Daniel E/B-2995-2012; Almasy, Laura/V-3156-2019	Weeks, Daniel E/0000-0001-9410-7228; 					0	66	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4		S		2474	A436	A436						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241JQ					2022-12-18	WOS:000082879802475
J	Reich, T; Hinrichs, A; Culverhouse, R; Bierut, L				Reich, T; Hinrichs, A; Culverhouse, R; Bierut, L			Genetic studies of alcoholism and substance dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEROTONIN TRANSPORTER GENE; FAMILY-BASED ANALYSIS; RECEPTOR GENE; BRAIN POTENTIALS; ASSOCIATION; MEN; ABUSE; RISK; DISORDERS; TRANSMISSION		Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Reich, T (corresponding author), Washington Univ, Dept Psychiat, 4940 Childrens Pl, St Louis, MO 63110 USA.	tedr@newhar.wustl.edu	Bierut, Laura Jean/W-6806-2019	Bierut, Laura Jean/0000-0002-9952-4810				ALMASY L, IN PRESS GENET EPIDE; ALMASY L, 1999, NEUROPSYCH GENET, V88, P383; *AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P166; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th, P194; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; Begleiter H, 1998, EVOKED POTENTIAL, V108, P244, DOI 10.1016/S0168-5597(98)00002-1; Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Blangero J, 1996, 6 SW FDN BIOM RES PO; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Catalano M, 1999, AM J HUM GENET, V65, P606, DOI 10.1086/302559; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cloninger CR, 1998, AM J MED GENET, V81, P313, DOI 10.1002/(SICI)1096-8628(19980710)81:4<313::AID-AJMG7>3.0.CO;2-U; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Duaux E, 1998, MOL PSYCHIATR, V3, P333, DOI 10.1038/sj.mp.4000409; Dufour M. C., 1995, 36 NAT I ALC AB ALC; Edenberg HJ, 1998, ALCOHOL CLIN EXP RES, V22, P1080, DOI 10.1097/00000374-199808000-00015; Edenberg HJ, 1998, ALCOHOL CLIN EXP RES, V22, P505, DOI 10.1097/00000374-199804000-00030; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Foroud T, 1998, ALCOHOL CLIN EXP RES, V22, P2035, DOI 10.1097/00000374-199812000-00020; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P690; Kendler KS, 1998, PSYCHOL MED, V28, P625, DOI 10.1017/S0033291798006643; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kittles RA, 1999, P NATL ACAD SCI USA, V96, P4204, DOI 10.1073/pnas.96.7.4204; Kranzler HR, 1998, ALCOHOL CLIN EXP RES, V22, P1359, DOI 10.1097/00000374-199809000-00023; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Mayer P, 1997, NEUROREPORT, V8, P2547, DOI 10.1097/00001756-199707280-00025; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; PFEFFERBAUM A, 1991, ALCOHOL CLIN EXP RES, V15, P839, DOI 10.1111/j.1530-0277.1991.tb00611.x; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Sander T, 1998, ALCOHOL CLIN EXP RES, V22, P2108, DOI 10.1097/00000374-199812000-00030; Sander T, 1997, ALCOHOL CLIN EXP RES, V21, P1356; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; Straub RE, 1999, MOL PSYCHIATR, V4, P129, DOI 10.1038/sj.mp.4000518; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; True WR, 1999, ARCH GEN PSYCHIAT, V56, P655, DOI 10.1001/archpsyc.56.7.655; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Uhl G R, 1998, Adv Pharmacol, V42, P1024; Vanyukov MM, 1998, BEHAV GENET, V28, P75, DOI 10.1023/A:1021463722326; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; *WHO, 1993, INT CLASS DIS, P56	45	66	67	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					599	605		10.1086/302561	http://dx.doi.org/10.1086/302561			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441565	Green Published, Bronze			2022-12-18	WOS:000082426400003
J	Foster, MW; Sharp, RR; Freeman, WL; Chino, M; Bernsten, D; Carter, TH				Foster, MW; Sharp, RR; Freeman, WL; Chino, M; Bernsten, D; Carter, TH			The role of community review in evaluating the risks of human genetic variation research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISCRIMINATION; POPULATIONS; DISEASE; HEALTH; FUTURE; GENOME	The practicality and moral value of community review of human genetic research has become a focus of debate. Examples from two Native American communities are used to address four aspects of that debate: (1) the value of community review in larger, geographically dispersed populations; (2) the identification of culturally specific risks; (3) the potential conflict between individual and group assessments of research-related risks; and (4) the confusion of social categories with biological categories. Our experiences working with these two communities suggest that: (1) successful community review may require the involvement of private social units (e.g., families); (2) culturally specific implications of genetic research may be identifiable only by community members and are of valid concern in their moral universes; (3) community concerns can be incorporated into existing review mechanisms without necessarily giving communities the power to veto research proposals; and (4) the conflation of social and biological categories presents recruitment problems for genetic studies. These conclusions argue for the use of community review to identify and minimize research-related risks posed by genetic studies. Community review also can assist in facilitating participant recruitment and retention, as well as in developing partnerships between researchers and communities.	Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; NIEHS, NIH, Res Triangle Pk, NC 27709 USA; Indian Hlth Serv, Albuquerque, NM USA; Albuquerque Indian Hlth Board, Albuquerque, NM USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oklahoma System; University of Oklahoma Health Sciences Center	Foster, MW (corresponding author), Univ Oklahoma, Dept Anthropol, 455 W Lindsey Ave,Room 515, Norman, OK 73019 USA.			Carter, Thomas/0000-0001-7796-2986	NHGRI NIH HHS [HG010302] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*AM JEW C, 1998, C MONTHLY AM JEW JUL, P3; Annas GJ, 1992, GENE MAPPING USING L, P3; [Anonymous], 1986, HIST THEORY INFORM C; Beauchamp T., 2009, PRINCIPLES BIOMEDICA; Bernstein T, 1994, RADON RENTAL HOUSING; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Brown PO, 1998, NAT GENET, V18, P91, DOI 10.1038/ng0298-91; CAPLAN AL, 1994, JUSTICE HUMAN GENOME, P30; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; *COMM HUM GEN DIV, 1997, EV HUM GEN DIV; Douglas M, 1966, PURITY DANGER; Elias, 1992, GENE MAPPING USING L, P94; FANOS JH, 1995, AM J HUM GENET, V57, P431; Foster MW, 1998, GENOME RES, V8, P755, DOI 10.1101/gr.8.8.755; Foster MW, 1998, AM J HUM GENET, V63, P696, DOI 10.1086/302013; Freeman HP, 1998, CANCER, V82, P219, DOI 10.1002/(SICI)1097-0142(19980101)82:1<219::AID-CNCR27>3.0.CO;2-4; Freeman W. L., 1998, STORED TISSUE SAMPLE, P267; GOSTIN L, 1991, AM J LAW MED, V17, P109; Greely H T, 1997, Houst Law Rev, V33, P1397; Grounds R. A., 1996, CULT SURVIVAL, V19, P64; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; *IND PEOPL COAL BI, 1996, KEY POINTS RES COND; Juengst ET, 1998, AM J HUM GENET, V63, P673, DOI 10.1086/302032; Juengst ET, 1998, KENNEDY INST ETHIC J, V8, P183, DOI 10.1353/ken.1998.0010; Katz Rothman B., 1998, GENETIC MAPS HUMAN I; Kegley J A, 1996, Med Law, V15, P377; Khoury MJ, 1997, EPIDEMIOL REV, V19, P175, DOI 10.1093/oxfordjournals.epirev.a017940; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; MOORE JH, 1996, CULT SURVIVAL, V20, P60; Murphy T. F., 1994, JUSTICE HUMAN GENOME; *NAT C AM IND, 1998, NV93118 NAT C AM IND; *NIH OFF PROT RES, 1993, PROT HUM RES SUBJ I; PHOENIX DD, 1995, J NATL MED ASSOC, V87, P807; *PROP MOD ETH PROT, 1997, HOUSTON LAW REV, V33, P1431; Reilly PR, 1998, AM J HUM GENET, V63, P682, DOI 10.1086/302028; Reilly PR, 1998, NAT GENET, V20, P15, DOI 10.1038/1668; Rothstein MA, 1997, GENETIC SECRETS PROT; ROTHSTEIN MA, 1993, MOL GENETIC MED; *RUR ADV FDN INT, 1993, RAFI COMM PAT IND PE; Schafer AJ, 1998, NAT BIOTECHNOL, V16, P33, DOI 10.1038/nbt0198-33; STOLBERG SG, 1998, NY TIMES        0422; Wolf SM, 1995, J LAW MED ETHICS, V23, P345, DOI 10.1111/j.1748-720X.1995.tb01376.x	43	66	66	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1719	1727		10.1086/302415	http://dx.doi.org/10.1086/302415			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330360	Green Published, Bronze			2022-12-18	WOS:000080696200025
J	van Bokhoven, H; Jung, M; Smits, APT; van Beersum, S; Ruschendorf, F; van Steensel, M; Veenstra, M; Tuerlings, JHAM; Mariman, ECM; Brunner, HG; Wienker, TF; Reis, A; Ropers, HH; Hamel, BCJ				van Bokhoven, H; Jung, M; Smits, APT; van Beersum, S; Ruschendorf, F; van Steensel, M; Veenstra, M; Tuerlings, JHAM; Mariman, ECM; Brunner, HG; Wienker, TF; Reis, A; Ropers, HH; Hamel, BCJ			Limb mammary syndrome: A new genetic disorder with mammary hypoplasia, ectrodactyly, and other hand/foot anomalies maps to human chromosome 3q27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL SEX REVERSAL; HOLT-ORAM SYNDROME; SRY-RELATED GENE; EEC-SYNDROME; VERTEBRATE LIMB; CAMPOMELIC DYSPLASIA; SONIC-HEDGEHOG; POLARITY GENE; FEEDBACK LOOP; MUTATIONS	We report on a large Dutch family with a syndrome characterized by severe hand and/or foot anomalies, and hypoplasia/aplasia of the mammary gland and nipple. Less frequent findings include lacrimal-duct atresia, nail dysplasia, hypohydrosis, hypodontia, and cleft palate with or without bifid uvula. This combination of symptoms has not been reported previously although there is overlap with the ulnar mammary syndrome (UMS) and with ectrodactyly, ectodermal dysplasia, and clefting syndrome. Allelism with UMS and other related syndromes was excluded by linkage studies with markers from the relevant chromosomal regions. A genomewide screening with polymorphic markers allowed the localization of the genetic defect to the subtelomeric region of chromosome 3q. Haplotype analysis reduced the critical region to a 3-cM interval of chromosome 3q27. This chromosomal segment has not been implicated previously in disorders with defective development of limbs and/or mammary tissue. Therefore, we propose to call this apparently new disorder "limb mammary syndrome" (LMS). The SOX2 gene at 3q27 might be considered an excellent candidate gene for LMS because the corresponding protein stimulates expression of FGF4, an important signaling molecule during limb outgrowth and development; However, no mutations were found in the SOX2 open reading frame, thus excluding its involvement in LMS.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Max Delbruck Ctr Mol Med, Mikrosatellitenzentrum, Berlin, Germany; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; Max Planck Inst Mol Genet, Berlin, Germany	Radboud University Nijmegen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Hamel, BCJ (corresponding author), Univ Nijmegen Hosp, Dept Human Genet 417, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Reis, André/D-2309-2009; van Beersum, Sylvia E.C./P-8653-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; van Steensel, Maurice A.M./V-3852-2019; van Bokhoven, Hans/D-8764-2012; Brunner, Han/C-9928-2013	Reis, André/0000-0002-6301-6363; van Beersum, Sylvia E.C./0000-0002-4552-2908; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; van Steensel, Maurice/0000-0002-7507-2442				Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1996, AM J MED GENET, V65, P325, DOI 10.1002/(SICI)1096-8628(19961111)65:4<325::AID-AJMG15>3.0.CO;2-W; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BUSS PW, 1995, J MED GENET, V32, P716, DOI 10.1136/jmg.32.9.716; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; COLEMANKRNACIK S, 1994, MOL ENDOCRINOL, V8, P218, DOI 10.1210/me.8.2.218; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Freire-Maia N, 1984, ECTODERMAL DYSPLASIA; GEMMILL RM, 1995, NATURE, V377, P299; Gorlin RJ, 1990, PLAST RECONSTR SURG; Hamel Ben, 1996, European Journal of Human Genetics, V4, P148; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Li QY, 1997, NAT GENET, V15, P21; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Maas SM, 1996, AM J MED GENET, V63, P472; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Niswander L, 1997, CURR OPIN GENET DEV, V7, P530, DOI 10.1016/S0959-437X(97)80082-2; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; O'Quinn JR, 1998, AM J HUM GENET, V62, P130, DOI 10.1086/301687; OPITZ JM, 1980, EUR J PEDIATR, V133, P217, DOI 10.1007/BF00496079; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; PROPPING P, 1993, AM J MED GENET, V45, P642, DOI 10.1002/ajmg.1320450525; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RODINI ESO, 1990, AM J MED GENET, V37, P42, DOI 10.1002/ajmg.1320370112; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; Saar K, 1997, AM J HUM GENET, V60, P605; SCHECHTMAN M, 1994, PHILOS PSYCHOL, V7, P3, DOI 10.1080/09515089408573107; STEVANOVIC M, 1994, MAMM GENOME, V5, P640, DOI 10.1007/BF00411460; Stoll C, 1998, AM J MED GENET, V77, P439, DOI 10.1002/(SICI)1096-8628(19980605)77:5<439::AID-AJMG16>3.0.CO;2-J; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; YANG YZ, 1995, CELL, V80, P939, DOI 10.1016/0092-8674(95)90297-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	51	66	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					538	546		10.1086/302246	http://dx.doi.org/10.1086/302246			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973291	Bronze, Green Published			2022-12-18	WOS:000078740600023
J	Montgomery, RA; Geraghty, MT; Bull, E; Gelb, BD; Johnson, M; McIntosh, I; Francomano, CA; Dietz, HC				Montgomery, RA; Geraghty, MT; Bull, E; Gelb, BD; Johnson, M; McIntosh, I; Francomano, CA; Dietz, HC			Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EGF-LIKE DOMAIN; CALCIUM-BINDING; FIBRILLIN GENE; MISSENSE MUTATION; FBN1 MUTATIONS; DISORDERS; ORGANIZATION; MICROFIBRILS; FIBROBLASTS; PHENOTYPE	Mutations in the FBN1 gene, which encodes fibrillin-1, cause Marfan syndrome (MFS) and have been associated with a wide range of milder, overlap phenotypes. The factors that modulate phenotypic severity, both between and within families, remain to be determined. This study examines the relationship between the FBN1 genotype and phenotype in families with extremely mild phenotypes and in those that show striking clinical variation among apparently affected individuals. In one family, clinically similar but etiologically distinct disorders are segregating independently. In another, somatic mosaicism for a mutant FBN1 allele is associated with subdiagnostic manifestations, whereas germ-line transmission of the identical mutation causes severe and rapidly progressive disease. A third family cosegregates mild mitral valve prolapse syndrome with a mutation in FBN1 that can be functionally distinguished from those associated with the classic MFS phenotype. These data have immediate relevance for the diagnostic and prognostic counseling of patients and their family members.	Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Mt Sinai Hosp, Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Hosp, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Nat Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Dietz, HC (corresponding author), Johns Hopkins Univ Hosp, Dept Med, Ross 1170,720 Rutland Ave, Baltimore, MD 21205 USA.				NIAMS NIH HHS [R01-AR41135] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HAYWARD C, 1994, MOL CELL PROBE, V8, P325, DOI 10.1006/mcpr.1994.1045; KIELTY CM, 1994, J CELL BIOL, V124, P997, DOI 10.1083/jcb.124.6.997; KIELTY CM, 1993, FEBS LETT, V336, P323, DOI 10.1016/0014-5793(93)80829-J; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; MAQUAT LE, 1995, RNA, V1, P453; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pyeritz Reed E., 1993, P437; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Reinhardt DP, 1997, J BIOL CHEM, V272, P7368, DOI 10.1074/jbc.272.11.7368; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SELANDERSUNNERHAGEN M, 1992, J BIOL CHEM, V267, P19642; TILSTRA DJ, 1994, GENOMICS, V23, P480, DOI 10.1006/geno.1994.1527; WU YS, 1995, CHEM BIOL, V2, P91, DOI 10.1016/1074-5521(95)90281-3; YIN WS, 1995, J BIOL CHEM, V270, P1798, DOI 10.1074/jbc.270.4.1798	29	66	69	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1703	1711		10.1086/302144	http://dx.doi.org/10.1086/302144			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837823	hybrid, Green Published			2022-12-18	WOS:000077707700016
J	Hennies, HC; Kuster, W; Wiebe, V; Krebsova, A; Reis, A				Hennies, HC; Kuster, W; Wiebe, V; Krebsova, A; Reis, A			Genotype/phenotype correlation in autosomal recessive lamellar ichthyosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COAGULATION-FACTOR-XIII; KERATINOCYTE TRANSGLUTAMINASE; HUMAN GENOME; TERMINAL DIFFERENTIATION; TISSUE TRANSGLUTAMINASE; GENE; MUTATIONS; LINKAGE; MAP; EXPRESSION	Autosomal recessive lamellar ichthyosis is a severe congenital disorder of keratinization, characterized by variable erythema of the whole body surface and by different scaling patterns. Recently, mutations have been identified in patients with lamellar ichthyosis in the TGM1 gene coding for keratinocyte transglutaminase, and a second locus has been mapped to chromosome 2. We have now analyzed the genotype/phenotype correlation in a total of 14 families with lamellar ichthyosis. Linkage analyses using microsatellites in the region of the TGM1 gene confirmed genetic heterogeneity. In patients not linked to the TGM1 gene, the second region identified on chromosome 2 and a further candidate region on chromosome 20 were excluded, confirming as well the existence of at least three loci for lamellar ichthyosis. Sequence analyses of the TGM1 gene in families compatible with linkage to this locus revealed seven different missense mutations, five of these unpublished so far, and one splice mutation. No genotype/phenotype correlation for mutations in the TGM1 gene was found in this group of patients, which included two unrelated patients homozygous for the same mutation. Similarly, no clear difference in the clinical picture was seen between patients with TGM1 mutations and those unlinked to the TGM1 locus. Comparison of genetic and clinical classifications for patients with lamellar ichthyosis shows no consistency and thus indicates that clinical criteria currently in use cannot discriminate between the molecularly different forms of the disease.	Humboldt Univ, Inst Human Genet, D-13353 Berlin, Germany; TOMESA, Clin Allergy Skin & Joint Dis & Rheumatism, Bad Salzschlirf, Germany; Charles Univ, Hosp Motol, Dept Med Genet 2, Prague, Czech Republic	Humboldt University of Berlin; Charles University Prague; Motol University Hospital	Reis, A (corresponding author), Humboldt Univ, Klinikum Rudolf Virchow, Inst Human Genet, Charite Campus,Augustenburger Pl 1, D-13353 Berlin, Germany.		Reis, André/D-2309-2009; Hennies, Hans C/G-9424-2014	Reis, André/0000-0002-6301-6363; Hennies, Hans C/0000-0001-7210-2389				AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; ANTONLAMPRECHT I, 1992, DIAGNOSTIC ULTRASTRU, P00459; Bale SJ, 1996, J INVEST DERMATOL, V107, P808, DOI 10.1111/1523-1747.ep12330566; COMPTON JG, 1992, NAT GENET, V1, P301, DOI 10.1038/ng0792-301; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GENTILE V, 1994, GENOMICS, V20, P295, DOI 10.1006/geno.1994.1170; HAZELL M, 1985, ARCH DERMATOL, V121, P489, DOI 10.1001/archderm.121.4.489; HOHL D, 1993, ARCH DERMATOL, V129, P618, DOI 10.1001/archderm.129.5.618; HUBER M, 1995, J INVEST DERMATOL, V105, P653, DOI 10.1111/1523-1747.ep12324122; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KIM IG, 1992, J BIOL CHEM, V267, P7710; KIM SY, 1994, J BIOL CHEM, V269, P27979; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAVRIJSEN APM, 1995, ARCH DERMATOL, V131, P363, DOI 10.1001/archderm.131.3.363; Mckusick V.A., 1994, MENDELIAN INHERITANC; Mikkola H, 1996, BLOOD, V87, P141; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; PHILLIPS MA, 1992, J BIOL CHEM, V267, P2282; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TRAUPE H, 1984, CLIN GENET, V26, P457; TRAUPE H, 1989, ICHTHYOSES GUIDE CLI; WANG M, 1994, GENOMICS, V23, P721, DOI 10.1006/geno.1994.1571; WILLIAMS ML, 1986, PATHOGENESIS SKIN DI, P519; YAMANISHI K, 1992, J BIOL CHEM, V267, P17858; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	32	66	67	0	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1052	1061		10.1086/301818	http://dx.doi.org/10.1086/301818			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545389	Green Published, Bronze			2022-12-18	WOS:000073487000008
J	Burwinkel, B; Bakker, HD; Herschkovitz, E; Moses, SW; Shin, YS; Kilimann, MW				Burwinkel, B; Bakker, HD; Herschkovitz, E; Moses, SW; Shin, YS; Kilimann, MW			Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI (Hers disease)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KINASE-DEFICIENCY; SEQUENCE-ANALYSIS; STORAGE DISEASE; MUSCLE; DIAGNOSIS; ISOZYME; CELLS; RAT	Deficiency of glycogen phosphorylase in the liver gives rise to glycogen-storage disease type VI (Hers disease; MIM 232700). We report the identification of the first mutations in PYGL, the gene encoding the liver isoform of glycogen phosphorylase, in three patients with Hers disease. These are two splice-site mutations and two missense mutations. A mutation of the 5' splice-site consensus of intron 14 causes the retention of intron 14 and the utilization of two illegitimate 5' splice sites, whereas a mutation of the 3' splice-site consensus of intron 4 causes the skipping of exon 5. Two missense mutations, N338S and N376K, both cause nonconservative replacements of amino acids that are absolutely conserved even in yeast and bacterial phosphorylases. We also report corrections of the PYGL coding sequence, sequence polymorphisms, and a partial PYGL gene structure with introns in the same positions as in PYGM, the gene of the muscle isoform of phosphorylase. Our findings demonstrate that PYGL mutations cause Hers disease, and they may improve laboratory diagnosis of deficiencies of the liver phosphorylase system.	Ruhr Univ Bochum, Inst Physiol Chem, D-4630 Bochum, Germany; Univ Amsterdam, Emma Kinderziekenhuis, Amsterdam, Netherlands; Ben Gurion Univ Negev, Dept Pediat, IL-84105 Beer Sheva, Israel; Univ Munich, Dr Von Haunerschen Kinderspital, Stoffwechselzentrum, D-80337 Munich, Germany	Ruhr University Bochum; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Ben Gurion University; University of Munich	Kilimann, MW (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, D-4630 Bochum, Germany.	manfred.kilimann@ruhr-uni-bochum.de						Aperlo C, 1996, GENOMICS, V37, P337, DOI 10.1006/geno.1996.0568; BARTRAM C, 1995, BBA-MOL BASIS DIS, V1272, P1, DOI 10.1016/0925-4439(95)00060-H; BURKE J, 1987, PROTEINS, V2, P177, DOI 10.1002/prot.340020303; Burwinkel B, 1997, HUM MOL GENET, V6, P1109, DOI 10.1093/hmg/6.7.1109; Burwinkel B, 1997, HUM GENET, V101, P170, DOI 10.1007/s004390050608; Burwinkel B, 1998, HUM MOL GENET, V7, P149, DOI 10.1093/hmg/7.1.149; Burwinkel B, 1996, HUM MOL GENET, V5, P653, DOI 10.1093/hmg/5.5.653; Chen Y-T, 1995, METABOLIC MOL BASES, P935; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; DAHAN N, 1988, J INHERIT METAB DIS, V11, P253, DOI 10.1007/BF01800366; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; HERS H G, 1959, Rev Int Hepatol, V9, P35; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; KILIMANN MW, 1997, PROTEIN DYSFUNCTION, P57; KOSTER JF, 1976, CLIN CHIM ACTA, V69, P121, DOI 10.1016/0009-8981(76)90481-2; LEDERER B, 1976, BIOCHEM J, V159, P689, DOI 10.1042/bj1590689; LEDERER B, 1975, BIOCHEM J, V147, P23, DOI 10.1042/bj1470023; Maichele AJ, 1996, NAT GENET, V14, P337, DOI 10.1038/ng1196-337; MAIRE I, 1991, CLIN BIOCHEM, V24, P169, DOI 10.1016/0009-9120(91)90511-C; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1986, P NATL ACAD SCI USA, V83, P8132, DOI 10.1073/pnas.83.21.8132; vandenBerg IET, 1997, AM J HUM GENET, V61, P539, DOI 10.1086/515502; Vorgerd M, 1998, ANN NEUROL, V43, P326, DOI 10.1002/ana.410430310	23	66	72	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					785	791		10.1086/301790	http://dx.doi.org/10.1086/301790			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529348	Bronze, Green Published			2022-12-18	WOS:000073514400008
J	Wandstrat, AE; Leana-Cox, J; Jenkins, L; Schwartz, S				Wandstrat, AE; Leana-Cox, J; Jenkins, L; Schwartz, S			Molecular cytogenetic evidence for a common breakpoint in the largest inverted duplications of chromosome 15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI-SYNDROME; IN-SITU HYBRIDIZATION; MARKER CHROMOSOMES; REGIONAL LOCALIZATION; INSITU HYBRIDIZATION; UNIPARENTAL DISOMY; ANGELMAN-SYNDROME; SNRPN GENE; DUP(15); HUMAN-CHROMOSOME-15	Chromosomes from 20 patients were used to delineate the breakpoints of inverted duplications of chromosome 15 (inv dup[15]) that include the Prader-Willi syndrome/Angelman syndrome (PWS/AS) chromosomal region (15q11-q13), YAC and cosmid clones from 15q11-q14 were used for FISH analysis, to detect the presence or absence of material on each inv dup(15). We describe two types of inv dup(15): those that break between D15S12 and D15S24, near the distal boundary of the PWS/AS chromosomal region, and those that share a breakpoint immediately proximal to D15S1010. Among the latter group, no breakpoint heterogeneity could be detected with the available probes, and one YAC (810f11) showed a reduced signal on each inv dup(15), compared with that on normal chromosomes 15. The lack of breakpoint heterogeneity may be the result of a U-type exchange involving particular sequences on either homologous chromosomes or sister chromatids. Parent-of-origin studies revealed that, in all the cases analyzed, the inv dup(15) was maternal in origin.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Maryland, Dept Obstet Gynecol, Div Human Genet, Baltimore, MD 21201 USA; Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; Kaiser Permanente Med Grp, San Jose, CA USA	Case Western Reserve University; University Hospitals of Cleveland; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Kaiser Permanente; Permanente Medical Groups	Schwartz, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Biomed Res Bldg,7th Floor W Adm,10900 Euclid Ave, Cleveland, OH 44106 USA.				NICHD NIH HHS [P01 HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amos-Landgraf J., 1994, American Journal of Human Genetics, V55, pA38; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; BUITING K, 1992, P NATL ACAD SCI USA, V89, P5457, DOI 10.1073/pnas.89.12.5457; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CHENG SD, 1994, AM J HUM GENET, V55, P753; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; CROLLA JA, 1995, HUM GENET, V95, P161; Flejter WL, 1996, AM J MED GENET, V61, P182, DOI 10.1002/(SICI)1096-8628(19960111)61:2<182::AID-AJMG17>3.3.CO;2-K; FUJITA H, 1980, HUM GENET, V55, P409, DOI 10.1007/BF00290227; Glenn CC, 1996, AM J HUM GENET, V58, P335; HALL JG, 1990, AM J HUM GENET, V46, P857; Huang B, 1997, HUM GENET, V99, P11; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KNIGHT LA, 1984, AM J MED GENET, V17, P649, DOI 10.1002/ajmg.1320170315; KRAMER PL, 1992, GENOMICS, V13, P904, DOI 10.1016/0888-7543(92)90185-U; LEANACOX J, 1994, AM J HUM GENET, V54, P748; LEANACOX J, 1993, THESIS U MARYLAND BA; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; MATTEI MG, 1984, HUM GENET, V66, P313, DOI 10.1007/BF00287636; Mignon C, 1996, EUR J HUM GENET, V4, P88; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PLATTNER R, 1991, HUM GENET, V87, P290; PLATTNER R, 1993, HUM GENET, V91, P589; RAUCH A, 1992, CLIN GENET, V42, P84; RICHARD I, 1994, GENOMICS, V23, P619, DOI 10.1006/geno.1994.1550; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROBINSON WP, 1993, J MED GENET, V30, P756, DOI 10.1136/jmg.30.9.756; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; SCHWARTZ S, 1990, AM J HUM GENET S, V47, pA40; SHIBUYA Y, 1991, CLIN GENET, V40, P233; SPEED RM, 1976, J MED GENET, V13, P295, DOI 10.1136/jmg.13.4.295; SPINNER NB, 1995, AM J MED GENET, V57, P61, DOI 10.1002/ajmg.1320570114; STETTEN G, 1981, HUM GENET, V57, P357, DOI 10.1007/BF00281684; SULLIVAN BA, 1993, AM J MED GENET, V47, P223, DOI 10.1002/ajmg.1320470217; VANDYKE DL, 1977, AM J HUM GENET, V29, P294; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; WISNIEWSKI LP, 1980, CLIN GENET, V18, P42; ZANNOTTI M, 1980, J MENT DEFIC RES, V24, P235	43	66	67	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					925	936		10.1086/301777	http://dx.doi.org/10.1086/301777			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529335	Bronze, Green Published			2022-12-18	WOS:000073514400024
J	Ober, C				Ober, C			HLA and pregnancy: The paradox of the fetal allograft	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-I; MATERNAL CELLS; ANTIGENS; EXPRESSION; PROTEIN; COUPLES; BLOOD		Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 924 E 57th St, Chicago, IL 60637 USA.							BEAN MA, 1990, TRANSPLANTATION, V49, P382, DOI 10.1097/00007890-199002000-00031; BEER AE, 1976, IMMUNOBIOLOGY REPROD; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BILLINGTON WD, 1964, NATURE, V202, P317, DOI 10.1038/202317a0; Bonney EA, 1997, J IMMUNOL, V158, P40; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; FUJII T, 1994, J IMMUNOL, V153, P5516; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; HUNT JS, 1996, HLA MATERNAL FETAL R, P1; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; JAMES DA, 1965, NATURE, V205, P613, DOI 10.1038/205613a0; King A, 1996, J IMMUNOL, V156, P2068; KIRBY DRS, 1970, P ROY SOC MED, V63, P59, DOI 10.1177/003591577006300126; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; NELSON JL, 1993, NEW ENGL J MED, V329, P466, DOI 10.1056/NEJM199308123290704; OBER C, 1995, PLACENTA, V16, P569, DOI 10.1016/0143-4004(95)90026-8; Ober C., 1996, HLA MATERNAL FETAL R, P133; OBER C, IN PRESS PLACENTA; OBER C, 1997, J REPROD IMMUNOL, V61, P497; OBER C, IN PRESS HUM REPROD; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Piotrowski P, 1996, BIOL REPROD, V54, P1103, DOI 10.1095/biolreprod54.5.1103; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; SCHACTER B, 1979, LANCET, V1, P796; SO A, 1994, HLA DIS, P1; SOCIE G, 1994, BLOOD, V83, P340; Suarez MB, 1997, IMMUNOGENETICS, V45, P464, DOI 10.1007/s002510050235; VANDERVEN K, 1994, J IMMUNOL, V153, P5628; VANROOD JJ, 1958, NATURE, V181, P1735, DOI 10.1038/1811735a0; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005	34	66	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					1	5		10.1086/301692	http://dx.doi.org/10.1086/301692			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443885	Green Published, Bronze			2022-12-18	WOS:000072127900001
J	Nishida, K; Honma, Y; Dota, A; Kawasaki, S; Adachi, W; Nakamura, T; Quantock, AJ; Hosotani, H; Yamamoto, S; Okada, M; Shimomura, Y; Kinoshita, S				Nishida, K; Honma, Y; Dota, A; Kawasaki, S; Adachi, W; Nakamura, T; Quantock, AJ; Hosotani, H; Yamamoto, S; Okada, M; Shimomura, Y; Kinoshita, S			Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; CROSS-LINKING; COILED-COIL; ROD DOMAIN; EXPRESSION; PROTEIN; HYPERKERATOSIS; ABNORMALITIES; FILAMENTS; INVITRO	Keratin 12 (K12) is an intermediate-filament protein expressed specifically in corneal epithelium. Recently, we isolated K12 cDNA from a human corneal epithelial cDNA library and determined its full sequence. Herein, we present the exon-intron boundary structure and chromosomal localization of human K12. In addition, we report four K12 mutations in Meesmann corneal epithelial dystrophy (MCD), an autosomal dominant disorder characterized by intraepithelial microcysts and corneal epithelial fragility in which mutations in keratin 3 (K3) and K12 have recently been implicated. In the human K12 gene, we identified seven introns, defining eight individual exons that cover the coding sequence. Together the exons and introns span similar to 6 kb of genomic DNA. Using FISH, we found that the K12 gene mapped to 17q12, where a type I keratin cluster exists. In this study, four new K12 mutations (Arg135Gly, Arg135Ile, Tyr429Asp, and Leu140Arg) were identified in three unrelated MCD pedigrees and in one individual with MCD. All mutations were either in the highly conserved alpha-helix-initiation motif of rod domain 1A or in the alpha-helix-termination motif of rod domain 2B. These sites are essential for keratin filament assembly, suggesting that the mutations described above may be causative for MCD. Of particular interest, one of these mutations (Tyr429Asp), detected in both affected individuals in one of our pedigrees, is the first mutation to be identified within the alpha-helix-termination motif in type I keratin.	Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto 602, Japan; Osaka Univ, Sch Med, Osaka, Japan	Kyoto Prefectural University of Medicine; Osaka University	Nishida, K (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kamigyo Ku, Kyoto 602, Japan.			Nishida, Kohji/0000-0001-9069-3610				BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHAN YM, 1993, P NATL ACAD SCI USA, V90, P7414, DOI 10.1073/pnas.90.15.7414; CHEN MA, 1993, HUM MOL GENET, V2, P1971, DOI 10.1093/hmg/2.11.1971; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HATZFELD M, 1991, J CELL SCI, V99, P351; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HUMPHRIES MM, 1993, HUM MUTAT, V2, P37, DOI 10.1002/humu.1380020107; Irvine AD, 1997, NAT GENET, V16, P184, DOI 10.1038/ng0697-184; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; KLINGE EM, 1987, J MOL EVOL, V24, P319, DOI 10.1007/BF02134130; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; KUWABARA T, 1964, ARCH OPHTHALMOL-CHIC, V71, P676, DOI 10.1001/archopht.1964.00970010692015; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; LIU CY, 1994, J BIOL CHEM, V269, P24627; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; LU X, 1990, CELL, V62, P681, DOI 10.1016/0092-8674(90)90114-T; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Meesmann A, 1939, KLIN MONATSBL AUGENH, V103, P361; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; NAKANISHI I, 1975, ARCH OPHTHALMOL-CHIC, V93, P259; Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800; NISHIDA K, 1995, CURR EYE RES, V14, P235, DOI 10.3109/02713689509033520; PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; RUGG EL, 1993, NAT GENET, V5, P294, DOI 10.1038/ng1193-294; SCAMSHER MK, 1995, HUM MOL GENET, V4, P1875; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEPHENS K, 1993, J INVEST DERMATOL, V101, P240, DOI 10.1111/1523-1747.ep12365079; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401; WU RL, 1994, J BIOL CHEM, V269, P28450	39	66	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1268	1275		10.1086/301650	http://dx.doi.org/10.1086/301650			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399908	Bronze, Green Published			2022-12-18	WOS:000071555900009
J	Murrell, JR; Koller, D; Foroud, T; Goedert, M; Spillantini, MG; Edenberg, HJ; Farlow, MR; Ghetti, B				Murrell, JR; Koller, D; Foroud, T; Goedert, M; Spillantini, MG; Edenberg, HJ; Farlow, MR; Ghetti, B			Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; PROGRESSIVE SUBCORTICAL GLIOSIS; PONTO-NIGRAL DEGENERATION; LINKAGE ANALYSIS; PROTEIN; DISEASE; GENE; TAU; PHENOTYPE; MUTATION	An autosomal dominant presenile dementia affecting 39 individuals in a seven-generation, 383-member pedigree has been studied at Indiana University. In the affected members of this family, clinical symptoms occurred early in life, with an average age at onset of 48.8 years. The presenting clinical features include disequilibrium, neck stiffness, dysphagia, and memory loss. As the disease progresses, further cognitive decline, superior-gaze palsy, and dystaxia also are observed. The average duration from onset of symptoms to death is similar to 10 years. Neuropathologic studies of nine affected individuals showed neuronal loss in several areas of the CNS, as well as argentophilic tau-immunopositive inclusions in neurons and in oligodendroglia. A limited genomic screen by use of DNA samples from 28 family members localized the gene for this disorder to a 3-cM region on chromosome 17, between the markers THRA1 and D17S791. The gene for tau also was analyzed, through samples from the family.	INDIANA UNIV,SCH MED,DEPT MED & MOL GENET,INDIANAPOLIS,IN 46204; INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOL BIOL,INDIANAPOLIS,IN 46204; INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46204; UNIV CAMBRIDGE,MRC,MOL BIOL LAB,CAMBRIDGE,ENGLAND; UNIV CAMBRIDGE,MRC,CAMBRIDGE CTR BRAIN REPAIR,DEPT NEUROL,CAMBRIDGE,ENGLAND	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge	Murrell, JR (corresponding author), INDIANA UNIV,MED CTR,DEPT PATHOL & LAB MED,SCH MED,ROOM A128,635 BARNHILL DR,INDIANAPOLIS,IN 47202, USA.			Edenberg, Howard/0000-0003-0344-9690	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029822, R01NS014426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG010133] Funding Source: NIH RePORTER; NIA NIH HHS [U24 AG021886, 2 P30 AG10133] Funding Source: Medline; NINDS NIH HHS [NS29822, NS14426] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; BONGCAMRUDLOFF E, 1991, CANCER RES, V51, P1553; BROWN J, 1995, HUM MOL GENET, V4, P1625, DOI 10.1093/hmg/4.9.1625; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; GHETTI B, 1995, BRAIN PATHOL, V5, P61, DOI 10.1111/j.1750-3639.1995.tb00578.x; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; GHETTI B, 1992, BRAIN RES, V571, P133, DOI 10.1016/0006-8993(92)90519-F; GHETTI B, 1994, BRAIN PATHOL, V4, P517; GOLDFARB LG, 1994, MOL NEUROBIOL, V8, P89, DOI 10.1007/BF02780658; GROEN JJ, 1982, BRAIN, V105, P443, DOI 10.1093/brain/105.3.443; Heutink P, 1997, ANN NEUROL, V41, P150, DOI 10.1002/ana.410410205; KNOPS J, 1991, J BIOL CHEM, V266, P7285; LANSKA DJ, 1994, NEUROLOGY, V44, P1633, DOI 10.1212/WNL.44.9.1633; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PETERSEN RB, 1995, NEUROLOGY, V45, P1062, DOI 10.1212/WNL.45.6.1062; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sima AAF, 1996, ANN NEUROL, V39, P734, DOI 10.1002/ana.410390609; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Wijker M, 1996, HUM MOL GENET, V5, P151, DOI 10.1093/hmg/5.1.151; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; WSZOLEK ZK, 1992, ANN NEUROL, V32, P312, DOI 10.1002/ana.410320303; YAMADA T, 1993, NEUROL PSYCHIAT BR, V2, P26; Yamaoka LH, 1996, AM J HUM GENET, V59, P1306	28	66	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1131	1138		10.1086/301594	http://dx.doi.org/10.1086/301594			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345089	Green Published, Bronze			2022-12-18	WOS:A1997YH01700019
J	Bremner, R; Du, DC; ConnollyWilson, MJ; Bridge, P; Ahmad, KF; Mostachfi, H; Rushlow, D; Dunn, JM; Gallie, BL				Bremner, R; Du, DC; ConnollyWilson, MJ; Bridge, P; Ahmad, KF; Mostachfi, H; Rushlow, D; Dunn, JM; Gallie, BL			Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							BECKER MUSCULAR-DYSTROPHY; ONCOGENIC POINT MUTATIONS; SOFT-TISSUE SARCOMAS; LARGE-T-ANTIGEN; GENE-PRODUCT; CELL-CYCLE; TRANSCRIPTION FACTOR; HEREDITARY RETINOBLASTOMA; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS	A deletion in the tumor-suppressor gene, RE, discovered by quantitative multiplex PCR, shows low penetrance (LP), since only 39% of eyes at risk in this family develop retinoblastoma. The 4-kb deletion spanning exons 24 and 25 (Delta 24-25) is the largest ever observed in an LP retinoblastoma family, Unlike the usual RE mutations, which cause retinoblastoma in 95% of at-risk eyes and yield no detectable protein, the Delta 24-25 allele transcribed a message splicing exon 23 to exon 26, resulting in a detectable protein (pRB(Delta 24-25)) that lacks 58 amino acids from the C-terminal domain, proving that this domain is essential for suppression of retinoblastoma. Two functions were partially impaired by Delta 24-25-nuclear localization and repression of E2F-consistent with the idea that LP mutations generate ''weak alleles'' by reducing but not eliminating essential activities. However, Delta 24-25 ablated interaction of pRB with MDM2. Since a homozygous LP allele is considered nontumorigenic, the pRB/MDM2 interaction may be semi-or nonessential for suppressing retinoblastoma. Alternatively, some homozygous LP alleles may not cause tumorigenesis because an additional event is required (the ''three-hit hypothesis''), or the resulting imbalance in pRB function may cause apoptosis (the ''death allele hypothesis''), pRB(Delta 24-25) also completely defective in suppressing growth of Saos-2 osteosarcoma cells. Targeting pRB(Delta 24-25) to the nucleus did not improve Saos-2 growth suppression, suggesting that C-terminal domain functions other than nuclear localization are essential for blocking proliferation in these cells. Since Delta 24-25 behaves like a null allele in these cells but Like an LP allele in the retina, pRB may use different mechanisms to control growth in different cell types.	UNIV TORONTO,HOSP SICK CHILDREN,DEPT OPHTHALMOL,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT MOL & CELLULAR PATHOL,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT MED & MOL GENET,TORONTO,ON M5G 1X8,CANADA; VISIBLE GENET INC,TORONTO,ON,CANADA; MED GENET PROGRAM,ST JOHNS,NF,CANADA; UNIV CALGARY,CALGARY,AB,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary	Bremner, R (corresponding author), EYE RES INST,399 BATHURST ST,TORONTO,ON M5T 2S8,CANADA.		Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212; Gallie, Brenda/0000-0002-9697-9211				ADUANE J, 1995, J BIOL CHEM, V270, P8837; AGUZZI A, 1995, GLIA, V15, P348, DOI 10.1002/glia.440150314; An B, 1996, FEBS LETT, V399, P158, DOI 10.1016/S0014-5793(96)01311-7; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Bautista D, 1996, INVEST OPHTH VIS SCI, V37, P2313; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; BIA B, 1995, ONCOGENE, V11, P977; BLANQUET V, 1993, HUM MOL GENET, V2, P975, DOI 10.1093/hmg/2.7.975; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; BREMNER R, 1995, MOL CELL BIOL, V15, P3256; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Chen WD, 1997, ONCOGENE, V14, P1243, DOI 10.1038/sj.onc.1201096; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CONNOLLY MJ, 1983, HUM GENET, V65, P122, DOI 10.1007/BF00286647; CORDONCARDO C, 1994, CANCER RES, V54, P794; Cowell JK, 1996, ONCOGENE, V12, P431; Cowell John K., 1994, European Journal of Human Genetics, V2, P281; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DRAPER GJ, 1986, BRIT J CANCER, V53, P661, DOI 10.1038/bjc.1986.110; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; GALLIE BL, 1982, OPHTHALMOLOGY, V89, P1393; GALLIE BL, 1982, BRIT J CANCER, V45, P513, DOI 10.1038/bjc.1982.87; GALLIE BL, 1995, CANC GENETICS, P1; GALLIE BL, 1979, IMMUNOLOGY IMMUNOPAT, P190; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; GOODRICH DW, 1991, CELL, V67, P293, DOI 10.1016/0092-8674(91)90181-W; GROUP MS, 1992, JAMA-J AM MED ASSOC, V267, P2609; HAGEMEIER C, 1993, P NATL ACAD SCI USA, V90, P1580, DOI 10.1073/pnas.90.4.1580; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; HAMEL PA, 1990, MOL CELL BIOL, V10, P6586, DOI 10.1128/MCB.10.12.6586; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HANSEN MF, 1990, CANCER GENET CYTOGEN, V49, P15, DOI 10.1016/0165-4608(90)90159-8; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HARRISON DJ, 1995, ONCOGENE, V10, P1615; HASHIMOTO T, 1991, ONCOGENE, V6, P463; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Herrmann J, 1976, Birth Defects Orig Artic Ser, V12, P79; HIEBERT SW, 1993, MOL CELL BIOL, V13, P3384, DOI 10.1128/MCB.13.6.3384; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; HOGG A, 1993, P NATL ACAD SCI USA, V90, P7351, DOI 10.1073/pnas.90.15.7351; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HOROWITZ JM, 1989, SCIENCE, V243, P936; HU NP, 1994, ONCOGENE, V9, P1021; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG S, 1991, NATURE, V350, P160, DOI 10.1038/350160a0; IOANNOU P, 1992, NEUROLOGY, V42, P1783, DOI 10.1212/WNL.42.9.1783; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; KATO G, 1988, IN VITRO CELL DEV B, V24, P274, DOI 10.1007/BF02628827; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KRATZKE RA, 1994, ONCOGENE, V9, P1321; KRATZKE RA, 1992, J BIOL CHEM, V267, P25998; LADANYI M, 1993, CANCER RES, V53, P16; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; LEACH FS, 1993, CANCER RES, V53, P2231; LEE YHP, 1992, NATURE, V359, P288; LI Y, 1993, GENE DEV, V7, P2366, DOI 10.1101/gad.7.12a.2366; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; LOHMANN DR, 1994, HUM GENET, V94, P349; Luna RMDO, 1996, GENOMICS, V33, P352, DOI 10.1006/geno.1996.0210; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; MATSUNAGA E, 1978, AM J HUM GENET, V30, P406; MAYOL X, 1993, ONCOGENE, V8, P2561; MCFALL RC, 1977, CANCER RES, V37, P1003; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; MUNIER FL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1507, DOI 10.1001/archopht.1993.01090110073028; Noorani HZ, 1996, AM J HUM GENET, V59, P301; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; ONADIM Z, 1991, BRIT J OPHTHALMOL, V75, P147, DOI 10.1136/bjo.75.3.147; ONADIM ZO, 1990, ARCH DIS CHILD-FETAL, V65, P651, DOI 10.1136/adc.65.7_Spec_No.651; QIAN YY, 1992, MOL CELL BIOL, V12, P5363, DOI 10.1128/MCB.12.12.5363; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; REIFENBERGER G, 1993, CANCER RES, V53, P2736; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; SCHWARTZ LS, 1992, AM J HUM GENET, V51, P721; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; SQUIRE J, 1984, HUM GENET, V66, P46, DOI 10.1007/BF00275185; STIRDIVANT SM, 1992, J BIOL CHEM, V267, P14846; STRONG LC, 1981, SCIENCE, V213, P1501, DOI 10.1126/science.7280668; Tan XQ, 1997, J BIOL CHEM, V272, P9613; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; WADAYAMA B, 1994, CANCER RES, V54, P3042; WANG CY, 1993, SCIENCE, V260, P1330, DOI 10.1126/science.8493578; WELCH PJ, 1995, GENE DEV, V9, P31, DOI 10.1101/gad.9.1.31; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; YOKOTA J, 1988, ONCOGENE, V3, P471; Zacksenhaus E, 1996, EMBO J, V15, P5917, DOI 10.1002/j.1460-2075.1996.tb00978.x; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	123	66	71	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					556	570		10.1086/515499	http://dx.doi.org/10.1086/515499			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326321	Green Published, Bronze			2022-12-18	WOS:A1997XY52300013
J	Jager, AC; Bisgaard, ML; Myrhoj, T; Bernstein, I; Rehfeld, JF; Nielsen, FC				Jager, AC; Bisgaard, ML; Myrhoj, T; Bernstein, I; Rehfeld, JF; Nielsen, FC			Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLON-CANCER; ADENOMATOUS POLYPOSIS; MUTATIONS; GENE; HOMOLOG; KINDREDS; RNA; LOCUS; ACID; MSH2	Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disease caused by mutations in one of at least four different DNA mismatch repair genes, hMLH1, hMSH2, hPMS1, and hPMS2. Phenotypically, HNPCC is characterized by the early onset of colorectal cancers and various extracolonic cancers. Depending on the presence or absence of extracolonic tumors, HNPCC has been divided into two syndromes (Lynch syndrome I and Lynch syndrome II), but, so far, no correlation to distinct genotypes has been demonstrated. In this study, we present a frequent hMLH1 intron 14 founder mutation that is associated with a highly reduced frequency of extracolonic tumors. The mutation disrupts the splice donor site and silences the mutated allele. Tumors exhibited microsatellite instability, and loss of the wild-type hMLH1 allele was prevalent. We propose that the mutation results in a milder phenotype, because the mutated hMLH1 protein is prevented from exerting a dominant negative effect on the concerted action of the mismatch repair system.	RIGSHOSP,DEPT CLIN BIOCHEM,DK-2100 COPENHAGEN,DENMARK; UNIV COPENHAGEN,HVIDOVRE HOSP,DANISH HNPCC REGISTER,DK-2650 HVIDOVRE,DENMARK	Rigshospitalet; University of Copenhagen; University of Copenhagen			Bernstein, Inge/AAD-8159-2020; Nielsen, Finn Cilius/AAA-4926-2020	Bernstein, Inge/0000-0003-4095-432X; Nielsen, Finn Cilius/0000-0002-9829-1031				Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Canzian F, 1996, CANCER RES, V56, P3331; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL R, 1994, CELL, V77, P167; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LYNCH HT, 1988, DIS COLON RECTUM, V31, P372, DOI 10.1007/BF02564888; MAQUAT LE, 1995, RNA, V1, P453; Moisio AL, 1996, AM J HUM GENET, V59, P1243; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; STORM HH, 1993, CANC INCIDENCE DENMA; STRAUSS WM, 1994, CURRENT PROTOCOLS MO; TANNERGARD P, 1995, CANCER RES, V55, P6092; VASEN HFA, 1990, INT J CANCER, V46, P31, DOI 10.1002/ijc.2910460108; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Wijnen J, 1996, AM J HUM GENET, V58, P300	33	66	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					129	138		10.1086/513896	http://dx.doi.org/10.1086/513896			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245993	Bronze, Green Published			2022-12-18	WOS:A1997XM72800020
J	Schumann, H; HammamiHauasli, N; Pulkkinen, L; Mauviel, A; Kuster, W; Luthi, U; Owaribe, K; Uitto, J; BrucknerTuderman, L				Schumann, H; HammamiHauasli, N; Pulkkinen, L; Mauviel, A; Kuster, W; Luthi, U; Owaribe, K; Uitto, J; BrucknerTuderman, L			Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: Relation to biological and clinical phenotypes of junctional epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEMPHIGOID ANTIGEN BPAG2; COLLAGEN-VII; BP180; IMMUNOFLUORESCENCE; AUTOANTIBODIES; HEMIDESMOSOME; AUTOANTIGEN; DOMAIN; CELLS	Junctional epidermolysis bullosa (JEB) is a clinically and biologically heterogeneous genodermatosis, characterized by trauma-induced blistering and healing without scarring but sometimes with skin atrophy. We investigated three unrelated patients with different JEB phenotypes. Patients 1 and 2 had generalized atrophic benign epidermolysis bullosa (GABEB), with features including skin atrophy and alopecia. Patient 3 had the localisata variant of JEB, with predominantly acral blistering and normal hair. All patients carried novel homozygous point mutations (Q1016X, R1226X, and R1303Q) in the COL17A1 gene encoding collagen XVII, a hemidesmosomal transmembrane component; and, therefore, not only GABEB but also the localisata JEB can be a collagen XVII disorder. The nonsense mutations led to drastically reduced collagen XVII mRNA and protein levels. In contrast, the missense mutation allowed expression of abnormal collagen XVII, and epidermal extracts from that patient contained polypeptides of normal size, as well as larger aggregates. The homozygous nonsense mutations in the COL17A1 gene were consistent with the absence of the collagen from the skin and with the GABEB phenotype, whereas homozygosity for the missense mutation resulted in expression of aberrant collagen XVII and, clinically, in localisata JEB.	UNIV MUNSTER,DEPT DERMATOL,D-48149 MUNSTER,GERMANY; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL & CUTANEOUS BIOL,PHILADELPHIA,PA 19107; UNIV MARBURG,DEPT DERMATOL,MARBURG,GERMANY; UNIV ZURICH,CENT LAB ELECTRON MICROSCOPY,ZURICH,SWITZERLAND; NAGOYA UNIV,SCH INFORMAT & SCI,DEPT NAT SCI INFORMAT,NAGOYA,AICHI,JAPAN	University of Munster; Jefferson University; Philipps University Marburg; University of Zurich; Nagoya University			MAUVIEL, Alain/F-6251-2013	Mauviel, Alain/0000-0002-0438-2793	NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Balding SD, 1996, J INVEST DERMATOL, V106, P141, DOI 10.1111/1523-1747.ep12329728; BRUCKNERTUDERMA.L, 1993, EXTRACELLULAR MATRIX, P507; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; Darling TN, 1997, J INVEST DERMATOL, V108, P463, DOI 10.1111/1523-1747.ep12289718; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gatalica B, 1997, AM J HUM GENET, V60, P352; GEDDEDAHL T, 1996, EMERY RIMOINS PRINCI, V1, P1225; GIUDICE GJ, 1994, J INVEST DERMATOL, V102, P878, DOI 10.1111/1523-1747.ep12382738; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; HASHIMOTO I, 1976, DERMATOLOGICA, V152, P72, DOI 10.1159/000251166; HINTNER H, 1981, J INVEST DERMATOL, V76, P113, DOI 10.1111/1523-1747.ep12525447; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; ISHIKO A, 1993, J CLIN INVEST, V91, P1608, DOI 10.1172/JCI116368; Jonkman MF, 1996, ARCH DERMATOL, V132, P145, DOI 10.1001/archderm.132.2.145; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; KITAJIMA Y, 1992, EXP CELL RES, V203, P17, DOI 10.1016/0014-4827(92)90034-6; Kivirikko S, 1996, HUM MOL GENET, V5, P231, DOI 10.1093/hmg/5.2.231; KONIG A, 1992, J CELL BIOL, V117, P679, DOI 10.1083/jcb.117.3.679; LI KH, 1993, J BIOL CHEM, V268, P8825; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; McGrath JA, 1996, J INVEST DERMATOL, V106, P771, DOI 10.1111/1523-1747.ep12345821; McGrath JA, 1996, AM J PATHOL, V148, P1787; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Pulkkinen Leena, 1996, Journal of Investigative Dermatology, V106, P829; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Sambrook J., 1990, MOL CLONING LAB MANU, V2nd; Schumann Hauke, 1996, Journal of Investigative Dermatology, V106, P821; SONNENBERG A, 1991, EXP CELL RES, V197, P234, DOI 10.1016/0014-4827(91)90428-W; ZORTEACAFLISCH C, 1985, HAUTARZT, V36, P176	34	66	68	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1344	1353		10.1086/515463	http://dx.doi.org/10.1086/515463			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199555	Green Published, Bronze			2022-12-18	WOS:A1997XE29400012
J	Loader, S; Caldwell, P; Kozyra, A; Levenkron, JC; Bohem, CD; Rowley, PT				Loader, S; Caldwell, P; Kozyra, A; Levenkron, JC; Bohem, CD; Rowley, PT			Cystic fibrosis carrier population screening in the primary care setting	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFORMATION LEAFLET; DNA ANALYSIS; GENE; IDENTIFICATION; APPROPRIATE; ATTITUDES; PROGRAM; TRIAL; CF	To determine the receptivity of prenatal care providers and their patients to carrier testing for cystic fibrosis (CF), we offered free carrier screening, followed by genetic counseling af carriers, to all prenatal care providers in Rochester, NY, for all their female patients of reproductive age, pregnant or not. Of 124 prenatal care providers, only 37 elected to participate, but many of these offered screening only to pregnant women. The acceptance rate among pregnant women was similar to 57%. The most common reasons for accepting screening were to obtain reassurance (50.7%) and to avoid having a child with CF (27.8%). The most common reasons for declining screening were not intending to terminate a pregnancy for CF (32.4%) and believing that the chance of having a CF child was very low (32.2%). Compared with decliners, acceptors were more likely to have no children, regarded having a child with CF as more serious, believed themselves more susceptible to having such a child, knew more about CF, would be more likely to terminate a pregnancy if the fetus were shown to have CF, and more strongly supported offering CF screening to women of reproductive age. Of 4,879 women on whom results were obtained, 124 were found to be carriers. Of these 124 carriers, the partners of 106 were tested. Of the five at-risk couples, four requested prenatal diagnosis and one requested neonatal diagnosis. No woman found to be a carrier whose partner tested negative requested prenatal diagnosis. Except for the imperfect knowledge of those testing negative, none of the adverse outcomes predicted for CF carrier testing in the general population were observed in this study.	UNIV ROCHESTER,SCH MED,DIV GENET,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED,DEPT PSYCHIAT,ROCHESTER,NY 14642; JOHNS HOPKINS UNIV,DEPT PEDIAT,BALTIMORE,MD 21218	University of Rochester; University of Rochester; Johns Hopkins University					NINR NIH HHS [NR03125] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR003125] Funding Source: NIH RePORTER	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BEAUDET AL, 1990, AM J HUM GENET, V47, P603; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; BIESECKER L, 1992, AM J HUM GENET, V50, P438; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BRAMBATI B, 1993, LANCET, V342, P624, DOI 10.1016/0140-6736(93)91456-V; BROCK DJH, 1994, PRENAT DIAGN, V14, P1248; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CLAYTON EW, 1995, AM J HUM GENET, V57, P171; *COMM OBST MAT FET, 1991, AM COLL OBST GYN COM; *COUNC ETH JUD AFF, 1991, ETH ISS CARR SCREEN; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P580; DODGE JA, 1992, B WORLD HEALTH ORGAN, V70, P561; ELIAS S, 1991, AM J OBSTET GYNECOL, V164, P1077, DOI 10.1016/0002-9378(91)90589-J; GELLER G, 1993, MED CARE, V31, P989, DOI 10.1097/00005650-199311000-00002; GILBERT F, 1990, AM J HUM GENET, V46, P394; GREGG RG, 1993, AM J HUM GENET, V52, P616; HAMMOND KB, 1991, NEW ENGL J MED, V325, P769, DOI 10.1056/NEJM199109123251104; HIGUCHI R, 1989, AMPLIFICATIONS   MAY, P1; JUNG U, 1994, HUM GENET, V94, P19, DOI 10.1007/BF02272835; KAPLAN F, 1991, AM J HUM GENET, V49, P240; KEREM E, 1991, AM REV RESPIR DIS, V143, P457, DOI 10.1164/ajrccm/143.3.457; LIVINGSTONE J, 1993, CLIN GENET, V43, P57, DOI 10.1111/j.1399-0004.1993.tb04427.x; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; MENNIE ME, 1993, J MED GENET, V30, P543, DOI 10.1136/jmg.30.7.543; MENNIE ME, 1992, J MED GENET, V29, P308, DOI 10.1136/jmg.29.5.308; MENNIE ME, 1993, PRENATAL DIAG, V13, P807, DOI 10.1002/pd.1970130904; MIEDZYBRODZKA ZH, 1995, BRIT MED J, V310, P353, DOI 10.1136/bmj.310.6976.353; MILLER SM, 1987, J PERS SOC PSYCHOL, V52, P345, DOI 10.1037/0022-3514.52.2.345; MITCHELL J, 1993, J MED GENET, V30, P538, DOI 10.1136/jmg.30.7.538; MODELL B, 1990, J MED GENET, V27, P475, DOI 10.1136/jmg.27.8.475; MODELL M, 1993, BRIT MED J, V307, P849, DOI 10.1136/bmj.307.6908.849; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstock I. M., 1990, Health behavior and health education: Theory, research, and practice, P39; ROWLEY PT, 1993, AM J PREV MED, V9, P261, DOI 10.1016/S0749-3797(18)30701-3; RYLEY HC, 1992, BRIT MED BULL, V48, P805, DOI 10.1093/oxfordjournals.bmb.a072579; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SCHMIDTKE J, 1994, HUM GENET, V94, P25, DOI 10.1007/BF02272836; Schwartz Marianne, 1993, European Journal of Human Genetics, V1, P239; SCRIVER CR, 1992, AM J HUM GENET, V51, P943; Spielberger C.D., 1970, STATETRAIT ANXIETY I; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; Tatsugawa Z H, 1994, J Genet Couns, V3, P279, DOI 10.1007/BF01412373; TENKATE LP, 1989, NATURE, V342, P131, DOI 10.1038/342131a0; TSUI LC, 1995, CF GENETIC ANAL 0322, P65; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WILLIAMSON R, 1993, NAT GENET, V3, P195, DOI 10.1038/ng0393-195; 1992, LANCET, V340, P209; 1990, NEW ENGL J MED, V323, P70; 1994, HUM MUTAT, V4, P167; 1992, AM J HUM GENET, V51, P1443	53	66	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					234	247						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659530				2022-12-18	WOS:A1996VL45500030
J	Takano, H; Onodera, O; Takahashi, H; Igarashi, S; Yamada, M; Oyake, M; Ikeuci, T; Koide, R; Tanaka, H; Iwabuchi, K; Tsuji, S				Takano, H; Onodera, O; Takahashi, H; Igarashi, S; Yamada, M; Oyake, M; Ikeuci, T; Koide, R; Tanaka, H; Iwabuchi, K; Tsuji, S			Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: Cellular population-dependent dynamics of mitotic instability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; MYOCLONUS EPILEPSY; TISSUES	Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disease caused by unstable expansion of a CAG repeat in the DRPLA gene. We performed detailed quantitative analysis of the size and the size distribution (range) of the expanded CAG repeats in various regions of the CNS of eight autopsied patients with DRPLA. Expanded alleles (AE) showed considerable variations in size, as well as in range, depending on the region of the CNS, whereas normal alleles did not show such variations, which indicates the occurrence of somatic mosaicism of AE in the CNS. The AE in the cerebellar cortex were consistently smaller by two to five repeat units than those in the cerebellar white matter. Moreover, the AE in the cerebral cortex were smaller by one to four repeat units than those in the cerebral white matter. These results suggest that the smaller AE in the cerebellar and cerebral cortices represent those of neuronal cells. The ranges of the AE in the cerebral cortex, cerebral white matter, and cerebellar white matter showed considerable variation ranging from 9 to 23 repeat units, whereas those in the cerebellar cortex showed little variance and were similar to 7 repeat units. The ranges of the AE in the cerebral cortex, cerebral white matter, and cerebellar white matter were much broader in patients with higher ages at death than they were in patients with lower ages at death, raising the possibility that the range of AE increases with time, as the result of mitotic instability of AE.	NIIGATA UNIV, BRAIN RES INST, DEPT NEUROL, NIIGATA 951, JAPAN; NIIGATA UNIV, BRAIN RES INST, DEPT PATHOL, NIIGATA 951, JAPAN; KANAGAWA REHABIL CTR, DEPT PSYCHIAT, KANAGAWA, JAPAN	Niigata University; Niigata University			Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472				ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; IWABUCHI K, 1993, ADV NEUROL SCI, V37, P678; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; LANDWEHRMEYER GB, 1995, ANN NEUROL, V37, P218, DOI 10.1002/ana.410370213; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maniatis T, 1989, MOL CLONING; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; NAITO H, 1977, PSYCHIAT NEUROL JPN, V78, P193; NAITO H, 1990, ADV NEUROL SCI, V34, P56; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OYANAGI S, 1976, ADV NEUROL SCI, V20, P410; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Reeves C., 1994, American Journal of Human Genetics, V55, pA238; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; STINE OC, 1995, HUM MOL GENET, V4, P15, DOI 10.1093/hmg/4.1.15; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TAKAHATA N, 1978, NEUROLOGY, V28, P913, DOI 10.1212/WNL.28.9.913; Takeda S, 1992, No To Shinkei, V44, P111; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; UENO S, 1995, HUM MOL GENET, V4, P663, DOI 10.1093/hmg/4.4.663; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99	41	66	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1212	1222						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651298				2022-12-18	WOS:A1996UM27100014
J	Witt, DR; Schaefer, C; Hallam, P; Wi, S; Blumberg, B; Fishbach, A; Holtzman, J; Kornfeld, S; Lee, R; Nemzer, L; Palmer, R				Witt, DR; Schaefer, C; Hallam, P; Wi, S; Blumberg, B; Fishbach, A; Holtzman, J; Kornfeld, S; Lee, R; Nemzer, L; Palmer, R			Cystic fibrosis heterozygote screening in 5,161 pregnant women	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE-BINDING FOLD; COMMUNITY ATTITUDES; CFTR GENE; IDENTIFICATION; MUTATIONS; CARRIERS; CARE; DNA; APPROPRIATE; DIAGNOSIS	A screening program for cystic fibrosis (CF) heterozygotes was conducted in a large HMO prenatal population, to evaluate the level of interest among eligible patients, the effectiveness of prescreening education, attitudes toward the screening process, psychological effects, and utilization of prenatal diagnosis and its outcomes. The heterozygote identification rate and frequency of specific CFTR mutations were also assessed. Identified carriers were offered genetic counseling and testing of male partners. Prenatal diagnosis was offered if both partners were identified as carriers. A total of 5,161 women underwent carrier testing; 947 others completed survey instruments only. The acceptance rate of screening was high (78%), and pretest education by videotape was generally effective. Adverse psychological effects were not reported. Participants generally found screening to be desirable and useful. Screening identified 142 female heterozygotes, 109 couples in which the male partner was not a carrier, and 7 high-risk couples. The incidence of R117H mutations was much higher than expected. The number of identified carriers was much lower in Hispanics than in Caucasians. We conclude that large-scale prenatal screening for CF heterozygotes in the absence of a family history of CF is an acceptable method for identifying couples at risk for affected fetuses. Sufficient pretest education can be accomplished efficiently, test insensitivity is well accepted, adverse psychological events are not observed, and general patient satisfaction is high.	KAISER PERMANENTE MED CARE PROGRAM,REG GENET PROGRAM,SAN JOSE,CA; KAISER PERMANENTE MED CARE PROGRAM,DIV RES,SAN JOSE,CA	Kaiser Permanente; Kaiser Permanente			Fishbach, Ayelet/R-6270-2019					ARZIMANOGLOU I, 1995, AM J HUM GENET, V56, P544; ASCH DA, 1993, AM J OBSTET GYNECOL, V168, P1; BEAUDET AL, 1990, AM J HUM GENET, V47, P603; BEAUDET AL, 1992, AM J HUM GENET, V50, P439; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; BEKKER H, 1994, J MED GENET, V31, P364, DOI 10.1136/jmg.31.5.364; BERNHARDT BA, 1991, NEW ENGL J MED, V324, P61; BIESECKER L, 1992, AM J HUM GENET, V50, P438; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOTKIN JR, 1992, AM J PUBLIC HEALTH, V82, P723, DOI 10.2105/AJPH.82.5.723; BROCK D, 1990, AM J HUM GENET, V47, P164; BROCK DJH, 1994, PRENATAL DIAG, V14, P1243, DOI 10.1002/pd.1970141309; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CLAYTON EW, 1994, 44 M AM SOC HUM GEN; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P580; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; FADEN RR, 1994, AM J MED GENET, V50, P1, DOI 10.1002/ajmg.1320500102; GARBER AM, 1991, MED CARE, V29, P473, DOI 10.1097/00005650-199105000-00007; GERVAIS R, 1993, NEW ENGL J MED, V328, P446, DOI 10.1056/NEJM199302113280619; GILBERT F, 1990, AM J HUM GENET, V46, P394; GILBERT F, 1990, 4 N AM CYST FIBR C A; GREBE TA, 1994, AM J HUM GENET, V54, P443; GREGG RG, 1993, AM J HUM GENET, V52, P616; HANNIG VL, 1994, 44 M AM SOC HUM GEN; HARRIS HJ, 1992, LANCET, V339, P1539, DOI 10.1016/0140-6736(92)91303-P; Holloway S, 1994, J Med Screen, V1, P159; JUNG U, 1994, HUM GENET, V94, P19, DOI 10.1007/BF02272835; KELSEWETTER S, 1993, NAT GENET, V5, P274; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KRAUSS CM, 1992, 42 M AM SOC HUM GEN; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LIVINGSTONE J, 1993, CLIN GENET, V43, P57, DOI 10.1111/j.1399-0004.1993.tb04427.x; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; MIEDZYBRODZKA Z, 1993, J MED GENET, V30, P86, DOI 10.1136/jmg.30.1.86-a; MITCHELL J, 1993, J MED GENET, V30, P538, DOI 10.1136/jmg.30.7.538; Neiger Ran, 1992, J Genet Couns, V1, P219, DOI 10.1007/BF00961583; OSBORNE L, 1991, AM J HUM GENET, V48, P608; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SCHULMAN JD, 1990, AM J HUM GENET, V47, P740; Schwartz Marianne, 1993, European Journal of Human Genetics, V1, P239; SCRIVER CR, 1992, AM J HUM GENET, V51, P943; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; SUPER M, 1990, NATURE, V344, P113, DOI 10.1038/344113b0; SUPER M, 1992, LANCET, V340, P490, DOI 10.1016/0140-6736(92)91816-Q; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; Tatsugawa Z H, 1994, J Genet Couns, V3, P279, DOI 10.1007/BF01412373; TENKATE LP, 1990, PRENATAL DIAG, V10, P275, DOI 10.1002/pd.1970100413; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; WALD NJ, 1991, LANCET, V338, P1318, DOI 10.1016/0140-6736(91)92605-2; WATSON EK, 1991, BRIT J GEN PRACT, V41, P237; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WILFOND BS, 1990, CYSTIC FIBROSIS HETE; WILLIAMSON R, 1989, PRENATAL DIAG, V9, P727, DOI 10.1002/pd.1970091008; WILLIAMSON R, 1993, NAT GENET, V3, P195, DOI 10.1038/ng0393-195; 1990, NEW ENGL J MED, V323, P70; 1992, OTABA532; 1990, AM J HUM GENET, V46, P393; 1992, AM J HUM GENET, V51, P1443	66	66	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					823	835						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644747				2022-12-18	WOS:A1996UA38000021
J	Clayton, EW; Hannig, VL; Pfotenhauer, JP; Parker, RA; Campbell, PW; Phillips, JA				Clayton, EW; Hannig, VL; Pfotenhauer, JP; Parker, RA; Campbell, PW; Phillips, JA			Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL-DIAGNOSIS; PRIMARY-CARE; DISCRIMINATION; ATTITUDES; POLICY	We used signs and letters to offer free cystic fibrosis (CF) carrier screening to nonpregnant adults in stable relationships who visited numerous clinical and nonclinical sites in Nashville. A total of 179 individuals (less than or equal to 1% of those eligible) elected to be tested. To understand this observation, we used questionnaires to assess individuals' attitudes about genetic testing in general and about CF carrier screening in particular (n = 873). Participants expressed conflicting views about carrier screening. More than 90% of people thought that genetic testing should at least be available. Most respondents said that the views of their partners and physicians were important in their decision making, and most believed that these others favored genetic testing. Yet, more than two-thirds indicated that such factors as insurability, being ''at risk,'' what they would need to learn, abortion, and religious beliefs were important in their decision making, opinions that mitigated against genetic testing. In particular, one-third feared that carriers would lose their health insurance, one-quarter said that they would have been more interested had they been able to provide DNA by buccal swab rather than by finger stick, and less than one-sixth believed that genetic testing was meddling in God's plan. In the face of both the low level of use of free CF carrier screening by nonpregnant couples when it was not offered in person by health-care professionals and the wide variety of concerns demonstrated, we believe that clinicians should not routinely offer carrier screening to nonpregnant individuals who do not have a family history of CF.	VANDERBILT UNIV, SCH MED, DEPT PEDIAT, NASHVILLE, TN 37212 USA; VANDERBILT UNIV, SCH MED, DEPT PREVENT MED, NASHVILLE, TN 37212 USA; VANDERBILT UNIV, SCH LAW, NASHVILLE, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University				Clayton, Ellen/0000-0002-0308-4110	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000638] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01 HG00638-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 1986, HIST THEORY INFORM C; ASCH DA, 1993, AM J OBSTET GYNECOL, V168, P1; ASCH DA, 1993, 3RD M CYST FIBR STUD; BEESON D, 1993, SEP CF CONS ELSI WOR; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; BOTKIN JR, 1992, AM J PUBLIC HEALTH, V82, P723, DOI 10.2105/AJPH.82.5.723; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CLAYTON EW, 1995, AM J HUM GENET, V57, P171; COLTEN HR, 1990, NEW ENGL J MED, V322, P328, DOI 10.1056/NEJM199002013220510; Doherty R., 1994, American Journal of Human Genetics, V55, pA278; FADEN RR, 1994, AM J MED GENET, V50, P1, DOI 10.1002/ajmg.1320500102; GILBERT F, 1990, AM J HUM GENET, V46, P394; Grody W. W., 1994, American Journal of Human Genetics, V55, pA292; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; Katz J., 1984, SILENT WORLD DOCTOR; LIPKIN M, 1986, ANN INTERN MED, V105, P115, DOI 10.7326/0003-4819-105-1-115; LIPPMAN A, 1991, AM J LAW MED, V17, P15; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; NANCE WE, 1992, AM J HUM GENET, V51, P1443; NATOWICZ MR, 1992, AM J HUM GENET, V50, P465; Rapp R., 1994, WOMEN PRENATAL TESTI, P219; REILLY P, 1977, GENETICS LAW SOC; ROBERTS L, 1990, SCIENCE, V247, P17, DOI 10.1126/science.2294585; Sorenson J. R., 1994, American Journal of Human Genetics, V55, pA22; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; VICKERS BB, 1993, TENNESSEE STATISTICA; WALD NJ, 1991, LANCET, V338, P1318, DOI 10.1016/0140-6736(91)92605-2; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; WERTZ DC, 1992, AM J HUM GENET, V50, P1077; WILFOND BS, 1992, MILBANK Q, V70, P629, DOI 10.2307/3350214; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WITT DR, 1992, PED PULM S, V8, P235; 1992, LANCET, V340, P209; 1990, NEW ENGL J MED, V323, P70; 1994, ASSESSING GENETICS R; 1975, GENETIC SCREENING PR; 1992, CYSTIC FIBROSIS DNA; 1993, 1990 CENSUS POPULATI	39	66	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					617	627						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644721				2022-12-18	WOS:A1996TV56400020
J	NAROD, S; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; EYFJORD, J; LENOIR, G; SEROVA, O; EASTON, D; GOLDGAR, D				NAROD, S; FORD, D; DEVILEE, P; BARKARDOTTIR, RB; EYFJORD, J; LENOIR, G; SEROVA, O; EASTON, D; GOLDGAR, D			GENETIC-HETEROGENEITY OF BREAST-OVARIAN CANCER REVISITED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA; CANC RES INST,EPIDEMIOL SECT,SUTTON,SURREY,ENGLAND; LEIDEN UNIV,DEPT PATHOL & HUMAN GENET,LEIDEN,NETHERLANDS; UNIV HOSP ICELAND,DEPT PATHOL,REYKJAVIK,ICELAND; ICELANDIC CANC SOC,MOLEC & CELL BIOL RES LAB,REYKJAVIK,ICELAND; INT AGCY RES CANC,F-69372 LYON,FRANCE; UNIV UTAH,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT 84112	McGill University; University of London; Institute of Cancer Research - UK; Leiden University; Leiden University - Excl LUMC; Landspitali National University Hospital; World Health Organization; International Agency for Research on Cancer (IARC); Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022; DEVILEE, PETER/ABR-2140-2022					HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	5	66	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					957	958						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573057				2022-12-18	WOS:A1995RV79300027
J	DEUFEL, T; SUDBRAK, R; FEIST, Y; RUBSAM, B; DUCHESNE, I; SCHAFER, KL; ROEWER, N; GRIMM, T; LEHMANNHORN, F; HARTUNG, EJ; MULLER, CR				DEUFEL, T; SUDBRAK, R; FEIST, Y; RUBSAM, B; DUCHESNE, I; SCHAFER, KL; ROEWER, N; GRIMM, T; LEHMANNHORN, F; HARTUNG, EJ; MULLER, CR			DISCORDANCE, IN A MALIGNANT HYPERTHERMIA PEDIGREE, BETWEEN IN-VITRO CONTRACTURE-TEST PHENOTYPES AND HAPLOTYPES FOR THE MHS1 REGION ON CHROMOSOME 19Q12-13.2, COMPRISING THE C1840T TRANSITION IN THE RYR1 GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; PROBABLE CAUSAL MUTATION; CALCIUM RELEASE CHANNEL; RYANODINE RECEPTOR GENE; SKELETAL-MUSCLE; GAMMA-SUBUNIT; SUSCEPTIBILITY; PORCINE; EXCLUSION; LOCUS	A point mutation in the gene encoding the skeletal muscle calcium release channel (RYR1) has been proposed as the probable cause of malignant hyperthermia (MH) in swine, where it segregates with the disease in all MH-prone strains investigated. The same C-to-T exchange in nucleotide position 1840 of the human RYR1 cDNA sequence was found in a few human MH pedigrees. We report a German MH pedigree where in vitro contracture test (IVCT) results and haplotypes of markers for the MHS1/RYR1 region including this base transition have yielded several discrepancies. The MH-susceptible phenotype was defined by IVCT performed according to the European standard protocol. Haplotypes were constructed for markers for the MHS1/RYR1 region on chromosome 19 and include the C1840T base exchange. Discussing the probabilities for a number of hypotheses to explain these data, we suggest that our results may challenge the causative role of this mutation-and possibly the role of the RYR1 gene itself-in human MH susceptibility, at least in some cases.	UNIV MUNSTER,GERHARD DOMAGK INST PATHOL,MUNSTER,GERMANY; UNIV WURZBURG,INST ANASTHESIOL,WURZBURG,GERMANY; UNIV HAMBURG,KRANKENHAUS EPPENDORF,ANASTHESIE ABT,HAMBURG,GERMANY; UNIV ULM,ANGEW PHYSIOL ABT,ULM,GERMANY	University of Munster; University of Wurzburg; University of Hamburg; Ulm University	DEUFEL, T (corresponding author), UNIV MUNSTER,KINDERKLIN,KINDERHEILKUNDE KLIN & POLIKLIN,ALLGEMEINE KINDERHEILKUNDE,D-48129 MUNSTER,GERMANY.			Deufel, Thomas/0000-0003-4839-3117				BRITT BA, 1970, CAN ANAESTH SOC J, V17, P293, DOI 10.1007/BF03004694; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; Deufel T., 1992, American Journal of Human Genetics, V51, pA213; ELLIS FR, 1980, BRIT J HOSP MED, V24, P318; FAGERLUND T, 1992, CLIN GENET, V41, P270; FLETCHER JE, 1993, BRIT J ANAESTH, V71, P410, DOI 10.1093/bja/71.3.410; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; HOGAN K, 1992, ANESTH ANALG, V75, P441; ILES DE, 1993, HUM MOL GENET, V2, P863; ILES DE, 1992, GENOMICS, V14, P749, DOI 10.1016/S0888-7543(05)80179-X; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, AM J HUM GENET, V52, P398; OBRIEN PJ, 1986, CAN J VET RES, V50, P318; ORDING H, 1988, BRIT J ANAESTH, V60, P287, DOI 10.1093/bja/60.3.287; ORDING H, 1991, ACTA ANAESTH SCAND, V35, P711, DOI 10.1111/j.1399-6576.1991.tb03377.x; ORDING H, 1985, ANESTH ANALG, V64, P700; ORDING H, 1987, MALIGNANT HYPERTHERM, P269; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; OTSU K, 1992, GENOMICS, V13, P835, DOI 10.1016/0888-7543(92)90163-M; RUBSAM B, 1993, ANAESTHESIST, V42, P868; SUDBRAK R, 1993, HUM MOL GENET, V2, P857, DOI 10.1093/hmg/2.7.857; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; 1984, BRIT J ANAESTH, V56, P1267	33	66	67	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1334	1342						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762556				2022-12-18	WOS:A1995RA79400011
J	GODFREY, M; VANDEMARK, N; WANG, M; VELINOV, M; WARGOWSKI, D; TSIPOURAS, P; HAN, J; BECKER, J; ROBERTSON, W; DROSTE, S; RAO, VH				GODFREY, M; VANDEMARK, N; WANG, M; VELINOV, M; WARGOWSKI, D; TSIPOURAS, P; HAN, J; BECKER, J; ROBERTSON, W; DROSTE, S; RAO, VH			PRENATAL-DIAGNOSIS AND A DONOR SPLICE-SITE MUTATION IN FIBRILLIN IN A FAMILY WITH MARFAN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIPOPROTEIN-LIPASE DEFICIENCY; TAY-SACHS DISEASE; BETA-GLOBIN GENE; SYNDROME TYPE-IV; CYSTIC-FIBROSIS; III PROCOLLAGEN; MISSENSE MUTATION; DECISION-MAKING; COLLAGEN GENE; COMMON CAUSE	The Marfan syndrome, an autosomal dominant connective tissue disorder, is manifested by abnormalities in the cardiovascular, skeletal, and ocular systems. Recently, fibrillin, an elastin-associated microfibrillar glycoprotein, has been linked to the Marfan syndrome, and fibrillin mutations in affected individuals have been documented. In this study, genetic linkage analysis with fibrillin specific markers was used to establish the prenatal diagnosis in an 11-wk-gestation fetus in a four-generation Marfan kindred. At birth, skeletal changes suggestive of the Marfan syndrome were observed. Reverse transcription-PCR amplification of the fibrillin gene mRNA detected a deletion of 123 bp in one allele in affected relatives. This deletion corresponds to an exon encoding an epidermal growth factor-like motif. Examination of genomic DNA showed a G-->C transversion at the +1 consensus donor splice site.	UNIV NEBRASKA,MED CTR,MUNROE CTR HUMAN GENET,OMAHA,NE 68182; UNIV CONNECTICUT,HLTH SCI CTR,DEPT PEDIAT,FARMINGTON,CT 06032; UNIV WISCONSIN,DEPT GENET,MADISON,WI 53706; UNIV WISCONSIN,DEPT OBSTET & GYNECOL,MADISON,WI 53706	University of Nebraska System; University of Nebraska Medical Center; University of Connecticut; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	GODFREY, M (corresponding author), UNIV NEBRASKA,MED CTR,DEPT PEDIAT,600 S 42D ST,OMAHA,NE 68198, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048126] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R29 HL48126-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; ATWEH GF, 1987, BLOOD, V70, P147; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BOTKIN JR, 1992, AM J PUBLIC HEALTH, V82, P723, DOI 10.2105/AJPH.82.5.723; BRIDGES AB, 1992, J MED GENET, V29, P81, DOI 10.1136/jmg.29.2.81; CHILD A, 1992, 2ND INT S MARF SYNDR; CHIMIENTI G, 1992, BIOCHEM BIOPH RES CO, V187, P620, DOI 10.1016/0006-291X(92)91240-Q; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLE WG, 1990, J BIOL CHEM, V265, P17070; DEBOER M, 1992, BLOOD, V80, P1553; DECRUYENAERE M, 1992, CLIN GENET, V41, P189; DENAYER L, 1992, AM J MED GENET, V44, P104, DOI 10.1002/ajmg.1320440124; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EVANS MI, 1989, AM J OBSTET GYNECOL, V160, P1332, DOI 10.1016/0002-9378(89)90852-1; FOJO SS, 1988, J CLIN INVEST, V82, P1489, DOI 10.1172/JCI113756; GODFREY M, 1990, AM J HUM GENET, V46, P652; GODFREY M, 1993, MCKUSICKS HERITABLE, P51; GONZALEZREDONDO JM, 1989, BRIT J HAEMATOL, V71, P113, DOI 10.1111/j.1365-2141.1989.tb06283.x; GOTODA T, 1991, J CLIN INVEST, V88, P1856, DOI 10.1172/JCI115507; GOTODA T, 1991, J BIOL CHEM, V266, P24757; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KOENIGSBERG M, 1981, PRENATAL DIAG, V1, P241, DOI 10.1002/pd.1970010403; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LANDELS EC, 1992, J MED GENET, V29, P563, DOI 10.1136/jmg.29.8.563; LEE B, 1991, J BIOL CHEM, V266, P5256; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MADDALENA A, 1992, J REPROD MED, V37, P437; MILLER SR, 1992, AM J PUBLIC HEALTH, V82, P236, DOI 10.2105/AJPH.82.2.236; MONONEN I, 1992, J BIOL CHEM, V267, P3196; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; POPE FM, 1992, BRIT J DERMATOL, V126, P77, DOI 10.1111/j.1365-2133.1992.tb08409.x; Sambrook J., 1989, MOL CLONING LAB MANU; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SUTTON VR, 1989, IMMUNOGENETICS, V29, P317, DOI 10.1007/BF00352841; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; VASAN NS, 1991, AM J HUM GENET, V48, P305; WATSON EK, 1992, J MED GENET, V29, P490; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1988, J BIOL CHEM, V263, P8561; WERTZ DC, 1992, AM J HUM GENET, V50, P1077	45	66	67	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					472	480						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8101042				2022-12-18	WOS:A1993LN82000019
J	SHOFFNER, JM; WALLACE, DC				SHOFFNER, JM; WALLACE, DC			MITOCHONDRIAL GENETICS - PRINCIPLES AND PRACTICE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							HEREDITARY OPTIC NEUROPATHY; DNA DELETION; MATERNAL INHERITANCE; MYOCLONUS EPILEPSY; HUMAN-HEART; MUTATION; MUSCLE; DISEASE; MYOPATHY; LEBER		EMORY UNIV, SCH MED, DEPT NEUROL, ATLANTA, GA 30322 USA	Emory University	SHOFFNER, JM (corresponding author), EMORY UNIV, SCH MED, DEPT GENET & MOLEC MED, 1462 CLIFTON RD, ROOM 423, ATLANTA, GA 30322 USA.				NHLBI NIH HHS [HL45572] Funding Source: Medline; NIGMS NIH HHS [GM46915-01] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; BOULET L, 1992, AM J HUM GENET, V51, P1187; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, FASEB J, V6, P2791, DOI 10.1096/fasebj.6.10.1634041; BROWN MD, 1992, GENETICS, V130, P163; BROWN MD, 1991, AM J HUM GENET, V49, P183; CASE JT, 1981, SOMAT CELL GENET, V7, P103, DOI 10.1007/BF01544751; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CLARK JM, 1986, NUCLEIC ACIDS RES, V14, P737, DOI 10.1093/nar/14.2.737; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORRALDEBRINSKI M, IN PRESS MUTAT RES; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GOTO Y, 1992, ANN NEUROL, V31, P672, DOI 10.1002/ana.410310617; GOTO Y, 1991, BIOCHIM BIOPHYS ACTA, V1097, P238, DOI 10.1016/0925-4439(91)90042-8; GOTO Y, 1992, NEUROLOGY, V42, P545, DOI 10.1212/WNL.42.3.545; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; LARSSON NG, 1991, ANN NEUROL, V30, P701, DOI 10.1002/ana.410300511; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; LERTRIT P, 1992, AM J HUM GENET, V51, P457; LESSELL S, 1983, ARCH NEUROL-CHICAGO, V40, P2, DOI 10.1001/archneur.1983.04050010022005; LUTZ WK, 1990, MUTAT RES, V238, P287, DOI 10.1016/0165-1110(90)90020-C; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4; POULTON J, 1989, LANCET, V1, P236; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; ROTIG A, 1992, AM J HUM GENET, V50, P364; ROTIG A, 1989, LANCET, V1, P902; Shoffner J M, 1992, Heart Dis Stroke, V1, P235; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, IN PRESS NEUROLOGY; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10; TATUCH Y, 1992, AM J HUM GENET, V50, P852; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; WELLER PA, 1986, MOL CELL BIOL, V6, P4539, DOI 10.1128/MCB.6.12.4539; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; ZEVIANI M, IN PRESS EUR J HUM G; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N	65	66	71	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1179	1186						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463005				2022-12-18	WOS:A1992KC99500001
J	HE, GS; GRABOWSKI, GA				HE, GS; GRABOWSKI, GA			GAUCHER DISEASE - A G+1-]A+1 IVS2 SPLICE DONOR SITE MUTATION CAUSING EXON-2 SKIPPING IN THE ACID BETA-GLUCOSIDASE MESSENGER-RNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GLUCOCEREBROSIDASE GENE; REPLACEMENT THERAPY; HETEROGENEITY; ALLELES; ENZYME; IDENTIFICATION; EXPRESSION; SEQUENCE; CDNA	Gaucher disease is the most frequent lysosomal storage disease and the most prevalent Jewish genetic disease. About 30 identified missense mutations are causal to the defective activity of acid beta-glucosidase in this disease. cDNAs were characterized from a moderately affected 9-year-old Ashkenazi Jewish Gaucher disease type 1 patient whose 80-year-old, enzyme-deficient, 1226G (Asn370 --> Ser [N370S]) homozygous grandfather was nearly asymptomatic. Sequence analyses revealed four populations of cDNAs with either the 1226G mutation, an exact exon 2 (DELTA EX2) deletion, a deletion of exon 2 and the first 115 bp of exon 3 (DELTA EX2-3), or a completely normal sequence. About 50% of the cDNAs were the DELTA EX2, the DELTA EX2-3, and the normal cDNAs, in a ratio of 6:3:1. Specific amplification and characterization of exon 2 and 5' and 3' intronic flanking sequences from the structural gene demonstrated clones with either the normal sequence or with a G+1 --> A+1 transition at the exon 2/intron 2 boundary. This mutation destroyed the splice donor consensus site (U1 binding site) for mRNA processing. This transition also was present at the corresponding exon/intron boundary of the highly homologous pseudogene. This new mutation, termed "IVS2 G+1 --> A+1," is the first splicing mutation described in Gaucher disease and accounted for about 3.4% of the Gaucher disease alleles in the Ashkenazi Jewish population. The occurrence of this "pseudogene"-type mutation in the structural gene indicates the role of acid beta-glucosidase pseudogene and structural gene rearrangements in the pathogenesis of this disease.	CHILDRENS HOSP, MED CTR, DIV HUMAN GENET, ELLAND & BETHESDA AVE, CINCINNATI, OH 45229 USA; CUNY MT SINAI SCH MED, DEPT PEDIAT, DIV MED & MOLEC GENET, NEW YORK, NY 10029 USA	Cincinnati Children's Hospital Medical Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [DK 36729] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNEVELD RA, 1983, HUM GENET, V64, P227, DOI 10.1007/BF00279398; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1991, P NATL ACAD SCI USA, V88, P10544, DOI 10.1073/pnas.88.23.10544; BEUTLER E, 1991, BLOOD, V78, P1183; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Devine E A, 1982, Prog Clin Biol Res, V95, P511; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; FALLET S, 1992, PEDIATR RES, V31, P496, DOI 10.1203/00006450-199205000-00018; FREDERICKSON DS, 1978, METABOLIC BASIS INHE, P730; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; GRABOWSKI GA, 1982, CLIN CHIM ACTA, V124, P123, DOI 10.1016/0009-8981(82)90326-6; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GRACE ME, 1991, AM J HUM GENET, V49, P646; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Institute of Gaucher Disease, 2020, EP GAUCH DIS; LATHAM T, 1990, AM J HUM GENET, V47, P79; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; OHASHI T, 1991, J BIOL CHEM, V266, P3661; REINER O, 1987, DNA-J MOLEC CELL BIO, V6, P101, DOI 10.1089/dna.1987.6.101; SAMBROOK J, 1988, MOL CLONING LABORATO; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P5708; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415; ZIMRAN A, 1991, AM J HUM GENET, V49, P855	33	66	66	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					810	820						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415223				2022-12-18	WOS:A1992JQ66700015
J	CARSTENS, RP; FENTON, WA; ROSENBERG, LR				CARSTENS, RP; FENTON, WA; ROSENBERG, LR			IDENTIFICATION OF RNA SPLICING ERRORS RESULTING IN HUMAN ORNITHINE TRANSCARBAMYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER RNA; FRAGMENT LENGTH POLYMORPHISMS; BETA-THALASSEMIA; PRENATAL-DIAGNOSIS; JUNCTION SEQUENCES; SITE SELECTION; GENE; MUTATIONS; EXPRESSION; PROTEINS	Ornithine transcarbamylase (OTC) is an X-linked, liver-specific enzyme that catalyzes the second step of the urea cycle. In humans, inherited deficiency of OTC in hemizygous affected males usually results in severe ammonia intoxication and early death. To characterize mutations responsible for OTC deficiency, we used the PCR to amplify cDNAs prepared from patient livers which demonstrated no OTC enzyme activity and no OTC cross-reacting material on western blots. In three of seven cases, smaller than normal products were observed. Sequencing of these cDNAs revealed that two were missing exon 7 of the OTC gene and that the other was missing the first 12 bp of exon 5. Sequencing of genomic DNA from these three patients revealed that one mutant missing exon 7 had a T-to-C substitution in the 5' splice donor site of intron 7. The other mutant missing exon 7 had an A-to-G change in the third position of intron 7. It is interesting that both of these mutations resulted in skipping the preceding exon rather than in inclusion of some or all of the affected intron. In the third mutant, an A-to-T substitution was found in the 3' splice acceptor site at the end of intron 4. Here, a cryptic splice acceptor site within exon 5 was used. Northern blotting of liver RNA from these patients demonstrated (a) reduced, but significant, amounts of OTC mRNA in one of the patients who had a deleted exon 7 but (b) very little OTC mRNA in the other two patients. We propose that these point mutations, which result in aberrant splicing of the OTC pre-mRNAs, lead to OTC deficiency through either decreased efficiency of mRNA export from the nucleus to the cytosol of synthesis of enzyme subunits that are unstable and rapidly degraded. We speculate that abnormal mRNA splicing may represent a relatively common mechanism in the pathogenesis of this disease.	YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510	Yale University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009527] Funding Source: NIH RePORTER; NHLBI NIH HHS [T35HL07649] Funding Source: Medline; NIDDK NIH HHS [DK09527] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; AKESON AL, 1988, P NATL ACAD SCI USA, V85, P5947; ATWEH GF, 1987, BLOOD, V70, P147; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; CAMPBELL AG, 1973, NEW ENGL J MED, V288, P1, DOI 10.1056/NEJM197301042880101; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FOX JE, 1986, AM J HUM GENET, V38, P841; GRANDCHAMP B, 1989, NUCLEIC ACIDS RES, V17, P6637, DOI 10.1093/nar/17.16.6637; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HARA A, 1989, AM J HUM GENET, V45, P123; HATA A, 1988, J BIOCHEM-TOKYO, V103, P302, DOI 10.1093/oxfordjournals.jbchem.a122265; HATA A, 1986, J BIOCHEM-TOKYO, V100, P717, DOI 10.1093/oxfordjournals.jbchem.a121764; HIDAKA Y, 1987, J CLIN INVEST, V80, P1409, DOI 10.1172/JCI113219; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; KAZAZIAN HH, 1988, BLOOD, V72, P1107; Kessler S W, 1981, Methods Enzymol, V73, P442; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG KM, 1983, SCIENCE, V220, P1351, DOI 10.1126/science.6304877; MADDALENA A, 1988, J CLIN INVEST, V82, P1353, DOI 10.1172/JCI113738; Maniatis T., 1982, MOL CLONING; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NUSSBAUM RL, 1986, AM J HUM GENET, V38, P149; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROSENBERG LE, 1987, ANN NY ACAD SCI, V488, P99; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; SHORT EM, 1973, NEW ENGL J MED, V288, P7, DOI 10.1056/NEJM197301042880102; STEITZ JA, 1988, SCI AM, V153, P56; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WEIL D, 1988, J BIOL CHEM, V263, P8561; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4; [No title captured]	46	66	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1105	1114						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035531				2022-12-18	WOS:A1991FP09200011
J	AMOS, CI; ELSTON, RC; BONNEY, GE; KEATS, BJB; BERENSON, GS				AMOS, CI; ELSTON, RC; BONNEY, GE; KEATS, BJB; BERENSON, GS			A MULTIVARIATE METHOD FOR DETECTING GENETIC-LINKAGE, WITH APPLICATION TO A PEDIGREE WITH AN ADVERSE LIPOPROTEIN PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INT AGCY RES CANC,F-69372 LYONS,FRANCE; HOWARD UNIV,CTR CANC,DIV BIOSTAT & EPIDEMIOL,WASHINGTON,DC 20059; LOUISIANA STATE UNIV,MED CTR,DEPT MED,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,DEPT GENET,NEW ORLEANS,LA 70112	World Health Organization; International Agency for Research on Cancer (IARC); Howard University; Louisiana State University System; Louisiana State University System; Louisiana State University System	AMOS, CI (corresponding author), NCI,FAMILY STUDIES SECT,SUITE 439,6130 EXECUT BLVD,N BETHESDA,MD 20892, USA.							ALBERS JJ, 1981, AM J HUM GENET, V33, P702; AMOS CI, 1986, GENET EPIDEMIOL, V3, P255, DOI 10.1002/gepi.1370030406; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; ANDERSON TW, 1984, INTRO MULTIVARIATE S, P480; BAILEYWILSON JE, 1989, PROG CLIN BIOL RES, V157, P129; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BLACKWELDER WC, 1977, I STATISTICS MEMEO S, V1114; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; CHEVALET C, 1984, GENET SEL EVOL, V16, P431, DOI 10.1186/1297-9686-16-4-431; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; FAUST RA, 1989, ATHEROSCLEROSIS, V77, P77, DOI 10.1016/0021-9150(89)90012-9; GLOMSET JA, 1983, METABOLIC BASIS INHE, P643; GOLDIN LR, 1978, AM J MED GENET, V6, P279; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASEMAN JK, 1970, THESIS U N CAROLINA; HILL AP, 1975, ANN HUM GENET, V38, P439, DOI 10.1111/j.1469-1809.1975.tb00633.x; JAYAKAR SD, 1970, BIOMETRICS, V26, P451, DOI 10.2307/2529101; KIDD KK, 1986, GENET EPIDEMIOL, V3, P195, DOI 10.1002/gepi.1370030306; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LOWRY D C, 1959, Ann Hum Genet, V23, P83; LUSIS A J, 1987, Genomics, V1, P232, DOI 10.1016/0888-7543(87)90049-8; NAMBOODIRI KK, 1975, AM J HUM GENET, V27, P454; RISCH N, 1990, AM J HUM GENET, V46, P242; ROSENBAUM PA, 1986, GENET EPIDEMIOL, V3, P241, DOI 10.1002/gepi.1370030405; Seber G. A. F, 1988, MULTIVARIATE OBSERVA; SMITH CAB, 1975, ANN HUM GENET, V38, P450; TEISBERG P, 1975, ANN HUM GENET, V38, P327, DOI 10.1111/j.1469-1809.1975.tb00617.x; ZLOTNIK LH, 1983, AM J MED GENET, V15, P307, DOI 10.1002/ajmg.1320150214	31	66	74	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					247	254						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378349				2022-12-18	WOS:A1990DT87100009
J	SUTHERS, GK; HYLAND, VJ; CALLEN, DF; OBERLE, I; ROCCHI, M; THOMAS, NS; MORRIS, CP; SCHWARTZ, CE; SCHMIDT, M; ROPERS, HH; BAKER, E; OOSTRA, BA; DAHL, N; WILSON, PJ; HOPWOOD, JJ; SUTHERLAND, GR				SUTHERS, GK; HYLAND, VJ; CALLEN, DF; OBERLE, I; ROCCHI, M; THOMAS, NS; MORRIS, CP; SCHWARTZ, CE; SCHMIDT, M; ROPERS, HH; BAKER, E; OOSTRA, BA; DAHL, N; WILSON, PJ; HOPWOOD, JJ; SUTHERLAND, GR			PHYSICAL MAPPING OF NEW DNA PROBES NEAR THE FRAGILE-X MUTATION (FRAXA) BY USING A PANEL OF CELL-LINES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA 5006,AUSTRALIA; IST GIANNIAN GASLINI,GENET MOLEC LAB,GENOA,ITALY; UNIV COLL CARDIFF,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; GREENWOOD GENET CTR,GREENWOOD,SC; ROYAL CHILDRENS HOSP,MURDOCH INST,PARKVILLE,VIC 3052,AUSTRALIA; CATHOLIC UNIV NIJMEGEN,RADBOUD HOSP,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; ERASMUS UNIV,DEPT CELL BIOL,3000 DR ROTTERDAM,NETHERLANDS; BIOMED CTR,DEPT MED GENET,S-75123 UPPSALA,SWEDEN; INSERM,U184,CNRS,LGME,F-67200 STRASBOURG,FRANCE	University of Genoa; IRCCS Istituto Giannina Gaslini; Cardiff University; Greenwood Genetic Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Radboud University Nijmegen; Erasmus University Rotterdam; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Callen, David F/G-1975-2012; Sutherland, Grant Robert/D-2606-2012	Callen, David/0000-0002-6189-9991; Morris, Phillip/0000-0001-8976-619X; Hyland, Valentine/0000-0002-6814-2094				ABRUZZO MA, 1986, HUM GENET, V73, P20, DOI 10.1007/BF00292657; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DURSO M, 1983, SOMAT CELL GENET, V9, P429, DOI 10.1007/BF01543044; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; HIRST MC, IN PRESS AM J MED GE; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HUPKES PE, 1989, CYTOGENET CELL GENET, V51, P1016; HYLAND VJ, 1989, HUM GENET, V83, P61, DOI 10.1007/BF00274150; HYLAND VJ, UNPUB PHYSICAL LINKA; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; LEDBETTER SA, IN PRESS AM J MED GE; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; Maniatis T., 1982, MOL CLONING; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; OOSTRA BA, IN PRESS AM J MED GE; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; ROCCHI M, 1989, CYTOGENET CELL GENET, V51, P1067; ROSENSTRAUS M, 1975, P NATL ACAD SCI USA, V72, P493, DOI 10.1073/pnas.72.2.493; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHMIDT M, 1990, HUM GENET, V84, P347, DOI 10.1007/BF00196232; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SIMMERS RN, 1988, HUM GENET, V78, P134, DOI 10.1007/BF00278182; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1985, AM J MED GENET, V22, P433, DOI 10.1002/ajmg.1320220234; SUTHERS GK, 1989, NUCLEIC ACIDS RES, V17, P8901, DOI 10.1093/nar/17.21.8901; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; VINCENT A, 1989, GENOMICS, V5, P797, DOI 10.1016/0888-7543(89)90121-3; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILSON PJ, UNPUB FREQUENT DELET	38	66	68	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					187	195						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378346				2022-12-18	WOS:A1990DT87100003
J	BATES, GP; MACDONALD, ME; BAXENDALE, S; SEDLACEK, Z; YOUNGMAN, S; ROMANO, D; WHALEY, WL; ALLITTO, BA; POUSTKA, A; GUSELLA, JF; LEHRACH, H				BATES, GP; MACDONALD, ME; BAXENDALE, S; SEDLACEK, Z; YOUNGMAN, S; ROMANO, D; WHALEY, WL; ALLITTO, BA; POUSTKA, A; GUSELLA, JF; LEHRACH, H			A YEAST ARTIFICIAL CHROMOSOME TELOMERE CLONE SPANNING A POSSIBLE LOCATION OF THE HUNTINGTON DISEASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									IMPERIAL CANC RES FUND,DEPT GENOME ANAL,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; ZENTRUM MOLEK BIOL,HEIDELBERG,GERMANY; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Cancer Research UK; The Genome Analysis Centre (TGAC); Ruprecht Karls University Heidelberg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Baxendale, Sarah/0000-0002-6760-9457	NINDS NIH HHS [NS16367, NS20012, NS22031] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020012, P50NS016367, R01NS022031, P01NS016367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLACKBURN EH, 1984, CELL, V37, P7, DOI 10.1016/0092-8674(84)90295-2; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BUCAN M, 1990, GENOMICS, V6, P1; BURGERS PMJ, 1987, ANAL BIOCHEM, V163, P391, DOI 10.1016/0003-2697(87)90240-5; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1989, TRENDS GENET, V5, P41, DOI 10.1016/0168-9525(89)90019-X; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MACDONALD ME, 1988, J CLIN INVEST, V84, P1013; MARCHUK D, 1988, NUCLEIC ACIDS RES, V16, P7743, DOI 10.1093/nar/16.15.7743; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MYERS RH, 1989, AM J HUM GENET, V45, P615; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; POUSTKA A, 1987, NATURE, V325, P353, DOI 10.1038/325353a0; POUSTKA A, 1988, GENET ENG, V10, P169; PRITCHARD CA, 1989, GENOMICS, V4, P408, DOI 10.1016/0888-7543(89)90348-0; RACKWITZ HR, 1985, GENE, V40, P259, DOI 10.1016/0378-1119(85)90048-4; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; ROBBINS C, 1989, AM J HUM GENET, V44, P422; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; YOUNGMAN S, 1989, GENOMICS, V5, P802, DOI 10.1016/0888-7543(89)90122-5; YOUNGMAN S, 1988, NUCLEIC ACIDS RES, V16, P1648, DOI 10.1093/nar/16.4.1648; ZEHETNER G, 1986, NUCLEIC ACIDS RES, V14, P335, DOI 10.1093/nar/14.1.335	51	66	68	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					762	775						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2138410				2022-12-18	WOS:A1990CW54900014
J	MAGER, DL; GOODCHILD, NL				MAGER, DL; GOODCHILD, NL			HOMOLOGOUS RECOMBINATION BETWEEN THE LTRS OF A HUMAN RETROVIRUS-LIKE ELEMENT CAUSES A 5-KB DELETION IN 2 SIBLINGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA	University of British Columbia	MAGER, DL (corresponding author), BRITISH COLUMBIA CANC RES CTR,TERRY FOX LAB,601 W 10TH AVE,VANCOUVER V5Z 1L3,BC,CANADA.			Mager, Dixie/0000-0002-5955-2550				BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; CANAANI E, 1983, P NATL ACAD SCI-BIOL, V80, P7118, DOI 10.1073/pnas.80.23.7118; COPELAND NG, 1983, CELL, V33, P379, DOI 10.1016/0092-8674(83)90419-1; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEUCHTER A, UNPUB HUMAN REPETITI; Fraser C, 1988, GENOMICS, V2, P280, DOI 10.1016/0888-7543(88)90015-8; HAWLEY RG, 1982, P NATL ACAD SCI-BIOL, V79, P7425, DOI 10.1073/pnas.79.23.7425; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5597, DOI 10.1073/pnas.83.15.5597; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KERE J, 1989, BLOOD, V73, P230; LAMBERT ME, 1988, BANBURY REP, V30; LARSSON E, IN PRESS CURR TOP MI; LAVAPPA KS, 1978, IN VITRO CELL DEV B, V14, P469; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LIN CS, 1988, CELL, V54, P153, DOI 10.1016/0092-8674(88)90547-8; MAGER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7510, DOI 10.1073/pnas.81.23.7510; MAGER DL, 1987, J VIROL, V61, P4060, DOI 10.1128/JVI.61.12.4060-4066.1987; MAGER DL, IN PRESS VIROLOGY; MAN YM, 1987, NUCLEIC ACIDS RES, V15, P3291, DOI 10.1093/nar/15.8.3291; Maniatis T., 1982, MOL CLONING; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; PAULSON KE, 1985, NATURE, V316, P359, DOI 10.1038/316359a0; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7202; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SEPARACK PK, 1988, P NATL ACAD SCI USA, V85, P189; Shapiro J. A., 1983, MOBILE GENETIC ELEME; SINGER MF, 1988, EUKARYOTIC TRANSPOSA, P71; STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; VARMUS HE, 1985, RNA TUMOR VIRUSES, V2, P75; WIRTH T, 1983, P NATL ACAD SCI-BIOL, V80, P3327, DOI 10.1073/pnas.80.11.3327; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0	37	66	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					848	854						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2573998				2022-12-18	WOS:A1989CF40300003
J	PUCK, JM; NUSSBAUM, RL; SMEAD, DL; CONLEY, ME				PUCK, JM; NUSSBAUM, RL; SMEAD, DL; CONLEY, ME			X-LINKED SEVERE COMBINED IMMUNODEFICIENCY - LOCALIZATION WITHIN THE REGION XQ13.1-Q21.1 BY LINKAGE AND DELETION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOWARD HUGHES MED INST,PHILADELPHIA,PA; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	Howard Hughes Medical Institute; University of Pennsylvania	PUCK, JM (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV INFECT DIS,1 CHILDRENS CTR,PHILADELPHIA,PA 19104, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023245, R01HD023679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI025129, R56AI025129, R01AI025129] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25129] Funding Source: Medline; NICHD NIH HHS [HD23245, HD23679] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARVEILER B, 1987, Genomics, V1, P60, DOI 10.1016/0888-7543(87)90105-4; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CREMERS FPM, 1988, AM J HUM GENET, V43, P452; CREMERS FPM, IN PRESS GENOMICS; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; DAVISSON MT, 1988, MOUSE NEWS LETT, V81, P12; DESAINTBASILE G, 1987, P NATL ACAD SCI USA, V84, P7576; Durandy A, 1983, Birth Defects Orig Artic Ser, V19, P125; Gelfand E W, 1983, Birth Defects Orig Artic Ser, V19, P65; Hirschhorn R, 1983, Birth Defects Orig Artic Ser, V19, P73; HOLZGREVE B, 1984, J REPROD IMMUNOL, V6, P341, DOI 10.1016/0165-0378(84)90043-3; HUTZ MH, 1984, HUM GENET, V66, P217, DOI 10.1007/BF00286604; KRUSE TA, 1986, NUCLEIC ACIDS RES, V14, P1921, DOI 10.1093/nar/14.4.1921; KWAN SP, 1986, J CLIN INVEST, V77, P649, DOI 10.1172/JCI112351; LATHROP GM, 1984, P NATL ACAD SCI USA, V80, P472; LESKO JG, 1987, AM J HUM GENET, V40, P303; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; NAHM MH, 1983, J EXP MED, V158, P920, DOI 10.1084/jem.158.3.920; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; PUCK JM, 1987, J CLIN INVEST, V79, P1396; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; VOGELSTEIN B, 1987, CANCER RES, V47, P4806	24	66	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1989	44	5					724	730						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U3338	2565084				2022-12-18	WOS:A1989U333800014
J	GRIFFIN, CA; SMITH, M; HENTHORN, PS; HARRIS, H; WEISS, MJ; RADUCHA, M; EMANUEL, BS				GRIFFIN, CA; SMITH, M; HENTHORN, PS; HARRIS, H; WEISS, MJ; RADUCHA, M; EMANUEL, BS			HUMAN PLACENTAL AND INTESTINAL ALKALINE-PHOSPHATASE GENES MAP TO 2Q34-Q37	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP,DEPT PEDIAT,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DEPT GENET,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV BIOCHEM DEV,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of California System; University of California Irvine			Weiss, Mitchell J/A-1245-2013; Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036	NICHD NIH HHS [HD 07107] Funding Source: Medline; NIGMS NIH HHS [GM 27018, GM 07170] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027018] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CARLOCK LR, 1985, SOMAT CELL MOLEC GEN, V11, P267, DOI 10.1007/BF01534683; CHANG CH, 1980, CANCER RES, V40, P1506; DEISSEROTH A, 1978, P NATL ACAD SCI USA, V75, P1456, DOI 10.1073/pnas.75.3.1456; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHMAN WH, 1968, NATURE, V219, P697, DOI 10.1038/219697a0; FRIEND KK, 1976, EXP CELL RES, V99, P31, DOI 10.1016/0014-4827(76)90676-5; GOLDSTEIN DJ, 1982, CLIN CHIM ACTA, V125, P63, DOI 10.1016/0009-8981(82)90046-8; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; Harris, 1976, HDB ENZYME ELECTROPH; HARRIS H, 1982, HARVEY LECTURES, V76, P92; HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234; HENTHORN PS, 1986, P NATL ACAD SCI USA, V83, P5597, DOI 10.1073/pnas.83.15.5597; INGLIS NR, 1973, CANCER RES, V33, P1657; JEFFREYS AJ, 1979, NATURE, V281, P606, DOI 10.1038/281606a0; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; LITTLEFI.JW, 1966, EXP CELL RES, V41, P190, DOI 10.1016/0014-4827(66)90558-1; MANIATIS T, 1982, MOL CLONING LABORATO; McComb R.B., 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MCKENNA MJ, 1979, BIOCHEM J, V181, P67, DOI 10.1042/bj1810067; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MILLAN JL, 1983, EUR J BIOCHEM, V136, P1, DOI 10.1111/j.1432-1033.1983.tb07697.x; MUELLER HD, 1985, BIOCHEM BIOPH RES CO, V126, P427, DOI 10.1016/0006-291X(85)90623-0; MULIVOR RA, 1978, P NATL ACAD SCI USA, V75, P3909, DOI 10.1073/pnas.75.8.3909; MULIVOR RA, 1978, ANN HUM GENET, V42, P1, DOI 10.1111/j.1469-1809.1978.tb00927.x; SEABRIGH.M, 1971, LANCET, V2, P971; SEARGEANT LE, 1979, NATURE, V281, P152, DOI 10.1038/281152a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWALLOW DM, 1986, ANN HUM GENET, V50, P229, DOI 10.1111/j.1469-1809.1986.tb01043.x; VOCKLEY J, 1984, AM J HUM GENET, V36, P987; VOCKLEY J, 1984, P NATL ACAD SCI-BIOL, V81, P6120, DOI 10.1073/pnas.81.19.6120; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182	34	66	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1987	41	6					1025	1034						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L2984	3687940				2022-12-18	WOS:A1987L298400006
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			A CONTROLLED-STUDY OF TOURETTE SYNDROME .4. OBSESSIONS, COMPULSIONS, AND SCHIZOID BEHAVIORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,1500 E DUARTE RD,DUARTE,CA 91010, USA.							Black A., 1974, OBSESSIONAL STATES, P19; Carey G, 1981, ANXIETY NEW RES CHAN, P117; CAREY G, 1978, THESIS U MINNESOTA; COHEN ME, 1951, AM J HUM GENET, V3, P126; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1982, AM J PSYCHIAT, V139, P913; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1987, AM J HUM GENET, V41, P839; COMINGS DE, 1987, IN PRESS BR J PSYCHI, V148; CORBETT JA, 1969, BRIT J PSYCHIAT, V115, P1229, DOI 10.1192/bjp.115.528.1229; CUMMINGS JL, 1985, BIOL PSYCHIAT, V20, P1117, DOI 10.1016/0006-3223(85)90011-3; ELDRIDGE R, 1977, NEUROLOGY, V27, P115, DOI 10.1212/WNL.27.2.115; FENTON WS, 1986, AM J PSYCHIAT, V143, P437; FRENANDO SJM, 1967, BR J PSYCHIATRY, V113, P607; FRIEDHOFF AJ, 1982, GILLES TOURETTE SYND; JAGGER J, 1982, SCHIZOPHRENIA BULL, V8, P267, DOI 10.1093/schbul/8.2.267; JENIKE MA, 1986, AM J PSYCHIAT, V143, P530; KRIGLEN E, 1965, BR J PSYCHIATRY, V111, P709; LEES AJ, 1984, J NEUROL NEUROSUR PS, V47, P1, DOI 10.1136/jnnp.47.1.1; MAHLER MS, 1946, J NERV MENT DIS, V103, P433, DOI 10.1097/00005053-194605000-00001; MARKS IM, 1969, BRIT J PSYCHIAT, V115, P991, DOI 10.1192/bjp.115.526.991; MCGUFFIN P, 1980, BRIT J PSYCHIAT, V137, P285, DOI 10.1192/bjp.137.3.285; MONTGOMERY MA, 1982, GILLES TOURETTE SYND, P335; MORPHEW JA, 1969, BRIT J MED PSYCHOL, V42, P293, DOI 10.1111/j.2044-8341.1969.tb02083.x; NEE LE, 1980, ANN NEUROL, V7, P41, DOI 10.1002/ana.410070109; PAULS DL, 1986, ARCH GEN PSYCHIAT, V43, P1180; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; RUTTER M, 1966, MAUDSLEY MONOGRAPH, V16; Shapiro A. K., 1978, GILLES TOURETTE SYND; SHAPIRO AK, 1973, BRIT J PSYCHIAT, V122, P659, DOI 10.1192/bjp.122.6.659; SHAPIRO AK, 1972, AM J PSYCHIAT, V129, P427, DOI 10.1176/ajp.129.4.427; SHAPIRO AK, 1970, NEW YORK STATE J MED, V70, P2210; TAKEUCHI K, 1986, J NERV MENT DIS, V174, P247, DOI 10.1097/00005053-198604000-00009; WALSH P J, 1962, Br J Clin Pract, V16, P651; WOODROW KM, 1974, AM J PSYCHIAT, V131, P1000; WOODRUFF R, 1964, AM J PSYCHIAT, V120, P1075, DOI 10.1176/ajp.120.11.1075; 1980, DIAGNOSTIC STATISTIC	39	66	68	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					782	803						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3479015				2022-12-18	WOS:A1987K936100004
J	BOERWINKLE, E; SING, CF				BOERWINKLE, E; SING, CF			BIAS OF THE CONTRIBUTION OF SINGLE-LOCUS EFFECTS TO THE VARIANCE OF A QUANTITATIVE TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note											BOERWINKLE, E (corresponding author), UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA.			Sing, Charles/0000-0001-5872-7956	NCI NIH HHS [P01 CA 26803] Funding Source: Medline; NHLBI NIH HHS [R01 HL30428, R01 HL24489] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA026803] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030428, R01HL024489] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1985, THESIS U MICHIGAN AN; BOERWINKLE E, 1984, RED CELL; Cochran W.G, 1957, STAT METHODS, V6th ed; DAIGER SP, 1984, AM J HUM GENET, V36, P663; Daniels H.E., 1939, JR STATIST SOC S, V6, P186; DONNER A, 1985, ANN HUM GENET, V49, P75, DOI 10.1111/j.1469-1809.1985.tb01677.x; ELSTON RC, 1974, AM J HUM GENET, V26, P13; Falconer D.S., 1960, INTRO QUANTITATIVE G; FISHER RA, 1958, STATISTICAL METHODS; GOLD RJM, 1974, ANN HUM GENET, V37, P315, DOI 10.1111/j.1469-1809.1974.tb01838.x; HANIS CL, 1985, LANCET, V1, P1339; HOPPER JL, 1982, CLIN EXP PHARMACOL P, V9, P247, DOI 10.1111/j.1440-1681.1982.tb00802.x; LALOUEL JM, 1983, AM J HUM GENET, V35, P938; LANGE K, 1976, AM J HUM GENET, V28, P167; LEWIS WHP, 1973, ANN HUM GENET, V36, P267, DOI 10.1111/j.1469-1809.1973.tb00589.x; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MOLL PP, 1986, AM J HUM GENET, V38, P361; NETER J, 1985, APPLIED LINEAR STATI; RAO CR, 1965, LINEAR STATISTICAL I; Scheffe H., 1959, ANAL VARIANCE; SCOTT J, 1985, LANCET, V1, P771; SING CF, 1985, AM J HUM GENET, V37, P268; SPENCER N, 1964, NATURE, V201, P299, DOI 10.1038/201299a0	24	66	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					137	144						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3463204				2022-12-18	WOS:A1986D961500014
J	BISHOP, DT; WILLIAMSON, JA; SKOLNICK, MH				BISHOP, DT; WILLIAMSON, JA; SKOLNICK, MH			A MODEL FOR RESTRICTION FRAGMENT LENGTH DISTRIBUTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,DEPT MATH,COLORADO SPRINGS,CO 80907	University of Colorado System; University of Colorado at Colorado Springs	BISHOP, DT (corresponding author), UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132, USA.			Bishop, Tim/0000-0002-8752-8785	NATIONAL CANCER INSTITUTE [R01CA028854] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28854] Funding Source: Medline; NIGMS NIH HHS [GM-27192] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Feller W., 1968, INTRO PROBABILITY TH, V1; LI SYR, 1980, ANN PROBAB, V8, P1171, DOI 10.1214/aop/1176994578; MANTEUIL S, 1975, CELL, V5, P413, DOI 10.1016/0092-8674(75)90060-4; NEI M, 1981, GENETICS, V97, P145; SCHAFER M, UNPUB METHYLATED CYT; SCHAFER M, 1982, BIRTH DEFECTS ORIG A, V18; SKOLNICK MH, 1982, BIRTH DEFECTS ORIG A, V18; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stevens WL, 1939, ANN EUGENIC, V9, P315, DOI 10.1111/j.1469-1809.1939.tb02216.x; SWARTZ MN, 1962, J BIOL CHEM, V237, P864; WILLIAMSON JA, UNPUB EXTENDED TABLE; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	13	66	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	5					795	815						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RK604	6310992				2022-12-18	WOS:A1983RK60400001
J	UCHIDA, IA; JOYCE, EM				UCHIDA, IA; JOYCE, EM			ACTIVITY OF THE FRAGILE-X IN HETEROZYGOUS CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCMASTER UNIV,HLTH SCI CTR,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	UCHIDA, IA (corresponding author), MCMASTER UNIV,CTR HLTH SCI,DEPT PEDIAT,HAMILTON L8N 3Z5,ONTARIO,CANADA.							DEROOVER J, 1977, ANN GENET-PARIS, V20, P263; GERALD PS, 1980, NEW ENGL J MED, V303, P696, DOI 10.1056/NEJM198009183031209; HAGEMEIJER A, 1976, HUM GENET, V34, P45, DOI 10.1007/BF00284433; HECHT F, 1979, AM J HUM GENET, V31, P223; HOWARDPEEBLES PN, 1979, AM J HUM GENET, V31, P214; ISCN An international system for human cytogenetic nomen-clature, 1978, CYTOGENET CELL GENET, V21, P309; JACKY PB, 1980, HUM GENET, V53, P267; JACOBS PA, 1980, AM J MED GENET, V7, P471, DOI 10.1002/ajmg.1320070408; LEHRKE R, 1972, AM J MENT DEF, V76, P611; LUBS HA, 1969, AM J HUM GENET, V21, P231; MARTIN RH, 1980, AM J MED GENET, V7, P433, DOI 10.1002/ajmg.1320070405; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; TOMMERUP N, 1981, AM J MED GENET, V9, P263, DOI 10.1002/ajmg.1320090313; TURNER G, 1980, NEW ENGL J MED, V303, P662, DOI 10.1056/NEJM198009183031202; 1978, BIRTH DEFECTS OAS, V14	18	66	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					286	293						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	6176123				2022-12-18	WOS:A1982NH73200012
J	CANNINGS, C; EDWARDS, AWF				CANNINGS, C; EDWARDS, AWF			EXPECTED GENOTYPIC FREQUENCIES IN A SMALL SAMPLE - DEVIATION FROM HARDY-WEINBERG EQUILIBRIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; HOGBEN L, 1946, INTRODUCTION MATHEMA; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093	3	66	69	0	12	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1969	21	3					245	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D4606	5794014				2022-12-18	WOS:A1969D460600002
J	SHREFFLER, DC				SHREFFLER, DC			GENETIC STUDIES OF BLOOD GROUP-ASSOCIATED VARIATIONS IN A HUMAN SERUM ALKALINE PHOSPHATASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARFORS KE, 1963, ACTA GENET STAT MED, V13, P366; ARFORS KE, 1963, ACTA GENET STAT MED, V13, P89; Bodansky A, 1933, J BIOL CHEM, V101, P93; BOYER SH, 1961, SCIENCE, V134, P1002, DOI 10.1126/science.134.3484.1002; CEPPELLINI R, 1959, BIOCHEMISTRY HUMAN G; CUNNINGHAM VR, 1963, BIOCHEM J, V89, pP50; EPSTEIN FH, 1960, U MICH MED B, V26, P307; GAHNE B, 1963, NATURE, V199, P305, DOI 10.1038/199305a0; GUTMAN AB, 1959, AM J MED, V27, P875, DOI 10.1016/0002-9343(59)90173-1; HODSON AW, 1962, CLIN CHIM ACTA, V7, P255, DOI 10.1016/0009-8981(62)90018-9; Kay HD, 1930, J BIOL CHEM, V89, P235; LAWRENCE SH, 1960, P SOC EXP BIOL MED, V105, P572; NAPIER JA, 1962, AM J PUBLIC HEALTH N, V52, P208, DOI 10.2105/AJPH.52.2.208; PLATO CC, 1961, VOX SANG, V6, P336, DOI 10.1111/j.1423-0410.1961.tb03171.x; RACE RR, 1962, BLOOD GROUPS MAN; RENDEL J, 1964, P SOC EXP BIOL MED, V115, P853, DOI 10.3181/00379727-115-29056; SCHLAMOWITZ M, 1958, ANN NY ACAD SCI, V75, P373, DOI 10.1111/j.1749-6632.1958.tb36885.x; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; WOLSTENHOLME GEW, 1959, BIOCHEMISTRY HUMAN G; [No title captured]	20	66	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1965	17	1					71	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	61289	14255558				2022-12-18	WOS:A19656128900009
J	MOORHEAD, PS; MELLMAN, WJ; WENAR, C				MOORHEAD, PS; MELLMAN, WJ; WENAR, C			A FAMILIAL CHROMOSOME TRANSLOCATION ASSOCIATED WITH SPEECH AND MENTAL RETARDATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CAFFEY J, 1958, AMER J ROENTGENOL RA, V80, P458; DAVIDSON WM, 1954, BRIT MED J, V2, P6, DOI 10.1136/bmj.2.4878.6; EDWARDS JH, 1960, LANCET, V1, P787; FRACCARO M, 1960, LANCET, V1, P724; JACOBS PA, 1959, LANCET, V1, P710; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEVAN A, 1959, HEREDITAS, V45, P665; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1960, LANCET, V1, P790; PATAU K, 1960, AM J HUM GENET, V12, P250; PENROSE LS, 1960, LANCET, V2, P409; POLANI PE, 1960, LANCET, V1, P721; ROTHFELS KH, 1958, STAIN TECHNOL, V33, P73, DOI 10.3109/10520295809111827; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; TURPIN R, 1959, CR HEBD ACAD SCI, V248, P3636; White MJD., 1954, ANIMAL CYTOLOGY EVOL, V2	16	66	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1961	13	1					32	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2959A	13772378				2022-12-18	WOS:A19612959A00015
J	Hannon, E; Gorrie-Stone, TJ; Smart, MC; Burrage, J; Hughes, A; Bao, YC; Kumari, M; Schalkwyk, LC; Mill, J				Hannon, Eilis; Gorrie-Stone, Tyler J.; Smart, Melissa C.; Burrage, Joe; Hughes, Amanda; Bao, Yanchun; Kumari, Meena; Schalkwyk, Leonard C.; Mill, Jonathan			Leveraging DNA-Methylation Quantitative-Trait Loci to Characterize the Relationship between Methylomic Variation, Gene Expression, and Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIGENOME-WIDE ASSOCIATION; BODY METHYLATION; DISEASE; RISK; EQTL; IDENTIFICATION; INTEGRATION; VARIANTS; TARGET; SITES	Characterizing the complex relationship between genetic, epigenetic, and transcriptomic variation has the potential to increase understanding about the mechanisms underpinning health and disease phenotypes. We undertook a comprehensive analysis of common genetic variation on DNA methylation (DNAm) by using the Illumina EPIC array to profile samples from the UK Household Longitudinal study. We identified 12,689,548 significant DNA methylation quantitative trait loci (mQTL) associations (p < 6.52 x 10(-14)) occurring between 2,907,234 genetic variants and 93,268 DNAm sites, including a large number not identified by previous DNAm-profiling methods. We demonstrate the utility of these data for interpreting the functional consequences of common genetic variation associated with > 60 human traits by using summary-data-based Mendelian randomization (SMR) to identify 1,662 pleiotropic associations between 36 complex traits and 1,246 DNAm sites. We also use SMR to characterize the relationship between DNAm and gene expression and thereby identify 6,798 pleiotropic associations between 5,420 DNAm sites and the transcription of 1,702 genes. Our mQTL database and SMR results are available via a searchable online database as a resource to the research community.	[Hannon, Eilis; Burrage, Joe; Mill, Jonathan] Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England; [Gorrie-Stone, Tyler J.; Schalkwyk, Leonard C.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Smart, Melissa C.; Hughes, Amanda; Bao, Yanchun; Kumari, Meena] Univ Essex, Inst Social & Econ Res, Colchester CO3 3LG, Essex, England	University of Exeter; University of Essex; University of Essex	Mill, J (corresponding author), Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England.	j.mill@exeter.ac.uk	Mill, Jonathan/B-5678-2014; Hughes, Amanda/GYA-1086-2022; Hannon, Eilis/T-1349-2019; Gorrie-Stone, Tyler/O-5286-2019; Schalkwyk, Leonard/A-2150-2010	Mill, Jonathan/0000-0003-1115-3224; Hannon, Eilis/0000-0001-6840-072X; Gorrie-Stone, Tyler/0000-0002-1817-1495; Smart, Melissa/0000-0002-2655-3880; Bao, Yanchun/0000-0002-6102-5098; Hughes, Amanda/0000-0001-5896-7650; Kumari, Meena/0000-0001-9716-1035; Schalkwyk, Leonard/0000-0001-7030-5756	Economic and Social Research Council (ESRC) [ES/K005146/1, ES/N00812X/1]; ESRC [RES-596-28-0001, ES/M008592/1]; University of Essex; Medical Research Council [K013807]; ESRC [ES/N00812X/1, ES/K005146/1, ES/S008349/1] Funding Source: UKRI; MRC [MR/N01104X/2, G1001799, MR/N01104X/1, MR/K013807/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Essex; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the Wellcome Trust Sanger Institute and Ele Zeggini for generating the genotype data. Both genotyping and DNA methylation in UKHLS were funded through enhancements to the Economic and Social Research Council (ESRC) grants ES/K005146/1 and ES/N00812X/1. A.H., M.C.S., and Y.B. are supported by the ESRC (ES/M008592/1). M.K. is supported by the University of Essex and ESRC (RES-596-28-0001). E.H., J.M., and L.C.S. were supported by Medical Research Council grant K013807 to J.M.. Analysis was facilitated by access to the Genome High-Performance Computing Cluster at the University of Essex School of Biological Sciences.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin S. B., 2016, COLD SPRING HARBOR P, V8; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Benzeval M., 2014, UNDERSTANDING SOC UK; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Drong AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055923; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gorrie-Stone TJ, 2019, BIOINFORMATICS, V35, P981, DOI 10.1093/bioinformatics/bty713; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Guo H, 2015, HUM MOL GENET, V24, P3305, DOI 10.1093/hmg/ddv077; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hannon E, 2017, AM J HUM GENET, V100, P954, DOI 10.1016/j.ajhg.2017.04.013; Hannon E, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1041-x; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Hauberg ME, 2017, AM J HUM GENET, V101, P157, DOI 10.1016/j.ajhg.2017.06.003; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Knies G., 2015, COLCHESTER; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu Y, 2014, AM J HUM GENET, V94, P485, DOI 10.1016/j.ajhg.2014.02.011; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCartney DL, 2016, GENOM DATA, V9, P22, DOI 10.1016/j.gdata.2016.05.012; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Moen EL, 2013, GENETICS, V194, P987, DOI 10.1534/genetics.113.151381; Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Prins BP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10812-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richardson TG, 2018, HUM MOL GENET, V27, P3293, DOI 10.1093/hmg/ddy210; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Team RC., 2022, R LANG ENV STAT COMP; van Dongen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11115; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2017, DIABETES, V66, P2296, DOI 10.2337/db16-1452; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03371-0; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zhao LN, 2018, BRIEF BIOINFORM, V19, P89, DOI 10.1093/bib/bbw098; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	61	65	65	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 1	2018	103	5					654	665		10.1016/j.ajhg.2018.09.007	http://dx.doi.org/10.1016/j.ajhg.2018.09.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GY9EO	30401456	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-18	WOS:000448942100003
J	Lu, QS; Li, BY; Ou, DR; Erlendsdottir, M; Powles, RL; Jiang, T; Hu, YM; Chang, D; Jin, CT; Dai, W; He, QD; Liu, ZF; Mukherjee, S; Crane, PK; Zhao, HY				Lu, Qiongshi; Li, Boyang; Ou, Derek; Erlendsdottir, Margret; Powles, Ryan L.; Jiang, Tony; Hu, Yiming; Chang, David; Jin, Chentian; Dai, Wei; He, Qidu; Liu, Zefeng; Mukherjee, Shubhabrata; Crane, Paul K.; Zhao, Hongyu			A Powerful Approach to Estimating Annotation-Stratified Genetic Covariance via GWAS Summary Statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SERUM URIC-ACID; MULTIPLE-SCLEROSIS; COMPLEX TRAITS; PARTITIONING HERITABILITY; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; METABOLIC SYNDROME; MAJOR DEPRESSION	Despite the success of large-scale genome-wide association studies (GWASs) on complex traits, our understanding of their genetic architecture is far from complete. Jointly modeling multiple traits' genetic profiles has provided insights into the shared genetic basis of many complex traits. However, large-scale inference sets a high bar for both statistical power and biological interpretability. Here we introduce a principled framework to estimate annotation-stratified genetic covariance between traits using GWAS summary statistics. Through theoretical and numerical analyses, we demonstrate that our method provides accurate covariance estimates, thereby enabling researchers to dissect both the shared and distinct genetic architecture across traits to better understand their etiologies. Among 50 complex traits with publicly accessible GWAS summary statistics (N-total approximate to 4.5 million), we identified more than 170 pairs with statistically significant genetic covariance. In particular, we found strong genetic covariance between late-onset Alzheimer disease (LOAD) and amyotrophic lateral sclerosis (ALS), two major neurodegenerative diseases, in single-nucleotide polymorphisms (SNPs) with high minor allele frequencies and in SNPs located in the predicted functional genome. Joint analysis of LOAD, ALS, and other traits highlights LOAD's correlation with cognitive traits and hints at an autoimmune component for ALS.	[Lu, Qiongshi; Li, Boyang; Hu, Yiming; Dai, Wei; Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Ou, Derek; Erlendsdottir, Margret] Yale Sch Med, New Haven, CT 06510 USA; [Powles, Ryan L.; Chang, David; Zhao, Hongyu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06510 USA; [Jiang, Tony; Jin, Chentian] Yale Coll, New Haven, CT 06520 USA; [He, Qidu; Liu, Zefeng] Shanghai Jiao Tong Univ, Dept Comp Sci & Engn, Shanghai 200240, Peoples R China; [Mukherjee, Shubhabrata; Crane, Paul K.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; [Zhao, Hongyu] VA Cooperat Studies Program Coordinating Ctr, West Haven, CT 06516 USA; [Lu, Qiongshi] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53792 USA	Yale University; Yale University; Yale University; Yale University; Shanghai Jiao Tong University; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Zhao, HY (corresponding author), Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA.; Zhao, HY (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06510 USA.; Zhao, HY (corresponding author), VA Cooperat Studies Program Coordinating Ctr, West Haven, CT 06516 USA.	hongyu.zhao@yale.edu	Lu, Qiongshi/AAF-5002-2021	Lu, Qiongshi/0000-0002-4514-0969	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aiba Y, 2015, J HUM GENET, V60, P525, DOI 10.1038/jhg.2015.59; Alnaes R, 1997, ACTA PSYCHIAT SCAND, V95, P336, DOI 10.1111/j.1600-0447.1997.tb09641.x; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anttila V., 2018, SCIENCE, V360, peaap8757; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Bulik-Sullivan B, 2015, BIORXIV; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chrabot BS, 2013, GENES IMMUN, V14, P471, DOI 10.1038/gene.2013.42; Cichonska A, 2016, BIOINFORMATICS, V32, P1981, DOI 10.1093/bioinformatics/btw052; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farooqi IS, 2014, CLIN MED, V14, P286, DOI 10.7861/clinmedicine.14-3-286; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; Gale CR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.56; Guloksuz SA, 2017, REV BRAS PSIQUIATR, V39, P195, DOI 10.1590/1516-4446-2015-1843; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Han B, 2016, NAT GENET, V48, P803, DOI 10.1038/ng.3572; Jang WC, 2012, RHEUMATOL INT, V32, P2257, DOI 10.1007/s00296-011-1952-5; Jung JY, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.62; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lu QS, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006933; Lu QS, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005947; Lu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10576; Majumdar A., 2017, BIORXIV; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Marenholz I, 2013, CURR OPIN ALLERGY CL, V13, P478, DOI 10.1097/ACI.0b013e328364e8f7; Matesanz F, 2015, HUM MOL GENET, V24, P5619, DOI 10.1093/hmg/ddv256; Nuytemans K, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000044; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; RAO CR, 1972, J AM STAT ASSOC, V67, P112, DOI 10.2307/2284708; RAO GN, 1991, J BIOL CHEM, V266, P8604; Reginato AM, 2012, NAT REV RHEUMATOL, V8, P610, DOI 10.1038/nrrheum.2012.144; Reppe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144531; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shi H., 2016, BIORXIV; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Sun HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143786; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zheng J, 2017, BIORXIV; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhou X., 2016, BIORXIV	63	65	65	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					939	964		10.1016/j.ajhg.2017.11.001	http://dx.doi.org/10.1016/j.ajhg.2017.11.001			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29220677	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000417644500006
J	Weiss, K; Terhal, PA; Cohen, L; Bruccoleri, M; Irving, M; Martinez, AF; Rosenfeld, JA; Machol, K; Yang, YP; Liu, PF; Walkiewicz, M; Beuten, J; Gomez-Ospina, N; Haude, K; Fong, CT; Enns, GM; Bernstein, JA; Fan, J; Gotway, G; Ghorbani, M; van Gassen, K; Monroe, GR; van Haaften, G; Basel-Vanagaite, L; Yang, XJ; Campeau, PM; Muenke, M				Weiss, Karin; Terhal, Paulien A.; Cohen, Lior; Bruccoleri, Michael; Irving, Melita; Martinez, Ariel F.; Rosenfeld, Jill A.; Machol, Keren; Yang, Yaping; Liu, Pengfei; Walkiewicz, Magdalena; Beuten, Joke; Gomez-Ospina, Natalia; Haude, Katrina; Fong, Chin-To; Enns, Gregory M.; Bernstein, Jonathan A.; Fan, Judith; Gotway, Garrett; Ghorbani, Mohammad; van Gassen, Koen; Monroe, Glen R.; van Haaften, Gijs; Basel-Vanagaite, Lina; Yang, Xiang-Jiao; Campeau, Philippe M.; Muenke, Maximilian		DDD Study	De Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive Dysmorphisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NICOLAIDES-BARAITSER SYNDROME; COFFIN-SIRIS SYNDROME; HISTONE DEACETYLASE; DEVELOPMENTAL DISORDERS; SWI/SNF COMPLEX; CHARGE-SYNDROME; DNA-DAMAGE; FAMILY; NURD; PROTEINS	Chromodomain helicase DNA-binding protein 4 (CHD4) is an ATP-dependent chromatin remodeler involved in epigenetic regulation of gene transcription, DNA repair, and cell cycle progression. Also known as Mi2 beta., CHD4 is an integral subunit of a well-characterized histone deacetylase complex. Here we report five individuals with de novo missense substitutions in CHD4 identified through whole-exome sequencing and web-based gene matching. These individuals have overlapping phenotypes including developmental delay, intellectual disability, hearing loss, macrocephaly, distinct facial dysmorphisms, palatal abnormalities, ventriculomegaly, and hypogonadism as well as additional findings such as bone fusions. The variants, c.3380G>A (p.Arg1127Gln), c.3443G>T (p.Trp1148Leu), c.3518G>T (p.Arg1173Leu), and c.3008G>A, (p.Gly1003Asp) (GenBank: NM_001273.3), affect evolutionarily highly conserved residues and are predicted to be deleterious. Previous studies in yeast showed the equivalent Arg1127 and Trp1148 residues to be crucial for SNF2 function. Furthermore, mutations in the same positions were reported in malignant tumors, and a de novo missense substitution in an equivalent arginine residue in the C-terminal helicase domain of SMARCA4 is associated with Coffin Sins syndrome. Cell-based studies of the p.Arg1127Gln and p.Arg1173Leu mutants demonstrate normal localization to the nucleus and HDAC1 interaction. Based on these findings, the mutations potentially alter the complex activity but not its formation. This report provides evidence for the role of CHD4 in human development and expands an increasingly recognized group of Mendelian disorders involving chromatin remodeling and modification.	[Weiss, Karin; Martinez, Ariel F.; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Terhal, Paulien A.; van Gassen, Koen; Monroe, Glen R.; van Haaften, Gijs] Univ Utrecht, Med Ctr, Dept Genet, NL-3584 CX Utrecht, Netherlands; [Cohen, Lior; Basel-Vanagaite, Lina] Schneider Children Med Ctr Israel, Pediat Genet, IL-49202 Petah Tiqwa, Israel; [Cohen, Lior; Basel-Vanagaite, Lina] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Bruccoleri, Michael; Ghorbani, Mohammad; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 2M1, Canada; [Bruccoleri, Michael; Ghorbani, Mohammad; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 2M1, Canada; [Irving, Melita] Guys Hosp, Dept Clin Genet, London SE1 9RT, England; [Rosenfeld, Jill A.; Machol, Keren; Yang, Yaping; Liu, Pengfei; Walkiewicz, Magdalena; Beuten, Joke] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gomez-Ospina, Natalia; Enns, Gregory M.; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Haude, Katrina; Fong, Chin-To] Univ Rochester, Med Ctr, Dept Pediat Genet, Rochester, NY 14642 USA; [Fan, Judith; Gotway, Garrett] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Monroe, Glen R.; van Haaften, Gijs] Univ Utrecht, Med Ctr, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [Basel-Vanagaite, Lina] Rabin Med Ctr, Raphael Recanati Genet Inst, Beilinson Campus, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Campeau, Philippe M.] Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ H3T 1C4, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Utrecht University; Tel Aviv University; Sackler Faculty of Medicine; McGill University; McGill University; Guy's & St Thomas' NHS Foundation Trust; Baylor College of Medicine; Stanford University; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utrecht University; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.; Campeau, PM (corresponding author), Univ Montreal, St Justine Hosp, Dept Pediat, Montreal, PQ H3T 1C4, Canada.	p.campeau@umontreal.ca; mmuenke@nhgri.nih.gov	Liu, Pengfei/U-9743-2019; Campeau, Philippe/J-8614-2015; van Haaften, Gijs/G-7832-2012	Liu, Pengfei/0000-0002-4177-709X; Campeau, Philippe/0000-0001-9713-7107; van Haaften, Gijs/0000-0003-3033-0329; Irving, Melita/0000-0002-2997-4461; van Gassen, Koen/0000-0001-7934-0662; Gomez-Ospina, Natalia/0000-0002-6740-1154; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Muenke, Maximilian/0000-0002-7719-6545	Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; Canadian Institutes of Health Research [RN315908, RN324373]; Fonds de Recherche du Quebec Sante [30647]; National Human Genome Research Institute, NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000209] Funding Source: NIH RePORTER	Health Innovation Challenge Fund; Wellcome Trust Sanger Institute(Wellcome Trust); National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec Sante(Fonds de la Recherche en Sante du Quebec); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to the patients and their families for consenting to participate in this publication. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The study has UK Research Ethics Committee approval (10/H0305/83, granted by the Cambridge South REC, and GEN/284/12, granted by the Republic of Ireland REC). The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. P.M.C. is funded by the Canadian Institutes of Health Research Grants RN315908 and RN324373 and the Fonds de Recherche du Quebec Sante grant 30647. We are thankful to the NIH Intramural Sequencing Center (NISC) for supporting sequencing in this project. This work was supported by the intramural program of the National Human Genome Research Institute, NIH.	Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bjornsson HT, 2015, GENOME RES, V25, P1473, DOI 10.1101/gr.190629.115; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Chenier S, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-9; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Denner DR, 2013, DEV BIOL, V375, P105, DOI 10.1016/j.ydbio.2012.11.018; Firth HV, 2011, DEV MED CHILD NEUROL, V53, P702, DOI 10.1111/j.1469-8749.2011.04032.x; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Ingram KG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004031; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kosho T, 2014, AM J MED GENET C, V166, P241, DOI 10.1002/ajmg.c.31415; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Linder B, 2007, GENE DEV, V21, P973, DOI 10.1101/gad.409507; Lopez AJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00100; Monroe G.R., 2016, GENET MED, V9, P999; Morra R, 2012, FEBS LETT, V586, P2513, DOI 10.1016/j.febslet.2012.06.017; O'Shaughnessy-Kirwan A, 2015, DEVELOPMENT, V142, P2586, DOI 10.1242/dev.125450; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Santen GWE, 2012, EPIGENETICS-US, V7, P1219, DOI 10.4161/epi.22299; SEELIG HP, 1995, ARTHRITIS RHEUM-US, V38, P1389, DOI 10.1002/art.1780381006; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sousa SB, 2014, AM J MED GENET C, V166, P302, DOI 10.1002/ajmg.c.31409; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Tsurusaki Y, 2014, CLIN GENET, V85, P548, DOI 10.1111/cge.12225; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Van Houdt JKJ, 2012, NAT GENET, V44, P445, DOI 10.1038/ng.1105; Van Nostrand JL, 2014, NATURE, V514, P228, DOI 10.1038/nature13585; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamada T, 2014, NEURON, V83, P122, DOI 10.1016/j.neuron.2014.05.039; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110	50	65	67	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					934	941		10.1016/j.ajhg.2016.08.001	http://dx.doi.org/10.1016/j.ajhg.2016.08.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616479	Green Published, Bronze			2022-12-18	WOS:000385333700014
J	Coutelier, M; Blesneac, I; Monteil, A; Monin, ML; Ando, K; Mundwiller, E; Brusco, A; Le Ber, I; Anheim, M; Castrioto, A; Duyckaerts, C; Brice, A; Durr, A; Lory, P; Stevanin, G				Coutelier, Marie; Blesneac, Iulia; Monteil, Arnaud; Monin, Marie-Lorraine; Ando, Kunie; Mundwiller, Emeline; Brusco, Alfredo; Le Ber, Isabelle; Anheim, Mathieu; Castrioto, Anna; Duyckaerts, Charles; Brice, Alexis; Durr, Alexandra; Lory, Philippe; Stevanin, Giovanni			A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA(1G) SUBUNIT; GENETIC-VARIATION; CA2+ CHANNELS; MECHANISMS; PHYSIOLOGY; DOMAIN; BRAIN	Hereditary cerebellar ataxias (CAs) are neurodegenerative disorders clinically characterized by a cerebellar syndrome, often accompanied by other neurological or non-neurological signs. All transmission modes have been described. In autosomal-dominant CA (ADCA), mutations in more than 30 genes are implicated, but the molecular diagnosis remains unknown in about 40% of cases. Implication of ion channels has long been an ongoing topic in the genetics of CA, and mutations in several channel genes have been recently connected to ADCA. In a large family affected by ADCA and mild pyramidal signs, we searched for the causative variant by combining linkage analysis and whole-exome sequencing. In CACNA1G, we identified a c.5144G>A mutation, causing an arginine-to-histidine (p.Arg1715His) change in the voltage sensor S4 segment of the T-type channel protein Cav3.1. Two out of 479 index subjects screened subsequently harbored the same mutation. We performed electrophysiological experiments in HEK293T cells to compare the properties of the p.Arg1715His and wild-type Cav3.1 channels. The current-voltage and the steady-state activation curves of the p.Arg1715His channel were shifted positively, whereas the inactivation curve had a higher slope factor. Computer modeling in deep cerebellar nuclei (DCN) neurons suggested that the mutation results in decreased neuronal excitability. Taken together, these data establish CACNA1G, which is highly expressed in the cerebellum, as a gene whose mutations can cause ADCA. This is consistent with the neuropathological examination, which showed severe Purkinje cell loss. Our study further extends our knowledge of the link between calcium channelopathies and CAs.	[Coutelier, Marie; Monin, Marie-Lorraine; Ando, Kunie; Le Ber, Isabelle; Duyckaerts, Charles; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] INSERM U1127, F-75013 Paris, France; [Coutelier, Marie; Monin, Marie-Lorraine; Ando, Kunie; Le Ber, Isabelle; Duyckaerts, Charles; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] CNRS, UMR 7225, F-75013 Paris, France; [Coutelier, Marie; Monin, Marie-Lorraine; Ando, Kunie; Le Ber, Isabelle; Duyckaerts, Charles; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Sorbonne Univ, Univ Paris 06, UMRS 1127, F-75013 Paris, France; [Coutelier, Marie; Monin, Marie-Lorraine; Ando, Kunie; Mundwiller, Emeline; Le Ber, Isabelle; Duyckaerts, Charles; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Coutelier, Marie] Catholic Univ Louvain, Lab Human Mol Genet, Duve Inst, B-1200 Brussels, Belgium; [Coutelier, Marie; Stevanin, Giovanni] Ecole Prat Hautes Etud, F-75014 Paris, France; [Blesneac, Iulia; Monteil, Arnaud; Lory, Philippe] Univ Montpellier, CNRS UMR 5203, F-34094 Montpellier, France; [Blesneac, Iulia; Monteil, Arnaud; Lory, Philippe] Univ Montpellier, INSERM U1191, Inst Genom Fonct, F-34094 Montpellier, France; [Blesneac, Iulia; Monteil, Arnaud; Lory, Philippe] LabEx Ion Channel Sci & Therapeut, F-34094 Montpellier, France; [Coutelier, Marie; Monin, Marie-Lorraine; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Hop La Pitie Salpetriere, AP HP, Ctr Reference Neurogenet, F-75013 Paris, France; [Ando, Kunie; Duyckaerts, Charles] Hop La Pitie Salpetriere, Lab Neuropathol Escourolle, F-75013 Paris, France; [Brusco, Alfredo] Univ Turin, Dept Med Sci, I-10126 Turin, Italy; [Brusco, Alfredo] Citta Salute & Sci Univ Hosp, Med Genet Unit, I-10126 Turin, Italy; [Le Ber, Isabelle] Hop La Pitie Salpetriere, AP HP, Federat Malad Syst Nerveux, F-75013 Paris, France; [Anheim, Mathieu] CHU Strasbourg, Dept Neurol, Hop Hautepierre, F-67098 Strasbourg, France; [Anheim, Mathieu] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM U964, CNRS UMR 7104, F-67400 Illkirch Graffenstaden, France; [Anheim, Mathieu] Univ Strasbourg, Federat Med Translat Strasbourg, F-67081 Strasbourg, France; [Castrioto, Anna] CHU Grenoble, Pole Neurol & Psychiat, Unite Troubles Mouvement, F-38700 Grenoble, France; [Castrioto, Anna] Univ Grenoble 1, Equipe Fonct Cerebrates & Neuromodulat, Grenoble Inst Neurosci,CHU Grenoble, NSERM U836,Commissariat Energie Atom & Energie A, F-38700 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Stevanin, G (corresponding author), INSERM U1127, F-75013 Paris, France.	giovanni.stevanin@upmc.fr	Brusco, Alfredo/A-1811-2013; brice, alexis/AAE-8275-2019; Monteil, Arnaud/G-3113-2012; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016	Brusco, Alfredo/0000-0002-8318-7231; brice, alexis/0000-0002-0941-3990; Monteil, Arnaud/0000-0003-1632-7318; Stevanin, Giovanni/0000-0001-9368-8657; Anheim, Mathieu/0000-0001-8121-0605; LORY, philippe/0000-0002-1638-7604; Ando, Kunie/0000-0003-3822-175X; Coutelier, Marie/0000-0002-0261-7210	Institut Hospitalo-Universitaire A-ICM; private foundation France Alzheimer; private foundation France Parkinson; Association de Recherche sur la Sclerose en Plaques; Connaitre les Syndromes Cerebelleux; French National Agency for Research (ANR); French Ministry of Health PHRC [AOM 09178]; European Union; Verum Foundation; Fondation Roger de Spoelberch; Association Connaitre les Syndromes Cerebelleux; program Investissements d'Avenir [ANR-10-IAIHU-06]; Associazione Italiana Sindromi Atassiche	Institut Hospitalo-Universitaire A-ICM; private foundation France Alzheimer; private foundation France Parkinson; Association de Recherche sur la Sclerose en Plaques; Connaitre les Syndromes Cerebelleux; French National Agency for Research (ANR)(French National Research Agency (ANR)); French Ministry of Health PHRC; European Union(European Commission); Verum Foundation; Fondation Roger de Spoelberch; Association Connaitre les Syndromes Cerebelleux; program Investissements d'Avenir(French National Research Agency (ANR)); Associazione Italiana Sindromi Atassiche	The authors thank the families for their contribution, as well as the DNA and cell bank of the Institut du Cerveau et de la Moe lle Epiniere (ICM) and the brain bank GIE NeuroCEB (funded by Institut Hospitalo-Universitaire A-ICM and by private foundations France Alzheimer, France Parkinson, Association de Recherche sur la Sclerose en Plaques, and Connaitre les Syndromes Cerebelleux). The authors also thank Celia Gautier for helping with this study, as well as Drs. Stephan Klebe, Chantal Tallaksen, and Imed Feld for examining subjects. M.C. was the recipient of a fellowship from the Fond National de la Recherche Scientifique (aspirant FNRS). This work received financial support from the French National Agency for Research (ANR; to G.S.), the French Ministry of Health PHRC 2009 program (AOM 09178 to A.D.), the European Union (Omics call: NeurOmics; to A. Brice and A.D.), the Verum Foundation (to A. Brice and G.S.), the Fondation Roger de Spoelberch (to A. Brice), the Association Connaitre les Syndromes Cerebelleux (to G.S.), the program Investissements d'Avenir (ANR-10-IAIHU-06; to the ICM), and the Associazione Italiana Sindromi Atassiche (to A. Brusco).	Alvina K, 2009, NEUROSCIENCE, V158, P635, DOI 10.1016/j.neuroscience.2008.09.052; Bidaud I, 2011, BIOCHIMIE, V93, P2080, DOI 10.1016/j.biochi.2011.05.015; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cain SM, 2011, BIOFACTORS, V37, P197, DOI 10.1002/biof.158; Chang KY, 2011, BIOCHEM BIOPH RES CO, V410, P19, DOI 10.1016/j.bbrc.2011.05.082; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chopra R, 2014, FUTUR NEUROL, V9, P187, DOI 10.2217/FNL.14.6; Coutelier M, 2015, J NEUROL, V262, P2382, DOI 10.1007/s00415-015-7725-4; Coutelier M, 2015, NEUROLOGY, V84, P1751, DOI 10.1212/WNL.0000000000001524; Craig PJ, 1999, EUR J NEUROSCI, V11, P2949, DOI 10.1046/j.1460-9568.1999.00711.x; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Eckle VS, 2014, J PHYSIOL-LONDON, V592, P795, DOI 10.1113/jphysiol.2013.264176; Engbers JDT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00230; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; Ernst WL, 2009, J NEUROSCI, V29, P1615, DOI 10.1523/JNEUROSCI.2081-08.2009; Giunti P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00036; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; Heiney SA, 2014, J NEUROSCI, V34, P14845, DOI 10.1523/JNEUROSCI.2820-14.2014; Heron SE, 2004, ANN NEUROL, V55, P595, DOI 10.1002/ana.20028; Hersheson J, 2012, HUM MUTAT, V33, P1324, DOI 10.1002/humu.22132; Hills LB, 2013, NEUROLOGY, V81, P1378, DOI 10.1212/WNL.0b013e3182a841a3; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kurejova M, 2007, PFLUG ARCH EUR J PHY, V455, P527, DOI 10.1007/s00424-007-0302-7; Lam AD, 2005, PFLUG ARCH EUR J PHY, V451, P349, DOI 10.1007/s00424-005-1407-5; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Luthman J, 2011, CEREBELLUM, V10, P667, DOI 10.1007/s12311-011-0295-9; Ly R, 2013, P NATL ACAD SCI USA, V110, P20302, DOI 10.1073/pnas.1311686110; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Matilla-Duenas A, 2014, CEREBELLUM, V13, P269, DOI 10.1007/s12311-013-0539-y; Molineux ML, 2008, J NEUROPHYSIOL, V100, P2684, DOI 10.1152/jn.90427.2008; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Na HS, 2008, MOL CELLS, V25, P242; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Rice RA, 2014, NEUROBIOL AGING, V35, P1002, DOI 10.1016/j.neurobiolaging.2013.10.090; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Steuber V, 2011, J COMPUT NEUROSCI, V30, P633, DOI 10.1007/s10827-010-0282-z; Strom SP, 2010, MOL PSYCHIATR, V15, P996, DOI 10.1038/mp.2009.41; Talley EM, 1999, J NEUROSCI, V19, P1895; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tscherter A, 2011, J PHYSIOL-LONDON, V589, P1707, DOI 10.1113/jphysiol.2010.203836; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Yalcin O, 2012, SEIZURE-EUR J EPILEP, V21, P79, DOI 10.1016/j.seizure.2011.12.002; Yan HD, 2013, CELL REP, V4, P66, DOI 10.1016/j.celrep.2013.06.012	61	65	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 5	2015	97	5					726	737		10.1016/j.ajhg.2015.09.007	http://dx.doi.org/10.1016/j.ajhg.2015.09.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW2ED	26456284	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000364803000008
J	Lalani, SR; Zhang, J; Schaaf, CP; Brown, CW; Magoulas, P; Tsai, ACH; El-Gharbawy, A; Wierenga, KJ; Bartholomew, D; Fong, CT; Barbaro-Dieber, T; Kukolich, MK; Burrage, LC; Austin, E; Keller, K; Pastore, M; Fernandez, F; Lotze, T; Wilfong, A; Purcarin, G; Zhu, WM; Craigen, WJ; McGuire, M; Jain, M; Cooney, E; Azamian, M; Bainbridge, MN; Muzny, DM; Boerwinkle, E; Person, RE; Niu, Z; Eng, CM; Lupski, JR; Gibbs, RA; Beaudet, AL; Yang, YP; Wang, MC; Xia, F				Lalani, Seema R.; Zhang, Jing; Schaaf, Christian P.; Brown, Chester W.; Magoulas, Pilar; Tsai, Anne Chun-Hui; El-Gharbawy, Areeg; Wierenga, Klaas J.; Bartholomew, Dennis; Fong, Chin-To; Barbaro-Dieber, Tina; Kukolich, Mary K.; Burrage, Lindsay C.; Austin, Elise; Keller, Kory; Pastore, Matthew; Fernandez, Fabio; Lotze, Timothy; Wilfong, Angus; Purcarin, Gabriela; Zhu, Wenmiao; Craigen, William J.; McGuire, Marianne; Jain, Mahim; Cooney, Erin; Azamian, Mahshid; Bainbridge, Matthew N.; Muzny, Donna M.; Boerwinkle, Eric; Person, Richard E.; Niu, Zhiyv; Eng, Christine M.; Lupski, James R.; Gibbs, Richard A.; Beaudet, Arthur L.; Yang, Yaping; Wang, Meng C.; Xia, Fan			Mutations in PURA Cause Profound Neonatal Hypotonia, Seizures, and Encephalopathy in 5q31.3 Microdeletion Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POSTNATAL BRAIN-DEVELOPMENT; ALPHA BINDS; REPEAT; GENES	5q31.3 microdeletion syndrome is characterized by neonatal hypotonia, encephalopathy with or without epilepsy, and severe developmental delay, and the minimal critical deletion interval harbors three genes. We describe 11 individuals with clinical features of 5q31.3 microdeletion syndrome and de novo mutations in PURA, encoding transcriptional activator protein Pur-a, within the critical region. These data implicate causative PURA mutations responsible for the severe neurological phenotypes observed in this syndrome.	[Lalani, Seema R.; Zhang, Jing; Schaaf, Christian P.; Brown, Chester W.; Magoulas, Pilar; Burrage, Lindsay C.; Austin, Elise; Zhu, Wenmiao; Craigen, William J.; McGuire, Marianne; Jain, Mahim; Cooney, Erin; Azamian, Mahshid; Person, Richard E.; Niu, Zhiyv; Eng, Christine M.; Lupski, James R.; Gibbs, Richard A.; Beaudet, Arthur L.; Yang, Yaping; Wang, Meng C.; Xia, Fan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bainbridge, Matthew N.; Muzny, Donna M.; Boerwinkle, Eric; Lupski, James R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Schaaf, Christian P.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Tsai, Anne Chun-Hui; Keller, Kory] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [El-Gharbawy, Areeg] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; [El-Gharbawy, Areeg] Univ Pittsburgh, Sch Med, Div Med Genet, Pittsburgh, PA 15213 USA; [Wierenga, Klaas J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Bartholomew, Dennis; Pastore, Matthew] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH 43205 USA; [Fong, Chin-To] Univ Rochester, Med Ctr, Clin Inherited Metab Dis, Rochester, NY 14642 USA; [Barbaro-Dieber, Tina; Kukolich, Mary K.] Cook Childrens Hosp, Ft Worth, TX 76102 USA; [Fernandez, Fabio; Lotze, Timothy; Wilfong, Angus] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Brown, Chester W.; Fernandez, Fabio; Lotze, Timothy; Wilfong, Angus; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Purcarin, Gabriela] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA; [Muzny, Donna M.; Person, Richard E.; Niu, Zhiyv; Eng, Christine M.; Yang, Yaping; Xia, Fan] Baylor Coll Med, Whole Genome Lab, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Wang, Meng C.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Rochester; Cook Children's Medical Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Lalani, SR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	seemal@bcm.edu; fxia@bcm.edu	Pastore, Matthew/AAD-8348-2019; Lalani, Seema/AAI-5090-2020; Schaaf, Christian P/AAJ-7318-2021; niu, zhiyv/A-6558-2009; Pastore, Matthew/B-6867-2012; Wang, Meng/F-2951-2019; El-gharbawy, Areeg/N-5134-2017	Pastore, Matthew/0000-0001-9888-0779; Schaaf, Christian P/0000-0002-2148-7490; Wang, Meng/0000-0002-5898-6007; Azamian, Mahshid/0000-0002-8543-8284	Stanford Alexander Family Foundation; NIH [U54HG003273, U54HG006542, R01AG045183, T32GM07526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045183] Funding Source: NIH RePORTER	Stanford Alexander Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to the families for participating in the study. This study was supported in part by the Doris Duke Foundation and Gillson-Longenbaugh Foundation to S.R.L., by the Joan and Stanford Alexander Family Foundation to C.P.S., and by NIH grants to R.A.G. (U54HG003273), J.R.L. (U54HG006542), M.C.W. (R01AG045183), and L.C.B. and M.J. (T32GM07526). The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from genetic testing offered in the Whole Genome Laboratory and Medical Genetics Laboratories. J.R.L. is a paid consultant for Athena Diagnostics, holds stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on United States and European patents related to molecular diagnostics. M.N.B. is a founder of Codified Genomics.	Aumiller V, 2012, RNA BIOL, V9, P633, DOI 10.4161/rna.19760; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P1257, DOI 10.1128/MCB.12.3.1257; Brown N, 2013, AM J MED GENET A, V161, P2604, DOI 10.1002/ajmg.a.36108; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Hokkanen S, 2012, HUM MOL GENET, V21, P473, DOI 10.1093/hmg/ddr476; Hosoki K, 2012, AM J MED GENET A, V158A, P1891, DOI 10.1002/ajmg.a.35439; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Rosenfeld JA, 2011, AM J MED GENET A, V155A, P1906, DOI 10.1002/ajmg.a.34100; Shimojima K, 2011, AM J MED GENET A, V155A, P732, DOI 10.1002/ajmg.a.33891; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	14	65	70	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					579	583		10.1016/j.ajhg.2014.09.014	http://dx.doi.org/10.1016/j.ajhg.2014.09.014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439098	Green Published, Bronze			2022-12-18	WOS:000344845000008
J	Boone, PM; Yuan, B; Campbell, IM; Scul, JC; Withers, MA; Baggett, BC; Beck, CR; Shaw, CJ; Stankiewicz, P; Moretti, P; Goodwin, WE; Hein, N; Fink, JK; Seong, MW; Seo, SH; Park, SS; Karbassi, ID; Batish, SD; Ordonez-Ugalde, A; Quintans, B; Sobrido, MJ; Stemmler, S; Lupski, JR				Boone, Philip M.; Yuan, Bo; Campbell, Ian M.; Scul, Jennifer C.; Withers, Marjorie A.; Baggett, Brett C.; Beck, Christine R.; Shaw, Christine J.; Stankiewicz, Pawel; Moretti, Paolo; Goodwin, Wendy E.; Hein, Nichole; Fink, John K.; Seong, Moon-Woo; Seo, Soo Hyun; Park, Sung Sup; Karbassi, Izabela D.; Batish, Sat Dev; Ordonez-Ugalde, Andres; Quintans, Beatriz; Sobrido, Maria-Jesus; Stemmler, Susanne; Lupski, James R.			The Alu-Rich Genomic Architecture of SPAST Predisposes to Diverse and Functionally Distinct Disease-Associated CNV Alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIANTS; MILD COGNITIVE IMPAIRMENT; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CLINICAL POPULATION; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; MISMATCH REPAIR; EXON DELETIONS	Intragenic copy-number variants (CNVs) contribute to the allelic spectrum of both Mendelian and complex disorders. Although pathogenic deletions and duplications in SPAST (mutations in which cause autosomal-dominant spastic paraplegia 4 [SPG4]) have been described, their origins and molecular consequences remain obscure. We mapped breakpoint junctions of 54 SPAST CNVs at nucleotide resolution. Diverse combinations of exons are deleted or duplicated, highlighting the importance of particular exons for spastin function. Of the 54 CNVs, 38 (70%) appear to be mediated by an Alu-based mechanism, suggesting that the Alu-rich genomic architecture of SPAST renders this locus susceptible to various genome rearrangements. Analysis of breakpoint Alus further informs a model of Alu-mediated CNV formation characterized by small CNV size and potential involvement of mechanisms other than homologous recombination. Twelve deletions (22%) overlap part of SPAST and a portion of a nearby, directly oriented gene, predicting novel chimeric genes in these subjects' genomes. cDNA from a subject with a SPAST final exon deletion contained multiple SPAST:SLC30A6 fusion transcripts, indicating that SPAST CNVs can have transcriptional effects beyond the gene itself. SLC30A6 has been implicated in Alzheimer disease, so these fusion gene data could explain a report of spastic paraplegia and dementia cosegregating in a family with deletion of the final exon of SPAST. Our findings provide evidence that the Alu genomic architecture of SPAST predisposes to diverse CNV alleles with distinct transcriptional-and possibly phenotypic-consequences. Moreover, we provide further mechanistic insights into Alu-mediated copy-number change that are extendable to other loci.	[Boone, Philip M.; Yuan, Bo; Campbell, Ian M.; Withers, Marjorie A.; Baggett, Brett C.; Beck, Christine R.; Shaw, Christine J.; Stankiewicz, Pawel; Moretti, Paolo; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Scul, Jennifer C.; Stankiewicz, Pawel; Lupski, James R.] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA; [Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Moretti, Paolo] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Goodwin, Wendy E.] Childrens Med Ctr Dallas, Dallas, TX 75207 USA; [Hein, Nichole; Fink, John K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Fink, John K.] Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA; [Fink, John K.] Vet Affairs Med Ctr, Ann Arbor, MI 48015 USA; [Seong, Moon-Woo; Seo, Soo Hyun; Park, Sung Sup] Seoul Natl Univ Hosp, Dept Lab Med, Seoul 110799, South Korea; [Karbassi, Izabela D.; Batish, Sat Dev] Athena Diagnost, Quest Diagnost, Worcester, MA 01605 USA; [Ordonez-Ugalde, Andres; Quintans, Beatriz; Sobrido, Maria-Jesus] CIBERER, Fdn Publ Galega Med Xenom SERGAS, IDIS, Santiago De Compostela 15706, Spain; [Stemmler, Susanne] Ruhr Univ Bochum, Dept Human Genet, D-44801 Bochum, Germany; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Seoul National University (SNU); Seoul National University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Ruhr University Bochum; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu	Stankiewicz, Paweł/AAP-7906-2021	Stankiewicz, Paweł/0000-0002-6456-7490; Boone, Philip/0000-0001-9528-252X; Campbell, Ian/0000-0002-3749-2884; Baggett, Brett/0000-0003-2227-0004; Seong, Moon-Woo/0000-0003-2954-3677; Park, Sung Sup/0000-0003-3754-4848	Spanish Familial Spastic Paraplegia Association (AEPEF); European Hereditary Spastic Paraplegia Federation (Euro-HSP); Baylor College of Medicine Medical Scientist Training Program [T32GM007330]; Wintermann Foundation; Baylor Research Advocates for Student Scientists; National Institute of Neurological Disorders and Stroke [F31 NS083159]; US National Institute of Neurological Disorders and Stroke [RO1NS058529]; US National Human Genome Research Institute/National Heart, Blood and Lung Institute [U54HG006542]; Spanish Fondo de Investigaciones Sanitarias [PS09/01830]; Spastic Paraplegia Foundation; U.S. National Institute of Neurological Disorders and Stroke [RO1NS0679700]; U.S. Department of Veterans Affairs [5I01CX000344]; Geriatric Research Education and Clinical Center AAVAMC; Paul and Lois Katzman Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, T32NS043124, R01NS069700, F31NS083159] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000344] Funding Source: NIH RePORTER	Spanish Familial Spastic Paraplegia Association (AEPEF); European Hereditary Spastic Paraplegia Federation (Euro-HSP); Baylor College of Medicine Medical Scientist Training Program; Wintermann Foundation; Baylor Research Advocates for Student Scientists; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Human Genome Research Institute/National Heart, Blood and Lung Institute; Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spastic Paraplegia Foundation; U.S. National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Geriatric Research Education and Clinical Center AAVAMC; Paul and Lois Katzman Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank the Spastic Paraplegia Foundation, Sandy Wilcock, and Amy Breman for assistance with subject/sample recruitment. We thank Gladys Zapata and Paula Patricia Hernandez for transforming lymphoblasts and Chad Shaw, Claudia Fonseca, and Avinash Dharmadhikari for technical advice. We are grateful to the Spanish Familial Spastic Paraplegia Association (AEPEF) and the European Hereditary Spastic Paraplegia Federation (Euro-HSP) for their support and collaboration. P.M.B. and I.M.C. are fellows of the Baylor College of Medicine Medical Scientist Training Program (T32GM007330). P.M.B. is supported by grants from the Wintermann Foundation and the Baylor Research Advocates for Student Scientists. I.M.C. was supported by a fellowship from the National Institute of Neurological Disorders and Stroke (F31 NS083159). C.R.B. is an HHMI Fellow of the Damon Runyon Cancer Research Foundation (DRG 2155-13). This work was supported in part by the US National Institute of Neurological Disorders and Stroke (RO1NS058529 to J.R.L.), the US National Human Genome Research Institute/National Heart, Blood and Lung Institute (U54HG006542), and the Spanish Fondo de Investigaciones Sanitarias (PS09/01830). J.K.F. is supported by the Spastic Paraplegia Foundation, the U.S. National Institute of Neurological Disorders and Stroke (RO1NS0679700), the U.S. Department of Veterans Affairs (Merit Review 5I01CX000344), the Geriatric Research Education and Clinical Center AAVAMC, and the Paul and Lois Katzman Family. J.R.L. holds stock ownership in 23andMe, Inc. and Ion Torrent Systems, Inc., and is a coinventor on multiple United States and European patents related to molecular diagnostics. M.J.S. is a shareholder of Genomic Consulting, a company related to the application of genomics in medicine. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories. I.D.K. and S.D.B. are employees of Quest Diagnostics.	Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P97, DOI 10.1007/978-1-61779-767-5_7; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Alvarez V, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-89; Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; BAILIS AM, 1990, GENETICS, V126, P535; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Benito-Sanz S, 2012, J MED GENET, V49, P442, DOI 10.1136/jmedgenet-2011-100678; Boone PM, 2013, GENET MED, V15, P45, DOI 10.1038/gim.2012.95; Boone PM, 2011, GENET MED, V13, P582, DOI 10.1097/GIM.0b013e3182106775; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; de Ligt J, 2013, HUM MUTAT, V34, P1439, DOI 10.1002/humu.22387; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Depienne C, 2007, J MED GENET, V44, P281, DOI 10.1136/jmg.2006.046425; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Erichsen AK, 2007, EUR J NEUROL, V14, P809, DOI 10.1111/j.1468-1331.2007.01861.x; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Gonzaga-Jauregui C, 2010, NEUROGENETICS, V11, P465, DOI 10.1007/s10048-010-0247-4; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Iwanaga H, 2005, AM J MED GENET A, V133A, P13, DOI 10.1002/ajmg.a.30510; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Loureiro JL, 2013, JAMA NEUROL, V70, P481, DOI 10.1001/jamaneurol.2013.1956; Lovell MA, 2006, J NEUROPATH EXP NEUR, V65, P489, DOI 10.1097/01.jnen.0000229237.98124.91; McDermott CJ, 2006, NEUROLOGY, V67, P45, DOI 10.1212/01.wnl.0000223315.62404.00; Mei D, 2008, J MED GENET, V45, P355, DOI 10.1136/jmg.2007.056507; METZENBERG AB, 1991, GENETICS, V128, P143; MEZARD C, 1992, CELL, V70, P659, DOI 10.1016/0092-8674(92)90434-E; Mitne-Neto M, 2007, EUR J HUM GENET, V15, P1276, DOI 10.1038/sj.ejhg.5201924; Miura S, 2011, NEUROGENETICS, V12, P25, DOI 10.1007/s10048-010-0260-7; Murphy S, 2009, NEUROLOGY, V73, P378, DOI 10.1212/WNL.0b013e3181b04c6c; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nielsen JE, 2004, EUR J NEUROL, V11, P817, DOI 10.1111/j.1468-1331.2004.00888.x; Okamoto Y, 2014, GENET MED, V16, P386, DOI 10.1038/gim.2013.155; Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Ribaie P, 2008, EUR J HUM GENET, V16, P97, DOI 10.1038/sj.ejhg.5201922; Rossetti Liliana C, 2004, Hum Mutat, V24, P440, DOI 10.1002/humu.9288; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Sauter S, 2002, HUM MUTAT, V20, P127, DOI 10.1002/humu.10105; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shoukier M, 2009, EUR J HUM GENET, V17, P187, DOI 10.1038/ejhg.2008.147; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sulek A, 2013, NEUROL SCI, V34, P239, DOI 10.1007/s10072-011-0899-3; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Vandebona H, 2012, INTERN MED J, V42, DOI 10.1111/j.1445-5994.2012.02941.x; WALDMAN AS, 1987, P NATL ACAD SCI USA, V84, P5340, DOI 10.1073/pnas.84.15.5340; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; White KD, 2000, NEUROLOGY, V55, P89, DOI 10.1212/WNL.55.1.89; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Yang D, 1997, MOL CELL BIOL, V17, P3614, DOI 10.1128/MCB.17.7.3614; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	68	65	65	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					143	161		10.1016/j.ajhg.2014.06.014	http://dx.doi.org/10.1016/j.ajhg.2014.06.014			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25065914	Green Published, Bronze			2022-12-18	WOS:000340076000002
J	Di Gregorio, E; Borroni, B; Giorgio, E; Lacerenza, D; Ferrero, M; Lo Buono, N; Ragusa, N; Mancini, C; Gaussen, M; Calcia, A; Mitro, N; Hoxha, E; Mura, I; Coviello, DA; Moon, YA; Tesson, C; Vaula, G; Couarch, P; Orsi, L; Duregon, E; Papotti, MG; Deleuze, JF; Imbert, J; Costanzi, C; Padovani, A; Giunti, P; Maillet-Vioud, M; Durr, A; Brice, A; Tempia, F; Funaro, A; Boccone, L; Caruso, D; Stevanin, G; Brusco, A				Di Gregorio, Eleonora; Borroni, Barbara; Giorgio, Elisa; Lacerenza, Daniela; Ferrero, Marta; Lo Buono, Nicola; Ragusa, Neftj; Mancini, Cecilia; Gaussen, Marion; Calcia, Alessandro; Mitro, Nico; Hoxha, Eriola; Mura, Isabella; Coviello, Domenico A.; Moon, Young-Ah; Tesson, Christelle; Vaula, Giovanna; Couarch, Philippe; Orsi, Laura; Duregon, Eleonora; Papotti, Mauro Giulio; Deleuze, Jean-Francois; Imbert, Jean; Costanzi, Chiara; Padovani, Alessandro; Giunti, Paola; Maillet-Vioud, Marcel; Durr, Alexandra; Brice, Alexis; Tempia, Filippo; Funaro, Ada; Boccone, Loredana; Caruso, Donatella; Stevanin, Giovanni; Brusco, Alfredo			ELOVLS Mutations Cause Spinocerebellar Ataxia 38	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY SPASTIC PARAPLEGIA; POLYUNSATURATED FATTY-ACIDS; NEURODEGENERATIVE DISORDERS; ENDOPLASMIC-RETICULUM; CIS-GOLGI; COMPLEX; FORM; PROTEIN; ELONGATION; ACTIVATION	Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal-dominant neurodegenerative disorders involving the cerebellum and 23 different genes. We mapped SCA38 to a 56 Mb region on chromosome 6p in a SCA-affected Italian family by whole-genome linkage analysis. Targeted resequencing identified a single missense mutation (c.689G>T [p.Gly230Val]) in ELOVL5. Mutation screening of 456 independent SCA-affected individuals identified the same mutation in two further unrelated Italian families. Haplotyping showed that at least two of the three families shared a common ancestor. One further missense variant (c.214C>G [p.Leu72Val]) was found in a French family. Both missense changes affect conserved amino acids, are predicted to be damaging by multiple bioinformatics tools, and were not identified in ethnically matched controls or within variant databases. ELOVL5 encodes an elongase involved in the synthesis of polyunsaturated fatty acids of the omega 3 and omega 6 series. Arachidonic acid and docosahexaenoic acid, two final products of the enzyme, were reduced in the serum of affected individuals. Immunohistochemistry on control mice and human brain demonstrated high levels in Purkinje cells. In transfection experiments, subcellular localization of altered ELOVL5 showed a perinuclear distribution with a signal increase in the Golgi compartment, whereas the wild-type showed a widespread signal in the endoplasmic reticulum. SCA38 and SCA34 are examples of SCAs due to mutations in elongase-encoding genes, emphasizing the importance of fatty-acid metabolism in neurological diseases.	[Di Gregorio, Eleonora; Giorgio, Elisa; Lacerenza, Daniela; Ferrero, Marta; Lo Buono, Nicola; Ragusa, Neftj; Mancini, Cecilia; Calcia, Alessandro; Funaro, Ada; Brusco, Alfredo] Univ Turin, Dept Med Sci, I-10126 Turin, Italy; [Di Gregorio, Eleonora; Brusco, Alfredo] Azienda Osped Univ Citta Salute & Sci, Med Genet Unit, I-10126 Turin, Italy; [Borroni, Barbara; Costanzi, Chiara; Padovani, Alessandro] Univ Brescia, Dept Neurol, I-25100 Brescia, Italy; [Gaussen, Marion; Tesson, Christelle; Couarch, Philippe; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, INSERM, U1127, F-75013 Paris, France; [Gaussen, Marion; Tesson, Christelle; Couarch, Philippe; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] CNRS, UMR 7225, F-75013 Paris, France; [Gaussen, Marion; Tesson, Christelle; Couarch, Philippe; Durr, Alexandra; Brice, Alexis; Stevanin, Giovanni] Univ Paris 06, Sorbonne Univ, UMR S 1127, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Gaussen, Marion; Tesson, Christelle; Stevanin, Giovanni] HeSam Univ, Neurogenet Team, Ecole Prat Hautes Etud, F-75013 Paris, France; [Mitro, Nico] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy; [Hoxha, Eriola; Tempia, Filippo; Caruso, Donatella] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, I-10043 Orbassano, Italy; [Mura, Isabella; Coviello, Domenico A.] Galliera Hosp, Lab Human Genet, I-16128 Genoa, Italy; [Moon, Young-Ah] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Vaula, Giovanna; Orsi, Laura] Azienda Osped Univ Citta Salute & Sci, Neurol Div 1, Dept Neurosci & Mental Hlth, I-10126 Turin, Italy; [Duregon, Eleonora; Papotti, Mauro Giulio] Univ Turin, San Luigi Hosp, Dept Oncol, I-10043 Orbassano, Italy; [Deleuze, Jean-Francois] Ctr Natl Genotypage, F-91057 Evry, France; [Imbert, Jean] Aix Marseille Univ, Transcript & Genom Marseille Luminy Platform, Technol Adv Genom & Clin Lab, INSERM,UMR S 1090, F-13009 Marseille, France; [Giunti, Paola] UCL, Dept Mol Neurosci, Inst Neurol, London WC1 N3BG, England; [Maillet-Vioud, Marcel] Ctr Hosp Gen Montlucon, F-03113 Montlucon, France; [Durr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Boccone, Loredana] Osped Reg Microcitemie, Azienda Unita Sanit Locale 8, I-09121 Cagliari, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Brescia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; heSam Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); University of Milan; University of Turin; Ente Ospedaliero Ospedali Galliera; University of Texas System; University of Texas Southwestern Medical Center Dallas; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Brusco, A (corresponding author), Univ Turin, Dept Med Sci, I-10126 Turin, Italy.	alfredo.brusco@unito.it	Padovani, Alessandro/ABI-7312-2020; Coviello, Domenico/J-9477-2016; Brice, Alexis/A-2170-2009; Hoxha, Eriola/N-1752-2017; Giunti, Paola/E-5526-2012; Giorgio, Elisa/K-4740-2018; Borroni, Barbara/AAN-4105-2020; Brusco, Alfredo/A-1811-2013; brice, alexis/AAE-8275-2019; Mancini, Cecilia/AAB-7442-2019; Imbert, Jean/G-3248-2013; Duregon, Eleonora/L-9509-2019; Funaro, Ada/AAC-3203-2019; Stevanin, Giovanni/E-5038-2016; Imbert, Jean/AAG-1165-2020; Lo Buono, Nicola/F-4817-2013	Padovani, Alessandro/0000-0002-0119-3639; Coviello, Domenico/0000-0001-8440-865X; Hoxha, Eriola/0000-0002-4452-889X; Giunti, Paola/0000-0003-3508-4788; Giorgio, Elisa/0000-0003-4076-4649; Brusco, Alfredo/0000-0002-8318-7231; brice, alexis/0000-0002-0941-3990; Imbert, Jean/0000-0002-0478-9593; Duregon, Eleonora/0000-0003-4018-3983; Stevanin, Giovanni/0000-0001-9368-8657; Imbert, Jean/0000-0002-0478-9593; Tempia, Filippo/0000-0003-2778-0943; Lo Buono, Nicola/0000-0001-5538-6869; Mitro, Nico/0000-0002-5000-3619; Funaro, Ada/0000-0001-6341-1817; Mancini, Cecilia/0000-0003-1282-0404	The Galliera Genetic Bank of the Telethon Network of Genetic Biobanks - Telethon Italy [GTB12001]; Associazione Italiana Sindromi Atassiche; Associazione E.E. Rulfo per la Genetica Medica, PRIN [20108WT59Y]; GIS - Institut des Maladies Rares [A10021DS]; Agence Nationale de la Recherche (SPATAX-Quest project); European Commission [E12009DD, E04006DD]; program "Investissements d'Avenir" [ANR-10-IAIHU-06]; Verum Foundation; Fondation Roger de Spoelberch [R12123DD]	The Galliera Genetic Bank of the Telethon Network of Genetic Biobanks - Telethon Italy(Fondazione Telethon); Associazione Italiana Sindromi Atassiche; Associazione E.E. Rulfo per la Genetica Medica, PRIN; GIS - Institut des Maladies Rares; Agence Nationale de la Recherche (SPATAX-Quest project)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); program "Investissements d'Avenir"(French National Research Agency (ANR)); Verum Foundation; Fondation Roger de Spoelberch	We are grateful to all family members who contributed to this study and to Fanny Mochel and Foudil Lamari for helpful discussions. We thank C. Castagnoli (Citta della Salute e della Scienza, Torino) and G. Matullo (Hugef Foundation, Torino) for providing control cell lines and R. Sitia (Ospedale San Raffaele - Milano) for providing anti-calreticulum, anti-ERGIC-53/p58, and anti-GM130 antibodies. The Galliera Genetic Bank of the Telethon Network of Genetic Biobanks (project GTB12001), funded by Telethon Italy, provided us with specimens. This work was funded by the Associazione Italiana Sindromi Atassiche, the Associazione E.E. Rulfo per la Genetica Medica, PRIN 2010_2011. project 20108WT59Y (to A. Brusco), the GIS - Institut des Maladies Rares (A10021DS to G.S.), the Agence Nationale de la Recherche (SPATAX-Quest project to G.S.), the European Commission Seventh Framework Programme (E12009DD [Neuromics] and E04006DD [EUROSCA] to A. Brice), the program "Investissements d'Avenir" ANR-10-IAIHU-06 (to the Institut du Cerveau et de la Moelle Epiniere), the Verum Foundation (to A. Brice and G.S.), and the Fondation Roger de Spoelberch (R12123DD to A. Brice). We thank Jay D. Horton (South Western University, Dallas) for comments and critical discussion of the manuscript.	Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Barabas P, 2013, P NATL ACAD SCI USA, V110, P5181, DOI 10.1073/pnas.1214707110; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Cadieux-Dion M, 2014, JAMA NEUROL, V71, P470, DOI 10.1001/jamaneurol.2013.6337; Cermenati G, 2012, J LIPID RES, V53, P300, DOI 10.1194/jlr.M021188; Craig K, 2004, ANN NEUROL, V55, P752, DOI 10.1002/ana.20110; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Hammer MB, 2013, EUR J NEUROL, V20, P486, DOI 10.1111/j.1468-1331.2012.03883.x; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Ito M, 2002, BIOCHEM J, V361, P473, DOI 10.1042/0264-6021:3610473; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; La Spada A, 2010, HUM MOL GENET, V19, pR1, DOI 10.1093/hmg/ddq193; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Logan S, 2013, P NATL ACAD SCI USA, V110, P5446, DOI 10.1073/pnas.1217251110; Manto M, 2009, CEREBELLUM, V8, P417, DOI 10.1007/s12311-009-0142-4; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Matilla-Duenas A, 2014, CEREBELLUM, V13, P269, DOI 10.1007/s12311-013-0539-y; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; van de Warrenburg BPC, 2002, NEUROLOGY, V58, P702, DOI 10.1212/WNL.58.5.702; van Gaalen J, 2011, MOVEMENT DISORD, V26, P792, DOI 10.1002/mds.23584	34	65	66	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					209	217		10.1016/j.ajhg.2014.07.001	http://dx.doi.org/10.1016/j.ajhg.2014.07.001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25065913	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000340076000007
J	Bogershausen, N; Shahrzad, N; Chong, JX; von Kleist-Retzow, JC; Stanga, D; Li, Y; Bernier, FP; Loucks, CM; Wirth, R; Puffenberger, EG; Hegele, RA; Schreml, J; Loucks, CM; Wirth, R; Puffenberger, EG; Hegele, RA; Schreml, J; Lapointe, G; Keupp, K; Brett, CL; Anderson, R; Hahn, A; Innes, AM; Suchowersky, O; Mets, MB; Nurnberg, G; McLeod, DR; Thiele, H; Waggoner, D; Altmuller, J; Boycott, KM; Schoser, B; Nurnberg, P; Ober, C; Heller, R; Parboosingh, JS; Wollnik, B; Sacher, M; Lamont, RE				Boegershausen, Nina; Shahrzad, Nassim.; Chong, Jessica X.; von Kleist-Retzow, Juergen-Christoph; Stanga, Daniela; Li, Yun; Bernier, Francois P.; Loucks, Catrina M.; Wirth, Radu; Puffenberger, Eric G.; Hegele, Robert A.; Schreml, Julia; Loucks, Catrina M.; Wirth, Radu; Puffenberger, Eric G.; Hegele, Robert A.; Schreml, Julia; Lapointe, Gabriel; Keupp, Katharina; Brett, Christopher L.; Anderson, Rebecca; Hahn, Andreas; Innes, A. Micheil; Suchowersky, Oksana; Mets, Marilyn B.; Nuernberg, Gudrun; McLeod, D. Ross; Thiele, Holger; Waggoner, Darrel; Altmueller, Janine; Boycott, Kym M.; Schoser, Benedikt; Nuernberg, Peter; Ober, Carole; Heller, Raoul; Parboosingh, Jillian S.; Wollnik, Bernd; Sacher, Michael; Lamont, Ryan E.			Recessive TRAPPC11 Mutations Cause a Disease Spectrum of Limb Girdle Muscular Dystrophy and Myopathy with Movement Disorder and Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUTTERITE POPULATION; IDENTIFICATION; COMPLEX; GOLGI; COMPONENTS; TRANSPORT; MUTANTS; PROGRAM; HISTORY; PROTEIN	Myopathies are a clinically and etiologically heterogeneous group of disorders that can range from limb girdle muscular dystrophy (LGMD) to syndromic forms with associated features including intellectual disability. Here, we report the identification of mutations in transport protein particle complex 11 (TRAPPC11) in three individuals of a consanguineous Syrian family presenting with LGMD and in five individuals of Hutterite descent presenting with myopathy, infantile hyperkinetic movements, ataxia, and intellectual disability. By using a combination of whole-exome or genome sequencing with homozygosity mapping, we identified the homozygous c.2938G>A (p.Gly980Arg) missense mutation within the gryzun domain of TRAPPC11 in the Syrian LGMD family and the homozygous c.1287+5G>A splice-site mutation resulting in a 58 amino acid in-frame deletion (p.Ala372_Ser429del) in the foie gras domain of TRAPPC11 in the Hutterite families. TRAPPC11 encodes a component of the multiprotein TRAPP complex involved in membrane trafficking. We demonstrate that both mutations impair the binding ability of TRAPPC11 to other TRAPP complex components and disrupt the Golgi apparatus architecture. Marker trafficking experiments for the p.Ala372_Ser429del deletion indicated normal ER-to-Golgi trafficking but dramatically delayed exit from the Golgi to the cell surface. Moreover, we observed alterations of the lysosomal membrane glycoproteins lysosome-associated membrane protein 1 (LAMP1) and LAMP2 as a consequence of TRAPPC11 dysfunction supporting a defect in the transport of secretory proteins as the underlying pathomechanism.	[Boegershausen, Nina; Li, Yun; Wirth, Radu; Schreml, Julia; Keupp, Katharina; Heller, Raoul; Wollnik, Bernd] Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Boegershausen, Nina; Li, Yun; Schreml, Julia; Keupp, Katharina; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, CMMC, D-50931 Cologne, Germany; Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Shahrzad, Nassim.; Stanga, Daniela; Lapointe, Gabriel; Brett, Christopher L.; Sacher, Michael] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada; [Chong, Jessica X.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [von Kleist-Retzow, Juergen-Christoph] Univ Hosp Cologne, Dept Pediat, D-50931 Cologne, Germany; [Loucks, Catrina M.; Innes, A. Micheil; McLeod, D. Ross; Parboosingh, Jillian S.; Lamont, Ryan E.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada; [Puffenberger, Eric G.] Clin Special Children, Strasburg, PA 17579 USA; [Hegele, Robert A.] Univ Western Ontario, London, ON N6G 2V4, Canada; [Hegele, Robert A.] Robarts Res Inst, London, ON N6G 2V4, Canada; [Bernier, Francois P.; Innes, A. Micheil; Parboosingh, Jillian S.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada; [Hahn, Andreas] Univ Hosp Giessen, Dept Child Neurol, D-35392 Giessen, Germany; [Suchowersky, Oksana] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2B7, Canada; [Suchowersky, Oksana] Univ Alberta, Dept Psychiat, Edmonton, AB T6G 2B7, Canada; [Mets, Marilyn B.] Northwestern Univ, Lurie Childrens Hosp Chicago, Dept Ophthalmol, Chicago, IL 60611 USA; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Gen, D-50931 Cologne, Germany; [Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON K1H 8L1, Canada; [Schoser, Benedikt] Univ Munich, Friedrich Bauer Inst, D-80336 Munich, Germany; [Ober, Carole] Univ Chicago, Dept Obstet, Chicago, IL 60637 USA; [Sacher, Michael] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	University of Cologne; University of Cologne; University of Cologne; Concordia University - Canada; University of Chicago; University of Cologne; University of Calgary; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Calgary; University Hospital of Giessen & Marburg; University of Alberta; University of Alberta; University of Alberta; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; University of Cologne; University of Ottawa; Children's Hospital of Eastern Ontario; University of Munich; University of Chicago; McGill University	Wollnik, B (corresponding author), Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de; michael.sacher@concordia.ca	Bernier, Francois/V-7150-2018; Bernier, Francois/AAP-2174-2020; Wollnik, Bernd/GRY-6062-2022; Hegele, Robert/G-3301-2011; Thiele, Holger/ABE-6792-2020; Hegele, Robert/AAF-6482-2020; innes, allan micheil/A-9955-2017; Schoser, Benedikt/AAH-6286-2020; Chong, Jessica/GZH-1625-2022	Wollnik, Bernd/0000-0003-2589-0364; Thiele, Holger/0000-0002-0169-998X; Hegele, Robert/0000-0003-2861-5325; Altmuller, Janine/0000-0003-4372-1521; Loucks, Catrina/0000-0003-1167-3721; Bogershausen, Nina/0000-0003-4300-8224; Puffenberger, Erik/0000-0002-6388-9148; Chong, Jessica/0000-0002-1616-2448; Innes, Micheil/0000-0001-9881-5467; Bernier, Francois/0000-0001-7063-4269; Schoser, Benedikt/0000-0002-2757-8131; Ober, Carole/0000-0003-4626-9809	German Federal Ministry of Education and Research (BMBF) [01GM1211A]; Canadian Institutes of Health Research; Natural Sciences and Engineering Council of Canada; March of Dimes Foundation [5-FY09-529]; National Institutes of Health [R01HD21244, R01HL085197]; Alberta Children's Hospital Foundation; Canadian Institutes of Health Research, Institute of Genetics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Children's Hospital Foundation; Canadian Institutes of Health Research, Institute of Genetics(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to all family members that participated in this study and to Karin Boss and Bob Argiropolous for critically reading the manuscript, Leo Dimnik for assistance with NGS data, and Kelley Moremon for the manII antibody. This work was supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM1211A (E-RARE network CRANIRARE-2) to B.W., by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Council of Canada to M.S., research grant #5-FY09-529 from the March of Dimes Foundation to K.M.B., and the National Institutes of Health grants R01HD21244 and R01HL085197 to C.O. R.E.L. was supported by a Remax clinical fellowship from the Alberta Children's Hospital Foundation and K.M.B. is supported by a Clinical Investigatorship Award from the Canadian Institutes of Health Research, Institute of Genetics. M.S. is a member of the Groupe de Recherche Axe sur la Structure des Proteines (GRASP) network.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; American Association on Intellectual and Developmental Disabilities, 2010, INTELLECTUAL DISABIL, V11th.; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; BERGMANN JE, 1983, J CELL BIOL, V97, P1777, DOI 10.1083/jcb.97.6.1777; Boucek D, 2011, GENET MED, V13, P563, DOI 10.1097/GIM.0b013e31820ad795; Boycott KM, 2008, AM J MED GENET A, V146A, P1088, DOI 10.1002/ajmg.a.32245; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Frosk P, 2005, HUM MUTAT, V25, P38, DOI 10.1002/humu.20110; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gross JM, 2005, GENETICS, V170, P245, DOI 10.1534/genetics.104.039727; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOSTETLER JA, 1985, AM J MED GENET, V22, P453, DOI 10.1002/ajmg.1320220303; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Moreau D, 2011, DEV CELL, V21, P231, DOI 10.1016/j.devcel.2011.06.014; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pegoraro E, 1993, GENEREVIEWS; Prall FR, 2006, OPHTHALMOLOGY, V113, P1010, DOI 10.1016/j.ophtha.2006.02.030; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rosales XQ, 2012, PEDIATR NEUROL, V46, P13, DOI 10.1016/j.pediatrneurol.2011.08.014; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	39	65	68	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					181	190		10.1016/j.ajhg.2013.05.028	http://dx.doi.org/10.1016/j.ajhg.2013.05.028			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23830518	Bronze, Green Published			2022-12-18	WOS:000321804500019
J	Beetz, C; Pieber, TR; Hertel, N; Schabhuttl, M; Fischer, C; Trajanoski, S; Graf, E; Keiner, S; Kurth, I; Wieland, T; Varga, RE; Timmerman, V; Reilly, MM; Strom, TM; Auer-Grumbach, M				Beetz, Christian; Pieber, Thomas R.; Hertel, Nicole; Schabhuettl, Maria; Fischer, Carina; Trajanoski, Slave; Graf, Elisabeth; Keiner, Silke; Kurth, Ingo; Wieland, Thomas; Varga, Rita-Eva; Timmerman, Vincent; Reilly, Mary M.; Strom, Tim M.; Auer-Grumbach, Michaela			Exome Sequencing Identifies a REEP1 Mutation Involved in Distal Hereditary Motor Neuropathy Type V	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBULAR ENDOPLASMIC-RETICULUM; SPASTIC PARAPLEGIA TYPE-31; HMN TYPE-V; SILVER-SYNDROME; MESSENGER-RNA; EXPRESSION; PHENOTYPE; CHILDREN; SPECTRUM; DISEASE	The distal hereditary motor neuropathies (dHMNs) are a heterogeneous group of neurodegenerative disorders affecting the lower motoneuron. In a family with both autosomal-dominant dHMN and dHMN type V (dHMN/dHMN-V) present in three generations, we excluded mutations in all genes known to be associated with a dHMN phenotype through Sanger sequencing and defined three potential loci through linkage analysis. Whole-exome sequencing of two affected individuals revealed a single candidate variant within the linking regions, i.e., a splice-site alteration in REEP1 (c.304-2A>G). A minigene assay confirmed complete loss of splice-acceptor functionality and skipping of the in-frame exon 5. The resulting mRNA is predicted to be expressed at normal levels and to encode an internally shortened protein (p.102_139del). Loss-of-function REEP1 mutations have previously been identified in dominant hereditary spastic paraplegia (HSP), a disease associated with upper-motoneuron pathology. Consistent with our clinical-genetic data, we show that REEP1 is strongly expressed in the lower motoneurons as well. Upon exogeneous overexpression in cell lines we observe a subcellular localization defect for p.102_139del that differs from that observed for the known HSP-associated missense mutation c.59C>A (p.Ala20Glu). Moreover, we show that p.102_139del, but not p.Ala20Glu, recruits atlastin-1, i.e., one of the REEP1 binding partners, to the altered sites of localization. These data corroborate the loss-of-function nature of REEP1 mutations in HSP and suggest that a different mechanism applies in REEP1-associated dHMN.	[Pieber, Thomas R.; Schabhuettl, Maria; Auer-Grumbach, Michaela] Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, A-8036 Graz, Austria; [Beetz, Christian; Varga, Rita-Eva] Jena Univ Hosp, Dept Clin Chem & Lab Med, D-07747 Jena, Germany; [Hertel, Nicole] Jena Univ Hosp, Inst Anat 1, D-07740 Jena, Germany; [Fischer, Carina; Trajanoski, Slave] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Graf, Elisabeth; Wieland, Thomas; Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Keiner, Silke] Jena Univ Hosp, Hans Berger Clin Neurol, D-07747 Jena, Germany; [Kurth, Ingo] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; [Reilly, Mary M.] UCL, Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	Medical University of Graz; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Medical University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of London; University College London; Technical University of Munich	Auer-Grumbach, M (corresponding author), Med Univ Graz, Div Endocrinol & Metab, Dept Internal Med, A-8036 Graz, Austria.	michaela.auergrumbach@medunigraz.at	Keiner, Silke/A-5405-2018; Timmerman, Vincent/O-7283-2019	Timmerman, Vincent/0000-0002-2162-0933; Beetz, Christian/0000-0001-7061-2895; Pieber, Thomas/0000-0003-3554-0405; Reilly, Mary/0000-0003-0686-905X; Kurth, Ingo/0000-0002-5642-8378	Austrian Science Fund (FWF) [P23223-B19]; German Research Foundation (DFG) [BE 4069-1/1, DE 307/8-1]; Tom Wahlig Foundation; MRC [G0601943] Funding Source: UKRI; Austrian Science Fund (FWF) [P 23223] Funding Source: researchfish; Medical Research Council [G0601943] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Tom Wahlig Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the family members for their participation in this study. This work was supported by the Austrian Science Fund (FWF, P23223-B19), the German Research Foundation (DFG) (BE 4069-1/1, DE 307/8-1), and the Tom Wahlig Foundation.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Auer-Grumbach M, 2005, ANN NEUROL, V57, P415, DOI 10.1002/ana.20410; Battini R, 2011, EUR J NEUROL, V18, P150, DOI 10.1111/j.1468-1331.2010.03102.x; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; de Bot ST, 2010, NEUROLOGY, V75, pE75, DOI 10.1212/WNL.0b013e3181fc2776; Dierick I, 2008, BRAIN, V131, P1217, DOI 10.1093/brain/awn029; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Harding AE, 1993, PERIPHERAL NEUROPATH, P1051; Hertel N, 2011, CEREB CORTEX, V21, P1105, DOI 10.1093/cercor/bhq183; Hewamadduma C, 2009, NEUROGENETICS, V10, P105, DOI 10.1007/s10048-008-0163-z; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Irobi J, 2004, BRAIN, V127, P2124, DOI 10.1093/brain/awh232; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Liu SG, 2009, SYNAPSE, V63, P201, DOI 10.1002/syn.20602; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Reid E, 2003, LANCET NEUROL, V2, P210, DOI 10.1016/S1474-4422(03)00345-4; Rohkamm B, 2007, J NEUROL SCI, V263, P100, DOI 10.1016/j.jns.2007.06.047; Rossor AM, 2012, J NEUROL NEUROSUR PS, V83, P6, DOI 10.1136/jnnp-2011-300952; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Schlang KJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-71; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Timmerman V., 2012, EXP NEUROL IN PRESS; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	30	65	71	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					139	145		10.1016/j.ajhg.2012.05.007	http://dx.doi.org/10.1016/j.ajhg.2012.05.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22703882	Green Published, hybrid			2022-12-18	WOS:000306445000011
J	Kurreeman, FAS; Stahl, EA; Okada, Y; Liao, K; Diogo, D; Raychaudhuri, S; Freudenberg, J; Kochi, Y; Patsopoulos, NA; Gupta, N; Sandor, C; Bang, SY; Lee, HS; Padyukov, L; Suzuki, A; Siminovitch, K; Worthington, J; Gregersen, PK; Hughes, LB; Reynolds, RJ; Bridges, SL; Bae, SC; Yamamoto, K; Plenge, RM				Kurreeman, Fina A. S.; Stahl, Eli A.; Okada, Yukinori; Liao, Katherine; Diogo, Dorothee; Raychaudhuri, Soumya; Freudenberg, Jan; Kochi, Yuta; Patsopoulos, Nikolaos A.; Gupta, Namrata; Sandor, Cynthia; Bang, So-Young; Lee, Hye-Soon; Padyukov, Leonid; Suzuki, Akari; Siminovitch, Kathy; Worthington, Jane; Gregersen, Peter K.; Hughes, Laura B.; Reynolds, Richard J.; Bridges, S. Louis, Jr.; Bae, Sang-Cheol; Yamamoto, Kazuhiko; Plenge, Robert M.		CLEAR Investigators	Use of a Multiethnic Approach to Identify Rheumatoid-Arthritis-Susceptibility Loci, 1p36 and 17q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LARGE-SCALE; RISK LOCI; METAANALYSIS; VARIANTS; DISEASE; IMPUTATION; AIOLOS	We have previously shown that rheumatoid arthritis (RA) risk alleles overlap between different ethnic groups. Here, we utilize a multiethnic approach to show that we can effectively discover RA risk alleles. Thirteen putatively associated SNPs that had not yet exceeded genome-wide significance (p < 5 x 10(-8)) in our previous RA genome-wide association study (GWAS) were analyzed in independent sample sets consisting of 4,366 cases and 17,765 controls of European, African American, and East Asian ancestry. Additionally, we conducted an overall association test across all 65,833 samples (a GWAS meta-analysis plus the replication samples). Of the 13 SNPs investigated, four were significantly below the study-wide Bonferroni corrected p value threshold (p < 0.0038) in the replication samples. Two SNPs (rs3890745 at the 1p36 locus [p = 2.3 x 10(-12)] and rs2872507 at the 17q12 locus [p = 1.7 x 10(-9)] surpassed genome-wide significance in all 16,659 RA cases and 49,174 controls combined. We used available GWAS data to fine map these two loci in Europeans and East Asians, and we found that the same allele conferred risk in both ethnic groups. A series of bioinformatic analyses identified TNERSF14-MMEL1 at the 1p36 locus and IKZE3-ORMDL3-GSDMB at the 17q12 locus as the genes most likely associated with RA. These findings demonstrate empirically that a multiethnic approach is an effective strategy for discovering RA risk loci, and they suggest that combining GWASs across ethnic groups represents an efficient strategy for gaining statistical power.	[Kurreeman, Fina A. S.; Stahl, Eli A.; Liao, Katherine; Diogo, Dorothee; Raychaudhuri, Soumya; Sandor, Cynthia; Plenge, Robert M.] Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kurreeman, Fina A. S.; Stahl, Eli A.; Liao, Katherine; Diogo, Dorothee; Raychaudhuri, Soumya; Patsopoulos, Nikolaos A.; Sandor, Cynthia; Plenge, Robert M.] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.] Harvard Univ, Sch Med, Div Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kurreeman, Fina A. S.; Stahl, Eli A.; Diogo, Dorothee; Raychaudhuri, Soumya; Patsopoulos, Nikolaos A.; Gupta, Namrata; Sandor, Cynthia; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kurreeman, Fina A. S.] Leiden Univ, Dept Rheumatol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Okada, Yukinori; Kochi, Yuta; Suzuki, Akari; Yamamoto, Kazuhiko] RIKEN, Lab Autoimmune Dis & Stat genet, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Okada, Yukinori; Kochi, Yuta; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Freudenberg, Jan; Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY USA; [Freudenberg, Jan; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA; [Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Padyukov, Leonid] Karolinska Inst, Rheumatol Unit, Dept Med, S-17176 Stockholm, Sweden; [Siminovitch, Kathy] Univ Toronto, Dept Med Immunol Mol Genet, Toronto, ON, Canada; [Siminovitch, Kathy] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Siminovitch, Kathy] Toronto Gen Res Inst, Toronto, ON, Canada; [Worthington, Jane] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Hughes, Laura B.; Reynolds, Richard J.; Bridges, S. Louis, Jr.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; RIKEN; University of Tokyo; Northwell Health; Northwell Health; Hanyang University; Karolinska Institutet; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Manchester; University of Alabama System; University of Alabama Birmingham	Plenge, RM (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp, Boston, MA 02115 USA.	rplenge@partners.org	Suzuki, Akari/N-5389-2015; Worthington, Jane/M-9770-2014; Siminovitch, Katherine/K-1475-2013; Bae, Sang-Cheol/P-2051-2015; Kochi, Yuta/P-4487-2018; Yamamoto, Kazuhiko/N-5096-2015; Padyukov, Leonid/A-4890-2009	Worthington, Jane/0000-0003-0544-042X; Padyukov, Leonid/0000-0003-2950-5670; Bae, Sang-Cheol/0000-0003-4658-1093; DIOGO, DOROTHEE/0000-0003-2913-5913; Patsopoulos, Nikolaos/0000-0003-3757-8941; Raychaudhuri, Soumya/0000-0002-1901-8265	European Community [PIOF-GA-2009-237280]; National Institutes of Health [R01-AR057108, R01-AR056768, U01-GM092691]; Burroughs Wellcome Fund; Ministry for Health and Welfare, Republic of Korea [A111218-11-GM01, A102065]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048095, R01AR057202, K01AR060848, R01AR057108, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER	European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	F.K. was supported by the European Community's FP7 Marie Curie grant (Grant Agreement number PIOF-GA-2009-237280). R.M.P. was supported by grants from the National Institutes of Health (R01-AR057108, R01-AR056768, and U01-GM092691) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. S.Y.B., H.S.L., and S.C.B. were supported by the Korea Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A111218-11-GM01, A102065).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Hughes LB, 2010, ARTHRITIS RHEUM-US, V62, P3547, DOI 10.1002/art.27732; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Schmitt C, 2002, APOPTOSIS, V7, P277, DOI 10.1023/A:1015372322419; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	35	65	66	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 9	2012	90	3					524	532		10.1016/j.ajhg.2012.01.010	http://dx.doi.org/10.1016/j.ajhg.2012.01.010			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911ZI	22365150	Green Published, Bronze			2022-12-18	WOS:000301762800019
J	Mayr, JA; Freisinger, P; Schlachter, K; Rolinski, B; Zimmermann, FA; Scheffner, T; Haack, TB; Koch, J; Ahting, U; Prokisch, H; Sperl, W				Mayr, Johannes A.; Freisinger, Peter; Schlachter, Kurt; Rolinski, Boris; Zimmermann, Franz A.; Scheffner, Thomas; Haack, Tobias B.; Koch, Johannes; Ahting, Uwe; Prokisch, Holger; Sperl, Wolfgang			Thiamine Pyrophosphokinase Deficiency in Encephalopathic Children with Defects in the Pyruvate Oxidation Pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASAL GANGLIA DISEASE; WERNICKE ENCEPHALOPATHY; MUTATIONS; CARRIER; BIOTIN	Thiamine pyrophosphate (TPP) is an essential cofactor of the cytosolic transketolase and of three mitochondrial enzymes involved in the oxidative decarboxylation of either pyruvate, alpha-ketoglutarate or branched chain amino acids. Thiamine is taken up by specific transporters into the cell and converted to the active TPP by thiamine pyrophosphokinase (TPK) in the cytosol from where it can be transported into mitochondria. Here, we report five individuals from three families presenting with variable degrees of ataxia, psychomotor retardation, progressive dystonia, and lactic acidosis. Investigation of the mitochondrial energy metabolism showed reduced oxidation of pyruvate but normal pyruvate dehydrogenase complex activity in the presence of excess TPP. A reduced concentration of TPP was found in the muscle and blood. Mutation analysis of TPK1 uncovered three missense, one splice-site, and one frameshift mutation resulting in decreased TPK protein levels.	[Mayr, Johannes A.; Zimmermann, Franz A.; Koch, Johannes; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Freisinger, Peter; Scheffner, Thomas] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Schlachter, Kurt] LKH Bregenz, Dept Pediat, A-6900 Bregenz, Austria; [Rolinski, Boris; Ahting, Uwe] Med Stadt Klinikum Munchen GmbH, Dept Klin Chem, D-80804 Munich, Germany; [Haack, Tobias B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Prokisch, Holger] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany	Paracelsus Private Medical University; Munchen Klinik; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.	h.mayr@salk.at	Prokisch, Holger/N-8964-2013	Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286	Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg; Jubilaumsfonds of the Oesterreichische Nationalbank [12568]; Helmholtz Association of the Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]; Bundesministerium fur Bildung und Forschung (BMBF) [mitoNET 01GM0867, SysMBo 0315494A]	Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg; Jubilaumsfonds of the Oesterreichische Nationalbank; Helmholtz Association of the Helmholtz Alliance for Mental Health in an Ageing Society; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Supported by the Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg (JAM, F.A.Z., J.K., and W.S.), the Jubilaumsfonds of the Oesterreichische Nationalbank (12568 to W.S.), by the Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215 to H.P.), by the Bundesministerium fur Bildung und Forschung (BMBF) funded German Network for Mitochondrial Disorders (mitoNET 01GM0867 to H.P., RE, B.R. and U.A.) and Systems Biology of Metabotypes (SysMBo 0315494A to H.P.).	Aasheim ET, 2008, ANN SURG, V248, P714, DOI 10.1097/SLA.0b013e3181884308; DEVATHASAN G, 1982, LANCET, V2, P1108; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Kril JJ, 1996, METAB BRAIN DIS, V11, P9, DOI 10.1007/BF02080928; Labay V, 1999, NAT GENET, V22, P300, DOI 10.1038/10372; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Ogershok PR, 2002, AM J MED SCI, V323, P107, DOI 10.1097/00000441-200202000-00010; Ozand PT, 1998, BRAIN, V121, P1267, DOI 10.1093/brain/121.7.1267; Rao SN, 2010, J TROP PEDIATRICS, V56, P284, DOI 10.1093/tropej/fmp108; Rosenberg MJ, 2002, NAT GENET, V32, P175, DOI 10.1038/ng948; Saad Laura, 2010, J Med Case Rep, V4, P217, DOI 10.1186/1752-1947-4-217; Santini S, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-33; Sica Domenic A, 2007, Congest Heart Fail, V13, P244, DOI 10.1111/j.1527-5299.2007.06260.x; Spiegel R, 2009, ANN NEUROL, V66, P419, DOI 10.1002/ana.21752; Strassburg HM, 2006, NEUROPEDIATRICS, V37, P137, DOI 10.1055/s-2006-924555; Subramanian VS, 2006, AM J PHYSIOL-CELL PH, V291, pC851, DOI 10.1152/ajpcell.00105.2006; Uruha A, 2011, CASE REP MED, V2011, DOI 10.1155/2011/156104; Zeng WQ, 2005, AM J HUM GENET, V77, P16, DOI 10.1086/431216; Zhao RB, 2001, J BIOL CHEM, V276, P1114, DOI 10.1074/jbc.M007919200	24	65	70	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 9	2011	89	6					806	812		10.1016/j.ajhg.2011.11.007	http://dx.doi.org/10.1016/j.ajhg.2011.11.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	864AF	22152682	Green Published, Bronze			2022-12-18	WOS:000298208700013
J	Zangen, D; Kaufman, Y; Zeligson, S; Perlberg, S; Fridman, H; Kanaan, M; Abdulhadi-Atwan, M; Abu Libdeh, A; Gussow, A; Kisslov, I; Carmel, L; Renbaum, P; Levy-Lahad, E				Zangen, David; Kaufman, Yotam; Zeligson, Sharon; Perlberg, Shira; Fridman, Hila; Kanaan, Moein; Abdulhadi-Atwan, Maha; Abu Libdeh, Abdulsalam; Gussow, Ayal; Kisslov, Irit; Carmel, Liran; Renbaum, Paul; Levy-Lahad, Ephrat			XX Ovarian Dysgenesis Is Caused by a PSMC3IP/HOP2 Mutation that Abolishes Coactivation of Estrogen-Driven Transcription	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; FETAL PLASMA; FSH RECEPTOR; HOP2 PROTEIN; HEARING-LOSS; BRCA1; MEIOSIS; SPERMATOGENESIS; PATHWAYS; DOMAINS	XX female gonadal dysgenesis (XX-GD) is a rare, genetically heterogeneous disorder characterized by lack of spontaneous pubertal development, primary amenorrhea, uterine hypoplasia, and hypergonadotropic hypogonadism as a result of streak gonads. Most cases are unexplained but thought to be autosomal recessive. We elucidated the genetic basis of XX-GD in a highly consanguineous Palestinian family by using homozygosity mapping and candidate-gene and whole-exome sequencing. Affected females were homozygous for a 3 bp deletion (NM_016556.2, c.600_602del) in the PSMC3IP gene, leading to deletion of a glutamic acid residue (p.Glu201del) in the highly conserved C-terminal acidic domain. Proteasome 26S subunit, ATPase, 3-Interacting Protein (PSMC3IP)/Tat Binding Protein Interacting Protein (TBPIP) is a nuclear, tissue-specific protein with multiple functions. It is critical for meiotic recombination as indicated by the known role of its yeast ortholog, Hop2. Through the C terminus (not present in yeast), PSMC3IP also coactivates ligand-driven transcription mediated by estrogen, androgen, glucocorticoid, progesterone, and thyroid nuclear receptors. In cell lines, the p.Glu201del mutation abolished PSMC3IP activation of estrogen-driven transcription. Impaired estrogenic signaling can lead to ovarian dysgenesis both by affecting the size of the follicular pool created during fetal development and by failing to counteract follicular atresia during puberty. PSMC3IP joins previous genes known to be mutated in XX-GD, the FSH receptor, and BMP15, highlighting the importance of hormonal signaling in ovarian development and maintenance and suggesting a common pathway perturbed in isolated XX-GD. By analogy to other XX-GD genes, PSMC3IP is also a candidate gene for premature ovarian failure, and its role in folliculogenesis should be further investigated.	[Zangen, David; Abdulhadi-Atwan, Maha; Abu Libdeh, Abdulsalam] Hadassah Hebrew Univ, Sch Med, Div Pediat Endocrinol, IL-91120 Jerusalem, Israel; [Kaufman, Yotam; Fridman, Hila; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, IL-91120 Jerusalem, Israel; [Kaufman, Yotam; Zeligson, Sharon; Perlberg, Shira; Fridman, Hila; Kisslov, Irit; Renbaum, Paul; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Kanaan, Moein] Bethlehem Univ, Hereditary Res Lab, Bethlehem 92248, Palestine; [Gussow, Ayal; Kisslov, Irit; Carmel, Liran] Hebrew Univ Jerusalem, Fac Sci, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem	Zangen, D (corresponding author), Hadassah Hebrew Univ, Sch Med, Div Pediat Endocrinol, IL-91120 Jerusalem, Israel.	zangend@hadassah.org.il; lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Abu-Libdeh, Abdulsalam/0000-0003-1160-3547; Fridman, Hila/0000-0002-1084-4800	Israel Science Foundation [1531/2009]; Chief Scientist Office of the Ministry of Health, Israel [3-00000-6245]; European Union [PIRG05-GA-2009-248639]	Israel Science Foundation(Israel Science Foundation); Chief Scientist Office of the Ministry of Health, Israel; European Union(European Commission)	This study was supported by the Legacy Heritage Biomedical Program of the Israel Science Foundation (grant 1531/2009 to D.Z.), the Chief Scientist Office of the Ministry of Health, Israel (grant 3-00000-6245 to E.L.L) and a European Union Marie Curie International Reintegration grant (PIRG05-GA-2009-248639 to L.C.). We thank Mira Korner (The Center for Genomic Technologies, The Alexander Silberman Institute of Life Sciences, Hebrew University, Jerusalem Israel) for performing massively parallel sequencing, Alberto Gabizon (Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel) for the kind gift of the IGROV1 cell line, Mary-Claire King and Sarah Pierce (Department of Genome Sciences, University of Washington, Seattle, WA), and Martin Kupiec (Department of Molecular Biology and Biotechnology, Tel Aviv University, Tel Aviv, Israel) for helpful discussions.	AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Albrecht ED, 2010, INT J DEV BIOL, V54, P397, DOI 10.1387/ijdb.082758ea; Amir El-Ad David, 2010, Hum Genomics, V4, P394; BENARD J, 1985, CANCER RES, V45, P4970; Biason-Lauber A, 2010, BEST PRACT RES CL EN, V24, P163, DOI 10.1016/j.beem.2009.12.002; Chen Y, 2009, J ENDOCRINOL, V202, P407, DOI 10.1677/JOE-09-0109; d'Estaing SG, 2005, FERTIL STERIL, V84, P785, DOI 10.1016/j.fertnstert.2005.02.037; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fowler PA, 2011, J CLIN ENDOCR METAB, V96, P1754, DOI 10.1210/jc.2010-2618; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hughes IA, 2008, BEST PRACT RES CL EN, V22, P119, DOI 10.1016/j.beem.2007.11.001; Ijichi H, 2000, GENE, V248, P99, DOI 10.1016/S0378-1119(00)00141-4; Jackson KA, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-15; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Pepe GJ, 2002, BIOL REPROD, V66, P1054, DOI 10.1095/biolreprod66.4.1054; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Rolland AD, 2011, BIOL REPROD, V84, P790, DOI 10.1095/biolreprod.110.088443; ROMMENS JM, 1995, GENOMICS, V28, P530, DOI 10.1006/geno.1995.1185; Sanders MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-41; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SHUTT DA, 1974, J ENDOCRINOL, V60, P333, DOI 10.1677/joe.0.0600333; SMITH ID, 1975, J STEROID BIOCHEM, V6, P657, DOI 10.1016/0022-4731(75)90048-5; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Tapanainen JS, 1997, NAT GENET, V15, P205, DOI 10.1038/ng0297-205; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Zachos NC, 2002, BIOL REPROD, V67, P1148, DOI 10.1095/biolreprod67.4.1148	42	65	68	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					572	579		10.1016/j.ajhg.2011.09.006	http://dx.doi.org/10.1016/j.ajhg.2011.09.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21963259	Green Published, Bronze			2022-12-18	WOS:000295951300011
J	Cario, H; Smith, DEC; Blom, H; Blau, N; Bode, H; Holzmann, K; Pannicke, U; Hopfner, KP; Rump, EM; Ayric, Z; Kohne, E; Debatin, KM; Smulders, Y; Schwarz, K				Cario, Holger; Smith, Desiree E. C.; Blom, Henk; Blau, Nenad; Bode, Harald; Holzmann, Karlheinz; Pannicke, Ulrich; Hopfner, Karl-Peter; Rump, Eva-Maria; Ayric, Zuleya; Kohne, Elisabeth; Debatin, Klaus-Michael; Smulders, Yvo; Schwarz, Klaus			Dihydrofolate Reductase Deficiency Due to a Homozygous DHFR Mutation Causes Megaloblastic Anemia and Cerebral Folate Deficiency Leading to Severe Neurologic Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TANDEM MASS-SPECTROMETRY; VITAMER DISTRIBUTION; HEALTHY-SUBJECTS; METABOLISM; ACID; GENE	The importance of intracellular folate metabolism is illustrated by the severity of symptoms and complications caused by inborn disorders of folate metabolism or by folate deficiency. We examined three children of healthy, distantly related parents presenting with megaloblastic anemia and cerebral folate deficiency causing neurologic disease with atypical childhood absence epilepsy. Genome-wide homozygosity mapping revealed a candidate region on chromosome 5 including the dihydrofolate reductase (DHFR) locus. DHFR sequencing revealed a homozygous DHFR mutation, c.458A>T (p.Asp153Val), in all siblings. The patients' folate profile in red blood cells (RBC), plasma, and cerebrospinal fluid (CSF), analyzed by liquid chromatography tandem mass spectrometry, was compatible with DHFR deficiency. DHFR activity and fluorescein-labeled methotrexate (FMTX) binding were severely reduced in EBV-immortalized lymphoblastoid cells of all patients. Heterozygous cells displayed intermediate DHFR activity and FMTX binding. RT-PCR of DHFR mRNA revealed no differences between wild-type and DHFR mutation-carrying cells, whereas protein expression was reduced in cells with the DHFR mutation. Treatment with folinic acid resulted in the resolution of hematological abnormalities, normalization of CSF folate levels, and improvement of neurological symptoms. In conclusion, the homozygous DHFR mutation p.Asp153Val causes DHFR deficiency and leads to a complex hematological and neurological disease that can be successfully treated with folinic acid. DHFR is necessary for maintaining sufficient CSF and RBC folate levels, even in the presence of adequate nutritional folate supply and normal plasma folate.	[Cario, Holger; Bode, Harald; Kohne, Elisabeth; Debatin, Klaus-Michael] Univ Hosp, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany; [Smith, Desiree E. C.; Blom, Henk] VU Free Univ, Dept Clin Chem, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Blau, Nenad] Univ Childrens Hosp, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; [Blau, Nenad] Zurich Ctr Integrat Human Physiol ZIHP, CH-8032 Zurich, Switzerland; [Blau, Nenad] RCC, CH-8032 Zurich, Switzerland; [Holzmann, Karlheinz] Univ Hosp, Interdisciplinary Ctr Clin Res, D-89081 Ulm, Germany; [Pannicke, Ulrich; Schwarz, Klaus] Univ Hosp, Inst Transfus Med, D-89081 Ulm, Germany; [Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, Gene Ctr, Dept Biochem, D-81377 Munich, Germany; [Rump, Eva-Maria; Schwarz, Klaus] Inst Clin Transfus Med & Immunogenet, D-89081 Ulm, Germany; [Ayric, Zuleya] Ctr Diagnost & Treatment Epilepsy Childhood & Ado, D-77694 Kehl, Germany; [Smulders, Yvo] VU Free Univ, Dept Internal Med, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Smulders, Yvo] VU Free Univ, Inst Cardiovasc Res, Med Ctr, NL-1081 HV Amsterdam, Netherlands	Ulm University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Ulm University; Ulm University; University of Munich; University of Munich; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Cario, H (corresponding author), Univ Hosp, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany.	holger.cario@uniklinik-ulm.de	Debatin, Klaus-Michael/J-9704-2014; Hopfner, Karl-Peter/B-6864-2014; Cario, Holger/AAH-6713-2019; Pannicke, Ulrich/D-7348-2014; Smulders, YM/AAG-7506-2021	Debatin, Klaus-Michael/0000-0002-8397-1886; Hopfner, Karl-Peter/0000-0002-4528-8357; Blau, Nenad/0000-0003-4347-3230; Smith, Desiree/0000-0003-2053-3392; Cario, Holger/0000-0002-6923-488X; Blom, Henk/0000-0001-5202-9241	Swiss National Science Foundation [3100A0-1199852/1]; DFG [Sonderforschungsbereich 684]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DFG(German Research Foundation (DFG))	This work was supported in part by the Swiss National Science Foundation grant no. 3100A0-1199852/1 (to N.B.) and by DFG Sonderforschungsbereich 684 (to KPH). The authors thank Marlies Just from the Institute for Virology, University Hospital Ulm, for her continuous support by establishing EBV-immortalized lymphoblast cell lines and Marina Jans for excellent technical assistance.	BLAU N, 2008, LAB GUIDE METHODS BI, P717; BLAU N, 2008, GUIDE METHODS BIOCH, P665; Cario H, 2009, NEUROLOGY, V73, P2127, DOI 10.1212/WNL.0b013e3181c679df; ERBE RW, 1975, NEW ENGL J MED, V293, P807, DOI 10.1056/NEJM197510162931606; HOFFBRAND AV, 1984, NEW ENGL J MED, V310, P789; KAUFMAN S, 1991, NEUROCHEM RES, V16, P1031, DOI 10.1007/BF00965847; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; POLLOCK RJ, 1978, J NEUROCHEM, V31, P115, DOI 10.1111/j.1471-4159.1978.tb12439.x; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; SMITH I, 1986, POSTGRAD MED J, V62, P113, DOI 10.1136/pgmj.62.724.113; Smulders YM, 2007, J NUTR BIOCHEM, V18, P693, DOI 10.1016/j.jnutbio.2006.11.010; Stanger O, 2002, CURR DRUG METAB, V3, P211, DOI 10.2174/1389200024605163; TAURO GP, 1976, NEW ENGL J MED, V294, P466, DOI 10.1056/NEJM197602262940903; WALTERS TR, 1967, J PEDIATR-US, V70, P686; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x	18	65	71	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					226	231		10.1016/j.ajhg.2011.01.007	http://dx.doi.org/10.1016/j.ajhg.2011.01.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21310277	Bronze, Green Published			2022-12-18	WOS:000287684100011
J	Wu, XL; Gu, MM; Huang, L; Liu, XS; Zhang, HX; Ding, XY; Xu, JQ; Cui, B; Wang, L; Lu, SY; Chen, XY; Zhang, HG; Huang, W; Yuan, WT; Yang, JM; Gu, Q; Fei, J; Chen, Z; Yuan, ZM; Wang, ZG				Wu, Xiao-lin; Gu, Ming-min; Huang, Lei; Liu, Xue-song; Zhang, Hong-xin; Ding, Xiao-yi; Xu, Jian-qing; Cui, Bin; Wang, Long; Lu, Shun-yuan; Chen, Xiao-yi; Zhang, Hai-guo; Huang, Wei; Yuan, Wen-tao; Yang, Jiang-ming; Gu, Qun; Fei, Jian; Chen, Zhu; Yuan, Zhi-min; Wang, Zhu-gang			Multiple Synostoses Syndrome Is Due to a Missense Mutation in Exon 2 of FGF9 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROBLAST GROWTH FACTOR-9; TGF-BETA-SUPERFAMILY; CHONDROCYTE DIFFERENTIATION; SIGNALING PATHWAYS; ENCODING NOGGIN; BONE-GROWTH; CATENIN; PROTEIN; MORPHOGENESIS; SECRETION	Fibroblast growth factors (FGFs) play diverse roles in several developmental processes. Mutations leading to deregulated FGF signaling can cause human skeletal dysplasias and cancer.(1,2) Here we report a missense mutation (Ser99Asp) in exon 2 of FGF9 in 12 patients with multiple synostoses syndrome (SYNS) in a large Chinese family. In vitro studies demonstrate that FGF9(S99N) is expressed and secreted as efficiently as wild-type FGF9 in transfected cells. However, FGF9(S99N) induces compromised chondrocyte proliferation and differentiation, which is accompanied by enhanced osteogenic differentiation and matrix mineralization of bone marrow-derived mesenchymal stem cells (BMSCs). Biochemical analysis reveals that S99N mutation in FGF9 leads to significantly impaired FGF signaling, as evidenced by diminished activity of Erk1/2 pathway and decreased beta-catenin and c-Myc expression when compared with wild-type FGF9. Importantly, the binding of FGF9(S99N) to its receptor is severely impaired although the dimerization ability of mutant FGF9 itself or with wildtype FGF9 is not detectably affected, providing a basis for the defective FGFR signaling. Collectively, our data demonstrate a previously uncharacterized mutation in FGF9 as one of the causes of SYNS, implicating an important role of FGF9 in normal joint development.	[Wu, Xiao-lin; Gu, Ming-min; Huang, Lei; Liu, Xue-song; Zhang, Hong-xin; Chen, Xiao-yi; Zhang, Hai-guo; Wang, Zhu-gang] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Univ, Dept Med Genet,Model Organism Div, Shanghai 200025, Peoples R China; [Liu, Xue-song; Wang, Long; Lu, Shun-yuan; Wang, Zhu-gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Genet Engn Lab, Shanghai 200025, Peoples R China; [Ding, Xiao-yi] Shanghai Jiao Tong Univ, Sch Med, Dept Radiol, Shanghai 200025, Peoples R China; [Xu, Jian-qing] Shanghai Jiao Tong Univ, Sch Med, Dept Orthopaed, Shanghai 200025, Peoples R China; [Cui, Bin] Shanghai Jiao Tong Univ, Sch Med, Dept Endocrinol, Shanghai 200025, Peoples R China; [Wang, Long; Lu, Shun-yuan; Chen, Zhu; Wang, Zhu-gang] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Wang, Long; Lu, Shun-yuan; Fei, Jian; Wang, Zhu-gang] Shanghai Res Ctr Model Organisms, Shanghai 201210, Peoples R China; [Huang, Wei; Yuan, Wen-tao; Chen, Zhu] Chinese Natl Human Genom Ctr Shanghai, Shanghai 201203, Peoples R China; [Yang, Jiang-ming; Gu, Qun] Qinghai Chinese Med Hosp, Dept Inspect, Xining 810000, Peoples R China; [Yuan, Zhi-min] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiat Oncol, Div Radiat Biol, San Antonio, TX 78229 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Texas System; University of Texas Health San Antonio	Wang, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Univ, Dept Med Genet,Model Organism Div, Shanghai 200025, Peoples R China.	zhugangw@shsmu.edu.cn	Liu, Xue-Song/ADF-2183-2022	Liu, Xue-Song/0000-0002-7736-0077; Huang, Lei/0000-0002-4851-4807				Abdel-Rahman WM, 2008, HUM MUTAT, V29, P390, DOI 10.1002/humu.20653; Akarsu AN, 1999, AM J HUM GENET, V65, pA281; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brown DJ, 2002, AM J HUM GENET, V71, P618, DOI 10.1086/342067; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dawson K, 2006, AM J HUM GENET, V78, P708, DOI 10.1086/503204; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; GOVINDARAJAN V, 2006, BMC DEV BIOL, V6; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Herrmann J, 1974, Birth Defects Orig Artic Ser, V10, P23; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; HURVITZ SA, 1985, CLIN GENET, V28, P61; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Krakow D, 1998, AM J HUM GENET, V63, P120, DOI 10.1086/301921; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; MAROTEAUX P, 1972, NOUV PRESSE MED, V1, P3041; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Miyakawa K, 1999, J BIOL CHEM, V274, P29352, DOI 10.1074/jbc.274.41.29352; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; Murakami H, 2002, MAMM GENOME, V13, P341, DOI 10.1007/s00335-001-2143-6; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Popovici C, 2004, J BIOL CHEM, V279, P40146, DOI 10.1074/jbc.M405795200; Revest JM, 2000, J BIOL CHEM, V275, P8083, DOI 10.1074/jbc.275.11.8083; Safran M, 2000, BIOCHEM J, V345, P107, DOI 10.1042/0264-6021:3450107; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Weksler NB, 1999, BIOCHEM J, V342, P677, DOI 10.1042/0264-6021:3420677; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	48	65	74	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					53	63		10.1016/j.ajhg.2009.06.007	http://dx.doi.org/10.1016/j.ajhg.2009.06.007			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19589401	Green Published, Bronze			2022-12-18	WOS:000267997600007
J	Piluso, G; D'Amico, F; Saccone, V; Bismuto, E; Rotundo, IL; Di Domenico, M; Aurino, S; Schwartz, CE; Neri, G; Nigro, V				Piluso, Giulio; D'Amico, Francesca; Saccone, Valentina; Bismuto, Ettore; Rotundo, Ida Luisa; Di Domenico, Marina; Aurino, Stefania; Schwartz, Charles E.; Neri, Giovanni; Nigro, Vincenzo			A Missense Mutation in CASK Causes FG Syndrome in an Italian Family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; ARRAY-CGH; PROTEIN COMPLEX; X-INACTIVATION; GENOME BROWSER; MAGUK FAMILY; GENE; EXPRESSION; HOMOLOG; BINDING	First described in 1974, FG syndrome (FGS) is an X-linked multiple congenital anomaly/mental retardation (MCA/MR) disorder, characterized by high clinical variability and genetic heterogeneity. Five loci (FGS1-5) have so far been linked to this phenotype on the X chromosome, but only one gene, MED12, has been identified to date. Mutations in this gene account for a restricted number of FGS patients with a more distinctive phenotype, referred to as the Opitz-Kaveggia phenotype. We report here that a p.R28L (c.83G -> T) missense mutation in CASK causes FGS phenotype in an Italian family previously mapped to Xp11.4-p11.3 (FGS4). The identified missense mutation cosegregates with the phenotype in this family and is absent in 1000 control X chromosomes of the same ethnic origin. An extensive analysis of CASK protein functions as well as structural and dynamic studies performed by molecular dynamics (MD) simulation did not reveal significant alterations induced by the p.R28L substitution. However, we observed a partial skipping of the exon 2 of CASK, presumably a consequence of improper recognition of exonic splicing enhancers (ESEs) induced by the c.83G -> T transversion. CASK is a multidomain scaffold protein highly expressed in the central nervous system (CNS) with specific localization to the synapses, where it forms large signaling complexes regulating neurotransmission. We suggest that the observed phenotype is most likely a consequence of an altered CASK expression profile during embryogenesis, brain development, and differentiation.	[Piluso, Giulio; D'Amico, Francesca; Rotundo, Ida Luisa; Di Domenico, Marina; Nigro, Vincenzo] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy; [Bismuto, Ettore] Univ Naples 2, Dipartimento Biochim & Biofis Francesco Cedrango, I-80138 Naples, Italy; [Saccone, Valentina; Rotundo, Ida Luisa; Aurino, Stefania; Nigro, Vincenzo] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Neri, Giovanni] Univ Cattolica Sacro Cuore, Ist Genet Med, I-00168 Rome, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Greenwood Genetic Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Piluso, G (corresponding author), Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy.	giulio.piluso@unina2.it	Piluso, Giulio/AAA-3661-2019; Nigro, Vincenzo/AAB-2274-2022; PILUSO, Giulio/AAA-3400-2019	PILUSO, Giulio/0000-0001-9418-125X; Di Domenico, Marina/0000-0002-6201-4200; Nigro, Vincenzo/0000-0002-3378-5006; Saccone, Valentina/0000-0002-0566-6384	NICHD [HD 26202]; South Carolina Department of Disabilities and Special Needs (SCDDSN); Telethon [TIGEM-TNP42TELC]; Ministero dell'Istruzione dell'Universita e della Ricerca [PRIN 2006]; Ministero della Salute [d.lgs 502/92]; Ricerca d'Ateneo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); South Carolina Department of Disabilities and Special Needs (SCDDSN); Telethon(Fondazione Telethon); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); Ricerca d'Ateneo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors are grateful to the family members for their participation and help. We thank Michele D'Avanzo, who first clinically evaluated the family. We are indebted to Agatino Battaglia, Hans van Bokhoven and Euro-MRX consortium, Sylvain Briault, Livia Garavelli, Alfredo Orrico, and Maria M. Rinaldi for their assistance in providing Lis with DNA samples. We also acknowledge Anna Cuomo for sequencing, Manuela Dionisi at the Telethon-SUN core facility of Mutation Detection, and Catherine Fischer for the English language revision. The authors have no disclosures and no conflicts of interest. C.F.S. was supported, in part, by a grant from NICHD (HD 26202) and a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN). V.N. was supported by grants from Telethon (TIGEM-TNP42TELC), Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR: PRIN 2006), Ministero della Salute ((d.lgs 502/92), and Ricerca d'Ateneo. This paper is dedicated to the memory of Francesco Piluso, 1931-2005.	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Bolton Bryan J., 1996, P283; Borg JP, 1999, J NEUROSCI, V19, P1307; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Briault S, 1999, AM J MED GENET, V86, P112, DOI 10.1002/(SICI)1096-8628(19990910)86:2<112::AID-AJMG4>3.0.CO;2-3; Briault S, 1997, AM J MED GENET, V73, P87; Briault S, 2000, AM J MED GENET, V95, P178, DOI 10.1002/1096-8628(20001113)95:2<178::AID-AJMG17>3.0.CO;2-V; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Dessay S, 2002, AM J MED GENET, V112, P6, DOI 10.1002/ajmg.10546; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Franco B, 2006, CURR OPIN GENET DEV, V16, P254, DOI 10.1016/j.gde.2006.04.012; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Graham JM, 1999, AM J MED GENET, V85, P470, DOI 10.1002/(SICI)1096-8628(19990827)85:5<470::AID-AJMG7>3.0.CO;2-S; Graham JM, 1998, AM J MED GENET, V80, P145; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hata Y, 1996, J NEUROSCI, V16, P2488; Hayashi S, 2008, AM J MED GENET A, V146A, P2145, DOI 10.1002/ajmg.a.32433; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jehee FS, 2005, AM J MED GENET A, V139A, P221, DOI 10.1002/ajmg.a.30991; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laverty HG, 1998, GENOMICS, V53, P29, DOI 10.1006/geno.1998.5479; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lopes C, 2001, BIOCHEM BIOPH RES CO, V284, P1004, DOI 10.1006/bbrc.2001.5050; LUTY BA, 1995, J CHEM PHYS, V103, P3014, DOI 10.1063/1.470490; Lyons MJ, 2009, J MED GENET, V46, P9, DOI 10.1136/jmg.2008.060509; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; NERI G, 1984, AM J MED GENET, V19, P369, DOI 10.1002/ajmg.1320190219; Ohno H, 2003, ONCOGENE, V22, P8422, DOI 10.1038/sj.onc.1206996; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; OPITZ JM, 1988, AM J MED GENET, V30, P309, DOI 10.1002/ajmg.1320300132; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Opitz John M, 2008, Adv Pediatr, V55, P123, DOI 10.1016/j.yapd.2008.07.014; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Piluso G, 2003, HUM GENET, V112, P124, DOI 10.1007/s00439-002-0863-7; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Baraitser M, 1994, Clin Dysmorphol, V3, P40; Rozen S, 2000, Methods Mol Biol, V132, P365; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Stevenson D, 2000, MAMM GENOME, V11, P934, DOI 10.1007/s003350010170; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; THOMPSON EM, 1985, CLIN GENET, V27, P582; Unger S, 2007, AM J MED GENET A, V143A, P1876, DOI 10.1002/ajmg.a.31751; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wang TF, 2004, J NEUROCHEM, V91, P1483, DOI 10.1111/j.1471-4159.2004.02845.x; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yoshikawa H, 1998, GENOMICS, V49, P237, DOI 10.1006/geno.1998.5246; Zordan MA, 2005, J NEUROPHYSIOL, V94, P1074, DOI 10.1152/jn.00954.2004	70	65	71	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					162	177		10.1016/j.ajhg.2008.12.018	http://dx.doi.org/10.1016/j.ajhg.2008.12.018			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200522	Green Published, Bronze			2022-12-18	WOS:000263799700007
J	Li, H; Mukherjee, N; Soundararajan, U; Tarnok, Z; Barta, C; Khaliq, S; Mohyuddin, A; Kajuna, SLB; Mehdi, SQ; Kidd, JR; Kidd, KK				Li, Hui; Mukherjee, Namita; Soundararajan, Usha; Tarnok, Zsanett; Barta, Csaba; Khaliq, Shagufta; Mohyuddin, Aisha; Kajuna, Sylvester L. B.; Mehdi, S. Qasim; Kidd, Judith R.; Kidd, Kenneth K.			Geographically separate increases in the frequency of the derived ADH1B*47His allele in eastern and western Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; ALCOHOL-DEHYDROGENASE; GENES; ALDH2; ADH; POPULATIONS; DEPENDENCE; DIVERSITY; RISK	The ADH1B Arg47His polymorphism has been convincingly associated with alcoholism in numerous studies of several populations in Asia and Europe. In a review of literature from the past 30 years, we have identified studies that report allele frequencies of this polymorphism for 131 population samples from many different parts of the world. The derived ADH1B*47His allele reaches high frequencies only in western and eastern Asia. To pursue this pattern, we report here new frequency data for 37 populations. Most of our data are from South and Southeast Asia and confirm that there is a low frequency of this allele in the region between eastern and western Asia. The distribution suggests that the derived allele increased in frequency independently in western and eastern Asia after humans had spread across Eurasia.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Semmelweis Univ, Vadaskert Child & Adolescent Psychiat Clin, H-1085 Budapest, Hungary; Semmelweis Univ, Inst Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; Univ Karachi, Inst Biotechnol & Genet Engn, Karachi, Pakistan; Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania	Yale University; Semmelweis University; Semmelweis University; University of Karachi	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, POB 208005,333 Cedar St,SHM I-353, New Haven, CT 06510 USA.	kenneth.kidd@yale.edu	tarnok, zsanett/X-1700-2018; Mehdi, Syed Qasim/L-2385-2015; Li, Hui/A-2014-2010; Khaliq, Shagufta/G-2337-2015	tarnok, zsanett/0000-0002-2493-0232; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA009379, AA009379] Funding Source: Medline; NIGMS NIH HHS [P01 GM057672, GM057672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen WJ, 1997, BIOL PSYCHIAT, V41, P703, DOI 10.1016/S0006-3223(96)00072-8; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; GOEDDE HW, 1992, HUM GENET, V88, P344; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Han Y, 2007, AM J HUM GENET, V80, P441, DOI 10.1086/512485; Kidd KK, 2002, AM J HUM GENET, V71, P1250, DOI 10.1086/344288; LI TK, 1977, P NATL ACAD SCI USA, V74, P4378, DOI 10.1073/pnas.74.10.4378; Mulligan CJ, 2003, HUM GENET, V113, P325, DOI 10.1007/s00439-003-0971-z; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Ogurtsov PP, 2001, ADDICT BIOL, V6, P377, DOI 10.1080/13556210020077109; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Whitfield JB, 2002, AM J HUM GENET, V71, P1247, DOI 10.1086/344287; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	15	65	66	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					842	846		10.1086/521201	http://dx.doi.org/10.1086/521201			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847010	Green Published, Bronze			2022-12-18	WOS:000249307600026
J	Chen, GK; Witte, JS				Chen, Gary K.; Witte, John S.			Enriching the analysis of genomewide association studies with hierarchical modeling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENE-EXPRESSION; EMPIRICAL-BAYES; EPIDEMIOLOGIC ANALYSES; QUANTITATIVE-TRAIT; WIDE ASSOCIATION; REGRESSION; CANCER; LIKELIHOOD; EXPOSURES; ELEMENTS	Genomewide association Studies (GWAs) initially investigate hundreds of thousands of single-nucleotide polymorphisms (SNPs), and the most promising SNPs are further evaluated with additional subjects, for replication or a joint analysis. Deciding which SNPs merit follow-up is one of the most crucial aspects of these studies. We present here an approach for selecting the most-promising SNPs that incorporates into a hierarchical model both conventional results and other existing information about the SNPs. The model is developed for general use, its potential value is shown by application, and toots are provided for undertaking hierarchical modeling. By quantitatively harnessing all available information in GWAs, hierarchical modeling may more clearly distinguish true causal variants from noise.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Witte, JS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 513 Parnassus,Room S965, San Francisco, CA 94143 USA.	JWitte@ucsf.edu			NCI NIH HHS [R25T CA112355, R25 CA112355, R01 CA88164, R01 CA088164] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA112355, R01CA088164] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; EFRON B, 1975, J AM STAT ASSOC, V70, P311, DOI 10.2307/2285814; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GREENLAND S, 1992, STAT MED, V11, P219, DOI 10.1002/sim.4780110208; GREENLAND S, 1993, STAT MED, V12, P717, DOI 10.1002/sim.4780120802; Greenland S, 1997, STAT MED, V16, P515; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; Hung RJ, 2004, CANCER EPIDEM BIOMAR, V13, P1013; Kim LL, 2001, GENET EPIDEMIOL, V21, pS668, DOI 10.1002/gepi.2001.21.s1.s668; Liu X, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S104; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; THOMAS D, 1992, ANN MED, V24, P387, DOI 10.3109/07853899209147843; Thomas DC, 2007, EPIDEMIOLOGY, V18, P186, DOI 10.1097/01.ede.0000254682.47697.70; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H; Witte JS, 1996, STAT MED, V15, P1161, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1161::AID-SIM221>3.0.CO;2-7; WITTE JS, 1994, EPIDEMIOLOGY, V5, P612, DOI 10.1097/00001648-199411000-00009	30	65	68	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					397	404		10.1086/519794	http://dx.doi.org/10.1086/519794			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668389	Green Published, Bronze			2022-12-18	WOS:000248540400019
J	Silberstein, M; Tzemach, A; Dovgolevsky, N; Fishelson, M; Schuster, A; Geiger, D				Silberstein, M.; Tzemach, A.; Dovgolevsky, N.; Fishelson, M.; Schuster, A.; Geiger, D.			Online system for faster multipoint linkage analysis via parallel execution on thousands of personal computers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREES; PROGRAM; COMPUTATIONS; INHERITANCE; GENE; MAPS; IMPLEMENTATION; STRATEGIES; ALGORITHM; PACKAGE	Computation of LOD scores is a valuable tool for mapping disease-susceptibility genes in the study of Mendelian and complex diseases. However, computation of exact multipoint likelihoods of large inbred pedigrees with extensive missing data is often beyond the capabilities of a single computer. We present a distributed system called "SUPERLINK-ONLINE," for the computation of multipoint LOD scores of large inbred pedigrees. It achieves high performance via the efficient parallelization of the algorithms in SUPERLINK, a state-of-the-art serial program for these tasks, and through the use of the idle cycles of thousands of personal computers. The main algorithmic challenge has been to efficiently split a large task for distributed execution in a highly dynamic, nondedicated running environment. Notably, the system is available online, which allows computationally intensive analyses to be performed with no need for either the installation of software or the maintenance of a complicated distributed environment. As the system was being developed, it was extensively tested by collaborating medical centers worldwide on a variety of real data sets, some of which are presented in this article.	Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Geiger, D (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	dang@cs.technion.ac.il						Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; Conant GC, 2003, J PARALLEL DISTR COM, V63, P674, DOI 10.1006/S0743-7315(03)00080-7; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dechter R, 1998, NATO ADV SCI I D-BEH, V89, P75; Dietter J, 2004, EUR J HUM GENET, V12, P542, DOI 10.1038/sj.ejhg.5201196; DWARKADAS S, 1994, HUM HERED, V44, P127, DOI 10.1159/000154205; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fishelson M, 2005, HUM HERED, V59, P41, DOI 10.1159/000084736; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Friedman N., 2000, P 16 C UNC ART INT U, P192; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GUPTA SK, 1995, COMPUT BIOMED RES, V28, P116, DOI 10.1006/cbmr.1995.1009; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Kothari K, 2001, J BIOMED INFORM, V34, P406, DOI 10.1006/jbin.2002.1031; Kozlov A. V., 1994, Proceedings Supercomputing '94 (Cat. No.94CH34819), P320, DOI 10.1109/SUPERC.1994.344295; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lauritzen SL, 1996, GRAPHICAL MODELS; MADSEN AL, 1999, R995002 AALB U DEP C; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; MATISE TC, 1995, HUM HERED, V45, P103, DOI 10.1159/000154268; MILLER PL, 1991, COMPUT BIOMED RES, V24, P234, DOI 10.1016/0010-4809(91)90046-Y; O'Connell JR, 2001, HUM HERED, V51, P226, DOI 10.1159/000053346; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1976, AM J HUM GENET, V28, P528; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Rai A, 2000, COMPUT BIOMED RES, V33, P350, DOI 10.1006/cbmr.2000.1547; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Seboun E, 2005, AM J MED GENET A, V134A, P290, DOI 10.1002/ajmg.a.30615; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; THAIN D, 2003, GRID BLUEPRINT NEW C, P285; Zlotogora J, 1998, AM J MED GENET, V77, P79, DOI 10.1002/(SICI)1096-8628(19980428)77:1<79::AID-AJMG18>3.0.CO;2-L	40	65	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					922	935		10.1086/504158	http://dx.doi.org/10.1086/504158			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685644	Green Published, Bronze			2022-12-18	WOS:000237553800003
J	Tzeng, JY; Wang, CH; Kao, JT; Hsiao, CK				Tzeng, JY; Wang, CH; Kao, JT; Hsiao, CK			Regression-based association analysis with clustered haplotypes through use of genotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-C-III; LINKAGE DISEQUILIBRIUM; DISEASE ASSOCIATIONS; AFFECTED INDIVIDUALS; GENETIC ASSOCIATION; HEART-DISEASE; TESTS; TRIGLYCERIDES; RISK	Haplotype-based association analysis has been recognized as a tool with high resolution and potentially great power for identifying modest etiological effects of genes. However, in practice, its efficacy has not been as successfully reproduced as expected in theory. One primary cause is that such analysis tends to require a large number of parameters to capture the abundant haplotype varieties, and many of those are expended on rare haplotypes for which studies would have insufficient power to detect association even if it existed. To concentrate statistical power on more-relevant inferences, in this study, we developed a regression-based approach using clustered haplotypes to assess haplotype-phenotype association. Specifically, we generalized the probabilistic clustering methods of Tzeng to the generalized linear model ( GLM) framework established by Schaid et al. The proposed method uses unphased genotypes and incorporates both phase uncertainty and clustering uncertainty. Its GLM framework allows adjustment of covariates and can model qualitative and quantitative traits. It can also evaluate the overall haplotype association or the individual haplotype effects. We applied the proposed approach to study the association between hypertriglyceridemia and the apolipoprotein A5 gene. Through simulation studies, we assessed the performance of the proposed approach and demonstrate its validity and power in testing for haplotype-trait association.	N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; Cardinal Tien Hosp, Dept Cardiol, Taipei, Taiwan; Fu Jen Catholic Univ, Dept Med, Coll Med, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10018, Taiwan; Natl Taiwan Univ, Inst Epidemiol, Div Biostat, Taipei 10764, Taiwan	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Fu Jen Catholic University; National Taiwan University; National Taiwan University	Tzeng, JY (corresponding author), N Carolina State Univ, Dept Stat, Campus Box 7566, Raleigh, NC 27695 USA.	jytzeng@stat.ncsu.edu		Tzeng, Jung-Ying/0000-0002-5505-1775; KAO, JAU-TSUEN/0000-0003-1918-0366; hsiao, chuhsing kate/0000-0003-4905-8484	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM045344, GM45344] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; Bourgain C, 2002, ANN HUM GENET, V66, P99, DOI 10.1017/S000348000100896X; Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; CRANDALL KA, 1993, GENETICS, V134, P959; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kao JT, 2003, HUM MOL GENET, V12, P2533, DOI 10.1093/hmg/ddg255; KENT JT, 1982, BIOMETRIKA, V69, P19, DOI 10.2307/2335849; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Molitor J, 2003, AM J HUM GENET, V73, P1368, DOI 10.1086/380415; Molitor J, 2003, GENET EPIDEMIOL, V25, P95, DOI 10.1002/gepi.10251; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; ORDOVAS JM, 1991, ATHEROSCLEROSIS, V87, P75, DOI 10.1016/0021-9150(91)90234-T; PEACOCK RE, 1994, CLIN GENET, V46, P273; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Satten GA, 2004, GENET EPIDEMIOL, V27, P192, DOI 10.1002/gepi.20020; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seltman H, 2003, GENET EPIDEMIOL, V25, P48, DOI 10.1002/gepi.10246; Seltman H, 2001, AM J HUM GENET, V68, P1250, DOI 10.1086/320110; Sham P., 1998, STAT HUMAN GENETICS; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Slatkin M, 1997, AM J HUM GENET, V60, P447; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Tzeng JY, 2005, GENET EPIDEMIOL, V28, P220, DOI 10.1002/gepi.20063; Tzeng JY, 2003, J AM STAT ASSOC, V98, P236, DOI 10.1198/016214503388619256; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Van der Meulen MA, 1997, GENET EPIDEMIOL, V14, P915, DOI 10.1002/(SICI)1098-2272(1997)14:6<915::AID-GEPI59>3.0.CO;2-P; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Waterworth DM, 2001, DIABETOLOGIA, V44, P245, DOI 10.1007/s001250051607; Waterworth DM, 2000, ARTERIOSCL THROM VAS, V20, P2663, DOI 10.1161/01.ATV.20.12.2663; Yu K, 2004, GENET EPIDEMIOL, V27, P182, DOI 10.1002/gepi.20022; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeng D, 2005, GENET EPIDEMIOL, V28, P70, DOI 10.1002/gepi.20040; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	55	65	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					231	242		10.1086/500025	http://dx.doi.org/10.1086/500025			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16365833	Green Published, Bronze			2022-12-18	WOS:000236744900005
J	Zhang, SL; Sha, QY; Chen, HS; Dong, JP; Jiang, RF				Zhang, SL; Sha, QY; Chen, HS; Dong, JP; Jiang, RF			Transmission/disequilibrium test based on haplotype sharing for tightly linked markers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION-DISEQUILIBRIUM TESTS; COMPLEX HUMAN-DISEASES; LINKAGE DISEQUILIBRIUM; FOUNDER POPULATIONS; QUANTITATIVE TRAITS; GENETIC-MARKERS; SIBSHIP TEST; TEST TDT; ASSOCIATION; INFORMATION	Studies using haplotypes of multiple tightly linked markers are more informative than those using a single marker. However, studies based on multimarker haplotypes have some difficulties. First, if we consider each haplotype as an allele and use the conventional single-marker transmission/ disequilibrium test (TDT), then the rapid increase in the degrees of freedom with an increasing number of markers means that the statistical power of the conventional tests will be low. Second, the parental haplotypes cannot always be unambiguously reconstructed. In the present article, we propose a haplotype-sharing TDT (HS-TDT) for linkage or association between a disease-susceptibility locus and a chromosome region in which several tightly linked markers have been typed. This method is applicable to both quantitative traits and qualitative traits. It is applicable to any size of nuclear family, with or without ambiguous phase information, and it is applicable to any number of alleles at each of the markers. The degrees of freedom ( in a broad sense) of the test increase linearly as the number of markers considered increases but do not increase as the number of alleles at the markers increases. Our simulation results show that the HS-TDT has the correct type I error rate in structured populations and that, in most cases, the power of HS-TDT is higher than the power of the existing single-marker TDTs and haplotype-based TDTs.	Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; Heilongjiang Univ, Dept Math, Harbin, Peoples R China	Michigan Technological University; Heilongjiang University	Zhang, SL (corresponding author), Michigan Technol Univ, Dept Math Sci, 1400 Townsend Dr, Houghton, MI 49931 USA.		Chen, Huann-Sheng/D-6328-2013	Chen, Huann-Sheng/0000-0002-5905-8050				Allison DB, 1997, AM J HUM GENET, V60, P676; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Bourgain C, 2002, ANN HUM GENET, V66, P99, DOI 10.1017/S000348000100896X; Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; CHEN HS, 2003, P INT C MATH ENG TEC, P165; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Li JM, 2001, GENET EPIDEMIOL, V21, pS632, DOI 10.1002/gepi.2001.21.s1.s632; Merriman TR, 1998, HUM MOL GENET, V7, P517, DOI 10.1093/hmg/7.3.517; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohde K, 2001, HUM MUTAT, V17, P289, DOI 10.1002/humu.26; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Seltman H, 2001, AM J HUM GENET, V68, P1250, DOI 10.1086/320110; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Sun FZ, 2000, ANN HUM GENET, V64, P555, DOI 10.1017/S000348000000840X; Teng J, 1999, GENOME RES, V9, P234; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073	33	65	65	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					566	579		10.1086/378205	http://dx.doi.org/10.1086/378205			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12929082	Green Published, Bronze			2022-12-18	WOS:000185134000009
J	Chagnon, P; Michaud, J; Mitchell, G; Mercier, J; Marion, JF; Drouin, E; Rasquin-Weber, A; Hudson, TJ; Richter, A				Chagnon, P; Michaud, J; Mitchell, G; Mercier, J; Marion, JF; Drouin, E; Rasquin-Weber, A; Hudson, TJ; Richter, A			A missense mutation (R565W) in Cirhin (FLJ14728) in North American Indian childhood cirrhosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; GENE; TRANSPORTER; HAPLOTYPE	North American Indian childhood cirrhosis (CIRH1A, or NAIC), a severe autosomal recessive intrahepatic cholestasis described in Ojibway-Cree children from northwestern Quebec, is one of several familial cholestases with unknown molecular etiology. It typically presents with transient neonatal jaundice, in a child who is otherwise healthy, and progresses to biliary cirrhosis and portal hypertension. Clinical and physiological investigations have not revealed the underlying cause of the disease. Currently, liver transplantation is the only effective therapy for patients with advanced disease. We previously identified the NAIC locus by homozygosity mapping to chromosome 16q22. Here we report that an exon 15 mutation in gene FLJ14728 (alias Cirhin) causes NAIC: c. 1741C-->T in GenBank cDNA sequence NM_032830, found in all NAIC chromosomes, changes the conserved arginine 565 codon to a tryptophan, altering the predicted secondary structure of the protein. Cirhin is preferentially expressed in embryonic liver, is predicted to localize to mitochondria, and contains WD repeats, which are structural motifs frequently associated with molecular scaffolds.	Univ Montreal, Ctr Hosp Univ Mere Enfant, Hop St Justine, Div Med Genet, Montreal, PQ, Canada; Univ Montreal, Ctr Hosp Univ Mere Enfant, Hop St Justine, Div Gastroenterol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal Genome Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Richter, A (corresponding author), Hop St Justine, Serv Genet Med, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.			Hudson, Thomas/0000-0002-1376-4849				Arnell H, 1997, HUM GENET, V100, P378, DOI 10.1007/s004390050519; Betard C, 2000, AM J HUM GENET, V67, P222, DOI 10.1086/302993; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Chen HL, 2001, PEDIATR RES, V50, P50, DOI 10.1203/00006450-200107000-00011; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Drouin E, 2000, J PEDIATR GASTR NUTR, V31, P395, DOI 10.1097/00005176-200010000-00013; DROUIN E, 2000, PEDIAT GASTROINTESTI, P1211; GREENBERG CR, 1995, HUM MOL GENET, V4, P493, DOI 10.1093/hmg/4.3.493; Hegele RA, 2001, ADV EXP MED BIOL, V498, P11; Jacquemin E, 2000, Clin Liver Dis, V4, P753, DOI 10.1016/S1089-3261(05)70139-2; Jansen PLM, 2000, CAN J GASTROENTEROL, V14, P233, DOI 10.1155/2000/514172; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867; Mok A, 2002, J CLIN ENDOCR METAB, V87, P724, DOI 10.1210/jc.87.2.724; ROBINSON BH, 1984, AM J HUM GENET, V36, P283; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Triggs-Raine BL, 2002, P NATL ACAD SCI USA, V99, P4614, DOI 10.1073/pnas.062059799; Weiler T, 1996, AM J HUM GENET, V59, P872; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	22	65	68	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1443	1449		10.1086/344580	http://dx.doi.org/10.1086/344580			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12417987	Green Published, Bronze			2022-12-18	WOS:000179586800018
J	Shaw, CJ; Bi, WM; Lupski, JR				Shaw, CJ; Bi, WM; Lupski, JR			Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; MARIE-TOOTH-DISEASE; INTERSTITIAL DUPLICATIONS; WILLIAMS-SYNDROME; HOMOLOGOUS RECOMBINATION; BREAKPOINT REGIONS; REPEAT SEQUENCES; REARRANGEMENTS; ORIGIN; MECHANISMS	A number of common contiguous gene syndromes have been shown to result from nonallelic homologous recombination (NAHR) within region-specific low-copy repeats (LCRs). The reciprocal duplications are predicted to occur at the same frequency; however, probably because of ascertainment bias and milder phenotypes, reciprocal events have been identified in only a few cases to date. We previously described seven patients with dup(17)(p11.2p11.2), the reciprocal of the Smith-Magenis syndrome (SMS) deletion, del(17)( p11.2p11.2). In >90% of patients with SMS, identical similar to3.7-Mb deletions in 17p11.2 have been identified. These deletions are flanked by large (similar to200 kb), highly homologous, directly oriented LCRs (i.e., proximal and distal SMS repeats [SMS-REPs]). The third (middle) SMS-REP is inverted with respect to them and maps inside the commonly deleted genomic region. To investigate the parental origin and to determine whether the common deletion and duplication arise by unequal crossovers mediated through NAHR between the proximal and distal SMS-REPs, we analyzed the haplotypes of 14 families with SMS and six families with dup(17)(p11.2p11.2), using microsatellite markers directly flanking the SMS common deletion breakpoints. Our data indicate that reciprocal deletion and duplication of 17p11.2 result from unequal meiotic crossovers. These rearrangements occur via both interchromosomal and intrachromosomal exchange events between the proximal and distal SMS-REPs, and there appears to be no parental-origin bias associated with common SMS deletions and the reciprocal duplications.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			NCRR NIH HHS [M01 RR00188, M01 RR000188] Funding Source: Medline; NICHD NIH HHS [HD2406407, P01 HD039420, P01 HD39420] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Carrozzo R, 1997, AM J HUM GENET, V61, P228, DOI 10.1086/513907; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; CHEN KS, 1995, AM J HUM GENET, V56, P175; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; Juyal RC, 1996, AM J HUM GENET, V58, P998; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; Lopes J, 1996, AM J HUM GENET, V58, P1223; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Lupski JR, 1998, MOL MED, V4, P3, DOI 10.1007/BF03401724; Osborne LR, 1997, GENOMICS, V45, P402, DOI 10.1006/geno.1997.4923; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Repetto GR, 1998, AM J MED GENET, V79, P82, DOI 10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P; Roberts SE, 2002, HUM GENET, V110, P227, DOI 10.1007/s00439-002-0678-6; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; Thomas NS, 1999, HUM GENET, V105, P384, DOI 10.1007/s004390051120; Trost D, 2000, J MED GENET, V37, P452, DOI 10.1136/jmg.37.6.452; Urban Z, 1996, AM J HUM GENET, V59, P958; Zhao Q, 1998, GENOMICS, V49, P394, DOI 10.1006/geno.1998.5285	47	65	67	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1072	1081		10.1086/344346	http://dx.doi.org/10.1086/344346			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12375235	Green Published, Bronze			2022-12-18	WOS:000178884300007
J	Stengard, JH; Clark, AG; Weiss, KM; Kardia, S; Nickerson, DA; Salomaa, V; Ehnholm, C; Boerwinkle, E; Sing, CF				Stengard, JH; Clark, AG; Weiss, KM; Kardia, S; Nickerson, DA; Salomaa, V; Ehnholm, C; Boerwinkle, E; Sing, CF			Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; E GENOTYPE INFLUENCE; ELDERLY FINNISH MEN; E POLYMORPHISM; ALZHEIMERS-DISEASE; TRANSPORT PROTEIN; PLASMA-LIPIDS; RISK; POPULATION; MORTALITY	Apolipoprotein E (ApoE) is a major constituent of many lipoprotein particles. Previous genetic studies have focused on six genotypes defined by three alleles, denoted epsilon2, epsilon3, and epsilon4, encoded by two variable exonic sites that segregate in most populations. We have reported studies of the distribution of alleles of 20 biallelic variable sites in the gene encoding the ApoE molecule within and among samples, ascertained without regard to health, from each of three populations: African Americans from Jackson, Miss.; Europeans from North Karelia, Finland; and non-Hispanic European Americans from Rochester, Minn. Here we ask (1) how much variation in blood levels of ApoE (lnApoE), of total cholesterol (TC), of high-density lipoprotein cholesterol (HDL-C), and of triglyceride (lnTG) is statistically explained by variation among APOE genotypes defined by the epsilon2, epsilon3, and epsilon4 alleles; (2) how much additional variation in these traits is explained by genotypes defined by combining the two variable sites that define these three alleles with one or more additional variable sites; and (3) what are the locations and relative allele frequencies of the sites that define multisite genotypes that significantly improve the statistical explanation of variation beyond that provided by the genotypes defined by the epsilon2, epsilon3, and epsilon4 alleles, separately for each of the six gender-population strata. This study establishes that the use of only genotypes defined by the epsilon2, epsilon3, and epsilon4 alleles gives an incomplete picture of the contribution that the variation in the APOE gene makes to the statistical explanation of interindividual variation in blood measurements of lipid metabolism. The addition of variable sites to the genotype definition significantly improved the ability to explain variation in lnApoE and in TC and resulted in the explanation of variation in HDL-C and in lnTG. The combination of additional sites that explained the greatest amount of trait variation was different for different traits and varied among the six gender-population strata. The role that noncoding variable sites play in the explanation of pleiotropic effects on different measures of lipid metabolism reveals that both regulatory and structural functional variation in the APOE gene influences measures of lipid metabolism. This study demonstrates that resequencing of the complete gene in a sample of greater than or equal to20 individuals and an evaluation of all combinations of the identified variable sites, separately for each population and interacting environmental context, may be necessary to fully characterize the impact that a gene has on variation in related traits of a metabolic system.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Natl Publ Hlth Inst, Helsinki, Finland; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA USA; Univ Texas, Ctr Hlth Sci, Ctr Human Genet, Houston, TX USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Finland National Institute for Health & Welfare; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston	Stengard, JH (corresponding author), Univ Michigan, Dept Human Genet, 1241 E Catherine St,5928 Buhl Bldg, Ann Arbor, MI 48109 USA.	jari.stengard@ktl.fi; csing@umich.edu		Clark, Andrew/0000-0001-7159-8511; Sing, Charles/0000-0001-5872-7956	NHLBI NIH HHS [R37 HL051021, U01 HL054481, U10 HL054481, HL51021, HL58239, R01 HL039107, HL58240, HL39107, HL54481, HL58238] Funding Source: Medline; NIGMS NIH HHS [P50 GM065509, GM65509] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058239, R01HL058240, U01HL054481, R01HL058238, U10HL054481, R01HL051021, R01HL039107, R37HL051021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Axelrod R., 2000, HARNESSING COMPLEXIT; BARR SI, 1981, CLIN CHEM, V27, P1142; BOERWINKLE E, 1986, AM J HUM GENET, V39, P137; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; CHURCHILL GA, 1994, GENETICS, V138, P963; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIES DB, 1993, ADV INFORMATION STOR, V5, P5; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Edgington E. S., 1995, RANDOMIZATION TESTS; Fisher R. A., 1935, DESIGN EXPT; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Good P, 2000, PERMUTATION TESTS PR, V2; Guo SW, 2000, THEOR POPUL BIOL, V57, P1, DOI 10.1006/tpbi.2000.1449; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Hamon SC, 2001, AM J HUM GENET, V69, P183; Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; KAPRIO J, 1991, ARTERIOSCLER THROMB, V11, P1330, DOI 10.1161/01.ATV.11.5.1330; KUUSI T, 1989, ARTERIOSCLEROSIS, V9, P237, DOI 10.1161/01.ATV.9.2.237; Lehmann E.L., 1994, TESTING STAT HYPOTHE; Lussier-Cacan S, 2002, ARTERIOSCL THROM VAS, V22, P824, DOI 10.1161/01.ATV.0000014589.22121.6C; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MOLL PP, 1986, AM J HUM GENET, V38, P361; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; *NIH, 1974, PUBL DHEW NIH; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; REILLY SL, 1992, AM J HUM GENET, V51, P1311; REILLY SL, 1994, AM J HUM GENET, V55, P1001; SALOMAA V, 1994, EUR HEART J, V15, P1293, DOI 10.1093/oxfordjournals.eurheartj.a060387; Schiele F, 2000, ATHEROSCLEROSIS, V152, P475, DOI 10.1016/S0021-9150(99)00501-8; Sing CF, 1996, CIBA F SYMP, V197, P211; SING CF, 1985, AM J HUM GENET, V37, P268; Sokal R. R., 1995, BIOMETRY PRINCIPLES; Sole R, 2000, SIGNS LIFE COMPLEXIT; STENGARD J, 2000, SAT S 12 INT S GEN A; Stengard JH, 1998, HUM GENET, V103, P234, DOI 10.1007/s004390050811; Stengard JH, 2001, BLOOD COAGUL FIBRIN, V12, P445, DOI 10.1097/00001721-200109000-00004; STENGARD JH, 1995, CIRCULATION, V91, P265, DOI 10.1161/01.CIR.91.2.265; Stengard JH, 1999, CLIN GENET, V56, P367; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; TURNER ST, 1989, HYPERTENSION, V13, P378, DOI 10.1161/01.HYP.13.4.378; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100	56	65	65	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					501	517		10.1086/342217	http://dx.doi.org/10.1086/342217			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12165926	Green Published, Bronze			2022-12-18	WOS:000177489600005
J	Delague, V; Bareil, C; Tuffery, S; Bouvagnet, P; Chouery, E; Koussa, S; Maisonobe, T; Loiselet, J; Megarbane, A; Claustres, M				Delague, V; Bareil, C; Tuffery, S; Bouvagnet, P; Chouery, E; Koussa, S; Maisonobe, T; Loiselet, J; Megarbane, A; Claustres, M			Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: Exclusion of MAG as a candidate gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEUROPATHY; LINKAGE; CELLS; MICE; DNA	Autosomal recessive Charcot-Marie-Tooth disease (CMT) type 4 (CMT4) is a complex group of demyelinating hereditary motor and sensory neuropathies presenting genetic heterogeneity. Five different subtypes that correspond to six different chromosomal locations have been described. We hereby report a large inbred Lebanese family affected with autosomal recessive CMT4, in whom we have excluded linkage to the already-known Loci. The results of a genomewide search demonstrated linkage to a locus on chromosome 19q13.1-13.3, over an 8.5-cM interval between markers D19S220 and D19S412, A maximum pairwise LOD score of 5.37 for marker D19S420, at recombination fraction [theta].00, and a multipoint LOD score of 10.3 for marker D19S881, at theta =.00, strongly supported linkage to this locus. Clinical features and the results of histopathologic studies confirm that the disease affecting this family constitutes a previously unknown demyelinating autosomal recessive CMT subtype known as "CMT4F." The myelin-associated glycoprotein (MAG) gene, located on 19q13.1 and specifically expressed in the CNS and the peripheral nervous system, was ruled out as being the gene responsible for this form of CMT.	Univ St Joseph, Fac Med, Unit Genet Med, Genet Mol Lab, F-75007 Paris, France; Hotel Dieu France, Neurol Serv, Beirut, Lebanon; Inst Biol, Genet Mol Lab, Montpellier, France; Univ Lyon 1, Inst Netien, Lab Genet Mol Humaine, Lyon, France; Grp Hosp Pitie Salpetriere, Neurol Serv, F-75634 Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Megarbane, A (corresponding author), Univ St Joseph, Fac Med, Unit Genet Med, Genet Mol Lab, 42 Rue Grenelle, F-75007 Paris, France.	megarban@dm.net.lb	Megarbane, Andre/ABD-5574-2021; TUFFERY-GIRAUD, Sylvie/A-9228-2008; BAREIL, Corinne/A-8387-2008; delague, valerie/K-5837-2013	delague, valerie/0000-0003-2652-362X				ATTIA J, 1989, CLIN CHEM, V35, P717; Bell C, 1997, ADV GENET, V36, P1, DOI 10.1016/S0065-2660(08)60306-5; Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dyck PJ, 1993, HEREDITARY MOTOR SEN, P1094; FRAIL DE, 1985, J NEUROCHEM, V45, P1071, DOI 10.1111/j.1471-4159.1985.tb05525.x; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEFRANC G, 1978, HUM GENET, V41, P197, DOI 10.1007/BF00273102; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; OTHMANE KB, 1993, HUM MOL GENET, V2, P1625, DOI 10.1093/hmg/2.10.1625; QUARLES RH, 1984, DEV NEUROSCI-BASEL, V6, P285; SATO S, 1989, BIOCHEM BIOPH RES CO, V163, P1473, DOI 10.1016/0006-291X(89)91145-5; SATO S, 1986, ACTA NEUROL SCAND, V74, P115, DOI 10.1111/j.1600-0404.1986.tb04636.x; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SKRE H, 1974, CLIN GENET, V6, P98; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382	24	65	72	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					236	243		10.1086/302980	http://dx.doi.org/10.1086/302980			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10848494	Bronze, Green Published			2022-12-18	WOS:000088926900027
J	Baird, DM; Coleman, J; Rosser, ZH; Royle, NJ				Baird, DM; Coleman, J; Rosser, ZH; Royle, NJ			High levels of sequence polymorphism and linkage disequilibrium at the telomere of 12q: Implications for telomere biology and human evolution	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN XP/YP TELOMERE; HUMAN GENOME; NATURAL-POPULATIONS; HIGHER PRIMATES; GENUS HOMO; RECOMBINATION; DNA; REGIONS; ORIGIN; AUSTRALOPITHECUS	The human Xp/Yp telomere-junction region exhibits high levels of sequence polymorphism and linkage disequilibrium. To determine whether this is a general feature of human telomeres, we have undertaken sequence analysis at the 12q telomere and have extended the analysis at Xp/Yp. A total of 22 single-nucleotide polymorphisms (SNPs) and one 30-bp duplication were detected in the 1,870 bp adjacent to the 12q telomere. Twenty polymorphic positions were in almost complete linkage disequilibrium, creating three common diverged haplotypes accounting for 80% of 12q telomeres in the white population. A further 6% of 12q telomeres contained a 1,439-bp deletion in the DNA flanking the telomere. The remaining 13% of 12q telomeres did not amplify with the primers used (nulls). The distribution of telomere (TTAGGG) and variant repeats within 12q telomeres was hypervariable, but alleles with similar distribution patterns were associated with the same haplotype in the telomere-adjacent DNA. These data suggest that 12q telomeres, like Xp/Yp telomeres, exhibit low levels of homologous recombination and evolve along haploid lineages. In contrast, high levels of homologous recombination: occur in the adjacent proterminal regions of human chromosomes. This suggests that there is a localized telomere-mediated suppression of recombination. In addition, the genetic characteristics of these regions may provide a source of deep lineages for the study of early human evolution, unaffected by both natural selection and recombination. To explain the presence of a few diverged haplotypes adjacent to the Xp/Yp and 12q telomeres, we propose a model that involves the hybridization of two archaic hominoid lineages ultimately giving rise to modern Homo sapiens.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Royle, NJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Baird, Duncan M/C-9671-2011	Baird, Duncan M/0000-0001-8408-5467; Royle, Nicola/0000-0003-1174-6329				Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 1997, HUM MOL GENET, V6, P2291, DOI 10.1093/hmg/6.13.2291; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COLEMAN J, 1996, AM J HUM GENET, V59, P176; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Flint J, 1997, HUM MOL GENET, V6, P1305, DOI 10.1093/hmg/6.8.1305; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Harding RM, 1997, AM J HUM GENET, V60, P772; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HULTEN M, 1974, HEREDITAS, V76, P55; IJDO JW, 1992, GENOMICS, V14, P1019, DOI 10.1016/S0888-7543(05)80125-9; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; McHenry HM, 1998, S AFR J SCI, V94, P447; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; *NAT I HLTH CEPH C, 1992, SCIENCE, V258, P148; NEI M, 1988, PHILOS T R SOC B, V319, P615, DOI 10.1098/rstb.1988.0069; Reddel RR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1254; ROYLE NJ, 1992, P ROY SOC B-BIOL SCI, V247, P57, DOI 10.1098/rspb.1992.0009; ROYLE NJ, 1994, NAT GENET, V6, P52, DOI 10.1038/ng0194-52; ROYLE NJ, 1995, ADV GENET, V32, P273; SLADE RW, 1992, GENETICS, V132, P861; Stavenhagen JB, 1998, GENE DEV, V12, P3044, DOI 10.1101/gad.12.19.3044; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Takahata N, 1996, CURR OPIN GENET DEV, V6, P767, DOI 10.1016/S0959-437X(96)80034-7; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	54	65	67	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					235	250		10.1086/302721	http://dx.doi.org/10.1086/302721			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631154	Bronze, Green Published			2022-12-18	WOS:000085033600025
J	Friddle, C; Koskela, R; Ranade, K; Hebert, J; Cargill, M; Clark, CD; McInnis, M; Simpson, S; McMahon, F; Stine, OC; Meyers, D; Xu, JF; MacKinnon, D; Swift-Scanlan, T; Jamison, K; Folstein, S; Daly, M; Kruglyak, L; Marr, T; DePaulo, JR; Botstein, D				Friddle, C; Koskela, R; Ranade, K; Hebert, J; Cargill, M; Clark, CD; McInnis, M; Simpson, S; McMahon, F; Stine, OC; Meyers, D; Xu, JF; MacKinnon, D; Swift-Scanlan, T; Jamison, K; Folstein, S; Daly, M; Kruglyak, L; Marr, T; DePaulo, JR; Botstein, D			Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANIC-DEPRESSIVE ILLNESS; AFFECTIVE-DISORDER; COMPLEX TRAITS; GENETIC-TRAITS; PEDIGREES; CHROMOSOME-18; TRANSMISSION; MARKERS; HUMANS; LOCUS	A genome scan of similar to 12-cM initial resolution was done on 50 of a set of 51 carefully ascertained unilineal multiplex families segregating the bipolar affective disorder phenotype. In addition to standard multipoint linkage analysis methods, a simultaneous-search algorithm was applied in an attempt to surmount the problem of genetic heterogeneity. The results revealed no linkage across the genome. The results exclude monogenic models and make it unlikely that two genes account for the disease in this sample. These results support the conclusion that at least several hundred kindreds will be required in order to establish linkage of susceptibility loci to bipolar disorder in heterogeneous populations.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Dept Computat Biol, Cold Spring Harbor, NY 11724 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Johns Hopkins University; Stanford University; Cold Spring Harbor Laboratory; Tufts University; Massachusetts Institute of Technology (MIT); Whitehead Institute	DePaulo, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Meyer 3-181,600 N Wolfe St, Baltimore, MD 21287 USA.		McMahon, Francis J/A-7290-2009; MacKinnon, Dean/AAG-6232-2020; Koskela, Rebecca/M-8666-2014	McMahon, Francis J/0000-0002-9469-305X; Koskela, Rebecca/0000-0002-1157-2798; DePaulo, J Raymond/0000-0001-9221-9226				Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Barden N, 1999, AM J MED GENET, V88, P260, DOI 10.1002/(SICI)1096-8628(19990618)88:3<260::AID-AJMG9>3.0.CO;2-U; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Clark L. K., 1994, Swine Health and Production, V2, P5; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Craddock N, 1999, AM J MED GENET, V88, P244, DOI 10.1002/(SICI)1096-8628(19990618)88:3<244::AID-AJMG7>3.0.CO;2-1; Curtis D, 1999, AM J MED GENET, V88, P272, DOI 10.1002/(SICI)1096-8628(19990618)88:3<272::AID-AJMG12>3.0.CO;2-1; Detera-Wadleigh SD, 1999, AM J MED GENET, V88, P255, DOI 10.1002/(SICI)1096-8628(19990618)88:3<255::AID-AJMG8>3.0.CO;2-V; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; DUPUIS J, 1995, GENETICS, V140, P843; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; Gschwend M, 1996, AM J HUM GENET, V59, P377; Gurling Hugh, 1998, Psychiatric Genetics, V8, P109, DOI 10.1097/00041444-199800820-00015; Kato T, 1998, J AFFECT DISORDERS, V50, P135, DOI 10.1016/S0165-0327(97)00102-X; KENNEDY JL, 1999, 6 WORLD C PSYCH GEN, V88, P224; Knowles JA, 1998, AM J HUM GENET, V62, P916, DOI 10.1086/301785; Kraepelin E., 1921, MANIC DEPRESSIVE INS; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; Lin JP, 1997, GENET EPIDEMIOL, V14, P665, DOI 10.1002/(SICI)1098-2272(1997)14:6<665::AID-GEPI19>3.0.CO;2-O; MacKinnon DF, 1997, ANNU REV NEUROSCI, V20, P355, DOI 10.1146/annurev.neuro.20.1.355; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; McMahon FJ, 1997, AM J HUM GENET, V61, P1397, DOI 10.1086/301630; Nothen MM, 1999, MOL PSYCHIATR, V4, P76, DOI 10.1038/sj.mp.4000454; Ott J., 1991, ANAL HUMAN GENETIC L; Rice J, 1997, GENET EPIDEMIOL, V14, P549, DOI 10.1002/(SICI)1098-2272(1997)14:6<549::AID-GEPI1>3.0.CO;2-V; Rice JP, 1997, AM J MED GENET, V74, P247, DOI 10.1002/(SICI)1096-8628(19970531)74:3<247::AID-AJMG3>3.0.CO;2-N; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SIMPSON SG, 1992, AM J PSYCHIAT, V149, P1660; Smyth C, 1997, GENOMICS, V39, P271, DOI 10.1006/geno.1996.4486; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRATENWERTH G, 1994, PSYCHIAT PRAX, V21, P3; Van Broeckhoven C, 1999, AM J MED GENET, V88, P263, DOI 10.1002/(SICI)1096-8628(19990618)88:3<263::AID-AJMG10>3.3.CO;2-X; Visscher PM, 1998, GENETICS, V149, P1605; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293	46	65	66	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					205	215		10.1086/302697	http://dx.doi.org/10.1086/302697			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631152	Green Published, Bronze			2022-12-18	WOS:000085033600023
J	Mervis, CB; Robinson, BF; Pani, JR				Mervis, CB; Robinson, BF; Pani, JR			Visuospatial construction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILLIAMS-SYNDROME; MENTAL ROTATION; INDIVIDUAL-DIFFERENCES; COGNITIVE-ABILITIES; HEMIZYGOSITY; SYSTEMS; TWINS		Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville	Mervis, CB (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Life Sci Bldg, Louisville, KY 40292 USA.	cbmervis@louisville.edu	Robinson, Byron/G-6144-2012	Robinson, Byron/0000-0003-2618-5771	NICHD NIH HHS [R37 HD029957, R01 HD029957, HD29957] Funding Source: Medline; NINDS NIH HHS [NS35102, R01 NS035102] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD029957] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], LANGUAGE DEV; BEERY KM, 1989, DEV TEST VISUOMOTOR; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Bellugi U., 1994, ATYPICAL COGNITIVE D, P23; Bertrand J, 1997, DEV NEUROPSYCHOL, V13, P41, DOI 10.1080/87565649709540667; BERTRAND J, 1996, VISUAL ARTS RES, V22, P19; Cardon L., 1994, NATURE NURTURE MIDDL, P57; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Elliott C.D., 1990, DIFFERENTIAL ABILITY; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FEINGOLD A, 1988, AM PSYCHOL, V43, P95, DOI 10.1037/0003-066X.43.2.95; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; JUST MA, 1985, PSYCHOL REV, V92, P137, DOI 10.1037/0033-295X.92.2.137; KEY AF, 1998, OBJECT PERCEPTION ME; LOHMAN DF, 1988, ADV PSYCHOL HUMAN IN, V4; Mackintosh N.J., 1998, IQ HUMAN INTELLIGENC; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; Meng X, 1998, HUM GENET, V103, P590, DOI 10.1007/s004390050874; Mervis CB, 1999, DEV COGN NEUROSCI, P65; Mervis CB, 1999, EMORY S COG, P193; MORRIS CA, 1993, AM J MED GENET, V46, P737, DOI 10.1002/ajmg.1320460634; Morris CA, 1999, HANDBOOK OF NEURODEVELOPMENTAL AND GENETIC DISORDERS IN CHILDREN, P555; PANI JR, 1994, PERCEPTION, V23, P929, DOI 10.1068/p230929; Pani JR, 1999, PSYCHOL SCI, V10, P453, DOI 10.1111/1467-9280.00186; PEDERSEN NL, 1992, PSYCHOL SCI, V3, P346, DOI 10.1111/j.1467-9280.1992.tb00045.x; PEDERSEN NL, 1994, INTELLIGENCE, V18, P133, DOI 10.1016/0160-2896(94)90024-8; Petrill SA, 1996, INTELLIGENCE, V23, P191, DOI 10.1016/S0160-2896(96)90003-3; PLOMIN R, 1998, AM J HUM GENET, V65, P1472; ROSE RJ, 1979, SCIENCE, V205, P1153, DOI 10.1126/science.572991; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; TAMBS K, 1984, INTELLIGENCE, V8, P283, DOI 10.1016/0160-2896(84)90012-6; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 1997, WECHSLER ADULT INTEL	36	65	65	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1222	1229		10.1086/302633	http://dx.doi.org/10.1086/302633			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	252YZ	10521286	Bronze, Green Published			2022-12-18	WOS:000083531000002
J	Sangha, KK; Stephenson, MD; Brown, CJ; Robinson, WP				Sangha, KK; Stephenson, MD; Brown, CJ; Robinson, WP			Extremely skewed X-chromosome inactivation is increased in women with recurrent spontaneous abortion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TRISOMY-18 MOSAICISM; NORMAL INTELLIGENCE; MISCARRIAGE; PREGNANCY; PATTERNS; FAMILIES; HISTORY; COUPLES; TWINS; ADULT		Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; BC Res Inst Childrens & Womens Hlth, Vancouver, BC, Canada; Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; BC Women's Hospital & Health Centre	Robinson, WP (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada.	wendyr@interchange.ubc.ca	Robinson, Wendy/AAB-6420-2020; Brown, Carolyn J/A-5159-2014; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Brown, Carolyn J/0000-0002-8959-0101; Robinson, Wendy P/0000-0002-2010-6174				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bamforth F, 1996, AM J MED GENET, V61, P209; Belmont JW, 1996, AM J HUM GENET, V58, P1101; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Busque L, 1996, BLOOD, V88, P59; BYRNE JLB, 1994, CLIN OBSTET GYNECOL, V37, P693, DOI 10.1097/00003081-199409000-00021; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; GAAL M, 1977, HUM HERED, V27, P396, DOI 10.1159/000152900; GERSDORF E, 1990, HUM GENET, V84, P298; Goodship J, 1996, AM J MED GENET, V61, P205, DOI 10.1002/(SICI)1096-8628(19960122)61:3<205::AID-AJMG3>3.0.CO;2-T; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hsu LYF, 1997, PRENATAL DIAG, V17, P201, DOI 10.1002/(SICI)1097-0223(199703)17:3<201::AID-PD56>3.0.CO;2-H; HUNT P, 1995, HUM MOL GENET, V4, P2007, DOI 10.1093/hmg/4.11.2007; KOHN G, 1987, AM J MED GENET, V26, P929, DOI 10.1002/ajmg.1320260423; Lanasa MC, 1999, AM J HUM GENET, V64, P934, DOI 10.1086/302352; Lau AW, 1997, AM J HUM GENET, V61, P1353, DOI 10.1086/301651; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; NIELSEN KG, 1988, HUM GENET, V78, P103, DOI 10.1007/BF00291249; PANGALOS CG, 1992, AM J HUM GENET, V51, P1015; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; PORTNOI MF, 1988, OBSTET GYNECOL, V72, P31; ROMAN E, 1984, J EPIDEMIOL COMMUN H, V38, P29, DOI 10.1136/jech.38.1.29; SACHS ES, 1990, AM J MED GENET, P186; Satge D, 1996, CLIN GENET, V50, P470; Stavropoulos DJ, 1998, AM J HUM GENET, V63, P1912, DOI 10.1086/302149; Stephenson MD, 1996, FERTIL STERIL, V66, P24; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; STRAYPEDERSEN B, 1979, SCAND J INFECT DIS, V11, P159, DOI 10.3109/inf.1979.11.issue-2.12; TSENG LH, 1994, ARCH GYNECOL OBSTET, V255, P213, DOI 10.1007/BF02335088; UCHIDA IA, 1985, HUM GENET, V70, P246; VEJERSLEV LO, 1989, PRENATAL DIAG, V9, P575, DOI 10.1002/pd.1970090807; WARBURTON, 1989, MOL CYTOGENETIC STUD, P165; WARBURTON D, 1964, AM J HUM GENET, V16, P1; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	35	65	67	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					913	917		10.1086/302552	http://dx.doi.org/10.1086/302552			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441596	Green Published, Bronze			2022-12-18	WOS:000082426400035
J	Timchenko, LT				Timchenko, LT			Myotonic dystrophy: The role of RNA CUG triplet repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNSTABLE CTG REPEAT; BINDING-PROTEIN; MESSENGER-RNA; UNTRANSLATED REGIONS; KINASE; GENE; IDENTIFICATION; EXPANSION; MICE; DIFFERENTIATION		Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA	Baylor College of Medicine	Timchenko, LT (corresponding author), Baylor Coll Med, Dept Med, Cardiol Sect, 1 Baylor Plaza, Houston, TX 77030 USA.							ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bhagwati S, 1996, BIOCHEM BIOPH RES CO, V228, P55, DOI 10.1006/bbrc.1996.1615; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bush EW, 1996, J BIOL CHEM, V271, P548, DOI 10.1074/jbc.271.1.548; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Caskey CT, 1996, COLD SPRING HARB SYM, V61, P607; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P., 1995, METABOLIC MOL BASES, P4227; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; KOOB MD, 1998, AM J HUM GENET S, V63, pA39; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Sabourin LA, 1997, J BIOL CHEM, V272, P29626, DOI 10.1074/jbc.272.47.29626; Steinbach P, 1998, AM J HUM GENET, V62, P278, DOI 10.1086/301711; Tapscott SJ, 1998, CURR OPIN GENET DEV, V8, P245, DOI 10.1016/S0959-437X(98)80148-2; TIMCHENKO L, 1995, SEMIN CELL BIOL, V6, P13, DOI 10.1016/1043-4682(95)90010-1; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; TIMCHENKO LT, 1998, AM J HUM GENET S, V63, pA32; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599	34	65	65	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					360	364		10.1086/302268	http://dx.doi.org/10.1086/302268			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973273	Bronze, Green Published			2022-12-18	WOS:000078740600005
J	Foster, MW; Bernsten, D; Carter, TH				Foster, MW; Bernsten, D; Carter, TH			A model agreement for genetic research in socially identifiable populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFORMED CONSENT; CLINICAL RESEARCH; CYSTIC-FIBROSIS; HUMAN GENOME; ETHICS; AUTONOMY; ISSUES; WORLD	Genetic research increasingly focuses on population-specific human genetic diversity. However, the naming of a human population in public databases and scientific publications entails collect ive risks for its members. Those collective risks can be evaluated and protections can be put in place by the establishment of a dialogue with the subject population, before a research study is initiated. Here we describe an agreement to undertake genetic research with a Native American tribe. We identified the culturally appropriate public and private social units within which community members are accustomed to make decisions about health. We then engaged those units in a process of communal discourse. In their discourses about our proposed study, community members expressed most concern about culturally specific implications. We also found that, in this population, private social units were more influential in communal decision making than were public authorities. An agreement was reached that defined the scope of research, provided options for naming the population in publications (including anonymity), and addressed the distribution of royalties from intellectual property, the future use of archival samples, and specific cultural concerns. We found that informed consent by individuals could not fully address these collective issues. This approach may serve as a general model for the undertaking of population-specific genetic studies.	Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, William K Warren Med Res Inst, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Foster, MW (corresponding author), Univ Oklahoma, Dept Anthropol, 455 W Lindsey Ave,Room 515, Norman, OK 73019 USA.			Carter, Thomas/0000-0001-7796-2986	NHGRI NIH HHS [HG010302] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Bernstein T, 1994, RADON RENTAL HOUSING; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Botkin JR, 1998, JAMA-J AM MED ASSOC, V279, P1808, DOI 10.1001/jama.279.22.1808; Brown PO, 1998, NAT GENET, V18, P91, DOI 10.1038/ng0298-91; CAPLAN AL, 1994, JUSTICE HUMAN GENOME, P30; CHRISTAKIS NA, 1992, SOC SCI MED, V35, P1079, DOI 10.1016/0277-9536(92)90220-K; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Devgan SA, 1997, PROSTATE, V33, P9, DOI 10.1002/(SICI)1097-0045(19970915)33:1<9::AID-PROS2>3.0.CO;2-H; Elias, 1992, GENE MAPPING USING L, P94; Foster MW, 1997, NAT GENET, V17, P277, DOI 10.1038/ng1197-277; FREIDLANDER J, 1996, CULT SURVIVAL Q, V20, P22; Glick SM, 1997, NEW ENGL J MED, V336, P954, DOI 10.1056/NEJM199703273361312; GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P844; KEREM E, 1995, HUM GENET, V96, P193, DOI 10.1007/BF00207378; Kevles D, 1985, NAME EUGENICS GENETI; Knoppers BM, 1996, GENOMICS, V34, P272, DOI 10.1006/geno.1996.0287; Lyttle J, 1997, CAN MED ASSOC J, V156, P257; Lyttle J, 1997, CAN MED ASSOC J, V156, P411; Macilwain C, 1996, NATURE, V383, P208, DOI 10.1038/383208b0; *NAT RES COUNC COM, 1997, EV HUM GEN DIV; OBER C, 1992, AM J HUM GENET, V51, P1344; Parker LS, 1996, CLIN OBSTET GYNECOL, V39, P873, DOI 10.1097/00003081-199612000-00014; PELLEGRINO ED, 1992, CAMB Q HEALTHC ETHIC, V3, P191; PHOENIX DD, 1995, J NATL MED ASSOC, V87, P801; POMPIDOU A, 1995, J MED ETHICS, V21, P69, DOI 10.1136/jme.21.2.69; Powers Madison, 1993, IRB, V15, P7, DOI 10.2307/3564322; STOLBERG SG, 1998, NY TIMES        0422; Szabo CI, 1997, AM J HUM GENET, V60, P1013; VINCENT J, 1990, POLITICAL ANTHR; WEIR RF, 1995, IRB, V17, P1; Wolf SM, 1995, J LAW MED ETHICS, V23, P345, DOI 10.1111/j.1748-720X.1995.tb01376.x	33	65	65	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					696	702		10.1086/302013	http://dx.doi.org/10.1086/302013			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	119VN	9718343	Bronze, Green Published			2022-12-18	WOS:000075919000006
J	Moghadaszadeh, B; Desguerre, I; Topaloglu, H; Muntoni, FN; Pavek, S; Sewry, C; Mayer, M; Fardeau, M; Tome, FMS; Guicheney, P				Moghadaszadeh, B; Desguerre, I; Topaloglu, H; Muntoni, FN; Pavek, S; Sewry, C; Mayer, M; Fardeau, M; Tome, FMS; Guicheney, P			Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEROSIN; GENE; LOCALIZATION; ASSIGNMENT; MYOPATHY; FAILURE; LINKAGE; MUSCLE; MAP	Classical congenital muscular dystrophies (CMDs) are autosomal recessive neuromuscular disorders characterized by early onset of hypotonia and weakness, atrophy of limbs and trunk muscles, contractures, and dystrophic changes in the muscle biopsy. So far, only one gene, LAMA2 (6q2), which encodes the laminin alpha 2 chain (or merosin), has been identified in these disorders. Mutations in LAMA2 cause CMD with complete or partial :merosin deficiency, detectable by immunocytochemistry ion muscle biopsies, and account for similar to 50%, of CMD cases. In a large consanguineous family (11 siblings) comprising three children affected by CMD without merosin deficiency, we undertook a genomewide search by homozygosity mapping and analyzed 380 microsatellite markers. The affected children were homozygous for several markers on chromosome 1p35-36. We ident ified two additional consanguineous families with affected children who also showed linkage to this locus. A maximum cumulative LOD score of 4.48, at a recombination fraction of .00, was obtained with D1S2885. A consistent feature in these three families was the presence of early rigidity of the spine, scoliosis, and reduced vital capacity, as found in rigid-spine syndrome (RSS). This study is the first description of a locus for a merosin-positive CMD and will help to better define the nosology of RSS.	Grp Hosp Pitie Salpetriere, INSERM, UR153, F-75651 Paris 13, France; Hop St Vincent de Paul, Serv Neuropediat, F-75674 Paris, France; Hacettepe Childrens Hosp, Dept Paediat Neurol, Ankara, Turkey; Hammersmith Hosp, Imperial Coll, Sch Med, Dept Pediat & Neonatal Med, London, England; CNRS, Genethon URA 1922, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; Imperial College London; Centre National de la Recherche Scientifique (CNRS)	Guicheney, P (corresponding author), Grp Hosp Pitie Salpetriere, INSERM, UR153, 47 Blvd Hop, F-75651 Paris 13, France.		TOPALOGLU, HALUK AYDIN/I-9318-2013; Guicheney, Pascale/D-1034-2017	Guicheney, Pascale/0000-0002-7663-2050; Moghadaszadeh, Behzad/0000-0001-9787-0106				BANKER BQ, 1994, MYOLOGY, P1275; BENHAMIDA M, 1987, REV NEUROL, V143, P284; BERTINI E, 1986, J NEUROL, V233, P248, DOI 10.1007/BF00314029; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dubowitz V, 1997, NEUROMUSCULAR DISORD, V7, P539; Dubowitz V, 1996, NEUROMUSCULAR DISORD, V6, P295, DOI 10.1016/0960-8966(96)00358-6; DUBOWITZ V, 1973, P ROY SOC MED, V66, P219, DOI 10.1177/003591577306600304; EFTHIMIOU J, 1987, AM REV RESPIR DIS, V136, P1483, DOI 10.1164/ajrccm/136.6.1483; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; FARACO J, 1995, GENOMICS, V25, P630, DOI 10.1016/0888-7543(95)80004-6; Fardeau M, 1996, REV NEUROL, V152, P11; Fontaine B, 1996, HUM GENET, V98, P380, DOI 10.1007/s004390050225; Fukuyama Y, 1960, PAEDIAT U TOKYO, V4, P5; GOTO I, 1981, J NEUROL, V226, P143, DOI 10.1007/BF00313443; HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; KALLUNKI P, 1991, GENOMICS, V11, P389, DOI 10.1016/0888-7543(91)90147-7; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MERLINI L, 1989, J CHILD NEUROL, V4, P274, DOI 10.1177/088307388900400405; MORITA H, 1990, J NEUROL NEUROSUR PS, V53, P782, DOI 10.1136/jnnp.53.9.782; MUSSINI JM, 1982, REV NEUROL, V138, P25; PALMUCCI L, 1991, J NEUROL NEUROSUR PS, V54, P42, DOI 10.1136/jnnp.54.1.42; PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; POEWE W, 1985, J NEUROL NEUROSUR PS, V48, P887, DOI 10.1136/jnnp.48.9.887; RAS GJ, 1994, AM J RESP CRIT CARE, V150, P540, DOI 10.1164/ajrccm.150.2.8049843; ROWLAND LP, 1979, ANN NEUROL, V5, P111, DOI 10.1002/ana.410050203; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; TOPALOGLU H, 1994, NEUROMUSCULAR DISORD, V4, P263, DOI 10.1016/0960-8966(94)90028-0; VANMUNSTER ETL, 1986, J NEUROL NEUROSUR PS, V49, P1292, DOI 10.1136/jnnp.49.11.1292; Vignal Alain, 1993, V1, P211	32	65	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1439	1445		10.1086/301882	http://dx.doi.org/10.1086/301882			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585610	Bronze, Green Published			2022-12-18	WOS:000074174700020
J	Pan, YZ; McCaskill, CD; Thompson, KH; Hicks, J; Casey, B; Shaffer, LG; Craigen, WJ				Pan, YZ; McCaskill, CD; Thompson, KH; Hicks, J; Casey, B; Shaffer, LG; Craigen, WJ			Paternal isodisomy of chromosome 7 associated with complete situs inversus and immotile cilia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							UNIPARENTAL DISOMY; CYSTIC-FIBROSIS; KARTAGENERS SYNDROME; GROWTH-RETARDATION; BEAT FREQUENCY; ULTRASTRUCTURE; PATIENT; HUMANS; MAP		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Craigen, WJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, S821,1 Baylor Plaza, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD027823] Funding Source: NIH RePORTER; NICHD NIH HHS [1P30-HD27823, 2P30-HD24064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRAMOWICZ MJ, 1994, J CLIN INVEST, V94, P418, DOI 10.1172/JCI117339; Afzelius BA, 1995, METABOLIC MOL BASES, P3943; Benlian P, 1996, AM J HUM GENET, V59, P431; BURNELL RH, 1974, AM J DIS CHILD, V127, P746, DOI 10.1001/archpedi.1974.02110240132022; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; GENUARDI M, 1993, AM J MED GENET, V47, P823, DOI 10.1002/ajmg.1320470606; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HERZON FS, 1980, ANN OTO RHINOL LARYN, V89, P81, DOI 10.1177/000348948008900120; HOGLUND P, 1994, AM J HUM GENET, V55, P747; HUBBARD VS, 1980, AM J DIS CHILD, V134, P317, DOI 10.1001/archpedi.1980.02130150071018; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; KOIFFMANN CP, 1993, AM J MED GENET, V47, P568, DOI 10.1002/ajmg.1320470426; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LIECHTIGALLATI S, 1995, CLIN GENET, V47, P328; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P78; PENTAO L, 1992, AM J HUM GENET, V50, P690; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; Quan F, 1997, AM J HUM GENET, V60, P160; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; RUTLAND J, 1980, LANCET, V2, P564; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; Teknos TN, 1997, OTOLARYNG HEAD NECK, V116, P68, DOI 10.1016/S0194-5998(97)70354-1; VOSS R, 1989, AM J HUM GENET, V45, P373; WOODAGE T, 1994, AM J HUM GENET, V55, P74	35	65	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1551	1555		10.1086/301857	http://dx.doi.org/10.1086/301857			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585585	Green Published, Bronze			2022-12-18	WOS:000074174700037
J	Austin, MA; Talmud, PJ; Luong, LA; Haddad, L; Day, INM; Newman, B; Edwards, KL; Krauss, RM; Humphries, SE				Austin, MA; Talmud, PJ; Luong, LA; Haddad, L; Day, INM; Newman, B; Edwards, KL; Krauss, RM; Humphries, SE			Candidate-gene studies of the atherogenic lipoprotein phenotype: A sib-pair linkage analysis of DZ women twins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; FAMILIAL COMBINED HYPERLIPIDEMIA; COMPLEX SEGREGATION ANALYSIS; APOLIPOPROTEIN-A-I; HORMONE-SENSITIVE LIPASE; LDL SUBCLASS PHENOTYPES; PLASMA TRIGLYCERIDE; INHERITED SUSCEPTIBILITY; MYOCARDIAL-INFARCTION; GEL-ELECTROPHORESIS	There is a growing body of evidence supporting the roles of small, dense LDL and plasma triglyceride (TG), both features of the atherogenic lipoprotein phenotype, as risk factors for coronary heart disease. Although family studies and twin studies have demonstrated genetic influences on these risk factors, the specific genes involved remain to be determined definitively. The purpose of this study was to investigate genetic linkage between LDL size, TG, and related atherogenic lipoproteins and candidate genes known to be involved in lipid metabolism. The linkage analysis was based on a sample of 126 DZ women twin pairs, which avoids the potentially confounding effects of both age and gender, by use of a quantitative sib-pair linkage-analysis approach. Eight candidate genes were examined, including those for microsomal TG-transfer protein (MTP), hepatic lipase, hormone-sensitive lipase, apolipoprotein (apo) B, apo CIII, apo E, insulin receptor, and LDL receptor: The analysis suggested genetic linkage between markers for the apo B gene and LDL size, plasma levels of TG, of HDL cholesterol, and of apo B, all features of the atherogenic lipoprotein phenotype. Furthermore, evidence for linkage was maintained when the analysis was limited to women with a major LDL-subclass diameter >255 Angstrom, indicating that the apo B gene may influence LDL heterogeneity in the intermediate-to-large size range. In addition, linkage was found between the MTP gene and TG, among all the women. These findings add to the growing evidence for genetic influences on the atherogenic lipoprotein phenotype and its role in genetic susceptibility to atherosclerosis.	Univ Washington, Dept Epidemiol, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA; UCL, Rayne Inst, Div Cardiovasc Genet, London, England; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; Ernest Orlando Lawrence Berkeley Natl Lab, Div Life Sci, Dept Mol & Nucl Med, Berkeley, CA USA	University of Washington; University of Washington Seattle; University of London; King's College London; University College London; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Austin, MA (corresponding author), Univ Washington, Dept Epidemiol, Sch Publ Hlth & Community Med, Box 357236, Seattle, WA 98195 USA.	maustin@u.washington.edu	Talmud, Philippa J/C-4402-2008	Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	NCI NIH HHS [R01 CA149051] Funding Source: Medline; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NHLBI NIH HHS [HL-46880, HL-41830] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA149051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046880, R01HL041830] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOS CI, 1988, THESIS LOUISANA STAT; [Anonymous], 1993, JAMA, V269, P505; AUSTIN MA, 1995, JAMA-J AM MED ASSOC, V273, P115, DOI 10.1001/jama.1995.03520260035025; AUSTIN MA, 1993, ARTERIOSCLER THROMB, V13, P687, DOI 10.1161/01.ATV.13.5.687; AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; AUSTIN MA, 1993, GENET EPIDEMIOL, V10, P599, DOI 10.1002/gepi.1370100645; AUSTIN MA, 1991, GENET EPIDEMIOL, V8, P287, DOI 10.1002/gepi.1370080502; Austin Melissa A., 1994, Current Opinion in Lipidology, V5, P395, DOI 10.1097/00041433-199412000-00002; BHATTACHARYA S, 1991, NUCLEIC ACIDS RES, V19, P5088, DOI 10.1093/nar/19.18.5088-a; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOLLA MK, 1995, CLIN CHEM, V41, P1599; Bredie SJH, 1996, AM J HUM GENET, V58, P812; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; DAMMERMAN M, 1993, P NATL ACAD SCI USA, V90, P4562, DOI 10.1073/pnas.90.10.4562; Day INM, 1997, J MED GENET, V34, P111, DOI 10.1136/jmg.34.2.111; DEGRAAF J, 1992, AM J HUM GENET, V51, P1295; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALEANO NF, 1994, J BIOL CHEM, V269, P511; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRIFFIN BA, 1994, ATHEROSCLEROSIS, V106, P241, DOI 10.1016/0021-9150(94)90129-5; HAFFNER SM, 1993, ARTERIOSCLER THROMB, V13, P1623, DOI 10.1161/01.ATV.13.11.1623; Haffner SM, 1996, ARTERIOSCL THROM VAS, V16, P1184, DOI 10.1161/01.ATV.16.9.1184; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Humphries S, 1996, PENN CTR N, V6, P279; HUMPHRIES SE, 1995, CLIN ENDOCRINOLOGY M, P797; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; KRAUSS RM, 1982, J LIPID RES, V23, P97; LABELLE M, 1991, GENET EPIDEMIOL, V8, P269, DOI 10.1002/gepi.1370080407; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; LAMONFAVA S, 1991, ATHEROSCLEROSIS, V91, P97, DOI 10.1016/0021-9150(91)90191-5; Levitt R. C., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139; MCNAMARA JR, 1992, ARTERIOSCLER THROMB, V12, P1284, DOI 10.1161/01.ATV.12.11.1284; MULLENBACH R, 1989, TRENDS GENET, V5, P391; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; OUCHERONY O, 1978, HDB EXPT IMMUNOLOGY; PEDERSEN TR, 1994, LANCET, V344, P1383; RIFAI N, 1986, CLIN CHEM, V32, P957; Rotter JI, 1996, AM J HUM GENET, V58, P585; SAGE, 1994, STAT AN GEN EP REL 2; SELBY JV, 1993, CIRCULATION, V88, P381, DOI 10.1161/01.CIR.88.2.381; SHARP D, 1994, BIOCHEMISTRY-US, V33, P9057, DOI 10.1021/bi00197a005; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shimada F, 1996, METABOLISM, V45, P862, DOI 10.1016/S0026-0495(96)90160-2; SMITH SJ, 1987, CLIN CHEM, V33, P2240; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; TALMUD PJ, 1994, GENET EPIDEMIOL, V11, P265, DOI 10.1002/gepi.1370110305; THOMSON G, 1994, GENET EPIDEMIOL, V11, P353, DOI 10.1002/gepi.1370110405; WARNICK GR, 1985, CLIN CHEM, V31, P217; XIANG K, 1991, NUCLEIC ACIDS RES, V19, P5094, DOI 10.1093/nar/19.18.5094-a; ZENG Q, 1995, HUM GENET, V95, P371; ZULIANI G, 1990, NUCLEIC ACIDS RES, V18, P4299	63	65	65	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					406	419		10.1086/301712	http://dx.doi.org/10.1086/301712			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463319	Green Published, Bronze			2022-12-18	WOS:000072416000025
J	Tysoe, C; Whittaker, J; Xuereb, J; Cairns, NJ; Cruts, M; Van Broeckhoven, C; Wilcock, G; Rubinsztein, DC				Tysoe, C; Whittaker, J; Xuereb, J; Cairns, NJ; Cruts, M; Van Broeckhoven, C; Wilcock, G; Rubinsztein, DC			A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE MUTATION; ASSOCIATION	We have examined genomic DNA from 40 cases of autopsy-confirmed early-onset Alzheimer disease (EOAD) (age at onset less than or equal to 65 years) that were all unselected for family history. We have sequenced the 10 exons and flanking intronic sequences of the presenilin-1 (PS-1) gene for all 40 individuals. A single mutation, a deletion of a G from the intron 4 splice-donor consensus sequence, was detected in two individuals in this study. The mutation was associated with two shortened transcripts, both with shifted reading frames resulting in premature-termination codons. All the PS-1 mutations described elsewhere have been missense or in-frame splice mutations, and recent data suggest that these result in disease by gain-df-function or dominant-negative mechanisms. The mutation that we have identified is likely to result in haploinsufficiency and would be most consistent with other mutations acting in a dominant-negative manner. However, we cannot exclude the possibility that the small amounts of truncated transcripts exert a gain of function. Since no other mutations or polymorphisms were detected in our patients, mutations in the coding regions and splice consensus sequences of PS-1 are likely to be rare in EOAD cases unselected for family history.	Addenbrookes NHS Trust, Dept Med Genet, Cambridge CB2 2QQ, England; Univ Cambridge, Sch Clin, Dept Psychiat, Cambridge Brain Bank Lab, Cambridge, England; Inst Psychiat, Dept Neuropathol, MRC, Brain Bank, London SE5 8AF, England; Univ Antwerp VIB, Dept Biochem, Born Bunge Fdn, Lab Neurogenet, B-2020 Antwerp, Belgium; Univ Bristol, Dept Care Elderly, Day Hosp Lab, Bristol, Avon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Bristol	Rubinsztein, DC (corresponding author), Addenbrookes NHS Trust, Dept Med Genet, Box 158,Hills Rd, Cambridge CB2 2QQ, England.	dcr1000@cus.cam.ac.uk	Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Cairns, Nigel/AAB-9713-2020; Rubinsztein, David C/C-3472-2011	Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Cairns, Nigel/0000-0001-9858-3344; 				Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449; CRUTS M, IN PRESS HUM MOL GEN; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; HESTON LL, 1992, GENETIC BASIS COMMON, P792; Hutton M, 1996, NEUROREPORT, V7, P801, DOI 10.1097/00001756-199602290-00029; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Maquat LE, 1996, AM J HUM GENET, V59, P279; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; PerezTur J, 1995, NEUROREPORT, V7, P297; Rossor MN, 1996, LANCET, V347, P1560, DOI 10.1016/S0140-6736(96)90715-1; Sandbrink R, 1996, MOL PSYCHIATR, V1, P27; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Tanahashi H, 1996, NEUROSCI LETT, V218, P139, DOI 10.1016/S0304-3940(96)13138-4; Tysoe C, 1997, AM J MED GENET, V74, P207, DOI 10.1002/(SICI)1096-8628(19970418)74:2<207::AID-AJMG20>3.0.CO;2-L; Van Broeckhoven C, 1995, NAT GENET, V11, P230; Van Broeckhoven C., 1996, Neurobiology of Aging, V17, pS194, DOI 10.1016/S0197-4580(96)80784-6; VANBROECKHOVEN CL, 1995, EUR NEUROL, V35, P8, DOI 10.1159/000117083; *WHO, 1996, WORLD HLTH STAT ANN; Wragg M, 1996, LANCET, V347, P509, DOI 10.1016/S0140-6736(96)91140-X	24	65	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					70	76		10.1086/301672	http://dx.doi.org/10.1086/301672			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443865	Green Published, Bronze			2022-12-18	WOS:000072127900012
J	DeGasperi, R; Sosa, MAG; Sartorato, EL; Battistini, S; MacFarlane, H; Gusella, JF; Krivit, W; Kolodny, EH				DeGasperi, R; Sosa, MAG; Sartorato, EL; Battistini, S; MacFarlane, H; Gusella, JF; Krivit, W; Kolodny, EH			Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KRABBE DISEASE; HUMAN GALACTOCEREBROSIDASE; GALC GENE; LARGE DELETION; SPLICE-SITE; MUTATION; SUBSTITUTION; EXON; CDNA	Globoid-cell leukodystrophy (GLD) is an autosomal recessive inherited disorder caused by the deficiency of galactocerebrosidase, the lysosomal enzyme responsible for the degradation of the myelin glycolipid galactocerebroside. Although the most common form of the disease is the classical infantile form (Krabbe disease), lateronset forms also have been described, We have analyzed the galactocerebrosidase gene in 17 patients (nine families) with late-onset GLD and in 1 patient with classical Krabbe disease. Half of the patients were heterozygous for the large gene deletion associated with the 502C-->T polymorphism, the most common mutation in infantile patients. Several novel mutations that result in deficient galactocerebrosidase activity were also identified in these patients. They include the missense mutations R63H, G95S, M101L, G268S, Y298C, and I234T; the nonsense mutation S7X; a one-base deletion (805delG); a mutation that interferes with the splicing of intron 1; and a 34-nt insertion in the RNA, caused by the aberrant splicing of intron 6. All of these genetic defects are clustered in the first 10 exons of the galactocerebrosidase gene and therefore affect the 50-kD subunit of the mature enzyme. Studies on the distribution and enzymatic activity of the polymorphic alleles 1637T/C (I546/T546) provided support for previous data that had indicated the existence of two galactocerebrosidase forms with different catalytic activities in the general population. Our data also indicate that the mutations occur preferentially in the ''low activity'' 1637C allele.	NYU,SCH MED,DEPT NEUROL,NEW YORK,NY; MASSACHUSETTS GEN HOSP,MOL NEUROGENET UNIT,CHARLESTOWN,MA; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455	New York University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities			Battistini, Stefania/N-2596-2015	Battistini, Stefania/0000-0003-2887-7624	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 24279] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKLI S, 1990, J BIOL CHEM, V265, P7324; [Anonymous], 1995, METABOLIC MOL BASES; CHEN YQ, 1993, HUM MOL GENET, V2, P1841, DOI 10.1093/hmg/2.11.1841; DEGASPERI R, 1995, BIOCHEM MOL MED, V56, P31, DOI 10.1006/bmme.1995.1053; GREWAL RP, 1991, J NEUROL NEUROSUR PS, V54, P1011, DOI 10.1136/jnnp.54.11.1011; HARA Y, 1994, BBA-GENE STRUCT EXPR, V1217, P49; Kolodny E. H., 1995, American Journal of Human Genetics, V57, pA217; KOLODNY EH, 1991, DEV NEUROSCI-BASEL, V13, P232, DOI 10.1159/000112166; KRAWCZAK M, 1992, HUM GENET, V90, P41; LIND B, 1993, BLOOD, V82, P2423; LUZI P, 1995, GENOMICS, V26, P407, DOI 10.1016/0888-7543(95)80230-J; LUZI P, 1995, HUM MOL GENET, V4, P2335, DOI 10.1093/hmg/4.12.2335; Luzi P., 1995, American Journal of Human Genetics, V57, pA245; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; RAFI MA, 1995, HUM MOL GENET, V4, P1285, DOI 10.1093/hmg/4.8.1285; Rafi MA, 1996, HUM GENET, V97, P304, DOI 10.1007/BF02185759; SAKAI N, 1994, BIOCHEM BIOPH RES CO, V198, P485, DOI 10.1006/bbrc.1994.1071; SATOKATA I, 1992, MUTAT RES, V273, P203, DOI 10.1016/0921-8777(92)90081-D; SHAPIRO EG, 1995, J INHERIT METAB DIS, V18, P413, DOI 10.1007/BF00710053; SOSA MAG, 1994, J VIROL, V68, P2662, DOI 10.1128/JVI.68.4.2662-2670.1994; Sosa MAG, 1996, BIOCHEM BIOPH RES CO, V218, P766, DOI 10.1006/bbrc.1996.0136; TATSUMI N, 1995, HUM MOL GENET, V4, P1865, DOI 10.1093/hmg/4.10.1865; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WENGER DA, 1993, MOL GENETIC BASIS NE, P485; WENGER DA, 1991, TECHNIQUES DIAGNOSTI, P587; ZLOTOGORA J, 1990, AM J HUM GENET, V47, P37	27	65	67	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1233	1242						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940268				2022-12-18	WOS:A1996VV31500009
J	Rathmann, M; Bunge, S; Beck, M; Kresse, H; TylkiSzymanska, A; Gal, A				Rathmann, M; Bunge, S; Beck, M; Kresse, H; TylkiSzymanska, A; Gal, A			Mucopolysaccharidosis type II (Hunter syndrome): Mutation ''hot spots'' in the iduronate-2-sulfatase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDS GENE; SULFATASE; SEQUENCE; DNA; IDENTIFICATION; EXPRESSION; DISEASE; EVENTS; CDNA	Mucopolysaccharidosis type II (MPS II, Hunter syndrome)) is an X-chromosomal storage disorder due to deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). We have identified IDS mutations in a total of 31 families/patients with MPS II, of which 20 are novel and unique and a further 1 is novel but has been found in 3 unrelated patients. One of the mutations detected is of special interest as an A-->G substitution in an intron, far apart from the coding region, is deleterious by creating a new 5'-splice-donor site that results in the inclusion of a 78-bp intronic sequence. While the distribution of gene rearrangements (deletions, insertions, and duplications) of <20 bp seems to be random over the IDS gene, the analysis of a total of 101 point mutations lying within the coding region shows that they tend to be more frequent in exons III, VIII, and IX. Forty-seven percent of the point mutations are at CpG dinucleotides, of which G:C-to-A:T transitions constitute nearly 80%. Almost all recurrent point mutations involve CpG sites. Analysis of a collective of 50 families studied in our laboratory, to date, revealed that mutations occur more frequently in male meioses (estimated male-to-female ratio between 3.76 and 6.3).	UNIV HAMBURG,KRANKENHAUS EPPENDORF,INST HUMAN GENET,D-22529 HAMBURG,GERMANY; UNIV MAINZ,KINDERKLIN,D-6500 MAINZ,GERMANY; UNIV MUNSTER,INST PHYSIOL CHEM,D-4400 MUNSTER,GERMANY; CHILD HLTH CTR,DEPT METAB DIS,WARSAW,POLAND	University of Hamburg; Johannes Gutenberg University of Mainz; University of Munster; Children's Memorial Health Institute				Tylki-Szymanska, Anna/0000-0002-8935-1768				Becker J, 1996, AM J HUM GENET, V58, P657; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; BUNGE S, 1993, HUM MOL GENET, V2, P1871, DOI 10.1093/hmg/2.11.1871; BUNGE S, 1996, METH MOL G, V8, P26; Bunge Susanna, 1992, Human Molecular Genetics, V1, P335, DOI 10.1093/hmg/1.5.335; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER DN, 1994, HUMAN GENE MUTATION; FLOMEN RH, 1993, HUM MOL GENET, V2, P5, DOI 10.1093/hmg/2.1.5; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Goldenfum SL, 1996, HUM MUTAT, V7, P76, DOI 10.1002/(SICI)1098-1004(1996)7:1<76::AID-HUMU14>3.3.CO;2-T; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hogervorst F. B. L., 1994, American Journal of Human Genetics, V55, pA223; HOPWOOD JJ, 1993, HUM MUTAT, V2, P435, DOI 10.1002/humu.1380020603; JONSSON JJ, 1995, AM J HUM GENET, V56, P597; KNOBLOCH O, 1993, HUM GENET, V92, P40, DOI 10.1007/BF00216143; Li P., 1994, American Journal of Human Genetics, V55, pA229; LI PN, 1995, HUM MUTAT, V5, P272, DOI 10.1002/humu.1380050314; MALMGREN H, 1995, GENOMICS, V29, P291, DOI 10.1006/geno.1995.1249; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OLDENBURG J, 1993, AM J HUM GENET, V53, P1229; Olsen TC, 1996, HUM GENET, V97, P198, DOI 10.1007/BF02265265; POPOWSKA E, 1995, HUM MUTAT, V5, P97, DOI 10.1002/humu.1380050114; RATHMANN M, 1995, HUM GENET, V95, P34; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SCHRODER W, 1994, HUM MUTAT, V4, P128, DOI 10.1002/humu.1380040206; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SUKEGAWA K, 1995, HUM MUTAT, V6, P136, DOI 10.1002/humu.1380060206; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; TIMMS KM, 1995, GENOME RES, V5, P71, DOI 10.1101/gr.5.1.71; TOMATSU S, 1991, BIOCHEM BIOPH RES CO, V181, P677, DOI 10.1016/0006-291X(91)91244-7; WEBER C, 1993, HUM MOL GENET, V2, P612; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WILSON PJ, 1993, GENOMICS, V17, P773, DOI 10.1006/geno.1993.1406	34	65	82	0	11	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1202	1209						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940265				2022-12-18	WOS:A1996VV31500006
J	SUPERTIFURGA, A				SUPERTIFURGA, A			A DEFECT IN THE METABOLIC-ACTIVATION OF SULFATE IN A PATIENT WITH ACHONDROGENESIS TYPE IB	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE SYNTHESIS; II COLLAGEN FIBRILLOGENESIS; BRACHYMORPHIC MICE; CHONDROITIN SULFATE; SMALL PROTEOGLYCAN; CARTILAGE MATRIX; CORE PROTEIN; FIBROBLASTS; PAPS; BIOSYNTHESIS	Achondrogenesis type I is a perinatally lethal, short-limb chondrodysplasia. Two types, IA and IB, have been distinguished by radiographic and histological criteria; both types appear to be inherited as autosomal recessive traits, The underlying molecular defects are not known, but histochemical studies have suggested that in achondrogenesis type IB, cartilage matrix is deficient in sulfated proteoglycans. We have studied cartilage extracts of one newborn with achondrogenesis type IB and found that proteoglycans were quantitatively reduced, and, unlike in control cartilage, they did not stain with toluidine blue and did not bind to DEAE. Impaired synthesis of sulfated proteoglycans was observed also in fibroblast cultures of the achondrogenesis IB patient. Radioactive labeling and immunoprecipitation studies indicated that core protein and side chains of proteoglycans were synthesized normally but were not sulfated. Analysis of sulfate metabolism in fibroblast cultures showed, in the patient's cells, normal intracellular levels of free sulfate but markedly reduced levels of the two intermediate compounds in the sulfate activation pathway, adenosine-phosphosulfate and phosphoadenosine-phosphosulfate. The results can be explained by deficient activity of one of the enzymes responsible for the biologic activation of sulfate, possibly similar to that observed in cartilage (but not in skin) of the recessive, nonlethal mouse mutant brachymorphic and leading to defective sulfation of macromolecules. Expression of the sulfation defect in cultured fibroblasts may offer a diagnostic tool for the disorder.			SUPERTIFURGA, A (corresponding author), UNIV ZURICH,CHILDRENS HOSP,DEPT PEDIAT,DIV METAB,STEINWIESSTR 75,CH-8032 ZURICH,SWITZERLAND.		superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531				BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BOROCHOWITZ Z, 1988, J PEDIATR-US, V112, P23, DOI 10.1016/S0022-3476(88)80113-6; CAPASSO JM, 1984, P NATL ACAD SCI-BIOL, V81, P7051, DOI 10.1073/pnas.81.22.7051; CONRAD GW, 1980, J BIOL CHEM, V255, P3086; EYRE DR, 1986, AM J HUM GENET, V39, P52; FRACCARO M, 1952, FOLIA HERED PATHOL, V1, P190; FREISINGER P, 1994, AM J MED GENET, V49, P439, DOI 10.1002/ajmg.1320490418; GELLER DH, 1987, J BIOL CHEM, V262, P7374; GLOSSL J, 1984, J BIOL CHEM, V259, P4144; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; Heinegard Dick, 1993, P189; HORTON WA, 1989, AM J MED GENET, V34, P579, DOI 10.1002/ajmg.1320340425; HUMPHRIES DE, 1989, METHOD ENZYMOL, V179, P428; KRESSE H, 1987, AM J HUM GENET, V41, P436; KUIJER R, 1988, CONNECT TISSUE RES, V17, P83, DOI 10.3109/03008208809015022; LANDAUER W, 1965, J HERED, V56, P131, DOI 10.1093/oxfordjournals.jhered.a107392; LANE PW, 1968, J HERED, V59, P300, DOI 10.1093/oxfordjournals.jhered.a107725; LI H, 1993, J BIOL CHEM, V268, P23504; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; MILLER WA, 1976, J COMP PATHOL, V86, P349, DOI 10.1016/0021-9975(76)90002-5; MOLZ G, 1980, EUR J PEDIATR, V134, P69, DOI 10.1007/BF00442406; MOURAO PAS, 1981, BIOCHEM BIOPH RES CO, V98, P388, DOI 10.1016/0006-291X(81)90852-4; NARDI F, 1974, VIRCHOWS ARCH A, V363, P311, DOI 10.1007/BF00447842; OMOY A, 1976, AM J PATHOL, V82, P71; ORKIN RW, 1977, J CELL BIOL, V73, P287, DOI 10.1083/jcb.73.2.287; ORKIN RW, 1976, DEV BIOL, V50, P82, DOI 10.1016/0012-1606(76)90069-5; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; RAUCH U, 1988, BIOL CHEM H-S, V369, P595, DOI 10.1515/bchm3.1988.369.2.595; Remagen W, 1971, Verh Dtsch Ges Pathol, V55, P510; RITTENHOUSE E, 1978, J EMBRYOL EXP MORPH, V43, P71; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SCHWARTZ NB, 1978, BIOCHEM BIOPH RES CO, V82, P173, DOI 10.1016/0006-291X(78)90592-2; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; SPRANGER JW, 1974, BONE DYSPLASIAS ATLA, P24; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P589, DOI 10.1016/0003-9861(82)90064-9; SUGAHARA K, 1982, ARCH BIOCHEM BIOPHYS, V214, P602, DOI 10.1016/0003-9861(82)90065-0; SUGAHARA K, 1979, P NATL ACAD SCI USA, V76, P6615, DOI 10.1073/pnas.76.12.6615; SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348; URSO F P, 1974, Birth Defects Original Article Series, V10, P10; van der Harten H J, 1988, Pediatr Pathol, V8, P571; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; WATANABE II, 1994, NAT GENET, V7, P154; WIEDEMANN HR, 1974, Z KINDERHEILKD, V116, P223, DOI 10.1007/BF00436949; YANG SS, 1974, J PEDIATR-US, V85, P796, DOI 10.1016/S0022-3476(74)80343-4; YANG SS, 1976, HUM PATHOL, V7, P667, DOI 10.1016/S0046-8177(76)80078-0	46	65	68	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1137	1145						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977372				2022-12-18	WOS:A1994QB68400009
J	KNAPP, M; SEUCHTER, SA; BAUR, MP				KNAPP, M; SEUCHTER, SA; BAUR, MP			2-LOCUS DISEASE-MODELS WITH 2-MARKER LOCI - THE POWER OF AFFECTED-SIB-PAIR TESTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; LINKAGE ANALYSIS; 2-LOCUS MODELS; TRAITS; HETEROGENEITY; STRATEGIES	Recently, Schork et al. found that two-trait-locus, two-marker-locus (parametric) linkage analysis can provide substantially mole linkage information than can standard one-trait-locus, one-marker-locus methods. However, because of the increased burden of computation, Schork et al. do not expect that their approach will be applied in an initial genome scan. Further, the specification of a suitable two-locus segregation model can be crucial. Affected-sib-pair tests are computationally simple and do not require an explicit specification of the disease model. In the past, however, these tests mainly have been applied to data with a single marker Locus. Here, we consider sib-pair tests that make it possible to analyze simultaneously two marker loci. The power of these tests is investigated for different (epistatic and heterogeneous) two-trait-locus models, each trait locus being linked to one of the marker loci. We compare these tests both with the test that is optimal for a certain model and with the strategy that analyzes each marker locus separately. The results indicate that a straightforward extension of the well-known mean test for two marker loci can be much more powerful than single-marker-locus analysis and that its power is only slightly inferior to the power of the optimal test.			KNAPP, M (corresponding author), UNIV BONN,INST MED STAT,SIGMUND FREUD STR 25,D-53105 BONN,GERMANY.							BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; Bishop YM., 2007, DISCRETE MULTIVARIAT; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; DIZIER MH, 1986, GENET EPIDEMIOL, V3, P343, DOI 10.1002/gepi.1370030507; DURNER M, 1992, AM J HUM GENET, V51, P859; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; HODGE SE, 1981, AM J HUM GENET, V33, P381; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; KNAPP M, 1991, GENET EPIDEMIOL, V8, P141, DOI 10.1002/gepi.1370080207; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1990, AM J HUM GENET, V46, P242; SCHAID DJ, 1990, GENET EPIDEMIOL, V7, P359, DOI 10.1002/gepi.1370070506; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WICHMANN BA, 1982, APPLIED STATISTICS, V31, P188	21	65	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					1030	1041						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977340				2022-12-18	WOS:A1994QB68200023
J	HASSTEDT, SJ; CLEGG, DO; INGLES, L; WARD, RH				HASSTEDT, SJ; CLEGG, DO; INGLES, L; WARD, RH			HLA-LINKED RHEUMATOID-ARTHRITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHARED-EPITOPE HYPOTHESIS; COLLAGEN-INDUCED ARTHRITIS; 3RD HYPERVARIABLE REGION; BETA-CHAIN GENES; EXTENDED HAPLOTYPES; MULTIPLE THRESHOLDS; MULTICASE FAMILIES; SUSCEPTIBILITY; ASSOCIATION; HLA-DR4	Twenty-eight pedigrees were ascertained through pairs of first-degree relatives diagnosed with rheumatoid arthritis (RA). RA was confirmed in 77 pedigree members including probands; the absence of disease was verified in an additional 261 pedigree members. Pedigree members were serologically typed for HLA. We used likelihood analysis to statistically characterize the HLA-linked RA susceptibility locus. The genetic model assumed tight linkage to HLA. The analysis supported the existence of an HLA-linked RA susceptibility locus, estimated the susceptibility allele frequency as 2.16%, and estimated the lifetime penetrance as 41% in male homozygotes and as 48% in female homozygotes. Inheritance was recessive in males and was nearly recessive in females. In addition, the analysis attributed 78% of the variance within genotypes to genetic or environmental effects shared by siblings. The genetic model inferred in this analysis is consistent with previous association, linkage, and familial aggregation studies of RA. The inferred HLA-linked RA susceptibility locus accounts for approximately one-half of familial RA, although it accounts for only approximately one-fifth of the RA in the population. Although other genes may account for the remaining familial RA, a large portion of RA cases may occur sporadically.	UNIV UTAH, DEPT MED, SALT LAKE CITY, UT 84112 USA; VET ADM MED CTR, SALT LAKE CITY, UT 84148 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	HASSTEDT, SJ (corresponding author), UNIV UTAH, DEPT HUMAN GENET, 2100 ECCLES INST HUMAN GENET, SALT LAKE CITY, UT 84112 USA.				NIAMS NIH HHS [AR40057] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040057] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHO K, 1986, J RHEUMATOL, V13, P899; BANERJEE S, 1988, J EXP MED, V167, P832, DOI 10.1084/jem.167.3.832; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BOKI KA, 1992, ARTHRITIS RHEUM, V35, P749, DOI 10.1002/art.1780350706; COLACO CB, 1986, DIS MARKERS, V4, P99; COX DW, 1976, LANCET, V1, P1216; CUTBUSH SD, 1986, DIS MARKERS, V4, P173; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DEIGHTON CM, 1993, BRIT J RHEUMATOL, V32, P893; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; DIZIER MH, 1993, AM J HUM GENET, V53, P715; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FUNKHOUSER SW, 1992, ARTHRITIS RHEUM, V35, P465, DOI 10.1002/art.1780350417; GAO XJ, 1991, J RHEUMATOL, V18, P801; GAO XJ, 1988, AM J MED, V85, P14, DOI 10.1016/0002-9343(88)90373-7; GIBOFSKY A, 1978, J EXP MED, V148, P1728, DOI 10.1084/jem.148.6.1728; GO RCP, 1987, ARTHRITIS RHEUM, V30, P1115; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAQQI TM, 1989, IMMUNOGENETICS, V29, P180, DOI 10.1007/BF00373643; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HASSTEDT SJ, 1994, PAP PEDIGREE ANAL PA; HAZELTON RA, 1982, Q J MED, V51, P336; KHAN MA, 1986, DIS MARKERS, V4, P67; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; MCDERMOTT M, 1986, DIS MARKERS, V4, P103; MICHALSKI JP, 1982, J RHEUMATOL, V9, P451; MOXLEY G, 1992, ARTHRITIS RHEUM, V35, P19, DOI 10.1002/art.1780350104; NEPOM GT, 1986, LANCET, V2, P1002; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; OLLIER W, 1986, DIS MARKERS, V4, P85; OLLIER W, 1988, ANN RHEUM DIS, V47, P843, DOI 10.1136/ard.47.10.843; OLLIER WER, 1991, ANN RHEUM DIS, V50, P295, DOI 10.1136/ard.50.5.295; PAPIHA SS, 1985, HUM GENET, V70, P278; PROPERT DN, 1982, IMMUNOGENETICS RHEUM, P127; PUTTICK A, 1986, DIS MARKERS, V4, P139; RAUM D, 1984, ARTHRITIS RHEUM, V27, P516, DOI 10.1002/art.1780270506; READ AP, 1986, DIS MARKERS, V4, P59; READ AP, 1983, DIS MARKERS, V1, P272; REICH T, 1979, ANN HUM GENET, V42, P371, DOI 10.1111/j.1469-1809.1979.tb00670.x; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311, DOI 10.1002/gepi.1370100504; RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153, DOI 10.1002/gepi.1370080303; RISCH N, 1990, AM J HUM GENET, V46, P222; ROPES M W, 1958, Bull Rheum Dis, V9, P175; ROSSEN RD, 1982, HUM IMMUNOL, V4, P183, DOI 10.1016/0198-8859(82)90034-9; ROSSEN RD, 1980, J CLIN INVEST, V65, P629, DOI 10.1172/JCI109708; SAKKAS LI, 1987, ARTHRITIS RHEUM, V30, P231, DOI 10.1002/art.1780300218; SAKKAS LI, 1987, J IMMUNOGENET, V14, P189; SANDERS PA, 1985, ANN RHEUM DIS, V44, P529, DOI 10.1136/ard.44.8.529; SANDERS PA, 1987, J RHEUMATOL, V14, P718; SEGLIAS J, 1992, ARTHRITIS RHEUM, V35, P163, DOI 10.1002/art.1780350207; SIDEBOTTOM D, 1987, ANN RHEUM DIS, V46, P587, DOI 10.1136/ard.46.8.587; SILMAN AJ, 1992, ARTHRITIS RHEUM, V35, pS47; SILMAN AJ, 1986, DIS MARKERS, V4, P55; SINGAL DP, 1989, TRANSPLANT P, V21, P632; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; STASTNY P, 1988, BRIT J RHEUMATOL, V27, P132; STROM H, 1981, TISSUE ANTIGENS, V18, P92, DOI 10.1111/j.1399-0039.1981.tb01370.x; STROM H, 1985, HUM IMMUNOL, V13, P243, DOI 10.1016/0198-8859(85)90003-5; TENWOLDE S, 1993, LANCET, V341, P200; THOMPSON EA, 1979, GENETIC ANAL COMMON, P363; TIWARI JL, 1985, HLA DISEASE ASS; WALKER DJ, 1987, ARTHRITIS RHEUM, V30, P31, DOI 10.1002/art.1780300104; WALKER DJ, 1986, DIS MARKERS, V4, P121; WALLIN J, 1991, ARTHRITIS RHEUM, V34, P1416; WARD RH, 1992, ARTHRITIS RHEUM, V35, pS127; WARD RH, 1992, ARTHRITIS RHEUM, V35, pS126; WILLKENS RF, 1991, ARTHRITIS RHEUM, V34, P43, DOI 10.1002/art.1780340107; WOODROW JC, 1986, DIS MARKERS, V4, P7; WOODROW JC, 1981, BRIT MED J, V283, P1287, DOI 10.1136/bmj.283.6302.1287; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P151; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; YAMASHITA TS, 1986, DIS MARKERS, V4, P113; ZARNOWSKI H, 1986, J RHEUMATOL, V13, P858; [No title captured]	79	65	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					738	746						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942852				2022-12-18	WOS:A1994PJ02700017
J	MARTINEZ, FD; HOLBERG, CJ; HALONEN, M; MORGAN, WJ; WRIGHT, AL; TAUSSIG, LM				MARTINEZ, FD; HOLBERG, CJ; HALONEN, M; MORGAN, WJ; WRIGHT, AL; TAUSSIG, LM			EVIDENCE FOR MENDELIAN INHERITANCE OF SERUM IGE LEVELS IN HISPANIC AND NON-HISPANIC WHITE FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNOGLOBULIN-E; SEGREGATION ANALYSIS; REGRESSIVE MODELS; GENETIC-ANALYSIS; MAJOR GENE; TRAITS; ASTHMA; TRANSMISSION; CHILDREN; DISEASE	Considerable evidence is available suggesting a significant genetic component in the pathogenesis of asthma, but the mechanism of inheritance is not well. understood. The main objective of this study was to assess if total serum IgE level, a known intermediate phenotype for asthma, is under the control of a major autosomal gene. We studied nuclear families participating in the Tucson Children's Respiratory Study in Tucson and originally selected because they belonged to a health maintenance organization. One hundred twenty-five Hispanic and 673 non-Hispanic White nuclear families were eligible; 50 Hispanic families (with 191 subjects) and 241 non-Hispanic White families (with 886 subjects) were included. Prevalence of asthma, hay fever, and parental smoking was similar among eligible families who were included and those who were not. Segregation analyses using regressive models for continuous traits showed that the best fit to the data was given by a model of Mendelian codominant inheritance of a major autosomal gene associated with higher serum IgE level. Log-likelihood for this model was not significantly different from that of the best-fitting (''unrestricted'') model (P=.3) and was significantly better than log-likelihood for a dominant model (P<.0001) and a recessive model (P<.0001). An environmental model showed significant departure (P<.0001) from the unrestricted model. Tests for genetic heterogeneity showed no significant difference between the two ethnic groups. The data strongly suggest that total serum IgE levels are controlled by a major autosomal codominant gene.	UNIV ARIZONA,COLL MED,CTR SCI RES,TUCSON,AZ; UNIV ARIZONA,COLL MED,STEELE MEM CHILDRENS RES CTR,TUCSON,AZ	University of Arizona; University of Arizona				Halonen, Marilyn/0000-0001-9606-935X	NCRR NIH HHS [1 P41 RR03635] Funding Source: Medline; NHLBI NIH HHS [HL-14136] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014136] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BLUMENTHAL MN, 1981, AM J MED GENET, V10, P219, DOI 10.1002/ajmg.1320100304; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BORECKI I B, 1985, Genetic Epidemiology, V2, P327, DOI 10.1002/gepi.1370020402; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; COOKSON WOCM, 1988, LANCET, V1, P86; DEMENAIS F, 1993, AM J HUM GENET, V52, P441; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; ELSTON RC, 1980, ADV HUM GENET, V2, P63; FREIDHOFF LR, 1987, J ALLERGY CLIN IMMUN, V80, P646, DOI 10.1016/0091-6749(87)90283-1; GERRARD JW, 1978, AM J HUM GENET, V30, P46; GO RCP, 1978, AM J HUM GENET, V30, P28; HANSON B, 1991, AM J HUM GENET, V48, P873; HASSTEDT SJ, 1983, AM J MED GENET, V14, P61, DOI 10.1002/ajmg.1320140110; HOLBERG CJ, 1987, INT J EPIDEMIOL, V16, P399, DOI 10.1093/ije/16.3.399; Khoury M, 1993, FUNDAMENTALS GENETIC; LEUNG DYM, 1993, PEDIATR RES, V33, pS56; LYMPANY P, 1992, J ALLERGY CLIN IMMUN, V89, P619, DOI 10.1016/0091-6749(92)90330-5; MARSH DG, 1992, NAT GENET, V2, P252, DOI 10.1038/ng1292-252; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MCGUFFIN P, 1990, AM J HUM GENET, V46, P994; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MEYERS DA, 1982, HUM HERED, V32, P15, DOI 10.1159/000153262; MORGAN WJ, 1992, PEDIATR CLIN N AM, V39, P1185; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; MYERS DA, 1990, GENETIC ENV FACTORS, P161; ROMAGNANI S, 1992, INT ARCH ALLERGY IMM, V98, P279, DOI 10.1159/000236199; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SIBBALD B, 1979, THORAX, V34, P322; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; 1992, STATISTICAL ANAL GEN	35	65	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					555	565						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079994				2022-12-18	WOS:A1994PF50900017
J	SUZUKI, Y; SHIMOZAWA, N; YAJIMA, S; TOMATSU, S; KONDO, N; NAKADA, Y; AKABOSHI, S; IAI, M; TANABE, Y; HASHIMOTO, T; WANDERS, RJA; SCHUTGENS, RBH; MOSER, HW; ORII, T				SUZUKI, Y; SHIMOZAWA, N; YAJIMA, S; TOMATSU, S; KONDO, N; NAKADA, Y; AKABOSHI, S; IAI, M; TANABE, Y; HASHIMOTO, T; WANDERS, RJA; SCHUTGENS, RBH; MOSER, HW; ORII, T			NOVEL SUBTYPE OF PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY AND BIFUNCTIONAL ENZYME DEFICIENCY WITH DETECTABLE ENZYME PROTEIN - IDENTIFICATION BY MEANS OF COMPLEMENTATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAT-LIVER PEROXISOMES; HEPATO-RENAL SYNDROME; CHAIN FATTY-ACIDS; BETA-OXIDATION; ZELLWEGER SYNDROME; ADRENOLEUKODYSTROPHY; DISORDERS; CELLS; FIBROBLASTS; CLOFIBRATE	We describe four infants with a novel subtype of an isolated deficiency of one of the peroxisomal beta-oxidation enzymes with detectable enzyme protein. The patients showed characteristic clinical and biochemical abnormalities, including hypotonia, psychomotor retardation, hepatomegaly, typical facial appearance, accumulation of very-long-chain fatty acids, and decreased lignoceric acid oxidation. However, beta-oxidation enzyme proteins were detected by immunoblot analyses, and large peroxisomes were identified by immunofluorescence staining. In order to identify the underlying defect in these patients, complementation analysis was introduced using fibroblasts from these patients and patients with an established deficiency of either acyl-CoA oxidase or bifunctional enzyme, as identified by immunoblotting. In the complementing combinations, fused cells showed increased lignoceric acid oxidation, resistance against 1-pyrene dodecanoic acid/UV selection, and normalization of the size and the distribution of peroxisomes. The results indicate that two patients with a more severe clinical course were suffering from bifunctional enzyme deficiency and that the other two infants, who were siblings and had a less severe clinical presentation, were the first patients with acyl-CoA oxidase deficiency with detectable enzyme protein.	UNIV RYUKYUS,SCH MED,DEPT PEDIAT,NAHA,OKINAWA 903,JAPAN; TOTTORI UNIV,SCH MED,INST NEUROL SCI,DIV CHILD NEUROL,YONAGO,TOTTORI 683,JAPAN; CHIBA CHILDRENS HOSP,DEPT NEUROL,CHIBA,JAPAN; SHINSHU UNIV,SCH MED,DEPT BIOCHEM,MATSUMOTO,NAGANO 390,JAPAN; UNIV AMSTERDAM HOSP,DEPT PEDIAT & CLIN BIOCHEM,AMSTERDAM,NETHERLANDS; JOHNS HOPKINS UNIV,KENNEDY KRIEGER INST,BALTIMORE,MD 21218	University of the Ryukyus; Tottori University; Chiba Children's Hospital; Shinshu University; University of Amsterdam; Academic Medical Center Amsterdam; Johns Hopkins University; Kennedy Krieger Institute	SUZUKI, Y (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN.							BARTH PG, 1990, EUR J PEDIATR, V149, P722, DOI 10.1007/BF01959531; CASTEELS M, 1988, J BIOL CHEM, V263, P4654; CLAYTON PT, 1988, J INHERIT METAB DIS, V11, P165, DOI 10.1007/BF01804226; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; GOLDFISCHER S, 1986, J PEDIATR-US, V108, P25, DOI 10.1016/S0022-3476(86)80764-8; HOEFLER G, 1991, J CLIN INVEST, V88, P1873, DOI 10.1172/JCI115509; KASE BF, 1985, J CLIN INVEST, V75, P427, DOI 10.1172/JCI111717; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; MANDEL H, 1992, J INHERIT METAB DIS, V15, P381, DOI 10.1007/BF02435982; MCGUINNESS MC, 1990, BIOCHEM BIOPH RES CO, V172, P364, DOI 10.1016/S0006-291X(05)80218-9; MIYAZAWA S, 1980, EUR J BIOCHEM, V103, P589, DOI 10.1111/j.1432-1033.1980.tb05984.x; NAIDU S, 1988, NEUROLOGY, V38, P1100, DOI 10.1212/WNL.38.7.1100; NELSON PV, 1985, J INHERIT METAB DIS, V8, P95, DOI 10.1007/BF01819286; OSUMI T, 1978, BIOCHEM BIOPH RES CO, V83, P479, DOI 10.1016/0006-291X(78)91015-X; PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; SCHRAM AW, 1987, P NATL ACAD SCI USA, V84, P2494, DOI 10.1073/pnas.84.8.2494; SCHUTGENS RBH, 1984, BIOCHEM BIOPH RES CO, V120, P179, DOI 10.1016/0006-291X(84)91430-X; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; STEPHENSON JBP, 1988, ARCH DIS CHILD, V63, P767, DOI 10.1136/adc.63.7.767; SUZUKI Y, 1986, CLIN CHIM ACTA, V156, P191, DOI 10.1016/0009-8981(86)90152-X; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; SUZUKI Y, 1990, CELL STRUCT FUNCT, V15, P301, DOI 10.1247/csf.15.301; TSUJI S, 1981, J NEUROCHEM, V36, P1046, DOI 10.1111/j.1471-4159.1981.tb01698.x; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P24676; VANVELDHOVEN PP, 1992, J BIOL CHEM, V267, P20065; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P375, DOI 10.1007/BF01799399; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P385, DOI 10.1007/BF02435983; WANDERS RJA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P199, DOI 10.1016/0005-2760(92)90099-H; WANDERS RJA, 1991, J INHERIT METAB DIS, V13, P371; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	34	65	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					36	43						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279468				2022-12-18	WOS:A1994MQ70000006
J	DEGRAAF, J; SWINKELS, DW; DEHAAN, AFJ; DEMACKER, PNM; STALENHOEF, AFH				DEGRAAF, J; SWINKELS, DW; DEHAAN, AFJ; DEMACKER, PNM; STALENHOEF, AFH			BOTH INHERITED SUSCEPTIBILITY AND ENVIRONMENTAL EXPOSURE DETERMINE THE LOW-DENSITY-LIPOPROTEIN SUBFRACTION PATTERN DISTRIBUTION IN HEALTHY DUTCH FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; CORONARY-ARTERY DISEASE; GRADIENT GEL-ELECTROPHORESIS; SUBCLASS PATTERNS; HEART-DISEASE; COMBINED HYPERLIPIDEMIA; PLASMA-LIPOPROTEINS; MOLECULAR-WEIGHT; RISK-FACTORS; HETEROGENEITY	A lipoprotein profile characterized by a predominance of small, dense, low-density lipoprotein (LDL) particles has been associated with an increased risk of atherosclerosis. To investigate whether genetic factors are involved in determining this heavy LDL subfraction pattern, this study was undertaken with the aim of resolving the effects that major genes, multifactorial heritability, and environmental exposures have on the LDL subfraction pattern. In a random sample of 19 healthy Dutch families including 162 individuals, the distribution of the LDL subfraction pattern was determined by density gradient ultracentrifugation. For each subject a specific LDL subfraction profile was observed, characterized by the relative contribution of the three major LDL subfractions-LDL1 (d = 1.030-1.033 g/ml), LDL2 (d = 1.033-1.040 g/ml), and LDL3 (d = 1.040-1.045 g/ml) - to total LDL. A continuous variable, parameter K, was defined to characterize each individual LDL subfraction pattern. Complex segregation analysis of this quantitative trait, under a model which includes a major locus, polygenes, and both common and random environment, was applied to analyze the distribution of the LDL subfraction pattern in these families. The results indicate that the LDL subfraction pattern, described by parameter K, is controlled by a major autosomal, highly penetrant, recessive allele with a population frequency of .19 and an additional multifactorial inheritance component. The penetrance of the more dense LDL subfraction patterns, characterized by values of K < 0, was dependent on age, gender, and, in women, on oral contraceptive use and postmenopausal status. Furthermore, multiple regression analysis revealed that approximately 60% of the variation in the LDL subfraction pattern could be accounted for by alterations in age, gender, relative body weight, smoking habits, hormonal status in women, and lipid and lipoprotein levels. In conclusion, our results indicate that genetic influences as well as environmental exposure, sex, age and hormonal status in women are important in determining the distribution of the LDL subfraction patterns in this population and that these influences may contribute to the explanation of familial clustering of coronary heart disease.	UNIV HOSP NIJMEGEN,DEPT STAT CONSULTAT,6500 HB NIJMEGEN,NETHERLANDS	Radboud University Nijmegen	DEGRAAF, J (corresponding author), UNIV HOSP NIJMEGEN,DEPT MED,DIV GEN INTERNAL MED,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Stalenhoef, A.F.H./H-8094-2014; de Graaf, J./H-8038-2014; Swinkels, Dorine W./H-8098-2014	Swinkels, Dorine W./0000-0002-1040-9446				AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917; AUSTIN MA, 1990, CIRCULATION, V82, P495, DOI 10.1161/01.CIR.82.2.495; AUSTIN MA, 1986, LANCET, V2, P5914; AUWERX JH, 1989, ARTERIOSCLEROSIS, V9, P319, DOI 10.1161/01.ATV.9.3.319; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P187, DOI 10.1161/01.ATV.12.2.187; CAMPOS H, 1988, J CLIN ENDOCR METAB, V67, P30, DOI 10.1210/jcem-67-1-30; CHIAT A, 1984, BIOCHIM BIOPHYS ACTA, V795, P314; CROUSE JR, 1985, J LIPID RES, V26, P566; DEGRAAF F, 1986, ARTERIOSCLEROSIS, V9, pA730; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, pA1491; DEMACKER PNM, 1980, CLIN CHEM, V26, P1775; DORMANS TPJ, 1991, CLIN CHEM, V37, P853; FISHER WR, 1983, METABOLISM, V32, P283, DOI 10.1016/0026-0495(83)90194-4; FISHER WR, 1975, P NATL ACAD SCI USA, V72, P2347, DOI 10.1073/pnas.72.6.2347; GAMBERT P, 1990, J LIPID RES, V31, P1199; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; ISELIUS L, 1991, AM J HUM GENET, V49, P459; KRAUSS RM, 1987, AM HEART J, V113, P578, DOI 10.1016/0002-8703(87)90636-3; KRAUSS RM, 1982, J LIPID RES, V23, P97; KWITEROVICH PO, 1988, CLIN CHEM, V34, pB71; LABELLE M, 1990, J LIPID RES, V31, P1577; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LEE DM, 1970, BIOCHEMISTRY-US, V9, P2244, DOI 10.1021/bi00813a004; MCNAMARA JR, 1987, ARTERIOSCLEROSIS, V7, P483, DOI 10.1161/01.ATV.7.5.483; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1983, CONTRIBUTIONS EPIDEM, V4, P62; MORTON NE, 1982, OUTLINE GENETIC EPID, P69; SEGAL P, 1982, EPIDEMIOL REV, V4, P137, DOI 10.1093/oxfordjournals.epirev.a036244; SHEN MMS, 1981, J LIPID RES, V22, P236; SWINKELS DW, 1989, ARTERIOSCLEROSIS, V9, P604, DOI 10.1161/01.ATV.9.5.604; SWINKELS DW, 1989, ATHEROSCLEROSIS, V77, P59, DOI 10.1016/0021-9150(89)90010-5; SWINKELS DW, 1990, BIOCHIM BIOPHYS ACTA, V1047, P212, DOI 10.1016/0005-2760(90)90519-4; TENG B, 1986, J CLIN INVEST, V77, P663, DOI 10.1172/JCI112360; TERRY RB, 1985, CIRCULATION, V72, P452; VOGLER GP, 1990, BEHAV GENET, V20, P461, DOI 10.1007/BF01067712	39	65	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1295	1310						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463012				2022-12-18	WOS:A1992KC99500012
J	ZHANG, ZP; LINDSTEDT, M; FALK, G; BLOMBACK, M; EGBERG, N; ANVRET, M				ZHANG, ZP; LINDSTEDT, M; FALK, G; BLOMBACK, M; EGBERG, N; ANVRET, M			NONSENSE MUTATIONS OF THE VONWILLEBRAND-FACTOR GENE IN PATIENTS WITH VONWILLEBRAND DISEASE TYPE-III AND TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR MESSENGER-RNA; FACTOR-VIII GENE; HEMOPHILIA-A; DELETIONS; DNA; POLYMERASE	von Willebrand disease (vWD) is the most common inherited bleeding disorder in humans. The disease is caused by qualitative and quantitative abnormalities of the von Willebrand factor (vWF). Genomic DNA from 25 patients with vWD type III, the most severe form of the disease, was studied using PCR followed by restriction-enzyme analysis and direct sequencing of the products. Nonsense mutations (CGA --> TGA) were detected in exons 28, 32, and 45 by screening of all the 11 CGA arginine codons of the vWF gene. Two patients were found to be homozygous and five heterozygous for the mutation. Both parents and some of the relatives of the homozygous patients carry the mutation. These are the first reported examples of homozygous point mutations associated with the severe form of vWD. In the three heterozygous probands, one of the parents carried the mutation and had vWD type I. Family studies including parents and family members with or without vWD type I indicated that these three heterozygous patients are likely to be compound heterozygous. Twenty-one individuals from these seven families with vWD type I were found to be heterozygous for the mutation.	KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA HOSP,DEPT CLIN CHEM & BLOOD COAGULAT,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA HOSP,DEPT MED,S-10401 STOCKHOLM 60,SWEDEN	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital								ANVRET M, 1992, HUM GENET, V89, P147; BLOMBACK M, 1992, AM J HEMATOL, V40, P117, DOI 10.1002/ajh.2830400208; BLOOM AL, 1987, HAEMOSTASIS THROMBOS, P409; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EGBERG N, 1976, THROMB RES, V9, P527, DOI 10.1016/0049-3848(76)90209-7; EIKENBOOM JCJ, 1991, THROMB HAEMOSTASIS, V65, P1127; LAVERGNE JM, 1991, THROMB HAEMOSTASIS, V65, P737; LEE JS, 1991, DNA CELL BIOL, V10, P67, DOI 10.1089/dna.1991.10.67; MANCUSO DJ, 1991, BIOCHEMISTRY-US, V30, P253, DOI 10.1021/bi00215a036; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; NGO KY, 1988, P NATL ACAD SCI USA, V85, P2753, DOI 10.1073/pnas.85.8.2753; NICHOLS WC, 1991, P NATL ACAD SCI USA, V88, P3857, DOI 10.1073/pnas.88.9.3857; PATTINSON JK, 1990, BLOOD, V76, P2242; PEAKE IR, 1990, BLOOD, V75, P651; RANDI AM, 1991, J CLIN INVEST, V87, P1220, DOI 10.1172/JCI115122; RUGGERI ZM, 1987, BLOOD, V70, P895; SHELTONINLOES BB, 1987, J CLIN INVEST, V79, P1459, DOI 10.1172/JCI112974; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; TUDDENHAM EGD, 1984, CLIN LAB HAEMATOL, V6, P307; ZHANG ZP, 1992, HUM MOL GENET, V1, P61, DOI 10.1093/hmg/1.1.61	21	65	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					850	858						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415226				2022-12-18	WOS:A1992JQ66700019
J	LUDECKE, HJ; JOHNSON, C; WAGNER, MJ; WELLS, DE; TURLEAU, C; TOMMERUP, N; LATOSBIELENSKA, A; SANDIG, KR; MEINECKE, P; ZABEL, B; HORSTHEMKE, B				LUDECKE, HJ; JOHNSON, C; WAGNER, MJ; WELLS, DE; TURLEAU, C; TOMMERUP, N; LATOSBIELENSKA, A; SANDIG, KR; MEINECKE, P; ZABEL, B; HORSTHEMKE, B			MOLECULAR DEFINITION OF THE SHORTEST REGION OF DELETION OVERLAP IN THE LANGER-GIEDION SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHINO-PHALANGEAL SYNDROME; SYNDROME TYPE-I; SEVERE MENTAL-RETARDATION; INTERSTITIAL DELETION; THYROGLOBULIN GENE; CRITICAL SEGMENT; HUMAN GENOME; LONG ARM; C-MYC; LOCUS	The Langer-Giedion syndrome (LGS), which is characterized by craniofacial dysmorphism and skeletal abnormalities, is caused by a genetic defect in 8q24.1. We have used 13 anonymous DNA markers from an 8q24.1-specific microdissection library, as well as c-myc and thyroglobulin gene probes, to map the deletion breakpoints in 16 patients with LGS. Twelve patients had a cytogenetically visible deletion, two patients had an apparently balanced translocation, and two patients had an apparently normal karyotype. In all cases except one translocation patient, loss of genetic material was detected. The DNA markers fall into 10 deletion intervals. Clone L48 (D8S51) defines the shortest region of deletion overlap (SRO), which is estimated to be less than 2 Mbp. Three clones-p17-2.3 EE (D8S43), L24 (D8S45), and L40 (D8S49)-which flank the SRO recognize evolutionarily conserved sequences.	UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMANGENET,HUFELANDSTR 55,W-4300 ESSEN 1,GERMANY; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MOLEC GENET,TORRANCE,CA 90509; UNIV HOUSTON,DEPT BIOL,HOUSTON,TX 77004; UNIV HOUSTON,INST MOLEC BIOL,HOUSTON,TX 77004; HOP NECKER ENFANTS MALAD,F-75730 PARIS 15,FRANCE; ULLEVAL HOSP,AVDEELING MED GENET,OSLO 1,NORWAY; JOHN F KENNEDY INST,GLOSTRUP,DENMARK; POLISH ACAD SCI,INST HUMAN GENET,PL-60479 POZNAN,POLAND; BIZIRKSKRANKENHAUS HEINRICH BRAUN,MED GENET & PRANATALE DIAGNOST ABT,ZWICKAU,GERMANY; ALTONAER KINDERKRANKENHAUS,MED GENET ABT,HAMBURG,GERMANY; UNIV MAINZ,KINDERKLIN,W-6500 MAINZ,GERMANY	University of Duisburg Essen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Houston System; University of Houston; University of Houston System; University of Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oslo; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	HORSTHEMKE, B (corresponding author), UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMANGENET,HUFELANDSTR 55,W-4300 ESSEN 1,GERMANY.		/AAD-2181-2020; Tommerup, Niels/T-8776-2017	Tommerup, Niels/0000-0003-2304-0112				BAAS F, 1985, HUM GENET, V69, P138, DOI 10.1007/BF00293284; BOWEN P, 1985, ANN GENET-PARIS, V28, P224; BRENHOLZ P, 1989, American Journal of Human Genetics, V45, pA41; BROCAS H, 1986, HUM GENET, V74, P178, DOI 10.1007/BF00282087; BUHLER EM, 1984, AM J MED GENET, V19, P113, DOI 10.1002/ajmg.1320190111; BUHLER EM, 1987, CLIN GENET, V31, P273; CAVENEE W, 1984, AM J HUM GENET, V36, P10; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRYNS JP, 1986, HUM GENET, V74, P188, DOI 10.1007/BF00282091; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIEDION A, 1973, HELV PAEDIATR ACTA, V28, P249; GROVER SC, 1989, AM J MED GENET, V34, P456, DOI 10.1002/ajmg.1320340326; HALUSKA FG, 1987, NUCLEIC ACIDS RES, V15, P865, DOI 10.1093/nar/15.2.865; HAMERS A, 1990, EUR J PEDIATR, V149, P618, DOI 10.1007/BF02034746; HORSTHEMKE B, 1990, NUCLEIC ACIDS RES, V18, P6174, DOI 10.1093/nar/18.20.6174-a; HORSTHEMKE B, 1990, NUCLEIC ACIDS RES, V18, P6175, DOI 10.1093/nar/18.20.6175; HORSTHEMKE B, 1990, NUCLEIC ACIDS RES, V18, P6172, DOI 10.1093/nar/18.20.6172; HORSTHEMKE B, 1990, NUCLEIC ACIDS RES, V18, P6171, DOI 10.1093/nar/18.20.6171; HORSTHEMKE B, 1987, HUM GENET, V76, P257; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LANGER LO, 1984, AM J MED GENET, V19, P81, DOI 10.1002/ajmg.1320190110; LUDECKE HJ, 1989, HUM GENET, V82, P327; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; Maniatis T., 1982, MOL CLONING; McKusick VA, 1990, MENDELIAN INHERITANC; MUCKE J, 1985, Z KLIN MED, V40, P1581; MURACHI S, 1981, CLIN GENET, V19, P149; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PARRISH JE, 1991, GENOMICS, V11, P54, DOI 10.1016/0888-7543(91)90101-J; PFEIFFER RA, 1980, CLIN GENET, V18, P142; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHWARZACHER HG, 1974, METHODS HUMAN CYTOGE; SHABTAI F, 1985, CLIN GENET, V27, P600; THREADGILL DW, 1990, CYTOGENET CELL GENET, V53, P32, DOI 10.1159/000132890; TURLEAU C, 1982, HUM GENET, V62, P183, DOI 10.1007/BF00333515; WILSON WG, 1983, AM J DIS CHILD, V137, P444, DOI 10.1001/archpedi.1983.02140310026006; YAMAMOTO Y, 1989, AM J MED GENET, V32, P133, DOI 10.1002/ajmg.1320320128; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; ZABEL BU, 1982, AM J MED GENET, V11, P353, DOI 10.1002/ajmg.1320110312	41	65	67	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1197	1206						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1836105				2022-12-18	WOS:A1991GU67200007
J	GROMPE, M; CASKEY, CT; FENWICK, RG				GROMPE, M; CASKEY, CT; FENWICK, RG			IMPROVED MOLECULAR DIAGNOSTICS FOR ORNITHINE TRANSCARBAMYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT LENGTH POLYMORPHISMS; MUSCULAR-DYSTROPHY LOCUS; PRENATAL-DIAGNOSIS; DNA ANALYSIS; MUTATIONS; GENE; IDENTIFICATION; REACTIVITY; SEQUENCES; DELETION	Since the cloning of the cDNA for X-linked ornithine transcarbamylase (OTC) in 1984, diagnostic accuracy of OTC deficiency for prenatal and carrier detection has been greatly improved by the use of linkage analysis. However, the use of RFLP-based diagnosis is limited in this and in other new mutation diseases. Here we report both the use of direct mutation detection by new PCR-based techniques and our experience with linkage-based diagnosis in 18 families. We have previously reported the use of chemical mismatch cleavage to detect mutations first in amplified mRNA and then in genomic DNA of patients. This technique has now been utilized for prenatal diagnosis. Primers for specific amplification of OTC exons 1, 3, 5, 9, and 10 have been developed and been employed to map deletions of the OTC gene in two families. These primers also have been used to detect alterations in the TaqI sites found in exons 1, 3, 5, and 9. Four novel mutations of the OTC gene leading to abolition of a TaqI site in the OTC cDNA were discovered. One of these mutations is in exon 1; two lie in exon 3; and one is in exon 9. In addition, we have used the PCR products as probes to identify the exon-specific bands seen on Southern blots and to map the polymorphic BamHI and MspI sites, which are commonly used for linkage analysis. This information will facilitate the interpretation of altered band patterns seen in deletion cases and in cases of point mutations affecting restriction sites. Utilization of the appropriate combination of these molecular techniques permitted accurate diagnostic evaluations in 17 of 18 families.	BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor University; Howard Hughes Medical Institute	GROMPE, M (corresponding author), BAYLOR UNIV,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.			Grompe, Markus/0000-0002-6616-4345	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NICHD NIH HHS [HD00850, HD24064] Funding Source: Medline; PHS HHS [MCJ009121] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINKELSTEIN JE, 1990, GENOMICS, V7, P167, DOI 10.1016/0888-7543(90)90537-5; Fox J E, 1988, Adv Neurol, V48, P71; FOX JE, 1986, AM J HUM GENET, V38, P841; FOX JE, 1980, NEW ENGL J MED, V315, P1205; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GIRGIS N, 1987, J INHERIT METAB DIS, V10, P274, DOI 10.1007/BF01800079; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HATA A, 1989, AM J HUM GENET, V45, P123; HATA A, 1988, J BIOCHEM-TOKYO, V103, P302, DOI 10.1093/oxfordjournals.jbchem.a122265; HAUSER ER, 1990, NEW ENGL J MED, V322, P1641, DOI 10.1056/NEJM199006073222305; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; LEE JT, 1989, J CLIN INVEST, V84, P1762, DOI 10.1172/JCI114360; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; MADDALENA A, 1988, J CLIN INVEST, V82, P1353, DOI 10.1172/JCI113738; Maniatis T., 1982, MOL CLONING; MCCLEAD RE, 1986, AM J MED GENET, V25, P513, DOI 10.1002/ajmg.1320250313; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NUSSBAUM RL, 1986, AM J HUM GENET, V38, P149; OTT J, 1985, ANAL HUMAN GENETIC L; ROWE PC, 1986, NEW ENGL J MED, V314, P541, DOI 10.1056/NEJM198602273140903; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ M, 1986, CLIN GENET, V29, P449; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE JE, 1989, J PEDIATR-US, V114, P582, DOI 10.1016/S0022-3476(89)80697-3; SVIRKLYS LG, 1988, ARCH DIS CHILD, V63, P297, DOI 10.1136/adc.63.3.297; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WENDEL U, 1988, EUR J PEDIATR, V46, P455	36	65	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					212	222						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1671317				2022-12-18	WOS:A1991EV74400005
J	LABUDA, M; MORGAN, K; GLORIEUX, FH				LABUDA, M; MORGAN, K; GLORIEUX, FH			MAPPING AUTOSOMAL RECESSIVE VITAMIN-D DEPENDENCY TYPE-I TO CHROMOSOME-12Q14 BY LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SHRINERS HOSP CRIPPLED CHILDREN, GENET UNIT, 1529 CEDAR AVE, MONTREAL H3G 1A6, QUEBEC, CANADA; MCGILL UNIV, CTR HUMAN GENET, DEPT EPIDEMIOL & BIOSTAT, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT MED, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT SURG & PEDIAT, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University; McGill University; McGill University; McGill University								BALAZ SI, 1987, CYTOGENET CELL GENET, V46, P574; Barker D, 1983, Mol Biol Med, V1, P199; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOTT RE, 1988, ENDOCRINOLOGY, V123, P2491; Bouchard G, 1984, CAHIERS QUEBECOIS DE, V13, P117; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; DEBRAEKELEER M, 1988, AM J HUM GENET, V43, pA213; DELVIN EE, 1981, J PEDIATR-US, V99, P26, DOI 10.1016/S0022-3476(81)80952-3; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRASER D, 1973, NEW ENGL J MED, V289, P817, DOI 10.1056/NEJM197310182891601; GHAZARIAN JG, 1974, J BIOL CHEM, V249, P3026; GHAZARIAN JG, 1974, ARCH BIOCHEM BIOPHYS, V160, P63, DOI 10.1016/S0003-9861(74)80009-3; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; Haldane JBS, 1919, J GENET, V8, P299; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LAW ML, 1986, ANN HUM GENET, V50, P131, DOI 10.1111/j.1469-1809.1986.tb01031.x; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MOREL Y, 1988, AM J HUM GENET, V43, P52; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P779, DOI 10.1093/nar/16.2.779; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OBERLE J, 1988, NUCLEIC ACIDS RES, V16, P8749, DOI 10.1093/nar/16.17.8749; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PEDERSEN JI, 1976, J BIOL CHEM, V251, P3933; PRADER A, 1961, HELV PAEDIATR ACTA, V16, P452; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; SCRIVER CR, 1970, PEDIATRICS, V45, P361; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SOLISH SB, 1988, P NATL ACAD SCI USA, V85, P7104, DOI 10.1073/pnas.85.19.7104; VAISANEN P, 1988, HUM HERED, V38, P65, DOI 10.1159/000153760; WHITE R, 1987, ADV HUM GENET, V16, P121; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	35	65	68	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					28	36						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971995				2022-12-18	WOS:A1990DK48200005
J	OTT, J				OTT, J			CUTTING A GORDIAN KNOT IN THE LINKAGE ANALYSIS OF COMPLEX HUMAN TRAITS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032	Columbia University	OTT, J (corresponding author), COLUMBIA UNIV,DEPT PSYCHIAT,BOX 58,722 W 168TH ST,NEW YORK,NY 10032, USA.							BERG K, 1978, CYTOGENET CELL GENET, V22, P621, DOI 10.1159/000131037; BISHOP DT, 1990, AM J HUM GENET, V46, P254; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; EDWARDS JH, 1982, CYTOGENET CELL GENET, V32, P43, DOI 10.1159/000131685; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; LANDER ES, 1989, GENETICS, V121, P185; OTT J, 1974, AM J HUM GENET, V26, P598; PALOTIE A, 1989, LANCET, V1, P924; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1989, PROG CLIN BIOL RES, V329, P183; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Wright S., 1968, EVOLUTION GENETICS P, P373	19	65	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					219	221						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2405655				2022-12-18	WOS:A1990CM93800001
J	SCHUMM, JW; KNOWLTON, RG; BRAMAN, JC; BARKER, DF; BOTSTEIN, D; AKOTS, G; BROWN, VA; GRAVIUS, TC; HELMS, C; HSIAO, K; REDIKER, K; THURSTON, JG; DONISKELLER, H				SCHUMM, JW; KNOWLTON, RG; BRAMAN, JC; BARKER, DF; BOTSTEIN, D; AKOTS, G; BROWN, VA; GRAVIUS, TC; HELMS, C; HSIAO, K; REDIKER, K; THURSTON, JG; DONISKELLER, H			IDENTIFICATION OF MORE THAN 500 RFLPS BY SCREENING RANDOM GENOMIC CLONES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLLABORAT RES INC,DEPT HUMAN GENET,2 OAK PK,BEDFORD,MA 01730					Barker, David/0000-0002-1438-4100				Arber W., 1983, LAMBDA, P433; BARKER D, 1985, CYTOGENET CELL GENET, V40, P576; BARKER D, 1984, AM J HUM GENET, V36, P1159; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BARKER D, IN PRESS P NATL ACAD; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BISHOP DT, 1980, BANBURY REPORT, V4, P389; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Davis R., 1980, ADV BACTERIAL GENETI; DEWET JR, 1980, J VIROL, V33, P401, DOI 10.1128/JVI.33.1.401-410.1980; DONISKELLER H, 1986, COLD SPRING HARB SYM, V51, P317, DOI 10.1101/SQB.1986.051.01.037; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; FEDER J, 1985, AM J HUM GENET, V37, P635; HELENTJARIS T, 1983, Journal of Molecular and Applied Genetics, V2, P237; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KAO FT, 1982, P NATL ACAD SCI-BIOL, V79, P865, DOI 10.1073/pnas.79.3.865; KAZAZIAN HH, 1986, AM J HUM GENET, V38, P860; KITTUR SD, 1985, P NATL ACAD SCI USA, V82, P5064, DOI 10.1073/pnas.82.15.5064; KNOWLTON RG, 1986, BLOOD, V68, P378; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANGE K, 1982, AM J HUM GENET, V34, P842; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAWN RM, 1978, CELL, V15, P1151; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Skolnick MH, 1980, BANBURY REPORT, P285, DOI DOI 10.1111/J.1365-2796.2006.01657.X; SOLOMON E, 1979, LANCET, V1, P923; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; ULLRICH A, 1980, SCIENCE, V209, P612, DOI 10.1126/science.6248962; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WIJSMAN EM, 1984, NUCLEIC ACIDS RES, V12, P9209, DOI 10.1093/nar/12.23.9209; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WYMAN AR, 1986, GENE, V49, P263, DOI 10.1016/0378-1119(86)90287-8; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	50	65	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					143	159						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2892396				2022-12-18	WOS:A1988L869700020
J	WILSON, AF; ELSTON, RC; SIERVOGEL, RM; TRAN, LD				WILSON, AF; ELSTON, RC; SIERVOGEL, RM; TRAN, LD			LINKAGE OF A GENE REGULATING DOPAMINE-BETA-HYDROXYLASE ACTIVITY AND THE ABO BLOOD-GROUP LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WRIGHT STATE UNIV,SCH MED,DEPT PEDIAT,DAYTON,OH 45435	University System of Ohio; Wright State University Dayton	WILSON, AF (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,1901 PERDIDO,NEW ORLEANS,LA 70112, USA.		Wilson, Alexander/C-2320-2009; Wilson, Alexander F./Q-6910-2019		NHLBI NIH HHS [HL23194, HL28522] Funding Source: Medline; NIGMS NIH HHS [GM28356] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAMOAH A, 1987, AM J MED GENET, V27, P613, DOI 10.1002/ajmg.1320270314; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1982, J AM STAT ASSOC, V77, P209, DOI 10.2307/2287791; Elston R C, 1984, Genet Epidemiol, V1, P175, DOI 10.1002/gepi.1370010210; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1979, HUM HERED, V29, P284, DOI 10.1159/000153059; GERSHON ES, 1975, ARCH GEN PSYCHIAT, V32, P1351; GERSHON ES, 1981, AM J HUM GENET S, pA136; GOLDIN LR, 1982, AM J HUM GENET, V34, P250; GOLDSTEIN M, 1971, EXPERIENTIA, V27, P632, DOI 10.1007/BF02136929; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KAUFMAN S, 1965, PHARMACOL REV, V17, P71; KHAN PM, 1984, CYTOGENET CELL GENET, V37, P71; MOLINOFF PB, 1971, J PHARMACOL EXP THER, V178, P425; NAGATSU T, 1972, CLIN CHEM, V18, P980; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; Siervogel R M, 1980, Hypertension, V2, P83; SIERVOGEL RM, 1984, AM J MED GENET, V19, P315, DOI 10.1002/ajmg.1320190214; WEINSHILBOUM RM, 1975, AM J HUM GENET, V27, P573; WEINSHILBOUM RM, 1979, PHARMACOL REV, V30, P133; WILSON AF, 1984, AM J MED GENET, V19, P525, DOI 10.1002/ajmg.1320190314	23	65	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					160	166						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3422127				2022-12-18	WOS:A1988L869700021
J	CHAN, V; CHAN, TK; CHEBAB, FF; TODD, D				CHAN, V; CHAN, TK; CHEBAB, FF; TODD, D			DISTRIBUTION OF BETA-THALASSEMIA MUTATIONS IN SOUTH CHINA AND THEIR ASSOCIATION WITH HAPLOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	CHAN, V (corresponding author), UNIV HONG KONG,QUEEN MARY HOSP,DEPT MED,HONG KONG,HONG KONG.				NIADDK NIH HHS [AM 16666] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM016666] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; ATWEH BS, 1986, BLOOD S1, V68, pA70; CHAN TK, 1972, AM J HUM GENET, V24, P475; CHAN V, 1986, HUM GENET, V73, P23, DOI 10.1007/BF00292658; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; FUKUMAKI Y, 1985, JUN INT C THAL BANGK, P6; GHOSH A, 1985, PRENATAL DIAG, V5, P59, DOI 10.1002/pd.1970050111; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1986, BLOOD, V68, P964; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KIMURA A, 1983, J BIOL CHEM, V258, P2748; LO HL, 1967, S HIST ARCHAELOGICAL, P139; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PIRASTU M, 1983, NEW ENGL J MED, V309, P284, DOI 10.1056/NEJM198308043090506; Suggs S. V., 1981, ICN UCLA S DEV BIOL, V23, P683; TAKIHARA Y, 1986, BLOOD, V67, P547; WONG C, 1986, P NATL ACAD SCI USA, V83, P6529, DOI 10.1073/pnas.83.17.6529	21	65	67	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1987	41	4					678	685						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K4621	2889357				2022-12-18	WOS:A1987K462100017
J	ELSAS, LJ; ENDO, F; STRUMLAUF, E; ELDERS, J; PRIEST, JH				ELSAS, LJ; ENDO, F; STRUMLAUF, E; ELDERS, J; PRIEST, JH			LEPRECHAUNISM - AN INHERITED DEFECT IN A HIGH-AFFINITY INSULIN-RECEPTOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ARKANSAS MED SCI,DEPT PEDIAT,LITTLE ROCK,AR 72201	University of Arkansas System; University of Arkansas Medical Sciences	ELSAS, LJ (corresponding author), EMORY UNIV,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322, USA.							ADAMS JM, 1977, SOUTHERN MED J, V70, P998, DOI 10.1097/00007611-197708000-00031; Bar R S, 1979, Adv Intern Med, V24, P23; BAR RS, 1978, NEW ENGL J MED, V298, P1164, DOI 10.1056/NEJM197805252982103; BIER DM, 1980, J CLIN ENDOCR METAB, V51, P988, DOI 10.1210/jcem-51-5-988; BODE HH, 1969, NEW ENGL J MED, V280, P750, DOI 10.1056/NEJM196904032801404; BROWN MS, 1976, NEW ENGL J MED, V294, P1386; CZECH MP, 1983, FED PROC, V42, P2598; CZECH MP, 1982, FED PROC, V41, P2719; CZECH MP, 1982, FED PROC, V41, P2717; CZECH MP, 1983, PHYSIOLOGIST, V26, P190; DAVID R, 1977, HUM HERED, V27, pA172; DEKABAN A, 1965, ARCH DIS CHILD, V40, P632, DOI 10.1136/adc.40.214.632; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DERCOLE AJ, 1979, J CLIN ENDOCR METAB, V48, P495, DOI 10.1210/jcem-48-3-495; DERKALOUSTIAN VM, 1971, AM J DIS CHILD, V122, P442, DOI 10.1001/archpedi.1971.02110050112018; DONOHUE WL, 1948, J PEDIATR, V32, P739, DOI 10.1016/S0022-3476(48)80231-3; DONOHUE WL, 1954, J PEDIATR-US, V45, P505, DOI 10.1016/S0022-3476(54)80113-2; DUNNIGAN MG, 1974, Q J MED, V43, P33; EDWARDS JA, 1976, AM J MED, V60, P23, DOI 10.1016/0002-9343(76)90529-5; ELDERS MJ, 1983, CLIN RES, V30, pA897; ELSAS LJ, 1971, J BIOL CHEM, V246, P6452; ELSAS LJ, 1982, AM J HUM GENET, V34, pA51; ELSAS LJ, 1975, J BIOL CHEM, V250, P9381; ENDO F, 1984, CLIN RES, V32, pA519; EVANS PR, 1955, ARCH DIS CHILD, V30, P479, DOI 10.1136/adc.30.154.479; FERGUSONSMITH MA, 1968, ANN GENET-PARIS, V11, P195; FITCH N, 1982, AM J MED GENET, V11, P11, DOI 10.1002/ajmg.1320110104; FORSSMAN H, 1945, ACTA MED SCANDINAV S, V159, P1; FRANKS RC, 1970, PEDIATRICS, V45, P43; GILLEROT Y, 1979, ACTA PAEDIATR BELG, V32, P279; GOLDSTEIN JL, 1973, MEDICINE, V52, P53, DOI 10.1097/00005792-197301000-00003; GORDEN P, 1969, J CLIN ENDOCR METAB, V29, P684, DOI 10.1210/jcem-29-5-684; GROSSKIE.E, 1973, AM J DIS CHILD, V126, P500, DOI 10.1001/archpedi.1973.02110190410011; HARTDEGEN RG, 1975, BRIT J DERMATOL, V93, P587, DOI 10.1111/j.1365-2133.1975.tb02254.x; HILL DE, 1978, SEMIN PERINATOL, V2, P319; IWASAKI H, 1974, JPN J HUM GENET, V19, P82; KAHN CR, 1976, J CELL BIOL, V70, P261, DOI 10.1083/jcb.70.2.261; KAHN CR, 1976, NEW ENGL J MED, V294, P739, DOI 10.1056/NEJM197604012941401; KALLO A, 1965, J PEDIATR-US, V66, P372, DOI 10.1016/S0022-3476(65)80195-0; KAPLOWITZ PB, 1982, J CLIN ENDOCR METAB, V55, P741, DOI 10.1210/jcem-55-4-741; KING GL, 1982, J BIOL CHEM, V257, P1; KOBAYASHI M, 1978, P NATL ACAD SCI USA, V75, P3469, DOI 10.1073/pnas.75.7.3469; KOONTZ JW, 1981, SCIENCE, V211, P947, DOI 10.1126/science.7008195; LARON Z, 1974, Birth Defects Original Article Series, V10, P231; MASSAGUE J, 1982, J BIOL CHEM, V257, P3958; MASSAGUE J, 1982, J BIOL CHEM, V257, P5038; Menon P S, 1980, Indian J Pediatr, V47, P161, DOI 10.1007/BF02822886; MIGEON CJ, 1968, PEDIATR RES, V2, P501, DOI 10.1203/00006450-196811000-00008; OLEFSKY JM, 1981, DIABETES, V30, P148, DOI 10.2337/diab.30.2.148; ORDWAY NK, 1973, J PEDIATR-US, V83, P867, DOI 10.1016/S0022-3476(73)80391-9; PATTERSON JH, 1962, J PEDIATR-US, V60, P730, DOI 10.1016/S0022-3476(62)80100-0; Poradovska W, 1972, Acta Chir Plast, V14, P4; RAMAAT LG, 1977, INDIAN PEDIATR, V14, P325; RECHLER MM, 1982, MEMBRANES GENETIC DI, P245; ROGERS DR, 1966, AM J CLIN PATHOL, V45, P614; ROSENBERG AM, 1980, AM J DIS CHILD, V134, P170, DOI 10.1001/archpedi.1980.02130140044014; RUDIGER HW, 1983, HUM GENET, V64, P407, DOI 10.1007/BF00292378; SACCHI F, 1981, EUR J PEDIATR, V137, P89, DOI 10.1007/BF00441177; SALMON MA, 1963, ARCH DIS CHILD, V38, P530, DOI 10.1136/adc.38.201.530; SANTORA AC, 1979, ENDOCRINOLOGY, V104, P1059, DOI 10.1210/endo-104-4-1059; SCARLETT JA, 1982, J CLIN ENDOCR METAB, V55, P123, DOI 10.1210/jcem-55-1-123; SCHILLING EE, 1979, P NATL ACAD SCI USA, V76, P5877, DOI 10.1073/pnas.76.11.5877; SERRAVEZZA JC, 1983, ENDOCRINOLOGY, V113, P497, DOI 10.1210/endo-113-2-497; SUMMITT RL, 1969, J PEDIATR, V74, P601, DOI 10.1016/S0022-3476(69)80044-2; TAYLOR SI, 1981, P NATL ACAD SCI-BIOL, V78, P7157, DOI 10.1073/pnas.78.11.7157; TAYLOR SI, 1982, J CLIN ENDOCR METAB, V54, P919, DOI 10.1210/jcem-54-5-919; TAYLOR SI, 1982, J CLIN ENDOCR METAB, V55, P1108, DOI 10.1210/jcem-55-6-1108; TSUJINO G, 1975, Z KINDERHEILKD, V118, P347, DOI 10.1007/BF00492338; VERHOEVEN GFM, 1979, METABOLISM, V28, P253, DOI 10.1016/0026-0495(79)90072-6; WHEELER FB, 1980, ENDOCRINOLOGY, V107, P195, DOI 10.1210/endo-107-1-195	70	65	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	1					73	88						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY57	3883764				2022-12-18	WOS:A1985AGY5700008
J	HASSOLD, T; WARBURTON, D; KLINE, J; STEIN, Z				HASSOLD, T; WARBURTON, D; KLINE, J; STEIN, Z			THE RELATIONSHIP OF MATERNAL AGE AND TRISOMY AMONG TRISOMIC SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT HUMAN GENET,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT DEV & PEDIAT,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST,GERTRUDE H SERGIEVSKY CTR,EPIDEMIOL BRAIN DISORDERS UNIT,NEW YORK,NY 10032; COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10027	Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University	HASSOLD, T (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.				NICHD NIH HHS [HD-12207, HD-08838, HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HULTEN M, 1974, HEREDITAS, V76, P55; STEIN Z, 1980, HUMAN EMBRYONIC FETA, P107; WARBURTON D, 1980, HUMAN EMBRYONIC FETA, P261; WARBURTON D, 1983, CYTOGENETICS MAMMA B, P23; WHITE MJD, 1973, ANIMAL CYTOLOGY EVOL, P163	8	65	67	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1349	1356						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6517056				2022-12-18	WOS:A1984TZ59000016
J	HEIMBUCH, RC; MATTHYSSE, S; KIDD, KK				HEIMBUCH, RC; MATTHYSSE, S; KIDD, KK			ESTIMATING AGE-OF-ONSET DISTRIBUTIONS FOR DISORDERS WITH VARIABLE ONSET	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCLEAN HOSP,MAILMAN RES CTR,BELMONT,MA 02178	Harvard University; McLean Hospital	HEIMBUCH, RC (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.							BATSCHELET E, 1963, BIOMETRIKA, V50, P265, DOI 10.1093/biomet/50.3-4.265; BATSCHELET E, 1960, BIOMETR Z, V2, P244; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; Cox D. R., 2018, ANAL BINARY DATA; CROWE RR, 1977, J PSYCHIATR RES, V13, P273, DOI 10.1016/0022-3956(77)90015-2; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; HODGE SE, AM J MED GENET; Hodge SE, 1979, AM J HUM GENET, V31, P761; LARSSON T, 1954, ACTA PSYCHIAT NEUR S, V89, P1; Lotka A. J., 1956, ELEMENTS MATH BIOL, DOI DOI 10.2307/1909476; MORTON LA, UNPUBLISHED; ROSENTHAL D, 1970, GENETIC THEORY ABNOR, P112; WENDT G G, 1959, Acta Genet Stat Med, V9, P18	13	65	65	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					564	574						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395869				2022-12-18	WOS:A1980KB52200010
J	OKADA, TA; COMINGS, DE				OKADA, TA; COMINGS, DE			A SEARCH FOR PROTEIN CORES IN CHROMOSOMES - IS THE SCAFFOLD AN ARTIFACT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											OKADA, TA (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,DUARTE,CA 91010, USA.				NIGMS NIH HHS [GM-15886] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUELO JG, 1969, J CELL BIOL, V41, P73, DOI 10.1083/jcb.41.1.73; ADOLPH KW, 1977, P NATL ACAD SCI USA, V74, P4937, DOI 10.1073/pnas.74.11.4937; ADOLPH KW, 1977, CELL, V12, P805, DOI 10.1016/0092-8674(77)90279-3; BAHR G F, 1973, P280; BAHR GF, 1974, ADV CELL MOL BIOL, V3, P191; BARNICOT NA, 1965, Q J MICROSC SCI, V106, P197; BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X; CHANG JP, 1968, CANCER RES, V28, P521; Comings D E, 1972, Adv Hum Genet, V3, P237; COMINGS DE, 1970, CYTOGENETICS, V9, P436, DOI 10.1159/000130113; COMINGS DE, 1971, EXP CELL RES, V67, P97, DOI 10.1016/0014-4827(71)90625-2; COMINGS DE, 1978, ANNU REV GENET, V12, P25, DOI 10.1146/annurev.ge.12.120178.000325; COMINGS DE, 1973, EXP CELL RES, V77, P469, DOI 10.1016/0014-4827(73)90601-0; COMINGS DE, 1978, J CELL SCI, V34, P233; COMINGS DE, 1975, EXP CELL RES, V96, P161, DOI 10.1016/S0014-4827(75)80049-8; COMINGS DE, 1973, COLD SPRING HARB SYM, V38, P145; COMINGS DE, 1970, CYTOGENETICS, V9, P450, DOI 10.1159/000130114; COMINGS DE, 1970, CHROMOSOMA, V30, P269, DOI 10.1007/BF00321061; COMINGS DE, 1972, ADV CELL MOL BIOL, V2, P309; COMINGS DE, 1977, CHROMOSOMES TODAY, V6, P19; COUNCE SJ, 1973, CHROMOSOMA, V44, P231, DOI 10.1007/BF00329119; DASKAL Y, 1976, EXP CELL RES, V100, P204, DOI 10.1016/0014-4827(76)90343-8; DUPRAW EJ, 1965, NATURE, V206, P338, DOI 10.1038/206338a0; DUPRAW EJ, 1966, NATURE, V209, P577, DOI 10.1038/209577a0; FILIP DA, 1975, EXP CELL RES, V92, P245, DOI 10.1016/0014-4827(75)90377-8; GALL JG, 1963, NATURE, V198, P36, DOI 10.1038/198036a0; KAVENOFF R, 1973, CHROMOSOMA, V41, P1, DOI 10.1007/BF00284071; KRISHAN A, 1965, J CELL BIOL, V24, P433, DOI 10.1083/jcb.24.3.433; LAEMMLI UK, 1977, COLD SPRING HARB SYM, V42, P351; LAIRD CD, 1971, CHROMOSOMA, V32, P378, DOI 10.1007/BF00285251; LAMPERT F, 1970, HUMANGENETIK, V11, P10; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; MOSES MJ, 1977, CHROMOSOMA, V60, P99, DOI 10.1007/BF00288459; MOSES MJ, 1974, J EXP ZOOL, V189, P115, DOI 10.1002/jez.1401890110; MOURIQUAND C, 1972, ANN GENET-PARIS, V15, P249; MOYNE G, 1976, EXP CELL RES, V98, P237, DOI 10.1016/0014-4827(76)90433-X; MURRAY RG, 1965, J CELL BIOL, V26, P601, DOI 10.1083/jcb.26.2.601; OKADA TA, 1979, CHROMOSOMA, V72, P1, DOI 10.1007/BF00286426; PAPSIDERO LD, 1973, CYTOBIOLOGIE, V8, P118; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; PORTER KR, 1960, J BIOPHYS BIOCHEM CY, V7, P167, DOI 10.1083/jcb.7.1.167; PRESCOTT DM, 1970, ADV CELL BIOL, V1, P57; RATTNER JB, 1978, CHROMOSOMA, V66, P259, DOI 10.1007/BF00330554; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; SALZMAN NP, 1966, P NATL ACAD SCI USA, V56, P1449, DOI 10.1073/pnas.56.5.1449; Schwarzacher H G, 1967, Humangenetik, V4, P153, DOI 10.1007/BF00291260; SORSA V, 1972, HEREDITAS, V72, P215; SPERLING K, 1974, HUMANGENETIK, V23, P235, DOI 10.1007/BF00272508; STOCKERT J C, 1970, Journal de Microscopie (Paris), V9, P823; STUBBLEFIELD E, 1971, CHROMOSOMA, V32, P262, DOI 10.1007/BF00284839; WOLFE SL, 1966, J CELL BIOL, V31, P31, DOI 10.1083/jcb.31.1.31; Wolff S, 1969, Int Rev Cytol, V25, P279, DOI 10.1016/S0074-7696(08)60205-3; WRAY W, 1970, EXP CELL RES, V59, P469, DOI 10.1016/0014-4827(70)90656-7; YUNIS JJ, 1979, EXP CELL RES, V122, P63, DOI 10.1016/0014-4827(79)90561-5	56	65	72	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	6					814	832						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT964	6160765				2022-12-18	WOS:A1980KT96400005
J	MAYEDA, K; WEISS, L; LINDAHL, R; DULLY, M				MAYEDA, K; WEISS, L; LINDAHL, R; DULLY, M			LOCALIZATION OF HUMAN LACTATE-DEHYDROGENASE B GENE ON SHORT ARM OF CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WAYNE STATE UNIV,DEPT BIOL,DETROIT,MI 48202; HENRY FORD HOSP,CYTOGENET LAB,DETROIT,MI 48202	Wayne State University; Henry Ford Health System; Henry Ford Hospital								BOONE C, 1972, P NATL ACAD SCI USA, V69, P510, DOI 10.1073/pnas.69.2.510; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHEN TR, 1973, AM J HUM GENET, V25, P200; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; RUDDLE FH, 1970, NATURE, V227, P251, DOI 10.1038/227251a0; RUDDLE FH, 1972, ADV HUM GENET, V3, P173; SANTACHIARA SA, 1970, NATURE, V227, P248	7	65	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	1					59	64						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S0166	4811755				2022-12-18	WOS:A1974S016600006
J	MYRIANTHOPOULOS, NC; ARONSON, SM				MYRIANTHOPOULOS, NC; ARONSON, SM			POPULATION DYNAMICS OF TAY-SACHS DISEASE .I. REPRODUCTIVE FITNESS AND SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARONSON S M, 1959, AMA J Dis Child, V98, P50; ARONSON SM, 1962, CEREBRAL SPHINGOLIPI, P375; ARONSON SM, 1964, TAYSACHS DISEASE, P118; ARONSON SM, 1962, CEREBRAL SPHINGOL ED, P359; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; GOLDSCHM.E, 1964, COLD SPRING HARB SYM, V29, P115, DOI 10.1101/SQB.1964.029.01.016; GOLDSCHMIDT E, 1960, ANN HUM GENET, V24, P191, DOI 10.1111/j.1469-1809.1960.tb01732.x; GOLDSCHMIDT E, 1956, 25 ANN M GEN SOC AM; HALD A, 1952, STATISTICAL THEORY E, P407; HALDANE JBS, 1948, ANN EUGENIC, V14, P117; KOZINN PJ, 1957, J PEDIATR-US, V51, P58, DOI 10.1016/S0022-3476(57)80282-0; KROOTH RS, 1955, AM J HUM GENET, V7, P325; KTENIDES M, 1954, THESIS U GENEVA; MYRIANTHOPOULOS NC, 1962, CEREBRAL SPHINGOLIPI, P359; POST RH, 1965, EUGEN QUART, V12, P162, DOI 10.1080/19485565.1965.9987624; REED TE, 1959, AM J HUM GENET, V11, P137; Slome D, 1933, J GENET, V27, P363, DOI 10.1007/BF02981749; VOLK BW, 1964, TAYSACHS DISEASE  ED, P118	18	65	64	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					313	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	5945951				2022-12-18	WOS:A19668130900001
J	NICHOLS, WW				NICHOLS, WW			ROLE OF VIRUSES IN ETIOLOGY OF CHROMOSOMAL ABNORMALITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		AHLSTROM CG, 1962, ACTA PATHOL MIC SC, P127; AHLSTROM CG, 1962, ACTA PATHOL MICROB S, V54, P2; AULA P, 1965, ANN ACAD SCI FENN A4, V89, P1; BELL S, 1964, P NATL ACAD SCI USA, V51, P195, DOI 10.1073/pnas.51.2.195; BLOCK J. B., 1965, PROC AMER ASS CANCER RES, V6, P6; BOUE A, 1965, ARCH GES VIRUSFORSCH, V16, P443, DOI 10.1007/BF01253853; BREWEN JG, 1965, CYTOGENETICS, V4, P28, DOI 10.1159/000129841; GRIPENBERG U, 1963, 11 P INT C GEN HAG, V1, P311; HARNDEN DG, 1964, AM J HUM GENET, V16, P204; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; KIHLMAN BA, 1963, HEREDITAS, V50, P139; KIHLMAN BA, 1963, J CELL COMPAR PHYSL, V62, P267, DOI 10.1002/jcp.1030620306; KOPROWSKI H, 1962, J CELL COMPAR PHYSL, V59, P281, DOI 10.1002/jcp.1030590308; MOORHEAD PS, 1965, HEREDITAS-GENETISK A, V52, P271; MUNROE JS, 1963, SCIENCE, V140, P1415, DOI 10.1126/science.140.3574.1415; NICHOLS WW, 1963, HEREDITAS, V50, P53; NICHOLS WW, 1965, HEREDITAS-GENETISK A, V52, P402; NICHOLS WW, 1964, SCIENCE, V146, P248, DOI 10.1126/science.146.3641.248; NICHOLS WW, 1964, HEREDITAS, V51, P380; NICHOLS WW, 1962, HEREDITAS, V48, P367; NICHOLS WW, IN PRESS; NORRBY E, IN PRESS; OSTERGREN G., 1954, Botaniska Notiser, P357; RAPP F, 1965, VIROLOGY, V25, P401, DOI 10.1016/0042-6822(65)90061-9; SCHMIDTRUPPIN H, 1959, KREBSFORSCHUNG KREBS, V3, P26; STICH HF, 1964, VIROLOGY, V22, P439, DOI 10.1016/0042-6822(64)90064-9; TANZER J, 1963, LANCET, V2, P1070; TAYLOR JH, 1962, P NATL ACAD SCI USA, V48, P190, DOI 10.1073/pnas.48.2.190	28	65	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	1					81	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	72413	4285072				2022-12-18	WOS:A19667241300009
J	LINDER, D; GARTLER, SM				LINDER, D; GARTLER, SM			DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE ELECTROPHORETIC VARIANTS IN DIFFERENT TISSUES OF HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DAVIDSON RG, 1963, SOC PEDIAT RES, P17; FILDES RA, 1963, NATURE, V200, P890, DOI 10.1038/200890a0; GARTLER S. M., 1964, CYTOGENETICS, V3, P135, DOI 10.1159/000129804; GARTLER SM, IN PRESS; GOLDBERG CAJ, 1960, CLIN CHEM, V6, P254; KIRKMAN HN, 1963, AM J HUM GENET, V15, P241; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; NANCE WB, IN PRESS; OHNO S., 1962, CYTOGENETICS, V1, P129, DOI 10.1159/000129725; PARK WW, 1957, J ANAT, V91, P369; RUSSELL LB, 1961, SCIENCE, V133, P1798; SZABO G, 1955, J PATHOL BACTERIOL, V70, P545, DOI 10.1002/path.1700700233	15	65	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	3					212	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	65219	14295491				2022-12-18	WOS:A19656521900003
J	CLEVE, H; HORSFALL, WR; PARKER, WC; SCHACHT, LE; BEARN, AG; KLEINMAN, H; KIRK, RL				CLEVE, H; HORSFALL, WR; PARKER, WC; SCHACHT, LE; BEARN, AG; KLEINMAN, H; KIRK, RL			2 GENETIC VARIANTS OF GROUP-SPECIFIC COMPONENT OF HUMAN SERUM - GC CHIPPEWA AND GC ABORIGINE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CLEVE H, 1961, AM J HUM GENET, V13, P372; CLEVE HARTWIG, 1962, PROGR MED GENET, V2, P64; HIRSCHFELD J, 1960, NATURE, V185, P931, DOI 10.1038/185931b0; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P155, DOI 10.1159/000313799; HIRSCHFELD J, 1959, ACTA PATHOL MIC SC, V46, P224; HIRSCHFELD J, 1962, SCIENCE TOOLS, V8, P17; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; KIRK RL, 1963, AMER J PHYS ANTHROP; KIRK RL, 1963, ACTA GENET BASEL, V3, P140; NERSTROM B, 1963, ACTA PATHOL MIC SC, V58, P257; PARKER WC, 1963, AM J HUM GENET, V15, P353; REINSKOU T, 1962, ACTA GENET STAT MED, V12, P51; SCHEIDEGGER JJ, 1955, INT ARCH ALLER A IMM, V7, P103, DOI 10.1159/000228215	13	65	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					368	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097231				2022-12-18	WOS:A19632968A00002
J	FALEK, A				FALEK, A			HANDEDNESS - A FAMILY STUDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Chamberlain HD, 1928, J HERED, V19, P557, DOI 10.1093/oxfordjournals.jhered.a102943; Dahlberg G., 1926, TWIN BIRTHS TWINS HE; DUROST WN, 1934, GENETIC PSYCHOL MONO, V16, P224; FALEK A, 1957, THESIS COLUMBIA U; Hull CJ, 1936, J EXP EDUC, V4, P287, DOI 10.1080/00220973.1936.11010014; HUSEN T, UNPUBLISHED; MERRELL D. J., 1957, HUMAN BIOL, V29, P314; OVERSTREET R, 1938, PSYCHOL BULL, V35, P520; Ramaley F, 1913, AM NAT, V47, P730, DOI 10.1086/279383; Rife DC, 1940, GENETICS, V25, P0178; TORGERSEN J, 1950, AM J HUM GENET, V2, P361; TRANKELL A, 1955, AM J HUM GENET, V7, P264	12	65	65	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	1					52	62						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF072	13626936				2022-12-18	WOS:A1959WF07200005
J	NOVITSKI, E; KIMBALL, AW				NOVITSKI, E; KIMBALL, AW			BIRTH ORDER, PARENTAL AGES, AND SEX OF OFFSPRING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		LEJEUNE J, 1957, CR HEBD ACAD SCI, V244, P2425; LEJEUNE J, 1957, CR HEBD ACAD SCI, V244, P1833; NOVITSKI E, 1956, ANN HUM GENET, V21, P123, DOI 10.1111/j.1469-1809.1971.tb00271.x; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531	4	65	65	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	3					268	275						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA220	13571218				2022-12-18	WOS:A1958WA22000002
J	Manousaki, D; Mitchell, R; Dudding, T; Haworth, S; Harroud, A; Forgetta, V; Shah, RL; Luan, JA; Langenberg, C; Timpson, NJ; Richards, JB				Manousaki, Despoina; Mitchell, Ruth; Dudding, Tom; Haworth, Simon; Harroud, Adil; Forgetta, Vincenzo; Shah, Rupal L.; Luan, Jian'an; Langenberg, Claudia; Timpson, Nicholas J.; Richards, J. Brent			Genome-wide Association Study for Vitamin D Levels Reveals 69 Independent Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							1,25-DIHYDROXYVITAMIN D-3; MENDELIAN RANDOMIZATION; RISK; HERITABILITY; DISEASES; DETERMINANTS; GLUCOSE; CYP2R1; ONSET	We aimed to increase our understanding of the genetic determinants of vitamin D levels by undertaking a large-scale genome-wide association study (GWAS) of serum 25 hydroxyvitamin D (25OHD). To do so, we used imputed genotypes from 401,460 white British UK Biobank participants with available 25OHD levels, retaining single-nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) > 0.1% and imputation quality score > 0.3. We performed a linear mixed model GWAS on standardized log-transformed 25OHD, adjusting for age, sex, season of measurement, and vitamin D supplementation. These results were combined with those from a previous GWAS including 42,274 Europeans. In silico functional follow-up of the GWAS results was undertaken to identify enrichment in gene sets, pathways, and expression in tissues, and to investigate the partitioned heritability of 25OHD and its shared heritability with other traits. Using this approach, the SNP heritability of 25OHD was estimated to 16.1%. 138 conditionally independent SNPs were detected (p value < 6.6 x 10(-9)) among which 53 had MAF < 5%. Single variant association signals mapped to 69 distinct loci, among which 63 were previously unreported. We identified enrichment in hepatic and lipid metabolism gene pathways and enriched expression of the 25OHD genes in liver, skin, and gastrointestinal tissues. We observed partially shared heritability between 25OHD and socio-economic traits, a feature which may be mediated through time spent outdoors. Therefore, through a large 25OHD GWAS, we identified 63 loci that underline the contribution of genes outside the vitamin D canonical metabolic pathway to the genetic architecture of 25OHD.	[Manousaki, Despoina; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Manousaki, Despoina; Forgetta, Vincenzo; Richards, J. Brent] Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst Med Res, Dept Epidemiol, Montreal, PQ H3T 1E2, Canada; [Mitchell, Ruth; Dudding, Tom; Haworth, Simon; Timpson, Nicholas J.] Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Dudding, Tom; Haworth, Simon] Univ Bristol, Bristol Dent Sch, Bristol BS8 2BN, Avon, England; [Harroud, Adil] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Shah, Rupal L.; Luan, Jian'an; Langenberg, Claudia] Univ Cambridge, MRC Epidemiol Unit, Cambridge CB2 0SL, England; [Richards, J. Brent] McGill Univ Montreal, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Richards, J. Brent] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Richards, J. Brent] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	McGill University; Lady Davis Institute; McGill University; University of Bristol; University of Bristol; McGill University; University of Cambridge; McGill University; University of London; King's College London	Richards, JB (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.; Richards, JB (corresponding author), Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst Med Res, Dept Epidemiol, Montreal, PQ H3T 1E2, Canada.; Richards, JB (corresponding author), McGill Univ Montreal, Dept Med, Montreal, PQ H3G 1Y6, Canada.; Richards, JB (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada.; Richards, JB (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	brent.richards@mcgill.ca	Timpson, Nicholas John/O-7548-2015; Shah, Rupal L./AAZ-5951-2020; Haworth, Simon/AAR-7586-2020	Timpson, Nicholas John/0000-0002-7141-9189; Shah, Rupal L./0000-0001-8789-8869; Haworth, Simon/0000-0001-7793-7326; Harroud, Adil/0000-0003-2616-7274; Dudding, Tom/0000-0003-3756-040X	UK Biobank Resource [16009]; Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation; Fonds de Recherche du Quebec Sante (FRQS); FRQS Clinical Research Scholarship; National MS Society; MS Society of Canada; JDRF; Medical Research Council Integrative Epidemiology Unit at the University of Bristol [MC_UU_00011/1]; National Institute for Health Research (NIHR) Academic Clinical Fellowship; Medical Research Council [MC_UU_12015/1]; NHS Research and Development; MRC [MC_UU_12015/1, G0701603, MC_PC_19009, MC_PC_12028] Funding Source: UKRI	UK Biobank Resource; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche du Quebec Sante (FRQS); FRQS Clinical Research Scholarship; National MS Society(National Multiple Sclerosis Society); MS Society of Canada; JDRF(Juvenile Diabetes Research Foundation); Medical Research Council Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Academic Clinical Fellowship(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Research and Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank Resource under application number 16009. J.B.R. is supported by the Canadian Institutes of Health Research (CIHR) and the Canadian Foundation for Innovation and the Fonds de Recherche du Que ' bec Sante ' (FRQS). J.B.R. is funded by a FRQS Clinical Research Scholarship and received research support from the National MS Society and the MS Society of Canada. D.M. is funded by the JDRF. R.M. works in program one within the Medical Research Council Integrative Epidemiology Unit at the University of Bristol (grant number MC_UU_00011/1). S.H. is funded by a National Institute for Health Research (NIHR) Academic Clinical Fellowship. The Ely study was supported by the Medical Research Council (MC_UU_12015/1) and NHS Research and Development. The funding agencies had no role in the study design, analysis, or interpretation of data; the writing of the manuscript; or in the decision to submit the article for publication. All data sources used in this study (UK Biobank, Ely Study) received approval from respective national ethical committees for medical research and obtained informed consent from all participants. Additional ethical approval was not required for this study.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Aspelund T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010074; Autier P, 2017, LANCET DIABETES ENDO, V5, P986, DOI [10.1016/S2213-8587(17)30357-1, 10.1016/s2213-8587(17)30357-1]; Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889; BAUMGARTI HJ, 1991, DIABETES RES CLIN EX, V16, P145; Bierschenk L, 2009, DIABETES CARE, V32, P1977, DOI 10.2337/dc09-1089; Bouillon R, 2019, ENDOCR REV, V40, P1109, DOI 10.1210/er.2018-00126; Bowman K, 2019, NEUROLOGY, V92, pE1387, DOI 10.1212/WNL.0000000000007136; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; CuellarPartida G., 2019, COMPLEX TRAITS GENET, DOI [10.1101/518027, DOI 10.1101/518027]; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Dong J, 2019, CLIN GASTROENTEROL H, V17, P2227, DOI 10.1016/j.cgh.2019.01.041; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Galinsky KJ, 2016, AM J HUM GENET, V98, P456, DOI 10.1016/j.ajhg.2015.12.022; Gianfrancesco MA, 2017, NEUROLOGY, V88, P1623, DOI [10.1212/wnl.0000000000003849, 10.1212/WNL.0000000000003849]; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5; Havdahl A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39359-z; He YZ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1119-2; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jiang X, 2019, INT J EPIDEMIOL, V48, P1416, DOI 10.1093/ije/dyy284; Jiang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02662-2; Kamat MA, 2019, BIOINFORMATICS, V35, P4851, DOI 10.1093/bioinformatics/btz469; Karohl C, 2010, AM J CLIN NUTR, V92, P1393, DOI 10.3945/ajcn.2010.30176; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; Larsson SC, 2018, STROKE, V49, P2508, DOI 10.1161/STROKEAHA.118.022242; Larsson SC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101501; Libuda L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051085; Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x; Liyanage UE, 2020, BRIT J DERMATOL, V182, P97, DOI 10.1111/bjd.18238; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lund-Nielsen J, 2018, J CLIN ENDOCR METAB, V103, P3267, DOI 10.1210/jc.2018-00250; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Mai XM, 2019, EUR J EPIDEMIOL, V34, P57, DOI 10.1007/s10654-018-0465-x; Manousaki D, 2017, AM J HUM GENET, V101, P227, DOI 10.1016/j.ajhg.2017.06.014; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mayer-Davis EJ, 2013, DIABETES CARE, V36, P1842, DOI 10.2337/dc12-2084; McKenna MJ, 2013, ENDOCR CONNECT, V2, P87, DOI 10.1530/EC-13-0008; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Meng XR, 2019, INT J EPIDEMIOL, V48, P1425, DOI 10.1093/ije/dyz182; Michaelsson K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121987; Milaneschi Y, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0554-y; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x; Multiple Sclerosis Society of Canada, 2019, VIT D MULT SCLER REC; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Persyn E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207677; Pozzilli P, 2005, HORM METAB RES, V37, P680, DOI 10.1055/s-2005-870578; Rhead B, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000097; Riachy R, 2006, APOPTOSIS, V11, P151, DOI 10.1007/s10495-006-3558-z; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Sun JY, 2019, J CELL MOL MED, V23, P2268, DOI 10.1111/jcmm.14153; Tan VY, 2018, CANCER EPIDEM BIOMAR, V27, P1462, DOI [10.1158/1055-9965.EPI-18-0113, 10.1158/1055-9965.epi-18-0113]; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang XL, 2016, TRANSL RES, V178, P54, DOI 10.1016/j.trsl.2016.07.006; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; Wong T, 2018, DRUG METAB DISPOS, V46, P367, DOI 10.1124/dmd.117.078428; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yarmolinsky J.R.C., 2018, EVALUATING CAUSAL AS, DOI [10.1101/472696, DOI 10.1101/472696]; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	73	64	64	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2020	106	3					327	337		10.1016/j.ajhg.2020.01.017	http://dx.doi.org/10.1016/j.ajhg.2020.01.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KT6CT	32059762	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000519101800011
J	Guo, L; Bertola, DR; Takanohashi, A; Saito, A; Segawa, Y; Yokota, T; Ishibashi, S; Nishida, Y; Yamamoto, GL; Franco, JFD; Honjo, RS; Kim, CA; Musso, CM; Timmons, M; Pizzino, A; Taft, RJ; Lajoie, B; Knight, MA; Fischbeck, KH; Singleton, AB; Ferreira, CR; Wang, Z; Yan, L; Garbern, JY; Simsek-Kiper, PO; Ohashi, H; Robey, PG; Boyde, A; Matsumoto, N; Miyake, N; Spranger, J; Schiffmann, R; Vanderver, A; Nishimura, G; Passos-Bueno, MRD; Simons, C; Ishikawa, K; Ikegawa, S				Guo, Long; Bertola, Debora Romeo; Takanohashi, Asako; Saito, Asuka; Segawa, Yuko; Yokota, Takanori; Ishibashi, Satoru; Nishida, Yoichiro; Yamamoto, Guilherme Lopes; da Silva Franco, Jose Francisco; Honjo, Rachel Sayuri; Kim, Chong Ae; Musso, Camila Manso; Timmons, Margaret; Pizzino, Amy; Taft, Ryan J.; Lajoie, Bryan; Knight, Melanie A.; Fischbeck, Kenneth H.; Singleton, Andrew B.; Ferreira, Carlos R.; Wang, Zheng; Yan, Li; Garbern, James Y.; Simsek-Kiper, Pelin O.; Ohashi, Hirofumi; Robey, Pamela G.; Boyde, Alan; Matsumoto, Naomichi; Miyake, Noriko; Spranger, Juergen; Schiffmann, Raphael; Vanderver, Adeline; Nishimura, Gen; dos Santos Passos-Bueno, Maria Rita; Simons, Cas; Ishikawa, Kinya; Ikegawa, Shiro			Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY; AXONAL SPHEROIDS; RECEPTOR; CSF-1; DEFICIENCY; EXPRESSION; SURVIVAL; CELLS; FORM; JNK	Colony stimulating factor 1 receptor (CSF1R) plays key roles in regulating development and function of the monocyte/macrophage lineage, including microglia and osteoclasts. Mono-allelic mutations of CSF1R are known to cause hereditary diffuse leukoencephalopathy with spheroids (HDLS), an adult-onset progressive neurodegenerative disorder. Here, we report seven affected individuals from three unrelated families who had bi-allelic CSF1R mutations. In addition to early-onset HDLS-like neurological disorders, they had brain malformations and skeletal dysplasia compatible to dysosteosclerosis (DOS) or Pyle disease. We identified five CSF1R mutations that were homozygous or compound heterozygous in these affected individuals. Two of them were deep intronic mutations resulting in abnormal inclusion of intron sequences in the mRNA. Compared with Csf1r-null mice, the skeletal and neural phenotypes of the affected individuals appeared milder and variable, suggesting that at least one of the mutations in each affected individual is hypomorphic. Our results characterized a unique human skeletal phenotype caused by CSF1R deficiency and implied that bi-allelic CSF1R mutations cause a spectrum of neurological and skeletal disorders, probably depending on the residual CSF1R function.	[Guo, Long; Wang, Zheng; Ikegawa, Shiro] RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Bertola, Debora Romeo; Yamamoto, Guilherme Lopes; da Silva Franco, Jose Francisco; Honjo, Rachel Sayuri; Kim, Chong Ae] Univ Sao Paulo, Unidade Genet Clin, Inst Crianca, Hosp Clin,Fac Med, BR-05403000 Sao Paulo, Brazil; [Bertola, Debora Romeo; Yamamoto, Guilherme Lopes; Musso, Camila Manso; dos Santos Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biociencias, BR-05508090 Sao Paulo, Brazil; [Takanohashi, Asako; Pizzino, Amy; Vanderver, Adeline] Univ Penn, Div Neurol, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Saito, Asuka; Yokota, Takanori; Ishibashi, Satoru; Nishida, Yoichiro; Ishikawa, Kinya] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Tokyo 1138519, Japan; [Segawa, Yuko] Tokyo Med & Dent Univ, Dept Orthoped Surg, Grad Sch, Tokyo 1138519, Japan; [Timmons, Margaret] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; [Taft, Ryan J.; Lajoie, Bryan] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA; [Knight, Melanie A.; Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Singleton, Andrew B.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Ferreira, Carlos R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Ferreira, Carlos R.] Childrens Natl Hlth Syst, Div Genet & Metab, Washington, DC 20010 USA; [Wang, Zheng] Peking Union Med Coll, Dept Med Genet, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Wang, Zheng] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Yan, Li] China Japan Friendship Hosp, Dept Neurol, Beijing 100029, Peoples R China; [Garbern, James Y.] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Simsek-Kiper, Pelin O.] Hacettepe Univ, Med Fac, Dept Pediat, TR-06100 Ankara, Turkey; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3308777, Japan; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Skeletal Biol Sect, NIH, Bethesda, MD 20892 USA; [Boyde, Alan] Queen Mary Univ London, Biophys Oral Growth & Dev, Dent Inst, Barts & London Sch Med & Dent, London E1 2AT, England; [Matsumoto, Naomichi; Miyake, Noriko] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Spranger, Juergen] Cent German Competence Ctr Rare Dis MKSE, D-39120 Magdeburg, Germany; [Spranger, Juergen] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Schiffmann, Raphael] Baylor Scott & White Res Inst, Dallas, TX 75204 USA; [Nishimura, Gen] Saitama Univ Hosp, Intractable Dis Ctr, Moroyama 3500495, Japan; [Simons, Cas] Royal Childrens Hosp, Murdoch Childrens Res Inst, Translat Bioinformat Grp, Melbourne, Vic 3052, Australia; [Simons, Cas] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	RIKEN; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Illumina; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; China-Japan Friendship Hospital; Wayne State University; Hacettepe University; Saitama Children's Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of London; Queen Mary University London; Yokohama City University; Greenwood Genetic Center; Baylor Health Care System; Baylor University Medical Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Queensland	Ikegawa, S (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.; Bertola, DR (corresponding author), Univ Sao Paulo, Unidade Genet Clin, Inst Crianca, Hosp Clin,Fac Med, BR-05403000 Sao Paulo, Brazil.; Bertola, DR (corresponding author), Univ Sao Paulo, Inst Biociencias, BR-05508090 Sao Paulo, Brazil.	debora.bertola@usp.br; sikegawa@ims.u-tokyo.ac.jp	Simsek-Kiper, Pelin Ozlem/AAI-3010-2021; Simons, Cas/A-7905-2011; GUO, Long/T-5237-2019; Singleton, Andrew B/C-3010-2009; Passos-Bueno, Maria Rita/I-6796-2016; Robey, Pamela Gehron/H-1429-2011; Vanderver, Adeline/CAG-5072-2022; Ikegawa, Shiro/N-6895-2015	Simons, Cas/0000-0003-3147-8042; GUO, Long/0000-0002-9660-6941; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Robey, Pamela Gehron/0000-0002-5316-5576; Ikegawa, Shiro/0000-0003-0316-2147; Takanohashi, Asako/0000-0003-3292-1595	Japan Agency for Medical Research and Development (AMED) [14525125]; Japan Society for the Promotion of Science (WAKATE B) [17K16710]; RIKEN-MOST; FAPESP [2015/21783-9/CEPID 2013/08028-1]; CNPq [304130/2016-8]; Australian National Health and Medical Research Council [NHMRC 1068278]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974] Funding Source: NIH RePORTER	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (WAKATE B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN-MOST; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the affected individuals and their family for their help to the study. This study was supported by research grants from Japan Agency for Medical Research and Development (AMED) (contract no. 14525125), the Japan Society for the Promotion of Science (WAKATE B, no. 17K16710), RIKEN-MOST, FAPESP 2015/21783-9/CEPID 2013/08028-1; CNPq 304130/2016-8, and the Australian National Health and Medical Research Council (NHMRC 1068278). The research conducted at the Murdoch Children's Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program.	ARCECI RJ, 1992, DEV BIOL, V151, P1, DOI 10.1016/0012-1606(92)90207-W; ARCECI RJ, 1989, P NATL ACAD SCI USA, V86, P8818, DOI 10.1073/pnas.86.22.8818; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Chitu V, 2015, NEUROBIOL DIS, V74, P219, DOI 10.1016/j.nbd.2014.12.001; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dorboz I, 2017, BRAIN, V140, P2550, DOI [10.1093/brain/awx215, 10.1093/brain/awx314, 10.1093/brain/awx207]; Eichler FS, 2016, BRAIN, V139, P1666, DOI 10.1093/brain/aww066; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Guo L, 2018, J HUM GENET, V63, P769, DOI 10.1038/s10038-018-0447-6; Guo L, 2017, J HUM GENET, V62, P797, DOI 10.1038/jhg.2017.38; Haraguchi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25198; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; HOUSTON CS, 1978, AM J ROENTGENOL, V130, P988, DOI 10.2214/ajr.130.5.988; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kiper POS, 2016, NEW ENGL J MED, V374, P2553, DOI 10.1056/NEJMoa1509342; Konno T, 2017, AM J NEURORADIOL, V38, P77, DOI 10.3174/ajnr.A4938; Menke J, 2009, J CLIN INVEST, V119, P2330, DOI 10.1172/JCI39087; Monies D, 2017, GENET MED, V19, P1144, DOI 10.1038/gim.2017.22; Morandi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027450; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pridans C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03013; Pyle E, 1931, J BONE JOINT SURG, V13, P874; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Robinson JL, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0219-x; SPRANGER J, 1968, FORTSCHR RONTG NEUEN, V109, P504; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Svensson C, 2011, BIOCHEM BIOPH RES CO, V406, P488, DOI 10.1016/j.bbrc.2011.02.083; Wang Z, 2017, J HUM GENET, V62, P503, DOI 10.1038/jhg.2016.157; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200	34	64	65	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					925	935		10.1016/j.ajhg.2019.03.004	http://dx.doi.org/10.1016/j.ajhg.2019.03.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	30982609	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000466608700011
J	Bombard, Y; Brothers, KB; Fitzgerald-Butt, S; Garrison, NA; Jamal, L; James, CA; Jarvik, GP; McCormick, JB; Nelson, TN; Ormond, KE; Rehm, HL; Richer, J; Souzeau, E; Vassy, JL; Wagner, JK; Levy, HP				Bombard, Yvonne; Brothers, Kyle B.; Fitzgerald-Butt, Sara; Garrison, Nanibaa' A.; Jamal, Leila; James, Cynthia A.; Jarvik, Gail P.; McCormick, Jennifer B.; Nelson, Tanya N.; Ormond, Kelly E.; Rehm, Heidi L.; Richer, Julie; Souzeau, Emmanuelle; Vassy, Jason L.; Wagner, Jennifer K.; Levy, Howard P.			The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MANAGING INCIDENTAL FINDINGS; VARIANT CLASSIFICATION; CLINICAL-PRACTICE; INFORMED-CONSENT; DUTY; GUIDELINES; RETURN; LABORATORIES; BRCA1; RECLASSIFICATION	The evidence base supporting genetic and genomic sequence-variant interpretations is continuously evolving. An inherent consequence is that a variant's clinical significance might be reinterpreted over time as new evidence emerges regarding its pathogenicity or lack thereof. This raises ethical, legal, and financial issues as to whether there is a responsibility to recontact research participants to provide updates on reinterpretations of variants after the initial analysis. There has been discussion concerning the extent of this obligation in the context of both research and clinical care. Although clinical recommendations have begun to emerge, guidance is lacking on the responsibilities of researchers to inform participants of reinterpreted results. To respond, an American Society of Human Genetics (ASHG) workgroup developed this position statement, which was approved by the ASHG Board in November 2018. The workgroup included representatives from the National Society of Genetic Counselors, the Canadian College of Medical Genetics, and the Canadian Association of Genetic Counsellors. The final statement includes twelve position statements that were endorsed or supported by the following organizations: Genetic Alliance, European Society of Human Genetics, Canadian Association of Genetic Counsellors, American Association of Anthropological Genetics, Executive Committee of the American Association of Physical Anthropologists, Canadian College of Medical Genetics, Human Genetics Society of Australasia, and National Society of Genetic Counselors.	[Bombard, Yvonne; Brothers, Kyle B.; Garrison, Nanibaa' A.; Jamal, Leila; McCormick, Jennifer B.; Ormond, Kelly E.; Wagner, Jennifer K.; Levy, Howard P.] Amer Soc Human Genet, Social Issues Comm, Rockville, MD 20852 USA; [Bombard, Yvonne] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Bombard, Yvonne] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada; [Brothers, Kyle B.] Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; [Fitzgerald-Butt, Sara; Jamal, Leila; James, Cynthia A.] Natl Soc Genet Counselors, Chicago, IL 60611 USA; [Fitzgerald-Butt, Sara] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Garrison, Nanibaa' A.] Seattle Childrens Hosp & Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Garrison, Nanibaa' A.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Jamal, Leila] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [James, Cynthia A.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Jarvik, Gail P.] Amer Soc Human Genet, Execut Comm, Rockville, MD 20852 USA; [Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [McCormick, Jennifer B.] Penn State Univ, Coll Med, Dept Humanities, Hershey, PA 17033 USA; [Nelson, Tanya N.; Richer, Julie] Canadian Coll Med Geneticists, Kingston, ON K7K 1Z7, Canada; [Nelson, Tanya N.] BC Childrens Hosp Res Inst, Vancouver, BC V5Z 4H4, Canada; [Nelson, Tanya N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Nelson, Tanya N.] BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC V6H 3N1, Canada; [Nelson, Tanya N.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Ormond, Kelly E.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Ormond, Kelly E.] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA; [Rehm, Heidi L.; Vassy, Jason L.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Rehm, Heidi L.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Rehm, Heidi L.] Broad Inst MIT & Harvard, Med & Populat Genet, Cambridge, MA 02142 USA; [Richer, Julie] CHEO, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Richer, Julie] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Souzeau, Emmanuelle] Canadian Assoc Genet Counsellors, Oakville, ON L6J 7N5, Canada; [Souzeau, Emmanuelle] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5042, Australia; [Vassy, Jason L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Vassy, Jason L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Vassy, Jason L.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Wagner, Jennifer K.] Geisinger Hlth Syst, Ctr Translat Bioeth & Hlth Care Policy, Danville, PA 17822 USA; [Levy, Howard P.] Johns Hopkins Univ, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Levy, Howard P.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Louisville; Indiana University System; Indiana University Bloomington; Seattle Children's Hospital; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; Stanford University; Stanford University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Flinders Medical Centre; Flinders University South Australia; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Geisinger Health System; Johns Hopkins University; Johns Hopkins University	Bombard, Y (corresponding author), Amer Soc Human Genet, Social Issues Comm, Rockville, MD 20852 USA.; Bombard, Y (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada.; Bombard, Y (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1T8, Canada.	yvonne.bombard@utoronto.ca	Vassy, Jason L./AAC-8220-2019; Souzeau, Emmanuelle/AAB-5608-2022	Souzeau, Emmanuelle/0000-0002-2015-6577; Ormond, Kelly/0000-0002-1033-0818; James, Cynthia/0000-0001-8040-4600; Nelson, Tanya/0000-0001-5344-3516; Vassy, Jason/0000-0001-6113-5564	Canadian Institutes of Health Research; National Institutes of Health [U41HG006834, U01HG008676, K01 HG008818, U01HG008657, U01HG007307]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR002014]; Veterans Affairs Office of Research and Development [IK2-CX001262]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG008818, U01HG008657, U41HG006834, U01HG008676] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001262] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs Office of Research and Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Veterans Affairs(US Department of Veterans Affairs)	The workgroup (see members below) would like to thank Jillian Galloway, Chloe Mighton, and Nikki Meadows for assistance with the development of this statement. Y.B. was supported in part by an early career investigator award from the Canadian Institutes of Health Research. N.A.G. was supported in part by National Institutes of Health grant K01 HG008818. The effort of G.P.J. was supported in part by National Institutes of Health grants U01HG008657 and U01HG007307. H.L.R. was supported in part by National Institutes of Health grants U41HG006834 and U01HG008676. J.B.M.'s effort was supported in part by UL1TR002014 through the National Center for Advancing Translational Sciences, National Institutes of Health. J.L.V. was supported by grant IK2-CX001262 from the Veterans Affairs Office of Research and Development.	Al-Murshedi F, 2019, EUR J MED GENET, V62, P39, DOI 10.1016/j.ejmg.2018.04.016; Al-Nabhani M, 2018, CLIN GENET, V94, P495, DOI 10.1111/cge.13438; Alfares A, 2018, GENET MED, V20, P1328, DOI 10.1038/gim.2018.41; Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; [Anonymous], 2018, AM J MED GENET A, V176, P264, DOI 10.1002/ajmg.a.38608; Appelbaum Paul S., 2002, American Journal of Bioethics, V2, P22, DOI 10.1162/152651602317533596; Arenas MAR, 2018, ANN SURG ONCOL, V25, P1395, DOI 10.1245/s10434-018-6366-0; Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Balmana J, 2016, J CLIN ONCOL, V34, P4071, DOI 10.1200/JCO.2016.68.4316; Bean LJH, 2013, HUM MUTAT, V34, P1183, DOI 10.1002/humu.22364; Beauchamp TL, 2013, PRINCIPLES BIOMEDICA, V7th; Berrios C, 2018, J GENET COUNS, V27, P263, DOI 10.1007/s10897-017-0143-2; Beunders G, 2018, EUR J MED GENET, V61, P213, DOI 10.1016/j.ejmg.2017.11.017; Bland A, 2018, GENET MED, V20, P369, DOI 10.1038/gim.2017.212; Bombard Y, 2013, J NATL COMPR CANC NE, V11, P1343, DOI 10.6004/jnccn.2013.0158; Boycott K, 2015, J MED GENET, V52, P431, DOI 10.1136/jmedgenet-2015-103144; Carrieri D, 2019, EUR J HUM GENET, V27, P169, DOI 10.1038/s41431-018-0285-1; Carrieri D, 2017, EUR J HUM GENET, V25, P275, DOI 10.1038/ejhg.2016.188; Carrieri D, 2016, GENET MED, V18, P876, DOI 10.1038/gim.2015.194; Chisholm C, 2018, GENET MED, V20, P365, DOI 10.1038/gim.2017.191; Cho MK, 2008, AM J BIOETHICS, V8, pW4, DOI 10.1080/15265160802132951; Cho Mildred K, 2008, IRB, V30, P1; Clayton EW, 2013, GENET MED, V15, P624, DOI 10.1038/gim.2013.7; Clayton EW, 2012, GENET MED, V14, P473, DOI 10.1038/gim.2012.10; Department of Health Education and Welfare, 2014, J Am Coll Dent, V81, P4; Dheensa S, 2017, EUR J MED GENET, V60, P403, DOI 10.1016/j.ejmg.2017.05.001; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Ewans LJ, 2018, GENET MED, V20, P1564, DOI 10.1038/gim.2018.39; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Fitzpatrick JL, 1999, AM J HUM GENET, V64, P852, DOI 10.1086/302293; Griffin CA, 2007, FAM CANCER, V6, P265, DOI 10.1007/s10689-007-9117-0; Harrison SM, 2018, HUM MUTAT, V39, P1641, DOI 10.1002/humu.23643; Hay-Smith EJC, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0203-6; hhs, 1979, BELM REP ETH PRINC G; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kast K, 2018, ARCH GYNECOL OBSTET, V297, P279, DOI 10.1007/s00404-017-4631-2; Kelly MA, 2018, GENET MED, V20, P351, DOI 10.1038/gim.2017.218; Laakmann Anna B., 2015, CARDOZO L REV, V36, P913; LANTOS J, 1993, CANCER, V72, P2811, DOI 10.1002/1097-0142(19931101)72:9+<2811::AID-CNCR2820721507>3.0.CO;2-G; Lebo MS, 2018, GENET MED, V20, P294, DOI 10.1038/gim.2017.80; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Macklin S, 2018, GENET MED, V20, P346, DOI 10.1038/gim.2017.207; Marchant GE, 2018, FOOD DRUG LAW J, V73, P1; Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226; McGuire AL, 2014, GENOME RES, V24, P719, DOI 10.1101/gr.170514.113; Mersch J, 2018, JAMA-J AM MED ASSOC, V320, P1266, DOI 10.1001/jama.2018.13152; Middleton A, 2015, LANCET, V385, P1289, DOI 10.1016/S0140-6736(14)62119-X; Miller FA, 2012, EUR J HUM GENET, V20, P837, DOI 10.1038/ejhg.2012.24; Murray ML, 2011, GENET MED, V13, P998, DOI 10.1097/GIM.0b013e318226fc15; Nambot S, 2018, GENET MED, V20, P645, DOI 10.1038/gim.2017.162; National Academies of Sciences Engineering and Medicine, 2018, RET IND RES RES PART; Otten E, 2015, GENET MED, V17, P668, DOI 10.1038/gim.2014.173; Pepin MG, 2016, GENET MED, V18, P20, DOI 10.1038/gim.2015.31; Pike ER, 2014, GEORGETOWN LAW J, V102, P795; Porter KM, 2018, AM J BIOETHICS, V18, P39, DOI 10.1080/15265161.2017.1401156; Prince AER, 2015, J LAW MED ETHICS, V43, P827, DOI 10.1111/jlme.12323; Pyeritz RE, 2011, NEW ENGL J MED, V365, P1367, DOI 10.1056/NEJMp1107564; Raper S, 2016, FOOD DRUG LAW J, V71, P59; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Rothstein MA, 2012, HOUSTON J HLTH LAW P, V12, P93; Scholtes E, 2016, MINN LAW REV, V100, P1171; Shah N, 2018, AM J HUM GENET, V102, P609, DOI 10.1016/j.ajhg.2018.02.019; Shalowitz DI, 2005, JAMA-J AM MED ASSOC, V294, P737, DOI 10.1001/jama.294.6.737; Shamseldin HE, 2017, GENET MED, V19, P593, DOI 10.1038/gim.2016.155; Shore N, 2006, J COMMUNITY PRACT, V14, P5, DOI 10.1300/J125v14n04_02; Sirchia F, 2018, EUR J HUM GENET, V26, P946, DOI 10.1038/s41431-018-0131-5; Slavin TP, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djy027; Smith ED, 2017, HUM MUTAT, V38, P600, DOI 10.1002/humu.23183; Stevens YA, 2017, PERS MED, V14, P367, DOI 10.2217/pme-2017-0012; Taber JM, 2018, GENET MED, V20, P337, DOI 10.1038/gim.2017.88; Tan NN, 2017, GENET MED, V19, P176, DOI 10.1038/gim.2016.96; Tovino SA, 2008, ACCOUNT RES, V15, P242, DOI 10.1080/08989620802388705; Turner SA, 2019, GENET MED, V21, P426, DOI 10.1038/s41436-018-0063-z; Vears DF, 2018, EUR J HUM GENET, V26, P1743, DOI 10.1038/s41431-018-0239-7; Wade CH, 2006, AM J BIOETHICS, V6, P26, DOI 10.1080/15265160600935746; Webber EM, 2018, HUM MUTAT, V39, P1677, DOI 10.1002/humu.23631; Weiner C, 2014, AM J EPIDEMIOL, V180, P562, DOI 10.1093/aje/kwu217; Wenger AM, 2017, GENET MED, V19, P209, DOI 10.1038/gim.2016.88; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2018, J LAW MED ETHICS, V46, P87, DOI 10.1177/1073110518766024; Wolf SM, 2015, J LAW MED ETHICS, V43, P440, DOI 10.1111/jlme.12288; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23; Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246; Yorczyk A, 2015, CLIN GENET, V88, P278, DOI 10.1111/cge.12488	86	64	65	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					578	595		10.1016/j.ajhg.2019.02.025	http://dx.doi.org/10.1016/j.ajhg.2019.02.025			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30951675	Green Published, Bronze			2022-12-18	WOS:000463474700002
J	Zhu, XL; Yin, L; Theisen, M; Zhuo, J; Siddiqui, S; Levy, B; Presnyak, V; Frassetto, A; Milton, J; Salerno, T; Benenato, KE; Milano, J; Lynn, A; Sabnis, S; Burke, K; Besin, G; Lukacs, CM; Guey, LT; Finn, PF; Martini, PGV				Zhu, Xuling; Yin, Ling; Theisen, Matt; Zhuo, Jenny; Siddiqui, Summar; Levy, Becca; Presnyak, Vladimir; Frassetto, Andrea; Milton, Jaclyn; Salerno, Timothy; Benenato, Kerry E.; Milano, Joe; Lynn, Andy; Sabnis, Staci; Burke, Kristine; Besin, Gilles; Lukacs, Christine M.; Guey, Lin T.; Finn, Patrick F.; Martini, Paolo G. V.			Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN ALPHA-GALACTOSIDASE; ENZYME REPLACEMENT THERAPY; SUBSTRATE REDUCTION; AGALSIDASE-BETA; EXPRESSION; BIOMARKERS	Fabry disease is an X-linked lysosomal storage disease caused by loss of alpha galactosidase A (alpha-Gal A) activity and is characterized by progressive accumulation of globotriaosylceramide and its analogs in all cells and tissues. Although enzyme replacement therapy (ERT) is considered standard of care, the long-term effects of ERT on renal and cardiac manifestations remain uncertain and thus novel therapies are desirable. We herein report preclinical studies evaluating systemic messenger RNA (mRNA) encoding human alpha-Gal A in wild-type (WT) mice, alpha-Gal A-deficient mice, and WT non-human primates (NHPs). The pharmacokinetics and distribution of h-alpha-Gal A mRNA encoded protein in WT mice demonstrated prolonged half-lives of alpha-Gal A in tissues and plasma. Single intravenous administration of h-alpha-Gal A mRNA to Gla-deficient mice showed dose-dependent protein activity and substrate reduction. Moreover, long duration (up to 6 weeks) of substrate reductions in tissues and plasma were observed after a single injection. Furthermore, repeat i.v. administration of h-alpha-Gal A mRNA showed a sustained pharmacodynamic response and efficacy in Fabry mice model. Lastly, multiple administrations to non-human primates confirmed safety and translatability. Taken together, these studies across species demonstrate preclinical proof-of-concept of systemic mRNA therapy for the treatment of Fabry disease and this approach may be useful for other lysosomal storage disorders.	[Zhu, Xuling; Yin, Ling; Theisen, Matt; Zhuo, Jenny; Siddiqui, Summar; Levy, Becca; Presnyak, Vladimir; Frassetto, Andrea; Milton, Jaclyn; Salerno, Timothy; Benenato, Kerry E.; Milano, Joe; Lynn, Andy; Sabnis, Staci; Burke, Kristine; Besin, Gilles; Lukacs, Christine M.; Guey, Lin T.; Finn, Patrick F.; Martini, Paolo G. V.] Moderna Inc, 200 Technol Sq, Cambridge, MA 02139 USA		Martini, PGV (corresponding author), Moderna Inc, 200 Technol Sq, Cambridge, MA 02139 USA.	paolo.martini@modernatx.com	Finn, Patrick/AGO-4771-2022	besin, gilles/0000-0002-7403-0574; Presnyak, Vladimir/0000-0001-6695-7102	Moderna, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER	Moderna, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by Moderna, Inc. We thank Dr. Ed Miracco for his careful review of the manuscript.	An D, 2017, CELL REP, V21, P3548, DOI 10.1016/j.celrep.2017.11.081; Auray-Blais C, 2017, CLIN CHIM ACTA, V466, P185, DOI 10.1016/j.cca.2017.01.018; Auray-Blais C, 2012, ANAL CHEM, V84, P2745, DOI 10.1021/ac203433e; Bangari DS, 2015, AM J PATHOL, V185, P651, DOI 10.1016/j.ajpath.2014.11.004; Beck M, 2018, DEV MED CHILD NEUROL, V60, P13, DOI 10.1111/dmcn.13600; Benjamin ER, 2012, MOL THER, V20, P717, DOI 10.1038/mt.2011.271; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; Brady RO, 2000, JAMA-J AM MED ASSOC, V284, P2771, DOI 10.1001/jama.284.21.2771; Elliott S, 2016, MOL GENET METAB, V118, P304, DOI 10.1016/j.ymgme.2016.05.015; Garman RD, 2004, CLIN EXP IMMUNOL, V137, P496, DOI 10.1111/j.1365-2249.2004.02567.x; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Hebert A, 2013, MOL GENET METAB, V108, pS47, DOI 10.1016/j.ymgme.2012.11.109; Higuchi K, 2010, MOL MED, V16, P216, DOI 10.2119/molmed.2009.00163; HOHMAN TC, 1984, J CELL BIOL, V98, P246, DOI 10.1083/jcb.98.1.246; Huston MW, 2017, MOL GENET METAB, V120, pS69, DOI 10.1016/j.ymgme.2016.11.160; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Ishii S, 2009, J PHARMACOL EXP THER, V328, P723, DOI 10.1124/jpet.108.149054; Jiang L, 2018, NAT MED, V24, P1899, DOI 10.1038/s41591-018-0199-z; Kizhner T, 2015, MOL GENET METAB, V114, P259, DOI 10.1016/j.ymgme.2014.08.002; Komori M., 2013, INT J OTOLARYNGOL, V2013, DOI DOI 10.1007/S10545-014-9717-4; Kramer J, 2018, NEPHROL DIAL TRANSPL, V33, P1362, DOI 10.1093/ndt/gfx319; Kubo T, 2017, J GEN FAM MED, V18, P225, DOI 10.1002/jgf2.76; Lee K, 2003, GLYCOBIOLOGY, V13, P305, DOI 10.1093/glycob/cwg034; Lux CT, 2017, HEMATOL ONCOL CLIN N, V31, P787, DOI 10.1016/j.hoc.2017.05.002; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Messalli G, 2012, RADIOL MED, V117, P19, DOI 10.1007/s11547-011-0710-9; Miller JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99171; Motabar Omid, 2010, Curr Chem Genomics, V4, P50, DOI 10.2174/1875397301004010050; Murray GJ, 2007, MOL GENET METAB, V90, P307, DOI 10.1016/j.ymgme.2006.11.008; Pacienza N, 2012, MOL THER, V20, P1454, DOI 10.1038/mt.2012.64; Pisani A, 2014, CLIN GENET, V86, P301, DOI 10.1111/cge.12386; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Sabnis S, 2018, MOL THER, V26, P1509, DOI 10.1016/j.ymthe.2018.03.010; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Seydelmann N, 2015, BEST PRACT RES CL EN, V29, P195, DOI 10.1016/j.beem.2014.10.003; Shen JS, 2016, J INHERIT METAB DIS, V39, P293, DOI 10.1007/s10545-015-9886-9; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sueoka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144958; Sueoka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127048; Tadevosyan A, 2017, CURR RES TRANSL MED, V65, P10, DOI 10.1016/j.retram.2016.09.001; Trimarchi Hernán, 2016, J. inborn errors metab. screen., V4, pe160004, DOI 10.1177/2326409816648169; Warnock D., 2018, NEPHROL DIAL TRANSPL, V33, pi634; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Xu S, 2015, MOL THER, V23, P1169, DOI 10.1038/mt.2015.87; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760; Yuasa T, 2017, J ECHOCARDIOGR, V15, P151, DOI 10.1007/s12574-017-0340-x; Ziegler RJ, 1999, HUM GENE THER, V10, P1667, DOI 10.1089/10430349950017671; Ziegler RJ, 2004, MOL THER, V9, P231, DOI 10.1016/j.ymthe.2003.11.015	51	64	65	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					625	637		10.1016/j.ajhg.2019.02.003	http://dx.doi.org/10.1016/j.ajhg.2019.02.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30879639	Bronze, Green Published			2022-12-18	WOS:000463474700005
J	Blackburn, PR; Xu, Z; Tumelty, KE; Zhao, RW; Monis, WJ; Harris, KG; Gass, JM; Cousin, MA; Boczek, NJ; Mitkov, MV; Cappel, MA; Francomano, CA; Parisi, JE; Klee, EW; Faqeih, E; Alkuraya, FS; Layne, MD; McDonnell, NB; Atwal, PS				Blackburn, Patrick R.; Xu, Zhi; Tumelty, Kathleen E.; Zhao, Rose W.; Monis, William J.; Harris, Kimberly G.; Gass, Jennifer M.; Cousin, Margot A.; Boczek, Nicole J.; Mitkov, Mario V.; Cappel, Mark A.; Francomano, Clair A.; Parisi, Joseph E.; Klee, Eric W.; Faqeih, Eissa; Alkuraya, Fowzan S.; Layne, Matthew D.; McDonnell, Nazli B.; Atwal, Paldeep S.			Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARBOXYPEPTIDASE-LIKE PROTEIN; DISCOIDIN DOMAIN RECEPTORS; EMBRYONIC-DEVELOPMENT; BINDING; MUSCLE; DIFFERENTIATION; DISORDERS; LUNG; DDR1	AEBP1 encodes the aortic carboxypeptidase-like protein (ACLP) that associates with collagens in the extracellular matrix (ECM) and has several roles in development, tissue repair, and fibrosis. ACLP is expressed in bone, the vasculature, and dermal tissues and is involved in fibroblast proliferation and mesenchymal stem cell differentiation into collagen-producing cells. Aebp1(-/-) mice have abnormal, delayed wound repair correlating with defects in fibroblast proliferation. In this study, we describe four individuals from three unrelated families that presented with a unique constellation of clinical findings including joint laxity, redundant and hyperextensible skin, poor wound healing with abnormal scarring, osteoporosis, and other features reminiscent of Ehlers-Danlos syndrome (EDS). Analysis of skin biopsies revealed decreased dermal collagen with abnormal collagen fibrils that were ragged in appearance. Exome sequencing revealed compound heterozygous variants in AEBP1 (c.1470delC [p.Asn490_Met495delins(40)] and c.1743C>A [p.Cys581*]) in the first individual, a homozygous variant (c.1320_1326del [p.Arg440Serfs*3]) in the second individual, and a homozygous splice site variant (c.1630thorn1G>A) in two siblings from the third family. We show that ACLP enhances collagen polymerization and binds to several fibrillar collagens via its discoidin domain. These studies support the conclusion that bi-allelic pathogenic variants in AEBP1 are the cause of this autosomal-recessive EDS subtype.	[Blackburn, Patrick R.; Boczek, Nicole J.; Parisi, Joseph E.; Klee, Eric W.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Blackburn, Patrick R.; Cousin, Margot A.; Boczek, Nicole J.; Klee, Eric W.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Blackburn, Patrick R.; Cousin, Margot A.; Boczek, Nicole J.; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Xu, Zhi; Francomano, Clair A.; McDonnell, Nazli B.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA; [Tumelty, Kathleen E.; Zhao, Rose W.; Monis, William J.; Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Harris, Kimberly G.; Atwal, Paldeep S.] Mayo Clin, Dept Clin Genom, Jacksonville, FL 32224 USA; [Gass, Jennifer M.; Atwal, Paldeep S.] Mayo Clin, Ctr Individualized Med, Jacksonville, FL 32224 USA; [Mitkov, Mario V.; Cappel, Mark A.] Mayo Clin, Dept Dermatol, Jacksonville, FL 32224 USA; [Francomano, Clair A.] Greater Baltimore Med Ctr, Baltimore, MD 21204 USA; [Parisi, Joseph E.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Klee, Eric W.] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA; [Faqeih, Eissa] King Fahad Med City, Childrens Hosp, Dept Pediat Specialties, Riyadh 12231, Saudi Arabia; [Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Project, Riyadh 12371, Saudi Arabia; [Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 12713, Saudi Arabia; [Alkuraya, Fowzan S.] KAUST, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia; [McDonnell, Nazli B.] Eastern Colorado Hlth Syst, Vet Adm, Denver, CO 80220 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Boston University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Greater Baltimore Medical Center; Mayo Clinic; Mayo Clinic; King Fahad Medical City; King Faisal Specialist Hospital & Research Center; King Abdullah University of Science & Technology	McDonnell, NB (corresponding author), NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.; Atwal, PS (corresponding author), Mayo Clin, Dept Clin Genom, Jacksonville, FL 32224 USA.; Atwal, PS (corresponding author), Mayo Clin, Ctr Individualized Med, Jacksonville, FL 32224 USA.; McDonnell, NB (corresponding author), Eastern Colorado Hlth Syst, Vet Adm, Denver, CO 80220 USA.	nazli.mcdonnell@va.gov; paldeep.atwal@googlemail.com	Atwal, Paldeep/H-7472-2019; Cousin, Margot/AAD-4591-2019	Atwal, Paldeep/0000-0002-8515-744X; Cousin, Margot/0000-0002-6119-9346	Mayo Clinic Center for Individualized Medicine (CIM) through the CIM Investigative and Functional Genomics Program; Intramural Research Program of the National Institutes of Health, National Institute on Aging [03-AG-N330, 11-AG-N079]; American Heart Association [14GRNT18690001]; NIH [HL078869, HL078869S1]; UROP award from Boston University; Saudi Human Genome Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078869] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine (CIM) through the CIM Investigative and Functional Genomics Program; Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UROP award from Boston University; Saudi Human Genome Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank the subjects and their families for participating in this study. This work was made possible through support provided by the Mayo Clinic Center for Individualized Medicine (CIM) through the CIM Investigative and Functional Genomics Program. This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute on Aging protocol numbers 03-AG-N330 (formerly 2003-086) and 11-AG-N079 (N.B.M. and C.A.F.), The American Heart Association grant 14GRNT18690001 (M.D.L.), and NIH grants HL078869 and HL078869S1 (M.D.L.). R.W.Z. was supported by a UROP award from Boston University. We acknowledge the support of the Saudi Human Genome Program.	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Alazami AM, 2016, HUM GENET, V135, P525, DOI 10.1007/s00439-016-1660-z; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Byers PH, 2012, J INVEST DERMATOL, V132, pE6, DOI 10.1038/skinbio.2012.3; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Damodarasamy M, 2010, J GERONTOL A-BIOL, V65, P209, DOI 10.1093/gerona/glp202; den Dunnen JT, 1998, HUM MOL GENET, V7, P1185; Didangelos A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008128; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Ith B, 2005, GENE EXPR PATTERNS, V5, P533, DOI 10.1016/j.modgep.2004.11.002; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Layne MD, 2002, CIRC RES, V90, P728, DOI 10.1161/01.RES.0000013289.97650.C8; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Murphy-Ryan M, 2010, GENET MED, V12, P344, DOI 10.1097/GIM.0b013e3181e074f0; Ohno I, 1996, BIOCHEM BIOPH RES CO, V228, P411, DOI 10.1006/bbrc.1996.1675; Pepin MG, 2014, GENET MED, V16, P881, DOI 10.1038/gim.2014.72; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; SILVER FH, 1983, COLLAGEN REL RES, V3, P393; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vanakker O, 2015, ANNU REV GENOM HUM G, V16, P229, DOI 10.1146/annurev-genom-090314-050039; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Zou YQ, 2017, HUM MOL GENET, V26, P2207, DOI 10.1093/hmg/ddx110	32	64	66	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					696	705		10.1016/j.ajhg.2018.02.018	http://dx.doi.org/10.1016/j.ajhg.2018.02.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29606302	Bronze, Green Published			2022-12-18	WOS:000429340800015
J	Mangold, E; Bohmer, AC; Ishorst, N; Hoebel, AK; Gultepe, P; Schuenke, H; Klamt, J; Hofmann, A; Golz, L; Raff, R; Tessmann, P; Nowak, S; Reutter, H; Hemprich, A; Kreusch, T; Kramer, FJ; Braumann, B; Reich, R; Schmidt, G; Jager, A; Reiter, R; Brosch, S; Stavusis, J; Ishida, M; Seselgyte, R; Moore, GE; Nothen, MM; Borck, G; Aldhorae, KA; Lace, B; Stanier, P; Knapp, M; Ludwig, KU				Mangold, Elisabeth; Boehmer, Anne C.; Ishorst, Nina; Hoebel, Ann-Kathrin; Gueltepe, Pinar; Schuenke, Hannah; Klamt, Johanna; Hofmann, Andrea; Goelz, Lina; Raff, Ruth; Tessmann, Peter; Nowak, Stefanie; Reutter, Heiko; Hemprich, Alexander; Kreusch, Thomas; Kramer, Franz-Josef; Braumann, Bert; Reich, Rudolf; Schmidt, Guel; Jaeger, Andreas; Reiter, Rudolf; Brosch, Sibylle; Stavusis, Janis; Ishida, Miho; Seselgyte, Rimante; Moore, Gudrun E.; Noethen, Markus M.; Borck, Guntram; Aldhorae, Khalid A.; Lace, Baiba; Stanier, Philip; Knapp, Michael; Ludwig, Kerstin U.			Sequencing the GRHL3 Coding Region Reveals Rare Truncating Mutations and a Common Susceptibility Variant for Nonsyndromic Cleft Palate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK LOCI; LIP; GENE; SCAN; METAANALYSIS; POPULATIONS; INHERITANCE; EFFICIENT; HISTORY	Nonsyndromic cleft lip with/without cleft palate (nsCL/P) and nonsyndromic cleft palate only (nsCPO) are the most frequent subphenotypes of orofacial clefts. A common syndromic form of orofacial clefting is Van der Woude syndrome (VWS) where individuals have CL/P or CPO, often but not always associated with lower lip pits. Recently, similar to 5% of VWS-affected individuals were identified with mutations in the grainy head-like 3 gene (GRHL3). To investigate GRHL3 in nonsyndromic clefting, we sequenced its coding region in 576 Europeans with nsCL/P and 96 with nsCPO. Most strikingly, nsCPO-affected individuals had a higher minor allele frequency for rs41268753 (0.099) than control subjects (0.049; p = 1.24 x 10(-2)). This association was replicated in nsCPO/control cohorts from Latvia, Yemen, and the UK (p(combined) = 2.63 x 10(-5); ORallelic = 2.46 [95% CI 1.6-3.7]) and reached genome-wide significance in combination with imputed data from a GWAS in nsCPO triads (p = 2.73 x 10(-9)). Notably, rs41268753 is not associated with nsCL/P (p = 0.45). rs41268753 encodes the highly conserved p.Thr454Met (c.1361C>T) (GERP = 5.3), which prediction programs denote as deleterious, has a CADD score of 29.6, and increases protein binding capacity in silico. Sequencing also revealed four novel truncating GRHL3 mutations including two that were de novo in four families, where all nine individuals harboring mutations had nsCPO. This is important for genetic counseling: given that VWS is rare compared to nsCPO, our data suggest that dominant GRHL3 mutations are more likely to cause nonsyndromic than syndromic CPO. Thus, with rare dominant mutations and a common risk variant in the coding region, we have identified an important contribution for GRHL3 in nsCPO.	[Mangold, Elisabeth; Boehmer, Anne C.; Ishorst, Nina; Hoebel, Ann-Kathrin; Gueltepe, Pinar; Schuenke, Hannah; Klamt, Johanna; Hofmann, Andrea; Raff, Ruth; Tessmann, Peter; Nowak, Stefanie; Reutter, Heiko; Noethen, Markus M.; Ludwig, Kerstin U.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Boehmer, Anne C.; Ishorst, Nina; Hoebel, Ann-Kathrin; Gueltepe, Pinar; Schuenke, Hannah; Klamt, Johanna; Hofmann, Andrea; Tessmann, Peter; Reutter, Heiko; Noethen, Markus M.; Ludwig, Kerstin U.] Univ Bonn, Dept Genom, Life & Brain Ctr, D-53127 Bonn, Germany; [Goelz, Lina; Jaeger, Andreas] Univ Bonn, Dept Orthodont, D-53127 Bonn, Germany; [Reutter, Heiko] Univ Bonn, Dept Neonatol & Pediat Intens Care, Childrens Hosp, D-53113 Bonn, Germany; [Hemprich, Alexander] Univ Hosp Leipzig, Clin Maxillofacial Surg, D-04103 Leipzig, Germany; [Kreusch, Thomas] Asklepios Klin Nord, Dept Oral & Maxillofacial Surg, Head & Neck Ctr, D-22417 Hamburg, Germany; [Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, D-37075 Gottingen, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, D-50931 Cologne, Germany; [Reich, Rudolf] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-53111 Bonn, Germany; [Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, D-13353 Berlin, Germany; [Reiter, Rudolf; Brosch, Sibylle] Univ Ulm, Dept Otolaryngol Head & Neck Surg, Sect Phoniatr & Pedaudiol, D-89070 Ulm, Germany; [Stavusis, Janis; Lace, Baiba] Latvian Biomed Res & Study Ctr, Med Genet & Mitochondrial Res Grp, LV-1067 Riga, Latvia; [Ishida, Miho; Seselgyte, Rimante; Moore, Gudrun E.; Stanier, Philip] UCL, Inst Child Hlth, London WC1N 1EH, England; [Borck, Guntram] Univ Ulm, Inst Human Genet, D-89073 Ulm, Germany; [Aldhorae, Khalid A.] Thamar Univ, Dept Orthodont, Coll Dent, Thamar, Yemen; [Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53127 Bonn, Germany; [Mangold, Elisabeth] Univ Bonn, Inst Human Genet, Biomed Ctr, Sigmund Freud Str 25, D-53127 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Leipzig University; University of Gottingen; University of Cologne; University of Bonn; Humboldt University of Berlin; Ulm University; Latvian Biomedical Research & Study Centre; University of London; University College London; Ulm University; University of Bonn; University of Bonn	Mangold, E (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.; Mangold, E (corresponding author), Univ Bonn, Inst Human Genet, Biomed Ctr, Sigmund Freud Str 25, D-53127 Bonn, Germany.	e.mangold@uni-bonn.de	Stanier, Philip/C-1593-2008; Ludwig, Kerstin U/H-7828-2019; Lace, Baiba/AAY-9362-2020; Aldhorae, Khalid/AAP-6764-2020; Aldhorae, khalid/L-8847-2019; Moore, Gudrun/A-2092-2009	Stanier, Philip/0000-0001-9340-8117; Ludwig, Kerstin U/0000-0002-8541-2519; Lace, Baiba/0000-0001-5371-6756; Schunke, Hannah/0000-0002-5271-1408; Moore, Gudrun/0000-0002-2099-3420; Aldhorae, Khalid/0000-0002-5920-8004; Nothen, Markus/0000-0002-8770-2464	Deutsche Forschungsgemeinschaft [FOR 423, MA 2546/3-1, MA 2546/5-1, LU 1944/2-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; BONFOR program of the Medical Faculty Bonn [0-149.0097]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR program of the Medical Faculty Bonn; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London	We thank all affected individuals and their families for their participation in this study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e.V.). We thank Prof. Bernd Potzsch for help with collecting DNA samples from anonymous blood donors. We acknowledge our collaborating clinical partners, our laboratory technicians, and colleagues responsible for database management. In particular, we would like to thank Susanne Raeder and Dietlinde Stienen for their technical assistance. The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423, individual grants MA 2546/3-1, MA 2546/5-1, LU 1944/2-1, KR 1912/7-1, NO 246/6-1, and WI 1555/5-1). K.U.L. was supported by the BONFOR program of the Medical Faculty Bonn (0-149.0097). P.S. and G.E.M. are supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. For the UK study, we are indebted to members of the North Thames Regional Cleft Centre for both recruitment and sample collection, which was approved by the Great Ormond Street Hospital and the Institute of Child Health Research Ethics Committee (REC No. 08H0713/46) and the Imperial College Hospital Ethics Committee (REC ref: 12/WA/0196), respectively. Datasets used for the genome-wide nsCPO analysis	Aldhorae KA, 2014, BIRTH DEFECTS RES A, V100, P307, DOI 10.1002/bdra.23221; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Beaty TH, 2013, HUM GENET, V132, P771, DOI 10.1007/s00439-013-1283-6; Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Birnbaum S, 2008, AM J MED GENET A, V146A, P787, DOI 10.1002/ajmg.a.32219; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cobat A, 2014, GENET EPIDEMIOL, V38, P560, DOI 10.1002/gepi.21842; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jackson MR, 2002, ANN HUM GENET, V66, P307, DOI 10.1017/S0003480002001203; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Lek M, 2015, BIORXIV; Ludwig KU, 2014, J DENT RES, V93, P376, DOI 10.1177/0022034514523987; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Mossey P., 2002, CLEFT LIP PALATE, P127; Nikopensius T, 2010, BIRTH DEFECTS RES A, V88, P748, DOI 10.1002/bdra.20700; Peyrard-Janvid M, 2014, AM J HUM GENET, V94, P23, DOI 10.1016/j.ajhg.2013.11.009; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; RINTALA AE, 1981, BRIT J PLAST SURG, V34, P26, DOI 10.1016/0007-1226(81)90090-4; Sun YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7414; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	38	64	66	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					755	762		10.1016/j.ajhg.2016.02.013	http://dx.doi.org/10.1016/j.ajhg.2016.02.013			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27018475	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000374203800013
J	White, JJ; Mazzeu, JE; Hoischen, A; Bayram, Y; Withers, M; Gezdirici, A; Kimonis, V; Steehouwer, M; Jhangiani, SN; Muzny, DM; Gibbs, RA; van Bon, BWM; Sutton, VR; Lupski, JR; Brunner, HG; Carvalho, CMB				White, Janson J.; Mazzeu, Juliana E.; Hoischen, Alexander; Bayram, Yavuz; Withers, Marjorie; Gezdirici, Alper; Kimonis, Virginia; Steehouwer, Marloes; Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; van Bon, Bregje W. M.; Sutton, V. Reid; Lupski, James R.; Brunner, Han G.; Carvalho, Claudia M. B.		Baylor-Hopkins Ctr Mendelian Genom	DVL3 Alleles Resulting in a-1 Frameshift of the Last Exon Mediate Autosomal-Dominant Robinow Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGULATE CONVERGENT EXTENSION; PATHWAY; ROR2; MECHANISMS; MUTATIONS; GENE; POLYMERIZATION; DISEASES; POLARITY	Robinow syndrome is a rare congenital disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial features. Recent reports have identified, in individuals with dominant Robinow syndrome, a specific type of variant characterized by being uniformly located in the penultimate exon of DVL1 and resulting in a - 1 frameshift allele with a premature termination codon that escapes nonsense-mediated decay. Here, we studied a cohort of individuals who had been clinically diagnosed with Robinow syndrome but who had not received a molecular diagnosis from variant studies of DVL1, WNT5A, and ROR2. Because of the uniform location of frameshift variants in DVLI-mediated Robinow syndrome and the functional redundancy of DVL1, DVL2, and DVL3, we elected to pursue direct Sanger sequencing of the penultimate exon of DVLI and its paralogs DVL2 and DVL3 to search for potential disease associated variants. Remarkably, targeted sequencing identified five unrelated individuals harboring heterozygous, de novo frameshift variants in DVL3, including two splice acceptor mutations and three 1 bp deletions. Similar to the variants observed in DVLI-mediated Robinow syndrome, all variants in DVL3 result in a 1 frameshift, indicating that these highly specific alterations might be a common cause of dominant Robinow syndrome. Here, we review the current knowledge of these peculiar variant alleles in DVLI- and DVL3-mediated Robinow syndrome and further elucidate the phenotypic features present in subjects with DVLI and DVL3 frameshift mutations.	[White, Janson J.; Bayram, Yavuz; Withers, Marjorie; Gibbs, Richard A.; Sutton, V. Reid; Lupski, James R.; Carvalho, Claudia M. B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mazzeu, Juliana E.] Univ Brasilia, Fac Med, BR-70910900 Brasilia, DF, Brazil; [Mazzeu, Juliana E.] Robinow Syndrome Fdn, Anoka, MN 55303 USA; [Hoischen, Alexander; Steehouwer, Marloes; van Bon, Bregje W. M.; Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Gezdirici, Alper] Kanuni Sultan Suleyman Training & Res Hosp, Dept Med Genet, TR-34303 Istanbul, Turkey; [Kimonis, Virginia] Univ Calif Irvine, Dept Pediat, Div Genet & Genom Med, Orange, CA 92868 USA; [Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Sutton, V. Reid; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands	Baylor College of Medicine; Universidade de Brasilia; Radboud University Nijmegen; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; University of California System; University of California Irvine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Maastricht University	Carvalho, CMB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Brunner, HG (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands.	han.brunner@radboudumc.nl; cfonseca@bcm.edu	Gezdirici, Alper/W-8459-2018; Hoischen, Alexander/D-1282-2013; Gezdirici, Alper/AAG-5480-2019; van Bon, Bregje/Q-2445-2015; Hoischen, Alexander/AGF-7293-2022; mazzeu, Juliana f/H-4279-2016	Gezdirici, Alper/0000-0002-2432-9279; Hoischen, Alexander/0000-0002-8072-4476; Gezdirici, Alper/0000-0002-2432-9279; van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; mazzeu, Juliana f/0000-0002-6161-0510; White, Janson/0000-0002-5701-728X	Baylor Hopkins Center for Mendelian Genomics [U54HG006542]; National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI); Smith-Magenis Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Baylor Hopkins Center for Mendelian Genomics; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Smith-Magenis Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Baylor Hopkins Center for Mendelian Genomics (U54HG006542), jointly funded by the National Human Genome Research Institute (NHGRI) and National Heart, Lung, and Blood Institute (NHLBI). J.J.W. is funded in part by the Smith-Magenis Syndrome Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI, NHLBI, or NIH. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bunn KJ, 2015, AM J HUM GENET, V96, P623, DOI 10.1016/j.ajhg.2015.02.010; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mazzeu JF, 2007, AM J MED GENET A, V143A, P320, DOI 10.1002/ajmg.a.31592; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Wang HY, 2012, ACTA PHYSIOL, V204, P65, DOI 10.1111/j.1748-1716.2011.02291.x; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; White J, 2015, AM J HUM GENET, V96, P612, DOI 10.1016/j.ajhg.2015.02.015; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yokoyama N, 2010, J CELL SCI, V123, P3693, DOI 10.1242/jcs.075275	31	64	67	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					553	561		10.1016/j.ajhg.2016.01.005	http://dx.doi.org/10.1016/j.ajhg.2016.01.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26924530	Green Published, Bronze			2022-12-18	WOS:000372383100017
J	Tabor, HK; Auer, PL; Jamal, SM; Chong, JX; Yu, JH; Gordon, AS; Graubert, TA; O'Donnell, CJ; Rich, SS; Nickerson, DA; Bamshad, MJ				Tabor, Holly K.; Auer, Paul L.; Jamal, Seema M.; Chong, Jessica X.; Yu, Joon-Ho; Gordon, Adam S.; Graubert, Timothy A.; O'Donnell, Christopher J.; Rich, Stephen S.; Nickerson, Deborah A.; Bamshad, Michael J.		NHLBI Exome Sequencing Project	Pathogenic Variants for Mendelian and Complex Traits in Exomes of 6,517 European and African Americans: Implications for the Return of Incidental Results	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME; PHARMACOGENOMICS; FRAMEWORK; RECOMMENDATIONS; INDIVIDUALS; PREVALENCE; MUTATIONS; TOOL; ERA	Exome sequencing (ES) is rapidly being deployed for use in clinical settings despite limited empirical data about the number and types of. incidental results (with potential clinical utility) that could be offered for return to an individual. We analyzed deidentified ES data from 6,517 participants (2,204 African Americans and 4,313 European Americans) from the National Heart, Lung, and Blood Institute Exome Sequencing Project. We characterized the frequencies of pathogenic alleles in genes underlying Mendelian conditions commonly assessed by newborn-screening (NBS, n = 39) programs, genes associated with age-related macular degeneration (ARMD, n = 17), and genes known to influence drug response (PGx, n = 14). From these 70 genes, we identified 10,789 variants and curated them by manual review of OMIM, HGMD, locus-specific databases, or primary literature to a total of 399 validated pathogenic variants. The mean number of risk alleles per individual was 15.3. Every individual had at least five known PGx alleles, 99% of individuals had at least one ARMD risk allele, and 45% of individuals were carriers for at least one pathogenic NBS allele. The carrier burden for severe recessive childhood disorders was 0.57. Our results demonstrate that risk alleles of potential clinical utility for both Mendelian and complex traits are detectable in every individual. These findings highlight the necessity of developing guidelines and policies that consider the return of results to all individuals and underscore the need to develop innovative approaches and tools that enable individuals to exercise their choice about the return of incidental results.	[Tabor, Holly K.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Tabor, Holly K.; Jamal, Seema M.; Chong, Jessica X.; Yu, Joon-Ho; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Auer, Paul L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Auer, Paul L.] Univ Wisconsin, Sch Publ Hlth, Milwaukee, WI 53201 USA; [Gordon, Adam S.; Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Graubert, Timothy A.] Harvard Univ, Dept Med, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Div Intramural Res, Framingham, MA 01702 USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; University of Washington; University of Washington Seattle; Harvard University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Virginia	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@u.washington.edu	Johnson, Andrew D/G-6520-2013; Auer, Paul/AAC-5060-2019; Singleton, Andrew B/C-3010-2009; Barbalić, Maja/E-2161-2017; Hardy, John/C-2451-2009; de Bakker, Paul IW/B-8730-2009; Chong, Jessica/GZH-1625-2022	Johnson, Andrew D/0000-0001-6369-5178; Barbalić, Maja/0000-0001-8914-1691; Hardy, John/0000-0002-3122-0423; de Bakker, Paul IW/0000-0001-7735-7858; Seshadri, Sudha/0000-0001-6135-2622; Rich, Stephen/0000-0003-3872-7793; Ballantyne, Christie/0000-0002-6432-1730; Bustamante, Carlos D./0000-0002-4187-7920; Caan, Bette/0000-0002-5803-310X; Akey, Joshua/0000-0002-4411-1330; Graubert, Timothy/0000-0002-7710-1171; Shendure, Jay/0000-0002-1516-1865; O'Connor, Timothy/0000-0002-0276-1896; Turner, Emily/0000-0001-9040-9229; Gordon, Adam/0000-0002-2058-7289; Chong, Jessica/0000-0002-1616-2448; Quinlan, Aaron/0000-0003-1756-0859	National Heart, Lung, and Blood Institute (NHLBI) [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, RC2HL102923, RC2HL102926, RC2HL102925, RC2HL102924, ZIAHL006173, T32HL007208, RC2HL103010, ZIAHL006175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG049505] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI), the contributions of the many research institutions that participated in this study, the study investigators, field staff, and the study participants who created the Exome Sequencing Project (ESP) resource for biomedical research. Funding for the NHLBI Grand Opportunity (GO) ESP was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO), and RC2 HL-102924 (Women's Health Initiative Sequencing Project). Exome sequencing was supported by NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Boone PM, 2013, GENOME RES, V23, P1383, DOI 10.1101/gr.156075.113; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Dickerson JA, 2014, ARCH PATHOL LAB MED, V138, P110, DOI 10.5858/arpa.2012-0726-OA; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Fabsitz RR, 2010, CIRC-CARDIOVASC GENE, V3, P574, DOI 10.1161/CIRCGENETICS.110.958827; Feero WG, 2014, JAMA-J AM MED ASSOC, V311, P1017, DOI 10.1001/jama.2014.1718; Filipski KK, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00073; Gonzalez-Garay ML, 2013, P NATL ACAD SCI USA, V110, P16957, DOI 10.1073/pnas.1315934110; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Lee JW, 2014, CLIN GENET, V86, P21, DOI 10.1111/cge.12392; Levenseller BL, 2014, J GENET COUNS, V23, P552, DOI 10.1007/s10897-013-9626-y; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parens E, 2013, HASTINGS CENT REP, V43, P16, DOI 10.1002/hast.189; Porter LF, 2014, CLIN GENET, V86, P1, DOI 10.1111/cge.12389; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rieder MJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00078; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Sapp J., 2013, CLIN GENET; Tabor HK, 2011, AM J MED GENET A, V155A, P2916, DOI 10.1002/ajmg.a.34357; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	47	64	67	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					183	193		10.1016/j.ajhg.2014.07.006	http://dx.doi.org/10.1016/j.ajhg.2014.07.006			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25087612	Bronze, Green Published			2022-12-18	WOS:000340076000005
J	Estrada-Cuzcano, A; Neveling, K; Kohl, S; Banin, E; Rotenstreich, Y; Sharon, D; Falik-Zaccai, TC; Hipp, S; Roepman, R; Wissinger, B; Letteboer, SJF; Mans, DA; Blokland, EAW; Kwint, MP; Gijsen, SJ; van Huet, RAC; Collin, RWJ; Scheffer, H; Veltman, JA; Zrenner, E; den Hollander, AI; Klevering, BJ; Cremers, FPM				Estrada-Cuzcano, Alejandro; Neveling, Kornelia; Kohl, Susanne; Banin, Eyal; Rotenstreich, Ygal; Sharon, Dror; Falik-Zaccai, Tzipora C.; Hipp, Stephanie; Roepman, Ronald; Wissinger, Bernd; Letteboer, Stef J. F.; Mans, Dorus A.; Blokland, Ellen A. W.; Kwint, Michael P.; Gijsen, Sabine J.; van Huet, Ramon A. C.; Collin, Rob W. J.; Scheffer, H.; Veltman, Joris A.; Zrenner, Eberhart; den Hollander, Anneke I.; Klevering, B. Jeroen; Cremers, Frans P. M.		European Retinal Dis Consortium	Mutations in C8orf37, Encoding a Ciliary Protein, are Associated with Autosomal-Recessive Retinal Dystrophies with Early Macular Involvement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; CONE-ROD DYSTROPHY; GENE; IDENTIFICATION; PHENOTYPE; MODEL	Cone-rod dystrophy (CRD) and retinitis pigmentosa (RP) are clinically and genetically overlapping heterogeneous retinal dystrophies. By using homozygosity mapping in an individual with autosomal-recessive (ar) RP from a consanguineous family, we identified three sizeable homozygous regions, together encompassing 46 Mb. Next-generation sequencing of all exons, flanking intron sequences, microRNAs, and other highly conserved genomic elements in these three regions revealed a homozygous nonsense mutation (c.497T>A [p.Leu166*]) in C8orf37, located on chromosome 8q22.1. This mutation was not present in 150 ethnically matched control individuals, single-nucleotide polymorphism databases, or the 1000 Genomes database. Immunohistochemical studies revealed C8orf37 localization at the base of the primary cilium of human retinal pigment epithelium cells and at the base of connecting cilia of mouse photoreceptors. C8orf37 sequence analysis of individuals who had retinal dystrophy and carried conspicuously large homozygous regions encompassing C8orf37 revealed a homozygous splice-site mutation (c.156-2A>G) in two siblings of a consanguineous family and homozygous missense mutations (c.529C>T [p.Arg177Trp]; c.545A>G [p.Gln182Arg]) in siblings of two other consanguineous families. The missense mutations affect highly conserved amino acids, and in silico analyses predicted that both variants are probably pathogenic. Clinical assessment revealed CRD in four individuals and RP with early macular involvement in two individuals. The two CRD siblings with the c.156-2A>G mutation also showed unilateral postaxial polydactyly. These results underline the importance of disrupted ciliary processes in the pathogenesis of retinal dystrophies.	[Estrada-Cuzcano, Alejandro; Neveling, Kornelia; Roepman, Ronald; Letteboer, Stef J. F.; Mans, Dorus A.; Blokland, Ellen A. W.; Kwint, Michael P.; Gijsen, Sabine J.; Collin, Rob W. J.; Scheffer, H.; Veltman, Joris A.; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Estrada-Cuzcano, Alejandro; Roepman, Ronald; Letteboer, Stef J. F.; Mans, Dorus A.; Collin, Rob W. J.; Veltman, Joris A.; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Estrada-Cuzcano, Alejandro; Neveling, Kornelia; Roepman, Ronald; Kwint, Michael P.; Gijsen, Sabine J.; Scheffer, H.; Veltman, Joris A.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Kohl, Susanne; Wissinger, Bernd] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Mol Genet Lab, D-72076 Tubingen, Germany; [Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Rotenstreich, Ygal] Tel Aviv Univ, Goldschleger Eye Res Inst, Electrophysiol Clin, IL-52621 Tel Hashomer, Israel; [Falik-Zaccai, Tzipora C.] Western Galilee Hosp, Inst Human Genet, IL-22100 Nahariyya, Israel; [Falik-Zaccai, Tzipora C.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Hipp, Stephanie; Zrenner, Eberhart] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [van Huet, Ramon A. C.; Collin, Rob W. J.; den Hollander, Anneke I.; Klevering, B. Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Western Galilee Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Radboud University Nijmegen	Cremers, FPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	f.cremers@antrg.umcn.nl	Kwint, Michael/AAC-9062-2019; van Huet, Ramon AC/A-4652-2016; Roepman, Ronald/B-1339-2014; Veltman, Joris A/F-5128-2010; Scheffer, Hans/E-4644-2012; Klevering, B.J./L-4434-2015; Cremers, Frans/A-5625-2014; De Baere, Elfride/E-7405-2017; Neveling, K./L-4544-2015; Estrada-Cuzcano, Alejandro/J-4365-2019; Collin, Rob/N-3575-2014; Hollander, Anneke den/N-4911-2014; Letteboer, Stef JF/P-8272-2015; Sharon, Dror/P-4539-2015	van Huet, Ramon AC/0000-0003-2786-3511; Roepman, Ronald/0000-0002-5178-8163; Veltman, Joris A/0000-0002-3218-8250; Scheffer, Hans/0000-0002-2986-0915; Cremers, Frans/0000-0002-4954-5592; De Baere, Elfride/0000-0002-5609-6895; Estrada-Cuzcano, Alejandro/0000-0001-9868-2465; Sharon, Dror/0000-0002-1789-5811; Rotenstreich, Ygal/0000-0003-2366-1779; Toomes, Carmel/0000-0001-8373-9545; Kohl, Susanne/0000-0002-6438-6331	Radboud University Nijmegen Medical Centre; European Community [FP7/2007-2013, 223143-TECHGENE, FP7/2009, 241955-SYSCILIA]; Netherlands Organization for Health Research and Development ZonMW [917-66-363, 911-08-025, Vidi-917-86-396]; Foundation Fighting Blindness USA [BR-GE-0510-0489-RAD, BR-GE-0510-0490-HUJ]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden; Retina Nederland; Stichting Oogfonds Nederland; Stichting Wetenschappelijk Onderzoek het Oogziekenhuis; Rotterdamse Stichting Blindenbelangen; Stichting AF Deutman Researchfonds Oogheelkunde	Radboud University Nijmegen Medical Centre; European Community(European Commission); Netherlands Organization for Health Research and Development ZonMW(Netherlands Organization for Health Research and Development); Foundation Fighting Blindness USA; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden; Retina Nederland; Stichting Oogfonds Nederland; Stichting Wetenschappelijk Onderzoek het Oogziekenhuis; Rotterdamse Stichting Blindenbelangen; Stichting AF Deutman Researchfonds Oogheelkunde	We thank all participating families, and we thank Emine Bolat, Lisette Hetterschijt, Liliana Mizrahi-Meissonnier, Susanne Roosing, and Theo Peters for their scientific and technical support. We thank Christian Gilissen and Nienke Wieskamp for their excellent bioinformatical analysis and Carsten Janke for antibody GT335. The other members of the European Retinal Disease Consortium are Carmen Ayuso, Sandro Banfi, Tamar Ben-Yosef, Elfride De Baere, Christian Hamel, Chris Inglehearn, Robert K. Koenekoop, Bart P. Leroy, and Carmel Toomes. These studies were supported by the Radboud University Nijmegen Medical Centre (to F.P.M.C. and A.I.d.H.); the European Community's Seventh Framework Programs FP7/2007-2013 under grant agreement number 223143-TECHGENE (to H.S. and J.A.V.) and FP7/2009 under grant agreement number 241955-SYSCILIA (to R.R.); the Netherlands Organization for Health Research and Development ZonMW grants 917-66-363, 911-08-025 (to J.A.V.), and Vidi-917-86-396 (to R.R.); the Foundation Fighting Blindness USA (BR-GE-0510-0489-RAD, to A.I.d.H.; BR-GE-0510-0490-HUJ to D.S.); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Gelderse Blinden Stichting; Landelijke Stichting voor Blinden en Slechtzienden; Retina Nederland; Stichting Oogfonds Nederland; Stichting Wetenschappelijk Onderzoek het Oogziekenhuis; Rotterdamse Stichting Blindenbelangen; and Stichting AF Deutman Researchfonds Oogheelkunde (to F.P.M.C. and A.I.d.H.).	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Beales PL, 1999, J MED GENET, V36, P437; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Cannon PS, 2008, OPHTHALMIC GENET, V29, P128, DOI 10.1080/13816810802216464; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Collin RWJ, 2011, INVEST OPHTH VIS SCI, V52, P2227, DOI 10.1167/iovs.10-6185; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Falik-Zaccai TC, 2008, GENET MED, V10, P903, DOI 10.1097/GIM.0b013e31818d0e0f; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Haim Marianne, 2002, Acta Ophthalmol Scand Suppl, P1; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Ostergaard E, 2010, J MED GENET, V47, P665, DOI 10.1136/jmg.2009.069120; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Pawlik B, 2010, MOL SYNDROMOL, V1, P27, DOI 10.1159/000276763; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pretorius PR, 2011, HUM MOL GENET, V20, P1625, DOI 10.1093/hmg/ddr039; Riazuddin SA, 2010, AM J HUM GENET, V86, P805, DOI 10.1016/j.ajhg.2010.04.001; Szlyk JP, 2001, OPHTHALMOLOGY, V108, P65, DOI 10.1016/S0161-6420(00)00413-9; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	34	64	67	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					102	109		10.1016/j.ajhg.2011.11.015	http://dx.doi.org/10.1016/j.ajhg.2011.11.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22177090	Green Published, hybrid			2022-12-18	WOS:000299409100010
J	Zhu, QQ; Ge, DL; Maia, JM; Zhu, MF; Petrovski, S; Dickson, SP; Heinzen, EL; Shianna, KV; Goldstein, DB				Zhu, Qianqian; Ge, Dongliang; Maia, Jessica M.; Zhu, Mingfu; Petrovski, Slave; Dickson, Samuel P.; Heinzen, Erin L.; Shianna, Kevin V.; Goldstein, David B.			A Genome-wide Comparison of the Functional Properties of Rare and Common Genetic Variants in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; ULTRACONSERVED ELEMENTS; COMPLEX DISEASES; HUMAN EXOMES; ASSOCIATION; ENHANCERS; SELECTION; PROJECT; POPULATIONS; MUTATIONS	One of the longest running debates in evolutionary biology concerns the kind of genetic variation that is primarily responsible for phenotypic variation in species. Here, we address this question for humans specifically from the perspective of population allele frequency of variants across the complete genome, including both coding and noncoding regions. We establish simple criteria to assess the likelihood that variants are functional based on their genomic locations and then use whole-genome sequence data from 29 subjects of European origin to assess the relationship between the functional properties of variants and their population allele frequencies. We find that for all criteria used to assess the likelihood that a variant is functional, the rarer variants are significantly more likely to be functional than the more common variants. Strikingly, these patterns disappear when we focus on only those variants in which the major alleles are derived. These analyses indicate that the majority of the genetic variation in terms of phenotypic consequence may result from a mutation-selection balance, as opposed to balancing selection, and have direct relevance to the study of human disease.	[Zhu, Qianqian; Ge, Dongliang; Maia, Jessica M.; Zhu, Mingfu; Petrovski, Slave; Dickson, Samuel P.; Heinzen, Erin L.; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia	Duke University; Royal Melbourne Hospital; University of Melbourne	Goldstein, DB (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	d.goldstein@duke.edu	Zhu, Mingfu/F-3217-2011; Goldstein, David/AAY-8125-2020	Zhu, Mingfu/0000-0003-0296-712X; Petrovski, Slave/0000-0002-1527-961X	Bill and Melinda Gates Foundation [157412]; National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology [AI067854]; National Institute of Neurological Disorders and Stroke [RC2NS070344]; National Institute of Mental Health [RC2MH089915]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070344] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Pelak, E. Ruzzo, A. Need, and T. Urban for helpful discussion and comments on the manuscript. We acknowledge J. Goedert, J. Milner, D. Valle, J. Hoover-Fong, N. Sobriera, J.P. McEvoy, A. Need, J. Silver, M. Silver, R. Radtke, N. Walley, A. Husain, D. Attix, L. Cirulli, J. McEvoy, K. Linney, W. Lowe, C. Depondt, G. Cavalleri, S. Sisodiya, and N. Delanty for supplying research material and C. Gumbs, H. Onabanjo, K. Cronin, and L. Little for DNA and RNA extraction. Funding for analysis of genomes was provided by Bill and Melinda Gates Foundation (grant 157412) with additional funding from National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology grant AI067854, National Institute of Neurological Disorders and Stroke grant RC2NS070344, and National Institute of Mental Health grant RC2MH089915.	Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Asthana S, 2007, PLOS COMPUT BIOL, V3, P2559, DOI 10.1371/journal.pcbi.0030254; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eyre-Walker A, 2006, GENETICS, V173, P891, DOI 10.1534/genetics.106.057570; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Nei M, 2010, ANNU REV GENOM HUM G, V11, P265, DOI 10.1146/annurev-genom-082908-150129; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Subramanian S, 2011, MOL BIOL EVOL, V28, P49, DOI 10.1093/molbev/msq287; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; ZHU M, 2010, ESTIMATION READ DEPT	45	64	64	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					458	468		10.1016/j.ajhg.2011.03.008	http://dx.doi.org/10.1016/j.ajhg.2011.03.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21457907	Green Published, Bronze			2022-12-18	WOS:000289664300006
J	Lessard, CJ; Adrianto, I; Kelly, JA; Kaufman, KM; Grundahl, KM; Adler, A; Williams, AH; Gallant, CJ; Alarcon-Riquelme, ME; Anaya, JM; Bae, SC; Boackle, SA; Brown, EE; Chang, DM; Criswell, LA; Edberg, JC; Freedman, BI; Gregersen, PK; Gilkeson, GS; Jacob, CO; James, JA; Kamen, DL; Kimberly, RP; Martin, J; Merrill, JT; Niewold, TB; Park, SY; Petri, MA; Pons-Estel, BA; Ramsey-Goldman, R; Reveille, JD; Song, YW; Stevens, AM; Tsao, BP; Vila, LM; Vyse, TJ; Yu, CY; Guthridge, JM; Bruner, GR; Langefeld, CD; Montgomery, C; Harley, JB; Scofield, RH; Gaffney, PM; Moser, KL				Lessard, Christopher J.; Adrianto, Indra; Kelly, Jennifer A.; Kaufman, Kenneth M.; Grundahl, Kiely M.; Adler, Adam; Williams, Adrienne H.; Gallant, Caroline J.; Alarcon-Riquelme, Marta E.; Anaya, Juan-Manuel; Bae, Sang-Cheol; Boackle, Susan A.; Brown, Elizabeth E.; Chang, Deh-Ming; Criswell, Lindsey A.; Edberg, Jeffrey C.; Freedman, Barry I.; Gregersen, Peter K.; Gilkeson, Gary S.; Jacob, Chaim O.; James, Judith A.; Kamen, Diane L.; Kimberly, Robert P.; Martin, Javier; Merrill, Joan T.; Niewold, Timothy B.; Park, So-Yeon; Petri, Michelle A.; Pons-Estel, Bernardo A.; Ramsey-Goldman, Rosalind; Reveille, John D.; Song, Yeong Wook; Stevens, Anne M.; Tsao, Betty P.; Vila, Luis M.; Vyse, Timothy J.; Yu, Chack-Yung; Guthridge, Joel M.; Bruner, Gail R.; Langefeld, Carl D.; Montgomery, Courtney; Harley, John B.; Scofield, R. Hal; Gaffney, Patrick M.; Moser, Kathy L.		BIOLUPUS Network; GENLES Network	Identification of a Systemic Lupus Erythematosus Susceptibility Locus at 11p13 between PDHX and CD44 in a Multiethnic Study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; ADMIXTURE; ASSOCIATION; LINKAGE; GENOME; THROMBOCYTOPENIA; POPULATIONS; EXPRESSION; ADHESION; VARIANT	Systemic lupus erythematosus (SLE) is considered to be the prototypic autoimmune disease, with a complex genetic architecture influenced by environmental factors. We sought to replicate a putative association at 11p13 not yet exceeding genome-wide significance (p < 5 x 10(-8)) identified in a genome-wide association study (GWAS). Our GWA scan identified two intergenic SNPs located between PDHX and CD44 showing suggestive evidence of association with SLE in cases of European descent (rs2732552, p = 0.004, odds ratio [OR] = 0.78; rs387619, p = 0.003, OR = 0.78). The replication cohort consisted of >15,000 subjects, including 3562 SLE cases and 3491 controls of European ancestry, 1527 cases and 1811 controls of African American (AA) descent, and 1265 cases and 1260 controls of Asian origin. We observed robust association at both rs2732552 (p = 9.03 x 10(-8), OR = 0.83) and rs387619 (p = 7.7 x 10(-7), OR = 0.83) in the European samples with p(meta) = 1.82 x 10(-9) for rs2732552. The AA and Asian SLE cases also demonstrated association at rs2732552 (p = 5 x 10(-3), OR = 0.81 and p = 4.3 x 10(-4), OR = 0.80, respectively). A meta-analysis of rs2732552 for all racial and ethnic groups studied produced p(meta) = 2.36 x 10(-13). This locus contains multiple regulatory sites that could potentially affect expression and functions of CD44, a cell-surface glycoprotein influencing immunologic, inflammatory, and oncologic phenotypes, or PDHX, a subunit of the pyruvate dehydrogenase complex.	[Lessard, Christopher J.; Adrianto, Indra; Kelly, Jennifer A.; Kaufman, Kenneth M.; Grundahl, Kiely M.; Adler, Adam; Alarcon-Riquelme, Marta E.; James, Judith A.; Guthridge, Joel M.; Bruner, Gail R.; Montgomery, Courtney; Scofield, R. Hal; Gaffney, Patrick M.; Moser, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Lessard, Christopher J.; James, Judith A.; Scofield, R. Hal; Gaffney, Patrick M.; Moser, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Kaufman, Kenneth M.; Scofield, R. Hal] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Williams, Adrienne H.; Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Gallant, Caroline J.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75105 Uppsala, Sweden; [Alarcon-Riquelme, Marta E.; BIOLUPUS Network; GENLES Network] Ctr Genom & Oncol Res, Granada 18100, Spain; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res, Bogota 111221, Colombia; [Bae, Sang-Cheol; Park, So-Yeon] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 133799, South Korea; [Boackle, Susan A.] Univ Colorado Denver, Div Rheumatol, Aurora, CO 80045 USA; [Brown, Elizabeth E.] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Chang, Deh-Ming] Natl Def Med Ctr, Taipei 114, Taiwan; [Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Edberg, Jeffrey C.; Kimberly, Robert P.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Freedman, Barry I.] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA; [Gilkeson, Gary S.; Kamen, Diane L.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29403 USA; [Jacob, Chaim O.] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA; [James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Niewold, Timothy B.] Univ Chicago, Rheumatol Sect, Chicago, IL 60637 USA; [Niewold, Timothy B.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Pons-Estel, Bernardo A.] Sanatorio Parque, RA-2000 Rosario, Santa Fe, Argentina; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Song, Yeong Wook] Seoul Natl Univ, Div Rheumatol, Seoul 110799, South Korea; [Stevens, Anne M.] Univ Washington, Dept Pediat, Div Rheumatol, Seattle, WA 98105 USA; [Stevens, Anne M.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98105 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Vila, Luis M.] Univ Puerto Rico Med Sci Campus, Div Rheumatol, Dept Med, San Juan, PR 00936 USA; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England; [Yu, Chack-Yung] Natl Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Yu, Chack-Yung] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Wake Forest University; Wake Forest University School of Medicine; Uppsala University; Universidad del Rosario; Hanyang University; Hanyang University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham; National Defense Medical Center; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Northwell Health; Medical University of South Carolina; University of Southern California; University of Oklahoma System; University of Oklahoma Health Sciences Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Chicago; University of Chicago; Johns Hopkins University; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; Seoul National University (SNU); University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California Los Angeles; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Imperial College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center	Moser, KL (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	moserk@omrf.org	Song, Yeong-Wook/J-2765-2012; Jacobsen, Søren/T-2491-2019; Yu, Chack-Yung/E-4360-2011; Martín, Javier/AAV-5209-2021; Merrill, Joan/HDL-9141-2022; Bae, Sang-Cheol/P-2051-2015; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Adrianto, Indra/D-4214-2013; Alarcón-Riquelme, Marta E./ABF-8163-2020; Scofield, Robert Hal/AEJ-8314-2022; Anaya, Juan-Manuel/J-1960-2016; Niewold, Timothy/D-2669-2018	Jacobsen, Søren/0000-0002-5654-4993; Martin, Javier/0000-0002-2202-0622; Adrianto, Indra/0000-0002-9973-3057; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Anaya, Juan-Manuel/0000-0002-6444-1249; Pons-Estel, Bernardo/0000-0003-2518-0266; Kelly, Jennifer/0000-0002-3203-2467; Niewold, Timothy/0000-0003-3532-6660; Montgomery, Courtney/0000-0002-9606-3772; Kimberly, Robert/0000-0002-5330-3086; Bae, Sang-Cheol/0000-0003-4658-1093; Lessard, Christopher J./0000-0003-2440-3843; Gaffney, Patrick/0000-0002-1580-869X; Yu, Chack-Yung/0000-0002-5218-7503; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Guthridge, Joel/0000-0002-9308-237X; Tsao, Betty/0000-0001-7938-5975	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, P30RR031152, UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070304, K24AI078004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308, R01AR043814, R01AR051545, P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000154] Funding Source: Medline; NCRR NIH HHS [P30 RR031152-01, UL1 RR025014, UL1 RR025741, P30 RR031152] Funding Source: Medline; NIAID NIH HHS [K24 AI078004, R21 AI070304] Funding Source: Medline; NIAMS NIH HHS [R01 AR043814, P30 AR053483, P60 AR053308, R01 AR051545, R01 AR043814-13] Funding Source: Medline; NIGMS NIH HHS [P30 GM103510] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Crispin JC, 2010, ARTHRITIS RHEUM-US, V62, P1431, DOI 10.1002/art.27385; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kaufman KM, 2002, GENES IMMUN, V3, pS86, DOI 10.1038/sj.gene.6363887; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; McHugh A, 2006, LIVER INT, V26, P406, DOI 10.1111/j.1478-3231.2006.01253.x; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Perez P, 2009, J AUTOIMMUN, V33, P99, DOI 10.1016/j.jaut.2009.05.001; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scofield RH, 2003, BLOOD, V101, P992, DOI 10.1182/blood-2002-04-1003; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Vivers S, 2002, CLIN SCI, V103, P441; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wibulswas A, 2002, ARTHRITIS RHEUM-US, V46, P2059, DOI 10.1002/art.10421; Wibulswas A, 2000, AM J PATHOL, V157, P2037, DOI 10.1016/S0002-9440(10)64842-0; Zhao L, 2008, ARTERIOSCL THROM VAS, V28, P1283, DOI 10.1161/ATVBAHA.108.165753	29	64	67	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					83	91		10.1016/j.ajhg.2010.11.014	http://dx.doi.org/10.1016/j.ajhg.2010.11.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194677	Green Published, Bronze			2022-12-18	WOS:000286501500008
J	Kloss-Brandstatter, A; Schafer, G; Erhart, G; Huttenhofer, A; Coassin, S; Seifarth, C; Summerer, M; Bektic, J; Klocker, H; Kronenberg, F				Kloss-Brandstaetter, Anita; Schaefer, Georg; Erhart, Gertraud; Huettenhofer, Alexander; Coassin, Stefan; Seifarth, Christof; Summerer, Monika; Bektic, Jasmin; Klocker, Helmut; Kronenberg, Florian			Somatic Mutations throughout the Entire Mitochondrial Genome Are Associated with Elevated PSA Levels in Prostate Cancer Patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; DNA MUTATIONS; MTDNA GENOME; IDENTIFICATION; HETEROPLASMY; SEQUENCE; EXPRESSION; VARIANTS; INCREASE; DATABASE	The genetic etiology of prostate cancer, the most common form of male cancer in western countries, is complex and the interplay of disease genes with environmental factors is far from being understood. Studies on somatic mitochondrial DNA (mtDNA) mutations have become an important aspect of cancer research because these mutations might have functional consequences and/or might serve as biosensors for tumor detection and progression. We sequenced the entire mitochondrial genome (16,569 bp) from 30 prospectively collected pairs of macrodissected cancerous and benign cells from prostate cancer patients and compared their genetic variability. Given recent concerns regarding the authenticity of newly discovered mtDNA mutations, we implemented a high-quality procedure for mtDNA whole-genome sequencing. In addition, the mitochondrial genes MT-CO2, MT-CO3, MT-ATP6, and MT-ND6 were sequenced in further 35 paired samples from prostate cancer patients. We identified a total of 41 somatic mutations in 22 out of 30 patients: the majority of these mutations have not previously been observed in the human phylogeny. The presence of somatic mutations in transfer RNAs (tRNAs) was found to be associated with elevated PSA levels (14.25 +/- 5.44 versus 7.15 +/- 4.32 ng/ml; p = 0.004). The level and degree of heteroplasmy increased with increasing tumor activity. In summary, somatic mutations in the mitochondrial genome are frequent events in prostate cancer. Mutations mapping to mitochondrial tRNAs, ribosomal RNAs, and protein coding genes might impair processes that occur within the mitochondrial compartment (e.g., transcription, RNA processing, and translation) and might finally affect oxidative phosphorylation.	[Kloss-Brandstaetter, Anita; Erhart, Gertraud; Coassin, Stefan; Summerer, Monika; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Schaefer, Georg; Seifarth, Christof; Bektic, Jasmin; Klocker, Helmut] Innsbruck Med Univ, Dept Urol, A-6020 Innsbruck, Austria; [Huettenhofer, Alexander] Innsbruck Med Univ, Div Genom & RN, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Kloss-Brandstatter, A (corresponding author), Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria.	anita.kloss@i-med.ac.at	Klocker, Helmut/AAI-7130-2020; Kronenberg, Florian/B-1736-2008; Coassin, Stefan/J-2611-2018; Bektic, Jasmin/AAB-3952-2021	Kronenberg, Florian/0000-0003-2229-1120; Coassin, Stefan/0000-0001-5677-8979; Kloss-Brandstatter, Anita/0000-0002-0873-6704	ONCOTYROL [SFB 021]	ONCOTYROL	The project was supported by Dr. Legerlotz-Stiftung (2007-02) and by ONCOTYROL (SFB 021). We appreciate the excellent technical assistance of Irma Sottsas, Birgit Stenzel, Eberhard Steiner (Department of Urology, Innsbruck Medical University), and Margot Haun (Division of Genetic Epidemiology, Innsbruck Medical University). We thank Krista Trappl (Division of Genomics & RNomics, Innsbruck Medical University) and Herve Seligmann (Department of Biology, University of Oslo) for useful discussion.	Abril J, 2008, PROSTATE, V68, P1086, DOI 10.1002/pros.20771; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], SIFT; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], POLYPHEN; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Bannwarth S, 2006, NAT PROTOC, V1, P2037, DOI 10.1038/nprot.2006.318; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Brandstatter A, 2004, INT J LEGAL MED, V118, P47, DOI 10.1007/s00414-003-0418-z; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Brandstatter A, 2003, INT J LEGAL MED, V117, P291, DOI 10.1007/s00414-003-0395-2; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Chen JJZ, 2002, CANCER RES, V62, P6470; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Fendt L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-139; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Gomez-Zaera M, 2006, MUTAT RES-FUND MOL M, V595, P42, DOI 10.1016/j.mrfmmm.2005.10.012; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Hung WY, 2010, BBA-GEN SUBJECTS, V1800, P264, DOI 10.1016/j.bbagen.2009.06.006; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeronimo C, 2001, ONCOGENE, V20, P5195, DOI 10.1038/sj.onc.1204646; Kim W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002211; KLOSSBRANDSTATT.A, 2010, HUM MUTAT IN PRESS; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Maki J, 2008, AM J CLIN PATHOL, V129, P57, DOI 10.1309/UJJTH4HFEPWAQ78Q; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Noller HF, 1995, BIOCHEM CELL BIOL, V73, P997, DOI 10.1139/o95-107; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Parr Ryan L., 2006, Human Genomics, V2, P252; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151; Schonherr S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-139; Seligmann H, 2010, BIOSYSTEMS, V99, P85, DOI 10.1016/j.biosystems.2009.09.003; Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sobin, 2009, UICC TNM CLASSIFICAT; Stafford P, 2010, J HUM GENET, V55, P605, DOI 10.1038/jhg.2010.76; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Weinstein MH, 2002, MODERN PATHOL, V15, P1302, DOI 10.1097/01.MP.0000038460.95912.6E; Weissensteiner H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-122; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; PMUT; GENEPI TOOLBOX	63	64	72	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					802	812		10.1016/j.ajhg.2010.11.001	http://dx.doi.org/10.1016/j.ajhg.2010.11.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129724	Green Published, Bronze			2022-12-18	WOS:000285564600006
J	Tian, J; Ling, L; Shboul, M; Lee, H; O'Connor, B; Merriman, B; Nelson, SE; Cool, S; Ababneh, OH; Al-Hadidy, A; Masri, A; Hamamy, H; Reversade, B				Tian, Jing; Ling, Ling; Shboul, Mohammad; Lee, Hane; O'Connor, Brian; Merriman, Barry; Nelson, Stanley E.; Cool, Simon; Ababneh, Osama H.; Al-Hadidy, Azmy; Masri, Amira; Hamamy, Hanan; Reversade, Bruno			Loss of CHSY1, a Secreted FRINGE Enzyme, Causes Syndromic Brachydactyly in Humans via Increased NOTCH Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SULFATE PROTEOGLYCANS; MENTAL-RETARDATION; MOLECULAR-CLONING; INDIAN HEDGEHOG; MUTATIONS; DIFFERENTIATION; PATHWAY; A2; PROLIFERATION; JAGGED1	We delineated a syndromic recessive preaxial brachydactyly with partial duplication of proximal phalanges to 16.8 Mb over 4 chromosomes. High-throughput sequencing of all 177 candidate genes detected a truncating frameshift mutation in the gene CHSY1 encoding a chondroitin synthase with a Fringe domain. CHSY1 was secreted from patients' fibroblasts and was required for synthesis of chondroitin sulfate moieties. Noticeably, its absence triggered massive production of JAG1 and subsequent NOTCH activation, which could only be reversed with a wild-type but not a Fringe catalytically dead CHSY1 construct. In vitro, depletion of CHSY1 by RNAi knockdown resulted in enhanced osteogenesis in fetal osteoblasts and remarkable upregulation of JAG2 in glioblastoma cells. In vivo, chsy1 knockdown in zebrafish embryos partially phenocopied the human disorder; it increased NOTCH output and impaired skeletal, pectoral-fin, and retinal development. We conclude that CHSY1 is a secreted FRINGE enzyme required for adjustment of NOTCH signaling throughout human and fish embryogenesis and particularly during limb patterning.	[Tian, Jing; Ling, Ling; Shboul, Mohammad; Cool, Simon; Reversade, Bruno] ASTAR, Inst Med Biol, Singapore, Singapore; [Lee, Hane; O'Connor, Brian; Merriman, Barry; Nelson, Stanley E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ababneh, Osama H.; Al-Hadidy, Azmy; Masri, Amira] Univ Jordan, Fac Med, Dept Ophthalmol, Amman, Jordan; [Ababneh, Osama H.; Al-Hadidy, Azmy; Masri, Amira] Univ Jordan, Fac Med, Dept Radiol, Amman, Jordan; [Ababneh, Osama H.; Al-Hadidy, Azmy; Masri, Amira] Univ Jordan, Fac Med, Dept Pediat, Amman, Jordan; [Hamamy, Hanan] Univ Hosp Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Reversade, Bruno] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Jordan; University of Jordan; University of Jordan; University of Geneva; National University of Singapore	Reversade, B (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	bruno@reversade.com	masri, amira/C-4570-2015; Cool, Simon/W-1257-2018; Nelson, Stanley F/D-4771-2009; Cool, Simon McKenzie/AAG-4346-2021	masri, amira/0000-0001-6103-8713; Cool, Simon/0000-0001-8543-3056; Nelson, Stanley F/0000-0002-2082-3114; REVERSADE, Bruno/0000-0002-4070-7997	A*STAR; Society in Science Branco Weiss Foundation	A*STAR(Agency for Science Technology & Research (A*STAR)); Society in Science Branco Weiss Foundation	We are indebted to the family for kindly partaking in this study. We thank H. Hall, K. Rogers, and S. Rogers for their diligent expertise with histology. The help of C.Y. Lim, C. Bonnard, N. Beillard, L. Ho, and S. Chng is gratefully acknowledged. We are also grateful to K. Sampath, Y-J. Jiang, and K. Sugahara for sharing reagents and to S. Roy for teaching us how to dissect pectoral fins. This study was supported by grants from A*STAR and the Society in Science Branco Weiss Foundation to B.R.	[Anonymous], ONLINE MENDELIAN INH; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; *HAPMAP, HAPMAP PHAS 2 REC RA; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Klopocki E, 2010, AM J HUM GENET, V86, P434, DOI 10.1016/j.ajhg.2010.01.023; Lee H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-646; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Ponio JBD, 2007, HUM MOL GENET, V16, P2683, DOI 10.1093/hmg/ddm222; Rump P, 2008, CLIN GENET, V74, P455, DOI 10.1111/j.1399-0004.2008.01064.x; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Sun M, 2008, J MED GENET, V45, P589, DOI 10.1136/jmg.2008.057646; Temtamy SA, 1998, CLIN DYSMORPHOL, V7, P249, DOI 10.1097/00019605-199810000-00003; Temtamy SA, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-15; Wagner DS, 2004, DEV CELL, V6, P781, DOI 10.1016/j.devcel.2004.04.001; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yin L, 2005, J BIOL CHEM, V280, P15666, DOI 10.1074/jbc.M409877200; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350; GENE GENE CORRELATIO; HUMAN REFERENCE GENO; PIPELINE SEQUENCE AN; BLAT LIKE FAST ACCUR	39	64	70	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					768	778		10.1016/j.ajhg.2010.11.005	http://dx.doi.org/10.1016/j.ajhg.2010.11.005			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129727	Green Published, Bronze			2022-12-18	WOS:000285564600003
J	Mitsui, J; Takahashi, Y; Goto, J; Tomiyama, H; Ishikawa, S; Yoshino, H; Minami, N; Smith, DI; Lesage, S; Aburatani, H; Nishino, I; Brice, A; Hattori, N; Tsuji, S				Mitsui, Jun; Takahashi, Yuji; Goto, Jun; Tomiyama, Hiroyuki; Ishikawa, Shunpei; Yoshino, Hiroyo; Minami, Narihiro; Smith, David I.; Lesage, Suzanne; Aburatani, Hiroyuki; Nishino, Ichizo; Brice, Alexis; Hattori, Nobutaka; Tsuji, Shoji			Mechanisms of Genomic Instabilities Underlying Two Common Fragile-Site-Associated Loci, PARK2 and DMD, in Germ Cell and Cancer Cell Lines	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-CHROMOSOME 7; COPY-NUMBER; DELETION BREAKPOINTS; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; REPLICATION; GENE; MUTATIONS; SEQUENCE; REARRANGEMENTS	Common fragile sites (CFSs) are specific chromosome regions that exhibit an increased frequency of breaks when cells are exposed to a DNA-replication inhibitor such as aphidicolin. PARK2 and DMD, the causative genes for autosomal-recessive juvenile Parkinsonism and Duchenne and Becker muscular dystrophy, respectively, are two very large genes that are located within aphidicolin-induced CFSs. Gross rearrangements within these two genes are frequently observed as the causative mutations for these diseases, and similar alterations within the large fragile sites that surround these genes are frequently observed in cancer cells. To elucidate the molecular mechanisms underlying this fragility, we performed a custom-designed high-density comparative genomic hybridization analysis to determine the junction sequences of approximately 500 breakpoints in germ cell lines and cancer cell lines involving PARK2 or DMD. The sequence signatures where these breakpoints occur share some similar features both in germ cell lines and in cancer cell lines. Detailed analyses of these structures revealed that microhomologies are predominantly involved in rearrangement processes. Furthermore, breakpoint-clustering regions coincide with the latest-replicating region and with large nuclear-lamina-associated domains and are flanked by the highest-flexibility peaks and RIG band boundaries, suggesting that factors affecting replication timing collectively contribute to the vulnerability for rearrangement in both germ cell and somatic cell lines.	[Mitsui, Jun; Takahashi, Yuji; Goto, Jun; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1138655, Japan; [Tomiyama, Hiroyuki; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Ishikawa, Shunpei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan; [Yoshino, Hiroyo] Juntendo Univ, Res Inst Dis Old Ages, Sch Med, Tokyo 1138421, Japan; [Minami, Narihiro; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Natl Inst Neurosci, Tokyo 1878502, Japan; [Smith, David I.] Mayo Clin, Coll Med, Div Expt Pathol, Dept Lab Med & Pathol, Rochester, MN 55902 USA; [Lesage, Suzanne; Brice, Alexis] Univ Paris 06, CRicm, INSERM, Hosp Pitie Salpetriere,CNRS,UMR S975,UMR 7225, F-75651 Paris 13, France; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo 1538904, Japan	University of Tokyo; Juntendo University; University of Tokyo; Juntendo University; National Center for Neurology & Psychiatry - Japan; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Tokyo	Tsuji, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1138655, Japan.	tsuji@m.u-tokyo.ac.jp	Nishino, Ichizo/G-2676-2010; Hattori, Nobutaka/ACR-0069-2022; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Mitsui, Jun/B-5455-2012	Nishino, Ichizo/0000-0001-9452-112X; brice, alexis/0000-0002-0941-3990; Mitsui, Jun/0000-0001-7425-4765	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the French Parkinson's Disease Genetics Study Group (PDG) and the DNA and cell bank of the CRicm for sample collection and preparation. This work was supported in part by KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas, Applied Genomics, the 21st Century COE Program, Integrated Database Project, Center for Integrated Brain Medical Science, and Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Asakawa S, 2009, BIOCHEM BIOPH RES CO, V389, P181, DOI 10.1016/j.bbrc.2009.08.115; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Clarimon J, 2005, AM J MED GENET B, V133B, P120, DOI 10.1002/ajmg.b.30119; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handt O, 2000, CHROMOSOME RES, V8, P677, DOI 10.1023/A:1026737203447; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lohmann E, 2009, NEUROLOGY, V72, P110, DOI 10.1212/01.wnl.0000327098.86861.d4; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Lupski JR, 1998, MOL MED, V4, P3, DOI 10.1007/BF03401724; McAvoy S, 2007, CYTOGENET GENOME RES, V119, P196, DOI 10.1159/000112061; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Moreno-Egea A, 2002, Hernia, V6, P21; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Nobile C, 2002, HUM GENET, V110, P418, DOI 10.1007/s00439-002-0721-7; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Rawal N, 2003, NEUROLOGY, V60, P1378, DOI 10.1212/01.WNL.0000056167.89221.BE; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SARAI A, 1989, BIOCHEMISTRY-US, V28, P7842, DOI 10.1021/bi00445a046; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Smith DI, 1998, INT J ONCOL, V12, P187; Sutherland GR, 2000, CLIN GENET, V58, P157, DOI 10.1034/j.1399-0004.2000.580301.x; Takebayashi S, 2005, EXP CELL RES, V304, P162, DOI 10.1016/j.yexcr.2004.10.024; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; Wang L, 1999, HUM MOL GENET, V8, P431, DOI 10.1093/hmg/8.3.431; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	52	64	64	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					75	89		10.1016/j.ajhg.2010.06.006	http://dx.doi.org/10.1016/j.ajhg.2010.06.006			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598272	Green Published, Bronze			2022-12-18	WOS:000280029200007
J	Matsuura, T; Fang, P; Pearson, CE; Jayakar, P; Ashizawa, T; Roa, BB; Nelson, DL				Matsuura, T; Fang, P; Pearson, CE; Jayakar, P; Ashizawa, T; Roa, BB; Nelson, DL			Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: Repeat purity as a disease modifier?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATAXIA TYPE-10; TRINUCLEOTIDE REPEAT; GENETIC-ANALYSIS; NORMAL ALLELES; EXPANSION; INSTABILITY; CLONING; SCA1	Spinocerebellar ataxia type 10 ( SCA10) is one of numerous genetic disorders that result from simple repeat expansions. SCA10 is caused by expansion of an intronic ATTCT pentanucleotide repeat tract. It is clinically characterized by progressive ataxia, seizures, and anticipation, which can vary within and between families. We report two SCA10 families showing distinct frequencies of seizures and correlations of repeat length with age at onset. One family displayed uninterrupted ATTCT expansions, whereas the other showed multiple interruptions of the repeat by nonconsensus repeat units, which differed both in the length and/ or sequence of the repeat unit. Disease-causing microsatellite expansions have been assumed to be composed of uninterrupted pure repeats. Our findings for SCA10 challenge this convention and suggest that the purity of the expanded repeat element may be a disease modifier.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, DNA Diagnost Lab, Houston, TX 77030 USA; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Miami Childrens Hosp, Div Genet & Metab, Miami, FL USA; Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77550 USA	Baylor College of Medicine; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Texas System; University of Texas Medical Branch Galveston	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 904E,Mailstop BCM225,1 Baylor Plaza, Houston, TX 77030 USA.	nelson@bcm.tmc.edu		Pearson, Christopher/0000-0001-9545-4205	NICHD NIH HHS [HD29256, HD38038, R01 HD038038] Funding Source: Medline; NINDS NIH HHS [NS41547, R01 NS041547] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038, R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041547] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Grewal RP, 1998, NEUROLOGY, V51, P1423, DOI 10.1212/WNL.51.5.1423; Grewal RP, 2002, ARCH NEUROL-CHICAGO, V59, P1285, DOI 10.1001/archneur.59.8.1285; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526; Matsuura T, 2002, ANN NEUROL, V51, P271, DOI 10.1002/ana.10049; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247; Zuhlke C, 2002, EUR J HUM GENET, V10, P204, DOI 10.1038/sj.ejhg.5200788	21	64	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					125	129		10.1086/498654	http://dx.doi.org/10.1086/498654			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385455	Green Published, Bronze			2022-12-18	WOS:000233930400012
J	Bjornsson, A; Gudmundsson, G; Gudfinnsson, E; Hrafnsdottir, M; Benedikz, J; Skuladottir, S; Kristjansson, K; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR				Bjornsson, A; Gudmundsson, G; Gudfinnsson, E; Hrafnsdottir, M; Benedikz, J; Skuladottir, S; Kristjansson, K; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR			Localization of a gene for migraine without aura to chromosome 4q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; SUSCEPTIBILITY LOCUS; TYPICAL MIGRAINE; CLINICAL CHARACTERISTICS; LINKAGE; PREVALENCE; 19P13; MAPS; MUTATIONS; HEADACHES	Migraine is a common form of headache and has a significant genetic component. Here, we report linkage results from a study in Iceland of migraine without aura (MO). The study group comprised patients with migraine recruited by neurologists and from the registry of the Icelandic Migraine Society, as well as through the use of a questionnaire sent to a random sample of 20,000 Icelanders. Migraine diagnoses were made and confirmed using diagnostic criteria established by the International Headache Society. A genomewide scan with multipoint allele-sharing methods was performed on 289 patients suffering from MO. Linkage was observed to a locus on chromosome 4q21 (LOD=2.05; P=.001). The locus reported here overlaps a locus (MGR1) reported elsewhere for patients with migraine with aura (MA) in the Finnish population. This replication of the MGR1 locus in families with MO indicates that the gene we have mapped may contribute to both MA and MO. Further analysis indicates that the linkage evidence improves for affected females and, especially, with a slightly relaxed definition of MO (LOD=4.08; P=7.2x10(-6)).	deCODE Geent, IS-101 Reykjavik, Iceland; Landspitalinn Univ Hosp, Reykjavik, Iceland; Haukeland Hosp, N-5021 Bergen, Norway	Landspitali National University Hospital	Bjornsson, A (corresponding author), deCODE Geent, Sturlugata 8, IS-101 Reykjavik, Iceland.	asgeir.bjornsson@decode.is; jgulcher@decode.is	Stefansson, Kari/AAE-7187-2019					Carlsson A, 2002, NEUROLOGY, V59, P1804, DOI 10.1212/01.WNL.0000036617.04943.96; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; FJALLDAL JB, 2001, P INT JOINT C NEUR N, pA1; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Gervil M, 1999, ANN NEUROL, V46, P606, DOI 10.1002/1531-8249(199910)46:4<606::AID-ANA8>3.0.CO;2-O; Gervil M, 1999, NEUROLOGY, V53, P995, DOI 10.1212/WNL.53.5.995; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HONKASALO ML, 1995, HEADACHE, V35, P70, DOI 10.1111/j.1526-4610.1995.hed3502070.x; Jones KW, 2001, GENOMICS, V78, P150, DOI 10.1006/geno.2001.6665; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Kallela M, 1999, CEPHALALGIA, V19, P151, DOI 10.1046/j.1468-2982.1999.1903151.x; Kallela M, 2001, EUR J NEUROL, V8, P61, DOI 10.1046/j.1468-1331.2001.00165.x; Kallela M, 2001, EUR J NEUROL, V8, P441, DOI 10.1046/j.1468-1331.2001.00260.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LARSSON B, 1995, HEADACHE, V35, P513, DOI 10.1111/j.1526-4610.1995.hed3509513.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lea RA, 2002, NEUROGENETICS, V4, P17, DOI 10.1007/s10048-001-0125-1; McCarthy LC, 2001, GENOMICS, V78, P135, DOI 10.1006/geno.2001.6647; MOCHI M, 1993, CEPHALALGIA, V13, P389, DOI 10.1046/j.1468-2982.1993.1306389.x; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, NEUROLOGY, V50, P1428, DOI 10.1212/WNL.50.5.1428; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; RUSSELL MB, 1995, HUM GENET, V96, P726, DOI 10.1007/BF00210307; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; Russell MB, 1996, CEPHALALGIA, V16, P305, DOI 10.1046/j.1468-2982.1996.1605305.x; Soragna D, 2003, AM J HUM GENET, V72, P161, DOI 10.1086/345298; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Stewart WF, 1997, ANN NEUROL, V41, P166, DOI 10.1002/ana.410410207; Svensson DA, 2002, HEADACHE, V42, P754, DOI 10.1046/j.1526-4610.2002.02177.x; Terwindt GM, 2001, NEUROLOGY, V56, P1028, DOI 10.1212/WNL.56.8.1028; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; Ulrich V, 1999, HEADACHE, V39, P173, DOI 10.1046/j.1526-4610.1999.3903173.x; ULRICH V, 2000, FRONTIERS HEADACHE R, V8, P27; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	50	64	65	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					986	993		10.1086/378417	http://dx.doi.org/10.1086/378417			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14513409	Bronze, Green Published			2022-12-18	WOS:000186493400002
J	Beever, CL; Stephenson, MD; Panaherrera, MS; Jiang, RH; Kalousek, DK; Hayden, M; Field, L; Brown, CJ; Robinson, WP				Beever, CL; Stephenson, MD; Panaherrera, MS; Jiang, RH; Kalousek, DK; Hayden, M; Field, L; Brown, CJ; Robinson, WP			Skewed X-chromosome inactivation is associated with trisomy in women ascertained on the basis of recurrent spontaneous abortion or chromosomally abnormal pregnancies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONFINED PLACENTAL MOSAICISM; DIMINISHED OVARIAN RESERVE; HUMAN ANEUPLOIDY; INCREASED RISK; METHYLATION; AGE; FAILURE; ORIGIN; MENOPAUSE; EMBRYOS	An increase in extremely skewed X-chromosome inactivation (XCI) (greater than or equal to90%) among women who experienced recurrent spontaneous abortion (RSA) has been previously reported. To further delineate the etiology of this association, we have evaluated XCI status in 207 women who experience RSA. A significant excess of trisomic losses was observed among the women who had RSA with skewed XCI versus those without skewed XCI (P = .02). There was also a significant excess of boys among live births in this group (P = .04), which is contrary to expectations if the cause of skewed XCI was only that these women carried X-linked lethal mutations. To confirm the association between skewed XCI and the risk of trisomy, an independent group of 53 women, ascertained on the basis of a prenatal diagnosis of trisomy mosaicism, were investigated. Only cases for which the trisomy was shown to be of maternal meiotic origin were included. The results show a significantly higher level of extreme skewing (greater than or equal to90%) in women whose pregnancies involved placental trisomy mosaicism (17%) than in either of two separate control populations (n = 102 and 99) (P = .02 compared with total control subjects). An additional 11 cases were ascertained on the basis of one or more trisomic-pregnancy losses. When all women in the present study with a trisomic pregnancy (n = 103) were considered together, skewed XCI was identified in 18%, as compared with 7% in all controls (n = 201) (P = .002). This difference was more pronounced when a cutoff of extreme skewing of 95% was used (10% vs. 1.5% skewed; P = .002). Maternal age was not associated with skewing in either the patient or control populations and therefore cannot account for the association with trisomy. Previous studies have shown that a reduced ovarian reserve is associated with increased risk of trisomic pregnancies. We hypothesize that the association between skewed XCI and trisomic pregnancies is produced by a common mechanism that underlies both and that involves a reduction of the size of the follicular pool.	Univ British Columbia, Dept Med Genet, BC Res Inst Childrens & Womens Hlth, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; British Columbia Res Inst Childrens & Womens Hlth, Vancouver, BC, Canada; Ctr Mol Med & Therapeut, Vancouver, BC, Canada; British Columbias Womens Hosp & Hlth Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Robinson, WP (corresponding author), Univ British Columbia, Dept Med Genet, BC Res Inst Childrens & Womens Hlth, 950 W 28th Ave,Room 3086, Vancouver, BC V5Z 4H4, Canada.		Brown, Carolyn J/A-5159-2014; Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; Hayden, Michael R/D-8581-2011	Brown, Carolyn J/0000-0002-8959-0101; Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; Hayden, Michael R/0000-0001-5159-1419				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Anderson CL, 2002, HUM GENET, V110, P271, DOI 10.1007/s00439-002-0676-8; BEEVER C, IN PRESS AM J MED GE; BROOK JD, 1984, HUM GENET, V66, P41, DOI 10.1007/BF00275184; Brown CJ, 2000, CLIN GENET, V58, P353, DOI 10.1034/j.1399-0004.2000.580504.x; Chernyshov VP, 2001, AM J REPROD IMMUNOL, V46, P220, DOI 10.1034/j.1600-0897.2001.d01-5.x; Cresswell JL, 1997, EARLY HUM DEV, V49, P143, DOI 10.1016/S0378-3782(97)00028-5; CUNNIFF C, 1991, HUM GENET, V86, P552; Freeman SB, 2000, AM J HUM GENET, V66, P1680, DOI 10.1086/302907; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOODFELLOW PJ, 1988, P NATL ACAD SCI USA, V85, P5605, DOI 10.1073/pnas.85.15.5605; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; Hecimovic S, 1997, CLIN GENET, V52, P147; Hofmann GE, 2000, FERTIL STERIL, V74, P1192, DOI 10.1016/S0015-0282(00)01626-5; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; KRISTIANSEN M, 1999, INT S X CHROM IN MAM; Lanasa MC, 1999, AM J HUM GENET, V65, P252, DOI 10.1086/302441; Lanasa MC, 2001, AM J OBSTET GYNECOL, V185, P563, DOI 10.1067/mob.2001.117670; Lau AW, 1997, AM J HUM GENET, V61, P1353, DOI 10.1086/301651; Levi AJ, 2001, FERTIL STERIL, V76, P666, DOI 10.1016/S0015-0282(01)02017-9; MORTON NE, 1987, AM J MED GENET, V28, P353, DOI 10.1002/ajmg.1320280213; Mumm S, 2001, GENOMICS, V76, P30, DOI 10.1006/geno.2001.6611; Nasseri A, 1999, FERTIL STERIL, V71, P715, DOI 10.1016/S0015-0282(98)00525-1; OGATA T, 1995, HUM GENET, V95, P607; Pegoraro E, 1997, AM J HUM GENET, V61, P160, DOI 10.1086/513901; Penaherrera MS, 2000, CLIN GENET, V58, P436, DOI 10.1034/j.1399-0004.2000.580603.x; Robinson WP, 1997, AM J HUM GENET, V60, P917; Robinson WP, 2001, SEMIN REPROD MED, V19, P175, DOI 10.1055/s-2001-15397; Robinson WP, 2001, AM J HUM GENET, V69, P1245, DOI 10.1086/324468; Sangha KK, 1999, AM J HUM GENET, V65, P913, DOI 10.1086/302552; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Simpson JL, 1999, AM J MED GENET, V89, P186, DOI 10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5; Stavropoulos DJ, 1998, AM J HUM GENET, V63, P1912, DOI 10.1086/302149; STEPHENSON MD, 1996, FERTIL STERIL, V66, P25; SULLIVAN A, 2002, ANN M SOC GYN INV LO; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; TRIBIOLI C, 1992, NUCLEIC ACIDS RES, V20, P727, DOI 10.1093/nar/20.4.727; Uehara S, 2001, FERTIL STERIL, V76, P908, DOI 10.1016/S0015-0282(01)02845-X; WARBURTON D, 1987, AM J HUM GENET, V41, P465; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759	42	64	68	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					399	407		10.1086/346119	http://dx.doi.org/10.1086/346119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12497247	Green Published, Bronze			2022-12-18	WOS:000180680000019
J	Eichers, ER; Green, JS; Stockton, DW; Jackman, CS; Whelan, J; McNamara, JA; Johnson, GJ; Lupski, JR; Katsanis, N				Eichers, ER; Green, JS; Stockton, DW; Jackman, CS; Whelan, J; McNamara, JA; Johnson, GJ; Lupski, JR; Katsanis, N			Newfoundland rod-cone dystrophy, an early-onset retinal dystrophy, is caused by splice-junction mutations in RLBP1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; BINDING PROTEIN CRALBP; BARDET-BIEDL-SYNDROME; PUNCTATA ALBESCENS; BOTHNIA DYSTROPHY; RNA SURVEILLANCE; GENE RLBP1; MESSAGE; CLONING; DECAY	Some isolated populations exhibit an increased prevalence of rare recessive diseases. The island of Newfoundland is a characteristic geographic isolate, settled by a small number of families primarily during the late 1700s and early 1800s. During our studies of this population, we identified a group of families exhibiting a retinal dystrophy reminiscent of retinitis punctata albescens but with a substantially lower age at onset and more-rapid and distinctive progression, a disorder that we termed "Newfoundland rod-cone dystrophy" (NFRCD). The size of one of these families was sufficient to allow us to perform a genomewide screen to map the NFRCD locus. We detected significant linkage to markers on the long arm of chromosome 15, in a region encompassing RLBP1, the gene encoding the cellular retinaldehyde-binding protein. Previously, mutations in RLBP1 have been associated with other retinal dystrophies, leading us to hypothesize that RLBP1 mutations might also cause NFRCD. To test this hypothesis, we sequenced all coding exons and splice junctions of RLBP1. We detected two sequence alterations, each of which is likely to be pathogenic, since each segregates with the disease and is predicted to interfere with mRNA splicing. In contrast to some previously reported RLBP1 mutations, which yield a protein that may retain some residual activity, each NFRCD mutation is likely to give rise to a null allele. This difference may account for the severe phenotype in these families and exemplifies the molecular continuum that underlies clinically distinct but genetically related entities.	Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Mem Univ Newfoundland, Dept Surg Ophthalmol, St John, NF, Canada; Mem Univ Newfoundland, Dept Genet, St John, NF, Canada; Mem Univ Newfoundland, Dept Med, St John, NF, Canada; Ottawa Hosp Eye Inst, Ottawa, ON, Canada; Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA; UCL, Int Ctr Eye Hlth, London WC1E 6BT, England	Johns Hopkins University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; University of Ottawa; Ottawa Hospital Research Institute; Jefferson University; University of London; London School of Hygiene & Tropical Medicine; University College London	Katsanis, N (corresponding author), Johns Hopkins Univ, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Jefferson St Bldg,Room 2-127, Baltimore, MD 21287 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171	NEI NIH HHS [EY 12666] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012666] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; BRIDGES CDB, 1987, VISION RES, V27, P2049, DOI 10.1016/0042-6989(87)90119-2; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; Burstedt MSL, 2001, ARCH OPHTHALMOL-CHIC, V119, P260; CRABB JW, 1988, J BIOL CHEM, V263, P18688; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Granse L, 2001, Ophthalmic Genet, V22, P97, DOI 10.1076/opge.22.2.97.2231; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; INTRES R, 1994, J BIOL CHEM, V269, P25411; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Katsanis N, 2001, CLIN GENET, V59, P424, DOI 10.1034/j.1399-0004.2001.590607.x; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; MAQUAT LE, 2000, TRANSLATIONAL CONTRO, P827; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO;2-O; ROGAN PK, 1995, HUM MUTAT, V6, P74, DOI 10.1002/humu.1380060114; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2000, INVEST OPHTH VIS SCI, V41, P337; Saari JC, 1997, GLIA, V21, P259; SPARKES RS, 1992, GENOMICS, V12, P58, DOI 10.1016/0888-7543(92)90406-I; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	29	64	66	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					955	964		10.1086/339688	http://dx.doi.org/10.1086/339688			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11868161	Bronze, Green Published			2022-12-18	WOS:000174252100012
J	Kaessmann, H; Zollner, S; Gustafsson, AC; Wiebe, V; Laan, M; Lundeberg, J; Uhlen, M; Paabo, S				Kaessmann, H; Zollner, S; Gustafsson, AC; Wiebe, V; Laan, M; Lundeberg, J; Uhlen, M; Paabo, S			Extensive linkage disequilibrium in small human populations in Eurasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; REAL-TIME PYROPHOSPHATE; LIPOPROTEIN-LIPASE GENE; MODERN HUMAN ORIGINS; DISEASE GENES; DEMOGRAPHIC HISTORY; HAPLOTYPE VARIATION; SEQUENCE DIVERSITY; MAPPING GENES; NUCLEAR-DNA	The extent of linkage disequilibrium (LD) was studied in two small food-gathering populations-Evenki and Saami- and two larger food-producing populations-Finns and Swedes-in northern Eurasia. In total, 50 single-nucleotide polymorphisms (SNPs) from five genes were genotyped using real-time pyrophosphate DNA sequencing, whereas 14 microsatellites were genotyped in two X-chromosomal regions. In addition, hypervariable region I of the mtDNA was sequenced to shed light on the demographic history of the populations. The SNP data, as well as the microsatellite data, reveal extensive levels of LD in Evenki and Saami when compared to Finns and Swedes. mtDNA-sequence variation is compatible with constant population size over time in Evenki and Saami but indicates population expansion in Finns and Swedes. Furthermore, the similarity between Finns and Swedes in SNP allele- and haplotype-frequency distributions indicate that these two populations may share a recent common origin. These findings suggest that populations such as the Evenki and the Saami, rather than the Finns, may be particularly suited for the initial coarse mapping of common complex diseases.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Royal Inst Technol, Stockholms Ctr Phys Astron & Biotechnol, Dept Biotechnol, Stockholm, Sweden; Univ Tartu, Inst Mol & Cell Biol, Estonian Bioctr, EE-50090 Tartu, Estonia	Max Planck Society; Royal Institute of Technology; Estonian Biocentre; University of Tartu	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Inselstr 22, D-04103 Leipzig, Germany.		Kaessmann, Henrik/B-4989-2013; Uhlen, Mathias/AAV-8746-2021; Laan, Maris/A-4100-2011; Uhlen, Mathias/B-3262-2016	Kaessmann, Henrik/0000-0001-7563-839X; Laan, Maris/0000-0002-8519-243X; Uhlen, Mathias/0000-0002-4858-8056				Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eaves IA, 2000, NAT GENET, V25, P320; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hartl DL, 1997, PRINCIPLES POPULATIO; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lahermo P, 1996, AM J HUM GENET, V58, P1309; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Peltonen L, 2000, HUM HERED, V50, P66, DOI 10.1159/000022892; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; RAYMOND M, 1994, GENEPOP; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; SAJANTILA A, 1995, NAT GENET, V11, P359, DOI 10.1038/ng1295-359; SLATKIN M, 1994, GENETICS, V137, P331; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; WATSON E, 1996, AM J HUM GENET, V59, P980; Weir B. S., 1996, GENETIC DATA ANAL; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Wright S, 1921, GENETICS, V6, P111; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766; 1996, VOLKER ERDE BERTELSM	55	64	67	1	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					673	685		10.1086/339258	http://dx.doi.org/10.1086/339258			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11813132	Green Published, Bronze			2022-12-18	WOS:000173880000011
J	Ianakiev, P; van Baren, MJ; Daly, MJ; Toledo, SPA; Cavalcanti, MG; Neto, JC; Silveira, EL; Freire-Maia, A; Heutink, P; Kilpatrick, MW; Tsipouras, P				Ianakiev, P; van Baren, MJ; Daly, MJ; Toledo, SPA; Cavalcanti, MG; Neto, JC; Silveira, EL; Freire-Maia, A; Heutink, P; Kilpatrick, MW; Tsipouras, P			Acheiropodia is caused by a genomic deletion in C7orf2, the human orthologue of the Lmbr1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; CHROMOSOME 7Q36; FAMILIES; REGION; LOCUS; MICE; MAPS	Acheiropodia is an autosomal recessive developmental disorder presenting with bilateral congenital amputations of the upper and lower extremities and aplasia of the hands and feet. This severely handicapping condition appears to affect only the extremities, with no other systemic manifestations reported. Recently, a locus for acheiropodia was mapped on chromosome 7q36. Herein we report the narrowing of the critical region for the acheiropodia gene and the subsequent identification of a common mutation in C7orf2-the human orthologue of the mouse Lmbr1 gene-that is responsible for the disease. Analysis of five families with acheiropodia, by means of 15 polymorphic markers, narrowed the critical region to 1.3 cM, on the basis of identity by descent, and to <0.5 Mb, on the basis of physical mapping. Analysis of C7orf2, the human orthologue of the mouse Lmbr1 gene, identified a deletion in all five families, thus identifying a common acheiropodia mutation. The deletion was identified at both the genomic-DNA and mRNA level. It leads to the production of a C7orf2 transcript lacking exon 4 and introduces a premature stop codon downstream of exon 3. Given the nature of the acheiropodia phenotype, it appears likely that the Lmbr1 gene plays an important role in limb development.	Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; Univ Estadual Paulista, UNESP, Dept Genet, Botucatu, SP, Brazil	University of Connecticut; Erasmus University Rotterdam; Massachusetts Institute of Technology (MIT); Whitehead Institute; Universidade de Sao Paulo; Universidade Estadual Paulista	Tsipouras, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Pediat, Farmington, CT 06030 USA.		Daly, Mark J/B-2453-2017; Silveira-Lucas, Elizabeth/AAI-3916-2021; Lucas, Elizabeth Lemos Silveira/Z-2488-2019; Toledo, Sergio P. A./S-9291-2018	Daly, Mark J/0000-0002-0949-8752; Silveira-Lucas, Elizabeth/0000-0002-4516-2121; Toledo, Sergio P. A./0000-0002-2590-3519; Heutink, Peter/0000-0001-5218-1737				Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Escamilla MA, 2000, AM J HUM GENET, V66, P1995, DOI 10.1086/302921; FREIREMAIA A, 1975, AM J HUM GENET, V27, P665; FREIREMAIA A, 1975, AM J HUM GENET, V27, P521; GRIMALDI A, 1983, AM J MED GENET, V16, P631, DOI 10.1002/ajmg.1320160420; Heus HC, 1999, GENOMICS, V57, P342, DOI 10.1006/geno.1999.5796; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; Ianakiev P, 2000, CLIN GENET, V57, P278, DOI 10.1034/j.1399-0004.2000.570406.x; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; KRUGER LM, 1994, J BONE JOINT SURG AM, V76A, P1557, DOI 10.2106/00004623-199410000-00017; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; MOURAO PAS, 1977, ACTA GENET MED GEMEL, V26, P92, DOI 10.1017/S0001566000010266; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Silveira EL, 1998, CLIN GENET, V54, P256; TOLEDO SPA, 1972, J GENET HUM, V20, P253; TOLEDO SPA, 1969, J GENET HUM, V17, P81; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; Zguricas J, 1999, J MED GENET, V36, P32	19	64	73	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					38	45		10.1086/316955	http://dx.doi.org/10.1086/316955			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11090342	Green Published, Bronze			2022-12-18	WOS:000166399900004
J	Wu, YQ; Badano, JL; McCaskill, C; Vogel, H; Potocki, L; Shaffer, LG				Wu, YQ; Badano, JL; McCaskill, C; Vogel, H; Potocki, L; Shaffer, LG			Haploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY MULTIPLE EXOSTOSES; INTERSTITIAL DELETION; MENTAL-RETARDATION; HOMEODOMAIN; FAMILY; EXT2; CRANIOSYNOSTOSIS; MUTATION; CLONING; ARM	Heterozygous mutations in MSX2 are responsible for an autosomal dominant form of parietal foramina (PFM). PFM are oval defects of the parietal bones that are also a characteristic feature of a contiguous gene-deletion syndrome caused by a proximal deletion in the short arm of chromosome 11 (Potocki-Shaffer syndrome). We have identified a human bacterial artificial chromosome (BAC) clone mapping to chromosome 11, containing a region homologous to the human homeobox gene MSX2. Further sequence analysis demonstrated that the human orthologue (ALX4) of the mouse Aristaless-like 4 gene (Alx4) is contained within this 11p clone. We used FISH to test for the presence-or for the heterozygous deletion-of this clone in two patients with the 11p11.2-deletion syndrome and showed that this clone is deleted in these patients. ALX4 and Alx4 were shown to be expressed in bone and to be absent from all other tissues tested. The involvement of Alx4 in murine skull development, its bone-specific expression pattern, the fact that Alx4 is a dosage-sensitive gene in mice, and the localization of a human genomic clone containing ALX4 to 11p11.2, with hemizygosity in patients with deletion of 11p11.2 who have biparietal foramina, support the contention that ALX4 is a candidate gene for the PFM in the 11p11.2-deletion syndrome.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Shaffer, LG (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 15E, Houston, TX 77030 USA.			Vogel, Otto Hannes/0000-0002-0960-3508; Badano, Jose/0000-0002-0706-8652				Bartsch O, 1996, AM J HUM GENET, V58, P734; FORSTHOEFEL PF, 1963, J MORPHOL, V113, P427, DOI 10.1002/jmor.1051130307; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Ligon AH, 1998, AM J MED GENET, V75, P538, DOI 10.1002/(SICI)1096-8628(19980217)75:5<538::AID-AJMG17>3.0.CO;2-L; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Potocki L, 1996, AM J MED GENET, V62, P319, DOI 10.1002/(SICI)1096-8628(19960329)62:3<319::AID-AJMG22>3.0.CO;2-M; Qu SM, 1997, DEVELOPMENT, V124, P3999; Qu SM, 1997, GENE, V203, P217, DOI 10.1016/S0378-1119(97)00497-6; Qu SM, 1998, DEVELOPMENT, V125, P2711; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; SCHINZEL A, 1988, J MED GENET, V25, P454, DOI 10.1136/jmg.25.7.454; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHAFFER LG, 1993, AM J MED GENET, V45, P581, DOI 10.1002/ajmg.1320450512; SHAFFER LG, 2001, METABOLIC MOL BASIS; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Wuyts W, 1999, EUR J HUM GENET, V7, P579, DOI 10.1038/sj.ejhg.5200339; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547	20	64	67	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1327	1332						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11017806				2022-12-18	WOS:000165091600030
J	Kurahashi, H; Shaikh, TH; Zackai, EH; Celle, L; Driscoll, DA; Budarf, ML; Emanuel, BS				Kurahashi, H; Shaikh, TH; Zackai, EH; Celle, L; Driscoll, DA; Budarf, ML; Emanuel, BS			Tightly clustered 11q23 and 22q11 breakpoints permit PCR-based detection of the recurrent constitutional t(11;22)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; TRANSLOCATION; HETEROZYGOSITY; SEQUENCE	Palindromic AT-rich repeats (PATRRs) on chromosomes 11q23 and 22q11 at the constitutional t(11;22) breakpoint are predicted to induce genomic instability, which mediates the translocation. A PCR-based translocation-detection system for the t(11;22) has been developed with PCR primers flanking the PATRRs of both chromosomes, to examine the involvement of the PATRRs in the recurrent rearrangement. Forty unrelated carriers of the t(11;22) balanced translocation, plus two additional, independent cases with the supernumerary-der(22) syndrome, were analyzed to compare their translocation breakpoints. Similar translocation-specific junction fragments were obtained from both derivative chromosomes in all 40 carriers of the t(11;22) balanced translocation and from the der(22) in both of the offspring with unbalanced supernumerary-der(22) syndrome, suggesting that the breakpoints in all cases localize within these PATRRs and that the translocation is generated by a similar mechanism. This PCR strategy provides a convenient technique for rapid diagnosis of the translocation, indicating its utility for prenatal and preimplantation diagnosis in families including carriers of the balanced translocation.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, 1002 Abramson Res Ctr,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NCI NIH HHS [R01 CA039926, CA39926] Funding Source: Medline; NICHD NIH HHS [P30 HD026979, P30 HD024061, HD26979] Funding Source: Medline; NIDCD NIH HHS [DC02027, P01 DC002027] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061, P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; CARTER SL, 1994, CANCER RES, V54, P6270; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, AM J HUM GENET, V65, P1608, DOI 10.1086/302689; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Fung J, 1999, REPROD FERT DEVELOP, V11, P17, DOI 10.1071/RD98110; HAMPTON GM, 1994, CANCER RES, V54, P4586; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; LINDBLOM A, 1994, AM J HUM GENET, V54, P871; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	13	64	67	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					763	768		10.1086/303054	http://dx.doi.org/10.1086/303054			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10903930	Green Published, Bronze			2022-12-18	WOS:000089002300024
J	Folstein, SE; Mankoski, RE				Folstein, SE; Mankoski, RE			Chromosome 7q: Where autism meets language disorder?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							INFANTILE-AUTISM; FAMILY HISTORY; ASPERGERS SYNDROME; CHILDREN; PATTERNS; PARENTS; IMPAIRMENT; TWINS; INDIVIDUALS; SPECTRUM		Tufts Univ New England Med Ctr, Dept Psychiat, Boston, MA 02111 USA	Tufts Medical Center	Folstein, SE (corresponding author), Tufts Univ New England Med Ctr, Dept Psychiat, 750 Washington St,NEMC 1007, Boston, MA 02111 USA.	sfolstein@hotmail.com						Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Ashley-Koch A, 1999, MOL PSYCHIATR, V4, pS15; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barrett S, 1999, AM J MED GENET, V88, P609; BARTAK L, 1977, J AUTISM CHILD SCHIZ, V7, P383, DOI 10.1007/BF01540396; BARTAK L, 1975, BRIT J PSYCHIAT, V126, P127, DOI 10.1192/bjp.126.2.127; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Bolton PF, 1998, PSYCHOL MED, V28, P385, DOI 10.1017/S0033291797006004; COX A, 1975, BRIT J PSYCHIAT, V126, P146, DOI 10.1192/bjp.126.2.146; DELONG R, 1994, DEV MED CHILD NEUROL, V36, P674; EISENBERG L, 1957, AM J ORTHOPSYCHIAT, V27, P715, DOI 10.1111/j.1939-0025.1957.tb05539.x; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Folstein SE, 1999, INT REV PSYCHIATR, V11, P269, DOI 10.1080/09540269974168; Folstein SE, 1999, J CHILD PSYCHOL PSYC, V40, P1117, DOI 10.1111/1469-7610.00528; Folstein SE, 1998, J AUTISM DEV DISORD, V28, P439, DOI 10.1023/A:1026008606672; FOLSTEIN SE, 2000, ASPERGER SYNDROME, P159; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Fombonne E, 1997, J CHILD PSYCHOL PSYC, V38, P667, DOI 10.1111/j.1469-7610.1997.tb01694.x; GILLBERG C, 1992, DEV MED CHILD NEUROL, V34, P389; Hafeman L, 1999, MOL PSYCHIATR, V4, pS14; HOWLIN P, IN PRESS J CHILD PSY; Klin A, 2000, ASPERGER SYNDROME, P309; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; LANDA R, 1991, J SPEECH HEAR RES, V34, P1339, DOI 10.1044/jshr.3406.1339; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; OZONOFF S, 1993, J AUTISM DEV DISORD, V23, P429, DOI 10.1007/BF01046049; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; PICKLES A, 1995, AM J HUM GENET, V57, P717; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; Santangelo SL, 1999, DEV COGN NEUROSCI, P431; Tager-Flusberg H, 1999, INT REV PSYCHIATR, V11, P325, DOI 10.1080/09540269974203; TMBLIN J, 1998, AM J HUM GENET S, V63, pA312; Tomblin JB, 1999, DEV COGN NEUROSCI, P361; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tomblin JB, 1999, TRENDS COGN SCI, V3, P283, DOI 10.1016/S1364-6613(99)01353-4; Vincent JB, 2000, AM J HUM GENET, V67, P510, DOI 10.1086/303005; WING L, 1981, PSYCHOL MED, V11, P115, DOI 10.1017/S0033291700053332; WING L, 1986, J AUTISM DEV DISORD, V16, P513, DOI 10.1007/BF01531716	42	64	66	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					278	281		10.1086/303034	http://dx.doi.org/10.1086/303034			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	354YA	10889044	Green Published, Bronze			2022-12-18	WOS:000089357800003
J	Saitoh, S; Wada, T				Saitoh, S; Wada, T			Parent-of-origin specific histone acetylation and reactivation of a key imprinted gene locus in Prader-Willi syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; DEACETYLASE COMPLEX; DNA METHYLATION; EXPRESSION; CHROMOSOME; MAMMALS; PROTEIN; MECP2; FMR1; PCR	To examine the chromatin basis of imprinting in chromosome 15q11-q13, we have investigated the status of histone acetylation of the SNURF-SNRPN locus, which is a key imprinted gene locus in Prader-Willi syndrome (PWS). Chromatin immunoprecipitation (ChIP) studies revealed that the unmethylated CpG island of the active, paternally derived allele of SNURF-SNRPN was associated with acetylated histones, whereas the methylated maternally derived, inactive allele was specifically hypoacetylated. The body of the SNURF-SNRPN gene was associated with acetylated histones on both alleles. Furthermore, treatment of PWS cells with the DNA methyltransferase inhibitor 5-azadeoxycytidine (5-aza-dC) induced demethylation of the SNURF-SNRPN CpG island and restoration of gene expression on the maternal allele. The reactivation was associated with increased H4 acetylation but not with H3 acetylation at the SNURF-SNRPN CpG island. These findings indicate that (1) a significant role for histone deacetylation in gene silencing is associated with imprinting in 15q11-q13 and (2) silenced genes in PWS can be reactivated by drug treatment.	Hokkaido Univ, Sch Med, Dept Pediat, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University	Saitoh, S (corresponding author), Hokkaido Univ, Sch Med, Dept Pediat, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.			Saitoh, Shinji/0000-0001-6911-3351				Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hu JF, 1998, BIOCHEM BIOPH RES CO, V251, P403, DOI 10.1006/bbrc.1998.9401; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; Pedone PV, 1999, FEBS LETT, V458, P45, DOI 10.1016/S0014-5793(99)01124-2; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664	20	64	69	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1958	1962		10.1086/302917	http://dx.doi.org/10.1086/302917			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775525	Green Published, Bronze			2022-12-18	WOS:000088373800023
J	Torroni, A; Richards, M; Macaulay, V; Forster, P; Villems, R; Norby, S; Savontaus, ML; Huoponen, K; Scozzari, R; Bandelt, HJ				Torroni, A; Richards, M; Macaulay, V; Forster, P; Villems, R; Norby, S; Savontaus, ML; Huoponen, K; Scozzari, R; Bandelt, HJ			mtDNA haplogroups and frequency patterns in Europe	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MITOCHONDRIAL-DNA ANALYSIS; AFRICAN POPULATIONS REVEALS; CONTROL-REGION; ANCIENT; IDENTIFICATION; DIVERSITY; LINEAGES; EASTERN; ORIGIN		Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy	University of Ferrara	Torroni, A (corresponding author), Univ Ferrara, Dipartimento Biol, Via L Borsari 46, I-44100 Ferrara, Italy.		Torroni, Antonio/E-1557-2011	Torroni, Antonio/0000-0002-4163-4478; Barbujani, Guido/0000-0001-7854-6669				Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CHEN YS, 1995, AM J HUM GENET, V57, P133; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Richards M, 1996, AM J HUM GENET, V59, P185; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	24	64	70	4	14	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1173	1177		10.1086/302789	http://dx.doi.org/10.1086/302789			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712231	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000088373200039
J	Fontaine, B; Davoine, CS; Durr, A; Paternotte, C; Feki, I; Weissenbach, J; Hazan, J; Brice, A				Fontaine, B; Davoine, CS; Durr, A; Paternotte, C; Feki, I; Weissenbach, J; Hazan, J; Brice, A			A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIES; MUTATIONS; PHENOTYPE; LINKAGE; PROTEIN; MAPS; GENE	Hereditary spastic paraplegia (HSP) comprises a group of clinically and genetically heterogeneous disorders causing progressive spasticity and weakness of the lower limbs. We report a large family of French descent with autosomal dominant pure HSP. We excluded genetic linkage to the known loci causing HSP and performed a genomewide search. We found evidence for linkage of the disorder to polymorphic markers on chromosome 2q24-q34: a maximum LOD score of 3.03 was obtained for marker D2S2318. By comparison with families having linkage to the major locus of pure autosomal dominant HSP (SPG4 on chromosome 2p), there were significantly more patients without Babinski signs, with increased reflexes in the upper limbs, and with severe functional handicaps.	Univ Paris 06, INSERM, CJF9711, F-75013 Paris, France; Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, INSERM, U289, F-75634 Paris, France; Genoscope, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Fontaine, B (corresponding author), Univ Paris 06, INSERM, CJF9711, 105 Blvd Hop, F-75013 Paris, France.	fontaine@infobiogen.fr	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Hazan, Jamile/0000-0001-8119-0325				BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURR A, 1994, NEUROLOGY, V44, P1274, DOI 10.1212/WNL.44.7.1274; Durr A, 1996, BRAIN, V119, P1487, DOI 10.1093/brain/119.5.1487; Fink JK, 1997, CURR OPIN NEUROL, V10, P313, DOI 10.1097/00019052-199708000-00006; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; FONTAINE B, 1995, NEUROMUSCULAR DISORD, V5, P11, DOI 10.1016/0960-8966(94)E0024-3; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hedera P, 1999, AM J HUM GENET, V64, P563, DOI 10.1086/302258; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; McHale DP, 1999, AM J HUM GENET, V64, P526, DOI 10.1086/302237; McKusick VA, 1990, MENDELIAN INHERITANC; Murillo FM, 1999, NEUROLOGY, V53, P50, DOI 10.1212/WNL.53.1.50; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; Reid E, 1999, AM J HUM GENET, V65, P757, DOI 10.1086/302555; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257	22	64	64	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					702	707		10.1086/302776	http://dx.doi.org/10.1086/302776			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677329	Bronze, Green Published			2022-12-18	WOS:000088373100036
J	Mangion, J; Rahman, N; Mansour, S; Brice, G; Rosbotham, J; Child, AH; Murday, VA; Mortimer, PS; Barfoot, R; Sigurdsson, A; Edkins, S; Sarfarazi, M; Burnand, K; Evans, AL; Nunan, TO; Stratton, MR; Jeffery, S				Mangion, J; Rahman, N; Mansour, S; Brice, G; Rosbotham, J; Child, AH; Murday, VA; Mortimer, PS; Barfoot, R; Sigurdsson, A; Edkins, S; Sarfarazi, M; Burnand, K; Evans, AL; Nunan, TO; Stratton, MR; Jeffery, S			A gene for lymphedema-distichiasis maps to 16q24.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISOTOPE LYMPHOGRAPHY; PRIMARY LYMPHOEDEMA; EDEMA; LIMB	Lymphedema-distichiasis (LD) is a dominantly inherited syndrome with onset of lymphedema at or just after puberty. Most affected individuals have distichiasis-fine hairs arising inappropriately from the eyelid meibomian glands-which is evident from birth. A study of three families with LD has shown linkage to chromosome 16q24.3, and subsequent analysis of the region for recombinant genes places the locus between D16S422 and D16S3074, a distance of similar to 16 cM. Possible candidate genes in this interval include the N-proteinase for type 3 collagen, PCOLN3; the metalloprotease PRSM1; and the cell matrix-adhesion regulator, CMAR.	St Georges Med Sch, Med Genet Unit, London SW17 0RE, England; St Georges Med Sch, Inst Canc Res, London SW17 0RE, England; St Georges Med Sch, Dept Cardiol Sci, London SW17 0RE, England; St Georges Med Sch, Dept Dermatol, London SW17 0RE, England; United Med & Dent Sch Guys & St Thomas Hosp, Acad Dept Surg, London, England; United Med & Dent Sch Guys & St Thomas Hosp, Dept Nucl Med, London, England; Univ Connecticut, Ctr Hlth, Surg Res Ctr, Dept Surg, Farmington, CT USA	St Georges University London; Royal Marsden NHS Foundation Trust; St Georges University London; University of London; Institute of Cancer Research - UK; St Georges University London; St Georges University London; University of London; King's College London; University of London; King's College London; University of Connecticut	Jeffery, S (corresponding author), St Georges Med Sch, Med Genet Unit, Cranmer Teraace, London SW17 0RE, England.		Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Edkins, Sarah/0000-0003-0717-1972; Rahman, Nazneen/0000-0003-4376-0440				DALE RF, 1985, J MED GENET, V22, P274, DOI 10.1136/jmg.22.4.274; DALE RF, 1987, J MED GENET, V24, P170, DOI 10.1136/jmg.24.3.170; Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; GOODMAN RM, 1962, AM J MED, V32, P651; HARDY C, 1995, M BRIT SOC CLIN GEN; HERBERT FA, 1983, ARCH INTERN MED, V143, P913, DOI 10.1001/archinte.143.5.913; KINMONTH JB, 1957, BRIT J SURG, V45, P1, DOI 10.1002/bjs.18004518902; LEVER W, 1997, LEVERS HISTOPATHOLOG, P747; MORTIMER PS, 1995, CLIN EXP DERMATOL, V20, P98, DOI 10.1111/j.1365-2230.1995.tb02665.x; PROBY CM, 1990, BRIT J DERMATOL, V123, P29, DOI 10.1111/j.1365-2133.1990.tb01821.x; ROBINOW M, 1970, AM J DIS CHILD, V119, P343, DOI 10.1001/archpedi.1970.02100050345013; STEWART G, 1985, BRIT J SURG, V72, P906, DOI 10.1002/bjs.1800721120; Temple I K, 1994, Clin Dysmorphol, V3, P139; WHEELER ES, 1981, PLAST RECONSTR SURG, V67, P362, DOI 10.1097/00006534-198103000-00016	15	64	70	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					427	432		10.1086/302500	http://dx.doi.org/10.1086/302500			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417285	Green Published, Bronze			2022-12-18	WOS:000081836900018
J	Liu, XZ; Hope, C; Liang, CY; Zou, JM; Xu, LR; Cole, T; Mueller, RF; Bundey, S; Nance, W; Steel, KP; Brown, SDM				Liu, XZ; Hope, C; Liang, CY; Zou, JM; Xu, LR; Cole, T; Mueller, RF; Bundey, S; Nance, W; Steel, KP; Brown, SDM			A mutation (2314delG) in the usher syndrome type IIA gene: High prevalence and phenotypic variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MYOSIN VIIA GENE; DEAFNESS		Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Otolaryngol, Richmond, VA 23298 USA; W China Univ Med Sci, Dept Otolaryngol, Chengdu 610041, Peoples R China; W China Univ Med Sci, Dept Ophthalmol, Chengdu 610041, Peoples R China; MRC, Inst Hearing Res, Nottingham, England; St James Univ Hosp, Dept Clin Genet, Leeds, W Yorkshire, England; Univ Birmingham, Clin Genet Unit, Birmingham, W Midlands, England; United Kingdom Mouse Genome Ctr, Harwell, Oxon, England; MRC, Mammalian Genet Unit, Harwell, Oxon, England	Virginia Commonwealth University; Virginia Commonwealth University; Sichuan University; Sichuan University; Saint James's University Hospital; University of Birmingham	Liu, XZ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	xzliu@hsc.vcu.edu			NIDCD NIH HHS [R01 DC005575, R01 DC012115, R01 DC02530] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002530, R01DC005575] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; PAKARINEN L, 1995, LARYNGOSCOPE, V105, P613, DOI 10.1288/00005537-199506000-00010; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; Rosenberg T, 1997, CLIN GENET, V51, P314; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolf U, 1997, HUM GENET, V100, P305, DOI 10.1007/s004390050509	12	64	65	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1221	1225		10.1086/302332	http://dx.doi.org/10.1086/302332			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090909	Green Published, Bronze			2022-12-18	WOS:000079632900035
J	Jacquot, S; Merienne, K; De Cesare, D; Pannetier, S; Mandel, JL; Sassone-Corsi, P; Hanauer, A				Jacquot, S; Merienne, K; De Cesare, D; Pannetier, S; Mandel, JL; Sassone-Corsi, P; Hanauer, A			Mutation analysis of the RSK2 gene in Coffin-Lowry patients: Extensive allelic heterogeneity and a high rate of de novo mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION SYNDROME; PROTEIN-KINASES; PP90(RSK); DOMAINS	Coffin-Lowry syndrome (CLS) is an X-linked disorder characterized by severe psychomotor retardation, facial and digital dysmorphisms, and progressive skeletal deformations. By using a positional cloning approach, we have recently shown that mutations in the gene ceding for the RSK2 serine-threonine protein kinase are responsible for this syndrome. To facilitate mutational analysis, we have now determined the genomic structure of the human RSK2 gene. The open reading frame of the RSK2. coding region is split into 22 exons. Primers were designed for PCR amplification of single exons from genomic DNA and subsequent single-strand conformation polymorphism analysis. We screened 37 patients with clinical features suggestive of CLS. Twenty-five nucleotide changes predicted to be disease-causing mutations were identified, including eight splice-site alterations, seven nonsense mutations, five frameshift mutations, and five missense mutations. Twenty three of them were novel mutations. Coupled with previously reported mutations, these findings bring the total of different RSK2 mutations to 34. These are distributed throughout the RSK2 gene, with no clustering, and all but two, which have been found in two independent patients, are unique. A very high (68%) rate of de novo mutations was observed. It is noteworthy also that three mutations were found in female probands, with no affected male relatives, ascertained through learning disability and mild but suggestive facial and digital dysmorphisms. No obvious correlation was observed between the position or type of the RSK2 mutations and the severity or particular clinical features of CLS.	CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Hanauer, A (corresponding author), CU Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, F-67404 Illkirch, France.		Sassone-Corsi, Paolo/H-6182-2011; Mandel, Jean Louis/Q-2668-2016	Merienne, Karine/0000-0003-2549-2315; Mandel, Jean Louis/0000-0002-0535-6589				BJORBAEK C, 1995, DIABETES, V44, P90, DOI 10.2337/diabetes.44.1.90; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; COFFIN GS, 1966, AM J DIS CHILD, V112, P205, DOI 10.1001/archpedi.1966.02090120073006; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; FRYNS JP, 1977, HUM GENET, V36, P271, DOI 10.1007/BF00446276; GILGENKRANTZ S, 1988, CLIN GENET, V34, P230; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARTSFIELD JK, 1993, AM J MED GENET, V45, P552, DOI 10.1002/ajmg.1320450505; HUNTER AGW, 1982, CLIN GENET, V21, P321; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; KRAJEWSKAWALASEK M, 1988, EUR J PEDIATR, V147, P448, DOI 10.1007/BF00496440; KRAWCZAK M, 1992, HUM GENET, V90, P41; LOWRY B, 1971, AM J DIS CHILD, V121, P496, DOI 10.1001/archpedi.1971.02100170078009; Merienne K, 1998, J MED GENET, V35, P890, DOI 10.1136/jmg.35.11.890; TEMTAMY SA, 1975, J PEDIATR-US, V86, P724, DOI 10.1016/S0022-3476(75)80357-X; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; YOUNG ID, 1988, J MED GENET, V25, P344, DOI 10.1136/jmg.25.5.344; ZHAO Y, 1995, MOL CELL BIOL, V15, P4353	18	64	71	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1631	1640		10.1086/302153	http://dx.doi.org/10.1086/302153			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837815	Bronze, Green Published			2022-12-18	WOS:000077707700008
J	Tassin, J; Durr, A; de Broucker, T; Abbas, N; Bonifati, V; De Michele, G; Bonnet, AM; Broussolle, E; Pollak, P; Vidailhet, M; De Mari, M; Marconi, R; Medjbeur, S; Filla, A; Meco, G; Agid, Y; Brice, A				Tassin, J; Durr, A; de Broucker, T; Abbas, N; Bonifati, V; De Michele, G; Bonnet, AM; Broussolle, E; Pollak, P; Vidailhet, M; De Mari, M; Marconi, R; Medjbeur, S; Filla, A; Meco, G; Agid, Y; Brice, A		French Parkinsons Dis Genet Study Grp; European Consortium Genetic Susceptibility Par	Chromosome 6-linked autosomal recessive early-onset parkinsonism: Linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE PARKINSONISM; DISEASE	The gene for autosomal recessive juvenile Parkinsonism (AR-JP) recently has been mapped to chromosome 6q25.2-27 in Japanese families. We have tested one Algerian and 10 European multiplex families with early-onset Parkinson disease for linkage to this locus, with marker D6S305. Homogeneity analysis provided a conditional probability in favor of linkage of >.9 in eight families, which were analyzed further with eight microsatellite markers spanning the 17-cM AR-JP region. Haplotype reconstruction for eight families and determination of the smallest region of homozygosity in two consanguineous families reduced the candidate interval to 11.3 cM. If the deletion of two microsatellite markers (D6S411 and D6S1550) that colocalize on the genetic map and that segregate with the disease in the Algerian family is taken into account, the candidate region would be reduced to <1 cM. These findings should facilitate identification of the corresponding gene. We have confirmed linkage of AR-JP, in European families and in an Algerian family, to the PARK2 locus. PARK2 appears to be an important locus for AR-JP in European patients. The clinical spectrum of the disease in our families, with age at onset less than or equal to 58 years and the presence of painful dystonia in some patients, is broader than that reported previously.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; Hop Casanova, Serv Neurol, St Denis, France; Univ La Sapienza, Dipartimento Sci Neurol, Rome, Italy; Univ Naples Federico II, Dipartimento Sci Neurol, Naples, Italy; Hop Neurol, Lyon, France; Ctr Hosp Reg, Grenoble, France; Univ Bari, Inst Neurol, Bari, Italy; Osped Misericordia, Div Neurol, Grosseto, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sapienza University Rome; University of Naples Federico II; CHU Lyon; Centre Hospitalier Annecy Genevois; CHU Grenoble Alpes; Universita degli Studi di Bari Aldo Moro	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Bd Hop, F-75651 Paris 13, France.	brice@moka.ccr.jussieu.fr	Broussolle, Emmanuel/H-1592-2017; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Martinez, Maria/B-3111-2013	Broussolle, Emmanuel/0000-0002-0410-9519; brice, alexis/0000-0002-0941-3990; Martinez, Maria/0000-0003-2180-4537				AGID Y, 1991, LANCET, V337, P1321, DOI 10.1016/0140-6736(91)92989-F; Brice A, 1998, SCIENCE, V279, P1116; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MATSUMINE H, 1997, AM J HUM GENET, V60, P58; Ott J., 1991, ANAL HUMAN GENETIC L; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quinn N, 1987, Mov Disord, V2, P73, DOI 10.1002/mds.870020201; Saito M, 1998, J HUM GENET, V43, P22, DOI 10.1007/s100380050032; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; VAUGHAN JR, IN PRESS ANN NEUROL; Wood N, 1997, J NEUROL NEUROSUR PS, V62, P305, DOI 10.1136/jnnp.62.4.305; YAMAMURA Y, 1973, NEUROLOGY, V23, P239, DOI 10.1212/WNL.23.3.239; YAMAMURA Y, 1993, CLIN NEUROL, V33, P491	21	64	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					88	94		10.1086/301934	http://dx.doi.org/10.1086/301934			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634531	Green Published, Bronze			2022-12-18	WOS:000074761000014
J	Eng, C; Ji, HL				Eng, C; Ji, HL			Molecular classification of the inherited hamartoma polyposis syndromes: Clearing the muddied waters	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							CHROMOSOME		Harvard Univ, Sch Med, Dana Farber Canc Inst,Translat Res Lab, Charles A Dana Human Canc Genet Unit, Boston, MA 02115 USA; Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge, England; Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Genet, Seattle, WA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; CRUK Cambridge Institute; University of Cambridge; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Eng, C (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst,Translat Res Lab, Charles A Dana Human Canc Genet Unit, 1 Jimmy Fund Way,SM 822, Boston, MA 02115 USA.			Eng, Charis/0000-0002-3693-5145				Arch EM, 1997, AM J MED GENET, V71, P489, DOI 10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B; ENG C, 1998, GENETIC BASIS HUMAN, P519; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Howe JR, 1998, AM J HUM GENET, V62, P1129, DOI 10.1086/301840; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Marsh DJ, 1997, CANCER RES, V57, P5017; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mehenni H, 1997, AM J HUM GENET, V61, pA74; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Olschwang S, 1998, NAT GENET, V18, P12, DOI 10.1038/ng0198-12; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Thomas HJW, 1996, AM J HUM GENET, V58, P770; Tsou HC, 1997, AM J HUM GENET, V61, P1036, DOI 10.1086/301607; Tsuchiya KD, 1998, GENE CHROMOSOME CANC, V21, P113, DOI 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3	20	64	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1998	62	5					1020	1022		10.1086/301847	http://dx.doi.org/10.1086/301847			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZL922	9545417	Green Published, Bronze			2022-12-18	WOS:000073487000004
J	Wartenfeld, R; Golomb, E; Katz, G; Bale, SJ; Goldman, B; Pras, M; Kastner, DL; Pras, E				Wartenfeld, R; Golomb, E; Katz, G; Bale, SJ; Goldman, B; Pras, M; Kastner, DL; Pras, E			Molecular analysis of cystinuria in Libyan Jews: Exclusion of the SLC3A1 gene and mapping of a new locus on 19q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID TRANSPORTER; BRUSH-BORDER VESICLES; LINKAGE ANALYSIS; RAT-KIDNEY; MUTATIONS; LOCALIZATION; HETEROGENEITY; EXPRESSION; CLONING; CDNA	Cystinuria is a hereditary disorder of amino acid transport and is manifested by the development of kidney stones. In some patients the disease is caused by mutations in the SLC3A1 gene, which is located on the short arm of chromosome 2 and encodes a renal/intestinal transporter for cystine and the dibasic amino acids. In Israel cystinuria is especially common among Jews of Libyan origin. After excluding SLC3A1 as the disease-causing gene in Libyan Jewish patients, we performed a genomewide search that shows that the Libyan Jewish cystinuria gene maps to the Long arm of chromosome 19. Significant linkage was obtained for seven chromosome 19 markers. A maximal LOD score of 9.22 was obtained with the marker D19S882. Multipoint data and recombination analysis placed the gene in an 8-cM interval between the markers D19S409 and D19S208. Significant Linkage disequilibrium was observed for alleles of four markers, and a specific haplotype comprising the markers D19S225, D19S208, D19S220, and D19S422 was found in 11 of 17 carrier chromosomes, versus 1 of 58 Libyan Jewish noncarrier chromosomes.	CHAIM SHEBA MED CTR,DEPT MED C,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,DEPT MED F,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,INST HUMAN GENET,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT PATHOL,IL-69978 TEL AVIV,ISRAEL; UNIV FLORIDA,DIV UROL,GAINESVILLE,FL; NIAMSD,SKIN BIOL LAB,BETHESDA,MD; NIAMSD,ARTHRIT & RHEUMATISM BRANCH,BETHESDA,MD	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)								AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P644; Battey, 1986, BASIC METHODS MOL BI; BERTRAN J, 1993, J BIOL CHEM, V268, P14842; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; DAHLBERG PJ, 1977, MAYO CLIN PROC, V52, P533; DENT CE, 1951, Q J MED, V20, P205; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; GARCIA E, 1995, GENOMICS, V27, P52, DOI 10.1006/geno.1995.1007; GASPARINI P, 1995, AM J HUM GENET, V57, P781; GOODYER PR, 1993, J PEDIATR-US, V122, P568, DOI 10.1016/S0022-3476(05)83537-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAWKINS GA, 1994, BIOTECHNIQUES, V16, P418; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; Horsford J, 1996, KIDNEY INT, V49, P1401, DOI 10.1038/ki.1996.197; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; LEVY HL, 1972, PEDIATRICS, V49, P825; MAKITA N, 1994, GENOMICS, V23, P628, DOI 10.1006/geno.1994.1551; McKusick V.A., 1992, MENDELIAN INHERITANC; MCNAMARA PD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P101, DOI 10.1016/0005-2736(92)90062-Q; MCNAMARA PD, 1981, BIOCHEM J, V194, P443, DOI 10.1042/bj1940443; MIYAMOTO K, 1995, BIOCHEM J, V310, P951, DOI 10.1042/bj3100951; Mora C, 1996, J BIOL CHEM, V271, P10569, DOI 10.1074/jbc.271.18.10569; MOSCKOVITZ R, 1994, FASEB J, V8, P1069, DOI 10.1096/fasebj.8.13.7926373; Ott J., 1991, ANAL HUMAN GENETIC L; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; Pras E, 1996, GENOMICS, V36, P163, DOI 10.1006/geno.1996.0437; PRAS E, 1995, AM J HUM GENET, V56, P1297; PRAS E, 1994, NAT GENET, V6, P415, DOI 10.1038/ng0494-415; Rosenberg L E, 1966, Trans Assoc Am Physicians, V79, P284; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; SEGAL S, 1977, SCIENCE, V197, P169, DOI 10.1126/science.877548; WANG Y, 1995, FEBS LETT, V368, P389, DOI 10.1016/0014-5793(95)00685-3; WEINBERGER A, 1974, HUM HERED, V24, P568, DOI 10.1159/000152696; WEIR BS, 1978, GENETICS, V88, P633; Weir BS, 1990, GENETIC DATA ANAL	40	64	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					617	624						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042922				2022-12-18	WOS:A1997WK40300019
J	Wright, FA				Wright, FA			The phenotypic difference discards sib-pair QTL linkage information	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							QUANTITATIVE TRAIT LOCI; GENETIC-LINKAGE; PEDIGREES		UNIV TEXAS,BIOSTAT LAB,EL PASO,TX 79968	University of Texas System; University of Texas El Paso	Wright, FA (corresponding author), UNIV CALIF SAN DIEGO,CTR CANC,DEPT FAMILY & PREVENT MED,9500 GILMAN DR,LA JOLLA,CA 92093, USA.				NCRR NIH HHS [5 G12 RR08124-04] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMOS CI, 1994, AM J HUM GENET, V54, P535; AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CAREY G, 1991, AM J HUM GENET, V49, P786; Cox DR, 1974, THEORETICAL STATISTI; DEMEESTER CA, 1995, AM J HUM GENET, V56, P287; FULKER DW, 1994, AM J HUM GENET, V54, P1092; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KONG A, 1994, P NATL ACAD SCI USA, V91, P9705, DOI 10.1073/pnas.91.21.9705; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; OLSON JM, 1995, GENET EPIDEMIOL, V12, P177, DOI 10.1002/gepi.1370120206; Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.1093/biomet/31.1-2.9; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857	17	64	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					740	742						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042938				2022-12-18	WOS:A1997WK40300036
J	Yamaoka, LH; WelshBohmer, KA; Hulette, CM; Gaskell, PC; Murray, M; Rimmler, JL; Helms, BR; Guerra, M; Roses, AD; Schmechel, DE; PericakVance, MA				Yamaoka, LH; WelshBohmer, KA; Hulette, CM; Gaskell, PC; Murray, M; Rimmler, JL; Helms, BR; Guerra, M; Roses, AD; Schmechel, DE; PericakVance, MA			Linkage of frontotemporal dementia to chromosome 17: Clinical and neuropathological characterization of phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CRITERIA; COMPLEX; LOCUS; GENE	Frontotemporal dementia is a behavioral disorder of insidious onset and variable progression. Clinically, its early features reflect frontal lobe dysfunction characterized by personality change, deterioration in memory and executive functions, and stereotypical and perseverative behaviors. Pathologically, there is degeneration of the neocortex and subcortical nuclei, without distinctive features such as plaques, neurofibrillary tangles, or Pick or Lewy bodies. Within-family variation in neuropathology and clinical phenotype is observed. In cases where family aggregation is observed, it is inherited as an autosomal dominant, age-dependent disorder. Family studies recently have identified two dementia loci: chromosome 17 for disinhibition-dementia-parkinsonism-amyotrophic complex and pallido-ponto-nigral degeneration and chromosome 3 for familial nonspecific dementia. We describe a family (DUK1684) with clinically and neuropathologically confirmed, autosomal dominant, non-Alzheimer disease dementia. Linkage analysis of this family showed evidence for linkage to chromosome 17q21, with a multipoint location score (log(10)) of 5.52. A comparison of the clinical and pathological features in DUK1684 with those of the other chromosome 17-linked families, together with the linkage data, suggests that these families are allelic. These studies emphasize that genetic linkage analysis remains a useful tool for differentiating disease loci in clinically complex traits.	DUKE UNIV,MED CTR,DEPT PSYCHIAT & BEHAV SCI,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT OPHTHALMOL,DURHAM,NC 27710; VET ADM MED CTR,DURHAM,NC	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Yamaoka, LH (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,BOX 2900,DURHAM,NC 27710, USA.		Welsh-Bohmer, Kathleen/AAA-3178-2020		NIA NIH HHS [AG09997] Funding Source: Medline; NINDS NIH HHS [NS531153, NS26630-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009997] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; BROWN J, 1995, HUM MOL GENET, V4, P1625, DOI 10.1093/hmg/4.9.1625; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; GYDESEN S, 1987, ACTA PSYCHIAT SCAND, V76, P276, DOI 10.1111/j.1600-0447.1987.tb02896.x; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Vance JM, 1996, AM J HUM GENET, V58, P757; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Wijker M, 1996, HUM MOL GENET, V5, P151, DOI 10.1093/hmg/5.1.151; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159	18	64	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1996	59	6					1306	1312						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV315	8940276				2022-12-18	WOS:A1996VV31500017
J	Collier, DA; Barrett, TG; Curtis, D; Macleod, A; Arranz, JM; Maassen, JA; Bundey, S				Collier, DA; Barrett, TG; Curtis, D; Macleod, A; Arranz, JM; Maassen, JA; Bundey, S			Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIABETES-MELLITUS; RECOMBINATION; PROGRAM; MARKER; GENE	Wolfram syndrome (DIDMOAD syndrome; MIM 222300) is an autosomal recessive neurodegenerative disorder characterized by juvenile-onset diabetes mellitus and bilateral optic atrophy. Previous linkage analysis of multiply affected families indicated that the gene for Wolfram syndrome is on chromosome 4p, and it produced no evidence for locus heterogeneity. We have investigated 12 U.K. families with Wolfram syndrome, and we report confirmation of linkage to chromosome 4p, with a maximum two-point LOD score of 4.6 with DRD5, assuming homogeneity, and of 5.1, assuming heterogeneity. Overlapping multipoint analysis using six markers at a time produced definite evidence for locus heterogeneity: the maximum multipoint LOD score under homogeneity was <2, whereas when heterogeneity was allowed for an admixture a LOD of 6.2 was obtained in the interval between D4S432 and D4S431, with the peak close to the marker D4S3023. One family with an atypical phenotype was definitely unlinked to the region. Haplotype inspection of the remaining 11 families, which appear linked to chromosome 4p and had typical phenotypes, revealed crossover events during meiosis, which also placed the gene in the interval D4S432 and D4S431. In these families no recombinants were detected with the marker D4S3023, which maps within the same interval.	INST PSYCHIAT,DEPT NEUROPATHOL,LONDON SE5 8AF,ENGLAND; ST BARTHOLOMEWS & ROYAL LONDON SCH MED & DENT,DEPT PSYCHOL MED,LONDON,ENGLAND; BIRMINGHAM MATERNITY HOSP,DEPT CLIN GENET,BIRMINGHAM B15 2TG,W MIDLANDS,ENGLAND; LEIDEN UNIV,SYLVIUS LABS,DEPT BIOCHEM MED,LEIDEN,NETHERLANDS; ROYAL SHREWSBURY HOSP NHS TRUST,SHREWSBURY,SALOP,ENGLAND	University of London; King's College London; University of London; Queen Mary University London; Leiden University; Leiden University - Excl LUMC	Collier, DA (corresponding author), INST PSYCHIAT,MOL GENET SECT,DE CRESPIGNY PK,DENMARK HILL,LONDON SE5 8AF,ENGLAND.		Curtis, David/HGB-3921-2022; Barrett, Timothy/F-1682-2010	Curtis, David/0000-0002-4089-9183; Barrett, Timothy/0000-0002-6873-0750				ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; BLASI C, 1986, DIABETES CARE, V9, P521, DOI 10.2337/diacare.9.5.521; COOK CCH, 1993, ANN HUM GENET, V57, P307, DOI 10.1111/j.1469-1809.1993.tb00905.x; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1990, ANN HUM GENET, V54, P365, DOI 10.1111/j.1469-1809.1990.tb00390.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FRASER FC, 1977, J MED GENET, V14, P190, DOI 10.1136/jmg.14.3.190; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; KINSLEY BT, 1995, DIABETES CARE, V18, P1566, DOI 10.2337/diacare.18.12.1566; LATHROP GM, 1985, AM J HUM GENET, V37, P482; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; SWIFT RG, 1991, AM J PSYCHIAT, V148, P775; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375	22	64	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					855	863						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808601				2022-12-18	WOS:A1996VL28300015
J	Blair, IP; Nash, J; Gordon, MJ; Nicholson, GA				Blair, IP; Nash, J; Gordon, MJ; Nicholson, GA			Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROPATHY TYPE-I; HEREDITARY MOTOR; POINT MUTATION; GENE; IDENTIFICATION; LOCALIZATION; POLYMORPHISM; LINKAGE; REGION; LOCUS	Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy. Sporadic cases of CMT have been described since the earliest reports of the disease. The most frequent form of the disorder, CMT1A, is associated with a 1.5-Mb DNA duplication on chromosome 17p11.2, which segregates with the disease. In order to investigate the prevalence of de novo CMT1A duplications, this study examined 118 duplication-positive CMT1A families. In 10 of these families it was demonstrated that the disease had arisen as the result of a de novo mutation. By taking into account the ascertainment of families, it can be estimated that greater than or equal to 10% of autosomal dominant CMT1 families are due to de novo duplications. The CMT1A duplication is thought to be the product of unequal crossing over between parental chromosome 17 homologues during meiosis. Polymorphic markers from within the duplicated region were used to determine the parental origin of these de novo duplications in eight informative families. Seven were of paternal and one of maternal origin. This study represents the first report of a de novo duplication with a maternal origin and indicates that it is not a phenomenon associated solely with male meioses. Recombination fractions for the region duplicated in CMT1A are larger in females than in males. That suggests that oogenesis may be afforded greater protection from misalignment during synapsis, and/or that there may be lower activity of those factors or mechanisms that lead to unequal crossing over at the CMT1A locus.			Blair, IP (corresponding author), UNIV SYDNEY,CONCORD HOSP,MOLEC MED LAB,CLIN SCI BLDG,SYDNEY,NSW 2139,AUSTRALIA.			Blair, Ian/0000-0003-3083-0075				ARCHARD C, 1924, REV NEUROL PARIS, V39, P146; BERGOFFEN J, 1993, AM J HUM GENET, V52, P312; BLAIR IP, 1995, CLIN CHEM, V41, P1105; Charcot JM, 1886, REV MED-PARIS, V6, P97; Dyck P.J., 1993, PERIPHERAL NEUROPATH, V2, P1094; FRIEDREICH N, 1873, PROGRESSIVE MUSKELAT; GRIFFITHS LR, 1988, AM J HUM GENET, V42, P756; GUO Z, 1990, NUCLEIC ACIDS RES, V18, P4967, DOI 10.1093/nar/18.16.4967-a; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HERTZ JM, 1994, CLIN GENET, V46, P291; HOFFMANN J, 1912, DTSCH Z NERVENHEILK, V44, P65; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; ISAACS H, 1960, S Afr Med J, V34, P758; KENNERSON ML, 1995, CLIN CHEM, V41, P1534; Krucke W, 1942, ARCH PSYCHIAT NERVEN, V115, P180, DOI 10.1007/BF01819406; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, V11, P1; MARIE MP, 1906, REV NEUROL PARIS, V14, P557; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P211; NICHOLSON GA, 1992, AM J MED GENET, V44, P455, DOI 10.1002/ajmg.1320440414; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REISECKER F, 1994, NEUROLOGY, V44, P753, DOI 10.1212/WNL.44.4.753; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SAINTON P, 1899, NOUV ICONOGRAPHIE SA, V12, P206; SCHALLER WF, 1935, REV NEUROL PARIS, V1, P529; SKRE H, 1974, CLIN GENET, V6, P98; TARASSIEWITCH IJ, 1935, REV NEUROL PARIS, V2, P18; TSUBOTA SI, 1989, GENETICS, V122, P881; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WALLIS J, 1990, HUM GENET, V85, P98; WEBER JL, 1989, AM J HUM GENET, V44, P388; WISE CA, 1993, AM J HUM GENET, V53, P853	41	64	64	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					472	476						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644705				2022-12-18	WOS:A1996TV56400004
J	SHEN, JJ; WILLIAMS, BJ; ZIPURSKY, A; DOYLE, J; SHERMAN, SL; JACOBS, PA; SHUGAR, AL; SOUKUP, SW; HASSOLD, TJ				SHEN, JJ; WILLIAMS, BJ; ZIPURSKY, A; DOYLE, J; SHERMAN, SL; JACOBS, PA; SHUGAR, AL; SOUKUP, SW; HASSOLD, TJ			CYTOGENETIC AND MOLECULAR STUDIES OF DOWN-SYNDROME INDIVIDUALS WITH LEUKEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOWN-SYNDROME; MEGAKARYOBLASTIC LEUKEMIA; NONDISJUNCTION; AMPLIFICATION; TRISOMY-21; DISEASE	There is an increased risk of leukemia in Down syndrome (DS) patients, with estimates ranging from 14 to 30 times the incidence rate observed for chromosomally normal children. Furthermore, one type of leukemia, called ''transient leukemia'' (TL), occurs almost exclusively in DS infants. The basis of the association between DS and leukemia is unknown, but we and others have hypothesized that it may be influenced by the mechanism of origin of the extra chromosome. Therefore, we initiated a cytogenetic and molecular study of nondisjunction in leukemic DS individuals. To date, we have obtained blood and/or tissue samples from 55 individuals consisting of 17 cases with TL, 7 cases of acute nonlymphocytic leukemia subtype M7 (ANLL-M7, or acute megakaryoblastic leukemia, postulated to be related to TL), and 31 cases of other forms of leukemia. Analysis of these cases suggests differences between DS children with TL and those with other types of leukemia or DS individuals with no history of leukemia. Specifically, the TL and ANLL-M7 cases have a highly significant increase in the frequency of ''atypical'' constitutional karyotypes (i.e., mosaic trisomies, rings, and/or isochromosomes) and are almost always male. Additionally, genetic mapping studies suggest an increase in the frequency of disomic homozygosity, especially in proximal 21q, in DS individuals with TL and ANLL-M7.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT HUMAN GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH; UNIV CLEVELAND HOSP,CLEVELAND,OH 44106; UNIV UTAH,SCH MED,DIV HUMAN GENET,SALT LAKE CITY,UT; EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ATLANTA,GA; SALISBURY DIST HOSP,WESSEX REG GENET LAB,SALISBURY,WILTS,ENGLAND; UNIV CINCINNATI,CINCINNATI,OH; HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,TORONTO,ON,CANADA; CINCINNATI CHILDRENS HOSP,CINCINNATI,OH	Case Western Reserve University; Case Western Reserve University; Utah System of Higher Education; University of Utah; Emory University; Salisbury District Hospital; University System of Ohio; University of Cincinnati; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Cincinnati Children's Hospital Medical Center			Shen, Joseph/AAY-5083-2020	Shen, Joseph/0000-0002-5604-7639; shugar, andrea/0000-0002-5238-921X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021341] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00080] Funding Source: Medline; NICHD NIH HHS [HD92709, HD 21341] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABE K, 1989, HUM GENET, V82, P313; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FEINGOLD E, 1995, AM J HUM GENET, V56, P475; HOOK EB, 1981, TRISOMY, V21, P3; ISELIUS L, 1990, HUM GENET, V85, P477; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; Korenberg Julie R., 1993, V384, P87; KORENBERGJR, 1994, P NATL ACAD SCI USA, V91, P4997; LORBER BJ, 1992, GENE CHROMOSOME CANC, V4, P222, DOI 10.1002/gcc.2870040306; LU GH, 1993, CANCER GENET CYTOGEN, V67, P81, DOI 10.1016/0165-4608(93)90157-H; PANGALOS C, 1994, AM J HUM GENET, V54, P473; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Sinet Pierre-Marie, 1993, V384, P63; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZIPURSKY A, 1987, PEDIATR HEMAT ONCOL, V4, P211, DOI 10.3109/08880018709141272; ZIPURSKY A, 1992, PEDIATR HEMAT ONCOL, V9, P139, DOI 10.3109/08880019209018329	19	64	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					915	925						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717402				2022-12-18	WOS:A1995QP66300013
J	TEAGUE, PW; ALDRED, MA; JAY, M; DEMPSTER, M; HARRISON, C; CAROTHERS, AD; HARDWICK, LJ; EVANS, HJ; STRAIN, L; BROCK, DJH; BUNDEY, S; JAY, B; BIRD, AC; BHATTACHARYA, SS; WRIGHT, AF				TEAGUE, PW; ALDRED, MA; JAY, M; DEMPSTER, M; HARRISON, C; CAROTHERS, AD; HARDWICK, LJ; EVANS, HJ; STRAIN, L; BROCK, DJH; BUNDEY, S; JAY, B; BIRD, AC; BHATTACHARYA, SS; WRIGHT, AF			HETEROGENEITY ANALYSIS IN 40 X-LINKED RETINITIS-PIGMENTOSA FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROXIMAL SHORT ARM; LINKAGE ANALYSIS; DINUCLEOTIDE REPEAT; CLONED DNA; LOCALIZATION; CHROMOSOME; LOCUS; XP21; MAP; POLYMORPHISMS	Analysis of genetic heterogeneity in 40 kindreds with X-linked retinitis pigmentosa (XLRP), with 20 polymorphic markers, showed that significant heterogeneity is present (P=.001) and that 56% of kindreds are of RP3 type and that 26% are of RP2 type. The location of the RP3 locus was found to be 0.4 cM distal to OTC in the Xp21.1 region, and that of the RP2 locus was 6.5 cM proximal to DXS7 in Xp11.2-p11.3. Bayesian probabilities of linkage to RP2, RP3, or to neither locus were calculated. This showed that 20 of 40 kindreds could be assigned to one or the other locus, with a probability >.70 (14 kindreds with RP3 and 6 kindreds with RP2 disease). A further three kindreds were found to be unlinked to either locus, with a probability >.8. The remaining 17 kindreds could not be classified unambiguously. This highlights the difficulty of classifying families in the presence of genetic heterogeneity, where the two loci are separated by an estimated 16 cM.	UNIV EDINBURGH, WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, WESTERN GEN HOSP, DEPT MED, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV LONDON, MOORFIELDS EYE HOSP, DEPT CLIN OPHTHALMOL, LONDON, ENGLAND; UNIV LONDON, INST OPHTHALMOL, LONDON, ENGLAND; UNIV BIRMINGHAM, BIRMINGHAM MATERNITY HOSP, DEPT CLIN GENET, BIRMINGHAM, W MIDLANDS, ENGLAND; UNIV BIRMINGHAM, BIRMINGHAM MATERNITY HOSP, DEPT OPHTHALMOL, BIRMINGHAM, W MIDLANDS, ENGLAND	University of Edinburgh; University of Edinburgh; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Birmingham; University of Birmingham			Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344				ALDRED MA, IN PRESS J MED GENET; BERGEN AAB, IN PRESS EUR J HUM G; BERTELSON CJ, 1988, AM J HUM GENET, V42, P703; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BROWNE DL, 1991, NUCLEIC ACIDS RES, V19, P1161, DOI 10.1093/nar/19.5.1161-a; BUNDEY S, 1984, J MED GENET, V21, P417, DOI 10.1136/jmg.21.6.417; CHEN JD, 1989, AM J HUM GENET, V45, P401; COLEMAN M, 1990, AM J HUM GENET, V47, P935; DAHL N, 1991, CLIN GENET, V40, P435; DAVIES KE, 1990, CYTOGENET CELL GENET, V55, P254, DOI 10.1159/000133019; DENTON MJ, 1988, HUM GENET, V78, P60, DOI 10.1007/BF00291236; DESTBASILE G, 1988, HUM GENET, V80, P85, DOI 10.1007/BF00451463; FEENER CA, 1991, AM J HUM GENET, V48, P621; FRIEDRICH U, 1985, HUM GENET, V71, P93; FRIEDRICH U, 1992, HUM GENET, V88, P683, DOI 10.1007/BF02265297; JACOBSON SG, 1992, INVEST OPHTH VIS SCI, V33, P3481; JAY M, 1982, BRIT J OPHTHALMOL, V66, P405, DOI 10.1136/bjo.66.7.405; KAPLAN J, 1992, J MED GENET, V29, P615, DOI 10.1136/jmg.29.9.615; KIRCHGESSNER CU, 1991, AM J HUM GENET, V49, P184; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAHTANI MM, 1991, GENOMICS, V10, P849, DOI 10.1016/0888-7543(91)90172-B; MUHLEBACH TJ, 1990, NUCLEIC ACIDS RES, V18, P4966, DOI 10.1093/nar/18.16.4966-a; MUSARELLA MA, 1990, GENOMICS, V8, P286, DOI 10.1016/0888-7543(90)90284-2; MUSARELLA MA, 1989, GENOMICS, V4, P601, DOI 10.1016/0888-7543(89)90285-1; MUSARELLA MA, 1988, AM J HUM GENET, V43, P484; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Ott J., 1991, ANAL HUMAN GENETIC L; VANDORP DB, 1992, HUM GENET, V88, P331, DOI 10.1007/BF00197269; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727; WRIGHT AF, 1983, T OPHTHAL SOC UK, V103, P467; WRIGHT AF, 1987, AM J HUM GENET, V41, P635; WRIGHT AF, 1991, J MED GENET, V28, P453, DOI 10.1136/jmg.28.7.453; WRIGHT AF, 1988, MOL BIOL EYE GENES V, V88, P293; WRIGHT AF, 1990, PROG RETINA RES, V9, P197	34	64	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					105	111						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023838				2022-12-18	WOS:A1994NW46100015
J	SHIMIZU, T; TOGUCHIDA, J; KATO, MV; KANEKO, A; ISHIZAKI, K; SASAKI, MS				SHIMIZU, T; TOGUCHIDA, J; KATO, MV; KANEKO, A; ISHIZAKI, K; SASAKI, MS			DETECTION OF MUTATIONS OF THE RBI GENE IN RETINOBLASTOMA PATIENTS BY USING EXON-BY-EXON PCR-SSCP ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; SUSCEPTIBILITY GENE; OSTEO-SARCOMA; DELETIONS; SEQUENCE; PROTEIN; ORGANIZATION; EXPRESSION; REGIONS; SITES	Most sporadic cases of retinoblastoma, malignant eye tumor of children, may require the identification of a mutation of the retinoblastoma gene (RB1 gene) for precise genetic counseling. We established a mutation detection system of and screened for the RB1 gene mutation in 24 patients with retinoblastoma-12 bilateral patients and 12 unilateral patients. Mutation analysis was performed by PCR-mediated SSCP analysis in the entire coding region and promoter region, as an initial screening method, followed by direct genomic sequencing. Possible oncogenic mutations were identified in 14 (58%) of 24 tumors, of which 6 were single base substitutions, 4 were small deletions, 3 were small insertions, and 1 was a complex alteration due to deletion-insertion. A constitutional somatic mosaicism was suggested in one bilateral patient. A majority (57%) of mutations were found in E1A binding domains, and all were presumed to truncate the normal gene products, The mutation analysis presented here may provide a basis for the screening system of RB1 gene mutations in retinoblastoma patients.	KYOTO CITY HOSP,DEPT ORTHOPAED SURG,KYOTO,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,ONCOL MOLEC LAB,IBARAKI,JAPAN; NATL CANC CTR,TOKYO 104,JAPAN	Kyoto City Hospital; RIKEN; National Cancer Center - Japan	SHIMIZU, T (corresponding author), KYOTO UNIV,CTR RADIAT BIOL,SAKYO KU,KYOTO 606,JAPAN.		Kato, Mitsuo/D-5411-2009	Kato, Mitsuo/0000-0002-1783-1084				BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; HOGG A, 1992, ONCOGENE, V7, P1445; HOGG A, 1993, P NATL ACAD SCI USA, V90, P7351, DOI 10.1073/pnas.90.15.7351; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; KATO MV, 1994, HUM MUTAT, V3, P44, DOI 10.1002/humu.1380030108; KATO MV, 1993, INT J CANCER, V54, P922, DOI 10.1002/ijc.2910540609; KLOSS K, 1991, AM J MED GENET, V39, P196, DOI 10.1002/ajmg.1320390215; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; REISSMANN PT, 1989, ONCOGENE, V4, P839; RIBEIRO MCM, 1988, CANCER GENET CYTOGEN, V32, P169, DOI 10.1016/0165-4608(88)90279-8; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Sambrook J., 1989, MOL CLONING LAB MANU; TANG A, 1989, ONCOGENE, V4, P401; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TOGUCHIDA J, 1993, GENOMICS, V17, P535, DOI 10.1006/geno.1993.1368; VOGEL F, 1979, HUM GENET, V52, P1; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; YOKOTA J, 1988, ONCOGENE, V3, P471; ZACKSENHAUS E, 1993, ONCOGENE, V8, P2343	32	64	69	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					793	800						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178820				2022-12-18	WOS:A1994NH39400008
J	DESMAZE, C; PRIEUR, M; AMBLARD, F; AIKEM, M; LEDEIST, F; DEMCZUK, S; ZUCMAN, J; PLOUGASTEL, B; DELATTRE, O; CROQUETTE, MF; BREVIERE, GM; HUON, C; LEMERRER, M; MATHIEU, M; SIDI, D; STEPHAN, JL; AURIAS, A				DESMAZE, C; PRIEUR, M; AMBLARD, F; AIKEM, M; LEDEIST, F; DEMCZUK, S; ZUCMAN, J; PLOUGASTEL, B; DELATTRE, O; CROQUETTE, MF; BREVIERE, GM; HUON, C; LEMERRER, M; MATHIEU, M; SIDI, D; STEPHAN, JL; AURIAS, A			PHYSICAL MAPPING BY FISH OF THE DIGEORGE CRITICAL REGION (DGCR) - INVOLVEMENT OF THE REGION IN FAMILIAL CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; AUTOSOMAL DOMINANT TRANSMISSION; CONTIGUOUS GENE SYNDROMES; PARTIAL MONOSOMY; INSITU HYBRIDIZATION; HUMAN CHROMOSOME-22; THYMIC APLASIA; DNA MARKERS; DELETIONS; 22Q11	We describe the relative ordering, by fluorescence in situ hybridization, of cosmid loci and translocation breakpoints in the DiGeorge syndrome (DGS) critical region of chromosome 22. This physical map enables us to define a large region, commonly deleted in a majority of affected patients, and the smallest deleted region which, when lost, is sufficient to produce DGS. In four instances, a similar large deleted region is observed in a familial context. In these pedigrees, the deletion is encountered in one parent with mild features of the disease.	INST CURIE, BIOL SECT, GENET TUMEURS LAB, INSERM, CJF 9201, F-75231 PARIS 05, FRANCE; INST CURIE, CNRS, URA 620, PARIS, FRANCE; HOP COCHIN, SERV MED NEONATALE, PARIS, FRANCE; HOP ENFANTS MALAD, CYTOGENET LAB, INSERM, UNITE 132, PARIS, FRANCE; HOP ENFANTS MALAD, GENET MED CLIN, PARIS, FRANCE; HOP ENFANTS MALAD, SERV CARDIOL INFANTILE, PARIS, FRANCE; HOP ENFANTS MALAD, SERV IMMUNOHEMATOL, PARIS, FRANCE; FAC MED GRENOBLE, GENET HISTOL & BIOL REPROD LAB, GRENOBLE, FRANCE; HOP ST ANTOINE, CYTOGENET LAB, LILLE, FRANCE; CHRU, SERV CARDIOL INFANTILE, LILLE, FRANCE; CHRU, SERV PEDIAT, AMIENS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens			zucman-rossi, Jessica/B-5098-2009	zucman-rossi, Jessica/0000-0002-5687-0334; delattre, olivier/0000-0002-8730-2276; Plougastel-Douglas, Beatrice/0000-0002-6389-561X; Desmaze, Chantal/0000-0003-0777-8854				AUBRY M, 1992, GENOMICS, V13, P641, DOI 10.1016/0888-7543(92)90135-F; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BACK E, 1980, ANN GENET-PARIS, V23, P244; CANNIZZARO LA, 1985, CYTOGENET CELL GENET, V39, P179, DOI 10.1159/000132131; CAREY AH, 1990, GENOMICS, V7, P299, DOI 10.1016/0888-7543(90)90161-M; COULY G, 1983, REV STOMATOL CHIR, V84, P103; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; DELATTRE O, 1991, GENOMICS, V9, P721, DOI 10.1016/0888-7543(91)90366-M; DESMAZE C, 1993, HUM GENET, V90, P663, DOI 10.1007/BF00202489; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; EMANUEL BS, 1988, AM J HUM GENET, V43, P575; FIBISON WJ, 1990, AM J HUM GENET, V46, P888; Geurts van Kessel A. H., 1980, CYTOGENET CELL GENET, V28, P169; GREENBERG F, 1988, AM J HUM GENET, V43, P605; GREENBERG F, 1984, HUM GENET, V65, P317, DOI 10.1007/BF00291554; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KELLEY RI, 1982, J PEDIATR-US, V101, P197, DOI 10.1016/S0022-3476(82)80116-9; KELLY D, 1993, AM J MED GENET, V45, P308, DOI 10.1002/ajmg.1320450306; KEPPEN LD, 1988, J PEDIATR-US, V113, P506, DOI 10.1016/S0022-3476(88)80640-1; KIRBY ML, 1984, ANAT RECORD, V209, P1, DOI 10.1002/ar.1092090102; Lammer E J, 1986, Am J Med Genet Suppl, V2, P113, DOI 10.1002/ajmg.1320250615; MULLER W, 1988, EUR J PEDIATR, V147, P496; ROHN RD, 1984, J PEDIATR-US, V105, P47, DOI 10.1016/S0022-3476(84)80355-8; ROSENTHA.IM, 1972, PEDIATR RES, V6, P358; Sambrook J., 1989, MOL CLONING LAB MANU; SCAMBLER P, 1991, 2ND INT WORKSH MAPP; SCAMBLER PJ, 1993, CURR OPIN GENET DEV, V3, P432, DOI 10.1016/0959-437X(93)90117-8; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHARKEY AM, 1992, HUM GENET, V89, P73, DOI 10.1007/BF00207046; SHPRINTZEN RJ, 1981, PEDIATRICS, V67, P167; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; STEELE RW, 1972, NEW ENGL J MED, V287, P787, DOI 10.1056/NEJM197210192871602; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VANKEUREN ML, 1987, CYTOGENET CELL GENET, V44, P142, DOI 10.1159/000132358; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q; WILSON DI, 1991, BRIT HEART J, V66, P308; ZHANG FR, 1990, GENOMICS, V7, P319, DOI 10.1016/0888-7543(90)90164-P	42	64	66	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1239	1249						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250039				2022-12-18	WOS:A1993MJ81800010
J	CUTTING, GR; CURRISTIN, SM; NASH, E; ROSENSTEIN, BJ; LERER, I; ABELIOVICH, D; HILL, A; GRAHAM, C				CUTTING, GR; CURRISTIN, SM; NASH, E; ROSENSTEIN, BJ; LERER, I; ABELIOVICH, D; HILL, A; GRAHAM, C			ANALYSIS OF 4 DIVERSE POPULATION GROUPS INDICATES THAT A SUBSET OF CYSTIC-FIBROSIS MUTATIONS OCCUR IN COMMON AMONG CAUCASIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								To determine the nature and frequency of non-DELTA-F508 cystic fibrosis (CF) mutations among diverse populations, we have sequenced exons 9-12 and 19-23 of the CF transmembrane conductance regulator (CFTR) gene from 128 CF chromosomes (39 U.S. Caucasian, 27 African-American, 42 Northern Irish, and 20 Israeli chromosomes). These regions were chosen because they encode the two putative ATP-binding folds of CFTR, domains which appear to have functional significance. In addition, CFTR exons 1 and 2 were analyzed in the American patients. Mutations were found on 49 of the 128 CF chromosomes. Nineteen different mutations were observed; six were novel, while the remaining 13 had been reported previously by our group or by other investigators. Six of nine different mutations found in African-American patients were unique to that population. However, the vast majority of the mutations found in U.S. Caucasians (eight of nine), Northern Irish (four of five), and Israelis (three of three) also occurred in other Caucasian groups. The preponderance of previously reported mutations in these three groups suggested that a subset of the non-DELTA-F508 mutations occur in common among Caucasians. A survey of mutation frequencies in other Caucasian groups confirmed this observation. Unfortunately, this subset accounts for less than half of non-DELTA-F508 CF mutations in most groups. These data suggest that screening for DELTA-F508 and this select group of mutations will efficiently and economically maximize the number of CF mutations identified in Caucasian groups. However, it will be difficult to detect more than 90% of mutant CFTR alleles except in ethnically and geographically discrete populations where CF is the result of founder effect.	JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; HADASSAH UNIV HOSP, DEPT HUMAN GENET, IL-91120 JERUSALEM, ISRAEL; BELFAST CITY HOSP, CTR REG GENET, BELFAST BT9 7AD, ANTRIM, NORTH IRELAND	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hebrew University of Jerusalem; Belfast City Hospital								ABELIOVICH D, 1991, JUL ANN M EUR SOC HU; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BEAUDET AL, 1990, AM J HUM GENET, V47, P603; BOZON D, 1991, AM J HUM GENET, V49, P400; BROCK D, 1990, AM J HUM GENET, V47, P164; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; COLTEN HR, 1990, NEW ENGL J MED, V322, P328, DOI 10.1056/NEJM199002013220510; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1989, AM J HUM GENET, V44, P307; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; CUTTING GR, 1990, PEDIATR PULM S, V5, P115; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P580; DEVOTO M, 1991, AM J HUM GENET, V48, P1127; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; FRIEDMAN KJ, 1991, CLIN CHEM, V37, P753; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; GILBERT F, 1990, AM J HUM GENET, V46, P394; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; IANNUZZI MC, 1991, AM J HUM GENET, V48, P227; IVASCHENKO TE, 1991, GENOMICS, V10, P298, DOI 10.1016/0888-7543(91)90517-I; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LERER I, 1992, J MED GENET, V29, P131, DOI 10.1136/jmg.29.2.131; MENNIE M, 1991, AM J HUM GENET, V49, P329; MULES EH, 1991, AM J HUM GENET, V48, P1181; NG ISL, 1991, HUM GENET, V87, P613; NUNES V, 1991, HUM GENET, V87, P737; OSBORNE L, 1991, AM J HUM GENET, V48, P608; REISS J, 1991, HUM GENET, V87, P457; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROZEN R, 1992, AM J MED GENET, V42, P360, DOI 10.1002/ajmg.1320420322; SATOKATA I, 1990, P NATL ACAD SCI USA, V87, P9908, DOI 10.1073/pnas.87.24.9908; SCHWARTZ M, 1991, AM J HUM GENET, V49, P330; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; SHRIMPTON AE, 1991, J MED GENET, V28, P317, DOI 10.1136/jmg.28.5.317; SU TS, 1990, J BIOL CHEM, V265, P19716; SUPER M, 1992, EUR J PEDIATR, V151, P108, DOI 10.1007/BF01958953; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WATSON EK, 1990, PEDIATR PULM S, V5, P117; WHITE MB, 1991, GENOMICS, V10, P266, DOI 10.1016/0888-7543(91)90510-L; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; 1990, NEW ENGL J MED, V323, P70	55	64	67	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1185	1194						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1376017				2022-12-18	WOS:A1992HY65400005
J	KNOLL, JHM; GLATT, KA; NICHOLLS, RD; MALCOLM, S; LALANDE, M				KNOLL, JHM; GLATT, KA; NICHOLLS, RD; MALCOLM, S; LALANDE, M			CHROMOSOME-15 UNIPARENTAL DISOMY IS NOT FREQUENT IN ANGELMAN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; HAPPY PUPPET SYNDROME; TUBEROUS SCLEROSIS; WILMS TUMOR; GENETIC-HETEROGENEITY; PARENTAL ORIGIN; DELETION; LINKAGE; 11P13; LOCUS	Genetic imprinting has been implicated in the etiology of two clinically distinct but cytogenetically indistinguishable disorders-Angelman syndrome (AS) and Parder-Willi syndrome (PWS). This hypothesis is derived from two lines of evidence. First, while the molecular extents of de novo cytogenetic deletions of chromosome 15q11q13 in AS and PWS patients are the same, the deletions originate from different parental chromosomes. In AS, the deletion occurs in the maternally inherited chromosome 15, while in PWS the deletion is found in the paternally inherited chromosome 15. The second line of evidence comes from the detection of an abnormal parental contribution of 15q11q13 in PWS patients without a cytogenetic and molecular deletion. These patients have two maternal copies and no paternal copy of 15q11q13 (maternal uniparental disomy) instead of one copy from each parent. By qualitative hybridization with chromosome 151q11q13 specific DNA markers, we have now examined DNA samples from 10 AS patients (at least seven of which are familial cases) with no cytogenetic or molecular deletion of chromosome 15q11q13. Inheritance of one maternal copy and one paternal copy of 15q11q13 was observed in each family, suggesting that paternal uniparental disomy of 15q11q13 is not responsible for expression of the AS phenotype in these patients.	CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; INST CHILD HLTH,MOTHERCARE DEPT PEDIAT GENET,LONDON WC1N 1EH,ENGLAND; UNIV FLORIDA,DEPT NEUROSCI,GAINESVILLE,FL 32611; UNIV FLORIDA,DEPT PEDIAT,GAINESVILLE,FL 32611	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of London; University College London; State University System of Florida; University of Florida; State University System of Florida; University of Florida				Knoll, Joan/0000-0001-6691-1710	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BARAITSER M, 1987, CLIN GENET, V31, P323; BUTLER MG, 1983, LANCET, V1, P1285; CATTANACH BM, INP RESS CHROMOSOMES; DONLON TA, 1988, HUM GENET, V80, P322, DOI 10.1007/BF00273644; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRELL RE, 1987, CYTOGENET CELL GENET, V46, P614; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HAINES JL, 1989, CYTOGENET CELL GENET, V51, P1010; HALL JG, 1990, AM J HUM GENET, V46, P857; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MCKUSICK VA, 1989, MENDELIAN INHERITANC; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PASHAYAN HM, 1982, AM J MED GENET, V13, P295, DOI 10.1002/ajmg.1320130311; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; RICH DC, 1988, NUCLEIC ACIDS RES, V16, P8740, DOI 10.1093/nar/16.17.8740; SAMPSON JR, 1989, CYTOGENET CELL GENET, V51, P1073; SMITH M, 1989, CYTOGENET CELL GENET, V51, P1082; SOLTER D, 1988, ANNU REV GENET, V22, P127; WILLEMS PJ, 1987, AM J MED GENET, V27, P773, DOI 10.1002/ajmg.1320270405; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313	27	64	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					16	21						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985457				2022-12-18	WOS:A1991ET18800002
J	FRANCKE, U; DARRAS, BT; ZANDER, NF; KILIMANN, MW				FRANCKE, U; DARRAS, BT; ZANDER, NF; KILIMANN, MW			ASSIGNMENT OF HUMAN GENES FOR PHOSPHORYLASE-KINASE SUBUNITS ALPHA-(PHKA) TO XQ12-Q13 AND BETA-(PHKB) TO 16Q12-Q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; RUHR UNIV BOCHUM,INST PHYSIOL CHEM,D-4630 BOCHUM,FED REP GER	Yale University; Ruhr University Bochum				Darras, Basil/0000-0002-1536-8145	NIGMS NIH HHS [GM26105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON D E, 1987, Genomics, V1, P107, DOI 10.1016/0888-7543(87)90002-4; BARTON DE, 1986, HUM GENET, V72, P221, DOI 10.1007/BF00291881; BASHAN N, 1981, PEDIATR RES, V15, P299, DOI 10.1203/00006450-198104000-00002; BROCKDORFF N, 1988, CYTOGENET CELL GENET, V48, P124, DOI 10.1159/000132605; CHAMBERLAIN JS, 1987, P NATL ACAD SCI USA, V84, P2886, DOI 10.1073/pnas.84.9.2886; COHEN PTW, 1976, EUR J BIOCHEM, V66, P347, DOI 10.1111/j.1432-1033.1976.tb10524.x; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DAVISSON MT, 1988, MOUSE NEWS LETT, V81, P12; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; EICHER EM, 1972, GENETICS, V71, P643; EISHI Y, 1985, HUM PATHOL, V16, P193, DOI 10.1016/S0046-8177(85)80071-X; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; GLASER TM, 1987, CYTOGENET CELL GENET, V46, P621; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HUIJING F, 1970, BIOCHEM GENET, V4, P187, DOI 10.1007/BF00484029; JACKSON IJ, 1987, NUCLEIC ACIDS RES, V15, P4357, DOI 10.1093/nar/15.10.4357; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; LYON JB, 1967, SCIENCE, V155, P1550, DOI 10.1126/science.155.3769.1550; LYON MF, 1988, MOUSE NEWS LETT, V81, P20; MALTHUS R, 1980, BIOCHEM J, V188, P99, DOI 10.1042/bj1880099; MIGEON BR, 1974, AM J HUM GENET, V26, P360; MIZUTA K, 1984, BIOCHEM BIOPH RES CO, V119, P582, DOI 10.1016/S0006-291X(84)80288-0; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1987, AM J HUM GENET, V40, P351; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; SCAMBLER PJ, 1987, HUM GENET, V76, P278; SCHIMKE RN, 1973, J PEDIATR-US, V83, P1031, DOI 10.1016/S0022-3476(73)80544-X; SENGUPTA B, 1987, J BIOL CHEM, V262, P16663; SERVIDEI S, 1988, J PEDIATR-US, V113, P82, DOI 10.1016/S0022-3476(88)80535-3; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; SPURR NK, 1987, ANN HUM GENET, V51, P189, DOI 10.1111/j.1469-1809.1987.tb00870.x; VARSANYI M, 1980, BIOCHEM GENET, V18, P247, DOI 10.1007/BF00484240; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929; 1988, MOUSE NEWS LETT, V80, P7; 1988, CYTOGENET CELL GENET, V49, P1; 1987, CYTOGENET CELL GENET, V46, P1	43	64	67	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					276	282						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2757032				2022-12-18	WOS:A1989AK38000010
J	LYONNET, S; CAILLAUD, C; REY, F; BERTHELON, M; FREZAL, J; REY, J; MUNNICH, A				LYONNET, S; CAILLAUD, C; REY, F; BERTHELON, M; FREZAL, J; REY, J; MUNNICH, A			MOLECULAR-GENETICS OF PHENYLKETONURIA IN MEDITERRANEAN COUNTRIES - A MUTATION ASSOCIATED WITH PARTIAL PHENYLALANINE-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											LYONNET, S (corresponding author), HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH GENET MED,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Lyonnet, Stanislas/H-5483-2017	Lyonnet, Stanislas/0000-0001-5426-9417				BAILEY JM, 1976, ANAL BIOCHEM, V70, P75, DOI 10.1016/S0003-2697(76)80049-8; BARTHOLOME K, 1975, PEDIATR RES, V9, P899, DOI 10.1203/00006450-197509120-00006; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DILELLA AG, 1985, LANCET, V1, P160; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; EFRON ML, 1967, AMINO ACID METABOLIS, P115; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; GUTHRIE R, 1968, Birth Defects Original Article Series, V4, P92; Kaufman S., 1977, ADV NEUROCHEM, V2, P1; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; MCCABE ERB, 1987, HUM GENET, V75, P213, DOI 10.1007/BF00281061; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MUNNICH A, 1982, PEDIATR RES, V16, P335, DOI 10.1203/00006450-198205000-00001; NIELSEN KH, 1969, EUR J BIOCHEM, V9, P497, DOI 10.1111/j.1432-1033.1969.tb00636.x; REY F, 1988, AM J HUM GENET, V43, P914; REY F, 1979, PEDIATR RES, V13, P21, DOI 10.1203/00006450-197901000-00005; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCRIVER CR, 1980, ANNU REV GENET, V14, P179, DOI 10.1146/annurev.ge.14.120180.001143; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	27	64	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					511	517						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2564729				2022-12-18	WOS:A1989T810900010
J	MIGEON, BR; AXELMAN, J; DEBEUR, SJ; VALLE, D; MITCHELL, GA; ROSENBAUM, KN				MIGEON, BR; AXELMAN, J; DEBEUR, SJ; VALLE, D; MITCHELL, GA; ROSENBAUM, KN			SELECTION AGAINST LETHAL ALLELES IN FEMALES HETEROZYGOUS FOR INCONTINENTIA PIGMENTI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,GENET LAB,BALTIMORE,MD 21205; CHILDRENS HOSP,NATL MED CTR,NATL MED CTR,DEPT MED GENET,WASHINGTON,DC 20010	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Children's National Health System					NICHD NIH HHS [HD 06545] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERTINI RJ, 1974, BIOCHEM GENET, V11, P397, DOI 10.1007/BF00486413; CARNEY RG, 1976, ARCH DERMATOL, V112, P535, DOI 10.1001/archderm.112.4.535; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; DANCIS J, 1968, LIFE SCI PT 1 PHYSI, V7, P587, DOI 10.1016/0024-3205(68)90079-9; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; EMMERSON BT, 1972, ANN INTERN MED, V76, P285, DOI 10.7326/0003-4819-76-2-285; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FEARON ER, 1986, NEW ENGL J MED, V315, P15, DOI 10.1056/NEJM198607033150103; GEALY WJ, 1980, LANCET, V1, P63; GILGENKRANTZ S, 1985, ANN GENET-PARIS, V28, P90; HARRIS A, 1988, CLIN GENET, V34, P1; HODGSON SV, 1985, HUM GENET, V71, P231, DOI 10.1007/BF00284581; KELLY TE, 1976, J HERED, V67, P171, DOI 10.1093/oxfordjournals.jhered.a108697; LENZ W, 1975, AM J HUM GENET, V27, P690; McKusick V. A., 1986, MENDELIAN INHERITANC; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1978, GENETIC MOSAICS CHIM, P417; NUSSBAUM RL, 1983, P NATL ACAD SCI USA, V80, P740; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; ONEILL BP, 1984, NEUROLOGY, V34, P789; PRCHAL JT, 1980, BLOOD, V56, P1048; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WETTKESCHAFER R, 1983, HUM GENET, V64, P1, DOI 10.1007/BF00289472; WIEACKER P, 1985, CLIN GENET, V28, P238; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; WOLF SF, 1984, NUCLEIC ACIDS RES, V12, P9333, DOI 10.1093/nar/12.24.9333; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759	29	64	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					100	106						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2562819				2022-12-18	WOS:A1989R559600016
J	SCHWARTZ, CE; JOHNSON, JP; HOLYCROSS, B; MANDEVILLE, TM; SEARS, TS; GRAUL, EA; CAREY, JC; SCHROER, RJ; PHELAN, MC; SZOLLAR, J; FLANNERY, DB; STEVENSON, RE				SCHWARTZ, CE; JOHNSON, JP; HOLYCROSS, B; MANDEVILLE, TM; SEARS, TS; GRAUL, EA; CAREY, JC; SCHROER, RJ; PHELAN, MC; SZOLLAR, J; FLANNERY, DB; STEVENSON, RE			DETECTION OF SUBMICROSCOPIC DELETIONS IN BAND 17P13 IN PATIENTS WITH THE MILLER-DIEKER SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP,OAKLAND,CA; UNIV UTAH,MED CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84112; E BIRMINGHAM HOSP,BIRMINGHAM B9 5ST,W MIDLANDS,ENGLAND; MED COLL GEORGIA,DEPT PEDIAT,AUGUSTA,GA 30912	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Utah System of Higher Education; University of Utah; University System of Georgia; Augusta University	SCHWARTZ, CE (corresponding author), GREENWOOD GENET CTR,ONE GREGOR MENDEL CIRCLE,GREENWOOD,SC 29646, USA.		Flannery, David/O-6719-2019					BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLOOM SE, 1976, HUM GENET, V34, P199, DOI 10.1007/BF00278889; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CAVENEE W, 1984, AM J HUM GENET, V36, P10; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; DIEKER H, 1969, Birth Defects Original Article Series, V5, P53; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; GILLIAM TC, 1984, HUM GENET, V68, P154, DOI 10.1007/BF00279306; GRAUL EA, 1985, FEB AM FED CLIN RES; HULTEN MA, 1982, ANN HUM GENET, V46, P167, DOI 10.1111/j.1469-1809.1982.tb00707.x; JONES KL, 1980, PEDIATRICS, V66, P277; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KONDOLEON S, 1987, NUCLEIC ACIDS RES, V15, P10605, DOI 10.1093/nar/15.24.10605; KRAUSS CM, 1987, NEW ENGL J MED, V317, P125, DOI 10.1056/NEJM198707163170301; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; McKusick V. A., 1986, MENDELIAN INHERITANC; MILLER JQ, 1963, NEUROLOGY, V13, P841, DOI 10.1212/WNL.13.10.841; MONACO AP, 1987, TRENDS GENET, V3, P33, DOI 10.1016/0168-9525(87)90163-6; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P782, DOI 10.1093/nar/16.2.782; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NUSSBAUM RL, 1987, P NATL ACAD SCI USA, V84, P6521, DOI 10.1073/pnas.84.18.6521; PAI GS, 1980, HUM GENET, V54, P41, DOI 10.1007/BF00279047; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PHELAN MC, 1988, AM J HUM GENET, V43; SCHWARTZ C, 1987, HUM GENET, V76, P54; SCHWARTZ CE, 1986, CYTOGENET CELL GENET, V43, P117, DOI 10.1159/000132307; SEABRIGH.M, 1971, LANCET, V2, P971; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANTUINEN P, 1986, AM J HUM GENET S, V39, pA172; VANTUINEN P, 1987, AM J HUM GENET S, V41, pA144; VISSING H, 1987, NUCLEIC ACIDS RES, V15, P1363, DOI 10.1093/nar/15.4.1363; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	42	64	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					597	604						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903661				2022-12-18	WOS:A1988Q933600005
J	PELLESTOR, F; SELE, B				PELLESTOR, F; SELE, B			ASSESSMENT OF ANEUPLOIDY IN THE HUMAN FEMALE BY USING CYTOGENETICS OF IVF FAILURES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									GRENOBLE UNIV,SCH MED,CYTOGENET & REPROD BIOL LAB,F-38700 LA TRONCHE,FRANCE	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Franche-Comte								ALFI OS, 1980, AM J HUM GENET, V32, P477; ANGELL RR, 1983, NATURE, V303, P336, DOI 10.1038/303336a0; ANGELL RR, 1986, HUM GENET, V72, P333, DOI 10.1007/BF00290960; BALKAN W, 1983, HUM GENET, V63, P345, DOI 10.1007/BF00274760; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1986, AM J HUM GENET, V38, P197; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; ELBLING L, 1985, MUTAT RES, V147, P189, DOI 10.1016/0165-1161(85)90057-3; GOSDEN RG, 1973, J REPROD FERTIL, V25, P351; HANSMANN I, 1983, MUTAT RES, V109, P99, DOI 10.1016/0027-5107(83)90099-4; HANSMANN I, 1979, CYTOGENET CELL GENET, V23, P70, DOI 10.1159/000131304; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD T, 1979, HUM GENET, V46, P285, DOI 10.1007/BF00273312; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; LOPATA A, 1980, FERTIL STERIL, V33, P12; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1984, BIOL REPROD, V31, P819, DOI 10.1095/biolreprod31.4.819; MARTIN RH, 1976, CYTOGENET CELL GENET, V17, P150, DOI 10.1159/000130707; MARTIN RH, 1986, J REPROD FERTIL, V78, P673; MATTEI JF, 1980, J MED GENET, V17, P368, DOI 10.1136/jmg.17.5.368; MICHELMANN HW, 1985, FERTIL STERIL, V43, P320; MIKAMO K, 1983, MUTAT RES, V108, P265, DOI 10.1016/0027-5107(83)90125-2; MIKKELSEN M, 1980, ANN HUM GENET, V44, P17, DOI 10.1111/j.1469-1809.1980.tb00942.x; PELLESTOR F, 1987, HUM GENET, V76, P116, DOI 10.1007/BF00284905; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; RUDAK E, 1984, FERTIL STERIL, V41, P538; SATHANANTHAN AH, 1985, GAMETE RES, V12, P237, DOI 10.1002/mrd.1120120303; SCHMIADY H, 1986, HUM GENET, V74, P441, DOI 10.1007/BF00280502; SELE B, 1985, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V14, P997; SELE B, 1985, Pathologie Biologie, V33, P875; SPIELMANN H, 1985, Journal of In Vitro Fertilization and Embryo Transfer, V2, P138, DOI 10.1007/BF01131500; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; TROCHETROVER C, 1981, REV FRANC GYNECOL OB, V76, P195; UCHIDA IA, 1979, ENVIRON HEALTH PERSP, V31, P13, DOI 10.2307/3429135; VEECK LL, 1983, FERTIL STERIL, V39, P594; WRAMSBY H, 1987, NEW ENGL J MED, V316, P121, DOI 10.1056/NEJM198701153160301; WRAMSBY H, 1982, IN VITRO FERTILIZATI, P263; WUTTKE A, 1986, 7TH INT C HUM GEN BE; YANAGIMACHI R, 1976, BIOL REPROD, V15, P471, DOI 10.1095/biolreprod15.4.471	40	64	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					274	283						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3341382				2022-12-18	WOS:A1988M313300009
J	NIGRO, JM; SCHWEINFEST, CW; RAJKOVIC, A; PAVLOVIC, J; JAMAL, S; DOTTIN, RP; HART, JT; KAMARCK, ME; RAE, PMM; CARTY, MD; MARTINDELEON, P				NIGRO, JM; SCHWEINFEST, CW; RAJKOVIC, A; PAVLOVIC, J; JAMAL, S; DOTTIN, RP; HART, JT; KAMARCK, ME; RAE, PMM; CARTY, MD; MARTINDELEON, P			CDNA CLONING AND MAPPING OF THE HUMAN CREATINE KINASE-M GENE TO 19Q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218; MOLEC DIAGNOST INC,W HAVEN,CT 06516; UNIV DELAWARE,SCH LIFE & HLTH SCI,NEWARK,DE 19716	Johns Hopkins University; University of Delaware					NIADDK NIH HHS [AM34479] Funding Source: Medline; NICHD NIH HHS [HD19040] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD019040] Funding Source: NIH RePORTER; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM034479] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENFIELD PA, 1984, J BIOL CHEM, V259, P4979; CANNIZZARO LA, 1984, CYTOGENET CELL GENET, V38, P308, DOI 10.1159/000132079; CHERN CJ, 1980, CYTOGENET CELL GENET, V27, P232, DOI 10.1159/000131491; EPPENBERGER HM, 1983, ISOZYMES CURRENT TOP, P19; FISHEL BR, 1985, DEV BIOL, V110, P369, DOI 10.1016/0012-1606(85)90096-X; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRUNBAUM BW, 1980, HDB FORENSIC INDIVID; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; Harris, 1976, HDB ENZYME ELECTROPH; INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704; KHAN PM, 1971, ARCH BIOCHEM BIOPHYS, V145, P470, DOI 10.1016/S0003-9861(71)80007-3; KIRSCH IR, 1982, SCIENCE, V216, P301, DOI 10.1126/science.6801764; KWIATKOWSKI RW, 1985, DEV BIOL, V112, P84, DOI 10.1016/0012-1606(85)90121-6; KWIATKOWSKI RW, 1984, NUCLEIC ACIDS RES, V12, P6925, DOI 10.1093/nar/12.18.6925; MARTINDELEON PA, 1985, CYTOGENET CELL GENET, V39, P87, DOI 10.1159/000132113; MCKUSICK VA, 1986, IN PRESS MENDELIAN I; MEERSON FZ, 1982, BASIC RES CARDIOL, V77, P349, DOI 10.1007/BF02005336; NICHOLS EA, 1973, J HISTOCHEM CYTOCHEM, V21, P1066, DOI 10.1177/21.12.1066; PICKERING L, 1985, P NATL ACAD SCI USA, V82, P2310, DOI 10.1073/pnas.82.8.2310; POVEY S, 1979, ANN HUM GENET, V43, P15; PUTNEY S, 1984, J BIOL CHEM, V259, P14317; REISS NA, 1981, J BIOL CHEM, V256, P5741; RYAN J, 1983, P NATL ACAD SCI-BIOL, V80, P4460, DOI 10.1073/pnas.80.14.4460; SCHWEINFEST CW, 1985, CYTOGENET CELL GENET, V40, P740; SCHWEINFEST CW, 1982, P NATL ACAD SCI-BIOL, V79, P4997, DOI 10.1073/pnas.79.16.4997; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEIRINGA B, 1985, CYTOGENET CELL GENET, V40, P777	29	64	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1987	40	2					115	125						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G7740	3031982				2022-12-18	WOS:A1987G774000004
J	LANGE, K				LANGE, K			THE AFFECTED SIB-PAIR METHOD USING IDENTITY BY STATE RELATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter											LANGE, K (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOMATH,LOS ANGELES,CA 90024, USA.							JACQUARD A, 1972, BIOMETRICS, V28, P1101, DOI 10.2307/2528643; THOMSON G, 1986, AM J HUM GENET	2	64	66	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1986	39	1					148	150						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D9615	3463205				2022-12-18	WOS:A1986D961500018
J	EDWARDS, CQ; GRIFFEN, LM; DADONE, MM; SKOLNICK, MH; KUSHNER, JP				EDWARDS, CQ; GRIFFEN, LM; DADONE, MM; SKOLNICK, MH; KUSHNER, JP			MAPPING THE LOCUS FOR HEREDITARY HEMOCHROMATOSIS - LOCALIZATION BETWEEN HLA-B AND HLA-A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,COLL MED,MED DEPT BIOPHYS & COMP,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah	EDWARDS, CQ (corresponding author), UNIV UTAH,LATTER DAY ST HOSP,MED CTR,50 N MEDICAL DR,4C-334,SALT LAKE CITY,UT 84132, USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM020630] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00064] Funding Source: Medline; NIADDK NIH HHS [AM-20630] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKKER E, 1979, CLIN GENET, V15, P198; BASSET ML, 1983, THESIS U QUEENSLAND; BASSETT ML, 1984, GASTROENTEROLOGY, V87, P628; BASSETT ML, 1979, LANCET, V2, P4; BASSETT ML, 1982, HUM GENET, V60, P352, DOI 10.1007/BF00569217; BAUR MP, 1984, HISTOCOMPATIBILITY T, P324; BEAUMONT C, 1979, NEW ENGL J MED, V301, P169, DOI 10.1056/NEJM197907263010401; BORWEIN ST, 1983, CLIN INVEST MED, V6, P171; Cartwright G E, 1978, Trans Assoc Am Physicians, V91, P273; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DAUSSET J, 1984, HISTOCOMPATIBILITY T, P22; DECASTRO JAL, 1982, P NATL ACAD SCI-BIOL, V79, P3813; EDWARDS CQ, 1977, NEW ENGL J MED, V297, P7, DOI 10.1056/NEJM197707072970102; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1981, PROG HEMATOL, V12, P43; EDWARDS CQ, 1980, HUM IMMUNOL, V1, P19, DOI 10.1016/0198-8859(80)90005-1; EDWARDS CQ, 1982, AM J HEMATOL, V13, P101, DOI 10.1002/ajh.2830130202; EDWARDS CQ, 1980, ANN INTERN MED, V93, P519, DOI 10.7326/0003-4819-93-4-519; EVANS GA, 1982, P NATL ACAD SCI-BIOL, V79, P1994, DOI 10.1073/pnas.79.6.1994; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; KRAVITZ K, 1978, GENETIC EPIDEMIOLOGY, P241; KUSHNER J, 1984, BLOOD S, V64, pA40; KUSHNER JP, 1985, GASTROENTEROLOGY, V88, P1232, DOI 10.1016/S0016-5085(85)80084-6; LIPINSKI M, 1978, TISSUE ANTIGENS, V11, P471, DOI 10.1111/j.1399-0039.1978.tb01286.x; LIPINSKI M, 1978, DIABETES METAB, V4, P109; LLOYD DA, 1978, CAN MED ASSOC J, V119, P1051; OLAISEN B, 1983, ANN HUM GENET, V47, P285, DOI 10.1111/j.1469-1809.1983.tb00998.x; OLSSON KS, 1983, ACTA MED SCAND, V213, P145; POLACEK LA, 1983, CLIN GENET, V23, P177; RAY JG, 1976, DHEW76545 PUBL, P22; RITTER B, 1984, HUM GENET, V68, P62, DOI 10.1007/BF00293874; RITTNER C, 1984, HISTOCOMPATIBILITY T, P318; SADDI R, 1974, CLIN GENET, V5, P234; Simon M, 1980, Prog Med Genet, V4, P135; SIMON M, 1979, NOUV PRESSE MED, V8, P421; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; VALBERG LS, 1976, CAN MED ASSOC J, V114, P417; VALBERG LS, 1980, GASTROENTEROLOGY, V79, P884; WEITKAMP LR, 1976, TISSUE ANTIGENS, V7, P273	40	64	63	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					805	811						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3460331				2022-12-18	WOS:A1986D392200002
J	GOEDDE, HW; AGARWAL, DP; HARADA, S; ROTHHAMMER, F; WHITTAKER, JO; LISKER, R				GOEDDE, HW; AGARWAL, DP; HARADA, S; ROTHHAMMER, F; WHITTAKER, JO; LISKER, R			ALDEHYDE DEHYDROGENASE POLYMORPHISM IN NORTH-AMERICAN, SOUTH-AMERICAN, AND MEXICAN INDIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TSUKUBA, INST COMMUNITY MED, SAKURA, IBARAKI 30031, JAPAN; UNIV CHILE, SANTIAGO, CHILE; PENN STATE UNIV, MIDDLETOWN, PA 17057 USA; INST NACL NUTR SALVADOR ZUBIRAN, MEXICO CITY 14000, DF, MEXICO	University of Tsukuba; Universidad de Chile; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	GOEDDE, HW (corresponding author), UNIV HAMBURG, INST HUMAN GENET, D-2000 HAMBURG 13, GERMANY.		Lisker, Ruben/N-3094-2013	Lisker, Ruben/0000-0003-4272-5766				AGARWAL D P, 1984, Alcohol, V1, P111, DOI 10.1016/0741-8329(84)90065-X; AGARWAL DP, 1981, ALCOHOL CLIN EXP RES, V5, P12; CZEIZEL A, UNPUB ECOGENETIC POP; Everett M.W., 1976, CROSS CULTURAL APPRO; FARRIS JJ, 1978, ALCOHOL CLIN EXP RES, V2, P77, DOI 10.1111/j.1530-0277.1978.tb04698.x; Goedde H Werner, 1983, KOREAN J GENET, V5, P88; GOEDDE HW, 1985, ALCOHOL, V2, P383, DOI 10.1016/0741-8329(85)90099-0; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; GOEDDE HW, 1980, ENZYME, V25, P281, DOI 10.1159/000459265; GOEDDE HW, 1984, HUM HERED, V34, P183, DOI 10.1159/000153459; GOEDDE HW, 1979, HUM GENET, V51, P331; GOEDDE HW, 1983, ISOZYMES-CURR T BIOL, V8, P175; GOEDDE HW, 1984, HUM GENET, V67, P343, DOI 10.1007/BF00291366; GOEDDE HW, UNPUB POPULATION GEN; HANNA JM, 1978, ALCOHOL CLIN EXP RES, V2, P89, DOI 10.1111/j.1530-0277.1978.tb04700.x; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; HARADA S, 1980, AM J HUM GENET, V32, P8; HARADA S, 1981, LANCET, V2, P982; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MIZOI Y, 1983, PHARMACOL BIOCHEM BE, V18, P127, DOI 10.1016/0091-3057(83)90159-4; NEI M, 1982, EVOLUTIONARY BIOL, P1; REED TE, 1978, ALCOHOLISM CLIN EXPT, V2, P61; REX DK, 1984, 2D C INT SOC BIOM RE, P115; WHITTAKER JO, 1979, BRIT J ALCOHOL ALCOH, V14, P140; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449; WOLFF PH, 1973, AM J HUM GENET, V25, P193; YOSHIDA A, 1984, HUM GENET, V66, P296, DOI 10.1007/BF00287631; Zegura S. L., 1985, J PACIFIC HIST CANBE, P1; ZEINER AR, 1984, 2ND C INT SOC BIOM R, P129	30	64	65	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					395	399						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3953578				2022-12-18	WOS:A1986A578100014
J	BATTISTUZZI, G; ESAN, GJF; FASUAN, FA; MODIANO, G; LUZZATTO, L				BATTISTUZZI, G; ESAN, GJF; FASUAN, FA; MODIANO, G; LUZZATTO, L			COMPARISON OF GDA AND GDB ACTIVITIES IN NIGERIANS - STUDY OF VARIATION OF G6PD ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLL HOSP IBADAN, DEPT HAEMATOL, IBADAN, NIGERIA	University of Ibadan; University College Hospital, Ibadan								AFOLAYAN A, 1971, BIOCHEMISTRY-US, V10, P415; BABALOLA O, 1972, P NATL ACAD SCI USA, V69, P946, DOI 10.1073/pnas.69.4.946; BABOLOLA AOG, IN PRESS; BATTISTUZZI G, 1974, NATURE, V251, P711, DOI 10.1038/251711a0; BIENZLE U, 1972, Z TROPENMED PARASIT, V23, P56; DAVIDSON RG, 1964, ANN HUM GENET, V28, P61, DOI 10.1111/j.1469-1809.1964.tb00460.x; Giblett ER., 1969, GENETIC MARKERS HUMA; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HARRIS H, 1975, PRINCIPLES HUMAN BIO; Long W.H., COMMUNICATION; LUZZATTO L, 1974, B WORLD HEALTH ORGAN, V50, P195; LUZZATTO L, 1973, ISRAEL J MED SCI, V9, P1484; LUZZATTO L, 1973, ISRAEL J MED SCI, V9, P1181; LUZZATTO L, 1968, NATURE, V219, P1041, DOI 10.1038/2191041a0; LUZZATTO L, 1968, J CLIN INVEST, V47, P1833, DOI 10.1172/JCI105873; LUZZATTO L, 1971, BIOCHEMISTRY-US, V10, P420, DOI 10.1021/bi00779a010; MODIANO G, 1976, GENETICALLY DETERMIN; MOTULSKY AG, 1971, ANN NY ACAD SCI, V179, P636, DOI 10.1111/j.1749-6632.1971.tb46939.x; MOTULSKY AG, 1968, HERED DISORD, P303; Mourant AE, 1976, DISTRIBUTION HUMAN B; NANCE WE, 1967, CLINICAL RESEARCH, V15, P66; PANICH V, 1973, HUMANGENETIK, V18, P39; PANICH V, 1973, GENETICS, V74, pS208; SINISCALCO M, 1966, B WORLD HEALTH ORGAN, V34, P379; STAMATOYANNOPOULOS G, 1970, AM J HUM GENET, V22, P587; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; YOSHIDA A, 1967, P NATL ACAD SCI USA, V57, P835, DOI 10.1073/pnas.57.3.835; 1967, ORG MOND SANTE    RT, V366, P1	28	64	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	1					31	36						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CU441	835573				2022-12-18	WOS:A1977CU44100004
J	PINSKY, L; MILLER, J; SHANFIELD, B; WATTERS, G; WOLFE, LS				PINSKY, L; MILLER, J; SHANFIELD, B; WATTERS, G; WOLFE, LS			GM1 GANGLIOSIDOSIS IN SKIN FIBROBLAST-CULTURE - ENZYMATIC DIFFERENCES BETWEEN TYPE-1 AND TYPE-2 AND OBSERVATIONS ON A THIRD VARIANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MCGILL UNIV, DEPT PEDIAT, MONTREAL, QUEBEC, CANADA; MCGILL UNIV, MONTREAL NEUROL INST, DONNER LAB EXPTL NEUROCHEM, MONTREAL, QUEBEC, CANADA; MCGILL UNIV, DEPT BIOL, MONTREAL, QUEBEC, CANADA; MCGILL UNIV, DEPT NEUROL, MONTREAL, QUEBEC, CANADA; JEWISH GEN HOSP, LADY DAVIS INST MED RES, CELL GENET LAB, MONTREAL, QUEBEC, CANADA	McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University								DERRY DM, 1968, NEUROLOGY, V18, P340, DOI 10.1212/WNL.18.4.340; FLUHARTY AL, 1971, BIOCHEM MED METAB B, V5, P158, DOI 10.1016/0006-2944(71)90083-4; HO MW, 1971, CLIN CHIM ACTA, V32, P443; HULTBERG B, 1969, SCAND J CLIN LAB INV, V23, P213, DOI 10.3109/00365516909077651; KABACK MM, 1973, J PEDIATR-US, V82, P1037, DOI 10.1016/S0022-3476(73)80438-X; KABACK MM, 1971, PEDIATR RES, V5, P366, DOI 10.1203/00006450-197108000-00005; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILUNSKY A, 1972, LIFE SCI 2-BIOCH GEN, V11, P1101, DOI 10.1016/0024-3205(72)90219-6; OBRIEN JS, 1972, CLIN GENET, V3, P411; OCKERMAN PA, 1968, SCAND J CLIN LAB INV, V22, P199, DOI 10.3109/00365516809166488; PINSKY L, 1970, NATURE, V228, P1093, DOI 10.1038/2281093b0; PINSKY L, 1974, PEDIATR RES, V8, P394; PINSKY L, 1972, AM J HUM GENET, V24, pA16; SHANFIELD B, 1972, CAN J GENET CYTOL, V14, P871, DOI 10.1139/g72-107; SINGER HS, 1972, PEDIATRICS, V49, P352; SINGER HS, 1972, AM J HUM GENET, V24, P454; SLOAN HR, 1969, PEDIATR RES, V3, P532, DOI 10.1203/00006450-196911000-00002; SUZUKI Y, 1971, ARCH NEUROL-CHICAGO, V24, P58, DOI 10.1001/archneur.1971.00480310086008; WANHO M, 1970, CLIN CHIM ACTA, V30, P531, DOI 10.1016/0009-8981(70)90147-6; YARBOROUGH DJ, 1967, J RETICULOENDOTH SOC, V4, P390; YOUNG E, 1972, PEDIATRICS, V50, P502	22	64	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1974	26	5					563	577						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	U0241	4420522				2022-12-18	WOS:A1974U024100003
J	TANIS, RJ; NEEL, JV; DOVEY, H; MORROW, M				TANIS, RJ; NEEL, JV; DOVEY, H; MORROW, M			GENETIC STRUCTURE OF A TRIBAL POPULATION, YANOMAMA-INDIANS .9. GENE-FREQUENCIES FOR 18 SERUM-PROTEIN AND ERYTHROCYTE ENZYME-SYSTEMS IN YANOMAMA AND 5 NEIGHBORING TRIBES - 9 NEW VARIANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,MED SCH,DEPT HUMAN GENET,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan								ARENDS T, 1964, SCIENCE, V143, P367, DOI 10.1126/science.143.3604.367; ARENDS T, 1970, AM J HUM GENET, V22, P526; ARENDS T, 1965, BRIT J HAEMATOL, V11, P350, DOI 10.1111/j.1365-2141.1965.tb06595.x; ARENDS T, 1962, 8 P C INT SOC BLOOD, P379; ARENDS T, 1964, 9 P C INT SOC BLOOD, P463; CARTER ND, 1972, AM J HUM GENET, V24, P330; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; CHEN SH, 1972, AM J HUM GENET, V24, P325; DAVIDSON RG, 1965, ANN HUM GENET, V29, P5, DOI 10.1111/j.1469-1809.1965.tb00497.x; DETTER JC, 1968, ANN HUM GENET, V31, P329, DOI 10.1111/j.1469-1809.1968.tb00565.x; FILDES RA, 1966, NATURE, V209, P261, DOI 10.1038/209261a0; GALLANGO ML, 1965, ACTA CIENT VENEZ, V16, P120; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; GIBLETT ER, 1962, PROGR MEDICAL GENETI, V2; HOPKINSON DA, 1966, ANN HUM GENET, V30, P167, DOI 10.1111/j.1469-1809.1966.tb00016.x; LEWIS WHP, 1967, NATURE, V215, P351, DOI 10.1038/215351a0; MIGLIAZZA E, 1972, THESIS U INDIANA; NEEL JV, IN PRESS; PAAR CW, 1966, NATURE LOND, V210, P487; SALZANO FM, 1972, HUM BIOL, V44, P443; SALZANO FM, 1965, AM J HUM GENET, V17, P280; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SICK K, 1967, BIOCHIM BIOPHYS ACTA, V140, P231, DOI 10.1016/0005-2795(67)90463-1; SMITHIES O, 1965, VOX SANG, V10, P359; SPIELMAN RS, IN PRESS; TASHIAN RE, 1969, BIOCHEMICAL METHODS; WARD RH, 1970, AM J HUM GENET, V22, P538; WEITKAMP LR, 1973, ANN HUM GENET, V36, P381, DOI 10.1111/j.1469-1809.1973.tb00602.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P433, DOI 10.1111/j.1469-1809.1957.tb01868.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P271, DOI 10.1111/j.1469-1809.1957.tb01401.x; WEITKAMP LR, 1968, NATURE, V217, P759, DOI 10.1038/217759a0; WEITKAMP LR, 1969, HUM HERED, V19, P159, DOI 10.1159/000152212; WEITKAMP LR, IN PRESS; [No title captured]; [No title captured]; [No title captured]	36	64	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	6					655	676						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R7135	4359275				2022-12-18	WOS:A1973R713500009
J	MORTON, NE; MIKI, C; YEE, S				MORTON, NE; MIKI, C; YEE, S			BIOASSAY OF POPULATION STRUCTURE UNDER ISOLATION BY DISTANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAILEY NTJ, 1961, INTRODUCTION MATHEMA; CAVALLISFORZA LL, 1962, USE VITAL HEALTH STA, P221; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; CROW JF, 1967, 3 P INT C HUM GEN ED, P249; FISHER RA, 1946, AM NAT, V80, P568, DOI 10.1086/281475; KIMURA M, 1964, GENETICS, V49, P561; Malecot G, 1948, MATH HEREDITE; Malecot Gustave, 1959, PUBL I STAT U PARIS, V8, P173; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1965, AM J HUM GENET, V17, P94; MORTON NE, 1962, DEPLACEMENTS HUMAINS, P185; MORTON NE, 1967, GENETICS INTERRACIAL; SUTTER J, 1962, DEPLACEMENTS HUMA ED, P185; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; YASUDA N, 1968, AM J HUM GENET, V20, P1; YASUDA N, 1966, THESIS U HAWAII; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	18	64	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	5					411	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B8383	5701613				2022-12-18	WOS:A1968B838300001
J	KNUDSON, AG; WAYNE, L; HALLETT, WY				KNUDSON, AG; WAYNE, L; HALLETT, WY			ON SELECTIVE ADVANTAGE OF CYSTIC FIBROSIS HETEROZYGOTES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DANKS DM, 1965, ANN HUM GENET, V28, P323, DOI 10.1111/j.1469-1809.1965.tb00489.x; HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714	2	64	65	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					388	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026931				2022-12-18	WOS:A19679607400003
J	WEBER, WW				WEBER, WW			SURVIVAL AND SEX RATIO IN TRISOMY 17-18	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		EDWARDS JH, 1960, LANCET, V1, P787; FERGUSONSMITH MA, 1962, LANCET, V2, P357; HOLMAN GH, 1963, NEW ENGL J MED, V268, P982, DOI 10.1056/NEJM196305022681804; LEVKOFF AH, 1964, AM J DIS CHILD, V107, P300, DOI 10.1001/archpedi.1964.02080060302015; LEWIS AJ, 1964, J PEDIATR-US, V65, P92, DOI 10.1016/S0022-3476(64)80557-6; MERRELL M, 1955, J Chronic Dis, V1, P12, DOI 10.1016/0021-9681(55)90018-7; SMITH DW, 1960, J PEDIATR-US, V57, P338, DOI 10.1016/S0022-3476(60)80241-7; TAYLOR ANGELA I., 1964, GUY S HOSP REP, V113, P231; TURNER B, 1964, J PEDIATR-US, V64, P601, DOI 10.1016/S0022-3476(64)80355-3; WAGSHALIVES R, 1963, HUMAN CHROMOSOME NEW, P12; WEBER WW, 1964, PEDIATRICS, V34, P533; YUNIS JJ, 1964, LANCET, V2, P286	12	64	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					369	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026929				2022-12-18	WOS:A19679607400001
J	BOYER, SH; RUCKNAGEL, DL; WEATHERALL, DJ; WATSONWILLIAMS, E				BOYER, SH; RUCKNAGEL, DL; WEATHERALL, DJ; WATSONWILLIAMS, E			FURTHER EVIDENCE FOR LINKAGE BETWEEN BETA AND DELTA LOCI GOVERNING HUMAN HEMOGLOBIN AND POPULATION DYNAMICS OF LINKED GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAGLIONI C, 1962, P NATL ACAD SCI USA, V48, P1880, DOI 10.1073/pnas.48.11.1880; BOYER SH, 1962, P NATL ACAD SCI USA, V48, P1868, DOI 10.1073/pnas.48.10.1868; CARLSON EA, 1959, Q REV BIOL, V34, P33, DOI 10.1086/402574; CEPPELLINI R, 1959, CIBA F S BIOCHEMISTR, P135; GLASS B, 1953, AM J HUM GENET, V5, P1; HELINSKI DR, 1962, P NATL ACAD SCI USA, V48, P173, DOI 10.1073/pnas.48.2.173; HORTON B, 1961, CLIN CHIM ACTA, V6, P246, DOI 10.1016/0009-8981(61)90091-2; HUISMAN TH, 1961, BLOOD, V17, P747, DOI 10.1182/blood.V17.6.747.747; INGRAM VM, 1961, NATURE, V190, P1079, DOI 10.1038/1901079a0; INGRAM VM, 1961, NATURE, V189, P704, DOI 10.1038/189704a0; KUNKEL HG, 1957, J CLIN INVEST, V36, P1615, DOI 10.1172/JCI103561; MARDER VJ, 1959, B JOHNS HOPKINS HOSP, V105, P77; MINNICH V, CITED INDIRECTLY; MOTULSKY AG, 1962, NATURE, V194, P607, DOI 10.1038/194607b0; MURPHY E, PERSONAL COMMUNICATI; NEEL JV, 1961, BLOOD, V18, P769, DOI 10.1182/blood.V18.6.769.769; PEARSON ES, 1958, BIOMETR TABLES ST, V1, P203; PORTER IH, TO BE PUBLISHED; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; RANNEY HM, 1963, NATURE, V197, P164, DOI 10.1038/197164a0; RIFE DC, 1954, AM J HUM GENET, V6, P26; RUCKNAGEL DONALD L., 1961, PROGR MED GENET, V1, P158; SAGER R, 1961, CELL HEREDITY; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585	24	64	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					438	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097238				2022-12-18	WOS:A19632968A00001
J	COOPER, HL; HIRSCHHORN, K				COOPER, HL; HIRSCHHORN, K			ENLARGED SATELLITES AS A FAMILIAL CHROMOSOME MARKER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUCKTON KE, PERSONAL COMMUNICATI; CHU EHY, 1959, AM J HUM GENET, V11, P63; COOPER HL, 1961, 2 INT C HUM GEN ROM; ELLIS JR, 1961, ANN HUM GENET, V25, P159, DOI 10.1111/j.1469-1809.1961.tb01514.x; FORD CE, 1960, AM J HUM GENET, V12, P104; HASTINGS J, 1961, NATURE, V192, P1214, DOI 10.1038/1921214a0; Heitz E., 1931, PLANTA, V15, P495, DOI [10.1007/BF01909065, DOI 10.1007/BF01909065]; HIRSCHFELD J, 1960, NATURE, V185, P931, DOI 10.1038/185931b0; HIRSCHHORN K, 1961, AM J MED, V31, P442, DOI 10.1016/0002-9343(61)90128-0; HIRSCHHORN K, UNPUBLISHED; HIRSCHHORN K, 1961, 2 INT C HUM GEN ROM; MILLER OJ, 1961, EUGEN QUART, V8, P23, DOI 10.1080/19485565.1961.9987458; MILLER OJ, PERSONAL COMMUNICATI; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; OHNO S, 1961, LANCET, V2, P123; STEINBERG A, 1961, AM J HUM GENET, V13, P205; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; TJIO JH, 1958, J EXP MED, V108, P259, DOI 10.1084/jem.108.2.259; TJIO JH, 1960, P NATL ACAD SCI USA, V46, P532, DOI 10.1073/pnas.46.4.532	19	64	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					107	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	13881132				2022-12-18	WOS:A19622963A00004
J	STERN, C				STERN, C			PROBLEM OF COMPLETE Y-LINKAGE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Aida T, 1921, GENETICS, V6, P554; BARRIGOZZI C, 1948, NATURE, V162, P30; BARRIGOZZI C, 1953, HEREDITY, V7, P389; BEERMANN W., 1955, BIOL ZENTRALBL, V74, P525; Brauer A, 1913, ARCH DERMATOL SYPH-G, V114, P211; Bridges CB, 1916, GENETICS, V1, P1; Bridges CB, 1916, GENETICS, V1, P107; CAINER A, 1898, ARCH PSICHIAT, V19, P447; Castle WE, 1922, SCIENCE, V55, P703, DOI 10.1126/science.55.1435.703-a; Cockayne EA, 1933, INHERITED ABNORMALIT; COOPER KW, 1956, GENETICS, V41, P242; CURTH HO, 1954, AM J HUM GENET, V6, P371; Davenport CB, 1924, ARCH SURG-CHICAGO, V8, P705, DOI 10.1001/archsurg.1924.01120060002001; DYER GS, 1846, PROVINCIAL MED SURG, P383; EICHWALD EJ, 1956, TRANSPLAN B, V3, P67; Enriques P, 1922, GENETICS, V7, P583; ENRIQUES P, 1924, EREDITA UOMO; FANTHAM H.B., 1924, S AFR J SCI, V21, P498; FOX AS, 1956, TRANSPLAN B, V3, P131; GATES R R, 1957, Acta Genet Med Gemellol (Roma), V6, P103; Gates Reginald Ruggles, 1946, HUMAN GENETICS; Gates Reginald Ruggles, 1923, HEREDITY EUGENICS; GATES RR, 1954, GENETIC LINKAGE MAN; GATES RR, 1929, HEREDITY MAN; GILCHRIST BM, 1947, HEREDITAS, V33, P175; Goldschmidt R, 1955, THEORETICAL GENETICS; Goldschmidt R. B., 1951, University of California Publications in Zoology, V55, P67; GOLDSCHMIDT RB, 1934, BIBLIOGR GENET, V1, P1; Gowen JW, 1934, GENETICS, V19, P0189; Gowen JW, 1933, P NATL ACAD SCI USA, V19, P122, DOI 10.1073/pnas.19.1.122; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; Haldane JBS, 1932, J GENET, V26, P341, DOI 10.1007/BF02984493; HANNAH A, 1951, ADV GENET, V4, P87, DOI 10.1016/S0065-2660(08)60232-1; HARMAN NB, 1910, TREASURY HUMAN INH 4, V1, P126; JUNGHANNS, 1922, DERM WSCHR, V74, P334; Key JA, 1927, J AMER MED ASSOC, V88, P1710, DOI 10.1001/jama.1927.02680480020010; Mather K, 1944, PROC R SOC SER B-BIO, V132, P308, DOI 10.1098/rspb.1944.0020; MORGAN LV, 1947, GENETICS, V32, P200; MORTON NE, 1957, AM J HUM GENET, V9, P55; ONO T, 1940, BOT MAGAZINE TOKYO, V54, P348; ONO T, 1940, BOT MAG TOKYO, V54, P225; ONO T0M0W0, 1935, SCI REPTS TOHOKU IMP UNIV SER 4, V10, P41; REED SC, 1951, AM J HUM GENET, V3, P282; Schmidt J., 1920, Copenhagen CR Lab Carlsberg, V14; Schofield R, 1921, J HERED, V12, P400, DOI 10.1093/oxfordjournals.jhered.a102132; SCHULTZ J, 1947, COLD SPRING HARB SYM, V12, P179, DOI 10.1101/SQB.1947.012.01.021; Sedgwick William, 1861, Br Foreign Med Chir Rev, V27, P477; Shen T.H., 1932, Z ZELLFORSCHUNG MIKR, V15, P547, DOI [10.1007/BF00387407, DOI 10.1007/BF00387407]; Smith EM, 1934, J AMER MED ASSOC, V102, P593; SORENSEN HR, 1953, OP EX DOM BIOL HERED, V31, P1; SPECTOR WS, 1956, HDB BIOL DATA      2, P101; Stern C., 1927, Zs indukt Abstamm u Vererblehre Berlin, V44, P187, DOI 10.1007/BF01740987; STERN C, AM J HUMAN GENET; STERN CURT, 1926, BIOL ZENTRALBL, V46, P344; STERN CURT, 1929, BIOL ZENTRALBL, V49, P261; TOMMASI C, 1907, GIORN PSYCH CLIN TEC, V35, P1; Tommasi C, 1907, ARCH PSICHIATR NEURO, V28, P60; WARMKE HE, 1946, AM J BOT, V33, P648, DOI 10.2307/2437345; Warmke HE, 1939, SCIENCE, V89, P391, DOI 10.1126/science.89.2313.391; Weiss F, 1929, J HERED, V20, P171, DOI 10.1093/oxfordjournals.jhered.a103172; WESTERGAARD M, 1948, HEREDITAS, V34, P257; WESTERGAARD M., 1940, DANSK BOT ARK, V10, P1; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249; Winge O, 1931, HEREDITAS, V15, P127; Winge O, 1922, J GENET, V12, P137, DOI 10.1007/BF02983077; Winge O, 1922, J GENET, V12, P145, DOI 10.1007/BF02983078; WINGE O, 1938, CR TRAV LAB CARLSB P, V22, P203; Yaffe S A, 1942, Can Med Assoc J, V47, P361; ZULUETA AD, 1925, REV ESPANOLA ENTOMOL, V1, P203	69	64	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	3					147	166						20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA216	13469791				2022-12-18	WOS:A1957WA21600001
J	Hillert, A; Anikster, Y; Belanger-Quintana, A; Burlina, A; Burton, BK; Carducci, C; Chiesa, AE; Christodoulou, J; Dordevic, M; Desviat, LR; Eliyahu, A; Evers, RAF; Fajkusova, L; Feillet, F; Bonfim-Freitas, PE; Gizewska, M; Gundorova, P; Karall, D; Kneller, K; Kutsev, SI; Leuzzi, V; Levy, HL; Lichter-Konecki, U; Muntau, AC; Namour, F; Oltarzewski, M; Paras, A; Perez, B; Polak, E; Polyakov, AV; Porta, F; Rohrbach, M; Scholl-Burgi, S; Specola, N; Stojiljkovic, M; Shen, N; Santana-da Silva, LC; Skouma, A; van Spronsen, F; Stoppioni, V; Thony, B; Trefz, FK; Vockley, J; Yu, YG; Zschocke, J; Hoffmann, GF; Garbade, SF; Blau, N				Hillert, Alicia; Anikster, Yair; Belanger-Quintana, Amaya; Burlina, Alberto; Burton, Barbara K.; Carducci, Carla; Chiesa, Ana E.; Christodoulou, John; Dordevic, Maja; Desviat, Lourdes R.; Eliyahu, Aviva; Evers, Roeland A. F.; Fajkusova, Lena; Feillet, Francois; Bonfim-Freitas, Pedro E.; Gizewska, Maria; Gundorova, Polina; Karall, Daniela; Kneller, Katya; Kutsev, Sergey, I; Leuzzi, Vincenzo; Levy, Harvey L.; Lichter-Konecki, Uta; Muntau, Ania C.; Namour, Fares; Oltarzewski, Mariusz; Paras, Andrea; Perez, Belen; Polak, Emil; Polyakov, Alexander, V; Porta, Francesco; Rohrbach, Marianne; Scholl-Burgi, Sabine; Specola, Norma; Stojiljkovic, Maja; Shen, Nan; Santana-da Silva, Luiz C.; Skouma, Anastasia; van Spronsen, Francjan; Stoppioni, Vera; Thony, Beat; Trefz, Friedrich K.; Vockley, Jerry; Yu, Youngguo; Zschocke, Johannes; Hoffmann, Georg F.; Garbade, Sven F.; Blau, Nenad			The Genetic Landscape and Epidemiology of Phenylketonuria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENYLALANINE-HYDROXYLASE DEFICIENCY; GENOTYPE-PHENOTYPE CORRELATIONS; MOLECULAR CHARACTERIZATION; PAH GENE; MUTATIONS; HYPERPHENYLALANINEMIA; DIAGNOSIS; PATIENT; ORIGINS; STATE	Phenylketonuria (PKU), caused by variants in the phenylalanine hydroxylase (PAH) gene, is the most common autosomal-recessive Mendelian phenotype of amino acid metabolism. We estimated that globally 0.45 million individuals have PKU, with global prevalence 1:23,930 live births (range 1:4,500 [Italy]-1:125,000 [Japan]). Comparing genotypes and metabolic phenotypes from 16,092 affected subjects revealed differences in disease severity in 51 countries from 17 world regions, with the global phenotype distribution of 62% classic PKU, 22% mild PKU, and 16% mild hyperphenylalaninemia. A gradient in genotype and phenotype distribution exists across Europe, from classic PKU in the east to mild PKU in the southwest and mild hyperphenylalaninemia in the south. The c.1241A>G (p.Tyr414Cys)-associated genotype can be traced from Northern to Western Europe, from Sweden via Norway, to Denmark, to the Netherlands. The frequency of classic PKU increases from Europe (56%) via Middle East (71%) to Australia (80%). Of 758 PAH variants, c.1222C>T (p.Arg408Trp) (22.2%), c.1066-11G>A (IVS10-11G>A) (6.4%), and c.782G>A (p.Arg261Gln) (5.5%) were most common and responsible for two prevalent genotypes: p.[Arg408Trp];[Arg408Trp] (11.4%) and c.[1066-11G>A];[1066-11G>A] (2.6%). Most genotypes (73%) were compound heterozygous, 27% were homozygous, and 55% of 3,659 different genotypes occurred in only a single individual. PAH variants were scored using an allelic phenotype value and correlated with pre-treatment blood phenylalanine concentrations (n = 6,115) and tetrahydrobiopterin loading test results (n = 4,381), enabling prediction of both a genotype-based phenotype (88%) and tetrahydrobiopterin responsiveness (83%). This study shows that large genotype databases enable accurate phenotype prediction, allowing appropriate targeting of therapies to optimize clinical outcome.	[Hillert, Alicia; Trefz, Friedrich K.; Hoffmann, Georg F.; Garbade, Sven F.; Blau, Nenad] Univ Hosp Heidelberg, Ctr Child & Adolescent Med, Div Child Neurol & Metab Med, Clin 1, D-69120 Heidelberg, Germany; [Anikster, Yair; Eliyahu, Aviva; Kneller, Katya] Tel Aviv Univ, Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Metab Dis Unit, IL-52621 Tel Aviv, Israel; [Belanger-Quintana, Amaya] Hosp Ramon & Cajal, Serv Pediat, Unidad Enfermedades Metab, Madrid 28034, Spain; [Burlina, Alberto] Univ Hosp, Dept Womans & Childs Hlth, Div Inherited Metab Dis, I-35129 Padua, Italy; [Burton, Barbara K.; Paras, Andrea] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Carducci, Carla] Sapienza Univ Rome, Dept Expt Med, I-00185 Rome, Italy; [Chiesa, Ana E.] Fdn Endocrinol Infantil FEI, C1425, Buenos Aires, DF, Argentina; [Christodoulou, John] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Christodoulou, John] Univ Melbourne, Dept Pediat, Melbourne, Vic 3052, Australia; [Dordevic, Maja] Inst Mother & Child Healthcare Dr Vukan Cupic, Belgrade 11000, Serbia; [Desviat, Lourdes R.; Perez, Belen] Univ Autonoma Madrid, Ctr Diagnost Enfermedades Mol, Ctr Biol Mol CSIC UAM, IdiPAz,CIBERER, Madrid 28049, Spain; [Evers, Roeland A. F.; van Spronsen, Francjan] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, NL-9712 CP Groningen, Netherlands; [Fajkusova, Lena] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Brno 62500, Czech Republic; [Feillet, Francois; Namour, Fares] Univ Hosp Nancy, Reference Ctr Inherited Metab Dis, F-54511 Vandoeuvre Les Nancy, France; [Bonfim-Freitas, Pedro E.; Santana-da Silva, Luiz C.] Fed Univ Para, Inst Biol Sci, Lab Inborn Errors Metab, BR-66075110 Belem, Para, Brazil; [Gizewska, Maria] Pomeranian Med Univ, Dept Pediat Endocrinol Diabetol Metab Dis & Cardi, PL-71252 Szczecin, Poland; [Gundorova, Polina; Kutsev, Sergey, I; Polyakov, Alexander, V] Res Ctr Med Genet, Moscow 115522, Russia; [Karall, Daniela; Scholl-Burgi, Sabine] Med Univ Innsbruck, Div Inherited Metab Disorders, Clin Pediat, A-6020 Innsbruck, Austria; [Leuzzi, Vincenzo] Sapienza Univ Rome, Dept Human Neurosci, I-00185 Rome, Italy; [Levy, Harvey L.] Harvard Med Sch, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Lichter-Konecki, Uta; Vockley, Jerry] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Muntau, Ania C.] Univ Med Ctr Hamburg Eppendorf, Univ Childrens Hosp, D-20246 Hamburg, Germany; [Oltarzewski, Mariusz] Inst Mother & Child Hlth, Dept Screening & Metab Diagnost, PL-01211 Warsaw, Poland; [Polak, Emil] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava 84215 4, Slovakia; [Porta, Francesco] AOU Citta Salute & Sci Torino, Dept Pediat, I-10126 Turin, Italy; [Rohrbach, Marianne; Thony, Beat; Blau, Nenad] Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland; [Specola, Norma] Hosp Ninos Sor Ludovica La Plata, Unidad Metab, RA-1904 Buenos Aires, DF, Argentina; [Stojiljkovic, Maja] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade 11000, Serbia; [Shen, Nan] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Infect Dis, Shanghai 2000025, Peoples R China; [Skouma, Anastasia] Inst Child Hlth, Athens 11526, Greece; [Stoppioni, Vera] Azienda Osped Osped Riuniti Marche Nord, Ctr Screening Neonatale Reg Marche, I-61032 Fano, Italy; [Yu, Youngguo] Shanghai Jiao Tong Univ, Xinhua Hosp, Shanghai Inst Pediat Res, Dept Pediat Endocrinol Genet,Sch Med, Shanghai 2000025, Peoples R China; [Zschocke, Johannes] Med Univ Innsbruck, Inst Human Genet, A-6020 Innsbruck, Austria	Ruprecht Karls University Heidelberg; Chaim Sheba Medical Center; Tel Aviv University; Hospital Universitario Ramon y Cajal; University of Padua; Azienda Ospedaliera - Universita di Padova; Ann & Robert H. Lurie Children's Hospital of Chicago; Sapienza University Rome; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); University of Groningen; University Hospital Brno; CHU de Nancy; Universite de Lorraine; Universidade Federal do Para; Pomeranian Medical University; Research Centre for Medical Genetics; Medical University of Innsbruck; Sapienza University Rome; Harvard University; Boston Children's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Comenius University Bratislava; A.O.U. Citta della Salute e della Scienza di Torino; University Children's Hospital Zurich; University of Belgrade; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Medical University of Innsbruck	Garbade, SF; Blau, N (corresponding author), Univ Hosp Heidelberg, Ctr Child & Adolescent Med, Div Child Neurol & Metab Med, Clin 1, D-69120 Heidelberg, Germany.; Blau, N (corresponding author), Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland.	sven.garbade@med.uni-heidelberg.de; nenad.blau@kispi.uzh.ch	Shen, Nan/AGK-6807-2022; burlina, alberto/AHE-6095-2022; Garbade, Sven F/S-2804-2016; Garbade, Sven Friedrich/HGA-2325-2022; Belanger-Quintana, Amaya/ABC-9643-2021; Santana-da-Silva, Luiz Carlosa LCSS/A-9195-2018; da+Silva, Luiz/AAN-6132-2021; Kutsev, Sergey I/L-3633-2018; Zschocke, Johannes/C-5885-2013; Thony, Beat/J-9895-2014; DESVIAT, LOURDES R/L-3055-2013; Gizewska, Maria/B-3020-2015	Garbade, Sven F/0000-0002-7420-4757; Kutsev, Sergey I/0000-0002-3133-8018; Zschocke, Johannes/0000-0002-0046-8274; Thony, Beat/0000-0002-5001-086X; Scholl-Burgi, Sabine/0000-0002-2529-4231; Gundorova, Polina/0000-0001-8703-7997; Evers, Roeland/0000-0003-1697-3571; Rohrbach, Marianne/0000-0002-4013-6012; DESVIAT, LOURDES R/0000-0003-0492-3323; Gizewska, Maria/0000-0001-8433-0864	Fundacion Isabel Gemio-Fundacion La Caixa [LCF/PR/PR16/11110018]; Regional Government of Madrid [B2017/BMD3721]; NIH, United States [R01DK117916, R01NR016991]; Victorian Government's Operational Infrastructure Support Program; Dietmar Hopp Foundation, St. Leon-Rot	Fundacion Isabel Gemio-Fundacion La Caixa; Regional Government of Madrid; NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; Dietmar Hopp Foundation, St. Leon-Rot	We are indebted to Suha Daas, who works at the National Newborn screening Program, Ministry of Health, Tel Hashomer Israel for her help and analyses. Farrah Rajabi, Fran Rohr, AnnWessel, Leslie Martell, Steven Dobrowolski, Per Guldberg, and the late Flemming Guttler were greatly responsible for the data from New England. This work was funded in part by the Fundacion Isabel Gemio-Fundacion La Caixa (LCF/PR/PR16/11110018), the Regional Government of Madrid (CAM, B2017/BMD3721), and by NIH, United States grants R01DK117916 and R01NR016991. The research conducted at the Murdoch Children's Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program. The work of G.F.H. on newborn screening has been generously supported by the Dietmar Hopp Foundation, St. Leon-Rot.	Bik-Multanowski M, 2013, ACTA BIOCHIM POL, V60, P613; Blau N, 2015, EXPERT OPIN PHARMACO, V16, P791, DOI 10.1517/14656566.2015.1013030; Blau N, 2014, EXPERT REV MOL DIAGN, V14, P655, DOI 10.1586/14737159.2014.923760; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Camp KM, 2014, MOL GENET METAB, V112, P87, DOI 10.1016/j.ymgme.2014.02.013; Danecka MK, 2015, J MED GENET, V52, P175, DOI 10.1136/jmedgenet-2014-102621; DESVIAT LR, 1995, AM J HUM GENET, V57, P337; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; El-Metwally A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7697210; Ellingsen S, 1997, HUM MUTAT, V9, P88, DOI 10.1002/(SICI)1098-1004(1997)9:1<88::AID-HUMU21>3.3.CO;2-R; Evers RAF, 2020, J INHERIT METAB DIS, V43, P244, DOI 10.1002/jimd.12173; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Garbade SF, 2019, GENET MED, V21, P580, DOI 10.1038/s41436-018-0081-x; GULDBERG P, 1995, J MED GENET, V32, P976, DOI 10.1136/jmg.32.12.976; Gundorova P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211048; Gundorova P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201489; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; GUTTLER F, 1993, J INHERIT METAB DIS, V16, P602, DOI 10.1007/BF00711693; Hennermann J. B., 2002, Journal of Inherited Metabolic Disease, V25, P21; Himmelreich N, 2018, MOL GENET METAB, V125, P86, DOI 10.1016/j.ymgme.2018.06.011; HOFMAN KJ, 1991, AM J HUM GENET, V48, P791; KADASI L, 1995, HUM GENET, V95, P112, DOI 10.1007/BF00225087; Kleiman Sandra, 1994, European Journal of Human Genetics, V2, P24; KONECKI DS, 1991, HUM GENET, V87, P389; Krawczak M, 2003, HUM MUTAT, V21, P394, DOI 10.1002/humu.10205; Li N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15769; Lillevali H, 2018, JIMD REP, V40, P39, DOI 10.1007/8904_2017_61; MATALON R, 1991, CLIN BIOCHEM, V24, P337, DOI 10.1016/0009-9120(91)80008-Q; Muntau AC, 2019, MOL GENET METAB, V127, P1, DOI 10.1016/j.ymgme.2019.04.004; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; Okano Y, 2011, J HUM GENET, V56, P306, DOI 10.1038/jhg.2011.10; Rajabi F, 2019, MOL GENET METAB, V128, P415, DOI 10.1016/j.ymgme.2019.09.004; Reblova K, 2013, CLIN CHIM ACTA, V419, P1, DOI 10.1016/j.cca.2013.01.006; Saadallah AA, 2007, J INHERIT METAB DIS, V30, P482, DOI 10.1007/s10545-007-0660-5; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Shen N, 2016, MOL GENET METAB, V117, P328, DOI 10.1016/j.ymgme.2016.01.004; Shoraka Hamid Reza, 2020, Clin Exp Pediatr, V63, P34, DOI 10.3345/kjp.2019.00465; Sterl E, 2013, J INHERIT METAB DIS, V36, P7, DOI 10.1007/s10545-012-9485-y; United States Census Bureau, OVERVIEW RACE HISPAN; van Spronsen FJ, 2017, LANCET DIABETES ENDO, V5, P743, DOI 10.1016/S2213-8587(16)30320-5; Vela-Amieva M, 2015, CLIN GENET, V88, P62, DOI 10.1111/cge.12444; Vockley J, 2014, GENET MED, V16, P188, DOI 10.1038/gim.2013.157; Xiang LC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031474; Zschocke J, 1997, HUM GENET, V100, P189, DOI 10.1007/s004390050488; Zschocke J, 2003, HUM MUTAT, V21, P345, DOI 10.1002/humu.10192; Zschocke J, 1999, HUM GENET, V104, P390, DOI 10.1007/s004390050973; Zschocke J, 2008, J INHERIT METAB DIS, V31, P599, DOI 10.1007/s10545-008-1016-5	48	63	64	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2020	107	2					234	250		10.1016/j.ajhg.2020.06.006	http://dx.doi.org/10.1016/j.ajhg.2020.06.006			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MY5YF	32668217	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-18	WOS:000558491800006
J	Han, DSC; Ni, M; Chan, RWY; Chan, VWH; Lui, KO; Chiu, RWK; Lo, YMD				Han, Diana S. C.; Ni, Meng; Chan, Rebecca W. Y.; Chan, Vicken W. H.; Lui, Kathy O.; Chiu, Rossa W. K.; Lo, Y. M. Dennis			The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASPASE-ACTIVATED DNASE; TEMPERATURE INDUCED APOPTOSIS; NUCLEASES; ENDONUCLEASE; CHROMATIN; HEPARIN; PLASMA; FETAL	Cell-freeDNA(cf.DNA) is a powerful noninvasive biomarker for cancer and prenatal testing, and it circulates in plasma as short fragments. To elucidate the biology of cf.DNA fragmentation, we explored the roles of deoxyribonuclease 1 (DNASE1), deoxyribonuclease 1 like 3 (DNASE1L3), and DNA fragmentation factor subunit beta (DFFB) with mice deficient in each of these nucleases. By analyzing the ends of cf.DNAfragments in each type of nuclease-deficient mice with those in wild-type mice, we show that each nuclease has a specific cutting preference that reveals the stepwise process of cf.DNA fragmentation. Essentially, we demonstrate that cf.DNA is generated first intracellularly with DFFB, intracellular DNASE1L3, and other nucleases. Then, cf.DNA fragmentation continues extracellularly with circulating DNASE1L3 and DNASE1. With the use of heparin to disrupt the nucleosomal structure, we also show that the 10 bp periodicity originates from the cutting of DNA within an intact nucleosomal structure. Altogether, this work establishes a model of cf.DNA fragmentation.	[Han, Diana S. C.; Ni, Meng; Chan, Rebecca W. Y.; Chan, Vicken W. H.; Lui, Kathy O.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Han, Diana S. C.; Ni, Meng; Chan, Rebecca W. Y.; Chan, Vicken W. H.; Lui, Kathy O.; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.; Lo, YMD (corresponding author), Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Lui, Kathy/AAC-8303-2020; Chan, Rebecca/GVR-9119-2022; Han, Diana SC/D-7252-2019	Lui, Kathy/0000-0002-1616-3643; Han, Diana SC/0000-0003-1137-3446; Chan, Rebecca/0000-0002-5202-4210	Research Grants Council of the Hong Kong Special Administrative Region (SAR) Government [T12-403/15-N, T12-401/16-W]; Chinese University of Hong Kong [VCF2014021]; Li Ka Shing Foundation; Grail	Research Grants Council of the Hong Kong Special Administrative Region (SAR) Government; Chinese University of Hong Kong(Chinese University of Hong Kong); Li Ka Shing Foundation; Grail	This work was supported by the Research Grants Council of the Hong Kong Special Administrative Region (SAR) Government under the theme-based research scheme (T12-403/15-N, T12-401/16-W), by a collaborative research agreement from Grail, and by the Vice Chancellor's One-Off Discretionary Fund of The Chinese University of Hong Kong (VCF2014021). Y.M.D.L. is supported by an endowed chair from the Li Ka Shing Foundation.	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; [Anonymous], 2002, INT J TOXICOL, V21, P95, DOI 10.1080/10915810290096522; Bergman M, 2003, INT J HEMATOL, V77, P351, DOI 10.1007/BF02982642; Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698; Chan KCA, 2017, NEW ENGL J MED, V377, P513, DOI [10.1056/NEJMoa1701717, 10.1056/nejmoa1701717]; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; Cheng THT, 2018, CLIN CHEM, V64, P406, DOI 10.1373/clinchem.2017.280446; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Errami Y, 2013, J BIOL CHEM, V288, P3460, DOI 10.1074/jbc.M112.423061; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Ivanov M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S13-S1; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; KLUG A, 1981, NUCLEIC ACIDS RES, V9, P4267, DOI 10.1093/nar/9.17.4267; Koyama R, 2016, GENES CELLS, V21, P1150, DOI 10.1111/gtc.12433; KRISHNAMURTI C, 1980, CANCER RES, V40, P4092; Larsen BD, 2017, FEBS J, V284, P1160, DOI 10.1111/febs.13970; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li Ruiqiang, 2009, SOAP2; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Manaster J, 1996, BRIT J HAEMATOL, V94, P48, DOI 10.1046/j.1365-2141.1996.6202063.x; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Napirei M, 2005, BIOCHEM J, V389, P355, DOI 10.1042/BJ20042124; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; Ozcakar ZB, 2013, ARTHRITIS RHEUM-US, V65, P2183, DOI 10.1002/art.38010; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinlan AR, 2010, BEDTOOLS V2 27 1; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Serpas L, 2019, P NATL ACAD SCI USA, V116, P641, DOI 10.1073/pnas.1815031116; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimura M, 1998, CANCER LETT, V132, P7, DOI 10.1016/S0304-3835(98)00116-5; Shimura M, 1997, FEBS LETT, V417, P379, DOI 10.1016/S0014-5793(97)01327-6; Sisirak V, 2016, CELL, V166, P88, DOI 10.1016/j.cell.2016.05.034; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sun K, 2019, GENOME RES, V29, P418, DOI 10.1101/gr.242719.118; VILLEPONTEAU B, 1992, BIOCHEM J, V288, P953, DOI 10.1042/bj2880953; Watanabe T, 2019, BIOCHEM BIOPH RES CO, V516, P790, DOI 10.1016/j.bbrc.2019.06.069; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	44	63	66	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2020	106	2					202	214		10.1016/j.ajhg.2020.01.008	http://dx.doi.org/10.1016/j.ajhg.2020.01.008			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK7IW	32004449	hybrid, Green Published			2022-12-18	WOS:000512913300006
J	Zouk, H; Venner, E; Muzny, DM; Lennon, NJ; Rehm, HL; Gibbs, RA; Walker, K; Gordon, AS; Bowser, M; Harden, MV; Chiang, T; Hynes, ED; Hu, JH; Lebo, MS; Macbeth, A; Mahanta, L; Wu, TJ; Jarvik, GP; Funke, B; Leduc, M; Kudalkar, E; Babb, LJ; Murugan, M; Ames, DC; Graham, C; Aronson, S; Lin, CF; Scherer, S; Jiang, YY; Witkowski, L; Yang, YP; Murdock, DR; Eng, CM; Varugheese, M; Leslie, ND; Myers, MF; Prows, CA; Chung, W; Fasel, D; Marasa, M; Rasouly, HM; Weng, CH; Wynn, J; Kelly, MA; Williams, MS; Larson, EB; Leppig, KA; Ralston, JD; Kochan, DC; Kullo, IJ; Lindor, NM; Lammers, P; Singh, R; Smoot, DT; Hoell, C; Rasmussen-Torvik, LJ; Smith, ME; Green, RC; Smoller, JW; Peterson, JF; Van Driest, SL; Wells, QS; Wiesner, GL; Hu, JH; Kalla, SE; Raj, R; Foster, A; Balasubramanian, A; Muniz, J; Denson, S; Chandanavelli, G; Liu, W; Mahadeshwar, H; Vargas, SM; Zhang, L; Liu, XP; Wang, QY; Jayaseelan, JC; Kalra, D; Riza, B; De La Cruz, J; Wang, LW; Korchina, V; Kovar, C; Jiang, YY; Yang, YP; Yi, V; Muru, M; Baxter, S; Brodeur, W; Dodge, S; Dunlea, P; Friedrich, C; DeSmet, T; Dinsmore, MJ; Fleharty, M; Lyon, H; Meldrim, J; Mullen, TE; Onofrio, RC; Slowik, K; Vicente, G; Wilson, MW; Woolf, B; Gabriel, S; Basford, M; City, B; Crosslin, DR; Howell, KM; Linder, JE; Stanaway, IB; Woods, LA; Rehm, H; Overby-Taylor, C; Puckelwartz, MJ; Sleiman, PMA; Hakonarson, H; Rasmussen-Torvik, L; Hripcsak, G; Wei, WQ; Weng, CH; Holm, I; Chisholm, RL; Adunyah, SE; Denny, JC; Gharavi, A; Harley, J; Karlson, EW; Murphy, S; Roden, DM; Ritchie, MD; Sharp, RR; Weng, CH; Weiss, ST; Li, RL; Wiley, KL; Dayal, J; Jose, S; Manolio, T; Abrams, D; Albertson-Junkans, L; Almoguera, B; Appelbaum, P; Aufox, S; Bangash, H; Bastarache, L; Behr, M; Benoit, B; Bhoj, E; Bielinski, SJ; Bland, ST; Blout, C; Bottinger, EP; Brand, H; Brilliant, M; Caraballo, P; Carrell, DS; Carroll, A; Castillo, L; Castro, V; Christensen, KD; Chute, CG; Cobb, BL; Connolly, JJ; Crane, P; Crew, K; De Andrade, M; Dikilitas, O; Edwards, TL; Fedotov, A; Feng, QP; Freimuth, R; Fullerton, SM; Gainer, V; Hayes, MG; Glazer, AM; Glessner, JT; Goehringer, J; Gundelach, JH; Hain, HS; Harr, M; Hartzler, A; Hebbring, S; Henrikson, N; Hershey, A; Joo, YY; Josyula, NS; Justice, AE; Keating, BJ; Kenny, EE; Key, D; Kiryluk, K; Kitchner, T; Klee, E; Kottyan, L; Lee, MT; Liang, WH; Lingren, T; Linneman, JG; Liu, C; Lynch, J; Malin, B; Marsolo, K; McGowan, ML; McNally, E; Mentch, F; Mosley, J; Mukherjee, S; Namjou, B; Ni, YZ; Obeng, AO; Person, TN; Petukhova, L; Pisieczko, CJ; Pratap, S; Rahm, AK; Ramaprasan, A; Ramirez, A; Rasmussen, L; Raychaudhuri, S; Rives, C; Rosenthal, EA; Santani, A; Schaid, D; Scott, S; Scrol, A; Sengupta, S; Shang, N; Sharma, H; Smith, JC; Sohn, S; Starren, J; Stroud, M; Su, J; Tolwinski, K; Veenstra, D; Verbitsky, M; Wagner, M; Walunas, T; White, PS; Williams, JL; Zhang, G				Zouk, Hana; Venner, Eric; Muzny, Donna M.; Lennon, Niall J.; Rehm, Heidi L.; Gibbs, Richard A.; Walker, Kimberly; Gordon, Adam S.; Bowser, Mark; Harden, Maegan, V; Chiang, Theodore; Hynes, Elizabeth D.; Hu, Jianhong; Lebo, Matthew S.; Macbeth, Alyssa; Mahanta, Lisa; Wu, Tsung-Jung; Jarvik, Gail P.; Funke, Birgit; Leduc, Magalie; Kudalkar, Emily; Babb, Lawrence J.; Murugan, Mullai; Ames, Darren C.; Graham, Chet; Aronson, Samuel; Lin, Chiao-Feng; Scherer, Steven; Jiang, Yunyun; Witkowski, Leora; Yang, Yaping; Murdock, David R.; Eng, Christine M.; Varugheese, Matthew; Leslie, Nancy D.; Myers, Melanie F.; Prows, Cynthia A.; Chung, Wendy; Fasel, David; Marasa, Maddalena; Rasouly, Hila Milo; Weng, Chunhua; Wynn, Julia; Kelly, Melissa A.; Williams, Marc S.; Larson, Eric B.; Leppig, Kathleen A.; Ralston, James D.; Kochan, David C.; Kullo, Iftikhar J.; Lindor, Noralane M.; Lammers, Philip; Singh, Rajbir; Smoot, Duane T.; Hoell, Christin; Rasmussen-Torvik, Laura J.; Smith, Maureen E.; Green, Robert C.; Smoller, Jordan W.; Peterson, Josh F.; Van Driest, Sara L.; Wells, Quinn S.; Wiesner, Georgia L.; Hu, Jianhong; Kalla, Sara E.; Raj, Ritika; Foster, Andrea; Balasubramanian, Adithya; Muniz, Jesse; Denson, Shawn; Chandanavelli, Gauthami; Liu, Wen; Mahadeshwar, Harshad; Vargas, Sean M.; Zhang, Lan; Liu, Xiuping; Wang, Qiaoyan; Jayaseelan, Joy C.; Kalra, Divya; Riza, Beenish; De La Cruz, Jessica; Wang, Liwen; Korchina, Viktoriya; Kovar, Christie; Jiang, Yunyun; Yang, Yaping; Yi, Victoria; Muru, Mullai; Baxter, Samantha; Brodeur, Wendy; Dodge, Sheila; Dunlea, Phil; Friedrich, Christopher; DeSmet, Tim; Dinsmore, Michael J.; Fleharty, Mark; Lyon, Hayley; Meldrim, Jim; Mullen, Thomas E.; Onofrio, Robert C.; Slowik, Kara; Vicente, Gina; Wilson, Michael W.; Woolf, Betty; Gabriel, Stacey; Basford, Melissa; City, Brittany; Crosslin, David R.; Howell, Kayla M.; Linder, Jodell E.; Stanaway, Ian B.; Woods, Laura A.; Rehm, Heidi; Overby-Taylor, Casey; Puckelwartz, Megan J.; Sleiman, Patrick M. A.; Hakonarson, Hakon; Rasmussen-Torvik, Laura; Hripcsak, George; Wei, Wei-Qi; Weng, Chunhua; Holm, Ingrid; Chisholm, Rex L.; Adunyah, Samuel E.; Denny, Josh C.; Gharavi, Ali; Harley, John; Karlson, Elizabeth W.; Murphy, Shawn; Roden, Dan M.; Ritchie, Marylyn D.; Sharp, Richard R.; Weng, Chunhua; Weiss, Scott T.; Li, Rongling; Wiley, Ken L., Jr.; Dayal, Jyoti; Jose, Sheethal; Manolio, Teri; Abrams, Debra; Albertson-Junkans, Ladia; Almoguera, Berta; Appelbaum, Paul; Aufox, Sharon; Bangash, Hana; Bastarache, Lisa; Behr, Meckenzie; Benoit, Barbara; Bhoj, Elizabeth; Bielinski, Suzette J.; Bland, Sarah T.; Blout, Carrie; Bottinger, Erwin P.; Brand, Harrison; Brilliant, Murray; Caraballo, Pedro; Carrell, David S.; Carroll, Andrew; Castillo, Lisa; Castro, Victor; Christensen, Kurt D.; Chute, Christopher G.; Cobb, Beth L.; Connolly, John J.; Crane, Paul; Crew, Katherine; De Andrade, Mariza; Dikilitas, Ozan; Edwards, Todd L.; Fedotov, Alex; Feng, Qiping; Freimuth, Robert; Fullerton, Stephanie M.; Gainer, Vivian; Hayes, M. Geoffrey; Glazer, Andrew M.; Glessner, Joseph T.; Goehringer, Jessica; Gundelach, Justin H.; Hain, Heather S.; Harr, Margaret; Hartzler, Andrea; Hebbring, Scott; Henrikson, Nora; Hershey, Andrew; Joo, Yoonjung Yoonie; Josyula, Navya Shilpa; Justice, Anne E.; Keating, Brendan J.; Kenny, Eimear E.; Key, Dustin; Kiryluk, Krzysztof; Kitchner, Terrie; Klee, Eric; Kottyan, Leah; Lee, Ming Ta (Michael); Liang, Wayne H.; Lingren, Todd; Linneman, James G.; Liu, Cong; Lynch, John; Malin, Bradley; Marsolo, Keith; McGowan, Michelle L.; McNally, Elizabeth; Mentch, Frank; Mosley, Jonathan; Mukherjee, Shubhabrata; Namjou, Bahram; Ni, Yizhao; Obeng, Aniwaa Owusu; Person, Thomas N.; Petukhova, Lynn; Pisieczko, Cassandra J.; Pratap, Siddharth; Rahm, Alanna Kulchak; Ramaprasan, Arvind; Ramirez, Andrea; Rasmussen, Luke; Raychaudhuri, Soumya; Rives, Catherine; Rosenthal, Elisabeth A.; Santani, Avni; Schaid, Dan; Scott, Stuart; Scrol, Aaron; Sengupta, Soumitra; Shang, Ning; Sharma, Himanshu; Smith, Joshua C.; Sohn, Sunghwan; Starren, Justin; Stroud, Mary; Su, Jessica; Tolwinski, Kasia; Veenstra, David; Verbitsky, Miguel; Wagner, Michael; Walunas, Theresa; White, Peter S.; Williams, Janet L.; Zhang, Ge		eMERGE Consortium	Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRISOMY-12 MOSAICISM; FRAMEWORK; VARIANTS; FEATURES	The advancement of precision medicine requires new methods to coordinate and deliver genetic data from heterogeneous sources to physicians and patients. The eMERGE III Network enrolled >25,000 participants from biobank and prospective cohorts of predominantly healthy individuals for clinical genetic testing to determine clinically actionable findings. The network developed protocols linking together the 11 participant collection sites and 2 clinical genetic testing laboratories. DNA capture panels targeting 109 genes were used for testing of DNA and sample collection, data generation, interpretation, reporting, delivery, and storage were each harmonized. A compliant and secure network enabled ongoing review and reconciliation of clinical interpretations, while maintaining communication and data sharing between clinicians and investigators. A total of 202 individuals had positive diagnostic findings relevant to the indication for testing and 1,294 had additional/secondary findings of medical significance deemed to be returnable, establishing data return rates for other testing endeavors. This study accomplished integration of structured genomic results into multiple electronic health record (EHR) systems, setting the stage for clinical decision support to enable genomic medicine. Further, the established processes enable different sequencing sites to harmonize technical and interpretive aspects of sequencing tests, a critical achievement toward global standardization of genomic testing. The eMERGE protocols and tools are available for widespread dissemination.	[Leslie, Nancy D.; Myers, Melanie F.; Prows, Cynthia A.] CCHMC, Cincinnati, OH USA; [Kelly, Melissa A.; Williams, Marc S.] Geisinger, Danville, PA USA; [Jarvik, Gail P.] UW, Seattle, WA USA; [Larson, Eric B.; Leppig, Kathleen A.; Ralston, James D.] KPW, Washington, DC USA; [Kochan, David C.; Kullo, Iftikhar J.; Lindor, Noralane M.] Mayo, Rochester, MN USA; [Lammers, Philip; Singh, Rajbir; Smoot, Duane T.] Meharry, Nashville, TN USA; [Hoell, Christin; Rasmussen-Torvik, Laura J.; Smith, Maureen E.] Northwestern, Evanston, IL USA; [Peterson, Josh F.; Van Driest, Sara L.; Wells, Quinn S.; Wiesner, Georgia L.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Mayo Clinic; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER		hrehm@mgh.harvard.edu; agibbs@bcm.edu	Castro, Victor M/CAF-9395-2022; Castro, Victor M/CAH-3428-2022; Bangash, Hana/AAZ-4557-2021; Kalra, D/H-6661-2019; Chute, Christopher/AAT-8540-2021; Roden, Dan/ABD-5412-2021; Chandanavelli, Gauthami/AAA-4661-2020; Rahm, Alanna Kulchak/AAG-1967-2021; Balasubramanian, Adithya/AAF-3005-2021; Denny, Josh/AAL-3359-2021; Hain, Heather/GON-3487-2022; Appelbaum, Paul/AFU-3908-2022; Taylor, Casey/V-1271-2018; Liang, Wayne/ADF-5362-2022; Bielinski, Suzette/A-2238-2009; Chisholm, Rex/B-3418-2009	Castro, Victor M/0000-0001-7390-6354; Castro, Victor M/0000-0001-7390-6354; Bangash, Hana/0000-0003-2552-9499; Kalra, D/0000-0001-5254-4067; Rahm, Alanna Kulchak/0000-0003-2513-9298; Denny, Josh/0000-0002-3049-7332; Hain, Heather/0000-0003-1139-2882; Appelbaum, Paul/0000-0002-1940-0042; Pratap, Siddharth/0000-0003-2200-0848; Myers, Melanie/0000-0002-6845-5226; Zouk, Hana/0000-0001-6492-6118; Lebo, Matthew/0000-0002-9733-5207; Connolly, John/0000-0003-4396-1226; Gordon, Adam/0000-0002-2058-7289; Taylor, Casey/0000-0001-9302-5968; Liang, Wayne/0000-0003-2354-9787; McNally, Elizabeth/0000-0002-1221-719X; Bielinski, Suzette/0000-0002-2905-5430; Justice, Anne/0000-0002-8903-8712; Hoell, Christin/0000-0001-9477-4928; Ni, Yizhao/0000-0001-8599-454X; Chisholm, Rex/0000-0002-5638-3990; Joo, Yoonjung Yoonie/0000-0001-9506-8742; Josyula, Navya Shilpa/0000-0003-2782-8812; Shang, Ning/0000-0001-7040-5204; Glazer, Andrew/0000-0002-3938-4713; Walunas, Theresa/0000-0002-7653-3650; Jose, Sheethal/0000-0002-0946-8991; Raychaudhuri, Soumya/0000-0002-1901-8265; Kalla, Sara/0000-0003-2437-5352; Gundelach, Justin/0000-0001-7347-0511; Kottyan, Leah/0000-0003-3979-2220	National Human Genome Research Institute (NHGRI) [U01HG8657, U01HG8685, U01HG8672, U01HG8666, U01HG6379, U01HG8679, U01HG8680, U01HG8684, U01HG8673, MD007593, U01HG8701, U01HG8676, U01HG8664]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133786] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008672, U01HG008664, U01HG008684, U01HG008657, U01HG008676, U01HG008673, U01HG008685, U01HG008666, U01HG008701, U01HG008680, U01HG006379, U01HG008679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG055620] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The eMERGE Phase III Network was initiated and funded by the National Human Genome Research Institute (NHGRI) through the following grants: U01HG8657 (Kaiser Permanente Washington Health Research Institute/University of Washington), U01HG8685 (Brigham andWomen's Hospital), U01HG8672 (Vanderbilt University Medical Center), U01HG8666 (Cincinnati Children's Hospital Medical Center), U01HG6379 (Mayo Clinic), U01HG8679 (Geisinger Clinic), U01HG8680 (Columbia University Health Sciences), U01HG8684 (Children's Hospital of Philadelphia), U01HG8673 (Northwestern University), MD007593 (Meharry Medical College), U01HG8701 (Vanderbilt University Medical Center serving as the Coordinating Center), U01HG8676 (Partners Healthcare/Broad Institute), and U01HG8664 (Baylor College of Medicine).	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; [Anonymous], 2014, CURR PROTOC HUM GENE; Aronson S, 2018, J AM MED INFORM ASSN, V25, P1375, DOI 10.1093/jamia/ocy051; Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Aronson SJ, 2011, HUM MUTAT, V32, P532, DOI 10.1002/humu.21470; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Chen CP, 2013, TAIWAN J OBSTET GYNE, V52, P454, DOI 10.1016/j.tjog.2013.06.008; Chiang T, 2019, GENET MED, V21, P2135, DOI 10.1038/s41436-019-0475-4; DeLozier-Blanchet CD, 2000, AM J MED GENET, V95, P444, DOI 10.1002/1096-8628(20001218)95:5<444::AID-AJMG7>3.0.CO;2-X; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; ENGLISH CJ, 1994, J MED GENET, V31, P253, DOI 10.1136/jmg.31.3.253; Fossey R, 2018, J PERS MED, V8, DOI 10.3390/jpm8010002; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hong B, 2017, AM J MED GENET A, V173, P1681, DOI 10.1002/ajmg.a.38194; Hsu LYF, 1997, PRENATAL DIAG, V17, P201, DOI 10.1002/(SICI)1097-0223(199703)17:3<201::AID-PD56>3.0.CO;2-H; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nawathe PA, 2013, J CARDIOVASC ELECTR, V24, P1021, DOI 10.1111/jce.12163; Pugh TJ, 2016, GENET MED, V18, P712, DOI 10.1038/gim.2015.156; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015	22	63	63	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					588	605		10.1016/j.ajhg.2019.07.018	http://dx.doi.org/10.1016/j.ajhg.2019.07.018			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31447099	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000484435700012
J	Chen, TL; Bian, YH; Liu, XM; Zhao, SG; Wu, KL; Yan, L; Li, M; Yang, ZL; Liu, HB; Zhao, H; Chen, ZJ				Chen, Tailai; Bian, Yuehong; Liu, Xiaoman; Zhao, Shigang; Wu, Keliang; Yan, Lei; Li, Mei; Yang, Zhenglin; Liu, Hongbin; Zhao, Han; Chen, Zi-Jiang			A Recurrent Missense Mutation in ZP3 Causes Empty Follicle Syndrome and Female Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZONA-PELLUCIDA GLYCOPROTEINS; EGG; GENE; COMMUNICATION; FERTILIZATION; LHCGR; MICE	Empty follicle syndrome (EFS) is defined as the failure to aspirate oocytes from mature ovarian follicles during in vitro fertilization. Except for some cases caused by pharmacological or iatrogenic problems, the etiology of EFS remains enigmatic. In the present study, we describe a large family with a dominant inheritance pattern of female infertility characterized by recurrent EFS. Genome-wide linkage analyses and whole-exome sequencing revealed a paternally transmitted heterozygous missense mutation of c.400 G>A (p.Ala134Thr) in zona pellucida glycoprotein 3 (ZP3). The same mutation was identified in an unrelated EFS pedigree. Haplotype analysis revealed that the disease allele of these two families came from different origins. Furthermore, in a cohort of 21 cases of EFS, two were also found to have the ZP3 c.400 G>A mutation. Immunofluorescence and histological analysis indicated that the oocytes of the EFS female had degenerated and lacked the zona pellucida (ZP). ZP3 is a major component of the ZP filament. When mutant ZP3 was co-expressed with wild-type ZP3, the interaction between wild-type ZP3 and ZP2 was markedly decreased as a result of the binding of wild-type ZP3 and mutant ZP3, via dominant negative inhibition. As a result, the assembly of ZP was impeded and the communication between cumulus cells and the oocyte was prevented, resulting in oocyte degeneration. These results identified a genetic basis for EFS and oocyte degeneration and, moreover, might pave the way for genetic diagnosis of infertile females with this phenotype.	[Chen, Tailai; Bian, Yuehong; Liu, Xiaoman; Zhao, Shigang; Wu, Keliang; Yan, Lei; Li, Mei; Liu, Hongbin; Zhao, Han; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250001, Shandong, Peoples R China; [Chen, Tailai; Bian, Yuehong; Liu, Xiaoman; Zhao, Shigang; Wu, Keliang; Yan, Lei; Li, Mei; Liu, Hongbin; Zhao, Han; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Shandong, Peoples R China; [Chen, Tailai; Bian, Yuehong; Liu, Xiaoman; Zhao, Shigang; Wu, Keliang; Yan, Lei; Li, Mei; Liu, Hongbin; Zhao, Han; Chen, Zi-Jiang] Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan 250001, Shandong, Peoples R China; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China; [Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Sichuan Acad Med Sci, Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China; [Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Sichuan Prov Peoples Hosp, Chengdu 610072, Sichuan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shanghai Jiao Tong University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China	Zhao, H; Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250001, Shandong, Peoples R China.; Zhao, H; Chen, ZJ (corresponding author), Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan 250001, Shandong, Peoples R China.; Zhao, H; Chen, ZJ (corresponding author), Shandong Univ, Minist Educ, Key Lab Reprod Endocrinol, Jinan 250001, Shandong, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China.; Chen, ZJ (corresponding author), Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China.	hanzh80@yahoo.com; chenzijiang@hotmail.com	Wu, Ke/HCQ-3503-2022; Liu, Xiaoman/J-2142-2015; Zhao, Shigang/ADG-6247-2022; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Tailai/0000-0001-6084-1547; Chen, Zi-Jiang/0000-0001-6637-6631	National Key Research and Development Program of China [2017YFC1001500, 2017YFC1001000, 2016YFC1000600]; National Natural Science Foundation of China [31371453, 31571548, 81622021, 81430029, 81601256, 81401266, 81490743]; Young Scholars Program of Shandong University [2015WLJH54]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scholars Program of Shandong University	This research was supported by the National Key Research and Development Program of China (2017YFC1001500, 2017YFC1001000, 2016YFC1000600), the National Natural Science Foundation of China (31371453, 31571548, 81622021, 81430029, 81601256, 81401266, 81490743), and the Young Scholars Program of Shandong University (2015WLJH54). The authors thank all participants. We thank Prof. Xue Zhang at Peking Union Medical College, China for his kind suggestions in Co-IP experiment and manuscript preparation. We are grateful to Prof. Qiji Liu at Shandong University, China for suggestions on linkage analyses; to Dr. Lulin Huang at the Key Laboratory for Human Disease Gene Study at the Sichuan Academy of Medical Sciences for sharing the exome sequencing data of 2213 population controls; and to BinWu from Guangdong Provincial Hospital for Traditional Chinese Medicine for bioinformatic analysis. We also thank Dr. Antoni Duleba from UCSD School of Medicine, USA for revising the manuscript.	Awonuga A, 1998, HUM REPROD, V13, P1281, DOI 10.1093/humrep/13.5.1281; Conner SJ, 2005, HUM REPROD, V20, P1148, DOI 10.1093/humrep/deh835; COULAM CB, 1986, FERTIL STERIL, V46, P1153; Gao LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41272; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Green D P, 1997, Rev Reprod, V2, P147, DOI 10.1530/ror.0.0020147; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; Huang HL, 2014, NEW ENGL J MED, V370, P1220, DOI 10.1056/NEJMoa1308851; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Lorusso F, 2005, REPROD BIOMED ONLINE, V10, P571, DOI 10.1016/S1472-6483(10)61662-8; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mesen TB, 2011, FERTIL STERIL, V96, P1375, DOI 10.1016/j.fertnstert.2011.09.047; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2011, BIOL REPROD, V85, P661, DOI 10.1095/biolreprod.111.092098; Rankin T, 1996, DEVELOPMENT, V122, P2903; Stevensan TL, 2008, FERTIL STERIL, V90, P691, DOI 10.1016/j.fertnstert.2007.07.1312; Vujisic S, 2005, HUM REPROD, V20, P2552, DOI 10.1093/humrep/dei083; Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Yariz KO, 2011, FERTIL STERIL, V96, pE125, DOI 10.1016/j.fertnstert.2011.05.057; Yuan P, 2017, HUM REPROD, V32, P944, DOI 10.1093/humrep/dex015; Zreik TG, 2000, HUM REPROD, V15, P999, DOI 10.1093/humrep/15.5.999	23	63	67	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					459	465		10.1016/j.ajhg.2017.08.001	http://dx.doi.org/10.1016/j.ajhg.2017.08.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FG1CS	28886344	Green Published, Bronze			2022-12-18	WOS:000409530900012
J	Chao, HT; Davids, M; Burke, E; Pappas, JG; Rosenfeld, JA; McCarty, AJ; Davis, T; Wolfe, L; Toro, C; Tifft, C; Xia, F; Stong, N; Johnson, TK; Warr, CG; Yamamoto, S; Adams, DR; Markello, TC; Gahl, WA; Bellen, HJ; Wangler, MF; Malicdan, MCV				Chao, Hsiao-Tuan; Davids, Mariska; Burke, Elizabeth; Pappas, John G.; Rosenfeld, Jill A.; McCarty, Alexandra J.; Davis, Taylor; Wolfe, Lynne; Toro, Camilo; Tifft, Cynthia; Xia, Fan; Stong, Nicholas; Johnson, Travis K.; Warr, Coral G.; Yamamoto, Shinya; Adams, David R.; Markello, Thomas C.; Gahl, William A.; Bellen, Hugo J.; Wangler, Michael F.; Malicdan, May Christine V.		Undiag Dis Network	A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURONAL DIFFERENTIATION; INTELLECTUAL DISABILITY; TRUNCATING MUTATIONS; MENTAL-RETARDATION; ABNORMAL GENITALIA; GENE; ARX; FAMILY; COLLIER; GENERATION	Early B cell factor 3 (EBF3) is a member of the highly evolutionarily conserved Collier/Olf/EBF (COE) family of transcription factors. Prior studies on invertebrate and vertebrate animals have shown that EBF3 homologs are essential for survival and that loss-of-function mutations are associated with a range of nervous system developmental defects, including perturbation of neuronal development and migration. Interestingly, aristaless-related homeobox (ARX), a homeobox-containing transcription factor critical for the regulation of nervous system development, transcriptionally represses EBF3 expression. However, human neurodevelopmental disorders related to EBF3 have not been reported. Here, we describe three individuals who are affected by global developmental delay, intellectual disability, and expressive speech disorder and carry de novo variants in EBF3. Associated features seen in these individuals include congenital hypotonia, structural CNS malformations, ataxia, and genitourinary abnormalities. The de novo variants affect a single conserved residue in a zinc finger motif crucial for DNA binding and are deleterious in a fly model. Our findings indicate that mutations in EBF3 cause a genetic neurodevelopmental syndrome and suggest that loss of EBF3 function might mediate a subset of neurologic phenotypes shared by ARX-related disorders, including intellectual disability, abnormal genitalia, and structural CNS malformations.	[Chao, Hsiao-Tuan] Baylor Coll Med, Dept Pediat, Sect Child Neurol, Houston, TX 77030 USA; [Chao, Hsiao-Tuan; Yamamoto, Shinya; Bellen, Hugo J.; Wangler, Michael F.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Davids, Mariska; McCarty, Alexandra J.; Wolfe, Lynne; Toro, Camilo; Tifft, Cynthia; Adams, David R.; Markello, Thomas C.; Gahl, William A.; Malicdan, May Christine V.] NHGRI, Undiagnosed Dis Program, NIH Common Fund, Off Director,NIH, Bethesda, MD 20892 USA; [Burke, Elizabeth; Davis, Taylor; Wolfe, Lynne; Toro, Camilo; Tifft, Cynthia; Adams, David R.; Markello, Thomas C.; Gahl, William A.; Malicdan, May Christine V.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Pappas, John G.] NYU, Dept Pediat, Langone Med Ctr, New York, NY 10016 USA; [Rosenfeld, Jill A.; Xia, Fan; Yamamoto, Shinya; Bellen, Hugo J.; Wangler, Michael F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xia, Fan] Baylor Genet Labs, Houston, TX 77030 USA; [Stong, Nicholas] Columbia Univ, Inst Genom Med, New York, NY 10032 USA; [Johnson, Travis K.; Warr, Coral G.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.; Wangler, Michael F.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); New York University; NYU Langone Medical Center; Baylor College of Medicine; Columbia University; Monash University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Wangler, MF (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Malicdan, MCV (corresponding author), NHGRI, Undiagnosed Dis Program, NIH Common Fund, Off Director,NIH, Bethesda, MD 20892 USA.; Malicdan, MCV (corresponding author), NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA.; Wangler, MF (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	mw147467@bcm.edu; maychristine.malicdan@nih.gov	Wangler, Michael/H-6368-2019; Pappas, John/Q-6683-2019; Stong, Nicholas/ABB-7516-2021; /AAI-8468-2020; Gourdine, Jean-Philippe/P-4323-2018; Malicdan, May Christine/AAK-7422-2021; Yamamoto, Shinya/ABB-2837-2021; , WaNgtJ/AAR-7045-2020	Wangler, Michael/0000-0001-5245-5910; Pappas, John/0000-0001-5625-2598; Gourdine, Jean-Philippe/0000-0001-9969-8610; Yamamoto, Shinya/0000-0003-2172-8036; Wheeler, Matthew/0000-0001-8721-3022; Levy, Shawn/0000-0002-1369-5740; Waters, Katrina/0000-0003-4696-5396; Holm, Ingrid/0000-0003-4712-8821; Hackbarth, Mary/0000-0003-1325-3165; Fisher, Paul/0000-0002-1196-1590; McCarty, Alexandra/0000-0002-7222-5255; Sweetser, David/0000-0002-1621-3284; Stong, Nicholas/0000-0002-0678-637X; Haendel, Melissa/0000-0001-9114-8737; Macnamara, Ellen/0000-0002-9418-3287; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Johnson, Travis/0000-0001-6846-9313; Bellen, Hugo/0000-0001-5992-5989; Warr, Coral/0000-0002-5289-3950; orange, jordan/0000-0001-7117-7725; Adams, David/0000-0002-6660-1242; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; Brown, Donna/0000-0002-8805-7225	NIH [U54NS093793, R24OD022005, R01GM067858, U01HG007709]; Intramural Research Program of the National Human Genome Research Institute; Common Fund of the NIH Office of the Director; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007709, U01HG007943, ZIDHG200352, U01HG007703, ZIAHG000215, U01HG007708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS098482, U54NS093793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD022005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Common Fund of the NIH Office of the Director; Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families and clinical staff at the Undiagnosed Diseases Program (UDP), Baylor College of Medicine (BCM), and New York University for participating in this study. This work was supported in part by NIH grants U54NS093793, R24OD022005, and R01GM067858 to H.J.B, by the Intramural Research Program of the National Human Genome Research Institute, and by the Common Fund of the NIH Office of the Director. H.J.B. is an investigator of the Howard Hughes Medical Institute (HHMI). F.X. and J.A.R. are supported by NIH grant U01HG007709. The Department of Molecular and Human Genetics at BCM derives revenue from the clinical exome sequencing offered at Baylor Genetics. We are thankful for the technical assistance provided by Y. Huang (NIH UDP Translational Laboratory) for Sanger sequencing; A. Weech (NIH UDP Translational Laboratory) for input on protein modeling; H. Pan (HHMI, BCM) for fly embryo injections; S. Nagarkar-Jaiswal, P. Lee, Y. He, J. Li, Z. Wang, Q. Gao, and L. Wang (BCM) for creating the 15,000 MIMIC insertion stocks; and W. Lin (BCM) for T2A-GAL4 conversion. We thank the Bloomington Drosophila Stock Center, Drosophila Genomics and Genetic Resources, and FIyORF for numerous stocks and the Developmental Studies Hybridoma Bank for antibodies. This study made use of data generated by the DECIPHER community. A full list of centers that contributed to the generation of the data is available at http://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Alwan A, 2003, NAT REV GENET, V4, P61, DOI 10.1038/nrg978; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, V5th, DOI 10.1176/appi.books.9780890425596; Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bellen HJ, 2015, CELL, V163, P12, DOI 10.1016/j.cell.2015.09.009; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bischof J, 2014, NAT PROTOC, V9, P1607, DOI 10.1038/nprot.2014.105; Boivin MJ, 2015, NATURE, V527, pS155, DOI 10.1038/nature16029; Chiara F, 2012, DEV BIOL, V365, P277, DOI 10.1016/j.ydbio.2012.02.034; Chowdhury TG, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.010.2010; Colasante G, 2009, DEV BIOL, V334, P59, DOI 10.1016/j.ydbio.2009.07.014; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Crozatier M, 1999, DEVELOPMENT, V126, P4385; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fountain M. D., 2016, GENET MED; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Gnerer JP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv113; Goriely A, 2013, AM J PSYCHIAT, V170, P599, DOI 10.1176/appi.ajp.2013.12101352; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Harms FL, 2017, AM J HUM GENET, V100, P117, DOI 10.1016/j.ajhg.2016.11.012; Harteveld CL, 2007, HUM GENET, V122, P283, DOI 10.1007/s00439-007-0399-y; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Ishibashi M, 2015, HUM GENET, V134, P1163, DOI 10.1007/s00439-015-1594-x; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Le Fevre AK, 2013, AM J MED GENET A, V161, P3166, DOI 10.1002/ajmg.a.36174; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liberg D, 2002, MOL CELL BIOL, V22, P8389, DOI 10.1128/MCB.22.24.8389-8397.2002; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Nagarkar-Jaiswal S, 2015, ELIFE, V4, DOI 10.7554/eLife.05338; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Okazaki S, 2008, ACTA NEUROPATHOL, V116, P453, DOI 10.1007/s00401-008-0382-2; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pfeifer D, 2000, GENOMICS, V63, P108, DOI 10.1006/geno.1999.6060; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Turner G, 2002, AM J MED GENET, V112, P405, DOI 10.1002/ajmg.10714; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	56	63	63	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					128	137		10.1016/j.ajhg.2016.11.018	http://dx.doi.org/10.1016/j.ajhg.2016.11.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28017372	Green Published, Bronze			2022-12-18	WOS:000391910500011
J	Kapferer-Seebacher, I; Pepin, M; Werner, R; Aitman, TJ; Nordgren, A; Stoiber, H; Thielens, N; Gaboriaud, C; Amberger, A; Schossig, A; Gruber, R; Giunta, C; Bamshad, M; Bjorck, E; Chen, C; Chitayat, D; Dorschner, M; Schmitt-Egenolf, M; Hale, CJ; Hanna, D; Hennies, HC; Heiss-Kisielewsky, I; Lindstrand, A; Lundberg, P; Mitchell, AL; Nickerson, DA; Reinstein, E; Rohrbach, M; Romani, N; Schmuth, M; Silver, R; Taylan, F; Vandersteen, A; Vandrovcova, J; Weerakkody, R; Yang, M; Pope, FM; Byers, PH; Zschocke, J				Kapferer-Seebacher, Ines; Pepin, Melanie; Werner, Roland; Aitman, Timothy J.; Nordgren, Ann; Stoiber, Heribert; Thielens, Nicole; Gaboriaud, Christine; Amberger, Albert; Schossig, Anna; Gruber, Robert; Giunta, Cecilia; Bamshad, Michael; Bjorck, Erik; Chen, Christina; Chitayat, David; Dorschner, Michael; Schmitt-Egenolf, Marcus; Hale, Christopher J.; Hanna, David; Hennies, Hans Christian; Heiss-Kisielewsky, Irene; Lindstrand, Anna; Lundberg, Pernilla; Mitchell, Anna L.; Nickerson, Deborah A.; Reinstein, Eyal; Rohrbach, Marianne; Romani, Nikolaus; Schmuth, Matthias; Silver, Rachel; Taylan, Fulya; Vandersteen, Anthony; Vandrovcova, Jana; Weerakkody, Ruwan; Yang, Margaret; Pope, F. Michael; Byers, Peter H.; Zschocke, Johannes		Mol Basis Periodontal EDS Consorti	Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-VIII; HETEROGENEOUS DISORDER; PROTEOLYTIC CLEAVAGE; GINGIVAL FLUID; ACTIVATION; EXPRESSION; COMPONENT; COLLAGEN; GENE; IDENTIFICATION	Periodontal Ehlers-Danlos syndrome (pEDS) is an autosomal-dominant disorder characterized by early-onset periodontitis leading to premature loss of teeth, joint hypermobility, and mild skin findings. A locus was mapped to an approximately 5.8 Mb region at 12p13.1 but no candidate gene was identified. In an international consortium we recruited 19 independent families comprising 107 individuals with pEDS to identify the locus, characterize the clinical details in those with defined genetic causes, and try to understand the physiological basis of the condition. In 17 of these families, we identified heterozygous missense or in-frame insertion/deletion mutations in C1R (15 families) or C1S (2 families), contiguous genes in the mapped locus that encode subunits C1r and C1s of the first component of the classical complement pathway. These two proteins form a heterotetramer that then combines with six C1q subunits. Pathogenic variants involve the subunit interfaces or inter-domain hinges of C1r and C1s and are associated with intracellular retention and mild endoplasmic reticulum enlargement. Clinical features of affected individuals in these families include rapidly progressing periodontitis with onset in the teens or childhood, a previously unrecognized lack of attached gingiva, pretibial hyperpigmentation, skin and vascular fragility, easy bruising, and variable musculoskeletal symptoms. Our findings open a connection between the inflammatory classical complement pathway and connective tissue homeostasis.	[Kapferer-Seebacher, Ines; Heiss-Kisielewsky, Irene] Med Univ Innsbruck, Dept Operat & Restorat Dent, A-6020 Innsbruck, Austria; [Pepin, Melanie; Dorschner, Michael; Hale, Christopher J.; Hanna, David; Yang, Margaret; Byers, Peter H.] Univ Washington, Dept Pathol, Collagen Diagnost Lab, Seattle, WA 98195 USA; [Werner, Roland; Amberger, Albert; Schossig, Anna; Gruber, Robert; Hennies, Hans Christian; Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Aitman, Timothy J.] Imperial Coll London, MRC Clin Sci Ctr, London W12 0NN, England; [Aitman, Timothy J.] Imperial Coll London, Dept Med, London W12 0NN, England; [Aitman, Timothy J.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Nordgren, Ann; Bjorck, Erik; Lindstrand, Anna; Taylan, Fulya] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Nordgren, Ann; Bjorck, Erik; Lindstrand, Anna; Taylan, Fulya] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Nordgren, Ann; Bjorck, Erik; Lindstrand, Anna] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Stoiber, Heribert] Med Univ Innsbruck, Div Virol, A-6020 Innsbruck, Austria; [Thielens, Nicole; Gaboriaud, Christine] Univ Grenoble Alpes, CNRS, CEA, IBS, F-38044 Grenoble, France; [Gruber, Robert; Hennies, Hans Christian; Romani, Nikolaus; Schmuth, Matthias] Med Univ Innsbruck, Dept Dermatol Venereol & Allergol, A-6020 Innsbruck, Austria; [Giunta, Cecilia; Rohrbach, Marianne] Univ Childrens Hosp, Div Metab, Connect Tissue Unit, CH-8032 Zurich, Switzerland; [Giunta, Cecilia; Rohrbach, Marianne] Univ Childrens Hosp, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bamshad, Michael; Chen, Christina; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael] Univ Washington, Ctr Mendelian Genom, Seattle, WA 98195 USA; [Bamshad, Michael] Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Chitayat, David; Silver, Rachel] Univ Toronto, Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Chitayat, David; Silver, Rachel] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Schmitt-Egenolf, Marcus] Umea Univ, Dept Publ Hlth & Clin Med, Dermatol, S-90187 Umea, Sweden; [Hennies, Hans Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Hennies, Hans Christian] Univ Huddersfield, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Lundberg, Pernilla] Umea Univ, Dept Mol Periodontol, S-90187 Umea, Sweden; [Mitchell, Anna L.] Case Western Reserve Univ, Med Ctr, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Mitchell, Anna L.] Case Western Reserve Univ, Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Reinstein, Eyal] Meir Med Ctr, Inst Med Genet, IL-44100 Kefar Sava, Israel; [Vandersteen, Anthony] IWK Hlth Ctr, Maritime Med Genet Serv, Halifax, NS B3K 6R8, Canada; [Vandrovcova, Jana] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Weerakkody, Ruwan] Imperial Coll London, Dept Surg & Canc, London W12 0NN, England; [Pope, F. Michael] West Middlesex Univ Hosp, Isleworth TW7 6AF, Middx, England; [Pope, F. Michael] Hosp St John & St Elizabeth, London NW8 9NH, England; [Byers, Peter H.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA	Medical University of Innsbruck; University of Washington; University of Washington Seattle; Medical University of Innsbruck; Imperial College London; Imperial College London; University of Edinburgh; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Medical University of Innsbruck; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Medical University of Innsbruck; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Umea University; University of Cologne; University of Huddersfield; Umea University; Case Western Reserve University; Case Western Reserve University; Tel Aviv University; Sackler Faculty of Medicine; Dalhousie University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; University of Washington; University of Washington Seattle	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Collagen Diagnost Lab, Seattle, WA 98195 USA.; Zschocke, J (corresponding author), Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria.; Byers, PH (corresponding author), Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA.	pbyers@u.washington.edu; johannes.zschocke@i-med.ac.at	Giunta, Cecilia/T-8222-2019; Zschocke, Johannes/C-5885-2013; Hennies, Hans C/G-9424-2014; Nordgren, Ann C/N-4057-2013; Schmitt-Egenolf, Marcus/H-7310-2014; Posch, Wilfried/AAH-6845-2019; Nordgren, Ann/AAQ-9142-2021; Thielens, Nicole M/F-2512-2013; Taylan, Fulya/V-7121-2019; Lindstrand, Anna/AAT-9969-2021; Lindstrand, Anna M/J-3566-2012; Bjorck, Erik/I-3261-2013	Giunta, Cecilia/0000-0002-9313-8257; Zschocke, Johannes/0000-0002-0046-8274; Hennies, Hans C/0000-0001-7210-2389; Nordgren, Ann C/0000-0003-3285-4281; Schmitt-Egenolf, Marcus/0000-0002-3858-8474; Posch, Wilfried/0000-0001-8955-7654; Nordgren, Ann/0000-0003-3285-4281; Thielens, Nicole M/0000-0002-7354-0302; Taylan, Fulya/0000-0002-2907-0235; Lindstrand, Anna/0000-0003-0806-5602; Lindstrand, Anna M/0000-0003-0806-5602; Kapferer-Seebacher, Ines/0000-0001-6169-6812; Meitinger, Thomas/0000-0002-8838-8403; Bjorck, Erik/0000-0002-1210-2245; Wilflingseder, Doris/0000-0002-5888-5118; Schmuth, Matthias/0000-0002-4064-1334; Rohrbach, Marianne/0000-0002-4013-6012; Romani, Nikolaus/0000-0003-1614-9128; Haririan, Hady/0000-0003-0783-609X; gaboriaud, christine/0000-0001-5308-0516; Banki, Zoltan/0000-0002-3826-5800; Dudas, Jozsef/0000-0002-9877-3399; Aitman, Timothy/0000-0002-7875-4502	Oesterreichische Nationalbank (Anniversary Fund) [15408]; Propter Homines Foundation (Liechtenstein); FWF (Horns doctoral Program) [W1253-B24]; SNF [310030_138288]; UK MRC Clinical Sciences Centre; Wellcome Clinical Training Fellowship [100565/Z/12/Z]; Freudmann Fund for Translational Research in Ehlers Danlos syndrome; Ehlers Danlos Research Fund; Center for Precision Diagnostics at the University of Washington; National Human Genome Research Institute; National Heart, Lung, and Blood Institute [U54HG006493]; MRC [MR/N005902/1, MC_U120061454] Funding Source: UKRI; Medical Research Council [MC_U120061454, MR/N005902/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER	Oesterreichische Nationalbank (Anniversary Fund); Propter Homines Foundation (Liechtenstein); FWF (Horns doctoral Program); SNF; UK MRC Clinical Sciences Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Clinical Training Fellowship; Freudmann Fund for Translational Research in Ehlers Danlos syndrome; Ehlers Danlos Research Fund; Center for Precision Diagnostics at the University of Washington; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We wish to thank the families and individuals with periodontal EDS for their participation in this study. We are grateful to Vincent Offermanns, Alexander Rinner, and Robert Stigler for providing oral tissue samples; Dieter Kotzot for providing additional DNA samples; Britta Berglund, S.M.C. George, and Aparna Sinha for DNA sample collection; and Hella Stossel for expert help with EM. The study was supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project number 15408), the Propter Homines Foundation (Liechtenstein), and the FWF (Horns doctoral Program, W1253-B24), by SNF grant number 310030_138288 to C.G. and M.R., by intramural funds from the UK MRC Clinical Sciences Centre, by a Wellcome Clinical Training Fellowship to R.W. (grant no. 100565/Z/12/Z), and by the Freudmann Fund for Translational Research in Ehlers Danlos syndrome, the Ehlers Danlos Research Fund, and the Center for Precision Diagnostics at the University of Washington. Sequencing was provided by the University of Washington Center for Mendelian Genomics (UVV-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute grant U54HG006493 to D.N., M.B., and S.L.	Albandar JM, 2014, PERIODONTOL 2000, V65, P13, DOI 10.1111/prd.12014; Amano MT, 2008, MOL IMMUNOL, V45, P1693, DOI 10.1016/j.molimm.2007.09.034; ARLAUD GJ, 1980, BIOCHIM BIOPHYS ACTA, V616, P116, DOI 10.1016/0005-2744(80)90269-7; Bally I, 2013, P NATL ACAD SCI USA, V110, P8650, DOI 10.1073/pnas.1304894110; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Beikler T, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-30; BIESECKER LG, 1991, AM J MED GENET, V41, P284, DOI 10.1002/ajmg.1320410305; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bourhis JM, 2013, P NATL ACAD SCI USA, V110, P6394, DOI 10.1073/pnas.1300480110; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Cikla U, 2014, J NEUROL SURG REP, V75, pE210, DOI 10.1055/s-0034-1387185; Costabile Maurizio, 2010, J Vis Exp, DOI 10.3791/1923; DeLano, 2002, PYMOL MOL GRAPHICS S; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Gaboriaud C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00565; Girija UV, 2013, P NATL ACAD SCI USA, V110, P13916, DOI 10.1073/pnas.1311113110; Hajishengallis G, 2015, ADV EXP MED BIOL, V865, P57, DOI 10.1007/978-3-319-18603-0_4; HARTSFIELD JK, 1990, AM J MED GENET, V37, P465, DOI 10.1002/ajmg.1320370408; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569; NELSON DL, 1981, J AM ACAD DERMATOL, V5, P297, DOI 10.1016/S0190-9622(81)70095-1; NIEKRASH CE, 1985, J PERIODONTAL RES, V20, P268, DOI 10.1111/j.1600-0765.1985.tb00434.x; PATRICK RA, 1970, IMMUNOCHEMISTRY, V7, P217, DOI 10.1016/0019-2791(70)90157-6; PATTERS MR, 1989, J CLIN PERIODONTOL, V16, P33, DOI 10.1111/j.1600-051X.1989.tb01609.x; Rahman N, 2003, AM J HUM GENET, V73, P198, DOI 10.1086/376416; Reinstein E, 2013, EUR J HUM GENET, V21, P233, DOI 10.1038/ejhg.2012.132; Reinstein E, 2012, AM J MED GENET A, V158A, P938, DOI 10.1002/ajmg.a.35261; Reinstein E, 2011, AM J MED GENET A, V155A, P742, DOI 10.1002/ajmg.a.33914; Rossi V, 2014, METHODS MOL BIOL, V1100, P43, DOI 10.1007/978-1-62703-724-2_4; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; Stewart R E, 1977, Birth Defects Orig Artic Ser, V13, P85; THIELENS NM, 1982, FEBS LETT, V141, P19, DOI 10.1016/0014-5793(82)80006-9; Vadon-Le Goff S, 2011, J BIOL CHEM, V286, P38932, DOI 10.1074/jbc.M111.274944; Vanakker O, 2015, ANNU REV GENOM HUM G, V16, P229, DOI 10.1146/annurev-genom-090314-050039; WAUTIER JL, 1980, MOL IMMUNOL, V17, P1399, DOI 10.1016/0161-5890(80)90009-7; Wu YL, 2011, LUPUS, V20, P1126, DOI 10.1177/0961203311404914; YAMAGUCHI K, 1990, FEBS LETT, V268, P206, DOI 10.1016/0014-5793(90)81009-D	40	63	70	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1005	1014		10.1016/j.ajhg.2016.08.019	http://dx.doi.org/10.1016/j.ajhg.2016.08.019			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745832	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000387529600001
J	Yu, P; Yang, WL; Han, D; Wang, X; Guo, S; Li, JC; Li, F; Zhang, XX; Wong, SW; Bai, BJ; Liu, Y; Du, J; Sun, ZS; Shi, ST; Feng, HL; Cai, T				Yu, Ping; Yang, Wenli; Han, Dong; Wang, Xi; Guo, Sen; Li, Jinchen; Li, Fang; Zhang, Xiaoxia; Wong, Sing-Wai; Bai, Baojing; Liu, Yao; Du, Jie; Sun, Zhong Sheng; Shi, Songtao; Feng, Hailan; Cai, Tao			Mutations in WNT10B Are Identified in Individuals with Oligodontia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; AUTOSOMAL-DOMINANT OLIGODONTIA; TOOTH AGENESIS; IN-VITRO; EXPRESSION; GENE; DIFFERENTIATION; DISEASE; MORPHOGENESIS; POPULATION	Tooth agenesis is one of the most common developmental anomalies in humans. Oligodontia, a severe form of tooth agenesis, is genetically and phenotypically a heterogeneous condition. Although significant efforts have been made, the genetic etiology of dental agenesis remains largely unknown. In the present study, we performed whole-exome sequencing to identify the causative mutations in Chinese families in whom oligodontia segregates with dominant inheritance. We detected a heterozygous missense mutation (c.632G > A [p.Arg211Gln]) in WNT10B in all affected family members. By Sanger sequencing a cohort of 145 unrelated individuals with non-syndromic oligodontia, we identified three additional mutations (c.569C > G [p.Pro190Arg], c.786G > A [p.Trp262*], and c.851T > G [p.Phe284Cys]). Interestingly, analysis of genotype-phenotype correlations revealed that mutations in WNT10B affect the development of permanent dentition, particularly the lateral incisors. Furthermore, a functional assay demonstrated that each of these mutants could not normally enhance the canonical Wnt signaling in HEPG2 epithelial cells, in which activity of the TOPFlash luciferase reporter was measured. Notably, these mutant WNT10B ligands could not efficiently induce endothelial differentiation of dental pulp stem cells. Our findings provide the identification of autosomal-dominant WNT10B mutations in individuals with oligodontia, which increases the spectrum of congenital tooth agenesis and suggests attenuated Wnt signaling in endothelial differentiation of dental pulp stem cells.	[Yu, Ping; Guo, Sen; Li, Jinchen; Cai, Tao] Wenzhou Med Univ, Inst Genom Med, Wenzhou 325000, Peoples R China; [Yang, Wenli; Wang, Xi] Zhengzhou Univ, Stomatol Hosp, Zhengzhou 450052, Peoples R China; [Han, Dong; Li, Fang; Zhang, Xiaoxia; Wong, Sing-Wai; Feng, Hailan] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100081, Peoples R China; [Wong, Sing-Wai] Univ North Carolina Chapel Hill, Sch Dent, Oral Biol Curriculum, Chapel Hill, NC 27599 USA; [Bai, Baojing] Beijing Stomatol Hosp, Dept Prosthodont, Beijing 100050, Peoples R China; [Liu, Yao; Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing 100000, Peoples R China; [Sun, Zhong Sheng] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100000, Peoples R China; [Cai, Tao] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20982 USA	Wenzhou Medical University; Zhengzhou University; Peking University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Capital Medical University; University of Pennsylvania; Capital Medical University; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Cai, T (corresponding author), Wenzhou Med Univ, Inst Genom Med, Wenzhou 325000, Peoples R China.; Feng, HL (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100081, Peoples R China.; Cai, T (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20982 USA.	kqfenghl@bjmu.edu.cn; tcai@mail.nih.gov	Wong, Sing-Wai/AAX-6018-2020; cai, tao/C-5060-2011; Han, Dong/V-2128-2018; Sun, Zhongsheng/AAS-4883-2020	Wong, Sing-Wai/0000-0002-6905-3050; Han, Dong/0000-0001-9625-3384; Sun, Zhongsheng/0000-0002-7640-5026; Guo, Sen/0000-0001-9546-7858; Cai, Tao/0000-0002-2877-8637; Sun, Zhongsheng/0000-0003-1992-2681	Wenzhou Medical University Research Fund; Beijing Collaborative Innovative Research Center for Cardiovascular Diseases [PXM2014_014226_000002]; National Natural Science Foundation of China [81110114]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R90DE022527] Funding Source: NIH RePORTER	Wenzhou Medical University Research Fund; Beijing Collaborative Innovative Research Center for Cardiovascular Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are indebted to the individuals with tooth agenesis and their families for their participation in this study. We thank Dr. Curtis Harris's lab for the wild-type WNT10B plasmid, Dr. DeeDee Smart's lab for the pTOPFLASH and pCMV beta-gal plasmids, and Qianzhi Shao for bioinformatics analysis. We wish to thank Drs. Yan Jin and Weidong Li for thoughtful suggestions. Research reported in this publication was supported by the Wenzhou Medical University Research Fund (to P.Y.), the Beijing Collaborative Innovative Research Center for Cardiovascular Diseases (PXM2014_014226_000002 to D.J.), and National Natural Science Foundation of China grant 81110114 (to Z.S.S.).	Arzoo PS, 2014, AM J MED GENET A, V164, P353, DOI 10.1002/ajmg.a.36243; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Cai T, 2015, P NATL ACAD SCI USA, V112, P8064, DOI 10.1073/pnas.1502454112; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Dhanrajani PJ, 2002, QUINTESSENCE INT, V33, P294; Feng Hai-Lan, 2011, Zhonghua Kou Qiang Yi Xue Za Zhi, V46, P54; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; Khalaf K, 2014, J ORTHOD, V41, P299, DOI 10.1179/1465313314Y.0000000116; Liu HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138221; Massink MPG, 2015, AM J HUM GENET, V97, P621, DOI 10.1016/j.ajhg.2015.08.014; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nguyen P, 2014, MOL CANCER RES, V12, P1244, DOI 10.1158/1541-7786.MCR-14-0223-T; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P28, DOI 10.1016/j.bbrc.2006.01.104; Ruf S, 2013, J OROFAC ORTHOP, V74, P295, DOI 10.1007/s00056-013-0138-z; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Scheller EL, 2008, J DENT RES, V87, P126, DOI 10.1177/154405910808700206; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Song SJ, 2014, HUM GENET, V133, P117, DOI 10.1007/s00439-013-1360-x; Song W, 2015, GENET MED; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Thesleff I, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12102; Wang Y, 2009, CELLS TISSUES ORGANS, V189, P80, DOI 10.1159/000151448; Wend P, 2012, ACTA PHYSIOL, V204, P34, DOI 10.1111/j.1748-1716.2011.02296.x; Xiao L, 2012, J CELL BIOCHEM, V113, P1875, DOI 10.1002/jcb.24056; Xuan K, 2008, ARCH ORAL BIOL, V53, P773, DOI 10.1016/j.archoralbio.2008.02.012; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yin W, 2015, J DENT RES, V94, P878, DOI 10.1177/0022034515583999; Yoshikawa H, 2007, MOL BIOL CELL, V18, P4292, DOI 10.1091/mbc.E06-10-0889; Yuan GH, 2014, CELL TISSUE RES, V356, P137, DOI 10.1007/s00441-013-1785-5; Zhang J, 2015, CHIN J DENT RES, V18, P59, DOI 10.3290/j.cjdr.a33969,PubMed:25815384; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1; Zhang Z, 2016, STEM CELLS	38	63	66	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					195	201		10.1016/j.ajhg.2016.05.012	http://dx.doi.org/10.1016/j.ajhg.2016.05.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27321946	Green Published, Bronze			2022-12-18	WOS:000381616600016
J	Jansen, JC; Cirak, S; van Scherpenzeel, M; Timal, S; Reunert, J; Rust, S; Perez, B; Vicogne, D; Krawitz, P; Wada, Y; Ashikov, A; Perez-Cerda, C; Medrano, C; Arnoldy, A; Hoischen, A; Huijben, K; Steenbergen, G; Quelhas, D; Diogo, L; Rymen, D; Jaeken, J; Guffon, N; Cheillan, D; van den Heuvel, LP; Maeda, Y; Kaiser, O; Schara, U; Gerner, P; van den Boogert, MAW; Holleboom, AG; Nassogne, MC; Sokal, E; Salomon, J; van den Bogaart, G; Drenth, JPH; Huynen, MA; Veltman, JA; Wevers, RA; Morava, E; Matthijs, G; Foulquier, F; Marquardt, T; Lefeber, DJ				Jansen, Jos C.; Cirak, Sebahattin; van Scherpenzeel, Monique; Timal, Sharita; Reunert, Janine; Rust, Stephan; Perez, Belen; Vicogne, Dorothee; Krawitz, Peter; Wada, Yoshinao; Ashikov, Angel; Perez-Cerda, Celia; Medrano, Celia; Arnoldy, Andrea; Hoischen, Alexander; Huijben, Karin; Steenbergen, Gerry; Quelhas, Dulce; Diogo, Luisa; Rymen, Daisy; Jaeken, Jaak; Guffon, Nathalie; Cheillan, David; van den Heuvel, Lambertus P.; Maeda, Yusuke; Kaiser, Olaf; Schara, Ulrike; Gerner, Patrick; van den Boogert, Marjolein A. W.; Holleboom, Adriaan G.; Nassogne, Marie-Cecile; Sokal, Etienne; Salomon, Jody; van den Bogaart, Geert; Drenth, Joost P. H.; Huynen, Martijn A.; Veltman, Joris A.; Wevers, Ron A.; Morava, Eva; Matthijs, Gert; Foulquier, Francois; Marquardt, Thorsten; Lefeber, Dirk J.			CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VACUOLAR PROTON PUMP; X-LINKED MYOPATHY; CONGENITAL DISORDERS; N-GLYCAN; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; MUTATIONS; ATPASE; YEAST; DIAGNOSIS	Disorders of Golgi homeostasis form an emerging group of genetic defects. The highly heterogeneous clinical spectrum is not explained by our current understanding of the underlying cell-biological processes in the Golgi. Therefore, uncovering genetic defects and annotating gene function are challenging. Exome sequencing in a family with three siblings affected by abnormal Golgi glycosylation revealed a homozygous missense mutation, c.92T>C (p.Leu31Ser), in coiled-coil domain containing 115 (CCDC115), the function of which is unknown. The same mutation was identified in three unrelated families, and in one family it was compound heterozygous in combination with a heterozygous deletion of CCDC115. An additional homozygous missense mutation, c.31G>T (p.Asp11Tyr), was found in a family with two affected siblings. All individuals displayed a storage-disease-like phenotype involving hepatosplenomegaly, which regressed with age, highly elevated bone-derived alkaline phosphatase, elevated aminotransferases, and elevated cholesterol, in combination with abnormal copper metabolism and neurological symptoms. Two individuals died of liver failure, and one individual was successfully treated by liver transplantation. Abnormal N- and mucin type O-glycosylation was found on serum proteins, and reduced metabolic labeling of sialic acids was found in fibroblasts, which was restored after complementation with wild-type CCDC115. PSI-BLAST homology detection revealed reciprocal homology with Vma22p, the yeast V-ATPase assembly factor located in the endoplasmic reticulum(ER). Human CCDC115 mainly localized to the ERGIC and to COPI vesicles, but not to the ER. These data, in combination with the phenotypic spectrum, which is distinct from that associated with defects in V-ATPase core subunits, suggest a more general role for CCDC115 in Golgi trafficking. Our study reveals CCDC115 deficiency as a disorder of Golgi homeostasis that can be readily identified via screening for abnormal glycosylation in plasma.	[Jansen, Jos C.; Salomon, Jody; Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 GA Nijmegen, Netherlands; [Jansen, Jos C.; van Scherpenzeel, Monique; Timal, Sharita; Ashikov, Angel; Huijben, Karin; Steenbergen, Gerry; van den Heuvel, Lambertus P.; Wevers, Ron A.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Translat Metab Lab, NL-6525 GA Nijmegen, Netherlands; [Cirak, Sebahattin] Uniklin Koln, Inst Humangenet, D-50931 Cologne, Germany; [Cirak, Sebahattin] Uniklin Koln, Klin & Poliklin Kinder & Jugendmed, D-50937 Cologne, Germany; [Cirak, Sebahattin] Uniklin Koln, Zentrum Mol Med, D-50931 Cologne, Germany; [van Scherpenzeel, Monique; Timal, Sharita; Ashikov, Angel; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands; [Reunert, Janine; Rust, Stephan; Marquardt, Thorsten] Univ Munster, Dept Pediat, D-48149 Munster, Germany; [Perez, Belen; Perez-Cerda, Celia; Medrano, Celia] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa UAM CSIC, Ctr Diagnost Enfermedades Mol, Campus Cantoblanco, E-28049 Madrid, Spain; [Perez, Belen; Perez-Cerda, Celia; Medrano, Celia] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28049, Spain; [Perez, Belen; Perez-Cerda, Celia; Medrano, Celia] Inst Invest Sanitaria IdiPAZ, Madrid 28049, Spain; [Vicogne, Dorothee; Foulquier, Francois] Univ Lille, CNRS UMR 8576, Struct & Funct Glycobiol Unit, Federat Res Struct & Funct Biochem Biomol Assembl, F-59655 Villeneuve Dascq, France; [Krawitz, Peter] Inst Med Genet, D-13353 Berlin, Germany; [Wada, Yoshinao] Osaka Med Ctr, Izumi, Osaka 5941101, Japan; [Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Arnoldy, Andrea] Univ Essen Gesamthsch, Dept Pediat, D-45122 Essen, Germany; [Hoischen, Alexander; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Quelhas, Dulce] Ctr Hosp Porto, Biochem Genet Unit, Ctr Genet Med Jacinto de Magalhaes, P-4050466 Porto, Portugal; [Diogo, Luisa] Ctr Hosp Univ Coimbra, Hosp Pediat, Metab Dis Unit, Ctr Desenvolvimento Crianca, P-3000609 Coimbra, Portugal; [Rymen, Daisy; Jaeken, Jaak; Morava, Eva; Matthijs, Gert] Univ Leuven, Dept Pediat, B-3000 Louvain, Belgium; [Guffon, Nathalie; Cheillan, David] Hop Femme Mere Enfant, Ctr Reference Malad Hereditaires Metab, F-69677 Bron, France; [van den Heuvel, Lambertus P.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Translat Metab Lab,Dept Pediat, NL-6525 GA Nijmegen, Netherlands; [Maeda, Yusuke] Osaka Univ, Microbial Dis Res Inst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Kaiser, Olaf; Schara, Ulrike] Childrens Hosp Essen, Dept Pediat Neurol, D-45122 Essen, Germany; [Gerner, Patrick] Univ Hosp, Dept Pediat Gastroenterol Hepatol & Endoscopy, D-79110 Freiburg, Germany; [van den Boogert, Marjolein A. W.; Holleboom, Adriaan G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Nassogne, Marie-Cecile; Sokal, Etienne] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Woluwe St Lambert, Belgium; [van den Bogaart, Geert] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, NL-6525 GA Nijmegen, Netherlands; [Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands; [Morava, Eva] Tulane Univ, Sch Med, Dept Pediat, Hayward Genet Ctr, New Orleans, LA 70112 USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; University of Cologne; University of Cologne; Radboud University Nijmegen; University of Munster; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Duisburg Essen; Radboud University Nijmegen; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); KU Leuven; CHU Lyon; Radboud University Nijmegen; Osaka University; University of Freiburg; University of Amsterdam; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; Tulane University	Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Translat Metab Lab, NL-6525 GA Nijmegen, Netherlands.; Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6525 GA Nijmegen, Netherlands.	dirk.lefeber@radboudumc.nl	Jansen, Jos/P-6362-2015; Medrano, Celia/ABF-8994-2021; Veltman, Joris A/F-5128-2010; van den Heuvel, Lambertus/AAM-1772-2021; Lefeber, Dirk DJ/A-2146-2014; Hoischen, Alexander/AGF-7293-2022; van den Heuvel, L.P.W.J./H-8044-2014; van den Bogaart, Geert/A-1089-2014; van den Bogaart, Geert/GLV-3283-2022; Huynen, Martijn A/A-1530-2014; Drenth, Joost/V-7436-2019; FOULQUIER, FRANCOIS/AAI-1182-2021; Drenth, J.P.H./H-8025-2014; Krawitz, Peter M/F-3142-2012; van Scherpenzeel, Monique/N-7008-2015; Hoischen, Alexander/D-1282-2013; Cirak, Sebahattin/AAX-9593-2020; Wevers, Ron A./H-8116-2014; foulquier, francois/ABE-5886-2020; Cirak, Sebahattin/AAZ-6829-2020; Ashikov, Angel/N-7714-2015; Carmen, Team1/Y-7382-2019	Veltman, Joris A/0000-0002-3218-8250; van den Heuvel, Lambertus/0000-0003-3917-6727; Hoischen, Alexander/0000-0002-8072-4476; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Huynen, Martijn A/0000-0001-6189-5491; Krawitz, Peter M/0000-0002-3194-8625; van Scherpenzeel, Monique/0000-0002-9696-4562; Hoischen, Alexander/0000-0002-8072-4476; Wevers, Ron A./0000-0003-2278-9746; foulquier, francois/0000-0002-6551-3240; Ashikov, Angel/0000-0001-9679-7955; Carmen, Team1/0000-0003-4234-1746; Diogo, Luisa/0000-0003-3821-6643; Sokal, Etienne/0000-0001-5597-4708; Medrano, Celia/0000-0001-9634-7874; Holleboom, A.G. (Onno)/0000-0002-2911-2917; cheillan, david/0000-0001-9535-2567; Quelhas, Dulce/0000-0001-9989-9236; Nassogne, Marie-Cecile/0000-0001-6936-1611; Lab, Carmen/0000-0002-5935-3236; Matthijs, Gert/0000-0001-6710-1912	Institute of Genetic and Metabolic Disease; Dutch Organization for Scientific Research (ZONMW Medium Investment grant) [40-00506-98-9001]; VIDI grant [91713359]; VENI grant; AMC graduate school PhD scholarship; Metakids foundation; Dr. Karel-Lodewijk Verleysen Award; Spanish Ministry of Economy and Competitiveness [PI11/01254]; German Research Foundation; Muscular Dystrophy Association; French national agency (ANR-SOLV_CDG); ERA-Net for Research Programs on Rare Diseases Joint Transnational Call (EURO-CDG) [ERARE11-135]	Institute of Genetic and Metabolic Disease; Dutch Organization for Scientific Research (ZONMW Medium Investment grant); VIDI grant; VENI grant; AMC graduate school PhD scholarship; Metakids foundation; Dr. Karel-Lodewijk Verleysen Award; Spanish Ministry of Economy and Competitiveness(Spanish Government); German Research Foundation(German Research Foundation (DFG)); Muscular Dystrophy Association(Muscular Dystrophy Association); French national agency (ANR-SOLV_CDG)(French National Research Agency (ANR)); ERA-Net for Research Programs on Rare Diseases Joint Transnational Call (EURO-CDG)	We would like to thank all individuals and their families for their participation in this study. We would also like to thank the group of Prof. C. Biot and Dr. Y. Guerardel for their generous donation of ManNAI and Dr. F. Pellicano and Dr. T. Iwata for their generous donation of the anti-CCDC115 antisera. This work was financially supported by grants from the Institute of Genetic and Metabolic Disease (D.J.L., J.A.V., and R.J. Rodenburg), the Dutch Organization for Scientific Research (ZONMW Medium Investment grant 40-00506-98-9001, VIDI grant 91713359 to D.J.L., and VENI grant to A.G.H.), the AMC graduate school PhD scholarship (M.A.W.v.d.B.), the Metakids foundation (J.C.J., M.V.S., J.D., D.J.L.), the Dr. Karel-Lodewijk Verleysen Award (J.D.), the Spanish Ministry of Economy and Competitiveness (grant PI11/01254 to B.P., C.P.C., and C.M.), the German Research Foundation (S.C.), Muscular Dystrophy Association (S.C.), the French national agency (ANR-SOLV_CDG to F.F.), and the ERA-Net for Research Programs on Rare Diseases Joint Transnational Call 2011 (EURO-CDG, grant ERARE11-135 to G.M. and F.F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Guillard M, 2011, J PEDIATR-US, V159, P1041, DOI 10.1016/j.jpeds.2011.08.007; Guillard M, 2011, J INHERIT METAB DIS, V34, P901, DOI 10.1007/s10545-011-9311-y; Guillard M, 2011, CLIN CHEM, V57, P593, DOI 10.1373/clinchem.2010.153635; Guillard M, 2009, BBA-MOL BASIS DIS, V1792, P903, DOI 10.1016/j.bbadis.2008.12.009; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; HO MN, 1993, J BIOL CHEM, V268, P221; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jansen JC, 2016, AM J HUM GENET, V98, P322, DOI 10.1016/j.ajhg.2015.12.011; Janssen MJ, 2010, J HEPATOL, V52, P432, DOI 10.1016/j.jhep.2009.12.011; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Mercier S, 2015, MUSCLE NERVE, V52, P673, DOI 10.1002/mus.24664; Miller VJ, 2012, TRAFFIC, V13, P891, DOI 10.1111/j.1600-0854.2012.01338.x; Mohamed M, 2011, BBA-MOL BASIS DIS, V1812, P691, DOI 10.1016/j.bbadis.2011.02.011; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Pellicano F, 2006, GENE EXPR PATTERNS, V6, P285, DOI 10.1016/j.modgep.2005.07.004; Pellicano F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-657; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Ruggieri A, 2015, NEUROMUSCULAR DISORD, V25, P207, DOI 10.1016/j.nmd.2014.11.014; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Stranecky V, 2013, AM J HUM GENET, V92, P792, DOI 10.1016/j.ajhg.2013.03.023; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tan J, 1996, AM J HUM GENET, V59, P810; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Scherpenzeel M, 2015, TRANSL RES, V166, P639, DOI 10.1016/j.trsl.2015.07.005; Vanbeselaere J, 2013, CHEM COMMUN, V49, P11293, DOI 10.1039/c3cc45914d; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Wopereis S, 2003, CLIN CHEM, V49, P1839, DOI 10.1373/clinchem.2003.022541; Wopereis S, 2007, CLIN CHEM, V53, P180, DOI 10.1373/clinchem.2006.073940	48	63	63	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					310	321		10.1016/j.ajhg.2015.12.010	http://dx.doi.org/10.1016/j.ajhg.2015.12.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26833332	Green Published, Bronze			2022-12-18	WOS:000370502300007
J	Rauch, F; Fahiminiya, S; Majewski, J; Carrot-Zhang, J; Boudko, S; Glorieux, F; Mort, JS; Bachinger, HP; Moffatt, P				Rauch, Frank; Fahiminiya, Somayyeh; Majewski, Jacek; Carrot-Zhang, Jian; Boudko, Sergei; Glorieux, Francis; Mort, John S.; Baechinger, Hans-Peter; Moffatt, Pierre			Cole-Carpenter Syndrome Is Caused by a Heterozygous Missense Mutation in P4HB	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN DISULFIDE-ISOMERASE; OSTEOGENESIS-IMPERFECTA; VARIANTS; DISEASE	Cole-Carpenter syndrome is a severe bone fragility disorder that is characterized by frequent fractures, craniosynostosis, ocular proptosis, hydrocephalus, and distinctive facial features. To identify the cause of Cole-Carpenter syndrome in the two individuals whose clinical results were presented in the original description of this disorder, we performed whole-exome sequencing of genomic DNA samples from both individuals. The two unrelated individuals had the same heterozygous missense mutation in exon 9 of P4HB (NM_000918.3: c.1178A>G [p.Tyr393Cys]), the gene that encodes protein disulfide isomerase (PDI). In one individual, the P4HB mutation had arisen de novo, whereas in the other the mutation was transmitted from the clinically unaffected father who was a mosaic carrier of the variant. The mutation was located in the C-terminal disulfide isomerase domain of PDI, sterically close to the enzymatic center, and affected disulfide isomerase activity in vitro. Skin fibroblasts showed signs of increased endoplasmic reticulum stress, but despite the reported importance of PDI for collagen type I production, the rate of collagen type I secretion appeared normal. In conclusion, Cole-Carpenter syndrome is caused by a specific de novo mutation in P4HB that impairs the disulfide isomerase activity of PDI.	[Rauch, Frank; Glorieux, Francis; Mort, John S.; Moffatt, Pierre] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek; Carrot-Zhang, Jian] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Fahiminiya, Somayyeh; Majewski, Jacek; Carrot-Zhang, Jian] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1B1, Canada; [Boudko, Sergei; Baechinger, Hans-Peter] Shriners Hosp Children, Portland, OR 97239 USA	McGill University; McGill University	Rauch, F (corresponding author), Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada.	frauch@shriners.mcgill.ca	Rauch, Frank/D-1554-2009; Carrot-Zhang, Jian/K-8618-2019	Rauch, Frank/0000-0002-6261-0360; Boudko, Sergei/0000-0003-3856-4859	Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante; Shriners of North America	Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante; Shriners of North America	We thank Patty Mason for technical assistance and Mark Lepik for the preparation of the figures. F.R. received support from the Chercheur-Boursier Clinicien program of the Fonds de Recherche du Quebec - Sante. J.M. is a recipient of a Canada Research Chair. We also wish to acknowledge the contribution of the high-throughput and Sanger sequencing platforms of the McGill University and Genome Quebec Innovation Centre. This study was supported by the Shriners of North America.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amor DJ, 2000, AM J MED GENET, V92, P273, DOI 10.1002/(SICI)1096-8628(20000605)92:4<273::AID-AJMG10>3.0.CO;2-T; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; COLE DEC, 1987, J PEDIATR-US, V110, P76; Fahiminiya S, 2013, BONE, V57, P41, DOI 10.1016/j.bone.2013.07.020; Fahiminiya S, 2013, J MED GENET, V50, P345, DOI 10.1136/jmedgenet-2013-101567; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Hahm E, 2013, BLOOD, V121, P3789, DOI 10.1182/blood-2012-11-467985; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; McDonald-McGinn DM, 2013, J MED GENET, V50, P80, DOI 10.1136/jmedgenet-2012-101320; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Obafemi AA, 2008, AM J MED GENET A, V146A, P2725, DOI 10.1002/ajmg.a.32508; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	34	63	69	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					425	431		10.1016/j.ajhg.2014.12.027	http://dx.doi.org/10.1016/j.ajhg.2014.12.027			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683117	Green Published, Bronze			2022-12-18	WOS:000350747800014
J	Failler, M; Gee, HY; Krug, P; Joo, K; Halbritter, J; Belkacem, L; Filhol, E; Porath, JD; Braun, DA; Schueler, M; Frigo, A; Alibeu, O; Masson, C; Brochard, K; de Ligny, BH; Novo, R; Pietrement, C; Kayserili, H; Salomon, R; Gubler, MC; Otto, EA; Antignac, C; Kim, J; Benmerah, A; Hildebrandt, F; Saunier, S				Failler, Marion; Gee, Heon Yung; Krug, Pauline; Joo, Kwangsic; Halbritter, Jan; Belkacem, Lilya; Filhol, Emilie; Porath, Jonathan D.; Braun, Daniela A.; Schueler, Markus; Frigo, Amandine; Alibeu, Olivier; Masson, Cecile; Brochard, Karine; de Ligny, Bruno Hurault; Novo, Robert; Pietrement, Christine; Kayserili, Hulya; Salomon, Remi; Gubler, Marie-Claire; Otto, Edgar A.; Antignac, Corinne; Kim, Joon; Benmerah, Alexandre; Hildebrandt, Friedhelm; Saunier, Sophie			Mutations of CEP83 Cause Infantile Nephronophthisis and Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL CILIOPATHIES; MOTHER CENTRIOLE; CAUSE JEUNE; CILIARY; DOCKING; CEP164; DEFECTS; DISEASE; COMPLEX	Ciliopathies are a group of hereditary disorders associated with defects in cilia structure and function. The distal appendages (DAPs) of centrioles are involved in the docking and anchoring of the mother centriole to the cellular membrane during ciliogenesis. The molecular composition of DAPs was recently elucidated and mutations in two genes encoding DAPs components (CEP164/NPHP15, SCLT1) have been associated with human ciliopathies, namely nephronophthisis and orofaciodigital syndrome. To identify additional DAP components defective in ciliopathies, we independently performed targeted exon sequencing of 1,221 genes associated with cilia and 5 known DAP protein-encoding genes in 1,255 individuals with a nephronophthisis-related ciliopathy. We thereby detected biallelic mutations in a key component of DAP-encoding gene, CEP83, in seven families. All affected individuals had early-onset nephronophthisis and four out of eight displayed learning disability and/or hydrocephalus. Fibroblasts and tubular renal cells from affected individuals showed an altered DAP composition and ciliary defects. In summary, we have identified mutations in CEP83, another DAP-component-encoding gene, as a cause of infantile nephronophthisis associated with central nervous system abnormalities in half of the individuals.	[Failler, Marion; Krug, Pauline; Belkacem, Lilya; Filhol, Emilie; Frigo, Amandine; Salomon, Remi; Gubler, Marie-Claire; Antignac, Corinne; Benmerah, Alexandre; Saunier, Sophie] INSERM, UMR 1163, Lab Inherited Kidney Dis, F-75015 Paris, France; [Failler, Marion; Krug, Pauline; Belkacem, Lilya; Filhol, Emilie; Frigo, Amandine; Masson, Cecile; Gubler, Marie-Claire; Antignac, Corinne; Benmerah, Alexandre; Saunier, Sophie] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, F-75015 Paris, France; [Gee, Heon Yung; Halbritter, Jan; Porath, Jonathan D.; Braun, Daniela A.; Schueler, Markus; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Dept Med, Div Nephrol,Boston Childrens Hosp, Boston, MA 02115 USA; [Krug, Pauline; Salomon, Remi; Gubler, Marie-Claire] Hop Necker Enfants Malad, AP HP, Dept Pediat Nephrol, F-75015 Paris, France; [Joo, Kwangsic; Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Alibeu, Olivier] Imagine Inst, Genom Core Facil, F-75015 Paris, France; [Brochard, Karine] Toulouse Hosp, Dept Pediat, F-31400 Toulouse, France; [de Ligny, Bruno Hurault] Clemenceau Hosp, Dept Nephrol, F-14033 Caen, France; [Novo, Robert] Jeanne de Flandre Hosp, Dept Pediat Nephrol, F-59037 Lille, France; [Pietrement, Christine] Amer Mem Hosp, Dept Pediat, F-51092 Reims, France; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Med Genet Dept, Istanbul, Turkey; [Salomon, Remi] Hop Necker Enfants Malad, AP HP, Ctr Reference Malad Renales Hereditaires Enfant &, F-75015 Paris, France; [Otto, Edgar A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48019 USA; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Korea Advanced Institute of Science & Technology (KAIST); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU de Caen NORMANDIE; Universite de Lille - ISITE; CHU Lille; CHU de Reims; Universite de Reims Champagne-Ardenne; Istanbul University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Nephrol,Boston Childrens Hosp, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu; sophie.saunier@inserm.fr	Kayserili, Hülya/AAA-5593-2021; benmerah, alexandre/H-3742-2017; Gee, Heon Yung/K-7781-2019; Braun, Daniela A/R-2259-2017; ANTIGNAC, Corinne/H-8945-2017; Kim, Joon/C-1833-2011; Schueler, Markus/AAF-6057-2021; Saunier, Sophie/G-6044-2015	Kayserili, Hülya/0000-0003-0376-499X; benmerah, alexandre/0000-0003-0188-8016; Gee, Heon Yung/0000-0002-8741-6177; Braun, Daniela A/0000-0003-3146-1566; ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047; Otto, Edgar/0000-0002-2387-9973; Gubler, Marie-Claire/0000-0002-3526-5661; Alibeu, Olivier/0000-0001-7984-8378	NIH [DK068306]; "Agence Nationale de la Recherche" (ANR) [20100BLAN112202, ANR-10-IAHY-01]; Fondation pour la Recherche Medicale (FRM) [DEQ20071210558, DEA20120624188]; Region ile de France, CORDDIM [RPH12173KKA]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Agence Nationale de la Recherche" (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region ile de France, CORDDIM(Region Ile-de-France); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the families who contributed to this study. We thank Vivette D. D'Agati and Michael B. Stokes (Columbia University) for a kidney biopsy report and images, as well as Gerard Pivert (Pathology Department, Necker Hospital) for kidney biopsy. We are grateful to James Sillibourne for his kind gift of the CEP89 antibody. We also thank Patrick Nitschke and the bioinformatic Plateform (Universite Paris Descartes, Institut Imagine) as well as Christine Bole-Feysot, Solenn Pruvost, and Mohammed Zarhrate for their support in exome sequencing and Ludovic Lecompte and Lucie Sengmanivong from the Nikon Imaging Centre at Institut Curie-CNRS (Paris, France) for the help with the n-SIM. This research was supported by a grant from the NIH to F.H. (DK068306). H.Y.G. is a Research Fellow of the American Society of Nephrology (ASN). F.H. is an Investigator of the Howard Hughes Medical Institute and Warren E. Grupe Professor of Pediatrics at the Harvard Medical School. This work was supported by grants from the "Agence Nationale de la Recherche" (ANR) to S.S. (20100BLAN112202) and investments for the future program-ANR-10-IAHY-01 to S.S., the "Fondation pour la Recherche Medicale" (FRM) to S.S. (DEQ20071210558) and to P.K. (DEA20120624188); M.F. is supported by a fellowship from the "Region ile de France, CORDDIM" (RPH12173KKA).	Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Arts HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/s00467-012-2259-9; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Delous M., 2013, DRUG DISCOV TODAY DI; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huber C, 2013, AM J HUM GENET, V93, P926, DOI 10.1016/j.ajhg.2013.10.007; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Morga Benjamin, 2013, Cilia, V2, P16, DOI 10.1186/2046-2530-2-16; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Schmidt KN, 2012, J CELL BIOL, V199, P1083, DOI 10.1083/jcb.201202126; Schmidts M, 2013, AM J HUM GENET, V93, P932, DOI 10.1016/j.ajhg.2013.10.003; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Thomas S, 2012, AM J HUM GENET, V91, P372, DOI 10.1016/j.ajhg.2012.06.017; Tory K, 2009, KIDNEY INT, V75, P839, DOI 10.1038/ki.2008.662	29	63	66	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					905	914		10.1016/j.ajhg.2014.05.002	http://dx.doi.org/10.1016/j.ajhg.2014.05.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24882706	Bronze, Green Published			2022-12-18	WOS:000337331200011
J	Riazuddin, SA; Vasanth, S; Katsanis, N; Gottsch, JD				Riazuddin, S. Amer; Vasanth, Shivakumar; Katsanis, Nicholas; Gottsch, John D.			Mutations in AGBL1 Cause Dominant Late-Onset Fuchs Corneal Dystrophy and Alter Protein-Protein Interaction with TCF4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE MUTATIONS; ENDOTHELIAL DYSTROPHY; LOCUS; COL8A2; GENE; COLLAGEN; LINKAGE	Fuchs corneal dystrophy (FCD) is a hereditary dystrophy of the corneal endothelium and is responsible for majority of the comeal transplantation performed in the United States. Here, we describe three generations of a family with 12 individuals affected by late-onset FCD and in which three individuals are unaffected. Genome-wide mapping provided suggestive linkage at two loci on chromosomal arms 3p and 15q. Alleles at either locus alone were not sufficient to explain FCD; however, considered together, both loci could explain the disorder in this pedigree. Subsequent next-generation sequencing identified a nonsense mutation in AGBL1 in the 15q locus; this mutation would result in a premature termination of AGBL1. Consistent with a causal role for this transcript, further sequencing of our cohort of late-onset-FCD-affected individuals identified two cases harboring the same nonsense mutation and a further three unrelated individuals bearing a second missense allele. AGBL1 encodes a glutamate decarboxylase previously identified in serial analysis of gene expression of corneal endothelium, a finding confirmed by immunohistochemical staining. Wild-type AGBL1 localizes predominantly to the cytoplasm; in sharp contrast, the truncated protein showed distinct nuclear localization. Finally, we show that AGBL1 interacts biochemically with the FCD-associated protein TCF4 and that the mutations found in our cohort of FCD individuals diminish this interaction. Taken together, our data identify a locus for FCD, extend the complex genetic architecture of the disorder, provide direct evidence for the involvement of TCF4 in FCD pathogenesis, and begin to explain how causal FCD mutations affect discrete biochemical complexes.	[Riazuddin, S. Amer; Gottsch, John D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Vasanth, Shivakumar; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27709 USA	Johns Hopkins University; Johns Hopkins Medicine; Duke University	Gottsch, JD (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA.	jgottsch@jhmi.edu		Katsanis, Nicholas/0000-0002-2480-0171	National Eye Institute [R01EY016835]; Kwok Research Fund; NATIONAL EYE INSTITUTE [R01EY016835] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Kwok Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank all family members for their participation in this study. None of the contributing authors have any financial interest related to this work. This study was supported in part by National Eye Institute Grant R01EY016835 and the Kwok Research Fund. J.D.G. is the Margaret C. Mosher Professor of Ophthalmology. N.K. is a Distinguished Brumley Professor.	Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Goar E L, 1933, Trans Am Ophthalmol Soc, V31, P48; Gottsch JD, 2006, CORNEA, V25, P485, DOI 10.1097/01.ico.0000178726.11693.14; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Mannis MJ, 2006, CORNEA, V25, P164; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; WILSON SE, 1988, CORNEA, V7, P2	23	63	69	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					758	764		10.1016/j.ajhg.2013.08.010	http://dx.doi.org/10.1016/j.ajhg.2013.08.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094747	Bronze, Green Published			2022-12-18	WOS:000326305600018
J	Roosing, S; Rohrschneider, K; Beryozkin, A; Sharon, D; Weisschuh, N; Staller, J; Kohl, S; Zelinger, L; Peters, TA; Neveling, K; Strom, TM; van den Bom, LI; Hoyng, CB; Klaver, CCW; Roepman, R; Wissinger, B; Banin, E; Cremers, FPM; den Hollander, AI				Roosing, Susanne; Rohrschneider, Klaus; Beryozkin, Avigail; Sharon, Dror; Weisschuh, Nicole; Staller, Jennifer; Kohl, Susanne; Zelinger, Lina; Peters, Theo A.; Neveling, Kornelia; Strom, Tim M.; van den Bom, L. Ingeborgh; Hoyng, Carel B.; Klaver, Caroline C. W.; Roepman, Ronald; Wissinger, Bernd; Banin, Eyal; Cremers, Frans P. M.; den Hollander, Anneke I.		European Retinal Dis Consortium	Mutations in RAB28, Encoding a Farnesylated Small GTPase, Are Associated with Autosomal-Recessive Cone-Rod Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POST-GOLGI TRAFFICKING; RETINITIS-PIGMENTOSA; GENE; PROTEIN; RHODOPSIN; TRANSPORT; ORTHOLOG; RPGRIP1L; RAB11	The majority of the genetic causes of autosomal-recessive (ar) cone-rod dystrophy (CRD) are currently unknown. A combined approach of homozygosity mapping and exome sequencing revealed a homozygous nonsense mutation (c.565C>T [p.G1u189*]) in RAB28 in a German family with three siblings with arCRD. Another homozygous nonsense mutation (c.409C>T [p.Arg137*]) was identified in a family of Moroccan Jewish descent with two siblings affected by arCRD. All five affected individuals presented with hyperpigmentation in the macula, progressive loss of the visual acuity, atrophy of the retinal pigment epithelium, and severely reduced cone and rod responses on the electroretinogram. RAB28 encodes a member of the Rab subfamily of the RAS-related small GTPases. Alternative RNA splicing yields three predicted protein isoforms with alternative C-termini, which are all truncated by the nonsense mutations identified in the arCRD families in this report. Opposed to other Rab GTPases that are generally geranylgeranylated, RAB28 is predicted to be farnesylated. Staining of rat retina showed localization of RAB28 to the basal body and the ciliary rootlet of the photoreceptors. Analogous to the function of other RAB family members, RAB28 might be involved in ciliary transport in photoreceptor cells. This study reveals a crucial role for RAB28 in photoreceptor function and suggests that mutations in other Rab proteins may also be associated with retinal dystrophies.	[Roosing, Susanne; Neveling, Kornelia; Roepman, Ronald; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Roosing, Susanne; Peters, Theo A.; Roepman, Ronald; Cremers, Frans P. M.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Roosing, Susanne; Neveling, Kornelia; Roepman, Ronald; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Rohrschneider, Klaus] Heidelberg Univ, Dept Ophthalmol, D-69120 Heidelberg, Germany; [Beryozkin, Avigail; Sharon, Dror; Zelinger, Lina; Banin, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Weisschuh, Nicole; Staller, Jennifer; Kohl, Susanne; Wissinger, Bernd] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Peters, Theo A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [van den Bom, L. Ingeborgh] Rotterdam Eye Hosp, NL-3000 LM Rotterdam, Netherlands; [Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; [Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands; [Klaver, Caroline C. W.] Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Ruprecht Karls University Heidelberg; Hebrew University of Jerusalem; Hadassah University Medical Center; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Rotterdam Eye Hospital; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	a.denhollander@ohk.umcn.nl	Hoyng, C.B./H-8050-2014; Klaver, Caroline C.W./A-2013-2016; Neveling, K./L-4544-2015; Hollander, Anneke den/N-4911-2014; Cremers, Frans/A-5625-2014; Roosing, Susanne/F-1616-2018; Sharon, Dror/P-4539-2015; Roosing, Susanne/AAK-3454-2020; Roepman, Ronald/B-1339-2014; Zelinger, Lina/L-3272-2019; Roosing, Susanne/ABF-9604-2021; Peters, T.A./L-4571-2015	Cremers, Frans/0000-0002-4954-5592; Roosing, Susanne/0000-0001-9038-0067; Sharon, Dror/0000-0002-1789-5811; Roosing, Susanne/0000-0001-9038-0067; Roepman, Ronald/0000-0002-5178-8163; Roosing, Susanne/0000-0001-9038-0067; Peters, T.A./0000-0001-8443-5500; Klaver, Caroline/0000-0002-2355-5258; Rohrschneider, Klaus/0000-0003-1996-7935; Kohl, Susanne/0000-0002-6438-6331; Zelinger, Lina/0000-0003-3028-7172	Foundation Fighting Blindness USA [BR-GE-0510-04890RAD, C-GE-0811-0545-RAD01, BR-GE-0510-0490-HUD]; Yedidut Research Grant; BMBF grant [01GM1108A]; German Ministry of Education and Research [01GR0802, 01GM0867]; European Commission (GEUVADIS) [261123]	Foundation Fighting Blindness USA; Yedidut Research Grant; BMBF grant(Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission (GEUVADIS)(European Commission)	We thank the individuals and their families for participating in this study. We thank Riet Bernaerts-Biskop, Rob W.J. Collin, Christian F.H.A. Gilissen, Arjen Henkes, Michael P. Kwint, Hans Scheffer, Marloes Steehouwer, Saskia D. van der Velde-Visser, Joris A. Veltman, Nienke A.W. Wieskamp, and Marijke Zonneveld for their valuable advice or expert assistance. We are thankful to Jose S. Ramalho for providing the pEGFP-RAB28 construct. We thank other members of the European Retinal Disease Consortium (Elfride De Baere, Tamar Ben-Yosef, Alejandro Garanto, Robert K. Koenekoop, Bart P. Leroy, Alberta A.H.J. Thiadens) for providing valuable samples and expertise. This study was financially supported by the Foundation Fighting Blindness USA (grants BR-GE-0510-04890RAD, C-GE-0811-0545-RAD01, and BR-GE-0510-0490-HUD to A.I.d.H, F.P.M.C., and D.S., the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, the Gelderse Blinden Stichting, the Landelijke Stichting voor Blinden en Slechtzienden, the Stichting Blinden-Penning, the Stichting Macula Degeneratie fonds, and the Rotterdamse Stichting Blindenbelangen (to F.P.M.C. and C.C.W.K.), by the Yedidut Research Grant (to E.B.), a Netherlands Organization for Scientific Research (NWO Vidi-91786396 and Vici-016.130.664 to R.R.), and a BMBF grant (01GM1108A) to B.W. and S.K.. The work was supported by the German Ministry of Education and Research (01GR0802 and 01GM0867) and the European Commission 7th Framework Program (261123, GEUVADIS) to T.M.S.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Brauers A, 1996, EUR J BIOCHEM, V237, P833, DOI 10.1111/j.1432-1033.1996.0833p.x; Coene KLM, 2011, HUM MOL GENET, V20, P3592, DOI 10.1093/hmg/ddr280; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 1997, ELECTROPHORESIS, V18, P2537, DOI 10.1002/elps.1150181408; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Estrada-Cuzcano A, 2012, AM J HUM GENET, V90, P102, DOI 10.1016/j.ajhg.2011.11.015; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Roosing S, 2013, OPHTHALMOLOGY, V120, P1239, DOI 10.1016/j.ophtha.2012.12.005; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Stenmark H, 2001, GENOME BIOL, V2; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; Tuson M, 2004, AM J HUM GENET, V74, P128, DOI 10.1086/381055; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Zangen D, 2011, AM J HUM GENET, V89, P572, DOI 10.1016/j.ajhg.2011.09.006	33	63	66	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					110	117		10.1016/j.ajhg.2013.05.005	http://dx.doi.org/10.1016/j.ajhg.2013.05.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746546	Bronze, Green Published			2022-12-18	WOS:000321804500010
J	Danhauser, K; Sauer, SW; Haack, TB; Wieland, T; Staufner, C; Graf, E; Zschocke, J; Strom, TM; Traub, T; Okun, JG; Meitinger, T; Hoffmann, GF; Prokisch, H; Kolker, S				Danhauser, Katharina; Sauer, Sven W.; Haack, Tobias B.; Wieland, Thomas; Staufner, Christian; Graf, Elisabeth; Zschocke, Johannes; Strom, Tim M.; Traub, Thorsten; Okun, Juergen G.; Meitinger, Thomas; Hoffmann, Georg F.; Prokisch, Holger; Koelker, Stefan			DHTKD1 Mutations Cause 2-Aminoadipic and 2-Oxoadipic Aciduria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-AMINOADIPIC ACIDURIA; LYSINE METABOLISM; MITOCHONDRIAL	Abnormalities in metabolite profiles are valuable indicators of underlying pathologic conditions at the molecular level. However, their interpretation relies on detailed knowledge of the pathways, enzymes, and genes involved. Identification and characterization of their physiological function are therefore crucial for our understanding of human disease: they can provide guidance for therapeutic intervention and help us to identify suitable biomarkers for monitoring associated disorders. We studied two individuals with 2-aminoadipic and 2-oxoadipic aciduria, a metabolic condition that is still unresolved at the molecular level. This disorder has been associated with varying neurological symptoms. Exome sequencing of a single affected individual revealed compound heterozygosity for an initiating methionine mutation (c.1A>G) and a missense mutation (c.2185G>A [p.Gly729Arg]) in DHTKD1. This gene codes for dehydrogenase El and transketolase domain-containing protein 1, which is part of a 2-oxoglutarate-dehydrogenase-complex-like protein. Sequence analysis of a second individual identified the same missense mutation together with a nonsense mutation (c.1228C>T [p.Arg410*]) in DHTKD1. Increased levels of 2-oxoadipate in individual-derived fibroblasts normalized upon lentiviral expression of the wild-type DHTKD1 mRNA. Moreover, investigation of L-lysine metabolism showed an accumulation of deuterium-labeled 2-oxoadipate only in noncomplemented cells, demonstrating that DHTKD1 codes for the enzyme mediating the last unresolved step in the L-lysine-degradation pathway. All together, our results establish mutations in DHTKD1 as a cause of human 2-aminoadipic and 2-oxoadipic aciduria via impaired turnover of decarboxylation 2-oxoadipate to glutaryl-CoA.	[Danhauser, Katharina; Haack, Tobias B.; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Danhauser, Katharina; Haack, Tobias B.; Wieland, Thomas; Graf, Elisabeth; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Sauer, Sven W.; Staufner, Christian; Traub, Thorsten; Okun, Juergen G.; Hoffmann, Georg F.; Koelker, Stefan] Univ Childrens Hosp, Div Inherited Metab Dis, Dept Gen Pediat, D-69120 Heidelberg, Germany; [Zschocke, Johannes] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Innsbruck	Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.	prokisch@helmholtz-muenchen.de	Meitinger, Thomas/O-1318-2015; Prokisch, Holger/N-8964-2013; Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286	Systems Biology of Metabotypes grant [SysMBo 0315494A]; German Federal Ministry of Education and Research; German Network for Mitochondrial Disorders [mitoNET 01GM1113c]; E-Rare project GENOMIT [01GM1207]; European Commission [261123]; Genetic European Variation in Disease Consortium; German Ministry for Education and Research [01GR0804-4]	Systems Biology of Metabotypes grant; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders; E-Rare project GENOMIT; European Commission(European CommissionEuropean Commission Joint Research Centre); Genetic European Variation in Disease Consortium; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	We thank the affected individuals and their families for participation in the study. We acknowledge the technical support of Evelyn Botz and Carola Fischer. T.M. and H.P. were supported by the Systems Biology of Metabotypes grant (SysMBo 0315494A) funded by the German Federal Ministry of Education and Research, the German Network for Mitochondrial Disorders (mitoNET 01GM1113c), and the E-Rare project GENOMIT (01GM1207). T.M. and T.M.S. were supported by the European Commission 7th Framework Program (N. 261123), the Genetic European Variation in Disease Consortium, and the German Ministry for Education and Research (01GR0804-4).	Bunik VI, 2008, PROTEINS, V71, P874, DOI 10.1002/prot.21766; Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004; DURAN M, 1984, J INHERIT METAB DIS, V7, P61, DOI 10.1007/BF01805803; Fiermonte G, 2001, J BIOL CHEM, V276, P8225, DOI 10.1074/jbc.M009607200; Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005; PRZYREMBEL H, 1975, CLIN CHIM ACTA, V58, P257, DOI 10.1016/0009-8981(75)90445-3; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Sahm F, 2012, BRAIN PATHOL, V22, P26, DOI 10.1111/j.1750-3639.2011.00506.x; Sauer SW, 2011, BRAIN, V134, P157, DOI 10.1093/brain/awq269; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Vallat C, 1996, EPILEPSIA, V37, P803, DOI 10.1111/j.1528-1157.1996.tb00655.x	11	63	68	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1082	1087		10.1016/j.ajhg.2012.10.006	http://dx.doi.org/10.1016/j.ajhg.2012.10.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23141293	Green Published, Bronze			2022-12-18	WOS:000312417400011
J	Carmignac, V; Thevenon, J; Ades, L; Callewaert, B; Julia, S; Thauvin-Robinet, C; Gueneau, L; Courcet, JB; Lopez, E; Holman, K; Renard, M; Plauchu, H; Plessis, G; De Backer, J; Child, A; Arno, G; Duplomb, L; Callier, P; Aral, B; Vabres, P; Gigot, N; Arbustini, E; Grasso, M; Robinson, PN; Goizet, C; Baumann, C; Di Rocco, M; Del Pozo, JS; Huet, F; Jondeau, G; Collod-Beroud, G; Beroud, C; Amiel, J; Cormier-Daire, V; Riviere, JB; Boileau, C; De Paepe, A; Faivre, L				Carmignac, Virginie; Thevenon, Julien; Ades, Lesley; Callewaert, Bert; Julia, Sophie; Thauvin-Robinet, Christel; Gueneau, Lucie; Courcet, Jean-Benoit; Lopez, Estelle; Holman, Katherine; Renard, Marjolijn; Plauchu, Henri; Plessis, Ghislaine; De Backer, Julie; Child, Anne; Arno, Gavin; Duplomb, Laurence; Callier, Patrick; Aral, Bernard; Vabres, Pierre; Gigot, Nadege; Arbustini, Eloisa; Grasso, Maurizia; Robinson, Peter N.; Goizet, Cyril; Baumann, Clarisse; Di Rocco, Maja; Sanchez Del Pozo, Jaime; Huet, Frederic; Jondeau, Guillaume; Collod-Beroud, Gwenaelle; Beroud, Christophe; Amiel, Jeanne; Cormier-Daire, Valerie; Riviere, Jean-Baptiste; Boileau, Catherine; De Paepe, Anne; Faivre, Laurence			In-Frame Mutations in Exon 1 of SKI Cause Dominant Shprintzen-Goldberg Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CRANIOSYNOSTOSIS; PROTOONCOGENE; REPRESSION; DACHSHUND; MICE	Shprintzen-Goldberg syndrome (SGS) is characterized by severe marfanoid habitus, intellectual disability, camptodactyly, typical facial dysmorphism, and craniosynostosis. Using family-based exome sequencing, we identified a dominantly inherited heterozygous inframe deletion in exon 1 of SKI. Direct sequencing of SKI further identified one overlapping heterozygous in-frame deletion and ten heterozygous missense mutations affecting recurrent residues in 18 of the 19 individuals screened for SGS; these individuals included one family affected by somatic mosaicism. All mutations were located in a restricted area of exon 1, within the R-SMAD binding domain of SKI. No mutation was found in a cohort of 11 individuals with other marfanoid-craniosynostosis phenotypes. The interaction between SKI and Smad2/3 and Smad 4 regulates TGF-beta signaling, and the pattern of anomalies in Ski-deficient mice corresponds to the clinical manifestations of SGS. These findings define SGS as a member of the family of diseases associated with the TGF-beta-signaling pathway.	[Carmignac, Virginie; Thevenon, Julien; Thauvin-Robinet, Christel; Gueneau, Lucie; Courcet, Jean-Benoit; Lopez, Estelle; Duplomb, Laurence; Callier, Patrick; Aral, Bernard; Vabres, Pierre; Gigot, Nadege; Huet, Frederic; Riviere, Jean-Baptiste; Faivre, Laurence] Univ Bourgogne, Equipe Genet Anomalies Dev, Equipe Accueil 4271, F-21079 Dijon, France; [Thevenon, Julien; Thauvin-Robinet, Christel; Faivre, Laurence] Hop Enfants, Ctr Genet, F-21079 Dijon, France; [Thevenon, Julien; Thauvin-Robinet, Christel; Faivre, Laurence] Hop Enfants, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Ades, Lesley; Holman, Katherine] Childrens Hosp Westmead, Marfan Res Grp, Sydney, NSW 2006, Australia; [Ades, Lesley; Holman, Katherine] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Ades, Lesley; Holman, Katherine] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2006, Australia; [Callewaert, Bert; Renard, Marjolijn; De Backer, Julie; De Paepe, Anne] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Julia, Sophie] CHU Purpan, Serv Genet, F-31000 Toulouse, France; [Plauchu, Henri] Univ Lyon 1, Dept Genet, F-69977 Bron, France; [Plauchu, Henri] Hosp Civils Lyon, Hop Louis Pradel, F-69977 Bron, France; [Plessis, Ghislaine] CHU Caen, Serv Genet, F-14033 Caen 9, France; [Child, Anne; Arno, Gavin] St Georges Univ London, Dept Cardiac & Vasc Sci, London SW17 0RE, England; [Callier, Patrick] Ctr Hosp Univ, Cytogenet Serv, F-21079 Dijon, France; [Aral, Bernard] Ctr Hosp Univ, Serv Biol Mol, F-21079 Dijon, France; [Vabres, Pierre] Ctr Hosp Univ Bocage, Serv Dermatol, F-21079 Dijon, France; [Arbustini, Eloisa; Grasso, Maurizia] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, Ctr Inherited Cardiovasc Dis, I-27100 Pavia, Italy; [Robinson, Peter N.] Charite, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Goizet, Cyril] Ctr Hosp Univ Bordeaux, Hop Pellegrin, Serv Genet, Ctr Reference Anomalies Dev, F-33076 Bordeaux, France; [Goizet, Cyril] Univ Bordeaux, Lab Malad Rares Genet & Metab, Equipe Accueil 4576, F-33076 Bordeaux, France; [Baumann, Clarisse] Hop Robert Debre, AP HP, Serv Genet Med, F-75019 Paris, France; [Di Rocco, Maja] Gaslini Inst, Dept Pediat, Unit Rare Dis, I-16147 Genoa, Italy; [Sanchez Del Pozo, Jaime] Hosp 12 Octubre, Div Endocrinol, Dept Genet, Madrid 28041, Spain; [Jondeau, Guillaume] INSERM, U698, F-75877 Paris, France; [Jondeau, Guillaume] Hop Bichat Claude Bernard, AP HP, Ctr Reference Syndromes Marfan & Apparentes, F-75877 Paris, France; [Collod-Beroud, Gwenaelle; Beroud, Christophe] Univ Aix Marseille, INSERM, UMR S 910, F-13100 Marseille, France; [Beroud, Christophe; Amiel, Jeanne] Hop Enfants La Timone, Assistance Publ Hop Marseille, Dept Med Genet, F-13000 Marseille, France; [Cormier-Daire, Valerie] Univ Paris Descartes Sorbonne Paris Cite, Hop Necker Enfants Malad, AP HP, INSERM,Fdn Imagine,U781, F-75015 Paris, France; [Cormier-Daire, Valerie] Univ Paris Descartes Sorbonne Paris Cite, Hop Necker Enfants Malad, AP HP, Fdn Imagine,Dept Genet, F-75015 Paris, France; [Boileau, Catherine] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Lab Genet Mol, F-92104 Boulogne, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; University of Sydney; University of Sydney; University of Sydney; Ghent University; Ghent University Hospital; CHU de Toulouse; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU de Caen NORMANDIE; St Georges University London; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; IRCCS Fondazione San Matteo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS Istituto Giannina Gaslini; Hospital Universitario 12 de Octubre; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Faivre, L (corresponding author), Univ Bourgogne, Equipe Genet Anomalies Dev, Equipe Accueil 4271, F-21079 Dijon, France.	laurence.faivre@chu-dijon.fr	Vabres, Pierre/D-3906-2011; GOIZET, Cyril/M-4576-2014; boileau, catherine/M-4482-2017; De Backer, Julie/B-2897-2014; COLLOD-BEROUD, Gwenaëlle/A-8342-2008; Arbustini, Eloisa/K-8174-2016; amiel, jeanne/AGX-1124-2022; Callewaert, Bert/J-6357-2014; amiel, jeanne/H-3501-2017; Vabres, Pierre/V-3850-2019; BEROUD, Christophe/A-8381-2008; cormier-daire, valerie/H-6520-2017	Vabres, Pierre/0000-0001-8693-3183; GOIZET, Cyril/0000-0002-1913-889X; boileau, catherine/0000-0002-0371-7539; De Backer, Julie/0000-0001-8878-1507; COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; Arbustini, Eloisa/0000-0003-2948-7994; Callewaert, Bert/0000-0002-9743-4205; amiel, jeanne/0000-0001-5973-4728; Vabres, Pierre/0000-0001-8693-3183; BEROUD, Christophe/0000-0003-2986-8738; Frederic, HUET/0000-0002-4510-7093; Duplomb, Laurence/0000-0002-5715-3759; Faivre, Laurence/0000-0001-9770-444X; Robinson, Peter/0000-0002-0736-9199; cormier-daire, valerie/0000-0002-2839-9856; Grasso, Maurizia/0000-0003-2611-4295	GIS-Institut des Maladies Rares; French Ministry of Health; Regional Council of Burgundy; Genoscope; Fund for Scientific Research, Flanders; Ghent University [BOF 08/01M01108]; Flemish government; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]	GIS-Institut des Maladies Rares; French Ministry of Health; Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Genoscope; Fund for Scientific Research, Flanders(FWO); Ghent University(Ghent University); Flemish government(European Commission); Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project	The authors thank the GIS-Institut des Maladies Rares for funding of the high-throughput-sequencing approach of the targeted region, the French Ministry of Health (PHRC national 2008) and Regional Council of Burgundy for their financial support of the project, the Genoscope (especially Vincent Meyer) and IntegraGen for technical assistance, and the families. The authors also thank Valerie Serre for her helpful comments regarding protein modeling. B.C. and J.D.B. are, respectively, postdoctoral and senior clinical researchers from the Fund for Scientific Research, Flanders. A.D.P. is a holder of a Methusalem grant (BOF 08/01M01108) from Ghent University and the Flemish government. Finally, the authors would like to thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). The authors thank Julie Plaisancie for the phenotyping of family 3.	ADES LC, 1995, AM J MED GENET, V57, P565, DOI 10.1002/ajmg.1320570410; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson J, 2006, DEV BIOL, V297, P536, DOI 10.1016/j.ydbio.2006.05.004; Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001; Baranek C, 2012, EPIGENETICS-US, V7, P676, DOI 10.4161/epi.20590; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kim KO, 2012, J CELL BIOCHEM, V113, P2156, DOI 10.1002/jcb.24089; Kosaki K, 2006, AM J MED GENET A, V140A, P104, DOI 10.1002/ajmg.a.31006; Le Goff C, 2012, AM J MED GENET C, V160C, P145, DOI 10.1002/ajmg.c.31337; Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Megarbane A, 1998, AM J MED GENET, V77, P170, DOI 10.1002/(SICI)1096-8628(19980501)77:2<170::AID-AJMG13>3.0.CO;2-K; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson PN, 2005, AM J MED GENET A, V135A, P251, DOI 10.1002/ajmg.a.30431; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; Van Lierde KM, 2007, INT J PEDIATR OTORHI, V71, P721, DOI 10.1016/j.ijporl.2007.01.009; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2	24	63	65	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					950	957		10.1016/j.ajhg.2012.10.002	http://dx.doi.org/10.1016/j.ajhg.2012.10.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103230	Green Published, Bronze			2022-12-18	WOS:000311011400019
J	Vedrenne, V; Gowher, A; De Lonlay, P; Nitschke, P; Serre, V; Boddaert, N; Altuzarra, C; Mager-Heckel, AM; Chretien, F; Entelis, N; Munnich, A; Tarassov, I; Rotig, A				Vedrenne, Vanessa; Gowher, Ali; De Lonlay, Pascale; Nitschke, Patrick; Serre, Valerie; Boddaert, Nathalie; Altuzarra, Cecilia; Mager-Heckel, Anne-Marie; Chretien, Florence; Entelis, Nina; Munnich, Arnold; Tarassov, Ivan; Roetig, Agnes			Mutation in PNPT1, which Encodes a Polyribonucleotide Nucleotidyltransferase, Impairs RNA Import into Mitochondria and Causes Respiratory-Chain Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CULTURED HUMAN-CELLS; POLYNUCLEOTIDE PHOSPHORYLASE; RIBOSOMAL-RNA; ORGANELLES; DISORDERS	Multiple-respiratory-chain deficiency represents an important cause of mitochondria! disorders. Hitherto, however, mutations in genes involved in mtDNA maintenance and translation machinery only account for a fraction of cases. Exome sequencing in two siblings, born to consanguineous parents, with severe encephalomyopathy, choreoathetotic movements, and combined respiratory-chain defects allowed us to identify a homozygous PNPT1 missense mutation (c.1160A>G) that encodes the mitochondrial polynucleotide phosphorylase (PNPase). Blue-native polyacrylamide gel electrophoresis showed that no PNPase complex could be detected in subject fibroblasts, confirming that the substitution encoded by c.1160A>G disrupts the trimerization of the protein. PNPase is predominantly localized in the mitochondrial intermembrane space and is implicated in RNA targeting to human mitochondria. Mammalian mitochondria import several small noncoding nuclear RNAs (SS rRNA, MRP RNA, some tRNAs, and miRNAs). By RNA hybridization experiments, we observed a significant decrease in 5S rRNA and MRP-related RNA import into mitochondria in fibroblasts of affected subject 1. Moreover, we found a reproducible decrease in the rate of mitochondrial translation in her fibroblasts. Finally, overexpression of the wild-type PNPT1 cDNA in fibroblasts of subject 1 induced an increase in SS rRNA import in mitochondria and rescued the mitochondrial-translation deficiency. In conclusion, we report here abnormal RNA import into mitochondria as a cause of respiratory-chain deficiency.	[Vedrenne, Vanessa; Serre, Valerie; Chretien, Florence; Munnich, Arnold; Roetig, Agnes] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Vedrenne, Vanessa; Serre, Valerie; Chretien, Florence; Munnich, Arnold; Roetig, Agnes] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Gowher, Ali; Mager-Heckel, Anne-Marie; Entelis, Nina; Tarassov, Ivan] Univ Strasbourg, UMR 7156, F-67084 Strasbourg, France; [Gowher, Ali; Mager-Heckel, Anne-Marie; Entelis, Nina; Tarassov, Ivan] CNRS, F-67084 Strasbourg, France; [De Lonlay, Pascale; Boddaert, Nathalie; Munnich, Arnold] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France; [Nitschke, Patrick] Plateforme Bioinformat Paris Descartes, F-75015 Paris, France; [Altuzarra, Cecilia] Hop St Jacques, Serv Pediat, F-25030 Besancon, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon	Rotig, A (corresponding author), Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, 149 Rue Sevres, F-75015 Paris, France.	agnes.rotig@inserm.fr	boddaert, nathalie/GWV-2865-2022; Rötig, Agnès/G-9592-2017; Chretien, fabrice B/D-4035-2018	Rötig, Agnès/0000-0003-0589-0703; Chretien, fabrice B/0000-0002-2794-1383; boddaert, nathalie/0000-0003-0991-7774; Tarassov, Ivan/0000-0001-8763-6703; Entelis, Nina/0000-0002-7915-5528	Association Francaise contre les Myopathies; French Agence Nationale pour la Recherche; GIS-Institut des maladies rares; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale; National Program "Investissement d'Avenir" (Labex MitoCross); Higher Education Comission, Pakistan (SFERE doctoral fellowship)	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Agence Nationale pour la Recherche(French National Research Agency (ANR)); GIS-Institut des maladies rares; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Program "Investissement d'Avenir" (Labex MitoCross); Higher Education Comission, Pakistan (SFERE doctoral fellowship)	This research was supported in part by the Association Francaise contre les Myopathies, the French Agence Nationale pour la Recherche, the GIS-Institut des maladies rares, the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the Fondation pour la Recherche Medicale, and the National Program "Investissement d'Avenir" (Labex MitoCross). A.G. was supported by the Higher Education Comission, Pakistan (SFERE doctoral fellowship).	Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; Holt IJ, 2010, TRENDS GENET, V26, P103, DOI 10.1016/j.tig.2009.12.011; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Rotig A, 2010, DIABETES METAB, V36, P97, DOI 10.1016/j.diabet.2009.11.002; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Rubio MAT, 2011, WIRES RNA, V2, P802, DOI 10.1002/wrna.93; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Slomovic S, 2008, RNA, V14, P310, DOI 10.1261/rna.697308; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; TOPPER JN, 1990, NUCLEIC ACIDS RES, V18, P793, DOI 10.1093/nar/18.4.793; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	21	63	64	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					912	918		10.1016/j.ajhg.2012.09.001	http://dx.doi.org/10.1016/j.ajhg.2012.09.001			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23084291	Bronze, Green Published			2022-12-18	WOS:000311011400014
J	Need, AC; McEvoy, JP; Gennarelli, M; Heinzen, EL; Ge, DL; Maia, JM; Shianna, KV; He, M; Cirulli, ET; Gumbs, CE; Zhao, Q; Campbell, CR; Hong, L; Rosenquist, P; Putkonen, A; Hallikainen, T; Repo-Tiihonen, E; Tiihonen, J; Levy, DL; Meltzer, HY; Goldstein, DB				Need, Anna C.; McEvoy, Joseph P.; Gennarelli, Massimo; Heinzen, Erin L.; Ge, Dongliang; Maia, Jessica M.; Shianna, Kevin V.; He, Min; Cirulli, Elizabeth T.; Gumbs, Curtis E.; Zhao, Qian; Campbell, C. Ryan; Hong, Linda; Rosenquist, Peter; Putkonen, Anu; Hallikainen, Tero; Repo-Tiihonen, Eila; Tiihonen, Jari; Levy, Deborah L.; Meltzer, Herbert Y.; Goldstein, David B.			Exome Sequencing Followed by Large-Scale Genotyping Suggests a Limited Role for Moderately Rare Risk Factors of Strong Effect in Schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D DEFICIENCY; COMMON VARIANTS; GENETIC ASSOCIATION; COLLAPSING METHODS; IDENTIFICATION; EXPRESSION; DELETIONS; CLOZAPINE; DISEASES	Schizophrenia is a severe psychiatric disorder with strong heritability and marked heterogeneity in symptoms, course, and treatment response. There is strong interest in identifying genetic risk factors that can help to elucidate the pathophysiology and that might result in the development of improved treatments. Linkage and genome-wide association studies (GWASs) suggest that the genetic basis of schizophrenia is heterogeneous. However, it remains unclear whether the underlying genetic variants are mostly moderately rare and can be identified by the genotyping of variants observed in sequenced cases in large follow-up cohorts or whether they will typically be much rarer and therefore more effectively identified by gene-based methods that seek to combine candidate variants. Here, we consider 166 persons who have schizophrenia or schizoaffective disorder and who have had either their genomes or their exomes sequenced to high coverage. From these data, we selected 5,155 variants that were further evaluated in an independent cohort of 2,617 cases and 1,800 controls. No single variant showed a study-wide significant association in the initial or follow-up cohorts. However, we identified a number of case-specific variants, some of which might be real risk factors for schizophrenia, and these can be readily interrogated in other data sets. Our results indicate that schizophrenia risk is unlikely to be predominantly influenced by variants just outside the range detectable by GWASs. Rather, multiple rarer genetic variants must contribute substantially to the predisposition to schizophrenia, suggesting that both very large sample sizes and gene-based association tests will be required for securely identifying genetic risk factors.	[Need, Anna C.; Heinzen, Erin L.; Ge, Dongliang; Maia, Jessica M.; Shianna, Kevin V.; He, Min; Cirulli, Elizabeth T.; Gumbs, Curtis E.; Zhao, Qian; Campbell, C. Ryan; Hong, Linda; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Need, Anna C.; Heinzen, Erin L.; Shianna, Kevin V.] Duke Univ, Dept Med, Med Genet Sect, Durham, NC 27708 USA; [Need, Anna C.; McEvoy, Joseph P.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Gennarelli, Massimo] Ist Ricovero & Cura Carattere Sci, Genet Unit, Ctr San Giovanni Dio Fatebenefratelli, I-25123 Brescia, Italy; [Gennarelli, Massimo] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Biol & Genet Div, I-25121 Brescia, Italy; [Rosenquist, Peter] Wake Forest Univ, N Carolina Baptist Hosp, Dept Psychiat & Behav Med, Winston Salem, NC 27157 USA; [Putkonen, Anu; Hallikainen, Tero; Repo-Tiihonen, Eila; Tiihonen, Jari] Univ Eastern Finland, Dept Forens Psychiat, Niuvanniemi Hosp, FI-70240 Kuopio, Finland; [Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden; [Levy, Deborah L.] McLean Hosp, Psychol Res Lab, Belmont, MA 02478 USA; [Meltzer, Herbert Y.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Goldstein, David B.] Duke Univ, Sch Med, Dept Mol Genet Microbiol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; IRCCS Fatebenefratelli; University of Brescia; Wake Forest University; Wake Forest Baptist Medical Center; University of Eastern Finland; Karolinska Institutet; Harvard University; McLean Hospital; Northwestern University; Feinberg School of Medicine; Duke University	Need, AC (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	anna.need@duke.edu; d.goldstein@duke.edu	Gennarelli, Massimo/B-1377-2010; Goldstein, David/AAY-8125-2020; Tiihonen, Jari/G-3078-2012; Rosenquist, Peter/ABI-7803-2020; Gennarelli, Massimo/AAL-3542-2020; Meltzer, Herbert Y/E-8131-2013	Tiihonen, Jari/0000-0002-0400-6798; Rosenquist, Peter/0000-0002-4457-9048; Need, Anna/0000-0003-3955-8207; GENNARELLI, Massimo/0000-0003-4192-945X; Rosenquist, Peter/0000-0001-9919-3380; Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health (NIMH) [3RC2MH089915-01W1, MH071523]; National Institute of Allergy and Infectious Diseases [UO1AIO67854]; Italian Ministry of Health (Ricerca Corrente); Associazione Fatebenefratelli per la Ricerca grants; Ellison Funding; National Institute on Aging [AG028377]; Sidney R. Baer, Jr. Foundation; Essel Foundation; Carmela and Menachem Abraham Fund; Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915, R01MH071523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028377] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Associazione Fatebenefratelli per la Ricerca grants; Ellison Funding; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sidney R. Baer, Jr. Foundation; Essel Foundation; Carmela and Menachem Abraham Fund; Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the participants who made their DNA available for research. We thank Jordan Silver and Marlyne Silver; doctors and staff at Central Regional Hospital; Robert Millet, Edward Leuth, and other doctors and staff at Carolina Behavioral Care for local patient recruitment; and Latasha Little, Ken Cronin, Melora McCall, and Alex McKenzie for lab support. For the Italian cohort, we acknowledge Catia Scassellati and Cristian Bonvicini for sample handling and Stefano Bignotti, Giuseppe Rossi, and Alessandra Minelli for recruitment. We thank the Murdock study community registry and biorepository pro00011196, D. Daskalakis, R. Brown, A. Holden, E. Behr, W. Lowe, P. Lugar, J. Milner, K. Welsh-Bohmer, D. Valle, J. Hoover-Fong, D. Marchuk, S. Palmer, E. Pras, D. Lancet, and Z. Farfel for control DNA. This work was funded by National Institute of Mental Health (NIMH) grant 3RC2MH089915-01W1 and R01 grant MH071523, National Institute of Neurological Disorders and Stroke grant RC2NS070344, National Institute of Allergy and Infectious Diseases grant UO1AIO67854, Italian Ministry of Health (Ricerca Corrente) and Associazione Fatebenefratelli per la Ricerca grants, Ellison Funding, National Institute on Aging P30 grant AG028377, the Sidney R. Baer, Jr. Foundation, the Essel Foundation, the Carmela and Menachem Abraham Fund, and the Brain and Behavior Research Foundation. This research was performed in collaboration with the International Serious Adverse Events Consortium, whose membership includes Abbott, Amgen, Astra-Zeneca, Cerner, Daiichi-Sankyo, GlaxoSmithKline, Merck, Novartis, Pfizer, Takeda, and the Wellcome Trust. The NIMH Cell Repository at Rutgers University provided schizophrenia follow-up samples. H.Y.M. is a shareholder in SureGene, LLC.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amato R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-351; Antonarakis SE, 2010, NAT REV GENET, V11, P380, DOI 10.1038/nrg2793; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bassett Anne S, 2008, Curr Psychiatry Rep, V10, P148; Baulac S, 2010, CLIN LAB MED, V30, P911, DOI 10.1016/j.cll.2010.07.008; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Bernheim J, 2011, NEPHROL DIAL TRANSPL, V26, P2433, DOI 10.1093/ndt/gfr208; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Fiedler MJ, 2011, NEUROSIGNALS, V19, P75, DOI 10.1159/000324507; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Heinzen E.L., 2012, AM J HUM GENET; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Kosakai A, 2011, BRAIN RES, V1382, P109, DOI 10.1016/j.brainres.2011.01.056; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Meltzer HY, 1997, CURR MED RES OPIN, V14, P1, DOI 10.1185/03007999709113338; Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nitta Atsumi, 2010, Japanese Journal of Alcohol Studies & Drug Dependence, V45, P525; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Parra M, 2004, GENOMICS, V84, P637, DOI 10.1016/j.ygeno.2004.06.004; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rees E, 2011, BIOL PSYCHIAT, V70, P1109, DOI 10.1016/j.biopsych.2011.07.011; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Shen L, 2000, J NEUROSCI, V20, P7932; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sun YV, 2011, GENET EPIDEMIOL, V35, pS101, DOI 10.1002/gepi.20658; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	54	63	65	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					303	312		10.1016/j.ajhg.2012.06.018	http://dx.doi.org/10.1016/j.ajhg.2012.06.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22863191	Green Published, Bronze			2022-12-18	WOS:000307608700008
J	Romi, H; Cohen, I; Landau, D; Alkrinawi, S; Yerushalmi, B; Hershkovitz, R; Newman-Heiman, N; Cutting, GR; Ofir, R; Sivan, S; Birk, OS				Romi, Hila; Cohen, Idan; Landau, Daniella; Alkrinawi, Suliman; Yerushalmi, Baruch; Hershkovitz, Reli; Newman-Heiman, Nitza; Cutting, Garry R.; Ofir, Rivka; Sivan, Sara; Birk, Ohad S.			Meconium Ileus Caused by Mutations in GUCY2C, Encoding the CFTR-Activating Guanylate Cyclase 2C	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEAT-STABLE ENTEROTOXIN; DEPENDENT PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; INTESTINAL-OBSTRUCTION; GENETIC COMPARISONS; PUTATIVE RECEPTOR; HCO3-SECRETION; MODIFIER LOCUS; MICE LACKING	Meconium ileus, intestinal obstruction in the newborn, is caused in most cases by CFTR mutations modulated by yet-unidentified modifier genes. We now show that in two unrelated consanguineous Bedouin kindreds, an autosomal-recessive phenotype of meconium ileus that is not associated with cystic fibrosis (CF) is caused by different homozygous mutations in GUCY2C, leading to a dramatic reduction or fully abrogating the enzymatic activity of the encoded guanlyl cyclase 2C. GUCY2C is a transmembrane receptor whose extracellular domain is activated by either the endogenous ligands, guanylin and related peptide uroguanylin, or by an external ligand, Escherichia coli (E. coli) heat-stable enterotoxin STa. GUCY2C is expressed in the human intestine, and the encoded protein activates the CFTR protein through local generation of cGMP. Thus, GUCY2C is a likely candidate modifier of the meconium ileus phenotype in CF. Because GUCY2C heterozygous and homozygous mutant mice are resistant to E. coli STa enterotoxin-induced diarrhea, it is plausible that GUCY2C mutations in the desert-dwelling Bedouin kindred are of selective advantage.	[Romi, Hila; Cohen, Idan; Ofir, Rivka; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel; [Landau, Daniella; Alkrinawi, Suliman; Yerushalmi, Baruch; Newman-Heiman, Nitza] Soroka Med Ctr, Div Pediat, IL-84101 Beer Sheva, Israel; [Hershkovitz, Reli] Soroka Med Ctr, Div Obstet & Gynecol, IL-84101 Beer Sheva, Israel; [Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA; [Birk, Ohad S.] Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Johns Hopkins University; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Morris Kahn Lab Human Genet, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il	Cohen, Idan/ACB-5528-2022	Cohen, Idan/0000-0002-5524-2344; Birk, Ohad/0000-0003-1430-1296; Romi, Hila/0000-0003-4071-4334	U.S. Cystic Fibrosis Foundation; Morris Kahn Family Foundation; National Institutes of Health [NHLBI HL068927, NIDDK DK 044003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044003, R37DK044003] Funding Source: NIH RePORTER	U.S. Cystic Fibrosis Foundation; Morris Kahn Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded through a grant from the U.S. Cystic Fibrosis Foundation. We thank the Morris Kahn Family Foundation for the kind support. Facilities used were donated in part by the Wolfson Foundation and the Wolfson Family Charitable Trust. G.R.C. was supported through National Institutes of Health grants NHLBI HL068927 and NIDDK DK 044003.	Al-Majali AM, 2007, FEMS IMMUNOL MED MIC, V49, P35, DOI 10.1111/j.1574-695X.2006.00167.x; Al-Majali AM, 1999, LAB ANIM SCI, V49, P254; ALLAN JL, 1981, EUR J PEDIATR, V135, P291, DOI 10.1007/BF00442105; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; BLACK RE, 1981, LANCET, V1, P141; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; BOUE A, 1986, HUM GENET, V74, P288; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Cohen R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-65; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; CUTHBERT AW, 1994, BRIT J PHARMACOL, V112, P31, DOI 10.1111/j.1476-5381.1994.tb13024.x; Deering R., 2004, PEDIAT PULMONOL, V38, P189; Dorfman R, 2009, HUM GENET, V126, P763, DOI 10.1007/s00439-009-0724-8; Eggermont E, 1996, EUR J GASTROEN HEPAT, V8, P731; FAKHOURY K, 1992, ARCH DIS CHILD-FETAL, V67, P1204, DOI 10.1136/adc.67.10_Spec_No.1204; Feingold J, 1999, ANN GENET-PARIS, V42, P147; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; FORTE LR, 1995, FASEB J, V9, P643, DOI 10.1096/fasebj.9.8.7768356; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; GIANNELLA RA, 1981, ANNU REV MED, V32, P341, DOI 10.1146/annurev.me.32.020181.002013; GIANNELLA RA, 1995, J LAB CLIN MED, V125, P173; GOLDSTEIN JL, 1994, GASTROENTEROLOGY, V107, P950, DOI 10.1016/0016-5085(94)90218-6; Gorter RR, 2010, J PEDIATR GASTR NUTR, V50, P569, DOI 10.1097/MPG.0b013e3181bb3427; Grubb BR, 1997, AM J PHYSIOL-GASTR L, V273, pG258, DOI 10.1152/ajpgi.1997.273.2.G258; Guba M, 1996, GASTROENTEROLOGY, V111, P1558, DOI 10.1016/S0016-5085(96)70018-5; HAMOSH A, 1992, AM J HUM GENET, V51, P245; HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464; Hasegawa M, 2005, J PEPT RES, V65, P261, DOI 10.1111/j.1399-3011.2005.00218.x; JASOFRIEDMANN L, 1992, AM J VET RES, V53, P2251; Joo NS, 1998, AM J PHYSIOL-GASTR L, V274, pG633, DOI 10.1152/ajpgi.1998.274.4.G633; Kerem B, 1996, EUR J HUM GENET, V4, P65; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1989, J PEDIATR-US, V114, P767, DOI 10.1016/S0022-3476(89)80134-9; Koch C, 2001, PEDIATR PULM, V31, P1, DOI 10.1002/1099-0496(200101)31:1<1::AID-PPUL1000>3.0.CO;2-T; KRAUSE WJ, 1994, J ANAT, V184, P407; LANEY DW, 1992, AM J PHYSIOL, V263, pG816, DOI 10.1152/ajpgi.1992.263.5.G816; Loening-Baucke V, 1999, AM FAM PHYSICIAN, V60, P2043; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; MORNET E, 1988, LANCET, V1, P376; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; Rohlfs EM, 1998, GENET TEST, V2, P85, DOI 10.1089/gte.1998.2.85; ROSENSTEIN BJ, 1980, AM J DIS CHILD, V134, P72, DOI 10.1001/archpedi.1980.02130130054016; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; TAL A, 1985, CLIN PEDIATR, V24, P460, DOI 10.1177/000992288502400809; TIEN XY, 1994, J BIOL CHEM, V269, P51; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635; Zielenski J., 2005, PEDIAT PULMONOL, VS28, P206	57	63	67	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2012	90	5					893	899		10.1016/j.ajhg.2012.03.022	http://dx.doi.org/10.1016/j.ajhg.2012.03.022			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	940QG	22521417	Bronze, Green Published			2022-12-18	WOS:000303907500014
J	Im, HK; Gamazon, ER; Nicolae, DL; Cox, NJ				Im, Hae Kyung; Gamazon, Eric R.; Nicolae, Dan L.; Cox, Nancy J.			On Sharing Quantitative Trait GWAS Results in an Era of Multiple-omics Data and the Limits of Genomic Privacy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE ASSOCIATION; INFORMATION	Recent advances in genome-scale, system-level measurements of quantitative phenotypes (transcriptome, metabolome, and proteome) promise to yield unprecedented biological insights. In this environment, broad dissemination of results from genome-wide association studies (GWASs) or deep-sequencing efforts is highly desirable. However, summary results from case-control studies (allele frequencies) have been withdrawn from public access because it has been shown that they can be used for inferring participation in a study if the individual's genotype is available. A natural question that follows is how much private information is contained in summary results from quantitative trait GWAS such as regression coefficients or p values. We show that regression coefficients for many SNPs can reveal the person's participation and for participants his or her phenotype with high accuracy. Our power calculations show that regression coefficients contain as much information on individuals as allele frequencies do, if the person's phenotype is rather extreme or if multiple phenotypes are available as has been increasingly facilitated by the use of multiple-omics data sets. These findings emphasize the need to devise a mechanism that allows data sharing that will facilitate scientific progress without sacrificing privacy protection.	[Im, Hae Kyung] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Gamazon, Eric R.; Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan L.; Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Im, HK (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	haky@uchicago.edu; ncox@bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Im, Hae Kyung/0000-0003-0333-5685; Nicolae, Dan/0000-0002-0918-4630	Genotype-Tissue Expression project [R01 MH090937]; University of Chicago DRTC (Diabetes Research and Training Center) [P60 DK20595]; Juvenile Diabetes Research Foundation; Centers for Disease Control; Special Statutory Funding Program for Type 1 Diabetes Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090937] Funding Source: NIH RePORTER	Genotype-Tissue Expression project; University of Chicago DRTC (Diabetes Research and Training Center); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Special Statutory Funding Program for Type 1 Diabetes Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Genotype-Tissue Expression project (R01 MH090937) and the University of Chicago DRTC (Diabetes Research and Training Center; P60 DK20595). The GoKinD study was conducted by the GoKinD investigators and supported by the Juvenile Diabetes Research Foundation, the Centers for Disease Control, and the Special Statutory Funding Program for Type 1 Diabetes Research administered by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This manuscript was not prepared in collaboration with Investigators of the GoKinD study and does not necessarily reflect the opinions or views of the GoKinD study or the NIDDK.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2010, R LANG ENV STAT COMP; Fisher RA, 1925, STAT METHODS RES WOR; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; Johnson AD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002269; Lumley T, 2010, JAMA-J AM MED ASSOC, V303, P659, DOI 10.1001/jama.2010.120; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Pluzhnikov A, 2010, AM J HUM GENET, V87, P123, DOI 10.1016/j.ajhg.2010.06.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sankararaman S, 2009, NAT GENET, V41, P965, DOI 10.1038/ng.436; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Visscher PM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000628	16	63	65	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					591	598		10.1016/j.ajhg.2012.02.008	http://dx.doi.org/10.1016/j.ajhg.2012.02.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22463877	Green Published, Bronze			2022-12-18	WOS:000302833400002
J	Yoneda, Y; Haginoya, K; Arai, H; Yamaoka, S; Tsurusaki, Y; Doi, H; Miyake, N; Yokochi, K; Osaka, H; Kato, M; Matsumoto, N; Saitsu, H				Yoneda, Yuriko; Haginoya, Kazuhiro; Arai, Hiroshi; Yamaoka, Shigeo; Tsurusaki, Yoshinori; Doi, Hiroshi; Miyake, Noriko; Yokochi, Kenji; Osaka, Hitoshi; Kato, Mitsuhiro; Matsumoto, Naomichi; Saitsu, Hirotomo			De Novo and Inherited Mutations in COL4A2, Encoding the Type IV Collagen alpha 2 Chain Cause Porencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL-VESSEL DISEASE; HEMORRHAGE; FAMILIES; STROKE	Porencephaly is a neurological disorder characterized by fluid-filled cysts or cavities in the brain that often cause hemiplegia. It has been suggested that porencephalic cavities result from focal cerebral degeneration involving hemorrhages. De novo or inherited heterozygous mutations in COL4A1, which encodes the type IV alpha 1 collagen chain that is essential for structural integrity for vascular basement membranes, have been reported in individuals with porencephaly. Most mutations occurred at conserved Gly residues in the Gly-Xaa-Yaa repeats of the triple-helical domain, leading to alterations of the alpha 1 alpha 1 alpha 2 heterotrimers. Here we report on two individuals with porencephaly caused by a heterozygous missense mutation in COL4A2, which encodes the type IV alpha 2 collagen chain. Mutations c.3455G>A and c.3110G>A, one in each of the individuals, cause Gly residues in the Gly-Xaa-Yaa repeat to be substituted as p.Gly1152Asp and p.Gly1037Glu, respectively, probably resulting in alterations of the alpha 1 alpha 1 alpha 2 heterotrimers. The c.3455G>A mutation was found in the proband's mother, who showed very mild monoparesis of the left upper extremity, and the maternal elder uncle, who had congenital hemiplegia. The maternal grandfather harboring the mutation is asymptomatic. The c.3110G>A mutation occurred de novo. Our study confirmed that abnormalities of the alpha 1 alpha 1 alpha 2 heterotrimers of type IV collagen cause porencephaly and stresses the importance of screening for COL4A2 as well as for COL4A1.	[Yoneda, Yuriko; Tsurusaki, Yoshinori; Doi, Hiroshi; Miyake, Noriko; Matsumoto, Naomichi; Saitsu, Hirotomo] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Haginoya, Kazuhiro] Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Haginoya, Kazuhiro] Takuto Rehabil Ctr Children, Dept Pediat Neurol, Taihaku Ku, Sendai, Miyagi 9820241, Japan; [Arai, Hiroshi] Morinomiya Hosp, Dept Pediat Neurol, Joto Ku, Osaka 5360025, Japan; [Yamaoka, Shigeo] Osaka Med Coll, Dept Neonatal Med & Pediat, Takatsuki, Osaka 5698686, Japan; [Yokochi, Kenji] Seirei Mikatahara Gen Hosp, Dept Pediat Neurol, Naka Ku, Hamamatsu, Shizuoka 4308558, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Kato, Mitsuhiro] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 9909585, Japan	Yokohama City University; Tohoku University; Osaka Medical College; Yamagata University	Saitsu, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp	Arai, Hiroshi/AAJ-8126-2020; Saitsu, Hirotomo/AAM-7131-2021	Arai, Hiroshi/0000-0002-7662-6697; Kato, Mitsuhiro/0000-0003-1485-8553; Saitsu, Hirotomo/0000-0003-0723-0960; Tsurusaki, Yoshinori/0000-0002-7240-6355	Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; (Foundation of Synapse and Neurocircuit Pathology)-from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21591312, 22790823] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Foundation of Synapse and Neurocircuit Pathology)-from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all the individuals and their families for their participation in this study. This work was supported by research grants from the Ministry of Health, Labour and Welfare (K.H., N. Miyake, HO., M.K., N. Matsumoto, and H.S.), the Japan Science and Technology Agency (N. Matsumoto), the Strategic Research Program for Brain Sciences (N. Matsumoto), and a Grant-in-Aid for Scientific Research on Innovative Areas-(Foundation of Synapse and Neurocircuit Pathology)-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (N. Matsumoto), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (H.O., N. Matsumoto), a Grant-in-Aid for Young Scientist from Japan Society for the Promotion of Science (H.D., N. Miyake, H.S.) and a grant from the Takeda Science Foundation (N. Miyake and N. Matsumoto). This work has been done at the Advanced Medical Research Center, Yokohama City University, Japan.	Alamowitch S, 2009, NEUROLOGY, V73, P1873, DOI 10.1212/WNL.0b013e3181c3fd12; BERG RA, 1983, ARCH NEUROL-CHICAGO, V40, P567, DOI 10.1001/archneur.1983.04050080067013; Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Govaert P, 2009, SEMIN FETAL NEONAT M, V14, P250, DOI 10.1016/j.siny.2009.07.008; Hunter AGW, 2006, HUMAN MALFORMATIONS, P645; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Lanfranconi S, 2010, STROKE, V41, pE513, DOI 10.1161/STROKEAHA.110.581918; Mancini GMS, 2004, EUR J PAEDIATR NEURO, V8, P45, DOI 10.1016/j.ejpn.2003.10.002; Meuwissen MEC, 2011, NEUROLOGY, V76, P844, DOI 10.1212/WNL.0b013e31820e7751; Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Vahedi K, 2011, CURR OPIN NEUROL, V24, P63, DOI 10.1097/WCO.0b013e32834232c6; Vilain C, 2002, AM J MED GENET, V112, P198, DOI 10.1002/ajmg.10452	17	63	65	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					86	90		10.1016/j.ajhg.2011.11.016	http://dx.doi.org/10.1016/j.ajhg.2011.11.016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22209246	Green Published, Bronze			2022-12-18	WOS:000299409100008
J	Shulman, JM; Chipendo, P; Chibnik, LB; Aubin, C; Tran, D; Keenan, BT; Kramer, PL; Schneider, JA; Bennett, DA; Feany, MB; De Jager, PL				Shulman, Joshua M.; Chipendo, Portia; Chibnik, Lori B.; Aubin, Cristin; Tran, Dong; Keenan, Brendan T.; Kramer, Patricia L.; Schneider, Julie A.; Bennett, David A.; Feany, Mel B.; De Jager, Philip L.			Functional Screening of Alzheimer Pathology Genome-wide Association Signals in Drosophila	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAU-INDUCED NEURODEGENERATION; NEUROFIBRILLARY TANGLES; COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; GENE; DISEASE; TAUOPATHY; PROTEIN; SUSCEPTIBILITY; EXPRESSION	We have leveraged a Drosophila model relevant to Alzheimer disease (AD) for functional screening of findings from a genome-wide scan for loci associated with a quantitative measure of AD pathology in humans. In six of the 15 genomic regions evaluated, we successfully identified a causal gene for the association, on the basis of in vivo interactions with the neurotoxicity of Tau, which forms neurofibrillary tangles in AD. Among the top results, rs10845990 within SLC2A14, encoding a glucose transporter, showed evidence of replication for association with AD pathology, and gain and loss of function in glut1, the Drosophila ortholog, was associated with suppression and enhancement of Tau toxicity, respectively. Our strategy of coupling genome-wide association in humans with functional screening in a model organism is likely to be a powerful approach for gene discovery in AD and other complex genetic disorders.	[Shulman, Joshua M.; Chipendo, Portia; Chibnik, Lori B.; Aubin, Cristin; Tran, Dong; Keenan, Brendan T.; Feany, Mel B.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Shulman, Joshua M.; Chipendo, Portia; Chibnik, Lori B.; Aubin, Cristin; Tran, Dong; Keenan, Brendan T.; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Kramer, Patricia L.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Kramer, Patricia L.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Schneider, Julie A.] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Feany, Mel B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Oregon Health & Science University; Oregon Health & Science University; Rush University; Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Feany, MB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu; pdejager@rics.bwh.harvard.edu	Chipendo, Portia/B-5457-2018	Feany, Mel/0000-0003-0315-7970; Chibnik, Lori/0000-0001-6293-806X	NIH [K08AG034290, P30AG10161, R01AG15819, R01AG17917]; Ellison Medical Foundation; Beth Israel Deaconess Medical Center - Harvard/MIT Health Sciences and Technology; Pfizer Inc.; Merck Co.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917, P30AG010161, R01AG015819, K08AG034290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Beth Israel Deaconess Medical Center - Harvard/MIT Health Sciences and Technology; Pfizer Inc.(Pfizer); Merck Co.(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to our colleagues, Lei Yu and Sue Leurgans, for assistance with statistical analyses. We thank Christian Klambt, Jimena Sierralta, and Hiroshi Nakato for generously providing Drosophila stocks. We are grateful Dr. Bradley Hyman and Chris Cotsapas for comments on the manuscript and valuable discussion. We also thank the Bloomington Drosophila stock center, the Vienna Drosophila RNAi Center (VDRC), and the Harvard Transgenic RNAi Project (TRiP, NIH/NIGMS R01GM084947) for providing fly stocks. J.M.S. is supported by NIH grant K08AG034290 and by the Clinical Investigator Training Program: Beth Israel Deaconess Medical Center - Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer Inc. and Merck & Co. M.B.F. is supported by the Ellison Medical Foundation. The authors also thank the participants of the Religious Orders Study and the Rush Memory and Aging Project, which were supported by NIH grants P30AG10161, R01AG15819, and R01AG17917.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Battye R, 1999, DEVELOPMENT, V126, P2475; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Blard O, 2007, HUM MOL GENET, V16, P555, DOI 10.1093/hmg/ddm011; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Samson ML, 2003, MECH DEVELOP, V120, P373, DOI 10.1016/S0925-4773(02)00444-6; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shulman JM, 2003, GENETICS, V165, P1233; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XH, 2002, GENOMICS, V80, P553, DOI 10.1006/geno.2002.7010; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	49	63	64	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					232	238		10.1016/j.ajhg.2011.01.006	http://dx.doi.org/10.1016/j.ajhg.2011.01.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21295279	Bronze, Green Published			2022-12-18	WOS:000287684100012
J	Gundesli, H; Talim, B; Korkusuz, P; Balci-Hayta, B; Cirak, S; Akarsu, NA; Topaloglu, H; Dincer, P				Gundesli, Hulya; Talim, Beril; Korkusuz, Petek; Balci-Hayta, Burcu; Cirak, Sebahattin; Akarsu, Nurten A.; Topaloglu, Haluk; Dincer, Pervin			Mutation in Exon 1f of PLEC, Leading to Disruption of Plectin Isoform 1f, Causes Autosomal-Recessive Limb-Girdle Muscular Dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; GENE; ORGANIZATION; SARCOLEMMA; INTEGRITY; DEFECTS; MUSCLE	Limb-girdle muscular dystrophy (LGMD) is a genetically heterogeneous group of inherited muscular disorders manifesting symmetric, proximal, and slowly progressive muscle weakness. Using Affymetrix 250K SNP Array genotyping and homozygosity mapping, we mapped an autosomal-recessive LGMD phenotype to the telomeric portion of chromosome 8q in a consanguineous Turkish family with three affected individuals. DNA sequence analysis of PLEC identified a homozygous c.1_9del mutation containing an initiation codon in exon 1f, which is an isoform-specific sequence of plectin isoform 1f. The same homozygous mutation was also detected in two additional families during the analysis of 72 independent LGMD2-affected families. Moreover, we showed that the expression of PLEC was reduced in the patient's muscle and that there was almost no expression for plectin 1f mRNA as a result of the mutation. In addition to dystrophic changes in muscle, ultrastructural alterations, such as membrane duplications, an enlarged space between the membrane and sarcomere, and misalignment of Z-disks, were observed by transmission electron microscopy. Unlike the control skeletal muscle, no sarcolemmal staining of plectin was detected in the patient's muscle. We conclude that as a result of plectin 1f deficiency, the linkage between the sarcolemma and sarcomere is broken, which could affect the structural organization of the myofiber. Our data show that one of the isoforms of plectin plays a key role in skeletal muscle function and that disruption of the plectin 1f can cause the LGMD2 phenotype without any dermatologic component as was previously reported with mutations in constant exons of PLEC.	[Gundesli, Hulya; Balci-Hayta, Burcu; Dincer, Pervin] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey; [Talim, Beril] Hacettepe Univ, Fac Med, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey; [Korkusuz, Petek] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey; [Cirak, Sebahattin] UCL Inst Chil Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Akarsu, Nurten A.] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey; [Topaloglu, Haluk] Hacettepe Univ, Fac Med, Dept Pediat, Neurol Unit, TR-06100 Ankara, Turkey	Hacettepe University; Hacettepe University; Hacettepe University; University of London; University College London; Hacettepe University; Hacettepe University	Dincer, P (corresponding author), Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey.	pdincer@hacettepe.edu.tr	Akarsu, Nurten/E-9758-2013; Cirak, Sebahattin/AAZ-6829-2020; KORKUSUZ, PETEK/I-8321-2013; Dincer, Pervin/AAL-6595-2021; Cirak, Sebahattin/AAX-9593-2020; TOPALOGLU, HALUK AYDIN/I-9318-2013; Gundesli, Hulya/ABE-8620-2020	Akarsu, Nurten/0000-0001-5432-0032; KORKUSUZ, PETEK/0000-0002-7553-3915; GUNDESLI, HULYA/0000-0002-1638-9087	Scientific and Technological Research Council of Turkey (TUBITAK) [108S124, SBAG-1774]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	We are very grateful to all of the patients and their families for their participation in the study. Special thanks to Kevin P. Campbell for critically reading the manuscript. We thank Gerhard Wiche for providing the plectin 10F6 mAb. We would like to acknowledge the Dubowitz Neuromuscular Centre, London, UK for the analysis of 50K SNP array data. This study was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (grant numbers 108S124 and SBAG-1774 to RD).	Andra K, 2003, J INVEST DERMATOL, V120, P189, DOI 10.1046/j.1523-1747.2003.12027.x; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; [Anonymous], ONLINE MENDELIAN INH; Banwell BL, 1999, J NEUROPATH EXP NEUR, V58, P832, DOI 10.1097/00005072-199908000-00006; Bolling MC, 2010, J INVEST DERMATOL, V130, P1178, DOI 10.1038/jid.2009.390; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Forrest K, 2010, NEUROMUSCULAR DISORD, V20, P709, DOI 10.1016/j.nmd.2010.06.003; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Guglieri M, 2008, NEUROL INDIA, V56, P271; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Kaplan Jean-Claude, 2009, Neuromuscul Disord, V19, P77; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; KossHarnes D, 1997, EXP DERMATOL, V6, P41, DOI 10.1111/j.1600-0625.1997.tb00144.x; Liu CG, 1996, P NATL ACAD SCI USA, V93, P4278, DOI 10.1073/pnas.93.9.4278; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMillan JR, 2007, MUSCLE NERVE, V35, P24, DOI 10.1002/mus.20655; Nakamura H, 2005, J MOL DIAGN, V7, P28, DOI 10.1016/S1525-1578(10)60005-0; *NCBI, NCBI MAP; *NCBI, NCBI UNISTS; Pfendner E, 2005, J INVEST DERMATOL, V124, P111, DOI 10.1111/j.0022-202X.2004.23564.x; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Uitto J, 1996, Exp Dermatol, V5, P237, DOI 10.1111/j.1600-0625.1996.tb00124.x; Uz E, 2010, AM J HUM GENET, V86, P789, DOI 10.1016/j.ajhg.2010.04.002; Wiche G, 1998, J CELL SCI, V111, P2477; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	29	63	67	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					834	841		10.1016/j.ajhg.2010.10.017	http://dx.doi.org/10.1016/j.ajhg.2010.10.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109228	Green Published, Bronze			2022-12-18	WOS:000285564600010
J	Baldwin, EL; May, LE; Justice, AN; Martin, CL; Ledbetter, DH				Baldwin, Erin L.; May, Lorraine E.; Justice, April N.; Martin, Christa L.; Ledbetter, David H.			Mechanisms and consequences of small supernumerary marker chromosomes: From Barbara McClintock to modern genetic-counseling issues	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENOTYPE-PHENOTYPE CORRELATION; PALLISTER-KILLIAN-SYNDROME; IMMORTALIZED CELL-LINES; IN-SITU HYBRIDIZATION; INTERSTITIAL DELETION; ARRAY CGH; RING CHROMOSOME; CLINICAL-SIGNIFICANCE; FISH	Supernumerary marker chromosomes (SMCs) are common, but their molecular content and mechanism of origin are often not precisely characterized. We analyzed all centromere regions to identify the junction between the unique chromosome arm and the pericentromeric repeats. A molecular-ruler clone panel for each chromosome arm was developed and used for the design of a custom oligonucleotide array. Of 27 nonsatellited SMCs analyzed by array comparative genomic hybridization (aCGH) and/or fluorescence in situ hybridization (FISH), seven (approximately 26%) were shown to be unique sequence negative. Of the 20 unique-sequence-positive SMCs, the average unique DNA content was approximately 6.5 Mb (range 0.3-22.2 Mb) and 33 known genes (range 0-149). Of the 14 informative nonacrocentric SMCs, five (approximately 36%) contained unique DNA from both the p and q arms, whereas nine (approximately 64%) contained unique DNA from only one arm. The latter cases are consistent with ring-chromosome formation by centromere misdivision, as first described by McClintock in maize. In one case, a r(4) containing approximately 4.4 Mb of unique DNA from 4p was also present in the proband's mother. However, FISH revealed a cryptic deletion in one chromosome 4 and reduced alpha satellite in the del(4) and r(4), indicating that the mother was a balanced ring and deletion carrier. Our data, and recent reports in the literature, suggest that this "McClintock mechanism" of small-ring formation might be the predominant mechanism of origin. Comprehensive analysis of SMCs by aCGH and FISH can distinguish unique-negative from unique-positive cases, determine the precise gene content, and provide information on mechanism of origin, inheritance, and recurrence risk.	[Baldwin, Erin L.; May, Lorraine E.; Justice, April N.; Martin, Christa L.; Ledbetter, David H.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Ledbetter, DH (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	diedbetter@genetics.emory.edu	CHEN, CHEN/HDM-6657-2022; Tsai, Fuu-Jen/J-4140-2015		NIMH NIH HHS [R01 MH074090] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074090] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Anderlid BM, 2001, AM J MED GENET, V99, P223, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1146>3.0.CO;2-W; ANDERSEN LB, 1990, CYTOGENET CELL GENET, V53, P206, DOI 10.1159/000132931; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BALDWIN EL, 2007, 57 AM SOC HUM GEN AN; Ballif BC, 2007, GENET MED, V9, P150, DOI 10.1097/GIM.0b013e3180312087; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Bartsch O, 2005, EUR J HUM GENET, V13, P1192, DOI 10.1038/sj.ejhg.5201473; Bettio D, 2008, AM J MED GENET A, V146A, P247, DOI 10.1002/ajmg.a.32083; Brecevic L, 2006, CYTOGENET GENOME RES, V114, P319, DOI 10.1159/000094220; CALLEN DF, 1991, AM J HUM GENET, V48, P769; CALLEN DF, 1990, AM J HUM GENET, V47, P493; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Chuang L, 2005, AM J MED GENET A, V133A, P180, DOI 10.1002/ajmg.a.30362; CROLLA JA, 1995, HUM GENET, V95, P161; Crolla JA, 2005, EUR J HUM GENET, V13, P154, DOI 10.1038/sj.ejhg.5201311; Crolla JA, 1998, AM J MED GENET, V75, P367, DOI 10.1002/(SICI)1096-8628(19980203)75:4<367::AID-AJMG5>3.0.CO;2-N; Crolla JA, 1998, AM J MED GENET, V75, P355, DOI 10.1002/(SICI)1096-8628(19980203)75:4<355::AID-AJMG4>3.0.CO;2-P; Dalpra L, 2005, GENET MED, V7, P620, DOI 10.1097/01.gim.0000182876.57766.2d; Donlon T. A., 1992, American Journal of Human Genetics, V51, pA78; Eggermann K, 2002, CLIN GENET, V62, P89, DOI 10.1034/j.1399-0004.2002.620113.x; Fickelscher I, 2007, PRENATAL DIAG, V27, P783, DOI 10.1002/pd.1776; FRIEDMAN JM, 1992, AM J MED GENET, V44, P37, DOI 10.1002/ajmg.1320440109; FRYNS JP, 1985, ANN GENET-PARIS, V28, P248; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Graf MD, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037887; Hansson K, 2007, AM J MED GENET A, V143A, P1354, DOI 10.1002/ajmg.a.31783; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang B, 1997, HUM GENET, V99, P11; Huang B, 2006, PRENATAL DIAG, V26, P1142, DOI 10.1002/pd.1575; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Karaman B, 2006, EUR J MED GENET, V49, P207, DOI 10.1016/j.ejmg.2005.06.002; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolialexi A, 2006, IN VIVO, V20, P473; KRAUSS CM, 1987, J MED GENET, V24, P308, DOI 10.1136/jmg.24.5.308; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liehr T, 2006, CYTOGENET GENOME RES, V112, P23, DOI 10.1159/000087510; Liehr T, 2004, CYTOGENET GENOME RES, V107, P55, DOI 10.1159/000079572; Liehr T, 2007, INT J MOL MED, V19, P719; Martin CL, 2002, J MED GENET, V39, P734, DOI 10.1136/jmg.39.10.734; McClintock B, 1938, GENETICS, V23, P315; MEARS AJ, 1995, AM J HUM GENET, V57, P667; Petit P, 1997, GENET COUNSEL, V8, P341; PFEIFFER RA, 1991, ANN GENET-PARIS, V34, P247; Pietrzak J, 2007, J APPL GENET, V48, P167, DOI 10.1007/BF03194675; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; QUACK B, 1992, ANN GENET-PARIS, V35, P241; Riethman H, 2004, GENOME RES, V14, P18, DOI 10.1101/gr.1245004; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; SCHINZEL A, 1991, J MED GENET, V28, P122, DOI 10.1136/jmg.28.2.122; Schuffenhauer S, 1996, AM J MED GENET, V65, P56, DOI 10.1002/(SICI)1096-8628(19961002)65:1<56::AID-AJMG9>3.3.CO;2-X; Shaw CJ, 2004, HUM GENET, V115, P1, DOI 10.1007/s00439-004-1119-5; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; SMITH GF, 1973, HUM HERED, V23, P561, DOI 10.1159/000152623; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Starke H, 2003, HUM GENET, V114, P51, DOI 10.1007/s00439-003-1016-3; Tonnies H, 2007, J HISTOCHEM CYTOCHEM, V55, P651, DOI 10.1369/jhc.6A7161.2007; Trcic RL, 2003, CROAT MED J, V44, P477; Veltman JA, 2006, CURR OPIN PEDIATR, V18, P598, DOI 10.1097/MOP.0b013e3280105417; Vermeesch JR, 2005, EUR J MED GENET, V48, P319, DOI 10.1016/j.ejmg.2005.04.018; Viersbach R, 1998, AM J MED GENET, V76, P351, DOI 10.1002/(SICI)1096-8628(19980401)76:4<351::AID-AJMG12>3.0.CO;2-N; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Warburton PE, 2004, CHROMOSOME RES, V12, P617, DOI 10.1023/B:CHRO.0000036585.44138.4b; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Yu S, 2007, CYTOGENET GENOME RES, V116, P141, DOI 10.1159/000097434	66	63	70	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					398	410		10.1016/j.ajhg.2007.10.013	http://dx.doi.org/10.1016/j.ajhg.2007.10.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252220	Green Published, Bronze			2022-12-18	WOS:000253223900012
J	van Zelm, MC; Geertsema, C; Nieuwenhuis, N; de Ridder, D; Conley, ME; Schiff, C; Tezcan, I; Bernatowska, E; Hartwig, NG; Sanders, EAM; Litzman, J; Kondratenko, I; van Dongen, JJM; van der Burg, M				van Zelm, Menno C.; Geertsema, Corinne; Nieuwenhuis, Nicole; de Ridder, Dick; Conley, Mary Ellen; Schiff, Claudine; Tezcan, Ilhan; Bernatowska, Ewa; Hartwig, Nico G.; Sanders, Elisabeth A. M.; Litzman, Jiri; Kondratenko, Irina; van Dongen, Jacques J. M.; van der Burg, Mirjarn			Gross deletions involving IGHM, BTK, or Artemis: A model for genomic lesions mediated by transposable elements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LDL RECEPTOR GENE; X-LINKED AGAMMAGLOBULINEMIA; FACTOR-VIII GENE; FAMILIAL ADENOMATOUS POLYPOSIS; HUMAN INHERITED DISEASE; B-CELL DIFFERENTIATION; CONSTANT-REGION LOCUS; HEAVY-CHAIN GENE; MOLECULAR CHARACTERIZATION; SUBCLASS DEFICIENCY	Most genetic disruptions underlying human disease are microlesions, whereas gross lesions are rare with gross deletions being most frequently found (6%). Similar observations have been made in primary immunodeficiency genes, such as BTK, but for unknown reasons the IGHM and DCLRE1C (Artemis) gene defects frequently represent gross deletions (similar to 60%). We characterized the gross deletion breakpoints in IGHM-, BTK-, and Artemis-deficient patients. The IGHM deletion breakpoints did not show involvement of recombination signal sequences or immunoglobulin switch regions. Instead, five IGHM, eight BTK, and five unique Artemis breakpoints were located in or near sequences derived from transposable elements (TE). The breakpoints of four out of five disrupted Artemis alleles were located in highly homologous regions, similar to Ig subclass deficiencies and V-H deletion polymorphisms. Nevertheless, these observations suggest a role for TEs in mediating gross deletions. The identified gross deletion breakpoints were mostly located in TE subclasses that were specifically overrepresented in the involved gene as compared to the average in the human genome. This concerned both long (LINE1) and short (Alu, MIR) interspersed elements, as well as LTR retrotransposons (ERV). Furthermore, a high total TE content (>40%) was associated with an increased frequency of gross deletions. Both findings were further investigated and confirmed in a total set of 20 genes disrupted in human disease. Thus, to our knowledge for the first time, we provide evidence that a high TE content, irrespective of the type of element, results in the increased incidence of gross deletions as gene disruption underlying human disease.	[van Zelm, Menno C.; Geertsema, Corinne; Nieuwenhuis, Nicole; van Dongen, Jacques J. M.; van der Burg, Mirjarn] Erasmus MC, Dept Immunol, NL-3015 GE Rotterdam, Netherlands; [van Zelm, Menno C.; Hartwig, Nico G.] Erasmus MC, Dept Pediat, NL-3015 GE Rotterdam, Netherlands; [de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat Commun Theory Grp, NL-2628 CD Delft, Netherlands; [Conley, Mary Ellen] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38101 USA; [Conley, Mary Ellen] St Jude Childrens Hosp, Memphis, TN 38101 USA; [Schiff, Claudine] Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Tezcan, Ilhan] Univ Hacettepe, Div Pediat Immunol, TR-06100 Ankara, Turkey; [Bernatowska, Ewa] Childrens Mem Hlth Inst, Dept Immunol, PL-04736 Warsaw, Poland; [Sanders, Elisabeth A. M.] UMCU, Wilhelmina Childrens Hosp, Dept Pediat, NL-3584 EA Utrecht, Netherlands; [Litzman, Jiri] Masaryk Univ, St Annes Univ Hosp, Dept Clin Immunol & Allergol, Brno 65691, Czech Republic; [Kondratenko, Irina] Russian Clin Children Hosp, Dept Clin Immunol, Moscow 117513, Russia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Hacettepe University; Children's Memorial Health Institute; Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	van Dongen, JJM (corresponding author), Erasmus MC, Dept Immunol, NL-3015 GE Rotterdam, Netherlands.	j.j.m.vandongen@erasmusmc.nl	de Ridder, Dick/F-3169-2010; Hartwig, Nico/ABI-5467-2020; Litzman, Jiri/E-2746-2012; van Dongen, Jacques J.M./F-8537-2015; van Zelm, Menno C/O-4404-2015	de Ridder, Dick/0000-0002-4944-4310; van Dongen, Jacques J.M./0000-0001-7686-0021; van Zelm, Menno C/0000-0003-4161-1919; Litzman, Jiri/0000-0002-1926-5426; van Dongen, Jacques J.M./0000-0002-3650-7087; Bernatowska, Ewa/0000-0002-0125-266X				Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Armaou S, 2007, EUR J CANCER, V43, P443, DOI 10.1016/j.ejca.2006.09.021; BECHHANSEN NT, 1986, AM J HUM GENET, V38, P67; BOTTARO A, 1991, AM J HUM GENET, V48, P745; BRUSCO A, 1995, HUM GENET, V95, P319; BRUSCO A, 1994, J IMMUNOL, V152, P129; Brusco A, 1999, J IMMUNOL, V163, P4392; Cao X, 2001, HUM GENET, V108, P436, DOI 10.1007/s004390100492; Casilli F, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040212; Cavalieri Simona, 2006, Hum Mutat, V27, P1061, DOI 10.1002/humu.9454; Centra M, 1998, GENOMICS, V51, P463, DOI 10.1006/geno.1998.5353; Chae JJ, 1997, HUM GENET, V99, P155, DOI 10.1007/s004390050331; Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133; Chimge NO, 2005, GENES IMMUN, V6, P186, DOI 10.1038/sj.gene.6364176; Chuzhanova N, 2003, HUM MUTAT, V22, P245, DOI 10.1002/humu.10253; Conley ME, 1998, AM J HUM GENET, V62, P1034, DOI 10.1086/301828; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P165, DOI 10.1159/000084949; Dimitri P, 1999, TRENDS GENET, V15, P123, DOI 10.1016/S0168-9525(99)01711-4; Gervasini C, 2005, GENOMICS, V85, P273, DOI 10.1016/j.ygeno.2004.10.014; Granados EL, 2002, J CLIN INVEST, V110, P1029, DOI 10.1172/JCI200215658; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jo EK, 2003, J HUM GENET, V48, P322, DOI 10.1007/s10038-003-0032-4; Kim SH, 1999, CLIN CHEM, V45, P1424; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Laccone F, 2004, HUM MUTAT, V23, P234, DOI 10.1002/humu.20004; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lefranc MP, 2001, EXP CLIN IMMUNOGENET, V18, P100, DOI 10.1159/000049189; Levran O, 1998, HUM MUTAT, V12, P145, DOI 10.1002/(SICI)1098-1004(1998)12:3<145::AID-HUMU2>3.3.CO;2-S; Li Lili, 2006, Hum Mutat, V27, P388, DOI 10.1002/humu.9417; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; McNaughton JC, 1998, GENE, V222, P41, DOI 10.1016/S0378-1119(98)00466-1; Milili M, 2002, EUR J PEDIATR, V161, P479, DOI 10.1007/s00431-002-0994-9; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nakaya SM, 2004, J THROMB HAEMOST, V2, P1941, DOI 10.1111/j.1538-7836.2004.00963.x; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pan Q, 2000, IMMUNOL REV, V178, P99, DOI 10.1034/j.1600-065X.2000.17815.x; Peeters AV, 1997, HUM GENET, V100, P266, DOI 10.1007/s004390050503; Plebani A, 1993, Immunodeficiency, V4, P245; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rabbani H, 1996, IMMUNOGENETICS, V45, P136, DOI 10.1007/s002510050181; Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629; Rossetti Liliana C, 2004, Hum Mutat, V24, P440, DOI 10.1002/humu.9288; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Schollen E, 2003, HUM MUTAT, V22, P116, DOI 10.1002/humu.10242; Simard LR, 2004, CLIN GENET, V65, P202, DOI 10.1111/j.0009-9163.2004.00223.x; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Staats B, 2005, NAT GENET, V37, P109, DOI 10.1038/ng0205-109; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Su LK, 2000, HUM GENET, V106, P101, DOI 10.1007/s004390051016; Terada T, 2001, J ALLERGY CLIN IMMUN, V108, P602, DOI 10.1067/mai.2001.118293; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Van de Water N, 1998, THROMB HAEMOSTASIS, V79, P938; van der Klift H, 2005, GENE CHROMOSOME CANC, V44, P123, DOI 10.1002/gcc.20219; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vidal F, 2002, THROMB HAEMOSTASIS, V88, P12; Williams GM, 2002, EUR J CANCER PREV, V11, P39, DOI 10.1097/00008469-200202000-00006; WOODSSAMUELS P, 1991, GENOMICS, V10, P94, DOI 10.1016/0888-7543(91)90489-2; Xie F, 2006, BLOOD CELL MOL DIS, V36, P385, DOI 10.1016/j.bcmd.2006.03.003; Yel L, 1996, NEW ENGL J MED, V335, P1486, DOI 10.1056/NEJM199611143352003	66	63	63	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					320	332		10.1016/j.ajhg.2007.10.011	http://dx.doi.org/10.1016/j.ajhg.2007.10.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252213	Green Published, Bronze			2022-12-18	WOS:000253223900005
J	Narkis, G; Ofir, R; Landau, D; Manor, E; Volokita, M; Hershkowitz, R; Elbedour, K; Birk, OS				Narkis, Ginat; Ofir, Rivka; Landau, Daniella; Manor, Esther; Volokita, Micha; Hershkowitz, Relly; Elbedour, Khalil; Birk, Ohad S.			Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASES; ARTHROGRYPOSIS MULTIPLEX CONGENITA; DEPENDENT MEMBRANE-FUSION; CHOLESTASIS ARC SYNDROME; RENAL DYSFUNCTION; NEUROPATHIC TYPE; NERVE-TERMINALS; FAMILY; VPS33B; FINLAND	Lethal congenital contractural syndrome (LCCS) is a severe form of arthrogryposis. To date, two autosomal recessive forms of the disease (LCCS and LCCS2) have been described and mapped to chromosomes 9q34 and 12q13, respectively. We now describe a third LCCS phenotype (LCCS3) - similar to LCCS2 yet without neurogenic bladder. Using 10K single-nucleotide-polymorphism arrays, we mapped the disease-associated gene to 8.8 Mb on chromosome 19p13. Further analysis using microsatallite markers narrowed the locus to a 3.4-Mb region harboring, 120 genes. Of these genes, 30 candidates were sequenced, which identified a single homozygous mutation in PIP5K1C. PIP5K1C encodes phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (PIPKI gamma), an enzyme that phophorylates phosphatidylinositol 4-phosphate to generate phosphatidylinositol-4,5-bisphosphate (PIP2). We demonstrate that the mutation causes substitution of aspartic acid with asparagine at amino acid 253 (D253N), abrogating the kinase activity of PIPKI gamma. Thus, a defect in the phosphatidylinositol pathway leading to a decrease in synthesis of PIP2, a molecule active in endocytosis of synaptic vesicle proteins, culminates in lethal congenital arthrogryposis.	Soroka Univ Med Ctr, Inst Genet, IL-84101 Beer Sheva, Israel; NIBN, Morris Kahn Lab Human Genet, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University	Birk, OS (corresponding author), Soroka Univ Med Ctr, Inst Genet, IL-84101 Beer Sheva, Israel.	obirk@bgu.ac.il		Birk, Ohad/0000-0003-1430-1296				Abdullah MA, 2000, SAUDI MED J, V21, P297; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; Carim L, 2000, CYTOGENET CELL GENET, V89, P92, DOI 10.1159/000015571; Denecke J, 2000, KLIN PADIATR, V212, P77, DOI 10.1055/s-2000-9656; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; DIROCCO M, 1995, EUR J PEDIATR, V154, P835, DOI 10.1007/BF01959793; Eastham KM, 2001, ARCH DIS CHILD, V85, P415, DOI 10.1136/adc.85.5.415; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Halstead JR, 2005, TRENDS PHARMACOL SCI, V26, P654, DOI 10.1016/j.tips.2005.10.004; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; HERVA R, 1985, AM J MED GENET, V20, P431, DOI 10.1002/ajmg.1320200303; HORSLEN SP, 1994, J MED GENET, V31, P62, DOI 10.1136/jmg.31.1.62; Landau D, 2003, AM J MED GENET A, V117A, P37, DOI 10.1002/ajmg.a.10894; Lo B, 2005, BLOOD, V106, P4159, DOI 10.1182/blood-2005-04-1356; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Makela-Bengs P, 1998, AM J HUM GENET, V63, P506, DOI 10.1086/301968; Narkis G, 2004, AM J MED GENET A, V130A, P272, DOI 10.1002/ajmg.a.30266; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Pakkasjarvi N, 2006, AM J MED GENET A, V140A, P1834, DOI 10.1002/ajmg.a.31381; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Shohat M, 1997, AM J HUM GENET, V61, P1139, DOI 10.1086/301598; Tanamy MG, 2001, AM J MED GENET, V104, P152, DOI 10.1002/ajmg.10030; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; VUOPALA K, 1994, J MED GENET, V31, P521, DOI 10.1136/jmg.31.7.521; VUOPALA K, 1994, NEUROPEDIATRICS, V25, P308, DOI 10.1055/s-2008-1073045; Wang L, 2005, J BIOL CHEM, V280, P16522, DOI 10.1074/jbc.M413263200; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	31	63	65	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					530	539		10.1086/520771	http://dx.doi.org/10.1086/520771			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701898	Green Published, Bronze			2022-12-18	WOS:000249128200009
J	Winnepenninckx, B; Debacker, K; Ramsay, J; Smeets, D; Smits, A; FitzPatrick, DR; Kooy, RF				Winnepenninckx, Birgitta; Debacker, Kim; Ramsay, Jacqueline; Smeets, Dominique; Smits, Arie; FitzPatrick, David R.; Kooy, R. Frank			CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLTRANSFERASE; ATR-X; METHYLATION PATTERNS; HISTONE DEACETYLASE; CNS NEURONS; EXPRESSION; FAMILY; CELLS; HYPOMETHYLATION; POPULATION	A high level of cytogenetic expression of the rare folate-sensitive fragile site FRA12A is significantly associated with mental retardation. Here, we identify an elongated polymorphic CGG repeat as the molecular basis of FRA12A. This repeat is in the 5' untranslated region of the gene DIP2B, which encodes a protein with a DMAP1-binding domain, which suggests a role in DNA methylation machinery. DIP2B mRNA levels were halved in two subjects with FRA12A with mental retardation in whom the repeat expansion was methylated. In two individuals without mental retardation but with an expanded and methylated repeat, DIP2B expression was reduced to approximately two-thirds of the values observed in controls. Interestingly, a carrier of an unmethylated CGG-repeat expansion showed increased levels of DIP2B mRNA, which suggests that the repeat elongation increases gene expression, as previously described for the fragile X-associated tremor/ataxia syndrome. These data suggest that deficiency of DIP2B, a brain-expressed gene, may mediate the neurocognitive problems associated with FRA12A.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; MRC, Human Genet Unit, Med Genet Sect, Edinburgh, Midlothian, Scotland; Univ Nijmegen, Dept Human Genet, Nijmegen, Netherlands	University of Antwerp; University of Edinburgh; Radboud University Nijmegen	Kooy, RF (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	Frank.Kooy@ua.ac.be	Smeets, D.F.C.M./L-4653-2015; FitzPatrick, David R/B-8311-2008; feng, jian/G-9313-2011; FitzPatrick, David R/C-7301-2013; Kooy, Frank/F-5276-2014	Kooy, Frank/0000-0003-2024-0485; FitzPatrick, David R./0000-0003-4861-969X	MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berg J, 2000, CLIN DYSMORPHOL, V9, P213, DOI 10.1097/00019605-200009030-00012; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brooks PJ, 1996, J NEUROSCI, V16, P939; CAMPOS AR, 1995, J NEUROBIOL, V28, P313, DOI 10.1002/neu.480280305; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; DONTI E, 1979, HUM GENET, V48, P53, DOI 10.1007/BF00273274; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Gecz J, 1997, HUM MOL GENET, V6, P435, DOI 10.1093/hmg/6.3.435; GIARDINO D, 1990, ANN GENET-PARIS, V33, P88; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; GUICHAOUA M, 1982, J GENET HUM, V30, P183; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hagerman PJ, 2004, MENT RETARD DEV D R, V10, P25, DOI 10.1002/mrdd.20005; Hassan KMA, 2001, HUM GENET, V109, P452; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KAHKONEN M, 1989, HUM GENET, V82, P3, DOI 10.1007/BF00288261; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; KUMAR D, 1986, CLIN GENET, V29, P530; MORICPETROVIC S, 1984, J MED GENET, V21, P216, DOI 10.1136/jmg.21.3.216; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; MULES EH, 1983, CLIN GENET, V23, P380; Muller S, 2000, EUR J CANCER, V36, P651, DOI 10.1016/S0959-8049(99)00328-7; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sarafidou T, 2004, GENOMICS, V84, P69, DOI 10.1016/j.ygeno.2003.12.017; SMEETS DFCM, 1985, CLIN GENET, V28, P145; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; STETTEN G, 1988, AM J MED GENET, V31, P521, DOI 10.1002/ajmg.1320310306; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1981, HUM GENET, V57, P217; Tucker KL, 2001, NEURON, V30, P649, DOI 10.1016/S0896-6273(01)00325-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; WEBB TP, 1987, J MENT DEFIC RES, V31, P61; Wieland I, 2005, NEUROGENETICS, V6, P45, DOI 10.1007/s10048-004-0190-3; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287	52	63	64	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					221	231		10.1086/510800	http://dx.doi.org/10.1086/510800			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236128	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000243729500002
J	Zhao, XZ; Tang, RQ; Gao, B; Shi, YY; Zhou, J; Guo, SZ; Zhang, J; Wang, YB; Tang, W; Meng, JW; Li, S; Wang, HS; Ma, G; Lin, CW; Xiao, Y; Feng, GY; Lin, ZG; Zhu, SM; Xing, YL; Sang, H; Clair, D; He, L				Zhao, Xinzhi; Tang, Ruqi; Gao, Bo; Shi, Yongyong; Zhou, Jian; Guo, Shengzhen; Zhang, Jing; Wang, Yabing; Tang, Wei; Meng, Junwei; Li, Sheng; Wang, Hongsheng; Ma, Gang; Lin, Chuwen; Xiao, Yue; Feng, Guoyin; Lin, Zhiguang; Zhu, Shaomin; Xing, Yangling; Sang, Hong; St. Clair, David; He, Lin			Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CARTILAGE GLYCOPROTEIN-39; NECROSIS-FACTOR-ALPHA; CYTOKINES; GENE; ASSOCIATION; EXPRESSION; DISEQUILIBRIUM; POLYMORPHISM; HAPLOTYPES; DISORDERS	The chitinase 3-like 1 gene (CHI3L1) is abnormally expressed in the hippocampus of subjects with schizophrenia and may be involved in the cellular response to various environmental events that are reported to increase the risk of schizophrenia. Here, we provide evidence that the functional variants at the CHI3L1 locus influence the genetic risk of schizophrenia. First, using case-control and transmission/disequilibrium-test (TDT) methodologies, we detected a significant association between schizophrenia and haplotypes within the promoter region of CHI3L1 in two independent cohorts of Chinese individuals. Second, the at-risk CCC haplotype (P = .00058 and .0018 in case-control and TDT studies, P = .00058 respectively) revealed lower transcriptional activity (P = 2.2 x 10(-7)) and was associated with lower expression (P = 3.1 x 10(-s)) compared with neutral and protective haplotypes. Third, we found that an allele of SNP4 (rs4950928), the tagging SNP of CCC, impaired the MYC/MAX-regulated transcriptional activation of CHI3L1 by altering the transcriptional-factor consensus sequences, and this may be responsible for the decreased expression of the CCC haplotype. In contrast, the protective TTG haplotype was associated with a high level of CHI3L1 expression. Our findings identify CHI3L1 as a potential schizophrenia-susceptibility gene and suggest that the genes involved in the biological response to adverse environmental conditions are likely to play roles in the predisposition to schizophrenia.	Shanghai Jiao Tong Univ, Bio X Life Sci Res Ctr, Shanghai 200030, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Shanghai, Peoples R China; Shanghai Inst Mental Hlth, Shanghai, Peoples R China; Jilin Inst Mental Hlth, Jilin, Peoples R China; Xian Inst Mental Hlth, Xian, Peoples R China; Changchun Kaixuan Hosp, Changchun, Peoples R China; Univ Aberdeen, Sch Med, Dept Mental Hlth, Aberdeen, Scotland	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Aberdeen	He, L (corresponding author), Shanghai Jiao Tong Univ, Bio X Life Sci Res Ctr, POB 501,Hao Ran Bldg,1954 Hua Shan Rd, Shanghai 200030, Peoples R China.	helin@bio-x.cn	gao, bo/HHC-7855-2022; Tang, Wei/H-7103-2013; ZHOU, JIAN/H-1089-2011; Shi, Yongyong/GSO-1627-2022	Tang, Wei/0000-0002-7089-4391; Shi, Yongyong/0000-0003-1710-1505; Gao, Bo/0000-0002-8684-5199				Boin F, 2001, MOL PSYCHIATR, V6, P79, DOI 10.1038/sj.mp.4000815; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Chiavetto LB, 2002, BIOL PSYCHIAT, V51, P480, DOI 10.1016/S0006-3223(01)01324-5; Chung C, 2003, SYNAPSE, V50, P29, DOI 10.1002/syn.10228; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Jones P, 1998, PSYCHIAT CLIN N AM, V21, P1, DOI 10.1016/S0193-953X(05)70358-0; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; Prolo P, 1999, MOL PSYCHIATR, V4, P109, DOI 10.1038/sj.mp.4000523; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stopkova P, 2004, BIOL PSYCHIAT, V55, P981, DOI 10.1016/j.biopsych.2004.01.014; Tohmi M, 2004, NEUROSCI RES, V50, P67, DOI 10.1016/j.neures.2004.05.010; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; van Bilsen JHM, 2004, P NATL ACAD SCI USA, V101, P17180, DOI 10.1073/pnas.0407704101; Werner T, 2000, Methods Mol Biol, V132, P337; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	30	63	65	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					12	18		10.1086/510438	http://dx.doi.org/10.1086/510438			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160890	Green Published, Bronze			2022-12-18	WOS:000243102500002
J	Hrebicek, M; Mrazova, L; Seyrantepe, V; Durand, S; Roslin, NM; Noskova, L; Hartmannova, H; Ivanek, R; Cizkova, A; Poupetova, H; Sikora, J; Urinovska, J; Stranecky, V; Zeman, J; Lepage, P; Roquis, D; Verner, A; Ausseil, J; Beesley, CE; Maire, I; Poorthuis, BJHM; van de Kamp, J; van Diggelen, OP; Wevers, RA; Hudson, TJ; Fujiwara, TM; Majewski, J; Morgan, K; Kmoch, S; Pshezhetsky, AV				Hrebicek, Martin; Mrazova, Lenka; Seyrantepe, Volkan; Durand, Stephaine; Roslin, Nicole M.; Noskova, Lenka; Hartmannova, Hana; Ivanek, Robert; Cizkova, Alena; Poupetova, Helena; Sikora, Jakub; Urinovska, Jana; Stranecky, Viktor; Zeman, Jiri; Lepage, Pierre; Roquis, David; Verner, Andrei; Ausseil, Jerome; Beesley, Clare E.; Maire, Irene; Poorthuis, Ben J. H. M.; van de Kamp, Jiddeke; van Diggelen, Otto P.; Wevers, Ron A.; Hudson, Thomas J.; Fujiwara, T. Mary; Majewski, Jacek; Morgan, Kenneth; Kmoch, Stanislav; Pshezhetsky, Alexey V.			Mutations in TMEM76* cause mucopolysaccharidosis IIIC (Sanfilippo C syndrome)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLUCOSAMINIDE N-ACETYLTRANSFERASE; ACETYL-COENZYME-A; LYSOSOMAL STORAGE DISEASES; SKIN FIBROBLASTS; TRANSMEMBRANE ACETYLATION; LINKAGE ANALYSIS; LOCALIZATION; PREDICTION; PROTEIN; GENE	Mucopolysaccharidosis IIIC (MPS IIIC, or Sanfilippo C syndrome) is a lysosomal storage disorder caused by the inherited deficiency of the lysosomal membrane enzyme acetyl-coenzyme A:alpha-glucosaminide N-acetyltransferase (N-acetyltransferase), which leads to impaired degradation of heparan sulfate. We report the narrowing of the candidate region to a 2.6-cM interval between D8S1051 and D8S1831 and the identification of the transmembrane protein 76 gene (TMEM76), which encodes a 73-kDa protein with predicted multiple transmembrane domains and glycosylation sites, as the gene that causes MPS IIIC when it is mutated. Four nonsense mutations, 3 frameshift mutations due to deletions or a duplication, 6 splice-site mutations, and 14 missense mutations were identified among 30 probands with MPS IIIC. Functional expression of human TMEM76 and the mouse ortholog demonstrates that it is the gene that encodes the lysosomal N-acetyltransferase and suggests that this enzyme belongs to a new structural class of proteins that transport the activated acetyl residues across the cell membrane.	Hop St Justine, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Charles Univ Prague, Sch Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; Charles Univ Prague, Sch Med 1, Ctr Appl Genom, Prague, Czech Republic; Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; McGill Univ, Ctr Hlth, Inst Res, Montreal, PQ, Canada; McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; UCL, Inst Child Hlth, Biochem Endocrinol & Metab Unit, London, England; Hop Debrousse, Lyon, France; UVA, Acad Med Ctr, Dept Biochem Med, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Univ Nijmegen, Med Ctr, Lab Pediat & Neurol, Nijmegen, Netherlands	Universite de Montreal; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; McGill University; McGill University; University of London; University College London; CHU Lyon; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	Pshezhetsky, AV (corresponding author), Hop St Justine, Serv Genet Med, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca	Noskova, Lenka/F-6564-2017; Sikora, Jakub/F-4842-2017; Roquis, David/K-4976-2012; Stranecky, Viktor/I-8524-2017; Ivanek, Robert/A-8852-2008; Mrázová, Lenka Steiner/K-4339-2017; Hartmannova, Hana/H-4735-2017; Kmoch, Stanislav/C-1575-2010; Ausseil, Jerome/AAA-4703-2019; Poupetova, Helena/K-1921-2017; Cizkova Vrbacka, Alena/F-4100-2011; Wevers, Ron A./H-8116-2014; Hrebicek, Martin/M-2019-2017; Zeman, Jiri/K-2691-2017	Noskova, Lenka/0000-0001-7011-4327; Sikora, Jakub/0000-0003-4104-2023; Roquis, David/0000-0001-5265-3132; Stranecky, Viktor/0000-0002-2599-6479; Mrázová, Lenka Steiner/0000-0003-4347-7768; Hartmannova, Hana/0000-0001-7787-832X; Kmoch, Stanislav/0000-0002-6239-707X; Ausseil, Jerome/0000-0002-3059-9777; Poupetova, Helena/0000-0002-8230-757X; Cizkova Vrbacka, Alena/0000-0003-4640-1646; Wevers, Ron A./0000-0003-2278-9746; Hrebicek, Martin/0000-0003-0628-8917; Zeman, Jiri/0000-0002-2678-7919; Ivanek, Robert/0000-0002-8403-056X; A, Pshezhetsky/0000-0002-6612-1062; Roslin, Nicole/0000-0002-4609-8299	NINR NIH HHS [F31 NR008069] Funding Source: Medline	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Ausseil J, 2004, J MED GENET, V41, P941, DOI 10.1136/jmg.2004.021501; Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1986, J BIOL CHEM, V261, P127; BAME KJ, 1985, J BIOL CHEM, V260, P1293; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BARTSOCAS C, 1979, EUR J PEDIATR, V130, P251, DOI 10.1007/BF00441361; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hodanova K, 2005, KIDNEY INT, V68, P1472, DOI 10.1111/j.1523-1755.2005.00560.x; HOPWOOD JJ, 1983, BIOCHEM INT, V6, P823; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; KLEIN U, 1981, CLIN GENET, V20, P55; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; Kmoch S, 2000, HUM MOL GENET, V9, P1501, DOI 10.1093/hmg/9.10.1501; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; KRESSE H, 1976, CLIN GENET, V10, P364; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; MEIKLE PJ, 1995, BIOCHEM J, V308, P327, DOI 10.1042/bj3080327; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; POHLMANN R, 1981, H-S Z PHYSIOL CHEM, V362, P1199, DOI 10.1515/bchm2.1981.362.2.1199; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; ROME LH, 1983, J BIOL CHEM, V258, P3006; SANFILIPPO SJ, 1963, J PEDIATR-US, V63, P837, DOI 10.1016/S0022-3476(63)80279-6; Seyrantepe V, 2006, HUM GENET, V120, P293, DOI 10.1007/s00439-006-0211-4; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; VOZNYI YV, 1993, J INHERIT METAB DIS, V16, P465, DOI 10.1007/BF00710299; ZAREMBA J, 1992, J MED GENET, V29, P514	37	63	65	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					807	819		10.1086/508294	http://dx.doi.org/10.1086/508294			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033958	Green Published, Bronze			2022-12-18	WOS:000241667400003
J	Hawi, Z; Segurado, R; Conroy, J; Sheehan, K; Lowe, N; Kirley, A; Shields, D; Fitzgerald, M; Gallagher, L; Gill, M				Hawi, Z; Segurado, R; Conroy, J; Sheehan, K; Lowe, N; Kirley, A; Shields, D; Fitzgerald, M; Gallagher, L; Gill, M			Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; DIAGNOSTIC OBSERVATION SCHEDULE; SEX-DIFFERENCES; MENTAL-HEALTH; RECEPTOR GENE; DRD4 GENE; ADHD; ASSOCIATION; PREVALENCE; LINKAGE	Family, twin, and adoption studies have demonstrated a significant genetic contribution to the etiology of attentiondeficit/hyperactivity disorder (ADHD). Pharmacological, neuroimaging, and animal-model findings suggest imbalances in monoaminergic (dopaminergic, serotonergic, and noradrenergic) neurotransmission in ADHD. We have examined monoaminergic candidate genes for possible genetic association with ADHD in the Irish population, focusing particularly on genes of the dopaminergic and serotonergic systems. We have observed that several of these genes are associated with ADHD, including DAT1, DBH, DRD4, DRD5, and 5HT1B. Here, we present what appears to be a systematic overtransmission of paternal alleles at candidate genes associated with ADHD. For the nine genes included in the analysis, the overall odds ratio for paternal transmission was 2, compared with 1.3 for maternal transmission (paternal vs. maternal;). Transmission to females, from either parent, x(2) = 9.6 P = .0019 was significantly stronger than to males. Possible reasons for this preferential transmission include imprinting and ascertainment bias, although results of further analyses show that the latter is unlikely.	Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Psychiat, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Hawi, Z (corresponding author), Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland.	zhhawi@tcd.ie	; Segurado, Ricardo/K-6116-2014	Shields, Denis/0000-0003-4015-2474; Gill, Michael/0000-0003-0206-5337; Hawi, Ziarih/0000-0002-0814-9112; Segurado, Ricardo/0000-0002-3547-6733; Gallagher, Louise/0000-0001-9462-2836	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTON SC, 1991, DEVELOPMENT, V113, P679; Biederman J, 2004, PSYCHIAT CLIN N AM, V27, P225, DOI 10.1016/j.psc.2003.12.004; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; CLONINGER CR, 1978, ARCH GEN PSYCHIAT, V35, P941; Craig IW, 2004, ANN HUM GENET, V68, P269, DOI 10.1046/j.1529-8817.2004.00098.x; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; FARAONE SV, 1995, J ABNORM PSYCHOL, V104, P334, DOI 10.1037/0021-843X.104.2.334; Fombonne E, 2001, J AM ACAD CHILD PSY, V40, P820, DOI 10.1097/00004583-200107000-00017; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Hawi Z, 2002, MOL PSYCHIATR, V7, P718, DOI 10.1038/sj.mp.4001048; Hawi Ziarih, 2003, Expert Rev Neurother, V3, P453, DOI 10.1586/14737175.3.4.453; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Kirley A, 2004, AM J MED GENET B, V131B, P38, DOI 10.1002/ajmg.b.30072; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Lowe N, 2004, AM J MED GENET B, V131B, P33, DOI 10.1002/ajmg.b.30071; Lowe N, 2004, AM J HUM GENET, V74, P348, DOI 10.1086/381561; Maher BS, 2002, PSYCHIATR GENET, V12, P207, DOI 10.1097/00041444-200212000-00003; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; NadaRaja S, 1997, J AM ACAD CHILD PSY, V36, P515, DOI 10.1097/00004583-199704000-00014; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; Poeta Lisiane Schilling, 2004, Rev. Bras. Psiquiatr., V26, P150, DOI 10.1590/S1516-44462004000300004; Rhee SH, 2004, AM J MED GENET B, V127B, P60, DOI 10.1002/ajmg.b.20131; Rhee SH, 1999, J ABNORM PSYCHOL, V108, P24, DOI 10.1037/0021-843X.108.1.24; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Shekim W.O, 1979, J OPER PSYCHIATR, V10, P145; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thapar A, 1999, BRIT J PSYCHIAT, V174, P105, DOI 10.1192/bjp.174.2.105; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945	35	63	66	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					958	965		10.1086/498174	http://dx.doi.org/10.1086/498174			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380908	Green Published, Bronze			2022-12-18	WOS:000233241200006
J	Nahed, BV; Seker, A; Guclu, B; Ozturk, AK; Finberg, K; Hawkins, AA; DiLuna, ML; State, M; Lifton, RP; Gunel, M				Nahed, BV; Seker, A; Guclu, B; Ozturk, AK; Finberg, K; Hawkins, AA; DiLuna, ML; State, M; Lifton, RP; Gunel, M			Mapping a Mendelian form of intracranial aneurysm to 1p34.3-p36.13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL SUBARACHNOID HEMORRHAGE; III COLLAGEN; LINKAGE; ASSOCIATION; GENE; PREDISPOSITION; HYPERTENSION; CONFIRMATION; POLYMORPHISM; DEFICIENCY	The identification of pathways that underlie common disease has been greatly impacted by the study of rare families that segregate single genes with large effect. Intracranial aneurysm is a common neurological problem; the rupture of these aneurysms constitutes a frequently catastrophic neurologic event. The pathogenesis of these aneurysms is largely unknown, although genetic and environmental factors are believed to play a role. Previous genomewide studies in affected relative pairs have suggested linkage to several loci, but underlying genes have not been identified. We have identified a large kindred that segregates nonsyndromic intracranial aneurysm as a dominant trait with high penetrance. Genomewide analysis of linkage was performed using a two-stage approach: an analysis of similar to 10,000 single-nucleotide polymorphisms in the 6 living affected subjects, followed by the genotyping of simple tandem repeats across resulting candidate intervals in all 23 kindred members. Analysis revealed significant linkage to a single locus, with a LOD score of 4.2 at 1p34.3- p36.13 under a dominant model with high penetrance. These findings identify a Mendelian form of intracranial aneurysm and map the location of the underlying disease locus.	Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, TMP 4,333 Cedar St, New Haven, CT 06510 USA.	murat.gunel@yale.edu	State, Matthew/W-2256-2019; Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X; State, Matthew/0000-0003-1624-8302				Albright LAC, 2003, J NEUROSURG, V99, P637, DOI 10.3171/jns.2003.99.4.0637; Anderson CS, 2004, STROKE, V35, P633, DOI 10.1161/01.STR.0000115751.45473.48; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHAPMAN AB, 1992, NEW ENGL J MED, V327, P916, DOI 10.1056/NEJM199209243271303; DEPAEPE A, 1988, CLIN NEUROL NEUROSUR, V90, P53, DOI 10.1016/S0303-8467(88)80010-6; ELSHUNNAR K S, 1990, British Journal of Neurosurgery, V4, P181, DOI 10.3109/02688699008992721; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; Farnham JM, 2004, HUM GENET, V114, P250, DOI 10.1007/s00439-003-1044-z; FOX JL, 1980, J NEUROSURG, V52, P501, DOI 10.3171/jns.1980.52.4.0501; Hofer A, 2003, STROKE, V34, P1207, DOI 10.1161/01.STR.0000069013.83336.1C; Juvela S, 2002, ACTA NEUROCHIR SUPPL, V82, P27; Juvela S, 2002, WIEN KLIN WOCHENSCHR, V114, P285; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; KUIVANIEMI H, 1993, NEUROLOGY, V43, P2652, DOI 10.1212/WNL.43.12.2652; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Litchfield WR, 1998, HYPERTENSION, V31, P445, DOI 10.1161/01.HYP.31.1.445; LOZANO AM, 1987, J NEUROSURG, V66, P522, DOI 10.3171/jns.1987.66.4.0522; MAROUN FB, 1986, SURG NEUROL, V25, P85, DOI 10.1016/0090-3019(86)90122-9; MOROOKA Y, 1983, SURG NEUROL, V19, P260, DOI 10.1016/S0090-3019(83)80012-3; Ohkuma H, 2003, STROKE, V34, P96, DOI 10.1161/01.STR.0000048161.57536.42; Olson Jane M, 2002, BMC Med Genet, V3, P7, DOI 10.1186/1471-2350-3-7; Onda H, 2001, AM J HUM GENET, V69, P804, DOI 10.1086/323614; POPE FM, 1990, J NEUROSURG, V72, P156; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronkainen A, 1999, STROKE, V30, P1099, DOI 10.1161/01.STR.30.5.1099; Roos YBWEM, 2004, STROKE, V35, P2276, DOI 10.1161/01.STR.0000141415.28155.46; Stehbens WE, 1998, NEUROSURGERY, V43, P1258, DOI 10.1097/00006123-199811000-00156; Takenaka K, 1999, J NEUROSURG, V90, P935, DOI 10.3171/jns.1999.90.5.0935; TERBERG HWM, 1986, ARCH NEUROL-CHICAGO, V43, P30, DOI 10.1001/archneur.1986.00520010026015; van der Voet M, 2004, AM J HUM GENET, V74, P564, DOI 10.1086/382285; Wermer MJH, 2003, STROKE, V34, P2788, DOI 10.1161/01.STR.0000099963.27578.75; Yoneyama T, 2003, J HUM GENET, V48, P309, DOI 10.1007/s10038-003-0030-6	33	63	69	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					172	179		10.1086/426953	http://dx.doi.org/10.1086/426953			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15540160	Green Published, Bronze			2022-12-18	WOS:000225643600017
J	Daly, KA; Brown, WM; Segade, F; Bowden, DW; Keats, BJ; Lindgren, BR; Levine, SC; Rich, SS				Daly, KA; Brown, WM; Segade, F; Bowden, DW; Keats, BJ; Lindgren, BR; Levine, SC; Rich, SS			Chronic and recurrent otitis media: A genome scan for susceptibility loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A GENE LOCUS; HERITABILITY; FAMILY; RISK; POLYMORPHISM; EXPRESSION; GENOTYPE; DISEASE; TWIN	Otitis media ( OM) is the most common childhood disease. Almost all children experience at least one episode, but morbidity is greatest in children who experience chronic/recurrent OM(COME/ROM). There is mounting evidence that COME/ROM clusters in families and exhibits substantial heritability. Subjects who had tympanostomy tube surgery for COME/ROM (probands) and their families were recruited for the present study, and an ear examination was performed, without knowledge of the subject's history, to determine presence of OM sequelae. In addition, tympanometric testing was performed at three frequencies (226, 630 or 710, and 1,400 Hz) to detect abnormal middle-ear mechanics, and hearing was screened at 20 dB for the speech frequencies. Of these families, 121 had at least two individuals who had received the diagnosis of COME/ROM ( 364 affected and genotyped individuals), of whom 238 affected and informative relative pairs were used for analyses. Single-point nonparametric linkage analysis provided evidence of linkage of COME/ROM to chromosome 10q at marker D10S212 (LOD 3.78; P = 3.0 x 10(-5)) and to chromosome 19q at marker D19S254 (LOD 2.61; P = 5.3 x 10(-4)). Analyses conditional on support for linkage at chromosomes 10q and 19q resulted in a significant increase in LOD score support on chromosome 3p ( between markers D3S4545 and D3S1259). These results suggest that risk of COME/ROM is determined by interactions between genes that reside in several candidate regions of the genome and are probably modulated by other environmental risk factors.	Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Univ Minnesota, Sch Med, Dept Otolaryngol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Otitis Med Res Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Gen, Winston Salem, NC 27157 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Rich, SS (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Med Ctr Blvd,3rd Floor MRI Ctr, Winston Salem, NC 27157 USA.	srich@wfubmc.edu	Brown, William/GXN-2777-2022	Rich, Stephen/0000-0003-3872-7793	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003166, P01DC000133, P30DC004660] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000400, M01 RR00400] Funding Source: Medline; NIDCD NIH HHS [R01 DC003166, P30 DC004660, P30 DC04660, P01 DC00133, R01 DC03166] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andre P, 2001, NAT IMMUNOL, V2, P661, DOI 10.1038/90589; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Daly KA, 1996, GENET EPIDEMIOL, V13, P451, DOI 10.1002/(SICI)1098-2272(1996)13:5<451::AID-GEPI2>3.0.CO;2-5; Ehrlich GD, 1999, JAMA-J AM MED ASSOC, V282, P2167, DOI 10.1001/jama.282.22.2167; Ho V, 2002, LARYNGOSCOPE, V112, P513, DOI 10.1097/00005537-200203000-00020; Hunter LL, 1996, EAR HEARING, V17, P1, DOI 10.1097/00003446-199602000-00001; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Joki-Erkkila VP, 2002, ARCH OTOLARYNGOL, V128, P17, DOI 10.1001/archotol.128.1.17; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; King NE, 2004, AM J RESP CELL MOL, V31, P257, DOI 10.1165/rcmb.2004-0026OC; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Langefeld CD, 2001, GENET EPIDEMIOL, V21, pS136, DOI 10.1002/gepi.2001.21.s1.s136; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ramet M, 2001, J PEDIATR-US, V138, P266, DOI 10.1067/mpd.2001.110133; RASMUSSEN F, 1993, INT J PEDIATR OTORHI, V26, P29, DOI 10.1016/0165-5876(93)90193-7; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; SIPILA M, 1988, ACTA OTO-LARYNGOL, V106, P94, DOI 10.3109/00016488809107375; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yamamoto S, 1999, IMMUNOL TODAY, V20, P278, DOI 10.1016/S0167-5699(99)01464-4; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515	28	63	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					988	997		10.1086/426061	http://dx.doi.org/10.1086/426061			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15514890	Bronze, Green Published			2022-12-18	WOS:000224866400005
J	Zhu, XF; Cooper, RS; Elston, RC				Zhu, XF; Cooper, RS; Elston, RC			Linkage analysis of a complex disease through use of admixed populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AFRICAN-AMERICAN; ADMIRED POPULATIONS; ETHNIC-DIFFERENCES; MAPPING GENES; HUMAN GENOME; DISEQUILIBRIUM; ADMIXTURE; ASSOCIATION; MARKERS; POLYMORPHISMS	Linkage disequilibrium arising from the recent admixture of genetically distinct populations can be potentially useful in mapping genes for complex diseases. McKeigue has proposed a method that conditions on parental admixture to detect linkage. We show that this method tests for linkage only under specific assumptions, such as equal admixture in the parental generation and admixture that occurs in a single generation. In practice, these assumptions are unlikely to hold for natural populations, resulting in an inflation of the type I error rate when testing for linkage by this method. In this article, we generalize McKeigue's approach of testing for linkage to allow two different admixture models: (1) intermixture admixture and (2) continuous gene flow. We calculate the sample size required for a genomewide search by this method under different disease models: multiplicative, additive, recessive, and dominant. Our results show that the sample size required to obtain 90% power to detect a putative mutant allele at a genomewide significance level of 5% can usually be achieved in practice if informative markers are available at a density of 2 cM.	Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Loyola University Chicago; Case Western Reserve University	Zhu, XF (corresponding author), Loyola Univ, Med Ctr, Dept Epidemiol & Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	xzhu1@lumc.edu	Zhu, Xiaofeng/O-6874-2019; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Zhu, Xiaofeng/0000-0003-0037-411X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL054466, U01HL054466, R03HL065702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHLBI NIH HHS [HL65702, HL54466, U01 HL054466, U10 HL054466] Funding Source: Medline; NIDDK NIH HHS [U01 DK057292, DK57292] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, GM28356, R01 GM028356] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Cheung KH, 2000, NUCLEIC ACIDS RES, V28, P361, DOI 10.1093/nar/28.1.361; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Falush D, 2003, GENETICS, V164, P1567; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Halder Indrani, 2003, Human Genomics, V1, P52; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; LONG JC, 1991, GENETICS, V127, P417; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; RIFE DC, 1954, AM J HUM GENET, V6, P26; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; THOMSON G, 1995, AM J HUM GENET, V57, P487; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N; Zhu XF, 2003, GENOME RES, V13, P173, DOI 10.1101/gr.302003	29	63	66	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1136	1153		10.1086/421329	http://dx.doi.org/10.1086/421329			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15131754	Green Published, Bronze			2022-12-18	WOS:000221651900007
J	Liquori, CL; Ikeda, Y; Weatherspoon, M; Ricker, K; Schoser, BGH; Dalton, JC; Day, JW; Ranum, LPW				Liquori, CL; Ikeda, Y; Weatherspoon, M; Ricker, K; Schoser, BGH; Dalton, JC; Day, JW; Ranum, LPW			Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT; MUSCULAR-DYSTROPHY; CTG REPEAT; EXPANSION; MUTATION; FAMILY; GENE; CATARACTS; MYOPATHY; PROTEIN	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on either chromosome 19 (DM1) or 3 (DM2). In 2001, we demonstrated that DM2 is caused by a CCTG expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene. To investigate the ancestral origins of the DM2 expansion, we compared haplotypes for 71 families with genetically confirmed DM2, using 19 short tandem repeat markers that we developed that flank the repeat tract. All of the families are white, with the majority of Northern European/ German descent and a single family from Afghanistan. Several conserved haplotypes spanning >700 kb appear to converge into a single haplotype near the repeat tract. The common interval that is shared by all families with DM2 immediately flanks the repeat, extending up to 216 kb telomeric and 119 kb centromeric of the CCTG expansion. The DM2 repeat tract contains the complex repeat motif (TG)(n)(TCTG)(n)(CCTG)(n). The CCTG portion of the repeat tract is interrupted on normal alleles, but, as in other expansion disorders, these interruptions are lost on affected alleles. We examined haplotypes of 228 control chromosomes and identified a potential premutation allele with an uninterrupted (CCTG)(20) on a haplotype that was identical to the most common affected haplotype. Our data suggest that the predominant Northern European ancestry of families with DM2 resulted from a common founder and that the loss of interruptions within the CCTG portion of the repeat tract may predispose alleles to further expansion. To gain insight into possible function of the repeat tract, we looked for evolutionary conservation. The complex repeat motif and flanking sequences within intron 1 are conserved among human, chimpanzee, gorilla, mouse, and rat, suggesting a conserved biological function.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, MMC 206, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wurzburg; University of Munich	Ranum, LPW (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 420 Delaware St SE, Minneapolis, MN 55455 USA.		Schoser, Benedikt/AAH-6286-2020	Schoser, Benedikt/0000-0002-2757-8131; Day, John/0000-0002-0086-9529	NINDS NIH HHS [NS35870, R01 NS035870] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Chakraborty R, 1996, AM J HUM GENET, V59, P109; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; FLINK IL, 1995, GENE, V163, P279, DOI 10.1016/0378-1119(95)00421-2; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gabellini N, 2001, EUR J BIOCHEM, V268, P1076, DOI 10.1046/j.1432-1327.2001.01974.x; Gunter C, 1998, HUM MOL GENET, V7, P1935, DOI 10.1093/hmg/7.12.1935; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper PS, 2001, MYOTONIC DYSTROPHY; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Ricker K, 1999, J NEUROL, V246, P334, DOI 10.1007/s004150050359; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	27	63	67	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					849	862		10.1086/378720	http://dx.doi.org/10.1086/378720			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14505273	Bronze, Green Published			2022-12-18	WOS:000185676100012
J	Allen, M; Barker, JWN; Bowcock, AM; Burden, AD; Chia, N; Capon, F; Christophers, E; Daly, MJ; Elder, JT; Helms, C; Henseler, T; Jenisch, S; Menter, A; Mistry, R; Nair, RP; Stuart, PE; Tillman, D; Trembath, RC; Veal, C; Voorhees, JJ				Allen, M; Barker, JWN; Bowcock, AM; Burden, AD; Chia, N; Capon, F; Christophers, E; Daly, MJ; Elder, JT; Helms, C; Henseler, T; Jenisch, S; Menter, A; Mistry, R; Nair, RP; Stuart, PE; Tillman, D; Trembath, RC; Veal, C; Voorhees, JJ		Int Psoriasis Genetics Consortium	The International Psoriasis Genetics study: Assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; FAMILIAL PSORIASIS; FRAMESHIFT MUTATION; COMPLEX TRAITS; CHROMOSOME; IDENTIFICATION; ASSOCIATION; PSORS1; REGION; SCAN	In an effort to confirm previously reported linkages to psoriasis, we analyzed 942 affected sibling pairs ( ASPs) from 710 pedigrees for 53 polymorphic microsatellites spanning 14 psoriasis candidate regions at an intermarker spacing of similar to5 cM. Maximum LOD score (MLS) analysis of ASPs yielded allele sharing of 60% for markers within the major histocompatibility complex (MHC) (P = 2 x 10(-14)), which yielded a gene-specific lambda(s) of 1.6. Across the remainder of the genome, the strongest evidence of allele sharing was obtained on chromosomes 16q (D16S3032; MLS = 1.3; P = .007) and 10q22 - q23 (D10S2327; MLS = 1.1; P = .012). None of the remaining loci exceeded MLS = 0.9, the value expected to occur by chance once in this study. In agreement with previous studies, strong linkage disequilibrium was also observed between psoriasis and the MHC ( pedigree disequilibrium test P = 3.9 x 10(-8) for D6S1014). Two psoriasis-associated MHC haplotypes were identified with the haplotype-based transmission/ disequilibrium test. Analysis of only those families carrying either of these haplotypes significantly increased the chromosome 16q LOD score from 1.3 to 2.4 (P = .045). These results underscore the importance of theMHCin psoriasis and provide a rationale for more- detailed examination of candidate regions on chromosomes 16q and 10q.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Univ Glasgow, Western Infirm, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland; Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Roma Tor Vergata, Div Genet, Rome, Italy; Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany; MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI USA; Ann Arbor Vet Affairs Hlth Syst, Ann Arbor, MI USA; Univ Kiel, Inst Immunol, D-24098 Kiel, Germany; Baylor Hosp, Dept Dermatol, Dallas, TX USA	Washington University (WUSTL); University of Glasgow; University of Michigan System; University of Michigan; University of Leicester; University of Rome Tor Vergata; University of Kiel; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Michigan System; University of Michigan; University of Kiel	Bowcock, AM (corresponding author), Washington Univ, Sch Med, Dept Genet, Box 8232,4566 Scott Ave, St Louis, MO 63110 USA.	bowcock@genetics.wustl.edu; jelder@umich.edu; rtrembat@hgmp.mrc.ac.uk	menter md, alan/A-8250-2009; Capon, Francesca/F-4763-2011; Daly, Mark J/B-2453-2017; Voorhees, John/AAM-9966-2020	Capon, Francesca/0000-0003-2432-5793; Daly, Mark J/0000-0002-0949-8752; Voorhees, John/0000-0003-1856-785X; Bowcock, Anne/0000-0001-8691-9090; Veal, Colin/0000-0002-9840-2512	NIAMS NIH HHS [R01-AR42742, R01 AR042742, AR44577] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR044577] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Balendran N, 1999, J INVEST DERMATOL, V113, P322, DOI 10.1046/j.1523-1747.1999.00710.x; Barker Jonathan N. W. N., 1998, Journal of Dermatology (Tokyo), V25, P778; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Borgiani P, 2002, EUR J DERMATOL, V12, P540; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Camp RDR., 1998, ROOK WILKINSON EBLIN, V6, P1589; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; CURTIS D, 1995, AM J HUM GENET, V56, P811; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Elder JT, 2001, ARCH DERMATOL, V137, P1447; ELDER JT, 1998, PRINCIPLES MOL MED, P793; Enlund F, 1999, EUR J HUM GENET, V7, P783, DOI 10.1038/sj.ejhg.5200365; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Nair RP, 2001, J INVEST DERMATOL, V117, P1671, DOI 10.1046/j.0022-202x.2001.01620.x; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Samuelsson L, 1999, HUM GENET, V105, P523, DOI 10.1007/s004390051141; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; Young C, 2003, EXP DERMATOL, V12, P506, DOI 10.1034/j.1600-0625.2002.120420.x; Zhang XJ, 2002, J INVEST DERMATOL, V119, P1361, DOI 10.1046/j.1523-1747.2002.19612.x	38	63	66	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					430	437						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12851855				2022-12-18	WOS:000184223900020
J	Clark, AG; Nielsen, R; Signorovitch, J; Matise, TC; Glanowski, S; Heil, J; Winn-Deen, ES; Holden, AL; Lai, E				Clark, AG; Nielsen, R; Signorovitch, J; Matise, TC; Glanowski, S; Heil, J; Winn-Deen, ES; Holden, AL; Lai, E			Linkage disequilibrium and inference of ancestral recombination in 538 single-nucleotide polymorphism clusters across the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; MEIOTIC RECOMBINATION; HAPLOTYPE DIVERSITY; GENE CONVERSION; POPULATION PARAMETERS; HOT-SPOTS; SEQUENCE; BLOCKS; EXTENT; MAP	The prospect of using linkage disequilibrium (LD) for fine-scale mapping in humans has attracted considerable attention, and, during the validation of a set of single-nucleotide polymorphisms ( SNPs) for linkage analysis, a set of data for 4,833 SNPs in 538 clusters was produced that provides a rich picture of local attributes of LD across the genome. LD estimates may be biased depending on the means by which SNPs are first identified, and a particular problem of ascertainment bias arises when SNPs identified in small heterogeneous panels are subsequently typed in larger population samples. Understanding and correcting ascertainment bias is essential for a useful quantitative assessment of the landscape of LD across the human genome. Heterogeneity in the population recombination rate, rho = 4Nr, along the genome reflects how variable the density of markers will have to be for optimal coverage. We find that ascertainment-corrected rho varies along the genome by more than two orders of magnitude, implying great differences in the recombinational history of different portions of our genome. The distribution of (rho) over cap is unimodal, and we show that this is compatible with a wide range of mixtures of hotspots in a background of variable recombination rate. Although (rho) over cap is significantly correlated across the three population samples, some regions of the genome exhibit population-specific spikes or troughs in rho that are too large to be explained by sampling. This result is consistent with differences in the genealogical depth of local genomic regions, a finding that has direct bearing on the design and utility of LD mapping and on the National Institutes of Health HapMap project.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; Celera Genom, Rockville, MD USA; Rutgers State Univ, Dept Genet, Piscataway, NJ USA; Roche Mol Syst, Pleasanton, CA USA; First Genet Trust, Deerfield, IL USA; GlaxoSmithKline, Res Triangle Pk, NC USA	Cornell University; Cornell University; Rutgers State University New Brunswick; Roche Holding; GlaxoSmithKline	Clark, AG (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 107 Biotechnol Bldg, Ithaca, NY 14853 USA.	ac347@cornell.edu	Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Clark, Andrew/0000-0001-7159-8511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM065509, GM65509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eisenbarth I, 2000, AM J HUM GENET, V67, P873, DOI 10.1086/303085; Fan QQ, 1997, GENETICS, V145, P661; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hey J, 1997, GENETICS, V145, P833; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2001, GENETICS, V159, P1805; Huttley GA, 1999, GENETICS, V152, P1711; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Kaplan N, 2001, THEOR POPUL BIOL, V60, P181, DOI 10.1006/tpbi.2001.1537; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kim Y, 2002, GENETICS, V160, P765; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kuhner MK, 2000, GENETICS, V156, P439; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen R, 2000, GENETICS, V154, P931; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; OHTA T, 1971, GENETICS, V68, P571; Olivier M, 2001, GENOMICS, V78, P64, DOI 10.1006/geno.2001.6646; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; SINNOCK P, 1972, AM J HUM GENET, V24, P393; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Wakeley J, 2001, AM J HUM GENET, V69, P1332, DOI 10.1086/324521; Wakeley J, 1997, GENET RES, V69, P45, DOI 10.1017/S0016672396002571; Wall JD, 2000, MOL BIOL EVOL, V17, P156, DOI 10.1093/oxfordjournals.molbev.a026228; Weir B., 1996, GENETIC DATA ANAL; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wiehe T, 2000, GENET RES, V75, P61, DOI 10.1017/S0016672399004036; Wiuf C, 1999, GENETICS, V151, P1217; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	55	63	67	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					285	300		10.1086/377138	http://dx.doi.org/10.1086/377138			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12844287	Green Published, Bronze			2022-12-18	WOS:000184223900006
J	Bougeard, L; Charbonnier, FO; Moerman, A; Martin, C; Ruchoux, MM; Drouot, N; Frebourg, T				Bougeard, L; Charbonnier, FO; Moerman, A; Martin, C; Ruchoux, MM; Drouot, N; Frebourg, T			Early-onset brain tumor and lymphoma in MSH2-deficient children	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NONPOLYPOSIS COLORECTAL-CANCER; HEMATOLOGICAL MALIGNANCY; TURCOTS-SYNDROME; MISMATCH REPAIR; MSH2; NEUROFIBROMATOSIS; PREDISPOSES; MUTATIONS; GENE		INSERM, EMI 9906, IFRMP, Fac Med, F-76183 Rouen, France; Ctr Hop Univ Rouen, Dept Genet, Rouen, France; CHU Lille, Hop Roger Salengro, Dept Genet, F-59037 Lille, France; CHU Lille, Hop Roger Salengro, Dept Neuropathol, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Bougeard, L (corresponding author), INSERM, EMI 9906, IFRMP, Fac Med, 22 Blvd Gambetta, F-76183 Rouen, France.		Frebourg, Thierry/AAK-8390-2020	CHARBONNIER, Francoise/0000-0002-4875-2506				Boland CR, 1998, CANCER RES, V58, P5248; Charbonnier F, 2000, CANCER RES, V60, P2760; Charbonnier F, 2002, CANCER RES, V62, P848; De Rosa M, 2000, ONCOGENE, V19, P1719, DOI 10.1038/sj.onc.1203447; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Paraf F, 1997, J CLIN ONCOL, V15, P2744, DOI 10.1200/JCO.1997.15.7.2744; Ricciardone MD, 1999, CANCER RES, V59, P290; Vilkki S, 2001, CANCER RES, V61, P4541; Wang Q, 1999, CANCER RES, V59, P294; Whiteside D, 2002, CANCER RES, V62, P359; Zink D, 2002, ONCOGENE, V21, P4788, DOI 10.1038/sj.onc.1205614	12	63	64	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					213	216		10.1086/345297	http://dx.doi.org/10.1086/345297			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12549480	Green Published, Bronze			2022-12-18	WOS:000180186800023
J	Shanske, S; Tang, YY; Hirano, M; Nishigaki, Y; Tanji, K; Bonilla, E; Sue, C; Krishna, S; Carlo, JR; Willner, J; Schon, EA; DiMauro, S				Shanske, S; Tang, YY; Hirano, M; Nishigaki, Y; Tanji, K; Bonilla, E; Sue, C; Krishna, S; Carlo, JR; Willner, J; Schon, EA; DiMauro, S			Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; MARROW-PANCREAS SYNDROME; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUMAN OOCYTES; MTDNA; TRANSMISSION; DISEASE; GENOME	Single deletions of mitochondrial DNA (mtDNA) are associated with three major clinical conditions: Kearns-Sayre syndrome, a multisystem disorder; Pearson syndrome (PS), a disorder of the hematopoietic system; and progressive external ophthalmoplegia (PEO), primarily affecting the ocular muscles. Typically, single mtDNA deletions are sporadic events, since the mothers, siblings, and offspring of affected individuals are unaffected. We studied a woman who presented with PEO, ptosis, and weakness of pharyngeal, facial, neck, and limb muscles. She had two unaffected children, but another of her children, an infant son, had sideroblastic anemia, was diagnosed with PS, and died at age 1 year. Morphological analysis of a muscle biopsy sample from the mother showed cytochrome c oxidase-negative ragged-red fibers-a typical pattern in patients with mtDNA deletions. Southern blot analysis using multiple restriction endonucleases and probed with multiple mtDNA fragments showed that both the mother and her infant son harbored an identical 5,355-bp single deletion in mtDNA, without flanking direct repeats. The deletion was the only abnormal species of mtDNA identified in both patients, and there was no evidence for duplications. We conclude that, although the vast majority of single large-scale deletions in mtDNA are sporadic, in rare cases, single deletions can be transmitted through the germline.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Mt Sinai Med Ctr, Dept Human Genet, New York, NY 10029 USA; Clin Las Amer, San Juan, PR USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	DiMauro, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St,Room PS 4-420, New York, NY 10032 USA.			Hirano, Michio/0000-0002-7070-7402	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, R01NS039854, R01NS028828, P50NS011766] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD032062, HD 32062] Funding Source: Medline; NINDS NIH HHS [NS 28828, P01 NS011766, NS 39854, R01 NS039854, NS 11766] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaike M, 1995, Rinsho Shinkeigaku, V35, P190; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; CHEN X, 1995, AM J HUM GENET, V57, P239; CORMIER V, 1990, J PEDIATR-US, V117, P599, DOI 10.1016/S0022-3476(05)80698-5; Graff C, 2000, PRENATAL DIAG, V20, P426, DOI 10.1002/(SICI)1097-0223(200005)20:5<426::AID-PD845>3.0.CO;2-K; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; LARSSON NG, 1992, AM J HUM GENET, V50, P360; Manfredi G, 1997, ANN NEUROL, V42, P180, DOI 10.1002/ana.410420208; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROWLAND LP, 1988, NEUROLOGY, V38, P1399, DOI 10.1212/WNL.38.9.1399; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118	21	63	64	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					679	683		10.1086/342482	http://dx.doi.org/10.1086/342482			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12152148	Green Published, Bronze			2022-12-18	WOS:000177489600024
J	DeStefano, AL; Lew, MF; Golbe, LI; Mark, MH; Lazzarini, AM; Guttman, M; Montgomery, E; Waters, CH; Singer, C; Watts, RL; Currie, LJ; Wooten, GF; Maher, NE; Wilk, JB; Sullivan, KM; Slater, KM; Saint-Hilaire, MH; Feldman, RG; Suchowersky, O; Lafontaine, AL; Labelle, N; Growdon, JH; Vieregge, P; Pramstaller, PP; Klein, C; Hubble, JP; Reider, CR; Stacy, M; MacDonald, ME; Gusella, JF; Myers, RH				DeStefano, AL; Lew, MF; Golbe, LI; Mark, MH; Lazzarini, AM; Guttman, M; Montgomery, E; Waters, CH; Singer, C; Watts, RL; Currie, LJ; Wooten, GF; Maher, NE; Wilk, JB; Sullivan, KM; Slater, KM; Saint-Hilaire, MH; Feldman, RG; Suchowersky, O; Lafontaine, AL; Labelle, N; Growdon, JH; Vieregge, P; Pramstaller, PP; Klein, C; Hubble, JP; Reider, CR; Stacy, M; MacDonald, ME; Gusella, JF; Myers, RH			PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; ASSOCIATION; TESTS	Parkinson disease (PD) is a late-onset neurodegenerative disorder. The mean age at onset is 61 years, but the disease can range from juvenile cases to cases in the 8th or 9th decade of life. The parkin gene on chromosome 6q and loci on chromosome 1p35-36 and 1p36 are responsible for some cases of autosomal recessive early-onset parkinsonism, but they do not appear to influence susceptibility or variability of age at onset for idiopathic PD. We have performed a genomewide linkage analysis using variance-component methodology to identify genes influencing age at onset of PD in a population of affected relatives (mainly affected sibling pairs) participating in the GenePD study. Four chromosomal loci showed suggestive evidence of linkage: chromosome 2p (maximum multipoint LOD [MaxLOD] = 2.08), chromosome 9q (MaxLOD = 2.00), chromosome 20 (MaxLOD = 1.82), and chromosome 21 (MaxLOD = 2.21). The 2p and 9q locations that we report here have previously been reported as loci influencing PD affection status. Association between PD age at onset and allele 174 of marker D2S1394, located on 2p13, was observed in the GenePD sample (P=.02). This 174 allele is common to the PD haplotype observed in two families that show linkage to PARK3 and have autosomal dominant PD, which suggests that this allele may be in linkage disequilibrium with a mutation influencing PD susceptibility or age at onset of PD.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; Univ So Calif, Dept Neurol, Los Angeles, CA USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08903 USA; Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Miami, Dept Neurol, Miami, FL 33152 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ Virginia Hlth Syst, Dept Neurol, Charlottesville, VA USA; Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Dept Med Genet, Calgary, AB, Canada; Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; Gen Reg Hosp Bolzano, Dept Neurol, Bolzano, Italy; Barrow Clin, Dept Neurol, Phoenix, AZ USA	Boston University; Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Southern California; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Toronto; University of Miami; Emory University; University of Virginia; University System of Ohio; Ohio State University; University of Calgary; University of Calgary; University of Lubeck; Krankenhaus Bozen; Barrow Neurological Institute	DeStefano, AL (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St T3E, Boston, MA 02118 USA.	adestef@bu.edu	Pramstaller, Peter P/C-2357-2008; Singer, Carlos/AAI-6643-2020; Klein, Christine/AGK-8003-2022	DeStefano, Anita/0000-0002-9335-2819; Saint-Hilaire, Marie-Helene/0000-0002-2355-5979; Sullivan, Kristin/0000-0001-6810-4998; Myers, Richard/0000-0002-8365-2674	NINDS NIH HHS [R01 NS036711] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cardno AG, 2001, AM J MED GENET, V105, P439, DOI 10.1002/ajmg.1404; DeStefano AL, 2001, NEUROLOGY, V57, P1124, DOI 10.1212/WNL.57.6.1124; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; MAHER NE, IN PRESS AM J MED GE; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rosenblatt A, 2001, AM J MED GENET, V105, P399, DOI 10.1002/ajmg.1400; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; West AB, 2001, EUR J HUM GENET, V9, P659, DOI 10.1038/sj.ejhg.5200698	21	63	63	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1089	1095		10.1086/339814	http://dx.doi.org/10.1086/339814			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11920285	Green Published, Bronze			2022-12-18	WOS:000175012400002
J	Motley, AM; Brites, P; Gerez, L; Hogenhout, E; Haasjes, J; Benne, R; Tabak, HF; Wanders, RJA; Waterham, HR				Motley, AM; Brites, P; Gerez, L; Hogenhout, E; Haasjes, J; Benne, R; Tabak, HF; Wanders, RJA; Waterham, HR			Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOMAL TARGETING SIGNAL; PTS2 RECEPTOR; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; 3-KETOACYL-COA THIOLASE; AMINO-TERMINUS; PHYTANIC ACID; READING-FRAME; WD REPEAT; PROTEIN; DEFICIENCY	Rhizomelic chondrodysplasia punctata (RCDP) is a genetically heterogeneous, autosomal recessive disorder of peroxisomal metabolism that is clinically characterized by symmetrical shortening of the proximal long bones, cataracts, periarticular calcifications, multiple joint contractures, and psychomotor retardation. Most patients with RCDP have mutations in the PEX7 gene encoding peroxin 7, the cytosolic PTS2-receptor protein required for targeting a subset of enzymes to peroxisomes. These enzymes are deficient in cells of patients with RCDP, because of their mislocalization to the cytoplasm. We report the mutational spectrum in the PEX7 gene of 78 patients (including five pairs of sibs) clinically and biochemically diagnosed with RCDP type I. We found 22 different mutations, including 18 novel ones. Furthermore, we show by functional analysis that disease severity correlates with PEX7 allele activity: expression of eight different alleles from patients with severe RCDP failed to restore the targeting defect in RCDP fibroblasts, whereas two alleles found only in patients with mild disease complemented the targeting defect upon overexpression. Surprisingly, one of the mild alleles comprises a duplication of nucleotides 45-52, which is predicted to lead to a frameshift at codon 17 and an absence of functional peroxin 7. The ability of this allele to complement the targeting defect in RCDP cells suggests that frame restoration occurs, resulting in full-length functional peroxin 7, which leads to amelioration of the predicted severe phenotype. This was confirmed in vitro by expression of the eight-nucleotide duplication-containing sequence fused in different reading frames to the coding sequence of firefly luciferase in COS cells.	Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Waterham, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis F0 224, POB 22700, NL-1100 DE Amsterdam, Netherlands.		Brites, Pedro/K-4231-2013	Brites, Pedro/0000-0003-1754-1543				Arnaud E, 1999, MOL CELL BIOL, V19, P505; Barth PG, 1996, AM J MED GENET, V62, P164, DOI 10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-W; Baumgartner MR, 1998, ANN NEUROL, V44, P720, DOI 10.1002/ana.410440505; Braverman N, 2000, GENOMICS, V63, P181, DOI 10.1006/geno.1999.6080; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Corneo B, 2000, J BIOL CHEM, V275, P12672, DOI 10.1074/jbc.275.17.12672; de Vet ECJM, 1998, J BIOL CHEM, V273, P10296, DOI 10.1074/jbc.273.17.10296; Garcia-Higuera I, 1998, J BIOL CHEM, V273, P9041, DOI 10.1074/jbc.273.15.9041; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; LINTON MF, 1992, P NATL ACAD SCI USA, V89, P11431, DOI 10.1073/pnas.89.23.11431; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1996, BBA-MOL BASIS DIS, V1315, P153, DOI 10.1016/0925-4439(95)00114-X; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Mullen RT, 1997, PLANT PHYSIOL, V115, P881, DOI 10.1104/pp.115.3.881; NUOFFER JM, 1994, J INHERIT METAB DIS, V17, P60, DOI 10.1007/BF00735395; Ofman R, 1998, HUM MOL GENET, V7, P847, DOI 10.1093/hmg/7.5.847; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; POLLTHE BT, 1991, J INHERIT METAB DIS, V14, P361, DOI 10.1007/BF01811703; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Ronsin C, 1999, J IMMUNOL, V163, P483; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Shimozawa N, 1999, J HUM GENET, V44, P123, DOI 10.1007/s100380050123; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Thai TP, 1997, FEBS LETT, V420, P205, DOI 10.1016/S0014-5793(97)01495-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; van den Hurk WH, 2001, J BIOL CHEM, V276, P11496, DOI 10.1074/jbc.M011040200; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; WANDERS RJA, 1995, J NEUROPATH EXP NEUR, V54, P726, DOI 10.1097/00005072-199509000-00016; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; Young M, 1997, AM J HUM GENET, V60, P565	44	63	65	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					612	624		10.1086/338998	http://dx.doi.org/10.1086/338998			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11781871	Bronze, Green Published			2022-12-18	WOS:000173880000006
J	Xu, X; Fang, Z; Wang, BY; Chen, CZ; Guang, WW; Jin, YT; Yang, JH; Lewitzky, S; Aelony, A; Parker, A; Meyer, J; Weiss, ST; Xu, XP				Xu, X; Fang, Z; Wang, BY; Chen, CZ; Guang, WW; Jin, YT; Yang, JH; Lewitzky, S; Aelony, A; Parker, A; Meyer, J; Weiss, ST; Xu, XP			A genomewide search for quantitative-trait loci underlying asthma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE SEARCH; FOUNDER POPULATION; LINKAGE ANALYSIS; HASEMAN; FAMILIES; SCREEN	A genomewide screen for quantitative-trait loci (QTLs) that underlie asthma was performed on 533 Chinese families with asthma, by the unified Haseman-Elston method. Nine asthma-related phenotypes were studied, including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), airway responsiveness as indicated by methacholine (MTCH)-challenge test, serum total immunoglobulin E (TIgE), serum-specific immunoglobulin E, eosinophil count in peripheral blood, and skin-prick tests with three different allergens (cockroach, Dermatophagoides pteronyssinus, and D. farinae). Our study showed significant linkage between airway responsiveness to MTCH and D2S1780 on chromosome 2 (P<.00002) and provided suggestive evidence (P<.002) for six additional possible QTLs: D10S1435 and D22S685, for FEV1; D16S412, for FVC; D19S433, for airway responsiveness to MTCH; D1S518, for TIgE; and D4S1647, for skin reactivity to cockroach. No significant or suggestive evidence of linkage for the other four traits was found.	Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; Millennium Pharmaceut, Div Genet, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Anhui Medical University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Xu, XP (corresponding author), Harvard Univ, Sch Publ Hlth, Program Populat Genet, 665 Huntington Ave,FXB-101, Boston, MA 02115 USA.		Xu, Xin/A-1687-2016	Xu, Xin/0000-0002-6324-5211	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066385, R01HL056371] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL66385, HL56371, R01 HL066385] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allison DB, 2000, AM J HUM GENET, V67, P249, DOI 10.1086/302966; Celedon JC, 2000, AM J RESP CRIT CARE, V162, P1679, DOI 10.1164/ajrccm.162.5.2003007; CHATHAM M, 1982, CHEST, V82, P15, DOI 10.1378/chest.82.1.15; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Holloway JW, 1999, CLIN EXP ALLERGY, V29, P1023; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Marsh DG, 1997, NAT GENET, V15, P389; Mathias RA, 2001, GENET EPIDEMIOL, V20, P340, DOI 10.1002/gepi.5; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; SANTILLI J, 1980, J ALLERGY CLIN IMMUN, V65, P406, DOI 10.1016/0091-6749(80)90232-8; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SHEFFER AL, 1995, ALLERGY PROC, V16, P1, DOI 10.2500/108854195778690011; TAGER I, 1976, American Review of Respiratory Disease, V114, P1201; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081; Xu X, 1999, HUM MOL GENET, V8, P2551, DOI 10.1093/hmg/8.13.2551; Xu XP, 1999, AM J RESP CRIT CARE, V160, P1928, DOI 10.1164/ajrccm.160.6.9902013; Yokouchi Y, 2000, GENOMICS, V66, P152, DOI 10.1006/geno.2000.6201	24	63	63	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1271	1277		10.1086/324650	http://dx.doi.org/10.1086/324650			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11673820	Bronze, Green Published			2022-12-18	WOS:000172086900012
J	Ligers, A; Dyment, DA; Willer, CJ; Sadovnick, AD; Ebers, G; Risch, N; Hillert, J				Ligers, A; Dyment, DA; Willer, CJ; Sadovnick, AD; Ebers, G; Risch, N; Hillert, J		Canadian Collaborative Study Grp	Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC SUSCEPTIBILITY	The importance of the HLA-DR locus to multiple sclerosis (MS) susceptibility was assessed in 542 sib pairs with MS and in their families. By genotyping 1,978 individuals for HLA- DRB1 alleles, we confirmed the well-established association of MS with HLA-DRB1*15 (HLA-DRB1*1501 and HLA-DRB5*0101), by the transmission/disequilibrium test (chi (2) = 138.3; P<.0001). We obtained significant evidence of linkage throughout the whole data set (mlod = 4.09; 59.9% sharing). Surprisingly, similar sharing was also observed in 58 families in which both parents lacked the DRB1*15 allele (mlod=1.56; 62.7% sharing; P = .0081). Our findings suggest that the notion that HLA-DRB1*15 is the sole major-histocompatibility-complex determinant of susceptibility in northern-European populations with MS may be incorrect. It remains possible that the association of MS with HLA-DRB1*15 is due to linkage disequilibrium with a nearby locus and/or to the presence of disease-influencing allele (s)in DRB1*15-negative haplotypes.	Huddinge Univ Hosp, Karolinska Inst, Div Neurol, SE-14186 Stockholm, Sweden; Karolinska Inst, Dept Biosci, Novum, SE-14186 Stockholm, Sweden; Univ Oxford, Dept Clin Neurol, Oxford OX1 2JD, England; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Karolinska Institutet; Karolinska Institutet; University of Oxford; University of British Columbia; Stanford University; University of Oxford; Wellcome Centre for Human Genetics	Hillert, J (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Div Neurol, SE-14186 Stockholm, Sweden.			Ebers, George/0000-0003-4771-4177; Willer, Cristen/0000-0001-5645-4966; Sadovnick, Dessa/0000-0003-2987-2008; Power, Christopher/0000-0002-5131-9711				Dyment DA, 1997, HUM MOL GENET, V6, P1693, DOI 10.1093/hmg/6.10.1693; Ebers GC, 2000, BRAIN, V123, P641, DOI 10.1093/brain/123.3.641; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1987, AM J HUM GENET, V40, P1; Sadovnick AD, 1998, CAN J NEUROL SCI, V25, P216, DOI 10.1017/S0317167100034041; Sadovnick AD, 1997, EPIDEMIOL REV, V19, P99, DOI 10.1093/oxfordjournals.epirev.a017951; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; WINCHESTER RJ, 1975, LANCET, V2, P814	11	63	65	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					900	903		10.1086/323480	http://dx.doi.org/10.1086/323480			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11519010	Bronze, Green Published			2022-12-18	WOS:000171008200024
J	Gedeon, AK; Tiller, GE; Le Merrer, M; Heuertz, S; Tranebjaerg, L; Chitayat, D; Robertson, S; Glass, IA; Savarirayan, R; Cole, WG; Rimoin, DL; Kousseff, BG; Ohashi, H; Zabel, B; Munnich, A; Gecz, J; Mulley, JC				Gedeon, AK; Tiller, GE; Le Merrer, M; Heuertz, S; Tranebjaerg, L; Chitayat, D; Robertson, S; Glass, IA; Savarirayan, R; Cole, WG; Rimoin, DL; Kousseff, BG; Ohashi, H; Zabel, B; Munnich, A; Gecz, J; Mulley, JC			The molecular basis of X-linked spondyloepiphyseal dysplasia tarda	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; MUTATIONS; SEDL; CHROMOSOME; LINKAGE; COL2A1; IDENTIFICATION; EXPRESSION; DYSTROPHY; COLLAGENS	The X-linked form of spondyloepiphyseal dysplasia tarda (SEDL), a radiologically distinct skeletal dysplasia affecting the vertebrae and epiphyses, is caused by mutations in the SEDL gene. To characterize the molecular basis for SEDL, we have identified the spectrum of SEDL mutations in 30 of 36 unrelated cases of X-linked SEDL ascertained from different ethnic populations. Twenty-one different disease-associated mutations now have been identified throughout the SEDL gene. These include nonsense mutations in exons 4 and 5, missense mutations in exons 4 and 6, small (2-7 bp) and large ( >1 kb) deletions, insertions, and putative splicing errors, with one splicing error due to a complex deletion/insertion mutation. Eight different frameshift mutations lead to a premature termination of translation and account for >43% (13/30) of SEDL cases, with half of these (7/13) being due to dinucleotide deletions. Altogether, deletions account for 57% (17/30) of all known SEDL mutations. Four recurrent mutations (IVS3+5G -->A, 157-158delAT, 191-192delTG, and 271-275delCAAGA) account for 43% (13/30) of confirmed SEDL cases. The results of haplotype analyses and the diverse ethnic origins of patients support recurrent mutations. Two patients with large deletions of SEDL exons were found, one with childhood onset of painful complications, the other relatively free of additional symptoms. However, we could not establish a clear genotype/phenotype correlation and therefore conclude that the complete unaltered SEDL-gene product is essential for normal bone growth. Molecular diagnosis can now be offered for presymptomatic testing of this disorder. Appropriate lifestyle decisions and, eventually, perhaps, specific SEDL therapies may ameliorate the prognosis of premature osteoarthritis and the need for hip arthroplasty.	Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, N Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Inst Necker, Paris, France; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Univ Melbourne, Victorian Clin Genet Serv, Melbourne, Vic, Australia; Univ Queensland, Sch Med, Brisbane, Qld, Australia; Queensland Clin Genet Serv, Brisbane, Qld, Australia; Univ Washington, CHRMC, Seattle, WA USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ S Florida, Tampa, FL USA; Saitama Childrens Med Ctr, Iwatsuki, Saitama, Japan; Univ Mainz, D-6500 Mainz, Germany	University of Adelaide; University of Adelaide; Vanderbilt University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Melbourne; University of Melbourne; University of Queensland; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; Saitama Children's Medical Center; Johannes Gutenberg University of Mainz	Gedeon, AK (corresponding author), Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, 72 King William Rd, N Adelaide, SA 5006, Australia.		Gedeon, Agi/G-7890-2011; Gecz, Jozef/X-3469-2019	Gecz, Jozef/0000-0002-7884-6861	NIAMS NIH HHS [AR45477, R01 AR045477] Funding Source: Medline; NICHD NIH HHS [HD22657, P01 HD022657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR045477, R01AR045477] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; BANNERMAN RM, 1971, J MED GENET, V8, P291, DOI 10.1136/jmg.8.3.291; BEIGHTON P, 1997, EMERY RIMOINS PRINCI, V2, P2773; Bernard LE, 1996, J MED GENET, V33, P432, DOI 10.1136/jmg.33.5.432; Bieganski T, 1999, EUR J PEDIATR, V158, P809, DOI 10.1007/s004310051211; Bleasel JF, 1998, HUM MUTAT, V12, P172, DOI 10.1002/(SICI)1098-1004(1998)12:3<172::AID-HUMU4>3.0.CO;2-J; Byers PH, 2000, CLIN GENET, V58, P270, DOI 10.1034/j.1399-0004.2000.580404.x; BYERS PH, 1978, HUM GENET, V40, P157, DOI 10.1007/BF00272296; CAMERA G, 1994, J MED GENET, V31, P371, DOI 10.1136/jmg.31.5.371; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; den Dunnen JT, 2000, HUM MUTAT, V15, P7; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Giannelli F, 1999, AM J HUM GENET, V65, P1580, DOI 10.1086/302652; HARPER PS, 1973, BRIT J RADIOL, V46, P676, DOI 10.1259/0007-1285-46-549-676; HEUERTZ S, 1993, GENOMICS, V18, P100, DOI 10.1006/geno.1993.1431; HEUERTZ S, 1995, HUM GENET, V96, P407, DOI 10.1007/BF00191797; HOLDERBAUM D, 1993, BIOCHEM BIOPH RES CO, V192, P1169, DOI 10.1006/bbrc.1993.1539; ICETON JA, 1986, J BONE JOINT SURG BR, V68, P616, DOI 10.1302/0301-620X.68B4.3733841; KAIBARA N, 1983, SKELETAL RADIOL, V10, P13, DOI 10.1007/BF00355384; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; MacKenzie JJ, 1996, J MED GENET, V33, P823, DOI 10.1136/jmg.33.10.823; Maquat LE, 1996, AM J HUM GENET, V59, P279; Milleding P, 1998, INT J PROSTHODONT, V11, P21; Mumm S, 2000, J CLIN ENDOCR METAB, V85, P3343, DOI 10.1210/jc.85.9.3343; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sudbrak R, 2001, HUM MOL GENET, V10, P77, DOI 10.1093/hmg/10.1.77; SZPIROTAPIA S, 1988, HUM GENET, V81, P61, DOI 10.1007/BF00283731; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; Whyte MP, 1999, MEDICINE, V78, P9, DOI 10.1097/00005792-199901000-00002; WICKING C, 1991, TRENDS GENET, V7, P288, DOI 10.1016/0168-9525(91)90177-R; WILLIAMS CJ, 1995, HUM MOL GENET, V4, P309, DOI 10.1093/hmg/4.2.309; WYNNEDAVIES R, 1985, J BONE JOINT SURG BR, V67, P133, DOI 10.1302/0301-620X.67B1.3155744	36	63	83	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1386	1397		10.1086/320592	http://dx.doi.org/10.1086/320592			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349230	Green Published, Bronze			2022-12-18	WOS:000169094600009
J	Janosik, M; Oliveriusova, J; Janosikova, B; Sokolova, J; Kraus, E; Kraus, JP; Kozich, V				Janosik, M; Oliveriusova, J; Janosikova, B; Sokolova, J; Kraus, E; Kraus, JP; Kozich, V			Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; PYRIDOXAL 5'-PHOSPHATE; ESCHERICHIA-COLI; MUTATIONS; DEFICIENCY; PROTEIN; EXPRESSION; DISEASE; SYSTEM; CELLS	During the past 20 years, cystathionine beta -synthase (CBS) deficiency has been detected in the former Czechoslovakia with a calculated frequency of 1:349,000. The clinical manifestation was typical of homocystinuria, and about half of the 21 patients were not responsive to pyridoxine. Twelve distinct mutations were detected in 30 independent homocystinuric alleles. One half of the alleles carried either the c.833 T -->C or the IVS11-2A -->C mutation; the remaining alleles contained private mutations. The abundance of five mutant mRNAs with premature stop codons was analyzed by PCR-RFLP. Two mRNAs, c.828_931ins104 (IVS7+1G -->A) and c.1226 G -->A, were severely reduced in the cytoplasm as a result of nonsense-mediated decay. In contrast, the other three mRNAs-c.19_20insC, c.28_29delG, and c.210_235del26 (IVS1 1G -->C)-were stable. Native western blot analysis of 14 mutant fibroblast lines showed a paucity of CBS antigen, which was detectable only in aggregates. Five mutations-A114V (c.341C -->T), A155T (c.463G -->A), E176K (c.526G -->A), I278T (c.833T -->C), and W409_G453del (IVS11-2A -->C)were expressed in Escherichia coli. All five mutant proteins formed substantially more aggregates than did the wild-type CBS, and no aggregates contained heme. These data suggest that abnormal folding, impaired heme binding, and aggregation of mutant CBS polypeptides may be common pathogenic mechanisms in CBS deficiency.	Charles Univ Prague, Fac Med 1, Inst IEM, Prague 12808 2, Czech Republic; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA	Charles University Prague; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Kozich, V (corresponding author), Charles Univ Prague, Fac Med 1, Inst IEM, Ke Karlovu 2, Prague 12808 2, Czech Republic.	vkozich@lf1.cuni.cz	Sokolová, Jitka/H-9924-2015; Kozich, Viktor/A-7672-2008; Janosikova, Bohumila/D-2940-2017	Sokolová, Jitka/0000-0002-0453-3336; Kozich, Viktor/0000-0001-5820-5277; Janosikova, Bohumila/0000-0002-0081-4018	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD008315] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW000989] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW00989] Funding Source: Medline; NICHD NIH HHS [P01 HD008315, P01-HD08315] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Cooper DN, 1995, METABOLIC MOL BASES, P259; Dawson PA, 1997, EUR J HUM GENET, V5, P15, DOI 10.1159/000484726; DEFRANCHIS R, 1994, HUM MOL GENET, V3, P1103, DOI 10.1093/hmg/3.7.1103; Farabaugh PJ, 2000, PROG NUCLEIC ACID RE, V64, P131, DOI 10.1016/S0079-6603(00)64004-7; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Horsburgh BC, 1996, CELL, V86, P949, DOI 10.1016/S0092-8674(00)80170-1; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kery V, 1997, FASEB J, V11, pA1134; KERY V, 1994, J BIOL CHEM, V269, P25283; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439; KOCH HG, 1994, PEDIATR RES, V36, pA21, DOI 10.1203/00006450-199407000-00111; Kozich Viktor, 1992, Human Mutation, V1, P113, DOI 10.1002/humu.1380010206; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; Kraus JP, 1999, HUM MUTAT, V13, P362; KRAUS JP, 1993, HUM MOL GENET, V2, P1633, DOI 10.1093/hmg/2.10.1633; Mudd S., 2001, METABOLIC MOL BASES, P2007; MUDD SH, 1985, AM J HUM GENET, V37, P1; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; SKOVBY F, 1984, AM J HUM GENET, V36, P452; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	26	63	67	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1506	1513		10.1086/320597	http://dx.doi.org/10.1086/320597			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11359213	Green Published			2022-12-18	WOS:000169094600022
J	Nemeth, AH; Bochukova, E; Dunne, E; Huson, SM; Elston, J; Hannan, MA; Jackson, M; Chapman, CJ; Taylor, AMR				Nemeth, AH; Bochukova, E; Dunne, E; Huson, SM; Elston, J; Hannan, MA; Jackson, M; Chapman, CJ; Taylor, AMR			Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OCULAR MOTOR APRAXIA; JOUBERT-SYNDROME; GENE; SCLEROSIS; MUTATIONS; LINKAGE	Ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome [AOA]; MIM 208920) is an autosomal recessive disorder characterized by ataxia, oculomotor apraxia, and choreoathetosis. These neurological features resemble those of ataxia-telangiectasia (AT), bur in AOA there are none of the extraneurological features of AT, such as immunodeficiency, neoplasia, chromosomal instability, or sensitivity to ionizing radiation, It is unclear whether these patients have a true disorder of chromosomal instability or a primary neurodegenerative syndrome, and it has not been possible to identify the defective gene in AOA, since the families have been too small for linkage analysis. We have identified a new family with AOA, and we show that the patients have no evidence of chromosomal instability or sensitivity to ionizing radiation, suggesting that AOA in this family is a true primary cerebellar ataxia. We have localized the disease gene, by linkage analysis and homozygosity mapping, to a 15.9-cM interval on chromosome 3q34, This work will ultimately allow the disease gene to be identified and its relevance to other types of autosomal recessive cerebellar ataxias to be determined.	Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Churchill Hosp, Dept Clin Genet, Oxford OX3 7BN, England; Oxford Eye Hosp, Dept Ophthalmol, Oxford, England; Radcliffe Infirm, Dept Neurol, Oxford OX2 6HE, England; King Faisal Specialist Hosp & Res Ctr, Dept Biomed Phys, Riyadh 11211, Saudi Arabia; Univ Birmingham, CRC, Inst Canc Studies, Birmingham, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Radcliffe Infirmary; King Faisal Specialist Hospital & Research Center; University of Birmingham	Nemeth, AH (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Dunne, Eimear/C-6785-2012; Dunne, Eimear/AGX-1949-2022	Dunne, Eimear/0000-0001-9862-1398; Dunne, Eimear/0000-0001-9862-1398; Bochukova, Elena/0000-0003-0275-1548; Nemeth, Andrea/0000-0002-2941-7657				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHADWICK B, 1998, 6 INT WORKSH CHROM 9; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GASCON GG, 1995, J CHILD NEUROL, V10, P118, DOI 10.1177/088307389501000210; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; HANNAN MA, 1994, J MED GENET, V31, P953, DOI 10.1136/jmg.31.12.953; Hassin-Baer S, 1999, J NEUROL, V246, P716, DOI 10.1007/s004150050438; HERNANDEZ D, 1993, J MED GENET, V30, P135, DOI 10.1136/jmg.30.2.135; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; McConville CM, 1996, AM J HUM GENET, V59, P320; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; MURRELL J, 1995, GENOMICS, V25, P59, DOI 10.1016/0888-7543(95)80109-Y; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schiavo G, 1998, ESSAYS BIOCHEM, V33, P29, DOI 10.1042/bse0330029; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sztriha L, 1999, PEDIATR NEUROL, V20, P274, DOI 10.1016/S0887-8994(98)00154-4; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; Tusa RJ, 1999, J CHILD NEUROL, V14, P621, DOI 10.1177/088307389901401001	25	63	65	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1320	1326		10.1016/S0002-9297(07)62962-0	http://dx.doi.org/10.1016/S0002-9297(07)62962-0			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11022012	Green Published, Bronze			2022-12-18	WOS:000165091600029
J	Buddles, MRH; Donne, RL; Richards, A; Goodship, J; Goodship, THJ				Buddles, MRH; Donne, RL; Richards, A; Goodship, J; Goodship, THJ			Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							REGULATORY PROTEINS; DISULFIDE BONDS; DEFICIENCY; SECRETION		Univ Newcastle Upon Tyne, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Buddles, MRH (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.		Richards, Anna/E-8337-2013					Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; JANATOVA J, 1989, BIOCHEMISTRY-US, V28, P4754, DOI 10.1021/bi00437a036; Schmidt BZ, 1999, J BIOL CHEM, V274, P11782, DOI 10.1074/jbc.274.17.11782; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	6	63	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1721	1722		10.1086/302877	http://dx.doi.org/10.1086/302877			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762557	Bronze, Green Published			2022-12-18	WOS:000088373700029
J	Shaikh, TH; Budarf, ML; Celle, L; Zackai, EH; Emanuel, BS				Shaikh, TH; Budarf, ML; Celle, L; Zackai, EH; Emanuel, BS			Clustered 11q23 and 22q11 breakpoints and 3 : 1 meiotic malsegregation in multiple unrelated t(11;22) families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL-SYNDROME; CAT EYE SYNDROME; 11Q-22Q TRANSLOCATION; RECIPROCAL TRANSLOCATION; MOLECULAR DEFINITION; DELETION SYNDROME; EWINGS-SARCOMA; 1ST MEIOSIS; CHROMOSOME; SEGREGATION	The t(11;22) is the only known recurrent, non-Robertsonian constitutional translocation. We have analyzed t(11;22) balanced-translocation carriers from multiple unrelated families by FISH, to localize the t(11;22) breakpoints on both chromosome 11 and chromosome 22. In 23 unrelated balanced-translocation carriers, the breakpoint was localized within a 400-kb interval between D22S788 (N41) and ZNF74, on 22q11. Also, 13 of these 23 carriers were tested with probes from chromosome 11, and, in each, the breakpoint was localized between D11S1340 and APOA1, on 11q23, to a region less than or equal to 185 kb. Thus, the breakpoints on both chromosome 11 and chromosome 22 are clustered in multiple unrelated families. Supernumerary-der(22)t(11;22) syndrome can occur in the progeny of balanced-t(11;22) carriers, because of malsegregation of the der(22). There has been speculation regarding the mechanism by which the malsegregation occurs. To elucidate this mechanism, we have analyzed 16 of the t(11;22) families, using short tandem-repeat-polymorphism markers on both chromosome 11 and chromosome 22. In all informative cases the proband received two of three alleles, for markers above the breakpoint on chromosome 22 and below the breakpoint on chromosome 11, from the t(11;22)carrier parent. These data strongly suggest that 3:1 meiosis I malsegregation in the t(11;22) balanced-translocation-carrier parent is the mechanism in all 16 families. Taken together, these results establish that the majority of t(11;22) translocations occur within the same genomic intervals and that the majority of supernumeraryder(22) offspring result from a 3:1 meiosis I malsegregation in the balanced-translocation carrier.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Abramson Res Ctr 1002, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Abramson Res Ctr 1002, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA.	beverly@mail.med.upenn.edu			NCI NIH HHS [CA39926, R01 CA039926] Funding Source: Medline; NIDCD NIH HHS [DC02027, P01 DC002027] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABELIOVICH D, 1990, AM J MED GENET, V37, P288, DOI 10.1002/ajmg.1320370227; Arai Y, 1996, GENOMICS, V35, P196, DOI 10.1006/geno.1996.0339; AURIAS A, 1984, CANCER GENET CYTOGEN, V12, P21, DOI 10.1016/0165-4608(84)90003-7; BUDARF M, 1989, AM J HUM GENET, V45, P128; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Collins JE, 1997, GENOME RES, V7, P522, DOI 10.1101/gr.7.5.522; Dawson AJ, 1996, J MED GENET, V33, P952, DOI 10.1136/jmg.33.11.952; DELACHAPELLE A, 1981, HUM GENET, V57, P253, DOI 10.1007/BF00278938; Driscoll DA, 1997, GENET TEST, V1, P109, DOI 10.1089/gte.1997.1.109; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; EMANUEL BS, 1998, AM J HUM GENET, V63, pA11; EMANUEL BS, IN PRESS ETIOLOGY MO; EMANUEL BS, 1999, HEART DEV, P463; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; Holmes SE, 1997, HUM MOL GENET, V6, P357, DOI 10.1093/hmg/6.3.357; Jurado LAP, 1998, HUM MOL GENET, V7, P325, DOI 10.1093/hmg/7.3.325; KAPLAN JC, 1987, J MED GENET, V24, P65, DOI 10.1136/jmg.24.2.65; Li M., 1995, American Journal of Human Genetics, V57, pA119; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LIN AE, 1986, CLIN GENET, V29, P269; LINDENBAUM RH, 1975, J MED GENET, V12, P29, DOI 10.1136/jmg.12.1.29; LOCKWOOD DH, 1989, HUM GENET, V83, P287, DOI 10.1007/BF00285174; LURIE IW, 1992, AM J MED GENET, V42, P216, DOI 10.1002/ajmg.1320420218; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P1430, DOI 10.1093/nar/20.6.1430; MARTIN RH, 1984, CLIN GENET, V25, P357; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; McTaggart KE, 1998, CYTOGENET CELL GENET, V81, P222, DOI 10.1159/000015035; MEARS AJ, 1994, AM J HUM GENET, V55, P134; MORROW B, 1995, AM J HUM GENET, V56, P1391; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; QUACKENBUSH J, 1995, GENOMICS, V29, P512, DOI 10.1006/geno.1995.9974; Rhodes CH, 1997, CYTOGENET CELL GENET, V78, P247, DOI 10.1159/000134667; Saitta SC, 1999, AM J HUM GENET, V65, P562, DOI 10.1086/302514; Shaikh TH, 1997, AM J HUM GENET, V61, pA50; SIMI P, 1992, HUM GENET, V88, P482, DOI 10.1007/BF00215688; SOLER A, 1993, PRENATAL DIAG, V13, P137, DOI 10.1002/pd.1970130209; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Tunnacliffe A, 1999, GENOME RES, V9, P44; TUNNACLIFFE A, 1993, GENOMICS, V17, P744, DOI 10.1006/geno.1993.1397; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; ZACKAI EH, 1980, AM J MED GENET, V7, P507, DOI 10.1002/ajmg.1320070412	49	63	63	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1595	1607		10.1086/302666	http://dx.doi.org/10.1086/302666			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577913	Bronze, Green Published			2022-12-18	WOS:000084282500014
J	Saitta, SC; McGrath, JM; Mensch, H; Shaikh, TH; Zackai, EH; Emanuel, BS				Saitta, SC; McGrath, JM; Mensch, H; Shaikh, TH; Zackai, EH; Emanuel, BS			A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							OPITZ G/BBB SYNDROME; LAMBDA GENE LOCUS; DIGEORGE-SYNDROME; CRITICAL REGION; XP22; MUTATIONS		Childrens Hosp, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Yale University	Emanuel, BS (corresponding author), Childrens Hosp, Div Human Genet & Mol Biol, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.				NHLBI NIH HHS [HL51533] Funding Source: Medline; NICHD NIH HHS [HD26979] Funding Source: Medline; NIDCD NIH HHS [DC02027] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL051533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BURN J, 1996, EMERY RIMOINS PRINCI, V1, P767; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; EMANUEL BS, 1998, AM J HUM GENET, V63, pA11; EMANUEL BS, 1996, IN PRESS ETIOLOGY MO; EMANUEL BS, 1999, HEART DEV, P463; Gaudenz K, 1998, AM J HUM GENET, V63, P703, DOI 10.1086/302010; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; KAWASAKI K, 1995, GENOME RES, V5, P125, DOI 10.1101/gr.5.2.125; Kawasaki K, 1997, GENOME RES, V7, P250, DOI 10.1101/gr.7.3.250; Kurahashi H, 1996, AM J HUM GENET, V58, P1377; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; MCDONALDMCGINN DM, 1995, AM J MED GENET, V59, P103, DOI 10.1002/ajmg.1320590122; MCLEAN SD, 1993, AM J DIS CHILD, V147, P1212; MCQUADE L, IN PRESS AM J MED GE; ODonnell H, 1997, AM J HUM GENET, V60, P1544; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P95; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Shaikh TH, 1999, MAMM GENOME, V10, P322, DOI 10.1007/s003359900996; Yamagishi H, 1999, SCIENCE, V283, P1158, DOI 10.1126/science.283.5405.1158	24	63	63	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					562	566		10.1086/302514	http://dx.doi.org/10.1086/302514			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417299	Bronze, Green Published			2022-12-18	WOS:000081836900032
J	McElreavey, K; Krausz, C				McElreavey, K; Krausz, C			Male infertility and the Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA-BINDING PROTEIN; CANDIDATE SPERMATOGENESIS GENE; DAZ GENE; DROSOPHILA-MELANOGASTER; SEVERE OLIGOZOOSPERMIA; CRITICAL REGION; AUTOSOMAL GENE; GERM-CELLS; LONG ARM; AZOOSPERMIA		Inst Pasteur, F-75724 Paris 15, France; Univ Florence, Dept Clin Physiopathol, Androl Unit, Florence, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Florence	McElreavey, K (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.			Krausz, Csilla Gabriella/0000-0001-6748-8918				AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; CASTRILLON DH, 1993, GENETICS, V135, P489; Chai NN, 1997, GENOMICS, V45, P355, DOI 10.1006/geno.1997.4944; Chai NN, 1998, GENOMICS, V49, P283, DOI 10.1006/geno.1998.5255; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Delbridge ML, 1997, NAT GENET, V15, P131, DOI 10.1038/ng0297-131; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Elliott DJ, 1998, J CELL SCI, V111, P1255; Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Foresta C, 1998, HUM REPROD, V13, P302, DOI 10.1093/humrep/13.2.302; Foresta C, 1997, J CLIN ENDOCR METAB, V82, P1075, DOI 10.1210/jc.82.4.1075; Girardi SK, 1997, HUM REPROD, V12, P1635, DOI 10.1093/humrep/12.8.1635; GONDO H, 1987, J IMMUNOL, V139, P3840; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Habermann B, 1998, HUM REPROD, V13, P363, DOI 10.1093/humrep/13.2.363; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hendriks W, 1995, J CELL BIOCHEM, V59, P418, DOI 10.1002/jcb.240590403; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Houston DW, 1998, DEVELOPMENT, V125, P171; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lau YFC, 1999, AM J HUM GENET, V64, P921, DOI 10.1086/302353; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; Menke DB, 1997, AM J HUM GENET, V60, P237; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Prosser J, 1996, MAMM GENOME, V7, P835, DOI 10.1007/s003359900246; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; Quershi S. J, 1996, MOL HUM REPROD, V2, P775; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; SOULARD M, 1993, NUCLEIC ACIDS RES, V21, P4210, DOI 10.1093/nar/21.18.4210; Stuppia L, 1996, CYTOGENET CELL GENET, V72, P155, DOI 10.1159/000134174; Stuppia L, 1997, J MED GENET, V34, P881, DOI 10.1136/jmg.34.11.881; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; vanderVen K, 1997, MOL HUM REPROD, V3, P699, DOI 10.1093/molehr/3.8.699; VANDERVENT K, 1997, MANN GENOME, V8, P756; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013	47	63	72	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					928	933		10.1086/302351	http://dx.doi.org/10.1086/302351			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090876	Bronze, Green Published			2022-12-18	WOS:000079632900002
J	Okabe, M; Ikawa, M; Ashkenas, J				Okabe, M; Ikawa, M; Ashkenas, J			Male infertility and the genetics of spermatogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENT MICE; MUTANT MICE; TARGETED DISRUPTION; MOUSE; SPERM; CREM; SPERMIOGENESIS; EXPRESSION; MUTATION; PROMOTER		Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Univ Washington, Amer Journal Human Genet, Seattle, WA 98195 USA	Osaka University; University of Washington; University of Washington Seattle	Okabe, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Yamadaoka 3-1, Suita, Osaka 5650871, Japan.	okabe@biken.osaka-u.ac.jp	ikawa, masahito/A-5315-2009; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Okabe, Masaru/0000-0002-0803-9044				ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Ashkenas J, 1997, AM J HUM GENET, V61, P267, DOI 10.1086/514865; BABA T, 1994, J BIOL CHEM, V269, P31845; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bestor TH, 1998, AM J HUM GENET, V62, P1269, DOI 10.1086/301891; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chai NN, 1997, MOL HUM REPROD, V3, P705, DOI 10.1093/molehr/3.8.705; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; CLERMONT Y, 1978, AM J ANAT, V151, P191, DOI 10.1002/aja.1001510204; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Eddy EM, 1993, MOL BIOL MALE REPROD, P181; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; FAJARDO MA, 1994, DEV BIOL, V166, P643, DOI 10.1006/dbio.1994.1344; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; Greenhouse S, 1998, AM J HUM GENET, V62, P1282, DOI 10.1086/301893; GROMOLL M, 1998, TESTICULAR FUNCTION, P273; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; JOHNSON LR, 1995, DEV BIOL, V168, P138, DOI 10.1006/dbio.1995.1067; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kirchhoff C, 1997, ADV EXP MED BIOL, V424, P221; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Loveland KL, 1997, J ENDOCRINOL, V153, P337, DOI 10.1677/joe.0.1530337; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Luoh SW, 1997, DEVELOPMENT, V124, P2275; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Moss SB, 1997, MAMM GENOME, V8, P37, DOI 10.1007/s003359900342; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Naumova AK, 1998, AM J HUM GENET, V62, P1493, DOI 10.1086/301860; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; SEYA T, 1993, EUR J IMMUNOL, V23, P1322, DOI 10.1002/eji.1830230620; SonnenbergRiethmacher E, 1996, GENE DEV, V10, P1184, DOI 10.1101/gad.10.10.1184; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Wakayama T, 1998, J REPROD FERTIL, V112, P11, DOI 10.1530/jrf.0.1120011; WATANABE D, 1995, FEBS LETT, V368, P509, DOI 10.1016/0014-5793(95)00729-S; Wu XQ, 1997, P NATL ACAD SCI USA, V94, P5640, DOI 10.1073/pnas.94.11.5640; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yanagimachi R., 1994, P189; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657	54	63	66	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1274	1281		10.1086/301895	http://dx.doi.org/10.1086/301895			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9644029	Green Published, Bronze			2022-12-18	WOS:000074174700002
J	Pennington, BF				Pennington, BF			Using genetics to dissect cognition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							SKILLS				Pennington, BF (corresponding author), UNIV DENVER, DEPT PSYCHOL, 2155 S RACE ST, DENVER, CO 80208 USA.							Barkow J.H., 1992, ADAPTED MIND; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CLARK DB, 1995, DYSLEXIA THEORY PRAC; Crowder RG, 1982, PSYCHOL READING; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DEFRIES JC, 1993, NATURE NURTURE PSYCH, P121; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Just M.A., 1987, PSYCHOL READING LANG; Kerr J, 1897, J ROYAL STATISTICAL, V60, P613, DOI DOI 10.2307/2979713; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN IY, 1974, J EXP CHILD PSYCHOL, V18, P201, DOI 10.1016/0022-0965(74)90101-5; MARTINGLY IG, 1972, LANGUAGE EAR EYE REL; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; Morgan W.P., 1896, BMJ-BRIT MED J, V2, P1543, DOI [10.1136/bmj.2.1871.1378, DOI 10.1136/BMJ.2.1871.1378]; Olson R., 1994, FRAMES REFERENCE ASS; Orton ST, 1925, ARCH NEURO PSYCHIATR, V14, P581, DOI 10.1001/archneurpsyc.1925.02200170002001; Orton ST., 1937, READING WRITING SPEE; PENNINGTON BF, 1990, CHILD DEV, V61, P1753, DOI 10.1111/j.1467-8624.1990.tb03564.x; PENNINGTON BF, 1995, J CHILD NEUROL, V10, pS69, DOI 10.1177/08830738950100S114; Perfetti C.A., 1985, READING ABILITY; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Thomas C. J., 1905, OPHTHALMOSCOPE, V3, P380; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192	25	63	65	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					13	16						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	WA818	8981941				2022-12-18	WOS:A1997WA81800004
J	Bredie, SJH; Kiemeney, LA; deHaan, AFJ; Demacker, PNM; Stalenhoef, AFH				Bredie, SJH; Kiemeney, LA; deHaan, AFJ; Demacker, PNM; Stalenhoef, AFH			Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-B LEVELS; LDL PARTICLE-SIZE; PLASMA-LIPOPROTEINS; SUBCLASS PATTERNS; GENETIC-ANALYSIS; TRIGLYCERIDE; HYPERTRIGLYCERIDEMIA; PHENOTYPE; INVITRO; DISEASE	Familial combined hyperlipidemia (FCH) is a heritable lipid disorder, in which dense low-density lipoprotein (LDL) subfraction profiles due to a predominance of small dense LDL particles are frequently observed. These small dense LDL particles are associated with cardiovascular disease. Using segregation analysis, we investigated to what extent these LDL subfraction profiles are genetically determined; also, the mode of inheritance was studied. Individual LDL subfraction profiles were determined by density gradient ultracentrifugation in 623 individuals of 40 well-defined Dutch FCH families. The individual LDL subfraction profile was defined as a quantitative trait by the continuous variable K, a reliable estimate of the relative contribution of each LDL subfraction to the overall profile. Variation in parameter K due to age, sex, and hormonal status was taken into account by introducing liability classes. Segregation analysis was performed by fitting a series of class D regressive models, implemented in the Statistical Analysis for Genetic Epidemiology (SAGE) program, after which genetic models were compared using log-likelihood ratio tests. Our data show that 60% of the variability of parameter K could be explained by lipid and lipoprotein levels and that a major autosomal locus, recessively inherited, with a population frequency of .42 +/- .07, and an additional polygenic component of .25 best explained the clustering of atherogenic dense LDL subfraction profiles in these FCH families. Therefore, dense LDL subfraction profiles, associated with elevated lipid levels, appear to have a genetic basis in FCH.	UNIV NIJMEGEN,DEPT MED,NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN,DEPT EPIDEMIOL,NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN,DEPT MED STAT,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen			Stalenhoef, A.F.H./H-8094-2014; Kiemeney, Lambertus A./D-3357-2009; de Haan, Antonius F J/L-4344-2015; Bredie, Sebastian JH/L-4226-2015	Kiemeney, Lambertus A./0000-0002-2368-1326; Bredie, Sebastian JH/0000-0002-6973-7540	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akaike H, 1974, IEEE T AUTOMAT CONTR, V19, P719; Assmann G, 1993, LIPID METABOLISM DIS, P19; AUSTIN MA, 1988, AM J HUM GENET, V43, P838; AUSTIN MA, 1990, ARTERIOSCLEROSIS, V10, P520, DOI 10.1161/01.ATV.10.4.520; AUSTIN MA, 1993, GENET EPIDEMIOL, V10, P599, DOI 10.1002/gepi.1370100645; AUSTIN MA, 1986, LANCET, V2, P592; Austin Melissa A., 1993, Current Opinion in Lipidology, V4, P125, DOI 10.1097/00041433-199304000-00008; BABIRAK SP, 1992, ARTERIOSCLER THROMB, V12, P1176, DOI 10.1161/01.ATV.12.10.1176; BREDIE SJH, 1995, AM J CARDIOL, V75, P348, DOI 10.1016/S0002-9149(99)80552-9; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CABEZAS MC, 1993, ARTERIOSCLER THROMB, V13, P804, DOI 10.1161/01.ATV.13.6.804; CAMPOS H, 1992, ARTERIOSCLER THROMB, V12, P1410, DOI 10.1161/01.ATV.12.12.1410; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; CORESH J, 1993, GENET EPIDEMIOL, V10, P159, DOI 10.1002/gepi.1370100303; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; DEGRAAF J, 1992, AM J HUM GENET, V51, P1295; DEGRAAF J, 1993, J CLIN ENDOCR METAB, V76, P197, DOI 10.1210/jc.76.1.197; DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; DEJAGER S, 1993, J LIPID RES, V34, P295; DEMACKER PNM, 1980, CLIN CHEM, V26, P1775; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; FISHER WR, 1975, P NATL ACAD SCI USA, V72, P2347, DOI 10.1073/pnas.72.6.2347; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; Hoffer MJV, 1996, ATHEROSCLEROSIS, V119, P159, DOI 10.1016/0021-9150(95)05641-6; HOKANSON JE, 1993, ARTERIOSCLER THROMB, V13, P427, DOI 10.1161/01.ATV.13.3.427; HOKANSON JE, 1995, ARTERIOSCL THROM VAS, V15, P452, DOI 10.1161/01.ATV.15.4.452; JARVIK GP, 1993, GENET EPIDEMIOL, V10, P257, DOI 10.1002/gepi.1370100406; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P233; KISSEBAH AH, 1981, METABOLISM, V30, P856, DOI 10.1016/0026-0495(81)90064-0; MCNAMARA JR, 1992, ARTERIOSCLER THROMB, V12, P1284, DOI 10.1161/01.ATV.12.11.1284; NISHINA PM, 1992, P NATL ACAD SCI USA, V89, P708, DOI 10.1073/pnas.89.2.708; STALENHOEF AFH, 1986, ARTERIOSCLEROSIS, V6, P387, DOI 10.1161/01.ATV.6.4.387; SWINKELS DW, 1989, ARTERIOSCLEROSIS, V9, P604, DOI 10.1161/01.ATV.9.5.604; SWINKELS DW, 1988, BIOCHIM BIOPHYS ACTA, V960, P1, DOI 10.1016/0005-2760(88)90002-1; VIRELLA MFL, 1980, CLIN CHEM, V26, P1205; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; 1992, STAT ANAL GENETIC EP	38	63	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					812	822						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644746				2022-12-18	WOS:A1996UA38000020
J	ONODERA, O; OYAKE, M; TAKANO, H; IKEUCHI, T; IGARASHI, S; TSUJI, S				ONODERA, O; OYAKE, M; TAKANO, H; IKEUCHI, T; IGARASHI, S; TSUJI, S			MOLECULAR-CLONING OF A FULL-LENGTH CDNA FOR DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY AND REGIONAL EXPRESSIONS OF THE EXPANDED ALLELES IN THE CNS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; POLYMERASE CHAIN-REACTION; TRINUCLEOTIDE CAG REPEAT; HUNTINGTONS-DISEASE GENE; ANDROGEN RECEPTOR; MESSENGER-RNAS; HUMAN BRAIN; DNA; DROSOPHILA; SEQUENCE	Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder characterized by genetic anticipation and variable combinations of symptoms including myoclonus, epilepsy, cerebellar ataxia, choreoathetosis, and dementia. Recently, we discovered that DRPLA is caused by unstable expansion of a CAG repeat of a gene on the short arm of chromosome 12. We determined the consensus DRPLA cDNA sequence containing the complete coding region for 1,185 amino acids. The CAG repeat, which is expanded in DRPLA, is located 1,462 bp downstream from the putative methionine initiation codon and encodes a poly-glutamine tract. Although poly-serine and proline tracts exist near the CAG repeats, these polyserine or proline tracts did not show any polymorphisms, which is in strong contrast to the high heterogeneity in the length of the CAG repeat. Northern blot analysis revealed a 4.7-kb transcript that is widely expressed in various tissues including heart, lung, kidney, placenta, skeletal muscle, and brain. Reverse transcription-PCR analysis revealed that the expanded alleles are transcribed to levels comparable to those of normal alleles. These results indicate that there is no difference in transcriptional efficiency between expanded and normal alleles. Furthermore, mRNA from cerebellar hemispheres of DRPLA patients showed smaller sizes of CAG repeats compared with other regions of the brain, which reflects somatic mosaicism of the expanded alleles of the DRPLA gene.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN	Niigata University			Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; AMEMIYA Y, 1988, NATURE, V336, P89, DOI 10.1038/336089a0; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASHLEEY CT, 1992, NAT GENET, V4, P244; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; HAYNES SR, 1989, DEV BIOL, V134, P246, DOI 10.1016/0012-1606(89)90094-8; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; HIRAYAMA K, 1990, ATAXIC DISEASES SPIN, P46; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Naito H., 1990, SEISHIN IGAKU, V32, P1135; NAITO H, 1990, ADV NEUROL SCI, V34, P56; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMITH JK, 1958, NEUROLOGY, V138, P2605; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; 1993, CELL, V72, P971	49	63	68	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1050	1060						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485154				2022-12-18	WOS:A1995TA44900010
J	AOYAMA, T; SOURI, M; UENO, I; KAMIJO, T; YAMAGUCHI, S; RHEAD, WJ; TANAKA, K; HASHIMOTO, T				AOYAMA, T; SOURI, M; UENO, I; KAMIJO, T; YAMAGUCHI, S; RHEAD, WJ; TANAKA, K; HASHIMOTO, T			CLONING OF HUMAN VERY-LONG-CHAIN ACYL-COENZYME-A DEHYDROGENASE AND MOLECULAR CHARACTERIZATION OF ITS DEFICIENCY IN 2 PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FATTY-ACID OXIDATION; COA DEHYDROGENASE; A DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; VACCINIA VIRUS; IMMUNOCHEMICAL CHARACTERIZATION; CULTURED FIBROBLASTS; LIVER MITOCHONDRIA; CATALYTIC ACTIVITY; MCAD GENE	Two overlapping cDNA clones (1,991 bp and 736 bp, respectively) encoding the precursor of human mitochondrial very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) were cloned and sequenced. The cDNA inserts of these clones together encompass a region of 2,177 bases, encoding the entire protein of 655 amino acids, including a 40-amino acid leader peptide and a 615-amino acid mature polypeptide. PCR-amplified VLCAD cDNAs were sequenced in cultured fibroblasts from two VLCAD-deficient patients. In both patients, a 105-bp deletion encompassing bases 1078-1182 in VLCAD cDNA was identified. The deletion seems to occur due to exon skipping during processing of VLCAD pre-mRNA. This is the first demonstration of a mutation causing VLCAD deficiency. Quantitative cDNA expression of normal human VLCAD was performed in the patients' fibroblasts, using vaccinia viral system, which demonstrated that the deficiency of the normal VLCAD protein causes impaired long-chain fatty acid beta-oxidation activity in the patients' fibroblasts. In patient fibroblasts, raising VLCAD activity to similar to 20% of normal control fibroblast activity raised palmitic acid beta-oxidation flux to the level found in control fibroblasts, which may offer important information for the rational design of future somatic gene therapy for VLCAD deficiency.	SHINSHU UNIV,SCH MED,DEPT PEDIAT,MATSUMOTO,NAGANO 390,JAPAN; SHINSHU UNIV HOSP,CENT CLIN LABS,MATSUMOTO,NAGANO,JAPAN; SHIMANE MED UNIV,DEPT PEDIAT,IZUMO,SHIMANE 693,JAPAN; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510	Shinshu University; Shinshu University; Shimane University; University of Iowa; Yale University	AOYAMA, T (corresponding author), SHINSHU UNIV,SCH MED,DEPT BIOCHEM,MATSUMOTO,NAGANO 390,JAPAN.							ANDRESEN BS, 1994, AM J HUM GENET, V54, P975; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; AOYAMA T, 1989, EUR J BIOCHEM, V181, P331, DOI 10.1111/j.1432-1033.1989.tb14728.x; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; AOYAMA T, 1989, J BIOL CHEM, V264, P21327; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V201, P1541, DOI 10.1006/bbrc.1994.1879; AOYAMA T, 1990, P NATL ACAD SCI USA, V87, P5425, DOI 10.1073/pnas.87.14.5425; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V198, P1113, DOI 10.1006/bbrc.1994.1158; AOYAMA T, 1995, ANAL BIOCHEM, V227, P85, DOI 10.1006/abio.1995.1256; AOYAMA T, IN PRESS J CLIN INVE; BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATES PM, 1992, J LIPID RES, V33, P1099; COATES PM, 1992, PEDIATR RES, V31, P34, DOI 10.1203/00006450-199201000-00006; COATES PM, 1988, J CLIN INVEST, V81, P171, DOI 10.1172/JCI113290; COATES PM, 1992, NEW DEV FATTY ACID O; ENGEL PC, 1992, CHEM BIOCH FLAVOENZY, P597; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; HALE DE, 1985, PEDIATR RES, V19, P666, DOI 10.1203/00006450-198507000-00006; HALE DE, 1992, J PEDIATR-US, V121, P1, DOI 10.1016/S0022-3476(05)82532-6; HALE DE, 1990, FATTY ACID OXIDATION, P333; HASHIMOTO T, 1992, NEW DEV FATTY ACID O, P19; HAY R, 1984, BIOCHIM BIOPHYS ACTA, V779, P65, DOI 10.1016/0304-4157(84)90004-2; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; INDO Y, 1991, PEDIATR RES, V30, P211, DOI 10.1203/00006450-199109000-00001; INDO Y, 1991, GENOMICS, V11, P609, DOI 10.1016/0888-7543(91)90068-P; IZAI K, 1992, J BIOL CHEM, V267, P1027; KAMIJO T, 1993, J BIOL CHEM, V268, P26452; KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; KIM JJP, 1991, FLAVINS AND FLAVOPROTEINS 1990, P291; Maniatis T., 1982, MOL CLONING; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; NAITO E, 1990, J CLIN INVEST, V85, P1575, DOI 10.1172/JCI114607; NAITO E, 1989, J CLIN INVEST, V83, P1605, DOI 10.1172/JCI114058; OZAKI M, 1993, BIOCHEM BIOPH RES CO, V193, P653, DOI 10.1006/bbrc.1993.1674; RHEAD WJ, 1991, CLIN BIOCHEM, V24, P319, DOI 10.1016/0009-9120(91)80006-O; SAIJO T, 1994, J BIOL CHEM, V269, P4401; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOURI M, 1994, ANAL BIOCHEM, V221, P362, DOI 10.1006/abio.1994.1426; Tanaka K., 1992, Human Mutation, V1, P271, DOI 10.1002/humu.1380010402; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025; YOKOTA I, 1991, AM J HUM GENET, V49, P1280	47	63	66	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					273	283						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668252				2022-12-18	WOS:A1995RL77100009
J	GARDNER, RJ; BOBROW, M; ROBERTS, RG				GARDNER, RJ; BOBROW, M; ROBERTS, RG			THE IDENTIFICATION OF POINT MUTATIONS IN DUCHENNE MUSCULAR-DYSTROPHY PATIENTS BY USING REVERSE-TRANSCRIPTION PCR AND THE PROTEIN TRUNCATION TEST	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE DELETIONS; MULTIPLEX PCR; MESSENGER-RNA; DMD GENE; LOCUS; CDNA; PHENOTYPE; TISSUES	The protein truncation test (PTT) is a mutation-detection method that monitors the integrity of the open reading frame (ORF). More than 60% of cases of Duchenne muscular dystrophy (DMD) result from gross frameshifting deletions in the dystrophin gene that are detectable by a multiplex PCR system. It has become apparent that virtually all of the remaining DMD mutations also disrupt the translational reading frame, making the PTT a logical next step toward a comprehensive strategy for the identification of all DMD mutations. We report here a pilot study involving 22 patients and describe the mutations characterized. These constitute 12 point mutations or small insertions/deletions and 4 gross rearrangements. We also have a remaining five patients in whom there does not appear to be a mutation in the ORF. We believe that reverse-transcription-PCR/PTT is an efficient method by which to screen for small mutations in DMD patients with no deletion.			GARDNER, RJ (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOLEC GENET,PAEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND.		Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579				ABBS S, 1991, J MED GENET, V28, P304, DOI 10.1136/jmg.28.5.304; BEGGS AH, 1990, HUM GENET, V86, P45; BOYD Y, 1990, GENOMICS, V7, P182, DOI 10.1016/0888-7543(90)90539-7; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FORREST SM, 1991, AM J HUM GENET, V49, P175; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; HU XY, 1990, AM J HUM GENET, V46, P682; KILIMANN MW, 1992, HUM GENET, V89, P253; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; VAINZOF M, 1993, J NEUROL SCI, V119, P38, DOI 10.1016/0022-510X(93)90189-6; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119	29	63	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					311	320						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668256				2022-12-18	WOS:A1995RL77100013
J	THOMAS, PM; COTE, GJ; HALLMAN, DM; MATHEW, PM				THOMAS, PM; COTE, GJ; HALLMAN, DM; MATHEW, PM			HOMOZYGOSITY MAPPING, TO CHROMOSOME 11P, OF THE GENE FOR FAMILIAL PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE INHERITANCE; WIEDEMANN-BECKWITH SYNDROME; MOLECULAR CHARACTERIZATION; NESIDIOBLASTOSIS; PANCREAS; MAP; TERM; SOMATOSTATIN; OCTREOTIDE; LINKAGE	Familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is a rare, autosomal recessive disease of unregulated insulin secretion, defined by elevations in serum insulin despite severe hypoglycemia. We used the homozygosity gene-mapping strategy to localize this disorder to the region of chromosome 11p between markers D11S1334 and D11S899 (maximum LOD score 5.02 [theta = 0] at marker D11S926) in five consanguineous families of Saudi Arabian origin. These results extend those of a recent report that also placed PHHI on chromosome 11p, between markers D11S926 and D11S928. Comparison of the boundaries of these two overlapping regions allows the PHHI locus to be assigned to the 4-cM region between the markers D11S926 and D11S899. Identification of this gene may allow a better understanding of other disorders of glucose homeostasis, by providing insight into the regulation of insulin release.	UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,CTR HUMAN GENET,HOUSTON,TX; DHAHRAN HLTH CTR,DIV SPECIALTY PEDIAT,DHAHRAN,SAUDI ARABIA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	THOMAS, PM (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,ENDOCRINOL SECT,BOX 15,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NIDDK NIH HHS [1 T32 DK07696-01/05, DK46660-01DDK] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046660, T32DK007696] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; BECKER K, 1978, EUR J PEDIATR, V127, P75, DOI 10.1007/BF00445763; BISHOP AE, 1981, DIABETES, V30, P122, DOI 10.2337/diabetes.30.2.122; BRUINING G J, 1990, Current Opinion in Pediatrics, V2, P758, DOI 10.1097/00008480-199008000-00024; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; GLASER B, 1990, AM J MED GENET, V37, P511, DOI 10.1002/ajmg.1320370416; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GLASER B, 1993, J PEDIATR-US, V123, P644, DOI 10.1016/S0022-3476(05)80970-9; GOUSDWAARD WB, 1986, HUM PATHOL, V17, P46; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JACOBS DG, 1986, J PEDIATR SURG, V21, P1184, DOI 10.1016/0022-3468(86)90035-7; JAFFE R, 1980, LAB INVEST, V42, P356; KAISER N, 1990, DIABETOLOGIA, V33, P482, DOI 10.1007/BF00405110; KEATS BJB, 1994, AM J HUM GENET, V54, P681; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1993, HUM MOL GENET, V2, P909, DOI 10.1093/hmg/2.7.909; Martinez y Martinez R, 1992, Genet Couns, V3, P67; MATHEW PM, 1988, CLIN PEDIATR, V27, P148, DOI 10.1177/000992288802700307; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; McKusick V.A., 1992, MENDELIAN INHERITANC; MELLERSH C, 1993, BIOTECHNIQUES, V15, P582; MORENO LA, 1989, AM J MED GENET, V34, P584, DOI 10.1002/ajmg.1320340426; OTONKOSKI T, 1993, J CLIN ENDOCR METAB, V76, P184, DOI 10.1210/jc.76.1.184; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; PING AJ, 1989, AM J HUM GENET, V44, P720; RAHIER J, 1984, DIABETOLOGIA, V26, P282; RAHIER J, 1989, DIABETES CARE, V12, P164, DOI 10.2337/diacare.12.2.164; RICHARD CW, 1993, AM J HUM GENET, V52, P915; THORNTON PS, 1991, J PEDIATR-US, V119, P721, DOI 10.1016/S0022-3476(05)80286-0; THORNTON PS, 1993, J PEDIATR-US, V123, P637, DOI 10.1016/S0022-3476(05)80969-2; WEKSBERG R, 1990, GENOMICS, V8, P693, DOI 10.1016/0888-7543(90)90256-T; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WOO D, 1976, ARCH DIS CHILD, V51, P528, DOI 10.1136/adc.51.7.528; WOOLF DA, 1991, ARCH DIS CHILD, V66, P529, DOI 10.1136/adc.66.4.529	37	63	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					416	421						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847376				2022-12-18	WOS:A1995QF42300009
J	OHASHI, H; WAKUI, K; OGAWA, K; OKANO, T; NIIKAWA, N; FUKUSHIMA, Y				OHASHI, H; WAKUI, K; OGAWA, K; OKANO, T; NIIKAWA, N; FUKUSHIMA, Y			A STABLE ACENTRIC MARKER CHROMOSOME - POSSIBLE EXISTENCE OF AN INTERCALARY ANCIENT CENTROMERE AT DISTAL 8P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICRODISSECTED CHROMOSOME; INSITU HYBRIDIZATION; ALPHA-SATELLITE; DNA; SEQUENCES; ORIGIN; PROBES; BAND; IDENTIFICATION; ANTIBODIES	A centromere is considered to be an essential chromosomal component where microtubule-kinetochore interaction occurs to segregate sister chromatids faithfully and acentric chromosomes are unstable and lost through cell divisions. We report a novel marker chromosome that was acentric but stable through cell divisions. The patient was a 2-year-old girl with mental retardation, patent ductus arteriosus, and mild dysmorphic features. G-banded chromosome analysis revealed that an additional small marker chromosome was observed in all 100 cells examined. By the reverse-chromosome-painting method, the marker was found to originate from the distal region of 8p, and a subsequent two-color FISH analysis with cosmid probes around the region revealed that the marker was an inverted duplication interpreted as 8pter-->p23.1:: p23.1-->8pter. No centromeric region was involved in the marker. By FISH, no a-satellite sequence was detected on the marker, while a telomere sequence was detected at each end. Anti-kinetochore immunostaining, using a serum from a patient with CREST (calcinosis, Raynaud syndrome, esophageal dismotility, sclerodactyly, and telangiectasia) syndrome, showed a pair of signals on the marker, which indicated that a functional kinetochore was present on the marker. The analysis of this patient might suggest the possibility that an ancient centromere sequence exists at distal 8p (8p23.1-pter) and was activated through the chromosome rearrangement in the patient.	SAITAMA CHILDRENS MED CTR,DEPT CLIN LAB,IWATSUKI,SAITAMA 339,JAPAN; SAITAMA CHILDRENS MED CTR,DEPT CARDIOL,IWATSUKI,SAITAMA 339,JAPAN; KITASATO UNIV,CTR HYG SCI RES & DEV,TOKYO,JAPAN; NAGASAKI UNIV,SCH MED,DEPT HUMAN GENET,NAGASAKI 852,JAPAN	Saitama Children's Medical Center; Saitama Children's Medical Center; Kitasato University; Nagasaki University	OHASHI, H (corresponding author), SAITAMA CHILDRENS MED CTR,DIV MED GENET,2100 MAGOME,IWATSUKI,SAITAMA 339,JAPAN.							BALDINI A, 1993, HUM GENET, V90, P577; BLENNOW E, 1992, HUM GENET, V90, P371, DOI 10.1007/BF00220461; BLENNOW E, 1993, AM J HUM GENET, V53, P433; BLENNOW E, 1994, AM J HUM GENET, V54, P877; BLOOM K, 1993, CELL, V73, P621, DOI 10.1016/0092-8674(93)90242-I; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; DENG HX, 1992, HUM GENET, V89, P13, DOI 10.1007/BF00207034; FUKUSHIMA Y, 1992, JPN J HUM GENET, V37, P149, DOI 10.1007/BF01899737; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; HAAF T, 1988, CANCER GENET CYTOGEN, V30, P73, DOI 10.1016/0165-4608(88)90094-5; HIROTA T, 1992, GENOMICS, V13, P349, DOI 10.1016/0888-7543(92)90252-N; IKEUCHI T, 1984, CYTOGENET CELL GENET, V38, P56, DOI 10.1159/000132030; INAZAWA J, 1994, CYTOGENET CELL GENET, V65, P130, DOI 10.1159/000133618; JINNO Y, 1992, J BIOCHEM-TOKYO, V112, P75, DOI 10.1093/oxfordjournals.jbchem.a123869; LEVAN A, 1981, GENES CHROMOSOMES NE, P223; LIN CC, 1990, CANCER GENET CYTOGEN, V48, P271, DOI 10.1016/0165-4608(90)90131-S; MAGNANI I, 1993, CLIN GENET, V43, P180; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; MERRY DE, 1985, AM J HUM GENET, V37, P425; OHTA T, 1993, HUM GENET, V92, P1, DOI 10.1007/BF00216136; PLATTNER R, 1993, HUM GENET, V91, P131; RAUCH A, 1992, CLIN GENET, V42, P84; SCHRANDERSTUMPE.CT, 1994, AM J MED GENET, V50, P377; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153	26	63	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1202	1208						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977381				2022-12-18	WOS:A1994QB68400018
J	SHERMAN, JB; RABEN, N; NICASTRI, C; ARGOV, Z; NAKAJIMA, H; ADAMS, EM; ENG, CM; COWAN, TM; PLOTZ, PH				SHERMAN, JB; RABEN, N; NICASTRI, C; ARGOV, Z; NAKAJIMA, H; ADAMS, EM; ENG, CM; COWAN, TM; PLOTZ, PH			COMMON MUTATIONS IN THE PHOSPHOFRUCTOKINASE-M GENE IN ASHKENAZI JEWISH PATIENTS WITH GLYCOGENESIS-VII - AND THEIR POPULATION FREQUENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SOMATIC-CELL HYBRIDS; SINGLE-BASE CHANGES; MESSENGER-RNA; REGIONAL ASSIGNMENT; NONSENSE MUTATIONS; DNA FRAGMENTS; GC-CLAMP; MUSCLE; DEFICIENCY	Phosphofructokinase (PFK) catalyzes the rate-limiting step of glycolysis. Deficiency of the muscle enzyme is manifested by exercise intolerance and a compensated hemolytic anemia. Case reports of this autosomal recessive disease suggest a predominance in Ashkenazi Jews in the United States. We have explored the genetic basis for this illness in nine affected families and surveyed the normal Ashkenazi population for the mutations we have found. Genomic DNA was amplified using PCR, and denaturing gradient-gel electrophoresis was used to localize exons with possible mutations. The polymorphic exons were sequenced or digested with restriction enzymes. A previously described splicing mutation, Delta 5, accounted for 11 (61%) of 18 abnormal alleles in the nine families. A single base deletion leading to a frameshift mutation in exon 22 (Delta C-22) was found in six of seven alleles. A third mutation, resulting in a nonconservative amino acid substitution in exon 4, accounted for the remaining allele. Thus, three mutations could account for all illness in this group, and two mutations could account for 17 of 18 alleles. In screening 250 normal Ashkenazi individuals for all three mutations, we found only one Delta 5 allele. Clinical data revealed no correlation between the particular mutations and symptoms, but male patients were more symptomatic than females, and only males had frank hemolysis and hyperuricemia. Because PFK deficiency in Ashkenazi Jews is caused by a limited number of mutations, screening genomic DNA from peripheral blood for the described mutations in this population should enable rapid diagnosis without muscle biopsy.	NIAMS, ARTHRIT & RHEUMATISM BRANCH, BETHESDA, MD USA; HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT NEUROL, IL-91010 JERUSALEM, ISRAEL; CUNY MT SINAI SCH MED, DEPT HUMAN GENET, NEW YORK, NY 10029 USA; UNIV MARYLAND, SCH MED, DIV HUMAN GENET, BALTIMORE, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Hebrew University of Jerusalem; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore								ARGOV Z, 1987, J APPL PHYSIOL, V63, P1428, DOI 10.1152/jappl.1987.63.4.1428; ARGOV Z, 1987, NEUROLOGY, V37, P1720, DOI 10.1212/WNL.37.11.1720; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; HALLER RG, 1991, NEW ENGL J MED, V324, P364, DOI 10.1056/NEJM199102073240603; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; HOTTA K, 1991, EUR J BIOCHEM, V202, P293, DOI 10.1111/j.1432-1033.1991.tb16375.x; LAYZER RB, 1967, ARCH NEUROL-CHICAGO, V17, P512, DOI 10.1001/archneur.1967.00470290066009; LEWIS SF, 1991, J APPL PHYSIOL, V70, P391, DOI 10.1152/jappl.1991.70.1.391; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MINEO I, 1987, NEW ENGL J MED, V317, P75, DOI 10.1056/NEJM198707093170203; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V166, P637, DOI 10.1016/0006-291X(90)90856-I; NAKAJIMA H, 1990, BIOCHEM BIOPH RES CO, V173, P1317, DOI 10.1016/S0006-291X(05)80931-3; NAKAJIMA H, 1987, FEBS LETT, V223, P113, DOI 10.1016/0014-5793(87)80519-7; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RABEN N, 1991, DIABETES, V40, P118, DOI 10.2337/diabetes.40.1.118; RABEN N, 1993, J BIOL CHEM, V268, P4963; ROWLAND LP, 1986, MYOLOGY, P1603; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARMA PM, 1989, GENE, V77, P177, DOI 10.1016/0378-1119(89)90372-7; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; SHEFFIELD VC, 1992, AM J HUM GENET, V50, P567; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TARUI S, 1965, BIOCHEM BIOPH RES CO, V19, P517, DOI 10.1016/0006-291X(65)90156-7; VALDEZ BC, 1989, GENE, V76, P167, DOI 10.1016/0378-1119(89)90019-X; VANKEUREN M, 1986, HUM GENET, V74, P34, DOI 10.1007/BF00278782; VORA S, 1986, BIOCHEM BIOPH RES CO, V135, P615, DOI 10.1016/0006-291X(86)90037-9; VORA S, 1983, HUM GENET, V63, P374, DOI 10.1007/BF00274765; VORA S, 1983, J CLIN INVEST, V72, P1995, DOI 10.1172/JCI111164; VORA S, 1982, SOMAT CELL GENET, V8, P95, DOI 10.1007/BF01538653; VORA S, 1983, ISOZYMES-CURR T BIOL, V11, P3; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A	41	63	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					305	313						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037209				2022-12-18	WOS:A1994NZ33600011
J	PERAL, B; WARD, CJ; SANMILLAN, JL; THOMAS, S; STALLINGS, RL; MORENO, F; HARRIS, PC				PERAL, B; WARD, CJ; SANMILLAN, JL; THOMAS, S; STALLINGS, RL; MORENO, F; HARRIS, PC			EVIDENCE OF LINKAGE DISEQUILIBRIUM IN THE SPANISH POLYCYSTIC KIDNEY-DISEASE-I POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; GENETIC-ANALYSIS; PKD1 LOCUS; CHROMOSOME-16; DNA; MARKER; IDENTIFICATION; COMPLEX; ALLELES; REGION	Forty-one Spanish families with polycystic kidney disease 1 (PKD1) were studied for evidence of linkage disequilibrium between the disease locus and six closely linked markers. Four of these loci-three highly polymorphic microsatellites (SM6, CW3, and CW2) and an RFLP marker (BLu24)-are described for the first time in this report. Overall the results reveal many different haplotypes on the disease-carrying chromosome, suggesting a variety of independent PKD1 mutations. However, linkage disequilibrium was found between BLu24 and PKD1, and this was corroborated by haplotype analysis including the microsatellite polymorphisms. From this analysis a group of closely related haplotypes, consisting of four markers, was found on 40% of PKD1 chromosomes, although markers flanking this homogeneous region showed greater variability. This study has highlighted an interesting subpopulation of Spanish PKD1 chromosomes, many of which have a common origin, that may be useful for localizing the PKD1 locus more precisely.	JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; HOSP RAMON Y CAJAL, UNIDAD GENET MOLEC, E-28034 MADRID, SPAIN; LOS ALAMOS NATL LAB, DIV LIFE SCI, LOS ALAMOS, NM USA; LOS ALAMOS NATL LAB, CTR HUMAN GENOME STUDIES, LOS ALAMOS, NM USA	University of Oxford; Hospital Universitario Ramon y Cajal; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory			Peral, Belén/F-4562-2015; Stallings, Raymond/A-7213-2008; San-Millán, José L./F-9944-2015	Peral, Belén/0000-0003-4984-4020; 				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BACHNER L, 1990, HUM GENET, V85, P221; BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; DAVIES F, 1991, Q J MED, V79, P477; GABOW PA, 1991, KIDNEY INT, V40, P989, DOI 10.1038/ki.1991.306; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GERMINO GG, 1990, AM J HUM GENET, V46, P925; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HARRIS PC, UNPUB LARGE DUPLICAT; HILL WG, 1975, THEOR POPUL BIOL, V8, P117, DOI 10.1016/0040-5809(75)90028-3; HIRST MC, 1991, NUCLEIC ACIDS RES, V19, P3283, DOI 10.1093/nar/19.12.3283; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MURRAY JC, 1987, HUM GENET, V76, P274; NELLIST M, 1993, CELL, V75, P1305; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; PERAL B, 1993, J MED GENET, V30, P910, DOI 10.1136/jmg.30.11.910; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; POUND SE, 1992, J MED GENET, V29, P247, DOI 10.1136/jmg.29.4.247; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; ROMEO G, 1988, LANCET, V2, P8; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SNAREY A, UNPUB LINKAGE DISEQU; SOMLO S, 1992, GENOMICS, V13, P152, DOI 10.1016/0888-7543(92)90215-E; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEIR BS, 1978, GENETICS, V88, P633	37	63	69	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					899	908						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	7909986				2022-12-18	WOS:A1994NH39400020
J	NAUMOVA, A; SAPIENZA, C				NAUMOVA, A; SAPIENZA, C			THE GENETICS OF RETINOBLASTOMA, REVISITED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ONCOGENIC POINT MUTATIONS; 13Q14 DELETION MOSAICISM; ESTERASE-D; RB1 GENE; TRILATERAL RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; DISTAL PORTION; MUTANT ALLELES; CHROMOSOME; FAMILIES	Our epidemiological and genetic analyses of sporadic and familial retinoblastoma indicate that an X-chromosome-linked gene is involved in the genesis of a significant fraction of new bilateral cases of the disease. The activity of this gene results in sex-ratio distortion in favor of males among patients with bilateral sporadic disease. Among the offspring of these males, both sex-ratio distortion in favor of males and transmission-ratio distortion in favor of affecteds are observed. We propose that these phenomena are due to the inability of these males to erase the genome imprint established on the half of the genome inherited from their mothers.	UNIV CALIF SAN DIEGO,LUDWIG INST CANC RES,LA JOLLA,CA; UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego				Naumova, Anna K./0000-0001-8481-5765				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; AKAZAWA K, 1981, JPN J OPHTHALMOL, V25, P321; Barry G, 1971, Trans Ophthalmol Soc U K, V91, P839; BECH K, 1961, ACTA OPHTHALMOL, V39, P561; BenEzra D, 1976, J Pediatr Ophthalmol, V13, P340; CARBAJAL UM, 1958, AM J OPHTHALMOL, V45, P391, DOI 10.1016/0002-9394(58)90821-3; CARLSON EA, 1979, AM J OPHTHALMOL, V87, P449, DOI 10.1016/0002-9394(79)90230-7; CARLSON EA, 1979, AM J MED GENET, V4, P365, DOI 10.1002/ajmg.1320040408; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; CAVENEE WK, 1986, NEW ENGL J MED, V314, P1201, DOI 10.1056/NEJM198605083141901; CONNOLLY MJ, 1983, HUM GENET, V65, P122, DOI 10.1007/BF00286647; COSTANZI E, 1989, AM J MED GENET, V34, P391, DOI 10.1002/ajmg.1320340314; COWELL JK, 1987, CANCER GENET CYTOGEN, V27, P27, DOI 10.1016/0165-4608(87)90256-1; CZEIZEL A, 1974, HUMANGENETIK, V22, P159; CZEIZEL A, 1974, HUMANGENETIK, V22, P153; DEGROUCHY J, 1980, ARCH FR PEDIATR, V37, P531; DEVESA SS, 1975, AM J OPHTHALMOL, V80, P263, DOI 10.1016/0002-9394(75)90143-9; DRYJA TP, 1993, AM J HUM GENET, V52, P1122; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; ERWENNE CW, 1983, REV BRAS OFTALMOL, V42, P324; FALLS HF, 1951, AMA ARCH OPHTHALMOL, V46, P367; FRANCKE U, 1976, MED PEDIATR ONCOL, V2, P379, DOI 10.1002/mpo.2950020404; FRANCOIS J, 1975, OPHTHALMOLOGICA, V170, P405, DOI 10.1159/000307248; FRANCOIS J, 1978, J PEDIATR OPHTHALMOL, V16, P85; GEDSCHOLD J, 1988, HUM GENET, V80, P399, DOI 10.1007/BF00273662; GEY W, 1970, HUMANGENETIK, V10, P362, DOI 10.1007/BF00278776; GODDARD AD, 1990, CLIN GENET, V37, P117; GREGER V, 1990, AM J HUM GENET, V46, P1187; Griffith A. D., 1944, BRIT JOUR OPHTHALMOL, V28, P279, DOI 10.1136/bjo.28.6.279; HANSEN MF, 1988, TRENDS GENET, V4, P125, DOI 10.1016/0168-9525(88)90134-5; HERM RJ, 1956, AM J OPHTHALMOL, V41, P22, DOI 10.1016/0002-9394(56)91459-3; HOLLADAY DA, 1991, CANCER-AM CANCER SOC, V67, P710, DOI 10.1002/1097-0142(19910201)67:3<710::AID-CNCR2820670330>3.0.CO;2-3; HOWARD RO, 1978, T AM OPHTHAL SOC, V76, P173; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JENSEN OA, 1965, ACTA OPHTHALMOL, V43, P821; JENSEN RD, 1971, NEW ENGL J MED, V285, P307, DOI 10.1056/NEJM197108052850602; JOHNSON MP, 1982, CANCER GENET CYTOGEN, V6, P29, DOI 10.1016/0165-4608(82)90018-8; KHODADOUST AA, 1977, SURV OPHTHALMOL, V21, P467, DOI 10.1016/S0039-6257(77)80003-9; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOCK E, 1979, ACTA OPHTHALMOL, V57, P344; KODILINYE HC, 1967, AM J OPHTHALMOL, V63, P469, DOI 10.1016/0002-9394(67)90246-2; KONDO I, 1985, HUM GENET, V71, P263, DOI 10.1007/BF00284588; LAIRD CD, 1987, GENETICS, V117, P587; LEACH RJ, 1989, CELL GROWTH DIFFER, V1, P401; LEELAWONGS N, 1968, AM J OPHTHALMOL, V66, P1050, DOI 10.1016/0002-9394(68)90813-1; LELE KP, 1963, ANN HUM GENET, V27, P171, DOI 10.1111/j.1469-1809.1963.tb00209.x; LENNOX EL, 1975, BRIT MED J, V3, P731, DOI 10.1136/bmj.3.5986.731; LIBERFARB RM, 1984, OPHTHALMOLOGY, V91, P1695; LOHMANN D, 1992, HUM GENET, V89, P49, DOI 10.1007/BF00207041; MACKLIN MT, 1959, ARCH OPHTHALMOL-CHIC, V62, P842; MALIK RK, 1986, AM J OPHTHALMOL, V102, P650, DOI 10.1016/0002-9394(86)90540-4; MASTRANGELO D, 1988, OPHTHALMIC PAEDIATR, V10, P161; MATSUNAGA E, 1976, JPN J OPHTHALMOL, V20, P266; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MOTEGI T, 1982, HUM GENET, V60, P193, DOI 10.1007/BF00569711; MOTEGI T, 1987, J MED GENET, V24, P696, DOI 10.1136/jmg.24.11.696; MOTEGI T, 1982, HUM GENET, V61, P95, DOI 10.1007/BF00274194; MOTEGI T, 1984, HUM GENET, V66, P186, DOI 10.1007/BF00286598; MOTEGI T, 1981, HUM GENET, V58, P168, DOI 10.1007/BF00278704; MOTEGI T, 1983, HUM GENET, V64, P205, DOI 10.1007/BF00327131; MUNIER F, 1992, HUM GENET, V89, P508, DOI 10.1007/BF00219175; MUNIER F, 1989, OPHTHALMIC PAED GEN, V10, P129, DOI 10.3109/13816818909088353; NAUMOVA A, 1994, AM J HUM GENET, V54, P274; NIELSEN M, 1968, ACTA OPHTHALMOL, V46, P736; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; ONADIM Z, 1992, BRIT J CANCER, V65, P711, DOI 10.1038/bjc.1992.150; ORYE E, 1974, CLIN GENET, V5, P457; OZAWA H, 1978, JPN J OPHTHALMOL, V22, P320; PATERSON MW, 1965, BRIT J OPHTHALMOL, V49, P347, DOI 10.1136/bjo.49.7.347; PRITCHARD DJ, 1991, HUM GENET, V87, P671; PRUETT RC, 1969, ARCH OPHTHALMOL-CHIC, V82, P177; RIBEIRO MCM, 1988, CANCER GENET CYTOGEN, V32, P169, DOI 10.1016/0165-4608(88)90279-8; RIVERA H, 1981, HUM GENET, V59, P211, DOI 10.1007/BF00283666; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SANDERS BM, 1988, BRIT J OPHTHALMOL, V72, P576, DOI 10.1136/bjo.72.8.576; SAPIENZA C, 1992, GENETICS, V132, P241; Sapienza C, 1992, Semin Cancer Biol, V3, P151; SAPIENZA C, 1990, GENOMIC IMPRINTING S, P107; SCHEFFER H, 1989, AM J HUM GENET, V45, P252; SINNIAH D, 1980, ACTA OPHTHALMOL, V58, P819; SIRACUSA LD, 1991, GENETICS, V128, P813; SORSBY A, 1972, BRIT MED J, V2, P580, DOI 10.1136/bmj.2.5813.580; SPARKES RS, 1984, HUM GENET, V68, P258, DOI 10.1007/BF00418397; SQUIRE J, 1985, HUM GENET, V70, P291, DOI 10.1007/BF00295364; SUCKLING RD, 1982, BRIT J CANCER, V46, P729, DOI 10.1038/bjc.1982.265; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TAYLOR AI, 1970, HUMANGENETIK, V10, P209, DOI 10.1007/BF00295782; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TURLEAU C, 1985, CANCER GENET CYTOGEN, V16, P321, DOI 10.1016/0165-4608(85)90240-7; VISARIA PM, 1967, EUGEN QUART, V14, P132, DOI 10.1080/19485565.1967.9987713; WALDBAUM R, 1978, HUM GENET, V44, P219; WEIRTHOMPSON E, 1991, ONCOGENE, V6, P2353; WILSON MG, 1977, CLIN GENET, V12, P1; YANDELL DW, 1989, AM J HUM GENET, V45, P547; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; ZHU X, 1992, CYTOGENET CELL GENET, V59, P248, DOI 10.1159/000133261; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	98	63	65	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					264	273						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304343				2022-12-18	WOS:A1994MU31500011
J	ALLEN, RC; NACHTMAN, RG; ROSENBLATT, HM; BELMONT, JW				ALLEN, RC; NACHTMAN, RG; ROSENBLATT, HM; BELMONT, JW			APPLICATION OF CARRIER TESTING TO GENETIC-COUNSELING FOR X-LINKED AGAMMAGLOBULINEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CHROMOSOME INACTIVATION PATTERNS; CHAIN-REACTION; DXS178 LOCUS; REPEAT; METHYLATION; POLYMORPHISMS; CELLS	Bruton X-linked agammaglobulinemia (XLA) is a phenotypically recessive genetic disorder of B lymphocyte development. Female carriers of XLA, although asymptomatic, have a characteristic B cell lineage-specific skewing of the pattern of X inactivation. Skewing apparently results from defective growth and maturation of B cell precursors bearing a mutant active X chromosome. In this study, carrier status was tested in 58 women from 22 families referred with a history of agammaglobulinemia. Primary carrier analysis to examine patterns of X inactivation in CD19+ peripheral blood cells (B lymphocytes) was conducted using quantitative PCR at the androgen-receptor locus. Obligate carriers of XLA demonstrated >95% skewing of X inactivation in peripheral blood CD19+ cells but not in CD19- cells. Carrier status for mothers of isolated affected males could be assessed in 10 of 11 families: 7 women showed skewing, and 3 did not. Five carriers were found in six families in which there were no living affected males. Among all those tested, one individual's carrier status was considered to be indeterminate and five women were noninformative for the carrier test. Results obtained by the carrier test were congruent with linkage analysis (where applicable) using the RFLPs DXS178 and DXS94 and two newly developed polymorphic microsatellite markers, DXS178CA and DXS101AAT. Refinements in techniques for primary carrier testing and genetic mapping of XLA now make possible an ordered approach to diagnosis, prenatal diagnosis, and genetic counseling.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine			Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021	Belmont, John W/0000-0001-7409-3578; 				ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ALLEN RC, 1992, HUM MOL GENET, V1, P216, DOI 10.1093/hmg/1.3.216; ALLEN RC, 1993, HUM MOL GENET, V2, P828, DOI 10.1093/hmg/2.6.828-a; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ALLEN RC, IN PRESS HUM MOL GEN; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BRUTON OC, 1952, PEDIATRICS, V9, P722; CACHIA PG, 1992, GENOMICS, V14, P70, DOI 10.1016/S0888-7543(05)80285-X; CAMPANA D, 1990, J IMMUNOL, V145, P1675; CHASE GA, 1973, HUM HERED, V23, P19, DOI 10.1159/000152548; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CONLEY ME, 1992, J CLIN IMMUNOL, V12, P139, DOI 10.1007/BF00918144; CONLEY ME, 1992, ANNU REV IMMUNOL, V10, P215; CONLEY ME, 1988, J PEDIATR, V112, P668; DEWEERS M, 1992, HUM MOL GENET, V1, P653, DOI 10.1093/hmg/1.8.653; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GUIOLI S, 1989, HUM GENET, V84, P12; HENDRIKS RW, 1992, CLIN GENET, V42, P114; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HUIGUCHI M, 1992, P NATL ACAD SCI USA, V88, P7405; JOURNET O, 1992, AM J MED GENET, V43, P885, DOI 10.1002/ajmg.1320430527; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; KWAN SP, 1986, J CLIN INVEST, V77, P649, DOI 10.1172/JCI112351; KWAN SP, 1990, GENOMICS, V6, P238, DOI 10.1016/0888-7543(90)90562-9; LOVERING R, 1993, HUM MOL GENET, V2, P139, DOI 10.1093/hmg/2.2.139; MALCOLM S, 1987, HUM GENET, V77, P172, DOI 10.1007/BF00272387; MANIATIS T, 1988, MOL CLONING; MENSINK EJBM, 1986, HUM GENET, V73, P327, DOI 10.1007/BF00279095; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NESBITT MN, 1972, DEV BIOL, V26, P252; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OCHS HD, 1989, IMMUNOLOGIC DISORDER, P226; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAROLINI O, 1993, GENOMICS, V15, P342, DOI 10.1006/geno.1993.1066; PUCK JM, 1992, AM J HUM GENET, V50, P742; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VERTIE D, 1993, NATURE, V361, P226; WENGLER GS, 1993, J IMMUNOL, V150, P700	47	63	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					25	35						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	7506482				2022-12-18	WOS:A1994MQ70000005
J	KUROSAKI, K; MATSUSHITA, T; UEDA, S				KUROSAKI, K; MATSUSHITA, T; UEDA, S			INDIVIDUAL DNA IDENTIFICATION FROM ANCIENT HUMAN REMAINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; DINUCLEOTIDE REPEAT POLYMORPHISM; MITOCHONDRIAL-DNA; ENZYMATIC AMPLIFICATION; MOLECULAR-CLONING; LOCUS	Individual identification of ancient human remains is one of the most fundamental requisites for studies of paleo-population genetics, including kinship among ancient people, intra- and interpopulation structures in ancient times, and the origin of human populations. However, knowledge of these subjects has been based mainly on circumstantial archaeological evidence for kinship and intrapopulation structure and on genetic studies of modern human populations. Here we describe individual identification of ancient humans by using short-nucleotide tandem repeats and mtDNAs as genetic markers. The application of this approach to kinship analysis shows clearly the presence or absence of kinship among the ancient remains examined.	UNIV TOKYO,FAC SCI,DEPT ANTHROPOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; CHIBA UNIV,SCH MED,DEPT LEGAL MED,CHIBA,JAPAN; NAGASAKI UNIV,SCH MED,DEPT ANAT 2,NAGASAKI 852,JAPAN	University of Tokyo; Chiba University; Nagasaki University								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; HAGELBERG E, 1989, NATURE, V342, P485, DOI 10.1038/342485a0; HUCHISON CA, 1974, NATURE, V251, P536; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KUROSAKI K, 1992, JPN J LEGAL MED, V46, P1; LAWLOR DA, 1991, NATURE, V349, P785, DOI 10.1038/349785a0; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P1961; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MM, 1991, NATURE, V353, P121, DOI 10.1038/353121b0; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968	25	63	65	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					638	643						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352274				2022-12-18	WOS:A1993LU55900007
J	SCHELLENBERG, GD; PAYAMI, H; WIJSMAN, EM; ORR, HT; GODDARD, KAB; ANDERSON, L; NEMENS, E; WHITE, JA; ALONSO, ME; BALL, MJ; KAYE, J; MORRIS, JC; CHUI, H; SADOVNICK, AD; HESTON, LL; MARTIN, GM; BIRD, TD				SCHELLENBERG, GD; PAYAMI, H; WIJSMAN, EM; ORR, HT; GODDARD, KAB; ANDERSON, L; NEMENS, E; WHITE, JA; ALONSO, ME; BALL, MJ; KAYE, J; MORRIS, JC; CHUI, H; SADOVNICK, AD; HESTON, LL; MARTIN, GM; BIRD, TD			CHROMOSOME-14 AND LATE-ONSET FAMILIAL ALZHEIMER-DISEASE (FAD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRECURSOR PROTEIN GENE; LINKAGE ANALYSIS; APP GENE; LOCUS; MUTATION; HETEROGENEITY; SEGREGATION; ASSOCIATION; KINDREDS; DEMENTIA	Familial Alzheimer disease (FAD) is genetically heterogeneous. Two loci responsible for early-onset FAD have been identified: the amyloid precursor protein gene on chromosome 21 and the as-yet-unidentified locus on chromosome 14. The genetics of late-onset FAD is unresolved. Maximum-likelihood, affected-pedigree-member (APM), and sib-pair analyses were used, in 49 families with a mean age at onset greater-than-or-equal-to 60 years, to determine whether the chromosome 14 locus is responsible for late-onset FAD. The markers used were D14S53, D14S43, and D14S52. The LOD score method was used to test for linkage of late-onset FAD to the chromosome 14 markers, under three different models: age-dependent penetrance, an affected-only analysis, and age-dependent penetrance with allowance for possible age-dependent sporadic cases. No evidence for linkage was obtained under any of these conditions for the late-onset kindreds, and strong evidence against linkage (LOD score less-than-or-equal-to -2.0) to this region was obtained. Heterogeneity tests of the LOD score results for the combined group of families (early onset, Volga Germans, and late onset) favored the hypothesis of linkage to chromosome 14 with genetic heterogeneity. The positive results are primarily from early-onset families. APM analysis gave significant evidence for linkage of D14S43 and D14S52 to FAD in early-onset kindreds (P < .02). No evidence for linkage was found for the entire late-onset family group. Significant evidence for linkage to D14S52, however, was found for a subgroup of families of intermediate age at onset (mean age at onset greater-than-or-equal-to 60 years and <70 years). These results indicate that the chromosome 14 locus is not responsible for Alzheimer disease in most late-onset FAD kindreds but could play a role in a subset of these kindreds.	UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA 98108; WASHINGTON INST MENTAL ILLNESS,DEPT PSYCHIAT,SEATTLE,WA; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DIV NEUROPATHOL,PORTLAND,OR 97201; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PSYCHIAT,MINNEAPOLIS,MN 55455; NATL INST NEUROL & NEUROSURG,DEPT GENET,MEXICO CITY,MEXICO; WASHINGTON UNIV,DEPT NEUROL,ST LOUIS,MO 63130; WASHINGTON UNIV,DEPT THEORET PHYS,ST LOUIS,MO 63130; UNIV SO CALIF,DEPT NEUROL,LOS ANGELES,CA 90089; UNIV BRITISH COLUMBIA,DEPT PHYS,VANCOUVER V6T 1W5,BC,CANADA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Washington University (WUSTL); University of Southern California; University of British Columbia	SCHELLENBERG, GD (corresponding author), UNIV WASHINGTON,DIV NEUROL,RG-27,SEATTLE,WA 98195, USA.		Morris, John C/A-1686-2012	Orr, Harry/0000-0001-6118-741X; Kaye, Jeffrey/0000-0002-9971-3478	NATIONAL INSTITUTE ON AGING [P50AG005681, P50AG005136, P30AG008017, U24AG021886] Funding Source: NIH RePORTER; NIA NIH HHS [NIA AG05136, NIA AG08017, U24 AG021886, NIA AG05681] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BERGEM A L M, 1992, Neurobiology of Aging, V13, pS66; Bird T. D., 1992, American Journal of Human Genetics, V51, pA92; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BRIETNER JCS, 1992, NEUROBIOL AGING S1, V13, pS66; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FARRER LA, 1991, AM J HUM GENET, V48, P1026; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HODGE SE, 1983, AM J HUM GENET, V35, P1139; KAMINO K, 1992, AM J HUM GENET, V51, P998; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MOTRO U, 1985, GENETICS, V110, P525; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PENROSE LS, 1935, ANN EUGEN, V6, P133; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; RAPOPORT SI, 1991, NEUROLOGY, V41, P1549, DOI 10.1212/WNL.41.10.1549; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SCHELLENBERG GD, 1992, ANN NEUROL, V31, P223, DOI 10.1002/ana.410310214; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TANZI RE, 1991, J BIOL CHEM, V266, P20579; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEEKS DE, 1988, AM J HUM GENET, V42, P315	37	63	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					619	628						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352272				2022-12-18	WOS:A1993LU55900005
J	TRIGGSRAINE, BL; MULES, EH; KABACK, MM; LIMSTEELE, JST; DOWLING, CE; AKERMAN, BR; NATOWICZ, MR; GREBNER, EE; NAVON, R; WELCH, JP; GREENBERG, CR; THOMAS, GH; GRAVEL, RA				TRIGGSRAINE, BL; MULES, EH; KABACK, MM; LIMSTEELE, JST; DOWLING, CE; AKERMAN, BR; NATOWICZ, MR; GREBNER, EE; NAVON, R; WELCH, JP; GREENBERG, CR; THOMAS, GH; GRAVEL, RA			A PSEUDODEFICIENCY ALLELE COMMON IN NON-JEWISH TAY-SACHS CARRIERS - IMPLICATIONS FOR CARRIER SCREENING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEXOSAMINIDASE ALPHA-CHAIN; BETA-HEXOSAMINIDASE; ASHKENAZI JEWS; DISEASE; GENE; MUTATIONS; FREQUENCY; SPLICE; IDENTIFICATION; ABNORMALITIES	Deficiency of beta-hexosaminidase A (Hex A) activity typically results in Tay-Sachs disease. However, healthy subjects found to be deficient in Hex A activity (i.e., pseudodeficient) by means of in vitro biochemical tests have been described. We analyzed the HEXA gene of one pseudodeficient subject and identified both a C739-to-T substitution that changes Arg247 --> Trp on one allele and a previously identified Tay-Sachs disease mutation on the second allele. Six additional pseudodeficient subjects were found to have the C739-to-T mutation. This allele accounted for 32% (20/62) of non-Jewish enzyme-defined Tay-Sachs disease carriers but for none of 36 Jewish enzyme-defined carriers who did not have one of three known mutations common to this group. The C739-to-T allele, together with a "true" Tay-Sachs disease allele, causes Hex A pseudodeficiency. Given both the large proportion of non-Jewish carriers with this allele and that standard biochemical screening cannot differentiate between heterozygotes for the C739-to-T mutations and Tay-Sachs disease carriers, DNA testing for this mutation in at-risk couples is essential. This could prevent unnecessary or incorrect prenatal diagnoses.	MCGILL UNIV, MONTREAL CHILDRENS HOSP, RES INST, 2300 TUPPER ST, MONTREAL H3H 1P3, QUEBEC, CANADA; KENNEDY INST, CTR MED GENET, GENET LAB, BALTIMORE, MD USA; MCGILL UNIV, DEPT BIOL, MONTREAL H3A 2T5, QUEBEC, CANADA; JOHNS HOPKINS SCH MED, DEPT PEDIAT, BALTIMORE, MD USA; CHILDRENS HOSP SAN DIEGO, SAN DIEGO, CA USA; UNIV CALIF SAN DIEGO, SCH MED, DEPT MICROBIOL IMMUNOL, LA JOLLA, CA 92093 USA; EUNICE KENNEDY SHRIVER CTR MENTAL RETARDAT INC, WALTHAM, MA USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; THOMAS JEFFERSON UNIV, DIV MED GENET, PHILADELPHIA, PA 19107 USA; TEL AVIV UNIV, SACKLER SCH MED, DEPT HUMAN GENET, TEL AVIV, ISRAEL; SAPIR MED CTR, DEPT MOLEC GENET, KEFAR SAVA, ISRAEL; DALHOUSIE UNIV, ATLANTIC RES CTR MENTAL RETARDAT, HALIFAX B3H 4H2, NS, CANADA; UNIV MANITOBA, DEPT PEDIAT, WINNIPEG R3T 2N2, MANITOBA, CANADA	McGill University; McGill University; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Jefferson University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Dalhousie University; University of Manitoba			Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BAYLERAN J, 1986, AM J HUM GENET S, V39, pA4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GEIGER B, 1976, BIOCHEMISTRY-US, V25, P3484; GRAVEL RA, 1991, CAN J NEUROL SCI, V18, P419, DOI 10.1017/S0317167100032583; GREBNER EE, 1986, AM J HUM GENET, V38, P505; GREBNER EE, 1991, AM J HUM GENET, V48, P604; GREENBERG DA, 1982, AM J HUM GENET, V34, P444; HOAR DI, 1984, PRENATAL DIAG, V4, P241, DOI 10.1002/pd.1970040402; KABACK MM, 1972, METHOD ENZYMOL, V28, P862; KABACK MM, 1978, PEDIATR RES, V12, pA530; KELLY TE, 1975, AM J HUM GENET, V27, P287; KELLY TE, 1976, CLIN GENET, V9, P540; KYTZIA HJ, 1985, J BIOL CHEM, V260, P7568; LANDELS EC, 1991, J MED GENET, V28, P177, DOI 10.1136/jmg.28.3.177; LOWDEN JA, 1976, TAYSACHS CARRIER SCR; MAHURAN D, 1980, CAN J BIOCHEM CELL B, V58, P287, DOI 10.1139/o80-038; Maniatis T., 1982, MOL CLONING; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18567; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; NAVON R, 1986, AM J MED GENET, V24, P179, DOI 10.1002/ajmg.1320240123; NEOTE K, 1988, GENOMICS, V3, P279, DOI 10.1016/0888-7543(88)90116-4; OBRIEN JS, 1978, AM J HUM GENET, V30, P602; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P463, DOI 10.1016/S0006-291X(88)81247-6; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAW BH, 1990, AM J HUM GENET, V47, P698; PAW BH, 1991, AM J HUM GENET, V48, P1139; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; PROIA RL, 1988, P NATL ACAD SCI USA, V85, P1883, DOI 10.1073/pnas.85.6.1883; PROIA RL, 1987, J BIOL CHEM, V262, P5677; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; Sandhoff K, 1989, METABOLIC BASIS INHE, VII, P1807; SRIVASTAVA SK, 1976, P NATL ACAD SCI USA, V73, P2833, DOI 10.1073/pnas.73.8.2833; TANAKA A, 1990, AM J HUM GENET, V46, P329; THOMAS GH, 1982, PEDIATR RES, V16, P232, DOI 10.1203/00006450-198203000-00014; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VIDGOFF J, 1973, AM J HUM GENET, V25, P372	40	63	66	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					793	801						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1384323				2022-12-18	WOS:A1992JQ66700013
J	POULTON, J; DEADMAN, ME; RAMACHARAN, S; GARDINER, RM				POULTON, J; DEADMAN, ME; RAMACHARAN, S; GARDINER, RM			GERM-LINE DELETIONS OF MESSENGER TRANSFER DNA IN MITOCHONDRIAL MYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; MATERNAL INHERITANCE; HETEROPLASMY; SEQUENCE; DISEASE; GENOME	mtDNA encodes subunits of the electron transport chain and is exclusively maternally inherited in mammals. It has been suggested that mtDNA might be the site of some of the mutations causing a group of human disorders called the "mitochondrial myopathies," because these may both be (1) accompanied by defects in the electron transport chain and (2) display a maternal pattern of inheritance. However, all of the deletions and duplications of mtDNA which occur in these patients have been sporadic, apart from families in whom affected members all carry different deletions suggesting a mutant autosomal dominantly inherited nuclear gene with de novo deletions in each individual. We present the first evidence for the presence of deleted mtDNAs in the germ line in these disorders. The patient carries a higher level of deleted mtDNAs than do his relatives, corresponding to severity of symptoms and consistent with a predicted dosage effect. "Selfishness" of deleted mtDNAs is probably one of the factors over and above random segregation of a small number of "founder" mtDNAs (the bottleneck hypothesis) which may be invoked to explain the usual distribution of mtDNAs in different tissues of patients with mtDNA deletions.			POULTON, J (corresponding author), UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND.		Poulton, Joanna/AAB-4828-2021	Deadman, Mary/0000-0002-6074-017X; Poulton, Joanna/0000-0002-2460-5587				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; DEZAMAROCZY M, 1981, NATURE, V292, P75, DOI 10.1038/292075a0; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOLT IJ, 1989, ANN NEUROL, V29, P600; HOLT IJ, 1989, THESIS U LONDON; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LESTIENNE P, 1988, LANCET, V1, P885; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; ROTIG A, 1988, LANCET, V2, P567; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	24	63	64	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					649	653						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014792				2022-12-18	WOS:A1991FK47800002
J	KOBAYASHI, K; KNOWLES, MR; BOUCHER, RC; OBRIEN, WE; BEAUDET, AL				KOBAYASHI, K; KNOWLES, MR; BOUCHER, RC; OBRIEN, WE; BEAUDET, AL			BENIGN MISSENSE VARIATIONS IN THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030; UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514	Baylor University; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor University; University of North Carolina; University of North Carolina Chapel Hill					NCRR NIH HHS [RR00046] Funding Source: Medline; NHLBI NIH HHS [HL34322] Funding Source: Medline; NIDDK NIH HHS [DK39617] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039617] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIJMAN J, 1984, AM J PHYSIOL, V247, pC3, DOI 10.1152/ajpcell.1984.247.1.C3; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; Cox DW, 1989, METABOLIC BASIS INHE, P2409; EVENSEN SA, 1981, ACTA MED SCAND, V209, P141; FUJIMURA FK, 1990, NEW ENGL J MED, V322, P61; GIBSON LE, 1959, PEDIATRICS, V23, P545; HIGGINS CF, 1988, BIOESSAYS, V8, P111, DOI 10.1002/bies.950080406; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1983, CLIN RES, V31, pA858; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; KNOWLES MR, 1989, ANN INTERN MED, V110, P599, DOI 10.7326/0003-4819-110-8-599; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; QUINTON PM, 1983, NEW ENGL J MED, V308, P1185, DOI 10.1056/NEJM198305193082002; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1988, J LAB CLIN MED, V111, P511; STERN RC, 1977, ANN INTERN MED, V87, P188, DOI 10.7326/0003-4819-87-2-188	21	63	66	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					611	615						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	1977306				2022-12-18	WOS:A1990EB31900004
J	DUFFY, DL; MARTIN, NG; MATHEWS, JD				DUFFY, DL; MARTIN, NG; MATHEWS, JD			APPENDECTOMY IN AUSTRALIAN TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									MENZIES SCH HLTH RES,DARWIN,AUSTRALIA	Charles Darwin University; Menzies School of Health Research	DUFFY, DL (corresponding author), QUEENSLAND INST MED RES,GENET EPIDEMIOL LAB,BRISBANE,QLD,AUSTRALIA.		Duffy, David L/B-7392-2013	Duffy, David L/0000-0001-7227-632X; Mathews, John/0000-0001-9029-7140				BASTA M, 1990, AM J HUM GENET, V46, P377; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; Joreskog K. G., 1989, LISREL 7 GUIDE PROGR; KASRIEL J, 1976, J BIOSOC SCI, V8, P263, DOI 10.1017/S0021932000010737; NEALE MC, 1989, AM J HUM GENET, V45, P226; PHLANZ M, 1978, SOC SCI MED B, V12, P171	6	63	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					590	592						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2248678				2022-12-18	WOS:A1990DX22300028
J	BALDINI, A; ROCCHI, M; ARCHIDIACONO, N; MILLER, OJ; MILLER, DA				BALDINI, A; ROCCHI, M; ARCHIDIACONO, N; MILLER, OJ; MILLER, DA			A HUMAN ALPHA-SATELLITE DNA SUBSET SPECIFIC FOR CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WAYNE STATE UNIV,DEPT MOLEC BIOL & GENET,SCOTT HALL ROOM 3126,540 E CANFIELD,DETROIT,MI 48201; IST GIANNINA GASLINI,GENET MOLEC LAB,I-16148 GENOA,ITALY; WAYNE STATE UNIV,CTR MOLEC BIOL,DETROIT,MI 48201	Wayne State University; University of Genoa; IRCCS Istituto Giannina Gaslini; Wayne State University			genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015	Baldini, Antonio/0000-0002-5330-0256; archidiacono, nicoletta/0000-0002-1439-9521	NIGMS NIH HHS [GM 34959, GM 39788] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039788, R01GM034959] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDROV IA, 1988, CHROMOSOMA, V96, P443, DOI 10.1007/BF00303039; DBALDINI A, 1989, GENOMICS, V5, P822; DELATTRE O, 1988, HUM HERED, V38, P156, DOI 10.1159/000153777; DEVILEE P, 1988, Genomics, V3, P1, DOI 10.1016/0888-7543(88)90151-6; JORGENSEN AL, 1986, J MOL BIOL, V187, P185, DOI 10.1016/0022-2836(86)90227-5; KURNIT DM, 1973, CHROMOSOMA, V42, P23, DOI 10.1007/BF00326328; MAIO JJ, 1971, J MOL BIOL, V56, P579, DOI 10.1016/0022-2836(71)90403-7; Maniatis T., 1982, MOL CLONING; MANUELIDIS L, 1978, NATURE, V276, P92, DOI 10.1038/276092a0; MANUELIDIS L, 1978, CHROMOSOMA, V66, P23, DOI 10.1007/BF00285813; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; ROCCHI M, 1986, HUM GENET, V74, P30; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; VANDEKKEN H, 1988, CYTOGENET CELL GENET, V48, P188, DOI 10.1159/000132622; WAYE JS, 1987, MOL CELL BIOL, V7, P349, DOI 10.1128/MCB.7.1.349; WAYE JS, 1989, CHROMOSOMA, V97, P475, DOI 10.1007/BF00295032; WILLARD HF, 1985, AM J HUM GENET, V37, P524; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; WU JC, 1980, J MOL BIOL, V142, P363, DOI 10.1016/0022-2836(80)90277-6; Yunis J J, 1986, Important Adv Oncol, P93; YUROV JB, 1986, MOL GEN MIKROBIOL VI, V7, P17	22	63	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					784	788						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2316524				2022-12-18	WOS:A1990CW54900016
J	BROWN, CJ; WILLARD, HF				BROWN, CJ; WILLARD, HF			LOCALIZATION OF A GENE THAT ESCAPES INACTIVATION TO THE X-CHROMOSOME PROXIMAL SHORT ARM - IMPLICATIONS FOR X-INACTIVATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	Stanford University; University of Toronto			Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101				AFFARA NA, 1989, NUCLEIC ACIDS RES, V17, P2987, DOI 10.1093/nar/17.8.2987; ARAHATA K, 1989, NEW ENGL J MED, V320, P138, DOI 10.1056/NEJM198901193200302; BEUSCHER ES, 1985, J CLIN INVEST, V76, P1581; BODRUG SE, 1989, GENOMICS, V4, P101, DOI 10.1016/0888-7543(89)90321-2; BROWN CJ, 1989, SOMAT CELL MOLEC GEN, V15, P173, DOI 10.1007/BF01535079; BROWN CJ, 1989, AM J HUM GENET, V45, P592; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOLDMAN MA, 1987, SCIENCE, V236, P593, DOI 10.1126/science.2437652; GOODFELLOW P, 1983, NATURE, V302, P346, DOI 10.1038/302346a0; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GRAVES JAM, 1987, TRENDS GENET, V3, P252, DOI 10.1016/0168-9525(87)90259-9; HAYMAN DL, 1982, CYTOGENET CELL GENET, V34, P265, DOI 10.1159/000131816; HURKO O, 1989, AM J HUM GENET, V44, P820; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1974, PROC R SOC SER B-BIO, V187, P243, DOI 10.1098/rspb.1974.0073; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; MANDEL JL, 1989, CYTOGENET CELL GENET, V51, P384, DOI 10.1159/000132801; MCBURNEY MW, 1988, BIOESSAYS, V9, P85, DOI 10.1002/bies.950090211; MCKUSICK, 1988, MEDELIAN INHERITANCE, P1243; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MILLER OJ, 1985, HUM GENET, V69, P97, DOI 10.1007/BF00293275; MOHANDAS T, 1987, P NATL ACAD SCI USA, V84, P4954, DOI 10.1073/pnas.84.14.4954; MOHANDAS T, 1979, P NATL ACAD SCI USA, V76, P5779, DOI 10.1073/pnas.76.11.5779; MULLER G, 1989, HUM GENET, V82, P82, DOI 10.1007/BF00288279; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; POLANI PE, 1982, HUM GENET, V60, P207, DOI 10.1007/BF00303003; RACE RR, 1975, BLOOD GROUPS MAN, P579; RICCIUTI FC, 1976, AM J HUM GENET, V28, P332; SALZMANN J, 1968, P NATL ACAD SCI USA, V60, P545, DOI 10.1073/pnas.60.2.545; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SINCLAIR AH, 1987, GENET RES, V50, P131, DOI 10.1017/S0016672300023533; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; THERMAN E, 1980, HUM GENET, V54, P133, DOI 10.1007/BF00278961; THERMAN E, 1976, CHROMOSOMA, V59, P137, DOI 10.1007/BF00328482; THOMPSON LH, 1970, P NATL ACAD SCI USA, V66, P377, DOI 10.1073/pnas.66.2.377; WILLARD HF, 1989, HUM GENET, V81, P234; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	47	63	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					273	279						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2301397				2022-12-18	WOS:A1990CM93800007
J	TRASK, B; VANDENENGH, G; MAYALL, B; GRAY, JW				TRASK, B; VANDENENGH, G; MAYALL, B; GRAY, JW			CHROMOSOME HETEROMORPHISM QUANTIFIED BY HIGH-RESOLUTION BIVARIATE FLOW KARYOTYPING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											TRASK, B (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,POB 5507,L-452,LIVERMORE,CA 94550, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARKESTEIJN GJA, 1988, BLOOD, V72, P282; CARTER NP, IN PRESS CYTOMETRY; COOKE A, 1988, HUM GENET, V79, P49, DOI 10.1007/BF00291709; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; CRAIGHOLMES AP, 1975, AM J HUM GENET, V27, P178; DEAN PN, 1978, J HISTOCHEM CYTOCHEM, V26, P622, DOI 10.1177/26.8.357646; GERAEDTS JP, 1974, CLIN GENET, V6, P247; GOSDEN JR, 1981, CYTOGENET CELL GENET, V29, P32, DOI 10.1159/000131549; GRAY JW, 1986, ANNU REV BIOPHYS BIO, V15, P195; GRAY JW, 1979, CHROMOSOMA, V73, P9, DOI 10.1007/BF00294840; GRAY JW, 1988, AM J HUM GENET, V42, P49; GREEN DK, 1984, HUM GENET, V66, P143, DOI 10.1007/BF00286588; HARRIS P, 1985, HUM GENET, V70, P59, DOI 10.1007/BF00389460; HARRIS P, 1986, CYTOGENET CELL GENET, V41, P14, DOI 10.1159/000132190; HARRIS P, 1987, HUM GENET, V76, P129, DOI 10.1007/BF00284908; HIGGINS MJ, 1985, CHROMOSOMA, V93, P77, DOI 10.1007/BF01259449; JABS EW, 1988, AM J HUM GENET, V43, P69; JABS EW, 1987, AM J HUM GENET, V41, P374; Jacobs P A, 1977, Prog Med Genet, V2, P251; JACOBS PA, 1975, CLIN GENET, V8, P169; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; LANGLOIS RG, 1980, CHROMOSOMA, V77, P229, DOI 10.1007/BF00286050; LANGLOIS RG, 1979, J HISTOCHEM CYTOCHEM, V27, P72, DOI 10.1177/27.1.86583; LATT SA, 1980, CYTOMETRY, V1, P2, DOI 10.1002/cyto.990010103; LATT SA, 1975, CHROMOSOMA, V52, P297, DOI 10.1007/BF00364015; LEBO RV, 1986, AM J MED GENET, V25, P519, DOI 10.1002/ajmg.1320250314; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; LIN MS, 1977, CHROMOSOMA, V60, P15, DOI 10.1007/BF00330407; LUBS HA, 1977, NATURE, V268, P631, DOI 10.1038/268631a0; LUBS HA, 1971, NATURE, V233, P134, DOI 10.1038/233134a0; MARTIN AO, 1988, AM J MED GENET, V31, P643, DOI 10.1002/ajmg.1320310320; MAYALL BH, 1984, CYTOMETRY, V5, P376, DOI 10.1002/cyto.990050414; MCKAY RDG, 1978, CYTOGENET CELL GENET, V21, P19, DOI 10.1159/000130875; MCKENZIE WH, 1975, CYTOGENET CELL GENET, V14, P97, DOI 10.1159/000130330; MCKENZIE WH, 1972, AM J HUM GENET, V24, P686; MENDELSOHN ML, 1973, SCIENCE, V179, P1126, DOI 10.1126/science.179.4078.1126; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; ROBINSON JA, 1976, ANN HUM GENET, V40, P113, DOI 10.1111/j.1469-1809.1976.tb00169.x; SANDRITTER W, 1966, INTRO QUANTITATIVE C, P295; SCHNEDL W, 1981, HUM GENET, V59, P10, DOI 10.1007/BF00278847; TRASK B, 1989, AM J HUM GENET, V45, P753; TRASK B, IN PRESS CYTOMETRY; TRASK B, 1988, HUM GENET, V78, P252; VANDENENGH G, 1984, CYTOMETRY, V5, P108; VANDENENGH G, 1989, CYTOMETRY, V10, P282, DOI 10.1002/cyto.990100307; VANDENENGH G, 1988, CYTOMETRY, V9, P266; VANDENENGH GJ, 1985, CYTOMETRY, V6, P92, DOI 10.1002/cyto.990060203; VANDENENGH GJ, 1986, HISTOCHEMISTRY, V84, P501, DOI 10.1007/BF00482983; VANDILLA MA, 1986, BIO-TECHNOL, V4, P537, DOI 10.1038/nbt0686-537; VERMA RS, 1976, HUM HERED, V26, P315, DOI 10.1159/000152820; WARD DC, 1965, SCIENCE, V149, P1259, DOI 10.1126/science.149.3689.1259; WILCOX DE, 1986, HUM GENET, V73, P175, DOI 10.1007/BF00291610	54	63	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					739	752						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2479266				2022-12-18	WOS:A1989AZ04900010
J	TOLAN, DR; NICLAS, J; BRUCE, BD; LEBO, RV				TOLAN, DR; NICLAS, J; BRUCE, BD; LEBO, RV			EVOLUTIONARY IMPLICATIONS OF THE HUMAN ALDOLASE-A, ALDOLASE-B, ALDOLASE-C, AND ALDOLASE-PSEUDOGENE CHROMOSOME LOCATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,DIV HEMATOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	TOLAN, DR (corresponding author), BOSTON UNIV,CTR BIOL SCI,BOSTON,MA 02215, USA.			Tolan, Dean/0000-0002-0598-7241	NIGMS NIH HHS [GM32344] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032344] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMSDEN AB, 1985, THESIS U CALIFORNIA; BARR PJ, 1986, BIOTECHNIQUES, V4, P428; Beutler E, 1973, Trans Assoc Am Physicians, V86, P154; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOONE C, 1972, P NATL ACAD SCI USA, V69, P510, DOI 10.1073/pnas.69.2.510; BURGESS DG, 1985, J BIOL CHEM, V260, P4604; CHAMBERS RA, 1956, LANCET, V2, P340; COLECLOUGH C, 1985, GENE, V34, P305, DOI 10.1016/0378-1119(85)90139-8; COMINGS DE, 1972, NATURE, V238, P455, DOI 10.1038/238455a0; DAVIS RW, 1980, ADV BACTERIAL GENET, P124; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FREEMONT PS, 1984, ARCH BIOCHEM BIOPHYS, V228, P342, DOI 10.1016/0003-9861(84)90075-4; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HUERRE C, 1983, NATURE, V305, P638, DOI 10.1038/305638a0; JOH K, 1986, J MOL BIOL, V190, P401, DOI 10.1016/0022-2836(86)90011-2; JOYNER AL, 1985, NATURE, V314, P173, DOI 10.1038/314173a0; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Lebo R V, 1987, Methods Enzymol, V151, P292, DOI 10.1016/S0076-6879(87)51025-4; LEBO RV, 1985, CYTOMETRY, V6, P478, DOI 10.1002/cyto.990060513; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; MANIATIS T, 1982, MOL CLONING LABORATO, P150; MCKUSICK VA, 1985, CLIN GENET, V27, P207; MORIZOT DC, 1983, J HERED, V74, P413, DOI 10.1093/oxfordjournals.jhered.a109827; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OBRIEN SJ, 1986, J HERED, V77, P374, DOI 10.1093/oxfordjournals.jhered.a110264; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; PAOLELLA G, 1986, EUR J BIOCHEM, V156, P229, DOI 10.1111/j.1432-1033.1986.tb09572.x; PENHOET E, 1966, P NATL ACAD SCI USA, V56, P1275, DOI 10.1073/pnas.56.4.1275; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; POPESCU NC, 1985, SOMAT CELL MOLEC GEN, V11, P149, DOI 10.1007/BF01534703; RABIN M, 1985, NATURE, V314, P175, DOI 10.1038/314175a0; ROTTMANN WH, 1984, P NATL ACAD SCI-BIOL, V81, P2738, DOI 10.1073/pnas.81.9.2738; ROTTMANN WH, 1987, BIOCHIMIE, V69, P137, DOI 10.1016/0300-9084(87)90246-X; RUTTER WJ, 1963, ADV ENZYME REGUL, V1, P39, DOI 10.1016/0065-2571(63)90005-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWYER JR, 1986, SCIENCE, V232, P1632; SEARLE AG, 1976, CYTOGENET CELL GENET, V16, P430, DOI 10.1159/000130651; SEUANEZ HN, 1979, PHYLOGENY HUMAN CHRO; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEBBINS GL, 1966, SCIENCE, V152, P1463, DOI 10.1126/science.152.3728.1463; TOLAN DR, 1984, J BIOL CHEM, V259, P1127; TOLAN DR, 1986, MOL BIOL MED, V3, P245; TSUTSUMI K, 1985, J MOL BIOL, V181, P153, DOI 10.1016/0022-2836(85)90081-6; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILLECKE K, 1977, SOMAT CELL GENET, V3, P237, DOI 10.1007/BF01538743; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; 1985, CYTOGENET CELL GENET, V40, P1; 1972, BIRTH DEFECTS, V8, P18	52	63	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					907	924						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3674018				2022-12-18	WOS:A1987K936100011
J	TRENT, JM; FLINK, IL; MORKIN, E; VANTUINEN, P; LEDBETTER, DH				TRENT, JM; FLINK, IL; MORKIN, E; VANTUINEN, P; LEDBETTER, DH			LOCALIZATION OF THE HUMAN THYROXINE-BINDING GLOBULIN GENE TO THE LONG ARM OF THE X-CHROMOSOME (XQ21-22)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ARIZONA,ARIZONA HLTH SCI CTR,CTR HEART,DEPT INTERNAL MED,TUCSON,AZ 85724; UNIV ARIZONA,ARIZONA HLTH SCI CTR,CTR CANC,DEPT RADIAT ONCOL,TUCSON,AZ 85724; UNIV ARIZONA,ARIZONA HLTH SCI CTR,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724; BAYLOR COLL MED,INST MOLEC GENET,KLEBERG CYTOGENET LAB,HOUSTON,TX 77030	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; Baylor College of Medicine					NATIONAL CANCER INSTITUTE [R37CA029476, R01CA029476] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020984, R01HL035751] Funding Source: NIH RePORTER; NCI NIH HHS [CA-29476] Funding Source: Medline; NHLBI NIH HHS [HL35751, HL20984] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BARTALENA L, 1984, J BIOL CHEM, V259, P3605; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BURR WA, 1980, Q J MED, V49, P295; DICKERMAN JD, 1981, ARCH SURG-CHICAGO, V116, P361; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; FOX MF, 1984, CYTOGENET CELL GENET, V38, P45, DOI 10.1159/000132028; FUSCOE JC, 1983, MOL CELL BIOL, V3, P1086, DOI 10.1128/MCB.3.6.1086; GLINOER D, 1976, BIOCHIM BIOPHYS ACTA, V418, P232, DOI 10.1016/0005-2787(76)90073-3; GRIMALDI S, 1983, J CLIN ENDOCR METAB, V57, P1186, DOI 10.1210/jcem-57-6-1186; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; KANDA Y, 1974, J BIOL CHEM, V249, P6796; MARSHALL JS, 1974, J CLIN INVEST, V54, P555, DOI 10.1172/JCI107792; MARSHALL JS, 1972, J CLIN INVEST, V51, P3173, DOI 10.1172/JCI107144; MURATA Y, 1986, NEW ENGL J MED, V314, P694, DOI 10.1056/NEJM198603133141107; NILSSON SF, 1975, J BIOL CHEM, V250, P8543; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P473; RABIN M, 1985, CYTOGENET CELL GENET, V40, P728; REFETOFF S, 1972, J CLIN INVEST, V51, P848, DOI 10.1172/JCI106880; REFETOFF S, 1976, J CLIN INVEST, V57, P485, DOI 10.1172/JCI108301; REFETOFF S, 1970, ENDOCRINOLOGY, V86, P793, DOI 10.1210/endo-86-4-793; Refetoff S., 1979, ENDOCRINOLOGY, V1, P347; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; TRENT JM, 1982, P NATL ACAD SCI-BIOL, V79, P7809, DOI 10.1073/pnas.79.24.7809; WORTON RG, 1984, SCIENCE, V224, P1447, DOI 10.1126/science.6729462	31	63	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					428	435						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3115094				2022-12-18	WOS:A1987K019100008
J	RUDER, A				RUDER, A			PATERNAL-AGE AND BIRTH-ORDER EFFECT ON THE HUMAN SECONDARY SEX-RATIO	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											RUDER, A (corresponding author), TEL AVIV UNIV,CHAIM SHEBA MED CTR,SACKLER MED SCH,DEPT CLIN EPIDEMIOL,IL-52621 TEL HASHOMER,ISRAEL.		Ruder, Avima/I-4155-2012	Ruder, Avima/0000-0003-0419-6664	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007413] Funding Source: NIH RePORTER; NCRR NIH HHS [S07-RR07080] Funding Source: Medline; NIGMS NIH HHS [5-T32-GM7413-05, 5-R01-GM18678-11] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERKSON J, 1949, J AM STAT ASSOC, V44, P273, DOI 10.2307/2280599; Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; CAUGHLEY G, 1971, J REPROD FERTIL, V25, P145, DOI 10.1530/jrf.0.0250145; COX DR, 1970, ANAL BINARY DATA, P1; DIXON WJ, 1979, BIOMEDICAL COMPUTER, P380; ERICKSON JD, 1976, ANN HUM GENET, V40, P205, DOI 10.1111/j.1469-1809.1976.tb00182.x; FINNEY DJ, 1947, PROBIT ANAL, P15; FISHER RA, 1964, STATISTICAL TABLES B, P45; GARFINKEL J, 1976, J BIOSOC SCI, V8, P113, DOI 10.1017/S0021932000010543; IMAIZUMI Y, 1979, ANN HUM GENET, V42, P457, DOI 10.1111/j.1469-1809.1979.tb00679.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; NOVITSKI E, 1958, AM J HUM GENET, V10, P268; NOVITSKI E, 1956, ANN HUM GENET, V21, P123, DOI 10.1111/j.1469-1809.1971.tb00271.x; NOVITSKI E, 1953, SCIENCE, V117, P531, DOI 10.1126/science.117.3046.531; POLLARD GN, 1969, J BIOSOC SCI, V1, P125, DOI 10.1017/S002193200000715X; ROSTRON J, 1977, ANN HUM GENET, V41, P205, DOI 10.1111/j.1469-1809.1977.tb01916.x; TEITELBAUM MS, 1971, AM J HUM GENET, V23, P271; 1978, STANDARDIZED MICRODA, P9; 1975, VITAL STATISTICS NAT, P1	19	63	65	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					362	372						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AGY59	3985011				2022-12-18	WOS:A1985AGY5900011
J	GERMAN, J; BLOOM, D; PASSARGE, E; FRIED, K; GOODMAN, RM; KATZENELLENBOGEN, I; LARON, Z; LEGUM, C; LEVIN, S; WAHRMAN, J				GERMAN, J; BLOOM, D; PASSARGE, E; FRIED, K; GOODMAN, RM; KATZENELLENBOGEN, I; LARON, Z; LEGUM, C; LEVIN, S; WAHRMAN, J			BLOOMS SYNDROME .6. DISORDER IN ISRAEL AND AN ESTIMATION OF GENE FREQUENCY IN ASHKENAZIM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK BLOOD CTR,HUMAN GENET LAB,NEW YORK,NY 10021; UNIV ESSEN GESAMTHSCH,INST HUMAN GENET,KLIN,D-4300 ESSEN,FED REP GER; ASAF HAROFE GOVT HOSP,DEPT GENET,ZERIFIN,ISRAEL; CHAIM SHEBA MED CTR,DEPT HUMAN GENET,TEL HASHOMER,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,RAMAT AVIV,ISRAEL; BEILINSON MED CTR,INST PEDIAT & ADOLESCENT ENDOCRINOL,PETAH TIKVA,ISRAEL; ROKACH HOSP,GENET UNIT,TEL AVIV,ISRAEL; KAPLAN HOSP,DEPT PEDIAT,REHOVOTH,ISRAEL; KAPLAN HOSP,DEPT PEDIAT RES,REHOVOTH,ISRAEL; HEBREW UNIV JERUSALEM,DEPT GENET,JERUSALEM 91000,ISRAEL	New York Blood Center; University of Duisburg Essen; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem								BLOOM D, 1966, J PEDIATR-US, V68, P103, DOI 10.1016/S0022-3476(66)80426-2; CHASE GA, 1972, AM J HUM GENET, V24, P339; GERMAN J, 1969, AM J HUM GENET, V21, P196; GERMAN J, 1974, CHROMOSOMES CANCER, P601; GERMAN J, IN PRESS; KATZENELLENBOGEN I, 1960, Arch Dermatol, V82, P609; KELLY TE, 1975, AM J HUM GENET, V27, P287; KNUDSON AG, 1973, AM J HUM GENET, V25, P108; LANDAU J, 1966, AM J OPHTHALMOL, V62, P753, DOI 10.1016/0002-9394(66)92204-5; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; RITCHIE J, 1971, 13 P INT C PED VIENN, P137	11	63	63	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	6					553	562						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EC270	930922				2022-12-18	WOS:A1977EC27000001
J	WOOLF, CM; GIANAS, AD				WOOLF, CM; GIANAS, AD			STUDY OF FLUCTUATING DERMATOGLYPHIC ASYMMETRY IN SIBS AND PARENTS OF CLEFT-LIP PROPOSITI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ARIZONA STATE UNIV,DEPT ZOOL,TEMPE,AZ 85281	Arizona State University; Arizona State University-Tempe								AASE JM, 1971, LANCET, V1, P432; ADAMS MS, 1967, GENET RES, V10, P313, DOI 10.1017/S0016672300011071; BEAR JC, 1976, CLIN GENET, V9, P277; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CUMMINS H, 1943, FINGER PRINTS PALMS; CZEIZEL A, 1972, HUM HERED, V22, P405, DOI 10.1159/000152518; FRASER FC, 1970, AM J HUM GENET, V22, P336; GORLIN RJ, 1964, SYNDROMES HEAD NECK; Lerner M., 1954, GENETIC HOMEOSTASIS; LUBS HA, 1961, LANCET, V2, P1001; MELNICK M, 1976, LANCET, V1, P176; NEEL JV, 1958, AM J HUM GENET, V10, P398; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; Waddington C.H., 1957, STRATEGY GENES; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; WOOLF CM, 1976, AM J HUM GENET, V28, P400; WOOLF CM, 1969, PLAST RECONSTR SURG, V44, P436, DOI 10.1097/00006534-196944050-00003	18	63	64	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					503	507						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	900124				2022-12-18	WOS:A1977DV67300009
J	POTTER, RHY; YU, PL; DAHLBERG, AA; MERRITT, AD; CONNEALL.PM				POTTER, RHY; YU, PL; DAHLBERG, AA; MERRITT, AD; CONNEALL.PM			GENETIC STUDIES OF TOOTH SIZE FACTORS IN PIMA INDIAN FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BADER RS, 1965, EVOLUTION, V19, P378, DOI 10.2307/2406448; BOHIDAR NR, 1963, 5 INT BIOM C CAMBR; BROTHWELL DR, 1962, DENTAL ANTHROPOLO ED, P1; BROWN T, 1965, GROWTH, V29, P97; BUTLER PM, 1962, DENTAL ANTHROPOLOGY, P1; BUTLER PM, 1939, PROC ZOOL SOC LONDON, VB109, P1; CONNEALLY PM, IN PRESS; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; DIXON WJ, 1964, BIOMEDICAL COMPUT ED, P169; FALCONER DS, 1960, INTRODUCTION QUANTIT; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GARN SM, 1965, J DENT RES, V44, P439, DOI 10.1177/00220345650440022201; GLASSTONE S, 1963, J DENT RES, V42, P1364, DOI 10.1177/00220345630420061101; Grainger, 1956, J CAN DENT ASSOC, V22, P519; HANNA B L, 1963, J Dent Res, V42, pSUPPL1322, DOI 10.1177/00220345630420060801; HARMAN HH, 1960, MODERN FACTOR ANALYS; HOLLOWAY PJ, 1961, ARCH ORAL BIOL, V3, P185, DOI 10.1016/0003-9969(61)90136-4; Horowitz L.S., 1958, ANGLE ORTHOD, V28, P87; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; KEMPTHORNE O, 1955, GENETICS, V40, P153; KEMPTHORNE O, 1957, INTRODUCTION GENETIC; KENNEY JF, 1951, MATHEMATICS STATIS 2; LEWIS DW, 1967, ARCH ORAL BIOL, V12, P539, DOI 10.1016/0003-9969(67)90028-3; LUNDSTROM A, 1948, TOOTH SIZE OCCLUSION; NISWANDER JD, 1965, AM J HUM GENET, V17, P391; OSBORNE RH, 1958, AM J HUM GENET, V10, P350; SHAW JH, 1963, J NUTR, V80, P123, DOI 10.1093/jn/80.2.123; Steel R. G., 1980, PRINCIPLES PROCEDURE, P481; TENCZAR P, 1966, SCIENCE, V152, P1398, DOI 10.1126/science.152.3727.1398; Wright S, 1921, GENETICS, V6, P111	30	63	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					89	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	B2183	5643181				2022-12-18	WOS:A1968B218300001
J	SANDBERG, AA; COHEN, MM; RIMM, AA; LEVIN, ML				SANDBERG, AA; COHEN, MM; RIMM, AA; LEVIN, ML			ANEUPLOIDY AND AGE IN A POPULATION SURVEY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BROWN WMC, 1966, CHROMOSOME STUDIES A; GRAHAM S, 1963, ANN NY ACAD SCI, V107, P557, DOI 10.1111/j.1749-6632.1963.tb13300.x; HAMERTON JL, 1965, NATURE, V206, P1232, DOI 10.1038/2061232a0; JACOBS PA, 1964, ANN HUM GENET, V27, P353; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; JACOBS PA, 1963, NATURE, V197, P1081; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; SANDBERG AA, 1962, BLOOD, V20, P393, DOI 10.1182/blood.V20.4.393.393	8	63	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	5					633	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	99950	6050737				2022-12-18	WOS:A19679995000003
J	PEDEN, VH				PEDEN, VH			TRUE IDIOPATHIC HYPOPARATHYROIDISM AS A SEX-LINKED RECESSIVE TRAIT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AXELROD DR, 1950, J CLIN ENDOCR, V19, P590; BERGSTRAND CG, 1958, ACTA ENDOCRINOL-COP, V29, P201, DOI 10.1530/acta.0.0290201; BLAIM A, 1955, Pediatr Pol, V30, P823; BONGIOVANNI AM, 1958, PEDIATRICS, V21, P661; BRONSKY D, 1958, MEDICINE, V37, P317, DOI 10.1097/00005792-195812000-00003; BUCHS S, 1957, ANN PAEDIATR-BASEL, V188, P124; BUCHS S, 1955, ANN PAEDIATR-BASEL, V184, P363; Cantarow A, 1939, ENDOCRINOLOGY, V24, P556, DOI 10.1210/endo-24-4-556; Drake TG, 1939, ANN INTERN MED, V12, P1751, DOI 10.7326/0003-4819-12-11-1751; EBERLEIN WR, 1958, PEDIATRICS, V21, P667; Emerson K, 1941, ANN INTERN MED, V14, P1256, DOI 10.7326/0003-4819-14-7-1256; FARBER S, 1960, J PEDIATR-US, V56, P690, DOI 10.1016/S0022-3476(60)80344-7; FORBES GB, 1956, ANN NY ACAD SCI, V64, P432, DOI 10.1111/j.1749-6632.1956.tb52465.x; GOLDMAN R, 1952, JAMA-J AM MED ASSOC, V150, P1104, DOI 10.1001/jama.1952.63680110002013a; HARRISON HE, 1956, PEDIATRICS, V17, P442; LEIFER E, 1953, J CLIN ENDOCR METAB, V13, P1264, DOI 10.1210/jcem-13-10-1264; LEONARD MF, 1946, J CLIN ENDOCR METAB, V6, P493, DOI 10.1210/jcem-6-7-493; LOBDELL DH, 1959, ARCH PATHOL, V67, P412; MACGREGOR ME, 1954, ARCH DIS CHILD, V29, P398, DOI 10.1136/adc.29.147.398; MALLOY BM, 1958, AMA J DIS CHILD, V95, P364, DOI 10.1001/archpedi.1958.02060050366004; McQuarrie I, 1941, J CLIN ENDOCRINOL, V1, P789, DOI 10.1210/jcem-1-10-789; NAEF RW, 1959, ANN INTERN MED, V50, P495, DOI 10.7326/0003-4819-50-2-495; PAPADATOS C, 1954, J CLIN ENDOCR METAB, V14, P653, DOI 10.1210/jcem-14-6-653; PERLMUTTER M, 1956, AM J MED, V21, P634, DOI 10.1016/0002-9343(56)90078-X; RHYNE JL, 1956, PEDIATRICS, V18, P448; ROBERTS JA, 1959, INTRO MED GENETICS; ROSSLE R, 1938, SCHWEIZ MED WSCHR, V68, P848; ROSSLE R, 1932, ARCH PATH ANAT, V283, P41; SOPER RT, 1957, PEDIATRICS, V20, P1097; STANBURY JB, 1957, AM J MED, V22, P712, DOI 10.1016/0002-9343(57)90122-5; STEINBERG AG, 1959, J MED EDUC, V34, P315; Sutphin A, 1943, J CLIN ENDOCRINOL, V3, P625, DOI 10.1210/jcem-3-12-625; SYMON L, 1959, BMJ-BRIT MED J, P1451; WHITAKER J, 1956, J CLIN ENDOCR METAB, V16, P1374, DOI 10.1210/jcem-16-10-1374	34	63	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					323	337						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	14431322				2022-12-18	WOS:A1960WF07900005
J	GOODMAN, HO; REED, SC				GOODMAN, HO; REED, SC			HEREDITY OF FIBROSIS OF THE PANCREAS - POSSIBLE MUTATION RATE OF THE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSEN DH, 1946, AM J DIS CHILD, V72, P62, DOI 10.1001/archpedi.1946.02020300069004; ANDERSEN DH, 1947, BRENNEMANN PRACTICE, V1, pHA29; CASTLE WE, 1951, GENETICS, V36, P254; Garrod AE, 1913, Q J MED, V6, P242; GIBBS GE, 1950, J PEDIATR-US, V37, P320, DOI 10.1016/S0022-3476(50)80150-6; GLASS B, 1950, AM J HUM GENET, V2, P269; Haldane JBS, 1942, ANN EUGEN, V11, P333; HALDANE JBS, 1948, HEREDITAS S, V267; HARPER M, 1949, MED J AUST, V36, P137; Howard PJ, 1944, AM J DIS CHILD, V68, P330; KELLER PD, 1949, J PEDIATR-US, V34, P588, DOI 10.1016/S0022-3476(49)80285-X; LOWE CU, 1949, AM J DIS CHILD, V78, P349, DOI 10.1001/archpedi.1949.02030050362008; MAY CD, 1949, J PEDIATR-US, V34, P663, DOI 10.1016/S0022-3476(49)80333-7; NEEL JV, 1947, GENETICS, V32, P38; NEEL JV, 1950, COLD SPRING HARB SYM, V15, P141, DOI 10.1101/SQB.1950.015.01.017; REED S. C., 1941, CANADIAN JOUR RES SECT D ZOOL SCI, V19, P75; STADLER LJ, 1948, AM NAT, V82, P289, DOI 10.1086/281585; STERN C, 1948, SCIENCE, V108, P538, DOI 10.1126/science.108.2811.538; WIGGLESWORTH FW, 1946, AM J M SC, V212, P351; ZUELZER WW, 1949, PEDIATRICS, V4, P53	20	63	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1952	4	2					59	71						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS397	14943708				2022-12-18	WOS:A1952XS39700001
J	Dobbyn, A; Huckins, LM; Boocock, J; Sloofman, LG; Glicksberg, BS; Giambartolomei, C; Hoffman, GE; Perumal, TM; Girdhar, K; Jiang, Y; Raj, T; Ruderfer, DM; Kramer, RS; Pinto, D; Akbarian, S; Roussos, P; Domenic, E; Devlin, B; Sklar, P; Stahl, EA; Sieberts, SK				Dobbyn, Amanda; Huckins, Laura M.; Boocock, James; Sloofman, Laura G.; Glicksberg, Benjamin S.; Giambartolomei, Claudia; Hoffman, Gabriel E.; Perumal, Thanneer M.; Girdhar, Kiran; Jiang, Yan; Raj, Towfique; Ruderfer, Douglas M.; Kramer, Robin S.; Pinto, Dalila; Akbarian, Schahram; Roussos, Panos; Domenic, Enrico; Devlin, Bernie; Sklar, Pamela; Stahl, Eli A.; Sieberts, Solveig K.		CommonMind Consortium	Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; GENOTYPE IMPUTATION; DNA METHYLATION; COMPLEX TRAITS; REGULATORY VARIATION; SUSCEPTIBILITY LOCI; DEPENDENT MANNER; CELL-TYPES; DISEASE	Causal genes and variants within genome-wide association study (GWAS) loci can be identified by integrating GWAS statistics with expression quantitative trait loci (eQTL) and determining which variants underlie both GWAS and eQTL signals. Most analyses, however, consider only the marginal eQTL signal, rather than dissect this signal into multiple conditionally independent signals for each gene. Here we show that analyzing conditional eQTL signatures, which could be important under specific cellular or temporal contexts, leads to improved fine mapping of GWAS associations. Using genotypes and gene expression levels from post-mortem human brain samples (n = 467) reported by the CommonMind Consortium (CMC), we find that conditional eQTL are widespread; 63% of genes with primary eQTL also have conditional eQTL. In addition, genomic features associated with conditional eQTL are consistent with context-specific (e.g., tissue-, cell type-, or developmental time point-specific) regulation of gene expression. Integrating the 2014 Psychiatric Genomics Consortium schizophrenia (SCZ) GWAS and CMC primary and conditional eQTL data reveals 40 loci with strong evidence for co-localization (posterior probability > 0.8), including six loci with co-localization of conditional eQTL. Our co-localization analyses support previously reported genes, identify novel genes associated with schizophrenia risk, and provide specific hypotheses for their functional follow-up.	[Dobbyn, Amanda; Huckins, Laura M.; Sloofman, Laura G.; Hoffman, Gabriel E.; Girdhar, Kiran; Jiang, Yan; Akbarian, Schahram; Roussos, Panos; Sklar, Pamela; Stahl, Eli A.] Icahn Sch Med Mt Sinai, Div Psychiat Genom, Dept Genet & Genom Sci, New York, NY 10029 USA; [Dobbyn, Amanda; Huckins, Laura M.; Glicksberg, Benjamin S.; Hoffman, Gabriel E.; Girdhar, Kiran; Raj, Towfique; Pinto, Dalila; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Boocock, James] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; [Glicksberg, Benjamin S.; Hoffman, Gabriel E.; Raj, Towfique; Pinto, Dalila; Roussos, Panos; Sklar, Pamela; Stahl, Eli A.] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Glicksberg, Benjamin S.] Icahn Sch Med Mt Sinai, Mt Sinai Hlth Syst, Inst Next Generat Healthcare, New York, NY 10029 USA; [Giambartolomei, Claudia] Univ Calif Los Angeles, Dept Pathol & Lab Med, New York, NY 10029 USA; [Perumal, Thanneer M.; Sieberts, Solveig K.] Sage Bionetworks, Syst Biol, Seattle, WA 98109 USA; [Jiang, Yan; Pinto, Dalila; Akbarian, Schahram; Roussos, Panos; Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Raj, Towfique] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Ruderfer, Douglas M.] Vanderbilt Univ, Div Genet Med, Dept Med Psychiat & Biomed Informat, Vanderbilt Genet Inst,Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kramer, Robin S.] NIMH, Human Brain Collect Core, Bethesda, MD 20892 USA; [Pinto, Dalila] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Pinto, Dalila] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Pinto, Dalila] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Domenic, Enrico] Univ Trento, Ctr Integrat Biol CIBIO, Lab Neurogen Biomarkers, Trento, Italy; [Domenic, Enrico] Microsoft Res Univ Trento Ctr Computat & Syst Bio, Rovereto, TN, Italy; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Trento; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stahl, EA (corresponding author), Icahn Sch Med Mt Sinai, Div Psychiat Genom, Dept Genet & Genom Sci, New York, NY 10029 USA.; Stahl, EA (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Sieberts, SK (corresponding author), Sage Bionetworks, Syst Biol, Seattle, WA 98109 USA.	eli.stahl@mssm.edu; solly.sieberts@sagebase.org	Domenici, Enrico/K-8194-2016; Huckins, Laura/GPX-8325-2022; Pinto, Dalila/C-4218-2016; Raj, Towfique/ABD-7620-2021; Girdhar, Kiran/J-6670-2019; Glicksberg, Benjamin/I-9500-2019; Brennand, Kristen/J-8704-2012	Domenici, Enrico/0000-0001-7436-6919; Huckins, Laura/0000-0002-5369-6502; Pinto, Dalila/0000-0002-8769-0846; Girdhar, Kiran/0000-0002-5622-042X; Glicksberg, Benjamin/0000-0003-4515-8090; Cicek, A. Ercument/0000-0001-8613-6619; Dang, Kristen/0000-0002-7512-4476; Johnson, Jessica/0000-0002-4519-3120; Perumal, Thanneer Malai/0000-0003-1168-8982; Talbot, Konrad/0000-0003-4549-0835; Boocock, James/0000-0002-5923-3701; Buxbaum, Joseph/0000-0001-8898-8313; Brennand, Kristen/0000-0003-0993-5956; Mangravite, Lara/0000-0001-7841-3612; Visintainer, Roberto/0000-0003-1289-6871	Takeda Pharmaceuticals Company Limited; F. Hoffmann-La Roche Ltd; NIH [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, MH06692]; NIA [P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152]; Illinois Department of Public Health; Translational Genomics Research Institute; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; ARRA [1RC2MH089921-01, 1RC2MH090047-01, 1RC2MH089929-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093725, R01MH080405, P50MH066392, R37MH057881, R01MH085542, RC2MH089929, R01MH097276, R01MH075916, P50MH084053, RC2MH090047, U01MH109536, RC2MH089921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030146, R01AG015819, U01AG032984, U01AG046152, P01AG002219, P50AG005138, R01AG036836, R01AG017917, RF1AG015819, P30AG010161] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	Takeda Pharmaceuticals Company Limited; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; Translational Genomics Research Institute; Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffmann-La Roche Ltd and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, and MH06692. Brain tissue for the study was obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer Disease Core Center, and the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories. Data from the NIMH Human Brain Collection Core were generated as part of the NIMH Human Brain Collection Core (NIH NCT00001260, 999917073).; ROSMAP study data were provided by the Rush Alzheimer Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, the Illinois Department of Public Health, and the Translational Genomics Research Institute. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from the GTEx Portal on 09/05/16. BrainSpan: Atlas of the Developing Human Brain. Funded by ARRA Awards 1RC2MH089921-01, 1RC2MH090047-01, and 1RC2MH089929-01.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Bhattarai P, 2016, CELL REP, V17, P941, DOI 10.1016/j.celrep.2016.09.075; Birnbaum R, 2015, BIOL PSYCHIAT, V77, pE43, DOI 10.1016/j.biopsych.2014.10.008; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Guo H, 2015, HUM MOL GENET, V24, P3305, DOI 10.1093/hmg/ddv077; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hoffman GE, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1323-z; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jansen R, 2017, HUM MOL GENET, V26, P1444, DOI 10.1093/hmg/ddx043; Kato K, 2015, PLOS ONE, V10, P119; Kim WJ, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S80227; Kryuchkova-Mostacci N, 2017, BRIEF BIOINFORM, V18, P205, DOI 10.1093/bib/bbw008; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin GN, 2015, NEURON, V85, P742, DOI 10.1016/j.neuron.2015.01.010; Liu XY, 2017, AM J HUM GENET, V100, P605, DOI 10.1016/j.ajhg.2017.03.002; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Marin O, 2016, NAT MED, V22, P1229, DOI 10.1038/nm.4225; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Ongen H, 2017, NAT GENET, V49, P1676, DOI 10.1038/ng.3981; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Ruan Zhenchao, 2011, Front Biosci (Elite Ed), V3, P33, DOI 10.2741/e217; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Skene N.G., 2017, BIORXIV, DOI [10.1101/145466, DOI 10.1101/145466]; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; van der Zwaag B, 2010, AM J MED GENET B, V153B, P960, DOI 10.1002/ajmg.b.31055; Vitale AM, 2017, NPJ SCHIZOPHR, V3, DOI 10.1038/s41537-016-0006-0; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wang L, 2010, J PROTEOME RES, V9, P521, DOI 10.1021/pr900867x; Windrem MS, 2017, CELL STEM CELL, V21, P195, DOI 10.1016/j.stem.2017.06.012; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang F, 2012, RNA BIOL, V9, P110, DOI 10.4161/rna.9.1.18332; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538; Zumbrennen-Bullough KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098072	83	62	62	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 7	2018	102	6					1169	1184		10.1016/j.ajhg.2018.04.011	http://dx.doi.org/10.1016/j.ajhg.2018.04.011			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ0LP	29805045	Green Published, hybrid			2022-12-18	WOS:000434946200013
J	White, JJ; Mazzeu, JF; Coban-Akdemir, Z; Bayram, Y; Bahrambeigi, V; Hoischen, A; van Bon, BWM; Gezdirici, A; Gulec, EY; Ramond, F; Touraine, R; Thevenon, J; Shinawi, M; Beaver, E; Heeley, J; Hoover-Fong, J; Durmaz, CD; Karabulut, HG; Marzioglu-Ozdemir, E; Cayir, A; Duz, MB; Seven, M; Price, S; Ferreira, BM; Vianna-Morgante, AM; Ellard, S; Parrish, A; Stals, K; Flores-Daboub, J; Jhangiani, SN; Gibbs, RA; Brunner, HG; Sutton, VR; Lupski, JR; Carvalho, CMB				White, Janson J.; Mazzeu, Juliana F.; Coban-Akdemir, Zeynep; Bayram, Yavuz; Bahrambeigi, Vahid; Hoischen, Alexander; van Bon, Bregje W. M.; Gezdirici, Alper; Gulec, Elif Yilmaz; Ramond, Francis; Touraine, Renaud; Thevenon, Julien; Shinawi, Marwan; Beaver, Erin; Heeley, Jennifer; Hoover-Fong, Julie; Durmaz, Ceren D.; Karabulut, Halil Gurhan; Marzioglu-Ozdemir, Ebru; Cayir, Atilla; Duz, Mehmet B.; Seven, Mehmet; Price, Susan; Ferreira, Barbara Merfort; Vianna-Morgante, Angela M.; Ellard, Sian; Parrish, Andrew; Stals, Karen; Flores-Daboub, Josue; Jhangiani, Shalini N.; Gibbs, Richard A.; Brunner, Han G.; Sutton, V. Reid; Lupski, James R.; Carvalho, Claudia M. B.		Baylor-Hopkins Ctr Mendelian	WNT Signaling Perturbations Underlie the Genetic Heterogeneity of Robinow Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEURAL-TUBE DEFECTS; DROSOPHILA TISSUE POLARITY; AUTOSOMAL-DOMINANT; CELL POLARITY; VERTEBRATE GASTRULATION; MENDELIAN-INHERITANCE; GROWTH-PLATE; DEP DOMAIN; MUTATIONS; PROTEIN	Locus heterogeneity characterizes a variety of skeletal dysplasias often due to interacting or overlapping signaling pathways. Robinow syndrome is a skeletal disorder historically refractory to molecular diagnosis, potentially stemming from substantial genetic heterogeneity. All current known pathogenic variants reside in genes within the noncanonical Wnt signaling pathway including ROR2, WNT5A, and more recently, DVL1 and DVL3. However, similar to 70% of autosomal-dominant Robinow syndrome cases remain molecularly unsolved. To investigate this missing heritability, we recruited 21 families with at least one family member clinically diagnosed with Robinow or Robinow-like phenotypes and performed genetic and genomic studies. In total, four families with variants in FZD2 were identified as well as three individuals from two families with biallelic variants in NXN that co-segregate with the phenotype. Importantly, both FZD2 and NXN are relevant protein partners in the WNT5A interactome, supporting their role in skeletal development. In addition to confirming that clustered-1 frameshifting variants in DVL1 and DVL3 are the main contributors to dominant Robinow syndrome, we also found likely pathogenic variants in candidate genes GPC4 and RAC3, both linked to the Wnt signaling pathway. These data support an initial hypothesis that Robinow syndrome results from perturbation of the Wnt/PCP pathway, suggest specific relevant domains of the proteins involved, and reveal key contributors in this signaling cascade during human embryonic development. Contrary to the view that non-allelic genetic heterogeneity hampers gene discovery, this study demonstrates the utility of rare disease genomic studies to parse gene function in human developmental pathways.	[White, Janson J.; Coban-Akdemir, Zeynep; Bayram, Yavuz; Lupski, James R.; Carvalho, Claudia M. B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mazzeu, Juliana F.; Ferreira, Barbara Merfort] Univ Brasilia, BR-70910 Brasilia, DF, Brazil; [Mazzeu, Juliana F.] Robinow Syndrome Fdn, Anoka, MN 55303 USA; [Bahrambeigi, Vahid] Univ Texas MD Anderson Canc Ctr, Sch Hlth Profess, Grad Program Diagnost Genet, Houston, TX 77030 USA; [Hoischen, Alexander; van Bon, Bregje W. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6500 HB Nijmegen, Netherlands; [Gezdirici, Alper; Gulec, Elif Yilmaz] Kanuni Sultan Suleyman Training & Res Hosp, Dept Med Genet, TR-34303 Istanbul, Turkey; [Ramond, Francis; Touraine, Renaud] CHU Hop Nord, Serv Genet, F-42000 St Etienne, France; [Thevenon, Julien] Univ Bourgogne Franche Comte, Genet Dev Anomalies, Inserm UMR 1231 GAD Team, F-21000 Dijon, France; [Thevenon, Julien] CHU Dijon, Univ Bourgogne, FHU TRANSLAD, F-21000 Dijon, France; [Thevenon, Julien] CHU Grenoble Alpes, Hop Couple Enfant, Ctr Genet, F-38700 La Tronche, France; [Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA; [Beaver, Erin; Heeley, Jennifer] Mercy Childrens Hosp St Louis, Mercy Clin Kids Genet, St Louis, MO 63141 USA; [Hoover-Fong, Julie] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Greenberg Ctr Skeletal Dysplasias, Baltimore, MD 21287 USA; [Durmaz, Ceren D.; Karabulut, Halil Gurhan] Ankara Univ, Sch Med, Dept Med Genet, TR-06100 Ankara, Turkey; [Marzioglu-Ozdemir, Ebru] Erzurum Reg & Training Hosp, Dept Med Genet, TR-25070 Erzurum, Turkey; [Cayir, Atilla] Erzurum Training & Res Hosp, Dept Pediat Endocrinol, TR-25070 Erzurum, Turkey; [Duz, Mehmet B.; Seven, Mehmet] Istanbul Univ, Cerrahpasa Med Sch, Dept Med Genet, TR-34452 Istanbul, Turkey; [Price, Susan] Nuffield Orthopaed Ctr, Oxford Ctr Genom Med, Oxford OX3 7LD, England; [Vianna-Morgante, Angela M.] Inst Biosci, Dept Genet & Evolutionary Biol, BR-05508090 Sao Paulo, Brazil; [Ellard, Sian; Parrish, Andrew; Stals, Karen] Royal Devon & Exeter NHS Fdn Trust, Dept Mol Genet, Exeter EX2 5DW, Devon, England; [Ellard, Sian] Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Flores-Daboub, Josue] Univ Utah, Sch Med, Dept Pediat Genet, Salt Lake City, UT 84108 USA; [Jhangiani, Shalini N.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behaviour, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Brunner, Han G.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Sutton, V. Reid; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Universidade de Brasilia; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Istanbul Kanuni Sultan Suleyman Training & Research Hospital; CHU de St Etienne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; CHU Grenoble Alpes; Washington University (WUSTL); Johns Hopkins University; Ankara University; Erzurum Bolge Training & Research Hospital; Erzurum Bolge Training & Research Hospital; Istanbul University; Istanbul University - Cerrahpasa; Nuffield Orthopaedic Centre; University of Exeter; University of Exeter; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Radboud University Nijmegen; Maastricht University; Baylor College of Medicine	Carvalho, CMB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	cfonseca@bcm.edu	Gezdirici, Alper/AAG-5480-2019; Durmaz, Ceren Damla/I-2457-2016; Hoischen, Alexander/AGF-7293-2022; Ramond, Francis/GVS-2149-2022; Vianna-Morgante, Angela/E-6815-2016; van Bon, Bregje/Q-2445-2015; Durmaz, Ceren Damla/AAC-5478-2019; Seven, Mehmet/E-1017-2019; Yılmaz Gulec, Elif/GPS-8141-2022; Hoischen, Alexander/D-1282-2013; Yilmaz Gulec, Elif/X-2778-2018; mazzeu, Juliana f/H-4279-2016; Gezdirici, Alper/W-8459-2018; Touraine, Renaud/AAV-1605-2020; Karabulut, Halil/AAJ-1020-2020	Gezdirici, Alper/0000-0002-2432-9279; Durmaz, Ceren Damla/0000-0002-6054-0709; Hoischen, Alexander/0000-0002-8072-4476; Vianna-Morgante, Angela/0000-0003-1473-9669; van Bon, Bregje/0000-0003-2234-0105; Durmaz, Ceren Damla/0000-0002-6054-0709; Seven, Mehmet/0000-0001-7878-2039; Yılmaz Gulec, Elif/0000-0003-0872-3898; Hoischen, Alexander/0000-0002-8072-4476; Yilmaz Gulec, Elif/0000-0003-0872-3898; mazzeu, Juliana f/0000-0002-6161-0510; Gezdirici, Alper/0000-0002-2432-9279; Karabulut, Halil/0000-0002-2842-0029; Hoover-Fong, Julie/0000-0002-1242-5626; Ellard, Sian/0000-0002-7620-5526; shinawi, Marwan/0000-0003-1329-4100; Bahrambeigi, Vahid/0000-0002-7964-6087	US National Human Genome Research Institute/National Heart Blood Lung Institute - Baylor Hopkins Center for Mendelian Genomics [UM1 HG006542]; Smith-Magenis Syndrome Research Foundation (SMSRF); FAPESP [CEPID 2013/08028-1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	US National Human Genome Research Institute/National Heart Blood Lung Institute - Baylor Hopkins Center for Mendelian Genomics; Smith-Magenis Syndrome Research Foundation (SMSRF); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the individuals and their families who contributed to this study and the Robinow Syndrome Foundation for facilitating collaboration. Supported by the US National Human Genome Research Institute/National Heart Blood Lung Institute jointly funded Baylor Hopkins Center for Mendelian Genomics (UM1 HG006542). J.J.W. was funded in part by the Smith-Magenis Syndrome Research Foundation (SMSRF). A.M.V.-M. is funded by FAPESP (CEPID 2013/08028-1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI/NHBLI, NIH.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Allache R, 2012, BIRTH DEFECTS RES A, V94, P176, DOI 10.1002/bdra.23002; Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; [Anonymous], 1928, Br Med J, V1, P914; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boles MK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000759; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Boone PM, 2013, GENOME RES, V23, P1383, DOI 10.1101/gr.156075.113; Boone PM, 2011, GENET MED, V13, P582, DOI 10.1097/GIM.0b013e3182106775; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Bunn KJ, 2015, AM J HUM GENET, V96, P623, DOI 10.1016/j.ajhg.2015.02.010; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2008, GENES CELLS, V13, P965, DOI 10.1111/j.1365-2443.2008.01220.x; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gambin T, 2017, NUCLEIC ACIDS RES, V45, P1633, DOI 10.1093/nar/gkw1237; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KRAWCZAK M, 1991, HUM GENET, V86, P425; Kurooka H, 1997, GENOMICS, V39, P331, DOI 10.1006/geno.1996.4493; Kuss P, 2014, DEV BIOL, V385, P83, DOI 10.1016/j.ydbio.2013.10.013; Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Mayle R, 2015, SCIENCE, V349, P742, DOI 10.1126/science.aaa8391; Mazzeu JF, 2007, AM J MED GENET A, V143A, P320, DOI 10.1002/ajmg.a.31592; McCarthy DJ, 2014, GENOME MED, V6, DOI 10.1186/gm543; MCKUSICK VA, 1969, PERSPECT BIOL MED, V12, P298; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; MORTON NE, 1956, AM J HUM GENET, V8, P80; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Punchihewa C, 2009, PROTEIN SCI, V18, P994, DOI 10.1002/pro.109; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Saal HM, 2015, HUM MOL GENET, V24, P3399, DOI 10.1093/hmg/ddv088; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira NL, 2016, MOL GENET GENOM MED, V4, P371, DOI 10.1002/mgg3.233; Strutt H, 2011, DEV CELL, V20, P511, DOI 10.1016/j.devcel.2011.03.018; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wang YS, 1996, J BIOL CHEM, V271, P4468; Waterson J, 2010, AM J MED GENET A, V152A, P3179, DOI 10.1002/ajmg.a.33450; White J, 2015, AM J HUM GENET, V96, P612, DOI 10.1016/j.ajhg.2015.02.015; White JJ, 2016, AM J HUM GENET, V98, P553, DOI 10.1016/j.ajhg.2016.01.005; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wiweger MI, 2011, J PATHOL, V223, P531, DOI 10.1002/path.2824; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	86	62	64	4	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					27	43		10.1016/j.ajhg.2017.10.002	http://dx.doi.org/10.1016/j.ajhg.2017.10.002			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29276006	Green Published, Bronze			2022-12-18	WOS:000419305500003
J	Lehman, A; Thouta, S; Mancini, GMS; Naidu, S; van Slegtenhorst, M; McWalter, K; Person, R; Mwenifumbo, J; Salvarinova, R; Guella, I; McKenzie, MB; Datta, A; Connolly, MB; Kalkhoran, SM; Poburko, D; Friedman, JM; Farrer, MJ; Demos, M; Desai, S; Claydon, T				Lehman, Anna; Thouta, Samrat; Mancini, Grazia M. S.; Naidu, Sakkubai; van Slegtenhorst, Marjon; McWalter, Kirsty; Person, Richard; Mwenifumbo, Jill; Salvarinova, Ramona; Guella, Ilaria; McKenzie, Marna B.; Datta, Anita; Connolly, Mary B.; Kalkhoran, Somayeh Mojard; Poburko, Damon; Friedman, Jan M.; Farrer, Matthew J.; Demos, Michelle; Desai, Sonal; Claydon, Thomas		CAUSES Study; EPGEN Study	Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POTASSIUM CHANNEL GENE; SEIZURES; CLONING	KCNQ5 is a highly conserved gene encoding an important channel for neuronal function; it is widely expressed in the brain and generates M-type current. Exome sequencing identified de novo heterozygous missense mutations in four probands with intellectual disability, abnormal neurological findings, and treatment-resistant epilepsy (in two of four). Comprehensive analysis of this potassium channel for the four variants expressed in frog oocytes revealed shifts in the voltage dependence of activation, including altered activation and deactivation kinetics. Specifically, both loss-of-function and gain-of-function KCNQ5 mutations, associated with increased excitability and decreased repolarization reserve, lead to pathophysiology.	[Lehman, Anna; Mwenifumbo, Jill; Friedman, Jan M.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Thouta, Samrat; Kalkhoran, Somayeh Mojard; Poburko, Damon; Claydon, Thomas] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Mancini, Grazia M. S.; van Slegtenhorst, Marjon] Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Naidu, Sakkubai; Desai, Sonal] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD 21211 USA; [McWalter, Kirsty; Person, Richard] GeneDx, Gaithersburg, MD 20877 USA; [Salvarinova, Ramona] Univ British Columbia, Div Biochem Dis, Dept Pediat, Vancouver, BC V6H 3N1, Canada; [CAUSES Study; EPGEN Study] Univ British Columbia, Vancouver, BC V6H 3N1, Canada; [Guella, Ilaria; McKenzie, Marna B.; Farrer, Matthew J.] Univ British Columbia, Ctr Appl Neurogenet, Vancouver, BC V6T 1Z3, Canada; [Datta, Anita; Connolly, Mary B.; Demos, Michelle] Univ British Columbia, Div Pediat Neurol, Dept Pediat, Vancouver, BC V6H 3N1, Canada	University of British Columbia; Simon Fraser University; Erasmus University Rotterdam; Erasmus MC; Kennedy Krieger Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Lehman, A (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada.; Claydon, T (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada.	alehman@cw.bc.ca; thomas_claydon@sfu.ca	Lehman, Anna/R-6706-2017; Guella, Ilaria/AAU-1286-2020; Guella, Ilaria/AAU-1319-2020	Lehman, Anna/0000-0003-0636-123X; Sinclair, Graham/0000-0002-3815-2005; Datta, Anita/0000-0001-7620-4868; Claydon, Tom/0000-0002-5143-7451; Connolly, Mary/0000-0002-7784-942X; Farrer, Matthew/0000-0003-1159-5321; Elliott, Alison/0000-0002-9896-1314; Nelson, Tanya/0000-0001-5344-3516; Salvarinova Zivkovic, Ramona/0000-0002-8132-9136; Buerki, Sarah Elisabeth/0000-0003-3054-1791; Friedman, Jan/0000-0002-7482-9570; Adam, Shelin/0000-0002-4401-6157; Thouta, Samrat/0000-0002-0460-6187; McKenzie, Marna/0000-0002-0869-345X	Mining for Miracles through the BCCH Foundation; Mining for Miracles (BCCH Foundation); Genome British Columbia; British Columbia Provincial Health Services Authority; British Columbia Women's Hospital; Rare Disease Foundation; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Canada Excellence Research Chair; Leading Edge Endowment Fund; Grocholski Foundation; Alva Foundation	Mining for Miracles through the BCCH Foundation; Mining for Miracles (BCCH Foundation); Genome British Columbia; British Columbia Provincial Health Services Authority; British Columbia Women's Hospital; Rare Disease Foundation; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Excellence Research Chair; Leading Edge Endowment Fund; Grocholski Foundation; Alva Foundation	We thank the families for participating in this research. We thank the British Columbia Children's Hospital (BCCH) BioBank, which is supported by Mining for Miracles through the BCCH Foundation. The bioinformatic pipeline used in the CAUSES study was developed in the laboratory of Wyeth Wasserman with intellectual contributions from Dave Arenillas, Phillip Richmond, Casper Shyr, Alison Matthews, and Maja Tarailo-Graovac. We are grateful for assistance from the BCCH Department of Pathology & Laboratory Medicine and the BCCH Electroencephalography Department. We thank Ji Qi and Jacob Kemp for expert technical assistance with functional-characterization experiments. The CAUSES study is funded by Mining for Miracles (BCCH Foundation) and Genome British Columbia with support from the British Columbia Provincial Health Services Authority and British Columbia Women's Hospital. Functional studies were funded by the Rare Disease Foundation and a Natural Sciences and Engineering Research Council of Canada Discovery Grant. EPGEN is funded by the Canada Excellence Research Chair, Leading Edge Endowment Fund, Rare Disease Foundation, Grocholski Foundation, and Alva Foundation.	Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Castaldo P, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0003.2002; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Demos M., 2017, BIORXIV; Fidzinski P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7254; Greene DL, 2017, CELL MOL LIFE SCI, V74, P495, DOI 10.1007/s00018-016-2359-y; Hu H, 2009, J NEUROSCI, V29, P14472, DOI 10.1523/JNEUROSCI.0187-09.2009; Hunter J, 2006, NEUROBIOL DIS, V24, P194, DOI 10.1016/j.nbd.2006.06.011; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Miceli F, 2015, EPILEPSIA, V56, pE15, DOI 10.1111/epi.12887; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tarailo-Graovac M, 2016, NEW ENGL J MED, V374, P2246, DOI 10.1056/NEJMoa1515792; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; van Vliet-Ostaptchouk JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032148; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644	30	62	63	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					65	74		10.1016/j.ajhg.2017.05.016	http://dx.doi.org/10.1016/j.ajhg.2017.05.016			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28669405	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000404886800005
J	Van Damme, T; Gardeitchik, T; Mohamed, M; Guerrero-Castillo, S; Freisinger, P; Guillemyn, B; Kariminejad, A; Dalloyaux, D; Van Kraaij, S; Lefeber, DJ; Syx, D; Steyaert, W; De Rycke, R; Hoischen, A; Kamsteeg, EJ; Wong, SY; van Scherpenzeel, M; Jamali, P; Brandt, U; Nijtmans, L; Korenke, GC; Chung, BHY; Mak, CCY; Hausser, I; Kornak, U; Fischer-Zirnsak, B; Strom, TM; Meitinger, T; Alanay, Y; Utine, GE; Leung, PKC; Ghaderi-Sohi, S; Coucke, P; Symoens, S; De Paepe, A; Thiel, C; Haack, TB; Malfait, F; Morava, E; Callewaert, B; Wevers, RA				Van Damme, Tim; Gardeitchik, Thatjana; Mohamed, Miski; Guerrero-Castillo, Sergio; Freisinger, Peter; Guillemyn, Brecht; Kariminejad, Ariana; Dalloyaux, Daisy; Van Kraaij, Sanne; Lefeber, Dirk J.; Syx, Delfien; Steyaert, Wouter; De Rycke, Riet; Hoischen, Alexander; Kamsteeg, Erik-Jan; Wong, Sunnie Y.; van Scherpenzeel, Monique; Jamali, Payman; Brandt, Ulrich; Nijtmans, Leo; Korenke, G. Christoph; Chung, Brian H. Y.; Mak, Christopher C. Y.; Hausser, Ingrid; Kornak, Uwe; Fischer-Zirnsak, Bjorn; Strom, Tim M.; Meitinger, Thomas; Alanay, Yasemin; Utine, Gulen E.; Leung, Peter K. C.; Ghaderi-Sohi, Siavash; Coucke, Paul; Symoens, Sofie; De Paepe, Anne; Thiel, Christian; Haack, Tobias B.; Malfait, Fransiska; Morava, Eva; Callewaert, Bert; Wevers, Ron A.			Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMAL PROTEIN GLYCOSYLATION; CONNECTIVE-TISSUE DISORDERS; RENAL TUBULAR-ACIDOSIS; VACUOLAR PROTON PUMP; IMAGE-ANALYSIS; CONGENITAL DISORDERS; MISSENSE MUTATIONS; GOLGI HOMEOSTASIS; DEFICIENCY CAUSES; I-TASSER	Defects of the V-type proton (H+) ATPase (V-ATPase) impair acidification and intracellular trafficking of membrane-enclosed compartments, including secretory granules, endosomes, and lysosomes. Whole-exome sequencing in five families affected by mild to severe cutis laxa, dysmorphic facial features, and cardiopulmonary involvement identified biallelic missense mutations in ATP6V1E1 and ATP6V1A, which encode the El and A subunits, respectively, of the V-1 domain of the heteromultimeric V-ATPase complex. Structural modeling indicated that all substitutions affect critical residues and inter- or intrasubunit interactions. Furthermore, complexome profiling, a method combining blue-native gel electrophoresis and liquid chromatography tandem mass spectrometry, showed that they disturb either the assembly or the stability of the V-ATPase complex. Protein glycosylation was variably affected. Abnormal vesicular trafficking was evidenced by delayed retrograde transport after brefeldin A treatment and abnormal swelling and fragmentation of the Golgi apparatus. In addition to showing reduced and fragmented elastic fibers, the histopathological hallmark of cutis laxa, transmission electron microscopy of the dermis also showed pronounced changes in the structure and organization of the collagen fibers. Our findings expand the clinical and molecular spectrum of metabolic cutis laxa syndromes and further link defective extracellular matrix assembly to faulty protein processing and cellular trafficking caused by genetic defects in the V-ATPase complex.	[Van Damme, Tim; Guillemyn, Brecht; Syx, Delfien; Steyaert, Wouter; Coucke, Paul; Symoens, Sofie; De Paepe, Anne; Malfait, Fransiska; Callewaert, Bert] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Van Damme, Tim; Guillemyn, Brecht; Syx, Delfien; Steyaert, Wouter; Coucke, Paul; Symoens, Sofie; De Paepe, Anne; Malfait, Fransiska; Callewaert, Bert] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Gardeitchik, Thatjana; Mohamed, Miski; Dalloyaux, Daisy; Van Kraaij, Sanne] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Gardeitchik, Thatjana; Hoischen, Alexander; Kamsteeg, Erik-Jan] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Guerrero-Castillo, Sergio; Brandt, Ulrich; Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Mitochondrial Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Guerrero-Castillo, Sergio; Dalloyaux, Daisy; Van Kraaij, Sanne; Lefeber, Dirk J.; van Scherpenzeel, Monique; Brandt, Ulrich; Nijtmans, Leo; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Freisinger, Peter] Klinikum Steinenberg, Childrens Hosp, D-72764 Reutlingen, Germany; [Kariminejad, Ariana; Ghaderi-Sohi, Siavash] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14656, Iran; [Lefeber, Dirk J.; van Scherpenzeel, Monique] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [De Rycke, Riet] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [De Rycke, Riet] VIB, Inflammat Res Ctr, B-9000 Ghent, Belgium; [Wong, Sunnie Y.; Morava, Eva] Tulane Univ, Sch Med, Hayward Genet Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Jamali, Payman] Shahrood Genet Counseling Ctr, Semnan 36156, Iran; [Korenke, G. Christoph] Childrens Hosp Klinikum Oldenburg, Dept Neuropediat, D-26133 Oldenburg, Germany; [Chung, Brian H. Y.; Mak, Christopher C. Y.; Leung, Peter K. C.] Univ Hong Kong, Dept Paediat & Adolescent Med, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Hausser, Ingrid] Univ Klinikum Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany; [Kornak, Uwe; Fischer-Zirnsak, Bjorn] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Kornak, Uwe; Fischer-Zirnsak, Bjorn] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Alanay, Yasemin] Acibadem Univ, Sch Med, Pediat Genet Unit, Dept Pediat, TR-34752 Istanbul, Turkey; [Utine, Gulen E.] Ihsan Dogramaci Childrens Hosp, Pediat Genet Unit, Dept Pediat, Hacettepe Sch Med, TR-06100 Ankara, Turkey; [Thiel, Christian] Univ Klinikum Heidelberg, Ctr Child & Adolescent Med, Klin Kinderheilkunde 1, D-69120 Heidelberg, Germany; [Haack, Tobias B.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Morava, Eva] Univ Hosp Leuven, Dept Pediat, B-3000 Leuven, Belgium	Ghent University; Ghent University; Ghent University Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Ghent University; Flanders Institute for Biotechnology (VIB); Tulane University; University of Hong Kong; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Acibadem University; Hacettepe University; Ruprecht Karls University Heidelberg; Technical University of Munich; Eberhard Karls University of Tubingen; KU Leuven; University Hospital Leuven	Callewaert, B (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.; Callewaert, B (corresponding author), Ghent Univ Hosp, B-9000 Ghent, Belgium.; Wevers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands.	bert.callewaert@ugent.be; ron.wevers@radboudumc.nl	Wevers, Ron A./H-8116-2014; Dalloyaux, Daisy/L-7379-2016; Lefeber, Dirk DJ/A-2146-2014; Hoischen, Alexander/D-1282-2013; Meitinger, Thomas/O-1318-2015; Steyaert, Wouter/AAB-6700-2019; Kamsteeg, Erik-Jan/L-4421-2015; Alanay, Yasemin/A-1516-2016; Brandt, Ulrich/C-4406-2008; Guerrero-Castillo, Sergio/T-1515-2019; Nijtmans, L.G.J./L-4549-2015; Guerrero-Castillo, Sergio/E-2285-2016; Hoischen, Alexander/AGF-7293-2022; Coucke, Paul J/AAO-2954-2020; Brandt, Ulrich/GLV-1242-2022; Fischer-Zirnsak, Björn/D-7487-2013; Callewaert, Bert/J-6357-2014	Wevers, Ron A./0000-0003-2278-9746; Hoischen, Alexander/0000-0002-8072-4476; Steyaert, Wouter/0000-0001-8393-0788; Alanay, Yasemin/0000-0003-0683-9731; Brandt, Ulrich/0000-0003-1869-6811; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Guerrero-Castillo, Sergio/0000-0002-6630-0562; Hoischen, Alexander/0000-0002-8072-4476; Coucke, Paul J/0000-0001-7119-586X; Brandt, Ulrich/0000-0003-1869-6811; Fischer-Zirnsak, Björn/0000-0002-1075-7571; Meitinger, Thomas/0000-0002-8838-8403; Kariminejad, Ariana/0000-0002-8467-4728; LEUNG, KAI CHING PETER/0000-0001-6371-7656; Malfait, Fransiska/0000-0002-5010-0304; Thiel, Christian/0000-0001-6419-8747; Callewaert, Bert/0000-0002-9743-4205; Van Damme, Tim/0000-0002-6424-4421	Ghent University [08/01M01108]; Dutch Metakids foundation; Netherlands Organisation for Scientific Research (NWO) [017.008.052]; ZonMw Medium Investment Grant [40-00506-98-9001]; Vidi [91713359]; Dutch Stofwisselkracht foundation; German Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01ZX1405C]; S.K. Yee Medical Research Fund; Society for the Relief of Disabled Children Research Fund in Hong Kong; European Commission [EURO-CDG-2 E-Rare]	Ghent University(Ghent University); Dutch Metakids foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMw Medium Investment Grant; Vidi(Netherlands Organization for Scientific Research (NWO)); Dutch Stofwisselkracht foundation; German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); S.K. Yee Medical Research Fund; Society for the Relief of Disabled Children Research Fund in Hong Kong; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors wish to thank Martin Lammens (Department of Pathology, Antwerp University Hospital and University of Antwerp) for his advice on the ultrastructural studies, Zsolt Urban (Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh) for checking the DNA of a number of individuals with cutis laxa, and Angel Ashikov (Department of Neurology, Radboud University Medical Center) for his advice on subcellular fractionation. B.C. and F.M. are senior clinical investigators and D.S. is a postdoctoral researcher of the Fund for Scientific Research - Flanders. This study was financially supported by Ghent University (Methusalem grant 08/01M01108 to A.D.P.), the Dutch Metakids foundation (MM.), the Netherlands Organisation for Scientific Research (NWO project 017.008.052 to M.M.), ZonMw Medium Investment Grant 40-00506-98-9001 (D.J.L.), Vidi grant 91713359 (D.J.L.), the Dutch Stofwisselkracht foundation (T.G.), the German Bundesministerium fur Bildung und Forschung (BMBF, Juniorverbund in der Systemmedizin "mitOmics," FKZ 01ZX1405C to T.B.H.), the S.K. Yee Medical Research Fund, the Society for the Relief of Disabled Children Research Fund in Hong Kong, and the EURO-CDG-2 E-Rare grant by the European Commission. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alazami AM, 2016, HUM GENET, V135, P525, DOI 10.1007/s00439-016-1660-z; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Guillard M, 2009, BBA-MOL BASIS DIS, V1792, P903, DOI 10.1016/j.bbadis.2008.12.009; He P, 2012, J BIOL CHEM, V287, P18210, DOI 10.1074/jbc.M112.355677; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Huynen MA, 2016, BBA-MOL CELL RES, V1863, P91, DOI 10.1016/j.bbamcr.2015.10.009; Jansen EJR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11600; Jansen JC, 2016, AM J HUM GENET, V98, P322, DOI 10.1016/j.ajhg.2015.12.011; Jansen JC, 2016, AM J HUM GENET, V98, P310, DOI 10.1016/j.ajhg.2015.12.010; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kortum F, 2015, NAT GENET, V47, P661, DOI 10.1038/ng.3282; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Malfait F, 2013, AM J HUM GENET, V92, P935, DOI 10.1016/j.ajhg.2013.04.016; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9; Morava E, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22; Nakajima M, 2013, AM J HUM GENET, V92, P927, DOI 10.1016/j.ajhg.2013.04.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Van Scherpenzeel M, 2015, TRANSL RES, V166, P639, DOI 10.1016/j.trsl.2015.07.005; Vanakker O, 2015, ANNU REV GENOM HUM G, V16, P229, DOI 10.1146/annurev-genom-090314-050039; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	45	62	63	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					216	227		10.1016/j.ajhg.2016.12.010	http://dx.doi.org/10.1016/j.ajhg.2016.12.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28065471	Green Published, Bronze			2022-12-18	WOS:000393352000004
J	Hamada, H; Okae, H; Toh, H; Chiba, H; Hiura, H; Shirane, K; Sato, T; Suyama, M; Yaegashi, N; Sasaki, H; Arima, T				Hamada, Hirotaka; Okae, Hiroaki; Toh, Hidehiro; Chiba, Hatsune; Hiura, Hitoshi; Shirane, Kenjiro; Sato, Tetsuya; Suyama, Mikita; Yaegashi, Nobuo; Sasaki, Hiroyuki; Arima, Takahiro			Allele-Specific Methylome and Transcriptome Analysis Reveals Widespread Imprinting in the Human Placenta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA METHYLATION DYNAMICS; GENE; EXPRESSION; INHERITANCE; GERMLINE; DISEASE; DNMT1; CELL	DNA methylation is globally reprogrammed after fertilization, and as a result, the parental genomes have similar DNA-methylation profiles after implantation except at the germline differentially methylated regions (gDMRs). We and others have previously shown that human blastocysts might contain thousands of transient maternally methylated gDMRs (transient mDMRs), whose maternal methylation is lost in embryonic tissues after implantation. In this study, we performed genome-wide allelic DNA methylation analyses of purified trophoblast cells from human placentas and, surprisingly, found that more than one-quarter of the transient-in-embryo mDMRs maintained their maternally biased DNA methylation. RNA-sequencing-based allelic expression analyses revealed that some of the placenta-specific mDMRs were associated with expression of imprinted genes (e.g., TIGAR, SLC4A7, PROSER2-AS1, and KLHDC10), and three imprinted gene clusters were identified. This approach also identified some X-linked gDMRs. Comparisons of the data with those from other mammals revealed that genomic imprinting in the placenta is highly variable. These findings highlight the incomplete erasure of germline DNA methylation in the human placenta; understanding this erasure is important for understanding normal placental development and the pathogenesis of developmental disorders with imprinting effects.	[Hamada, Hirotaka; Okae, Hiroaki; Chiba, Hatsune; Hiura, Hitoshi; Arima, Takahiro] Tohoku Univ, Environm & Genome Res Ctr, Dept Informat Genet, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Toh, Hidehiro; Shirane, Kenjiro; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigen & Dev, Fukuoka 8128582, Japan; [Sato, Tetsuya; Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Yaegashi, Nobuo] Tohoku Univ, Dept Obstet, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Yaegashi, Nobuo] Tohoku Univ, Dept Gynecol, Grad Sch Med, Sendai, Miyagi 9808575, Japan	Tohoku University; Kyushu University; Kyushu University; Tohoku University; Tohoku University	Okae, H; Arima, T (corresponding author), Tohoku Univ, Environm & Genome Res Ctr, Dept Informat Genet, Grad Sch Med, Sendai, Miyagi 9808575, Japan.	okaehiro@m.tohoku.ac.jp; tarima@med.tohoku.ac.jp	Hamada, Hirotaka/AAG-8073-2021; Okae, Hiroaki/AAC-3705-2019	Hamada, Hirotaka/0000-0002-6397-5898; Okae, Hiroaki/0000-0002-1539-5063; Suyama, Mikita/0000-0001-9526-3193	Japan Agency for Medical Research and Development (AMED) [15ek0109132, 15ek0109101h0001]; Banyu Life Science Foundation International; Smoking Research Foundation; Takeda Science Foundation; KAKENHI [26112502, 15K10657]; Core Research for Evolutional Science and Technology (CREST) from AMED;  [15K15592]; Grants-in-Aid for Scientific Research [15K10657] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Banyu Life Science Foundation International(Banyu Life Science Foundation International); Smoking Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST) from AMED(Core Research for Evolutional Science and Technology (CREST)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the individuals and their families who participated in this study. We also thank Professor K. Nakayama, Dr. R. Funayama, Ms. N. Miyauchi, Ms. A. Kitamura, Ms. M. Tsuda, Ms. M. Kikuchi, Ms. M. Nakagawa, and Mr. K. Kuroda for technical assistance and Professor Rosalind M. John for support and valuable suggestions. We are also grateful to the Biomedical Research Core of Tohoku University Graduate School of Medicine for technical support. This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (15K15592), the Japan Agency for Medical Research and Development (AMED) (15ek0109132, 15ek0109101h0001), Banyu Life Science Foundation International, Smoking Research Foundation, and the Takeda Science Foundation to TA and KAKENHI (26112502, 15K10657) to HO. This work was also supported by the Core Research for Evolutional Science and Technology (CREST) from AMED (HS and TA).	Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Das R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-685; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fisher RA, 2003, PLACENTA, V24, pS111, DOI 10.1053/plac.2002.0939; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Gascoin-Lachambre G, 2010, PLACENTA, V31, P151, DOI 10.1016/j.placenta.2009.11.008; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hanna CW, 2016, GENOME RES, V26, P756, DOI 10.1101/gr.196139.115; Herse F, 2012, CIRCULATION, V126, P2990, DOI 10.1161/CIRCULATIONAHA.112.127340; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; John RM, 1996, CURR OPIN CELL BIOL, V8, P348, DOI 10.1016/S0955-0674(96)80008-1; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knickmeyer RC, 2012, CURR OPIN NEUROL, V25, P144, DOI 10.1097/WCO.0b013e3283515e9e; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Miura F, 2015, DNA RES, V22, P13, DOI 10.1093/dnares/dsu034; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson WP, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023044; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Sanchez-Delgado M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005644; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schroeder DI, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005442; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wang X, 2013, P NATL ACAD SCI USA, V110, P10705, DOI 10.1073/pnas.1308998110; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-10	50	62	63	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1045	1058		10.1016/j.ajhg.2016.08.021	http://dx.doi.org/10.1016/j.ajhg.2016.08.021			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27843122	Bronze, Green Published			2022-12-18	WOS:000387529600004
J	Auer, PL; Reiner, AP; Wang, G; Kang, HM; Abecasis, GR; Altshuler, D; Bamshad, MJ; Nickerson, DA; Tracy, RP; Rich, SS; Leal, SM				Auer, Paul L.; Reiner, Alex P.; Wang, Gao; Kang, Hyun Min; Abecasis, Goncalo R.; Altshuler, David; Bamshad, Michael J.; Nickerson, Deborah A.; Tracy, Russell P.; Rich, Stephen S.; Leal, Suzanne M.		NHLBI GO Exome Sequencing Project	Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-AMERICANS; CODING VARIANTS; IDENTIFIES RARE; GENOTYPE IMPUTATION; INCIDENTAL FINDINGS; GENETIC-VARIANTS; LOW-FREQUENCY; CELL-TRAIT; MUTATIONS	Massively parallel whole-genome sequencing (WGS) data have ushered in a new era in human genetics. These data are now being used to understand the role of rare variants in complex traits and to advance the goals of precision medicine. The technological and computing advances that have enabled us to generate WGS data on thousands of individuals have also outpaced our ability to perform analyses in scientifically and statistically rigorous and thoughtful ways. The past several years have witnessed the application of whole-exome sequencing (WES) to complex traits and diseases. From our analysis of NHLBI Exome Sequencing Project (ESP) data, not only have a number of important disease and complex trait association findings emerged, but our collective experience offers some valuable lessons for WGS initiatives. These include caveats associated with generating automated pipelines for quality control and analysis of rare variants; the importance of studying minority populations; sample size requirements and efficient study designs for identifying rare-variant associations; and the significance of incidental findings in population-based genetic research. With the ESP as an example, we offer guidance and a framework on how to conduct a large-scale association study in the era of WGS.	[Auer, Paul L.] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53205 USA; [Auer, Paul L.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Wang, Gao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Wang, Gao] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kang, Hyun Min; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Altshuler, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Altshuler, David] Vertex Pharmaceut, Boston, MA 02210 USA; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tracy, Russell P.] Univ Vermont, Dept Pathol, Colchester, VT 05405 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Chicago; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vertex Pharmaceuticals; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of Vermont; University of Virginia	Leal, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA.	sleal@bcm.edu	Auer, Paul/AAC-5060-2019; Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Rich, Stephen/0000-0003-3872-7793	National Heart, Lung and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103010, RC2HL102925, RC2HL102923, RC2HL102926, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U24HG007307, R01HG008972] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the National Heart, Lung and Blood Institute (NHLBI), the contributions of the research institutions that participated in this study, and the study investigators, field staff, and study participants who created this resource for biomedical research. Funding for the GO (Grand Opportunity) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO), and RC2 HL-102924 (WHISP). The exome sequencing was supported by NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Auer PL, 2015, JAMA NEUROL, V72, P781, DOI 10.1001/jamaneurol.2015.0582; Auer PL, 2013, GENET EPIDEMIOL, V37, P529, DOI 10.1002/gepi.21736; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Du MM, 2014, HUM MOL GENET, V23, P6607, DOI 10.1093/hmg/ddu361; Duan Q, 2013, BIOINFORMATICS, V29, P2744, DOI 10.1093/bioinformatics/btt477; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin DY, 2013, P NATL ACAD SCI USA, V110, P12247, DOI 10.1073/pnas.1221713110; Liu DJJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003075; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy S., 2016, NAT GENET; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Peng B, 2015, GENET EPIDEMIOL, V39, P45, DOI 10.1002/gepi.21867; Pistis G, 2015, EUR J HUM GENET, V23, P975, DOI 10.1038/ejhg.2014.216; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang GT, 2014, BIOINFORMATICS, V30, P2377, DOI 10.1093/bioinformatics/btu296; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	48	62	64	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					791	801		10.1016/j.ajhg.2016.08.012	http://dx.doi.org/10.1016/j.ajhg.2016.08.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27666372	Green Published, Bronze			2022-12-18	WOS:000385333700001
J	Wen, XQ; Lee, Y; Luca, F; Pique-Regi, R				Wen, Xiaoquan; Lee, Yeji; Luca, Francesca; Pique-Regi, Roger			Efficient Integrative Multi-SNP Association Analysis via Deterministic Approximation of Posteriors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ASSOCIATION; MODEL SELECTION; ELEMENTS; TRAITS; HUMANS; LOCUS; QTLS	With the increasing availability of functional genomic data, incorporating genomic annotations into genetic association analysis has become a standard procedure. However, the existing methods often lack rigor and/or computational efficiency and consequently do not maximize the utility of functional annotations. In this paper, we propose a rigorous inference procedure to perform integrative association analysis incorporating genomic annotations for both traditional GWASs and emerging molecular QTL mapping studies. In particular, we propose an algorithm, named deterministic approximation of posteriors (DAP), which enables highly efficient and accurate joint enrichment analysis and identification of multiple causal variants. We use a series of simulation studies to highlight the power and computational efficiency of our proposed approach and further demonstrate it by analyzing the cross-population eQTL data from the GEUVADIS project and the multi-tissue eQTL data from the GTEx project. In particular, we find that genetic variants predicted to disrupt transcription factor binding sites are enriched in cis-eQTLs across all tissues. Moreover, the enrichment estimates obtained across the tissues are correlated with the cell types for which the annotations are derived.	[Wen, Xiaoquan; Lee, Yeji] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Luca, Francesca; Pique-Regi, Roger] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Luca, Francesca; Pique-Regi, Roger] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Wen, XQ (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	xwen@umich.edu	Pique-Regi, Roger/A-4110-2009; Luca, Francesca/B-4850-2019	Pique-Regi, Roger/0000-0002-1262-2275; Luca, Francesca/0000-0001-8252-9052; Wen, Xiaoquan/0000-0001-8990-2737	NIH [MH101825, HG007022, GM109215]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the GTEx consortium and the GEUVADIS RNA sequencing project for releasing valuable data in a timely fashion. This work is supported by NIH grants MH101825, HG007022, and GM109215.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Berger JO, 1996, J AM STAT ASSOC, V91, P109, DOI 10.2307/2291387; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Moyerbrailean GA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005875; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Savic D, 2013, DIABETOLOGIA, V56, P121, DOI 10.1007/s00125-012-2730-y; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wen X., 2015, EFFECTIVE QTL DISCOV; Wen XQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005176; Wen XQ, 2014, ANN APPL STAT, V8, P176, DOI 10.1214/13-AOAS695; Wen XQ, 2014, BIOMETRICS, V70, P73, DOI 10.1111/biom.12112; Wen XQ, 2010, ANN APPL STAT, V4, P1158, DOI 10.1214/10-AOAS338; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	32	62	62	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1114	1129		10.1016/j.ajhg.2016.03.029	http://dx.doi.org/10.1016/j.ajhg.2016.03.029			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236919	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000377286000007
J	Mbarek, H; Steinberg, S; Nyholt, DR; Gordon, SD; Miller, MB; McRae, AF; Hottenga, JJ; Day, FR; Willemsen, G; de Geus, EJ; Davies, GE; Martin, HC; Penninx, BW; Jansen, R; McAloney, K; Vink, JM; Kaprio, J; Plomin, R; Spector, TD; Magnusson, PK; Reversade, B; Harris, RA; Aagaard, K; Kristjansson, RP; Olafsson, I; Eyjolfsson, GI; Sigurdardottir, O; Iacono, WG; Lambalk, CB; Montgomery, GW; McGue, M; Ong, KK; Perry, JRB; Martin, NG; Stefansson, H; Stefansson, K; Boomsma, DI				Mbarek, Hamdi; Steinberg, Stacy; Nyholt, Dale R.; Gordon, Scott D.; Miller, Michael B.; McRae, Allan F.; Hottenga, Jouke Jan; Day, Felix R.; Willemsen, Gonneke; de Geus, Eco J.; Davies, Gareth E.; Martin, Hilary C.; Penninx, Brenda W.; Jansen, Rick; McAloney, Kerrie; Vink, Jacqueline M.; Kaprio, Jaakko; Plomin, Robert; Spector, Tim D.; Magnusson, Patrik K.; Reversade, Bruno; Harris, R. Alan; Aagaard, Kjersti; Kristjansson, Ragnar P.; Olafsson, Isleifur; Eyjolfsson, Gudmundur Ingi; Sigurdardottir, Olof; Iacono, William G.; Lambalk, Cornelis B.; Montgomery, Grant W.; McGue, Matt; Ong, Ken K.; Perry, John R. B.; Martin, Nicholas G.; Stefansson, Hreinn; Stefansson, Kari; Boomsma, Dorret I.			Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twinning and Female Fertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLLICLE-STIMULATING-HORMONE; GENOME-WIDE ASSOCIATION; 1ST 5 YEARS; OVARIAN STIMULATION; HOSPITAL COSTS; NETHERLANDS; MOTHERS; REGISTER; SMAD3; TWINS	Spontaneous dizygotic (DZ) twinning occurs in 1%-4% of women, with familial clustering and unknown physiological pathways and genetic origin. DZ twinning might index increased fertility and has distinct health implications for mother and child. We performed a GWAS in 1,980 mothers of spontaneous DZ twins and 12,953 control subjects. Findings were replicated in a large Icelandic cohort and tested for association across a broad range of fertility traits in women. Two SNPs were identified (rs11031006 near FSHB, p = 1.54 x 10 (9), and rs17293443 in SMAD3, p = 1.57 x 10(-8)) and replicated (p = 3 x 10(-3) and p = 1.44 x 10(-4), respectively). Based on similar to 90,000 births in Iceland, the risk of a mother delivering twins increased by 18% for each copy of allele rs11031006-G and 9% for rs17293443-C. A higher polygenic risk score (PRS) for DZ twinning, calculated based on the results of the DZ twinning GWAS, was significantly associated with DZ twinning in Iceland (p = 0.001). A higher PRS was also associated with having children (p = 0.01), greater lifetime parity (p = 0.03), and earlier age at first child (p = 0.02). Allele rs11031006-G was associated with higher serum FSH levels, earlier age at menarche, earlier age at first child, higher lifetime parity, lower PCOS risk, and earlier age at menopause. Conversely, rs17293443-C was associated with later age at last child. We identified robust genetic risk variants for DZ twinning: one near FSHB and a second within SMAD3, the product of which plays an important role in gonadal responsiveness to FSH. These loci contribute to crucial aspects of reproductive capacity and health.	[Mbarek, Hamdi; Hottenga, Jouke Jan; Willemsen, Gonneke; de Geus, Eco J.; Vink, Jacqueline M.; Boomsma, Dorret I.] Free Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Steinberg, Stacy; Kristjansson, Ragnar P.; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Nyholt, Dale R.; Gordon, Scott D.; McRae, Allan F.; McAloney, Kerrie; Montgomery, Grant W.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia; [Miller, Michael B.; Iacono, William G.; McGue, Matt] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [McRae, Allan F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD 57108 USA; [Martin, Hilary C.] Wellcome Trust Ctr Human Genet, Oxford OX3 TBN, England; [Penninx, Brenda W.; Jansen, Rick] Vrije U Univ, Med Ctr GGZ inGeest, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands; [Penninx, Brenda W.; Jansen, Rick] Vrije U Univ, Med Ctr GGZ inGeest, EMGO Inst Hlth & Care Res, NL-1081 HL Amsterdam, Netherlands; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welfare, Helsinki 00014, Finland; [Plomin, Robert] Kings Coll London, Med Res Council, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Magnusson, Patrik K.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Reversade, Bruno] ASTAR, Lab Human Genet & Embryol, Inst Med Biol, Singapore 138648, Singapore; [Reversade, Bruno] Acad Med Ctr, Amsterdam Reprod & Dev, Reprod Biol Lab Q3 119, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Harris, R. Alan; Aagaard, Kjersti] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Harris, R. Alan; Aagaard, Kjersti] Baylor Coll Med, Div Maternal Fetal Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Harris, R. Alan; Aagaard, Kjersti] Baylor Coll Med, Div Maternal Fetal Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Harris, R. Alan; Aagaard, Kjersti] Texas Childrens Hosp, Houston, TX 77030 USA; [Olafsson, Isleifur] Landspitali Natl Univ Hosp Iceland, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Eyjolfsson, Gudmundur Ingi] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, IS-101 Reykjavik, Iceland; [Sigurdardottir, Olof] Akureyri Hosp, Dept Clin Biochem, IS-109 Akureyri, Iceland; [Lambalk, Cornelis B.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet Gynecol & Reprod Med, NL-1007 MB Amsterdam, Netherlands; [Ong, Ken K.; Perry, John R. B.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Mbarek, Hamdi; Hottenga, Jouke Jan; Willemsen, Gonneke; Boomsma, Dorret I.] EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; Vrije Universiteit Amsterdam; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Amsterdam; Academic Medical Center Amsterdam; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Vrije Universiteit Amsterdam; University of Cambridge; Vrije Universiteit Amsterdam	Mbarek, H; Boomsma, DI (corresponding author), Free Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands.; Mbarek, H; Boomsma, DI (corresponding author), EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands.	h.mbarek@vu.nl; di.boomsma@vu.nl	Stefansson, Kari/AAE-7187-2019; Harris, R. Alan/AAI-2784-2020; de Geus, Eco J.C./M-9318-2015; Nyholt, Dale Robert/J-3174-2017; Penninx, Brenda WJH/S-7627-2017; Montgomery, Grant W/B-7148-2008; McRae, Allan F/J-2644-2014; Kaprio, Jaakko/A-1820-2008; Magnusson, Patrik KE/C-4458-2017; Boomsma, Dorret I/AAX-4470-2020	Harris, R. Alan/0000-0002-7333-4752; de Geus, Eco J.C./0000-0001-6022-2666; Nyholt, Dale Robert/0000-0001-7159-3040; Penninx, Brenda WJH/0000-0001-7779-9672; Montgomery, Grant W/0000-0002-4140-8139; McRae, Allan F/0000-0001-5286-5485; Kaprio, Jaakko/0000-0002-3716-2455; Magnusson, Patrik KE/0000-0002-7315-7899; Lambalk, Cornelis/0000-0003-3947-5129; Plomin, Robert/0000-0002-0756-3629; REVERSADE, Bruno/0000-0002-4070-7997; Jansen, Rick/0000-0002-3333-6737; Day, Felix/0000-0003-3789-7651; Kristjansson, Ragnar/0000-0002-3678-5693; Mbarek, Hamdi/0000-0002-1108-0371; Willemsen, Gonneke/0000-0003-3755-0236	NIAAA NIH HHS [R01 AA011886, R37 AA009367] Funding Source: Medline; NIDA NIH HHS [R01 DA005147, R01 DA024417, R01 DA036216, R01 DA013240, R37 DA005147] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011886, R37AA009367, R01AA009367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024417, R01DA005147, R37DA005147, R01DA013240, R01DA036216] Funding Source: NIH RePORTER; MRC [MC_U106179472, MC_UU_12015/2] Funding Source: UKRI; Medical Research Council [MC_U106179472, MC_UU_12015/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10228, NF-SI-0514-10027] Funding Source: researchfish	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Abdellaoui A, 2013, EUR J HUM GENET, V21, P1277, DOI 10.1038/ejhg.2013.48; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/twin.9.6.849; Bulmer M. G., 1970, BIOL TWINNING MAN; Chambers GM, 2014, JAMA PEDIATR, V168, P1045, DOI 10.1001/jamapediatrics.2014.1357; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9842; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9464; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duffy D, 2001, NAT GENET, V28, P315, DOI 10.1038/91074; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ERIKSSON AW, 1988, ACTA GENET MED GEMEL, V37, P277, DOI 10.1017/S0001566000003871; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Fisher RA, 1925, STAT METHODS RES WOR; Gilfillan CP, 1996, J CLIN ENDOCR METAB, V81, P1557, DOI 10.1210/jc.81.4.1557; Gong XY, 2009, BIOL REPROD, V81, P730, DOI 10.1095/biolreprod.108.070086; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Hagen CP, 2014, SCI REP-UK, V4, DOI 10.1038/srep06412; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hefler LA, 2001, FERTIL STERIL, V75, P1206, DOI 10.1016/S0015-0282(01)01797-6; Hillier SG, 2009, MOL HUM REPROD, V15, P843, DOI 10.1093/molehr/gap086; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Hoekstra C, 2010, FERTIL STERIL, V93, P885, DOI 10.1016/j.fertnstert.2008.10.012; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kirkpatrick BW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129025; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Laisk-Podar T, 2015, REPROD BIOMED ONLINE, V31, P199, DOI 10.1016/j.rbmo.2015.05.001; Lambalk CB, 1998, LANCET, V351, P909, DOI 10.1016/S0140-6736(05)70326-3; Lambalk CB, 1998, J CLIN ENDOCR METAB, V83, P481, DOI 10.1210/jc.83.2.481; Lambalk CB, 2001, LANCET, V357, P735, DOI 10.1016/S0140-6736(00)04178-7; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu YX, 2014, IUBMB LIFE, V66, P424, DOI 10.1002/iub.1280; Looyenga BD, 2007, MOL ENDOCRINOL, V21, P2440, DOI 10.1210/me.2006-0402; Lunetta KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8756; Luong HTT, 2011, TWIN RES HUM GENET, V14, P408, DOI 10.1375/twin.14.5.408; Magill JC, 2013, MATH BIOSCI, V246, P38, DOI 10.1016/j.mbs.2013.09.006; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Medland SE, 2009, NEUROPSYCHOLOGIA, V47, P330, DOI 10.1016/j.neuropsychologia.2008.09.005; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; Moore RK, 2004, TRENDS ENDOCRIN MET, V15, P356, DOI 10.1016/j.tem.2004.08.008; Painter JN, 2010, HUM REPROD, V25, P1569, DOI 10.1093/humrep/deq084; Palmer JS, 2006, J CLIN ENDOCR METAB, V91, P4713, DOI 10.1210/jc.2006-0970; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers W., 1994, STATA TECHNICAL B, V3, P19, DOI DOI 10.1016/J.IJFORECAST.2005.03.004; Ruth KS, 2016, EUR J HUM GENET, V24, P284, DOI 10.1038/ejhg.2015.102; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; Tong S, 1997, LANCET, V349, P843, DOI 10.1016/S0140-6736(96)10003-9; van Beijsterveldt CEMT, 2008, TWIN RES HUM GENET, V11, P349, DOI 10.1375/twin.11.3.349; van Beijsterveldt CEM, 2013, TWIN RES HUM GENET, V16, P252, DOI 10.1017/thg.2012.118; Van der Stroom EMC, 2013, TWIN RES HUM GENET, V16, P634, DOI 10.1017/thg.2013.4; van Heesch MMJ, 2015, HUM REPROD, V30, P1481, DOI 10.1093/humrep/dev059; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; WHITE C, 1964, NEW ENGL J MED, V271, P1003, DOI 10.1056/NEJM196411052711908; Wide L, 2013, UPSALA J MED SCI, V118, P153, DOI 10.3109/03009734.2013.782081; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042	70	62	64	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					898	908		10.1016/j.ajhg.2016.03.008	http://dx.doi.org/10.1016/j.ajhg.2016.03.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27132594	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000375869300008
J	Makrythanasis, P; Kato, M; Zaki, MS; Saitsu, H; Nakamura, K; Santoni, FA; Miyatake, S; Nakashima, M; Issa, MY; Guipponi, M; Letourneau, A; Logan, CV; Roberts, N; Parry, DA; Johnson, CA; Matsumoto, N; Hamamy, H; Sheridan, E; Kinoshita, T; Antonarakis, SE; Murakami, Y				Makrythanasis, Periklis; Kato, Mitsuhiro; Zaki, Maha S.; Saitsu, Hirotomo; Nakamura, Kazuyuki; Santoni, Federico A.; Miyatake, Satoko; Nakashima, Mitsuko; Issa, Mahmoud Y.; Guipponi, Michel; Letourneau, Audrey; Logan, Clare V.; Roberts, Nicola; Parry, David A.; Johnson, Colin A.; Matsumoto, Naomichi; Hamamy, Hanan; Sheridan, Eamonn; Kinoshita, Taroh; Antonarakis, Stylianos E.; Murakami, Yoshiko			Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANCHOR-SYNTHESIS PATHWAY; CONGENITAL-ANOMALIES; CAUSE HYPERPHOSPHATASIA; DEVELOPMENTAL DELAY; MUTATIONS; EPILEPSY; PROTEIN; ENCEPHALOPATHY; BIOSYNTHESIS; DEFICIENCY	Glycosylphosphatidylinositol (GPI) is a glycolipid that anchors >150 various proteins to the cell surface. At least 27 genes are involved in biosynthesis and transport of GPI-anchored proteins (GPI-APs). To date, mutations in 13 of these genes are known to cause inherited GPI deficiencies (IGDs), and all are inherited as recessive traits. IGDs mainly manifest as intellectual disability, epilepsy, coarse facial features, and multiple organ anomalies. These symptoms are caused by the decreased surface expression of GPI-APs or by structural abnormalities of GPI. Here, we present five affected individuals (from two consanguineous families from Egypt and Pakistan and one non-consanguineous family from Japan) who show intellectual disability, hypotonia, and early -onset seizures. We identified pathogenic variants in PIGG, a gene in the GPI pathway. In the consanguineous families, homozygous variants c.928C>T (p.G1n310*) and c.2261+1G>C were found, whereas the Japanese individual was compound heterozygous for c.2005C>T (p.Arg669Cys) and a 2.4 Mb deletion involving PIGG. PIGG is the enzyme that modifies the second mannose with ethanolamine phosphate, which is removed soon after GPI is attached to the protein. Physiological significance of this transient modification has been unclear. Using B lymphoblasts from affected individuals of the Egyptian and Japanese families, we revealed that PIGG activity was almost completely abolished; however, the GPI-APs had normal surface levels and normal structure, indicating that the pathogenesis of PIGG deficiency is not yet fully understood. The discovery of pathogenic variants in PIGG expands the spectrum of IGDs and further enhances our understanding of this etiopathogenic class of intellectual disability.	[Makrythanasis, Periklis; Santoni, Federico A.; Letourneau, Audrey; Hamamy, Hanan; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Makrythanasis, Periklis; Santoni, Federico A.; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Hosp Geneva, Serv Genet Med, CH-1211 Geneva, Switzerland; [Kato, Mitsuhiro; Nakamura, Kazuyuki] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 9909585, Japan; [Kato, Mitsuhiro] Showa Univ, Sch Med, Dept Pediat, Tokyo 1428666, Japan; [Zaki, Maha S.; Issa, Mahmoud Y.] Natl Res Ctr, Dept Clin Genet, Cairo 12311, Egypt; [Saitsu, Hirotomo; Nakashima, Mitsuko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Logan, Clare V.; Roberts, Nicola; Parry, David A.; Johnson, Colin A.; Sheridan, Eamonn] Univ Leeds, Sch Med, Leeds LS2 9NL, W Yorkshire, England; [Kinoshita, Taroh; Murakami, Yoshiko] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka 5650871, Japan; [Kinoshita, Taroh; Murakami, Yoshiko] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Antonarakis, Stylianos E.] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; Yamagata University; Showa University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Yokohama City University; University of Leeds; Osaka University; Osaka University; University of Geneva	Antonarakis, SE (corresponding author), Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.; Antonarakis, SE (corresponding author), Univ Hosp Geneva, Serv Genet Med, CH-1211 Geneva, Switzerland.; Murakami, Y (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka 5650871, Japan.; Murakami, Y (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka 5650871, Japan.; Antonarakis, SE (corresponding author), Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland.	stylianos.antonarakis@unige.ch; yoshiko@biken.osaka-u.ac.jp	Zaki, Maha S/B-9361-2013; Saitsu, Hirotomo/AAM-7131-2021; Issa, Mahmoud/AAL-5118-2020; Antonarakis, Stylianos E/N-8866-2014; Makrythanasis, Periklis/AAD-7180-2019; Kinoshita, Taroh/C-7353-2009	Issa, Mahmoud/0000-0002-3899-2821; Antonarakis, Stylianos E/0000-0001-8907-5823; Parry, David/0000-0003-0376-7736; Zaki, Maha/0000-0001-7840-0002; Santoni, Federico/0000-0002-3258-4747; Johnson, Colin/0000-0002-2979-8234; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553; Logan, Clare/0000-0003-4323-1602	Gebert Ruf Stiftung foundation; von Meissner foundation; Japan Agency for Medical Research and Development; Japan Ministry of Education, Culture, Sports, Science, and Technology; Japan Society of the Promotion of Science; Takeda Science Foundation; Sir Jules Thorm Award for Biomedical Research [JTA/09]; Ministry of Health, Labour, and Welfare; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	Gebert Ruf Stiftung foundation; von Meissner foundation; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sir Jules Thorm Award for Biomedical Research; Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); The Sir Jules Thorn Charitable Trust	We thank the affected individuals and their families for their participation in the study. This study was funded by grants from the Gebert Ruf Stiftung foundation to S.E.A., the von Meissner foundation to P.M., the Japan Agency for Medical Research and Development and Ministry of Health, Labour, and Welfare to Y.M., M.K., and N.M., the Japan Ministry of Education, Culture, Sports, Science, and Technology to N.M., the Japan Society of the Promotion of Science to N.M., Y.M., and H.S., and the Takeda Science Foundation to Y.M., H.S., and N.M. This work was also supported by a Sir Jules Thorm Award for Biomedical Research (JTA/09 to C.A.J. and E.S.). We also thank Dr. Abou Rami, Dr. Yusuke Maeda, and Dr. Christelle Borel for constructive discussions and Mrs. Emilie Falconnet, Pascale Ribaux, Anne Vannier, and Kana Miyanagi for their technical assistance.	Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; American Psychiatric Association, 2013, DSM 5 INT DIS FACT S; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Belet S, 2014, HUM MUTAT, V35, P350, DOI 10.1002/humu.22498; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; Bosch DGM, 2015, EUR J HUM GENET, V23, P1689, DOI 10.1038/ejhg.2015.42; Brady PD, 2014, EUR J MED GENET, V57, P487, DOI 10.1016/j.ejmg.2014.05.001; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EXAC, 2015, AN PROT COD GEN VAR; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fujita M, 2004, J BIOL CHEM, V279, P51869, DOI 10.1074/jbc.M405232200; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Fujiwara I, 2015, AM J MED GENET A, V167, P777, DOI 10.1002/ajmg.a.36987; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Horn D, 2014, EUR J HUM GENET, V22, P762, DOI 10.1038/ejhg.2013.241; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Ilkovski B, 2015, HUM MOL GENET, V24, P6146, DOI 10.1093/hmg/ddv331; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Kinoshita T, 2014, P JPN ACAD B-PHYS, V90, P130, DOI 10.2183/pjab.90.130; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuki I, 2013, NEUROLOGY, V81, P1467, DOI 10.1212/WNL.0b013e3182a8411a; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; Makrythanasis P, 2014, HUM MUTAT, V35, P1203, DOI 10.1002/humu.22617; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyatake S, 2015, J HUM GENET, V60, P175, DOI 10.1038/jhg.2014.124; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Nakashima M, 2014, NEUROGENETICS, V15, P193, DOI 10.1007/s10048-014-0408-y; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Nozaki M, 1999, LAB INVEST, V79, P293; Ohba C, 2014, NEUROGENETICS, V15, P85, DOI 10.1007/s10048-013-0384-7; Richard M, 2002, MICROBIOL-SGM, V148, P2125, DOI 10.1099/00221287-148-7-2125; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Santoni FA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0727-5; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; Tarailo-Graovac M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0243-8; World Health Organization Division of Mental Health and Prevention of Substance Abuse, 1996, ICD 10 GUID MENT RET	47	62	65	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					615	626		10.1016/j.ajhg.2016.02.007	http://dx.doi.org/10.1016/j.ajhg.2016.02.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	26996948	Bronze, Green Published			2022-12-18	WOS:000374203800002
J	Hadchouel, A; Wieland, T; Griese, M; Baruffini, E; Lorenz-Depiereux, B; Enaud, L; Graf, E; Dubus, JC; Halioui-Louhaichi, S; Coulomb, A; Delacourt, C; Eckstein, G; Zarbock, R; Schwarzmayr, T; Cartault, F; Meitinger, T; Lodi, T; de Blic, J; Strom, TM				Hadchouel, Alice; Wieland, Thomas; Griese, Matthias; Baruffini, Enrico; Lorenz-Depiereux, Bettina; Enaud, Laurent; Graf, Elisabeth; Dubus, Jean Christophe; Halioui-Louhaichi, Sonia; Coulomb, Aurore; Delacourt, Christophe; Eckstein, Gertrud; Zarbock, Ralf; Schwarzmayr, Thomas; Cartault, Francois; Meitinger, Thomas; Lodi, Tiziana; de Blic, Jacques; Strom, Tim M.			Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Reunion Island	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; FAMILY; GENE	Methionyl-tRNA synthetase (MARS) catalyzes the ligation of methionine to tRNA and is critical for protein biosynthesis. We identified biallelic missense mutations in MARS in a specific form of pediatric pulmonary alveolar proteinosis (PAP), a severe lung disorder that is prevalent on the island of Reunion and the molecular basis of which is unresolved. Mutations were found in 26 individuals from Reunion and nearby islands and in two families from other countries. Functional consequences of the mutated alleles were assessed by growth of wild-type and mutant strains and methionine-incorporation assays in yeast. Enzyme activity was attenuated in a liquid medium without methionine but could be restored by methionine supplementation. In summary, identification of a founder mutation in MARS led to the molecular definition of a specific type of PAP and will enable carrier screening in the affected community and possibly open new treatment opportunities.	[Hadchouel, Alice; Delacourt, Christophe; de Blic, Jacques] Hop Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, F-75015 Paris, France; [Hadchouel, Alice] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75006 Paris, France; [Hadchouel, Alice] INSERM, U1163, Team Embryol & Genet Congenital Malformat, F-75015 Paris, France; [Hadchouel, Alice; Delacourt, Christophe] INSERM, U955, Equipe 4, F-94000 Creteil, France; [Wieland, Thomas; Lorenz-Depiereux, Bettina; Graf, Elisabeth; Eckstein, Gertrud; Schwarzmayr, Thomas; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Griese, Matthias; Zarbock, Ralf] Univ Munich, Hauner Childrens Univ Hosp, German Ctr Lung Res, D-80337 Munich, Germany; [Baruffini, Enrico; Lodi, Tiziana] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Enaud, Laurent] Ctr Hosp Univ La Reunion, Dept Pediat, F-97410 St Pierre, Reunion, France; [Dubus, Jean Christophe] Timone Univ Hosp, Dept Pediat, F-13385 Marseille, France; [Halioui-Louhaichi, Sonia] Univ Tunis El Manar, Mongi Slim Hosp La Marsa, Dept Pediat, Tunis 1007, Tunisia; [Coulomb, Aurore] Ctr Hosp Univ Paris Est, Hop Enfants Armand Trousseau, AP HP, Serv Anat & Cytol Pathol, F-75012 Paris, France; [Delacourt, Christophe; de Blic, Jacques] Univ Paris 05, F-75006 Paris, France; [Cartault, Francois] Ctr Hosp Univ Reunion, Serv Genet, F-97400 St Denis, Reunion, France; [Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Parma; CHU Reunion; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Tunis-El-Manar; Hopital Mongi Slim; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; CHU Reunion; Technical University of Munich	Strom, TM (corresponding author), Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	timstrom@helmholtz-muenchen.de	Meitinger, Thomas/O-1318-2015; Dubus, Jean-Christophe/P-8242-2016; Zarbock, Ralf/K-9031-2019; Delacourt, Christophe/K-6161-2019; Baruffini, Enrico/AAL-2608-2020; Baruffini, Enrico/C-1057-2015; lodi, tiziana/A-5993-2012	Baruffini, Enrico/0000-0002-8280-7849; Baruffini, Enrico/0000-0002-8280-7849; lodi, tiziana/0000-0002-7294-8971; Meitinger, Thomas/0000-0002-8838-8403	German Ministry of Education and Research [01GM1113B]; Else-Kroener Stiftung [MG 2013_A72]; eRARE Project (EUPAPNet); European Register and Biobank on Childhood Interstitial Lung Diseases (European Commission, FP7) [GA 305653]; Telethon [GGP11011]; l'Agence Nationale de la Recherche [ANR-12-BSV1-0004-01]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Else-Kroener Stiftung; eRARE Project (EUPAPNet); European Register and Biobank on Childhood Interstitial Lung Diseases (European Commission, FP7); Telethon(Fondazione Telethon); l'Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank the families for participating in this study, Sandy Losecke, Traudl Wesselack, and Andrea Schams for technical assistance, and Abdourahim Chamouine for his support in recruiting patients from Comoros Island. We thank the Centre de Ressources Biologiques de la Reunion (CRB-CHU REUNION UF1646) for providing DNA of controls. This work was supported by the German Ministry of Education and Research (01GM1113B), Else-Kroener Stiftung (MG 2013_A72), the eRARE Project 2009 (EUPAPNet), the European Register and Biobank on Childhood Interstitial Lung Diseases (European Commission, FP7, GA 305653), Telethon (GGP11011), and l'Agence Nationale de la Recherche (ANR-12-BSV1-0004-01).	Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Casina VC, 2011, BIOCHEMISTRY-US, V50, P763, DOI 10.1021/bi101375d; de Blic Jacques, 2004, Paediatr Respir Rev, V5, P316; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Dirksen U, 1997, J CLIN INVEST, V100, P2211, DOI 10.1172/JCI119758; Enaud L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-85; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; Halioui-Louhaichi Sonia, 2005, Tunis Med, V83, P488; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Mahut B, 1996, PEDIATRICS, V97, P117; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; SCHMITT E, 1994, J MOL BIOL, V242, P566, DOI 10.1006/jmbi.1994.1601; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Uchida K, 2007, NEW ENGL J MED, V356, P567, DOI 10.1056/NEJMoa062505; van Meel E, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-106; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wallen RC, 2013, CURR OPIN GENET DEV, V23, P302, DOI 10.1016/j.gde.2013.02.002	22	62	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 7	2015	96	5					826	831		10.1016/j.ajhg.2015.03.010	http://dx.doi.org/10.1016/j.ajhg.2015.03.010			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CH7AZ	25913036	Green Published, Bronze			2022-12-18	WOS:000354189300013
J	Rehman, AU; Santos-Cortez, RLP; Morell, RJ; Drummond, MC; Ito, T; Lee, K; Khan, AA; Basra, MAR; Wasif, N; Ayub, M; Ali, RA; Raza, SI; Nickerson, DA; Shendure, J; Bamshad, M; Riazuddin, S; Billington, N; Khan, SN; Friedman, PL; Griffith, AJ; Ahmad, W; Riazuddin, S; Leal, SM; Friedman, TB				Rehman, Atteeq U.; Santos-Cortez, Regie Lyn P.; Morell, Robert J.; Drummond, Meghan C.; Ito, Taku; Lee, Kwanghyuk; Khan, Asma A.; Basra, Muhammad Asim R.; Wasif, Naveed; Ayub, Muhammad; Ali, Rana A.; Raza, Syed I.; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael; Riazuddin, Saima; Billington, Neil; Khan, Shaheen N.; Friedman, Penelope L.; Griffith, Andrew J.; Ahmad, Wasim; Riazuddin, Sheikh; Leal, Suzanne M.; Friedman, Thomas B.		Univ Washington	Mutations in TBC1D24, a Gene Associated With Epilepsy, Also Cause Nonsyndromic Deafness DFNB86	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUDITORY NEUROPATHY; HAIR-CELLS; MET RECEPTOR; PROTEIN; HUMANS; MECHANOTRANSDUCTION; FAMILY; ACTIN; GAPS; RAB	Inherited deafness is clinically and genetically heterogeneous. We recently mapped DFNB86, a locus associated with nonsyndromic deafness, to chromosome 16p. In this study, whole-exome sequencing was performed with genomic DNA from affected individuals from three large consanguineous families in which markers linked to DFNB86 segregate with profound deafness. Analyses of these data revealed homozygous mutation c.208G>T (p.Asp70Tyr) or c.878G>C (p.Arg293Pro) in TBC1D24 as the underlying cause of deafness in the three families. Sanger sequence analysis of TBC1D24 in an additional large family in which deafness segregates with DFNB86 identified the c.208G>T (p.Asp70Tyr) substitution. These mutations affect TBC1D24 amino acid residues that are conserved in orthologs ranging from fruit fly to human. Neither variant was observed in databases of single-nucleotide variants or in 634 chromosomes from ethnically matched control subjects. TBC1D24 in the mouse inner ear was immunolocalized predominantly to spiral ganglion neurons, indicating that DFNB86 deafness might be an auditory neuropathy spectrum disorder. Previously, six recessive mutations in TBC1D24 were reported to cause seizures (hearing loss was not reported) ranging in severity from epilepsy with otherwise normal development to epileptic encephalopathy resulting in childhood death. Two of our four families in which deafness segregates with mutant alleles of TBC1D24 were available for neurological examination. Cosegregation of epilepsy and deafness was not observed in these two families. Although the causal relationship between genotype and phenotype is not presently understood, our findings, combined with published data, indicate that recessive alleles of TBC1D24 can cause either epilepsy or nonsyndromic deafness.	[Rehman, Atteeq U.; Morell, Robert J.; Drummond, Meghan C.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, NIH, Rockville, MD 20850 USA; [Santos-Cortez, Regie Lyn P.; Lee, Kwanghyuk; Leal, Suzanne M.] Baylor Coll Med, Ctr Stat Genet, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ito, Taku; Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, NIH, Rockville, MD 20850 USA; [Khan, Asma A.; Basra, Muhammad Asim R.; Ali, Rana A.; Khan, Shaheen N.; Riazuddin, Sheikh] Univ Punjab, Ctr Excellence Mol Biol, Lahore 54500, Pakistan; [Wasif, Naveed] Univ Lahore, Inst Mol Biol & Biotechnol, Ctr Res Mol Med, Lahore 54000, Pakistan; [Ayub, Muhammad] Univ Baluchistan, Inst Biochem, Quetta 87300, Pakistan; [Raza, Syed I.; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad 45320, Pakistan; [Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Riazuddin, Saima] Cincinnati Childrens Res Fdn, Div Pediat Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA; [Riazuddin, Saima] Univ Cincinnati, Coll Med, Dept Otolaryngol Head & Neck Surg, Cincinnati, OH 45267 USA; [Billington, Neil] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Friedman, Penelope L.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Riazuddin, Sheikh] Univ Hlth Sci, Allama Iqbal Med Coll, Lahore 54550, Pakistan; [Riazuddin, Sheikh] Univ Hlth Sci, Jinnah Hosp Complex, Lahore 54550, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; University of Lahore; University of Balochistan; Quaid I Azam University; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Health Science - Pakistan; University of Health Science - Pakistan	Leal, SM (corresponding author), Baylor Coll Med, Ctr Stat Genet, Dept Mol & Human Genet, Houston, TX 77030 USA.	sleal@bcm.edu; friedman@nidcd.nih.gov	Ahmad, Wasim/GSD-8904-2022; Morell, Robert James/Q-2042-2019; Rehman, Atteeq/AAG-8342-2020; Shendure, Jay/AAU-3684-2021; Khan, Asma Al/AAH-5277-2021; Wasif, Naveed/J-1807-2015; Wasif, Naveed/AAY-8452-2020	Wasif, Naveed/0000-0002-3455-8833; Lee, Kwanghyuk/0000-0003-1389-1220; Morell, Robert/0000-0003-1537-7356; Shendure, Jay/0000-0002-1516-1865; Basra, Muhammad Asim Raza/0000-0002-4242-0025; Billington, Neil/0000-0003-2306-0228	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC011651, R01 DC003594]; Higher Education Commission; Ministry of Science and Technology of Pakistan; International Center for Genetic Engineering and Biotechnology in Trieste [CRP/PAK08-01, 08/009]; NIH National Human Genome Research Institute; National Heart, Lung, and Blood Institute (NHLBI) [U54 HG006493]; NIH [N01 HG65403]; NHLBI [HL004232];  [DC000060-12];  [DC000039-16]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004232, K08HL004232] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, N01HG065403, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000086, ZIADC000039, R01DC003594, Z01DC000039, ZIADC000048, ZIADC000060, R01DC011748, T32DC000039, R01DC011803, Z01DC000060, R01DC011651] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Science and Technology of Pakistan; International Center for Genetic Engineering and Biotechnology in Trieste; NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the subjects who participated in this study, as well as Dennis Drayna, Katie S. Kindt, and Julie Schultz for their critiques of our manuscript. We also thank Barbara Zwiesler, Elizabeth Wilson, Roger Murayi, and Hashim Raza for technical assistance. This study was supported by National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (NIDCD) grants R01 DC011651 and R01 DC003594 to S.M.L., the Higher Education Commission, the Ministry of Science and Technology of Pakistan (Sh.R. and W.A.), the International Center for Genetic Engineering and Biotechnology in Trieste (CRP/PAK08-01 contract 08/009 to Sh.R.), and the NIH National Human Genome Research Institute and National Heart, Lung, and Blood Institute (NHLBI) (U54 HG006493 to the University of Washington Center for Mendelian Genomics). Genotyping for S.M.L. was performed at the Center for Inherited Disease Research, which is funded by the NIH (contract number N01 HG65403 to Johns Hopkins University). N.B. was supported by NHLBI intramural funds HL004232 to James Sellers. Work at the NIH NIDCD was supported by intramural funds DC000060-12 to A.J.G. and DC000039-16 to T.B.F.	Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Ali RA, 2012, CLIN GENET, V81, P498, DOI 10.1111/j.1399-0004.2011.01729.x; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Choi BY, 2011, SCALABLE NETWORK MONITORING IN HIGH SPEED NETWORKS, P1; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Drummond MC, 2012, HEARING RES, V288, P89, DOI 10.1016/j.heares.2011.12.003; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gao X, 2008, PROTEIN PEPTIDE LETT, V15, P505, DOI 10.2174/092986608784567483; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Madden C, 2002, ARCH OTOLARYNGOL, V128, P1026, DOI 10.1001/archotol.128.9.1026; McCann KL, 2013, SCIENCE, V341, P849, DOI 10.1126/science.1244156; Milh M, 2013, HUM MUTAT, V34, P869, DOI 10.1002/humu.22318; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; Oliver PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002338; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Parachoniak CA, 2011, DEV CELL, V20, P751, DOI 10.1016/j.devcel.2011.05.007; Park SY, 2011, J BIOL CHEM, V286, P18130, DOI 10.1074/jbc.M110.217323; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Schoen CJ, 2010, P NATL ACAD SCI USA, V107, P13396, DOI 10.1073/pnas.1003027107; Schuknecht H., 1993, PATHOLOGY EAR, V2nd ed.; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	37	62	72	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					144	152		10.1016/j.ajhg.2013.12.004	http://dx.doi.org/10.1016/j.ajhg.2013.12.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387994	Green Published, Bronze			2022-12-18	WOS:000329888400016
J	Barwick, KES; Wright, J; Al-Turki, S; McEntagart, MM; Nair, A; Chioza, B; Al-Memar, A; Modarres, H; Reilly, MM; Dick, KJ; Ruggiero, AM; Blakely, RD; Hurles, ME; Crosby, AH				Barwick, Katy E. S.; Wright, Jane; Al-Turki, Saeed; McEntagart, Meriel M.; Nair, Ajith; Chioza, Barry; Al-Memar, Ali; Modarres, Hamid; Reilly, Mary M.; Dick, Katherine J.; Ruggiero, Alicia M.; Blakely, Randy D.; Hurles, Matt E.; Crosby, Andrew H.			Defective Presynaptic Choline Transport Underlies Hereditary Motor Neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MYASTHENIC SYNDROMES; VII DHMN-VII; NEUROMUSCULAR-JUNCTION; SYNAPTIC VESICLES; MICE; LOCALIZATION; MUTATIONS; EXPRESSION; PROTEIN; GENE	The neuromuscular junction (NMJ) is a specialized synapse with a complex molecular architecture that provides for reliable transmission between the nerve terminal and muscle fiber. Using linkage analysis and whole-exome sequencing of DNA samples from subjects with distal hereditary motor neuropathy type VII, we identified a mutation in SLC5A7, which encodes the presynaptic choline transporter (CHT), a critical determinant of synaptic acetylcholine synthesis and release at the NMJ. This dominantly segregating SLC5A7 mutation truncates the encoded product just beyond the final transmembrane domain, eliminating cytosolic-C-terminus sequences known to regulate surface transporter trafficking. Choline-transport assays in both transfected cells and monocytes from affected individuals revealed significant reductions in hemicholinium-3-sensitive choline uptake, a finding consistent with a dominant-negative mode of action. The discovery of CHT dysfunction underlying motor neuropathy identifies a biological basis for this group of conditions and widens the spectrum of disorders that derive from impaired NMJ transmission. Our findings compel consideration of mutations in SLC5A7 or its functional partners in relation to unexplained motor neuronopathies.	[Barwick, Katy E. S.; Nair, Ajith; Chioza, Barry; Dick, Katherine J.; Crosby, Andrew H.] St Georges Univ London, Ctr Human Genet, London SW17 0RE, England; [Wright, Jane; Ruggiero, Alicia M.; Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Al-Turki, Saeed; Hurles, Matt E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Al-Memar, Ali; Modarres, Hamid] St George Hosp, Dept Neurol, London SW17 0RE, England; [Reilly, Mary M.] UCL, Inst Neurol, Med Res Council, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Blakely, Randy D.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA	St Georges University London; Vanderbilt University; Wellcome Trust Sanger Institute; St Georges University London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; Vanderbilt University	Crosby, AH (corresponding author), St Georges Univ London, Ctr Human Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sgul.ac.uk	Crosby, Andrew H/E-2218-2015; Chioza, Barry/C-1586-2008	Crosby, Andrew H/0000-0003-3667-9054; Chioza, Barry/0000-0002-3546-1726; Reilly, Mary/0000-0003-0686-905X	Medical Research Council; Neurosciences Research Foundation; National Institutes of Mental Health; MRC [G1002279] Funding Source: UKRI; Medical Research Council [G1002279] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neurosciences Research Foundation; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank the families described herein for participating in our study. The study was supported by the Medical Research Council and the Neurosciences Research Foundation, as well as by a National Institutes of Mental Health MERIT award to R.D.B. Special thanks also go to the family of J.M. for supporting this work.	Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Barisic N, 2011, EUR J PAEDIATR NEURO, V15, P189, DOI 10.1016/j.ejpn.2011.03.006; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Dick KJ, 2008, GENOME, V51, P959, DOI 10.1139/G08-078; Ferguson SM, 2004, MOL INTERV, V4, P22, DOI 10.1124/mi.4.1.22; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Ferguson SM, 2003, J NEUROSCI, V23, P9697; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Hughes BW, 2006, MUSCLE NERVE, V33, P445, DOI 10.1002/mus.20440; Jephson CG, 2010, INT J PEDIATR OTORHI, V74, P991, DOI 10.1016/j.ijporl.2010.05.022; Kinali M, 2008, J NEUROIMMUNOL, V201, P6, DOI 10.1016/j.jneuroim.2008.06.026; Krishnaswamy A, 2009, NEURON, V61, P272, DOI 10.1016/j.neuron.2008.11.025; McEntagart M, 2001, AM J HUM GENET, V68, P1270, DOI 10.1086/320122; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Nakata K, 2004, SYNAPSE, V53, P53, DOI 10.1002/syn.20029; O'Regan S, 2000, P NATL ACAD SCI USA, V97, P1835, DOI 10.1073/pnas.030339697; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; PRIDMORE C, 1992, J MED GENET, V29, P197, DOI 10.1136/jmg.29.3.197; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Quiram PA, 1999, J CLIN INVEST, V104, P1403, DOI 10.1172/JCI8179; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rossor AM, 2012, J NEUROL NEUROSUR PS, V83, P6, DOI 10.1136/jnnp-2011-300952	27	62	64	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1103	1107		10.1016/j.ajhg.2012.09.019	http://dx.doi.org/10.1016/j.ajhg.2012.09.019			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23141292	Green Published, hybrid			2022-12-18	WOS:000312417400014
J	Basel-Vanagaite, L; Dallapiccola, B; Ramirez-Solis, R; Segref, A; Thiele, H; Edwards, A; Arends, MJ; Miro, X; White, JK; Desir, J; Abramowicz, M; Dentici, ML; Lepri, F; Hofmann, K; Har-Zahav, A; Ryder, E; Karp, NA; Estabel, J; Gerdin, AKB; Podrini, C; Ingham, NJ; Altmuller, J; Nurnberg, G; Frommolt, P; Abdelhak, S; Pasmanik-Chor, M; Konen, O; Kelley, RI; Shohat, M; Nurnberg, P; Flint, J; Steel, KP; Hoppe, T; Kubisch, C; Adams, DJ; Borck, G				Basel-Vanagaite, Lina; Dallapiccola, Bruno; Ramirez-Solis, Ramiro; Segref, Alexandra; Thiele, Holger; Edwards, Andrew; Arends, Mark J.; Miro, Xavier; White, Jacqueline K.; Desir, Julie; Abramowicz, Marc; Dentici, Maria Lisa; Lepri, Francesca; Hofmann, Kay; Har-Zahav, Adi; Ryder, Edward; Karp, Natasha A.; Estabel, Jeanne; Gerdin, Anna-Karin B.; Podrini, Christine; Ingham, Neil J.; Altmueller, Janine; Nuernberg, Gudrun; Frommolt, Peter; Abdelhak, Sonia; Pasmanik-Chor, Metsada; Konen, Osnat; Kelley, Richard I.; Shohat, Mordechai; Nuernberg, Peter; Flint, Jonathan; Steel, Karen P.; Hoppe, Thorsten; Kubisch, Christian; Adams, David J.; Borck, Guntram			Deficiency for the Ubiquitin Ligase UBE3B in a Blepharophimosis-Ptosis-Intellectual-Disability Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; CAENORHABDITIS-ELEGANS; HECT-DOMAIN; OXIDATIVE STRESS; OHDO SYNDROME; GENOME-WIDE; GENE; EVOLUTION; E3; DEGRADATION	Ubiquitination plays a crucial role in neurodevelopment as exemplified by Angelman syndrome, which is caused by genetic alterations of the ubiquitin ligase-encoding UBE3A gene. Although the function of UBE3A has been widely studied, little is known about its paralog UBE3B. By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels. UBE3B encodes an uncharacterized E3 ubiquitin ligase. The identified UBE3B variants include one frameshift and two splice-site mutations as well as a missense substitution affecting the highly conserved HECT domain. Disruption of mouse Ube3b leads to reduced viability and recapitulates key aspects of the human disorder, such as reduced weight and brain size and a downregulation of cholesterol synthesis. We establish that the probable Caenorhabditis elegans ortholog of UBE3B, oxi-1, functions in the ubiquitin/proteasome system in vivo and is especially required under oxidative stress conditions. Our data reveal the pleiotropic effects of UBE3B deficiency and reinforce the physiological importance of ubiquitination in neuronal development and function in mammals.	[Basel-Vanagaite, Lina; Shohat, Mordechai] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Har-Zahav, Adi; Konen, Osnat; Shohat, Mordechai] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Basel-Vanagaite, Lina; Shohat, Mordechai] Rabin Med Ctr, Felsenstein Med Res Ctr, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, IL-49202 Petah Tiqwa, Israel; [Dallapiccola, Bruno; Dentici, Maria Lisa; Lepri, Francesca] IRCCS, Bambino Gesu Childrens Hosp, I-00165 Rome, Italy; [Ramirez-Solis, Ramiro; White, Jacqueline K.; Ryder, Edward; Karp, Natasha A.; Estabel, Jeanne; Gerdin, Anna-Karin B.; Podrini, Christine; Ingham, Neil J.; Steel, Karen P.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB1O 1HH, England; [Segref, Alexandra; Hofmann, Kay; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Segref, Alexandra; Frommolt, Peter; Nuernberg, Peter; Hoppe, Thorsten] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Gudrun; Frommolt, Peter; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Edwards, Andrew; Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 0QQ, England; [Miro, Xavier] Univ Bonn, Inst Mol Psychiat, D-53127 Bonn, Germany; [Desir, Julie; Abramowicz, Marc] Hop Erasme, Dept Med Genet, B-1070 Brussels, Belgium; [Abramowicz, Marc] ULB, IRIBHM, B-1070 Brussels, Belgium; [Hofmann, Kay] Miltenyi Biotec GmbFl, Bioinformat Grp, D-51429 Bergisch Gladbach, Germany; [Abdelhak, Sonia] Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis 1002, Tunisia; [Pasmanik-Chor, Metsada] Tel Aviv Univ, GSW Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; Schneider Childrens Med Ctr Israel, Imaging Dept, IL-49202 Petah Tiqwa, Israel; [Kelley, Richard I.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Kubisch, Christian; Borck, Guntram] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; IRCCS Bambino Gesu; Wellcome Trust Sanger Institute; University of Cologne; University of Cologne; University of Cologne; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bonn; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Miltenyi Biotec; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Tel Aviv University; Kennedy Krieger Institute; University of Cologne; Ulm University	Basel-Vanagaite, L (corresponding author), Rabin Med Ctr, Raphael Recanati Genet Inst, Beilinson Campus, IL-49100 Petah Tiqwa, Israel.	basel@post.tau.ac.il; guntram.borck@uni-ulm.de	Lepri, Francesca Romana/AAA-6115-2020; Abramowicz, Marc/AAX-6419-2020; Podrini, Christine/K-8621-2016; Borck, Guntram/F-1868-2015; Ryder, Edward/AAK-1243-2021; Frommolt, Peter/L-9656-2016; Dentici, Maria Lisa/AAC-7654-2022; Thiele, Holger/ABE-6792-2020; Kubisch, Christian/F-1893-2011; Hoppe, Thorsten/AAC-7880-2020; Abdelhak, Sonia/L-2831-2013; Dallapiccola, Bruno/K-8692-2016	Podrini, Christine/0000-0002-5391-3378; Ryder, Edward/0000-0002-1799-9899; Frommolt, Peter/0000-0002-1966-8014; Dentici, Maria Lisa/0000-0002-9505-5906; Thiele, Holger/0000-0002-0169-998X; Kubisch, Christian/0000-0003-4220-0978; Abdelhak, Sonia/0000-0001-8466-5525; Karp, Natasha/0000-0002-8404-2907; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Hoppe, Thorsten/0000-0002-4734-9352; Dallapiccola, Bruno/0000-0002-5031-1013; Lepri, Francesca Romana/0000-0001-5331-0473; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Abramowicz, Marc/0000-0003-0623-8768; Segref, Alexandra/0000-0001-8095-4469; Altmuller, Janine/0000-0003-4372-1521; Adams, David/0000-0001-9490-0306	NIH Center for Research Resources; Deutsche Forschungsgemeinschaft [FOR 885, HO 2541/4-1]; Rubicon European Union Network of Excellence; Israeli Ministry of Health Chief Scientist Foundation [3-4963]; Israeli Science Foundation [558/09]; Wellcome Trust; MRC; EC (EUMODIC); Cancer Research UK; MRC [G0300212, MC_qA137918] Funding Source: UKRI; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [MC_qA137918, G0300212] Funding Source: researchfish	NIH Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rubicon European Union Network of Excellence; Israeli Ministry of Health Chief Scientist Foundation; Israeli Science Foundation(Israel Science Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC (EUMODIC); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families for participating in this study and B. Wollnik for discussions. We thank A. Fire, the Caenorhabditis Genetics Center (funded by the NIH Center for Research Resources), the Dana-Farber Cancer Institute, and Geneservice Ltd for antibodies, plasmids, cDNAs, and strains. We also thank E. Delaney for ES cell work leading to the generation of the Ube3b mutant mice and auditory phenotyping. This work was supported by the Deutsche Forschungsgemeinschaft (FOR 885, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases and DIP grant HO 2541/4-1 to T.H.), the Rubicon European Union Network of Excellence (to T.H.), the Israeli Ministry of Health Chief Scientist Foundation (grant no. 3-4963) and the Israeli Science Foundation (grant no. 558/09; both to L.B.-V.), the Wellcome Trust, the MRC, and the EC (EUMODIC). D.J.A. and M.J.A. are supported by Cancer Research UK. T.H. is an EMBO Young Investigator. G.B. was supported by the Deutsche Forschungsgemeinschaft.	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Brancati F, 2009, CLIN GENET, V76, P210, DOI 10.1111/j.1399-0004.2009.01235.x; BRENNER S, 1974, GENETICS, V77, P71; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Day R, 2008, CLIN GENET, V74, P434, DOI 10.1111/j.1399-0004.2008.01087.x; Dentici ML, 2011, AM J MED GENET A, V155A, P459, DOI 10.1002/ajmg.a.33642; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Miro X, 2009, DIS MODEL MECH, V2, P412, DOI 10.1242/dmm.001602; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nascimento RMP, 2006, AM J HUM GENET, V79, P549, DOI 10.1086/507047; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Verloes A, 2006, AM J MED GENET A, V140A, P1285, DOI 10.1002/ajmg.a.31270; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; West BT, 2007, LINEAR MIXED MODELS; Yanase S, 1999, J RADIAT RES, V40, P39, DOI 10.1269/jrr.40.39; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	48	62	67	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					998	1010		10.1016/j.ajhg.2012.10.011	http://dx.doi.org/10.1016/j.ajhg.2012.10.011			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23200864	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000312417400003
J	Gal, A; Rau, I; El Matri, L; Kreienkamp, HJ; Fehr, S; Baklouti, K; Chouchane, I; Li, Y; Rehbein, M; Fuchs, J; Fledelius, HC; Vilhelmsen, K; Schorderet, DF; Munier, FL; Ostergaard, E; Thompson, DA; Rosenberg, T				Gal, Andreas; Rau, Isabella; El Matri, Leila; Kreienkamp, Hans-Juergen; Fehr, Susanne; Baklouti, Karim; Chouchane, Ibtissem; Li, Yun; Rehbein, Monika; Fuchs, Josefine; Fledelius, Hans C.; Vilhelmsen, Kaj; Schorderet, Daniel F.; Munier, Francis L.; Ostergaard, Elsebet; Thompson, Debra A.; Rosenberg, Thomas			Autosomal-Recessive Posterior Microphthalmos Is Caused by Mutations in PRSS56, a Gene Encoding a Trypsin-Like Serine Protease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAPILLOMACULAR FOLD; HIGH HYPEROPIA; NANOPHTHALMOS; GLAUCOMA; THROMBIN; INSIGHTS; FEATURES	Posterior microphthalmos (MCOP) is a rare isolated developmental anomaly of the eye characterized by extreme hyperopia due to short axial length. The population of the Faroe Islands shows a high prevalence of an autosomal-recessive form (arMCOP) of the disease. Based on published linkage data, we refined the position of the disease locus (MCOP6) in an interval of 250 kb in chromosome 2q37.1 in two large Faroese families. We detected three different mutations in PRSS56. Patients of the Faroese families were either homozygous for c.926G > C (p.Trp309Ser) or compound heterozygous for c.926G > C and c.526C > G (p.Arg176Gly), whereas a homozygous 1 bp duplication (c.1066dupC) was identified in five patients with arMCOP from a consanguineous Tunisian family. In one patient with MCOP from the Faroe Islands and in another one from Turkey, no PRSS56 mutation was detected, suggesting nonallelic heterogeneity of the trait. Using RT-PCR, PRSS56 transcripts were detected in samples derived from the human adult retina, cornea, sclera, and optic nerve. The expression of the mouse ortholog could be first detected in the eye at E17 and was maintained into adulthood. The predicted PRSS56 protein is a 603 amino acid long secreted trypsin-like serine peptidase. The c.1066dupC is likely to result in a functional null allele, whereas the two point mutations predict the replacement of evolutionary conserved and functionally important residues. Molecular modeling of the p.Trp309Ser mutant suggests that both the affinity and reactivity of the enzyme toward in vivo protein substrates are likely to be substantially reduced.	[Gal, Andreas; Rau, Isabella; Kreienkamp, Hans-Juergen; Li, Yun; Rehbein, Monika] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [El Matri, Leila; Baklouti, Karim; Chouchane, Ibtissem] Hedi Rais Inst Ophthalmol, Tunis, Tunisia; [Fehr, Susanne] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Fuchs, Josefine] Univ Copenhagen, Glostrup Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark; [Fledelius, Hans C.] Univ Copenhagen, Rigshosp, Dept Ophthalmol, DK-2100 Copenhagen, Denmark; [Schorderet, Daniel F.] Univ Lausanne, Inst Rech Ophthalmol, Ecole Polytech Lausanne, CH-1950 Sion, Switzerland; [Munier, Francis L.] Jules Gonin Eye Hosp, CH-1004 Lausanne, Switzerland; [Ostergaard, Elsebet] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Thompson, Debra A.] Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Dept Biol Chem, Sch Med, Kellogg Eye Ctr, Ann Arbor, MI 48105 USA; [Rosenberg, Thomas] Kennedy Ctr, Natl Eye Clin, Gordon Norrie Ctr Genet Eye Dis, DK-2600 Glostrup, Denmark	University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite de Tunis-El-Manar; Institut Hedi Raies d'ophtalmologie de Tunis; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Lausanne; Rigshospitalet; University of Copenhagen; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gal, A (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany.	gal@uke.de		Thompson, Debra/0000-0003-3485-0794	Alcon Research Institute (ARI); Danish Society of the Blind; Swiss National Science Foundation [320030-127558]; National Eye Institute [P30-EY09003]; Unite de Recherche en Oculo-Genetique de l'Institut Hedi Rais d'Ophtalmologie de Tunis [UR 17/04]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R43EY009003] Funding Source: NIH RePORTER	Alcon Research Institute (ARI); Danish Society of the Blind; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Unite de Recherche en Oculo-Genetique de l'Institut Hedi Rais d'Ophtalmologie de Tunis; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was performed in collaboration with the Genetic Resource Center, Ilegusavnio, and approved by the National Scientific Ethics Committee, Visindasiosemisnevnd Foroya; it also conformed to the guidelines of the University of Michigan, Laboratory of Animal Medicine. The study was supported by grants of the Alcon Research Institute (ARI Award 2006 to A.G.), the Danish Society of the Blind, the Swiss National Science Foundation (grant 320030-127558 to D.F.S. and F.L.M.), the National Eye Institute (P30-EY09003), and the Unite de Recherche en Oculo-Genetique UR 17/04 de l'Institut Hedi Rais d'Ophtalmologie de Tunis. D.A.T. is the recipient of a Research to Prevent Blindness Senior Investigator award. Mouse RNAs were prepared by Marina Zieger and Afaf Absood. Human donor eyes were obtained from the Midwest Eye Banks and Transplantation centers.	Aras C, 2005, RETINA-J RET VIT DIS, V25, P665, DOI 10.1097/00006982-200507000-00021; Burgoyne C, 2002, J GLAUCOMA, V11, P525, DOI 10.1097/00061198-200212000-00013; Buyukyldiz HZ, 2008, ANN OPHTHALMOL, V40, P45; Cal S, 2003, P NATL ACAD SCI USA, V100, P9185, DOI 10.1073/pnas.1633392100; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Coulpier F, 2009, GLIA, V57, P1450, DOI 10.1002/glia.20862; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Erdol H, 2008, EUR J OPHTHALMOL, V18, P479, DOI 10.1177/112067210801800331; Fledelius HC, 2004, OPTOMETRY VISION SCI, V81, P762, DOI 10.1097/00006324-200410000-00008; FLEDELIUS HC, 1987, OPHTHALMIC ECHOGRAPH, P87; Fuchs Josefine, 2005, Ophthalmic Genet, V26, P9, DOI 10.1080/13816810590918406; Hmani-Aifa M, 2009, HUM GENET, V126, P575, DOI 10.1007/s00439-009-0688-8; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Khairallah M, 2002, OPHTHALMOLOGY, V109, P569, DOI 10.1016/S0161-6420(01)00996-4; LARSEN JS, 1971, ACTA OPHTHALMOL, V49, P441; Lesnoni G, 1999, EUR J OPHTHALMOL, V9, P315, DOI 10.1177/112067219900900411; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; OSTERGAARD E, 2011, MOL VIS IN PRESS; Ostergaard E, 2007, BRAIN, V130, P853, DOI 10.1093/brain/awl383; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Serrano JC, 1998, BRIT J OPHTHALMOL, V82, P276, DOI 10.1136/bjo.82.3.276; SPITZNAS M, 1983, ARCH OPHTHALMOL-CHIC, V101, P413; Thapa Suman Shumsher, 2005, Nepal Med Coll J, V7, P81; Walsh MK, 2007, AM J OPHTHALMOL, V143, P1067, DOI 10.1016/j.ajo.2007.01.051; Yalvac IS, 2008, EYE, V22, P838, DOI 10.1038/sj.eye.6702742	26	62	65	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 11	2011	88	3					382	390		10.1016/j.ajhg.2011.02.006	http://dx.doi.org/10.1016/j.ajhg.2011.02.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	737SR	21397065	Bronze, Green Published			2022-12-18	WOS:000288589000015
J	Klopocki, E; Lohan, S; Brancati, F; Koll, R; Brehm, A; Seemann, P; Dathe, K; Stricker, S; Hecht, J; Bosse, K; Betz, RC; Garaci, FG; Dallapiccola, B; Jain, M; Muenke, M; Ng, VCW; Chan, W; Chan, D; Mundlos, S				Klopocki, Eva; Lohan, Silke; Brancati, Francesco; Koll, Randi; Brehm, Anja; Seemann, Petra; Dathe, Katarina; Stricker, Sigmar; Hecht, Jochen; Bosse, Kristin; Betz, Regina C.; Garaci, Francesco Giuseppe; Dallapiccola, Bruno; Jain, Mahim; Muenke, Maximilian; Ng, Vivian C. W.; Chan, Wilson; Chan, Danny; Mundlos, Stefan			Copy-Number Variations Involving the IHH Locus Are Associated with Syndactyly and Craniosynostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INDIAN HEDGEHOG; TRIPHALANGEAL THUMB; MUTATIONS; MOUSE; MUTANT; GLI3; DIFFERENTIATION; PROLIFERATION; DUPLICATIONS; DOUBLEFOOT	Indian hedgehog (IHH) is a secreted signaling molecule of the hedgehog family known to play important roles in the regulation of chondrocyte differentiation, cortical bone formation, and the development of joints. Here, we describe that copy-number variations of the IHH locus involving conserved noncoding elements (CNEs) are associated with syndactyly and craniosynostosis. These CNEs are able to drive reporter gene expression in a pattern highly similar to wild-type Ihh expression. We postulate that the observed duplications lead to a misexpression and/or overexpression of IHH and by this affect the complex regulatory signaling network during digit and skull development.	[Klopocki, Eva; Lohan, Silke; Koll, Randi; Brehm, Anja; Dathe, Katarina; Stricker, Sigmar; Mundlos, Stefan] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Klopocki, Eva; Lohan, Silke; Brehm, Anja; Dathe, Katarina; Stricker, Sigmar; Mundlos, Stefan] Max Planck Inst Mol Genet, Res Grp Dev & Dis, D-14195 Berlin, Germany; [Lohan, Silke; Brehm, Anja] Free Univ Berlin, D-14195 Berlin, Germany; [Brancati, Francesco] San Giovanni Rotondo & CSS Mendel Inst, IRCCS, I-00198 Rome, Italy; [Seemann, Petra; Hecht, Jochen; Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Bosse, Kristin] Univ Hosp Cologne, Dept Obstet & Gynecol, Div Mol Gynecol, D-50924 Cologne, Germany; [Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Garaci, Francesco Giuseppe] Univ Roma Tor Vergata, Dept Diagnost Imaging & Intervent Radiol, I-00133 Rome, Italy; [Dallapiccola, Bruno] Bambino Gesu Children Hosp, IRCCS, I-00198 Rome, Italy; [Jain, Mahim; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Ng, Vivian C. W.; Chan, Wilson; Chan, Danny] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Brancati, Francesco] Univ Roma Tor Vergata, Dept Biopathol, I-00198 Rome, Italy; [Brancati, Francesco] Gabriele DAnnunzio Univ, Dept Biomed Sci, I-66013 Chieti, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Cologne; University of Bonn; University of Rome Tor Vergata; IRCCS Bambino Gesu; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Hong Kong; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara	Klopocki, E (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	eva.klopocki@charite.de	Lohan, Silke SL/N-8917-2013; Garaci, Francesco/AAC-3433-2022; Seemann, Petra/G-3606-2011; Betz, Regina C/E-8591-2011; Brancati, Francesco/AAC-3778-2022; Stricker, Sigmar/B-9169-2009; Klopocki, Eva/B-6823-2017; Mundlos, Stefan/ABH-9585-2020; Chan, Danny/C-4203-2009; Dallapiccola, Bruno/K-8692-2016	Garaci, Francesco/0000-0003-1499-5718; Seemann, Petra/0000-0002-6056-6669; Betz, Regina C/0000-0001-5024-3623; Brancati, Francesco/0000-0003-3624-2354; Stricker, Sigmar/0000-0002-7174-5363; Klopocki, Eva/0000-0003-1438-2081; Chan, Danny/0000-0003-3824-5778; Muenke, Maximilian/0000-0002-7719-6545; Mundlos, Stefan/0000-0002-9788-3166; Dathe, Katarina/0000-0002-8674-5817; Dallapiccola, Bruno/0000-0002-5031-1013; Lohan, Silke/0000-0001-8156-0074	Deutsche Forschungsgemeinschaft [KL 2158/2-1]; University Grants Council of Hong Kong [AoE 04/04]; General Research Grant of Hong Kong [HKU760608M]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIEHG200354] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Grants Council of Hong Kong; General Research Grant of Hong Kong; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to E.K., K.D., and S.M. (KL 2158/2-1) and by funding from the University Grants Council (AoE 04/04) and the General Research Grant (HKU760608M) of Hong Kong. We thank Douglas P. Mortlock for generously providing us with the vector pSfi-Hsp68lacZ. We acknowledge Fabienne Trotier for excellent technical assistance.	Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Amano K, 2008, J BIOL CHEM, V283, P29513, DOI 10.1074/jbc.M803681200; Babbs C, 2008, MECH DEVELOP, V125, P517, DOI 10.1016/j.mod.2008.01.001; Bosse K, 2000, AM J HUM GENET, V67, P492, DOI 10.1086/303028; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cantagrel V, 2007, HUM MUTAT, V28, P356, DOI 10.1002/humu.20450; Crick AP, 2003, J ANAT, V202, P21, DOI 10.1046/j.1469-7580.2003.00132.x; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Furniss D, 2008, HUM MOL GENET, V17, P2417, DOI 10.1093/hmg/ddn141; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jain M, 2008, AM J MED GENET A, V146A, P2308, DOI 10.1002/ajmg.a.32445; Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047; KANTAPUTRA PN, 2010, EUR J HUM GENET; Klopocki E, 2008, J MED GENET, V45, P370, DOI 10.1136/jmg.2007.055699; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McDonald-McGinn DM, 2010, AM J MED GENET A, V152A, P1654, DOI 10.1002/ajmg.a.33495; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Robin NH, 1996, AM J MED GENET, V62, P184, DOI 10.1002/(SICI)1096-8628(19960315)62:2<184::AID-AJMG13>3.3.CO;2-H; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yang Y, 1998, DEVELOPMENT, V125, P3123	32	62	62	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					70	75		10.1016/j.ajhg.2010.11.006	http://dx.doi.org/10.1016/j.ajhg.2010.11.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21167467	Green Published, Bronze			2022-12-18	WOS:000286501500006
J	Li, Y; Laue, K; Temtamy, S; Aglan, M; Kotan, LD; Yigit, G; Canan, H; Pawlik, B; Nurnberg, G; Wakeling, EL; Quarrell, OW; Baessmann, I; Lanktree, MB; Yilmaz, M; Hegele, RA; Amr, K; May, KW; Nurnberg, P; Topaloglu, AK; Hammerschmidt, M; Wollnik, B				Li, Yun; Laue, Kathrin; Temtamy, Samia; Aglan, Mona; Kotan, L. Damla; Yigit, Goekhan; Canan, Husniye; Pawlik, Barbara; Nuernberg, Gudrun; Wakeling, Emma L.; Quarrell, Oliver W.; Baessmann, Ingelore; Lanktree, Matthew B.; Yilmaz, Mustafa; Hegele, Robert A.; Amr, Khalda; May, Klaus W.; Nuernberg, Peter; Topaloglu, A. Kemal; Hammerschmidt, Matthias; Wollnik, Bernd			Temtamy Preaxial Brachydactyly Syndrome Is Caused by Loss-of-Function Mutations in Chondroitin Synthase 1, a Potential Target of BMP Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ZEBRAFISH INNER-EAR; LINKAGE ANALYSIS; LATERAL-LINE; EXPRESSION; MORPHOGENESIS; HYPERPHALANGISM; DEAFNESS; DISEASE; SULFATE; EMBRYO	Altered Bone Morphogenetic Protein (BMP) signaling leads to multiple developmental defects, including brachydactyly and deafness. Here we identify chondroitin synthase 1 (CHSY1) as a potential mediator of BMP effects. We show that loss of human CHSY1 function causes autosomal-recessive Temtamy preaxial brachydactyly syndrome (ITBS), mainly characterized by limb malformations, short stature, and hearing loss. After mapping the TITS locus to chromosome 15q26-qterm, we identified causative mutations in five consanguineous TPBS families. In zebrafish, antisense-mediated chsy1 knockdown causes defects in multiple developmental processes, some of which are likely to also be causative in the etiology of TPBS. In the inner ears of zebrafish larvae, chsy1 is expressed similarly to the BMP inhibitor don and in a complementary fashion to bmp2b. Furthermore, unrestricted Bmp2b signaling or loss of Dan activity leads to reduced chsy1 expression and, during epithelial morphogenesis, defects similar to those that occur upon Chsy1 inactivation, indicating that Bmp signaling affects inner-ear development by repressing chsy1. In addition, we obtained strikingly similar zebrafish phenotypes after chsy1 overexpression, which might explain why, in humans, brachydactyly can be caused by mutations leading either to loss or to gain of BMP signaling.	[Li, Yun; Yigit, Goekhan; Pawlik, Barbara; Nuernberg, Gudrun; Nuernberg, Peter; Hammerschmidt, Matthias; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Li, Yun; Yigit, Goekhan; Pawlik, Barbara; Wollnik, Bernd] Univ Cologne, Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Laue, Kathrin; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, Cologne, Germany; [Temtamy, Samia; Aglan, Mona; Amr, Khalda] Natl Res Ctr, Dept Clin Genet, Cairo, Egypt; [Temtamy, Samia; Aglan, Mona; Amr, Khalda] Natl Res Ctr, Dept Mol Genet, Div Human Genet & Human Genome Res, Cairo, Egypt; [Kotan, L. Damla] Cukurova Univ, Inst Sci, Dept Biotechnol, Adana, Turkey; [Canan, Husniye] Cukurova Univ, Dept Forens Med, Fac Med, Adana, Turkey; [Nuernberg, Gudrun; Baessmann, Ingelore; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Wakeling, Emma L.] NW Thames Reg Genet Serv, London, England; [Quarrell, Oliver W.] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England; [Lanktree, Matthew B.; Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON, Canada; [Yilmaz, Mustafa] Cukurova Univ, Fac Med, Dept Pediat Allergy & Immunol, Adana, Turkey; [May, Klaus W.] Genomatix Software GmbH, Munich, Germany; [Topaloglu, A. Kemal] Cukurova Univ, Fac Med, Dept Pediat Endocrinol, Adana, Turkey	University of Cologne; University of Cologne; University of Cologne; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Cukurova University; Cukurova University; University of Cologne; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Western University (University of Western Ontario); Cukurova University; Cukurova University	Hammerschmidt, M (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.	mhammers@uni-koeln.de; bwollnik@uni-koeln.de	Kotan, Leman Damla/A-2474-2015; Hegele, Robert/AAF-6482-2020; Wollnik, Bernd/GRY-6062-2022; TOPALOGLU, ALI/O-1408-2015; Hegele, Robert/G-3301-2011; Lanktree, Matthew Bruce/I-9790-2019	Kotan, Leman Damla/0000-0001-6176-8986; Hegele, Robert/0000-0003-2861-5325; Wollnik, Bernd/0000-0003-2589-0364; Lanktree, Matthew Bruce/0000-0002-5750-6286; aglan, mona/0000-0002-0908-0639; Amr, Khalda/0000-0001-8472-5911; Wakeling, Emma/0000-0001-5712-0044; temtamy, samia/0000-0002-6452-823X	German Federal Ministry of Education and Research (BMBF) [01GM0880, 01GM0801]; National Institutes of Health [1R01 GM63904]; German Research Foundation [SFB572]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to all family members who participated in this study, Esther Milz and Evelin Fahle for excellent technical assistance, and Karin Boss for critical reading of the manuscript. This work was supported by the German Federal Ministry of Education and Research (BMBF) by grant number 01GM0880 (SKELNET) and by 01GM0801 (E-RARE network CRANIRARE) to B.W. Work in M.H.'s laboratory was supported by the National Institutes of Health (grant 1R01 GM63904) and the German Research Foundation (SFB572).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], POLYPHEN; Bok J, 2007, DEV BIOL, V311, P69, DOI 10.1016/j.ydbio.2007.08.013; Busch-Nentwich E, 2004, DEVELOPMENT, V131, P943, DOI 10.1242/dev.00961; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Dawson K, 2006, AM J HUM GENET, V78, P708, DOI 10.1086/503204; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hammond KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004368; Herzog W, 2003, DEV BIOL, V254, P36, DOI 10.1016/S0012-1606(02)00124-0; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Mowbray C, 2001, MECH DEVELOP, V108, P179, DOI 10.1016/S0925-4773(01)00479-8; Mundlos S, 2009, CLIN GENET, V76, P123, DOI 10.1111/j.1399-0004.2009.01238.x; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Omata Y, 2007, DEV GROWTH DIFFER, V49, P711, DOI [10.1111/j.1440-169x.2007.00964.x, 10.1111/j.1440-169X.2007.00964.x]; Peal DS, 2009, DEV DYNAM, V238, P3103, DOI 10.1002/dvdy.22154; Petko JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-27; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Race H, 2010, CLIN DYSMORPHOL, V19, P23, DOI 10.1097/MCD.0b013e328334557e; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Stemple DL, 1996, DEVELOPMENT, V123, P117; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Temtamy SA, 1998, CLIN DYSMORPHOL, V7, P249, DOI 10.1097/00019605-199810000-00003; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Whitfield TT, 1996, DEVELOPMENT, V123, P241; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yin L, 2005, J BIOL CHEM, V280, P15666, DOI 10.1074/jbc.M409877200; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	43	62	65	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					757	767		10.1016/j.ajhg.2010.10.003	http://dx.doi.org/10.1016/j.ajhg.2010.10.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21129728	Green Published, Bronze			2022-12-18	WOS:000285564600002
J	Ferreira, MAR; Hottenga, JJ; Warrington, NM; Medland, SE; Willemsen, G; Lawrence, RW; Gordon, S; de Geus, EJC; Henders, AK; Smit, JH; Campbell, MJ; Wallace, L; Evans, DM; Wright, MJ; Nyholt, DR; James, AL; Beilby, JP; Penninx, BW; Palmer, LJ; Frazer, IH; Montgomery, GW; Martin, NG; Boomsma, DI				Ferreira, Manuel A. R.; Hottenga, Jouke-Jan; Warrington, Nicole M.; Medland, Sarah E.; Willemsen, Gonneke; Lawrence, Robert W.; Gordon, Scott; de Geus, Eco J. C.; Henders, Anjali K.; Smit, Johannes H.; Campbell, Megan J.; Wallace, Leanne; Evans, David M.; Wright, Margaret J.; Nyholt, Dale R.; James, Alan L.; Beilby, John P.; Penninx, Brenda W.; Palmer, Lyle J.; Frazer, Ian H.; Montgomery, Grant W.; Martin, Nicholas G.; Boomsma, Dorret I.			Sequence Variants in Three Loci Influence Monocyte Counts and Erythrocyte Volume	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; BUSSELTON HEALTH; LUNG-FUNCTION; HBS1L-MYB; MORTALITY; ASTHMA	Blood cells participate in vital physiological processes, and their numbers are tightly regulated so that homeostasis is maintained. Disruption of key regulatory mechanisms underlies many blood-related Mendelian diseases but also contributes to more common disorders, including atherosclerosis. We searched for quantitative trait loci (QTL) for hematology traits through a whole-genome association study, because these could provide new insights into both hemopoeitic and disease mechanisms. We tested 1.8 million variants for association with 13 hematology traits measured in 6015 individuals from the Australian and Dutch populations. These traits included hemoglobin composition, platelet counts, and red blood cell and white blood cell indices. We identified three regions of strong association that, to our knowledge, have not been previously reported in the literature. The first was located in an intergenic region of chromosome 9q31 near LRAR1, explaining 1.5% of the variation in monocyte counts (best SNP rs7023923, p = 8.9 x 10(-14)). The second locus was located on chromosome 6p21 and associated with mean cell erythrocyte volume (rs12661667, p = 1.2 x 10(-9), 0.7% variance explained) in a region that spanned five genes, including CCND3, a member of the D-cyclin gene family that is involved in hematopoietic stem cell expansion. The third region was also associated with erythrocyte volume and was located in an intergenic region on chromosome 6q24 (rs592423, p = 5.3 x 10(-9), 0.60% variance explained). All three loci replicated in an independent panel of 1543 individuals (p values = 0.001, 9.9 x 10(-5), and 7 x 10(-5), respectively). The identification of these QTL provides new opportunities for furthering our understanding of the mechanisms regulating hemopoietic cell fate.	[Ferreira, Manuel A. R.; Medland, Sarah E.; Gordon, Scott; Henders, Anjali K.; Campbell, Megan J.; Wallace, Leanne; Evans, David M.; Wright, Margaret J.; Nyholt, Dale R.; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Hottenga, Jouke-Jan; Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO & NCA Inst, Netherlands Twin Register, NL-1081 BT Amsterdam, Netherlands; [Warrington, Nicole M.; Lawrence, Robert W.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [Smit, Johannes H.; James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Crawley 6009, Australia; [Beilby, John P.] PathWest Lab Med, Perth, WA 6009, Australia; [Beilby, John P.] Univ Western Australia, Sch Surg & Pathol, Perth, WA 6009, Australia; [Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Frazer, Ian H.] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute; Vrije Universiteit Amsterdam; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Vrije Universiteit Amsterdam; University of Queensland	Ferreira, MAR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	manuel.ferreira@qimr.edu.au	de Geus, Eco J.C./M-9318-2015; Wright, Margaret Jane/A-4560-2016; Montgomery, Grant W/B-7148-2008; Palmer, Lyle John/N-1948-2019; Medland, Sarah/AAT-7595-2020; Wright, Margaret J/H-3308-2014; Penninx, Brenda WJH/S-7627-2017; Boomsma, Dorret I/AAX-4470-2020; Evans, David M/H-6325-2013; Ferreira, Manuel A R/D-3609-2013; Warrington, Nicole/P-4868-2014; Nyholt, Dale Robert/J-3174-2017; Medland, Sarah E/C-7630-2013; Palmer, Lyle John/K-3196-2014; Henders, Anjali/E-3126-2017; Frazer, Ian/A-1137-2007; WALLACE, Leanne/V-2097-2018	de Geus, Eco J.C./0000-0001-6022-2666; Wright, Margaret Jane/0000-0001-7133-4970; Montgomery, Grant W/0000-0002-4140-8139; Palmer, Lyle John/0000-0002-1628-3055; Medland, Sarah/0000-0003-1382-380X; Penninx, Brenda WJH/0000-0001-7779-9672; Evans, David M/0000-0003-0663-4621; Ferreira, Manuel A R/0000-0001-9059-1825; Warrington, Nicole/0000-0003-4195-775X; Nyholt, Dale Robert/0000-0001-7159-3040; Medland, Sarah E/0000-0003-1382-380X; Palmer, Lyle John/0000-0002-1628-3055; Campbell, Megan/0000-0002-6056-6140; Martin, Nicholas/0000-0003-4069-8020; Henders, Anjali/0000-0003-3672-1451; Beilby, John/0000-0002-4915-2254; Frazer, Ian/0000-0002-8002-4680; WALLACE, Leanne/0000-0003-4310-7572; Willemsen, Gonneke/0000-0003-3755-0236	Australian National Health and Medical Research Council (NHMRC) [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0212016, DP0343921]; Busselton Health Study; Healthway, Western Australia (WA); Great Wine Estates of the Margaret River region of WA; Netherlands Society for Scientific Research [904-61-090, 904-61-193, 480-04-004, 400-05-717, SPI 56-464-14192]; Center for Medical Systems Biology; Geestkracht program of ZonMW [10-000-1002]; matching funds from institutes involved in NESDA; GGZ Buitenamstel-Geestgronden, Rivierduinen; University Medical Center Groningen; GGZ Lentis; GGZ Friesland; GGZ Drenthe; Centre for Neurogenomics; Cognitive Research VU University; European Science Foundation [EU/QLRT-2001-01254]; National Institute of Mental Health (NIMH) [R01 MH059160)]; Genetic Association Information Network (GAIN); GAIN; NIMH [MH081802]; Medical Research Council [G0800582, G0600705] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059160, R01MH081802] Funding Source: NIH RePORTER; MRC [G0800582, G0600705] Funding Source: UKRI	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Busselton Health Study; Healthway, Western Australia (WA); Great Wine Estates of the Margaret River region of WA; Netherlands Society for Scientific Research; Center for Medical Systems Biology; Geestkracht program of ZonMW; matching funds from institutes involved in NESDA; GGZ Buitenamstel-Geestgronden, Rivierduinen; University Medical Center Groningen; GGZ Lentis; GGZ Friesland; GGZ Drenthe; Centre for Neurogenomics; Cognitive Research VU University; European Science Foundation(European Science Foundation (ESF)European Commission); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Genetic Association Information Network (GAIN); GAIN; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	QIMR. We thank the Brisbane twins and their families for their participation, as well as Dixie Statham, Ann Eldridge, Marlene Grace; Lisa Bowdler, Steven Crooks; David Smyth, Harry Beeby; and Peter Visscher. Funding: Australian National Health and Medical Research Council (NHMRC, grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496739, 552485, 552498), Australian Research Council (A7960034, A79906588, A79801419, DP0212016, DP0343921). Busselton Health Study, We thank the people of the Busselton community for their participation. We also acknowledge the support for the 1994 and 1995 follow-up study from Healthway, Western Australia (WA). The Busselton population studies are supported by The Great Wine Estates of the Margaret River region of WA. The authors acknowledge the assistance of the WA DNA Bank (NHMRC Enabling Facility) with DNA samples and the support of the WA Genetic Epidemiology Resource (NHMRC Enabling Facility). NTR and NESDA studies. Funding: The Netherlands Society for Scientific Research (NWO 904-61-090, 904-61-193, 480-04-004, 400-05-717; SPI 56-464-14192), Center for Medical Systems Biology (NWO Genomics), Geestkracht program of ZonMW (10-000-1002), matching funds from institutes involved in NESDA (GGZ Buitenamstel-Geestgronden, Rivierduinen, University Medical Center Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe), Centre for Neurogenomics and Cognitive Research VU University (CNCR-VU), European Science Foundation (EU/QLRT-2001-01254), the National Institute of Mental Health (NIMH) (R01 MH059160), and matching funds from participating institutes in NTR. Genotyping was funded by the Genetic Association Information Network (GAIN), and 11 analysis was supported by grants from GAIN and the NIMH (MH081802).	Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; BENYAMIN B, 2009, NAT GENET IN PRESS; BONNEFOND A, 2009, DIABETES; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; James AL, 1999, EUR RESPIR J, V13, P1115, DOI 10.1034/j.1399-3003.1999.13e29.x; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000312; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	24	62	63	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					745	749		10.1016/j.ajhg.2009.10.005	http://dx.doi.org/10.1016/j.ajhg.2009.10.005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853236	Green Published, Bronze			2022-12-18	WOS:000271916500022
J	Parry, DA; Toomes, C; Bida, L; Danciger, M; Towns, KV; McKibbin, M; Jacobson, SG; Logan, CV; Ali, M; Bond, J; Chance, R; Swendeman, S; Daniele, LL; Springell, K; Adams, M; Johnson, CA; Booth, AP; Jafri, H; Rashid, Y; Banin, E; Strom, TM; Farber, DB; Sharon, D; Blobel, CP; Pugh, EN; Pierce, EA; Inglehearn, CF				Parry, David A.; Toomes, Carmel; Bida, Lina; Danciger, Michael; Towns, Katherine V.; McKibbin, Martin; Jacobson, Samuel G.; Logan, Clare V.; Ali, Manir; Bond, Jacquelyn; Chance, Rebecca; Swendeman, Steven; Daniele, Lauren L.; Springell, Kelly; Adams, Matthew; Johnson, Colin A.; Booth, Adam P.; Jafri, Hussain; Rashid, Yasmin; Banin, Eyal; Strom, Tim M.; Farber, Debora B.; Sharon, Dror; Blobel, Carl P.; Pugh, Edward N., Jr.; Pierce, Eric A.; Inglehearn, Chris F.			Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; GENE; MUTATIONS; SUSCEPTIBILITY; DISINTEGRIN; EXPRESSION; BINDING; LOCUS; MOUSE	Cone-rod dystrophy (CRD) is an inherited progressive retinal dystrophy affecting the function of cone and rod photoreceptors. By autozygosity mapping, we identified null mutations in the ADAM metallopeptidase domain 9 (ADAM9) gene in four consanguineous families with recessively inherited early-onset CRD. We also found reduced photoreceptor responses in Adam9 knockout mice, previously reported to be asymptomatic. In 12-month-old knockout mice, photoreceptors appear normal, but the apical processes of the retinal pigment epithelium (RPE) cells are disorganized and contact between photoreceptor outer segments (POSs) and the RPE apical surface is compromised. In 20-month-old mice, there is clear evidence of progressive retinal degeneration with disorganized POS and thinning of the outer nuclear layer (ONL) in addition to the anomaly at the POS-RPE junction. RPE basal deposits and macrophages were also apparent in older mice. These findings therefore not identify ADAM9 as a CRD gene but also identify a form of pathology wherein retinal disease first manifests at the POS-RPE junction.	[Parry, David A.; Toomes, Carmel; Towns, Katherine V.; Logan, Clare V.; Ali, Manir; Bond, Jacquelyn; Springell, Kelly; Adams, Matthew; Johnson, Colin A.; Inglehearn, Chris F.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Danciger, Michael; Banin, Eyal; Sharon, Dror] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Danciger, Michael] Loyola Marymount Univ, Los Angeles, CA 90045 USA; [McKibbin, Martin] St James Univ Hosp, Eye Dept, Leeds LS9 7TF, W Yorkshire, England; [Jacobson, Samuel G.; Chance, Rebecca; Daniele, Lauren L.; Pugh, Edward N., Jr.; Pierce, Eric A.] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Swendeman, Steven; Blobel, Carl P.] Cornell Univ, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA; [Booth, Adam P.] Peninsula Med Sch, Plymouth PL6 8BU, Devon, England; [Jafri, Hussain] Gene Tech Lab, Lahore 54000, Pakistan; [Rashid, Yasmin] King Edward Med Univ, Dept Obstet & Gynaecol, Lahore 54000, Pakistan; [Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Farber, Debora B.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	Saint James's University Hospital; University of Leeds; Hebrew University of Jerusalem; Hadassah University Medical Center; Loyola Marymount University; Saint James's University Hospital; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Plymouth; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Inglehearn, CF (corresponding author), St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	c.inglehearn@leeds.ac.uk	Inglehearn, Chris/GYD-9783-2022; Zelinger, Lina/L-3272-2019; Ali, Manir/ABE-5251-2020; Sharon, Dror/P-4539-2015	Ali, Manir/0000-0003-3204-3788; Sharon, Dror/0000-0002-1789-5811; Jacobson, Samuel/0000-0003-2122-169X; Parry, David/0000-0003-0376-7736; Farber, Debora/0000-0002-3207-697X; Chance, Rebecca K./0000-0001-7059-6119; Toomes, Carmel/0000-0001-8373-9545; Zelinger, Lina/0000-0003-3028-7172; Johnson, Colin/0000-0002-2979-8234; Logan, Clare/0000-0003-4323-1602; Pierce, Eric/0000-0002-2354-4102	Wellcome Trust [073477]; Yorkshire Eye Research [009]; Medical Research Council [G0501050]; Foundation Fighting Blindness [BR-GE-0607-0395-HUJ]; National Institutes of Health [EY12910]; MRC [G0501050] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY012910, R01EY015719] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Yorkshire Eye Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Foundation Fighting Blindness(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the CORD families for their participation, Dr. Phil Robinson for useful discussion, Mike Shires for technical assistance with immunofluorescence, Dr. Li Fu for technical assistance with retinal histology, and Alex Saveliev for technical assistance with ERGs. Antibodies to Adam10 and Adam17 were a kind gift from Professor jean Crabtree. This work was funded by the Wellcome Trust (grant number 073477), Yorkshire Eye Research (grant number 009), the Medical Research Council (grant number G0501050 to M.A.), the Foundation Fighting Blindness (grant number BR-GE-0607-0395-HUJ to D.S.), the National Institutes of Health (EY12910 to E.A.P.), the Yedidut Research Grant to E.B., the F.M. Kirby Foundation, and the Rosanne Silbermann Foundation. C.T. is a Royal Society University Research Fellow.	Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; ANDERSON DH, 1995, J COMP NEUROL, V360, P1, DOI 10.1002/cne.903600102; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; Danciger M, 2001, INVEST OPHTH VIS SCI, V42, P2458; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Ducroq D, 2002, AM J HUM GENET, V71, P1480, DOI 10.1086/344829; Ebenezer ND, 2005, INVEST OPHTH VIS SCI, V46, P1891, DOI 10.1167/iovs.04-1482; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Khaliq S, 2000, INVEST OPHTH VIS SCI, V41, P3709; Lim JM, 2002, J CATARACT REFR SURG, V28, P697, DOI 10.1016/S0886-3350(01)01236-6; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mahimkar RM, 2005, BIOCHEM J, V385, P461, DOI 10.1042/BJ20041133; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Schwettmann L, 2001, PROTEIN EXPRES PURIF, V21, P65, DOI 10.1006/prep.2000.1374; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Weber BHF, 2002, INVEST OPHTH VIS SCI, V43, P2732; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155	41	62	63	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					683	691		10.1016/j.ajhg.2009.04.005	http://dx.doi.org/10.1016/j.ajhg.2009.04.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409519	hybrid, Green Published			2022-12-18	WOS:000266338800014
J	Tzeng, JY; Zhang, D				Tzeng, Jung-Ying; Zhang, Daowen			Haplotype-based association analysis via variance-components score test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIKELIHOOD RATIO TESTS; LINKAGE DISEQUILIBRIUM; MIXED MODELS; TRAITS; PHASE	Haplotypes provide a more informative format of polymorphisms for genetic association analysis than do individual single-nucleotide polymorphisms. However, the practical efficacy of haplotype-based association analysis is challenged by a trade-off between the benefits of modeling abundant variation and the cost of the extra degrees of freedom. To reduce the degrees of freedom, several strategies have been considered in the literature. They include (1) clustering evolutionarily close haplotypes, (2) modeling the level of haplotype sharing, and (3) smoothing haplotype effects by introducing a correlation structure for haplotype effects and studying the variance components (VC) for association. Although the first two strategies enjoy a fair extent of power gain, empirical evidence showed that VC methods may exhibit only similar or less power than the standard haplotype regression method, even in cases of many haplotypes. In this study, we report possible reasons that cause the underpowered phenomenon and show how the power of the VC strategy can be improved. We construct a score test based on the restricted maximum likelihood or the marginal likelihood function of the VC and identify its nontypical limiting distribution. Through simulation, we demonstrate the validity of the test and investigate the power performance of the VC approach and that of the standard haplotype regression approach. With suitable choices for the correlation structure, the proposed method can be directly applied to unphased genotypic data. Our method is applicable to a wide-ranging class of models and is computationally efficient and easy to implement. The broad coverage and the fast and easy implementation of this method make the VC strategy an effective tool for haplotype analysis, even in modern genomewide association studies.	N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Tzeng, JY (corresponding author), N Carolina State Univ, Dept Stat, Campus Box 7566, Raleigh, NC 27695 USA.	jytzeng@stat.ncsu.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Tzeng, Jung-Ying/0000-0002-5505-1775	NCI NIH HHS [R01 CA085848, R01 CA85848-04] Funding Source: Medline; NIMH NIH HHS [R01 MH074027] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Allen AS, 2007, HUM HERED, V64, P35, DOI 10.1159/000101421; CARLIN B, 2000, BAYES EMPIRICAL BAYE, P262; Crainiceanu CM, 2004, J ROY STAT SOC B, V66, P165, DOI 10.1111/j.1467-9868.2004.00438.x; DERMEULEN MAV, 1997, GENET EPIDEMIOL, V14, P915; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harville D.A., 1977, J AM STAT ASSOC, V72, P322; IMHOF JP, 1961, BIOMETRIKA, V48, P419, DOI 10.2307/2332763; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Molitor J, 2003, GENET EPIDEMIOL, V25, P95, DOI 10.1002/gepi.10251; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; SEARLE SR, 1992, VARIANCE COMPONENTS, P232; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Seltman H, 2003, GENET EPIDEMIOL, V25, P48, DOI 10.1002/gepi.10246; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Thomas DC, 2001, GENET EPIDEMIOL, V21, pS712, DOI 10.1002/gepi.2001.21.s1.s712; Tzeng JY, 2005, GENET EPIDEMIOL, V28, P220, DOI 10.1002/gepi.20063; Tzeng JY, 2006, AM J HUM GENET, V78, P231, DOI 10.1086/500025; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57	29	62	64	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					927	938		10.1086/521558	http://dx.doi.org/10.1086/521558			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924336	Green Published, Bronze			2022-12-18	WOS:000250480900006
J	Vernesi, C; Caramelli, D; Dupanloup, I; Bertorelle, G; Lari, M; Cappellini, E; Moggi-Cecchi, J; Chiarelli, B; Castri, L; Casoli, A; Mallegni, F; Lalueza-Fox, C; Barbujani, G				Vernesi, C; Caramelli, D; Dupanloup, I; Bertorelle, G; Lari, M; Cappellini, E; Moggi-Cecchi, J; Chiarelli, B; Castri, L; Casoli, A; Mallegni, F; Lalueza-Fox, C; Barbujani, G			The Etruscans: A population-genetic study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; ANCIENT DNA; BRIEF COMMUNICATION; SEQUENCE DIVERSITY; MODERN HUMANS; MTDNA; HISTORY; EUROPE; GENOME; ORIGIN	The origins of the Etruscans, a non-Indo-European population of preclassical Italy, are unclear. There is broad agreement that their culture developed locally, but the Etruscans' evolutionary and migrational relationships are largely unknown. In this study, we determined mitochondrial DNA sequences in multiple clones derived from bone samples of 80 Etruscans who lived between the 7th and the 3rd centuries B. C. In the first phase of the study, we eliminated all specimens for which any of nine tests for validation of ancient DNA data raised the suspicion that either degradation or contamination by modern DNA might have occurred. On the basis of data from the remaining 30 individuals, the Etruscans appeared as genetically variable as modern populations. No significant heterogeneity emerged among archaeological sites or time periods, suggesting that different Etruscan communities shared not only a culture but also a mitochondrial gene pool. Genetic distances and sequence comparisons show closer evolutionary relationships with the eastern Mediterranean shores for the Etruscans than for modern Italian populations. All mitochondrial lineages observed among the Etruscans appear typically European or West Asian, but only a few haplotypes were found to have an exact match in a modern mitochondrial database, raising new questions about the Etruscans' fate after their assimilation into the Roman state.	Univ Ferrara, Dipartimento Biol, I-44100 Ferrara, Italy; Univ Florence, Lab Antropol, Dipartimento Biol Anim & Genet, Florence, Italy; Univ Bologna, Dipartimento Biol Evoluz & Sperimentale, Bologna, Italy; Univ Parma, Dipartimento Chim Gen & Inorgan Chim Analit Chim, I-43100 Parma, Italy; Univ Pisa, Dipartimento Sci Archeol, Pisa, Italy; Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Unitat Biol Evolut, Barcelona, Spain	University of Ferrara; University of Florence; University of Bologna; University of Parma; University of Pisa; Pompeu Fabra University	Barbujani, G (corresponding author), Univ Ferrara, Dipartimento Biol, Via Borsari 46, I-44100 Ferrara, Italy.	g.barbujani@unife.it	LALUEZA-FOX, CARLES/AAG-5341-2020; casoli, antonella/H-6953-2016; Lari, Martina/A-4085-2009; Barbujani, Guido/ABE-9998-2020; Bertorelle, Giorgio/AAE-9078-2022; Cappellini, Enrico/F-9346-2013; Dupanloup, Isabelle/AAD-5372-2020; Dupanloup, Isabelle/O-8609-2017	LALUEZA-FOX, CARLES/0000-0002-1730-5914; Barbujani, Guido/0000-0001-7854-6669; Cappellini, Enrico/0000-0001-7885-7811; Dupanloup, Isabelle/0000-0002-9258-6963; Bertorelle, Giorgio/0000-0002-2498-2702; Vernesi, Cristiano/0000-0001-7534-5669; Caramelli, David/0000-0001-6468-1675; MOGGI CECCHI, IACOPO/0000-0001-5055-8369; casoli, antonella/0000-0002-9212-9463				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barbujani G, 2001, P NATL ACAD SCI USA, V98, P22, DOI 10.1073/pnas.98.1.22; Barker G, 1998, ETRUSCANS; BARTOLINI G, 1989, CULTURA VILLANOVIANA; Beekes Robert S. P, 2002, BIBLIO ORIENTALIS, V59, P206; Bonfante G., 2002, ETRUSCAN LANGUAGE; BONFANTE L, 1999, P 20 C ETRUSC STUD, P501; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Cooper A, 2000, SCIENCE, V289, P1139; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Endicott P, 2003, AM J HUM GENET, V72, P178, DOI 10.1086/345487; EXCOFFIER L, 1992, GENETICS, V131, P479; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Haynes S., 2000, ETRUSCAN CIVILIZATIO; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumar SS, 2000, AM J PHYS ANTHROPOL, V113, P129, DOI 10.1002/1096-8644(200009)113:1<129::AID-AJPA12>3.0.CO;2-2; Lalueza-Fox C, 2003, AM J PHYS ANTHROPOL, V121, P97, DOI 10.1002/ajpa.10236; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; Lindahl T, 1997, CELL, V90, P1, DOI 10.1016/S0092-8674(00)80306-2; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Moggi-Cecchi J., 1997, ETRUSCAN STUD, V4, P73; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nasidze I, 2001, P ROY SOC B-BIOL SCI, V268, P1197, DOI 10.1098/rspb.2001.1610; Nei M., 1987, MOL EVOLUTIONARY GEN; Pallottino M., 1975, ETRUSCANS; Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Poinar HN, 1999, P NATL ACAD SCI USA, V96, P8426, DOI 10.1073/pnas.96.15.8426; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; RASMUSSEN T, 2004, MEDITERRANEAN URBANI; Reed FA, 2003, AM J PHYS ANTHROPOL, V121, P112, DOI 10.1002/ajpa.10211; RELETHFORD JH, 1995, AM J PHYS ANTHROPOL, V96, P25, DOI 10.1002/ajpa.1330960104; RENFREW C, 1989, T PHILOL SOC, V87, P103, DOI 10.1111/j.1467-968X.1989.tb00622.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Roessli D, 2000, ARLEQUIN VERSION 2 0; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; SOKAL RR, 1991, ANNU REV ANTHROPOL, V20, P119, DOI 10.1146/annurev.an.20.100191.001003; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tykot RH, 1994, ETRUSCAN STUD, V1, P59; Vernesi C, 2002, HUM BIOL, V74, P725, DOI 10.1353/hub.2002.0060; Vernesi C, 2001, P NATL ACAD SCI USA, V98, P13460, DOI 10.1073/pnas.211540498; vonHaeseler A, 1996, NAT GENET, V14, P135, DOI 10.1038/ng1096-135	61	62	65	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					694	704		10.1086/383284	http://dx.doi.org/10.1086/383284			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	804EA	15015132	Green Published, Bronze			2022-12-18	WOS:000220280800008
J	Chung, EK; Yang, Y; Rennebohm, RM; Lokki, ML; Higgins, GC; Jones, KN; Zhou, B; Blanchong, CA; Yu, CY				Chung, EK; Yang, Y; Rennebohm, RM; Lokki, ML; Higgins, GC; Jones, KN; Zhou, B; Blanchong, CA; Yu, CY			Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; CLASS-III REGION; 4TH COMPONENT; 21-HYDROXYLASE DEFICIENCY; STEROID 21-HYDROXYLASE; REVISED CRITERIA; DUPLICATED C4A; POLYMORPHISM; HAPLOTYPES; MHC	Human populations are endowed with a sophisticated genetic diversity of complement C4 and its flanking genes RP, CYP21, and TNX in the RCCX modules of the major histocompatibility complex class III region. We applied definitive techniques to elucidate (a) the complement C4 polymorphisms in gene sizes, gene numbers, and protein isotypes and (b) their gene orders. Several intriguing features are unraveled, including (1) a trimodular RCCX haplotype with three long C4 genes expressing C4A protein only, (2) two trimodular haplotypes with two long (L) and one short (S) C4 genes organized in LSL configurations, (3) a quadrimodular haplotype with four C4 genes organized in a SLSL configuration, and (4) another quadrimodular structure, with four long C4 genes (LLLL), that has the human leukocyte antigen haplotype that is identical to ancestral haplotype 7.2 in the Japanese population. Long-range PCR and PsbAI-RFLP analyses conclusively revealed that the short genes from the LSL and SLSL haplotypes are C4A. In four informative families, an astonishingly complex pattern of genetic diversity for RCCX haplotypes with one, two, three and four C4 genes is demonstrated; each C4 gene may be long or short, encoding a C4A or C4B protein. Such diversity may be related to different intrinsic strengths among humans to defend against infections and susceptibilities to autoimmune diseases.	Ohio State Univ, Childrens Res Inst, Columbus, OH 43205 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; Finnish Red Cross, Blood Transfus Serv, Helsinki, Finland	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yu, CY (corresponding author), Ohio State Univ, Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.		Yu, Chack-Yung/E-4360-2011	Yu, Chack-Yung/0000-0002-5218-7503	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055546] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR006009, 1P41 RR06009] Funding Source: Medline; NIAMS NIH HHS [R01 AR43969] Funding Source: Medline; NIDDK NIH HHS [P01 DK55546, P01 DK055546] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AWDEH ZL, 1979, NATURE, V282, P205, DOI 10.1038/282205a0; AWDEH ZL, 1980, P NATL ACAD SCI-BIOL, V77, P3576, DOI 10.1073/pnas.77.6.3576; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BELT KT, 1985, IMMUNOGENETICS, V21, P173; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; CARROLL MC, 1985, IMMUNOL REV, V87, P39, DOI 10.1111/j.1600-065X.1985.tb01144.x; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CARROLL MC, 1990, P NATL ACAD SCI USA, V87, P6868, DOI 10.1073/pnas.87.17.6868; Chung EK, 2002, AM J HUM GENET, V71, P810, DOI 10.1086/342778; COLLIER S, 1989, EMBO J, V8, P1393, DOI 10.1002/j.1460-2075.1989.tb03520.x; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; GILES CM, 1987, HUM GENET, V77, P359, DOI 10.1007/BF00291427; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jaatinen T, 2002, J IMMUNOL, V168, P5652, DOI 10.4049/jimmunol.168.11.5652; Martinez OP, 2001, FRONT BIOSCI-LANDMRK, V6, pD904, DOI 10.2741/Martinez; Mauff G, 1998, EXP CLIN IMMUNOGENET, V15, P249, DOI 10.1159/000019079; Milner CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD914, DOI 10.2741/Milner; MOULDS JM, 1990, COMPLEMENT INFLAMMAT, V7, P95, DOI 10.1159/000463134; OLAISEN B, 1980, IMMUNOBIOLOGY, V158, P82, DOI 10.1016/S0171-2985(80)80044-1; ONEILL GJ, 1978, P NATL ACAD SCI USA, V75, P5165, DOI 10.1073/pnas.75.10.5165; Porter R R, 1983, Mol Biol Med, V1, P161; RAUM D, 1984, AM J HUM GENET, V36, P72; REBMANN V, 1992, VOX SANG, V62, P117, DOI 10.1111/j.1423-0410.1992.tb01182.x; RITTNER C, 1984, IMMUNOGENETICS, V19, P321, DOI 10.1007/BF00345405; ROOS MH, 1982, NATURE, V298, P854, DOI 10.1038/298854a0; ROSENFELD SI, 1969, J CLIN INVEST, V48, P2283, DOI 10.1172/JCI106194; Rupert KL, 1999, EXP CLIN IMMUNOGENET, V16, P81, DOI 10.1159/000019099; Rupert KL, 2002, J IMMUNOL, V169, P1570, DOI 10.4049/jimmunol.169.3.1570; SCHENDEL DJ, 1985, VOX SANG, V48, P110, DOI 10.1111/j.1423-0410.1985.tb00154.x; Schneider PM, 2001, IMMUNOGENETICS, V53, P1, DOI 10.1007/s002510000288; SIM E, 1986, BIOCHEM J, V239, P763, DOI 10.1042/bj2390763; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TEISBERG P, 1976, NATURE, V264, P253, DOI 10.1038/264253a0; TEISBERG P, 1988, ANN HUM GENET, V52, P77, DOI 10.1111/j.1469-1809.1988.tb01082.x; TOKUNAGA K, 1985, IMMUNOGENETICS, V22, P359, DOI 10.1007/BF00430919; TOKUNAGA K, 1991, IMMUNOGENETICS, V34, P247, DOI 10.1007/BF00215260; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yang Y, 2001, MOL IMMUNOL, V38, P129; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1988, IMMUNOGENETICS, V27, P399, DOI 10.1007/BF00364425; Yu CY, 2002, MANUAL CLIN LAB IMMU, V6th, P117	44	62	63	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					823	837		10.1086/342777	http://dx.doi.org/10.1086/342777			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12226794	Green Published, Bronze			2022-12-18	WOS:000178613800011
J	Hassan, Z; Mohan, V; Ali, L; Allotey, R; Barakat, K; Faruque, MO; Deepa, R; McDermott, MF; Jackson, AE; Cassell, P; Curtis, D; Gelding, SV; Vijayaravaghan, S; Gyr, N; Whitcomb, DC; Khan, AKA; Hitman, GA				Hassan, Z; Mohan, V; Ali, L; Allotey, R; Barakat, K; Faruque, MO; Deepa, R; McDermott, MF; Jackson, AE; Cassell, P; Curtis, D; Gelding, SV; Vijayaravaghan, S; Gyr, N; Whitcomb, DC; Khan, AKA; Hitman, GA			SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; CYSTIC-FIBROSIS GENE; IDIOPATHIC PANCREATITIS; HEREDITARY PANCREATITIS; MUTATIONS; INHIBITOR; MELLITUS; RECURRENT	Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatitis. Since the N34S variant of the SPINK1 trypsin inhibitor gene has been found to partially account for genetic susceptibility to chronic pancreatitis, we used a family-based and case-control approach in two separate ethnic groups from the Indian subcontinent, to determine whether N34S was associated with susceptibility to FCPD. Clear excess transmission of SPINK1 N34S to the probands with FCPD in 69 Bangladeshi families was observed (P<.0001; 20 transmissions and 2 nontransmissions). In the total study group (Bangladeshi and southern Indian) the N34S variant was present in 33% of 180 subjects with FCPD, 4.4% of 861 nondiabetic subjects (odds ratio 10.8; P<.0001 compared with FCPD), 3.7% of 219 subjects with type 2 diabetes, and 10.6% of 354 subjects with early-onset diabetes (aged <30 years) (P =.02 compared with the ethnically matched control group). These results suggest that the N34S variant of SPINK1 is a susceptibility gene for FCPD in the Indian subcontinent, although, by itself, it is not sufficient to cause disease.	Barts & London Queen Mary Sch Med & Dent, London, England; Madras Diabet Res Fdn, Chennai, India; Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dhaka, Bangladesh; Univ Basel Hosp, CH-4031 Basel, Switzerland; Univ Pittsburgh, Pittsburgh, PA USA	University of London; Queen Mary University London; Madras Diabetes Research Foundation; University of Basel; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hitman, GA (corresponding author), Royal London Hosp, Dept Diabet & Meatb Med, London E1 1BB, England.		McDermott, Michael Francis/GZM-5330-2022; McDermott, Michael/S-8490-2019; Curtis, David/HGB-3921-2022	McDermott, Michael/0000-0002-1015-0745; Curtis, David/0000-0002-4089-9183; Ali, Prof Liaquat/0000-0001-9024-0291				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Chen JM, 2000, J MED GENET, V37, P67, DOI 10.1136/jmg.37.1.67; Chowdhury ZM, 2002, GENES IMMUN, V3, P5, DOI 10.1038/sj.gene.6363814; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; Hassan Z, 2000, DIABETES-METAB RES, V16, P454, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR155>3.0.CO;2-K; KAMBO PK, 1989, DIABETOLOGIA, V32, P45; MOHAN V, 1989, PANCREAS, V4, P690, DOI 10.1097/00006676-198912000-00006; Mohan V, 1998, DIABETES METAB REV, V14, P153, DOI 10.1002/(SICI)1099-0895(199806)14:2<153::AID-DMR212>3.3.CO;2-H; Noone PG, 2001, GASTROENTEROLOGY, V121, P1310, DOI 10.1053/gast.2001.29673; Ockenga J, 2000, AM J GASTROENTEROL, V95, P2061; Pfutzer R, 2002, GUT, V50, P271, DOI 10.1136/gut.50.2.271; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Plendl H, 2001, AM J MED GENET, V100, P252, DOI 10.1002/ajmg.1287; RAMACHANDRAN A, 1992, DIABETES CARE, V15, P1348, DOI 10.2337/diacare.15.10.1348; Rossi L, 2001, PANCREATOLOGY, V1, P242, DOI 10.1159/000055818; Rossi L, 1998, PANCREAS, V17, P278, DOI 10.1097/00006676-199810000-00009; Sanjeevi CB, 1999, TISSUE ANTIGENS, V54, P83, DOI 10.1034/j.1399-0039.1999.540109.x; SCHNEIDER A, IN PRESS GASTROENTER; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; TEICH N, 2002, GENETIC DISORDERS EX, P20; Threadgold J, 2002, GUT, V50, P675, DOI 10.1136/gut.50.5.675; Truninger K, 2001, SWISS MED WKLY, V131, P565; Whitcomb DC, 1999, GUT, V45, P317, DOI 10.1136/gut.45.3.317; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Whitcomb DC, 2000, MED CLIN N AM, V84, P531, DOI 10.1016/S0025-7125(05)70238-8; Whitcomb DC, 2002, AM J GASTROENTEROL, V97, P1085; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2002, GUT, V50, P590, DOI 10.1136/gut.50.5.590	30	62	66	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					964	968		10.1086/342731	http://dx.doi.org/10.1086/342731			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12187509	Green Published, Bronze			2022-12-18	WOS:000178613800024
J	Wooding, SP; Watkins, WS; Bamshad, MJ; Dunn, DM; Weiss, RB; Jorde, LB				Wooding, SP; Watkins, WS; Bamshad, MJ; Dunn, DM; Weiss, RB; Jorde, LB			DNA sequence variation in a 3.7-kb noncoding sequence 5 ' of the CYP1A2 gene: Implications for human population history and natural selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN Y-CHROMOSOME; MODERN HUMAN ORIGINS; HUMAN MITOCHONDRIAL-DNA; RECENT COMMON ANCESTRY; LINKAGE DISEQUILIBRIUM; HUMAN-EVOLUTION; HAPLOTYPE FREQUENCIES; MICROSATELLITE MUTATIONS; MOLECULAR EVOLUTION	CYP1A2 is a cytochrome P450 gene that is involved in human physiological responses to a variety of drugs and toxins. To investigate the role of population history and natural selection in shaping genetic diversity in CYP1A2, we sequenced a 3.7-kb region 5 from CYP1A2 in a diverse collection of 113 individuals from three major continental regions of the Old World (Africa, Asia, and Europe). We also examined sequences in the 90-member National Institutes of Health DNA Polymorphism Discovery Resource (PDR). Eighteen single-nucleotide polymorphisms (SNPs) were found. Most of the high-frequency SNPs found in the Old World sample were also found in the PDR sample. However, six SNPs were detected in the Old World sample but not in the PDR sample, and two SNPs found in the PDR sample were not found in the Old World sample. Most pairs of SNPs were in complete linkage disequilibrium with one another, and there was no indication of a decline of disequilibrium with physical distance in this region. The average +/- SD nucleotide diversity in the Old World sample was. The 0.00043 +/- 0.00026 African population had the highest level of nucleotide diversity and the lowest level of linkage disequilibrium. Two distinct haplotype clusters with broadly overlapping geographical distributions were present. Of the 17 haplotypes found in the Old World sample, 12 were found in the African sample, 8 were found in Indians, 5 were found in non-Indian Asians, and 5 were found in Europeans. Haplotypes found outside Africa were mostly a subset of those found within Africa. These patterns are all consistent with an African origin of modern humans. Seven SNPs were singletons, and the site-frequency spectrum showed a significant departure from neutral expectations, suggesting population expansion and/ or natural selection. Comparison with outgroup species showed that four derived SNPs have achieved high ( 0.90) frequencies in human populations, a trend consistent with the action of positive natural selection. These patterns have a number of implications for disease-association studies in CYP1A2 and other genes.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jorde, LB (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu			NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NIEHS NIH HHS [ES-10058] Funding Source: Medline; NIGMS NIH HHS [GM-59290, R01 GM059290] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitchison KJ, 2000, PHARMACOGENETICS, V10, P695, DOI 10.1097/00008571-200011000-00004; Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; BAMSHAD M, IN PRESS P NATL ACAD; Basile VS, 2000, MOL PSYCHIATR, V5, P410, DOI 10.1038/sj.mp.4000736; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Deinard A, 1999, J HUM EVOL, V36, P687, DOI 10.1006/jhev.1999.0298; DEKA R, 1995, ELECTROPHORESIS, V16, P1659, DOI 10.1002/elps.11501601275; Deka R, 1999, J GENET, V78, P99, DOI 10.1007/BF02924561; Di Rienzo A, 1998, GENETICS, V148, P1269; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Evett IW., 1998, INTERPRETING DNA EVI, P23; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; FAY J, 2002, H TEST VERSION 1 0; Fay JC, 2001, GENETICS, V158, P1227; Fay JC, 2000, GENETICS, V155, P1405; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1996, GENETICS, V143, P557; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; Gonser R, 2000, GENETICS, V154, P1793; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Harding RM, 1997, AM J HUM GENET, V60, P772; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hey J, 2001, HKA; HUDSON RR, 1987, GENETICS, V116, P153; IKEYA K, 1989, MOL ENDOCRINOL, V3, P1399, DOI 10.1210/mend-3-9-1399; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 2000, ANN HUM GENET, V64, P117, DOI 10.1017/S0003480000008034; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; JORDE LB, 1994, AM J HUM GENET, V54, P884; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kimmel M, 1998, GENETICS, V148, P1921; Labuda D, 2000, GENETICS, V156, P799; LEWONTIN RC, 1966, GENETICS, V54, P595; LEWONTIN RC, 1964, GENETICS, V49, P49; LI WH, 1991, GENETICS, V129, P513; Mountain JL, 1998, EVOL ANTHROPOL, V7, P21, DOI 10.1002/(SICI)1520-6505(1997)6:4<21::AID-EVAN4>3.0.CO;2-Z; Nachman MW, 2000, GENETICS, V155, P1855; Nachman MW, 2000, GENETICS, V156, P297; Nachman MW, 1998, GENETICS, V150, P1133; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; NEI M, 1984, EVOL BIOL, V17, P73; Nei Masatoshi, 1993, P239; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NICKERSON DA, 1997, NUCLEIC ACIDS RES, V25, P2475; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Ott J, 1997, GENETICS, V147, P927; Owens K, 1999, SCIENCE, V286, P451, DOI 10.1126/science.286.5439.451; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; PerezLezaun A, 1997, HUM GENET, V99, P1; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Roessli D, 2000, ARLEQUIN VERSION 2 0; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Schulze TG, 2001, AM J MED GENET, V105, P498, DOI 10.1002/ajmg.1472; SCHWEIKL H, 1993, PHARMACOGENETICS, V3, P239, DOI 10.1097/00008571-199310000-00003; Seielstad M, 1999, GENOME RES, V9, P558; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Sherry ST, 1997, GENETICS, V147, P1977; Shriver MD, 1997, GENOME RES, V7, P586, DOI 10.1101/gr.7.6.586; SLATKIN M, 1991, GENETICS, V129, P555; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STONEKING M, 1997, PROGR POPULATION GEN; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1995, THEOR POPUL BIOL, V48, P198, DOI 10.1006/tpbi.1995.1026; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Terwilliger JD, 2000, HUM BIOL, V72, P63; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wall JD, 2000, GENETICS, V155, P1865; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wise CA, 1998, GENETICS, V148, P409; Yu N, 2002, GENETICS, V161, P269; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	122	62	66	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					528	542		10.1086/342260	http://dx.doi.org/10.1086/342260			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12181774	Green Published, Bronze			2022-12-18	WOS:000177489600007
J	Kehrer-Sawatzki, H; Schreiner, B; Tanzer, S; Platzer, M; Muller, S; Hameister, H				Kehrer-Sawatzki, H; Schreiner, B; Tanzer, S; Platzer, M; Muller, S; Hameister, H			Molecular characterization of the pericentric inversion that causes differences between chimpanzee chromosome 19 and human chromosome 17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC MYELOID-LEUKEMIA; TOPOISOMERASE-II; GREAT APES; GENOMIC REORGANIZATION; PRIMATE EVOLUTION; DNA-SEQUENCE; HUMAN GENE; BREAKPOINTS; TRANSLOCATIONS; REARRANGEMENTS	A comparison of the human genome with that of the chimpanzee is an attractive approach to attempts to understand the specificity of a certain phenotype's development. The two karyotypes differ by one chromosome fusion, nine pericentric inversions, and various additions of heterochromatin to chromosomal telomeres. Only the fusion, which gave rise to human chromosome 2, has been characterized at the sequence level. During the present study, we investigated the pericentric inversion by which chimpanzee chromosome 19 differs from human chromosome 17. Fluorescence in situ hybridization was used to identify breakpoint-spanning bacterial artificial chromosomes (BACs) and plasmid artificial chromosomes (PACs). By sequencing the junction fragments, we localized breakpoints in intergenic regions rich in repetitive elements. Our findings suggest that repeat-mediated nonhomologous recombination has facilitated inversion formation. No addition or deletion of any sequence element was detected at the breakpoints or in the surrounding sequences. Next to the break, at a distance of 10.2-39.1 kb, the following genes were found: NGFR and NXPH3 (on human chromosome 17q21.3) and GUC2D and ALOX15B (on human chromosome 17p13). The inversion affects neither the genomic structure nor the gene-activity state with regard to replication timing of these genes.	Univ Ulm, Dept Human Genet, D-89081 Ulm, Germany; Inst Mol Biotechnol, Dept Genome Anal, Jena, Germany; Univ Munich, Inst Anthropol & Human Genet, D-8000 Munich, Germany	Ulm University; University of Munich	Kehrer-Sawatzki, H (corresponding author), Univ Ulm, Dept Human Genet, Albert Einstein Allee 11, D-89081 Ulm, Germany.	hildegard.kehrer-sawatzki@medizin.uni-ulm.de						Angata T, 2001, J BIOL CHEM, V276, P40282, DOI 10.1074/jbc.M105926200; AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; DUTRILLAUX B, 1975, ANN GENET-PARIS, V18, P153; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Jeffs AR, 1998, HUM MOL GENET, V7, P767, DOI 10.1093/hmg/7.5.767; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kanoe H, 1999, ONCOGENE, V18, P721, DOI 10.1038/sj.onc.1202364; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; King M., 1993, SPECIES EVOLUTION RO; KOEHLER U, 1995, GENOMICS, V30, P287, DOI 10.1006/geno.1995.9875; KOEHLER U, 1995, AM J PHYS ANTHROPOL, V97, P37, DOI 10.1002/ajpa.1330970104; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lyon CJ, 1996, MOL IMMUNOL, V33, P157, DOI 10.1016/0161-5890(95)00125-5; Marzella R, 2000, GENOMICS, V63, P307, DOI 10.1006/geno.1999.6092; Missler M, 1998, J NEUROSCI, V18, P3630; Muller S, 1998, CYTOMETRY, V33, P445; Muller S, 2001, HUM GENET, V109, P85; Nickerson E, 1998, GENOMICS, V50, P368, DOI 10.1006/geno.1998.5332; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; Romana SP, 1999, LEUKEMIA, V13, P1754, DOI 10.1038/sj.leu.2401564; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; SANDER M, 1985, NUCLEIC ACIDS RES, V13, P1057, DOI 10.1093/nar/13.4.1057; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; Szabo Z, 1999, J MOL EVOL, V49, P664, DOI 10.1007/PL00006587; Todd R, 2001, BRIT J HAEMATOL, V113, P143, DOI 10.1046/j.1365-2141.2001.02713.x; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; WIENBERG J, 1990, GENOMICS, V8, P347, DOI 10.1016/0888-7543(90)90292-3; Winter H, 2001, HUM GENET, V108, P37, DOI 10.1007/s004390000439; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; ZHANG JG, 1995, BRIT J HAEMATOL, V90, P138, DOI 10.1111/j.1365-2141.1995.tb03392.x; ZIETKIEWICZ E, 1994, NUCLEIC ACIDS RES, V22, P5608, DOI 10.1093/nar/22.25.5608	43	62	64	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					375	388		10.1086/341963	http://dx.doi.org/10.1086/341963			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12094327	Bronze, Green Published			2022-12-18	WOS:000176977700015
J	Garner, CP; Tatu, T; Best, S; Creary, L; Thein, SL				Garner, CP; Tatu, T; Best, S; Creary, L; Thein, SL			Evidence of genetic interaction between the beta-globin complex and chromosome 8q in the expression of fetal hemoglobin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							F-CELLS; HEREDITARY PERSISTENCE; THALASSEMIA-INTERMEDIA; MAP	During human development, the switch from fetal to adult hemoglobin (Hb) is not complete with the residual gamma-globin expression being restricted to a subset of erythrocytes termed "F cells" (FC). Statistical analyses have shown the FC trait to be influenced by a common sequence variant (C-->T) at position 5 158 upstream of the Ggamma-globin gene, termed the "XmnI-Ggamma polymorphism." The XmnI-Ggamma site is believed to be involved in the expression of the Ggamma-globin gene through interaction with transcription factors, and polymorphisms in the transcription factors could be influencing fetal Hb expression, conditional on the XmnI-Ggamma site. Using a two-locus model, in which the second locus was the known quantitative-trait locus (QTL) at the XmnI-Ggamma site, we showed suggestive linkage to chromosome 8q. A maximum single-point LOD score of 4.33 and a multipoint LOD score of 4.75 were found in a 15-20 cM region of chromosome 8q. A single-locus analysis failed to show linkage of FC to the region when the XmnI-Ggamma site was accounted for by removing its effects from the data or including it as a covariate. Results of the single-locus analysis were significant when the effects of the XmnI-Ggamma site were not accounted for in any way. The results of analysis in a large Indian kindred indicate that there is an interaction between the XmnI-Ggamma site and a QTL on chromosome 8q that is influencing the production of fetal Hb.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Guys Kings & St Thomas Sch Med, Dept Haematol Med, London, England	University of California System; University of California Berkeley; University of London; King's College London	Garner, CP (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	cgarner@socrates.berkeley.edu	Best, Steve/A-7531-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-40282, R01 GM040282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; CRAIG JE, 1993, BRIT J HAEMATOL, V84, P106, DOI 10.1111/j.1365-2141.1993.tb03032.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOVER GJ, 1992, BLOOD, V80, P816; ECONOMOU EP, 1991, BLOOD, V77, P174; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; GILMAN JG, 1985, BLOOD, V66, P783; Green P, 1990, DOCUMENTATION CRI MA; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; Ho PJ, 1998, BRIT J HAEMATOL, V100, P70; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MIYOSHI K, 1988, BLOOD, V72, P1854; MORTON NE, 1974, AM J HUM GENET, V26, P489; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; SAMPIETRO M, 1992, BLOOD, V79, P832; THEIN SL, 1994, AM J HUM GENET, V54, P214; THEIN SL, 1987, BRIT J HAEMATOL, V65, P367, DOI 10.1111/j.1365-2141.1987.tb06870.x; Thein SL, 1989, HEMOGLOBIN SWITCHI B, P97; Wood WG, 2001, DISORDERS HEMOGLOBIN, P356; ZAGO MA, 1979, BLOOD, V53, P977	26	62	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					793	799		10.1086/339248	http://dx.doi.org/10.1086/339248			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11822023	Green Published, Bronze			2022-12-18	WOS:000173880000024
J	Lee, C; Gisselsson, D; Jin, C; Nordgren, A; Ferguson, DO; Blennow, E; Fletcher, JA; Morton, CC				Lee, C; Gisselsson, D; Jin, C; Nordgren, A; Ferguson, DO; Blennow, E; Fletcher, JA; Morton, CC			Limitations of chromosome classification by multicolor karyotyping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; HUMAN BREAST-CANCER; MULTIPLEX-FISH; IDENTIFICATION; REARRANGEMENTS	Multicolor karyotyping technologies, such as spectral karyotyping (SKY) (Schrock et al. 1996; Liyanage et al. 1996) and multiplex (M-) FISH (Speicher et al. 1996), have proved to be extremely useful in prenatal, postnatal, and cancer cytogenetics. However, these technologies have inherent limitations that, in certain situations, may result in chromosomal misclassification. In this report, we present nine cases, which fall into five categories, in which multicolor karyotyping has produced erroneous interpretations. Most errors appear to have a similar mechanistic basis.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA USA; Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; Karolinska Inst, Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Nordgren, Ann/AAQ-9142-2021; Mohammed, Reem/C-6508-2015; Nordgren, Ann C/N-4057-2013	Nordgren, Ann/0000-0003-3285-4281; Nordgren, Ann C/0000-0003-3285-4281				Andersen CL, 2000, CYTOGENET CELL GENET, V90, P30, DOI 10.1159/000015656; Castleman KR, 2000, CYTOMETRY, V41, P139; Choo KHA., 1997, CENTROMERE; Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Fan YS, 2000, GENET TEST, V4, P9, DOI 10.1089/109065700316417; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Haddad BR, 1998, HUM GENET, V103, P619, DOI 10.1007/s004390050878; Jalal SM, 1999, GENET MED, V1, P181; Jin C, 2001, GENE CHROMOSOME CANC, V30, P161, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1077>3.3.CO;2-2; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; LEE C, 2000, CURRENT PROTOCOLS HU; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lu YJ, 2000, CHROMOSOME RES, V8, P127, DOI 10.1023/A:1009242502960; Nordgren A, 2000, Hematol J, V1, P95, DOI 10.1038/sj.thj.6200011; Sawyer JR, 1998, BLOOD, V92, P4269, DOI 10.1182/blood.V92.11.4269.423k31_4269_4278; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265; Uhrig S, 1999, AM J HUM GENET, V65, P448, DOI 10.1086/302508; Veldman T, 1997, NAT GENET, V15, P406, DOI 10.1038/ng0497-406	20	62	71	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1043	1047		10.1086/319503	http://dx.doi.org/10.1086/319503			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11222105	Green Published, Bronze			2022-12-18	WOS:000167666000024
J	Bull, LN; Roche, E; Song, EJ; Pedersen, J; Knisely, AS; van der Hagen, CB; Eiklid, K; Aagenaes, O; Freimer, NB				Bull, LN; Roche, E; Song, EJ; Pedersen, J; Knisely, AS; van der Hagen, CB; Eiklid, K; Aagenaes, O; Freimer, NB			Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY CHOLESTASIS; MDR3 GENE; HETEROGENEITY; MUTATIONS; LIVER; CHILD	Patients with cholestasis-lymphedema syndrome (CLS) suffer severe neonatal cholestasis that usually lessens during early childhood and becomes episodic; they also develop chronic severe lymphedema. The genetic cause of CLS is unknown. We performed a genome screen, using DNA from eight Norwegian patients with CLS and from seven unaffected relatives, all from an extended pedigree. Regions potentially shared identical by descent in patients were further characterized in a larger set of Norwegian patients. The patients manifest extensive allele and haplotype sharing over the 6.6-cM D15S979-D15S652 region: 30 (83.3%) of 36 chromosomes of affected individuals carry a six-marker haplotype not found on any of the 32 nontransmitted parental chromosomes. All Norwegian patients with CLS are likely homozygous for the same disease mutation, inherited from a shared ancestor.	Univ Calif San Francisco, San Francisco Gen Hosp, Liv Ctr Lab, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Neurogenet Lab, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94110 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94110 USA; Univ Oslo, Ulleval Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; Univ Oslo, Ulleval Univ Hosp, Dept Pediat, N-0407 Oslo, Norway; Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77550 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oslo; University of Oslo; University of Texas System; University of Texas Medical Branch Galveston	Bull, LN (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Liv Ctr Lab, 1001 Potrero Ave,Bldg 40,Room 4102, San Francisco, CA 94110 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050697] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK50697, R01 DK050697] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AAGENAES O, 1974, ACTA PAEDIATR SCAND, V63, P465, DOI 10.1111/j.1651-2227.1974.tb04832.x; AAGENAES O, 1968, ARCH DIS CHILD, V43, P646, DOI 10.1136/adc.43.232.646; Aagenaes O, 1998, SCAND J GASTROENTERO, V33, P335, DOI 10.1080/00365529850170955; AAGENAES O, 1970, ARCH DIS CHILD, V45, P690, DOI 10.1136/adc.45.243.690; Bull LN, 1999, HUM GENET, V104, P241, DOI 10.1007/PL00008714; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Evans AL, 1999, AM J HUM GENET, V64, P547, DOI 10.1086/302248; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Green RM, 2000, GENE, V241, P117, DOI 10.1016/S0378-1119(99)00460-6; HENNEKAM RCM, 1989, AM J MED GENET, V34, P593, DOI 10.1002/ajmg.1320340429; Jacquemin E, 1999, LANCET, V353, P210, DOI 10.1016/S0140-6736(05)77221-4; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Knisely AS, 2000, PEDIATR DEVEL PATHOL, V3, P113, DOI 10.1007/s100240050016; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Mangion J, 1999, AM J HUM GENET, V65, P427, DOI 10.1086/302500; Morris AAM, 1997, J MED GENET, V34, P852, DOI 10.1136/jmg.34.10.852; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; PAWLOWSKA J, 1994, HEPATOL POLSKA, V1, P43; PAWLOWSKA J, 1995, SURG CHILD INT, V1, P54; SHARP HL, 1971, J PEDIATR-US, V78, P491, DOI 10.1016/S0022-3476(71)80232-9; Shneider BL, 1999, J PEDIATR GASTR NUTR, V28, P124, DOI 10.1097/00005176-199902000-00005; SIGSTAD H, 1970, ACTA MED SCAND, V188, P213; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; VAJRO P, 1984, ACTA PAEDIATR SCAND, V73, P695; Witte MH, 1998, LYMPHOLOGY, V31, P145	27	62	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					994	999		10.1086/303080	http://dx.doi.org/10.1086/303080			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10968776	Green Published, Bronze			2022-12-18	WOS:000089651100023
J	Crow, YJ; Jackson, AP; Roberts, E; van Beusekom, E; Barth, P; Corry, P; Ferrie, CD; Hamel, BCJ; Jayatunga, R; Karbani, G; Kalmanchey, R; Kelemen, A; King, M; Kumar, R; Livingstone, J; Massey, R; McWilliam, R; Meager, A; Rittey, C; Stephenson, JBP; Tolmie, JL; Verrips, A; Voit, T; van Bokhoven, H; Brunner, HG; Woods, CG				Crow, YJ; Jackson, AP; Roberts, E; van Beusekom, E; Barth, P; Corry, P; Ferrie, CD; Hamel, BCJ; Jayatunga, R; Karbani, G; Kalmanchey, R; Kelemen, A; King, M; Kumar, R; Livingstone, J; Massey, R; McWilliam, R; Meager, A; Rittey, C; Stephenson, JBP; Tolmie, JL; Verrips, A; Voit, T; van Bokhoven, H; Brunner, HG; Woods, CG			Aicardi-Goutieres syndrome display genetic heterogeneity with one locus (AGS1) on chromosome 3p21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE FAMILIAL ENCEPHALOPATHY; CEREBROSPINAL-FLUID LYMPHOCYTOSIS; INFECTION-LIKE SYNDROME; CENTRAL-NERVOUS-SYSTEM; INTRACRANIAL CALCIFICATION; INTERFERON-ALPHA; BASAL GANGLIA; INTRAUTERINE INFECTION; LINKAGE ANALYSIS; 2 SIBLINGS	We have studied 23 children from 13 families with a clinical diagnosis of Aicardi-Goutieres syndrome. Affected individuals had developed an early-onset progressive encephalopathy that was characterized by a normal head circumference at birth, basal ganglia calcification, negative viral studies, and abnormalities of cerebrospinal fluid comprising either raised white cell counts and/or raised levels of interferon-alpha. By means of genomewide linkage analysis, a maximum-heterogeneity LOD score of 5.28 was reached at marker D3S3563, with alpha =.48, where alpha is the proportion of families showing linkage. Our data suggest the existence of locus heterogeneity in Aicardi-Goutieres syndrome and highlight potential difficulties in the differentiation of this condition from pseudo-TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus types 1 and 2) syndrome.	Univ Leeds, St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Leeds Gen Infirm, Dept Paediat Neurol, Leeds, W Yorkshire, England; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen Hosp, Dept Child Neurol, NL-6500 HB Nijmegen, Netherlands; Univ Amsterdam, Dept Paediat, NL-1012 WX Amsterdam, Netherlands; St Lukes Hosp, Dept Paediat, Bradford, W Yorkshire, England; Sandwell Dist Gen Hosp, Dept Paediat, W Bromwich, England; Semmelweis Univ, Dept Pediat, H-1085 Budapest, Hungary; Childrens Hosp, Dept Paediat Neurol, Dublin, Ireland; Sheffield Childrens Hosp, Clin Genet Unit, Sheffield, S Yorkshire, England; Sheffield Childrens Hosp, Dept Paediat Neurol, Sheffield, S Yorkshire, England; Hull Royal Infirm, Dept Paediat, Kingston Upon Hull HU3 2JZ, N Humberside, England; Yorkhill Hosp, Dept Paediat Neurol, Glasgow, Lanark, Scotland; Yorkhill Hosp, Dept Clin Genet, Glasgow, Lanark, Scotland; Natl Inst Biol Stand & Controls, S Mimms, Herts, England; Univ Essen Gesamthsch, Dept Paediat, Essen, Germany	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Leeds General Infirmary; University of Leeds; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Semmelweis University; Trinity College Dublin; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Hull; National Institute for Biological Standards & Control; University of Duisburg Essen	Crow, YJ (corresponding author), Univ Leeds, St James Univ Hosp, Mol Med Unit, Clin Sci Bldg, Leeds LS9 7TF, W Yorkshire, England.	ycrow@hgmp.mrc.ac.uk	woods, christopher g/A-1361-2010; Bokhoven, J.H.L.M. van van/H-8015-2014; van Bokhoven, Hans/D-8764-2012; van Beusekom, Ellen/AAF-2687-2019; Crow, Yanick J/N-6120-2014; Brunner, Han/C-9928-2013; Jackson, Andrew P/D-3442-2009	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Crow, Yanick J/0000-0001-7211-7564; Jackson, Andrew P/0000-0002-8739-2646				AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Akwa Y, 1998, J IMMUNOL, V161, P5016; Al-Dabbous R, 1998, CLIN DYSMORPHOL, V7, P127, DOI 10.1097/00019605-199804000-00009; Bachmeyer C, 1996, BRIT J DERMATOL, V135, P481, DOI 10.1046/j.1365-2133.1996.d01-1028.x; BARAITSER M, 1983, J MED GENET, V20, P210, DOI 10.1136/jmg.20.3.210; Barth PG, 1999, ACTA NEUROPATHOL, V98, P212, DOI 10.1007/s004010051071; BOLTSHAUSER E, 1991, NEUROPEDIATRICS, V22, P33, DOI 10.1055/s-2008-1071412; BONNEMANN CG, 1992, NEUROPEDIATRICS, V23, P157, DOI 10.1055/s-2008-1071333; BURN J, 1986, CLIN GENET, V30, P112; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Campo-Voegeli A, 1998, DERMATOLOGY, V196, P361, DOI 10.1159/000017917; Cid MC, 1999, ARTHRITIS RHEUM-US, V42, P1051, DOI 10.1002/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q; Creutzig A, 1996, ANGIOLOGY, V47, P185, DOI 10.1177/000331979604700210; DIAMENT A J, 1986, Arquivos de Neuro-Psiquiatria, V44, P185; Faure S, 1999, CLIN GENET, V56, P149, DOI 10.1034/j.1399-0004.1999.560210.x; Foster GR, 1998, J VIRAL HEPATITIS, V5, P143, DOI 10.1046/j.1365-2893.1998.00103.x; GIROUD M, 1986, CHILD NERV SYST, V2, P47, DOI 10.1007/BF00274035; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; GOUTIERES F, 2000, AICARDI GOUTIERES SY; ISHITSU T, 1985, JPN J HUM GENET, V30, P213, DOI 10.1007/BF01876471; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumar D, 1998, AM J MED GENET, V75, P508, DOI 10.1002/(SICI)1096-8628(19980217)75:5<508::AID-AJMG10>3.0.CO;2-O; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; McEntagart M, 1998, NEUROPEDIATRICS, V29, P163, DOI 10.1055/s-2007-973555; MEHTA L, 1986, J MED GENET, V23, P157, DOI 10.1136/jmg.23.2.157; Monastiri K, 1997, CLIN GENET, V51, P142; MORTON NE, 1956, AM J HUM GENET, V8, P80; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ostergaard JR, 1999, NEUROPEDIATRICS, V30, P38, DOI 10.1055/s-2007-973455; Ott J., 1991, ANAL HUMAN GENETIC L; REARDON W, 1994, AM J MED GENET, V52, P58, DOI 10.1002/ajmg.1320520112; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; STEPHENSON JBP, 1997, DEV MED CHILD NE S77, V39; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881; Verrips A, 1997, PEDIATR NEUROL, V16, P323, DOI 10.1016/S0887-8994(97)00028-3	37	62	62	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					213	221		10.1086/302955	http://dx.doi.org/10.1086/302955			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10827106	Green Published, Bronze			2022-12-18	WOS:000088926900024
J	Sacksteder, KA; Biery, BJ; Morrell, JC; Goodman, BK; Geisbrecht, BV; Cox, RP; Gould, SJ; Geraghty, MT				Sacksteder, KA; Biery, BJ; Morrell, JC; Goodman, BK; Geisbrecht, BV; Cox, RP; Gould, SJ; Geraghty, MT			Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSINE-KETOGLUTARATE REDUCTASE; SACCHAROPINE DEHYDROGENASE; PATHWAY	The first two steps in the mammalian lysine-degradation pathway are catalyzed by lysine-ketoglutarate reductase and saccharopine dehydrogenase, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Defects in one or both of these activities result in familial hyperlysinemia, an autosomal recessive condition characterized by hyperlysinemia, lysinuria, and variable saccharopinuria. In yeast, lysine-ketoglutarate reductase and saccharopine dehydrogenase are encoded by the LYS1 and LYS9 genes, respectively, and we searched the available sequence databases for their human homologues. We identified a single cDNA that encoded an apparently bifunctional protein, with the N-terminal half similar to that of yeast LYS1 and with the C-terminal half similar to that of yeast LYS9. This bifunctional protein has previously been referred to as "alpha-aminoadipic semialdehyde synthase," and we have tentatively designated this gene "AASS." The AASS cDNA contains an open reading frame of 2,781 be predicted to encode a 927-amino-acid-long protein. The gene has been sequenced and contains 24 exons scattered over 68 kb and maps to chromosome 7q31.3. Northern blot analysis revealed the presence of several transcripts in all tissues examined, with the highest expression occurring in the liver. We sequenced the genomic DNA from a single patient with hyperlysinemia (JJa). The patient is the product of a consanguineous mating and is homozygous for an out-of-frame 9-bp deletion in exon 15, which results in a premature stop codon at position 534 of the protein. On the basis of these and other results, we propose that AASS catalyzes the first two steps of the major lysine-degradation pathway in human cells and that inactivating mutations in the AASS gene are a cause of hyperlysinemia.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21287 USA; Univ Texas, SW Med Ctr, Div Gen Internal Med, Dallas, TX 75216 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Geraghty, MT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Blalock 1008,600 N Wolfe St, Baltimore, MD 21287 USA.				NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; CHANG YF, 1978, J NEUROCHEM, V30, P347, DOI 10.1111/j.1471-4159.1978.tb06536.x; COX RP, 1995, METABOLIC MOL BASES, P1233; DANCIS J, 1969, J CLIN INVEST, V48, P1447, DOI 10.1172/JCI106110; DANCIS J, 1976, PEDIATR RES, V10, P686, DOI 10.1203/00006450-197610070-00011; Epelbaum S, 1997, PLANT MOL BIOL, V35, P735, DOI 10.1023/A:1005808923191; Geraghty MT, 1999, P NATL ACAD SCI USA, V96, P2937, DOI 10.1073/pnas.96.6.2937; GIACOBINI E, 1980, CELL MOL BIOL, V26, P135; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; MARKOVITZ PJ, 1984, J BIOL CHEM, V259, P1643; MARKOVITZ PJ, 1987, J BIOL CHEM, V262, P9353; OZALP I, 1981, ACTA PAEDIATR SCAND, V70, P951, DOI 10.1111/j.1651-2227.1981.tb06259.x; PRAGOBPOL S, 1984, ARCH BIOCHEM BIOPHYS, V230, P285, DOI 10.1016/0003-9861(84)90109-7; Sigurdardottir S, 1999, AM J MED GENET, V87, P384, DOI 10.1002/(SICI)1096-8628(19991222)87:5<384::AID-AJMG3>3.0.CO;2-R; WOODY NC, 1964, AM J DIS CHILD, V108, P543, DOI 10.1001/archpedi.1964.02090010545015	15	62	63	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1736	1743		10.1086/302919	http://dx.doi.org/10.1086/302919			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775527	Green Published, Bronze			2022-12-18	WOS:000088373800002
J	Fischer, J; Faure, A; Bouadjar, B; Blanchet-Bardon, C; Karaduman, A; Thomas, I; Emre, S; Cure, S; Ozguc, M; Weissenbach, J; Prud'homme, JF				Fischer, J; Faure, A; Bouadjar, B; Blanchet-Bardon, C; Karaduman, A; Thomas, I; Emre, S; Cure, S; Ozguc, M; Weissenbach, J; Prud'homme, JF			Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMELLAR ICHTHYOSIS; LINKAGE ANALYSIS; MUTATIONS; TRANSGLUTAMINASE-1; IDENTIFICATION; KERATINOCYTES; EXPRESSION; DISEASE; MAP	Autosomal recessive ichthyosis (ARI) includes a heterogeneous group of disorders of keratinization characterized by desquamation over the whole body. Two forms largely limited to the skin have been defined: lamellar ichthyosis (LI) and nonbullous congenital ichthyosiform erythroderma (NCIE). A first gene for LI, transglutaminase TGM1, has been identified on chromosome 14, and a second one has been localized on chromosome 2. In a genomewide scan of nine large consanguineous families, using homozygosity mapping, two new loci for ARI were found, one for a lamellar form in a 6-cM interval on chromosome 19 and a second for an erythrodermic form in a 7.7-cM interval on chromosome 3. Linkage to one of the four loci could be demonstrated in more than half of 51 consanguineous families, most of them from the Mediterranean basin. All four loci could be excluded in the others, implying further genetic heterogeneity in this disorder. Multipoint Linkage analysis gave maximal LOD scores of 11.25 at locus D19S566 and 8.53 at locus D3SS564.	Ctr Natl Genotypage, F-91057 Evry, France; Genethon, Evry, France; Genoscope, Ctr Natl Sequencage, Evry, France; Bab Oued Hosp, Dept Dermatol, Algiers, Algeria; Hop St Louis, Dept Dermatol, Paris, France; Hacettepe Univ, Fac Med, Dept Dermatol, Ankara, Turkey; Hacettepe Univ, Fac Med, Dept Med Biol, Ankara, Turkey; Tubiak DNA Cell Bank, Ankara, Turkey	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; Hacettepe University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)	Fischer, J (corresponding author), Ctr Natl Genotypage, 2 Rue Gaston Cremieux, F-91057 Evry, France.		Fischer, Judith/E-6327-2016	Fischer, Judith/0000-0002-8580-8118; OZGUC, Meral/0000-0003-4577-8759				Aeschlimann D, 1998, J BIOL CHEM, V273, P3452, DOI 10.1074/jbc.273.6.3452; ANTONLAMPRECHT I, 1974, ARCH DERMATOL FORSCH, V250, P207, DOI 10.1007/BF00561188; BERGERS M, 1990, J INVEST DERMATOL, V94, P407, DOI 10.1111/1523-1747.ep12874475; Bhat A, 1999, HUM HERED, V49, P229, DOI 10.1159/000022879; DeLaurenzi V, 1996, NAT GENET, V12, P52; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dubbink HJ, 1996, BIOCHEM J, V315, P901, DOI 10.1042/bj3150901; ELIAS PM, 1984, J CLIN INVEST, V74, P1414, DOI 10.1172/JCI111552; EVANS CB, 1993, PROSTAG LEUKOTR ESS, V49, P777, DOI 10.1016/0952-3278(93)90025-R; FRENK E, 1992, PEDIATR DERMATOL, V9, P95, DOI 10.1111/j.1525-1470.1992.tb01221.x; Griffiths WAD, 1998, ROOK WILKINSON EBLIN, V2, P1483; Hammami-Hauasli N, 1998, J INVEST DERMATOL, V111, P1214, DOI 10.1046/j.1523-1747.1998.00394.x; HAZELL M, 1985, ARCH DERMATOL, V121, P489, DOI 10.1001/archderm.121.4.489; Hennies HC, 1998, AM J HUM GENET, V62, P1052, DOI 10.1086/301818; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laiho E, 1997, AM J HUM GENET, V61, P529, DOI 10.1086/515498; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Parmentier L, 1999, EUR J HUM GENET, V7, P77, DOI 10.1038/sj.ejhg.5200271; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; Refsum S., 1946, ACTA PSYCHIAT SCAND, V38, P1; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; SHAPIRO LJ, 1978, LANCET, V1, P70; Sjogren T, 1957, ACTA PSYCHIAT NEUROL, V32, P1; TAUPE H, 1989, ICHTHYOSES GUIDE CLI, P111; TRAUPE H, 1984, CLIN GENET, V26, P457; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; Williams ML, 1995, PEDIATR DERMATOL, V4th, P413	30	62	64	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					904	913		10.1086/302814	http://dx.doi.org/10.1086/302814			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712205	Bronze, Green Published			2022-12-18	WOS:000088373200013
J	Goring, HHH; Terwilliger, JD				Goring, HHH; Terwilliger, JD			Linkage analysis in the presence of errors I: Complex-valued recombination fractions and complex phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE ANALYSIS; TRAITS; MAPS; MISCLASSIFICATION; GUIDELINES; SYSTEM; HUMANS; MODEL; LOCUS	Linkage is a phenomenon that correlates the genotypes of loci, rather than the phenotypes of one locus to the genotypes of another. It is therefore necessary to convert the observed trait phenotypes into trait-locus genotypes, which can then be analyzed for coinheritance with marker-locus genotypes. However, if the mode of inheritance of the trait is not known accurately, this conversion can often result in errors in the inferred trait-locus genotypes, which, in turn, can lead to the misclassification of the recombination status of meioses. As a result, the recombination fraction can be overestimated in two-point analysis, and false exclusions of the true trait locus can occur in multipoint analysis. We propose a method that increases the robustness of multipoint analysis to errors in the mode of inheritance assumptions of the trait, by explicitly allowing for misclassification of trait-locus genotypes. To this end, the definition of the recombination fraction is extended to the complex plane, as theta = theta + epsilon i; theta is the recombination fraction benveen actual ("real") genotypes of marker and trait loci, and epsilon is the probability of apparent but false ("imaginary") recombinations between the actual and inferred trait-locus genotypes, "Complex" multipoint LOD scores are proven to be stochastically equivalent to conventional two-point LOD scores. The greater robustness to modeling errors normally associated with two-poiut analysis can thus be extended to multiple two-point analysis and multipoint analysis. The use of complex-valued recombination fractions also allows the stochastic equivalence of "model-based" and "model-free" methods to be extended to multipoint analysis.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; New York State Psychiat Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Terwilliger, JD (corresponding author), Columbia Univ, Dept Genet & Dev, 1150 St Nicholas Ave,Unit 109,Room 548, New York, NY 10032 USA.				NHGRI NIH HHS [HG00008, R01 HG000008] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000008, R01HG000008] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Buskes G., 1997, TOPOLOGICAL SPACES D; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DUPUIS J, 1995, GENETICS, V140, P843; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; GORING HHH, 2000, IN PRESS AM J HUM GE; Haldane JBS, 1919, J GENET, V8, P299; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Jaynes Edwin T., 1996, PROBABILITY THEORY L; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Krause E. F., 1975, TAXICAB GEOMETRY ADV; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARTINEZ M, 1989, GENET EPIDEMIOL, V6, P253, DOI 10.1002/gepi.1370060144; MORTON NE, 1988, ANN HUM GENET, V52, P309, DOI 10.1111/j.1469-1809.1988.tb01110.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nahin P.J., 1998, IMAGINARY TALE STORY; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1985, ANAL HUMAN GENETIC L; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Sarkar S., 1998, GENETICS REDUCTIONIS; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Smith HF, 1937, ANN EUGENIC, V8, P94, DOI 10.1111/j.1469-1809.1937.tb02163.x; Terwilliger JD, 1997, AM J HUM GENET, V61, P430, DOI 10.1086/514855; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, 2000, IN PRESS EUR J HUM G; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 2000, IN PRESS GENETIC DIS; TERWILLIGER JD, 1998, ENCY BIOSTATISTICS, P2279; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Walley P., 1991, STAT REASONING IMPRE	36	62	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					1095	1106		10.1086/302797	http://dx.doi.org/10.1086/302797			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712220	Bronze, Green Published			2022-12-18	WOS:000088373200028
J	Leal, SM; Ott, J				Leal, SM; Ott, J			Effects of stratification in the analysis of affected-sib-pair data: Benefits and costs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; LINKAGE STRATEGIES	The benefits and costs of stratification of affected-sib-pair (ASP) data were examined in three situations: (1) when there is no difference in identity-by-descent (IBD) allele sharing between stratified and unstratified ASP data sets; (2) when there is an increase in IBD allele sharing in one of the stratified groups; and (3) when the data are stratified on the basis of IBD allele-sharing status at one locus, and the stratified ASPs are then analyzed for linkage at a second locus. When there is no difference in IBD sharing between strata, a penalty is always paid for stratifying the data. The loss of power to detect linkage in the stratified ASP data sets is the result of multiple testing and the smaller sample size within individual strata. In the case in which etiologic heterogeneity (i.e., severity of phenotype, age at onset) represents genetic heterogeneity, the power to detect linkage can be increased by stratifying the ASP data. This benefit is obtained when there is sufficient IBD allele sharing and sample sizes. Once linkage has been established for a given locus, data can be stratified on the basis of IBD status at this locus and can be tested for linkage at a second locus. When the relative risk is in the vicinity of 1, the power to detect linkage at the second locus is always greater for the unstratified ASP data set. Even for values of the relative risk that diverge sufficiently from 1, with adequate sample sizes and IBD allele sharing, the benefits of stratifying ASP data are minimal.	Rockefeller Univ, Lab State Genet, New York, NY 10021 USA	Rockefeller University	Leal, SM (corresponding author), Rockefeller Univ, Lab State Genet, 1230 York Ave,Box 192, New York, NY 10021 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003594, R29DC003594] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008, R01 HG000008] Funding Source: Medline; NIDCD NIH HHS [R29 DC003594, DC03594, R01 DC003594] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Ott J, 1999, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x	8	62	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					567	575		10.1086/302748	http://dx.doi.org/10.1086/302748			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677317	Green Published, Bronze			2022-12-18	WOS:000088373100024
J	Au, KS; Hebert, AA; Roach, ES; Northrup, H				Au, KS; Hebert, AA; Roach, ES; Northrup, H			Complete inactivation of the TSC2 gene leads to formation of hamartomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							EKER RAT MODEL; TUBEROUS SCLEROSIS HAMARTOMAS; LINKAGE DISEQUILIBRIUM; HETEROZYGOSITY; KIDNEY; DISEASE; REGION; POLYMORPHISMS; POPULATION; MUTATIONS		Univ Texas, Sch Med, Dept Pediat, Div Med Genet, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Dermatol, Houston, TX USA; Univ Texas, SW Med Ctr, Div Pediat Neurol, Dallas, TX USA; Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA	University of Texas System; University of Texas System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children	Northrup, H (corresponding author), Univ Texas, Sch Med, Dept Pediat, Div Med Genet, 6431 Fannin St, Houston, TX 77030 USA.	hnorthru@ped1.med.uth.tmc.edu	Roach, Ewell/E-3958-2011	Au, Kit Sing/0000-0002-2694-5833	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032300] Funding Source: NIH RePORTER; NINDS NIH HHS [R29NS32300-05] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLSEN G, 1994, ARCH NEUROL-CHICAGO, V51, P76, DOI 10.1001/archneur.1994.00540130110018; Al-Saleem T, 1998, CANCER-AM CANCER SOC, V83, P2208, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K; Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; Au KS, 1997, HUM MUTAT, V9, P23, DOI 10.1002/(SICI)1098-1004(1997)9:1<23::AID-HUMU4>3.0.CO;2-Q; Bjornsson J, 1996, AM J PATHOL, V149, P1201; Carbonara C, 1996, GENE CHROMOSOME CANC, V15, P18, DOI 10.1002/(SICI)1098-2264(199601)15:1<18::AID-GCC3>3.0.CO;2-7; Cook JA, 1996, J MED GENET, V33, P480, DOI 10.1136/jmg.33.6.480; EKER R, 1981, DIAGN HISTOPATHOL, V4, P99; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Henske EP, 1996, AM J HUM GENET, V59, P400; HENSKE EP, 1995, GENE CHROMOSOME CANC, V13, P295, DOI 10.1002/gcc.2870130411; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kobayashi T, 1997, JPN J CANCER RES, V88, P254, DOI 10.1111/j.1349-7006.1997.tb00375.x; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; KUBO Y, 1995, CANCER RES, V55, P989; NELLIST M, 1993, CELL, V75, P1305; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; PERAL B, 1994, AM J HUM GENET, V54, P899; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Rose VM, 1999, AM J HUM GENET, V64, P986, DOI 10.1086/302322; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SHEN Y, 1994, HUM MOL GENET, V3, P210, DOI 10.1093/hmg/3.1.210; SNAREY A, 1994, AM J HUM GENET, V55, P365; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verhoef S, 1999, EUR J PEDIATR, V158, P284, DOI 10.1007/s004310051073; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413	28	62	64	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1790	1795		10.1086/302648	http://dx.doi.org/10.1086/302648			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577937	Green Published, Bronze			2022-12-18	WOS:000084282500038
J	Grohmann, K; Wienker, TF; Saar, K; Rudnik-Schoneborn, S; Stoltenburg-Didinger, G; Rossi, R; Novelli, G; Nurnberg, G; Pfeufer, A; Wirth, B; Reis, A; Zerres, K; Hubner, C				Grohmann, K; Wienker, TF; Saar, K; Rudnik-Schoneborn, S; Stoltenburg-Didinger, G; Rossi, R; Novelli, G; Nurnberg, G; Pfeufer, A; Wirth, B; Reis, A; Zerres, K; Hubner, C			Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							PROGRESSIVE MOTOR NEURONOPATHY; PARALYSIS; VARIANT; MAPS; GENE		Humboldt Univ, Clin Neuropediat, D-13353 Berlin, Germany; Humboldt Univ, Inst Lab Med, D-13353 Berlin, Germany; Univ Hosp Benjamin Franklin, Dept Neuropathol, Berlin, Germany; Childrens Hosp Neukolln, Berlin, Germany; Univ Bonn, Inst Med Stat, D-5300 Bonn, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Max Delbruck Ctr Mol Med, Microsatellite Ctr, Berlin, Germany; Aachen Tech Univ, Dept Human Genet, Aachen, Germany; Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Rome, Italy	Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; University of Bonn; Helmholtz Association; Max Delbruck Center for Molecular Medicine; RWTH Aachen University; University of Rome Tor Vergata	Hubner, C (corresponding author), Humboldt Univ, Clin Neuropediat, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.		Rudnik-Schöneborn, Sabine/F-8473-2015; Novelli, Giuseppe/T-8822-2019; Wirth, Brunhilde/H-3192-2019; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/A-5195-2013; Pfeufer, Arne/B-6634-2013; Reis, André/D-2309-2009	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Reis, André/0000-0002-6301-6363; Wirth, Brunhilde/0000-0003-4051-5191; Saar, Kathrin/0000-0002-4483-1557				BERTINI E, 1989, AM J MED GENET, V33, P328, DOI 10.1002/ajmg.1320330309; BRUNIALTI ALB, 1995, GENOMICS, V29, P131, DOI 10.1006/geno.1995.1223; GROHMANN K, 1998, 5 WORKSH NEUR GERM F; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MELLINS RB, 1974, PEDIATRICS, V53, P33; NOVELLI G, 1995, J MED GENET, V32, P216, DOI 10.1136/jmg.32.3.216; RudnikSchoneborn S, 1996, NEUROPEDIATRICS, V27, P8, DOI 10.1055/s-2007-973741; Saar K, 1997, AM J HUM GENET, V60, P605; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002	10	62	62	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1459	1462		10.1086/302636	http://dx.doi.org/10.1086/302636			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521314	Bronze, Green Published			2022-12-18	WOS:000083531000030
J	O'Donovan, MC; Owen, MJ				O'Donovan, MC; Owen, MJ			Candidate-gene association studies of schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC CAG REPEAT; RECEPTOR GENE; T102C POLYMORPHISM; BIPOLAR DISORDER; TRANSMISSION DISEQUILIBRIUM; PSYCHIATRIC GENETICS; TRIPLET REPEAT; HKCA3 GENE; METAANALYSIS; EXPANSIONS		Univ Wales, Coll Med, Neuropsychiat Genet Unit, Dept Med Psychol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Owen, MJ (corresponding author), Univ Wales, Coll Med, Neuropsychiat Genet Unit, Dept Med Psychol, Tenovus Bldg,Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		O'Donovan, Michael C/P-7005-2018	O'Donovan, Michael C/0000-0001-7073-2379				Austin CP, 1999, MOL PSYCHIATR, V4, P261, DOI 10.1038/sj.mp.4000548; Bonnet-Brilhault F, 1999, EUR J HUM GENET, V7, P247, DOI 10.1038/sj.ejhg.5200278; Bowen T, 1998, MOL PSYCHIATR, V3, P266, DOI 10.1038/sj.mp.4000400; Bunzel R, 1998, MOL BRAIN RES, V59, P90, DOI 10.1016/S0169-328X(98)00146-6; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; CROCQ MA, 1992, J MED GENET, V29, P858, DOI 10.1136/jmg.29.12.858; Dror V, 1999, MOL PSYCHIATR, V4, P254, DOI 10.1038/sj.mp.4000508; Inayama Y, 1996, AM J MED GENET, V67, P103, DOI 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO;2-S; Joober R, 1999, AM J MED GENET, V88, P154, DOI 10.1002/(SICI)1096-8628(19990416)88:2<154::AID-AJMG11>3.0.CO;2-A; Laurent C, 1998, AM J MED GENET, V81, P342, DOI 10.1002/(SICI)1096-8628(19980710)81:4<342::AID-AJMG12>3.0.CO;2-L; Li T, 1998, BIOL PSYCHIAT, V44, P1160, DOI 10.1016/S0006-3223(97)00492-7; Li T, 1998, BIOCHEM BIOPH RES CO, V251, P662, DOI 10.1006/bbrc.1998.9484; Lindblad K, 1998, MOL PSYCHIATR, V3, P405, DOI 10.1038/sj.mp.4000416; MCGUE M, 1989, ARCH GEN PSYCHIAT, V46, P478; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; MCGUFFIN P, 1994, SEMINARS PSYCHIAT GE; Morel BA, 1857, TRAITE DEGENERESCENC; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; ODonovan MC, 1996, PSYCHOL MED, V26, P1145, DOI 10.1017/S0033291700035868; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ODonovan MC, 1996, PSYCHOL MED, V26, P1, DOI 10.1017/S0033291700033663; Owen MJ, 1997, MOL PSYCHIATR, V2, P270, DOI 10.1038/sj.mp.4000292; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ross CA, 1999, MOL PSYCHIATR, V4, P4, DOI 10.1038/sj.mp.4000502; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Sidransky E, 1998, AM J HUM GENET, V62, P1548, DOI 10.1086/301876; Spurlock G, 1998, MOL PSYCHIATR, V3, P42, DOI 10.1038/sj.mp.4000342; Stober G, 1998, NEUROREPORT, V9, P3595; Tsai MT, 1999, MOL PSYCHIATR, V4, P271, DOI 10.1038/sj.mp.4000482; Vincent JB, 1999, MOL PSYCHIATR, V4, P229, DOI 10.1038/sj.mp.4000498; Williams J, 1996, LANCET, V347, P1294, DOI 10.1016/S0140-6736(96)90939-3; Williams J, 1998, MOL PSYCHIATR, V3, P141, DOI 10.1038/sj.mp.4000376; Williams J, 1997, LANCET, V349, P1221, DOI 10.1016/S0140-6736(05)62413-0; Wittekindt O, 1999, MOL PSYCHIATR, V4, P267, DOI 10.1038/sj.mp.4000495	37	62	65	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					587	592		10.1086/302560	http://dx.doi.org/10.1086/302560			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441563	Green Published, Bronze			2022-12-18	WOS:000082426400001
J	DeSandro, A; Nagarajan, UM; Boss, JM				DeSandro, A; Nagarajan, UM; Boss, JM			The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MHC CLASS-I; TRANSACTIVATOR CIITA; DEFICIENCY; EXPRESSION; BINDING; CELLS; MUTATIONS; PROMOTERS; PATIENT; INVIVO		Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, 1510 Clifton Rd,Room 3131, Atlanta, GA 30322 USA.	boss@microbio.emory.edu			NIAID NIH HHS [AI34000] Funding Source: Medline; NICHD NIH HHS [HD34440] Funding Source: Medline; NIGMS NIH HHS [GM47310] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034000, R21AI034000, R56AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENICHOU B, 1991, P NATL ACAD SCI USA, V88, P4285, DOI 10.1073/pnas.88.10.4285; Bontron S, 1997, HUM GENET, V99, P541, DOI 10.1007/s004390050403; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; Brown JA, 1996, IMMUNOGENETICS, V43, P88; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; CHANG CH, 1992, J EXP MED, V176, P1465, DOI 10.1084/jem.176.5.1465; Clausen BE, 1998, IMMUNITY, V8, P143, DOI 10.1016/S1074-7613(00)80467-7; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; DEPREVAL C, 1985, NATURE, V318, P291, DOI 10.1038/318291a0; Durand B, 1997, EMBO J, V16, P1045, DOI 10.1093/emboj/16.5.1045; Elhasid R, 1996, BLOOD REV, V10, P242, DOI 10.1016/S0268-960X(96)90008-9; Fondaneche MC, 1998, HUM MOL GENET, V7, P879, DOI 10.1093/hmg/7.5.879; Fontes JD, 1999, MOL CELL BIOL, V19, P941; GLADSTONE P, 1978, NATURE, V271, P459, DOI 10.1038/271459a0; GLADSTONE P, 1980, SOMAT CELL GENET, V6, P285, DOI 10.1007/BF01538802; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Gobin SJP, 1998, IMMUNITY, V9, P531, DOI 10.1016/S1074-7613(00)80636-6; Griscelli C, 1989, Immunodefic Rev, V1, P135; KARA CJ, 1991, SCIENCE, V252, P709, DOI 10.1126/science.1902592; KARA CJ, 1993, J IMMUNOL, V150, P4934; KLEIN C, 1993, J PEDIATR-US, V123, P921, DOI 10.1016/S0022-3476(05)80388-9; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; Moreno CS, 1997, J IMMUNOL, V158, P5841; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; Peijnenburg A, 1999, IMMUNOGENETICS, V49, P338, DOI 10.1007/s002510050501; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; SEIDL C, 1992, J IMMUNOL, V148, P1576; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Villard J, 1997, NEW ENGL J MED, V337, P748, DOI 10.1056/NEJM199709113371104; Villard J, 1997, HUM MUTAT, V10, P430; Westerheide SD, 1999, NUCLEIC ACIDS RES, V27, P1635, DOI 10.1093/nar/27.7.1635; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wright KL, 1998, P NATL ACAD SCI USA, V95, P6267, DOI 10.1073/pnas.95.11.6267; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9	41	62	62	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					279	286		10.1086/302519	http://dx.doi.org/10.1086/302519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417269	Green Published, Bronze			2022-12-18	WOS:000081836900001
J	Echaniz-Laguna, A; Miniou, P; Bartholdi, D; Melki, J				Echaniz-Laguna, A; Miniou, P; Bartholdi, D; Melki, J			The promoters of the survival motor neuron gene (SMN) and its copy (SMNc) share common regulatory elements	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; PROTEIN; EXPRESSION; BINDING; DIFFERENTIATION; COMPLEX; MOTIF; CAMP	Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder characterized by degeneration of motor neurons of the spinal cord. The survival motor neuron gene (SMN) has been recognized as the disease-causing gene. SMN is duplicated, and the almost identical copy gene (SMNc) remains functional in patients with SMA. The expression level of SMNc is tightly correlated with the clinical severity of the disease. Here, we define the transcription initiation site, delineate the region containing promoter activity, and analyze the sequence of the promoter region of both SMN and SMNc. We show that the promoter sequence and activity of the two genes are quasi identical, providing strong evidence for similar transcription regulation of the two genes. Therefore, the difference in the level of protein encoded by SMN and SMNc is the result of either different regulatory region(s) further apart or different posttranscriptional regulation. Interestingly, sequence analysis of the promoter region revealed several consensus binding sites for transcription factors. Therefore, the identification of transcription factors involved in the regulation of SMNc gene expression may lead to attractive strategies for therapy in SMA.	Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Melki, J (corresponding author), Univ Strasbourg 1, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, BP163, F-67404 Strasbourg, France.							Battaglia G, 1997, HUM MOL GENET, V6, P1961, DOI 10.1093/hmg/6.11.1961; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; Burglen L, 1996, GENOMICS, V32, P479, DOI 10.1006/geno.1996.0147; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Dupont E, 1998, J NEUROSCI RES, V51, P257, DOI 10.1002/(SICI)1097-4547(19980115)51:2<257::AID-JNR14>3.0.CO;2-5; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; GOODBOURN S, 1985, CELL, V41, P509, DOI 10.1016/S0092-8674(85)80024-6; Jacob A, 1997, EXP CELL RES, V234, P277, DOI 10.1006/excr.1997.3622; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; LODISH H, 1995, MOL CELL BIOL, P405; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; Sambrook J, 1989, MOL CLONING LAB MANU; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; SCHREIBER E, 1993, NUCLEIC ACIDS RES, V21, P253, DOI 10.1093/nar/21.2.253; TRIPATHI J, 1991, J BIOMOL STRUCT DYN, V9, P387, DOI 10.1080/07391102.1991.10507919; Zambrano N, 1997, BIOCHEM J, V328, P293, DOI 10.1042/bj3280293	24	62	69	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1365	1370		10.1086/302372	http://dx.doi.org/10.1086/302372			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205267	Green Published, Bronze			2022-12-18	WOS:000080093000014
J	Haider, NB; Carmi, R; Shalev, H; Sheffield, VC; Landau, D				Haider, NB; Carmi, R; Shalev, H; Sheffield, VC; Landau, D			A Bedouin kindred with infantile nephronophthisis demonstrates linkage to chromosome 9 by homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; FAMILIAL JUVENILE NEPHRONOPHTHISIS; GENE; MAPS; DNA; PROGRESSION; HOMOLOGY	A novel type of infantile nephronophthisis was identified in an extended Bedouin family from Israel. This disease has an autosomal recessive mode of inheritance, with the phenotypic presentation ranging from a Potter-like syndrome to hyperechogenic kidneys, renal insufficiency, hypertension, and hyperkalemia, Affected individuals show rapid deterioration of kidney function, leading to end-stage renal failure within 3 years. Histopathologic examination of renal tissue revealed variable findings, ranging from infantile polycystic kidneys to chronic tubulointerstitial nephritis, fibrosis, and cortical microcysts, A known familial juvenile nepbronophthisis locus on chromosome 2q13 and autosomal recessive polycystic kidney disease on chromosome 6p21.1-p1.2 were excluded by genetic linkage analysis. A genomewide screen for linkage was conducted by searching for a locus inherited by descent in all affected individuals. Pooled DNA samples from parents and unaffected siblings and individual DNA samples from four affected individuals were used as PCR templates with trinucleotide- and tetranucleotide-repeat polymorphic markers. Using this approach, we identified linkage to infantile nephronophthisis for markers on chromosome 9q22-31. The disorder maps to a 12.8-cM region flanked by markers D9S280 and GGAT3C09.	Univ Iowa, Div Med Genet, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Ben Gurion Univ Negev, Inst Genet, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pediat Nephrol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel	University of Iowa; Howard Hughes Medical Institute; University of Iowa; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Div Med Genet, Dept Pediat, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Sheffield, Val/0000-0002-6282-0835	NHGRI NIH HHS [HG00457] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Chadwick BP, 1997, GENOMICS, V41, P390, DOI 10.1006/geno.1997.4692; GAGNADOUX MF, 1989, PEDIATR NEPHROL, V3, P50, DOI 10.1007/BF00859626; Gattone VH, 1996, ANAT REC, V245, P488; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; GUAYWOODFORD LM, 1995, AM J HUM GENET, V56, P1101; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; ISDALE JM, 1973, S AFR MED J, V47, P1892; KAPLAN BS, 1989, PEDIATR NEPHROL, V3, P43, DOI 10.1007/BF00859625; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; LUNDIN M, 1961, ACTA PAEDIATR, V50, P185, DOI 10.1111/j.1651-2227.1961.tb08038.x; Martinez JR, 1997, AM J KIDNEY DIS, V29, P435, DOI 10.1016/S0272-6386(97)90206-7; MEDHIOUB M, 1994, GENOMICS, V22, P296, DOI 10.1006/geno.1994.1387; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; QAMAR IU, 1991, CHILD NEPHROL UROL, V11, P159; SCHAMBELAN M, 1980, KIDNEY INT, V17, P89, DOI 10.1038/ki.1980.11; Schieren G, 1996, NEPHROL DIAL TRANSPL, V11, P38; SENIOR B, 1973, AM J DIS CHILD, V125, P442, DOI 10.1001/archpedi.1973.04160030094021; SHAIKEWITZ ST, 1993, J AM SOC NEPHROL, V3, P1858; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; STRAUSS MB, 1967, NEW ENGL J MED, V277, P863, DOI 10.1056/NEJM196710192771606; Sung LPA, 1996, GENOMICS, V34, P92, DOI 10.1006/geno.1996.0245; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; WELLING LW, 1996, KIDNEY, V2, P1828; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429	29	62	67	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1404	1410		10.1086/302108	http://dx.doi.org/10.1086/302108			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792867	Green Published, Bronze			2022-12-18	WOS:000076985200016
J	Jarvik, GP				Jarvik, GP			Complex segregation analyses: Uses and limitations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; FAMILIAL PROSTATE-CANCER; HIGH-RISK FAMILIES; LINKAGE ANALYSIS; BREAST-CANCER; MAJOR LOCUS; APOLIPOPROTEIN-B; GENOTYPE; TRANSMISSION; INHERITANCE		Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Jarvik, GP (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.		Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708				Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Blangero J, 1995, GENET EPIDEMIOL, V12, P689, DOI 10.1002/gepi.1370120628; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; DEMENAIS FM, 1989, GENET EPIDEMIOL, V6, P597, DOI 10.1002/gepi.1370060505; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASSTEDT S, 1981, PAP PEDIGREE ANAL PA; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 1995, GENET EPIDEMIOL, V12, P545, DOI 10.1002/gepi.1370120604; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; Jarvik GP, 1996, AM J HUM GENET, V58, P191; JARVIK GP, 1993, GENET EPIDEMIOL, V10, P257, DOI 10.1002/gepi.1370100406; Khoury M, 1993, FUNDAMENTALS GENETIC; MCGUFFIN P, 1990, AM J HUM GENET, V46, P994; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MOLL PP, 1989, AM J HUM GENET, V44, P124; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; PAIRITZ G, 1988, AM J HUM GENET, V43, P311; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; *SAGE, 1994, STAT AN GEN EP; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Snow GL, 1998, GENET EPIDEMIOL, V15, P355, DOI 10.1002/(SICI)1098-2272(1998)15:4<355::AID-GEPI3>3.0.CO;2-1; THOMPSON E, 1994, MONTE CARLO PROGRAMS; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	31	62	65	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					942	946		10.1086/302075	http://dx.doi.org/10.1086/302075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758633	Green Published, Bronze			2022-12-18	WOS:000076577800004
J	Roume, J; Genin, E; Cormier-Daire, V; Ma, HW; Mehaye, B; Attie, T; Razavi-Encha, F; Fallet-Bianco, C; Buenerd, A; Clerget-Darpoux, F; Munnich, A; Le Merrer, M				Roume, J; Genin, E; Cormier-Daire, V; Ma, HW; Mehaye, B; Attie, T; Razavi-Encha, F; Fallet-Bianco, C; Buenerd, A; Clerget-Darpoux, F; Munnich, A; Le Merrer, M			A gene for Meckel syndrome maps to chromosome 11q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DANDY-WALKER MALFORMATION; CENTRAL-NERVOUS-SYSTEM; HEPATIC-FIBROSIS; ANOMALIES; DISORDERS; KIDNEYS; HETEROGENEITY	Meckel syndrome (MKS) is a rare autosomal recessive lethal condition of unknown origin, characterized by (i) an occipital meningo-encephalocele with (ii) enlarged kidneys, with multicystic dysplasia and fibrotic changes in the portal area of the liver and with ductal proliferation, and (iii) postaxial polydactyly. A gene responsible for MKS in Finland has been mapped to chromosome 17q21-q24. Studying a subset of Middle Eastern and northern African MKS families, we have recently excluded the chromosome 17 region and have suggested a genetic heterogeneity. In the present study, we report on the mapping of a second MKS locus (MKS2) to chromosome 11q13, by homozygosity mapping in seven families that do not show linkage to chromosome 17q21-q24 (maximum LOD score 4.41 at recombination fraction .01). Most interestingly, the affected fetuses of southern Tunisian ancestry shared a particular haplotype at loci D11S911 and D11S906, suggesting that a founder effect is involved. Our observation gives support to the clinical and genetic heterogeneity of MKS.	Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM U393, F-75743 Paris, France; Hop St Antoine, Serv Histol Embryol Cytogenet, Unite Embryofoetopathol, F-75571 Paris, France; INSERM U155, Unite Rech Epidemiol Genet, Paris, France; Hop Robert Debre, Unite Embryofoetopathol, Serv Histol Embryol Cytogenet, F-75019 Paris, France; Hop Henri Mondor, Serv Anatomopathol, F-94010 Creteil, France; Hop Edouard Herriot, Serv Anatomopathol, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Lyon	Le Merrer, M (corresponding author), Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM U393, 149 Rue Sevres, F-75743 Paris, France.		ATTIE-BITACH, Tania/K-1453-2017; Genin, Emmanuelle/C-4974-2013; Fallet-Bianco, Catherine/AAP-7390-2020; cormier-daire, valerie/H-6520-2017; Clerget-Darpoux, Francoise/I-4825-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Genin, Emmanuelle/0000-0003-4117-2813; cormier-daire, valerie/0000-0002-2839-9856; Clerget-Darpoux, Francoise/0000-0003-4816-6619				AHDABBARMADA M, 1990, J NEUROPATH EXP NEUR, V49, P610, DOI 10.1097/00005072-199011000-00007; ALEKSIC S, 1984, CHILD BRAIN, V11, P99; Blankenberg T A, 1987, Am J Med Genet Suppl, V3, P395; CRAWFORD A, 1978, J MED GENET, V15, P242; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EnchaRazavi F, 1997, ANN PATHOL, V17, P281; FRASER FC, 1981, AM J MED GENET, V9, P67, DOI 10.1002/ajmg.1320090112; GENUARDI M, 1993, AM J MED GENET, V47, P50, DOI 10.1002/ajmg.1320470111; HORI A, 1980, ACTA NEUROPATHOL, V51, P93, DOI 10.1007/BF00690449; HUNTER AG, 1991, AM J MED GENET, V4, P201; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LURIE IW, 1991, CLIN GENET, V39, P104; MECKE S, 1971, ANN GENET-PARIS, V14, P97; Meckel J., 1882, DTSCH ARCH PHYSL, V7, P99; Merscher S, 1997, GENOMICS, V39, P340, DOI 10.1006/geno.1996.4460; Moerman P., 1993, Genetic Counseling, V4, P97; OTT J, 1985, ANAL HUMAN GENETIC L; Paavola P, 1997, HUM GENET, V101, P88, DOI 10.1007/s004390050592; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; PAAVOLA P, 1996, 7 BIRTH DEF MANCH C; Paavola Paulina, 1996, European Journal of Human Genetics, V4, P66; Pattyn A, 1997, DEVELOPMENT, V124, P4065; PLAUCHU H, 1981, J GENET HUM, V29, P431; Roume J, 1997, J MED GENET, V34, P1003, DOI 10.1136/jmg.34.12.1003; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; SALONEN R, 1984, AM J MED GENET, V18, P691, DOI 10.1002/ajmg.1320180415; SELLER MJ, 1981, CLIN GENET, V20, P74; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; VERLOES A, 1992, AM J MED GENET, V43, P669, DOI 10.1002/ajmg.1320430404; WALPOLE IR, 1991, AM J MED GENET, V39, P294, DOI 10.1002/ajmg.1320390310; WRIGHT C, 1994, J MED GENET, V31, P482, DOI 10.1136/jmg.31.6.482; Zlotogora J, 1997, AM J MED GENET, V71, P33, DOI 10.1002/(SICI)1096-8628(19970711)71:1<33::AID-AJMG6>3.0.CO;2-R	33	62	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1095	1101		10.1086/302062	http://dx.doi.org/10.1086/302062			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758620	Green Published, Bronze			2022-12-18	WOS:000076577800023
J	Mulley, J; Saar, K; Hewitt, G; Ruschendorf, F; Phillips, H; Colley, A; Sillence, D; Reis, A; Wilson, M				Mulley, J; Saar, K; Hewitt, G; Ruschendorf, F; Phillips, H; Colley, A; Sillence, D; Reis, A; Wilson, M			Gene localization for an autosomal dominant familial periodic fever to 12p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEDITERRANEAN FEVER; INHERITANCE	We report gene localization in a family with a benign autosomal dominant familial periodic fever (FPF) syndrome characterized by recurrent fever associated with abdominal pain. The clinical features are similar to the disorder previously described as familial Hibernian fever, and they differ from familial Mediterranean fever (FMF) in that FPF episodes usually do not respond to colchicine and FPF is not associated with amyloidosis. Frequent recombination with the marker D16S2622, <1 Mb from FMF, at 16p13.3, excluded allelism between these clinically similar conditions. Subsequently, a semiautomated genome search detected linkage of FMF to a cluster of markers at 12p13, with a multipoint LOD score of 6.14 at D12S356. If penetrance of 90% is assumed, the FPF gene maps to a 19-cM interval between D12S314 and D12S364; however, if complete penetrance is assumed, then FPF maps to a 9-cM region between D12S314 and D12S1695. This interval includes the dentatorubropallidoluysian atrophy locus, which, with FPF, gave a maximum two-point LOD score of 3.7 at a recombination fraction of 0. This is the first of the periodic-fever genes, other than FMF, to be mapped. Positional candidate genes may now be selected for mutation analysis to determine the molecular basis for FPF. Together with the recent identification of the defective gene in FMF, identification of a gene for FPF might provide new insights into the regulation of inflammatory responses.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Genet, Adelaide, SA, Australia; Max Delbruck Centrum, Mikrosatellitenzentrum, Berlin, Germany; Wairau Hosp, Blenheim, New Zealand; New Childrens Hosp, Dept Clin Genet, Sydney, NSW, Australia; Liverpool Hlth Serv, Dept Clin Genet, Liverpool, NSW, Australia; Humboldt Univ, Inst Human Genet, Berlin, Germany	Womens & Childrens Hospital Australia; University of Adelaide; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Sydney; Humboldt University of Berlin	Mulley, J (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Ctr Med Genet, 72 King William Rd, Adelaide, SA 5006, Australia.	mulleyj@mail.wch.sa.gov.au	Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Saar, Kathrin/0000-0002-4483-1557				Aksentijevich I, 1997, CELL, V90, P797; ANTONARAKIS SE, 1994, NAT GENET, V8, P211, DOI 10.1038/ng1194-211; BERGMAN F, 1968, AM J MED, V45, P601, DOI 10.1016/0002-9343(68)90174-5; Bernot A, 1997, NAT GENET, V17, P25; BOURONCLE BA, 1957, AM J MED, V23, P502, DOI 10.1016/0002-9343(57)90330-3; Christiano AM, 1996, AM J HUM GENET, V58, P671; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRENTH JPH, 1994, HUM GENET, V94, P616, DOI 10.1007/BF00206953; Dupont M, 1997, J MED GENET, V34, P375, DOI 10.1136/jmg.34.5.375; FRENCH FMF, 1996, AM J HUM GENET, V59, P603; GERTZ MA, 1987, MAYO CLIN PROC, V62, P1095, DOI 10.1016/S0025-6196(12)62502-6; Green P, 1990, DOCUMENTATION CRI MA; HAWLE H, 1989, DEUT MED WOCHENSCHR, V114, P665, DOI 10.1055/s-2008-1066652; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; Inglehearn CF, 1997, NAT GENET, V16, P15, DOI 10.1038/ng0597-15; KARENKO L, 1992, J INTERN MED, V232, P365, DOI 10.1111/j.1365-2796.1992.tb00600.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Levy EN, 1996, AM J HUM GENET, V58, P523; Livneh A, 1997, J RHEUMATOL, V24, P1558; Mache CJ, 1996, EUR J PEDIATR, V155, P787; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; REICH CB, 1970, ARCH INTERN MED, V125, P337, DOI 10.1001/archinte.125.2.337; Saar K, 1997, AM J HUM GENET, V60, P605; Sood R, 1997, GENOMICS, V42, P83, DOI 10.1006/geno.1997.4629; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILLIAMSON LM, 1982, Q J MED, V51, P469; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319	29	62	63	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					884	889		10.1086/301793	http://dx.doi.org/10.1086/301793			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529351	Green Published, Bronze			2022-12-18	WOS:000073514400020
J	Koda, Y; Soejima, M; Yoshioka, N; Kimura, H				Koda, Y; Soejima, M; Yoshioka, N; Kimura, H			The haptoglobin-gene deletion responsible for anhaptoglobinemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; EXPRESSION; AMPLIFICATION; POLYMORPHISMS; DUPLICATION; CHROMOSOMES; POPULATION; POLYMERASE; SEQUENCE; LOCUS	We have found an allelic deletion of the haptaglobin (Hp) gene from an individual with anhaptoglobinemia. The Hp gene cluster consists of coding regions of the a chain and beta chain of the haptoglobin gene (Hp) and of the a chain and beta chain of the haptoglobin-related gene (Hpr), in tandem from the 5' side. Southern blot and PCR analyses have indicated that the individual with anhaptoglobinemia was homozygous for the gene deletion and that the gene deletion was included at least from the promoter region of Hp to Hpr or but not to Hpr beta (Hp(del)). In addition, we found seven individuals with hypohaptoglobinemia in three families, and the genotypes of six of the seven individuals were found to be Hp(2)/Hp(del). The phenotypes and genotypes in one of these three families showed the father to be hypohaptoglobinemic (Hp2) and Hp(2)/Hp(del), the mother to be Hp2-1 and Hp(1)/Hp(2), one of the two children to be hypohaptoglobinemic (Hp2) and Hp(2)/Hp(del), and the other child to be Hp1 and Hp(1)/Hp(del) showing an anomalous inheritance of Hp phenotypes in the child with Hpl. The Hp(2)/Hp(del) individuals had an extremely low level of Hp (mean +/- SD = 0.049 +/- 0.043 mg/ml; n := 6), compared with the level (1.64 +/- 1.07 mg/ml) obtained from 52 healthy volunteers having phenotype Hp2, whereas the serum Hp level of an individual with Hp(1)/Hp(del) was 0.50 mg/ml, which was approximately half the level of Hp in control sera from the Hp1 phenotype (1.26 +/- 0.33 mg/ml; n = 9), showing a gene-dosage effect. The other allele (Hp(2)) of individuals with Hp(2)/Hp(del) was found to have, in all exons, no mutation, by DNA sequencing. On the basis of the present study, the mechanism of anhaptoglobinemia and the mechanism of anomalous inheritance of Hp phenotypes were well explained. However, the mechanism of hypohaptoglobinemia remains unknown.	Kurume Univ, Sch Med, Dept Forens Med, Div Human Genet, Kurume, Fukuoka 8300011, Japan; Akita Univ, Sch Med, Dept Forens Med, Akita 010, Japan	Kurume University; Akita University	Kimura, H (corresponding author), Kurume Univ, Sch Med, Dept Forens Med, Div Human Genet, Kurume, Fukuoka 8300011, Japan.		Koda, Yoshiro/AAY-6902-2020	Koda, Yoshiro/0000-0003-1368-0116				ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; AZEVEDO E, 1969, HUM HERED, V19, P609, DOI 10.1159/000152275; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; BLACK JA, 1968, NATURE, V218, P736, DOI 10.1038/218736a0; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; HILL AVS, 1986, AM J HUM GENET, V38, P382; HYLAND VJ, 1988, NUCLEIC ACIDS RES, V16, P8203, DOI 10.1093/nar/16.16.8203; KASAI K, 1990, J FORENSIC SCI, V35, P1196; Koda Y, 1997, J BIOL CHEM, V272, P7501, DOI 10.1074/jbc.272.11.7501; Koda Y, 1996, AM J HUM GENET, V59, P343; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LINKE RP, 1984, ANAL BIOCHEM, V141, P55, DOI 10.1016/0003-2697(84)90424-X; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1991, AM J HUM GENET, V49, P158; MAEDA N, 1986, P NATL ACAD SCI USA, V83, P7395, DOI 10.1073/pnas.83.19.7395; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; MATSUNAGA E, 1970, JPN J HUM GENET, V15, P166; OLIVIERO S, 1985, HUM GENET, V71, P49, DOI 10.1007/BF00295668; PENA SDJ, 1991, ELECTROPHORESIS, V12, P146, DOI 10.1002/elps.1150120209; ROUGEMONT A, 1980, HUM HERED, V30, P201, DOI 10.1159/000153127; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LAB MANU; SHABTAI F, 1983, HUM GENET, V63, P341, DOI 10.1007/BF00274759; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SUTHERLAND GR, 1984, AM J HUM GENET, V36, P110; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; Wang BJ, 1997, VOX SANG, V72, P31, DOI 10.1046/j.1423-0410.1997.00031.x; YOSHIOKA N, 1991, SEIBUTSU BUTSURI KAG, V35, P297	30	62	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					245	252		10.1086/301701	http://dx.doi.org/10.1086/301701			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463309	Green Published, Bronze			2022-12-18	WOS:000072416000006
J	Fischel-Ghodsian, N				Fischel-Ghodsian, N			Mitochondrial mutations and hearing loss: Paradigm for mitochondrial genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-SYNDROMIC DEAFNESS; RIBOSOMAL-RNA MUTATION; DIABETES-MELLITUS; SENSORINEURAL DEAFNESS; POINT MUTATION; DNA DELETION; PEDIGREE		Cedars Sinai Med Ctr, Ahmanson Dept Pediat, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fischel-Ghodsian, N (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402, R01DC002273, R01DC003395] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01DC03395, R01DC02273, R01DC01402] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALCOLADO JC, 1994, DIABETOLOGIA, V37, P372, DOI 10.1007/s001250050119; ARNAUDO E, 1992, GENE, V119, P299, DOI 10.1016/0378-1119(92)90287-Y; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; ElSchahawi M, 1997, NEUROLOGY, V48, P453, DOI 10.1212/WNL.48.2.453; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; FISCHELGHODSIAN N, 1995, AM J OTOLARYNG, V16, P403, DOI 10.1016/0196-0709(95)90078-0; FischelGhodsian N, 1997, HEARING RES, V110, P147, DOI 10.1016/S0378-5955(97)00077-4; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; FISCHELGHODSIAN N, 1993, AM J OTOLARYNG, V14, P399, DOI 10.1016/0196-0709(93)90113-L; FISCHELGHODSIAN N, 1996, GENETICS HEARING IMP, P244; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; GUAN MX, 1997, AM J HUM GENET, V61, P1807; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HU DN, 1991, J MED GENET, V28, P79, DOI 10.1136/jmg.28.2.79; HUTCHIN T, 1993, NUCLEIC ACIDS RES, V21, P4174, DOI 10.1093/nar/21.18.4174; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KATAGIRI H, 1994, DIABETOLOGIA, V37, P504, DOI 10.1007/s001250050139; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; Matthijs G, 1996, EUR J HUM GENET, V4, P46; Nagley Phillip, 1993, P137; OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; SEVIOR KB, IN PRESS AM J MED GE; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1995, HUMAN GENE MAPPING 1, P910; WANG CR, 1991, CELL, V66, P335, DOI 10.1016/0092-8674(91)90623-7	31	62	69	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1998	62	1					15	19		10.1086/301695	http://dx.doi.org/10.1086/301695			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YY246	9443888	Bronze, Green Published			2022-12-18	WOS:000072127900004
J	Maslen, C; Babcock, D; Raghunath, M; Steinmann, B				Maslen, C; Babcock, D; Raghunath, M; Steinmann, B			A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER RNA; MARFAN-SYNDROME; SPLICE SITE; GENES; DISORDER; LINKAGE	Congenital contractural arachnodactyly (CCA) is an autosomal dominant disorder that is phenotypically similar to but genetically distinct from Marfan syndrome. Genetic-linkage analysis has implicated the fibrillin-2 gene (FBN2) as the CCA locus. Mutation analysis of two isolated CCA patients revealed missense mutations, indicating that defects in FBN2 may be responsible for this disorder. However, cosegregation of a mutant allele with the disease phenotype has not yet been established. We have investigated the primary cause of CCA in a large well-characterized kindred with five generations comprising 18 affected individuals. Previous studies demonstrated linkage of this family's CCA phenotype to FBN2. Mutation analysis of cDNA derived from the proband and her affected brother, using a nonisotopic RNase cleavage assay, revealed the partial skipping of exon 31. Approximately 25% mutant transcript is produced, which is apparently sufficient to cause a CCA phenotype. Sequence analysis of genomic DNA revealed an unusual base composition for intron 30 and identified the mutation, a g-26t transversion, in the vicinity of the splicing branch-point site in intron 30. Genomic DNA from 30 additional family members, both affected and unaffected, then was analyzed for the mutation. The results clearly demonstrate cosegregation of the branchpoint mutation with the CCA phenotype. This is the first report of a CCA mutation in a multiplex family, unequivocally establishing that mutations in FBN2 are responsible for the CCA phenotype. In addition, branchpoint mutations only very rarely have been associated with human disease, suggesting that the unusual composition of this intron influences splicing stability.	OREGON HLTH SCI UNIV,DEPT MOL & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,CONGENITAL HEART RES CTR,PORTLAND,OR 97201; UNIV MUNSTER,INST PHYSIOL CHEM & PATHOBIOCHEM,D-4400 MUNSTER,GERMANY; UNIV ZURICH,CHILDRENS HOSP,DIV METAB & MOL DIS,ZURICH,SWITZERLAND	Oregon Health & Science University; Oregon Health & Science University; University of Munster; University Children's Hospital Zurich; University of Zurich	Maslen, C (corresponding author), OREGON HLTH SCI UNIV,DEPT MED,L465,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.		Raghunath, Michael/E-6483-2010; Raghunath, Michael/M-2727-2019	Raghunath, Michael/0000-0002-2138-6614; 	NIAMS NIH HHS [5R29AR41846-03] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR041846] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON RA, 1984, AM J MED GENET, V18, P265, DOI 10.1002/ajmg.1320180210; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; BOTTEMA CDK, 1993, METHOD ENZYMOL, V218, P388; Fulop C, 1996, BIOCHEM J, V319, P935; GOGUEL V, 1993, CELL, V72, P893, DOI 10.1016/0092-8674(93)90578-E; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HECHT F, 1972, PEDIATRICS, V49, P574; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Mckusick V.A., 1994, MENDELIAN INHERITANC; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Raben N, 1996, HUM MOL GENET, V5, P995, DOI 10.1093/hmg/5.7.995; Ramirez F, 1996, CURR OPIN GENET DEV, V6, P309, DOI 10.1016/S0959-437X(96)80007-4; Ramos Arroyo M A, 1985, Clin Genet, V27, P570; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; VELINOV MT, 1992, AM J MED GENET, V47, P159; VILJOEN D, 1994, J MED GENET, V31, P640, DOI 10.1136/jmg.31.8.640; WANG M, 1995, HUM MOL GENET, V4, P607, DOI 10.1093/hmg/4.4.607; WANG M, 1996, J HUM GENET, V59, P1027; Webb JC, 1996, HUM MOL GENET, V5, P1325, DOI 10.1093/hmg/5.9.1325; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	25	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1389	1398		10.1086/515472	http://dx.doi.org/10.1086/515472			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199560	Green Published, Bronze			2022-12-18	WOS:A1997XE29400017
J	Thomas, HJW; Whitelaw, SC; Cottrell, SE; Murday, VA; Tomlinson, IPM; Markie, D; Jones, T; Bishop, DT; Hodgson, SV; Sheer, D; Northover, JMA; Talbot, IC; Solomon, E; Bodmer, WF				Thomas, HJW; Whitelaw, SC; Cottrell, SE; Murday, VA; Tomlinson, IPM; Markie, D; Jones, T; Bishop, DT; Hodgson, SV; Sheer, D; Northover, JMA; Talbot, IC; Solomon, E; Bodmer, WF			Mapping of the hereditary mixed polyposis syndrome to chromosome 6q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Hereditary mixed polyposis syndrome (HMPS) is characterized by atypical juvenile polyps, colonic adenomas, and colorectal carcinomas. HMPS appears to be inherited in an autosomal dominant manner. Genetic linkage analysis has been performed on a large family with HMPS. Data did not support linkage to the APC locus or to any of the loci for hereditary nonpolyposis colorectal cancer. Evidence that the HMPS locus lies on chromosome 6q was, however, provided by significant two-point LOD scores for linkage between HMPS and the D6S283 locus. Analysis of recombinants and multipoint linkage analysis suggested that the HMPS locus lies in a 4-cM interval containing the D6S283 locus and flanked by markers D6S468 and D6S301.	IMPERIAL CANC RES FUND,CANC GENET LAB,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,COLORECTAL UNIT,LONDON,MIDDX,ENGLAND; IMPERIAL CANC RES FUND,FAMILY CANC CLIN,LONDON,MIDDX,ENGLAND; IMPERIAL CANC RES FUND,HUMAN CYTOGENET LAB,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,SOMAT CELL GENET LAB,LONDON WC2A 3PX,ENGLAND; ST JAMES HOSP,IMPERIAL CANC RES FUND,CANC EPIDEMIOL LAB,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Saint James's University Hospital			Sheer, Denise/C-6705-2011; Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011; Markie, David/I-7893-2019	Sheer, Denise/0000-0001-9067-1796; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Bodmer, Walter/0000-0001-6244-9792; Markie, David/0000-0001-5452-9194; Bishop, Tim/0000-0002-8752-8785	Cancer Research UK [A3585] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		DESAI DC, 1995, BRIT J SURG, V82, P14, DOI 10.1002/bjs.1800820106; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; FIDLEROVA H, 1994, CYTOGENET CELL GENET, V65, P203, DOI 10.1159/000133632; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MIYAKI M, 1994, CRIT REV ONCOL HAEMA, V19, P1; MURDAY V, 1989, CANCER SURV, V8, P139; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	10	62	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					770	776						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644741				2022-12-18	WOS:A1996UA38000015
J	FANOS, JH; JOHNSON, JP				FANOS, JH; JOHNSON, JP			PERCEPTION OF CARRIER STATUS BY CYSTIC-FIBROSIS SIBLINGS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HETEROZYGOTE DETECTION; GENE; DIAGNOSIS	Now that the cystic fibrosis (CF) gene has been identified, direct genetic testing for this disorder is available. The current lack of precision has generated a controversy concerning whether population screening is advisable. However, there is general agreement that testing for CF carriers should be offered to CF-affected families. The purpose of this study was to explore levels of understanding and feelings about carrier status and genetics of CF in affected families. Fifty-four adult CF siblings and their 30 spouses drawn from Children's Hospital, Oakland, and Children's Hospital, Boston, were interviewed, and transcripts were coded on various categories. The relationship between birth order and beliefs about carrier status was significant, with last-born siblings more likely to believe they are not carriers. Higher sibling resentment was found to be significantly related to willingness to abort an affected fetus, to more guilt, and to assumption of carrier status. Thirty percent of siblings believe that carrier status implies health difficulties. Increased feelings of guilt were significantly related to the belief that carrier status implies health problems and to the wish to be a carrier. Interestingly, beliefs regarding carrier status and the wish to be a carrier are not influenced by educational or income level. Some siblings have had their child tested for carrier status and others are planning to do so before the child reaches the age of 18 years. Perception of carrier status is strongly influenced by psychological factors. CF siblings face the impact of genetic illness without the support of genetic counseling and develop many mistaken beliefs surrounding carrier status in the absence of reliable information.	CALIF PACIFIC MED CTR,DEPT PEDIAT,SAN FRANCISCO,CA; CALIF PACIFIC MED CTR,DEPT MED,SAN FRANCISCO,CA; CALIF PACIFIC MED CTR,DEPT PSYCHIAT,SAN FRANCISCO,CA; CHILDRENS HOSP OAKLAND,DEPT MED GENET,OAKLAND,CA	California Pacific Medical Center; California Pacific Medical Center; California Pacific Medical Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000639] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG00639] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALJADER LN, 1990, CLIN GENET, V38, P460; BEAUDET AL, 1989, AM J HUM GENET, V44, P319; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CHASE GA, 1986, SOC BIOL, V33, P57; COLLINS FS, 1990, HOSP PRACT, V25, P47; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P580; DEROGATIS LR, 1971, ARCH GEN PSYCHIAT, V24, P454; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FANOS JH, 1992, PEDIATR PULM S, V8, P228; FANOS JH, 1987, THESIS U CALIFORNIA; GASPARINI P, 1990, NEW ENGL J MED, V323, P62; GILBERT F, 1990, AM J HUM GENET, V46, P394; HOLTZMAN NA, 1978, PEDIATRICS, V62, P1056; HOLTZMAN NA, 1989, PROCEED CAUTION PRED; Janes S R, 1990, Birth Defects Orig Artic Ser, V26, P254; JOHNSON JP, 1988, J PEDIATR-US, V113, P957, DOI 10.1016/S0022-3476(88)80563-8; KABACK M, 1984, CYSTIC FIBROSIS HORI, P15; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LEONARD CO, 1972, NEW ENGL J MED, V287, P433, DOI 10.1056/NEJM197208312870904; LIEBERMAN MA, 1978, AM J COMMUN PSYCHOL, V6, P499, DOI 10.1007/BF00941425; MODELL B, 1990, J MED GENET, V27, P475, DOI 10.1136/jmg.27.8.475; Nickerson B., 1991, J ADOLESCENT RES, V6, P70, DOI DOI 10.1177/074355489161006; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; REID KJ, 1976, WESTERN J MED, V124, P6; VALVERDE K, 1990, AM J HUM GENET S, V47, pA125; WATSON EK, 1992, LANCET, V340, P217, DOI 10.1016/0140-6736(92)90477-K; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; Zelson J H, 1973, Conn Med, V37, P435; 1990, NEW ENGL J MED, V323, P70; 1983, B WORLD HEALTH ORGAN, V61, P63	31	62	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					431	438						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668270				2022-12-18	WOS:A1995RL77100027
J	RAVEHAREL, N; MADGAR, I; GOSHEN, R; NISSIMRAFINIA, M; ZIADNI, A; RAHAT, A; CHIBA, O; KALMAN, YM; BRAUTBAR, C; LEVINSON, D; AUGARTEN, A; KEREM, E; KEREM, B				RAVEHAREL, N; MADGAR, I; GOSHEN, R; NISSIMRAFINIA, M; ZIADNI, A; RAHAT, A; CHIBA, O; KALMAN, YM; BRAUTBAR, C; LEVINSON, D; AUGARTEN, A; KEREM, E; KEREM, B			CFTR HAPLOTYPE ANALYSIS REVEALS GENETIC-HETEROGENEITY IN THE ETIOLOGY OF CONGENITAL BILATERAL APLASIA OF THE VAS-DEFERENS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS GENE; ENZYMATIC AMPLIFICATION; MUTATIONS; DNA; IDENTIFICATION; ABSENCE; DISEASE; JEWISH; PSEUDODEFICIENCY; POLYMORPHISMS	Congenital bilateral aplasia of the vas deferens (CBAVD) was suggested to be a mild form of cystic fibrosis (CF). Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in males with CBAVD revealed that in some males CBAVD is caused by two defective CFTR alleles. The genetic basis of CBAVD in the other males and its association with CF remained unclear. We undertook this study to test the hypothesis of commonality of CBAVD and CF by haplotype analysis, in the CFTR locus, of males suffering from CBAVD and of their families. According to the hypothesis of commonality of CBAVD and CF, two brothers with CBAVD are expected to carry the same two CFTR alleles, while their fertile brothers are expected to carry at least one different allele. Eleven families were studied, of which two families, with unidentified CFTR mutations, did not support this hypothesis. In these families two brothers with CBAVD inherited different CFTR alleles. Their fertile brothers inherited the same CFTR alleles as their brothers with CBAVD. These results provide evidence for genetic heterogeneity in CBAVD. Though in some families CBAVD is associated with two CFTR mutations, we suggest that in others it is caused by other mechanisms, such as mutations at other loci or homozygosity or heterozygosity for partially penetrant CFTR mutations.	HEBREW UNIV JERUSALEM,DEPT GENET,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED CTR,TISSUE TYPING UNIT,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,SCH MED,LAUTENBERG CTR GEN & TUMOR IMMUNOL,IL-91904 JERUSALEM,ISRAEL; SHAARE ZADEK MED CTR,DEPT PAEDIAT,PULM & CYST FIBROSIS CLIN,JERUSALEM,ISRAEL; CHAIM SHEBA MED CTR,DEPT UROL,TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,DEPT PAEDIAT,TEL HASHOMER,ISRAEL; KUPAT CHOLIM CLIN,TAMRA,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center								ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; AMAR A, 1993, EUR J IMMUNOGENET, V20, P327, DOI 10.1111/j.1744-313X.1993.tb00152.x; ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; AUGARTEN A, 1994, LANCET, V344, P1473, DOI 10.1016/S0140-6736(94)90292-5; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CAO Z, 1993, AM J HUM GENET, V53, P1198; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CULARD JF, 1994, HUM GENET, V93, P467; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEAN M, 1990, NUCLEIC ACIDS RES, V18, P345, DOI 10.1093/nar/18.2.345; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; DORK T, 1993, HUM MOL GENET, V3, P1965; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P947; HORN GT, 1990, CLIN CHEM, V36, P1614; HOROWITZ M, 1993, AM J HUM GENET, V53, P921; KEREM B, 1989, SCIENCE, V254, P1073; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM E, IN PRESS HUM GENET; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; LERER I, 1990, HUM GENET, V416, P85; MARTIN RA, 1992, AM J MED GENET, V42, P714, DOI 10.1002/ajmg.1320420517; MERCIER B, 1995, AM J HUM GENET, V56, P272; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; NG ISL, 1991, HUM GENET, V87, P613; OATES RD, 1994, J ANDROL, V15, P1; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OSBORNE L, 1991, AM J HUM GENET, V48, P608; OSBORNE LR, 1993, HUM MOL GENET, V2, P1605, DOI 10.1093/hmg/2.10.1605; PATRIZIO P, 1993, HUM REPROD, V8, P215, DOI 10.1093/oxfordjournals.humrep.a138025; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENBLOOM CL, 1989, NUCLEIC ACIDS RES, V17, P7117, DOI 10.1093/nar/17.17.7117; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SERETH H, 1993, HUM GENET, V92, P289; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; SHOSHANI T, 1994, HUM MOL GENET, V3, P657, DOI 10.1093/hmg/3.4.657; SHOSHANI T, 1992, GENOMICS, V15, P236; SHOSHANI T, 1994, PEDIATR PULM S, V10, P213; SILBER SJ, 1990, NEW ENGL J MED, V323, P1788, DOI 10.1056/NEJM199012273232602; TOMCZAK J, 1993, AM J HUM GENET, V53, P537; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	45	62	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1359	1366						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7539210				2022-12-18	WOS:A1995RA79400014
J	CHEN, KS; GUNARATNE, PH; HOHEISEL, JD; YOUNG, IG; MIKLOS, GLG; GREENBERG, F; SHAFFER, LG; CAMPBELL, HD; LUPSKI, JR				CHEN, KS; GUNARATNE, PH; HOHEISEL, JD; YOUNG, IG; MIKLOS, GLG; GREENBERG, F; SHAFFER, LG; CAMPBELL, HD; LUPSKI, JR			THE HUMAN HOMOLOG OF THE DROSOPHILA-MELANOGASTER FLIGHTLESS-I GENE (FLII) MAPS WITHIN THE SMITH-MAGENIS MICRODELETION CRITICAL REGION IN 17P11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; DELETION SYNDROME; INTERSTITIAL DELETION; GELSOLIN VARIANT; X-CHROMOSOME; (17)(P11.2P11.2); DUPLICATION; BINDING; SEQUENCES; PROTEIN	The Smith-Magenis syndrome (SMS) appears to be a contiguous-gene-deletion syndrome associated with a proximal deletion of the short arm of chromosome 17 in band p11.2. The spectrum of clinical findings includes short stature, brachydactyly, developmental delay, dysmorphic features, sleep disturbances, and behavioral problems. The complex phenotypic features suggest deletion of several contiguous genes. However, to date, no protein-encoding gene has been mapped to the SMS critical region. Recently, the Drosophila melanogaster flightless-I gene, fliI, and the homologous human cDNA have been isolated. Mutations in fliI result in loss of flight ability and, when severe, cause lethality due to incomplete cellularization with subsequent abnormal gastrulation. Here, we demonstrate that the human homologue (FLI) maps within the SMS critical region. Genomic cosmids were used as probes for FISH, which localized this gene to the 17p11.2 region. Somatic-cell hybrid-panel mapping further localized this gene to the SMS critical region. Southern blot analysis of somatic-cell hybrids and/or FISH analysis of lymphoblastoid cell lines from 12 SMS patients demonstrates the deletion of one copy of FLI in all SMS patients analyzed.	BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,TEXAS CHILDRENS HOSP,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; GERMAN CANC RES CTR,HEIDELBERG,GERMANY; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,CANBERRA,ACT 2601,AUSTRALIA; AUSTRALIAN NATL UNIV,RES SCH BIOL SCI,CANBERRA,ACT 2601,AUSTRALIA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Australian National University; John Curtin School of Medical Research; Australian National University					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NCRR NIH HHS [MOI RR-00188] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BODMER WF, 1981, AM J HUM GENET, V33, P664; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; CAMPBELL HD, 1983, P NATL ACAD SCI USA, V90, P11386; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; COLLEY AF, 1990, J PAEDIATR CHILD HLT, V26, P7; ELDER FFB, 1985, AM J MED GENET, V20, P519, DOI 10.1002/ajmg.1320200312; ELDON E, 1994, DEVELOPMENT, V120, P885; EPSTEIN CJ, 1986, CONSEQUENCE CHROMOSO, P174; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINUCANE BM, 1993, AM J MED GENET, V45, P443, DOI 10.1002/ajmg.1320450409; Fischer H, 1993, Klin Padiatr, V205, P162; FRIEDERICH E, 1990, BIOESSAYS, V12, P403, DOI 10.1002/bies.950120902; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; GUZZETTA V, 1991, GENOMICS, V9, P31, DOI 10.1016/0888-7543(91)90217-3; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; KONDO I, 1991, AM J MED GENET, V41, P225, DOI 10.1002/ajmg.1320410219; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEDBETTER DH, 1989, METABOLIC BASIS INHE, P334; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; LEGUERN E, 1994, CYTOGENET CELL GENET, V65, P261, DOI 10.1159/000133643; LOCKWOOD D, 1988, J MED GENET, V25, P732, DOI 10.1136/jmg.25.11.732; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1994, JIKKEN IGAKU, V12, P109; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; MAURY CPJ, 1993, BIOCHEM BIOPH RES CO, V191, P41, DOI 10.1006/bbrc.1993.1181; MIKLOS GLG, 1990, J NEUROGENET, V6, P133, DOI 10.3109/01677069009107106; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; PERRIMON N, 1989, GENETICS, V121, P313; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; SHAFFER LG, 1994, AM J HUM GENET, V55, P968; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; Sunada Y, 1992, Rinsho Shinkeigaku, V32, P840; SUNADA Y, 1993, ANN NEUROL, V33, P57, DOI 10.1002/ana.410330110; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WISE CA, 1993, AM J HUM GENET, V53, P853; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	47	62	65	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					175	182						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825574				2022-12-18	WOS:A1995QC10100022
J	KIMBERLING, WJ; WESTON, MD; MOLLER, C; VANAAREM, A; CREMERS, CWRJ; SUMEGI, J; ING, PS; CONNOLLY, C; MARTINI, A; MILANI, M; TAMAYO, ML; BERNAL, J; GREENBERG, J; AYUSO, C				KIMBERLING, WJ; WESTON, MD; MOLLER, C; VANAAREM, A; CREMERS, CWRJ; SUMEGI, J; ING, PS; CONNOLLY, C; MARTINI, A; MILANI, M; TAMAYO, ML; BERNAL, J; GREENBERG, J; AYUSO, C			GENE-MAPPING OF USHER SYNDROME TYPE IIA - LOCALIZATION OF THE GENE TO A 2.1-CM SEGMENT ON CHROMOSOME 1Q41	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; HUMAN HOMEOBOX GENE; GROWTH-FACTOR-BETA; LINKAGE MAP; HETEROGENEITY	Usher syndrome type II is associated with hearing loss and retinitis pigmentosa but not with any vestibular problems. It is known to be genetically heterogeneous, and one locus (termed USH2A) has been linked to chromosome 1q41. In an effort to refine the localization of USH2A, the genetic map of the region between and adjacent to the marker loci previously recognized as flanking USH2A (D1S70 and PPOL) is updated. Analysis of marker data on 68 Usher II families places the USH2A gene into a 2.1-cM region between the markers D1S237 and D1S229. The gene for transforming growth factor beta 2 (TGFB2) and the gene for the homeodomain box (HLX1) are both eliminated as candidates for USH2A, by virtue of their localization outside these flanking markers. The earlier finding of genetic heterogeneity was confirmed in six new families, and the proportion of unlinked Usher II families is estimated at 12.5%. The placement of the USH2A gene into this region will aid in the physical mapping and isolation of the gene itself.	UNIV NEBRASKA,SCH MED,DEPT PATHOL,OMAHA,NE 68131; LINKOPING UNIV,SCH MED,DEPT OTOLARYNGOL,LINKOPING,SWEDEN; UNIV NIJMEGEN HOSP,DEPT OTORHINOLARYNGOL,NIJMEGEN,NETHERLANDS; UNIV FERRARA,FERRARA,ITALY; UNIV JAVERIANA,BOGOTA,COLOMBIA; UNIV CAPE TOWN,SCH MED,DEPT HUMAN GENET,CAPE TOWN 7925,SOUTH AFRICA; FDN JIMENEZ DIAZ,MADRID,SPAIN	University of Nebraska System; Linkoping University; Radboud University Nijmegen; University of Ferrara; Pontificia Universidad Javeriana; University of Cape Town	KIMBERLING, WJ (corresponding author), UNIV NEBRASKA,SCH MED,BOYS TOWN NATL RES INST,CTR HEREDITARY COMMUN DISORDERS,555 N 30TH ST,OMAHA,NE 68131, USA.		Cremers, C.W.R.J./L-4254-2015; milani, massimo/H-3205-2013; Martini, Alessandro/K-2513-2018	milani, massimo/0000-0001-7559-1202; Martini, Alessandro/0000-0002-2003-6348; Tamayo, Martha Lucia/0000-0001-8297-3970; Ayuso, Carmen/0000-0002-9242-7065; Bernal Villegas, Jaime Eduardo/0000-0002-9733-5143	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER; NIDCD NIH HHS [P01 DC01813-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; DAHL SP, 1993, J MED GENET, V30, P843, DOI 10.1136/jmg.30.10.843; DEGUCHI Y, 1991, NEW BIOL, V3, P353; DELANNET M, 1992, DEVELOPMENT, V116, P275; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1166, DOI 10.1093/nar/20.5.1166; HALLGREN B, 1959, ACTA PSYCHIAT SCAND, V138, P1; JOHNSON MD, 1993, HUM PATHOL, V24, P457, DOI 10.1016/0046-8177(93)90156-B; KAPLAN J, 1990, ANN GENET-PARIS, V33, P105; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KARJALAINEN S, 1989, ANN OTO RHINOL LARYN, V98, P863, DOI 10.1177/000348948909801106; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; KIMBERLING WJ, 1991, DEGENERATIVE RETINOPATHIES : ADVANCES IN CLINICAL AND GENETIC RESEARCH, P111; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; MERIN S, 1974, ACTA GENET MED GEMEL, V23, P49, DOI 10.1017/S1120962300023623; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; NISHIMURA DY, 1993, GENOMICS, V15, P357, DOI 10.1006/geno.1993.1068; NUUTILA A, 1970, J GENET HUM, V18, P57; Ott J., 1991, ANAL HUMAN GENETIC L; RYBAK J, 1982, HUM GENET, V60, P328, DOI 10.1007/BF00569213; SANKILA EM, IN PRESS HUM MOL GEN; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; VERNON M, 1969, J CHRON DIS, V22, P133, DOI 10.1016/0021-9681(69)90055-1; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WESTON MD, 1994, HUM MOL GENET, V3, P1212, DOI 10.1093/hmg/3.7.1212; WESTON MD, 1994, HUM MOL GENET, V3, P1211, DOI 10.1093/hmg/3.7.1211-a; 1992, SCIENCE, V258, P148	29	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					216	223						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825581				2022-12-18	WOS:A1995QC10100028
J	WOLFF, DJ; BROWN, CJ; SCHWARTZ, S; DUNCAN, AMV; SURTI, U; WILLARD, HF				WOLFF, DJ; BROWN, CJ; SCHWARTZ, S; DUNCAN, AMV; SURTI, U; WILLARD, HF			SMALL MARKER X-CHROMOSOMES LACK THE X-INACTIVATION CENTER - IMPLICATIONS FOR KARYOTYPE/PHENOTYPE CORRELATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ULLRICH-TURNER SYNDROME; INCONTINENTIA PIGMENTI IP; SMALL RING-X; MOLECULAR CHARACTERIZATION; MENTAL-RETARDATION; INSITU HYBRIDIZATION; CYTOGENETIC FINDINGS; ABNORMAL KARYOTYPES; DNA PROBES; REGION	The abnormal phenotype and/or mental retardation seen in persons with small marker X (mar(X)) chromosomes has been hypothesized to be due to the loss of the X inactivation center (XIC) at Xq13.2, resulting in two active copies of genes in the pericentromeric region. In order to define precisely the DNA content of mar(X) chromosomes and to correlate phenotype with karyotype, we studied small mar(X) chromosomes, using FISH with probes in the juxtacentromeric region. One of the probes was a 40-kb genomic cosmid for the XIST gene, which maps to the smallest interval known to contain the XIC and is thought to be involved in X inactivation. Our findings reveal that small mar(X) chromosomes do not include the XIC and therfore cannot be subject to X inactivation, supporting the premise that abnormal dosage of expressed genes in the pericentromeric region of the X generates the aberrant phenotype seen in patients with small mar(X) chromosomes.	CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,CLEVELAND,OH 44106; QUEENS UNIV,DEPT PATHOL,KINGSTON K7L 3N6,ON,CANADA; KINGSTON GEN HOSP,KINGSTON K7L 2V7,ON,CANADA; UNIV PITTSBURGH,MAGEE WOMENS HOSP,DEPT PATHOL GENET,PITTSBURGH,PA 15213	Case Western Reserve University; Case Western Reserve University; Queens University - Canada; Queens University - Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00107] Funding Source: Medline; NIGMS NIH HHS [GM45441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACKBURN WR, 1982, BIRTH DEFECTS-ORIG, V18, P251; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1991, AM J HUM GENET, V48, P769; CAMARGO M, 1984, HUM GENET, V67, P37, DOI 10.1007/BF00270556; COCO R, 1977, J GENET HUM, V25, P95; COHEN MM, 1967, CYTOGENETICS, V6, P254, DOI 10.1159/000129946; COOPER C, 1991, J MED GENET, V28, P6, DOI 10.1136/jmg.28.1.6; CROLLA JA, 1988, HUM GENET, V81, P81, DOI 10.1007/BF00283735; DEALMEIDA JCC, 1985, ANN GENET-PARIS, V28, P37; DEGROUCHY J, 1985, ANN GENET-PARIS, V28, P86; DENNIS NR, 1993, J MED GENET, V30, P482, DOI 10.1136/jmg.30.6.482; DUNCAN AMV, 1993, AM J MED GENET, V47, P1153, DOI 10.1002/ajmg.1320470804; GILGENKRANTZ S, 1985, ANN GENET-PARIS, V28, P90; GORSKI JL, 1991, AM J HUM GENET, V48, P53; GREIG GM, 1993, HUM MOL GENET, V2, P1611; GROMPE M, 1992, AM J MED GENET, V42, P39, DOI 10.1002/ajmg.1320420110; GUTTENBACH M, 1991, HUM GENET, V87, P680; HAGEMEIJER A, 1976, HUM GENET, V34, P45, DOI 10.1007/BF00284433; HART ZH, 1965, J PEDIATR-US, V66, P120, DOI 10.1016/S0022-3476(65)80347-X; Hou Jia-Woei, 1992, Journal of the Formosan Medical Association, V91, P1108; ISHIKIRIYAMA S, 1993, AM J MED GENET, V47, P41, DOI 10.1002/ajmg.1320470109; JONES IM, 1981, AM J HUM GENET, V33, P252; KAJII T, 1985, ANN GENET-PARIS, V28, P219; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KUSHNICK T, 1987, AM J MED GENET, V28, P567, DOI 10.1002/ajmg.1320280304; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEPPIG KA, 1993, HUM MOL GENET, V2, P883, DOI 10.1093/hmg/2.7.883; LIN CC, 1990, AM J MED GENET, V37, P71, DOI 10.1002/ajmg.1320370117; LINDGREN V, 1992, HUM GENET, V88, P393, DOI 10.1007/BF00215672; MIGEON BR, 1993, P NATL ACAD SCI USA, V90, P12025, DOI 10.1073/pnas.90.24.12025; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; NIELSEN J, 1973, J MENT DEFIC RES, V17, P227; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; SCHLESSINGER D, 1993, CYTOGENET CELL GENET, V64, P147, DOI 10.1159/000133572; SCHMID W, 1974, HUMANGENETIK, V24, P93; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; SCHWARTZ S, IN PRESS AM J MED GE; THARAPEL AT, 1993, AM J HUM GENET, V52, P463; THARAPEL SA, 1992, AM J MED GENET, V42, P720, DOI 10.1002/ajmg.1320420519; THERMAN E, 1974, HUMANGENETIK, V25, P1; THERMAN E, 1979, HUM GENET, V50, P59, DOI 10.1007/BF00295590; THERMAN E, 1980, HUM GENET, V54, P133, DOI 10.1007/BF00278961; VANDYKE DL, 1992, AM J MED GENET, V43, P996, DOI 10.1002/ajmg.1320430617; VANDYKE DL, 1991, J PEDIATR-US, V118, P415, DOI 10.1016/S0022-3476(05)82159-6; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WILLARD HF, IN PRESS COLD SPRING; ZENGERHAIN JL, 1993, AM J MED GENET, V47, P490, DOI 10.1002/ajmg.1320470412	54	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					87	95						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023855				2022-12-18	WOS:A1994NW46100013
J	MEYN, MS; LUKUO, JM; HERZING, LBK				MEYN, MS; LUKUO, JM; HERZING, LBK			EXPRESSION CLONING OF MULTIPLE HUMAN CDNAS THAT COMPLEMENT THE PHENOTYPIC DEFECTS OF ATAXIA-TELANGIECTASIA GROUP-D FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNCTIONAL COMPLEMENTATION; INTEGRATED DNA; HUMAN-CELLS; GENE; HYBRIDIZATION; PROTEIN; REGION; LOCUS	Ataxia-telangiectasia (A-T) is an inherited human disease of unknown etiology associated with neurologic degeneration, immune dysfunction, cancer risk, and genetic instability. A-T cells are sensitive to ionizing radiation and radiomimetic drugs, offering the possibility of cloning A-T genes by phenotypic complementation. We have used this sensitivity to isolate the first human cDNAs reported to complement A-T cells in culture. Complementation group D A-T fibroblasts were transfected with an episomal vector-based human cDNA library, similar to 610,000 resultant transformants were treated with the radiomimetic drug streptonigrin-resistent, and nine unrelated cDNAs were recovered from 29 surviving streptonigrin-resistant clones. Five cDNAs were mapped, but none localized to 11q23, the site of A-T complementation group A and C loci. Four of the mapped cDNAs conferred mutagen resistance to A-T D fibroblasts on secondary transfection. One cDNA was identified as a fragment of dek, a gene involved in acute myeloid leukemia. The dek cDNA fragment and pCAT4.5, a 4.5-kb cDNA that mapped to 17p11, independently complemented three different phenotypic abnormalities of A-T D fibroblasts (mutagen sensitivity, hyperrecombination, and radio-resistant DNA synthesis). The pCAT4.5 cDNA did not complement the mutagen sensitivity of an A-T group C fibroblast line, suggesting that it represents a candidate disease gene for group D A-T. Our results indicate that phenotypic complementation alone is insufficient evidence to prove that a candidate cDNA is an A-T disease gene. The complementing cDNAs may represent previously uncharacterized genes that function in the same pathway as does the A-T gene product(s) in the regulation of cellular responses to DNA damage.	YALE UNIV, SCH MED, DEPT PEDIAT, NEW HAVEN, CT 06510 USA	Yale University	MEYN, MS (corresponding author), YALE UNIV, SCH MED, DEPT GENET, 333 CEDAR ST, NEW HAVEN, CT 06510 USA.							ARNOLD N, IN PRESS TECHNIQUES; BATES PR, 1989, MUTAT RES, V218, P165, DOI 10.1016/0921-8777(89)90023-2; BELT PBGM, 1989, GENE, V84, P407, DOI 10.1016/0378-1119(89)90515-5; BRIGATI DJ, 1983, VIROLOGY, V126, P32, DOI 10.1016/0042-6822(83)90460-9; COHEN MM, 1989, ADV HUM GENET, V18, P43; EJIMA Y, 1990, INT J RADIAT BIOL, V58, P989, DOI 10.1080/09553009014552301; GREEN MHL, 1987, J CELL SCI, P127; GROGER RK, 1989, GENE, V81, P285, DOI 10.1016/0378-1119(89)90189-3; HECHT F, 1990, CANCER GENET CYTOGEN, V46, P9, DOI 10.1016/0165-4608(90)90003-S; HERNANDEZ D, 1993, J MED GENET, V30, P135, DOI 10.1136/jmg.30.2.135; HERZING LBK, IN PRESS GENE; HILGERS G, 1987, CARCINOGENESIS, V8, P315, DOI 10.1093/carcin/8.2.315; HILGERS G, 1989, MUTAGENESIS, V4, P271, DOI 10.1093/mutage/4.4.271; HOEIJMAKERS JHJ, 1987, EXP CELL RES, V169, P111, DOI 10.1016/0014-4827(87)90230-8; KAPP LN, 1989, INT J RADIAT BIOL, V56, P667, DOI 10.1080/09553008914551891; KAPP LN, 1992, AM J HUM GENET, V51, P45; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; LAMBERT C, 1991, P NATL ACAD SCI USA, V88, P5907, DOI 10.1073/pnas.88.13.5907; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LOHRER H, 1988, MOL GEN GENET, V212, P474, DOI 10.1007/BF00330852; MAYNE LV, 1988, GENE, V66, P65, DOI 10.1016/0378-1119(88)90225-9; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; MEYN MS, UNPUB ATAXIA TELANGI; Sambrook J., 1989, MOL CLONING LAB MANU; SANAL O, 1990, AM J HUM GENET, V47, P860; SCHIMKE RT, 1991, COLD SH Q B, V56, P417; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; SETTLEMAN J, 1989, MOL CELL BIOL, V9, P5563, DOI 10.1128/MCB.9.12.5563; SOBEL E, 1992, AM J HUM GENET, V50, P1343; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; WAKE CT, 1984, MOL CELL BIOL, V4, P387, DOI 10.1128/MCB.4.3.387; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651	38	62	63	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1206	1216						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	7504406				2022-12-18	WOS:A1993MJ81800007
J	PASSARINO, G; SEMINO, O; MODIANO, G; SANTACHIARABENERECETTI, AS				PASSARINO, G; SEMINO, O; MODIANO, G; SANTACHIARABENERECETTI, AS			COII TRANSFER RNA(LYS) INTERGENIC 9-BP DELETION AND OTHER MTDNA MARKERS CLEARLY REVEAL THAT THE THARUS (SOUTHERN NEPAL) HAVE ORIENTAL AFFINITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; MALARIA MORBIDITY; LENGTH MUTATIONS; POPULATIONS; MIGRATIONS	We searched for the East Asian mtDNA 9-bp deletion in the intergenic COII/tRNA(Lys) region in a sample of 107 Tharus (50 from central Terai and 57 from eastern Terai), a population whose anthropological origin has yet to be completely clarified. The deletion, detected by electrophoresis of the PCR-amplified nt 7392-8628 mtDNA fragment after digestion with HaeIII, was found in about 8% of both Tharu groups but was found in none of the 76 Hindus who were examined as a non-Oriental neighboring control population. A complete triplication of the 9-bp unit, the second case so far reported, was also observed in one eastern Tharu. All the mtDNAs with the deletion, and that with the triplication, were further characterized (by PCR amplification of the relevant mtDNA fragments and their digestion with the appropriate enzymes) to locate them in the Ballinger et al. phylogeny of East Asian mtDNA haplotypes. The deletion was found to be associated with four different haplotypes, two of which are reported for the first time. One of the deletions and especially the triplication could be best explained by the assumption of novel length-change events. Ballinger's classification of East Asian mtDNA haplotypes is mainly based on the phenotypes for the DdeI site at nt 10394 and the AluI site at nt 10397. Analysis of the entire Tharu sample revealed that more than 70% of the Tharus have both sites, the association of which has been suggested as an ancient East Asian peculiarity. These results conclusively indicate that the Tharus have a predominantly maternal Oriental ancestry. Moreover, they show at least one and perhaps two further distinct length mutations, and this suggests that the examined region is a hot spot of rearrangements.	UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL,VIA ABBIATEGRASSO 207,I-27100 PAVIA,ITALY; UNIV CALABRIA,CNR,ISMEC,COSENZA,ITALY; UNIV CALABRIA,DIPARTIMENTO BIOL CELLULARE,COSENZA,ITALY; UNIV TOR VEGATA ROME,DIPARTIMENT BIOL,ROME,ITALY	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); University of Calabria; University of Calabria				SEMINO, Ornella/0000-0002-9675-9403				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BISTA DB, 1980, PEOPLE NEPAL; BLANC H, 1983, AM J HUM GENET, V35, P167; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN MD, 1992, GENETICS, V130, P163; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHOPRA VP, 1970, HUMANGENETIK, V10, P35, DOI 10.1007/BF00297638; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; HARIHARA S, 1992, HUM BIOL, V64, P161; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1986, HUM GENET, V72, P105; MODIANO G, 1991, AM J HUM GENET, V48, P390; Passarino G, 1992, Gene Geogr, V6, P139; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STONEKING M, 1990, GENETICS, V124, P717; TERRENATO L, 1988, ANN TROP MED PARASIT, V82, P1; TORRONI A, 1992, GENETICS, V130, P153; WALLACE DC, 1992, HUM BIOL, V64, P403; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	21	62	64	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					609	618						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8102506				2022-12-18	WOS:A1993LU55900004
J	KORKKO, J; RITVANIEMI, P; HAATAJA, L; KAARIAINEN, H; KIVIRIKKO, KI; PROCKOP, DJ; ALAKOKKO, L				KORKKO, J; RITVANIEMI, P; HAATAJA, L; KAARIAINEN, H; KIVIRIKKO, KI; PROCKOP, DJ; ALAKOKKO, L			MUTATION IN TYPE-II PROCOLLAGEN (COL2A1) THAT SUBSTITUTES ASPARTATE FOR GLYCINE ALPHA-1-67 AND THAT CAUSES CATARACTS AND RETINAL-DETACHMENT - EVIDENCE FOR MOLECULAR HETEROGENEITY IN THE WAGNER SYNDROME AND THE STICKLER SYNDROME (ARTHROOPHTHALMOPATHY)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE COL2A1; SINGLE-BASE CHANGES; SPONDYLOEPIPHYSEAL DYSPLASIA; SERINE SUBSTITUTION; CHAIN; SEQUENCES; DISEASES; FAMILY; EXON	A search for mutations in the gene for type II procollagen (COL2A1) was carried out in affected members of a family with early-onset cataracts, lattice degeneration of the retina, and retinal detachment. They had no symptoms suggestive of involvement of nonocular tissues, as is typically found in the Stickler syndrome. The COL2A1 gene was amplified with PCR, and the products were analyzed by denaturing gradient gel electrophoresis. The results suggested a mutation in one allele for exon 10. Sequencing of the fragment demonstrated a single-base mutation that converted the codon for glycine at position alpha1-67 to aspartate. The mutation was found in three affected members of the family available for study but not in unaffected members or 100 unrelated individuals. Comparison with previously reported mutations suggested that mutations introducing premature termination codons in the COL2A1 gene are a frequent cause of the Stickler syndrome, but mutations in the COL2A1 gene that replace glycine codons with codons for bulkier amino acid can produce a broad spectrum of disorders that range from lethal chondrodysplasias to a syndrome involving only ocular tissues, similar to the syndrome in the family originally described by Wagner in 1938.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, JEFFERSON INST MOLEC MED, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; UNIV OULU, BIOCTR, COLLAGEN RES UNIT, SF-90100 OULU 10, FINLAND; UNIV OULU, DEPT MED BIOCHEM, SF-90100 OULU 10, FINLAND; UNIV TURKU, DEPT MED GENET, SF-20500 TURKU 50, FINLAND	Jefferson University; University of Oulu; University of Oulu; University of Turku			Haataja, Leena/GPG-3986-2022; Haataja, Leena/G-1160-2016	Haataja, Leena/0000-0002-8057-6194	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039740] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-39740] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLAIR NP, 1979, AM J OPHTHALMOL, V88, P876, DOI 10.1016/0002-9394(79)90566-X; Brown D. M., 1992, American Journal of Human Genetics, V51, pA301; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHAN D, 1991, J BIOL CHEM, V266, P12487; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; DELANEY WV, 1963, ARCH OPHTHALMOL-CHIC, V69, P44; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; FRANCOMANO C A, 1988, American Journal of Human Genetics, V43, pA83; FRYER AE, 1990, J MED GENET, V27, P91, DOI 10.1136/jmg.27.2.91; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; HUANG MC, 1991, EUR J BIOCHEM, V195, P593, DOI 10.1111/j.1432-1033.1991.tb15742.x; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; OPITZ JM, 1972, NEW ENGL J MED, V286, P546; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; Pyeritz RE, 1989, ARTHRITIS ALLIED CON, P1332; RITVANIEMI P, IN PRESS GENOMICS; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; TEMPLE IK, 1989, J MED GENET, V26, P119, DOI 10.1136/jmg.26.2.119; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; VIKKULA M, 1989, FEBS LETT, V250, P171, DOI 10.1016/0014-5793(89)80713-6; VIKKULA M, IN PRESS GENOMICS; VISSING H, 1989, J BIOL CHEM, V264, P18265; Wagner H., 1938, KLIN MONATSBL AUGENH, V100, P840; ZLOTOGORA J, 1992, AM J MED GENET, V42, P337, DOI 10.1002/ajmg.1320420316	38	62	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					55	61						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317498				2022-12-18	WOS:A1993LJ38500008
J	FREIMER, NB; SANDKUIJL, LA; BLOWER, SM				FREIMER, NB; SANDKUIJL, LA; BLOWER, SM			INCORRECT SPECIFICATION OF MARKER ALLELE FREQUENCIES - EFFECTS ON LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVITY ANALYSIS; DNA POLYMORPHISMS; COMPUTER-MODELS	Most current linkage analyses make use of highly polymorphic DNA markers. Assigning correct allele frequencies for these markers may be extremely difficult in particular study populations. Designation of erroneous frequencies may result in false-positive evidence for linkage, as well as in failure to correctly exclude linkage. These effects are most pronounced in small pedigrees with key individuals unavailable for typing. The power to correctly detect true linkage does not appear to be greatly affected by inaccurate allele frequencies. Before linkage analyses are performed for specific pedigrees, it is recommended that simulation analyses be performed, followed by uncertainty and sensitivity analyses.	ERASMUS UNIV ROTTERDAM,DEPT MED GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV CALIF BERKELEY,SCH PUBL HLTH,DEPT EPIDEMIOL & BIOSTAT,BERKELEY,CA 94720	Erasmus University Rotterdam; University of California System; University of California Berkeley	FREIMER, NB (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,NEUROGENET LAB,BOX F-0984,SAN FRANCISCO,CA 94143, USA.							BLOWER SM, 1991, PHIL T R SOC LOND B, V321, P171; Bowcock A M, 1991, Gene Geogr, V5, P151; DEVLIN B, 1991, AM J HUM GENET, V48, P662; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FREIMER NB, 1992, MOL GENETIC BASIS NE; IMAN RL, 1981, J QUAL TECHNOL, V13, P232, DOI 10.1080/00224065.1981.11978763; IMAN RL, 1981, J QUAL TECHNOL, V13, P174, DOI 10.1080/00224065.1981.11978748; KIDD JR, 1991, HUM BIOL, V63, P775; KNOWLES JA, 1992, AM J HUM GENET, V51, P905; KRUGER SD, 1982, BIOL PSYCHIAT, V17, P1081; LANDER ES, 1988, GENOME ANAL PRACTICA; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1989, AM J HUM GENET, V44, P397; MORTON NE, 1978, CYTOGENET CELL GENET, V22, P15, DOI 10.1159/000130916; NAKAMURA Y, 1985, SCIENCE, V217, P939; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J., 1991, ANAL HUMAN GENETIC L; SAMPSON JR, 1992, J MED GENET, V29, P861, DOI 10.1136/jmg.29.12.861; SANDKUYL L, 1989, HUM GENET, V82, P159, DOI 10.1007/BF00284050; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; VALDES AM, 1993, GENETICS, V133, P737; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402	24	62	62	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1102	1110						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503444				2022-12-18	WOS:A1993LG13300011
J	FRANK, MB; ITOH, K; FUJISAKU, A; PONTAROTTI, P; MATTEI, MG; NEAS, BR				FRANK, MB; ITOH, K; FUJISAKU, A; PONTAROTTI, P; MATTEI, MG; NEAS, BR			THE MAPPING OF THE HUMAN 52-KD RO/SSA AUTOANTIGEN GENE TO HUMAN CHROMOSOME-II, AND ITS POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; SOLUBLE CYTOPLASMIC ANTIGEN; CONGENITAL HEART-BLOCK; RET TRANSFORMING GENE; RO SS-A; NEONATAL LUPUS; GM ALLOTYPES; SJOGRENS SYNDROME; BINDING-PROTEINS; ANTIBODIES	Autoantibodies to Ro/SSA occur in nearly half of the patients with systemic lupus erythematosus and are associated with lymphopenia, photosensitive dermatitis, and pulmonary and renal disease, which suggests that they have an immunopathologic role. The majority of Ro/SSA precipitin-positive patients produce serum antibodies that bind to the 60-kD and 52-kD Ro/SSA proteins. We previously isolated and determined the nucleotide sequence of a cDNA done that encodes the 52-kD form of the human Ro/SSA protein. In the present study, we have determined the chromosomal location of the gene by in situ hybridization to the end of the short arm of chromosome 11. Hybridization of portions of the cDNA probe to restriction enzyme-digested DNA indicated the gene is composed of at least three exons. The exon encoding the putative zinc fingers of this protein was found to be distinct from that which encodes the leucine zipper. An RFLP of this gene was identified and is associated with the presence of lupus, primarily in black Americans.	UNIV OKLAHOMA, HLTH SCI CTR, DEPT BIOSTAT & EPIDEMIOL, OKLAHOMA CITY, OK 73190 USA; HOKKAIDO UNIV, SCH MED, DEPT INTERNAL MED 2, SAPPORO, HOKKAIDO 060, JAPAN; CTR RECH POLYMORPHISME GENET POPULAT HUMAINES, TOULOUSE, FRANCE; CTR GENET MED, INSERM, U242, MARSEILLE, FRANCE	University of Oklahoma System; University of Oklahoma Health Sciences Center; Hokkaido University; Institut National de la Sante et de la Recherche Medicale (Inserm)	FRANK, MB (corresponding author), OKLAHOMA MED RES FDN, ARTHRITHIS & IMMUNOL PROGRAM, 825 NE 13TH ST, OKLAHOMA CITY, OK 73104 USA.		, pontarotti/ABB-1753-2021	Pierre, Pontarotti/0000-0001-7202-3648	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024717, R37AI024717, P01AI021568] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21568, AI24717] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALSPAUGH MA, 1975, J CLIN INVEST, V55, P1067, DOI 10.1172/JCI108007; ARNETT FC, 1976, MEDICINE, V55, P313, DOI 10.1097/00005792-197607000-00003; BENCHETRIT E, 1989, J CLIN INVEST, V83, P1284, DOI 10.1172/JCI114013; BENCHETRIT E, 1988, J EXP MED, V167, P1560, DOI 10.1084/jem.167.5.1560; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BIAS WB, 1986, AM J HUM GENET, V39, P584; BLOCK SR, 1975, AM J MED, V59, P533, DOI 10.1016/0002-9343(75)90261-2; BLOCK SR, 1976, ARTHRITIS RHEUM, V19, P545, DOI 10.1002/art.1780190306; BUYON JP, 1989, J CLIN INVEST, V84, P627, DOI 10.1172/JCI114208; BUYON JP, 1990, J IMMUNOL METHODS, V129, P207, DOI 10.1016/0022-1759(90)90440-7; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; CLARK G, 1969, J IMMUNOL, V102, P117; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; DEUTSCHER SL, 1988, P NATL ACAD SCI USA, V85, P9479, DOI 10.1073/pnas.85.24.9479; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FEDRICK JA, 1983, HUM IMMUNOL, V8, P177, DOI 10.1016/0198-8859(83)90012-5; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FESSEL WJ, 1988, SYSTEMIC LUPUS ERYTH, P15; FRANK MB, 1990, J CLIN INVEST, V85, P33, DOI 10.1172/JCI114430; FUJISAKU A, 1990, J CLIN INVEST, V86, P606, DOI 10.1172/JCI114751; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; HANAS JS, 1983, J BIOL CHEM, V258, P4120; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; HARLEY JB, 1989, ARTHRITIS RHEUM, V32, P826; HEDGPETH MT, 1988, ARTHRITIS RHEUM, V31, P545, DOI 10.1002/art.1780310412; HOFFMAN RW, 1991, ARTHRITIS RHEUM, V34, P453, DOI 10.1002/art.1780340410; ITOH K, 1991, J CLIN INVEST, V87, P177, DOI 10.1172/JCI114968; ITOH Y, 1990, CLIN EXP IMMUNOL, V81, P45; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEONHARDT T, 1964, ACTA MED SCAND, V176, P1; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; MADDISON P, 1979, J RHEUMATOL, V6, P189; MADDISON PJ, 1979, ARTHRITIS RHEUM, V22, P858; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MOND CB, 1989, ARTHRITIS RHEUM, V32, P202, DOI 10.1002/anr.1780320213; MORTON NE, 1982, HUM GENET, V62, P266, DOI 10.1007/BF00333534; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; RADER MD, 1989, ARTHRITIS RHEUM, V32, P1563, DOI 10.1002/anr.1780321210; RAMSEYGOLDMAN R, 1986, ARTHRITIS RHEUM, V29, P1269, DOI 10.1002/art.1780291013; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; REICHLIN M, 1986, J CLIN IMMUNOL, V6, P339, DOI 10.1007/BF00915372; Rothfield N. J., 1985, ARTHRITIS ALLIED CON, P911; SCHUR PH, 1985, ARTHRITIS RHEUM, V28, P828, DOI 10.1002/art.1780280716; SILVERMAN E, 1991, J RHEUMATOL, V18, P120; SMOLEN JS, 1985, AM J MED SCI, V289, P139, DOI 10.1097/00000441-198504000-00003; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STENSZKY V, 1986, J IMMUNOGENET, V13, P11; SUTHERLAND GR, 1990, GENETIC MAPS LOCUS M; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1853, DOI 10.1128/MCB.8.4.1853; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TEBIB J, 1908, ARTHRITIS RHEUM S, V31, pS121; WASICEK CA, 1982, J CLIN INVEST, V69, P835, DOI 10.1172/JCI110523; WATSON RM, 1984, MEDICINE, V63, P362, DOI 10.1097/00005792-198411000-00003; WHITTINGHAM S, 1983, TISSUE ANTIGENS, V21, P50; WOLIN SL, 1984, P NATL ACAD SCI-BIOL, V81, P1996, DOI 10.1073/pnas.81.7.1996; YAMAGATA H, 1984, J CLIN INVEST, V74, P625, DOI 10.1172/JCI111460; [No title captured]	60	62	62	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					183	191						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8094596				2022-12-18	WOS:A1993KK90800021
J	FOROUD, T; WEI, S; ZIV, Y; SOBEL, E; LANGE, E; CHAO, A; GORADIA, T; HUO, Y; TOLUN, A; CHESSA, L; CHARMLEY, P; SANAL, O; SALMAN, N; JULIER, C; CONCANNON, P; MCCONVILLE, C; TAYLOR, AMR; SHILOH, Y; LANGE, K; GATTI, RA				FOROUD, T; WEI, S; ZIV, Y; SOBEL, E; LANGE, E; CHAO, A; GORADIA, T; HUO, Y; TOLUN, A; CHESSA, L; CHARMLEY, P; SANAL, O; SALMAN, N; JULIER, C; CONCANNON, P; MCCONVILLE, C; TAYLOR, AMR; SHILOH, Y; LANGE, K; GATTI, RA			LOCALIZATION OF AN ATAXIA-TELANGIECTASIA LOCUS TO A 3-CM INTERVAL ON CHROMOSOME-11Q23 - LINKAGE ANALYSIS OF 111 FAMILIES BY AN INTERNATIONAL CONSORTIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA POLYMORPHISM; GENETIC-LINKAGE; GENOTYPE ELIMINATION; RECEPTOR COMPLEX; HUMAN TYROSINASE; HUMAN GENOME; N-CAM; CDNA; SEQUENCE	Linkage of at least two complementation groups of ataxia-telangiectasia (AT) to the chromosomal region 11q23 is now well established. We provide here an 18-point map of the surrounding genomic region, derived from linkage analysis of 40 CEPH families. On the basis of this map, 111 AT families from Turkey, Israel, England, Italy, and the United States were analyzed, localizing the AT gene(s) to an 8-cM sex-averaged interval between the markers STMY and D11S132/NCAM. A new Monte Carlo method for computing approximate location scores estimates this location as being at least 10(8) times more likely than the next most likely interval, with a support interval midway between STMY and D11S132 that is either 5.2 cM (sex-averaged and conservatively based on 3 lod scores from the maximum-location score) or 2.8 cM (male specific, based on a 2.72:1 interval-specific female-to-male distance ratio).	UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90024; TEL AVIV UNIV,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL; BOGAZICI UNIV,DEPT BIOL,ISTANBUL,TURKEY; ISTANBUL UNIV,DEPT PEDIAT,ISTANBUL,TURKEY; UNIV ROME LA SAPIENZA,DEPT MOLEC GENET,I-00185 ROME,ITALY; HACETTEPE UNIV,DEPT PEDIAT,ANKARA,TURKEY; CTR ETUD POLYMORPHISME HUMAIN,PARIS,FRANCE; VIRGINIA MASON RES CTR,DEPT IMMUNOL,SEATTLE,WA 98101; UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195; UNIV BIRMINGHAM,CANC RES CAMPAIGN LABS,DEPT CANC STUDIES,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tel Aviv University; Bogazici University; Istanbul University; Sapienza University Rome; Hacettepe University; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Birmingham	GATTI, RA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024, USA.		JULIER, Cécile/M-9824-2017	JULIER, Cécile/0000-0002-1538-0240; Sobel, Eric/0000-0002-1718-0031; tolun, aslihan/0000-0002-0328-6046; Concannon, Patrick/0000-0002-5801-1859				BODER E, 1985, ATAXIA TELANGIECTASI, P1; BUDARF M, 1989, AM J HUM GENET, V45, P128; CARLSON M, 1988, NUCLEIC ACIDS RES, V16, P378, DOI 10.1093/nar/16.1.378; CHARMLEY C, 1991, GENOMICS, V10, P606; CHARMLEY P, 1990, GENOMICS, V6, P316, DOI 10.1016/0888-7543(90)90572-C; CHARMLEY P, 1989, NUCLEIC ACIDS RES, V17, P2374, DOI 10.1093/nar/17.6.2374; CHARMLEY P, 1990, NUCLEIC ACIDS RES, V18, P207, DOI 10.1093/nar/18.1.207; CHARMLEY P, 1989, NUCLEIC ACIDS RES, V17, P2373; CONCANNON P, 1990, AM J HUM GENET, V46, P789; CURRY CJR, 1989, AM J HUM GENET, V45, P270; DAUSSET J, 1986, PRESSE MED, V15, P1801; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Edwards A.W.F, 1972, LIKELIHOOD; EJIMA Y, 1990, INT J RADIAT BIOL, V58, P989, DOI 10.1080/09553009014552301; GATTI R A, 1984, Biotechniques, V2, P148; GATTI RA, 1987, CYTOGENET CELL GENET, V46, P618; GATTI RA, 1988, HUM IMMUNOL, V22, P145, DOI 10.1016/0198-8859(88)90023-7; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GATTI RA, 1990, AM J HUM GENET S, V47, pA179; GOLD DP, 1986, NATURE, V321, P431, DOI 10.1038/321431a0; GORIDIS C, 1985, EMBO J, V4, P631, DOI 10.1002/j.1460-2075.1985.tb03676.x; GRANDY DK, 1989, AM J HUM GENET, V45, P778; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JASPERS NGJ, 1985, ATAXIA TELANGIECTASI, P147; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; JULIER C, 1989, NUCLEIC ACIDS RES, V17, P9510, DOI 10.1093/nar/17.22.9510; KERCKAERT JP, 1987, NUCLEIC ACIDS RES, V15, P5905, DOI 10.1093/nar/15.14.5905; KOMATSU K, 1990, MUTAT RES, V235, P59, DOI 10.1016/0921-8777(90)90058-D; KRISSANSEN GW, 1986, EMBO J, V5, P1799, DOI 10.1002/j.1460-2075.1986.tb04429.x; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LANGE K, 1987, AM J HUM GENET, V40, P250; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LLEWELLYN DH, 1987, NUCLEIC ACIDS RES, V15, P1349, DOI 10.1093/nar/15.3.1349; MALHOTRA U, 1989, NUCLEIC ACIDS RES, V17, P2373, DOI 10.1093/nar/17.6.2373; Maslen CL, 1988, GENOMICS, V2, P66, DOI 10.1016/0888-7543(88)90110-3; MCCONVILLE CM, 1990, NUCLEIC ACIDS RES, V18, P4335, DOI 10.1093/nar/18.15.4335; MCCONVILLE CM, 1990, HUM GENET, V85, P215; MIETUSSNYDER M, 1990, GENOMICS, V7, P633, DOI 10.1016/0888-7543(90)90211-C; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SANAL O, 1990, AM J HUM GENET, V47, P860; SPRITZ R, 1988, NUCLEIC ACIDS RES, V16, P9890, DOI 10.1093/nar/16.20.9890; SPURR N K, 1988, Genomics, V2, P119, DOI 10.1016/0888-7543(88)90093-6; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; VANDENELSEN P, 1984, NATURE, V312, P413, DOI 10.1038/312413a0; WARNICH L, 1986, NUCLEIC ACIDS RES, V14, P1920, DOI 10.1093/nar/14.4.1920; WEEKS D E, 1987, Genomics, V1, P236, DOI 10.1016/0888-7543(87)90050-4; WEI S, 1990, CANCER GENET CYTOGEN, V46, P1, DOI 10.1016/0165-4608(90)90002-R; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; ZIV Y, 1991, GENOMICS, V9, P373, DOI 10.1016/0888-7543(91)90268-J	57	62	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1263	1279						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1746555				2022-12-18	WOS:A1991GU67200013
J	ROUSSEAU, F; VINCENT, A; RIVELLA, S; HEITZ, D; TRIBOLI, C; MAESTRINI, E; WARREN, ST; SUTHERS, GK; GOODFELLOW, P; MANDEL, JL; TONIOLO, D; OBERLE, I				ROUSSEAU, F; VINCENT, A; RIVELLA, S; HEITZ, D; TRIBOLI, C; MAESTRINI, E; WARREN, ST; SUTHERS, GK; GOODFELLOW, P; MANDEL, JL; TONIOLO, D; OBERLE, I			4 CHROMOSOMAL BREAKPOINTS AND 4 NEW PROBES MARK OUT A 10-CM REGION ENCOMPASSING THE FRAGILE-X LOCUS (FRAXA)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; SEQUENCES	We report the validation and use of a cell hybrid panel which allowed us a rapid physical localization of new DNA probes in the vicinity of the fragile-X locus (FRAXA). Seven regions are defined by this panel, two of which lie between DXS369 and DXS296, until now the closest genetic markers that flank FRAXA. Of those two interesting regions, one is just distal to DXS369 and defined by probe 2-71 (DXS476), which is not polymorphic. The next one contains probes St677 (DXS463) and 2-34 (DXS477), which are within 130 kb and both detect TaqI RFLPs. The combined informativeness of these two probes is 30%. We cloned from an irradiation-reduced hybrid line another new polymorphic probe, Do33 (DXS465; 42% heterozygosity). This probe maps to the DXS296 region, proximal to a chromosomal breakpoint that corresponds to the Hunter syndrome locus (IDS). The physical order is thus Cen-DXS369-DXS476-(DXS463,DXS477)-(DXS296,DXS465)-IDS-DXS304-tel. We performed a linkage analysis for five of these markers in both the Centre d'Etude du Polymorphisme Humain families and in a large set of fragile-X families. This establishes that DXS296 is distal to FRAXA. The relative position of DXS463 and DXS477 with respect to FRAXA remains uncertain, but our results place them genetically halfway between DXS369 and DXS304. Thus the DXS463-DXS477 cluster defines presently either the closest proximal or the closest distal polymorphic marker with respect to FRAXA. The three new polymorphic probes described here have a combined heterozygosity of 60% and represent a major improvement for genetic analysis of fragile-X families, in particular for diagnostic applications.	FAC MED STRASBOURG,GENET MOLEC EUCARYOTES LAB,CNRS,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; IST GENET BIOCHIM & EVOLUZ,PAVIA,ITALY; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Emory University; Emory University; Cancer Research UK			Warren, Stephen T/A-2498-2012; Rivella, Stefano/A-1597-2010; Maestrini, Elena/K-7508-2012; Toniolo, Daniela/AAE-2969-2019	Maestrini, Elena/0000-0001-5924-3179; Toniolo, Daniela/0000-0001-9545-6032; Rivella, Stefano/0000-0002-0938-6558				BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; COUTURIER J, 1979, HUM GENET, V49, P319, DOI 10.1007/BF00569351; COX DR, 1989, GENOMICS, V4, P397, DOI 10.1016/0888-7543(89)90347-9; DAHL N, 1989, AM J HUM GENET, V45, P304; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAESTRINI E, IN PRESS GENOMICS; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NUSSBAUM RL, 1986, ANNU REV GENET, V20, P109; OBERLE I, IN PRESS AM J MED GE; OOSTRA BA, 1990, GENOMICS, V6, P129, DOI 10.1016/0888-7543(90)90457-6; OPITZ JM, IN PRESS X LINKED ME; ROUSSEAU F, 1990, HUM GENET, V84, P263; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; VINCENT A, 1989, GENOMICS, V5, P797, DOI 10.1016/0888-7543(89)90121-3; WARREN ST, 1990, P NATL ACAD SCI USA, V87, P3856, DOI 10.1073/pnas.87.10.3856	17	62	63	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					108	116						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1670748				2022-12-18	WOS:A1991ET18800015
J	VILKKI, J; SAVONTAUS, ML; NIKOSKELAINEN, EK				VILKKI, J; SAVONTAUS, ML; NIKOSKELAINEN, EK			SEGREGATION OF MITOCHONDRIAL GENOMES IN A HETEROPLASMIC LINEAGE WITH LEBER HEREDITARY OPTIC NEURORETINOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU,INST BIOMED,DEPT MED GENET,SF-20500 TURKU 50,FINLAND; UNIV TURKU,DEPT BIOL,SF-20500 TURKU 50,FINLAND; UNIV TURKU,CENT HOSP,DEPT OPHTHALMOL,SF-20520 TURKU 52,FINLAND	University of Turku; University of Turku; University of Turku								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1984, GENETICS, V106, P479; HARIHARA S, 1988, AM J HUM GENET, V43, P134; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IA, 1989, J MED GENET, V6, P739; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NIKOSKELAINEN E, 1985, T OPHTHAL SOC UK, V104, P845; NIKOSKELAINEN EK, 1987, ARCH OPHTHALMOL-CHIC, V105, P665, DOI 10.1001/archopht.1987.01060050083043; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; POULTON J, 1989, LANCET, V1, P236; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; VILKKI J, 1989, HUM GENET, V82, P208, DOI 10.1007/BF00291155; VILKKI J, 1988, HUM GENET, V80, P317, DOI 10.1007/BF00273643; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	24	62	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					95	100						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	1971999				2022-12-18	WOS:A1990DK48200013
J	LAGERSTROM, M; DAHL, N; ISELIUS, L; BACKMAN, B; PETTERSSON, U				LAGERSTROM, M; DAHL, N; ISELIUS, L; BACKMAN, B; PETTERSSON, U			MAPPING OF THE GENE FOR X-LINKED AMELOGENESIS IMPERFECTA BY LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UPPSALA,CTR BIOMED,DEPT MED GENET,BOX 589,S-75123 UPPSALA,SWEDEN; SOUTHAMPTON GEN HOSP,DEPT COMMUNITY MED,CRC RES GRP GENET EPIDEMIOL,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND; UMEA UNIV,DEPT PEDODONT,S-90187 UMEA,SWEDEN	Uppsala University; University of Southampton; Umea University								ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BACKMAN B, 1988, HUM HERED, V38, P189, DOI 10.1159/000153785; BAKKER E, 1985, LANCET, V1, P655; BERKMAN M D, 1971, Birth Defects Original Article Series, V7, P204; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DAVIES KE, 1985, NUCLEIC ACIDS RES, V13, P3419, DOI 10.1093/nar/13.10.3419; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; EASTOE J. E., 1965, ADVANCE FLUORINE RES DENT CARIES PREVENT, V3, P5; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; MCKUSICK VA, 1988, MENDELIAN INHERITANC; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; REILLY DS, 1988, AM J HUM GENET, V42, P748; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; WITKOP C J JR, 1971, Birth Defects Original Article Series, V7, P153; WITKOP CJ, 1958, EUGEN QUART, V5, P15, DOI 10.1080/19485565.1958.9987342; Witkop CJ, 1976, ORAL FACIAL GENETICS, P151	22	62	62	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					120	125						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	1967204				2022-12-18	WOS:A1990CJ04300015
J	HASSTEDT, SJ; RAMIREZ, ME; KUIDA, H; WILLIAMS, RR				HASSTEDT, SJ; RAMIREZ, ME; KUIDA, H; WILLIAMS, RR			RECESSIVE INHERITANCE OF A RELATIVE FAT PATTERN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah	HASSTEDT, SJ (corresponding author), UNIV UTAH,MED CTR,DEPT HUMAN GENET,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038702] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 24855-08] Funding Source: Medline; NIDDK NIH HHS [DK 38702-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAUMGARTNER RN, 1986, HUM BIOL, V58, P719; BAUMGARTNER RN, 1987, AM J EPIDEMIOL, V126, P614, DOI 10.1093/oxfordjournals.aje.a114701; BLAIR D, 1984, AM J EPIDEMIOL, V119, P526, DOI 10.1093/oxfordjournals.aje.a113770; BOUCHARD C, 1988, INT J OBESITY, V12, P205; BOUCHARD C, 1985, METABOLIC COMPLICATI, P87; BOYLE CR, 1979, BIOMETRICS, V35, P55, DOI 10.2307/2529936; BRAY GA, 1985, ANN INTERN MED, V103, P1052, DOI 10.7326/0003-4819-103-6-1052; BURTON BT, 1985, INT J OBESITY, V9, P155; DUSTAN HP, 1985, ANN INTERN MED, V103, P1047, DOI 10.7326/0003-4819-103-6-1047; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GARN SM, 1988, HUM BIOL, V60, P43; HASSTEDT S J, 1987, American Journal of Human Genetics, V41, pA256; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1989, GENET EPIDEMIOL, V6, P319, DOI 10.1002/gepi.1370060203; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; IVERIUS PH, 1985, ANN INTERN MED, V103, P1050, DOI 10.7326/0003-4819-103-6-1050; KARLIN S, 1984, AM J HUM GENET, V36, P873; KRAL JG, 1985, ANN INTERN MED, V103, P1043, DOI 10.7326/0003-4819-103-6-1043; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; MORTON NE, 1974, AM J HUM GENET, V26, P489; MUELLER WH, 1983, YEARB PHYS ANTHROPOL, V26, P215; MUELLER WH, 1982, SOC SCI MED, V16, P191, DOI 10.1016/0277-9536(82)90022-3; RAMIREZ ME, 1987, HUM BIOL, V59, P901; RAMIREZ ME, UNPUB SUBCUTANEOUS F; SIERVOGEL RM, 1988, FAT DISTRIBUTION GRO, P243; STERN MP, 1986, ARTERIOSCLEROSIS, V6, P123, DOI 10.1161/01.ATV.6.2.123; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; WILLIAMS RR, 1984, GENETIC EPIDEMIOLOGY, P419; [No title captured]; [No title captured]	32	62	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1989	45	6					917	925						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF403	2589320				2022-12-18	WOS:A1989CF40300011
J	OCONNELL, P; LEACH, RJ; LEDBETTER, DH; CAWTHON, RM; CULVER, M; ELDRIDGE, JR; FREJ, AK; HOLM, TR; WOLFF, E; THAYER, MJ; SCHAFER, AJ; FOUNTAIN, JW; WALLACE, MR; COLLINS, FS; SKOLNICK, MH; RICH, DC; FOURNIER, REK; BATY, BJ; CAREY, JC; LEPPERT, MF; LATHROP, GM; LALOUEL, JM; WHITE, R				OCONNELL, P; LEACH, RJ; LEDBETTER, DH; CAWTHON, RM; CULVER, M; ELDRIDGE, JR; FREJ, AK; HOLM, TR; WOLFF, E; THAYER, MJ; SCHAFER, AJ; FOUNTAIN, JW; WALLACE, MR; COLLINS, FS; SKOLNICK, MH; RICH, DC; FOURNIER, REK; BATY, BJ; CAREY, JC; LEPPERT, MF; LATHROP, GM; LALOUEL, JM; WHITE, R			FINE-STRUCTURE DNA MAPPING STUDIES OF THE CHROMOSOMAL REGION HARBORING THE GENETIC-DEFECT IN NEUROFIBROMATOSIS TYPE-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84132; UNIV SO CALIF,CTR COMPREHENS CANC,LOS ANGELES,CA 90089; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Southern California; Baylor College of Medicine; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan	OCONNELL, P (corresponding author), UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132, USA.			Baty, Bonnie/0000-0001-5478-6078; Leach, Robin/0000-0002-3201-5579				BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CAVENEE W, 1984, AM J HUM GENET, V36, P10; DAUSSET J, 1986, PRESSE MED, V15, P1801; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOUNTAIN JW, 1989, AM J HUM GENET, V44, P58; JULIER C, 1988, AM J HUM GENET, V42, P45; KILLARY AM, 1984, CELL, V38, P523, DOI 10.1016/0092-8674(84)90507-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LUGO TG, 1987, MOL CELL BIOL, V7, P2814, DOI 10.1128/MCB.7.8.2814; MATHIEUMAHUL D, 1985, HUM GENET, V71, P41, DOI 10.1007/BF00295666; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; Skolnick M H, 1987, Genomics, V1, P382, DOI 10.1016/0888-7543(87)90043-7; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WYNSHAWBORIS A, 1984, J BIOL CHEM, V259, P2161	25	62	63	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					51	57						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2562822				2022-12-18	WOS:A1989R559600011
J	KHLAT, M				KHLAT, M			CONSANGUINEOUS MARRIAGE AND REPRODUCTION IN BEIRUT, LEBANON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									AMER UNIV BEIRUT, FAC HLTH SCI, BEIRUT, LEBANON	American University of Beirut	KHLAT, M (corresponding author), WHO, INT AGCY RES CANC, 150 COURS ALBERT THOMAS, F-69372 LYON 08, FRANCE.			Khlat, Myriam/0000-0002-6674-3718				ALAWADI SA, 1986, CLIN GENET, V29, P384; ANSARI NA, 1978, INDIAN J MED RES, V68, P295; BAI PVA, 1981, TROP GEOGR MED, V33, P275; BENALLEGUE A, 1984, ARCH FR PEDIATR, V41, P435; Brass W, 1985, Asian Pac Cens Forum, V11, P5; BRYCE J, 1985, BEIRUT 1984 POPULATI, P159; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAMIE J, 1977, POP STUD-J DEMOG, V31, P365, DOI 10.1080/00324728.1977.10410434; COOK R, 1966, J TROP PEDIAT    MAR, P95; Cooley W.W., 1971, MULTIVARIATE DATA AN; DEVI ARR, 1981, ANN HUM BIOL, V8, P469; FARAH AA, 1982, POPUL DEV REV, V8, P365, DOI 10.2307/1972992; FEINGOLD J, 1971, GENET POPUL TRAVAUX, V60, P209; FREIREMAIA N, 1983, AM J MED GENET, V16, P331, DOI 10.1002/ajmg.1320160306; FRIED K, 1974, AM J HUM GENET, V26, P65; HANN KL, 1985, ANN HUM BIOL, V12, P267, DOI 10.1080/03014468500007771; KALOUSTIAN VMD, 1980, AM J MED GENET, V7, P187; KHLAT M, 1986, AM J MED GENET, V25, P299, DOI 10.1002/ajmg.1320250215; KHLAT M, 1986, J BIOSOC SCI, V18, P489; KHLAT M, 1986, THESIS C BERNARD U L; KHLAT M, IN PRESS HUM BIOL; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P453, DOI 10.1093/oxfordjournals.aje.a114551; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P473, DOI 10.1093/oxfordjournals.aje.a114553; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P462, DOI 10.1093/oxfordjournals.aje.a114552; KHOURY MJ, 1987, AM J EPIDEMIOL, V125, P251, DOI 10.1093/oxfordjournals.aje.a114524; KLAT M, 1984, J BIOSOC SCI, V16, P369, DOI 10.1017/S0021932000015182; KLAT M, 1986, SOC BIOL, V33, P138; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; NADERI S, 1979, OBSTET GYNECOL, V53, P195; PHILIPPE P, 1974, HUM BIOL, V46, P405; RAO PSS, 1979, J MED GENET, V16, P24, DOI 10.1136/jmg.16.1.24; RAO PSS, 1980, J MED GENET, V17, P27, DOI 10.1136/jmg.17.1.27; RAO PSS, 1977, ANN HUM GENET, V41, P87, DOI 10.1111/j.1469-1809.1977.tb01964.x; RAO PSSS, 1979, ANN HUM GENET, V42, P401, DOI 10.1111/j.1469-1809.1979.tb00672.x; REDDY P C, 1983, Zeitschrift fuer Morphologie und Anthropologie, V74, P45; REDDY PG, 1985, HUM BIOL, V57, P47; Reddy VM, 1978, ACTA GENET MED GEMEL, V27, P89; REID RM, 1976, HUM BIOL, V48, P139; Schlesselman James J., 1982, CASE CONTROL STUDIES; SCHULL WJ, 1970, AM J HUM GENET, V22, P239; SCHULL WJ, 1970, HUMANGENETIK, V9, P294, DOI 10.1007/BF00286995; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; SCOTTEMUAKPOR AB, 1974, AM J HUM GENET, V26, P674; Tanner R E, 1958, Eugen Rev, V49, P197; Tekce B, 1984, POPUL DEV REV, V10, P257, DOI 10.2307/2807964; TEMPLETON AR, 1980, AM J HUM GENET, V32, P575; Wesolowsky GO, 1976, MULTIPLE REGRESSION; ZURAYK H, 1985, BEIRUT 1984 POPULATI, P37; Zurayk H., 1985, BEIRUT 1984 POPULATI; 1985, SOCIOECONOMIC DIFFER	51	62	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					188	196						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	3400644				2022-12-18	WOS:A1988P608400013
J	SUTHERLAND, GR; BAKER, E; SESHADRI, RS				SUTHERLAND, GR; BAKER, E; SESHADRI, RS			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .5. A NEW CLASS OF FRAGILE SITE REQUIRING BRDU FOR EXPRESSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									FLINDERS MED CTR,DEPT HAEMATOL,BEDFORD PK,SA 5062,AUSTRALIA	Flinders Medical Centre	SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					DUTRILLAUX B, 1974, ANN GENET-PARIS, V17, P207; HECHT F, 1979, AM J HUM GENET, V31, P223; HSU TC, 1961, P NATL ACAD SCI USA, V47, P396, DOI 10.1073/pnas.47.3.396; KORENBERG JR, 1974, CHROMOSOMA, V48, P355, DOI 10.1007/BF00290992; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; MAZRIMAS JA, 1978, EXP CELL RES, V117, P23, DOI 10.1016/0014-4827(78)90423-8; PALMER C G, 1970, Canadian Journal of Genetics and Cytology, V12, P816; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1979, HUM GENET, V53, P29, DOI 10.1007/BF00289446; ZAKHAROV AF, 1974, CHROMOSOMA, V44, P343	12	62	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					542	548						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	7395866				2022-12-18	WOS:A1980KB52200007
J	TIWARI, JL; HODGE, SE; TERASAKI, PI; SPENCE, MA				TIWARI, JL; HODGE, SE; TERASAKI, PI; SPENCE, MA			HLA AND THE INHERITANCE OF MULTIPLE-SCLEROSIS - LINKAGE ANALYSIS OF 72 PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES, SCH MED, INST NEUROPSYCHIAT, MENTAL RETARDAT UNIT, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	TIWARI, JL (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA.							ALTER M, 1976, NEUROLOGY, V26, P31, DOI 10.1212/WNL.26.1.31; [Anonymous], 1978, HISTOCOMPATIBILITY T; BERTRAMS J, 1976, Z IMMUNITATSFORSCH, V152, P200; BIRD TD, 1975, ARCH NEUROL-CHICAGO, V32, P414, DOI 10.1001/archneur.1975.00490480080009; BROMAN T, 1965, ACTA NEUROL SCAND, VS 41, P543; DAVISON AN, 1975, MULTIPLE SCLEROSIS R; DRACHMAN DA, 1976, ARCH NEUROL-CHICAGO, V33, P406, DOI 10.1001/archneur.1976.00500060012004; EDWARDS J. H., 1960, ACTA GENET ET STATIST MED, V10, P63; ELDRIDGE R, 1978, ANN NEUROL, V3, P72, DOI 10.1002/ana.410030111; Field EJ, 1977, MULTIPLE SCLEROSIS C; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HENS L, 1978, TISSUE ANTIGENS, V11, P75, DOI 10.1111/j.1399-0039.1978.tb01230.x; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JERSILD C, 1973, LANCET, V2, P1221; Jersild C, 1978, Birth Defects Orig Artic Ser, V14, P123; KHAN PM, 1976, BIRTH DEFECTS OAS, V12, P328; MACKAY RP, 1966, ARCH NEUROL-CHICAGO, V15, P449, DOI 10.1001/archneur.1966.00470170003001; MCALPINE E, 1965, MULTIPLE SCLEROSIS R, P83; MOLLER E, 1978, TISSUE ANTIGENS, V12, P357, DOI 10.1111/j.1399-0039.1978.tb01345.x; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; MYRIANTHOPOULOS N. C., 1960, ACTA GENET ET STATIST MED, V10, P33; MYRIANTHOPOULOS NC, 1970, HDB CLINICAL NEUROLO, V9, P85; NAITO S, 1972, TISSUE ANTIGENS, V2, P1; NINO HE, NEUROLOGY MINNEAP; OLSSON JE, 1976, ARCH NEUROL-CHICAGO, V33, P808, DOI 10.1001/archneur.1976.00500120012002; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1974, AM J HUM GENET, V26, P588; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SMITH CAB, 1953, J R STAT SOC B, V15, P153; SUAREZ B, 1979, DIABETES, V28, P527, DOI 10.2337/diabetes.28.6.527; TROUILLAS P, 1977, J NEUROL SCI, V32, P425, DOI 10.1016/0022-510X(77)90024-7; VISSCHER B, NEUROLOGY MINNEAP; WHELAN MA, 1967, 2ND INT C NEUR NEUR	35	62	62	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	1					103	111						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JH296	7361760				2022-12-18	WOS:A1980JH29600013
J	DAIGER, SP; LABOWE, ML; PARSONS, M; WANG, L; CAVALLISFORZA, LL				DAIGER, SP; LABOWE, ML; PARSONS, M; WANG, L; CAVALLISFORZA, LL			DETECTION OF GENETIC-VARIATION WITH RADIOACTIVE LIGANDS .3. GENETIC-POLYMORPHISM OF TRANSCOBALAMIN-II IN HUMAN-PLASMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305	Stanford University								ALLEN RH, 1976, PROGR HEMATOLOGY, V9, P357; BENSON RE, 1972, J LAB CLIN MED, V80, P488; BLOOMFIELD FJ, 1972, BRIT J HAEMATOL, V22, P33, DOI 10.1111/j.1365-2141.1972.tb08784.x; CARMEL R, 1974, AM J CLIN PATHOL, V62, P367, DOI 10.1093/ajcp/62.3.367; CARMEL R, 1969, BLOOD-J HEMATOL, V33, P1; CAVALLISFORZA LL, 1977, AM J HUM GENET, V29, P581; CLAMP JR, 1975, PLASMA PROTEINS, V2, P163; COOPER BA, 1970, BLOOD-J HEMATOL, V35, P829, DOI 10.1182/blood.V35.6.829.829; COOPER BA, 1973, AM J PHYSIOL, V224, P758, DOI 10.1152/ajplegacy.1973.224.4.758; DAIGER SP, 1975, GENETICS TRANSPORT P; ENGLAND JM, 1973, BRIT J HAEMATOL, V25, P737, DOI 10.1111/j.1365-2141.1973.tb01786.x; GILBERT HS, 1974, BLOOD, V44, P926; GLASS GBJ, 1974, GASTRIC INTRINSIC FA; HAKAMI N, 1971, NEW ENGL J MED, V285, P1163, DOI 10.1056/NEJM197111182852103; HALL CA, 1965, J LAB CLIN MED, V65, P459; HERBERT V, 1975, PHARMACOL BASIS, P1324; HITZIG WH, 1974, J PEDIATR-US, V85, P622, DOI 10.1016/S0022-3476(74)80503-2; HOM BL, 1968, SCAND J HAEMATOL, V5, P107; LINDSTRAND K, 1967, SCAND J CLIN LAB INV, V95, P3; MATHER K, 1964, STATISTICAL ANALYSIS, P222; MEYER LEO M., 1965, SER HAEMATOL, V3, P91; MEYER LM, 1972, P SOC EXP BIOL MED, V140, P1099; Putnam FW, 1975, PLASMA PROTEINS, V1, P141; RETIEF FP, 1966, J CLIN INVEST, V45, P1907, DOI 10.1172/JCI105495; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; RODBARD D, 1971, ANAL BIOCHEM, V40, P95, DOI 10.1016/0003-2697(71)90086-8; ROSENBERG LE, 1973, J CLIN INVEST, V52, pA69; SCOTT CR, 1972, J PEDIATR-US, V81, P1106, DOI 10.1016/S0022-3476(72)80239-7; SCOTT JM, 1974, J CLIN INVEST, V53, P228, DOI 10.1172/JCI107543	29	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					202	214						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	655167				2022-12-18	WOS:A1978EV59500012
J	LAU, YF; PFEIFFER, RA; ARRIGHI, FE; HSU, TC				LAU, YF; PFEIFFER, RA; ARRIGHI, FE; HSU, TC			COMBINATION OF SILVER AND FLUORESCENT STAINING FOR METAPHASE CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,HOUSTON,TX 77030; MED HSCH LUBECK KLINIKUM,HUMAN GENET ABT,D-2400 LUBECK 1,FED REP GER	University of Texas System; University of Texas Health Science Center Houston; University of Lubeck	LAU, YF (corresponding author), UNIV TEXAS SYST,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOL,HOUSTON,TX 77030, USA.		Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050				BLOOM SE, 1976, HUM GENET, V34, P199, DOI 10.1007/BF00278889; GOODPASTURE C, 1976, AM J HUM GENET, V28, P559; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HOWELL WM, 1975, EXPERIENTIA, V31, P260, DOI 10.1007/BF01990741; LAU YF, 1976, CYTOGENET CELL GENET, V17, P51, DOI 10.1159/000130687	5	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					76	79						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	74950				2022-12-18	WOS:A1978EL57500009
J	CHUNG, CS; CHING, GHS; MORTON, NE				CHUNG, CS; CHING, GHS; MORTON, NE			GENETIC STUDY OF CLEFT-LIP AND PALATE IN HAWAII .2. COMPLEX SEGREGATION ANALYSIS AND GENETIC RISKS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV HAWAII,DEPT PUBL HLTH,1960 E W RD,HONOLULU,HI 96822; UNIV HAWAII,DEPT GENET,1960 E W RD,HONOLULU,HI 96822; UNIV HAWAII,POPULATION GENET LAB,1980 EW RD,HONOLULU,HI 96822	University of Hawaii System; University of Hawaii System; University of Hawaii System								Cavalli-Sforza L L, 1972, Neurosci Res Program Bull, V10, P406; CHING GHS, 1974, AM J HUM GENET, V26, P162; CHING GHS, 1970, THESIS U HAWAII; CURTIS E, 1971, AM J DIS CHILD, V102, P853; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1970, AM J HUM GENET, V22, P336; Kobayasi Y., 1958, JPN J HUM GENET, V3, P73; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1969, COMPUTER APPLICATION; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; SANUI Y., 1962, JAPAN J HUMAN GENET, V7, P194; SMITH C, 1971, AM J HUM GENET, V23, P578; SMITH C, 1971, Clinical Genetics, V2, P303; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; [No title captured]	18	62	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	2					177	188						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	S7582	4823026				2022-12-18	WOS:A1974S758200006
J	WARBURTON, D; HENDERSON, AS; SHAPIRO, LR; HSU, LYF				WARBURTON, D; HENDERSON, AS; SHAPIRO, LR; HSU, LYF			STABLE HUMAN DICENTRIC CHROMOSOME, T-DIC (12-14) (P13-P13) INCLUDING AN INTERCALARY SATELLITE REGION BETWEEN CENTROMERES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									COLUMBIA UNIV, COLL PHYS & SURG, DEPT HUMAN GENET & DEV, NEW YORK, NY 10032 USA; MT SINAI SCH MED, DEPT PEDIAT, DIV MED GENET, NEW YORK, NY 10029 USA	Columbia University; Icahn School of Medicine at Mount Sinai								BUHLER EM, 1971, HUMANGENETIK, V12, P170, DOI 10.1007/BF00291474; CASPERSSON T, 1971, HEREDITAS-GENETISK A, V68, P317; DISTECHE C, 1972, CLIN GENET, V3, P388; FERGUS.MA, 1961, LANCET, V1, P638, DOI 10.1016/S0140-6736(61)91655-5; HAIR JB, 1952, HEREDITY, V6, P215; HENDERSON AH, IN PRESS; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; Mather K, 1933, J GENET, V28, P1, DOI 10.1007/BF02981766; MULLER HJ, 1954, RADIATION BIOLOGY; NIEBUHR E, 1972, HUMANGENETIK, V16, P217, DOI 10.1007/BF00273467; NIEBUHR E, 1972, HUMANGENETIK, V15, P96, DOI 10.1007/BF00273440; ROBINSON JA, 1971, CHROMOSOMA, V35, P342, DOI 10.1007/BF00326283; SEARS ER, 1952, GENETICS, V37, P125; 1972, BIRTH DEFECTS OAS, V8	14	62	62	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					439	445						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4716663				2022-12-18	WOS:A1973Q015800011
J	ERICKSON, RP				ERICKSON, RP			LEBERS OPTIC ATROPHY, A POSSIBLE EXAMPLE OF MATERNAL INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note																		BRACKETT BG, 1971, P NATL ACAD SCI USA, V68, P353, DOI 10.1073/pnas.68.2.353; DICKINSO.AG, 1965, HEREDITY, V20, P485, DOI 10.1038/hdy.1965.64; Imai Y, 1936, J GENET, V33, P163, DOI 10.1007/BF02982530; LUNDSGARD R, 1944, ACTA OPHTHALMOL S3, V21, P3; NANCE WE, 1969, NATURE, V224, P373, DOI 10.1038/224373a0; RONNE H, 1943, ACTA OPHTHAL KOBENHA, V23, P89; RONNE H, 1944, ACTA OPHTHALMOL, V22, P203; SEEDORFF T, 1968, ACTA OPHTHALMOL, V46, P4; SEEDORFF T, 1968, ACTA OPHTHALMOL, V46, P985; SEEDORFF T, 1969, ACTA OPHTHALMOL, V47, P23; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; WAARDENB.PJ, 1969, J GENET HUM, V17, P479; WALLACE DC, 1970, BRAIN, V93, P121, DOI 10.1093/brain/93.1.121; WALLACE DC, 1970, AUST ANN MED, V19, P1; WILSON J, 1963, BRAIN, V86, P347, DOI 10.1093/brain/86.2.347	15	62	64	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					348	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5063796				2022-12-18	WOS:A1972M694800017
J	CHEN, SH; GIBLETT, ER				CHEN, SH; GIBLETT, ER			GENETIC VARIATION OF SOLUBLE GLUTAMIC-OXALOACETIC TRANSAMINASE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BORST P, 1961, BIOCHIM BIOPHYS ACTA, V54, P188, DOI 10.1016/0006-3002(61)90953-2; BOYD JW, 1966, BIOCHIM BIOPHYS ACTA, V113, P302, DOI 10.1016/S0926-6593(66)80069-3; BOYD JW, 1961, BIOCHEM J, V81, P434, DOI 10.1042/bj0810434; CHEN SH, 1971, AM J HUM GENET, V23, P87; DAVIDSON RG, 1970, SCIENCE, V169, P391, DOI 10.1126/science.169.3943.391; DEJIMENEZ ES, 1967, ARCH BIOCHEM BIOPHYS, V120, P175, DOI 10.1016/0003-9861(67)90611-X; DELORENZO RJ, 1970, BIOCHEM GENET, V4, P259, DOI 10.1007/BF00485777; FLEISHER GA, 1960, P SOC EXP BIOL MED, V103, P229, DOI 10.3181/00379727-103-25469; JENKINS WT, 1959, J BIOL CHEM, V234, P51; MARTINEZCARRION M, 1967, BIOCHEMISTRY-US, V6, P1715, DOI 10.1021/bi00858a021; MOORE BW, 1960, J BIOL CHEM, V235, P1359; NISSELBA.JS, 1965, FED PROC, V24, P356; NISSELBA.JS, 1965, SCIENCE, V149, P195, DOI 10.1126/science.149.3680.195; NISSELBAUM JS, 1966, J BIOL CHEM, V241, P2661; SILBER R, 1962, J CLIN INVEST, V41, P230, DOI 10.1172/JCI104474; SIZER IW, 1962, METHOD ENZYMOL, V5, P677, DOI 10.1016/S0076-6879(62)05295-7	16	62	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					419	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J8113	5097908				2022-12-18	WOS:A1971J811300010
J	STEPHENS, FE; TYLER, FH				STEPHENS, FE; TYLER, FH			STUDIES IN DISORDERS OF MUSCLE .5. THE INHERITANCE OF CHILDHOOD PROGRESSIVE MUSCULAR DYSTROPHY IN 33 KINDREDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARBUSE DI, 1937, N YORK STATE J M, V37, P1111; Bell, 1943, TREASURY HUMAN INH 4, VIV; Gowers W.R, 1879, PSEUDO HYPERTROPHIC; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HALDANE JBS, 1949, 8TH P INT C GEN, P267; KOSTAKOW ST, 1934, DEUTSCHES ARCH KLIN MED, V176, P467; Polacheck WS, 1941, AM J DIS CHILD, V61, P1251; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; TYLER FH, 1950, ANN INTERN MED, V32, P72, DOI 10.7326/0003-4819-32-1-72; TYLER FH, 1950, ARCH NEURO PSYCHIATR, V63, P425, DOI 10.1001/archneurpsyc.1950.02310210071005; TYLER FH, IN PRESS STUDIES D 4; VOSHELL AF, 1933, SO M J, V26, P156	12	62	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	2					111	125						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS393	14902757				2022-12-18	WOS:A1951XS39300002
J	Liu, CY; Miyata, H; Gao, Y; Sha, YW; Tang, SY; Xu, ZL; Whitfield, M; Patrat, C; Wu, H; Dulioust, E; Tian, SX; Shimada, K; Cong, JS; Noda, T; Li, H; Morohoshi, A; Cazin, C; Kherraf, ZE; Arnoult, C; Jin, L; He, XJ; Ray, PF; Cao, YX; Toure, A; Zhang, F; Ikawa, M				Liu, Chunyu; Miyata, Haruhiko; Gao, Yang; Sha, Yanwei; Tang, Shuyan; Xu, Zoulan; Whitfield, Marjorie; Patrat, Catherine; Wu, Huan; Dulioust, Emmanuel; Tian, Shixiong; Shimada, Keisuke; Cong, Jiangshan; Noda, Taichi; Li, Hang; Morohoshi, Akane; Cazin, Caroline; Kherraf, Zine-Eddine; Arnoult, Christophe; Jin, Li; He, Xiaojin; Ray, Pierre F.; Cao, Yunxia; Toure, Aminata; Zhang, Feng; Ikawa, Masahito			Bi-allelic DNAH8 Variants Lead to Multiple Morphological Abnormalities of the Sperm Flagella and Primary Male Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY CILIARY DYSKINESIA; WORLD-HEALTH-ORGANIZATION; CYTOPLASMIC MATURATION; DYNEIN; MUTATIONS; PROTEIN; ENCODES; GENES; ODA10	Sperm malformation is a direct factor for male infertility. Multiple morphological abnormalities of the flagella (MMAF), a severe form of asthenoteratozoospermia, are characterized by immotile spermatozoa with malformed and/or absent flagella in the ejaculate. Previous studies indicated genetic heterogeneity in MMAF. To further define genetic factors underlying MMAF, we performed whole-exome sequencing in a cohort of 90 Chinese MMAF-affected men. Two cases (2.2%) were identified as carrying bi-allelic missense DNAH8 variants, variants which were either absent or rare in the control human population and were predicted to be deleterious by multiple bioinformatic tools. Re-analysis of exome data from a second cohort of 167 MMAF-affected men from France, Iran, and North Africa permitted the identification of an additional male carrying a DNAH8 homozygous frameshift variant. DNAH8 encodes a dynein axonemal heavy-chain component that is expressed preferentially in the testis. Hematoxylin-eosin staining and electron microscopy analyses of the spermatozoa from men harboring bi-allelic DNAH8 variants showed a highly aberrant morphology and ultrastructure of the sperm flagella. Immunofluorescence assays performed on the spermatozoa from men harboring bi-allelic DNAH8 variants revealed the absent or markedly reduced staining of DNAH8 and its associated protein DNAH17. Dnah8-knockout male mice also presented typical MMAF phenotypes and sterility. Interestingly, intracytoplasmic sperm injections using the spermatozoa from Dnah8-knockout male mice resulted in good pregnancy outcomes. Collectively, our experimental observations from humans and mice demonstrate that DNAH8 is essential for sperm flagellar formation and that bi-allelic deleterious DNAH8 variants lead to male infertility with MMAF.	[Liu, Chunyu; Tang, Shuyan; Tian, Shixiong; Cong, Jiangshan; Jin, Li; Zhang, Feng] Fudan Univ, Shanghai Inst Planned Parenthood Res, State Key Lab Genet Engn,NHC Key Lab Reprod Regul, Sch Life Sci,Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Liu, Chunyu; Tang, Shuyan; Tian, Shixiong; Cong, Jiangshan; Zhang, Feng] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China; [Liu, Chunyu; Zhang, Feng] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211116, Peoples R China; [Miyata, Haruhiko; Xu, Zoulan; Shimada, Keisuke; Noda, Taichi; Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Gao, Yang; Wu, Huan; Li, Hang; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Reprod Med Ctr, Hefei 230022, Peoples R China; [Gao, Yang; Wu, Huan; Li, Hang; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, NHC Key Lab Study Abnormal Gametes & Reprod Tract, Hefei 230032, Anhui, Peoples R China; [Gao, Yang; Wu, Huan; Li, Hang; He, Xiaojin; Cao, Yunxia] Anhui Med Univ, Key Lab Populat Hlth Life Cycle, Minist Educ Peoples Republ China, Hefei 230032, Peoples R China; [Sha, Yanwei] Xiamen Univ, Sch Publ Hlth, United Diagnost & Res Ctr Clin Genet, Dept Androl, Xiamen 361005, Fujian, Peoples R China; [Sha, Yanwei] Xiamen Univ, Women & Childrens Hosp, Xiamen 361005, Fujian, Peoples R China; [Sha, Yanwei] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Peoples R China; [Sha, Yanwei] Xiamen Univ, Sch Publ Hlth, Ctr Mol Imaging & Translat Med, Xiamen 361102, Peoples R China; [Xu, Zoulan; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Whitfield, Marjorie; Patrat, Catherine; Dulioust, Emmanuel; Toure, Aminata] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Whitfield, Marjorie; Patrat, Catherine; Dulioust, Emmanuel; Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [Whitfield, Marjorie; Patrat, Catherine; Dulioust, Emmanuel; Toure, Aminata] Univ Paris, Fac Med, F-75014 Paris, France; [Patrat, Catherine; Dulioust, Emmanuel] CECOS Grp Hosp Univ Paris Ctr, AP HP, Lab Histol Embryol Biol Reprod, F-75014 Paris, France; [Morohoshi, Akane; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Cazin, Caroline; Kherraf, Zine-Eddine; Arnoult, Christophe; Ray, Pierre F.] Grenoble Alpes Univ UGA, Team Genet Epigenet & Therapies Infertil, Inst Adv Biosci, INSEAM,U1209,CNRS,UMR 5309, F-38000 Grenoble, France; [Cazin, Caroline; Kherraf, Zine-Eddine; Ray, Pierre F.] Ctr Hosp Univ Grenoble Alpes CHUGA, UM Genet Infertilite & Diagnost Preimplantatoire, F-38000 Grenoble, France; [Cazin, Caroline] Lab Eurofins Biomnis, Serv Genet, Lyon, France; [Ikawa, Masahito] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan	Fudan University; Nanjing Medical University; Osaka University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Ministry of Education, China; Xiamen University; Xiamen University; Xiamen University; Xiamen University; Osaka University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Osaka University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; University of Tokyo	Zhang, F (corresponding author), Fudan Univ, Shanghai Inst Planned Parenthood Res, State Key Lab Genet Engn,NHC Key Lab Reprod Regul, Sch Life Sci,Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China.; Zhang, F (corresponding author), Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211116, Peoples R China.; Ikawa, M (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan.; Ikawa, M (corresponding author), Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan.; Ikawa, M (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan.	zhangfeng@fudan.edu.cn; ikawa@biken.osaka-u.ac.jp	Shimada, Keisuke/N-6112-2019; TOURE, Aminata/B-3236-2018; ikawa, masahito/A-5315-2009; Zhang, Feng/C-7735-2009; WHITFIELD, Marjorie/ABH-3433-2021; KHERRAF, Zine-Eddine/F-1585-2019; Shimada, Keisuke/E-8958-2019; Tang, Shuyan/K-9582-2018; liu, chunyu/GWQ-9357-2022; NODA, Taichi/K-1785-2018; Ray, Pierre/D-7315-2019	Shimada, Keisuke/0000-0003-3739-7163; TOURE, Aminata/0000-0001-5629-849X; ikawa, masahito/0000-0001-9859-6217; Zhang, Feng/0000-0003-4556-8276; WHITFIELD, Marjorie/0000-0001-7956-3436; KHERRAF, Zine-Eddine/0000-0003-0351-6689; Shimada, Keisuke/0000-0003-3739-7163; Tang, Shuyan/0000-0003-2701-1976; liu, chunyu/0000-0002-6732-3758; NODA, Taichi/0000-0003-0260-7861; Ray, Pierre/0000-0003-1544-7449; CAZIN, Caroline/0000-0001-8962-3447; Miyata, Haruhiko/0000-0003-4758-5803	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) (KAKENHI) [JP17H04987, JP19H05750]; National Natural Science Foundation of China [31625015, 31521003, 81901541, 81971441, 81871200]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD087157, R01HD088412]; Bill and Melinda Gates Foundation [INV-001902]; Institut National de la Santeet de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Paris; Shanghai Medical Center of Key Programs for Female Reproductive Diseases [2017ZZ01016]; Shanghai Municipal Science and Technology Major Project [2017SHZDZX01]; French National Research Agency (MASFLAGELLA) [ANR-14-CE15-0002]; French National Research Agency (FLAGEL-OME) [ANR18-CE17-0014]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) (KAKENHI); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Institut National de la Santeet de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de Paris; Shanghai Medical Center of Key Programs for Female Reproductive Diseases; Shanghai Municipal Science and Technology Major Project; French National Research Agency (MASFLAGELLA)(French National Research Agency (ANR)); French National Research Agency (FLAGEL-OME)(French National Research Agency (ANR))	We would like to thank the families for participating and supporting this study. We also thank the Center of Cryo-electron Microscopy at Zhejiang University, the transmission electron microscopy core facility of the Institut Cochin (INSERM U1016, Paris), and Yonggang Lu at Osaka University for technical support. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) (KAKENHI grants JP17H04987 to H.M. and JP19H05750 to M.I.), the National Natural Science Foundation of China (31625015, 31521003, 81901541, 81971441, and 81871200), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD087157 and R01HD088412 to M.I.), the Bill and Melinda Gates Foundation (INV-001902 to M.I.), the Institut National de la Santeet de la Recherche Medicale (Inserm), the Centre National de la Recherche Scientifique (CNRS), the Universite de Paris and the French National Research Agency (MASFLAGELLA ANR-14-CE15-0002 and FLAGEL-OME ANR18-CE17-0014 to P.F.R. and A.T.), Shanghai Medical Center of Key Programs for Female Reproductive Diseases (2017ZZ01016), and Shanghai Municipal Science and Technology Major Project (2017SHZDZX01).	Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Auguste Y, 2018, AM J HUM GENET, V103, P413, DOI 10.1016/j.ajhg.2018.07.013; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Beurois J, 2019, HUM REPROD, V34, P2071, DOI 10.1093/humrep/dez166; Caballero-Campo P., 2020, ASIAN J ANDROL, V22, DOI [10.4103/aja.aja_4143_4119, DOI 10.4103/AJA.AJA_4143_4119]; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Coutton C, 2019, AM J HUM GENET, V104, P331, DOI 10.1016/j.ajhg.2018.12.013; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Dean AB, 2015, MOL BIOL CELL, V26, P3596, DOI 10.1091/mbc.E15-05-0317; Dean AB, 2013, MOL BIOL CELL, V24, P3689, DOI 10.1091/mbc.E13-06-0310; Desai PB, 2015, CYTOSKELETON, V72, P16, DOI 10.1002/cm.21206; Dong FN, 2018, AM J HUM GENET, V102, P636, DOI 10.1016/j.ajhg.2018.03.007; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Fassad MR, 2018, AM J HUM GENET, V103, P984, DOI 10.1016/j.ajhg.2018.10.016; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Hosseini B, 2019, J DIET SUPPL, V16, P245, DOI 10.1080/19390211.2018.1431753; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Kherraf ZE, 2018, AM J HUM GENET, V103, P400, DOI 10.1016/j.ajhg.2018.07.014; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Liu CY, 2019, AM J HUM GENET, V105, P1168, DOI 10.1016/j.ajhg.2019.10.010; Liu SD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43109-6; Liu WJ, 2019, AM J HUM GENET, V104, P738, DOI 10.1016/j.ajhg.2019.02.020; Loges NT, 2018, AM J HUM GENET, V103, P995, DOI 10.1016/j.ajhg.2018.10.020; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Lores P, 2019, AM J HUM GENET, V105, P1148, DOI 10.1016/j.ajhg.2019.10.007; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Samant SA, 2005, DEV BIOL, V285, P57, DOI 10.1016/j.ydbio.2005.06.002; Sha YW, 2017, GENE, V633, P48, DOI 10.1016/j.gene.2017.08.033; Stoecklin G, 2013, BBA-GENE REGUL MECH, V1829, P487, DOI 10.1016/j.bbagrm.2013.04.002; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Toure A., 2020, HUM GENET, DOI [10.1007/s00439-00020-02113-x, DOI 10.1007/S00439-00020-02113-X]; Viswanadha R, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018325; Wambergue C, 2016, HUM REPROD, V31, P1164, DOI 10.1093/humrep/dew083; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YX, 2014, FERTIL STERIL, V101, P945, DOI 10.1016/j.fertnstert.2013.12.047; Whitfield M, 2019, AM J HUM GENET, V105, P198, DOI 10.1016/j.ajhg.2019.04.015; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang BB, 2020, J EXP MED, V217, DOI 10.1084/jem.20182365	47	61	64	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2020	107	2					330	341		10.1016/j.ajhg.2020.06.004	http://dx.doi.org/10.1016/j.ajhg.2020.06.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MY5YF	32619401	Green Published, Bronze			2022-12-18	WOS:000558491800013
J	O'Connor, LJ; Schoech, AP; Hormozdiari, F; Gazal, S; Patterson, N; Price, AL				O'Connor, Luke J.; Schoech, Armin P.; Hormozdiari, Farhad; Gazal, Steven; Patterson, Nick; Price, Alkes L.			Extreme Polygenicity of Complex Traits Is Explained by Negative Selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; MISSING HERITABILITY; GENETIC ARCHITECTURE; GENOME; DISEASE; ASSOCIATION; VARIANTS; SCHIZOPHRENIA; PROPORTION; DISCOVERY	Complex traits and common diseases are extremely polygenic, their heritability spread across thousands of loci. One possible explanation is that thousands of genes and loci have similarly important biological effects when mutated. However, we hypothesize that for most complex traits, relatively few genes and loci are critical, and negative selection-purging large-effect mutations in these regions-leaves behind common-variant associations in thousands of less critical regions instead. We refer to this phenomenon as flattening. To quantify its effects, we introduce a mathematical definition of polygenicity, the effective number of independently associated SNPs (M-e), which describes how evenly the heritability of a trait is spread across the genome. We developed a method, stratified LD fourth moments regression (S-LD4M), to estimate M-e,M- validating that it produces robust estimates in simulations. Analyzing 33 complex traits (average N = 361k), we determined that heritability is spread similar to 4 x more evenly among common SNPs than among low-frequency SNPs. This difference, together with evolutionary modeling of new mutations, suggests that complex traits would be orders of magnitude less polygenic if not for the influence of negative selection. We also determined that heritability is spread more evenly within functionally important regions in proportion to their heritability enrichment; functionally important regions do not harbor common SNPs with greatly increased causal effect sizes, due to selective constraint. Our results suggest that for most complex traits, the genes and loci with the most critical biological effects often differ from those with the strongest common-variant associations.	[O'Connor, Luke J.; Schoech, Armin P.; Hormozdiari, Farhad; Gazal, Steven; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [O'Connor, Luke J.] Harvard Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Patterson, Nick; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	O'Connor, LJ; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; O'Connor, LJ (corresponding author), Harvard Grad Sch Arts & Sci, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA.	loconnor@g.harvard.edu; aprice@hsph.harvard.edu	Gazal, Steven/AAK-3764-2020		NIH [T32 HG002295, U01 HG009379, R01 MH101244, R01 MH107649, U01 HG009088, R01 MH109978]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U01HG009088, U01HG009379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109978, R37MH107649, R01MH107649, R01MH101244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Benjamin Neale, Dr. Hilary Finucane, Dr. Omer Weissbrod, Dr. Yakir Reshef, Dr. Xuanyao Liu, and Dr. Yuval Simons for helpful comments. This research was funded by NIH grants T32 HG002295, U01 HG009379, R01 MH101244, R01 MH107649, U01 HG009088, and R01 MH109978.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; di Iulio J, 2018, NAT GENET, V50, P333, DOI 10.1038/s41588-018-0062-7; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Ernst J, 2016, NAT BIOTECHNOL, V34, P1180, DOI 10.1038/nbt.3678; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frei O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10310-0; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gazal S., 2018, BIORXIV, DOI [10.1101/256412, DOI 10.1101/256412]; Gazal S, 2018, NAT GENET, V50, P1600, DOI 10.1038/s41588-018-0231-8; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hormozdiari F, 2017, AM J HUM GENET, V100, P789, DOI 10.1016/j.ajhg.2017.04.005; Howrigan D, 2018, SCHIZOPHRENIA RISK C, DOI [10.1101/495036, DOI 10.1101/495036]; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Hunter DJ, 2008, NEW ENGL J MED, V358, P2760, DOI 10.1056/NEJMp0804318; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; KEIGHTLEY PD, 1988, GENET RES, V52, P33, DOI 10.1017/S0016672300027282; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu XY, 2019, CELL, V177, P1022, DOI 10.1016/j.cell.2019.04.014; Loh PR, 2018, NAT GENET, V50, P906, DOI 10.1038/s41588-018-0144-6; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Mahajan A, 2018, NAT GENET, V50, P559, DOI 10.1038/s41588-018-0084-1; Mancuso N, 2016, NAT GENET, V48, P30, DOI 10.1038/ng.3446; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Moser G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004969; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niemi MEK, 2018, NATURE, V562, P268, DOI 10.1038/s41586-018-0566-4; O'Connor LJ, 2018, NAT GENET, V50, P1728, DOI 10.1038/s41588-018-0255-0; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Schoech AP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08424-6; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Shooshtari P, 2017, AM J HUM GENET, V101, P75, DOI 10.1016/j.ajhg.2017.06.001; Simons YB, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002985; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Thornton KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003258; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wray NR, 2018, CELL, V173, P1573, DOI 10.1016/j.cell.2018.05.051; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang JJ, 2017, AM J HUM GENET, V101, P404, DOI 10.1016/j.ajhg.2017.08.002; Zeng J, 2018, NAT GENET, V50, P746, DOI 10.1038/s41588-018-0101-4; Zhang Y, 2018, NAT GENET, V50, P1318, DOI 10.1038/s41588-018-0193-x; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6; Zhu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06805-x; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	70	61	61	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2019	105	3					456	476		10.1016/j.ajhg.2019.07.003	http://dx.doi.org/10.1016/j.ajhg.2019.07.003			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV7GX	31402091	Green Published, Bronze			2022-12-18	WOS:000484435700003
J	Shibata, SB; Ranum, PT; Moteki, H; Pan, BF; Goodwin, AT; Goodman, SS; Abbas, PJ; Holt, JR; Smith, RJH				Shibata, Seiji B.; Ranum, Paul T.; Moteki, Hideaki; Pan, Bifeng; Goodwin, Alexander T.; Goodman, Shawn S.; Abbas, Paul J.; Holt, Jeffrey R.; Smith, Richard J. H.			RNA Interference Prevents Autosomal-Dominant Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EAR HAIR-CELLS; MOUSE MODEL; ADENOASSOCIATED VIRUS; TMC1 GENE; INNER; THERAPY; MECHANOTRANSDUCTION; EXPRESSION; MUTATION; CHANNEL	Hearing impairment is the most common sensory deficit. It is frequently caused by the expression of an allele carrying a single dominant missense mutation. Herein, we show that a single intracochlear injection of an artificial microRNA carried in a viral vector can slow progression of hearing loss for up to 35 weeks in the Beethoven mouse, a murine model of non-syndromic human deafness caused by a dominant gain-of-function mutation in Tmc1 (transmembrane channel-like 1). This outcome is noteworthy because it demonstrates the feasibility of RNA-interference-mediated suppression of an endogenous deafness-causing allele to slow progression of hearing loss. Given that most autosomal-dominant non-syndromic hearing loss in humans is caused by this mechanism of action, microRNA-based therapeutics might be broadly applicable as a therapy for this type of deafness.	[Shibata, Seiji B.; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Shibata, Seiji B.; Ranum, Paul T.; Moteki, Hideaki; Goodwin, Alexander T.; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA; [Ranum, Paul T.; Smith, Richard J. H.] Univ Iowa, Grad Coll, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Moteki, Hideaki] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 3908621, Japan; [Pan, Bifeng; Holt, Jeffrey R.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA 02115 USA; [Pan, Bifeng; Holt, Jeffrey R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goodman, Shawn S.; Abbas, Paul J.] Univ Iowa, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA; [Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Iowa Inst Human Genet, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Shinshu University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Iowa; University of Iowa	Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Grad Coll, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.; Smith, RJH (corresponding author), Univ Iowa, Carver Coll Med, Iowa Inst Human Genet, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu		Smith, Richard/0000-0003-1201-6731; Kabardiev, Sadrutdin/0000-0001-6129-8371	NIH National Institute on Deafness and Other Communication Disorders [RO1 DC003544, T32 DC000040-17]; American Academy of Otolaryngology - Head and Neck Surgery Foundation; Bertarelli Program in Translational Neuroscience and Neuroengineering; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000040, R01DC003544, P50DC000242] Funding Source: NIH RePORTER	NIH National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Academy of Otolaryngology - Head and Neck Surgery Foundation; Bertarelli Program in Translational Neuroscience and Neuroengineering; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Dr. Karen Steel for providing the Tmc1<SUP>Bth/+</SUP> mutant mouse and Drs. Kiyoto Kurima and Andrew Griffith for the generous gift of the p. AcGFPmTmc1ex1WT and p. GEMT-easyTmc1ex1Bth constructs. We thank Maria Scheel and Susan Stamnes (University of Iowa Viral Vector Core) for assistance and providing the viral vectors. We thank and acknowledge Drs. Hela Azaiez, Yuzhou Zhang, Yukihide Maeda, Samuel P. Gubbels, Michael S. Hildebrand, A. Eliot Shearer, Abraham M. Sheffield, Mark A. Behlke, and Scott D. Rose for earlier work on using RNA interference to suppress hearing loss. We thank Drs. Beverly Davidson and Andrew Griffith for their valuable critiques of the paper. The current work was supported in part by NIH National Institute on Deafness and Other Communication Disorders grants RO1 DC003544 (to R.J.H.S.) and T32 DC000040-17 (to S.B.S.), a Resident Research Award from the American Academy of Otolaryngology - Head and Neck Surgery Foundation (to S.B.S.), and the Bertarelli Program in Translational Neuroscience and Neuroengineering (J.R.H.).	Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Askew C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1996; Bakhchane A, 2015, GENE, V574, P28, DOI 10.1016/j.gene.2015.07.075; Boudreau RL, 2012, METHOD ENZYMOL, V507, P275, DOI 10.1016/B978-0-12-386509-0.00014-4; Boudreau RL, 2011, MOL THER, V19, P2169, DOI 10.1038/mt.2011.185; Chien WW, 2016, MOL THER, V24, P17, DOI 10.1038/mt.2015.150; Geleoc GSG, 2014, SCIENCE, V344, P596, DOI 10.1126/science.1241062; Hilgert N, 2009, J HUM GENET, V54, P188, DOI 10.1038/jhg.2009.1; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kim MA, 2016, ANTIOXID REDOX SIGN, V24, P590, DOI 10.1089/ars.2015.6442; Kitajiri S, 2007, CLIN GENET, V71, P148, DOI 10.1111/j.1399-0004.2007.00739.x; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kurima K, 2015, CELL REP, V12, P1606, DOI 10.1016/j.celrep.2015.07.058; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Maeda Y, 2005, HUM MOL GENET, V14, P1641, DOI 10.1093/hmg/ddi172; Maeda Y, 2007, NEUROSCI RES, V58, P250, DOI 10.1016/j.neures.2007.03.006; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Noguchi Y, 2006, GENETICS, V173, P2111, DOI 10.1534/genetics.106.057372; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Shibata SB, 2009, GENE THER, V16, P990, DOI 10.1038/gt.2009.57; Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Soken H, 2013, LARYNGOSCOPE, V123, pE109, DOI 10.1002/lary.24174; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yang T, 2010, CLIN GENET, V77, P395, DOI 10.1111/j.1399-0004.2009.01338.x; Yu Q, 2014, GENE THER, V21, P71, DOI 10.1038/gt.2013.59; Zhao Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090836, 10.1371/journal.pone.0104330]; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	37	61	67	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1101	1113		10.1016/j.ajhg.2016.03.028	http://dx.doi.org/10.1016/j.ajhg.2016.03.028			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27236922	Green Published, hybrid			2022-12-18	WOS:000377286000006
J	Reijnders, MRF; Zachariadis, V; Latour, B; Jolly, L; Mancini, GM; Pfundt, R; Wu, KM; van Ravenswaaij-Arts, CMA; Veenstra-Knol, HE; Anderlid, BMM; Wood, SA; Cheung, SW; Barnicoat, A; Probst, F; Magoulas, P; Brooks, AS; Malmgren, H; Harila-Saari, A; Marcelis, CM; Vreeburg, M; Hobson, E; Sutton, VR; Stark, Z; Vogt, J; Cooper, N; Lim, JY; Price, S; Lai, AHM; Domingo, D; Reversade, B; Gecz, J; Gilissen, C; Brunner, HG; Kini, U; Roepman, R; Nordgren, A; Kleefstra, T				Reijnders, Margot R. F.; Zachariadis, Vasilios; Latour, Brooke; Jolly, Lachlan; Mancini, Grazia M.; Pfundt, Rolph; Wu, Ka Man; van Ravenswaaij-Arts, Conny M. A.; Veenstra-Knol, Hermine E.; Anderlid, Britt-Marie M.; Wood, Stephen A.; Cheung, Sau Wai; Barnicoat, Angela; Probst, Frank; Magoulas, Pilar; Brooks, Alice S.; Malmgren, Helena; Harila-Saari, Arja; Marcelis, Carlo M.; Vreeburg, Maaike; Hobson, Emma; Sutton, V. Reid; Stark, Zornitza; Vogt, Julie; Cooper, Nicola; Lim, Jiin Ying; Price, Sue; Lai, Angeline Hwei Meeng; Domingo, Deepti; Reversade, Bruno; Gecz, Jozef; Gilissen, Christian; Brunner, Han G.; Kini, Usha; Roepman, Ronald; Nordgren, Ann; Kleefstra, Tjitske		DDD Study	De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED INTELLECTUAL DISABILITY; X-CHROMOSOME INACTIVATION; FAT-FACETS GENE; DEUBIQUITINATING ENZYME; DEUBIQUITYLATING ENZYME; EXPRESSION ANALYSIS; BETA-CATENIN; DISORDERS; FAM/USP9X; INTERACTS	Mutations in more than a hundred genes have been reported to cause X-linked recessive intellectual disability (ID) mainly in males. In contrast, the number of identified X-linked genes in which de novo mutations specifically cause ID in females is limited. Here, we report 17 females with de novo loss-of-function mutations in USP9X, encoding a highly conserved deubiquitinating enzyme. The females in our study have a specific phenotype that includes ID/developmental delay (DD), characteristic facial features, short stature, and distinct congenital malformations comprising choanal atresia, anal abnormalities, post-axial polydactyly, heart defects, hypomastia, cleft palate/bifid uvula, progressive scoliosis, and structural brain abnormalities. Four females from our cohort were identified by targeted genetic testing because their phenotype was suggestive for USP9X mutations. In several females, pigment changes along Blaschko lines and body asymmetry were observed, which is probably related to differential (escape from) X-inactivation between tissues. Expression studies on both mRNA and protein level in affected-female-derived fibroblasts showed significant reduction of USP9X level, confirming the loss-of-function effect of the identified mutations. Given that some features of affected females are also reported in known ciliopathy syndromes, we examined the role of USP9X in the primary cilium and found that endogenous USP9X localizes along the length of the ciliary axoneme, indicating that its loss of function could indeed disrupt cilium-regulated processes. Absence of dysregulated ciliary parameters in affected female-derived fibroblasts, however, points toward spatiotemporal specificity of ciliary USP9X (dys-) function.	[Reijnders, Margot R. F.; Latour, Brooke; Pfundt, Rolph; Wu, Ka Man; Marcelis, Carlo M.; Gilissen, Christian; Brunner, Han G.; Roepman, Ronald; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Zachariadis, Vasilios; Anderlid, Britt-Marie M.; Malmgren, Helena; Nordgren, Ann] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Zachariadis, Vasilios; Anderlid, Britt-Marie M.; Malmgren, Helena; Nordgren, Ann] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Latour, Brooke; Wu, Ka Man; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Jolly, Lachlan; Gecz, Jozef] Univ Adelaide, Neurogenet, Sch Med, Adelaide, SA 5005, Australia; [Jolly, Lachlan; Gecz, Jozef] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia; [Mancini, Grazia M.; Brooks, Alice S.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [van Ravenswaaij-Arts, Conny M. A.; Veenstra-Knol, Hermine E.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Anderlid, Britt-Marie M.; Malmgren, Helena; Nordgren, Ann] Karolinska Univ Hosp, Dept Clin Genet, S-17176 Stockholm, Sweden; [Wood, Stephen A.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia; [Cheung, Sau Wai; Probst, Frank; Magoulas, Pilar; Sutton, V. Reid] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Barnicoat, Angela] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England; [Harila-Saari, Arja] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Vreeburg, Maaike; Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; [Hobson, Emma] Chapel Allerton Hosp, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Stark, Zornitza] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia; [Vogt, Julie] Birmingham Womens Hosp, Clin Genet Unit, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cooper, Nicola] Birmingham Womens NHS Fdn Trust, Clin Genet Unit, Mindelsohn Way, Birmingham B15 2G, W Midlands, England; [Lim, Jiin Ying; Lai, Angeline Hwei Meeng] KK Womens & Childrens Hosp, Singapore 229899, Singapore; [Price, Sue; Kini, Usha] Oxford Univ Hosp NHS Fdn Trust, Dept Clin Genet, Oxford OX3 7LE, England; [Domingo, Deepti] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5000, Australia; [Reversade, Bruno] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Reversade, Bruno] Univ Amsterdam, Acad Med Ctr, Amsterdam Reprod & Dev, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Vrije Univ Amsterdam, Med Ctr, Reprod Biol Lab Q3 119, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; Radboud University Nijmegen; University of Adelaide; Robinson Research Institute; University of Adelaide; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Groningen; Karolinska Institutet; Karolinska University Hospital; Griffith University; Baylor College of Medicine; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital; Maastricht University; Chapel Allerton Hospital; Murdoch Children's Research Institute; Birmingham Women's Hospital; KK Women's & Children's Hospital; Oxford University Hospitals NHS Foundation Trust; University of Adelaide; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Roepman, R; Kleefstra, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Roepman, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.	ronald.roepman@radboudumc.nl; tjitske.kleefstra@radboudumc.nl	Gecz, Jozef/X-3469-2019; Kleefstra, Tjitske/G-2619-2012; Latour, Brooke/AAW-9199-2021; Nordgren, Ann/AAQ-9142-2021; Pfundt, Rolph/L-4576-2015; Gilissen, Christian/E-5246-2012; Harila-Saari, Arja/E-2124-2014; Roepman, Ronald/B-1339-2014; Nordgren, Ann C/N-4057-2013; Marcelis, C.L.M./L-4504-2015; Wood, Stephen A/E-8357-2011	Gecz, Jozef/0000-0002-7884-6861; Nordgren, Ann/0000-0003-3285-4281; Gilissen, Christian/0000-0003-1693-9699; Harila-Saari, Arja/0000-0003-2767-5828; Roepman, Ronald/0000-0002-5178-8163; Nordgren, Ann C/0000-0003-3285-4281; Marcelis, C.L.M./0000-0001-7095-4641; Wood, Stephen A/0000-0002-2576-7457; Lim, Jiin Ying/0000-0003-3253-2768; Domingo, Deepti/0000-0002-7706-872X; REVERSADE, Bruno/0000-0002-4070-7997	Netherlands Organization for Health Research and Development, ZonMw [907-00-365]; Netherlands Organization for Scientific Research (NWO) [Vici-865.12.005]; Stockholm County Council; Karolinska Institutet; Frimurare Barnhuset i Stockholm; Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation; Karolinska Institutet research funds; Australian National Health and Medical Research Council (NHMRC) [628952, 1041920]; Strategic Positioning Fund on Genetic Orphan Diseases; Industry Alignment Fund seeding grant from the Biomedical Research Council, A*STAR, Singapore	Netherlands Organization for Health Research and Development, ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Frimurare Barnhuset i Stockholm; Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation(European Commission); Karolinska Institutet research funds; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Strategic Positioning Fund on Genetic Orphan Diseases; Industry Alignment Fund seeding grant from the Biomedical Research Council, A*STAR, Singapore	We thank all the families for their contributions. We thank J. Hehir-Kwa, N. de Leeuw, and N. Nadif-Kasri for providing data and useful discussions. This work was supported by grants from the Netherlands Organization for Health Research and Development, ZonMw (grant 907-00-365 to T.K.) and the Netherlands Organization for Scientific Research (NWO Vici-865.12.005 to R.R.). A. N., A. H.-S., H.M., B.-M.M.A., and V.Z. were supported through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, by grants from Frimurare Barnhuset i Stockholm, The Cancer Research Foundations of Radiumhemmet, The Swedish Childhood Cancer Foundation, and the Karolinska Institutet research funds. J.G. was supported by Australian National Health and Medical Research Council (NHMRC) Program Grant (628952) and Research Fellowship (1041920). B.R. is a fellow of the Branco Weiss Foundation, an EMBO Young Investigator, and a recipient of the A*STAR Investigatorship. This work was partly funded by a Strategic Positioning Fund on Genetic Orphan Diseases and an Industry Alignment Fund seeding grant from the Biomedical Research Council, A*STAR, Singapore. Acknowledgments of the DDD Study are included in the Supplemental Data.	Agrawal P, 2012, J BIOL CHEM, V287, P21164, DOI 10.1074/jbc.M111.328021; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004; Brett M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093409; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Firth H.V., 2009, CLIN GENETICS; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Friocourt G, 2005, MOL CELL NEUROSCI, V28, P153, DOI 10.1016/j.mcn.2004.09.005; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Khut PY, 2007, ZEBRAFISH, V4, P95, DOI 10.1089/zeb.2006.0502; Lepri FR, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-14; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Luise C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015891; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Paemka L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005022; Peeters SB, 2014, BIOESSAYS, V36, P746, DOI 10.1002/bies.201400032; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Stegeman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068287; Stevens-Kroef MJPL, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-3; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Ware Stephanie M, 2011, Proc Am Thorac Soc, V8, P444, DOI 10.1513/pats.201103-025SD; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xu J, 2005, EUR J NEUROSCI, V21, P3017, DOI 10.1111/j.1460-9568.2005.04134.x; Yang C, 2011, HUM GENET, V130, P175, DOI 10.1007/s00439-011-0994-9; Zweier C, 2013, J MED GENET, V50, P838, DOI 10.1136/jmedgenet-2013-101918	51	61	62	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					373	381		10.1016/j.ajhg.2015.12.015	http://dx.doi.org/10.1016/j.ajhg.2015.12.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26833328	Green Published, Bronze			2022-12-18	WOS:000370502300014
J	Guo, DC; Gong, LM; Regalado, ES; Santos-Cortez, RL; Zhao, R; Cai, B; Veeraraghavan, S; Prakash, SK; Johnson, RJ; Muilenburg, A; Willing, M; Jondeau, G; Boileau, C; Pannu, H; Moran, R; Debacker, J; Bamshad, MJ; Shendure, J; Nickerson, DA; Leal, SM; Raman, CS; Swindell, EC; Milewicz, DM				Guo, Dong-chuan; Gong, Limin; Regalado, Ellen S.; Santos-Cortez, Regie L.; Zhao, Ren; Cai, Bo; Veeraraghavan, Sudha; Prakash, Siddharth K.; Johnson, Ralph J.; Muilenburg, Ann; Willing, Marcia; Jondeau, Guillaume; Boileau, Catherine; Pannu, Hariyadarshi; Moran, Rocio; Debacker, Julie; Bamshad, Michael J.; Shendure, Jay; Nickerson, Deborah A.; Leal, Suzanne M.; Raman, C. S.; Swindell, Eric C.; Milewicz, Dianna M.		GenTAC Investigators; Natl Heart Lung Blood Inst Go; Montalcino Aortic Consortium	MAT2A Mutations Predispose Individuals to Thoracic Aortic Aneurysms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							METHIONINE ADENOSYLTRANSFERASE; S-ADENOSYLMETHIONINE; GENE-EXPRESSION; DISSECTIONS; SUBUNIT; MICE	Up to 20% of individuals who have thoracic aortic aneurysms or acute aortic dissections but who do not have syndromic features have a family history of thoracic aortic disease. Significant genetic heterogeneity is established for this familial condition. Whole-genome linkage analysis and exome sequencing of distant relatives from a large family with autosomal-dominant inheritance of thoracic aortic aneurysms variably associated with the bicuspid aortic valve was used for identification of additional genes predisposing individuals to this condition. A rare variant, c.1031A>C (p.Glu344Ala), was identified in MAT2A, which encodes methionine adenosyltransferase II alpha (MAT II alpha). This variant segregated with disease in the family, and Sanger sequencing of DNA from affected probands from unrelated families with thoracic aortic disease identified another MAT2A rare variant, c.1067G>A (p.Arg356His). Evidence that these variants predispose individuals to thoracic aortic aneurysms and dissections includes the following: there is a paucity of rare variants in MAT2A in the population; amino acids Glu344 and Arg356 are conserved from humans to zebrafish; and substitutions of these amino acids in MAT I alpha are found in individuals with hypermethioninemia. Structural analysis suggested that p.Glu344Ala and p.Arg356His disrupt MAT II alpha enzyme function. Knockdown of mat2aa in zebrafish via morpholino oligomers disrupted cardiovascular development. Co-transfected wild-type human MAT2A mRNA rescued defects of zebrafish cardiovascular development at significantly higher levels than mRNA edited to express either the Glu344 or Arg356 mutants, providing further evidence that the p.Glu344Ala and p.Arg356His substitutions impair MAT II alpha function. The data presented here support the conclusion that rare genetic variants in MAT2A predispose individuals to thoracic aortic disease.	[Guo, Dong-chuan; Gong, Limin; Regalado, Ellen S.; Zhao, Ren; Cai, Bo; Prakash, Siddharth K.; Johnson, Ralph J.; Pannu, Hariyadarshi; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Santos-Cortez, Regie L.; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Veeraraghavan, Sudha; Raman, C. S.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Muilenburg, Ann] Univ Iowa, Iowa City, IA 52242 USA; [Willing, Marcia] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Jondeau, Guillaume] Hop Bichat Claude Bernard, Ctr Natl Reference Syndrome Marfan & Apparentes, F-75018 Paris, France; [Boileau, Catherine] Univ Paris, INSERM U383, Hop Necker Enfants Malad, F-75018 Paris, France; [Moran, Rocio] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Debacker, Julie] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Bamshad, Michael J.; Shendure, Jay; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Swindell, Eric C.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University System of Maryland; University of Maryland Baltimore; University of Iowa; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Ghent University; Ghent University Hospital; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Shendure, Jay/AAU-3684-2021; boileau, catherine/M-4482-2017; Reinhardt, Dieter P/A-3102-2008; De Backer, Julie/B-2897-2014	boileau, catherine/0000-0002-0371-7539; Reinhardt, Dieter P/0000-0001-6535-9872; De Backer, Julie/0000-0001-8878-1507; Swindell, Eric/0000-0002-1193-8200; Regalado, Ellen/0000-0002-5859-218X; Shendure, Jay/0000-0002-1516-1865; Raman, C. S./0000-0002-1036-3193	Lung Cohorts Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Heart Cohorts Sequencing Project [HL-103010]; Broad Institute Sequencing Project [HL-102925]; Northwest Genomics Center Sequencing Project [HL-102926]; Family Studies Project Team; Vivian L. Smith Foundation; Richard T. Pisani Funds; GIS-Maladies Rares; Programme Hospitalier de Recherche Clinique (PHRC) [AOM09093]; PHRC [AOM 10108]; Agence Nationale de la Recherche from the French National Research Agency [2010 BLAN 1129];  [RO1 HL62594];  [P01HL110869-01];  [UL1 RR024148]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, KL2TR000370] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869, R01HL062594, R01HL109942] Funding Source: NIH RePORTER	Lung Cohorts Sequencing Project; Women's Health Initiative Sequencing Project; Heart Cohorts Sequencing Project; Broad Institute Sequencing Project; Northwest Genomics Center Sequencing Project; Family Studies Project Team; Vivian L. Smith Foundation; Richard T. Pisani Funds; GIS-Maladies Rares; Programme Hospitalier de Recherche Clinique (PHRC); PHRC; Agence Nationale de la Recherche from the French National Research Agency(French National Research Agency (ANR)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are extremely grateful to the individuals involved in this study and to the physicians and genetic counselors who aided in the collection of clinical data from the families. We would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung Cohorts Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Heart Cohorts Sequencing Project (HL-103010), the Broad Institute Sequencing Project (HL-102925), the Northwest Genomics Center Sequencing Project (HL-102926, D.A.N, M.J.R, and J.S.), and the Family Studies Project Team. The following sources provided funding for these studies: RO1 HL62594 (D.M.M.), P01HL110869-01 (D.M.M.), UL1 RR024148, Vivian L. Smith Foundation (D.M.M.), Richard T. Pisani Funds (D.M.M.), GIS-Maladies Rares (C.B.), Programme Hospitalier de Recherche Clinique (PHRC) AOM09093 (G.J.), PHRC AOM 10108 (C.B.), and Agence Nationale de la Recherche 2010 BLAN 1129 from the French National Research Agency (G.J.).	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; ALVAREZ L, 1993, BIOCHEM J, V293, P481, DOI 10.1042/bj2930481; Attias D, 2009, CIRCULATION, V120, P2541, DOI 10.1161/CIRCULATIONAHA.109.887042; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Chamberlin ME, 2000, AM J HUM GENET, V66, P347, DOI 10.1086/302752; Ding YH, 2013, CIRC RES, V112, P606, DOI 10.1161/CIRCRESAHA.112.300603; Fernandez-Irigoyen J, 2010, MOL GENET METAB, V101, P172, DOI 10.1016/j.ymgme.2010.07.009; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; GAHL WA, 1988, J CLIN INVEST, V81, P390, DOI 10.1172/JCI113331; Girdauskas E, 2011, ANN THORAC SURG, V91, pE70, DOI 10.1016/j.athoracsur.2010.12.060; Grillo MA, 2008, AMINO ACIDS, V34, P187, DOI 10.1007/s00726-007-0500-9; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Halim AB, 2001, J BIOL CHEM, V276, P9784, DOI 10.1074/jbc.M002347200; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Hoffjan S, 2011, EUR J HUM GENET, V19, P520, DOI 10.1038/ejhg.2010.239; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Liu R., 2014, BIOCH BIOPHYS ACTA; Liu RJ, 2013, CIRCULATION, V128, P2047, DOI 10.1161/CIRCULATIONAHA.113.002887; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Michelena HI, 2014, CIRCULATION, V129, P2691, DOI 10.1161/CIRCULATIONAHA.113.007851; Milewicz DM, 2014, TRENDS CARDIOVAS MED, V24, P53, DOI 10.1016/j.tcm.2013.06.004; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Renard M, 2013, INT J CARDIOL, V165, P314, DOI 10.1016/j.ijcard.2011.08.079; Ryan BM, 2001, J LAB CLIN MED, V138, P164, DOI 10.1067/mlc.2001.117161; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Svensson LG, 2008, J CARDIOVASC SURG, V49, P297; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Weber DS, 2005, AM J PHYSIOL-HEART C, V288, pH37, DOI 10.1152/ajpheart.00638.2004; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	40	61	65	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					170	177		10.1016/j.ajhg.2014.11.015	http://dx.doi.org/10.1016/j.ajhg.2014.11.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557781	Bronze, Green Published			2022-12-18	WOS:000347707800014
J	Lindstrand, A; Davis, EE; Carvalho, CMB; Pehlivan, D; Willer, JR; Tsai, IC; Ramanathan, S; Zuppan, C; Sabo, A; Muzny, D; Gibbs, R; Liu, PF; Lewis, RA; Banin, E; Lupski, JR; Clark, R; Katsanis, N				Lindstrand, Anna; Davis, Erica E.; Carvalho, Claudia M. B.; Pehlivan, Davut; Willer, Jason R.; Tsai, I-Chun; Ramanathan, Subhadra; Zuppan, Craig; Sabo, Aniko; Muzny, Donna; Gibbs, Richard; Liu, Pengfei; Lewis, Richard A.; Banin, Eyal; Lupski, James R.; Clark, Robin; Katsanis, Nicholas			Recurrent CNVs and SNVs at the NPHP1 Locus Contribute Pathogenic Alleles to Bardet-Biedl Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE NEPHRONOPHTHISIS; RETINAL DEGENERATION; JOUBERT-SYNDROME; BBS LOCUS; MUTATIONS; DISEASE; CILIOPATHY; PROTEIN; GENE; INDIVIDUALS	Homozygosity for a recurrent 290 kb deletion of NPHP1 is the most frequent cause of isolated nephronophthisis (NPHP) in humans. A deletion of the same genomic interval has also been detected in individuals with Joubert syndrome (JBTS), and in the mouse, Nphp1 interacts genetically with Ahi1, a known JBTS locus. Given these observations, we investigated the contribution of NPHP1 in Bardet-Biedl syndrome (BBS), a ciliopathy of intermediate severity. By using a combination of array-comparative genomic hybridization, TaqMan copy number assays, and sequencing, we studied 200 families affected by BBS. We report a homozygous NPHP1 deletion CNV in a family with classical BBS that is transmitted with autosomal-recessive inheritance. Further, we identified heterozygous NPHP1 deletions in two more unrelated persons with BBS who bear primary mutations at another BBS locus. In parallel, we identified five families harboring an SNV in NPHP1 resulting in a conserved missense change, c.14G>T (p.Arg5Leu), that is enriched in our Hispanic pedigrees; in each case, affected individuals carried additional bona fide pathogenic alleles in another BBS gene. In vivo functional modeling in zebrafish embryos demonstrated that c.14G>T is a loss-of-function variant, and suppression of nphp1 in concert with each of the primary BBS loci found in our NPHP1-positive pedigrees exacerbated the severity of the phenotype. These results suggest that NPHP1 mutations are probably rare primary causes of BBS that contribute to the mutational burden of the disorder.	[Lindstrand, Anna; Davis, Erica E.; Willer, Jason R.; Tsai, I-Chun; Katsanis, Nicholas] Duke Univ, Sch Med, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Carvalho, Claudia M. B.; Pehlivan, Davut; Liu, Pengfei; Lewis, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Carvalho, Claudia M. B.] Ctr Pesquisas Rene Rachou FIOCRUZ, BR-30190002 Belo Horizonte, MG, Brazil; [Ramanathan, Subhadra; Clark, Robin] Loma Linda Univ, Sch Med, Div Med Genet, Dept Pediat, Loma Linda, CA 92350 USA; [Zuppan, Craig] Loma Linda Univ, Sch Med, Pathol & Human Anat, Loma Linda, CA 92350 USA; [Sabo, Aniko; Muzny, Donna; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Banin, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Ctr Retinal & Macular Degenerat, IL-91120 Jerusalem, Israel; [Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA	Duke University; Baylor College of Medicine; Fundacao Oswaldo Cruz; Loma Linda University; Loma Linda University; Baylor College of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Baylor College of Medicine; Baylor College of Medicine	Katsanis, N (corresponding author), Duke Univ, Sch Med, Ctr Human Dis Modeling, Durham, NC 27710 USA.	nicholas.katsanis@duke.edu	Lindstrand, Anna/AAT-9969-2021; Lindstrand, Anna M/J-3566-2012; Liu, Pengfei/U-9743-2019; Pehlivan, Davut/I-3235-2019	Lindstrand, Anna/0000-0003-0806-5602; Lindstrand, Anna M/0000-0003-0806-5602; Liu, Pengfei/0000-0002-4177-709X; Willer, Jason/0000-0002-5869-3992; Davis, Erica/0000-0002-2412-8397; Katsanis, Nicholas/0000-0002-2480-0171	NIH [DK072301, DK075972-09, HD042601, NS058529, EY021872, F32DK094578]; EU [241955]; project SYSCILIA; Swedish Research Council [2010-978]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601, U54HD083092] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415, R01DK072301, R01DK075972, F32DK094578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); project SYSCILIA; Swedish Research Council(Swedish Research CouncilEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the BBS-affected families for their continued enthusiasm in our work. We thank John Belmont at Baylor College of Medicine and Shelby Strickland, Yutao Liu, Rand Allingham, and Michael Hauser at Duke University for Hispanic control DNAs. This work was funded by NIH grants DK072301, DK075972-09, and HD042601 to N.K., NS058529 to J.R.L., and EY021872 to E.E.D. and F32DK094578 to I.-C. T.; by funding from EU 7th FP under GA nr. 241955, project SYSCILIA to N.K. and E.E.D.; and by the Swedish Research Council grant 2010-978 to A.L. N.K. is a distinguished Jean and George Brumley Professor.	Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; de Pontual L, 2009, P NATL ACAD SCI USA, V106, P13921, DOI 10.1073/pnas.0901219106; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; McIntyre JC, 2012, NAT MED, V18, P1423, DOI 10.1038/nm.2860; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Redin C, 2012, J MED GENET, V49, P502, DOI 10.1136/jmedgenet-2012-100875; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Slanchev K, 2011, HUM MOL GENET, V20, P3119, DOI 10.1093/hmg/ddr214; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wiszniewski W, 2013, AM J HUM GENET, V93, P197, DOI 10.1016/j.ajhg.2013.05.027; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	39	61	67	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					745	754		10.1016/j.ajhg.2014.03.017	http://dx.doi.org/10.1016/j.ajhg.2014.03.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24746959	Bronze, Green Published			2022-12-18	WOS:000335485700008
J	Esteves, T; Durr, A; Mundwiller, E; Loureiro, JL; Boutry, M; Gonzalez, MA; Gauthier, J; El-Hachimi, KH; Depienne, C; Muriel, MP; Lebrigio, RFA; Gaussen, M; Noreau, A; Speziani, F; Dionne-Laporte, A; Deleuze, JF; Dion, P; Coutinho, P; Rouleau, GA; Zuchner, S; Brice, A; Stevanin, G; Darios, F				Esteves, Typhaine; Durr, Alexandra; Mundwiller, Emeline; Loureiro, Jose L.; Boutry, Maxime; Gonzalez, Michael A.; Gauthier, Julie; El-Hachimi, Khalid H.; Depienne, Christel; Muriel, Marie-Paule; Lebrigio, Rafael F. Acosta; Gaussen, Marion; Noreau, Anne; Speziani, Fiorella; Dionne-Laporte, Alexandre; Deleuze, Jean-Francois; Dion, Patrick; Coutinho, Paula; Rouleau, Guy A.; Zuchner, Stephan; Brice, Alexis; Stevanin, Giovanni; Darios, Frederic			Loss of Association of REEP2 with Membranes Leads to Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBULAR ENDOPLASMIC-RETICULUM; AUTOSOMAL-DOMINANT; GENOME ANALYSIS; MUTATIONS; MECHANISMS; ER; NEUROPATHY; GENETICS; SPECTRUM; TYPE-31	Hereditary spastic paraplegias (HSPs) are clinically and genetically heterogeneous neurological conditions. Their main pathogenic mechanisms are thought to involve alterations in endomembrane trafficking, mitochondrial function, and lipid metabolism. With a combination of whole-genome mapping and exome sequencing, we identified three mutations in REEP2 in two families with HSP: a missense variant (c.107T>A [p.Va136Glu]) that segregated in the heterozygous state in a family with autosomal-dominant inheritance and a missense change (c.215T>A [p.Phe72Tyr]) that segregated in trans with a splice site mutation (c.105+3G>T) in a family with autosomal-recessive transmission. REEP2 belongs to a family of proteins that shape the endoplasmic reticulum, an organelle that was altered in fibroblasts from an affected subject. In vitro, the p.Val36Glu variant in the autosomal-dominant family had a dominant-negative effect; it inhibited the normal binding of wild-type REEP2 to membranes. The missense substitution p.Phe72Tyr, in the recessive family, decreased the affinity of the mutant protein for membranes that, together with the splice site mutation, is expected to cause complete loss of REEP2 function. Our findings illustrate how dominant and recessive inheritance can be explained by the effects and nature of mutations in the same gene. They have also important implications for genetic diagnosis and counseling in clinical practice because of the association of various modes of inheritance to this new clinico-genetic entity.	[Esteves, Typhaine; Durr, Alexandra; Boutry, Maxime; El-Hachimi, Khalid H.; Depienne, Christel; Muriel, Marie-Paule; Gaussen, Marion; Brice, Alexis; Stevanin, Giovanni; Darios, Frederic] Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Ctr Rech,Unite Mixte Rech S975, F-75013 Paris, France; [Esteves, Typhaine; Durr, Alexandra; Boutry, Maxime; El-Hachimi, Khalid H.; Depienne, Christel; Muriel, Marie-Paule; Gaussen, Marion; Brice, Alexis; Stevanin, Giovanni; Darios, Frederic] Inst Natl Sante & Rech Med, U975, F-75013 Paris, France; [Esteves, Typhaine; Durr, Alexandra; Boutry, Maxime; El-Hachimi, Khalid H.; Depienne, Christel; Muriel, Marie-Paule; Gaussen, Marion; Brice, Alexis; Stevanin, Giovanni; Darios, Frederic] Ctr Natl Rech Sci, Unite Mixte Rech 7225, F-75013 Paris, France; [Esteves, Typhaine; El-Hachimi, Khalid H.; Gaussen, Marion; Stevanin, Giovanni] Grp Hosp Pitie Salpetriere, Ecole Prat Hautes Etud, Inst Cerveau & Moelle Epiniere, Lab Neurogenet, F-75013 Paris, France; [Durr, Alexandra; Depienne, Christel; Brice, Alexis] Grp Hosp Pitie Salpetriere, APHP, Ctr Genet Mol & Chromosom, F-75013 Paris, France; [Mundwiller, Emeline; Brice, Alexis; Stevanin, Giovanni] Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Loureiro, Jose L.; Coutinho, Paula] UnIGENe, P-4050 Oporto, Portugal; [Loureiro, Jose L.; Coutinho, Paula] Inst Mol & Cellular Biol, Ctr Genet Predit & Prevent, P-4050 Oporto, Portugal; [Gonzalez, Michael A.; Lebrigio, Rafael F. Acosta; Speziani, Fiorella; Zuchner, Stephan] Univ Miami, Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael A.; Lebrigio, Rafael F. Acosta; Speziani, Fiorella; Zuchner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Gauthier, Julie; Noreau, Anne; Dionne-Laporte, Alexandre; Dion, Patrick; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Deleuze, Jean-Francois] Ctr Natl Genotypage, F-91057 Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade do Porto; University of Miami; University of Miami; McGill University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Stevanin, G (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Ctr Rech,Unite Mixte Rech S975, F-75013 Paris, France.	giovanni.stevanin@upmc.fr; frederic.darios@upmc.fr	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Depienne, Christel/AAL-3835-2021; Stevanin, Giovanni/E-5038-2016	brice, alexis/0000-0002-0941-3990; Depienne, Christel/0000-0002-7212-9554; Stevanin, Giovanni/0000-0001-9368-8657; Boutry, Maxime/0000-0002-9676-7999; Darios, Frederic/0000-0001-9800-5990	program "Investissements d'avenir" [ANR-10-IAIHU-06]; Verum Foundation; French Agency for Research (ANR); Association Francaise contre les Myopathies; Fondation Roger de Spoelberch [R12123DD]; Canadian Institutes of Health Research; National Institutes of Health [R01NS072248, R01NS072248S1/S2]; European Union; ANR [E12009DD]; European Research Council (ERC) [311149]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	program "Investissements d'avenir"(French National Research Agency (ANR)); Verum Foundation; French Agency for Research (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation Roger de Spoelberch; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); ANR(French National Research Agency (ANR)); European Research Council (ERC)(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We first of all thank the family members that kindly participated in this study. We also thank Imed Feki who performed, some clinical examinations, Merle Ruberg for the critical reading of the manuscript, and Isabel Alonso, Sara Morais, Eva Brandao, and Celine Lustremant for their help. We are also grateful to Craig Blackstone (NINDS, Bethesda, MD) and Gia K. Voeltz (University of Colorado, Boulder, CO) for the REEP1 and GFP-Sec61 beta expression vectors, respectively. Some aspects of this work were performed thanks to the contribution of the DNA and Cell Bank (coordinators Sylvie Forlani and A.D.) of the Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere (ICM), the genomic P3S facility (coordinators Wassilla Carpentier and Florent Soubrier), the ICM genotyping/sequencing facility (coordinators Yannick Marie and G.S.), and the Plateforme d'Imagerie Cellulaire de la Pitie-Salpetriere. This study was funded by the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Institut du Cerveau et de la Moelle epiniere), the Verum Foundation (to A.B.), the French Agency for Research (ANR) (to G.S. and A.D.), the Association Francaise contre les Myopathies (to G.S.), The Fondation Roger de Spoelberch (R12123DD to A.B.), the Canadian Institutes of Health Research (to G.A.R.), the National Institutes of Health (R01NS072248 and R01NS072248S1/S2 to S.Z. and M.G.), and the European Union with the ANR (E12009DD to A.B., Seventh Framework Program - FP7, Omics call) and with the European Research Council (ERC, Starting grant No 311149 to F.D.).	Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Beetz C, 2013, J CLIN INVEST, V123, P4273, DOI 10.1172/JCI65665; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Coutinho P, 1999, ARCH NEUROL-CHICAGO, V56, P943, DOI 10.1001/archneur.56.8.943; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dursun U, 2009, NEUROGENETICS, V10, P325, DOI 10.1007/s10048-009-0191-3; Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; HARDING AE, 1983, LANCET, V1, P1151; Ilegems E, 2010, J NEUROSCI, V30, P13774, DOI 10.1523/JNEUROSCI.0091-10.2010; Klebe S, 2012, BRAIN, V135, P2980, DOI 10.1093/brain/aws240; Kumar KR, 2013, J NEUROL, V260, P2516, DOI 10.1007/s00415-013-7008-x; Lausch E, 2009, AM J HUM GENET, V85, P168, DOI 10.1016/j.ajhg.2009.06.014; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meijer IA, 2004, ANN NEUROL, V56, P579, DOI 10.1002/ana.20239; Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Schlaitz AL, 2013, DEV CELL, V26, P315, DOI 10.1016/j.devcel.2013.06.016; Schlang KJ, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-71; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Schule R, 2009, NEUROLOGY, V72, P1893, DOI 10.1212/WNL.0b013e3181a6086c; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Steinmuller R, 1997, HUM GENET, V100, P287, DOI 10.1007/s004390050507; Stevanin G, 2008, CURR NEUROL NEUROSCI, V8, P198, DOI 10.1007/s11910-008-0032-z; Tallaksen CME, 2001, CURR OPIN NEUROL, V14, P457, DOI 10.1097/00019052-200108000-00005; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	35	61	63	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 6	2014	94	2					268	277		10.1016/j.ajhg.2013.12.005	http://dx.doi.org/10.1016/j.ajhg.2013.12.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA9NF	24388663	Bronze, Green Published			2022-12-18	WOS:000331419500010
J	Schifano, ED; Li, L; Christiani, DC; Lin, XH				Schifano, Elizabeth D.; Li, Lin; Christiani, David C.; Lin, Xihong			Genome-wide Association Analysis for Multiple Continuous Secondary Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LUNG-CANCER; SUSCEPTIBILITY LOCUS; SMOKING; VARIANTS; DEPENDENCE; MEDIATION; GENES; TESTS	There is increasing interest in the joint analysis of multiple phenotypes in genome-wide association studies (GWASs), especially for the analysis of multiple secondary phenotypes in case-control studies and in detecting pleiotropic effects. Multiple phenotypes often measure the same underlying trait. By taking advantage of similarity across phenotypes, one could potentially gain statistical power in association analysis. Because continuous phenotypes are likely to be measured on different scales, we propose a scaled marginal model for testing and estimating the common effect of single-nucleotide polymorphism (SNP) on multiple secondary phenotypes in case-control studies. This approach improves power in comparison to individual phenotype analysis and traditional multivariate analysis when phenotypes are positively correlated and measure an underlying trait in the same direction (after transformation) by borrowing strength across outcomes with a one degree of freedom (1-DF) test and jointly estimating outcome-specific scales along with the SNP and covariate effects. To account for case-control ascertainment bias for the analysis of multiple secondary phenotypes, we propose weighted estimating equations for fitting scaled marginal models. This weighted estimating equation approach is robust to departures from normality of continuous multiple phenotypes and the misspecification of within-individual correlation among multiple phenotypes. Statistical power improves when the within-individual correlation is correctly specified. We perform simulation studies to show the proposed 1-DF common effect test outperforms several alternative methods. We apply the proposed method to investigate SNP associations with smoking behavior measured with multiple secondary smoking phenotypes in a lung cancer case-control GWAS and identify several SNPs of biological interest.	[Schifano, Elizabeth D.] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Li, Lin; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Connecticut; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Schifano, ED (corresponding author), Univ Connecticut, Dept Stat, Storrs, CT 06269 USA.	elizabeth.schifano@uconn.edu; xlin@hsph.harvard.edu			National Institutes of Health [T32 ES007142, T32 ES016645, R37 CA076404, P01 CA134294, CA074386, CA092824, CA090578]; NATIONAL CANCER INSTITUTE [R01CA074386, P20CA090578, P50CA090578, R37CA076404, P01CA134294, R01CA092824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142, T32ES016645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors wish to thank the anonymous reviewers whose comments greatly improved this manuscript. This work was supported by grants from the National Institutes of Health (T32 ES007142 and T32 ES016645 to E.D.S.; R37 CA076404 and P01 CA134294 to L.L. and X.L.; and CA074386, CA092824, and CA090578 to D.C.C.).	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BRESLOW N, 1990, J AM STAT ASSOC, V85, P565, DOI 10.2307/2289799; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rencher AC, 2002, METHODS MULTIVARIATE; Rose JE, 2010, MOL MED, V16, P247, DOI 10.2119/molmed.2009.00159; Roy J, 2003, BIOSTATISTICS, V4, P371, DOI 10.1093/biostatistics/4.3.371; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	30	61	61	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					744	759		10.1016/j.ajhg.2013.04.004	http://dx.doi.org/10.1016/j.ajhg.2013.04.004			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23643383	Green Published, Bronze			2022-12-18	WOS:000318582800009
J	von Ameln, S; Wang, G; Boulouiz, R; Rutherford, MA; Smith, GM; Li, Y; Pogoda, HM; Nurnberg, G; Stiller, B; Volk, AE; Borck, G; Hong, JS; Goodyear, RJ; Abidi, O; Nurnberg, P; Hofmann, K; Richardson, GYP; Hammerschmidt, M; Moser, T; Wollnik, B; Koehler, CM; Teitell, MA; Barakat, A; Kubisch, C				von Ameln, Simon; Wang, Geng; Boulouiz, Redouane; Rutherford, Mark A.; Smith, Geoffrey M.; Li, Yun; Pogoda, Hans-Martin; Nuernberg, Gudrun; Stiller, Barbara; Volk, Alexander E.; Borck, Guntram; Hong, Jason S.; Goodyear, Richard J.; Abidi, Omar; Nuernberg, Peter; Hofmann, Kay; Richardson, Gu Y. P.; Hammerschmidt, Matthias; Moser, Tobias; Wollnik, Bernd; Koehler, Carla M.; Teitell, Michael A.; Barakat, Abdelhamid; Kubisch, Christian			A Mutation in PNPT1, Encoding Mitochondrial-RNA-Import Protein PNPase, Causes Hereditary Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; ESCHERICHIA-COLI; DEGRADATION; DISEASE; GENES; DNA	A subset of nuclear-encoded RNAs has to be imported into mitochondria for the proper replication and transcription of the mitochondrial genome and, hence, for proper mitochondrial function. Polynucleotide phosphorylase (PNPase or PNPT1) is one of the very few components known to be involved in this poorly characterized process in mammals. At the organismal level, however, the effect of PNPase dysfunction and impaired mitochondrial RNA import are unknown. By positional cloning, we identified a homozygous PNPT1 missense mutation (c.1424A>G predicting the protein substitution p.Glu475Gly) of a highly conserved PNPase residue within the second RNase-PH domain in a family affected by autosomal-recessive nonsyndromic hearing impairment. In vitro analyses in bacteria, yeast, and mammalian cells showed that the identified mutation results in a hypofunctional protein leading to disturbed PNPase trimerization and impaired mitochondrial RNA import. Immunohistochemistry revealed strong PNPase staining in the murine cochlea, including the sensory hair cells and the auditory ganglion neurons. In summary, we show that a component of the mitochondrial RNA-import machinery is specifically required for auditory function.	[von Ameln, Simon; Stiller, Barbara; Volk, Alexander E.; Borck, Guntram; Kubisch, Christian] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [von Ameln, Simon; Li, Yun; Stiller, Barbara; Volk, Alexander E.; Borck, Guntram; Wollnik, Bernd; Kubisch, Christian] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Wang, Geng; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Boulouiz, Redouane; Abidi, Omar; Barakat, Abdelhamid] Inst Pasteur Maroc, Dept Genet, Casablanca 20100, Morocco; [Rutherford, Mark A.; Moser, Tobias] Univ Med Ctr Gottingen, Dept Otolaryngol, InnerEarLab, D-37075 Gottingen, Germany; [Smith, Geoffrey M.; Hong, Jason S.; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Li, Yun; Nuernberg, Peter; Hammerschmidt, Matthias; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Pogoda, Hans-Martin; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Goodyear, Richard J.; Richardson, Gu Y. P.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Moser, Tobias] Univ Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Broad Stem Cell Res Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Ctr Cell Control, Los Angeles, CA 90095 USA	Ulm University; University of Cologne; University of California System; University of California Los Angeles; University of Gottingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Cologne; University of Cologne; University of Sussex; University of Cologne; University of Cologne; University of Gottingen; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kubisch, C (corresponding author), Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany.	christian.kubisch@uni-ulm.de	Kubisch, Christian/F-1893-2011; Moser, Tobias/L-5068-2014; Borck, Guntram/F-1868-2015; Wollnik, Bernd/GRY-6062-2022; Abidi, Omar/AAM-5088-2020	Kubisch, Christian/0000-0003-4220-0978; Moser, Tobias/0000-0001-7145-0533; Wollnik, Bernd/0000-0003-2589-0364; von Ameln, Simon/0000-0002-2242-3165; BOULOUIZ, Redouane/0000-0003-4430-3612; Rutherford, Mark/0000-0002-2627-6254	National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; European Commission FP6 Integrated Project EUROHEAR [LSHG-CT-20054-512063]; National Institutes of Health [GM061721, GM073981, CA90571, CA156674]; Muscular Dystrophy Association [022398]; American Heart Association [0640076N]; California Institute for Regenerative Medicine [RS1-00313, RB1-01397]; Wellcome Trust [087737]; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA156674, R01CA090571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073981, R01GM061721] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project; Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; European Commission FP6 Integrated Project EUROHEAR(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Wellcome Trust(Wellcome TrustEuropean Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the family members for their participation and cooperation, K. Schnetz for providing E. coli K-12 wild-type strain BW25113, S.R. Kushner for providing plasmid pKAK7, and Thomas Langer and Rudolf Wiesner for discussions. The authors also thank the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). This work was supported by the European Commission FP6 Integrated Project EUROHEAR (LSHG-CT-20054-512063), the National Institutes of Health (GM061721, GM073981, CA90571, and CA156674), the Muscular Dystrophy Association (022398), the American Heart Association (0640076N), the California Institute for Regenerative Medicine (RS1-00313 and RB1-01397), the Wellcome Trust (087737), and the Alexander von Humboldt Foundation.	Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Kalay E, 2006, HUM MUTAT, V27, P633, DOI 10.1002/humu.20368; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kim HY, 2004, BIOCHEM BIOPH RES CO, V320, P1277, DOI 10.1016/j.bbrc.2004.06.078; Kokotas H, 2007, CLIN GENET, V71, P379, DOI 10.1111/j.1399-0004.2007.00800.x; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Sieber F, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr380; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Wu JH, 2009, BIOCHEMISTRY-US, V48, P2012, DOI 10.1021/bi801752p; Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004; Yehudai-Resheff S, 2003, PLANT CELL, V15, P2003, DOI 10.1105/tpc.013326	27	61	63	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					919	927		10.1016/j.ajhg.2012.09.002	http://dx.doi.org/10.1016/j.ajhg.2012.09.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23084290	Green Published, Bronze			2022-12-18	WOS:000311011400015
J	Huang, LL; Jolly, LA; Willis-Owen, S; Gardner, A; Kumar, R; Douglas, E; Shoubridge, C; Wieczorek, D; Tzschach, A; Cohen, M; Hackett, A; Field, M; Froyen, G; Hu, H; Haas, SA; Ropers, HH; Kalscheuer, VM; Corbett, MA; Gecz, J				Huang, Lingli; Jolly, Lachlan A.; Willis-Owen, Saffron; Gardner, Alison; Kumar, Raman; Douglas, Evelyn; Shoubridge, Cheryl; Wieczorek, Dagmar; Tzschach, Andreas; Cohen, Monika; Hackett, Anna; Field, Michael; Froyen, Guy; Hu, Hao; Haas, Stefan A.; Ropers, Hans-Hilger; Kalscheuer, Vera M.; Corbett, Mark A.; Gecz, Jozef			A Noncoding, Regulatory Mutation Implicates HCFC1 in Nonsyndromic Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOST-CELL FACTOR; TRANSCRIPTIONAL REGULATION; MLL FAMILY; GENE; HCF-1; EXPRESSION; DISEASE; COMPLEX; PREDISPOSE; VARIANTS	The discovery of mutations causing human disease has so far been biased toward protein-coding regions. Having excluded all annotated coding regions, we performed targeted massively parallel resequencing of the nonrepetitive genomic linkage interval at Xq28 of family MRX3. We identified in the binding site of transcription factor YY1 a regulatory mutation that leads to overexpression of the chromatin-associated transcriptional regulator HCFC1. When tested on embryonic murine neural stem cells and embryonic hippocampal neurons, HCFC1 overexpression led to a significant increase of the production of astrocytes and a considerable reduction in neurite growth. Two other nonsynonymous, potentially deleterious changes have been identified by X-exome sequencing in individuals with intellectual disability, implicating HCFC1 in normal brain function.	[Huang, Lingli; Jolly, Lachlan A.; Willis-Owen, Saffron; Gardner, Alison; Douglas, Evelyn; Shoubridge, Cheryl; Corbett, Mark A.; Gecz, Jozef] SA Pathol, Genet & Mol Pathol, Adelaide, SA 5006, Australia; [Huang, Lingli] Cent South Univ, Inst Reprod & Stem Cell Engn, Changsha 410004, Hunan, Peoples R China; [Gardner, Alison; Kumar, Raman; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Tzschach, Andreas; Hu, Hao; Haas, Stefan A.; Ropers, Hans-Hilger; Kalscheuer, Vera M.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Cohen, Monika] Kinderzentrum Munchen, D-81377 Munich, Germany; [Hackett, Anna; Field, Michael] Hunter Genet, Genet Learning Disabil Serv, Waratah, NSW 2298, Australia; [Froyen, Guy] VIB Ctr Biol Dis, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia; [Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia	SA Pathology; Central South University; Womens & Childrens Hospital Australia; University of Duisburg Essen; Max Planck Society; Flanders Institute for Biotechnology (VIB); University of Adelaide; University of Adelaide	Gecz, J (corresponding author), SA Pathol, Genet & Mol Pathol, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Wieczorek, Dagmar/AAU-6008-2021; Shoubridge, Cheryl/A-1571-2016; Jolly, Lachlan/B-5892-2015; Gecz, Jozef/X-3469-2019; Kumar, Raman/AHE-0538-2022; Corbett, Mark/A-8063-2010; Tzschach, Andreas/I-2648-2019	Wieczorek, Dagmar/0000-0003-2812-6492; Shoubridge, Cheryl/0000-0002-0157-3084; Jolly, Lachlan/0000-0003-4538-2658; Gecz, Jozef/0000-0002-7884-6861; Kumar, Raman/0000-0001-7976-8386; Corbett, Mark/0000-0001-9298-3072; Tzschach, Andreas/0000-0002-6840-965X; Willis-Owen, Saffron/0000-0003-2633-1150; Kalscheuer, Vera/0000-0001-6898-3259; Haas, Stefan/0000-0003-3418-3688	China Scholarship Council; German Federal Ministry of Education and Research through the German Mental Retardation Network [01GS08167, 01GS08161]; European Union [241995]; project GENCODYS; National Health and Medical Research Council of Australia [1008077, 508043]	China Scholarship Council(China Scholarship Council); German Federal Ministry of Education and Research through the German Mental Retardation Network; European Union(European Commission); project GENCODYS; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We would like to express our gratitude to all participating individuals, L. Hobson for assistance with Sanger sequencing, M. Bienek for assistance with X-exome sequencing, K. Friend for linkage analysis, C. Schwartz for additional information about the c.5379+2T>C mutation, and F. Lammers and W. Herr for kindly providing HCFC1 full-length cDNA and rabbit anti-HCFC1 antibody. L.H. was supported by a scholarship under the State Scholarship Fund from China Scholarship Council. This work was supported by the German Federal Ministry of Education and Research through the German Mental Retardation Network (grant 01GS08167 to D.W. and grant 01GS08161 to H.H.R.), the European Union's Seventh Framework Program under grant agreement number 241995, project GENCODYS, and grants from the National Health and Medical Research Council of Australia (project grant 1008077 and Principal Research Fellowship 508043 to J.G.).	Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Corbett MA, 2011, AM J HUM GENET, V88, P657, DOI 10.1016/j.ajhg.2011.04.011; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Delehouzee S, 2005, GENES CELLS, V10, P717, DOI 10.1111/j.1365-2443.2005.00873.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; GEDEON A, 1991, J MED GENET, V28, P372, DOI 10.1136/jmg.28.6.372; Giachino Claudio, 2009, V482, P143, DOI 10.1007/978-1-59745-060-7_9; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kolb-Kokocinski A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-29; Kouroupi G, 2010, J NEUROCHEM, V115, P460, DOI 10.1111/j.1471-4159.2010.06939.x; Kristie TM, 1997, J BIOL CHEM, V272, P26749, DOI 10.1074/jbc.272.42.26749; Kumar R, 2011, J CELL BIOCHEM, V112, P2742, DOI 10.1002/jcb.23214; Liu J, 2006, HUM MOL GENET, V15, P1769, DOI 10.1093/hmg/ddl099; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Mu W, 2010, DEV BIOL, V347, P279, DOI 10.1016/j.ydbio.2010.08.026; Piluso D, 2002, J BIOL CHEM, V277, P46799, DOI 10.1074/jbc.M206226200; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Scarr RB, 2002, ONCOGENE, V21, P5245, DOI 10.1038/sj.onc.1205647; Shoubridge C, 2012, HUM MOL GENET, V21, P1639, DOI 10.1093/hmg/ddr601; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; WILSON AC, 1995, GENOMICS, V25, P462, DOI 10.1016/0888-7543(95)80046-O; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yu JK, 2009, J BIOL CHEM, V284, P1505, DOI 10.1074/jbc.M805113200	47	61	68	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					694	702		10.1016/j.ajhg.2012.08.011	http://dx.doi.org/10.1016/j.ajhg.2012.08.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23000143	Bronze, Green Published			2022-12-18	WOS:000309568500011
J	Mochida, GH; Ganesh, VS; Felie, JM; Gleason, D; Hill, RS; Clapham, KR; Rakiec, D; Tan, WH; Akawi, N; Al-Saffar, M; Partlow, JN; Tinschert, S; Barkovich, AJ; Ali, B; Al-Gazali, L; Walsh, CA				Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Felie, Jillian M.; Gleason, Danielle; Hill, R. Sean; Clapham, Katie Rose; Rakiec, Daniel; Tan, Wen-Hann; Akawi, Nadia; Al-Saffar, Muna; Partlow, Jennifer N.; Tinschert, Sigrid; Barkovich, A. James; Ali, Bassam; Al-Gazali, Lihadh; Walsh, Christopher A.			A Homozygous Mutation in the Tight-Junction Protein JAM3 Causes Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADHESION MOLECULE-C; INFECTION-LIKE SYNDROME; NANCE-HORAN-SYNDROME; INTRACRANIAL CALCIFICATION; PSEUDO-TORCH; COL4A1 MUTATION; EXPRESSION; GENE; PERMEABILITY; MALFORMATION	The tight junction, or zonula occludens, is a specialized cell-cell junction that regulates epithelial and endothelial permeability, and it is an essential component of the blood-brain barrier in the cerebrovascular endothelium. In addition to functioning as a diffusion barrier, tight junctions are also involved in signal transduction. In this study, we identified a homozygous mutation in the tight-junction protein gene JAM3 in a large consanguineous family from the United Arab Emirates. Some members of this family had a rare autosomal-recessive syndrome characterized by severe hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Their clinical presentation overlaps with some reported cases of pseudo-TORCH syndrome as well as with cases involving mutations in occludin, another component of the tight-junction complex. However, massive intracranial hemorrhage distinguishes these patients from others. Homozygosity mapping identified the disease locus in this family on chromosome 11q25 with a maximum multipoint LOD score of 6.15. Sequence analysis of genes in the candidate interval uncovered a mutation in the canonical splice-donor site of intron 5 of JAM3. RT-PCR analysis of a patient lymphoblast cell line confirmed abnormal splicing, leading to a frameshift mutation with early termination. JAM3 is known to be present in vascular endothelium, although its roles in cerebral vasculature have not been implicated. Our results suggest that JAM3 is essential for maintaining the integrity of the cerebrovascular endothelium as well as for normal lens development in humans.	[Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; [Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Felie, Jillian M.; Gleason, Danielle; Hill, R. Sean; Clapham, Katie Rose; Rakiec, Daniel; Tan, Wen-Hann; Al-Saffar, Muna; Partlow, Jennifer N.; Walsh, Christopher A.] Manton Ctr Orphan Dis Res, Div Genet, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Ganesh, Vijay S.; Felie, Jillian M.; Gleason, Danielle; Hill, R. Sean; Clapham, Katie Rose; Rakiec, Daniel; Tan, Wen-Hann; Al-Saffar, Muna; Partlow, Jennifer N.; Walsh, Christopher A.] Childrens Hosp Boston, Howard Hughes Med Inst, Dept Med, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Hill, R. Sean; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Hill, R. Sean; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [Akawi, Nadia; Ali, Bassam] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Tinschert, Sigrid] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Klin Genet, D-01307 Dresden, Germany; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Walsh, Christopher A.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	United Arab Emirates University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; United Arab Emirates University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, POB 17666, Al Ain, U Arab Emirates.	l.algazali@uaeu.ac.ae; christopher.walsh@childrens.harvard.edu	Akawi, Nadia/AAX-2650-2020; Ali, Bassam/J-7014-2012	Akawi, Nadia/0000-0001-6311-7028; Tan, Wen-Hann/0000-0002-1593-6149; Walsh, Christopher/0000-0002-0156-2238; Clapham, Katharine/0000-0003-3659-4755; Ali, Bassam R/0000-0003-1306-6618; Mochida, Ganeshwaran/0000-0001-7912-4097	National Institute of Neurological Disorders and Stroke [5R01NS035129-13]; Fogarty International Center [5R21TW008223-02]; Nancy Lurie Marks Family Foundation; Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; National Alliance for Research on Schizophrenia and Depression (NARSAD); FOGARTY INTERNATIONAL CENTER [R21TW008223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Nancy Lurie Marks Family Foundation; Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the family for their participation in this research. SNP genotyping was performed at The W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University through the National Institutes of Health Neuroscience Microarray Consortium. We thank the Partners Health Care Center for Personalized Genetic Medicine for establishing the lymphoblast cell lines. We thank Brenda J. Barry for coordinating patient studies and Philippe Schroter and Juliane Artelt for help with cell culture. This research was supported by grants from the National Institute of Neurological Disorders and Stroke (5R01NS035129-13) and Fogarty International Center (5R21TW008223-02) to C.A.W. and by the Nancy Lurie Marks Family Foundation, the Dubai Harvard Foundation for Medical Research, the Simons Foundation, and the Manton Center for Orphan Disease Research. G.H.M. was supported by the Young Investigator Award of the National Alliance for Research on Schizophrenia and Depression (NARSAD) as a NARSAD Lieber Investigator. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Abdel-Salam GMH, 2008, AM J MED GENET A, V146A, P2929, DOI 10.1002/ajmg.a.32549; Abdel-Salam GMH, 2009, AM J MED GENET A, V149A, P1565, DOI 10.1002/ajmg.a.32894; Al-Gazali LI, 1999, J MED GENET, V36, P461; [Anonymous], BERKELEY DROSOPHILA; [Anonymous], NETGENE2; [Anonymous], ONLINE MENDELIAN INH; Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Briggs TA, 2008, AM J MED GENET A, V146A, P3173, DOI 10.1002/ajmg.a.32614; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Carlton VEH, 2003, NAT GENET, V34, P91, DOI 10.1038/ng1147; Daniele LL, 2007, J COMP NEUROL, V505, P166, DOI 10.1002/cne.21489; de Vries LS, 2009, ANN NEUROL, V65, P12, DOI 10.1002/ana.21525; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Economopoulou M, 2009, INVEST OPHTH VIS SCI, V50, P1454, DOI 10.1167/iovs.08-2129; Erpenbeck L, 2010, THROMB HAEMOSTASIS, V103, P857, DOI 10.1160/TH09-08-0572; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Knoblauch H, 2003, AM J MED GENET A, V120A, P261, DOI 10.1002/ajmg.a.20138; Li XC, 2009, ARTERIOSCL THROM VAS, V29, P1200, DOI 10.1161/ATVBAHA.109.189217; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; *NCBI, NCBI REF SEQ REFSEQ; O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Plaisier E, 2007, NEW ENGL J MED, V357, P2687, DOI 10.1056/NEJMoa071906; REARDON W, 1994, AM J MED GENET, V52, P58, DOI 10.1002/ajmg.1320520112; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Rozen S, 2000, Methods Mol Biol, V132, P365; Sado Y, 1998, J BIOCHEM-TOKYO, V123, P767; Scheiermann C, 2007, SCIENCE, V318, P1472, DOI 10.1126/science.1149276; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Vestweber D, 2000, J PATHOL, V190, P281; Volpe JJ., 2008, NEUROLOGY NEWBORN, P483; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Ye MQ, 2009, AM J MED GENET A, V149A, P1438, DOI 10.1002/ajmg.a.32913; PRIMER3; ALLEN DEV MOUSE BRAI; ALLEN MOUSE BRAIN AT	45	61	63	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					882	889		10.1016/j.ajhg.2010.10.026	http://dx.doi.org/10.1016/j.ajhg.2010.10.026			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21109224	Bronze, Green Published			2022-12-18	WOS:000285564600016
J	Prakash, SK; LeMaire, SA; Guo, DC; Russell, L; Regalado, ES; Golabbakhsh, H; Johnson, RJ; Safi, HJ; Estrera, AL; Coselli, JS; Bray, MS; Leal, SM; Milewicz, DM; Belmont, JW				Prakash, Siddharth K.; LeMaire, Scott A.; Guo, Dong-Chuan; Russell, Ludivine; Regalado, Ellen S.; Golabbakhsh, Hossein; Johnson, Ralph J.; Safi, Hazim J.; Estrera, Anthony L.; Coselli, Joseph S.; Bray, Molly S.; Leal, Suzanne M.; Milewicz, Dianna M.; Belmont, John W.			Rare Copy Number Variants Disrupt Genes Regulating Vascular Smooth Muscle Cell Adhesion and Contractility in Sporadic Thoracic Aortic Aneurysms and Dissections	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATURAL-HISTORY; MUTATIONS; INTEGRIN; TETRALOGY; PATHOLOGY; PROTEIN; DOMAIN; ELASTOGENESIS; PATHOGENESIS; ASSOCIATION	Thoracic aortic aneurysms and dissections (TAAD) cause significant morbidity and mortality, but the genetic origins of TAAD remain largely unknown. In a genome-wide analysis of 418 sporadic TAAD cases, we identified 47 copy number variant (CNV) regions that were enriched in or unique to TAAD patients compared to population controls. Gene ontology, expression profiling, and network analysis showed that genes within TAAD CNVs regulate smooth muscle cell adhesion or contractility and interact with the smooth muscle-specific isoforms of alpha-actin and beta-myosin, which are known to cause familial TAAD when altered. Enrichment of these gene functions in rare CNVs was replicated in independent cohorts with sporadic TAAD (STAAD, n = 387) and inherited TAAD (FTAAD, n = 88). The overall prevalence of rare CNVs (23%) was significantly increased in FTAAD compared with STAAD patients (Fisher's exact test, p = 0.03). Our findings suggest that rare CNVs disrupting smooth muscle adhesion or contraction contribute to both sporadic and familial disease.	[Prakash, Siddharth K.; Bray, Molly S.; Leal, Suzanne M.; Belmont, John W.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [LeMaire, Scott A.; Russell, Ludivine; Coselli, Joseph S.] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Cardiothorac Surg, Houston, TX 77030 USA; [LeMaire, Scott A.; Coselli, Joseph S.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Guo, Dong-Chuan; Regalado, Ellen S.; Golabbakhsh, Hossein; Johnson, Ralph J.; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Med Genet, Houston, TX 77030 USA; [Safi, Hazim J.; Estrera, Anthony L.] Univ Texas Hlth Sci Ctr Houston, Dept Cardiothorac & Vasc Surg, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Belmont, JW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jbelmont@bcm.edu	Estrera, Anthony/ABG-4175-2021; Belmont, John/AAH-6084-2021; Belmont, John W/AAI-2494-2019	Belmont, John W/0000-0001-7409-3578; LeMaire, Scott/0000-0002-8736-4266; Regalado, Ellen/0000-0002-5859-218X	Vivian L. Smith Foundation; TexGen Foundation; Thoracic Surgery Foundation for Research and Education;  [P50HL083794-01];  [RO1 HL62594];  [K08 HL080085]; NATIONAL CANCER INSTITUTE [Z01CP010200, P01CA089392] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, K08HL080085, P50HL083794] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446, U01HG004438, U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423] Funding Source: NIH RePORTER	Vivian L. Smith Foundation; TexGen Foundation; Thoracic Surgery Foundation for Research and Education; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to Chad Shaw for valuable discussions. Charles C. Miller provided additional clinical data for UTHSCH patients. The authors are extremely grateful to patients involved in this study. The following sources provided funding for these studies: P50HL083794-01 (D.M.M.), RO1 HL62594 (D.M.M.), the Vivian L. Smith Foundation (D.M.M.), the TexGen Foundation (D.M.M.), K08 HL080085 (S.A.L.), and the Thoracic Surgery Foundation for Research and Education (S.A.L.). D.M.M. is a Doris Duke Distinguished Clinical Scientist.	Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; [Anonymous], ONLINE MENDELIAN INH; Beunders G, 2010, J MED GENET, V47, P271, DOI 10.1136/jmg.2009.070490; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Choudhary B, 2009, GENESIS, V47, P115, DOI 10.1002/dvg.20466; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; DAVIS EC, 1993, LAB INVEST, V68, P89; Dimitrakakis G, 2009, ANN THORAC SURG, V88, P1000, DOI 10.1016/j.athoracsur.2009.02.029; Elefteriades JA, 2002, ANN THORAC SURG, V74, pS1877, DOI 10.1016/S0003-4975(02)04147-4; Elefteriades John A., 2008, Yale Journal of Biology and Medicine, V81, P175; Ergun S, 2001, ANGIOGENESIS, V4, P193, DOI DOI 10.1023/A:1014027218980; Galaxy, GALAXY; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Grainger DJ, 1998, J CELL SCI, V111, P2977; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Huang JB, 2010, CIRC RES, V106, P583, DOI 10.1161/CIRCRESAHA.109.207852; Ihling C, 1999, HEART, V82, P286, DOI 10.1136/hrt.82.3.286; Kappert K, 2010, THROMB HAEMOSTASIS, V103, P556, DOI 10.1160/TH09-07-0478; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Leung-Hagesteijn C, 2001, EMBO J, V20, P2160, DOI 10.1093/emboj/20.9.2160; Li XC, 2009, ARTERIOSCL THROM VAS, V29, P1200, DOI 10.1161/ATVBAHA.109.189217; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 1998, AM J CARDIOL, V82, P474, DOI 10.1016/S0002-9149(98)00364-6; Moser M, 2003, ARTERIOSCL THROM VAS, V23, pA6; Nesi G, 2009, CARDIOVASC PATHOL, V18, P134, DOI 10.1016/j.carpath.2008.04.001; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Patel HJ, 2008, CIRCULATION, V118, P188, DOI 10.1161/CIRCULATIONAHA.107.690933; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Schmidhuber SM, 2007, J INVEST DERMATOL, V127, P716, DOI 10.1038/sj.jid.5700569; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sheen VL, 2005, NEUROLOGY, V64, P254, DOI 10.1212/01.WNL.0000149512.79621.DF; Tran-Fadulu V, 2009, J MED GENET, V46, P607, DOI 10.1136/jmg.2008.062844; Tsai TT, 2006, CIRCULATION, V114, pE362, DOI 10.1161/CIRCULATIONAHA.106.630210; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Unezaki S, 2007, GENES CELLS, V12, P773, DOI 10.1111/j.1365-2443.2007.01084.x; Urban Z, 2009, AM J HUM GENET, V85, P593, DOI 10.1016/j.ajhg.2009.09.013; Vaughan CJ, 2001, CIRCULATION, V103, P2469; Wang CH, 2010, J CELL PHYSIOL, V222, P685, DOI 10.1002/jcp.21990; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, pD156, DOI 10.1093/nar/gkl782; Zhu L, 2007, CARDIOL YOUNG, V17, P666, DOI 10.1017/S1047951107001473; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; PLINK VERSION 1 07; GENEHUB GEPIS GENE I	57	61	65	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					743	756		10.1016/j.ajhg.2010.09.015	http://dx.doi.org/10.1016/j.ajhg.2010.09.015			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21092924	Green Published, Bronze			2022-12-18	WOS:000285564600001
J	Rajadhyaksha, AM; Elemento, O; Puffenberger, EG; Schierberl, KC; Xiang, JZ; Putorti, ML; Berciano, J; Poulin, C; Brais, B; Michaelides, M; Weleber, RG; Higgins, JJ				Rajadhyaksha, Anjali M.; Elemento, Olivier; Puffenberger, Erik G.; Schierberl, Kathryn C.; Xiang, Jenny Z.; Putorti, Maria L.; Berciano, Jose; Poulin, Chantal; Brais, Bernard; Michaelides, Michel; Weleber, Richard G.; Higgins, Joseph J.			Mutations in FLVCR1 Cause Posterior Column Ataxia and Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPRESSION; NEUROGLOBIN; ERYTHROPOIESIS; DISORDER; CEREBLON; BRAIN; GENE; MAPS	The study of inherited retinal diseases has advanced our knowledge of the cellular and molecular mechanisms involved in sensory neural signaling Dysfunction of two specific sensory modalities, vision and proprioception, characterizes the phenotype of the rare, auto somal recessive disorder posterior column ataxia and retinitis pigmentosa (PCARP) Using targeted DNA capture and high throughput sequencing, we analyzed the entire 4 2 Mb candidate sequence on chromosome 1q32 to find the gene mutated in PCARP in a single family Employing comprehensive bioinformatic analysis and filtering, we identified a single nucleotide coding variant in the feline leukemia virus subgroup C cellular receptor 1 (FLVCR1), a gene encoding a heme transporter protein Sanger sequencing confirmed the FLVCR1 mutation in this family and identified different homozygous missense mutations located within the protein's transmembrane channel segment in two other unrelated families with PCARP To determine whether the selective pathologic features of PCARP correlated with FLVCR1 expression, we examined wild type mouse Flvcr1 mRNA levels in the posterior column of the spinal cord and the retina via quantitative real time reverse transcriptase PCR The Flvcr1 mRNA levels were most abundant in the retina, followed by the posterior column of the spinal cord and other brain regions These results suggest that aberrant FLVCR1 causes a selective degeneration of a subpopulation of neurons in the retina and the posterior columns of the spinal cord via dysregulation of heme or Iron homeostasis This finding broadens the molecular basis of sensory neural signaling to include common mechanisms that involve proprioception and vision	[Rajadhyaksha, Anjali M.; Schierberl, Kathryn C.; Higgins, Joseph J.] New York Presbyterian Hosp, Dept Pediat, Div Pediat Neurol, Lab Mol & Dev Neurobiol,Weill Cornell Med Coll, New York, NY 10065 USA; [Rajadhyaksha, Anjali M.; Schierberl, Kathryn C.] Weill Cornell Med Coll, Grad Program Neurosci, Weill Cornell Grad Sch Biomed Sci, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, Inst Computat Biomed, New York, NY 10065 USA; [Xiang, Jenny Z.] Weill Cornell Med Coll, Dept Microbiol & Immunol, Genom Resources Core Facil, New York, NY 10065 USA; [Puffenberger, Erik G.] Clin Special Children, Strasburg, PA 17579 USA; [Putorti, Maria L.; Brais, Bernard] Univ Montreal, Lab Neurogenet Motricite, Ctr Rech, Ctr Hosp, Montreal, PQ H2L 4M1, Canada; [Berciano, Jose] Univ Cantabria, Dept Neurol, Univ Hosp Marques de Valdecilla, Santander 39008, Spain; [Berciano, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Santander 39008, Spain; [Poulin, Chantal] McGill Univ, Montreal Childrens Hosp, Div Pediat Neurol, Dept Neurol, Montreal, PQ H3H 1P3, Canada; [Poulin, Chantal] McGill Univ, Montreal Childrens Hosp, Div Pediat Neurol, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada; [Poulin, Chantal] McGill Univ, Montreal Childrens Hosp, Div Pediat Neurol, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Michaelides, Michel; Weleber, Richard G.] Oregon Hlth & Sci Univ, Oregon Retinal Degenerat Ctr, Casey Eye Inst, Portland, OR 97239 USA; [Michaelides, Michel] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Michaelides, Michel] Moorfields Eye Hosp, London EC1V 2PD, England	Cornell University; NewYork-Presbyterian Hospital; Cornell University; Cornell University; Cornell University; Universite de Montreal; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; McGill University; McGill University; McGill University; Oregon Health & Science University; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Higgins, JJ (corresponding author), New York Presbyterian Hosp, Dept Pediat, Div Pediat Neurol, Lab Mol & Dev Neurobiol,Weill Cornell Med Coll, New York, NY 10065 USA.		Brais, Bernard/Y-3910-2019	Puffenberger, Erik/0000-0002-6388-9148	National Institute of Neurological Disorders and Stroke (NINDS); US National Institutes of Health; New York State Department of Health; Hartwell Foundation; Association de la Neuropa thir Sensorielle et Autonomique Hereditaire de; Research to Prevent Blindness (New York, NY, USA); Moorfields Special Trustees; National Institute for Health Research UK	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Hartwell Foundation; Association de la Neuropa thir Sensorielle et Autonomique Hereditaire de; Research to Prevent Blindness (New York, NY, USA)(Research to Prevent Blindness (RPB)); Moorfields Special Trustees; National Institute for Health Research UK(National Institute for Health Research (NIHR))	We thank the families for their participation in this study I his research was supported by intramural funding from the National Institute of Neurological Disorders and Stroke (NINDS), of the 3 US National Institutes of Health, and the New York State Department of Health (to J J H) and by funds from The Hartwell Foundation (to A M R and J J H) The Association de la Neuropa thir Sensorielle et Autonomique Hereditaire de Type 2 supported 4 the recruitment and genetic mapping of the French Canadian family by C P and B B The Foundation Fighting Blindness (Columbia, MD, USA) and an unrestricted grant from Research to Prevent Blindness (New York, NY, USA) supported R G W in the evaluation of the Western European families M M was supported by grants from Moorfields Special Trustees and the National Institute for Health Research UK to the Biomedical Research Centre for Ophthalmology, based at Moorfields Eye Hospital NHS Foundation Trust and the University College London Institute of Ophthalmology, UK We thank B E Kosofsky Chief Division of Pediatric Neurology, Department of Pediatrics, Weill Cornell Medical College, New York New York USA, for securing funding for resequencing, D H Morton and the staff at the Clinic for Special Children in Strasburg PA USA for financially supporting the sequencing of candidate genes in the American family, S Ra and A L Tal from the Laboratory of Molecular and Developmental Neurobiology, Weill Cornell Medical College New York NY USA for their technical assistance, and N B Stover from the Oregon Retinal Degeneration Center, Casey Eye Institute, Portland OR, USA, S J Hayflick and P Hogarth from the Departments of Neurology and Medical & Molecular Genetics, and S K Westaway from the Departments of Neurology and Cardiology, Oregon Health & Science University, Portland, OR USA for characterizing the two Western European families with a PCARP like phenotype	Berciano J, 1998, NEUROLOGY, V51, P1772, DOI 10.1212/WNL.51.6.1772-a; BIEMOND A, 1951, Folia Psychiatr Neurol Neurochir Neerl, V54, P216; Brown JK, 2006, J VIROL, V80, P1742, DOI 10.1128/JVI.80.4.1742-1751.2006; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; GHEZ C, 1991, PRINCIPLES NEURAL SC, P530; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Higgins JJ, 1997, NEUROLOGY, V49, P1717, DOI 10.1212/WNL.49.6.1717; Higgins JJ, 1999, NEUROLOGY, V52, P146, DOI 10.1212/WNL.52.1.146; Higgins JJ, 2000, MOVEMENT DISORD, V15, P575, DOI 10.1002/1531-8257(200005)15:3<575::AID-MDS1023>3.0.CO;2-7; Higgins JJ, 2008, NEUROGENETICS, V9, P219, DOI 10.1007/s10048-008-0128-2; Higgins JJ, 2010, J NEUROGENET, V24, P18, DOI 10.3109/01677060903567849; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Laufs TL, 2004, NEUROSCI LETT, V362, P83, DOI 10.1016/j.neulet.2004.02.072; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meyer E, 2010, AM J HUM GENET, V86, P471, DOI 10.1016/j.ajhg.2010.02.004; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Rey MA, 2008, HAEMATOL-HEMATOL J, V93, P1617, DOI 10.3324/haematol.13359; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; SINGH N, 1973, EUR NEUROL, V10, P160, DOI 10.1159/000114272; TUCK RR, 1983, J NEUROL NEUROSUR PS, V46, P206, DOI 10.1136/jnnp.46.3.206; Valdmanis PN, 2004, J MED GENET, V41, P634, DOI 10.1136/jmg.2004.019711; vanSoest S, 1996, CYTOGENET CELL GENET, V73, P81, DOI 10.1159/000134313; Ye WZ, 2004, BIOCHEM BIOPH RES CO, V319, P1065, DOI 10.1016/j.bbrc.2004.05.089	29	61	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					643	654		10.1016/j.ajhg.2010.10.013	http://dx.doi.org/10.1016/j.ajhg.2010.10.013			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21070897	Bronze, Green Published			2022-12-18	WOS:000284668400009
J	Liu, XZ; Han, DY; Li, JZ; Han, B; Ouyang, XM; Cheng, J; Li, X; Jin, ZG; Wang, YQ; Bitner-Glindzicz, M; Kong, XY; Xu, H; Kantardzhieva, A; Eavey, RD; Seidman, CE; Seidman, JG; Du, LL; Chen, ZY; Dai, P; Teng, MK; Yan, D; Yuan, HJ				Liu, Xuezhong; Han, Dongyi; Li, Jianzhong; Han, Bing; Ouyang, Xiaomei; Cheng, Jing; Li, Xu; Jin, Zhanguo; Wang, Youqin; Bitner-Glindzicz, Maria; Kong, Xiangyin; Xu, Heng; Kantardzhieva, Albena; Eavey, Roland D.; Seidman, Christine E.; Seidman, Jonathan G.; Du, Li L.; Chen, Zheng-Yi; Dai, Pu; Teng, Maikun; Yan, Denise; Yuan, Huijun			Loss-of-Function Mutations in the PRPS1 Gene Cause a Type of Nonsyndromic X-linked Sensorineural Deafness, DFN2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY; PURINE METABOLISM; HEARING-LOSS; OVERPRODUCTION; ASSOCIATION	We report a large Chinese family with X-linked postlingual nonsyndromic hearing impairment in which the critical linkage interval spans a genetic distance of 5.41 cM and a physical distance of 15.1 Mb that overlaps the DFN2 locus. Mutation screening of the PRPS1 gene in this family and in the three previously reported DFN2 families identified four different missense mutations in PRPS1. These Mutations result in a loss of phosphoribosyl pyrophosphate (PRPP) synthetase I activity, as was shown in silico by structural analysis and was shown in vitro by enzymatic activity assays in erythrocytes and fibroblasts from patients. By ill Situ hybridization, we demonstrate expression of Prps1 in murine vestibular and cochlea hair cells, with Continuous expression in hair cells and postnatal expression in the spiral ganglion. Being the second identified gene associated with X-linked nonsyndromic deafness, PRPS1 will be a good candidate gene for genetic testing for X-linked nonsyndromic hearing loss.	[Liu, Xuezhong; Han, Dongyi; Li, Jianzhong; Han, Bing; Cheng, Jing; Jin, Zhanguo; Dai, Pu; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing 100853, Peoples R China; [Liu, Xuezhong; Ouyang, Xiaomei; Du, Li L.; Yan, Denise] Univ Miami, Dept Otolaryngol, Miami, FL 33136 USA; [Li, Xu; Teng, Maikun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Li, Xu; Teng, Maikun] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Li, Xu; Teng, Maikun] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Peoples R China; [Wang, Youqin] Guizhou Prov Peoples Hosp, Hearing Ctr, Guiyang 550002, Peoples R China; [Bitner-Glindzicz, Maria] UCL Inst Child Hlth, London WC1N 1EH, England; [Kong, Xiangyin; Xu, Heng] Chinese Acad Sci, Shanghai Inst Biol Sci, Hlth Sci Ctr, Shanghai 200025, Peoples R China; [Kong, Xiangyin; Xu, Heng] Shanghai Med Univ 2, Shanghai 200025, Peoples R China; [Kantardzhieva, Albena; Eavey, Roland D.; Chen, Zheng-Yi] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otolaryngol,Easton Peabody Lab, Boston, MA 02114 USA; [Seidman, Christine E.; Seidman, Jonathan G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Seidman, Christine E.; Seidman, Jonathan G.] Howard Hughes Med Inst, Boston, MA 02115 USA	Chinese People's Liberation Army General Hospital; University of Miami; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of London; University College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Yuan, HJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing 100853, Peoples R China.	yuanhj301@yahoo.com.cn	Bitner-Glindzicz, Maria/A-4231-2009; Xu, Heng/AAS-3465-2021	Xu, Heng/0000-0002-7748-2621; Li, Xu/0000-0001-5221-0817	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575, R01DC006908] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01DC005575, R01 DC005575, R01 DC012115, R01 DC006908] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BECKER MA, 1995, J CLIN INVEST, V96, P2133, DOI 10.1172/JCI118267; BECKER MA, 1988, AM J MED, V85, P383, DOI 10.1016/0002-9343(88)90591-8; Cohen M. M., 1995, HEREDITARY HEARING L, P9; Cui B, 2004, J GENET, V83, P35, DOI 10.1007/BF02715827; de Brouwer APM, 2007, AM J HUM GENET, V81, P507, DOI 10.1086/520706; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Manolis EN, 1999, AM J OTOL, V20, P621; REARDON W, 1990, J MED GENET, V27, P376, DOI 10.1136/jmg.27.6.376; ROESSLER BJ, 1993, J BIOL CHEM, V268, P26476; ROESSLER BJ, 1990, NUCLEIC ACIDS RES, V18, P193, DOI 10.1093/nar/18.1.193; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; SIMMONDS HA, 1985, NEUROPEDIATRICS, V16, P106, DOI 10.1055/s-2008-1052552; Skvorak AB, 1999, HUM MOL GENET, V8, P439, DOI 10.1093/hmg/8.3.439; Torres RJ, 1996, CLIN CHIM ACTA, V245, P105, DOI 10.1016/0009-8981(95)06178-9; Tyson J, 1996, HUM MOL GENET, V5, P2055, DOI 10.1093/hmg/5.12.2055; ZOREF E, 1975, J CLIN INVEST, V56, P1093, DOI 10.1172/JCI108183	19	61	79	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					65	71		10.1016/j.ajhg.2009.11.015	http://dx.doi.org/10.1016/j.ajhg.2009.11.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20021999	Green Published, Bronze			2022-12-18	WOS:000274471200006
J	Noor, A; Windpassinger, C; Vitcu, I; Orlic, M; Rafiq, MA; Khalid, M; Malik, MN; Ayub, M; Alman, B; Vincent, JB				Noor, Abdul; Windpassinger, Christian; Vitcu, Irina; Orlic, Marija; Rafiq, Muhammad Arshad; Khalid, Mahwish; Malik, Mahmood Nasir; Ayub, Muhammad; Alman, Benjamin; Vincent, John B.			Oligodontia Is Caused by Mutation in LTBP3, the Gene Encoding Latent TGF-beta Binding Protein 3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEIGHT; GROWTH; LOCI	We have identified a consanguineous Pakistani family where oligodontia is inherited along with short stature in all autosomal-recessive fashion. Increased bone density was present in the spine and at the base of the skull. Using high-density single-nucleotide polymorphism microarrays for homozygosity mapping, we identified a 28 Mb homozygous stretch shared between affected individuals on chromosome 11q13. Screening selected candidate genes within this region, we identified a homozygous nonsense mutation, Y774X, within LTBP3, the gene for the latent TGF-beta binding protein 3, an extracellular matrix protein believed to be required for osteoclast function.	[Noor, Abdul; Windpassinger, Christian; Vitcu, Irina; Orlic, Marija; Vincent, John B.] Ctr Addict & Mental Hlth, Neurogenet Sect, Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada; [Windpassinger, Christian] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Alman, Benjamin] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Rafiq, Muhammad Arshad] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Khalid, Mahwish; Ayub, Muhammad] Lahore Inst Res & Dev, Lahore 54000, Pakistan; [Malik, Mahmood Nasir] Jinnah Hosp, Lahore 54590, Pakistan; [Malik, Mahmood Nasir] Allama Iqbal Med Coll, Lahore 54590, Pakistan; [Ayub, Muhammad] St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Medical University of Graz; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Neurogenet Sect, Neuropsychiat & Dev Lab, Toronto, ON M5T 1R8, Canada.	john_vincent@camh.net	Noor, Abdul/J-2345-2016	Orlic-Milacic, Marija/0000-0002-3218-5631	Canadian Institutes of Health Research (CIHR) Collaborative Graduate Training Program; Centre for Addiction and Mental Health Postdoctoral Fellowship; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award	Canadian Institutes of Health Research (CIHR) Collaborative Graduate Training Program(Canadian Institutes of Health Research (CIHR)); Centre for Addiction and Mental Health Postdoctoral Fellowship; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award(NARSAD)	We wish to indicate Our deep gratitude to the Pakistani family members for their participation. In addition, we wish to acknowledge the assistance of Dr. Abbas Cheema and Mr. H.M. Ashfaq Bhatti. A.N. is supported by a Canadian Institutes of Health Research (CIHR) Collaborative Graduate Training Program in Molecular Medicine. C.W. is supported by a Centre for Addiction and Mental Health Postdoctoral Fellowship. J.B.V. is supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Award.	Ahmad W, 1998, AM J HUM GENET, V62, P987, DOI 10.1086/301799; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Khan A, 2008, INT J CARDIOL, V124, P259, DOI 10.1016/j.ijcard.2006.12.040; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lui W, 2001, J DENT RES, V80, P1716, DOI 10.1177/00220345010800080701; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Sammalisto S, 2009, EUR J HUM GENET, V17, P258, DOI 10.1038/ejhg.2008.152; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vignon E, 1999, OSTEOARTHR CARTILAGE, V7, P434, DOI 10.1053/joca.1999.0235; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; WOOLF CM, 1971, AM J HUM GENET, V23, P289; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147	19	61	63	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					519	523		10.1016/j.ajhg.2009.03.007	http://dx.doi.org/10.1016/j.ajhg.2009.03.007			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19344874	Green Published, Bronze			2022-12-18	WOS:000265232800012
J	Rommelse, NNJ; Arias-Vasquez, A; Altink, ME; Buschgens, CJM; Fliers, E; Asherson, P; Faraone, SV; Buitelaar, JK; Sergeant, JA; Osterlaan, J; Franke, B				Rommelse, Nanda N. J.; Arias-Vasquez, Alejandro; Altink, Marieke E.; Buschgens, Cathelijne J. M.; Fliers, Ellen; Asherson, Philip; Faraone, Stephen V.; Buitelaar, Jan K.; Sergeant, Joseph A.; Osterlaan, Jaap; Franke, Barbara			Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; AUTISM; ASSOCIATION; DYSLEXIA; ADOLESCENTS; SIBLINGS; DEFICITS; ADULTS; SCAN	ADHD linkage findings have not all been consistently replicated, suggesting that other approaches to linkage analysis in ADHD might be necessary, such as the use of (quantitative) endophenotypes (heritable traits associated with an increased risk for ADHD). Genome-wide linkage analyses were performed in the Dutch subsample of the International Multi-Center ADHD Genetics (IMAGE) study comprising 238 DSM-IV combined-type ADHD probands and their 112 affected and 195 nonaffected siblings. Eight candidate neuropsychological ADHD endophenotypes with heritabilities > 0.2 were used as quantitative traits. In addition, an overall component score of neuropsychological functioning was used. A total of 5407 autosomal single-nucleotide polymorphisms (SNPs) were used to run multipoint regression-based linkage analyses. Two significant genome-wide linkage signals were found, one for Motor Timing on chromosome 2q21.1 (LOD score: 3.944) and one for Digit Span on 13q12.11 (LOD score: 3.959). Ten suggestive linkage signals were found (LOD scores > 2) on chromosomes 2p, 2q, 3p, 4q, 8q, 12p, 12q, 14q, and 17q. The suggestive linkage signal for the component score that was found at 2q14.3 (LOD score: 2.878) overlapped with the region significantly linked to Motor Timing. Endophenotype approaches may increase power to detect susceptibility loci in ADHD and possibly in other complex disorders.	[Rommelse, Nanda N. J.; Arias-Vasquez, Alejandro; Altink, Marieke E.; Buschgens, Cathelijne J. M.; Fliers, Ellen; Buitelaar, Jan K.; Franke, Barbara] Radboud Univ Nijmegen, Dept Psychiat, Donders Ctr Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Rommelse, Nanda N. J.; Sergeant, Joseph A.; Osterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Asherson, Philip] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, London SE5 A87, England; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat & Neurosci, Syracuse, NY USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Physiol, Syracuse, NY USA	Radboud University Nijmegen; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Franke, B (corresponding author), Radboud Univ Nijmegen, Dept Psychiat, Donders Ctr Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	b.franke@antrg.umcn.nl	Buitelaar, Jan K/E-4584-2012; Faraone, Stephen/AAE-7334-2019; Vasquez, A. Arias/L-4175-2015; Faraone, Stephen V/O-7239-2018; Buitelaar, J.K./AAY-7522-2020; Franke, Barbara/D-4836-2009; Vasquez, Alejandro Arias/E-4762-2012; Rommelse, Nanda NJ/D-4872-2009	Buitelaar, Jan K/0000-0001-8288-7757; Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982; Franke, Barbara/0000-0003-4375-6572; Vasquez, Alejandro Arias/0000-0002-4786-0169; Rommelse, Nanda NJ/0000-0002-1711-0359; Asherson, Philip/0000-0003-2667-2254	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062873] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH062873, R01 MH62873-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ASHERSON P, 2008, MOL PSYCHIAT; Banaschewski T, 2005, DEVELOPMENTAL SCI, V8, P132, DOI 10.1111/j.1467-7687.2005.00400.x; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Faraone S V, 2000, Curr Psychiatry Rep, V2, P143, DOI 10.1007/s11920-000-0059-6; FARAONE SV, 2007, AM J MED GENET B; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hebebrand J, 2006, MOL PSYCHIATR, V11, P196, DOI 10.1038/sj.mp.4001761; Jain M, 2007, BIOL PSYCHIAT, V61, P1329, DOI 10.1016/j.biopsych.2006.06.026; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khodiyar VK, 2007, GENOMICS, V90, P285, DOI 10.1016/j.ygeno.2007.04.008; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Loveland KA, 2008, NEUROPSYCHOLOGIA, V46, P49, DOI 10.1016/j.neuropsychologia.2007.08.017; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Oosterlaan J, 2005, J ABNORM CHILD PSYCH, V33, P69, DOI 10.1007/s10802-005-0935-y; ROMANOS M, 2008, MOL PSYCHIAT; Rommelse NNJ, 2007, J CHILD PSYCHOL PSYC, V48, P1071, DOI 10.1111/j.1469-7610.2007.01781.x; Rommelse NNJ, 2007, J ABNORM CHILD PSYCH, V35, P957, DOI 10.1007/s10802-007-9146-z; Rommelse NNJ, 2007, J AM ACAD CHILD PSY, V46, P582, DOI 10.1097/chi.0b013e3180335af7; ROMMELSE NN, 2008, PSYCHOL MED; ROMMELSE NN, 2007, BEHAV GENET; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Sinzig Judith, 2008, Child Adolesc Psychiatry Ment Health, V2, P4, DOI 10.1186/1753-2000-2-4; Smith-Spark JH, 2007, MEMORY, V15, P34, DOI 10.1080/09658210601043384; Vasic N, 2008, NEUROPSYCHOLOGIA, V46, P640, DOI 10.1016/j.neuropsychologia.2007.09.002; Waber DP, 2000, DEV NEUROPSYCHOL, V17, P181, DOI 10.1207/S15326942DN1702_03; Williams DL, 2006, NEUROPSYCHOLOGY, V20, P21, DOI 10.1037/0894-4105.20.1.21; Yang MS, 2007, INT J DEV NEUROSCI, V25, P69, DOI 10.1016/j.ijdevneu.2006.12.002; ZHOU K, 2008, BIOL PSYCHIAT	35	61	61	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					99	105		10.1016/j.ajhg.2008.06.006	http://dx.doi.org/10.1016/j.ajhg.2008.06.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18599010	Green Published, Bronze			2022-12-18	WOS:000257784000012
J	Hermanns, P; Unger, S; Rossi, A; Perez-Aytes, A; Cortina, H; Bonafe, L; Boccone, L; Setzu, V; Dutoit, M; Sangiorgi, L; Pecora, F; Reicherter, K; Nishimura, G; Spranger, J; Zabel, B; Superti-Furga, A				Hermanns, Pia; Unger, Sheila; Rossi, Antonio; Perez-Aytes, Antonio; Cortina, Hector; Bonafe, Luisa; Boccone, Loredana; Setzu, Valeria; Dutoit, Michel; Sangiorgi, Luca; Pecora, Fabio; Reicherter, Kerstin; Nishimura, Gen; Spranger, Juergen; Zabel, Bernhard; Superti-Furga, Andrea			Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSPLASIA; GENE; INVOLVEMENT; MUTATIONS; CHONDRODYSPLASIA; CARTILAGE; DISEASE; SLC26A2; MOUSE	Deficiency of carbohydrate sulfotransferase 3 (CHST3; also known as chondroitin-6-sulfotransferase) has been reported in a single kindred so far and in association with a phenotype of severe chondrodysplasia with progressive spinal involvement. We report eight CHST3 mutations in six unrelated individuals who presented at birth with congenital joint dislocations. These patients had been given a diagnosis of either Larsen syndrome (three individuals) or humero-spinal dysostosis (three individuals), and their clinical features included congenital dislocation of the knees, elbow joint dysplasia with subluxation and limited extension, hip dysplasia or dislocation, clubfoot, short stature, and kyphoscoliosis developing in late childhood. Analysis of chondroitin sulfate proteoglycans in dermal fibroblasts showed markedly decreased 6-O-sulfation but enhanced 4-O-sulfation, confirming functional impairment of CHST3 and distinguishing them from diastrophic dysplasia sulphate transporter (DTDST) -deficient cells. These observations provide a molecular basis for recessive Larsen syndrome and indicate that recessive Larsen syndrome, humero-spinal dysostosis, and spondyloepiphyseal dysplasia Omani type form a phenotypic spectrum.	[Hermanns, Pia; Unger, Sheila; Reicherter, Kerstin; Spranger, Juergen; Zabel, Bernhard; Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Unger, Sheila; Zabel, Bernhard] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Rossi, Antonio; Pecora, Fabio] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Perez-Aytes, Antonio; Cortina, Hector] Hosp Infantil La Fe, Valencia 46000, Spain; [Bonafe, Luisa; Dutoit, Michel] Univ Lausanne, CHUV, Div Mol Pediat, CH-1011 Lausanne, Switzerland; [Boccone, Loredana; Setzu, Valeria] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, UO Genet Clin & Malattie Rare, I-09100 Cagliari, Italy; [Sangiorgi, Luca] Ist Ortoped Rizzoli, Med Genet Unit, I-40136 Bologna, Italy; [Nishimura, Gen] Tokyo Metropolitan Kiyose Children Hosp, Dept Radiol, Tokyo 2048567, Japan	University of Freiburg; University of Freiburg; University of Pavia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Cagliari; IRCCS Istituto Ortopedico Rizzoli	Superti-Furga, A (corresponding author), Univ Freiburg, Ctr Pediat & Adolescent Med, Hugstetter Str 55, D-79106 Freiburg, Germany.	asuperti@uniklinik-freiburg.de	Hermanns, Pia/HHN-5709-2022; Rossi, Antonio/E-9935-2012; superti-furga, andrea/E-9162-2015; Sangiorgi, Luca/AHI-1694-2022; unger, sheila/E-9177-2015	superti-furga, andrea/0000-0002-3543-7531; Boccone, Loredana/0000-0002-0168-0322; Unger, Sheila/0000-0002-9539-8941; Perez-Aytes, Antonio/0000-0003-3401-6943; Sangiorgi, Luca/0000-0003-3658-1209	Telethon [GGP06076] Funding Source: Medline	Telethon(Fondazione Telethon)		Bicknell LS, 2007, J MED GENET, V44, P89, DOI 10.1136/jmg.2006.043687; BONAVENTURE J, 1992, J MED GENET, V29, P465; CORTINA H, 1979, PEDIATR RADIOL, V8, P188, DOI 10.1007/BF00973833; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Hall BD, 1997, J PEDIATR ORTHOP B, V6, P11, DOI 10.1097/01202412-199701000-00003; Joseph B, 2003, PEDIATR RADIOL, V33, P7, DOI 10.1007/s00247-002-0660-4; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; KOZLOWSKI KS, 1974, AM J DIS CHILD, V127, P407, DOI 10.1001/archpedi.1974.02110220105015; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; LARSEN LJ, 1950, J PEDIATR-US, V37, P574, DOI 10.1016/S0022-3476(50)80268-8; LATTA RJ, 1971, J PEDIATR-US, V78, P291, DOI 10.1016/S0022-3476(71)80014-8; LAVILLE JM, 1994, J PEDIATR ORTHOPED, V14, P63, DOI 10.1097/01241398-199401000-00014; Rajab A, 2004, AM J MED GENET A, V126A, P413, DOI 10.1002/ajmg.a.20606; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Rossi A, 1998, MATRIX BIOL, V17, P361, DOI 10.1016/S0945-053X(98)90088-9; SOBUE M, 1987, BIOCHEM J, V241, P591, DOI 10.1042/bj2410591; SPARKS MJW, 1994, CLIN RADIOL, V49, P829, DOI 10.1016/S0009-9260(05)81977-4; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; WALLIS GA, 1995, CURR BIOL, V5, P225, DOI 10.1016/S0960-9822(95)00044-3; Weisenbach J, 1996, PEDIATR RADIOL, V26, P682, DOI 10.1007/BF01356836	23	61	64	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1368	1374		10.1016/j.ajhg.2008.05.006	http://dx.doi.org/10.1016/j.ajhg.2008.05.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513679	Bronze, Green Published			2022-12-18	WOS:000256647000015
J	Vogt, J; Harrison, BJ; Spearman, H; Cossins, J; Vermeer, S; ten Cate, LN; Morgan, NV; Beeson, D; Maher, ER				Vogt, Julie; Harrison, Benjamin J.; Spearman, Hayley; Cossins, Judy; Vermeer, Sascha; ten Cate, Lambert Naudin; Morgan, Neil V.; Beeson, David; Maher, Eamonn R.			Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MYASTHENIC SYNDROME; ACETYLCHOLINE-RECEPTOR DEFICIENCY; NEUROMUSCULAR-JUNCTION; MUSCLE; FETAL; SUBUNIT; LETHAL; PHENOTYPES; UNDERLIE; DEVELOP	Multiple pterygium syndromes (MPS) comprise a group of multiple congenital anomaly disorders characterized by webbing (pterygia) of the neck, elbows, and/or knees and joint contractures (arthrogryposis). MPS are phenotypically and genetically heterogeneous but are traditionally divided into prenatally lethal and nonlethal (Escobar) types. Previously, we and others reported that recessive mutations in the embryonal acetylcholine receptor g subunit (CHRNG) can cause both lethal and nonlethal MPS, thus demonstrating that pterygia resulted from fetal akinesia. We hypothesized that mutations in acetylcholine receptor-related genes might also result in a MPS/fetal akinesia phenotype and so we analyzed 15 cases of lethal MPS/fetal akinesia without CHRNG mutations for mutations in the CHRNA1, CHRNB1, CHRND, and rapsyn (RAIISN) genes. No CHRNA1, CHRNB1, or CHRND mutations were detected, but a homozygous RAPSN frameshift mutation, c.1177-1178delAA, was identified in a family with three children affected with lethal fetal akinesia sequence. Previously, RAPSN mutations have been reported in congenital myasthenia. Functional studies were consistent with the hypothesis that whereas incomplete loss of rapsyn function may cause congenital myasthenia, more severe loss of function can result in a lethal fetal akinesia phenotype.	[Vogt, Julie; Harrison, Benjamin J.; Morgan, Neil V.; Maher, Eamonn R.] Univ Birmingham, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; [Vogt, Julie; Harrison, Benjamin J.; Morgan, Neil V.; Maher, Eamonn R.] Univ Birmingham, WellChild Paediat Res Ctr, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England; [Vogt, Julie; Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Clin Genet Serv, Birmingham B15 2TG, W Midlands, England; [Spearman, Hayley; Cossins, Judy; Beeson, David] John Radcliffe Hosp, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England; [Vermeer, Sascha] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 849, NL-6500 HB Nijmegen, Netherlands; [ten Cate, Lambert Naudin] Lab Pathol Oost Nederland, NL-7512 AD Enschede, Netherlands	University of Birmingham; University of Birmingham; Birmingham Women's Hospital; University of Oxford; Radboud University Nijmegen	Maher, ER (corresponding author), Univ Birmingham, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	e.r.maher@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Vermeer, Sascha/0000-0001-7625-1912	MRC [G117/490] Funding Source: UKRI; Medical Research Council [G117/490] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Banwell BL, 2004, NEUROMUSCULAR DISORD, V14, P202, DOI 10.1016/j.nmd.2003.11.004; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brownlow S, 2001, J CLIN INVEST, V108, P125, DOI 10.1172/JCI12935; Burke G, 2004, NEUROMUSCULAR DISORD, V14, P356, DOI 10.1016/j.nmd.2004.03.005; Burke G, 2003, NEUROLOGY, V61, P826, DOI 10.1212/01.WNL.0000085865.55513.AE; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Cossins J, 2006, BRAIN, V129, P2773, DOI 10.1093/brain/awl219; Cox PM, 2003, PEDIATR DEVEL PATHOL, V6, P59, DOI 10.1007/s10024-002-0042-9; Dunne V, 2003, J HUM GENET, V48, P204, DOI 10.1007/s10038-003-0005-7; Engel AG, 2003, ANN NY ACAD SCI, V998, P138, DOI 10.1196/annals.1254.016; Froster UG, 1997, AM J MED GENET, V68, P82, DOI 10.1002/(SICI)1096-8628(19970110)68:1<82::AID-AJMG16>3.0.CO;2-K; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; HALL JG, 1984, AM J MED GENET, V17, P803, DOI 10.1002/ajmg.1320170410; HALL JG, 1982, AM J MED GENET, V12, P377, DOI 10.1002/ajmg.1320120404; HESSELMANS LFGM, 1993, ANAT REC, V236, P553, DOI 10.1002/ar.1092360315; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Jacobson L, 1999, J NEUROIMMUNOL, V98, P112, DOI 10.1016/S0165-5728(99)00086-7; Jurkat-Rott K, 2005, J CLIN INVEST, V115, P2000, DOI 10.1172/JCI25525; KUES WA, 1995, EUR J NEUROSCI, V7, P1376, DOI 10.1111/j.1460-9568.1995.tb01129.x; Maselli RA, 2003, MUSCLE NERVE, V28, P293, DOI 10.1002/mus.10433; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Muller JS, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.021139; Muller JS, 2003, NEUROLOGY, V60, P1805, DOI 10.1212/01.WNL.0000072262.14931.80; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Takahashi M, 2002, EMBO REP, V3, P674, DOI 10.1093/embo-reports/kvf128	28	61	65	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					222	227		10.1016/j.ajhg.2007.09.016	http://dx.doi.org/10.1016/j.ajhg.2007.09.016			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179903	Green Published, Bronze			2022-12-18	WOS:000253223800025
J	Zheng, G; Freidlin, B; Gastwirth, JL				Zheng, G; Freidlin, B; Gastwirth, JL			Robust genomic control for association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX HUMAN-DISEASES; POPULATION STRATIFICATION; CONTINGENCY-TABLES; GENETIC-MARKERS; SAMPLE-SIZE; TREND TESTS; CHOICE; FUTURE; SCORES; POWER	Population-based case-control studies are a useful method to test for a genetic association between a trait and a marker. However, the analysis of the resulting data can be affected by population stratification or cryptic relatedness, which may inflate the variance of the usual statistics, resulting in a higher-than-nominal rate of false-positive results. One approach to preserving the nominal type I error is to apply genomic control, which adjusts the variance of the Cochran-Armitage trend test by calculating the statistic on data from null loci. This enables one to estimate any additional variance in the null distribution of statistics. When the underlying genetic model ( e. g., recessive, additive, or dominant) is known, genomic control can be applied to the corresponding optimal trend tests. In practice, however, the mode of inheritance is unknown. The genotype-based x 2 test for a general association between the trait and the marker does not depend on the underlying genetic model. Since this general association test has 2 degrees of freedom ( df), the existing formulas for estimating the variance factor by use of genomic control are not directly applicable. By expressing the general association test in terms of two Cochran-Armitage trend tests, one can apply genomic control to each of the two trend tests separately, thereby adjusting the x 2 statistic. The properties of this robust genomic control test with 2 df are examined by simulation. This genomic control-adjusted 2-df test has control of type I error and achieves reasonable power, relative to the optimal tests for each model.	NHLBI, Off Biostat Res, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; NCI, Biometr Res Branch, Div Canc Treatment & Diagnosis, Bethesda, MD 20892 USA; George Washington Univ, Dept Stat, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Zheng, G (corresponding author), NHLBI, Off Biostat Res, Div Epidemiol & Clin Applicat, 6701 Rockledge Dr, Bethesda, MD 20892 USA.	zhengg@nhlbi.nih.gov						Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; GASTWIRTH JL, 1966, J AM STAT ASSOC, V61, P929, DOI 10.2307/2283190; GASTWIRTH JL, 1985, J AM STAT ASSOC, V80, P380, DOI 10.2307/2287901; Gibson G., 2004, PRIMER GENOME SCI; GRAUBARD BI, 1987, BIOMETRICS, V43, P471, DOI 10.2307/2531828; Khoury MJ, 1998, EPIDEMIOLOGY, V9, P350, DOI 10.1097/00001648-199805000-00023; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Sham P., 1998, STAT HUMAN GENETICS; Weir B., 1996, GENETIC DATA ANAL; Zheng G, 2005, BIOMETRICS, V61, P186, DOI 10.1111/j.0006-341X.2005.t01-1-.x; Zheng G, 2003, BIOMETRICAL J, V45, P335, DOI 10.1002/bimj.200390016; ZHENG G, 2006, IN PRESS LECT NOTES; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	22	61	64	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					350	356		10.1086/500054	http://dx.doi.org/10.1086/500054			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400614	Green Published, Bronze			2022-12-18	WOS:000236744900016
J	Weinberg, CR; Umbach, DM				Weinberg, CR; Umbach, DM			A hybrid design for studying genetic influences on risk of diseases with onset early in life	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASE-PARENT TRIADS; LINKAGE DISEQUILIBRIUM; POPULATION STRATIFICATION; RELATIVE RISKS; ASSOCIATION; GENOTYPE; TESTS	Studies of genetic contributions to risk can be family-based, such as the case-parents design, or population-based, such as the case-control design. Both provide powerful inference regarding associations between genetic variants and risks, but both have limitations. The case-control design requires identifying and recruiting appropriate controls, but it has the advantage that nongenctic risk factors like exposures can be assessed. For a condition with an onset early in life, such as a birth defect, one should also genotype the mothers of cases and the mothers of controls to avoid potential confounding due to maternally mediated genetic effects acting on the fetus during gestation. The case-parents approach is less vulnerable than the case-mother/control-mother approach to biases due to population structure and self-selection. The case-parents approach also allows access to epigenetic phenomena like imprinting, but it cannot evaluate the role of nongenetic cofactors like exposures. We propose a hybrid design based on augmenting a set of affected individuals and their parents with a set of unaffected, unrelated individuals and their parents. The affected individuals and their parents are all genotyped, whereas only the parents of unaffected individuals are genotyped, although exposures are ascertained for both affected and unaffected offspring. The proposed hybrid design, through log-linear, likelihood-based analysis, allows estimation of the relative risk parameters, can provide more power than either the case-parents approach or the case-mother/control-mother approach, permits straightforward likelihood-ratio tests for bias due to mating asymmetry or population stratification, and admits valid alternative analyses when mating is asymmetric or when population stratification is detected.	Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Weinberg, CR (corresponding author), Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC 27709 USA.	weinber2@niehs.nih.gov		Weinberg, Clarice/0000-0002-7713-8556	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES040007, Z01ES040007] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Epstein MP, 2005, AM J HUM GENET, V76, P592, DOI 10.1086/429225; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Lee PJ, 2005, ARCH DIS CHILD, V90, P143, DOI 10.1136/adc.2003.037762; Martin ER, 2000, GENET EPIDEMIOL, V18, P48, DOI 10.1002/(SICI)1098-2272(200001)18:1<48::AID-GEPI4>3.0.CO;2-S; MITCHELL L, 2003, NEUR TUB DEF C SEABR; Nagelkerke NJD, 2004, EUR J HUM GENET, V12, P964, DOI 10.1038/sj.ejhg.5201255; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Umbach DH, 2000, AM J HUM GENET, V66, P251, DOI 10.1086/302707; van den Oord EJCG, 2000, AM J HUM GENET, V66, P335, DOI 10.1086/302708; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893	19	61	65	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					627	636		10.1086/496900	http://dx.doi.org/10.1086/496900			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175508	Green Published, Bronze			2022-12-18	WOS:000232106900010
J	Epstein, MP; Veal, CD; Trembath, RC; Barker, JNWN; Li, C; Satten, GA				Epstein, MP; Veal, CD; Trembath, RC; Barker, JNWN; Li, C; Satten, GA			Genetic association analysis using data from triads and unrelated subjects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; DISEASE GENES; DIABETES-MELLITUS; FAMILY DATA; PARENT; LIKELIHOOD; TESTS	The selection of an appropriate control sample for use in association mapping requires serious deliberation. Unrelated controls are generally easy to collect, but the resulting analyses are susceptible to spurious association arising from population stratification. Parental controls are popular, since triads comprising a case and two parents can be used in analyses that are robust to this stratification. However, parental controls are often expensive and difficult to collect. In some situations, studies may have both parental and unrelated controls available for analysis. For example, a candidate-gene study may analyze triads but may have an additional sample of unrelated controls for examination of background linkage disequilibrium in genomic regions. Also, studies may collect a sample of triads to confirm results initially found using a traditional case-control study. Initial association studies also may collect each type of control, to provide insurance against the weaknesses of the other type. In these situations, resulting samples will consist of some triads, some unrelated controls, and, possibly, some unrelated cases. Rather than analyze the triads and unrelated subjects separately, we present a likelihood-based approach for combining their information in a single combined association analysis. Our approach allows for joint analysis of data from both triad and case-control study designs. Simulations indicate that our proposed approach is more powerful than association tests that are based on each separate sample. Our approach also allows for flexible modeling and estimation of allele effects, as well as for missing parental data. We illustrate the usefulness of our approach using SNP data from a candidate- gene study of psoriasis.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Univ Leicester, Div Med Genet, Leicester, Leics, England; Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	Emory University; Centers for Disease Control & Prevention - USA; University of Leicester; University of London; King's College London; Vanderbilt University	Epstein, MP (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St,Suite 301, Atlanta, GA 30322 USA.	mepstein@genetics.emory.edu	Li, Chun/R-1095-2019; Li, Chun/B-8388-2012	Li, Chun/0000-0002-8819-2443; Satten, Glen/0000-0001-7275-5371; Veal, Colin/0000-0002-9840-2512; Barker, Jonathan/0000-0002-9030-183X; Trembath, Richard/0000-0003-0550-3400				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Akaike H., 1985, CELEBRATION STAT, P1; Allen AS, 2003, AM J HUM GENET, V72, P671, DOI 10.1086/368276; BOOS DD, 1992, AM STAT, V46, P327, DOI 10.2307/2685328; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falk CT, 1987, ANN HUM GENET, V57, P455; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Lindsay B. G., 1988, CONT MATH, P221, DOI DOI 10.1090/CONM/080/999014; Martin ER, 2000, GENET EPIDEMIOL, V18, P48, DOI 10.1002/(SICI)1098-2272(200001)18:1<48::AID-GEPI4>3.0.CO;2-S; Nagelkerke NJD, 2004, EUR J HUM GENET, V12, P964, DOI 10.1038/sj.ejhg.5201255; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Rabinowitz D, 2002, J AM STAT ASSOC, V97, P742, DOI 10.1198/016214502388618528; Romphruk AV, 2003, TISSUE ANTIGENS, V62, P217, DOI 10.1034/j.1399-0039.2003.00056.x; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SCHAID DJ, 2004, 72 MAYO CLIN; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Thomas DC, 2004, STAT METHODS GENETIC; Tu IP, 2000, AM J HUM GENET, V66, P1341, DOI 10.1086/302852; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Whittemore AS, 2000, AM J HUM GENET, V66, P1328, DOI 10.1086/302851	29	61	64	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					592	608		10.1086/429225	http://dx.doi.org/10.1086/429225			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15712104	Bronze, Green Published			2022-12-18	WOS:000227516000006
J	Russo, L; Mariotti, P; Sangiorgi, E; Giordano, T; Ricci, I; Lupi, F; Chiera, R; Guzzetta, F; Neri, G; Gurrieri, F				Russo, L; Mariotti, P; Sangiorgi, E; Giordano, T; Ricci, I; Lupi, F; Chiera, R; Guzzetta, F; Neri, G; Gurrieri, F			A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; TRIGEMINOVASCULAR NOCICEPTIVE NEUROTRANSMISSION; VALPROATE; LINKAGE; MAPS; HYPEREXCITABILITY; MECHANISMS; MUTATIONS	Migraine is the most common type of chronic episodic headache. Several population-based family studies have suggested a strong genetic predisposition to migraine, especially migraine with aura (MA). Although several susceptibility loci have been identified, none of the numerous studies performed to date have led to the identification of a gene responsible for the more common forms of migraine. GABA-A receptors and their modulator sites seem to be involved in the pathophysiological events that underlie migraine. We report on clinical and molecular data from a total of 10 families with MA, in which MA segregates as an autosomal dominant trait and presents with homogeneous clinical features. After excluding linkage with the known candidate loci, we used a functional candidate approach and genotyped these families with markers from the 15q11-q13 genomic region, which contains the genes encoding GABA-A receptor subunits. Evidence of linkage was obtained with a parametric two-point linkage analysis (maximum LOD score of 5.56 at a recombination fraction of 0.001 for marker GABRB3) and was supported by multipoint analysis (maximum LOD score of 6.54 between markers D15S113 and D15S1019). The critical region spanned 3.6 Mb. These results provide the basis for further investigation of the hypothesized relationship between a GABA-A receptor dysfunction and migraine.	Univ Cattolica Sacro Cuore, Inst Med Genet, I-00168 Rome, Italy; Univ Cattolica Sacro Cuore, Unit Child Neuropsychiat, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Gurrieri, F (corresponding author), Univ Cattolica Sacro Cuore, Inst Med Genet, Largo Francesco Vito 1, I-00168 Rome, Italy.	fgurrieri@rm.unicatt.it	Sangiorgi, Eugenio/AAP-9836-2020; Gurrieri, Fiorella/K-3214-2016	Sangiorgi, Eugenio/0000-0001-9079-9175; Gurrieri, Fiorella/0000-0002-6775-5972				Aurora SK, 1998, NEUROLOGY, V50, P1111, DOI 10.1212/WNL.50.4.1111; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Cutrer FM, 1995, BRIT J PHARMACOL, V116, P3199, DOI 10.1111/j.1476-5381.1995.tb15124.x; Cutrer FM, 1996, HEADACHE, V36, P579, DOI 10.1046/j.1526-4610.1996.3610579.x; Cutrer FM, 1997, CEPHALALGIA, V17, P93, DOI 10.1046/j.1468-2982.1997.1702093.x; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Iadecola C, 2002, NAT MED, V8, P110, DOI 10.1038/nm0202-110; Jones KW, 2001, GENOMICS, V78, P150, DOI 10.1006/geno.2001.6665; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Krusz JC, 2000, HEADACHE, V40, P224, DOI 10.1046/j.1526-4610.2000.00032.x; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Nyholt DR, 2000, HUM GENET, V107, P18; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Palmer JE, 2000, CEPHALALGIA, V20, P525, DOI 10.1046/j.1468-2982.2000.00075.x; Parsons AA, 1998, CURR OPIN NEUROL, V11, P227, DOI 10.1097/00019052-199806000-00006; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; Russell MB, 2001, CEPHALALGIA, V21, P778, DOI 10.1046/j.1468-2982.2001.00249.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2004, NEUROL SCI, V25, pS244, DOI 10.1007/s10072-004-0297-1; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soragna D, 2003, AM J HUM GENET, V72, P161, DOI 10.1086/345298; Storer RJ, 2004, BRAIN RES, V1013, P188, DOI 10.1016/j.brainres.2004.03.068; Storer RJ, 2001, BRIT J PHARMACOL, V134, P896, DOI 10.1038/sj.bjp.0704325; Wessman M, 2002, AM J HUM GENET, V70, P652, DOI 10.1086/339078; Ziegler DK, 1998, HEADACHE, V38, P417, DOI 10.1046/j.1526-4610.1998.3806417.x	32	61	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					327	333		10.1086/427521	http://dx.doi.org/10.1086/427521			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15586324	Green Published, Bronze			2022-12-18	WOS:000226215100017
J	Freedman, ML; Pearce, CL; Penney, KL; Hirschhorn, JN; Kolonel, LN; Henderson, BE; Altshuler, D				Freedman, ML; Pearce, CL; Penney, KL; Hirschhorn, JN; Kolonel, LN; Henderson, BE; Altshuler, D			Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAG REPEAT POLYMORPHISM; POPULATION STRATIFICATION; ALLELIC VARIANTS; ASSOCIATION; LENGTH; MEN; SUSCEPTIBILITY; PREDISPOSITION; SURVIVAL; LINKAGE	Repeat length of the CAG microsatellite polymorphism in exon 1 of the androgen receptor (AR) gene has been associated with risk of prostate cancer in humans. This association has been the focus of greater than 120 primary epidemiological publications and multiple review articles, but a consistent and reproducible association has yet to be confirmed. We systematically addressed possible causes of false-negative and false-positive association in greater than 4,000 individuals from a multiethnic, prospective cohort study of prostate cancer, comprehensively studying genetic variation by microsatellite genotyping, direct resequencing of exons in advanced cancer cases, and haplotype analysis across the 180-kb AR genomic locus. These data failed to confirm that common genetic variation in the AR gene locus influences risk of prostate cancer. A systematic approach that assesses both coding and noncoding genetic variation in large and diverse patient samples can help clarify hypotheses about association between genetic variants and disease.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; Univ So Calif, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System	Altshuler, D (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman 8, Boston, MA 02114 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107	NCI NIH HHS [5R01 CA 63464, R01 CA063464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balic I, 2002, J UROLOGY, V168, P2245, DOI 10.1016/S0022-5347(05)64364-9; Beilin J, 2000, J MOL ENDOCRINOL, V25, P85, DOI 10.1677/jme.0.0250085; Beilin J, 2001, CANCER-AM CANCER SOC, V92, P941, DOI 10.1002/1097-0142(20010815)92:4<941::AID-CNCR1404>3.0.CO;2-P; Bratt O, 1999, BRIT J CANCER, V81, P672, DOI 10.1038/sj.bjc.6690746; Buchanan G, 2001, CANCER METAST REV, V20, P207, DOI 10.1023/A:1015531326689; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chen C, 2002, CANCER EPIDEM BIOMAR, V11, P1033; Cicek MS, 2004, PROSTATE, V59, P69, DOI 10.1002/pros.10358; Coetzee G, 2002, J CLIN ONCOL, V20, P3572, DOI 10.1200/JCO.2002.20.17.3572; Correa-Cerro L, 1999, EUR J HUM GENET, V7, P357, DOI 10.1038/sj.ejhg.5200298; dos Santos ML, 2003, CANCER DETECT PREV, V27, P321, DOI 10.1016/S0361-090X(03)00106-5; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Edwards SM, 1999, INT J CANCER, V84, P458, DOI 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y; Ekman P, 1999, PROSTATE, V39, P262; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gsur A, 2002, CARCINOGENESIS, V23, P1647, DOI 10.1093/carcin/23.10.1647; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Hsing AW, 2000, CANCER RES, V60, P5111; Huang SP, 2003, J FORMOS MED ASSOC, V102, P680; Ingles SA, 1997, J NATL CANCER I, V89, P166, DOI 10.1093/jnci/89.2.166; IRVINE RA, 1995, CANCER RES, V55, P1937; Kantoff P, 1998, BBA-REV CANCER, V1378, pC1; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lange EM, 2000, CANCER EPIDEM BIOMAR, V9, P439; Latil AG, 2001, CANCER-AM CANCER SOC, V92, P1130, DOI 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B; LEWONTIN RC, 1964, GENETICS, V49, P49; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Modugno F, 2001, CLIN CANCER RES, V7, P3092; Mononen N, 2002, HUM GENET, V111, P166, DOI 10.1007/s00439-002-0776-5; Nelson KA, 2002, AM J EPIDEMIOL, V155, P883, DOI 10.1093/aje/155.10.883; Panz VR, 2001, ENDOCRINE, V15, P213, DOI 10.1385/ENDO:15:2:213; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Quinn M, 2002, BJU INT, V90, P174, DOI 10.1046/j.1464-410X.2002.02823.x; Sartor O, 1999, UROLOGY, V53, P378, DOI 10.1016/S0090-4295(98)00481-6; Simard J, 2003, ENDOCR-RELAT CANCER, V10, P225, DOI 10.1677/erc.0.0100225; Stanford JL, 1997, CANCER RES, V57, P1194; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Xue WM, 2000, CANCER RES, V60, P839	44	61	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					82	90		10.1086/427224	http://dx.doi.org/10.1086/427224			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15570555	Green Published, Bronze			2022-12-18	WOS:000225643600007
J	Abecasis, GR; Burt, RA; Hall, D; Bochum, S; Doheny, KF; Lundy, SL; Torrington, M; Roos, JL; Gogos, JA; Karayiorgou, M				Abecasis, GR; Burt, RA; Hall, D; Bochum, S; Doheny, KF; Lundy, SL; Torrington, M; Roos, JL; Gogos, JA; Karayiorgou, M			Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; SOUTH-AFRICAN AFRIKANERS; SUSCEPTIBILITY LOCI; WIDE SCAN; VARIEGATE PORPHYRIA; GENETIC-LINKAGE; COMPLEX TRAITS; FANCONI-ANEMIA; SIBLING PAIRS; PEDIGREES	We report on our initial genetic linkage studies of schizophrenia in the genetically isolated population of the Afrikaners from South Africa. A 10-cM genomewide scan was performed on 143 small families, 34 of which were informative for linkage. Using both nonparametric and parametric linkage analyses, we obtained evidence for a small number of disease loci on chromosomes 1, 9, and 13. These results suggest that few genes of substantial effect exist for schizophrenia in the Afrikaner population, consistent with our previous genealogical tracing studies. The locus on chromosome 1 reached genomewide significance levels ( nonparametric LOD score of 3.30 at marker D1S1612, corresponding to an empirical P value of .012) and represents a novel susceptibility locus for schizophrenia. In addition to providing evidence for linkage for chromosome 1, we also identified a proband with a uniparental disomy (UPD) of the entire chromosome 1. This is the first time a UPD has been described in a patient with schizophrenia, lending further support to involvement of chromosome 1 in schizophrenia susceptibility in the Afrikaners.	Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY USA; Columbia Univ, Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY USA; Johns Hopkins Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD USA; Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; Weskoppies Hosp, Pretoria, South Africa	Rockefeller University; University of Michigan System; University of Michigan; Columbia University; Columbia University; Johns Hopkins University; Johns Hopkins Medicine; University of Pretoria	Karayiorgou, M (corresponding author), Rockefeller Univ, Human Neurogenet Lab, 1230 York Ave,Box 313, New York, NY 10021 USA.	karayim@rockefeller.edu	Abecasis, Goncalo R/B-7840-2010; Burt, Rachel/I-7874-2012	Burt, Rachel/0000-0001-8827-8266; Roos, Johannes/0000-0002-0572-1072; Abecasis, Goncalo/0000-0003-1509-1825	NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIMH NIH HHS [R01 MH061399, MH61399] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; BRINK PA, 1995, CIRCULATION, V91, P1633, DOI 10.1161/01.CIR.91.6.1633; BRINK PA, 1987, HUM GENET, V77, P32, DOI 10.1007/BF00284709; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Camp NJ, 2001, AM J HUM GENET, V69, P1278, DOI 10.1086/324590; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Chen H, 1999, AM J MED GENET, V82, P215, DOI 10.1002/(SICI)1096-8628(19990129)82:3<215::AID-AJMG4>3.0.CO;2-Z; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; CLONINGER CR, 1989, COMPREHENSIVE TXB PS, P732; Collier DA, 1997, MOL PSYCHIATR, V2, P181, DOI 10.1038/sj.mp.4000274; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; COON H, 1994, AM J MED GENET, V54, P72, DOI 10.1002/ajmg.1320540112; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; Devlin B, 2002, MOL PSYCHIATR, V7, P689, DOI 10.1038/sj.mp.4001056; Dufourcq-Lagelouse R, 1999, EUR J HUM GENET, V7, P633, DOI 10.1038/sj.ejhg.5200355; Dyer TD, 2001, GENET EPIDEMIOL, V21, pS236, DOI 10.1002/gepi.2001.21.s1.s236; Ekelund J, 2000, HUM MOL GENET, V9, P1049, DOI 10.1093/hmg/9.7.1049; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Field LL, 1998, AM J HUM GENET, V63, P1216, DOI 10.1086/302050; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; Genin E, 1996, AM J HUM GENET, V59, P1149; Goldman A, 1996, AM J HUM GENET, V59, P445; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Groenewald JZ, 1998, AM J HUM GENET, V62, P1254, DOI 10.1086/301833; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; HAYDEN MR, 1980, S AFR MED J, V58, P197; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Kendler KS, 1996, AM J MED GENET, V67, P179, DOI 10.1002/(SICI)1096-8628(19960409)67:2<179::AID-AJMG8>3.0.CO;2-N; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Maziade M, 2002, AM J MED GENET, V114, P51, DOI 10.1002/ajmg.1616; Miura Y, 2000, HUM GENET, V107, P205, DOI 10.1007/s004390000369; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Ober C, 1998, CLIN EXP ALLERGY, V28, P101; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; PRONK JC, 1995, NAT GENET, V11, P338, DOI 10.1038/ng1195-338; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; Rees MI, 1999, MOL PSYCHIATR, V4, P353, DOI 10.1038/sj.mp.4000521; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; ROSENDORFF J, 1987, AM J MED GENET, V27, P793, DOI 10.1002/ajmg.1320270408; Sengul H, 2001, AM J HUM GENET, V69, P179, DOI 10.1086/321264; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; Sullivan PF, 2003, AM J MED GENET B, V121B, P89, DOI 10.1002/ajmg.b.20069; Takizawa Y, 2000, J INVEST DERMATOL, V115, P307, DOI 10.1046/j.1523-1747.2000.00052.x; Thompson DA, 2002, AM J HUM GENET, V70, P224, DOI 10.1086/338455; TORRINGTON M, 1991, S AFR MED J, V79, P7; Tsuang Ming T., 1994, Comprehensive Therapy, V20, P130; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Wijsman EM, 2003, MOL PSYCHIATR, V8, P695, DOI 10.1038/sj.mp.4001356; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	79	61	63	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					403	417		10.1086/381713	http://dx.doi.org/10.1086/381713			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14750073	Green Published, Bronze			2022-12-18	WOS:000220118500008
J	Anderson, EC; Novembre, J				Anderson, EC; Novembre, J			Finding haplotype block boundaries by using the minimum-description-length principle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; POPULATION HISTORY; MODEL; INFERENCE; ORIGIN	We present a method for detecting haplotype blocks that simultaneously uses information about linkage-disequilibrium decay between the blocks and the diversity of haplotypes within the blocks. By use of phased single-nucleotide polymorphism data, our method partitions a chromosome into a series of adjacent, nonoverlapping blocks. The partition is made by choosing among a family of Markov models for block structure in a chromosomal region. Specifically, in the model, the occurrence of haplotypes within blocks follows a time-inhomogeneous Markov process along the chromosome, and we choose among possible partitions by using the two-stage minimum-description-length criterion. When applied to data simulated from the coalescent with recombination hotspots, our method reliably situates block boundaries at the hotspots and infrequently places block boundaries at sites with background levels of recombination. We apply three previously published block-finding methods to the same data, showing that they either are relatively insensitive to recombination hotspots or fail to discriminate between background sites of recombination and hotspots. When applied to the 5q31 data of Daly et al., our method identifies more block boundaries in agreement with those found by Daly et al. than do other methods. These results suggest that our method may be useful for designing association-based mapping studies that exploit haplotype blocks.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Anderson, EC (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	eric.anderson@stanfordalumni.org	Novembre, John/G-1339-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM040282, GM-40282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cover T.M., 2006, ELEMENTS INFORMATION, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; GREENSPAN G, 2003, 7 ANN INT C RES COMP; Hansen MH, 2001, J AM STAT ASSOC, V96, P746, DOI 10.1198/016214501753168398; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; JOHNSON N. L., 1997, DISCRETE MULTIVARIAT; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Koivisto M, 2003, Pac Symp Biocomput, P502; Lanterman AD, 2001, INT STAT REV, V69, P185, DOI 10.2307/1403813; Lee TCM, 2001, INT STAT REV, V69, P169, DOI 10.1111/j.1751-5823.2001.tb00455.x; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rissanen J., 1989, SERIES COMPUTER SCI, V15; Stephens M, 2000, J ROY STAT SOC B, V62, P605, DOI 10.1111/1467-9868.00254; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Zhang K, 2002, AM J HUM GENET, V71, P1386, DOI 10.1086/344780; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	30	61	62	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					336	354		10.1086/377106	http://dx.doi.org/10.1086/377106			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12858289	Green Published, Bronze			2022-12-18	WOS:000184223900010
J	Matsumoto, N; Tamura, S; Furuki, S; Miyata, N; Moser, A; Shimozawa, N; Moser, HW; Suzuki, Y; Kondo, N; Fujiki, Y				Matsumoto, N; Tamura, S; Furuki, S; Miyata, N; Moser, A; Shimozawa, N; Moser, HW; Suzuki, Y; Kondo, N; Fujiki, Y			Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFICIENT ZELLWEGER-SYNDROME; ANIMAL-CELL MUTANTS; TARGETING SIGNAL; PTS1 RECEPTOR; REPRESENT; ENCODES; IMPORT	The human disorders of peroxisome biogenesis (PBDs) are subdivided into 12 complementation groups (CGs). CG8 is one of the more common of these and is associated with varying phenotypes, ranging from the most severe, Zellweger syndrome (ZS), to the milder neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD). PEX26, encoding the 305-amino-acid membrane peroxin, has been shown to be deficient in CG8. We studied the PEX26 genotype in fibroblasts of eight CG8 patients - four with the ZS phenotype, two with NALD, and two with IRD. Catalase was mostly cytosolic in all these cell lines, but import of the proteins that contained PTS1, the SKL peroxisome targeting sequence, was normal. Expression of PEX26 reestablished peroxisomes in all eight cell lines, confirming that PEX26 defects are pathogenic in CG8 patients. When cells were cultured at 30 degreesC, catalase import was restored in the cell lines from patients with the NALD and IRD phenotypes, but to a much lesser extent in those with the ZS phenotype, indicating that temperature sensitivity varied inversely with the severity of the clinical phenotype. Several types of mutations were identified, including homozygous G89R mutations in two patients with ZS. Expression of these PEX26 mutations in pex26 Chinese hamster ovary cells resulted in cell phenotypes similar to those in the human cell lines. These findings confirm that the degree of temperature sensitivity in pex26 cell lines is predictive of the clinical phenotype in patients with PEX26 deficiency.	Kyushu Univ, Grad Sch, Fac Sci, Dept Biol,Higashi Ku, Fukuoka 8128581, Japan; Johns Hopkins Univ, Kennedy Krieger Inst, Dept Neurol & Pediat, Baltimore, MD USA; Gifu Univ, Sch Med, Dept Pediat, Gifu 500, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama, Japan	Kyushu University; Johns Hopkins University; Kennedy Krieger Institute; Gifu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Fac Sci, Dept Biol,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Matsumoto, Naomi/AFL-4833-2022; Matsumoto, Naomi/AAD-3468-2022	Shimozawa, Nobuyuki/0000-0003-3040-5458	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000052, RR 00052] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Ghaedi K, 2000, AM J HUM GENET, V67, P976, DOI 10.1086/303086; Ghaedi K, 1999, EXP CELL RES, V248, P482, DOI 10.1006/excr.1999.4412; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Imamura A, 1998, HUM MOL GENET, V7, P2089, DOI 10.1093/hmg/7.13.2089; Imamura A, 1998, AM J HUM GENET, V62, P1539, DOI 10.1086/301881; LAZAROW PB, 1995, METABOLIC BASIS INHE, V7, P2287; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Matsumoto N, 2001, J HUM GENET, V46, P273, DOI 10.1007/s100380170078; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Shimizu T, 1999, J GASTROEN HEPATOL, V14, P274, DOI 10.1046/j.1440-1746.1999.01850.x; Shimozawa N, 1999, HUM MOL GENET, V8, P1077, DOI 10.1093/hmg/8.6.1077; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tamura S, 2001, BIOCHEM J, V357, P417, DOI 10.1042/0264-6021:3570417; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Walter C, 2001, AM J HUM GENET, V69, P35, DOI 10.1086/321265; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; Yanago E, 2002, BIOCHEM BIOPH RES CO, V293, P225, DOI 10.1016/S0006-291X(02)00219-X	28	61	66	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					233	246		10.1086/377004	http://dx.doi.org/10.1086/377004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12851857	Bronze, Green Published			2022-12-18	WOS:000184223900002
J	Bugawan, TL; Mirel, DB; Valdes, AM; Panelo, A; Pozzilli, P; Erlich, HA				Bugawan, TL; Mirel, DB; Valdes, AM; Panelo, A; Pozzilli, P; Erlich, HA			Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROMOTER REGION; CLASS-I; GENE; SUSCEPTIBILITY; POLYMORPHISMS; ASTHMA; MELLITUS; ALLELES; LINKAGE; CTLA4	In the search for genes involved in type 1 diabetes (TED), other than the well-established risk alleles at the human leukocyte antigen loci, we have investigated the association and interaction of polymorphisms in genes involved in the IL4/IL13 pathway in a sample of 90 Filipino patients with T1D and 94 controls. Ten single-nucleotide polymorphisms (SNPs), including two promoter SNPs in the IL4R locus on chromosome 16p11, one promoter SNP in the IL4 locus on chromosome 5q31, and four SNPs-including two promoter SNPs-in the IL13 locus on chromosome 5q31 were examined for association, linkage disequilibrium, and interaction. We found that both individual SNPs (IL4R L389L; odds ratio [OR] 0.34; 95% confidence interval [CI] 0.17-0.67; P = .001) and specific haplotypes both in IL4R (OR 0.10; 95% CI 0-0.5; P = .001) and for the five linked IL4 and IL13 SNPs (OR 3.47; P = .004) were strongly associated with susceptibility to T1D. Since IL4 and IL13 both serve as ligands for a receptor composed, in part, of the IL4R alpha chain, we looked for potential epistasis between polymorphisms in the IL4R locus on chromosome 16p11 and the five SNPs in the IL4 and IL13 loci on chromosome 5q31 and found, through use of a logistic-regression model, significant gene-gene interactions (P = .045, corrected for multiple comparisons by permutation analysis). Our data suggest that the risk for T1D is determined, in part, by polymorphisms within the IL4R locus, including promoter and coding-sequence variants, and by specific combinations of genotypes at the IL4R and the IL4 and IL13 loci.	Roche Mol Syst, Alameda, CA 94501 USA; Diabet Fdn Inst, Manila, Philippines; Dept Endocrinol & Diabet, Rome, Italy	Roche Holding	Erlich, HA (corresponding author), Roche Mol Syst, 1145 Atlantic Ave, Alameda, CA 94501 USA.	Henry.Erlich@Roche.com	Pozzilli, Paolo/A-5235-2010	Valdes, Ana M./0000-0003-1141-4471	NIAID NIH HHS [R01 AI029042, R01 AI29042-09A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029042] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306, DOI 10.1128/CDLI.6.3.306-310.1999; Bennett ST, 1996, J AUTOIMMUN, V9, P415, DOI 10.1006/jaut.1996.0057; Berman MA, 1996, J IMMUNOL, V157, P4690; Bugawan TL, 2002, TISSUE ANTIGENS, V59, P452, DOI 10.1034/j.1399-0039.2002.590602.x; Cox NJ, 2001, AM J HUM GENET, V69, P820, DOI 10.1086/323501; Erlich HA, 1996, DIABETES, V45, P610, DOI 10.2337/diabetes.45.5.610; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gavin JR, 1997, DIABETES CARE, V20, P1183; Glimcher LH, 2000, GENE DEV, V14, P1693; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Hackstein H, 2001, IMMUNOGENETICS, V53, P264, DOI 10.1007/s002510100324; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Klitz W, 2002, IMMUNOGENETICS, V54, P310, DOI 10.1007/s00251-002-0471-7; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Kretowski A, 2000, SCAND J IMMUNOL, V51, P321; Kruse S, 1999, IMMUNOLOGY, V96, P365; Larsen ZM, 1999, AUTOIMMUNITY, V31, P35, DOI 10.3109/08916939908993857; Lee YJ, 2001, J PEDIATR ENDOCR MET, V14, P383; Medici F, 1999, DIABETES CARE, V22, P1458, DOI 10.2337/diacare.22.9.1458; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Noble JA, 2000, DIABETES, V49, P121, DOI 10.2337/diabetes.49.1.121; Noguchi E, 1998, CLIN EXP ALLERGY, V28, P449; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; RISCH N, 1987, AM J HUM GENET, V40, P1; Sandford AJ, 2000, J ALLERGY CLIN IMMUN, V106, P135, DOI 10.1067/mai.2000.107926; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Zaccone P, 1999, DIABETES, V48, P1522, DOI 10.2337/diabetes.48.8.1522	33	61	64	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1505	1514		10.1086/375655	http://dx.doi.org/10.1086/375655			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12748907	Green Published, Bronze			2022-12-18	WOS:000183275500013
J	Slager, SL; Schaid, DJ; Cunningham, JM; McDonnell, SK; Marks, AF; Peterson, BJ; Hebbring, SJ; Anderson, S; French, AJ; Thibodeau, SN				Slager, SL; Schaid, DJ; Cunningham, JM; McDonnell, SK; Marks, AF; Peterson, BJ; Hebbring, SJ; Anderson, S; French, AJ; Thibodeau, SN			Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; FAMILY HISTORY; RISK-FACTORS; PROGRESSION; 1Q42.2-43; HASEMAN; GENE; SCAN	Regions on chromosomes 7 and 19 were recently reported to contain susceptibility loci that regulate tumor aggressiveness of prostate cancer. To confirm these findings, we analyzed genome scan data from 161 pedigrees affected with prostate cancer. Using the Gleason score as a quantitative measure of tumor aggressiveness, we regressed the squared trait difference, as well as the mean-corrected cross product, on the estimated proportion of alleles shared identical-by-descent at each marker position. Our results confirm the previous linkage results for chromosome 19q (D19S902, P < .00001). In addition, we report suggestive evidence for linkage on chromosome 4 (D4S403, P = .00012). The results of previous findings, together with our results, provide strong evidence that chromosome 19 harbors a gene for tumor aggressiveness.	Mayo Clin Fdn, Dept Hlth Sci Res, Rochester, MN USA; Mayo Clin Fdn, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin, Hardwick 7,200 1st St SW, Rochester, MN 55905 USA.		Slager, Susan L./B-6756-2009	McDonnell, Shannon/0000-0001-6201-369X	NATIONAL CANCER INSTITUTE [R01CA072818, K07CA094919] Funding Source: NIH RePORTER; NCI NIH HHS [CA 94919, K07 CA094919, R01 CA072818, CA 72818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; EPSTEIN JI, 1993, J UROLOGY, V149, P1478, DOI 10.1016/S0022-5347(17)36421-2; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Gibbs M, 1999, AM J HUM GENET, V64, P1087, DOI 10.1086/302342; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lerner SE, 1996, J UROLOGY, V156, P137, DOI 10.1016/S0022-5347(01)65967-6; NEVILLE PJ, 2002, P ANN M AM ASS CANC, V23, P3131; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Palmer LJ, 2000, GENET EPIDEMIOL, V19, P456, DOI 10.1002/1098-2272(200012)19:4<456::AID-GEPI15>3.0.CO;2-N; *SAGE, 2002, STAT AN GEN EP; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vieland VJ, 2001, NAT GENET, V29, P244, DOI 10.1038/ng1101-244; Visscher PM, 2001, ANN HUM GENET, V65, P583, DOI [10.1046/j.1469-1809.2001.6560583.x, 10.1017/S0003480001008909]; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; Witte JS, 2000, AM J HUM GENET, V67, P92, DOI 10.1086/302960; Xu J, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477	27	61	65	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					759	762		10.1086/368230	http://dx.doi.org/10.1086/368230			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12563560	Green Published, Bronze			2022-12-18	WOS:000181152600027
J	Hauser, MA; Conde, CB; Kowaljow, V; Zeppa, G; Taratuto, AL; Torian, UM; Vance, J; Pericak-Vance, MA; Speer, MC; Rosa, AL				Hauser, MA; Conde, CB; Kowaljow, V; Zeppa, G; Taratuto, AL; Torian, UM; Vance, J; Pericak-Vance, MA; Speer, MC; Rosa, AL			myotilin mutation found in second pedigree with LGMD1A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SARCOMERIC PROTEIN; NEMALINE MYOPATHY; BETA-SARCOGLYCAN; GENE; FILAMIN; IDENTIFICATION; LOCALIZATION; CAVEOLIN-3; TELETHONIN	Limb-girdle muscular dystrophy 1A (LGMD1A [MIM 159000]) is an autosomal dominant form of muscular dystrophy characterized by adult onset of proximal weakness progressing to distal muscle weakness. We have reported elsewhere a mutation in the myotilin gene in a large, North American family of German descent. Here, we report the mutation screening of an additional 86 families with a variety of neuromuscular pathologies. We have identified a new myotilin mutation in an Argentinian pedigree with LGMD1 that is predicted to result in the conversion of serine 55 to phenylalanine (S55F). This mutation has not been found in 392 control chromosomes and is located in the unique N-terminal domain of myotilin, only two residues from the T57I mutation reported elsewhere. Both T57I and S55F are located outside the alpha-actinin and gamma-filamin binding sites within myotilin. The identification of two independent pedigrees with the same disease, each bearing a different mutation in the same gene, has long been the gold standard for establishing a causal relationship between defects in a gene and the resultant disease. As a description of the second known pedigree with LGMD1A, this finding constitutes that gold standard of proof that mutations in the myotilin gene cause LGMD1A.	Duke Univ, Med Ctr, Dept Med, Med Genet Sect, Durham, NC 27710 USA; Consejo Nacl Invest Cient & Tecn, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, RA-1033 Buenos Aires, DF, Argentina; Hosp Cordoba, Cordoba, Argentina; Hosp Ninos Cordoba, Cordoba, Argentina; Hosp Garrahan, Buenos Aires, DF, Argentina	Duke University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires	Hauser, MA (corresponding author), Duke Univ, Med Ctr, Dept Med, Med Genet Sect, Box 3445, Durham, NC 27710 USA.			Conde, Cecilia/0000-0002-5103-6391; Vance, Jeffery/0000-0003-3815-8199	NINDS NIH HHS [P01 NS026630, NS26630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Hauser MA, 2000, HUM MOL GENET, V9, P2141, DOI 10.1093/hmg/9.14.2141; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Peckham M, 1997, CELL STRUCT FUNCT, V22, P95, DOI 10.1247/csf.22.95; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Salmikangas P, 1999, HUM MOL GENET, V8, P1329, DOI 10.1093/hmg/8.7.1329; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Speer MC, 1999, AM J HUM GENET, V64, P556, DOI 10.1086/302252; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Vance Jeffery M., 1998, P213; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WANG K, 1977, P NATL ACAD SCI USA, V74, P2021, DOI 10.1073/pnas.74.5.2021	28	61	65	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1428	1432		10.1086/344532	http://dx.doi.org/10.1086/344532			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12428213	Bronze, Green Published			2022-12-18	WOS:000179586800016
J	Derbeneva, OA; Sukernik, RI; Volodko, NV; Hosseini, SH; Lott, MT; Wallace, DC				Derbeneva, OA; Sukernik, RI; Volodko, NV; Hosseini, SH; Lott, MT; Wallace, DC			Analysis of mitochondrial DNA diversity in the Aleuts of the Commander islands and its implications for the genetic history of Beringia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA VARIATION; NEW-WORLD; ESKIMOS; ORIGIN	The Aleuts are aboriginal inhabitants of the Aleutian archipelago, including Bering and Copper (Medny) Islands of the Commanders, and seem to be the survivors of the inhabitants of the southern belt of the Bering Land Bridge that connected Chukotka/Kamchatka and Alaska during the end of the Ice Age. Thirty mtDNA samples collected in the Commanders, as well as seven mtDNA samples from Sireniki Eskimos in Chukotka who belong to the Beringian-specific subhaplogroup D2, were studied through complete sequencing. This analysis has provided evidence that all 37 of these mtDNAs are closely related, since they share the founding haplotype for subhaplogroup D2. We also demonstrated that, unlike the Eskimos and Na-Dene, the Aleuts of the Commanders were founded by a single lineage of haplogroup D2, which had acquired the novel transversion mutation 8910A. The phylogeny of haplogroup D complete sequences showed that (1) the D2 root sequence type originated among the latest inhabitants of Beringia and (2) the Aleut 8910A sublineage of D2 is a part of larger radiation of rooted D2, which gave rise to D2a (Na-Dene), D2b (Aleut), and D2c (Eskimo) sublineages. The geographic specificity and remarkable intrinsic diversity of D2 lineages support the refugial hypothesis, which assumes that the founding population of Eskimo-Aleut originated in Beringan/southwestern Alaskan refugia during the early postglacial period, rather than having reached the shores of Alaska as the result of recent wave of migration from interior Siberia.	Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Lab Human Mol Genet, Novosibirsk 630090, Russia; Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Emory University	Sukernik, RI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Lab Human Mol Genet, 10 Lavrentev Ave, Novosibirsk 630090, Russia.		Sukernik, Rem I/N-6990-2015	Lott, Marie/0000-0003-2035-479X	FIC NIH HHS [TW 1175] Funding Source: Medline; NHLBI NIH HHS [HL 64017] Funding Source: Medline; NIA NIH HHS [R01 AG013154, AG 13154] Funding Source: Medline; NINDS NIH HHS [R01 NS021328, R01 NS041850, NS 21328, NS 41850] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS041850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Black L., 1988, CROSSROADS CONTINENT, P52; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; DIKOV NN, 1994, ANTHR PACIFIC RIM, P87; Forster P, 1996, AM J HUM GENET, V59, P935; Fortescue Michael, 1998, LANGUAGE RELATIONS B; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hayes MG, 2001, AM J HUM GENET, V69, P179; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jochelson W., 1933, HIST ETHNOLOGY ANTHR; LYAPUNOVA RG, 1975, ESSAYS ETHNOLOGY ALE; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; ROGERS RA, 1991, J BIOGEOGR, V18, P623, DOI 10.2307/2845543; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; TORRONI A, 1993, AM J HUM GENET, V53, P563; Veniaminov I., 1840, NOTES ISLANDS UNALAS, V1; West F.H., 1996, AM BEGINNINGS PREHIS; [No title captured]	20	61	65	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					415	421		10.1086/341720	http://dx.doi.org/10.1086/341720			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12082644	Bronze, Green Published			2022-12-18	WOS:000176977700020
J	Robinson, WP; McFadden, DE; Stephenson, MD				Robinson, WP; McFadden, DE; Stephenson, MD			The origin of abnormalities in recurrent aneuploidy/polyploidy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL AGE; SPONTANEOUS-ABORTIONS; DOWN-SYNDROME; CHROMOSOME-ABNORMALITIES; TRISOMY-21 MOSAICISM; PLACENTAL MOSAICISM; NORMAL INTELLIGENCE; UNIPARENTAL DISOMY; MEIOTIC ORIGIN; INCREASED RISK	Recurrent miscarriage due to sporadic chromosomal abnormalities may simply be a consequence of the dramatic increase of trisomic conceptions with increased maternal age. However, it is also possible that some couples are at increased risk of abnormalities as a result of gonadal mosaicism, factors affecting chromosome structure and segregation, increased sperm aneuploidy in the male partner, or accelerated "aging" of the ovaries. We report cytogenetic and molecular findings from 122 spontaneous abortions (SAs) from 54 couples who were ascertained as having two or more documented aneuploid or polyploid SAs. The distribution of abnormalities in this group was similar to those from 307 SAs that involved chromosome abnormalities and were diagnosed at the same center but did not involve documented recurrent aneuploidy/polyploidy. Although recurrence of the same abnormality was observed in eight families, this number was equal to that expected by chance, indicating that gonadal mosaicism is rarely the explanation for recurrence. The origin of the abnormality was determined in 37 SAs from 23 of the couples in the study. A maternal meiotic origin was involved in 30 trisomies and in 1 triploid SA; 3 additional maternal trisomies were of possible somatic origin. A paternal origin was found in the remaining two trisomies and in one triploid SA. In addition, one double trisomy was the consequence of both a maternal and a paternal meiotic error. These results confirm that the etiology of trisomy is predominantly a result of meiotic errors related to increased maternal age, regardless of whether the couple has experienced one or multiple aneuploid SAs. Furthermore, this is true even when a second SA involves the same abnormality. Nonetheless, these data do not exclude some population variability in risk for aneuploidy.	Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Robinson, WP (corresponding author), Univ British Columbia, Dept Med Genet, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.		Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; McFadden, Deborah/0000-0002-0629-3436				Amiel A, 2000, CHROMOSOME RES, V8, P141, DOI 10.1023/A:1009246603868; Battaglia DE, 1996, HUM REPROD, V11, P2217; Bruyere H, 2000, AM J MED GENET, V94, P35, DOI 10.1002/1096-8628(20000904)94:1<35::AID-AJMG8>3.0.CO;2-9; DEBRAEKELEER M, 1991, HUM REPROD, V6, P245, DOI 10.1093/oxfordjournals.humrep.a137315; Freeman SB, 2000, AM J HUM GENET, V66, P1680, DOI 10.1086/302907; GERSDORF E, 1990, HUM GENET, V84, P298; Giorlandino C, 1998, FERTIL STERIL, V70, P576, DOI 10.1016/S0015-0282(98)00192-7; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1984, AM J HUM GENET, V36, P1349; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; Hassold TJ, 2001, AM J HUM GENET, V69, P434, DOI 10.1086/321971; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; Kalousek D K, 1993, Birth Defects Orig Artic Ser, V29, P53; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; KOHN G, 1987, AM J MED GENET, V26, P929, DOI 10.1002/ajmg.1320260423; Martin RH, 2000, AM J HUM GENET, V66, P1149, DOI 10.1086/302805; Martinez-Pasarell O, 1999, HUM GENET, V104, P345, DOI 10.1007/s004390050964; McFadden DE, 2000, CLIN GENET, V58, P192, DOI 10.1034/j.1399-0004.2000.580306.x; MORTON NE, 1987, AM J MED GENET, V28, P353, DOI 10.1002/ajmg.1320280213; NIELSEN KG, 1988, HUM GENET, V78, P103, DOI 10.1007/BF00291249; PANGALOS CG, 1992, AM J HUM GENET, V51, P1015; Rajcan-Separovic E, 2001, AM J MED GENET, V99, P320, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1173>3.0.CO;2-1; ROBINSON WP, 1995, AM J HUM GENET, V56, P444; Robinson WP, 1997, AM J HUM GENET, V60, P917; Robinson WP, 1999, AM J MED GENET, V84, P34, DOI 10.1002/(SICI)1096-8628(19990507)84:1<34::AID-AJMG8>3.3.CO;2-Z; Rubio C, 1999, J ASSIST REPROD GEN, V16, P253, DOI 10.1023/A:1020315529090; SACHS ES, 1990, AM J MED GENET, P186; Satge D, 1996, CLIN GENET, V50, P470; Schon E A, 2000, Hum Reprod, V15 Suppl 2, P160; Shi Q, 2000, CYTOGENET CELL GENET, V90, P219, DOI 10.1159/000056773; Stavropoulos DJ, 1998, AM J HUM GENET, V63, P1912, DOI 10.1086/302149; STEPHENSON MD, IN PRESS HUM REPROD; Torfs CP, 2000, AM J EPIDEMIOL, V152, P1185, DOI 10.1093/aje/152.12.1185; TSENG LH, 1994, ARCH GYNECOL OBSTET, V255, P213, DOI 10.1007/BF02335088; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; WARBURTON D, 1987, AM J HUM GENET, V41, P465; Zaragoza MV, 2000, AM J HUM GENET, V66, P1807, DOI 10.1086/302951	39	61	67	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1245	1254		10.1086/324468	http://dx.doi.org/10.1086/324468			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11675616	Green Published, Bronze			2022-12-18	WOS:000172086900009
J	Miano, MG; Jacobson, SG; Carothers, A; Hanson, I; Teague, P; Lovell, J; Cideciyan, AV; Haider, N; Stone, EM; Sheffield, VC; Wright, AF				Miano, MG; Jacobson, SG; Carothers, A; Hanson, I; Teague, P; Lovell, J; Cideciyan, AV; Haider, N; Stone, EM; Sheffield, VC; Wright, AF			Pitfalls in homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								There is much interest in use of identity-by-descent (IBD) methods to map genes, both in Mendelian and in complex disorders. Homozygosity mapping provides a rapid means of mapping autosomal recessive genes in consanguineous families by identifying chromosomal regions that show homozygous IBD segments in pooled samples. In this report, we point out some potential pitfalls that arose during the course of homozygosity mapping of the enhanced S-cone syndrome gene, resulting from (1) unexpected allelic heterogeneity, so that the region containing the disease locus was missed as a result of pooling; (2) identification of a homozygous IBD region unrelated to the disease locus; and (3) the potential for inflation of LOD scores as a result of underestimation of the extent of inbreeding, which Broman and Weber suggest may be quite common.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Int Inst Genet & Biophys, I-80125 Naples, Italy; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Edinburgh; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Pennsylvania; Pennsylvania Medicine; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Miano, Maria Giuseppina/AAX-8437-2020; Miano, Maria Giuseppina/E-9056-2011; Cideciyan, Artur V/A-1075-2007; Giuseppina, Miano Maria/B-9169-2015	Miano, Maria Giuseppina/0000-0003-1396-9673; Miano, Maria Giuseppina/0000-0003-1396-9673; Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X; Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Hanson, Isabel/0000-0002-1878-0530	NATIONAL EYE INSTITUTE [R01EY005627] Funding Source: NIH RePORTER; NEI NIH HHS [EY05627] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Wright AF, 1997, GENETIC MAPPING OF DISEASE GENES, P255	4	61	62	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1348	1351		10.1016/S0002-9297(07)62966-8	http://dx.doi.org/10.1016/S0002-9297(07)62966-8			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11007652	Green Published, Bronze			2022-12-18	WOS:000165091600033
J	Azofeifa, J; Fauth, C; Kraus, J; Maierhofer, C; Langer, S; Bolzer, A; Reichman, J; Schuffenhauer, S; Speicher, MR				Azofeifa, J; Fauth, C; Kraus, J; Maierhofer, C; Langer, S; Bolzer, A; Reichman, J; Schuffenhauer, S; Speicher, MR			An optimized probe set for the detection of small interchromosomal aberrations by use of 24-color FISH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-CHROMOSOMES; MULTIPLEX-FISH; IDENTIFICATION	The rapid spread of the use of new 24-color karyotyping techniques has preceded their standardization. This is best documented by the fact that the exact resolution limits have not yet been defined. Indeed, it is shown here that a substantial proportion of interchromosomal aberrations will be missed by all multicolor karyotyping systems currently in use. We demonstrate that both the sensitivity and the specificity of 24-color karyotyping critically depend on the fluorochrome composition of chromosomes involved in an interchromosomal rearrangement. As a solution, we introduce a conceptual change in probe labeling. Seven-fluorochrome sets that overcome many of the current limitations are described, and examples of their applications are shown. The criteria presented here for an optimized probe-set design and for the estimation of resolution limits should have important consequences for pre-and postnatal diagnostics and for research applications.	Univ Munich, Inst Anthropol & Human Genet, D-80336 Munich, Germany; Univ Munich, Abt Med Genet Kinderklin, D-80336 Munich, Germany; Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; Univ Costa Rica, Inst Invest Salud, San Jose, Costa Rica; Chroma Technol Corp, Brattleboro, VT USA	University of Munich; University of Munich; Universidad Costa Rica; Universidad Costa Rica	Speicher, MR (corresponding author), Univ Munich, Inst Anthropol & Human Genet, Geothestr 31, D-80336 Munich, Germany.		Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X				Eils R, 1998, CYTOGENET CELL GENET, V82, P160, DOI 10.1159/000015092; Haddad BR, 1998, HUM GENET, V103, P619, DOI 10.1007/s004390050878; Holinski-Feder E, 2000, AM J HUM GENET, V66, P16, DOI 10.1086/302703; Macville M, 1999, CANCER RES, V59, P141; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Schrock E, 1997, HUM GENET, V101, P255, DOI 10.1007/s004390050626; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Uhrig S, 1999, AM J HUM GENET, V65, P448, DOI 10.1086/302508	9	61	65	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1684	1688		10.1086/302875	http://dx.doi.org/10.1086/302875			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762552	Green Published, Bronze			2022-12-18	WOS:000088373700022
J	Silveira, I; Alonso, I; Guimaraes, L; Mendonca, P; Santos, C; Maciel, P; de Matos, JMF; Costa, M; Barbot, C; Tuna, A; Barros, J; Jardim, L; Coutinho, P; Sequeiros, J				Silveira, I; Alonso, I; Guimaraes, L; Mendonca, P; Santos, C; Maciel, P; de Matos, JMF; Costa, M; Barbot, C; Tuna, A; Barros, J; Jardim, L; Coutinho, P; Sequeiros, J			High germinal instability of the (CTG)(n) at the SCA8 locus of both expanded and normal alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MACHADO-JOSEPH DISEASE; SPINOCEREBELLAR ATAXIA TYPE-1; DOMINANT CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEAT LENGTH; MYOTONIC-DYSTROPHY PATIENTS; CAG REPEAT; CTG REPEAT; CALCIUM-CHANNEL; EXPANSION; GENE	The autosomal dominant spinocerebellar ataxias (SCAs) are a group of late-onset, neurodegenerative disorders for which 10 loci have been mapped (SCA1, SCA2, SCA4-SCA8, SCA10, MJD, and DRPLA). The mutant proteins have shown an expanded polyglutamine tract in SCA1, SCA2, MJD/SCA3, SCA6, SCA7, and DRPLA; a glycine-to-arginine substitution was found in SCA6 as well. Recently, an untranslated (CTG), expansion on chromosome 13q was described as being the cause of SCA8. We have now (1) assessed the repeat size in a group of patients with ataxia and a large number of controls, (2) examined the intergenerational transmission of the repeat, and (3) estimated the instability of repeat size in the sperm of one patient and two healthy controls. Normal SCA8 chromosomes showed an apparently trimodal distribution, with classes of small (15-21 CTGs), intermediate (22-37 CTGs), and large (40-91 CTGs) alleles; large alleles accounted for only0.7% of all normal-size alleles. No expanded alleles (greater than or equal to 100 CTGs) were found in controls. Expansion of the CTC; tract was found in five families with ataxia; expanded alleles (all paternally transmitted) were characterized mostly by repeat-size contraction. There was a high germinal instability of both expanded and normal alleles: in one patient, the expanded allele (152 CTGs) had mostly contraction in size (often into the normal range); in the sperm of two normal controls, contractions were also more frequent, but occasional expansions into the upper limit of the normal size range were also seen. In conclusion, our results show (1) no overlapping between control (15-91) and pathogenic (100-152) alleles and (2) a high instability in spermatogenesis (both for expanded and normal alleles), suggesting a high mutational rate at the SCA8 locus.	UnIGENe, IBMC, P-4150180 Porto, Portugal; Univ Porto, ICBAS, Med Genet Lab, P-4100 Porto, Portugal; Hosp Maria Pia, Serv Neuropediat, Oporto, Portugal; HGSA, Neurol Serv, Porto, Portugal; ISCS Norte, Paredes, Portugal; Hosp Pedro Hispano, Neurol Serv, Matosinhos, Portugal; Hosp Sao Sebastiao, Urol Serv, Feira, Portugal; Hosp Sao Sebastiao, Neurol Serv, Feira, Portugal; Hosp Clin, Serv Genet Med, Porto Alegre, RS, Brazil	Universidade do Porto; Universidade do Porto	Silveira, I (corresponding author), UnIGENe, IBMC, R Campo Alegre 823, P-4150180 Porto, Portugal.		Guimaraes, Laura/A-6759-2011; Maciel, Patricia/AAH-2102-2020; Coutinho, Paula/K-6053-2013; Alonso, Isabel/I-4307-2013; Maciel, Patrícia/B-5989-2009; Barbot, Clara/K-6378-2013; Jardim, Laura B/B-6149-2013; Silveira, Isabel/D-6881-2012	Guimaraes, Laura/0000-0003-3360-3783; Maciel, Patricia/0000-0002-0920-6350; Alonso, Isabel/0000-0001-8549-6903; Maciel, Patrícia/0000-0002-0920-6350; Barbot, Clara/0000-0002-5597-107X; Silveira, Isabel/0000-0002-2610-5260; Franco Mendonca, Pedro/0000-0002-3850-2909; Coutinho, Paula/0000-0002-3461-230X; Sequeiros, Jorge/0000-0002-9846-1037; Barros, Jose/0000-0001-6183-5050				ASHIZAWA T, 1994, AM J HUM GENET, V54, P414; BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; CANCEL G, 1995, AM J HUM GENET, V57, P809; CHONG SS, 1995, NAT GENET, V10, P344, DOI 10.1038/ng0795-344; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Deka R, 1999, AM J HUM GENET, V65, P192, DOI 10.1086/302453; Dow DJ, 1997, J MED GENET, V34, P871, DOI 10.1136/jmg.34.10.871; Durr A, 1999, AM J HUM GENET, V65, pA247; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Giunti P, 1999, AM J HUM GENET, V64, P1594, DOI 10.1086/302406; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; JANSEN G, 1994, AM J HUM GENET, V54, P575; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kennedy JL, 1999, AM J HUM GENET, V65, pA278; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; MACIEL P, 1995, AM J HUM GENET, V57, P54; Martorell L, 1998, HUM MOL GENET, V7, P307, DOI 10.1093/hmg/7.2.307; Meiner A, 1998, J MED GENET, V35, P791, DOI 10.1136/jmg.35.9.791; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ranum LPW, 1999, AM J HUM GENET, V65, pA466; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Sambrook J, 1989, MOL CLONING LAB MANU; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Silveira I, 1996, NEUROLOGY, V46, P214, DOI 10.1212/WNL.46.1.214; Silveira I, 1998, AM J MED GENET, V81, P134, DOI 10.1002/(SICI)1096-8628(19980328)81:2<134::AID-AJMG3>3.0.CO;2-W; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; ZERYLNICK C, 1995, AM J HUM GENET, V56, P123; ZHANG L, 1994, NAT GENET, V7, P531, DOI 10.1038/ng0894-531; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	40	61	64	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					830	840		10.1086/302827	http://dx.doi.org/10.1086/302827			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712199	Green Published, Bronze			2022-12-18	WOS:000088373200007
J	Kosaki, K; Kosaki, R; Craigen, WJ; Matsuo, N				Kosaki, K; Kosaki, R; Craigen, WJ; Matsuo, N			Isoform-specific imprinting of the human PEG1/MEST gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHROMOSOME-7; EXPRESSION; METHYLATION; LIVER; PEG1		Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Pharmacia Upjohn Fund Growth & Dev Res, Tokyo 1608582, Japan; Keio Univ, Ctr Hlth, Tokyo, Japan; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Keio University; Keio University; Keio University; Baylor College of Medicine	Kosaki, K (corresponding author), Keio Univ, Sch Med, Dept Pediat, Div Med Genet,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.		Kosaki, Kenjiro/K-5350-2013					Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; Cuisset L, 1997, ANN GENET-PARIS, V40, P211; Dao D, 1998, HUM MOL GENET, V7, P597, DOI 10.1093/hmg/7.4.597; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lefebvre L, 1997, HUM MOL GENET, V6, P1907, DOI 10.1093/hmg/6.11.1907; Pan YZ, 1998, AM J HUM GENET, V62, P1551, DOI 10.1086/301857; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; SADO T, 1993, DEV GROWTH DIFFER, V35, P551; SPENCE JE, 1988, AM J HUM GENET, V42, P217; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0	20	61	64	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					309	312		10.1086/302712	http://dx.doi.org/10.1086/302712			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631159	Green Published, Bronze			2022-12-18	WOS:000085033600030
J	Pandya, A; Xia, XJ; Erdenetungalag, R; Amendola, M; Landa, B; Radnaabazar, J; Dangaasuren, B; Van Tuyle, G; Nance, WE				Pandya, A; Xia, XJ; Erdenetungalag, R; Amendola, M; Landa, B; Radnaabazar, J; Dangaasuren, B; Van Tuyle, G; Nance, WE			Heterogenous point mutations in the mitochondrial tRNA Ser(UCN) precursor coexisting with the A1555G mutation in deaf students from Mongolia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RIBOSOMAL-RNA MUTATION; NON-SYNDROMIC DEAFNESS; SENSORINEURAL DEAFNESS; INHERITANCE; GENE; AMINOGLYCOSIDES; PEDIGREE		Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA; Maternal & Child Hlth Res Ctr, Dept Human Genet, Ulan Bator, Mongolia	Virginia Commonwealth University; Virginia Commonwealth University	Pandya, A (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, 1101 E Marshal St,Sanger Hall,Room 11-048, Richmond, VA 23298 USA.	apandya@hsc.vcu.edu			NICHD NIH HHS [KO8HD01172-01A1] Funding Source: Medline; NIDCD NIH HHS [DC02530-01A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002530] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HANKE M, 1994, BIOTECHNIQUES, V17, P858; HIGASHI K, 1989, CLIN GENET, V35, P433; HU DN, 1991, J MED GENET, V28, P79, DOI 10.1136/jmg.28.2.79; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; Pandya A, 1997, J MED GENET, V34, P169, DOI 10.1136/jmg.34.2.169; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; ROSSMANITH W, 1995, J BIOL CHEM, V270, P12885, DOI 10.1074/jbc.270.21.12885; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Rossmanith W, 1997, J MOL BIOL, V265, P365, DOI 10.1006/jmbi.1996.0750; Sevior KB, 1998, AM J MED GENET, V75, P179, DOI 10.1002/(SICI)1096-8628(19980113)75:2<179::AID-AJMG11>3.3.CO;2-1; VERNHAM GA, 1994, CLIN OTOLARYNGOL, V19, P314, DOI 10.1111/j.1365-2273.1994.tb01238.x	19	61	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1803	1806		10.1086/302658	http://dx.doi.org/10.1086/302658			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577941	Green Published, Bronze			2022-12-18	WOS:000084282500042
J	Ohno, K; Brengman, JM; Felice, KJ; Cornblath, DR; Engel, AG				Ohno, K; Brengman, JM; Felice, KJ; Cornblath, DR; Engel, AG			Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A -> G splice-donor-site mutation at position+3 of the collagenlike-tail-subunit gene (COLQ): How does G at position+3 result in aberrant splicing?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRE-MESSENGER-RNA; NUCLEAR RIBONUCLEOPROTEIN PARTICLE; FACTOR-VIII GENE; MYASTHENIC SYNDROME; ASYMMETRIC ACETYLCHOLINESTERASE; RETINITIS-PIGMENTOSA; RAT DIAPHRAGM; RPGR GENE; SEQUENCE; BINDING	Congenital end-plate acetylcholinesterase (AChE) deficiency (CEAD), the cause of a disabling myasthenic syndrome, arises from defects in the COLQ gene, which encodes the AChE triple-helical collagenlike-tail subunit that anchors catalytic subunits of AChE to the synaptic basal lamina. Here we describe a patient with CEAD with a nonsense mutation (R315X) and a splice-donor-site mutation at position +3 of intron 16 (IVS16 + 3A-->G) of COLQ. Because both A and G are consensus nucleotides at the +3 position of splice-donor sites, we constructed a minigene that spans exons 15-17 and harbors IVS16 + 3A-->G for expression in COS cells. We found that the mutation causes skipping of exon 16. The mutant splice-donor site of intron 16 harbors five discordant nucleotides (at -3, -2, +3, +4, and +6) that do not base-pair with U1 small-nuclear RNA (snRNA), the molecule responsible for splice-donor-site recognition. Versions of the minigene harboring, at either +4 or +6, nucleotides complementary to U1 snRNA restore normal splicing. Analysis of 1,801 native splice-donor sites reveals that presence of a G nucleotide at +3 is associated with preferential usage, at positions +4 to +6, of nucleotides concordant to U1 snRNA. Analysis of 11 disease-associated NS + 3A-->G mutations indicates that, on average, two of three nucleotides at positions +4 to +6 fail to base-pair, and that the nucleotide at +4 never base-pairs, with U1 snRNA. We conclude that, with G at +3, normal splicing generally depends on the concordance that residues at +4 to +6 have with U1 snRNA, but other cis-acting elements may also be important in assuring the fidelity of splicing.	Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin, Neuromuscular Res Lab, Rochester, MN 55905 USA; Univ Connecticut, Ctr Hlth, Dept Neurol, Farmington, CT USA; Johns Hopkins Univ, Dept Neurol & Pathol, Baltimore, MD USA	Mayo Clinic; Mayo Clinic; University of Connecticut; Johns Hopkins University	Engel, AG (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.		Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS006277, R01NS006277] Funding Source: NIH RePORTER; NINDS NIH HHS [NS6277] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson K, 1997, SCIENCE, V276, P1712, DOI 10.1126/science.276.5319.1712; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; BIDICHANDANI SI, 1994, HUM MOL GENET, V3, P651, DOI 10.1093/hmg/3.4.651; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CARSTENS RP, 1991, AM J HUM GENET, V48, P1105; Casanueva OI, 1998, BIOCHEM BIOPH RES CO, V250, P312, DOI 10.1006/bbrc.1998.9303; CLOUET DB, 1991, SCIENCE, V252, P1823; DEPREZ PN, 1995, J BIOL CHEM, V270, P11043, DOI 10.1074/jbc.270.19.11043; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; DOMINSKI Z, 1992, MOL CELL BIOL, V12, P2108, DOI 10.1128/MCB.12.5.2108; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; ENGEL AG, 1977, ANN NEUROL, V1, P315, DOI 10.1002/ana.410010403; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Fujita R, 1997, AM J HUM GENET, V61, P571, DOI 10.1086/515523; GRABOWSKI PJ, 1991, MOL CELL BIOL, V11, P5919, DOI 10.1128/MCB.11.12.5919; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; HUTCHINSON DO, 1993, BRAIN, V116, P633, DOI 10.1093/brain/116.3.633; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; Ketterling RP, 1999, HUM MUTAT, V13, P221, DOI 10.1002/(SICI)1098-1004(1999)13:3<221::AID-HUMU6>3.3.CO;2-L; KISTER L, 1993, J BIOL CHEM, V268, P21955; KRAWCZAK M, 1992, HUM GENET, V90, P41; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LEE BS, 1991, J BIOL CHEM, V266, P11448; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MOUNT SM, 1983, CELL, V33, P509, DOI 10.1016/0092-8674(83)90432-4; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 1998, ANN NEUROL, V44, P234, DOI 10.1002/ana.410440214; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PURANDARE SM, 1994, HUM MOL GENET, V3, P1109, DOI 10.1093/hmg/3.7.1109; RICHARD MM, 1995, BIOCHEM MOL MED, V55, P74, DOI 10.1006/bmme.1995.1035; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Rotundo RL, 1994, MYOLOGY, P607; Sambrook J, 1989, MOL CLONING LAB MANU; SARKANY RPE, 1995, QJM-INT J MED, V88, P541; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; TSUKAHARA T, 1994, NUCLEIC ACIDS RES, V22, P2318, DOI 10.1093/nar/22.12.2318; WANG XH, 1995, BBA-MOL BASIS DIS, V1271, P358, DOI 10.1016/0925-4439(95)00059-D; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; YOUNKIN SG, 1982, J BIOL CHEM, V257, P13630; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919; Zolezzi F, 1997, AM J MED GENET, V71, P366, DOI 10.1002/(SICI)1096-8628(19970822)71:3<366::AID-AJMG21>3.0.CO;2-H	52	61	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					635	644		10.1086/302551	http://dx.doi.org/10.1086/302551			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441569	Green Published, Bronze			2022-12-18	WOS:000082426400007
J	Ruuls, SR; Sedgwick, JD				Ruuls, SR; Sedgwick, JD			Unlinking tumor necrosis factor biology from the major histocompatibility complex: Lessons from human genetics and animal models	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FACTOR-ALPHA; LYMPHOTOXIN-ALPHA; TNF-ALPHA; DEFICIENT MICE; POLYMORPHISM; INFLAMMATION; PREDISPOSITION; RELEVANCE; NETWORKS		DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Sedgwick, JD (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, 901 Calif Ave, Palo Alto, CA 94304 USA.							Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bean AGD, 1999, J IMMUNOL, V162, P3504; BEUTLER BE, 1992, TUMOR NECROSIS FACTO; Brinkman BMN, 1996, J INFLAMM, V46, P32; Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516; Broide DH, 1999, AM J HUM GENET, V65, P302, DOI 10.1086/302520; Cope AP, 1998, CURR OPIN IMMUNOL, V10, P669, DOI 10.1016/S0952-7915(98)80087-3; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Feldmann M, 1998, SPRINGER SEMIN IMMUN, V20, P211, DOI 10.1007/BF00832008; Frei K, 1997, J EXP MED, V185, P2177, DOI 10.1084/jem.185.12.2177; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; GALLITALIADOROS LA, 1995, J IMMUNOL METHODS, V181, P1, DOI 10.1016/0022-1759(95)00017-5; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gruen JR, 1997, BLOOD, V90, P4252; Hodgson H, 1999, LANCET, V353, P425, DOI 10.1016/S0140-6736(98)00304-3; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Karpus WJ, 1998, J IMMUNOL, V161, P2667; Kassiotis G, 1999, EUR J IMMUNOL, V29, P774, DOI 10.1002/(SICI)1521-4141(199903)29:03<774::AID-IMMU774>3.0.CO;2-T; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Mackay F, 1997, J IMMUNOL, V159, P3299; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, J IMMUNOL, V160, P943; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; Sacca R, 1998, J IMMUNOL, V160, P485; Smyth MJ, 1998, J EXP MED, V188, P1611, DOI 10.1084/jem.188.9.1611; Stuber F, 1996, J INFLAMM, V46, P42; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Tessier PA, 1997, J IMMUNOL, V159, P3595; THEOFILOPOULOS AN, 1995, IMMUNOL TODAY, V16, P150, DOI 10.1016/0167-5699(95)80133-2; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WILSON AG, 1995, J INFLAMM, V45, P1; Zhang Minghuang, 1998, P517	38	61	63	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					294	301		10.1086/302517	http://dx.doi.org/10.1086/302517			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417271	Green Published, Bronze			2022-12-18	WOS:000081836900003
J	Gaudenz, K; Roessler, E; Quaderi, N; Franco, B; Feldman, G; Gasser, DL; Wittwer, B; Montini, E; Opitz, JM; Ballabio, A; Muenke, M				Gaudenz, K; Roessler, E; Quaderi, N; Franco, B; Feldman, G; Gasser, DL; Wittwer, B; Montini, E; Opitz, JM; Ballabio, A; Muenke, M			Opitz G/BBB syndrome in Xp22: Mutations in the MID1 gene cluster in the carboxy-terminal domain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RING FINGER; ZINC-FINGER; SEQUENCE MOTIF; GBBB SYNDROME; PROTEIN; FAMILY; CLONING; XNF7	The MID1 gene in Xp22 codes for a novel member of proteins containing a RING finger, B-box, coiled-coil and a conserved C-terminal domain. Initially, three mutations in the C-terminal region were found in patients with Opitz G/BBB syndrome, a defect of midline development. Here we have determined the complete gene structure of the MID1 gene and have analyzed all nine exons for mutations in a set of 40 unrelated Opitz G/BBB patients. We now report six additional mutations all clustered in the carboxy-terminal domain of the MID1 protein. These data suggest that this conserved domain of the B-box proteins may play a fundamental role in the pathogenesis of Opitz syndrome and in morphogenetic events at the midline during blastogenesis.	Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Genet, Philadelphia, PA 19104 USA; Telethon Inst Genet & Med, Milan, Italy; Univ Vita Salute, Milan, Italy; Univ Munster, Inst Human Genet, D-4400 Munster, Germany; Univ Utah, Dept Pediat, Salt Lake City, UT USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Vita-Salute San Raffaele University; University of Munster; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Muenke, M (corresponding author), Natl Human Genome Res Inst, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1852,Bldg 10,10C101, Bethesda, MD 20892 USA.	mmuenke@nhgri.nih.gov	Quaderi, Nandita/V-8708-2019; Montini, Eugenio/L-1152-2016; BALLABIO, Andrea/AAL-2672-2020; FRANCO, Brunella/S-2882-2018	Montini, Eugenio/0000-0003-1771-6067; BALLABIO, Andrea/0000-0003-1381-4604; FRANCO, Brunella/0000-0001-5588-4569; Muenke, Maximilian/0000-0002-7719-6545	NICHD NIH HHS [HD29862, HD28732] Funding Source: Medline; Telethon [TGM06S01, TGM97000] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BELLINI M, 1993, EMBO J, V12, P107, DOI 10.1002/j.1460-2075.1993.tb05636.x; Borden KLB, 1996, P NATL ACAD SCI USA, V93, P1601, DOI 10.1073/pnas.93.4.1601; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; BROOKS JK, 1992, AM J MED GENET, V43, P595, DOI 10.1002/ajmg.1320430318; CHAN EKL, 1991, J CLIN INVEST, V87, P68, DOI 10.1172/JCI115003; CHRISTIAN JC, 1969, OAS, V5, P82; CORDERO JF, 1978, AM J MED GENET, V2, P145, DOI 10.1002/ajmg.1320020205; Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; FARNDON PA, 1983, CLIN GENET, V24, P446; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; May M, 1997, AM J MED GENET, V68, P244, DOI 10.1002/(SICI)1096-8628(19970120)68:2<244::AID-AJMG27>3.0.CO;2-T; Opitz, 1969, BIRTH DEFECTS OAS, VV, P95; Opitz J. M., 1969, BIRTH DEFECTS AOS, VV, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; PATARCA R, 1988, P NATL ACAD SCI USA, V85, P2733, DOI 10.1073/pnas.85.8.2733; Perry J, 1998, HUM MOL GENET, V7, P299, DOI 10.1093/hmg/7.2.299; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; REDDY BA, 1991, NUCLEIC ACIDS RES, V19, P6330, DOI 10.1093/nar/19.22.6330; REDDY BA, 1991, DEV BIOL, V148, P107, DOI 10.1016/0012-1606(91)90321-S; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Robin NH, 1996, AM J MED GENET, V62, P305, DOI 10.1002/(SICI)1096-8628(19960329)62:3<305::AID-AJMG20>3.0.CO;2-N; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; STOLL C, 1985, AM J MED GENET, V20, P221, DOI 10.1002/ajmg.1320200203; VERLOES A, 1995, AM J MED GENET, V59, P123, DOI 10.1002/ajmg.1320590124	28	61	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					703	710		10.1086/302010	http://dx.doi.org/10.1086/302010			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718340	Bronze, Green Published			2022-12-18	WOS:000075919000007
J	Hoglund, P; Auranen, M; Socha, J; Popinska, K; Nazer, H; Rajaram, U; Al Sanie, A; Al-Ghanim, M; Holmberg, C; de la Chapelle, A; Kere, J				Hoglund, P; Auranen, M; Socha, J; Popinska, K; Nazer, H; Rajaram, U; Al Sanie, A; Al-Ghanim, M; Holmberg, C; de la Chapelle, A; Kere, J			Genetic background of congenital chloride diarrhea in high-incidence populations: Finland, Poland, and Saudi Arabia and Kuwait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHILDREN; MUTATIONS; PROTEIN	Congenital chloride diarrhea (CLD) is an inherited intestinal disorder caused by mutations in the down-regulated in adenoma gene. In Finland, the disease is prevalent because of a founder effect, and all but one of the CLD-associated chromosomes carry the same mutation, V317del. In Poland, another area with a high incidence of CLD, as many as seven different mutations have been detected so far. A third known cluster of CLD, around the Persian Gulf, has not been genetically studied. We studied the allelic diversity of CLD in Poland, in Saudi Arabia and Kuwait, and in three isolated families from North America and Hong Kong. Altogether, eight novel mutations were identified, making a total of 19 known CLD gene mutations. The Polish major mutation I675-676ins was found in 47% of the Polish CLD-associated chromosomes. Haplotype analysis and clustering of the I675-676ins mutation supported a founder effect and common ancestral origin. As in Finland, a major founder effect was observed in Arab patients: 94% of the CLD-associated chromosomes carried a nonsense mutation, G187X, which occurred in either a conserved ancestral haplotype or its derivative, Our data confirm that the same locus is mutated in all cases of CLD studied so far. In Poland, a relatively common founder mutation is likely to highlight a set of rare mutations that would very rarely produce homozygosity alone. This suggests that mutations in the CLD locus are not rare events. Although the disease is thought to be rare, undiagnosed patients may not be uncommon.	Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Folkhalsan Inst Genet, Helsinki, Finland; Ctr Child Hlth, Dept Gastroenterol, Warsaw, Poland; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; Al Jahra Hosp, Dept Pediat, Kuwait, Kuwait; Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA	University of Helsinki; University of Helsinki; Children's Memorial Health Institute; King Faisal Specialist Hospital & Research Center; King Saud University; Jahra Hosptial; University System of Ohio; Ohio State University	Hoglund, P (corresponding author), Univ Helsinki, Haartman Inst, Dept Med Genet, POB 21,Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	Pia.Hoglund@Helsinki.Fi	Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Popinska, Katarzyna/0000-0002-0420-8277				ABDULLAH AMA, 1990, ANN TROP PAEDIATR, V10, P71, DOI 10.1080/02724936.1990.11747412; AlAbbad A, 1995, ANN SAUDI MED, V15, P466, DOI 10.5144/0256-4947.1995.466; ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; DARROW DC, 1945, J PEDIATR-US, V26, P519, DOI 10.1016/S0022-3476(45)80079-3; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GAMBLE JL, 1945, J PEDIATR-US, V26, P509, DOI 10.1016/S0022-3476(45)80078-1; HAILA S, IN PRESS GENE; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Hoglund P, 1998, HUM MUTAT, V11, P321; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; HOLMBERG C, 1977, ARCH DIS CHILD, V52, P255, DOI 10.1136/adc.52.4.255; HOLMBERG C, 1986, CLIN GASTROENTEROL, V15, P583; KAGALWALLA AF, 1994, J CLIN GASTROENTEROL, V19, P36, DOI 10.1097/00004836-199407000-00010; Khan S N, 1992, J Perinatol, V12, P112; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Leskinen M, 1996, Duodecim, V112, P608; LUBANI MM, 1989, EUR J PEDIATR, V148, P333, DOI 10.1007/BF00444128; Mckusick V.A., 1994, MENDELIAN INHERITANC; NORIO R, 1971, Clinical Genetics, V2, P182; Norio R., 1981, BIOCULTURAL ASPECTS, P359; NUKI G, 1991, ADV EXP MED BIOL, V309, P203; PASTERNACK A, 1966, LANCET, P1047; PEARSON AJG, 1973, Q J MED, V167, P453; PERHEENTUPA J., 1965, ACTA PAEDIAT SCAND, VSuppl. 159, P119; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SHALTOUT AA, 1989, ANN TROP PAEDIATR, V9, P30, DOI 10.1080/02724936.1989.11748591; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; TOMASZEWSKI L, 1987, MAT MED POL, V4, P271; Zlotogora J, 1996, AM J HUM GENET, V58, P241	32	61	63	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					760	768		10.1086/301998	http://dx.doi.org/10.1086/301998			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718329	Green Published, Bronze			2022-12-18	WOS:000075919000013
J	Simonic, I; Gericke, GS; Ott, J; Weber, JL				Simonic, I; Gericke, GS; Ott, J; Weber, JL			Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT TRANSMISSION; LINKAGE DISEQUILIBRIUM; VARIEGATE PORPHYRIA; ALLELE FREQUENCIES; LARGE PEDIGREE; RECEPTOR GENE; SOUTH-AFRICA; GENOME; INHERITANCE; DISEASE	Because gene-mapping efforts, using large kindreds and parametric methods of analysis, for the neurologic disorder Tourette syndrome have failed, efforts are being redirected toward association studies in young, genetically isolated populations. The availability of dense marker maps makes it feasible to search for association throughout the entire genome. We report the results of such a genome scan using DNA samples from Tourette patients and unaffected control subjects from the South African Afrikaner population. To optimize mapping efficiency, we chose a two-step strategy. First, we screened pools of DNA samples from both affected and control individuals, using a dense collection of 1,167 short tandem-repeat polymorphisms distributed throughout the genome. Second, we typed those markers displaying evidence of allele frequency-distribution shifts, along with additional tightly linked markers, using DNA from each affected and unaffected individual. To reduce false positives, we tested two independent groups of case and control subjects. Strongest evidence for association (P values 10(-2) to 10(-5)) were obtained for markers within chromosomal regions encompassing D2S1790 near the chromosome 2 centromere, D6S477 on distal 6p, D8S257 on 8q, D11S933 on 11q, D14S1003 on proximal 14q, D20S1085 on distal 20q, and D21S1252 on 21q.	Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; Rockefeller Univ, New York, NY 10021 USA; MRC, Neurogenet Res Lab, Arcadia, South Africa	Rockefeller University	Weber, JL (corresponding author), Marshfield Med Res Fdn, Ctr Med Genet, 1000 N Oak Ave, Marshfield, WI 54449 USA.				NHGRI NIH HHS [HG00008] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barcellos LF, 1997, AM J HUM GENET, V61, P734, DOI 10.1086/515512; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; BROMAN KW, IN PRESS AM J HUM GE; Comings D E, 1994, Ann Clin Psychiatry, V6, P235, DOI 10.3109/10401239409149010; COMINGS DE, 1988, AM J HUM GENET, V43, P209; COMINGS DE, 1993, LANCET, V341, P906, DOI 10.1016/0140-6736(93)93123-I; COMINGS DE, 1984, AM J HUM GENET, V36, P586; DEVOR EJ, IN PRESS PSYCHIAT GE; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; Gadow K. D., 1998, CHILD SYMPTOM INVENT; Graff C, 1997, CLIN GENET, V51, P145; Grice DE, 1996, AM J HUM GENET, V59, P644; Groenewald JZ, 1998, AM J HUM GENET, V62, P1254, DOI 10.1086/301833; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; HEBEBRAND J, 1997, AM J HUM GENET, V61, P38; HEUTINK P, 1995, AM J HUM GENET, V57, P465; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Jenkins T, 1996, NAT GENET, V13, P7, DOI 10.1038/ng0596-7; JENKINS T, 1990, J MED GENET, V27, P760, DOI 10.1136/jmg.27.12.760; Kruglyak L, 1997, AM J HUM GENET, V61, P810, DOI 10.1086/514893; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; MCMAHON WM, 1992, ADV NEUROL, V58, P159; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; NOTHEN MM, 1994, AM J MED GENET, V54, P249, DOI 10.1002/ajmg.1320540311; Pacek P, 1993, PCR Methods Appl, V2, P313; PAKSTIS AJ, 1991, AM J HUM GENET, V48, P281; Patel PI, 1996, AM J HUM GENET, V59, P980; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1988, AM J HUM GENET, V43, P206; Peltonen L, 1997, GENOME RES, V7, P765, DOI 10.1101/gr.7.8.765; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; ROBERTSON MM, 1991, BRIT J PSYCHIAT, V158, P416, DOI 10.1192/bjp.158.3.416; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Starfield M, 1997, AM J HUM GENET, V61, P370, DOI 10.1086/514848; TORRINGTON M, 1984, S AFR MED J, V65, P762; VANDEWETERING BJM, 1993, J LAB CLIN MED, V121, P638; Walkup JT, 1996, AM J HUM GENET, V59, P684; Warnich L, 1996, HUM GENET, V97, P690; WILKIE PJ, 1992, ADV NEUROL, V58, P173	47	61	63	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					839	846		10.1086/302002	http://dx.doi.org/10.1086/302002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718333	Bronze, Green Published			2022-12-18	WOS:000075919000023
J	Ferlini, A; Galie, N; Merlini, L; Sewry, C; Branzi, A; Muntoni, F				Ferlini, A; Galie, N; Merlini, L; Sewry, C; Branzi, A; Muntoni, F			A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MESSENGER-RNA; MEDIATED INSERTION; DNA AMPLIFICATION; L1 ELEMENT; SEQUENCES; DELETION; LOCUS; MECHANISM; INTRON	We have identified and characterized a genomic sequence with some features typical of Alu-like mobile elements rearranged into the dystrophin gene in a family affected by X-linked dilated cardiomyopathy. The Alu-like sequence rearrangement occurred 2.4 kb downstream from the 5' end of intron 11 of the dystrophin gene. This rearrangement activated one cryptic splice site in intron 11 and produced an alternative transcript containing the Alu-like sequence and part of the adjacent Intron la, spliced between exons 11 and 12. Translation of this alternative transcript is truncated because of the numerous stop codons present in every frame of the Alu-like sequence. Only the mutant mRNA was detected in the heart muscle, but in the skeletal muscle it coexisted with the normal one. This result is supported by the immunocytochemical findings, which failed to detect dystrophin in the patient's cardiac muscle but showed expression of a reduced level of protein in the skeletal muscle. Comparative analysis of the Alu-like sequence showed high homology with other repeated-element-containing regions and with several expressed sequence tags. We suggest that this Alu-like sequence could represent a novel class of repetitive elements, reiterated and clustered with some known mobile elements-and capable of transposition. Our report underlines the complexity of the pathogenic mechanism leading to X-linked dilated cardiomyopathy but suggests that differences in tissue-specific expression of dystrophin mutations may be a common feature in this condition.	Imperial Coll Sci Technol & Med, Sch Med, Dept Paediat & Neonatal Med, London, England; Hammersmith Hosp, MRC, Ctr Clin Sci, Muscle Cell Biol Grp, London, England; Univ Bologna, Ist Malattie Apparato Cardiovasc, Bologna, Italy; Ist Ortoped Rizzoli, Bologna, Italy	Imperial College London; Imperial College London; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Ferlini, A (corresponding author), Hammersmith Hosp, Dept Paediat & Neonatal Med, Neuromuscular Unit, Du Cane Rd, London W12 0NN, England.		Merlini, Luciano/N-6478-2019; Galie, Nazzareno/F-7004-2014	Merlini, Luciano/0000-0002-1108-1198; Galie, Nazzareno/0000-0003-4271-8670; FERLINI, ALESSANDRA/0000-0001-8385-9870				ADENIYIJONES S, 1985, NATURE, V317, P81, DOI 10.1038/317081a0; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; BEGGS AH, 1990, HUM GENET, V86, P45; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; FAVOR J, 1992, MUTAT RES, V284, P53, DOI 10.1016/0027-5107(92)90024-V; Ferlini A, 1998, BIOCHEM BIOPH RES CO, V242, P401, DOI 10.1006/bbrc.1997.7976; HAHN SH, 1995, HUM MUTAT, V6, P66, DOI 10.1002/humu.1380060113; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; JANICIC N, 1995, AM J HUM GENET, V56, P880; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KLOECKENERGRUISSEM B, 1995, P NATL ACAD SCI USA, V92, P1836, DOI 10.1073/pnas.92.6.1836; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; LI L, 1993, AM J HUM GENET, V53, P140; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MCNAUGHTON JC, 1995, J MOL EVOL, V40, P127, DOI 10.1007/BF00167108; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MUNTONI F, 1995, AM J HUM GENET, V56, P151; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; NELSON KK, 1990, P NATL ACAD SCI USA, V87, P6253, DOI 10.1073/pnas.87.16.6253; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; PIZZUTI A, 1992, GENOMICS, V13, P594, DOI 10.1016/0888-7543(92)90129-G; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SEBILLON P, 1995, NUCLEIC ACIDS RES, V23, P3419, DOI 10.1093/nar/23.17.3419; SEWRY CA, 1993, NEUROMUSCULAR DISORD, V3, P141, DOI 10.1016/0960-8966(93)90006-6; TANDA S, 1991, EMBO J, V10, P407, DOI 10.1002/j.1460-2075.1991.tb07962.x; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; YOSHIDA K, 1993, MUSCLE NERVE, V16, P1161, DOI 10.1002/mus.880161104	46	61	61	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					436	446		10.1086/301952	http://dx.doi.org/10.1086/301952			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683584	Green Published, Bronze			2022-12-18	WOS:000075360800019
J	von Kleist-Retzow, JC; Cormier-Daire, V; de Lonlay, P; Parfait, B; Chretien, D; Rustin, P; Feingold, J; Rotig, A; Munnich, A				von Kleist-Retzow, JC; Cormier-Daire, V; de Lonlay, P; Parfait, B; Chretien, D; Rustin, P; Feingold, J; Rotig, A; Munnich, A			A high rate (20%-30%) of parental consanguinity in cytochrome-oxidase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-Q REDUCTASE; X-LINKED GENE; BARTH SYNDROME; COMPLEX-I; MITOCHONDRIAL; DISEASE	By studying a large series of 157 patients, we found that complex I (33%), complex IV (28%), and complex I+IV (28%) deficiencies were the most common causes of respiratory chain (RC) defects in childhood. Truncal hypotonia (36%), antenatal (20%) and postnatal (31%) growth retardation, cardiomyopathy (24%), encephalopathy (20%), and liver failure (20%) were the main clinical features in our series. No correlation between I-he type of RC defect and the clinical presentation was noted, hut complex I and complex I+IV deficiencies were significantly more frequent in cases of cardiomyopathy (P <.01) and hepatic failure (P <.05), respectively. The sex ratio (male/female) in our entire series was mostly balanced but was skewed toward males being affected with complex I deficiency (sex ratio R = 1.68). Interestingly, a high rate of parental consanguinity was observed in complex IV (20%) and complex II-IV (28%) deficiencies. When parental consanguinity was related to geographic origin, an even higher rate of inbreeding was observed in North African families (76%, P<.01). This study gives strong support to the view that an autosomal recessive mode of inheritance is involved in most cases of mitochondrial disorders in childhood, a feature that is particularly relevant to genetic counseling for this devastating condition.	Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, F-75743 Paris 15, France; Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; INSERM, U155, Unite Rech Epidemiol Genet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Munnich, A (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, 149 Rue Sevres, F-75743 Paris 15, France.		PARFAIT, Beatrice/O-7392-2017; Rötig, Agnès/G-9592-2017; cormier-daire, valerie/H-6520-2017	Rötig, Agnès/0000-0003-0589-0703; cormier-daire, valerie/0000-0002-2839-9856				Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOUVET JP, 1974, ANN GENET-PARIS, V17, P181; Buddiger PAL, 1997, AM J HUM GENET, V61, pA305; JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339; KHLAT M, 1997, OXFORD MONOGRAPHS ME, V30, P63; Parfait B, 1997, HUM GENET, V101, P247, DOI 10.1007/s004390050625; Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; ROBINSON BH, 1993, BIOCHIM BIOPHYS ACTA, V1182, P231, DOI 10.1016/0925-4439(93)90064-8; ROBINSON BH, 1987, J PEDIATR-US, V110, P216, DOI 10.1016/S0022-3476(87)80157-9; ROWLAND LP, 1991, REV NEUROL-FRANCE, V147, P467; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; TIRANTI V, 1995, HUM MOL GENET, V4, P2017, DOI 10.1093/hmg/4.11.2017; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Valnot I, 1997, AM J HUM GENET, V61, pA263; Vogel F., 1997, HUMAN GENETICS; Wong LJC, 1997, AM J HUM GENET, V61, pA324; Zhuchenko O, 1996, GENOMICS, V37, P281, DOI 10.1006/geno.1996.0561	20	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					428	435		10.1086/301957	http://dx.doi.org/10.1086/301957			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683589	Green Published, Bronze			2022-12-18	WOS:000075360800018
J	Rubio, JP; Danek, A; Stone, C; Chalmers, R; Wood, N; Verellen, C; Ferrer, X; Malandrini, A; Fabrizi, GM; Manfredi, M; Vance, J; PericakVance, M; Brown, R; Rudolf, G; Picard, F; Alonso, E; Brin, M; Nemeth, AH; Farrall, M; Monaco, AP				Rubio, JP; Danek, A; Stone, C; Chalmers, R; Wood, N; Verellen, C; Ferrer, X; Malandrini, A; Fabrizi, GM; Manfredi, M; Vance, J; PericakVance, M; Brown, R; Rudolf, G; Picard, F; Alonso, E; Brin, M; Nemeth, AH; Farrall, M; Monaco, AP			Chorea-acanthocytosis: Genetic linkage to chromosome 9q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MCLEOD SYNDROME; FRIEDREICH ATAXIA; NEUROACANTHOCYTOSIS; CHOREOACANTHOCYTOSIS; PROTEIN; PHENOTYPE; PEDIGREE; ENCODES; FAMILY; HUMANS	Chorea-acanthocytosis (CHAC) is a rare autosomal recessive disorder characterized by progressive neurodegeneration and unusual red-cell morphology (acanthocytosis), with onset in the third to fifth decade of life. Neurological impairment with acanthocytosis (neuroacanthocytosis) also is seen in abetalipoproteinemia and X-linked McLeod syndrome. Whereas the molecular etiology of McLeod syndrome has been defined (Ho et al. 1994), that of CHAC is still unknown. In the absence of cytogenetic rearrangements, we initiated a genomewide scan for linkage in 11 families, segregating for CHAC, who are of diverse geographical origin. We report here that the disease is linked, in all families, to a 6-cM region of chromosome 9q21 that is flanked by the recombinant markers GATA89a11 and D9S1843. A maximum two-point LOD score of 7.1 (theta = .00) for D9S1867 was achieved, and the linked region has been confirmed by homozygosity-by-descent, in offspring from inbred families. These findings provide strong evidence for the involvement of a single locus for CHAC and are the first step in positional cloning of the disease gene.	WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; RADCLIFFE INFIRM,DEPT CLIN NEUROL,OXFORD OX2 6HE,ENGLAND; UNIV MUNICH,NEUROL KLIN,D-80539 MUNICH,GERMANY; INST NEUROL,LONDON WC1N 3BG,ENGLAND; UNITE GENET MED,BRUSSELS,BELGIUM; CHU BORDEAUX,BORDEAUX,FRANCE; IST SCI NEUROL,SIENA,ITALY; UNIV VERONA,NEUROL CLIN,I-37100 VERONA,ITALY; DUKE UNIV,MED CTR,DURHAM,NC 27706; CECIL B DAY LAB MUSCULAR RES,CHARLESTOWN,MA; HOP UNIV STRASBOURG,STRASBOURG,FRANCE; NATL INST NEUROL & NEUROSURG MVS,DEPT GENET,MEXICO CITY,DF,MEXICO; MT SINAI MED CTR,NEW YORK,NY 10029	University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Munich; University of London; University College London; CHU Bordeaux; University of Verona; Duke University; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Icahn School of Medicine at Mount Sinai			Wood, Nicholas W/C-2505-2009; Danek, Adrian/G-7339-2011; Monaco, Anthony P/A-4495-2010	Wood, Nicholas W/0000-0002-9500-3348; Danek, Adrian/0000-0001-8857-5383; Monaco, Anthony P/0000-0001-7480-3197; Nemeth, Andrea/0000-0002-2941-7657; Rudolf, Gabrielle/0000-0002-2050-3911; RUBIO, JUSTIN/0000-0003-3750-917X; Vance, Jeffery/0000-0003-3815-8199	NINDS NIH HHS [1P01 NS-26630] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALONSO ME, 1989, CAN J NEUROL SCI, V16, P426, DOI 10.1017/S0317167100029516; BASCOMPTE JLA, 1988, ACTA HAEMATOL-BASEL, V80, P175, DOI 10.1159/000205628; BASSEN FA, 1950, BLOOD, V5, P381, DOI 10.1182/blood.V5.4.381.381; BIRD TD, 1978, ANN NEUROL, V3, P253, DOI 10.1002/ana.410030312; BRENES LG, 1990, CLIN RES, V38, pA93; BRIN MF, 1993, HDB CLIN NEUROLOGY, V19, P271; Carvajal JJ, 1996, NAT GENET, V14, P157, DOI 10.1038/ng1096-157; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FAILLACE RT, 1982, ANN INTERN MED, V96, P616, DOI 10.7326/0003-4819-96-5-616; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; FERRER X, 1990, REV NEUROL, V146, P739; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; HARDIE RJ, 1989, Q J MED, V71, P291; HARDIE RJ, 1991, BRAIN, V114, P13; HO MF, 1994, CELL, V77, P869, DOI 10.1016/0092-8674(94)90136-8; Ho MF, 1996, ANN NEUROL, V39, P672, DOI 10.1002/ana.410390518; JANKOVIC J, 1986, NEUROLOGY, V36, P1276; KAPLAN PW, 1986, ELECTROEN CLIN NEURO, V63, P349, DOI 10.1016/0013-4694(86)90019-2; Kartsounis LD, 1996, ARCH NEUROL-CHICAGO, V53, P77, DOI 10.1001/archneur.1996.00550010095022; KITO S, 1980, ARCH NEUROL-CHICAGO, V37, P514, DOI 10.1001/archneur.1980.00500570062010; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANGE H, 1976, J NEUROL SCI, V28, P401, DOI 10.1016/0022-510X(76)90114-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lench NJ, 1996, GENOMICS, V38, P199, DOI 10.1006/geno.1996.0616; LEVINE IM, 1968, ARCH NEUROL-CHICAGO, V19, P403, DOI 10.1001/archneur.1968.00480040069007; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MALANDRINI A, 1993, ACTA NEUROPATHOL, V86, P651, DOI 10.1007/BF00294306; Marsh WL., 1983, BLOOD GROUP ANTIGENS, P165; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; Ott J., 1991, ANAL HUMAN GENETIC L; PEPPARD RF, 1990, CAN J NEUROL SCI, V17, P298, DOI 10.1017/S0317167100030602; REDMAN CM, 1993, SEMIN HEMATOL, V30, P209; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SAKAI T, 1985, NEUROLOGY, V35, P1679, DOI 10.1212/WNL.35.11.1679; SAKAI T, 1991, ANN NEUROL, V29, P664, DOI 10.1002/ana.410290615; SCHWARTZ MS, 1992, J NEUROL, V239, P261; SERRA S, 1986, ITAL J NEUROL SCI, V7, P521, DOI 10.1007/BF02342031; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sobel E, 1996, AM J HUM GENET, V58, P1323; SUNG LA, 1992, J BIOL CHEM, V267, P2616; TAKASHIMA H, 1994, J NEUROL SCI, V124, P56, DOI 10.1016/0022-510X(94)90010-8; VANCE JM, 1987, AM J MED GENET, V28, P403, DOI 10.1002/ajmg.1320280219; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WITT TN, 1992, J NEUROL, V239, P302, DOI 10.1007/BF00867584	46	61	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					899	908		10.1086/514876	http://dx.doi.org/10.1086/514876			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382101	Green Published, Bronze			2022-12-18	WOS:A1997YA59100017
J	Pulkkinen, L; Bullrich, F; Czarnecki, P; Weiss, L; Uitto, J				Pulkkinen, L; Bullrich, F; Czarnecki, P; Weiss, L; Uitto, J			Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PATERNAL ISODISOMY; PRENATAL-DIAGNOSIS; NONSENSE MUTATION; LAMININ-5 LAMB3; BETA-3 CHAIN; LAMC2 GENE; GROWTH; MAP; IDENTIFICATION; ABNORMALITIES	Junctional epidermolysis bullosa (JEB) is an autosomal recessive disorder characterized by blister formation at the level of the lamina lucida within the cutaneous basement-membrane zone. Classic lethal JEB (Herlitz type [H-JEB]; OMIM 226700) is frequently associated with premature-termination-codon mutations in both alleles of one of the three genes (LAMA3, LAMC2, or LAMB3) encoding the subunit polypeptides (alpha 3, beta 3, and gamma 2) of laminin 5. In this study, we describe a unique patient with H-JEB, who was homozygous for a nonsense mutation, Q243X, in the LAMB3 gene on chromosome 1 and who had normal karyotype 46,XY. The mother was found to be a carrier of the Q243X mutation, whereas the father had two normal LAMB3 alleles. Nonpaternity was excluded by use of 11 microsatellite markers from six different chromosomes. The use of 17 partly or fully informative microsatellite markers spanning the entire chromosome 1 revealed that the patient had both maternal uniparental meroisodisomy of a 35-cM region on Iq containing the maternal LAMB3 mutation and maternal uniparental heterodisomy of other regions of chromosome 1. Thus, the results suggested that reduction to homozygosity of the Iq region containing the maternal LAMB3 mutation caused the H-JEB phenotype. The patient was normally developed at term and did not show overt dysmorphisms or malformations. This is the first description of uniparental disomy of human chromosome 1.	THOMAS JEFFERSON UNIV,DEPT DERMATOL & CUTANEOUS BIOL,JEFFERSON MED COLL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MOL PHARMACOL & BIOCHEM,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT IMMUNOL & MICROBIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOL MED,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,KIMMEL CANC INST,PHILADELPHIA,PA 19107; HENRY FORD HOSP,DEPT MED GENET,DETROIT,MI 48202	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University; Henry Ford Health System; Henry Ford Hospital					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ABRUZZO M, 1995, ENV MOL MUTAGEN S, V26, P38; BAUDOIN C, 1994, HUM MOL GENET, V3, P1909, DOI 10.1093/hmg/3.10.1909; BAUMGARTEN E, 1993, LEUKEMIA LYMPHOMA, V10, P237, DOI 10.3109/10428199309145889; Benlian P, 1996, AM J HUM GENET, V59, P431; Bernasconi F, 1996, AM J HUM GENET, V59, P1114; CASSIDY SB, 1995, ENVIRON MOL MUTAGEN, V25, P13, DOI 10.1002/em.2850250605; Dierlamm J, 1996, BLOOD, V87, P299; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; ENGEL E, 1993, AM J MED GENET, V46, P670, DOI 10.1002/ajmg.1320460613; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL JG, 1990, AM J HUM GENET, V46, P857; HOGLUND P, 1994, AM J HUM GENET, V55, P747; Kivirikko S, 1996, HUM MOL GENET, V5, P231, DOI 10.1093/hmg/5.2.231; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LEONARD JH, 1993, CANCER GENET CYTOGEN, V67, P65, DOI 10.1016/0165-4608(93)90046-O; Michaux L, 1996, CANCER GENET CYTOGEN, V88, P86, DOI 10.1016/0165-4608(95)00218-9; NIIKAWA N, 1984, AM J HUM GENET, V36, P123; PENTAO L, 1992, AM J HUM GENET, V50, P690; POLITO P, 1995, INT J CANCER, V61, P370, DOI 10.1002/ijc.2910610316; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PULKKINEN L, 1995, HUM MUTAT, V6, P77, DOI 10.1002/humu.1380060115; Pulkkinen L, 1997, MOL MED, V3, P124, DOI 10.1007/BF03401804; Robinson W. P., 1993, European Journal of Human Genetics, V1, P280; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Schlegelberger B, 1996, J CLIN ONCOL, V14, P2188; SEARLE AG, 1994, J MED GENET, V31, P1, DOI 10.1136/jmg.31.1.1; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; TIDMAN MJ, 1986, J INVEST DERMATOL, V86, P51, DOI 10.1111/1523-1747.ep12283807; Uitto J, 1996, MOL BIOL REP, V23, P35, DOI 10.1007/BF00357071; Uitto J, 1995, P 7 INT S BAS MEMBR, P257; VAILLY J, 1995, J INVEST DERMATOL, V104, P462, DOI 10.1111/1523-1747.ep12605898; VAILLY J, 1994, GENOMICS, V21, P286, DOI 10.1006/geno.1994.1263; VAILLY J, 1995, J INVEST DERMATOL, V104, P434, DOI 10.1111/1523-1747.ep12666027; VOSS R, 1989, AM J HUM GENET, V45, P373	39	61	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					611	619		10.1086/515524	http://dx.doi.org/10.1086/515524			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326326	Green Published, Bronze			2022-12-18	WOS:A1997XY52300018
J	Vehmanen, P; Friedman, LS; Eerola, H; Sarantaus, L; Pyrhonen, S; Ponder, BAJ; Muhonen, T; Nevanlinna, H				Vehmanen, P; Friedman, LS; Eerola, H; Sarantaus, L; Pyrhonen, S; Ponder, BAJ; Muhonen, T; Nevanlinna, H			A low proportion of BRCA2 mutations in Finnish breast cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE	One hundred breast cancer families were identified at the Helsinki University Central Hospital in Finland and were screened for germ-line mutations in the coding regions and splice boundaries of the BRCA2 gene. Eight families (8%) were found to carry five different mutations, all of which are predicted to prematurely truncate the protein product. These BRCA2 families have early-onset breast cancer (mean and median age = 49 years), with four of the eight families including ovarian cancer but with no families including male breast cancer. A wide spectrum of other cancers also is seen in these families. Three mutations were identified in more than one family, and haplotype analysis in the families suggested a common founder for each recurrent mutation. One recurrent mutation, 999del5, previously has been noted as a common mutation in Iceland. The relationship between the Icelandic 999del5 mutation and the Finnish 999del5 mutation was explored by comparison of families from both countries. A common haplotype covering a minimal region intragenic to the BRCA2 gene was shared between the Icelandic and the Finnish mutation carriers.	UNIV HELSINKI,CENT HOSP,DEPT OBSTET & GYNECOL,FIN-00290 HELSINKI,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT ONCOL,FIN-00290 HELSINKI,FINLAND; ADDENBROOKES HOSP,CRC,HUMAN CANC GENET GRP,CAMBRIDGE,ENGLAND	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge				Nevanlinna, Heli/0000-0002-0916-2976	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; Couch FJ, 1996, GENOMICS, V36, P86, DOI 10.1006/geno.1996.0428; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; *FINN CANC REGFFFF, 1995, PUBL CANC SOC FINL, V56; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; JENSEN OM, 1988, ATLAS CANC INCIDENCE; Johannesdottir G, 1996, CANCER RES, V56, P3663; NAROD S, 1993, LANCET, V341, P1101, DOI 10.1016/0140-6736(93)92468-9; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Rebbeck TR, 1996, AM J HUM GENET, V59, P547; Roesdahl Else, 1991, VIKINGS; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1995, NAT GENET, V11, P238	22	61	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1050	1058						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150152				2022-12-18	WOS:A1997WX76000005
J	Raymond, V				Raymond, V			Molecular genetics of the glaucomas: Mapping of the first five ''GLC'' loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							OPEN-ANGLE GLAUCOMA; DOMINANT JUVENILE GLAUCOMA; RIEGER SYNDROME; LINKAGE; HETEROGENEITY; FAMILY; REGION				Raymond, V (corresponding author), CHU LAVAL,CTR RECH,MOL ENDOCRINOL LAB,CTR HOSP,2705 BLVD LAURIER,QUEBEC CITY,PQ G1V 4G2,CANADA.							Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; BENEDICT TWG, 1842, ABHANDLUNGEN GEBIETE; Clepet C, 1996, EUR J HUM GENET, V4, P250; CROMBIE A L, 1964, Br J Ophthalmol, V48, P143, DOI 10.1136/bjo.48.3.143; DICKENS CJ, 1996, GLAUCOMAS, V2, P729; FRANCOIS J, 1980, J FR OPHTALMOL, V3, P429; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; Gencik A, 1989, Dev Ophthalmol, V16, P76; GOLDWYN R, 1970, ARCH OPHTHALMOL-CHIC, V84, P579; GORIN G, 1977, OPHTHALMOLOGY SERIES, V1; GRAFF C, 1995, HUM GENET, V96, P285; GROSSKREUTZ C, 1994, INT OPHTHALMOL CLIN, V34, P173, DOI 10.1097/00004397-199403430-00016; HARRIS D, 1965, AM J OPHTHALMOL, V60, P91, DOI 10.1016/0002-9394(65)92398-6; HEON E, 1995, HUM MOL GENET, V4, P1435, DOI 10.1093/hmg/4.8.1435; HOSKINS HD, 1989, DEV INFANTILE GLAUCO; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; Johnson AT, 1996, OPHTHALMOLOGY, V103, P808; JOHNSON AT, 1996, GLAUCOMAS, V1, P39; LEE DA, 1985, ANN OPHTHALMOL, V17, P739; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; Mckusick V.A., 1994, MENDELIAN INHERITANC; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Meyer A, 1996, HUM GENET, V98, P567, DOI 10.1007/s004390050260; MEYER A, 1994, CR ACAD SCI III-VIE, V317, P565; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; Phillips JC, 1996, AM J HUM GENET, V59, P613; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shields M, 1996, GLAUCOMAS, V2, P717; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stokes WH, 1940, ARCH OPHTHALMOL-CHIC, V24, P885, DOI 10.1001/archopht.1940.00870050035002; Sunden SLF, 1996, GENOME RES, V6, P862, DOI 10.1101/gr.6.9.862; THYLEFORS B, 1994, B WORLD HEALTH ORGAN, V72, P323; WAARDENBURG P. J., 1950, GENETICA, V25, P79; WERNER EB, 1996, GLAUCOMAS, V2, P769; Wiggs JL, 1995, OPHTHALMOLOGY, V102, P1782, DOI 10.1016/S0161-6420(95)30793-2; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; Wilson RM., 1996, GLAUCOMAS, P753; Wirtz MK, 1997, AM J HUM GENET, V60, P296	43	61	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					272	277						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012399				2022-12-18	WOS:A1997WE93100005
J	Subramanian, PS; Nelson, DL; Chinault, AC				Subramanian, PS; Nelson, DL; Chinault, AC			Large domains of apparent delayed replication timing associated with triplet repeat expansion at FRAXA and FRAXE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; DE-NOVO DELETION; MENTAL-RETARDATION; FMR1 GENE; CGG REPEAT; HETEROZYGOUS CARRIERS; INSITU HYBRIDIZATION; DNA METHYLATION; SITE; IDENTIFICATION	Trinucleotide repeat expansions have been implicated in the causation of a number of neurodegenerative disorders. In the case of fragile X syndrome, full expansion of the FMR1 repeat element (CGG)(n) has also been correlated with replication timing delay of the locus and proximal flanking sequences in male lymphoblasts. To define more extensively this altered region of DNA replication, as well as to extend these studies to female cells containing premutant and mutant alleles, study of the replication timing properties of a > 2-Mb zone in the FRAXA region (Xq27.3-q28) was undertaken by using a FISH technique. In this assay, relative times of replication of specific loci are inferred from the ratios of singlet and doublet hybridization signals in interphase nuclei. In all individuals with a full expansion of the trinucleotide repeat, a large (1-1.2-Mb) region of delayed timing was observed; the apparent timing of the earlier-replicating allele in female cells in this region was intermediate between normal and affected alleles in males, which is in accordance with expectations of a mixed population of cells resulting from random X inactivation. In addition, expansion of the nearby FRAXE locus also was found to correlate with replication timing delay, although the extent of the altered region was somewhat less. Trinucleotide repeat expansion thus may be acting in the Xq27.3-q28 region to alter long-range chromatin structure that could influence transcription of gene sequences within the affected domain.	BAYLOR COLL MED,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine				Subramanian, Prem/0000-0001-5824-8322	NEI NIH HHS [EY07102-05S3] Funding Source: Medline; NIGMS NIH HHS [GM53033, GM37187] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053033, R01GM037187] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOGGS BA, 1994, P NATL ACAD SCI USA, V91, P6083, DOI 10.1073/pnas.91.13.6083; Chakrabarti L, 1996, HUM MOL GENET, V5, P275, DOI 10.1093/hmg/5.2.275; CLARKE A, 1992, AM J MED GENET, V43, P299, DOI 10.1002/ajmg.1320430146; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DHAR V, 1989, MOL CELL BIOL, V9, P3524, DOI 10.1128/MCB.9.8.3524; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; FRYNS JP, 1988, AM J MED GENET, V30, P401, DOI 10.1002/ajmg.1320300140; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1995, AM J HUM GENET, V56, P907; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; HAMEL BCJ, 1994, AM J HUM GENET, V55, P923; HANSEN RS, 1995, HUM MOL GENET, V4, P813; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HIRST M, 1995, AM J HUM GENET, V56, P67; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; KAWAME H, 1995, HUM MOL GENET, V4, P2287, DOI 10.1093/hmg/4.12.2287; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LAIRD CD, 1987, GENETICS, V117, P587; LICHTER P, 1991, GENET ANAL-BIOMOL E, V8, P24, DOI 10.1016/1050-3862(91)90005-C; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; MEIJER H, 1994, HUM MOL GENET, V3, P615; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NUSSBAUM RL, 1986, AM J MED GENET, V23, P715, DOI 10.1002/ajmg.1320230162; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OHASHI H, 1990, AM J HUM GENET, V47, P988; QUAN F, 1995, AM J HUM GENET, V56, P1042; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RIGGS AD, 1990, PHILOS T R SOC B, V326, P285, DOI 10.1098/rstb.1990.0012; ROSENBERG C, 1991, AM J MED GENET, V38, P421, DOI 10.1002/ajmg.1320380255; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; TORCHIA BS, 1994, AM J HUM GENET, V55, P96; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WEBB T, 1992, AM J MED GENET, V43, P1057, DOI 10.1002/ajmg.1320430633; WILHELM D, 1988, AM J MED GENET, V30, P407, DOI 10.1002/ajmg.1320300141; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140; YU WD, 1990, HUM GENET, V85, P590	48	61	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					407	416						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755928				2022-12-18	WOS:A1996VM28800017
J	Villard, L; Toutain, A; Lossi, AM; Gecz, J; Houdayer, C; Moraine, C; Fontes, M				Villard, L; Toutain, A; Lossi, AM; Gecz, J; Houdayer, C; Moraine, C; Fontes, M			Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION; INACTIVATION; LINKAGE; REPEAT	We have previously reported the isolation of a gene from Xq13 that codes for a putative regulator of transcription (XNP) and has now been shown to be the gene involved in the X-linked alpha-thalassemia with mental retardation (ATR-X) syndrome. The widespread expression and numerous domains present in the putative protein suggest that this gene could be involved in other phenotypes. The predominant expression of the gene in the developing brain, as well as its association with neuron differentiation, indicates that mutations of this gene might result in a mental retardation (MR) phenotype. In this paper we present a family with a splice junction mutation in XNP that results in the skipping of an exon and in the introduction of a stop codon in the middle of the XNP-coding sequence. Only the abnormal transcript is expressed in two first cousins presenting the classic ATR-X phenotype (with alpha-thalassemia and HbH inclusions). In a distant cousin presenting a similar dysmorphic MR phenotype but not having thalassemia, similar to 30% of the XNP transcripts are normal. These data demonstrate that the mode of action of the XNP gene product on globin expression is distinct from its mode of action in brain development and facial morphogenesis and suggest that other dysmorphic mental retardation phenotypes, such as Juberg-Marsidi or some sporadic cases of Coffin-Lowry, could be due to mutations in XNP.	INSERM U406,F-13385 MARSEILLE 5,FRANCE; HOP BRETONNEAU,UNITE GENET,TOURS,FRANCE; ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET,ADELAIDE,SA,AUSTRALIA	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours			Gecz, Jozef/X-3469-2019; Villard, Laurent/E-3941-2016	Gecz, Jozef/0000-0002-7884-6861; Villard, Laurent/0000-0001-6657-5008; Toutain, Annick/0000-0002-5999-5300; Houdayer, Claude/0000-0002-5190-0389				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GECZ J, 1994, HUM MOL GENET, V3, P39, DOI 10.1093/hmg/3.1.39; GECZ J, 1993, HUM MOL GENET, V2, P1389, DOI 10.1093/hmg/2.9.1389; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; HOUDAYER C, 1993, ANN GENET-PARIS, V36, P194; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; LEFORT G, 1993, ANN GENET-PARIS, V36, P200; MURRU S, 1991, BLOOD, V77, P1342; NERI G, 1994, AM J MED GENET, V51, P542, DOI 10.1002/ajmg.1320510451; SAUGIERVEBER P, 1993, AM J HUM GENET, V52, P1040; SAUGIERVEBER P, 1995, AM J MED GENET, V55, P300, DOI 10.1002/ajmg.1320550310; SCHWARTZ CE, 1993, AM J HUM GENET, V52, P1025; SCHWARTZ CE, 1992, AM J MED GENET, V43, P467, DOI 10.1002/ajmg.1320430170; SCHWARTZ CE, 1992, AM J MED GENET, V43, P454; STAYTON CL, 1994, HUM MOL GENET, V3, P1957, DOI 10.1093/hmg/3.11.1957; VILLARD L, 1995, GENOMICS, V26, P115, DOI 10.1016/0888-7543(95)80089-5	20	61	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					499	505						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644709				2022-12-18	WOS:A1996TV56400008
J	Ducros, A; Nagy, T; Alamowitch, S; Nibbio, A; Joutel, A; Vahedi, K; Chabriat, H; IbaZizen, MT; Julien, J; Davous, P; Goas, JY; LyonCaen, O; Dubois, B; Ducrocq, X; Salsa, F; Ragno, M; Burkhard, P; Bassetti, C; Hutchinson, M; Verin, M; Viader, F; Chapon, F; Levasseur, M; Mas, JL; Delrieu, O; Maciazek, J; Prieur, M; Mohrenweiser, H; Bach, JF; Bousser, MG; TournierLasserve, E				Ducros, A; Nagy, T; Alamowitch, S; Nibbio, A; Joutel, A; Vahedi, K; Chabriat, H; IbaZizen, MT; Julien, J; Davous, P; Goas, JY; LyonCaen, O; Dubois, B; Ducrocq, X; Salsa, F; Ragno, M; Burkhard, P; Bassetti, C; Hutchinson, M; Verin, M; Viader, F; Chapon, F; Levasseur, M; Mas, JL; Delrieu, O; Maciazek, J; Prieur, M; Mohrenweiser, H; Bach, JF; Bousser, MG; TournierLasserve, E			Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEMENTIA; STROKES; MAPS	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a recently identified autosomal dominant cerebral arteriopathy characterized by the recurrence of subcortical infarcts leading to dementia. A genetic linkage analysis conducted in two large families recently allowed us to map the affected gene on chromosome 19 in a 12-cM interval bracketed by D19S221 and D19S215. In the present study, these first 2 families and 13 additional ones, including a total of 199 potentially informative meiosis, have been genotyped with eight polymorphic markers located between D19S221 and D19S215. All families were linked to chromosome 19. The highest combined lod score (Z(max) = 37.24 at theta = .01) was obtained with marker D19S841, a new CA(n) microsatellite marker that we isolated from chromosome 19 cosmids. The recombinant events observed within these families were used to refine the genetic mapping of CADASIL within a 2-cM interval that is now bracketed by D19S226 and D19S139 on 19p13.1. These data strongly suggest the genetic homogeneity of this recently identified condition and establish the value of its clinical and neuroimaging diagnostic criteria. Besides their importance for the ongoing positional cloning of the CADASIL gene, these data help to refine the genetic mapping of CADASIL relative to familiar hemiplegic migraine and hereditary paroxysmal cerebellar ataxia, conditions that we both mapped within the same chromosome 19 region.	CHU ST ANTOINE, INSERM, U25, PARIS, FRANCE; CHU ST ANTOINE, SERV NEUROL, PARIS, FRANCE; IRM HOP QUINZE VINGT, PARIS, FRANCE; HOP ARGENTEUIL, ARGENTEUIL, FRANCE; CHU PITIE SALPETRIERE, PARIS, FRANCE; HOP ORSAY, ORSAY, FRANCE; CTR HOSP ST ANNE, PARIS, FRANCE; LAB CYTOGENET, PARIS, FRANCE; HOP HAUT LEVEQUE, PESSAC, FRANCE; CHU BREST, F-29285 BREST, FRANCE; CHU NANCY, NANCY, FRANCE; OSPED CIVILE, BASSANO DEL GRAPPA, ITALY; C&C MAZZONI HOSP, ASCOLI PISCENO, ITALY; HOP CANTONAL GENEVA, CH-1211 GENEVA, SWITZERLAND; HOP BERN, BERN, SWITZERLAND; ST VINCENTS HOSP, DUBLIN 4, IRELAND; CHU RENNES, RENNES, FRANCE; CHU CAEN, CAEN, FRANCE; LAWRENCE LIVERMORE NATL LAB, LIVERMORE, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU Brest; CHU de Nancy; University of Geneva; University College Dublin; CHU Rennes; CHU de Caen NORMANDIE; Universite de Caen Normandie; United States Department of Energy (DOE); Lawrence Livermore National Laboratory			Tournier-Lasserve, Elisabeth/N-7134-2017; Joutel, Anne/K-5601-2017; DUCROS, Anne/D-1899-2010; Chabriat, Hugues/G-5699-2010	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Joutel, Anne/0000-0003-3963-3860; DUCROS, Anne/0000-0001-5560-5013; Chabriat, Hugues/0000-0001-8436-6074; Bassetti, Claudio/0000-0002-4535-0245; hutchinson, michael/0000-0002-8675-1723				BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; COLMANT HJ, 1980, ZENTRALBL ALLG PATHO, V124, P163; DAVOUS P, 1991, REV NEUROL-FRANCE, V147, P376; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DUCROS A, 1995, D19S841 POLYMORPHIC; GRAY F, 1994, NEUROPATH APPL NEURO, V20, P22, DOI 10.1111/j.1365-2990.1994.tb00953.x; GUTIERREZMOLINA M, 1994, ACTA NEUROPATHOL, V87, P98; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; JEN J, 1995, NEUROLOGY, V45, pA294; JOUTEL A, 1994, AM J HUM GENET, V55, P1166; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; JUNG HH, 1995, J NEUROL NEUROSUR PS, V59, P138, DOI 10.1136/jnnp.59.2.138; KRAMER PL, 1995, AM J HUM GENET, V57, P182; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MAS JL, 1992, NEUROLOGY, V42, P1015, DOI 10.1212/WNL.42.5.1015; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OPHOFF RA, 1994, GENOMICS, V22, P21, DOI 10.1006/geno.1994.1340; Ott J., 1991, ANAL HUMAN GENETIC L; RAGNO M, 1995, ANN NEUROL, V38, P231, DOI 10.1002/ana.410380216; SABBADINI G, 1995, BRAIN, V118, P207, DOI 10.1093/brain/118.1.207; SALVI F, 1992, ITAL J NEUROL SCI, V13, P135, DOI 10.1007/BF02226962; SONNINEN V, 1987, EUR NEUROL, V27, P209, DOI 10.1159/000116158; SOURANDER P, 1977, ACTA NEUROPATHOL, V39, P247, DOI 10.1007/BF00691704; STCLAIR D, 1995, J MED GENET, V32, P57, DOI 10.1136/jmg.32.1.57; STEVENS DL, 1977, LANCET, V1, P1364; TEH BT, 1995, AM J HUM GENET, V56, P1443; TOURNIERLASSERVE E, 1991, STROKE, V22, P1297, DOI 10.1161/01.STR.22.10.1297; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; VAHEDI K, 1995, ANN NEUROL, V37, P289, DOI 10.1002/ana.410370304; VONBREDERLOW B, 1995, HUM MOL GENET, V4, P279, DOI 10.1093/hmg/4.2.279; WEBER JL, 1989, AM J HUM GENET, V44, P388; YAMAMURA T, 1987, J NEUROL SCI, V78, P175, DOI 10.1016/0022-510X(87)90059-1	34	61	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					171	181						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554054				2022-12-18	WOS:A1996TL69700021
J	MIGEON, BR; DUNN, MA; THOMAS, G; SCHMECKPEPER, BJ; NAIDU, S				MIGEON, BR; DUNN, MA; THOMAS, G; SCHMECKPEPER, BJ; NAIDU, S			STUDIES OF X-INACTIVATION AND ISODISOMY IN TWINS PROVIDE FURTHER EVIDENCE THAT THE X-CHROMOSOME IS NOT INVOLVED IN RETT-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; DUCHENNE MUSCULAR-DYSTROPHY; GENETICS; FAMILIES; PATTERNS; CARRIER; SEARCH; GIRLS; DNA	Rett syndrome (RS), a progressive encephalopathy with onset in infancy, has been attributed to an X-linked mutation, mainly on the basis of its occurrence almost exclusively in females and its concordance in female MZ twins. The underlying mechanisms proposed are an X-linked dominant mutation with male lethality, uniparental disomy of the X chromosome, and/or some disturbance in the process of X inactivation leading to unequal distributions of cells expressing maternal or paternal alleles (referred to as a ''nonrandom'' or ''skewed'' pattern of X inactivation). To determine if the X chromosome is in fact involved in RS, we studied a group of affected females including three pairs of MZ twins, two concordant for RS and one uniquely discordant for RS. Analysis of X-inactivation patterns confirms the frequent nonrandom X inactivation previously observed in MZ twins but indicates that this is independent of RS. Analysis of 29 RS females reveals not one instance of uniparental X disomy, extending the observations previously reported. Therefore, our findings contribute no support for the hypothesis that RS is an X-linked disorder. Furthermore, the concordant phenotype in most MZ female twins with RS, which has not been observed in female twins with known X-linked mutations, argues against an X mutation.	JOHNS HOPKINS UNIV,CTR MED GENET,BALTIMORE,MD; JOHNS HOPKINS UNIV,DEPT PEDIAT,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT MED,BALTIMORE,MD; JOHNS HOPKINS UNIV,DEPT NEUROL,BALTIMORE,MD 21218; KENNEDY KREIGER INST,BALTIMORE,MD	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NICHD NIH HHS [HD2448, HD05465] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKESSON HO, 1992, AM J MED GENET, V42, P104, DOI 10.1002/ajmg.1320420121; ALLEN LS, 1992, P NATL ACAD SCI USA, V89, P7199, DOI 10.1073/pnas.89.15.7199; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ANVRET M, 1994, CLIN GENET, V45, P274; ANVRET M, 1993, RETT SYNDROME CLIN B, P99; BENEDETTI L, 1992, AM J MED GENET, V44, P121, DOI 10.1002/ajmg.1320440131; BIAS WB, 1986, AM J HUM GENET, V39, P584; Boklage C E, 1981, Prog Clin Biol Res, V69A, P155; BUHLER EM, 1990, AM J MED GENET, V36, P126, DOI 10.1002/ajmg.1320360125; BURN J, 1986, J MED GENET, V23, P494, DOI 10.1136/jmg.23.6.494; CAMUS P, 1994, AM J MED GENET, V50, P307, DOI 10.1002/ajmg.1320500321; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; COLEMAN M, 1987, BRAIN DEV-JPN, V9, P475, DOI 10.1016/S0387-7604(87)80067-0; COLEMAN M, 1988, J MENT DEFIC RES, V32; COMINGS DE, 1986, AM J MED GENET, V24, P383; FEENER CA, 1991, AM J HUM GENET, V48, P621; FRANCESCHINI P, 1993, AM J MED GENET, V46, P353, DOI 10.1002/ajmg.1320460327; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P521, DOI 10.1001/archneur.1985.04060060019009; Goodship J. A., 1992, American Journal of Human Genetics, V51, pA120; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; JORGENSEN AL, 1992, AM J HUM GENET, V51, P291; KILLIAN W, 1986, AM J MED GENET, V24, P369; KRUYER H, 1994, AM J HUM GENET, V54, P437; LUBINSKY MS, 1991, LANCET, V337, P1288, DOI 10.1016/0140-6736(91)92956-3; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1994, AM J HUM GENET, V55, P497; MURPHY M, 1986, AM J MED GENET, V24, P73; NANCE WE, 1990, AM J HUM GENET, V46, P646; Rett A., 1966, WIENER MED WOCHENSCH, V116, P723; RICCARDI VM, 1986, AM J MED GENET, V24, P389; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; RICHARDS CS, 1990, AM J HUM GENET S, V47, pA105; RIVKIN MJ, 1992, BRAIN DEV-JPN, V14, P273, DOI 10.1016/S0387-7604(12)80247-6; SCHWENGEL DA, 1994, GENOMICS, V22, P46, DOI 10.1006/geno.1994.1344; TUCKERMAN E, 1985, J MED GENET, V22, P85, DOI 10.1136/jmg.22.2.85; WEBB T, 1993, CLIN GENET, V44, P236; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WITTENGERSTROM I, 1992, DEV MED CHILD NEUROL, V34, P1022; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	41	61	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					647	653						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887418				2022-12-18	WOS:A1995QK91800013
J	HAMEL, BCJ; SMITS, APT; DEGRAAFF, E; SMEETS, DFCM; SCHOUTE, F; EUSSEN, BHJ; KNIGHT, SJL; DAVIES, KE; ASSMANHULSMANS, CFCH; OOSTRA, BA				HAMEL, BCJ; SMITS, APT; DEGRAAFF, E; SMEETS, DFCM; SCHOUTE, F; EUSSEN, BHJ; KNIGHT, SJL; DAVIES, KE; ASSMANHULSMANS, CFCH; OOSTRA, BA			SEGREGATION OF FRAXE IN A LARGE FAMILY - CLINICAL, PSYCHOMETRIC, CYTOGENETIC, AND MOLECULAR-DATA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION; FMR-1 GENE; 2 FAMILIES; CGG REPEAT; CPG ISLAND; SITE; DNA; IDENTIFICATION; EXPRESSION	During an ongoing study on X-linked mental retardation, we ascertained a large family in which mild mental retardation was cosegregating with a fragile site at Xq27-28. Clinical, psychometric, cytogenetic, and molecular studies were performed. Apart from mild mental retardation, affected males and females did not show a specific clinical phenotype. Psychometric assessment of four representative affected individuals revealed low academic achievements, with verbal and performance IQs of 61-75 and 70-82, respectively. Cytogenetically the fragile site was always present in affected males and was not always present in affected females. With FISH the fragile site was located within the FRAXE region. The expanded GCC repeat of FRAXE was seen in affected males and females either as a discrete band or as a broad smear. No expansion was seen in unaffected males, whereas three unaffected females did have an enlarged GCC repeat. Maternal transmission of FRAXE may lead to expansion or contraction of the GCC repeat length, whereas in all cases of paternal transmission contraction was seen. In striking contrast to the situation in fragile X syndrome, affected males may have affected daughters. In addition, there appears to be no premutation of the FRAXE GCC repeat, since in the family studied here al males lacking the normal allele were found to be affected.	UNIV NIJMEGEN HOSP,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND	Radboud University Nijmegen; Erasmus University Rotterdam; University of Oxford	HAMEL, BCJ (corresponding author), UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		de Graaff, Esther/D-3287-2011; Smeets, D.F.C.M./L-4653-2015	Knight, Samantha/0000-0002-6047-3462				BEERY KE, 1989, DEV REST VISUAL MOTO; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BOURDON B, 1988, BOURDON VOS TEST; BRAINARD SS, 1991, AM J MED GENET, V38, P505, DOI 10.1002/ajmg.1320380273; BRUS B, 1979, EEN MINUUT TEST; DAKER MG, 1981, LANCET, V1, P780; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; FRIJNS JP, 1989, FRAGILE X SYNDROME, P1; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEESEN H, 1974, SCHIEDAMSE REKENTEST; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; Kema G. N., 1987, GRONINGER SCH ONDERZ; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; KNIGHT SJL, 1994, AM J HUM GENET, V55, P81; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; Koppitz E. M., 1964, BENDER GESTALT TEST; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1214; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1992, AM J MED GENET, V43, P224, DOI 10.1002/ajmg.1320430136; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OJEMAN PC, 1977, REKENBLAD OJEMAN; OOSTRA BA, 1993, J MED GENET, V30, P410, DOI 10.1136/jmg.30.5.410; OOSTRA BA, 1993, GENOME ANAL GENOME M, V6, P45; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROMAIN DR, 1992, CLIN GENET, V41, P33; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; STINISSEN J, 1970, WECHSLER ADULT INTEL; STRUIKSMA A, 1986, DIAGNOSTIEK TECHNISC; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; VANDENBERG R, 1977, AVI TOETSKAARTEN; VANDERSTEENE G, 1986, WECHSLER INTELLIGENC; VERKERK AJM, 1992, AM J MED GENET, V43, P17; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V329, P624; VOELCKEL MA, 1989, HUM GENET, V81, P353, DOI 10.1007/BF00283690; Wiegersma S., 1971, LEESVAARDIGHEIDSTEST; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	41	61	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					923	931						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977354				2022-12-18	WOS:A1994QB68200011
J	CHIPEV, CC; YANG, JM; DIGIOVANNA, JJ; STEINERT, PM; MAREKOV, L; COMPTON, JG; BALE, SJ				CHIPEV, CC; YANG, JM; DIGIOVANNA, JJ; STEINERT, PM; MAREKOV, L; COMPTON, JG; BALE, SJ			PREFERENTIAL SITES IN KERATIN-10 THAT ARE MUTATED IN EPIDERMOLYTIC HYPERKERATOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-BASIS; MUTATIONS; SUBDOMAIN; SEQUENCE; LINKAGE; CLUSTER; BULLOSA; PEPTIDE; PCR; END	Epidermolytic hyperkeratosis (EH) is a rare autosomal dominant skin disease. Recent studies in our laboratory established genetic linkage to the type II keratin gene locus on chromosome 12q in one family with EH and identified a single amino acid mutation in keratin 1 that is responsible for the disease. Other point mutations in the keratin 1 or keratin 10 genes have now been reported in other patients with EH. We have examined a series of probands with EH in order to develop a catalog of mutations in keratin 10. Using direct sequencing of PCR-amplified genomic DNA, we have identified mutations in six families, in which five mutations occur in the beginning of the 1A rod domain of keratin 10-namely, two Arg10 to His, one Arg10 to Cys, an Asn8 to His, and a Tyr14 to Asp. This region contains highly conserved residues among all keratins. An additional mutation (Leu103 to Gln) was found in the conserved region late in the 2B rod domain in keratin 10. We developed several allele-specific assays to assess the frequency of these mutations in the general population. No evidence was found for the presence of such changes in unaffected individuals. In vitro functional assays performed with peptides corresponding to the 1A mutations in these families show severely diminished capacity to disaggregate preformed keratin intermediate filaments, in comparison with a wild-type control peptide. Results from this work support the hypothesis that the beginning of the 1A rod domain segment in keratin 10 contains preferential sites for disease-causing mutation in EH. This should be of considerable use when developing prenatal diagnostic tests and biologically based therapies for this disease.	NIAMSD,SKIN BIOL BRANCH,BETHESDA,MD 20892; NCI,DERMATOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				DiGiovanna, John J./0000-0002-2750-2313				ANTON-LAMPBRECHT I, 1983, J INVEST DERMATOL S, V81, P149; BIJVOET SM, 1992, HUM MOL GENET, V1, P541; BONIFAS JM, 1992, J INVEST DERMATOL, V99, P524, DOI 10.1111/1523-1747.ep12658061; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COMPTON JG, 1992, NAT GENET, V1, P301, DOI 10.1038/ng0792-301; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DIGIOVANNA JJ, 1993, J INVEST DERMATOL, V100, P538; DIGIOVANNA JJ, UNPUB CLIN HETEROGEN; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; GOLDSMITH LA, 1976, PROG MED GENET, V1, P185; HATZFELD M, 1992, J CELL BIOL, V116, P157, DOI 10.1083/jcb.116.1.157; ISHIDAYAMAMOTO A, 1992, J INVEST DERMATOL, V99, P19, DOI 10.1111/1523-1747.ep12611391; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KORGE BP, 1992, J INVEST DERMATOL, V99, P697, DOI 10.1111/1523-1747.ep12614149; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; MCLEAN WHI, 1993, J INVEST DERMATOL, V100, P516; REIGER M, 1988, J MOL BIOL, V204, P841; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; WILLIAMS ML, 1987, DERMATOL CLIN, P155; YANG JM, IN PRESS J INVEST DE; ZHOU XM, 1988, J BIOL CHEM, V263, P15584	29	61	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					179	190						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	7508181				2022-12-18	WOS:A1994MU31500003
J	GOLDIN, LR; WEEKS, DE				GOLDIN, LR; WEEKS, DE			2-LOCUS MODELS OF DISEASE - COMPARISON OF LIKELIHOOD AND NONPARAMETRIC LINKAGE METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; PEDIGREE-MEMBER METHOD; LOD SCORE; STRATEGIES; LOCUS; POWER	The power to detect linkage for likelihood and nonparametric (Haseman-Elston, affected-sib-pair, and affected-pedigree-member) methods is compared for the case of a common, dichotomous trait resulting from the segregation of two loci. Pedigree data for several two-locus epistatic and heterogeneity models have been simulated, with one of the loci linked to a marker locus. Replicate samples of 20 three-generation pedigrees (16 individuals/pedigree) were simulated and then ascertained for having at least 6 affected individuals. The power of linkage detection calculated under the correct two-locus model is only slightly higher than that under a single locus model with reduced penetrance. As expected, the nonparametric linkage methods have somewhat lower power than does the lod-score method, the difference depending on the mode of transmission of the linked locus. Thus, for many pedigree linkage studies, the lod-score method will have the best power. However, this conclusion depends on how many times the lod score will be calculated for a given marker. The Haseman-Elston method would likely be preferable to calculating lod scores under a large number of genetic models (i.e., varying both the mode of transmission and the penetrances), since such an analysis requires an increase in the critical value of the lod criterion. The power of the affected-pedigree-member method is lower than the other methods, which can be shown to be largely due to the fact that marker genotypes for unaffected individuals are not used.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	GOLDIN, LR (corresponding author), NIMH,CLIN NEUROGENET BRANCH,BLDG 10,ROOM 3N218,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000719] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41RR03655] Funding Source: Medline; NHGRI NIH HHS [HG00719] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P349, DOI 10.1002/gepi.1370060205; AMOS CI, 1988, LSU NEW ORLEANS; AMOS CL, 1989, GENETIC ANAL WORKSHO, V6, P207; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DEMENAIS FM, 1989, MULTIPOINT MAPPING L, V6, P201; Elston R C, 1981, Adv Hum Genet, V11, P63; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GOLDIN LR, 1992, GENET EPIDEMIOL, V9, P61, DOI 10.1002/gepi.1370090107; GOLDIN LR, IN PRESS NEW GENETIC; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MACLEAN CJ, 1993, AM J HUM GENET, V52, P354; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; NURNBERGER JI, 1986, MED BASIS PSYCHIATRY, P486; OLSON JM, 1993, GENET EPIDEMIOL, V10, P87, DOI 10.1002/gepi.1370100202; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1992, INSERM ATELIER 44 LI; WEEKS DE, 1991, 23RD P S INT SEATTL, P386; 1992, STATISTICAL ANAL GEN	31	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					908	915						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213819				2022-12-18	WOS:A1993LY62700015
J	ABDALLA, JA; CASLEY, WL; COUSIN, HK; HUDSON, AJ; MURPHY, EG; CORNELIS, FC; HASHIMOTO, L; EBERS, GC				ABDALLA, JA; CASLEY, WL; COUSIN, HK; HUDSON, AJ; MURPHY, EG; CORNELIS, FC; HASHIMOTO, L; EBERS, GC			LINKAGE OF THOMSEN DISEASE TO THE T-CELL-RECEPTOR BETA (TCRB) LOCUS ON CHROMOSOME-7Q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; RECESSIVE GENERALIZED MYOTONIA; POLYMERASE CHAIN-REACTION; CHANNEL ALPHA-SUBUNIT; PARAMYOTONIA-CONGENITA; GENE; DNA; IDENTIFICATION; DYSTROPHY; MUTATION	The chromosomal localization of the gene for Thomsen disease, an autosomal dominant form of myotonia congenita, is unknown. Electrophysiologic data in Thomsen disease point to defects in muscle-membrane ion-channel function. A mouse model of myotonia congenita appears to result from transposon inactivation of a muscle chloride-channel gene which maps to a region of mouse chromosome 6. The linkage group containing this gene includes several loci which have human homologues on human chromosome 7q31-35 (synteny), and this is a candidate region for the Thomsen disease locus. Linkage analysis of Thomsen disease to the T-cell-receptor beta (TCRB) locus at 7q35 was carried out in four pedigrees (25 affected and 23 unaffected individuals) by using a PCR-based dinucleotide repeat polymorphism in the TCRB gene. Two-point linkage analysis between Thomsen disease and TCRB showed a maximum cumulative lod score of 3.963 at a recombination fraction of .10 (1-lod support interval .048-.275). We conclude that the Thomsen disease locus is linked to the TCRB locus in these families.	UNIV WESTERN ONTARIO,UNIV HOSP,RICHARD IVEY CTR MOLEC BIOL,339 WINDERMERE RD,LONDON N6A 5A5,ONTARIO,CANADA; UNIV WESTERN ONTARIO,UNIV HOSP,DEPT CLIN NEUROL SCI,LONDON N6A 5A5,ONTARIO,CANADA; HOSP SICK CHILDREN,TORONTO M5G 1X8,ONTARIO,CANADA; NUFFIELD HOSP,DEPT MED,OXFORD,ENGLAND	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford				Ebers, George/0000-0003-4771-4177				ABDALLA JA, IN PRESS NEUROLOGY; BENDER K, 1989, CLIN GENET, V36, P92; BROOKE MH, 1986, CLIN VIEW NEUROMUSCU, P206; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EBERS GC, 1991, ANN NEUROL, V30, P810, DOI 10.1002/ana.410300610; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; FURMAN RE, 1978, ANN NEUROL, V4, P357, DOI 10.1002/ana.410040411; HUNG T, 1990, NUCLEIC ACIDS RES, V18, P4953, DOI 10.1093/nar/18.16.4953; Iaizzo P A, 1991, Neuromuscul Disord, V1, P47, DOI 10.1016/0960-8966(91)90042-Q; KOCH M, 1989, HUM GENET, V82, P163, DOI 10.1007/BF00284051; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KOCH MC, 1991, J MED GENET, V28, P583, DOI 10.1136/jmg.28.9.583; LI YX, 1991, J EXP MED, V174, P1537, DOI 10.1084/jem.174.6.1537; LIPICKY RJ, 1973, NEW DEVELOPMENTS ELE, V1, P451; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; OTT J, 1974, AM J HUM GENET, V26, P588; Ott J., 1991, ANAL HUMAN GENETIC L; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; ROPERS HH, 1991, CYTOGENET CELL GENET, V58, P751, DOI 10.1159/000133179; RUDEL R, 1989, MUSCLE NERVE, V12, P281; RUDEL R, 1990, TRENDS NEUROSCI, V13, P1, DOI 10.1016/0166-2236(90)90049-G; Sambrook J., 1989, MOL CLONING LAB MANU; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; STREIB EW, 1987, MUSCLE NERVE, V10, P603, DOI 10.1002/mus.880100704; WEBER JL, 1989, AM J HUM GENET, V44, P388	30	61	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					579	584						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1386711				2022-12-18	WOS:A1992JJ82800015
J	KLOCKER, H; KASPAR, F; EBERLE, J; UBERREITER, S; RADMAYR, C; BARTSH, G				KLOCKER, H; KASPAR, F; EBERLE, J; UBERREITER, S; RADMAYR, C; BARTSH, G			POINT MUTATION IN THE DNA-BINDING DOMAIN OF THE ANDROGEN RECEPTOR IN 2 FAMILIES WITH REIFENSTEIN SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MALE PSEUDOHERMAPHRODITISM; INSENSITIVITY; GENE; PROTEIN; PATIENT; FORM	Inadequate androgen action in genetic and gonadal males causes an intersex phenotype. We have analyzed the androgen receptor (AR) gene in male pseudohermaphrodites with normal specific binding of dihydrotestosterone in their genital skin fibroblasts. In five patients with Reifenstein syndrome we have detected a point mutation in the DNA binding domain. They are from two unrelated families and presented with perineoscrotal hypospadias and undescended testes. After puberty they showed small testes, no palpable prostate, micropenis, azoospermia, and gynecomastia. The mutation was discovered when cDNA fragments from three brothers were sequenced. For rapid detection of the mutation in heterozygous and hemizygous carriers, allele-specific PCRs and restriction-analysis techniques have been developed. Relatives of the patients, a group of normal blood donors, and other patients were screened with these methods. Among 41 intersex patients with incomplete virilization, another two brothers presenting with this mutation were identified. The mutation is a guanine-to-adenine transition at nucleotide 2314, which changes the alanine codon (GCC) immediately after the first cysteine of the second zinc finger motif of the AR into a threonine codon (ACC). The mutation was recreated in an AR expression vector, and wild-type as well as mutant ARs were expressed in COS-7 cells. Cotransfection experiments were made using a mouse mammary tumor virus-chloramphenicol acetyltransferase reporter gene. The ability of the mutant receptor to stimulate transcription of the reporter gene was reduced by about two-thirds, as compared with the wild-type receptor.			KLOCKER, H (corresponding author), UNIV INNSBRUCK,DEPT UROL,ANICHSTR 35,A-6020 INNSBRUCK,AUSTRIA.		Radmayr, Christian/AAL-5276-2020; Klocker, Helmut/AAI-7130-2020					[Anonymous], METABOLIC BASIS INHE; BROWN CJ, 1989, AM J HUM GENET, V44, P264; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; CATO ACB, 1988, EMBO J, V7, P1403, DOI 10.1002/j.1460-2075.1988.tb02957.x; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HUGHES IA, 1987, HORM RES, V28, P25, DOI 10.1159/000180921; IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; LESHIN M, 1978, J CLIN INVEST, V62, P685, DOI 10.1172/JCI109176; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MARCELLI M, 1990, J CLIN INVEST, V85, P1522, DOI 10.1172/JCI114599; MARCELLI M, 1991, J CLIN INVEST, V87, P1123, DOI 10.1172/JCI115076; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MCPHAUL MJ, 1991, FASEB J, V5, P2910, DOI 10.1096/fasebj.5.14.1752359; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; PEREZPALACIOS G, 1987, J STEROID BIOCHEM, V27, P1101, DOI 10.1016/0022-4731(87)90196-8; RISSTALPERS C, 1990, P NATL ACAD SCI USA, V87, P7866, DOI 10.1073/pnas.87.20.7866; SAI T, 1990, AM J HUM GENET, V46, P1095; SAMBROOK J, 1989, MOL CLONING LAB MANU, P1666; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; TERAKAWA T, 1990, ACTA ENDOCRINOL-COP, V123, P24, DOI 10.1530/acta.0.1230024; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2	27	61	61	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1318	1327						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598912				2022-12-18	WOS:A1992HY65400021
J	ZHOU, J; HERTZ, JM; TRYGGVASON, K				ZHOU, J; HERTZ, JM; TRYGGVASON, K			MUTATION IN THE ALPHA-5(IV) COLLAGEN CHAIN IN JUVENILE-ONSET ALPORT SYNDROME WITHOUT HEARING-LOSS OR OCULAR LESIONS - DETECTION BY DENATURING GRADIENT GEL-ELECTROPHORESIS OF A PCR PRODUCT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASEMENT-MEMBRANE; IV COLLAGEN; X-CHROMOSOME; GENE; IDENTIFICATION; LOCALIZATION; DOMAIN	A single base mutation was identified in the type IV collagen alpha-5 chain gene (COL4A5) of a Danish kindred with Alport syndrome. The 27-year-old male proband developed hematuria in childhood and terminal renal failure at the age of 25 years. He has no hearing loss or ocular lesions. Electron microscopy demonstrated splitting of the lamina densa of the glomerular basement membrane. The proband's mother has had persistent microscopic hematuria since the age of 40 years, but no other manifestations. Southern analysis of MspI-digested genomic DNA from the proband showed the absence of 1.3-kb and 0.9-kb fragments present in control DNA but the presence of a 2.2-kb variant fragment, indicating the loss of an MspI restriction site in the 3' end of the gene. The mother had all three fragments, indicating heterozygosity. PCR amplification of exon 14 (counted from the 3' end) and subsequent denaturing gradient gel electrophoresis analysis suggested a sequence variant in the proband and his mother. This was confirmed by sequencing of the PCR-amplified exon 14 region of the hemizygous proband, which demonstrated the base change G-A abolishing an MspI restriction site. Hybridization analysis with allele-specific probes confirmed the inheritance of the mutation with the phenotype. The mutation changed the GGC codon for glycine-1143 to GAC for aspartate. Substitution of glycine-1143, located in the collagenous domain of the alpha-5(IV) chain, for any other amino acid can be expected to interfere with the maintenance of the triple-helical conformation of the collagen molecule. This could, in turn, weaken the glomerular-basement-membrane framework and lead to increased permeability.	UNIV OULU,BIOCENTER,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90100 OULU 10,FINLAND; AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS,DENMARK	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Aarhus University			Hertz, Jens Michael/H-6269-2014	Hertz, Jens Michael/0000-0003-0087-4739				ABRAMS ES, IN PRESS METHODS ENZ; ALPORT AC, 1927, BRIT MED J, V1, P504; ATKIN CL, 1988, AM J HUM GENET, V42, P249; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BRUNNER H, 1988, KIDNEY INT, V34, P507, DOI 10.1038/ki.1988.210; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; ERLICH HA, 1988, NATURE, V331, P461, DOI 10.1038/331461a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLINTER FA, 1989, GENOMICS, V4, P335, DOI 10.1016/0888-7543(89)90339-X; FLINTER FA, 1987, PEDIATR NEPHROL, V1, P438, DOI 10.1007/BF00849251; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; KROLEWSKI AS, IN PRESS GENOMICS; KUIVANIEMI H, 1991, FASEB J, V5, P2053; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; SAUS J, 1988, J BIOL CHEM, V263, P13374; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SHEFFIELD VC, 1990, PCR PROTOCOLS GUIDE, P206; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y; ZHOU J, IN PRESS J BIOL CHEM; [No title captured]	27	61	66	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1291	1300						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598909				2022-12-18	WOS:A1992HY65400018
J	FARRER, LA; CUPPLES, LA; KIELY, DK; CONNEALLY, PM; MYERS, RH				FARRER, LA; CUPPLES, LA; KIELY, DK; CONNEALLY, PM; MYERS, RH			INVERSE RELATIONSHIP BETWEEN AGE AT ONSET OF HUNTINGTON DISEASE AND PATERNAL AGE SUGGESTS INVOLVEMENT OF GENETIC IMPRINTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETERMINES METHYLATION; AFFECTED PARENT; ORIGIN; CHOREA; MICE; HETEROGENEITY; TRANSMISSION; INHERITANCE; EXPRESSION; MECHANISM	It is well recognized that age at onset of Huntington disease (HD) is strongly influenced by the sex of the affected parent, and this has lead to suggestions that genetic imprinting or maternal specific factors may play a role in the expression of the disease. This study evaluated maternal and paternal ages, birth order, parental age at onset, and sex of the affected parent and grandparent in 1,764 patients in the National HD Roster by using linear-regression techniques which incorporated a weighted least-squares approach to accommodate the correlation among siblings. It was found that paternal age is negatively associated with age at onset of HD, particularly among subjects who inherit the mutant gene from grandfathers. Apparent associations between age at onset and birth order and between age at onset and maternal age were not significant after adjustment for paternal age. The paternal age effect is strongest among juvenile-onset cases and individuals with anticipation of greater-than-or-equal-to 10 years, although it is detectable across the entire age-at-onset distribution. The tendency for older fathers, including those not transmitting the HD gene, to have affected offspring with early-onset disease may be consistent with a genetic imprinting mechanism involving DNA methylation. Because paternal age in unaffected fathers is also a significant determinant of age at onset, methylation in this context might involve HD modifier genes or the normal HD allele.	BOSTON UNIV,SCH MED,SCH PUBL HLTH,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Boston University; Boston University; Indiana University System; Indiana University-Purdue University Indianapolis	FARRER, LA (corresponding author), BOSTON UNIV,SCH MED,DEPT NEUROL,80 E CONCORD ST,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Myers, Richard/0000-0002-8365-2674; Farrer, Lindsay/0000-0001-5533-4225; Cupples, L. Adrienne/0000-0003-0273-7965	NINDS NIH HHS [NS16367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOEHNKE M, 1983, AM J HUM GENET, V35, P845; BRACKENRIDGE CJ, 1975, J MED GENET, V12, P64, DOI 10.1136/jmg.12.1.64; BRACKENRIDGE CJ, 1972, J MED GENET, V9, P23, DOI 10.1136/jmg.9.1.23; BRACKENRIDGE CJ, 1978, J MED GENET, V15, P23, DOI 10.1136/jmg.15.1.23; BRACKENRIDGE CJ, 1973, J MED GENET, V10, P333, DOI 10.1136/jmg.10.4.333; BURKE W, 1976, J MED GENET, V13, P462, DOI 10.1136/jmg.13.6.462; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; DRAPER NR, 1966, APPLIED REGRESSION A, P77; DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6; ERICKSON RP, 1985, AM J HUM GENET, V37, P827; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, 1987, ARCH NEUROL-CHICAGO, V44, P109, DOI 10.1001/archneur.1987.00520130083023; HALL JG, 1983, AM J MED GENET, V16, P289, DOI 10.1002/ajmg.1320160218; HALL JG, 1990, AM J HUM GENET, V46, P857; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HOLLIDAY R, 1989, SCI AM           JUN, P60; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MASTROMAURO CA, 1989, AM J MED GENET, V33, P248, DOI 10.1002/ajmg.1320330222; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MONK M, 1987, DEVELOPMENT, V99, P371; MYERS RH, 1983, LANCET, V1, P208; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; PERICAKVANCE MA, 1983, AM J MED GENET, V14, P49, DOI 10.1002/ajmg.1320140109; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; RIDLEY RM, 1992, AM J HUM GENET, V50, P536; SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0; SAX DS, 1989, NEUROLOGY, V39, P1332, DOI 10.1212/WNL.39.10.1332; SOLTER D, 1988, ANNU REV GENET, V22, P127; STEVENS DL, 1976, THESIS U LONDON; SUDARSKY L, 1983, J MED GENET, V20, P408, DOI 10.1136/jmg.20.6.408; SURANI MAH, 1986, J EMBRYOL EXP MORPH, V97, P123; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; WILSON VL, 1987, J BIOL CHEM, V262, P9948; [No title captured]	44	61	61	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					528	535						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1531729				2022-12-18	WOS:A1992HH97400011
J	DEPREZ, RHL; GROEN, NA; VANBIEZEN, NA; HAGEMEIJER, A; VANDRUNEN, E; KOPER, JW; AVEZAAT, CJJ; BOOTSMA, D; ZWARTHOFF, EC				DEPREZ, RHL; GROEN, NA; VANBIEZEN, NA; HAGEMEIJER, A; VANDRUNEN, E; KOPER, JW; AVEZAAT, CJJ; BOOTSMA, D; ZWARTHOFF, EC			A T(4-22) IN A MENINGIOMA POINTS TO THE LOCALIZATION OF A PUTATIVE TUMOR-SUPPRESSOR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOS-ANGELES COUNTY; CLINICAL-SIGNIFICANCE; HUMAN CHROMOSOME-22; EWINGS-SARCOMA; DNA-SEQUENCE; LINKAGE; LOCUS; NEUROFIBROMATOSIS; ORGANIZATION; DELETION	Cytogenetic analysis of meningioma cells from one particular patient (MN32) displayed the stem-line karyo-type 45, XY, -1, 4p+, 22q-, 22q+, which thus had rearrangements of both chromosomes 22. The 22q+ marker appeared as a dicentric: 22 pter-->q11::1p11-->qter. The reciprocal product of this translocation has presumably been lost because it lacked a centromere. The 22q- chromosome also appeared to have lost sequences distal to band q11. We assumed that this marker could have been the result of a reciprocal translocation between chromosomes 4 and 22. To investigate the 4p+ and 22q- chromosomes in more detail, human-hamster somatic cell hybrids were constructed that segregated the 22q- and 4p+ chromosomes. Southern blot analysis with DNA from these hybrids showed that sequences from 22q were indeed translocated to 4p+ and that reciprocally sequences from 4p were translocated to 22q-, demonstrating a balanced t(4;22)(p16;q11). On the basis of these results we presume that in this tumor a tumor-suppressor gene is deleted in the case of the 22q+ marker and that the t(4;22) disrupts the second allele of this gene. The latter translocation was mapped between D22S1 and D22S15, a distance of 1 cM on the linkage map of this chromosome. The area in which we have located the translocation is within the region where the gene predisposing to neurofibromatosis 2 has been mapped.	ERASMUS UNIV,DEPT PATHOL,POB 1738,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT INTERNAL MED,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,DEPT NEUROSURG,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam								ALSAADI A, 1987, CANCER GENET CYTOGEN, V26, P127, DOI 10.1016/0165-4608(87)90140-3; AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BAKKER E, 1987, NUCLEIC ACIDS RES, V15, P9100, DOI 10.1093/nar/15.21.9100; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BUCAN M, 1990, GENOMICS, V6, P1; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CASALONE R, 1987, CANCER GENET CYTOGEN, V27, P145, DOI 10.1016/0165-4608(87)90269-X; CASARTELLI C, 1989, CANCER GENET CYTOGEN, V40, P33, DOI 10.1016/0165-4608(89)90143-X; CAVENEE WK, 1986, MUTAT RES, V168, P3, DOI 10.1016/0165-1110(86)90019-9; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHENG SV, 1989, GENOMICS, V4, P419, DOI 10.1016/0888-7543(89)90349-2; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HEISTERKAMP N, 1983, Journal of Molecular and Applied Genetics, V2, P57; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; JULIER C, 1988, AM J HUM GENET, V42, P297; KATSUYAMA J, 1986, CANCER GENET CYTOGEN, V22, P63, DOI 10.1016/0165-4608(86)90138-X; KOPER JW, 1990, CANCER RES, V50, P2604; MALTBY EL, 1988, CANCER GENET CYTOGEN, V31, P199, DOI 10.1016/0165-4608(88)90218-X; MCKEON C, 1988, CANCER RES, V48, P4307; MEESE E, 1987, HUM GENET, V77, P349, DOI 10.1007/BF00291425; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; POULSGARD L, 1989, ANTICANCER RES, V9, P109; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; REY JA, 1988, CANCER GENET CYTOGEN, V33, P275, DOI 10.1016/0165-4608(88)90036-2; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; ROULEAU GA, 1988, NUCLEIC ACIDS RES, V16, P1646, DOI 10.1093/nar/16.4.1646; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; THAYER RE, 1987, CYTOGENET CELL GENET, V45, P75, DOI 10.1159/000132433; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; VANKESSEL AHMG, 1981, CYTOGENET CELL GENET, V30, P83; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEINBERG RA, 1989, CANCER RES, V49, P3713; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505; ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2; ZHANG FR, 1990, GENOMICS, V6, P174, DOI 10.1016/0888-7543(90)90463-5	47	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					783	790						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014801				2022-12-18	WOS:A1991FK47800018
J	BLANGERO, J; MACCLUER, JW; KAMMERER, CM; MOTT, GE; DYER, TD; MCGILL, HC				BLANGERO, J; MACCLUER, JW; KAMMERER, CM; MOTT, GE; DYER, TD; MCGILL, HC			GENETIC-ANALYSIS OF APOLIPOPROTEIN A-I IN 2 DIETARY ENVIRONMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio	BLANGERO, J (corresponding author), SW FDN BIOMED RES,DEPT GENET,7620 NW LOOP 410,POB 28147,SAN ANTONIO,TX 78228, USA.		Blangero, John/ABA-7175-2021	Kammerer, Candace M/0000-0002-2841-4761	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575, F32GM012782] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28972] Funding Source: Medline; NIGMS NIH HHS [GM12782, GM31575] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; AVOGARO P, 1979, LANCET, V1, P901; BASFORD KE, 1979, THEOR APPL GENET, V55, P225, DOI 10.1007/BF00268116; BERG K, 1984, ACTA GENET MED GEMEL, V33, P349, DOI 10.1017/S0001566000005808; BERG K, 1989, CLIN GENET, V35, P437; BLANGERO J, 1989, American Journal of Human Genetics, V45, pA234; BOEHNKE M, 1987, AM J EPIDEMIOL, V125, P679, DOI 10.1093/oxfordjournals.aje.a114581; BORECKI IB, 1988, GENET EPIDEMIOL, V5, P393, DOI 10.1002/gepi.1370050604; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; Coelho A, 1985, NONHUMAN PRIMATE MOD, P125; DEBACKER G, 1982, ATHEROSCLEROSIS, V42, P197, DOI 10.1016/0021-9150(82)90150-2; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Everitt B., 1981, FINITE MIXTURE DISTR; Falconer D. S., 1981, INTRO QUANTITATIVE G; FLOW BL, 1984, J LIPID RES, V25, P469; FLOW BL, 1982, ATHEROSCLEROSIS, V43, P83, DOI 10.1016/0021-9150(82)90101-0; FLOW BL, 1981, J HERED, V172, P97; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1984, ATHEROSCLEROSIS, V51, P21, DOI 10.1016/0021-9150(84)90141-2; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; KAMMERER C, 1988, American Journal of Human Genetics, V43, pA216; KAMMERER CM, 1984, AM J MED GENET, V19, P333, DOI 10.1002/ajmg.1320190216; KAMMERER CM, 1988, GENOME S1, V30, P332; KAPRIO J, 1989, CLIN GENET, V36, P266; KONDO I, 1989, CLIN GENET, V35, P49; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; KUUSI T, 1987, ARTERIOSCLEROSIS, V7, P421, DOI 10.1161/01.ATV.7.4.421; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LEBOUEF RC, 1989, J LIPID RES, V31, P91; LEWIS DS, 1988, ARTERIOSCLEROSIS, V8, P274, DOI 10.1161/01.ATV.8.3.274; LEWONTIN RC, 1964, GENETICS, V49, P49; MACCLUER JW, 1988, AM J HUM GENET, V43, P401; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P3, DOI 10.1161/01.ATV.1.1.3; MCGILL HC, 1960, CIRC RES, V8, P670, DOI 10.1161/01.RES.8.3.670; MOLL PP, 1986, AM J HUM GENET, V38, P361; MOLL PP, 1989, AM J HUM GENET, V44, P124; MOTT GE, 1990, J NUTR, V120, P243, DOI 10.1093/jn/120.3.243; MOTT GE, 1982, ATHEROSCLEROSIS, V45, P191, DOI 10.1016/0021-9150(82)90138-1; MOTT GE, 1978, CIRC RES, V43, P364, DOI 10.1161/01.RES.43.3.364; PAIGEN B, 1989, GENETICS, V122, P163; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; SCHMIDT SB, 1985, AM J CARDIOL, V55, P1459, DOI 10.1016/0002-9149(85)90953-1; SISTONEN P, 1980, AM J HUM GENET, V32, P1; TIKKANEN MJ, 1989, CIRCULATION, V80, P379; WILLIAMS MC, 1987, LIPIDS, V22, P336	51	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					414	428						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	2118306				2022-12-18	WOS:A1990DX22300006
J	OSHAUGHNESSY, DF; HILL, AVS; BOWDEN, DK; WEATHERALL, DJ; CLEGG, JB				OSHAUGHNESSY, DF; HILL, AVS; BOWDEN, DK; WEATHERALL, DJ; CLEGG, JB			GLOBIN GENES IN MICRONESIA - ORIGINS AND AFFINITIES OF PACIFIC ISLAND PEOPLES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV OXFORD, JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; MONASH UNIV, DEPT ANAT, CLAYTON, VIC 3168, AUSTRALIA	University of Oxford; Monash University			HILL, Adrian V>S>/C-1306-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AIZAWA M, 1986, HLA ASIA OCEANIA 198; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; BENFANTE RJ, 1979, HUM BIOL, V51, P201; BODMER WF, 1978, BRIT MED BULL, V34, P309, DOI 10.1093/oxfordjournals.bmb.a071518; BOWDEN DK, 1982, BRIT J HAEMATOL, V51, P243, DOI 10.1111/j.1365-2141.1982.tb08481.x; BROCKWAY RW, 1983, J HUM EVOL, V12, P501, DOI 10.1016/S0047-2484(83)80028-1; Buck Sir Peter Henry, 1938, VIKINGS SUNRISE; CHAN V, 1986, BRIT J HAEMATOL, V64, P97, DOI 10.1111/j.1365-2141.1986.tb07577.x; Clark Ross, 1979, PREHISTORY POLYNESIA, P249, DOI [10.4159/harvard.9780674181267.c11, DOI 10.4159/HARVARD.9780674181267.C11]; CRAIB JL, 1983, SCIENCE, V219, P922, DOI 10.1126/science.219.4587.922; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; FEI YJ, 1989, HEMOGLOBIN, V13, P45, DOI 10.3109/03630268908998052; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; GAJDUSEK D. C., 1967, J MED GENET, V4, P1, DOI 10.1136/jmg.4.1.1; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; Green R.C., 1979, PREHISTORY POLYNESIA, P27; HARANO K, 1985, FEBS LETT, V190, P45, DOI 10.1016/0014-5793(85)80424-5; HERTZBERG MS, 1988, AM J HUM GENET, V43, P971; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HIGGS DR, 1989, BLOOD, V73, P1081; HILL AVS, 1987, AM J HUM GENET, V40, P453; HILL AVS, 1985, AM J HUM GENET, V37, P571; HILL AVS, 1985, CELL, V42, P809, DOI 10.1016/0092-8674(85)90277-6; HILL AVS, 1986, BLOOD, V67, P1611; HILL AVS, 1986, THESIS U OXFORD; HILL AVS, 1989, COLONIZATION PACIFIC, P246; Howells, 1973, PACIFIC ISLANDERS; Kirk R. L., 1986, GENETIC VARIATION IT, P111; KIRK RL, 1980, POPULATION STRUCTURE, P113; KOHONENCORISH MRJ, 1988, TISSUE ANTIGENS, V32, P32, DOI 10.1111/j.1399-0039.1988.tb01634.x; LAMBERT SM, 1949, MALARIOLOGY, P820; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; OLD JM, 1983, THALASSAEMIAS METHOD, P74; PAWLEY A, 1984, J PAC HIST, V19, P123, DOI 10.1080/00223348408572489; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; SERJEANTSON SW, 1983, TISSUE ANTIGENS, V22, P49; SERJEANTSON SW, 1984, J PAC HIST, V19, P160, DOI 10.1080/00223348408572491; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P120; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P286; SIMMONS RT, 1962, OCEANIA, V32, P198, DOI 10.1002/j.1834-4461.1962.tb01763.x; SIMMONS RT, 1965, OCEANIA, V36, P132, DOI 10.1002/j.1834-4461.1965.tb00282.x; Spoehr A., 1957, FIELDIANA ANTHR, V48, DOI [10.5962/bhl.title.3552, DOI 10.5962/BHL.TITLE.3552]; SPRIGGS M, 1984, J PAC HIST, V19, P202, DOI 10.1080/00223348408572495; THOMSON G, 1988, ANNU REV GENET, V22, P31; TRENT RJ, 1986, AM J HUM GENET, V39, P350; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; TRENT RJ, 1988, AM J HUM GENET, V42, P601; TRENT RJ, 1985, AM J HEMATOL, V18, P431, DOI 10.1002/ajh.2830180414; TRYON DT, 1984, J PAC HIST, V19, P147, DOI 10.1080/00223348408572490; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853; WURM SA, 1967, J PAC HIST, V2, P25, DOI 10.1080/00223346708572100; WURM SA, 1971, 1000 LANGUAGES; YENCHITSOMANUS P, 1986, HUM GENET, V74, P432, DOI 10.1007/BF00280500	56	61	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					144	155						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	1967206				2022-12-18	WOS:A1990CJ04300019
J	DAIGER, SP; CHAKRABORTY, R; REED, L; FEKETE, G; SCHULER, D; BERENSSI, G; NASZ, I; BRDICKA, R; KAMARYT, J; PIJACKOVA, A; MOORE, S; SULLIVAN, S; WOO, SLC				DAIGER, SP; CHAKRABORTY, R; REED, L; FEKETE, G; SCHULER, D; BERENSSI, G; NASZ, I; BRDICKA, R; KAMARYT, J; PIJACKOVA, A; MOORE, S; SULLIVAN, S; WOO, SLC			POLYMORPHIC DNA HAPLOTYPES AT THE PHENYLALANINE-HYDROXYLASE (PAH) LOCUS IN EUROPEAN FAMILIES WITH PHENYLKETONURIA (PKU)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									PEDIAT RES INST, DEPT BIOCHEM, BRNO, CZECHOSLOVAKIA; PEDIAT RES INST, DEPT MOLEC GENET, BRNO, CZECHOSLOVAKIA; PEDIAT RES INST, DEPT CLIN, BRNO, CZECHOSLOVAKIA; CHARLES UNIV, USTAV BIOL, CS-11636 PRAGUE 1, CZECHOSLOVAKIA; BAYLOR UNIV, INST MOLEC GENET, HOUSTON, TX 77030 USA; BAYLOR UNIV, HOWARD HUGHES MED INST, DEPT CELL BIOL, HOUSTON, TX 77030 USA; SEMMELWEIS UNIV MED, SCH MED, DEPT PEDIAT 2, H-1085 BUDAPEST 8, HUNGARY; SEMMELWEIS UNIV MED, SCH MED, DEPT MICROBIOL, H-1085 BUDAPEST 8, HUNGARY	Charles University Prague; Baylor College of Medicine; Baylor University; Baylor University; Howard Hughes Medical Institute; Semmelweis University; Semmelweis University	DAIGER, SP (corresponding author), UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, POB 20334, HOUSTON, TX 77225 USA.				NICHD NIH HHS [HD-17711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017711, R37HD017711] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AULEHLASCHOLZ C, 1988, HUM GENET, V78, P353, DOI 10.1007/BF00291734; AVIGAD S, 1988, American Journal of Human Genetics, V43, pA210; CARTER CO, 1961, ANN HUM GENET, V25, P57, DOI 10.1111/j.1469-1809.1961.tb01497.x; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; DAIGER SP, 1986, LANCET, V1, P229; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; GUTHRIE R, 1963, PEDIATRICS, V32, P338; GUTTLER F, 1980, ACTA PAEDIATR SCAND, P1; HERTZBERG M, 1989, AM J HUM GENET, V44, P382; KIDD KK, 1987, NATURE, V327, P282, DOI 10.1038/327282a0; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1988, J PEDIATR-US, V113, P463, DOI 10.1016/S0022-3476(88)80629-2; LICHTERKONECKI U, 1988, HUM GENET, V78, P347, DOI 10.1007/BF00291733; LICHTERKONECKI U, 1988, BIOCHEMISTRY-US, V27, P2881, DOI 10.1021/bi00408a032; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LYONNET S, 1988, American Journal of Human Genetics, V43, pA193; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MORTON NE, 1988, AM J HUM GENET, V42, P173; REY F, 1988, AM J HUM GENET, V43, P914; RIESS O, 1988, HUM GENET, V78, P343, DOI 10.1007/BF00291732; SULLIVAN SE, 1989, AM J HUM GENET, V44, P652; SULLIVAN SE, 1985, AM J HUM GENET S, V37, pA235; WOO SLC, 1988, AM J HUM GENET, V43, P781; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	30	61	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1989	45	2					310	318						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AK380	2569271				2022-12-18	WOS:A1989AK38000014
J	FOUNTAIN, JW; WALLACE, MR; BRERETON, AM; OCONNELL, P; WHITE, RL; RICH, DC; LEDBETTER, DH; LEACH, RJ; FOURNIER, REK; MENON, AG; GUSELLA, JF; BARKER, D; STEPHENS, K; COLLINS, FS				FOUNTAIN, JW; WALLACE, MR; BRERETON, AM; OCONNELL, P; WHITE, RL; RICH, DC; LEDBETTER, DH; LEACH, RJ; FOURNIER, REK; MENON, AG; GUSELLA, JF; BARKER, D; STEPHENS, K; COLLINS, FS			PHYSICAL MAPPING OF THE VON RECKLINGHAUSEN NEUROFIBROMATOSIS REGION ON CHROMOSOME-17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN, HOWARD HUGHES MED INST, ROOM 5520 - MSRB 1, 1150 W MED CTR DR, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; HOWARD HUGHES MED INST, SALT LAKE CITY, UT USA; UNIV UTAH, SALT LAKE CITY, UT 84112 USA; BAYLOR COLL MED, HOUSTON, TX 77030 USA; KENNETH NORRIS CANC INST, LOS ANGELES, CA USA; MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA; COLLABORAT RES INC, BEDFORD, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Harvard University; Massachusetts General Hospital				Barker, David/0000-0002-1438-4100; Leach, Robin/0000-0002-3201-5579	NIGMS NIH HHS [5-T32-GMO7544-10] Funding Source: Medline; NINDS NIH HHS [NS23410, NS23427] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023427, R01NS023410] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; Crowe FW, 1956, CLIN PATHOLOGICAL GE; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; LAW ML, 1986, CYTOGENET CELL GENET, V42, P202, DOI 10.1159/000132279; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; Maniatis T., 1982, MOL CLONING; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MULVIHILL J J, 1987, Genomics, V1, P337, DOI 10.1016/0888-7543(87)90033-4; MURPHY PD, 1987, NUCLEIC ACIDS RES, V15, P6311, DOI 10.1093/nar/15.15.6311; NAKAMURA Y, 1987, CYTOGENET CELL GENET, V46, P668; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; OCONNELL P, 1989, AM J HUM GENET, V44, P51; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; RIDER SH, 1987, NUCLEIC ACIDS RES, V15, P863, DOI 10.1093/nar/15.2.863; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; RUBIN CM, 1988, P NATL ACAD SCI USA, V85, P2795, DOI 10.1073/pnas.85.8.2795; RUDDLE FH, 1984, AM J HUM GENET, V36, P944; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; TAKEUCHI T, 1985, P NATL ACAD SCI USA, V82, P1536, DOI 10.1073/pnas.82.5.1536; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WALLACE MR, UNPUB DIRECT CONTRUC; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0	41	61	64	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					58	67						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2491783				2022-12-18	WOS:A1989R559600012
J	SEPEHRNIA, B; KAMBOH, MI; ADAMSCAMPBELL, LL; NWANKWO, M; FERRELL, RE				SEPEHRNIA, B; KAMBOH, MI; ADAMSCAMPBELL, LL; NWANKWO, M; FERRELL, RE			GENETIC-STUDIES OF HUMAN APOLIPOPROTEINS .7. POPULATION-DISTRIBUTION OF POLYMORPHISMS OF APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-A-II, APOLIPOPROTEIN-A-IV, APOLIPOPROTEIN-C-II, APOLIPOPROTEIN-E, AND APOLIPOPROTEIN-H IN NIGERIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DIV HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT EPIDEMIOL,PITTSBURGH,PA 15261; UNIV BENIN,COLL MED SCI,BENIN CITY,NIGERIA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Benin				Kamboh, M. Ilyas/0000-0002-3453-1438	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039107] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 39107] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; COLE SA, 1988, AM J PHYS ANTHROPOL, V75, P197; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; EHNHOLM C, 1986, J LIPID RES, V27, P227; HEGELE RA, 1987, GENET EPIDEMIOL, V4, P163, DOI 10.1002/gepi.1370040302; HUMPHRIES SE, 1987, CIBA F SYMP, V130, P128; KAMBOH MI, 1987, ELECTROPHORESIS, V8, P355, DOI 10.1002/elps.1150080805; KAMBOH MI, 1988, AM J HUM GENET, V42, P452; KAMBOH MI, 1987, AM J HUM GENET, V41, P119; KAMBOH MI, IN PRESS J LIPID RES; KAMBOH MI, IN PRESS DIS MARKERS; KARATHANASIS SK, 1983, NATURE, V305, P823, DOI 10.1038/305823a0; MENZEL HJ, 1986, J CLIN INVEST, V77, P595, DOI 10.1172/JCI112342; SEPEHRNIA B, 1988, HUM HERED, V38, P136, DOI 10.1159/000153774	15	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1988	43	6					847	853						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R3449	3143263				2022-12-18	WOS:A1988R344900006
J	SUTHERLAND, GR; BAKER, E; CALLEN, DF; HYLAND, VJ; MAY, BK; BAWDEN, MJ; HEALY, HM; BORTHWICK, IA				SUTHERLAND, GR; BAKER, E; CALLEN, DF; HYLAND, VJ; MAY, BK; BAWDEN, MJ; HEALY, HM; BORTHWICK, IA			5-AMINOLEVULINATE SYNTHASE IS AT 3P21 AND THUS NOT THE PRIMARY DEFECT IN X-LINKED SIDEROBLASTIC ANEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ADELAIDE, DEPT BIOCHEM, ADELAIDE, SA 5001, AUSTRALIA	University of Adelaide	SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP, CYTOGENET UNIT, N ADELAIDE, SA 5006, AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012; Callen, David F/G-1975-2012	Callen, David/0000-0002-6189-9991; Hyland, Valentine/0000-0002-6814-2094				AOKI Y, 1973, ACTA HAEMATOLOGICA J, V36, P74; BAWDEN MJ, 1987, NUCLEIC ACIDS RES, V15, P8563, DOI 10.1093/nar/15.20.8563; BOTTOMLEY SS, 1982, CLIN HAEMATOL, V11, P389; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; ELFERINK CJ, 1987, J BIOL CHEM, V262, P3988; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GRANDCHAMP B, 1983, HUM GENET, V64, P180, DOI 10.1007/BF00327121; HYLAND VJ, 1988, AM J HUM GENET, V42, P373; KAPPAS A, 1983, METABOLIC BASIS INHE, P1301; LEE GR, 1968, BLOOD, V32, P59, DOI 10.1182/blood.V32.1.59.59; MAGUIRE DJ, 1986, NUCLEIC ACIDS RES, V14, P1379, DOI 10.1093/nar/14.3.1379; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; McKusick V. A., 1986, MENDELIAN INHERITANC; POTLURI VR, 1987, HUM GENET, V76, P236; POVEY S, 1985, CYTOGENET CELL GENET, V40, P67, DOI 10.1159/000132170; SIMMERS RN, 1988, HUM GENET, V78, P144, DOI 10.1007/BF00278185; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	18	61	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1988	43	3					331	335						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P8841	3414687				2022-12-18	WOS:A1988P884100014
J	ARVEILER, B; OBERLE, I; VINCENT, A; HOFKER, MH; PEARSON, PL; MANDEL, JL				ARVEILER, B; OBERLE, I; VINCENT, A; HOFKER, MH; PEARSON, PL; MANDEL, JL			GENETIC-MAPPING OF THE XQ27-Q28 REGION - NEW RFLP MARKERS USEFUL FOR DIAGNOSTIC APPLICATIONS IN FRAGILE-X AND HEMOPHILIA-B FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; UNIV LEIDEN,DEPT HUMAN GENET,SYLVIUS LABS,LEIDEN,NETHERLANDS	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Leiden University; Leiden University - Excl LUMC								BROWN WT, 1986, AM J MED GENET, V23, P643, DOI 10.1002/ajmg.1320230158; BROWN WT, 1987, LANCET, V1, P280; BROWN WT, 1987, HUM GENET, V75, P311, DOI 10.1007/BF00284100; BROWN WT, IN PRESS HUM GENET; CAMERINO G, 1983, NATURE, V306, P701, DOI 10.1038/306701a0; CONNOR JM, 1987, J MED GENET, V24, P14, DOI 10.1136/jmg.24.1.14; DAVIES KE, 1985, HUM GENET, V70, P249; DAVIES KE, IN PRESS CYTOGENET C; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JENKINS EC, 1986, AM J MED GENET, V23, P297, DOI 10.1002/ajmg.1320230123; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MULLIGAN L, 1987, HUM GENET, V75, P381, DOI 10.1007/BF00284113; OBERLE I, 1987, HUM GENET, V77, P60; OBERLE I, 1985, NEW ENGL J MED, V312, P682, DOI 10.1056/NEJM198503143121103; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OBERLE I, 1986, P NATL ACAD SCI USA, V83, P1016, DOI 10.1073/pnas.83.4.1016; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; OBERLE I, 1986, HUMAN GENES DISEASES, P51; OTT J, 1985, ANAL HUMAN GENETIC L; PATTERSON M, 1987, NUCLEIC ACIDS RES, V15, P2639, DOI 10.1093/nar/15.6.2639; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SZABO P, 1984, P NATL ACAD SCI-BIOL, V81, P7855, DOI 10.1073/pnas.81.24.7855; TURNER G, 1986, AM J MED GENET, V23, P11, DOI 10.1002/ajmg.1320230103; TURNER G, 1983, ADV HUM GENET, V13, P83; VEENEMA H, 1987, J MED GENET, V24, P413, DOI 10.1136/jmg.24.7.413; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861	30	61	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					380	389						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2893549				2022-12-18	WOS:A1988M313300021
J	WIJSMAN, EM				WIJSMAN, EM			A DEDUCTIVE METHOD OF HAPLOTYPE ANALYSIS IN PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WIJSMAN, EM (corresponding author), STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA.				NIGMS NIH HHS [GM28428] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUR M P, 1985, Genetic Epidemiology, V2, P201, DOI 10.1002/gepi.1370020213; BAUR MP, 1984, CYTOGENET CELL GENET, V37, P416; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BUFTON L, 1986, AM J HUM GENET, V38, P447; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; COHENHAGUENAUER O, 1985, P NATL ACAD SCI USA, V82, P3335, DOI 10.1073/pnas.82.10.3335; ELBEIN SC, 1986, P NATL ACAD SCI USA, V83, P5223, DOI 10.1073/pnas.83.14.5223; ENG CEL, 1985, AM J HUM GENET, V37, P719; HASSTEDT SJ, 1982, COMPUT BIOMED RES, V15, P295, DOI 10.1016/0010-4809(82)90064-7; HASSTEDT SJ, 1979, 13 U UT DEP BIOPH CO; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOHNSON MJ, 1986, AM J HUM GENET, V38, P617; JOHNSON MJ, 1984, THESIS STANFORD U ST; JULIER C, 1985, CYTOGENET CELL GENET, V40, P664; LARSEN SO, 1979, COMPUT PROG BIOMED, V10, P48, DOI 10.1016/0010-468X(79)90050-3; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEGALL I, 1985, P NATL ACAD SCI USA, V82, P5433; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; LITT M, 1985, CYTOGENET CELL GENET, V40, P682; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; OHLSSON M, 1985, P NATL ACAD SCI USA, V82, P4473, DOI 10.1073/pnas.82.13.4473; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; Steinberg A.G., 1981, DISTRIBUTION HUMAN I; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180	28	61	65	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					356	373						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3115093				2022-12-18	WOS:A1987K019100003
J	BUETOW, KH; CHAKRAVARTI, A				BUETOW, KH; CHAKRAVARTI, A			MULTIPOINT GENE-MAPPING USING SERIATION .1. GENERAL-METHODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,DEPT BIOSTAT,HUMAN GENET PROGRAM,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NIGMS NIH HHS [GM33771] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUETOW KH, 1987, AM J HUM GENET, V41, P189; BUETOW KH, 1986, GENET EPID, V1, P135; Gelfand A. E., 1971, MATH ARCHAEOLOGICAL, P186; KEATS BJB, 1979, SOURCE BOOK LINKAGE; KEATS BJB, 1981, LINKAGE CHROMOSOME M; Kruskal JosephB., 1978, MULTIDIMENSIONAL SCA, DOI [10.4135/9781412985130, DOI 10.4135/9781412985130]; LALOUEL JM, 1977, HEREDITY, V38, P61, DOI 10.1038/hdy.1977.8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MEYERS DA, 1976, 3RD BALT C INT WORKS, P335; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; RAO CR, 1973, LINEAR STATISTICAL I; RAO DC, 1979, AM J HUM GENET, V31, P680; RAO DC, 1977, HUM HERED, V27, P38	16	61	63	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					180	188						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3475978				2022-12-18	WOS:A1987J757500009
J	BREGA, A; GARDELLA, R; SEMINO, O; MORPURGO, G; RICOTTI, GBA; WALLACE, DC; BENERECETTI, ASS				BREGA, A; GARDELLA, R; SEMINO, O; MORPURGO, G; RICOTTI, GBA; WALLACE, DC; BENERECETTI, ASS			GENETIC-STUDIES ON THE THARU POPULATION OF NEPAL - RESTRICTION ENDONUCLEASE POLYMORPHISMS OF MITOCHONDRIAL-DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PAVIA,DIPARTIMENTO GENET & MICROBIOL A BUZZATI TRAVERSO,I-27100 PAVIA,ITALY; UNIV LA SAPIENZA,DIPARTIMENTO BIOL VEGETALE,I-00100 ROME,ITALY; EMORY UNIV,SCH MED,DEPT BIOCHEM & PEDIAT,ATLANTA,GA 30322	University of Pavia; Sapienza University Rome; Emory University	BREGA, A (corresponding author), CNR,IST GENET BIOCHIM & EVOLUZIONIST,207 VIA ABBIATEGRASSO,I-27100 PAVIA,ITALY.			SEMINO, Ornella/0000-0002-9675-9403	NINDS NIH HHS [NS-21328] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BENVENISTE RE, 1976, NATURE, V261, P101, DOI 10.1038/261101a0; BISTA DB, 1980, PEOPLE NEPAL; BLANC H, 1983, AM J HUM GENET, V35, P167; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, V15, P485; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; FERRIS SD, 1981, P NATL ACAD SCI-BIOL, V78, P2432, DOI 10.1073/pnas.78.4.2432; GILES RE, 1980, SOMAT CELL GENET, V6, P543, DOI 10.1007/BF01539155; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; TERRENATO L, UNPUB DECREASE MALAR; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1982, HUM GENET, V61, P145, DOI 10.1007/BF00274205; Wallace DC, 1983, ENDOCYTOBIOLOGY, VII, P87	21	61	61	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					502	512						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	2876631				2022-12-18	WOS:A1986E706300008
J	ROBINSON, BH; OEI, J; SHERWOOD, WG; APPLEGARTH, D; WONG, L; HAWORTH, J; GOODYER, P; CASEY, R; ZALESKI, LA				ROBINSON, BH; OEI, J; SHERWOOD, WG; APPLEGARTH, D; WONG, L; HAWORTH, J; GOODYER, P; CASEY, R; ZALESKI, LA			THE MOLECULAR-BASIS FOR THE 2 DIFFERENT CLINICAL PRESENTATIONS OF CLASSICAL PYRUVATE-CARBOXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA; BRITISH COLUMBIA CHILDRENS HOSP, VANCOUVER, BC, CANADA; CHILDRENS HOSP, DEPT PEDIAT, WINNIPEG, MANITOBA, CANADA; UNIV SASKATCHEWAN HOSP, ALVIN BUCKWOLD CTR, SASKATOON S7N 0W8, SASKATCHEWAN, CANADA; MONTREAL CHILDRENS HOSP, DEPT PEDIAT, MONTREAL H3H 1P3, QUEBEC, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); BC Childrens Hospital; University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Saskatchewan; McGill University	ROBINSON, BH (corresponding author), UNIV TORONTO, DEPT PEDIAT & BIOCHEM, TORONTO M5S 1A1, ONTARIO, CANADA.							ATKIN BM, 1979, PEDIATR RES, V13, P109, DOI 10.1203/00006450-197902000-00005; ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009; BARTLETT K, 1976, LANCET, V2, P804; BAUMGARTNER R, 1982, HELV PAEDIATR ACTA, V37, P499; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; CHARPENTIER C, 1982, J INHERIT METAB DIS, V5, P11, DOI 10.1007/BF01799804; COUDE FX, 1981, PEDIATRICS, V68, P914; DEVIVO DC, 1977, J CLIN ENDOCR METAB, V45, P1281, DOI 10.1210/jcem-45-6-1281; GOLDMAN BM, 1978, P NATL ACAD SCI USA, V75, P5066, DOI 10.1073/pnas.75.10.5066; HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589; KALOUSEK F, 1983, AM J HUM GENET, V35, P409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OSBORN M, 1977, EXP CELL RES, V106, P339, DOI 10.1016/0014-4827(77)90179-3; ROBINSON BH, 1983, J BIOL CHEM, V258, P6660; ROBINSON BH, 1980, PEDIATR RES, V14, P956, DOI 10.1203/00006450-198008000-00013; ROBINSON BH, 1970, BIOCHEM J, V116, P229, DOI 10.1042/bj1160229; SAUDUBRAY JM, 1976, ACTA PAEDIATR SCAND, V65, P717, DOI 10.1111/j.1651-2227.1976.tb04960.x; SAUNDERS M, 1979, J CLIN INVEST, V64, P1695, DOI 10.1172/JCI109632; SAUNDERS ME, 1982, AM J HUM GENET, V34, P590; WAH AMLH, 1983, AM J HUM GENET, V35, P889; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; WOLF B, 1983, NEW ENGL J MED, V308, P161; WOLF B, 1982, AM J HUM GENET, V34, P699	24	61	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					283	294						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6424438				2022-12-18	WOS:A1984SM32400003
J	BLUME, KG; BEUTLER, E; BROSS, KJ; SCHMIDT, GM; SPRUCE, WE; TEPLITZ, RL				BLUME, KG; BEUTLER, E; BROSS, KJ; SCHMIDT, GM; SPRUCE, WE; TEPLITZ, RL			GENETIC-MARKERS IN HUMAN-BONE MARROW TRANSPLANTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BLUME, KG (corresponding author), CITY HOPE NATL MED CTR,DEPT BONE MARROW TRANSPLANTAT,DUARTE,CA 91010, USA.							BROSS KJ, 1978, TRANSPLANTATION, V25, P331, DOI 10.1097/00007890-197806000-00011; BROSS KJ, 1979, TRANSPLANTATION, V28, P257, DOI 10.1097/00007890-197909000-00021; BUCKLEY RH, 1977, PEDIATR CLIN N AM, V24, P313; CHEN SH, 1978, J CLIN INVEST, V62, P1386, DOI 10.1172/JCI109259; ELFENBEIN GJ, 1978, BLOOD, V52, P627; FEFER A, 1979, NEW ENGL J MED, V300, P333, DOI 10.1056/NEJM197902153000702; FIALKOW PJ, 1971, LANCET, V1, P251; GALE RP, 1978, SCIENCE, V201, P937, DOI 10.1126/science.356266; Giblett ER., 1969, GENETIC MARKERS HUMA; Harris, 1976, HDB ENZYME ELECTROPH; MASON DY, 1975, J CLIN PATHOL, V28, P594, DOI 10.1136/jcp.28.7.594; SCHMIDT GM, 1979, BLUT, V38, P135, DOI 10.1007/BF01007954; SENSENBRENNER LL, 1977, EXP HEMATOL, V5, P51; SPARKES MC, 1977, VOX SANG, V33, P202, DOI 10.1111/j.1423-0410.1977.tb04464.x; SPARKES RS, 1979, TRANSPLANTATION, V27, P212, DOI 10.1097/00007890-197903000-00015; SPECK B, 1976, EXP HEMATOL, V4, P131; STIEHM ER, 1972, NEW ENGL J MED, V286, P797, DOI 10.1056/NEJM197204132861501; STORB R, 1978, TRANSPLANT P, V10, P135; TERRITO MC, 1977, BRIT J HAEMATOL, V36, P305, DOI 10.1111/j.1365-2141.1977.tb00653.x; THOMAS ED, 1976, EXP HEMATOL, V4, P97; THOMAS ED, 1972, LANCET, V1, P1310; THOMAS ED, 1976, SCIENCE, V192, P1016, DOI 10.1126/science.775638; THOMAS ED, 1977, BLOOD, V49, P511; THOMAS EDL, 1978, CANCER-AM CANCER SOC, V42, P895, DOI 10.1002/1097-0142(197808)42:2+<895::AID-CNCR2820420711>3.0.CO;2-5; WILSON FD, 1978, TRANSPLANTATION, V25, P87, DOI 10.1097/00007890-197802000-00010; WITHERSPOON RP, 1978, TRANSPLANTATION, V26, P407, DOI 10.1097/00007890-197812000-00008; YUNIS JJ, 1974, HUMAN CHROMOSOME MET	27	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					414	419						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6992565				2022-12-18	WOS:A1980JX05900011
J	ALVESALO, L; OSBORNE, RH; KARI, M				ALVESALO, L; OSBORNE, RH; KARI, M			47,XYY MALE, Y-CHROMOSOME, AND TOOTH SIZE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TURKU,INST DENT,TURKU,FINLAND; UNIV WISCONSIN,DEPT ANTHROPOL,MADISON,WI 53706	University of Turku; University of Wisconsin System; University of Wisconsin Madison								BARLOW P, 1973, HUMANGENETIK, V17, P105; BARTLETT DJ, 1968, NATURE, V219, P351, DOI 10.1038/219351a0; FILIPSSON R, 1965, ACTA ENDOCRINOL-COP, V48, P91, DOI 10.1530/acta.0.0480091; GARN SM, 1962, NATURE, V196, P695, DOI 10.1038/196695a0; GARN SM, 1968, ARCH ORAL BIOL, V13, P129, DOI 10.1016/0003-9969(68)90043-5; GORLIN RJ, 1965, J DENT RES, V44, P269, DOI 10.1177/00220345650440012201; HOOK EB, 1971, SCIENCE, V172, P284, DOI 10.1126/science.172.3980.284; JACOBS PA, 1965, NATURE, V208, P1351, DOI 10.1038/2081351a0; KRAUS BS, 1965, HUMAN DENTITION BEFO; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; OSBORNE RH, 1958, AM J HUM GENET, V10, P350; OWEN DR, 1972, PSYCHOL BULL, V78, P209, DOI 10.1037/h0033068; SCOTT JH, 1964, INTRO DENTAL ANATOMY; SHAPIRO BL, 1966, THESIS U MINNESOTA; TANNER JM, 1959, LANCET, V2, P141; [No title captured]	16	61	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					53	61						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	V5202	1155450				2022-12-18	WOS:A1975V520200004
J	WARD, RH; GERSHOWITZ, H; LAYRISSE, M; NEEL, JV				WARD, RH; GERSHOWITZ, H; LAYRISSE, M; NEEL, JV			GENETIC STRUCTURE OF A TRIBAL POPULATION, YANOMAMA INDIANS .11. GENE-FREQUENCIES FOR 10 BLOOD-GROUPS AND ABH-LE SECRETOR TRAITS IN YANOMAMA AND THEIR NEIGHBORS - UNIQUENESS OF TRIBE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48104; INST VENEZOLANO INVEST CIENT,DEPT MED EXPTL HEMATOL,APARTADO 1827,CARACAS 101,VENEZUELA	University of Michigan System; University of Michigan; Venezuelan Institute Science Research								Bhattacharyya A, 1946, SANKHYA, V7, P401; CAVALLISFORZA L, 1967, AM J HUM GENET, V19, P234; CAVALLISFORZA LL, 1964, GENETICS TODAY, P923; CHAGNON NA, 1970, AM J PHYS ANTHROPOL, V32, P339, DOI 10.1002/ajpa.1330320304; Chagnon Napoleon, 1968, YANOMAMO FIERCE PEOP; CRUXENT JM, 1968, WHO165 PAN AM HEALTH, P11; EDWARDS AWF, 1971, BIOMETRICS, V27, P873, DOI 10.2307/2528824; EDWARDS AWF, 1965, BIOMETRICS, V21, P262; FITCH WM, 1969, AM J HUM GENET, V21, P384; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; Gower J. C., 1972, ASSESSMENT POPULATIO, P1; GOWER JC, 1967, BIOMETRICS, V23, P623, DOI 10.2307/2528417; HARPENDING HC, IN PRESS; Jardine N, 1971, MATHEMATICAL TAXONOM; JOHNSTON FE, 1969, AM J HUM GENET, V21, P376; JOHNSTON FE, 1968, HUM BIOL, V40, P508; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; LAYRISSE M, 1966, INDIAN SOC VENEZUELA; LAYRISSE Z, 1970, AM J PHYS ANTHROPOL, V32, P465, DOI 10.1002/ajpa.1330320318; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LEWONTIN RC, 1973, GENETICS, V74, P175; Migliazza, 1972, THESIS INDIANA U; MIGLIAZZA E, 1966, TERRA AMERIGA, V7, P3; NEEL J V, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P323, DOI 10.1073/pnas.65.2.323; NEEL JV, 1974, AM J HUM GENET, V26, P281; NEEL JV, 1972, GENETICS, V72, P639; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Riviere Peter, 1969, MARRIAGE AMONG TRIO; SALZANO FM, 1972, HUM BIOL, V44, P443; SALZANO FM, 1972, AM J PHYS ANTHROPOL, V36, P417, DOI 10.1002/ajpa.1330360313; SALZANO FM, 1964, AM J HUM GENET, V16, P301; SPIELMAN RS, 1974, SCIENCE, V184, P637, DOI 10.1126/science.184.4137.637; TANIS RJ, 1973, AM J HUM GENET, V25, P665; WARD RH, 1970, AM J HUM GENET, V22, P538; WARD RH, 1972, ANN HUM GENET, V36, P21, DOI 10.1111/j.1469-1809.1972.tb00579.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; [No title captured]; [No title captured]	39	61	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					1	30						30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	50736				2022-12-18	WOS:A1975V520200001
J	COX, DW; SASSKORT.A; FRASER, FC				COX, DW; SASSKORT.A; FRASER, FC			GENETIC STUDY OF WILSONS DISEASE - EVIDENCE FOR HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AISEN P, 1965, J BIOL CHEM, V240, P1974; ARIMA M, 1962, PAEDIATR U TOKYO, V7, P1; ARIMA M, 1962, PAEDIATR U TOKYO, V7, P7; ASPIN N, 1966, BIOCHEMISTRY COPPER, P503; BEARN AG, 1960, ANN HUM GENET, V24, P33; BEARN AG, 1953, AM J MED, V15, P442, DOI 10.1016/0002-9343(53)90134-X; BEARN AG, 1954, P SOC EXP BIOL MED, V85, P44; BEARN AG, 1972, METABOLIC BASIS INHE, P1033; BUSH JA, 1955, J CLIN INVEST, V34, P1766, DOI 10.1172/JCI103232; CARRICO RJ, 1969, BIOCHEM MED METAB B, V3, P117, DOI 10.1016/0006-2944(69)90004-0; CARRUTHE.ME, 1966, J CLIN PATHOL, V19, P498, DOI 10.1136/jcp.19.5.498; COX D, 1968, THESIS MCGILL U; COX D, 1971, 4 P INT C HUM GEN PA, P190; COX DW, 1967, CAN MED ASSOC J, V96, P83; COX DW, 1966, J LAB CLIN MED, V68, P893; CROPP GJA, 1971, J PEDIATR-US, V78, P220, DOI 10.1016/S0022-3476(71)80004-5; Eden A, 1940, BIOCHEM J, V34, P1202, DOI 10.1042/bj0341202; EVANS GW, 1969, AM J PHYSIOL, V216, P340, DOI 10.1152/ajplegacy.1969.216.2.340; EVANS GW, 1971, FED P, V30, P416; GREGORIADIS G, 1968, NATURE, V218, P290, DOI 10.1038/218290a0; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2350; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2354; LEVI AJ, 1967, LANCET, V2, P575; LI CC, 1968, AM J HUM GENET, V20, P61; LI CC, 1961, HUMAN GENETICS PRINC, P58; MARCEAU N, 1970, INT J APPL RADIAT IS, V21, P667, DOI 10.1016/0020-708X(70)90121-3; MARCEAU N, 1971, THESIS U TORONTO; MATTHEWS WB, 1952, Q J MED, V21, P425; NADLER SB, 1962, SURGERY, V51, P224; NEUMANN PZ, 1966, NATURE, V210, P414, DOI 10.1038/210414a0; OREILLY S, 1970, NEUROLOGY, V20, P1133; OSAKI S, 1971, J BIOL CHEM, V246, P3018; OSBORN SB, 1967, LANCET, V1, P346; PETERS R, 1966, PROC R SOC SER B-BIO, V166, P285, DOI 10.1098/rspb.1966.0099; PHILLIPS JN, 1967, ENZYMOLOGIA, V32, P13; Sass-Kortsak A, 1965, Adv Clin Chem, V8, P1; Sass-Kortsak A, 1961, WILSONS DIS SOME CUR, P151; SASSKORTSAK A, 1959, J CLIN INVEST, V38, P1672, DOI 10.1172/JCI103945; SCHEINBERG IH, 1952, SCIENCE, V116, P484, DOI 10.1126/science.116.3018.484; SCHEINBERG IH, 1954, J CLIN INVEST, V33, P963; SHOKEIR MHK, 1969, P NATL ACAD SCI USA, V62, P867, DOI 10.1073/pnas.62.3.867; SOOTHILL JF, 1961, J CLIN PATHOL, V14, P264, DOI 10.1136/jcp.14.3.264; STERNLIEB I, 1968, NEW ENGL J MED, V278, P352, DOI 10.1056/NEJM196802152780702; STERNLIEB I, 1961, J CLIN INVEST, V40, P707, DOI 10.1172/JCI104304; STERNLIEB I, 1963, JAMA-J AM MED ASSOC, V183, P747; STERNLIEB I, 1961, WILSONS DISEASE SOME, P133; TAUXE WN, 1966, AM J MED, V41, P375, DOI 10.1016/0002-9343(66)90083-0; WALSHE JM, 1967, BRAIN, V90, P149, DOI 10.1093/brain/90.1.149; WALSHE JM, 1969, 5 S SOC STUD INB ERR, P130; [No title captured]; [No title captured]; [No title captured]	52	61	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	6					646	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O0504	5082916				2022-12-18	WOS:A1972O050400004
J	LICHTENSTEIN, J; WARSON, R; JORGENSON, R; DORST, JP; MCKUSICK, VA				LICHTENSTEIN, J; WARSON, R; JORGENSON, R; DORST, JP; MCKUSICK, VA			TRICHO-DENTO-OSSEOUS (TDO) SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		[Anonymous], DYNAMIC CLASSIFICATI; BELL NH, 1967, J CHRON DIS, V20, P829, DOI 10.1016/0021-9681(67)90020-3; CAFFEY J, 1967, AMER J ROENTGENOL RA, V100, P1; CAFFEY J, 1967, PEDIATRIC XRAY DIAGN; COHEN P, 1969, CLIN ORTHOP RELAT R, P221; CRAWFORD JL, 1970, J DENT CHILD, V37, P83; Garn S.M., 1970, EARLIER GAIN LATER L; GORLIN RJ, 1970, THOMAS ORAL PATHOLOG, P107; Greulich W, 1959, RADIOGRAPHIC ATLAS S; HALLIDAY J, 1949, BRIT J SURG, V37, P52; HINKEL G, 1957, CLIN ORTHOP RELAT R, V9, P85; HOWARD JE, 1971, AM J MED, V50, P562, DOI 10.1016/0002-9343(71)90112-4; JOHNSTON CC, 1968, MEDICINE, V47, P149, DOI 10.1097/00005792-196803000-00004; MCKUSICK VA, 1966, HERITABLE DISORDERS; MCKUSICK VA, 1969, HUMAN GENETICS; MENKES JH, 1962, PEDIATRICS, V29, P764; Mohr OL, 1932, J HERED, V23, P345, DOI 10.1093/oxfordjournals.jhered.a103655; PATTON GT, 1968, RADIOGRAPHY, V34, P3; PORTER P, 1970, BRIT J DERMATOL, V83, P17; Reed E. W., 1965, MENTAL RETARDATION F; ROBINSON GC, 1966, PEDIATRICS, V37, P498; RUSSELL WJ, 1968, RADIOLOGY, V90, P70, DOI 10.1148/90.1.70; Smith D.W., 1970, RECOGNIZABLE PATTERN; STANESCO V, 1963, Rev Fr Endocrinol Clin, V4, P219; VANBUCHEM FSP, 1962, AM J MED, V33, P387, DOI 10.1016/0002-9343(62)90235-8; WINTER G B, 1969, British Dental Journal, V127, P157; WITKOP C J JR, 1971, Birth Defects Original Article Series, V7, P153	27	61	61	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	5					569	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N4590	5054226				2022-12-18	WOS:A1972N459000008
J	YASUDA, N; FURUSHO, T				YASUDA, N; FURUSHO, T			RANDOM AND NONRANDOM INBREEDING REVEALED FROM ISONYMY STUDY .1. SMALL CITIES OF JAPAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CAVALLISFORZA LL, 1969, 12 P INT C GEN TOK, V3, P405; COCHRAN GW, 1954, BIOMETRICS, V10, P417; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; Darwin G., 1875, J STAT SOC, V38, P153; LASKER GW, 1968, AM J HUM GENET, V20, P250; OHKURA K, 1960, JPN J HUM GENET, V5, P61; SAKUMA E, 1965, RARE CURIOUS SURNAME; SHAW RF, 1960, J HERED, V51, P230; SHAW RICHARD F., 1960, JOUR HEREDITY, V51, P221; Watanabe M, 1966, SURNAMES JAPAN; WRIGHT S, 1951, ANN EUGENIC, V15, P323; YANASE T, 1962, USE VITAL HLTH STATI, P119; YASUDA N, 1967, 3RD P INT C HUM GEN, P249	13	61	61	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	3					303	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J3602	5089846				2022-12-18	WOS:A1971J360200007
J	SCOTT, EM; DUNCAN, IW; EKSTRAND, V; WRIGHT, RC				SCOTT, EM; DUNCAN, IW; EKSTRAND, V; WRIGHT, RC			FREQUENCY OF POLYMORPHIC TYPES OF RED CELL ENZYMES AND SERUM FACTORS IN ALASKAN ESKIMOS AND INDIANS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1957, BRIT MED J, V2, P1137, DOI 10.1136/bmj.2.5054.1137; BLUMBERG BS, 1959, ANN HUM GENET, V23, P349, DOI 10.1111/j.1469-1809.1959.tb01478.x; GIBLETT ER, 1965, AM J HUM GENET, V17, P425; HIRSCHFELD J, 1960, NATURE, V185, P931, DOI 10.1038/185931b0; HIRSCHFELD JAN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P160; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; PERSSON I, 1962, ACTA GENET STAT MED, V12, P292; SCOTT EH, IN PRESS; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0	9	61	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	4					408	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	81309	5945954				2022-12-18	WOS:A19668130900007
J	KNOX, WE; MESSINGER, EC				KNOX, WE; MESSINGER, EC			DETECTION IN THE HETEROZYGOTE OF THE METABOLIC EFFECT OF THE RECESSIVE GENE FOR PHENYLKETONURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		EVERED DF, 1956, BIOCHEM J, V62, P416, DOI 10.1042/bj0620416; HSIA DYY, 1956, NATURE, V178, P1239, DOI 10.1038/1781239a0; HSIA DYY, 1957, AMA J DIS CHILD, V94, P33, DOI 10.1001/archpedi.1957.04030020035008; HSIA DYY, 1956, LANCET, V2, P1337; JERVIS GA, 1953, P SOC EXP BIOL MED, V82, P514; KNOX WE, 1957, AM J MED, V22, P687, DOI 10.1016/0002-9343(57)90120-1; MCGILVERY RW, 1948, J BIOL CHEM, V174, P813; STEIN WH, 1954, J CLIN INVEST, V33, P410, DOI 10.1172/JCI102913; UDENFRIEND S, 1953, J BIOL CHEM, V203, P953; UDENFRIEND S, 1953, J BIOL CHEM, V203, P961; WAELSCH H, 1955, BIOCH DEV NERVOUS SY, P414	11	61	61	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	1					53	60						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA218	13520699				2022-12-18	WOS:A1958WA21800006
J	FREIREMAIA, N				FREIREMAIA, N			INBREEDING IN BRAZIL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BIRDSELL JB, 1953, AM NAT, V87, P171, DOI 10.1086/281776; BIRDSELL JB, 1950, COLD SPRING HARB SYM, V15, P259, DOI 10.1101/SQB.1950.015.01.028; BOOK JA, 1955, AM J HUM GENET, V7, P426; BOOK JA, 1956, ANN HUM GENET, V20, P239, DOI 10.1111/j.1469-1809.1956.tb01369.x; CAVALLISFORZA LL, 1957, 1ST P INT C HUM GEN, P239; DAHLBERG GUNNAR, 1938, PROC ROY SOC EDINBURGH, V58, P213; DUNN LC, 1947, P NATL ACAD SCI USA, V33, P359, DOI 10.1073/pnas.33.12.359; ELLIS A, 1936, PRIMEIROS TRONCOS PA; FRACCARO M, 1957, EUGEN QUART, V4, P36, DOI 10.1080/19485565.1957.9987307; FREIREMAIA N, 1957, EUGEN QUART, V4, P127, DOI 10.1080/19485565.1957.9987319; FREIREMAIA N, 1952, AM J HUM GENET, V4, P194; FREIREMAIA N, 1954, 9 P INT C GEN CAR, P923; FREIREMAIA N, 1957, SOME ASPECTS PROBLEM; FREIREMAIA N, 1953, CIENCIA, V1, P26; FREIREMAIA N, 1951, LOGOS, V6, P65; FROTAPESSOA O, 1957, AM J HUM GENET, V9, P9; FROTAPESSOA O, 1957, REV BRASIL BIOL, V17, P73; GLASS B, 1952, AM NAT, V86, P145, DOI 10.1086/281719; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; KRAUS BS, 1956, AM ANTHROPOL, V58, P1017, DOI 10.1525/aa.1956.58.6.02a00040; Lasker GW, 1954, SOUTHWEST J ANTHROP, V10, P353, DOI 10.1086/soutjanth.10.4.3628832; Lasker GW, 1952, AM ANTHROPOL, V54, P433, DOI 10.1525/aa.1952.54.3.02a00340; LUDWIG WILHELM, 1948, BIOL ZENTRALBL, V67, P268; Malaurie J, 1952, POPULATION, V7, P675, DOI 10.2307/1524871; MORTON NE, 1955, ANN HUM GENET, V20, P116; RASERI E, 1900, ARCH ITAL BIOL, V33, P230; Schull WJ, 1953, AM ANTHROPOL, V55, P74, DOI 10.1525/aa.1953.55.1.02a00060; Schwidetzky I., 1955, ETNOBIOLOGIA; SPUHLER J. N., 1953, HUMAN BIOL, V25, P295; SPUHLER JN, 1956, MIGRATION HUMAN BREE; SUTTER J, 1951, POPULATION, V3, P481; Sutter J, 1955, POPULATION, V10, P645, DOI 10.2307/1525257; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; WRIGHT S, 1946, GENETICS, V31, P33	36	61	62	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	4					284	298						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA217	13497997				2022-12-18	WOS:A1957WA21700003
J	Haas, ME; Aragam, KG; Emdin, CA; Bick, AG; Hemani, G; Smith, GD; Kathiresan, S				Haas, Mary E.; Aragam, Krishna G.; Emdin, Connor A.; Bick, Alexander G.; Hemani, Gibran; Smith, George Davey; Kathiresan, Sekar		Int Consortium Blood Pressure	Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INDIVIDUAL PARTICIPANT DATA; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; MENDELIAN RANDOMIZATION; URINARY ALBUMIN; CARDIOVASCULAR EVENTS; GENERAL-POPULATION; RISK-FACTOR; COLLABORATIVE METAANALYSIS	Excretion of albumin in urine, or albuminuria, is associated with the development of multiple cardiovascular and metabolic diseases. However, whether pathways leading to albuminuria are causal for cardiometabolic diseases is unclear. We addressed this question using a Mendelian randomization framework in the UK Biobank, a large population-based cohort. We first performed a genome-wide association study for albuminuria in 382,500 individuals and identified 32 new albuminuria loci. We constructed albuminuria genetic risk scores and tested for association with cardiometabolic diseases. Genetically elevated albuminuria was strongly associated with increased risk of hypertension (1.38 OR; 95% CI, 1.27-1.50 per 1 SD predicted increase in albuminuria, p = 7.01 x 10(-14)). We then examined bidirectional associations of albuminuria with blood pressure which suggested that genetically elevated albuminuria led to higher blood pressure (2.16 mmHg systolic blood pressure; 95% CI, 1.51-2.82 per 1 SD predicted increase in albuminuria, p = 1.22 x 10(-10)) and that genetically elevated blood pressure led to more albuminuria (0.005 SD; 95% CI 0.004-0.006 per 1 mmHg predicted increase in systolic blood pressure, p = 2.45 x 10(-13)). These results support the existence of a feed-forward loop between albuminuria and blood pressure and imply that albuminuria could increase risk of cardiovascular disease through blood pressure. Moreover, they suggest therapies that target albuminuria-increasing processes could have antihypertensive effects that are amplified through inhibition of this feed-forward loop.	[Haas, Mary E.; Aragam, Krishna G.; Emdin, Connor A.; Bick, Alexander G.; Kathiresan, Sekar] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Haas, Mary E.; Aragam, Krishna G.; Emdin, Connor A.; Bick, Alexander G.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Aragam, Krishna G.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Aragam, Krishna G.; Emdin, Connor A.; Bick, Alexander G.; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Hemani, Gibran; Smith, George Davey] Univ Bristol, MRC, Populat Hlth Sci, Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bristol	Kathiresan, S (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02139 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02114 USA.	skathiresan1@mgh.harvard.edu	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Hemani, Gibran/0000-0003-0920-1055; Bick, Alexander/0000-0001-5824-9595; Haas, Mary Elizabeth/0000-0002-2816-9268	National Institutes of Health [R01 HL127564]; Massachusetts General Hospital; Donovan Family Foundation; American Heart Association Institute for Precision Cardiovascular Medicine [17IFUNP33840012]; Medical Research Council [MC_UU_00011/1]; University of Bristol; Wellcome Trust [208806/Z/17/Z]; National Heart, Lung, and Blood Institute (NHLBI) [HHSN2682011 00005C, HHSN268201100006C, HHSN268201100007C, HHSN2 68201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; National Human Genome Research Institute [U01HG004402]; NHLBI; Boston University [N01-HC-25195, N02-HL64278, HHSN268201500001I]; MRC [MC_UU_00011/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127564, R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); Donovan Family Foundation; American Heart Association Institute for Precision Cardiovascular Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Wellcome Trust(Wellcome Trust); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Institutes of Health R01 HL127564 to S.K. and was conducted using the UK Biobank resource under application 7089. S.K. is supported by a research scholar award from Massachusetts General Hospital and the Donovan Family Foundation. K.G.A. is supported by the American Heart Association Institute for Precision Cardiovascular Medicine (17IFUNP33840012). G.D.S. and G.H. work within the Medical Research Council Integrative Epidemiology Unit, supported by the Medical Research Council (MC_UU_00011/1) and the University of Bristol. G.H. is supported by the Wellcome Trust (208806/Z/17/Z). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute (NHLBI, contracts HHSN2682011 00005C, HHSN268201100006C, HHSN268201100007C, HHSN2 68201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C); funding for GENEVA was provided by National Human Genome Research Institute grant U01HG004402. The authors thank the staff and participants of the ARIC study for their important contributions. The Framingham Heart Study is conducted and supported by the NHLBI in collaboration with Boston University (contracts N01-HC-25195, N02-HL64278, and HHSN268201500001I). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI.	Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bakris G.L., 2016, MODERATELY INCREASED; Bianchi S, 1999, AM J KIDNEY DIS, V34, P973, DOI 10.1016/S0272-6386(99)70002-8; Bowden J, 2017, STAT MED, V36, P1783, DOI 10.1002/sim.7221; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brantsma AH, 2005, DIABETES CARE, V28, P2525, DOI 10.2337/diacare.28.10.2525; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S., 2015, INTEGRATING SUMMARIZ; Burgess S., 2018, ANNU REV GENOM HUM G, DOI [10.1146/an-nurev-genom-083117-021731, DOI 10.1146/AN-NUREV-GENOM-083117-021731]; Burgess S, 2017, EUR J EPIDEMIOL, V32, P377, DOI 10.1007/s10654-017-0255-x; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Burgess S, 2013, INT J EPIDEMIOL, V42, P1134, DOI 10.1093/ije/dyt093; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Clausen P, 1999, CLIN SCI, V97, P37, DOI 10.1042/CS19990002; Corbin LJ, 2016, DIABETES, V65, P3002, DOI 10.2337/db16-0418; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; Crowley SD, 2014, J CLIN INVEST, V124, P2341, DOI 10.1172/JCI72274; Currie G, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0337-0; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Emdin CA, 2017, JAMA-J AM MED ASSOC, V317, P626, DOI 10.1001/jama.2016.21042; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goldblatt H, 1934, J EXP MED, V59, P347, DOI 10.1084/jem.59.3.347; Guidi E, 1996, J AM SOC NEPHROL, V7, P1131; Halimi JM, 2008, J HYPERTENS, V26, P2198, DOI 10.1097/HJH.0b013e328310ddff; Hartwig FP, 2016, INT J EPIDEMIOL, V45, P1676, DOI 10.1093/ije/dyw240; Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216; Hemani G, 2017, AUTOMATING MENDELIAN, DOI [10.1101/173682, DOI 10.1101/173682]; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hemani G, 2018, HUM MOL GENET, V27, pR195, DOI 10.1093/hmg/ddy163; Hemani G, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007081; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Holtkamp FA, 2011, EUR HEART J, V32, P1493, DOI 10.1093/eurheartj/ehr017; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Lee SH, 2012, GENET EPIDEMIOL, V36, P214, DOI 10.1002/gepi.21614; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Ma TKW, 2012, RENAL FAILURE, V34, P810, DOI 10.3109/0886022X.2012.672156; Matsushita K, 2017, LANCET DIABETES ENDO, V5, P718, DOI 10.1016/S2213-8587(17)30183-3; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; Richmond R., 2017, BIORXIV, DOI [10.1101/155739, DOI 10.1101/155739]; Rossi R, 2004, J AM COLL CARDIOL, V44, P1636, DOI 10.1016/j.jacc.2004.07.027; Sander M, 1999, HYPERTENSION, V33, P937, DOI 10.1161/01.HYP.33.4.937; Sarafidis PA, 2007, AM J KIDNEY DIS, V49, P12, DOI 10.1053/j.ajkd.2006.10.014; Scirica BM, 2018, JAMA CARDIOL, V3, P155, DOI 10.1001/jamacardio.2017.4228; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; STRANDGAARD S, 1986, BRIT MED J, V292, P1041, DOI 10.1136/bmj.292.6527.1041; Teumer A, 2016, DIABETES, V65, P803, DOI 10.2337/db15-1313; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Wain LV, 2017, HYPERTENSION, V70, pE4, DOI 10.1161/HYPERTENSIONAHA.117.09438; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; Williams ME, 2005, AM J NEPHROL, V25, P77, DOI 10.1159/000084286; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Zheng Jie, 2017, Curr Epidemiol Rep, V4, P330, DOI 10.1007/s40471-017-0128-6	70	60	61	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 4	2018	103	4					461	473		10.1016/j.ajhg.2018.08.004	http://dx.doi.org/10.1016/j.ajhg.2018.08.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GV7MS	30220432	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000446312200001
J	Haber, M; Doumet-Serhal, C; Scheib, C; Xue, YL; Danecek, P; Mezzavilla, M; Youhanna, S; Martiniano, R; Prado-Martinez, J; Szpak, M; Matisoo-Smith, E; Schutkowski, H; Mikulski, R; Zalloua, P; Kivisild, T; Tyler-Smith, C				Haber, Marc; Doumet-Serhal, Claude; Scheib, Christiana; Xue, Yali; Danecek, Petr; Mezzavilla, Massimo; Youhanna, Sonia; Martiniano, Rui; Prado-Martinez, Javier; Szpak, Michal; Matisoo-Smith, Elizabeth; Schutkowski, Holger; Mikulski, Richard; Zalloua, Pierre; Kivisild, Toomas; Tyler-Smith, Chris			Continuity and Admixture in the Last Five Millennia of Levantine History from Ancient Canaanite and Present-Day Lebanese Genome Sequences	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; EARLY FARMERS; ORIGIN; DNA; CONTAMINATION; POPULATIONS; EXPANSIONS; FOOTPRINTS; INSIGHTS; REVEALS	The Canaanites inhabited the Levant region during the Bronze Age and established a culture that became influential in the Near East and beyond. However, the Canaanites, unlike most other ancient Near Easterners of this period, left few surviving textual records and thus their origin and relationship to ancient and present-day populations remain unclear. In this study, we sequenced five whole genomes from similar to 3,700-year-old individuals from the city of Sidon, a major Canaanite city-state on the Eastern Mediterranean coast. We also sequenced the genomes of 99 individuals from present-day Lebanon to catalog modern Levantine genetic diversity. We find that a Bronze Age Canaanite-related ancestry was widespread in the region, shared among urban populations inhabiting the coast (Sidon) and inland populations (Jordan) who likely lived in farming societies or were pastoral nomads. This Canaanite-related ancestry derived from mixture between local Neolithic populations and eastern migrants genetically related to Chalcolithic Iranians. We estimate, using linkage-disequilibrium decay patterns, that admixture occurred 6,600-3,550 years ago, coinciding with recorded massive population movements in Mesopotamia during the mid-Holocene. We show that present-day Lebanese derive most of their ancestry from a Canaanite-related population, which therefore implies substantial genetic continuity in the Levant since at least the Bronze Age. In addition, we find Eurasian ancestry in the Lebanese not present in Bronze Age or earlier Levantines. We estimate that this Eurasian ancestry arrived in the Levant around 3,750-2,170 years ago during a period of successive conquests by distant populations.	[Haber, Marc; Xue, Yali; Danecek, Petr; Mezzavilla, Massimo; Martiniano, Rui; Prado-Martinez, Javier; Szpak, Michal; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England; [Doumet-Serhal, Claude] Sidon Excavat, Saida, Lebanon; [Scheib, Christiana; Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 1QH, England; [Youhanna, Sonia] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Dunedin 9054, New Zealand; [Schutkowski, Holger; Mikulski, Richard] Bournemouth Univ, Dept Archaeol Anthropol & Forens Sci, Talbot Campus, Poole BH12 5BB, Dorset, England; [Zalloua, Pierre] Lebanese Amer Univ, Beirut 11022801, Lebanon; [Zalloua, Pierre] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; University of Cambridge; University of Zurich; University of Otago; Bournemouth University; Lebanese American University; Harvard University; Harvard T.H. Chan School of Public Health	Haber, M; Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England.	mh25@sanger.ac.uk; cts@sanger.ac.uk	Prado-Martinez, Javier/AAA-6341-2020; Mezzavilla, Massimo/J-2948-2018; Kivisild, Toomas/P-5889-2017; Scheib, Christiana/AAE-3886-2021; Haber, Marc/Y-5090-2019; Martiniano, Rui/AAE-7748-2020; Mezzavilla, Massimo/AAL-8225-2020	Prado-Martinez, Javier/0000-0001-5402-2721; Mezzavilla, Massimo/0000-0002-9000-4595; Kivisild, Toomas/0000-0002-6297-7808; Scheib, Christiana/0000-0003-4158-8296; Haber, Marc/0000-0003-1000-1448; Martiniano, Rui/0000-0003-0216-778X; Mezzavilla, Massimo/0000-0002-9000-4595; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Mikulski, Richard/0000-0002-2593-4809; Szpak, Michal/0000-0002-9096-852X	Wellcome Trust [098051]	Wellcome Trust(Wellcome Trust)	We thank the present-day donors who contributed their samples to this study and bioRxiv readers for helpful comments. M.H., Y.X., P.D., R.M., J.P.-M., M.S., and C.T.-S. were supported by The Wellcome Trust (098051).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Bowersock G., 1986, BAHRAIN AGES ARCHAEO, P399; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Garrison E., 2012, ARXIV12073907QBIO; Ghassibe-Sabbagh M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07351; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haber M, 2016, AM J HUM GENET, V99, P1316, DOI 10.1016/j.ajhg.2016.10.012; Haber M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0866-z; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Hitti Philip, 1967, LEBANON HIST EARLIES; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Markoe G.E, 2000, PHOENICIANS; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Nakouzi G, 2015, J COMMUN GENET, V6, P83, DOI 10.1007/s12687-014-0203-3; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Pagani L, 2015, AM J HUM GENET, V96, P986, DOI 10.1016/j.ajhg.2015.04.019; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117301; Platt DE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40338; Poznik G. D., 2016, BIORXIV; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tubb Jonathan N, 1998, CANAANITES; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW64, DOI 10.1093/nar/gkw247; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	54	60	60	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					274	282		10.1016/j.ajhg.2017.06.013	http://dx.doi.org/10.1016/j.ajhg.2017.06.013			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28757201	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-18	WOS:000406854800011
J	Dey, R; Schmidt, EM; Abecasis, GR; Lee, S				Dey, Rounak; Schmidt, Ellen M.; Abecasis, Goncalo R.; Lee, Seunggeun			A Fast and Accurate Algorithm to Test for Binary Phenotypes and Its Application to PheWAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; PHENOME-WIDE; GENOTYPE IMPUTATION; VARIANTS; GENE; PIGMENTATION; POPULATION; CHALLENGES; STRATEGIES; EUROPEANS	The availability of electronic health record (EHR)-based phenotypes allows for genome-wide association analyses in thousands of traits and has great potential to enable identification of genetic variants associated with clinical phenotypes. We can interpret the phenome-wide association study (PheWAS) result for a single genetic variant by observing its association across a landscape of phenotypes. Because a PheWAS can test thousands of binary phenotypes, and most of them have unbalanced or often extremely unbalanced case-control ratios (1: 10 or 1: 600, respectively), existing methods cannot provide an accurate and scalable way to test for associations. Here, we propose a computationally fast score-test-based method that estimates the distribution of the test statistic by using the saddlepoint approximation. Our method is much (similar to 100 times) faster than the state-of-the-art Firth's test. It can also adjust for covariates and control type I error rates even when the case-control ratio is extremely unbalanced. Through application to PheWAS data from the Michigan Genomics Initiative, we show that the proposed method can control type I error rates while replicating previously known association signals even for traits with a very small number of cases and a large number of controls.	[Dey, Rounak; Schmidt, Ellen M.; Abecasis, Goncalo R.; Lee, Seunggeun] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Dey, Rounak; Schmidt, Ellen M.; Abecasis, Goncalo R.; Lee, Seunggeun] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, S (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.; Lee, S (corresponding author), Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA.	leeshawn@umich.edu	wang, edwin/G-5372-2010; Dey, Rounak/AAQ-9662-2021	Dey, Rounak/0000-0002-6540-8280; Schmidt, Ellen/0000-0003-1198-7536	NIH [R01 HG008773]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008773] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant R01 HG008773 (R.D. and S.L.). We would like to thank the investigators of the Michigan Genomics Initiative project for access to the PheWAS dataset and Dr. Hyun Min Kang for implementing the methods in the Epacts package.	[Anonymous], 1995, SADDLEPOINT APPROXIM; BARNDORFFNIELSEN OE, 1990, J ROY STAT SOC B MET, V52, P485; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Berry AC, 1941, T AM MATH SOC, V49, P122, DOI 10.2307/1990053; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Brent R.P., 1973, ALGORITHMS MINIMIZAT; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cox DR., 1974, THEORETICAL STAT; DANIELS HE, 1954, ANN MATH STAT, V25, P631, DOI 10.1214/aoms/1177728652; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; FELLER W, 1945, B AM MATH SOC, V51, P800, DOI 10.1090/S0002-9904-1945-08448-1; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Jacobs LC, 2015, J INVEST DERMATOL, V135, P1735, DOI 10.1038/jid.2015.62; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Lee S, 2016, BIOSTATISTICS, V17, P1, DOI 10.1093/biostatistics/kxv033; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Liu F, 2015, HUM GENET, V134, P823, DOI 10.1007/s00439-015-1559-0; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Press W. H., 1992, NUMERICAL RECIPES FO; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shevtsova IG, 2010, DOKL MATH, V82, P862, DOI 10.1134/S1064562410060062; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whittaker E.T., 1967, CALCULUS OBSERVATION, P84; Zhang MF, 2013, HUM MOL GENET, V22, P2948, DOI 10.1093/hmg/ddt142	42	60	62	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 6	2017	101	1					37	49		10.1016/j.ajhg.2017.05.014	http://dx.doi.org/10.1016/j.ajhg.2017.05.014			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EZ7FK	28602423	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000404886800003
J	Schueler, M; Braun, DA; Chandrasekar, G; Gee, HY; Klasson, TD; Halbritter, J; Bieder, A; Porath, JD; Airik, R; Zhou, WB; LoTurco, JJ; Che, A; Otto, EA; Bockenhauer, D; Sebire, NJ; Honzik, T; Harris, PC; Koon, SJ; Gunay-Aygun, M; Saunier, S; Zerres, K; Bruechle, NO; Drenth, JPH; Pelletier, L; Tapia-Paez, I; Lifton, RP; Giles, RH; Kere, J; Hildebrandt, F				Schueler, Markus; Braun, Daniela A.; Chandrasekar, Gayathri; Gee, Heon Yung; Klasson, Timothy D.; Halbritter, Jan; Bieder, Andrea; Porath, Jonathan D.; Airik, Rannar; Zhou, Weibin; LoTurco, Joseph J.; Che, Alicia; Otto, Edgar A.; Boeckenhauer, Detlef; Sebire, Neil J.; Honzik, Tomas; Harris, Peter C.; Koon, Sarah J.; Gunay-Aygun, Meral; Saunier, Sophie; Zerres, Klaus; Bruechle, Nadina Ortiz; Drenth, Joost P. H.; Pelletier, Laurence; Tapia-Paez, Isabel; Lifton, Richard P.; Giles, Rachel H.; Kere, Juha; Hildebrandt, Friedhelm			DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; JOUBERT-SYNDROME; CAUSE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; DOMAIN PROTEIN; GENE; CILIARY; DISEASE; INTERACTS; ZEBRAFISH	Nephronophthisis-related ciliopathies (NPHP-RC) are recessive diseases characterized by renal dysplasia or degeneration. We here identify mutations of DCDC2 as causing a renal-hepatic ciliopathy. DCDC2 localizes to the ciliary axoneme and to mitotic spindle fibers in a cell-cycle-dependent manner. Knockdown of Dcdc2 in IMCD3 cells disrupts ciliogenesis, which is rescued by wild-type (WT) human DCDC2, but not by constructs that reflect human mutations. We show that DCDC2 interacts with DVL and DCDC2 overexpression inhibits beta-catenin-dependent Wnt signaling in an effect additive to Wnt inhibitors. Mutations detected in human NPHP-RC lack these effects. A Wnt inhibitor likewise restores ciliogenesis in 3D IMCD3 cultures, emphasizing the importance of Wnt signaling for renal tubulogenesis. Knockdown of dcdc2 in zebrafish recapitulates NPHP-RC phenotypes, including renal cysts and hydrocephalus, which is rescued by a Wnt inhibitor and by WT, but not by mutant, DCDC2. We thus demonstrate a central role of Wnt signaling in the pathogenesis of NPHP-RC, suggesting an avenue for potential treatment of NPHP-RC.	[Schueler, Markus; Braun, Daniela A.; Gee, Heon Yung; Halbritter, Jan; Porath, Jonathan D.; Airik, Rannar; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Chandrasekar, Gayathri; Bieder, Andrea; Tapia-Paez, Isabel; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Klasson, Timothy D.; Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Zhou, Weibin; Otto, Edgar A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [LoTurco, Joseph J.; Che, Alicia] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Boeckenhauer, Detlef] UCL, Inst Child Hlth & Pediat Nephrol, Great Ormond St Hosp, London WC1N 3JH, England; [Sebire, Neil J.; Hildebrandt, Friedhelm] Great Ormond St Hosp Sick Children, Dept Histopathol, London WC1N 3JH, England; [Honzik, Tomas] Charles Univ Prague, Fac Med 1, Dept Pediat & Adolescent Med, Prague 12808 2, Czech Republic; [Honzik, Tomas] Gen Univ Hosp, Prague 12808 2, Czech Republic; [Harris, Peter C.; Koon, Sarah J.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Gunay-Aygun, Meral] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Saunier, Sophie] Univ Paris 05, Necker Hosp, Inserm U574, F-75015 Paris, France; [Saunier, Sophie] Univ Paris 05, Necker Hosp, Dept Genet, F-75015 Paris, France; [Zerres, Klaus; Bruechle, Nadina Ortiz] Rhein Westfal TH Aachen, Univ Hosp, Inst Human Genet, D-52074 Aachen, Germany; [Drenth, Joost P. H.] Radboud UMC, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands; [Pelletier, Laurence] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pelletier, Laurence] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Kere, Juha] Univ Helsinki, Mol Neurol Res Program, Helsinki 00014, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki 00014, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, S-17121 Solna, Sweden	Harvard University; Boston Children's Hospital; Harvard Medical School; Karolinska Institutet; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; University of Connecticut; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Charles University Prague; General University Hospital Prague; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; RWTH Aachen University; RWTH Aachen University Hospital; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Yale University; Howard Hughes Medical Institute; University of Helsinki; Karolinska Institutet	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.	juha.kere@ki.se; friedhelm.hildebrandt@childrens.harvard.edu	Honzik, Tomas/N-7509-2017; Pelletier, Laurence/F-8858-2013; Airik, Rannar/AAS-7810-2021; Drenth, J.P.H./H-8025-2014; Tapia-Páez, Isabel/N-1210-2013; Braun, Daniela A/R-2259-2017; Wang, Guilin/G-8794-2018; Kere, Juha/AAX-9117-2021; Saunier, Sophie/G-6044-2015; Tapia-Páez, Isabel/ABD-7197-2021; Bockenhauer, Detlef/AAF-6495-2020; Schueler, Markus/AAF-6057-2021; Gee, Heon Yung/K-7781-2019; Kere, Juha/A-9179-2008; Drenth, Joost/V-7436-2019	Honzik, Tomas/0000-0003-4300-2519; Airik, Rannar/0000-0002-7055-6325; Braun, Daniela A/0000-0003-3146-1566; Kere, Juha/0000-0003-1974-0271; Saunier, Sophie/0000-0002-1069-0047; Bockenhauer, Detlef/0000-0001-5878-941X; Gee, Heon Yung/0000-0002-8741-6177; Kere, Juha/0000-0003-1974-0271; Tapia-Paez, Isabel/0000-0002-0535-4233; Otto, Edgar/0000-0002-2387-9973; Giles, Rachel/0000-0001-9133-2008; Bieder, Andrea/0000-0002-4566-050X; Sebire, Neil/0000-0001-5348-9063	Live Cell Imaging unit/Nikon Center of Excellence; Department of Biosciences and Nutrition, Karolinska Institutet; National Institutes of Health [DK1069274, DK1068306, DK064614, DK090728, DK059597, DK099434]; CIHR [MOP130507]; NephCure Foundation; ASN Foundation for Kidney Research; General University Hospital [RVO-VFN 64165/2012]; Knut and Alice Wallenberg Foundation; Swedish Research Council; Centre for Biosciences; Centre for Innovative Medicine; Kungliga Tekniska Hogskolan; Swedish Brain Foundation (Hjarnfonden); Swedish Brain Foundation; European Union [241955, 305608]; Dutch Kidney Foundation [CP11.18 "KOUNCIL"/13A3D103]; Deutsche Forschungs-gemeinschaft [ZE 205/14-1]; Jonasson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK091405, P30DK090728, R01DK068306, P30DK079310, R00DK099434, R01DK064614, K99DK099434, R01DK059597] Funding Source: NIH RePORTER	Live Cell Imaging unit/Nikon Center of Excellence; Department of Biosciences and Nutrition, Karolinska Institutet; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NephCure Foundation; ASN Foundation for Kidney Research; General University Hospital; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Biosciences; Centre for Innovative Medicine; Kungliga Tekniska Hogskolan; Swedish Brain Foundation (Hjarnfonden); Swedish Brain Foundation; European Union(European Commission); Dutch Kidney Foundation; Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG)); Jonasson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to families and study individuals for their contribution. We would like to thank Milan Elleder and Helena Hulkova (Institute for Inherited Metabolic Disorders) for histological preparation of liver biopsy specimen. We thank the zebrafish core facility, Karolinska Institutet for providing zebrafish embryos. We thank Kjell Hultenby, Eva Blomen, and Sally Cheung for technical support. We thank the Live Cell Imaging unit/Nikon Center of Excellence, Department of Biosciences and Nutrition, Karolinska Institutet for their support. This research was supported by grants from the National Institutes of Health to F.H. (DK1069274, DK1068306, DK064614), to P.C.H. (DK090728, DK059597), to R.A. (DK099434), and by the CIHR to L.P. (MOP130507). H.Y.G. is supported by the NephCure Foundation and by the ASN Foundation for Kidney Research. T.H. was supported by General University Hospital program RVO-VFN 64165/2012. This work was in part supported by grants to J.K. from Knut and Alice Wallenberg Foundation, the Swedish Research Council, the Centre for Biosciences, the Centre for Innovative Medicine, and Jonasson donation to the School of Technology and Health, Kungliga Tekniska Hogskolan, Swedish Brain Foundation (Hjarnfonden) and Swedish Brain Foundations postdoc fellowship award to G.C., from the European Union Framework Programmes 241955 "SYSCILIA" and 305608 "EURenOmics" as well as the Dutch Kidney Foundation grants CP11.18 "KOUNCIL"/13A3D103 to R.H.G., and from the Deutsche Forschungs-gemeinschaft to K.Z. (ZE 205/14-1). F.H. is an Investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist, and the Warren E. Grupe Professor.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Ge WS, 2014, MOL MED REP, V9, P2145, DOI 10.3892/mmr.2014.2099; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jaeschke A, 2004, GENE DEV, V18, P1976, DOI 10.1101/gad.1216504; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Miller RK, 2010, DEV DYNAM, V239, P77, DOI 10.1002/dvdy.22059; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2008, J AM SOC NEPHROL, V19, P587, DOI 10.1681/ASN.2007040490; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Renkema KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/nrneph.2014.95; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Shmueli A, 2006, MOL CELL NEUROSCI, V32, P15, DOI 10.1016/j.mcn.2006.01.014; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Truong DT, 2014, GENES BRAIN BEHAV, V13, P802, DOI 10.1111/gbb.12170; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347; Zhou WB, 2009, GENE EXPR PATTERNS, V9, P282, DOI 10.1016/j.gep.2009.03.003	41	60	66	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					81	92		10.1016/j.ajhg.2014.12.002	http://dx.doi.org/10.1016/j.ajhg.2014.12.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25557784	Green Published, Bronze			2022-12-18	WOS:000347707800006
J	Fu, WQ; Gittelman, RM; Bamshad, MJ; Akey, JM				Fu, Wenqing; Gittelman, Rachel M.; Bamshad, Michael J.; Akey, Joshua M.			Characteristics of Neutral and Deleterious Protein-Coding Variation among Individuals and Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUTATION LOAD; DEMOGRAPHIC HISTORY; VARIANTS; REVEALS; ACCUMULATION; VARIABILITY; BOTTLENECK; DIVERSITY; SEQUENCES; ABUNDANCE	Whole-genome and exome data sets continue to be produced at a frenetic pace, resulting in massively large catalogs of human genomic variation. However, a clear picture of the characteristics and patterns of neutral and deleterious variation within and between populations has yet to emerge, given that recent large-scale sequencing studies have often emphasized different aspects of the data and sometimes appear to have conflicting conclusions. Here, we comprehensively studied characteristics of protein-coding variation in high-coverage exome sequence data from 6,515 European American (EA) and African American (AA) individuals. We developed an unbiased approach to identify putatively deleterious variants and investigated patterns of neutral and deleterious single-nucleotide variants and alleles between individuals and populations. We show that there are substantial differences in the composition of genotypes between EA and AA populations and that small but statistically significant differences exist in the average number of deleterious alleles carried by EA and AA individuals. Furthermore, we performed extensive simulations to delineate the temporal dynamics of deleterious alleles for a broad range of demographic models and use these data to inform the interpretation of empirical patterns of deleterious variation. Finally, we illustrate that the effects of demographic perturbations, such as bottlenecks and expansions, often manifest in opposing patterns of neutral and deleterious variation depending on whether the focus is on populations or individuals. Our results clarify seemingly disparate empirical characteristics of protein-coding variation and provide substantial insights into how natural selection and demographic history have patterned neutral and deleterious variation within and between populations.	[Fu, Wenqing; Gittelman, Rachel M.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fu, WQ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	wqfu@uw.edu; akeyj@uw.edu		Gittelman, Rachel/0000-0003-3202-6582; Akey, Joshua/0000-0002-4411-1330				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Casals F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003815; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; CROW J. F., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P128; CROW JF, 1958, AM ANTHROPOL, V60, P1; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Do R., 2014, ARXIV14024896; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gavrilov LA, 1997, MUTAT RES-FUND MOL M, V377, P61, DOI 10.1016/S0027-5107(97)00058-4; Gazave E, 2013, GENETICS, V195, P969, DOI 10.1534/genetics.113.153973; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hernandez R.D., 2008, BIOINFORMATICS; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; Hodgkinson A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-495; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; KIMURA M, 1963, GENETICS, V48, P1303; KIMURA M, 1955, COLD SPRING HARB SYM, V20, P33, DOI 10.1101/SQB.1955.020.01.006; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lohmueller K.E., 2014, DISTRIBUTION DELETER; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maher MC, 2012, HUM HERED, V74, P118, DOI 10.1159/000346826; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Peischl S, 2013, MOL ECOL, V22, P5972, DOI 10.1111/mec.12524; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Subramanian S, 2012, GENETICS, V190, P1578, DOI 10.1534/genetics.111.137893; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POP PROSP 2010; Wang SR, 2014, AM J HUM GENET, V94, P710, DOI 10.1016/j.ajhg.2014.03.019; Waxman D, 2011, GENETICS, V188, P907, DOI 10.1534/genetics.111.129288	57	60	60	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					421	436		10.1016/j.ajhg.2014.09.006	http://dx.doi.org/10.1016/j.ajhg.2014.09.006			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25279984	Bronze, Green Published			2022-12-18	WOS:000342654300007
J	Shaheen, R; Rahbeeni, Z; Alhashem, A; Faqeih, E; Zhao, Q; Xiong, Y; Almoisheer, A; Al-Qattan, SM; Almadani, HA; Al-Onazi, N; Al-Baqawi, BS; Saleh, MA; Alkuraya, FS				Shaheen, Ranad; Rahbeeni, Zuhair; Alhashem, Amal; Faqeih, Eissa; Zhao, Qi; Xiong, Yong; Almoisheer, Agaadir; Al-Qattan, Sarah M.; Almadani, Halima A.; Al-Onazi, Noufa; Al-Baqawi, Badi S.; Saleh, Mohammad Ali; Alkuraya, Fowzan S.			Neu-Laxova Syndrome, an Inborn Error of Serine Metabolism, Is Caused by Mutations in PHGDH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE; EMBRYONIC LETHALITY; MENTAL-RETARDATION; DEFICIENCY; BIOSYNTHESIS; DISRUPTION; DEFECTS; ENTITY; GROWTH; GENE	Neu-Laxova syndrome (NLS) is a rare autosomal-recessive disorder characterized by severe fetal growth restriction, microcephaly, a distinct facial appearance, ichthyosis, skeletal anomalies, and perinatal lethality. The pathogenesis of NLS remains unclear despite extensive clinical and pathological phenotyping of the >70 affected individuals reported to date, emphasizing the need to identify the underlying genetic etiology, which remains unknown. In order to identify the cause of NLS, we conducted a positional-mapping study combining autozygosity mapping and whole-exome sequencing in three consanguineous families affected by NLS. Surprisingly, the NLS-associated locus identified in this study was solved at the gene level to reveal mutations in PHGDH, which is known to be mutated in individuals with microcephaly and developmental delay. PHGDH encodes the first enzyme in the phosphorylated pathway of de novo serine synthesis, and complete deficiency of its mouse ortholog recapitulates many of the key features of NLS. This study shows that NLS represents the extreme end of a known inborn error of serine metabolism and highlights the power of genomic sequencing in revealing the unsuspected allelic nature of apparently distinct clinical entities.	[Shaheen, Ranad; Almoisheer, Agaadir; Al-Qattan, Sarah M.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Rahbeeni, Zuhair] King Faisal Specialist Hosp & Res Ctr, Dept Med Genet, Riyadh 11211, Saudi Arabia; [Faqeih, Eissa; Saleh, Mohammad Ali] King Fahad Med City, Dept Pediat, Riyadh 59046, Saudi Arabia; [Alhashem, Amal; Al-Onazi, Noufa] Prince Sultan Mil Med City, Dept Pediat, Riyadh 11159, Saudi Arabia; [Zhao, Qi; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Al-Baqawi, Badi S.] King Fahad Med City, Womens Specialist Hosp, Maternal Fetal Dept, Riyadh 59046, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Dept Anat & Cell Biol, Coll Med, Riyadh 11533, Saudi Arabia; [Almadani, Halima A.] Prince Sultan Mil Med City, Pediat Metab Lab, Riyadh 11159, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Fahad Medical City; Prince Sultan Military Medical City; Yale University; King Fahad Medical City; Alfaisal University; Prince Sultan Military Medical City	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa		SHAHEEN, RANAD/0000-0002-2590-1759; Alhashem, Amal/0000-0002-9668-7809	Dubai Harvard Foundation for Medical Research	Dubai Harvard Foundation for Medical Research	We thank the affected individuals and their families for their enthusiastic participation. We thank Mais Hashem, Niema Ibrahim, and Firdous Mohammed for their help as clinical research coordinators. We also thank the Genotyping and Sequencing Core Facilities at King Faisal Specialist Hospital and Research Center for their technical help. Thanks are also due to Dietrich Matem and Piero Rinaldo of the Biochemical Genetics Laboratory, Mayo Clinic, for the amino acid analysis in a dried blood spot from the index individual in family 3. This work was supported by a collaborative research grant from the Dubai Harvard Foundation for Medical Research (to F.S.A.).	Alazami AM, 2012, AM J MED GENET A, V158A, P245, DOI 10.1002/ajmg.a.34347; Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Alkuraya FS, 2010, AM J MED GENET A, V152A, P2160, DOI 10.1002/ajmg.a.33575; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; de Koning TJ, 2004, LANCET, V364, P2221, DOI 10.1016/S0140-6736(04)17596-X; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Horn D, 1997, CLIN DYSMORPHOL, V6, P323, DOI 10.1097/00019605-199710000-00004; Hunter AGW, 2002, CAN MED ASSOC J, V167, P367; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; KARIMINEJAD MH, 1987, AM J MED GENET, V28, P17, DOI 10.1002/ajmg.1320280104; LAXOVA R, 1972, J MENT DEFIC RES, V16, P139; LAZJUK GI, 1979, AM J MED GENET, V3, P261, DOI 10.1002/ajmg.1320030304; Mallory SB, 2003, PEDIATR DERMATOL, V20, P78, DOI 10.1046/j.1525-1470.2003.03017.x; Mishra V, 2012, MOL BIOCHEM PARASIT, V181, P117, DOI 10.1016/j.molbiopara.2011.10.008; MUELLER RF, 1983, AM J MED GENET, V16, P645, DOI 10.1002/ajmg.1320160424; NEU RL, 1971, PEDIATRICS, V47, P610; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; OSTROVSKAYA TI, 1988, AM J MED GENET, V30, P747, DOI 10.1002/ajmg.1320300308; Sayano T, 2013, FEBS J, V280, P1502, DOI 10.1111/febs.12146; SCOTT CI, 1981, AM J MED GENET, V9, P165, DOI 10.1002/ajmg.1320090211; Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113; SHVED IA, 1985, AM J MED GENET, V20, P1, DOI 10.1002/ajmg.1320200102; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Turgeon C, 2008, CLIN CHEM, V54, P657, DOI 10.1373/clinchem.2007.101949; van der Crabben SN, 2013, J INHERIT METAB DIS, V36, P613, DOI 10.1007/s10545-013-9592-4; Yamasaki M, 2001, J NEUROSCI, V21, P7691, DOI 10.1523/JNEUROSCI.21-19-07691.2001; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200	28	60	63	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					898	904		10.1016/j.ajhg.2014.04.015	http://dx.doi.org/10.1016/j.ajhg.2014.04.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24836451	Green Published, Bronze			2022-12-18	WOS:000337331200010
J	Eggert, SL; Huyck, KL; Somasundaram, P; Kavalla, R; Stewart, EA; Lu, AT; Painter, JN; Montgomery, GW; Medland, SE; Nyholt, DR; Treloar, SA; Zondervan, KT; Heath, AC; Madden, PAF; Rose, L; Buring, JE; Ridker, PM; Chasman, DI; Martin, NG; Cantor, RM; Morton, CC				Eggert, Stacey L.; Huyck, Karen L.; Somasundaram, Priya; Kavalla, Raghava; Stewart, Elizabeth A.; Lu, Ake T.; Painter, Jodie N.; Montgomery, Grant W.; Medland, Sarah E.; Nyholt, Dale R.; Treloar, Susan A.; Zondervan, Krina T.; Heath, Andrew C.; Madden, Pamela A. F.; Rose, Lynda; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.; Martin, Nicholas G.; Cantor, Rita M.; Morton, Cynthia C.			Genome-wide Linkage and Association Analyses Implicate FASN in Predisposition to Uterine Leiomyomata	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FATTY-ACID SYNTHASE; PHARMACOLOGICAL INHIBITORS; CYTOGENETIC ABNORMALITIES; CANCER; SUSCEPTIBILITY; TRANSCRIPTION; HYSTERECTOMY; EXPRESSION; DISTINCT; HEALTH	Uterine leiomyomata (UL), the most prevalent pelvic tumors in women of reproductive age, pose a major public health problem given their high frequency, associated morbidities, and most common indication for hysterectomies. A genetic component to UL predisposition is supported by analyses of ethnic predisposition, twin studies, and familial aggregation. A genome-wide SNP linkage panel was genotyped and analyzed in 261 white UL-affected sister-pair families from the Finding Genes for Fibroids study. Two significant linkage regions were detected in 10p11 (LOD = 4.15) and 3p21 (LOD = 3.73), and five additional linkage regions were identified with LOD scores > 2.00 in 2q37, 5p13, 11p15, 12q14, and 17q25. Genome-wide association studies were performed in two independent cohorts of white women, and a meta-analysis was conducted. One SNP (rs4247357) was identified with a p value (p = 3.05 x 10(-8)) that reached genome-wide significance (odds ratio = 1.299). The candidate SNP is under a linkage peak and in a block of linkage disequilibrium in 17q25.3, which spans fatty acid synthase (FASN), coiled-coil-domain-containing 57 (CCDC57), and solute-carrier family 16, member 3 (SLC16A3). By tissue microarray immunohistochemistry, we found elevated (3-fold) FAS levels in UL-affected tissue compared to matched myometrial tissue. FAS transcripts and/or protein levels are upregulated in various neoplasms and implicated in tumor cell survival. FASN represents the initial UL risk allele identified in white women by a genome-wide, unbiased approach and opens a path to management and potential therapeutic intervention.	[Somasundaram, Priya; Kavalla, Raghava; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Eggert, Stacey L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Huyck, Karen L.] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03756 USA; [Stewart, Elizabeth A.] Mayo Clin, Dept Obstet & Gynecol & Surg, Rochester, MN 55902 USA; [Stewart, Elizabeth A.] Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55902 USA; [Lu, Ake T.; Cantor, Rita M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Painter, Jodie N.; Montgomery, Grant W.; Medland, Sarah E.; Nyholt, Dale R.; Treloar, Susan A.; Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Treloar, Susan A.] Univ Queensland, Ctr Mil & Vet Hlth, Herston, Qld 4006, Australia; [Zondervan, Krina T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Rose, Lynda; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Zondervan, Krina T.] Univ Oxford, Nuffield Dept Obstet & Gynecol, Oxford OX3 7BN, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dartmouth College; Mayo Clinic; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; University of Oxford	Morton, CC (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 75 Francis St, Boston, MA 02115 USA.	cmorton@partners.org	Martin, Nicholas/R-9235-2019; Nyholt, Dale Robert/J-3174-2017; Medland, Sarah E/C-7630-2013; Painter, Jodie N/AAC-6332-2019; Zondervan, Krina T/M-1143-2013; Medland, Sarah/AAT-7595-2020; Montgomery, Grant W/B-7148-2008	Martin, Nicholas/0000-0003-4069-8020; Nyholt, Dale Robert/0000-0001-7159-3040; Medland, Sarah E/0000-0003-1382-380X; Painter, Jodie N/0000-0002-4992-2458; Zondervan, Krina T/0000-0002-0275-9905; Medland, Sarah/0000-0003-1382-380X; Montgomery, Grant W/0000-0002-4140-8139; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Stewart, Elizabeth/0000-0003-1110-2400	National Institute of Child Health & Human Development [HD046226, HD060530]; National Heart, Lung, and Blood Institute [HL043851, HL69757]; National Cancer Institute [CA047988]; Donald W. Reynolds Foundation; Fondation Leducq; Amgen; NIH [AA07535, AA07728, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, DA019951, HHSN268200782096C]; Australian National Health and Medical Research Council [339462, 389927, 389938, 442981, 443036, 496739]; 5th Framework Programme (FP-5) GenomEUtwin Project [QLG2-CT-2002-01254]; Wellcome Trust [WT085235/Z/08/Z]; Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne); National Health and Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060530] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046226] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, R01HL043851, U19HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R01AA014041, P50AA011998, R01AA007535, K05AA017688, P60AA011998, R01AA007728, R01AA013321, R37AA007728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854, K08DA019951] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); Amgen(Amgen); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); 5th Framework Programme (FP-5) GenomEUtwin Project(European Commission); Wellcome Trust(Wellcome Trust); Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank all of the women and their families who participated in the Finding Genes for Fibroids (FGFF) study, the Women's Genome Health Study (WGHS), and the Australian study. The FGFF study is supported by National Institute of Child Health & Human Development grants HD046226 and HD060530 (to C.C.M.). The WGHS is supported by HL043851 and HL69757 from the National Heart, Lung, and Blood Institute and CA047988 from the National Cancer Institute, the Donald W. Reynolds Foundation, and the Fondation Leducq; collaborative scientific support and funding for genotyping was provided by Amgen. The Australian cohort was supported by NIH Grants (AA07535, AA07728, AA13320, AA13321, AA14041, AA11998, AA17688, DA012854, and DA019951); by grants from the Australian National Health and Medical Research Council (339462, 389927, 389938, 442981, 443036, and 496739); by the 5th Framework Programme (FP-5) GenomEUtwin Project (QLG2-CT-2002-01254); by the Wellcome Trust (WT085235/Z/08/Z); and by funding provided by the Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne). G.W.M., S.E.M., and D.R.N. are supported by the National Health and Medical Research Council Fellowship Scheme, and K.T.Z. is supported by a Wellcome Trust Research Career Development Fellowship. Genotyping services for the FGFF study were provided by the Center for Inherited Disease Research (CIDR). The CIDR is funded through a federal contract from the NIH to The Johns Hopkins University (contract number HHSN268200782096C).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alli PM, 2005, ONCOGENE, V24, P39, DOI 10.1038/sj.onc.1208174; Alo PL, 1999, TUMORI, V85, P35, DOI 10.1177/030089169908500108; Brosens I, 1998, FERTIL STERIL, V69, P232, DOI 10.1016/S0015-0282(97)00472-X; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; Cha PC, 2011, NAT GENET, V43, P447, DOI 10.1038/ng.805; Christacos NC, 2006, GENE CHROMOSOME CANC, V45, P304, DOI 10.1002/gcc.20291; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fejzo MS, 1996, GENE CHROMOSOME CANC, V17, P1, DOI 10.1002/(SICI)1098-2264(199609)17:1<1::AID-GCC1>3.0.CO;2-0; Flynn M, 2006, AM J OBSTET GYNECOL, V195, P955, DOI 10.1016/j.ajog.2006.02.020; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Gross KL, 2001, CLIN OBSTET GYNECOL, V44, P335, DOI 10.1097/00003081-200106000-00020; Hodge JC, 2009, HUM GENET, V125, P257, DOI 10.1007/s00439-008-0621-6; Huyck KL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.038; Kharazmi E, 2007, ACTA OBSTET GYN SCAN, V86, P1476, DOI 10.1080/00016340701698633; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Lepine L A, 1997, MMWR CDC Surveill Summ, V46, P1; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Luoto R, 2000, MATURITAS, V37, P15, DOI 10.1016/S0378-5122(00)00160-2; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Ogino S, 2008, J CLIN ONCOL, V26, P5713, DOI 10.1200/JCO.2009.22.8858; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Pizer ES, 1996, CANCER RES, V56, P2745; Pizer ES, 1998, CANCER RES, V58, P4611; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REIN MS, 1991, OBSTET GYNECOL, V77, P923; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rossi S, 2003, MOL CANCER RES, V1, P707; Takeda T, 2008, GYNECOL OBSTET INVES, V66, P14, DOI 10.1159/000114250; Treloar SA, 2005, AM J HUM GENET, V77, P365, DOI 10.1086/432960; Treloar SA, 1998, LANCET, V352, P1084, DOI 10.1016/S0140-6736(05)79753-1; Treloar SA, 1999, AM J OBSTET GYNECOL, V180, P945, DOI 10.1016/S0002-9378(99)70666-6; Van de Sande T, 2002, CANCER RES, V62, P642; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I	40	60	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2012	91	4					621	628		10.1016/j.ajhg.2012.08.009	http://dx.doi.org/10.1016/j.ajhg.2012.08.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	017CU	23040493	Bronze, Green Published			2022-12-18	WOS:000309568500004
J	Shaheen, R; Faqeih, E; Shamseldin, HE; Noche, RR; Sunker, A; Alshammari, MJ; Al-Sheddi, T; Adly, N; Al-Dosari, MS; Megason, SG; Al-Husain, M; Al-Mohanna, F; Alkuraya, FS				Shaheen, Ranad; Faqeih, Eissa; Shamseldin, Hanan E.; Noche, Ramil R.; Sunker, Asma; Alshammari, Muneera J.; Al-Sheddi, Tarfa; Adly, Nouran; Al-Dosari, Mohammed S.; Megason, Sean G.; Al-Husain, Muneera; Al-Mohanna, Futwan; Alkuraya, Fowzan S.			POC1A Truncation Mutation Causes a Ciliopathy in Humans Characterized by Primordial Dwarfism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEIER-GORLIN-SYNDROME; II MOPD-II; SECKEL-SYNDROME; RECESSIVE MUTATIONS; DISEASE; PROTEIN; CENTROSOME; CENTRIOLES; COMPONENT; CEP152	Primordial dwarfism (PD) is a phenotype characterized by profound growth retardation that is prenatal in onset. Significant strides have been made in the last few years toward improved understanding of the molecular underpinning of the limited growth that characterizes the embryonic and postnatal development of PD individuals. These include impaired mitotic mechanics, abnormal IGF2 expression, perturbed DNA-damage response, defective spliceosomal machinery, and abnormal replication licensing. In three families affected by a distinct form of PD, we identified a founder truncating mutation in POC1A. This gene is one of two vertebrate paralogs of POC1, which encodes one of the most abundant proteins in the Chlamydomonas centriole proteome. Cells derived from the index individual have abnormal mitotic mechanics with multipolar spindles, in addition to clearly impaired ciliogenesis. siRNA knockdown of POC1A in fibroblast cells recapitulates this ciliogenesis defect. Our findings highlight a human ciliopathy syndrome caused by deficiency of a major centriolar protein.	[Shaheen, Ranad; Shamseldin, Hanan E.; Sunker, Asma; Alshammari, Muneera J.; Al-Sheddi, Tarfa; Adly, Nouran; Al-Dosari, Mohammed S.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Faqeih, Eissa] King Fahad Med City, Dept Pediat, Riyadh 11411, Saudi Arabia; [Noche, Ramil R.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Al-Dosari, Mohammed S.] King Saud Univ, Coll Pharm, Dept Pharmacognosy, Riyadh 11451, Saudi Arabia; [Alshammari, Muneera J.; Al-Husain, Muneera; Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11411, Saudi Arabia; [Alshammari, Muneera J.; Al-Husain, Muneera; Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11411, Saudi Arabia; [Al-Mohanna, Futwan] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; Harvard University; Harvard Medical School; King Saud University; King Saud University; King Khalid University Hospital; King Saud University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, POB 3354, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	aldosari, mohammed/GZK-2460-2022; Alkuraya, Fowzan S./A-1542-2009	Alkuraya, Fowzan S./0000-0003-4158-341X; Noche, Ramil R./0000-0002-4894-5682; SHAHEEN, RANAD/0000-0002-2590-1759	King Abdulaziz City for Science and Technology [09-MED941-20]; Collaborative Research Grant from the Dubai Harvard Foundation for Medical Research	King Abdulaziz City for Science and Technology; Collaborative Research Grant from the Dubai Harvard Foundation for Medical Research	We would like to express our deep appreciation to the family members for their enthusiastic and generous participation. We thank our Sequencing and Genomic Core Facilities at the King Faisal Specialist Hospital and Research Center. This study was supported in part by King Abdulaziz City for Science and Technology grant 09-MED941-20 (F.S.A.) and a Collaborative Research Grant from the Dubai Harvard Foundation for Medical Research (F.S.A.).	Al-Dosari MS, 2012, J PEDIATR-US, V161, P139, DOI 10.1016/j.jpeds.2011.12.051; Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; Al-Dosari MS, 2012, J PEDIAT, V161, p[139, e1]; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Bongers EMHF, 2001, AM J MED GENET, V102, P115, DOI 10.1002/ajmg.1452; Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Delaval B., 2010, J CELL BIOL, V188, P181; Eggermann T, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-19; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kaler SG, 2009, ANN NEUROL, V65, P108, DOI 10.1002/ana.21576; Karlberg N, 2007, PEDIATRICS, V120, pE102, DOI 10.1542/peds.2006-2686; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Nagy R, 2012, CLIN GENET, V82, P140, DOI 10.1111/j.1399-0004.2011.01756.x; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298	31	60	62	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					330	336		10.1016/j.ajhg.2012.05.025	http://dx.doi.org/10.1016/j.ajhg.2012.05.025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22840364	Green Published, Bronze			2022-12-18	WOS:000307608700011
J	Huppke, P; Brende, C; Kalscheuer, V; Korenke, GC; Marquardt, I; Freisinger, P; Christodoulou, J; Hillebrand, M; Pitelet, G; Wilson, C; Gruber-Sedlmayr, U; Ullmann, R; Haas, S; Elpeleg, O; Nurnberg, G; Nurnberg, P; Dad, S; Moller, LB; Kaler, SG; Gartner, J				Huppke, Peter; Brende, Cornelia; Kalscheuer, Vera; Korenke, Georg Christoph; Marquardt, Iris; Freisinger, Peter; Christodoulou, John; Hillebrand, Merle; Pitelet, Gaele; Wilson, Callum; Gruber-Sedlmayr, Ursula; Ullmann, Reinhard; Haas, Stefan; Elpeleg, Orly; Nuernberg, Gudrun; Nuernberg, Peter; Dad, Shzeena; Moller, Lisbeth Birk; Kaler, Stephen G.; Gaertner, Jutta			Mutations in SLC33A1 Cause a Lethal Autosomal-Recessive Disorder with Congenital Cataracts, Hearing Loss, and Low Serum Copper and Ceruloplasmin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACETYL-COA TRANSPORTER; DOMINANT SPASTIC PARAPLEGIA; MENKES DISEASE; CANDIDATE GENE; PROTEIN; ENCODES; METABOLISM; FEATURES; DEFECTS; ATROPHY	Low copper and ceruloplasmin in serum are the diagnostic hallmarks for Menkes disease, Wilson disease, and aceruloplasminemia. We report on five patients from four unrelated families with these biochemical findings who presented with a lethal autosomal-recessive syndrome of congenital cataracts, hearing loss, and severe developmental delay. Cerebral MRI showed pronounced cerebellar hypoplasia and hypomyelination. Homozygosity mapping was performed and displayed a region of commonality among three families at chromosome 3q25. Deep sequencing and conventional sequencing disclosed homozygous or compound heterozygous mutations for all affected subjects in SLC33A1 encoding a highly conserved acetylCoA transporter (AT-1) required for acetylation of multiple gangliosides and glycoproteins. The mutations were found to cause reduced or absent AT-1 expression and abnormal intracellular localization of the protein. We also showed that AT-1 knockdown in HepG2 cells leads to reduced ceruloplasmin secretion, indicating that the low copper in serum is due to reduced ceruloplasmin levels and is not a sign of copper deficiency. The severity of the phenotype implies an essential role of AT-1 in proper posttranslational modification of numerous proteins, without which normal lens and brain development is interrupted. Furthermore, AT-1 defects are a new and important differential diagnosis in patients with low copper and ceruloplasmin in serum.	[Huppke, Peter; Brende, Cornelia; Hillebrand, Merle; Gaertner, Jutta] Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Kalscheuer, Vera; Ullmann, Reinhard] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Korenke, Georg Christoph; Marquardt, Iris] Childrens Hosp, Dept Neuropediat, D-26133 Oldenburg, Germany; [Freisinger, Peter] Klinikum Steinenberg, Dept Pediat, D-72764 Reutlingen, Germany; [Christodoulou, John] Univ Sydney, Childrens Hosp Westmead, Western Sydney Genet Program, Westmead, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Westmead, NSW 2145, Australia; [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia; [Pitelet, Gaele] CHU Nice, Serv Neuropediat, F-6200 Nice, France; [Wilson, Callum] Starship Childrens Hosp, Natl Metab Serv, Auckland 1142, New Zealand; [Gruber-Sedlmayr, Ursula] Med Univ Graz, Dept Pediat, A-8010 Graz, Austria; [Haas, Stefan] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Dept Genet & Metab Dis, Monique & Jacques Roboh Dept Genet Res, IL-91050 Jerusalem, Israel; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, CMMC, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Dad, Shzeena; Moller, Lisbeth Birk] Kennedy Ctr, Dept Appl Human Mol Genet, DK-2600 Glostrup, Denmark; [Kaler, Stephen G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Human Copper Metab, Mol Med Program, NIH, Bethesda, MD 20814 USA	University of Gottingen; Max Planck Society; University of Sydney; University of Sydney; University of Sydney; CHU Nice; Starship Children's Hospital; Medical University of Graz; Max Planck Society; Hebrew University of Jerusalem; University of Cologne; University of Cologne; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Huppke, P (corresponding author), Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany.	phuppke@med.uni-goettingen.de	Christodoulou, John/M-3628-2019; Christodoulou, John/E-5866-2015; Kaler, Stephen/GPT-3845-2022	Christodoulou, John/0000-0002-8431-0641; Moller, Lisbeth/0000-0002-9524-4301; Kalscheuer, Vera/0000-0001-6898-3259; Haas, Stefan/0000-0003-3418-3688	European Union [241995]; GENCODYS; National Institutes of Health, Bethesda, MD [HD008768-08]; German Research Foundation [GA 354/9-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008768] Funding Source: NIH RePORTER	European Union(European Commission); GENCODYS; National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Ines Muller and Melanie Bienek for excellent technical assistance. Part of this work was financed by the European Union's Seventh Framework Program under grant agreement number 241995, project GENCODYS, the Intramural Research Program of the National Institutes of Health, Bethesda, MD (Project #HD008768-08), and the German Research Foundation (GA 354/9-1).	Borck G, 2011, AM J HUM GENET, V88, P127, DOI 10.1016/j.ajhg.2010.12.011; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Ferenci P, 2004, METAB BRAIN DIS, V19, P229, DOI 10.1023/B:MEBR.0000043973.10494.85; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hattori Ayako, 2010, No To Hattatsu, V42, P42; Hirabayashi H, 1998, Rinsho Shinkeigaku, V38, P38; Horvath R, 2005, J INHERIT METAB DIS, V28, P479, DOI 10.1007/s10545-005-0479-x; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kaler SG, 2011, NAT REV NEUROL, V7, P15, DOI 10.1038/nrneurol.2010.180; Kanamori A, 1997, P NATL ACAD SCI USA, V94, P2897, DOI 10.1073/pnas.94.7.2897; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2007, J MED GENET, V44, P641, DOI 10.1136/jmg.2007.049627; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyama S, 2000, NEUROPEDIATRICS, V31, P214, DOI 10.1055/s-2000-7462; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Schlipf NA, 2010, EUR J HUM GENET, V18, P1065, DOI 10.1038/ejhg.2010.68; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	22	60	63	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 13	2012	90	1					61	68		10.1016/j.ajhg.2011.11.030	http://dx.doi.org/10.1016/j.ajhg.2011.11.030			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	880LR	22243965	Green Published, Bronze			2022-12-18	WOS:000299409100005
J	Browning, SR; Browning, BL				Browning, Sharon R.; Browning, Brian L.			Population Structure Can Inflate SNP-Based Heritability Estimates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									[Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98105 USA; [Browning, Brian L.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, SR (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98105 USA.	sguy@uw.edu	Browning, Brian L/A-1178-2010; Browning, Sharon/B-1530-2008	Browning, Brian L/0000-0001-6454-6633; Browning, Sharon/0000-0001-7251-9715	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG005701] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG005701, R01HG004960, R01 HG004960, R01 HG005701] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], GCTA TOOL GENOME WID; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Haldane JBS, 1919, J GENET, V8, P299; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	9	60	60	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					191	193		10.1016/j.ajhg.2011.05.025	http://dx.doi.org/10.1016/j.ajhg.2011.05.025			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763486	Green Published, Bronze			2022-12-18	WOS:000293041700019
J	Shteyer, E; Saada, A; Shaag, A; Al-Hijawi, FA; Kidess, R; Revel-Vilk, S; Elpeleg, O				Shteyer, Eyal; Saada, Ann; Shaag, Avraharn; Al-Hijawi, Fida' Aziz; Kidess, Rojette; Revel-Vilk, Shoshanah; Elpeleg, Orly			Exocrine Pancreatic Insufficiency, Dyserythropoeitic Anemia, and Calvarial Hyperostosis Are Caused by a Mutation in the COX4I2 Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; SIDEROBLASTIC ANEMIA; SUBUNIT; DYSFUNCTION; DEFICIENCY; YEAST	Steatorrhea and malabsorption of lipid-soluble vitamins due to exocrine pancreatic insufficiency are common in patients with cystic fibrosis and are predominant in Shwachnian-Bodian-Diamond, Pearson, and Johanson-Blizzard syndromes. In four patients who suffered from congenital exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis, we excluded these disorders and identified, by using homozygosity mapping, a mutation in the COX4I2 gene. The COX4 protein is an essential structural subunit of cytochrome c oxidase complex and has two isoforms, encoded by two different genes. We show that the ratio of COX4I2 to COX41I mRNA is relatively high in human acinar cells. The mutation is associated with marked reduction of COX4I2 expression and with striking attenuation of the physiologic COX4I2 response to hypoxia. Mutation analysis of COX4I2 is warranted in patients with malabsorption due to exocrine pancreatic insufficiency and in patients with dyserythropoeitic anemia.	[Shteyer, Eyal; Saada, Ann; Shaag, Avraharn; Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel; [Shteyer, Eyal] Hadassah Hebrew Univ, Med Ctr, Pediat Gastroenterol Unit, IL-91120 Jerusalem, Israel; [Kidess, Rojette; Revel-Vilk, Shoshanah] Hadassah Hebrew Univ, Med Ctr, Dept Pediat Hematol, IL-91120 Jerusalem, Israel; [Al-Hijawi, Fida' Aziz] Minist Hlth, Dept Primary Hlth Care, Jenin, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Elpeleg, O (corresponding author), Hadassah Hebrew Univ, Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel.	elpeleg@cc.huji.ac.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656				Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gasparini P, 1997, AM J HUM GENET, V61, P1112, DOI 10.1086/301609; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; JOHANSON A, 1971, J PEDIATR-US, V79, P982, DOI 10.1016/S0022-3476(71)80194-4; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Mack DR, 1996, GASTROENTEROLOGY, V111, P1593, DOI 10.1016/S0016-5085(96)70022-7; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; ROTIG A, 1989, LANCET, V1, P902; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Wickramasinghe SN, 2005, BRIT J HAEMATOL, V131, P431, DOI 10.1111/j.1365-2141.2005.05757.x; Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201	20	60	62	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					412	417		10.1016/j.ajhg.2009.02.006	http://dx.doi.org/10.1016/j.ajhg.2009.02.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19268275	Bronze, Green Published			2022-12-18	WOS:000264304200012
J	Chakarova, CF; Papaioannou, MG; Khanna, H; Lopez, I; Waseem, N; Shah, A; Theis, T; Friedman, J; Maubaret, C; Bujakowska, K; Veraitch, B; El-Aziz, MMA; Prescott, DQ; Parapuram, SK; Bickmore, WA; Munro, PMG; Gal, A; Hamel, CP; Marigo, V; Ponting, CP; Wissinger, B; Zrenner, E; Matter, K; Swaroop, A; Koenekoop, RK; Bhattacharya, SS				Chakarova, Christina F.; Papaioannou, Myrto G.; Khanna, Hemant; Lopez, Irma; Waseem, Naushin; Shah, Amna; Theis, Torsten; Friedman, James; Maubaret, Cecilia; Bujakowska, Kinga; Veraitch, Brotati; El-Aziz, Mai M. Abd; Prescott, De Quincy; Parapuram, Sunil K.; Bickmore, Wendy A.; Munro, Peter M. G.; Gal, Andreas; Hamel, Christian P.; Marigo, Valeria; Ponting, Chris P.; Wissinger, Bernd; Zrenner, Eberhart; Matter, Karl; Swaroop, Anand; Koenekoop, Robert K.; Bhattacharya, Shomi S.			Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigment epithelium atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							I BINDING-PROTEIN; TOPOISOMERASE-I; GENE-EXPRESSION; NUCLEAR-BODIES; LIGASE; PROSPECTS; DISEASES; THERAPY; P53	We report mutations in the gene for topoisomerase I-binding RS protein (TOPORS) in patients with autosomal dominant retinitis pigmentosa (adRP) linked to chromosome 9p21.1 (locus RP31). A positional-cloning approach, together with the use of bioinformatics, identified TOPORS (comprising three exons and encoding a protein of 1,045 aa) as the gene responsible for adRP. Mutations that include an insertion and a deletion have been identified in two adRP-affected families-one French Canadian and one German family, respectively. Interestingly, a distinct phenotype is noted at the earlier stages of the disease, with an unusual perivascular cuff of retinal pigment epithelium atrophy, which was found surrounding the superior and inferior arcades in the retina. TOPORS is a RING domain-containing E3 ubiquitin ligase and localizes in the nucleus in speckled loci that are associated with promyelocytic leukemia bodies. The ubiquitous nature of TOPORS expression and a lack of mutant protein in patients are highly suggestive of haploinsufficiency, rather than a dominant negative effect, as the molecular mechanism of the disease and make rescue of the clinical phenotype amenable to somatic gene therapy.	UCL, Inst Ophthalmol, London, England; Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Visual Sci, Ann Arbor, MI 48109 USA; McGill Univ, Ctr Hlth, McGill Ocular Genet Lab, Montreal, PQ, Canada; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Univ Hamburg, Inst Human Genet, D-2000 Hamburg, Germany; INSERM, Montpellier, France; Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; Univ Oxford, Dept Physiol Anat & Genet, Med Res Council Funct Genet Unit, Oxford, England; Univ Eye Hosp, Dept Pathophysiol Vis & Neuroophthalmol, Tubingen, Germany; Univ Paris 06, UMRS 592, Inst Vis, INSERM U592, Paris, France	University of London; University College London; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; McGill University; University of Edinburgh; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universita di Modena e Reggio Emilia; University of Oxford; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bhattacharya, SS (corresponding author), UCL, Inst Ophthalmol, London, England.	smbcssb@ucl.ac.uk	Koenekoop, Robert/AAT-6676-2021; Chakarova, Christina/C-9479-2013; Marigo, Valeria/B-7947-2015; Waseem, Naushin/C-9573-2013; Bickmore, Wendy A/C-7314-2013; Bujakowska, Kinga Maria/AGL-1293-2022; Prescott, Q/C-4017-2013; Bhattacharya, Shom/N-2926-2016; Ponting, Chris/AAV-2621-2021; Shah, Amna/C-4471-2013; Matter, Karl/C-4880-2008	Marigo, Valeria/0000-0002-4428-2084; Bickmore, Wendy A/0000-0001-6660-7735; Prescott, Q/0000-0002-5496-9541; Bhattacharya, Shom/0000-0002-1601-6344; Matter, Karl/0000-0001-8026-7220; Bujakowska, Kinga/0000-0001-6809-9818; Ponting, Chris/0000-0003-0202-7816; Swaroop, Anand/0000-0002-1975-1141	Medical Research Council [MC_U137761446] Funding Source: Medline; NEI NIH HHS [P30 EY007003, R01 EY007961, F31 EY007003] Funding Source: Medline; MRC [MC_U137761446] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY007961, Z01EY000449, F31EY007003, P30EY007003] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Cazalla D, 2005, MOL CELL BIOL, V25, P2969, DOI 10.1128/MCB.25.8.2969-2980.2005; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hims MM, 2003, DEV OPHTHALMOL, V37, P109; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Papaioannou M, 2005, HUM GENET, V118, P501, DOI 10.1007/s00439-005-0063-3; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Sharon D, 2002, INVEST OPHTH VIS SCI, V43, P1971; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Weger S, 2002, J GEN VIROL, V83, P511, DOI 10.1099/0022-1317-83-3-511; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	22	60	65	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1098	1103		10.1086/521953	http://dx.doi.org/10.1086/521953			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924349	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000250480900019
J	Loupatty, FJ; Clayton, PT; Ruiter, JPN; Ofman, R; Ijlst, L; Brown, GK; Thorburn, DR; Harris, RA; Duran, M; DeSousa, C; Krywawych, S; Heales, SJR; Wanders, RJA				Loupatty, Ference J.; Clayton, Peter T.; Ruiter, Jos P. N.; Ofman, Rob; Ijlst, Lodewijk; Brown, Garry K.; Thorburn, David R.; Harris, Robert A.; Duran, Marinus; DeSousa, Carlos; Krywawych, Steve; Heales, Simon J. R.; Wanders, Ronald J. A.			Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-HYDROXYISOBUTYRYL-COENZYME; AMINO-ACIDS; DEHYDROGENASE; DEFICIENCY	Only a single patient with 3-hydroxyisobutyryl-CoA hydrolase deficiency has been described in the literature, and the molecular basis of this inborn error of valine catabolism has remained unknown until now. Here, we present a second patient with 3-hydroxyisobutyryl-CoA hydrolase deficiency, who was identified through blood spot acylcarnitine analysis showing persistently increased levels of hydroxy-C(4)-carnitine. Both patients manifested hypotonia, poor feeding, motor delay, and subsequent neurological regression in infancy. Additional features in the newly identified patient included episodes of ketoacidosis and Leigh-like changes in the basal ganglia on a magnetic resonance imaging scan. In cultured skin fibroblasts from both patients, the 3-hydroxyisobutyryl- CoA hydrolase activity was deficient, and virtually no 3-hydroxyisobutyryl-CoA hydrolase protein could be detected by western blotting. Molecular analysis in both patients uncovered mutations in the HIBCH gene, including one missense mutation in a conserved part of the protein and two mutations affecting splicing. A carefully interpreted acylcarnitine profile will allow more patients with 3-hydroxyisobutyrylCoA hydrolase deficiency to be diagnosed.	Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, Emma Childrens Hosp, NL-1012 WX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Div Pediat, Emma Childrens Hosp, NL-1012 WX Amsterdam, Netherlands; UCL, Great Ormond St Hosp Children, Inst Child Hlth, London, England; UCL, Natl Hosp Neurol & Surg, Neurol Inst, London, England; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England; Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Bloomington, IN 47405 USA	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Oxford; University of Melbourne; Indiana University System; Indiana University Bloomington	Wanders, RJA (corresponding author), Acad Med Ctr Amsterdam, Lab Genet Metabol Dis F0 224, Dept Pediat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	R.J.Wanders@amc.uva.nl	Clayton, Peter T/C-1523-2008; Thorburn, David R/G-6266-2013	Clayton, Peter/0000-0001-7592-4302; thorburn, david/0000-0002-7725-9470				BROWN GK, 1982, PEDIATRICS, V70, P532; Clayton PT, 2001, J CLIN INVEST, V108, P457; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; HEALES SJR, 1996, J INHER METAB DIS S1, V19, pP151; KING TE, 1967, METHOD ENZYMOL, V10, P446; MOORE S, 1958, FED PROC, V17, P1107; Ragan CI, 1988, MITOCHONDRIA PRACTIC, P79; RASMUSSEN JT, 1990, BIOCHEM J, V265, P849, DOI 10.1042/bj2650849; ROUGRAFF PM, 1988, J BIOL CHEM, V263, P327; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; TRUSCOTT RJW, 1981, BIOMED MASS SPECTROM, V8, P99, DOI 10.1002/bms.1200080304; Wharton DC., 1967, METHOD ENZYMOL, P245	12	60	64	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2007	80	1					195	199		10.1086/510725	http://dx.doi.org/10.1086/510725			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	120RG	17160907	Green Published, Bronze			2022-12-18	WOS:000243102500019
J	Ferdinandusse, S; Ylianttila, MS; Gloerich, J; Koski, MK; Oostheim, W; Waterham, HR; Hiltunen, JK; Wanders, RJA; Glumoff, T				Ferdinandusse, S; Ylianttila, MS; Gloerich, J; Koski, MK; Oostheim, W; Waterham, HR; Hiltunen, JK; Wanders, RJA; Glumoff, T			Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype-phenotype analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOMAL MULTIFUNCTIONAL ENZYME; ENOYL-COA HYDRATASE; HUMAN SKIN FIBROBLASTS; BILE-ACID SYNTHESIS; D-3-HYDROXYACYL-COA DEHYDRATASE; PRISTANIC ACID; BETA-OXIDATION; ZELLWEGER-SYNDROME; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	D-bifunctional protein (DBP) deficiency is an autosomal recessive inborn error of peroxisomal fatty acid oxidation. The clinical presentation of DBP deficiency is usually very severe, but a few patients with a relatively mild presentation have been identified. In this article, we report the mutational spectrum of DBP deficiency on the basis of molecular analysis in 110 patients. We identified 61 different mutations by DBP cDNA analysis, 48 of which have not been reported previously. The predicted effects of the different disease-causing amino acid changes on protein structure were determined using the crystal structures of the (3R)-hydroxyacyl-coenzyme A ( CoA) dehydrogenase unit of rat DBP and the 2-enoyl-CoA hydratase 2 unit and liganded sterol carrier protein 2-like unit of human DBP. The effects ranged from the replacement of catalytic amino acid residues or residues in direct contact with the substrate or cofactor to disturbances of protein folding or dimerization of the subunits. To study whether there is a genotype-phenotype correlation for DBP deficiency, these structure-based analyses were combined with extensive biochemical analyses of patient material ( cultured skin fibroblasts and plasma) and available clinical information on the patients. We found that the effect of the mutations identified in patients with a relatively mild clinical and biochemical presentation was less detrimental to the protein structure than the effect of mutations identified in those with a very severe presentation. These results suggest that the amount of residual DBP activity correlates with the severity of the phenotype. From our data, we conclude that, on the basis of the predicted effect of the mutations on protein structure, a genotype-phenotype correlation exists for DBP deficiency.	Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Oulu, Dept Biochem, Bioctr, Oulu, Finland	University of Amsterdam; Academic Medical Center Amsterdam; Finland National Institute for Health & Welfare; University of Oulu	Ferdinandusse, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, F0-224,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.Ferdinandusse@amc.uva.nl	Gloerich, Jolein/L-4327-2015	Gloerich, Jolein/0000-0001-5976-8426; Ferdinandusse, Sacha/0000-0002-7738-5709				Adamski J, 1996, ANN NY ACAD SCI, V784, P124, DOI 10.1111/j.1749-6632.1996.tb16232.x; ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bootsma AH, 1999, J INHERIT METAB DIS, V22, P307, DOI 10.1023/A:1005543802724; DieuaideNoubhani M, 1997, BIOCHEM J, V325, P367, DOI 10.1042/bj3250367; Ferdinandusse S, 2002, AM J HUM GENET, V70, P1589, DOI 10.1086/340970; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Gloerich J, 2003, J LIPID RES, V44, P640, DOI 10.1194/jlr.D200039-JLR200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Itoh M, 2000, BRAIN RES, V858, P40, DOI 10.1016/S0006-8993(99)02423-3; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P364; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LEENDERS F, 1994, MOL CELL ENDOCRINOL, V104, P127, DOI 10.1016/0303-7207(94)90114-7; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; MALILA LH, 1993, J BIOL CHEM, V268, P21578; Novikov D, 1997, BBA-MOL BASIS DIS, V1360, P229, DOI 10.1016/S0925-4439(97)00003-3; Paton BC, 2002, PRENATAL DIAG, V22, P38, DOI 10.1002/pd.233; Paton BC, 2000, CELL BIOCHEM BIOPHYS, V32, P247, DOI 10.1385/CBB:32:1-3:247; Paton BC, 1996, J CLIN INVEST, V97, P681, DOI 10.1172/JCI118465; Qin YM, 1999, J BIOL CHEM, V274, P28619, DOI 10.1074/jbc.274.40.28619; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Qin YM, 1997, BIOCHEM J, V328, P377, DOI 10.1042/bj3280377; Schroder JM, 2004, ACTA NEUROPATHOL, V108, P154, DOI 10.1007/s00401-004-0877-4; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; Vreken P, 1998, J CHROMATOGR B, V713, P281, DOI 10.1016/S0378-4347(98)00186-8; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P345, DOI 10.1016/0005-2760(93)90239-6	36	60	62	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					112	124		10.1086/498880	http://dx.doi.org/10.1086/498880			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385454	Green Published, Bronze			2022-12-18	WOS:000233930400011
J	Frank, CG; Grubenmann, CE; Eyaid, W; Berger, EG; Aebi, M; Hennet, T				Frank, CG; Grubenmann, CE; Eyaid, W; Berger, EG; Aebi, M; Hennet, T			Identification and functional analysis of a defect in the human ALG9 gene: Definition of congenital disorder of glycosylation type IL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDE; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; DEFICIENCY; CDG; GLYCOPROTEINS; IK; TRANSLOCATION; BIOSYNTHESIS	Defects of lipid-linked oligosaccharide assembly lead to alterations of N-linked glycosylation known as "type I congenital disorders of glycosylation" (CDG). Dysfunctions along this stepwise assembly pathway are characterized by intracellular accumulation of intermediate lipid-linked oligosaccharides, the detection of which contributes to the identification of underlying enzymatic defects. Using this approach, we have found, in a patient with CDG, a deficiency of the ALG9 alpha1,2 mannosyltransferase enzyme, which causes an accumulation of lipid-linked-GlcNAc(2)Man(6) and -GlcNAc2Man8 structures, which was paralleled by the transfer of incomplete oligosaccharides precursors to protein. A homozygous point-mutation 1567G-->A (amino acid substitution E523K) was detected in the ALG9 gene. The functional homology between the human ALG9 and Saccharomyces cerevisiae ALG9, as well as the deleterious effect of the E523K mutation detected in the patient with CDG, were confirmed by a yeast complementation assay lacking the ALG9 gene. The ALG9 defect found in the patient with CDG-who presented with developmental delay, hypotonia, seizures, and hepatomegaly-shows that efficient lipid-linked oligosaccharide synthesis is required for proper human development and physiology. The ALG9 defect presented here defines a novel form of CDG named "CDG-IL."	Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; King Abdul Aziz Med City, Dept Pediat, Riyadh, Saudi Arabia	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh	Hennet, T (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thennet@access.unizh.ch						Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Baysal BE, 2002, NEUROGENETICS, V4, P43, DOI 10.1007/s10048-001-0129-x; Briones P, 2002, J INHERIT METAB DIS, V25, P635; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1996, P NATL ACAD SCI USA, V93, P7160, DOI 10.1073/pnas.93.14.7160; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; Freeze HH, 2001, GLYCOBIOLOGY, V11, p129R, DOI 10.1093/glycob/11.12.129R; Grubenmann CE, 2004, HUM MOL GENET, V13, P535, DOI 10.1093/hmg/ddh050; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; Grunewald S, 2001, AM J HUM GENET, V68, P347, DOI 10.1086/318199; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jaeken J, 2001, ANNU REV GENOM HUM G, V2, P129, DOI 10.1146/annurev.genom.2.1.129; Jaeken J, 2003, J INHERIT METAB DIS, V26, P99, DOI 10.1023/A:1024431131208; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; KILKER RD, 1981, J BIOL CHEM, V256, P5299; Kranz C, 2004, AM J HUM GENET, V74, P545, DOI 10.1086/382493; Krasnewich D, 1997, Adv Pediatr, V44, P109; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Schwarz M, 2004, AM J HUM GENET, V74, P472, DOI 10.1086/382492; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239	27	60	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2004	75	1					146	150		10.1086/422367	http://dx.doi.org/10.1086/422367			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	829FG	15148656	Green Published, Bronze			2022-12-18	WOS:000222031300018
J	Yang, Z; Lau, R; Marcadier, JL; Chitayat, D; Pearson, CE				Yang, Z; Lau, R; Marcadier, JL; Chitayat, D; Pearson, CE			Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CTG REPEAT; DNA-REPLICATION; SOMATIC INSTABILITY; MISMATCH REPAIR; PROTEIN-SYNTHESIS; TRIPLET REPEATS; SKELETAL-MUSCLE; FRAGILE SITES; CAG REPEAT; IN-VITRO	Gene-specific CTG/CAG repeat expansion is associated with at least 14 human diseases, including myotonic dystrophy type 1 (DM1). Most of our understanding of trinucleotide instability is from nonhuman models, which have presented mixed results, supporting replication errors or processes independent of cell division as causes. Nevertheless, the mechanism occurring at the disease loci in patient cells is poorly understood. Using primary fibroblasts derived from a fetus with DM1, we have shown that spontaneous expansion of the diseased (CTG)(216) allele occurred in proliferating cells but not in quiescent cells. Expansions were "synchronous," with mutation frequencies approaching 100%. Furthermore, cells were treated with agents known to alter DNA synthesis but not to directly damage DNA. Inhibiting replication initiation with mimosine had no effect upon instability. Inhibiting both leading- and lagging-strand synthesis with aphidicolin or blocking only lagging strand synthesis with emetine significantly enhanced CTG expansions. It was striking that only the expanded DM1 allele was altered, leaving the normal allele, (CTG)(12), and other repeat loci unaffected. Standard and small-pool polymerase chain reaction revealed that inhibitors enhanced the magnitude of short expansions in most cells threefold, whereas 11%-25% of cells experienced gains of 122-170 repeats, to sizes of (CTG)(338)-(CTG)(386). Similar results were observed for an adult DM1 cell line. Our results support a role for the perturbation of replication fork dynamics in DM1 CTG expansions within patient fibroblasts. This is the first report that repeat-length alterations specific to a disease allele can be modulated by exogenously added compounds.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave,Elm Wing 11-135, Toronto, ON M5G 1X8, Canada.	cepearson@genet.sickkids.on.ca	Yang, Zhi/B-8629-2012	Pearson, Christopher/0000-0001-9545-4205				ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; Ashizawa T, 1996, GENOMICS, V36, P47, DOI 10.1006/geno.1996.0424; BENITEZ J, 1995, HUM GENET, V96, P229, DOI 10.1007/BF00207386; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; CLARKE JB, 1997, MAMMALIAN CELL CULTU, P93; Cleary JD, 2003, CYTOGENET GENOME RES, V100, P25, DOI 10.1159/000072837; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; DELLORCO RT, 1974, FED PROC, V33, P1969; DELLORCO RT, 1978, MECH AGEING DEV, V8, P269, DOI 10.1016/0047-6374(78)90027-1; Dietmaier W, 1997, CANCER RES, V57, P4749; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Furling D, 2001, HUM MOL GENET, V10, P2079, DOI 10.1093/hmg/10.19.2079; GAUTSCHI JR, 1973, EXP CELL RES, V76, P87, DOI 10.1016/0014-4827(73)90422-9; Gomes-Pereira M, 2001, HUM MOL GENET, V10, P845, DOI 10.1093/hmg/10.8.845; Habib M, 1999, EXP CELL RES, V249, P46, DOI 10.1006/excr.1999.4434; HOY CA, 1987, J BIOL CHEM, V262, P11927; JALAL SM, 1993, AM J MED GENET, V46, P441, DOI 10.1002/ajmg.1320460419; JANSEN G, 1994, AM J HUM GENET, V54, P575; Jedele KB, 1998, CLIN GENET, V54, P148; Karthikeyan R, 2000, J MOL BIOL, V299, P405, DOI 10.1006/jmbi.2000.3744; Khajavi M, 2001, HUM MOL GENET, V10, P855, DOI 10.1093/hmg/10.8.855; Kinoshita M, 2002, INTERNAL MED, V41, P312, DOI 10.2169/internalmedicine.41.312; Kramer PR, 1996, HUM GENET, V98, P151, DOI 10.1007/s004390050179; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Lahue RS, 2003, FRONT BIOSCI-LANDMRK, V8, pS653, DOI 10.2741/1107; Lenzmeier BA, 2003, CYTOGENET GENOME RES, V100, P7, DOI 10.1159/000072836; Lia AS, 1998, HUM MOL GENET, V7, P1285, DOI 10.1093/hmg/7.8.1285; Libby RT, 2003, HUM MOL GENET, V12, P41, DOI 10.1093/hmg/ddg006; Martorell L, 1998, HUM MOL GENET, V7, P307, DOI 10.1093/hmg/7.2.307; Martorell L, 1997, HUM MOL GENET, V6, P877, DOI 10.1093/hmg/6.6.877; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; Nakamoto M, 1997, NAT GENET, V17, P385, DOI 10.1038/ng1297-385; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; OPPENHEIM A, 1981, MOL CELL BIOL, V1, P753, DOI 10.1128/MCB.1.8.753; Osanai R, 2000, MUSCLE NERVE, V23, P804, DOI 10.1002/(SICI)1097-4598(200005)23:5<804::AID-MUS19>3.0.CO;2-E; Pearson CE, 2003, TRENDS MOL MED, V9, P490, DOI 10.1016/j.molmed.2003.09.006; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Peterlin B., 1996, Pfluegers Archiv European Journal of Physiology, V431, pR199, DOI 10.1007/BF02346337; Rhim J S, 2000, Ann N Y Acad Sci, V919, P16; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Spiegel R, 1996, HUM MUTAT, V8, P32, DOI 10.1002/(SICI)1098-1004(1996)8:1<32::AID-HUMU4>3.0.CO;2-R; STIMAC E, 1977, J MOL BIOL, V115, P485, DOI 10.1016/0022-2836(77)90167-X; Sutherland GR, 1999, AM J HUM GENET, V64, P354, DOI 10.1086/302267; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Wenger SL, 1996, AM J MED GENET, V66, P60, DOI 10.1002/(SICI)1096-8628(19961202)66:1<60::AID-AJMG13>3.0.CO;2-O; WOHRLE D, 1995, HUM MOL GENET, V4, P1147, DOI 10.1093/hmg/4.7.1147; WONG LJC, 1995, AM J HUM GENET, V56, P114; Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605; WRIGHT GE, 1994, FEBS LETT, V341, P128, DOI 10.1016/0014-5793(94)80254-8; ZATZ M, 1995, HUM MOL GENET, V4, P401, DOI 10.1093/hmg/4.3.401	56	60	62	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1092	1105		10.1086/379523	http://dx.doi.org/10.1086/379523			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14574643	Green Published, Bronze			2022-12-18	WOS:000186493400011
J	Newman, DL; Abney, M; McPeek, MS; Ober, C; Cox, NJ				Newman, DL; Abney, M; McPeek, MS; Ober, C; Cox, NJ			The importance of genealogy in determining genetic associations with complex traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GENOMIC CONTROL; POPULATION; RECEPTOR; SCREEN; ASTHMA		Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Newman, DL (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 501, Chicago, IL 60637 USA.		Newman, Dina/AAN-5119-2020		NHGRI NIH HHS [R01 HG001645, HG01645, R29 HG001645] Funding Source: Medline; NICHD NIH HHS [R21 HD056399, HD56399] Funding Source: Medline; NIDDK NIH HHS [DK55889, R01 DK055889] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001645, R01HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bitti PP, 2001, GENET EPIDEMIOL, V20, P271, DOI 10.1002/1098-2272(200102)20:2<271::AID-GEPI9>3.0.CO;2-L; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; de Silva AM, 1999, INT J OBESITY, V23, P816, DOI 10.1038/sj.ijo.0800931; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DYER TD, IN PRESS GENET EPI S; Hegele RA, 2001, ATHEROSCLEROSIS, V154, P579, DOI 10.1016/S0021-9150(00)00419-6; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Laprise C, 2000, IMMUNOGENETICS, V51, P695, DOI 10.1007/s002510000185; Mathias RA, 2000, AM J PHYS ANTHROPOL, V112, P29, DOI 10.1002/(SICI)1096-8644(200005)112:1<29::AID-AJPA4>3.0.CO;2-5; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Ospina-Duque J, 2000, NEUROSCI LETT, V292, P199, DOI 10.1016/S0304-3940(00)01464-6; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Slutsky AS, 1997, AM J RESP CRIT CARE, V156, pS130, DOI 10.1164/ajrccm.156.4.12tac-10; Summerhill E, 2000, AM J RESP CRIT CARE, V162, P599, DOI 10.1164/ajrccm.162.2.9910108; SUN L, IN PRESS GENET EPI S; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	24	60	60	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1146	1148		10.1086/323659	http://dx.doi.org/10.1086/323659			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11590549	Green Published, Bronze			2022-12-18	WOS:000171413400022
J	Dreyer, B; Tranebjaerg, L; Brox, V; Rosenberg, T; Moller, C; Beneyto, M; Weston, MD; Kimberling, WJ; Nilssen, O				Dreyer, B; Tranebjaerg, L; Brox, V; Rosenberg, T; Moller, C; Beneyto, M; Weston, MD; Kimberling, WJ; Nilssen, O			A common ancestral origin of the frequent and widespread 2299delG USH2A mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-IIA; USHER-SYNDROME; GENE; PREVALENCE; IDENTIFICATION; PROTEIN	Usher syndrome type IIa is an autosomal recessive disorder characterized by mild-to-severe hearing loss and progressive visual loss due to retinitis pigmentosa. The mutation that most commonly causes Usher syndrome type IIa is a 1-bp deletion, described as "2299delG," in the USH2A gene. The mutation has been identified in several patients from northern and southern Europe and from North America, and it has been found in single patients from South America, South Africa, and China. Various studies have reported a range of frequencies (.16-.44) among patients with Usher syndrome, depending on the geographic origin of the patients. The 2299delG mutation may be the one that most frequently causes retinitis pigmentosa in humans. Given the high frequencies and the wide geographic distribution of the mutation, it was of interest to determine whether the mutation resulted from an ancestral mutational event or represented a mutational hotspot in the USH2A gene. Haplotype analysis was performed on DNA samples from 116 unrelated patients with Usher syndrome type IIa; the patients were from 14 countries and represented 148 2299delG alleles. On the basis of six single-nucleotide polymorphisms within the USH2A gene, 12 core haplotypes were observed in a panel of normal chromosomes. However, in our analysis, only one core haplotype was found to be associated with the 2299delG mutation. The data indicate that the widespread geographic distribution of the 2299delG mutation is the result of an ancestral mutation that has spread throughout Europe and into the New World as a result of migration.	Univ Tromso, Dept Med Genet, N-9037 Tromso, Norway; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Natl Eye Clin Visually Impaired, Hellerup, Denmark; Sahlgrens Univ Hosp, Dept Audiol, Gothenburg, Sweden; Hosp La Fe, Dept Genet, E-46009 Valencia, Spain; Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Sahlgrenska University Hospital; Hospital Universitari i Politecnic La Fe; Boys Town National Research Hospital	Dreyer, B (corresponding author), Univ Tromso, Dept Med Genet, N-9037 Tromso, Norway.	bodreyer@fagmed.uit.no	Cremers, C.W.R.J./L-4254-2015		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC012115, R01 DC005575] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adato A, 2000, HUM MUTAT, V15, P388, DOI 10.1002/(SICI)1098-1004(200004)15:4<388::AID-HUMU27>3.0.CO;2-N; Beneyto M M, 2000, Ophthalmic Genet, V21, P123, DOI 10.1076/1381-6810(200006)21:2;1-8;FT123; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Dreyer B, 2000, EUR J HUM GENET, V8, P500, DOI 10.1038/sj.ejhg.5200491; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Liu XZ, 1999, AM J HUM GENET, V64, P1221, DOI 10.1086/302332; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Rosenberg T, 1997, CLIN GENET, V51, P314; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855	11	60	67	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					228	234		10.1086/321269	http://dx.doi.org/10.1086/321269			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11402400	Bronze, Green Published			2022-12-18	WOS:000170108100024
J	Patel, H; Hart, PE; Warner, TT; Houlston, RS; Patton, MA; Jeffery, S; Crosby, AH				Patel, H; Hart, PE; Warner, TT; Houlston, RS; Patton, MA; Jeffery, S; Crosby, AH			The silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MENTAL-RETARDATION; COPPER CHAPERONE; LOCUS; MUTATIONS; PARAPARESIS; IMPAIRMENT; PHENOTYPE; CCS	The hereditary spastic paraplegias (HSPs) are a complex group of neurodegenerative disorders characterized by lower-limb spasticity and weakness. Silver syndrome (SS) is a particularly disabling dominantly inherited form of HSP, complicated by amyotrophy of the hand muscles. Having excluded the multiple known HSP loci, we undertook a genomewide screen for linkage of SS in one large multigenerational family, which revealed evidence for linkage of the SS locus, which we have designated "SPG17," to chromosome 11q12-q14. Haplotype construction and analysis of recombination events permitted the minimal interval defining SPG17 to be refined to similar to 13 cM, flanked by markers D11S1765 and D11S4136. SS in a second family was not linked to SPG17, demonstrating further genetic heterogeneity in HSP, even within this clinically distinct subtype.	Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Royal Free Hosp, Sch Med, Dept Clin Neurosci, London, England; Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England	St Georges University London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Institute of Cancer Research - UK	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Warner, Thomas T/A-1454-2013; Crosby, Andrew H/E-2218-2015	Warner, Thomas T/0000-0001-6195-6995; Crosby, Andrew H/0000-0003-3667-9054; Houlston, Richard/0000-0002-5268-0242				Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Bartnikas TB, 2000, MAMM GENOME, V11, P409, DOI 10.1007/s003350010078; Byrne PC, 1998, EUR J HUM GENET, V6, P275, DOI 10.1038/sj.ejhg.5200185; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Claes S, 2000, AM J MED GENET, V94, P1, DOI 10.1002/1096-8628(20000904)94:1<1::AID-AJMG1>3.0.CO;2-V; De Jonghe P, 1996, EUR J HUM GENET, V4, P260; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DURR A, 1994, NEUROLOGY, V44, P1274, DOI 10.1212/WNL.44.7.1274; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; Fontaine B, 2000, AM J HUM GENET, V66, P702, DOI 10.1086/302776; GIGLI GL, 1993, AM J MED GENET, V45, P711, DOI 10.1002/ajmg.1320450610; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; Hedera P, 1999, AM J HUM GENET, V64, P563, DOI 10.1086/302258; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Murillo FM, 1999, NEUROLOGY, V53, P50, DOI 10.1212/WNL.53.1.50; Nielsen JE, 1997, HUM MOL GENET, V6, P1811, DOI 10.1093/hmg/6.11.1811; PATEL H, IN PRESS AM J MED GE; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; Reid E, 2000, AM J HUM GENET, V66, P728, DOI 10.1086/302783; Reid E, 1999, AM J HUM GENET, V65, P757, DOI 10.1086/302555; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; Vazza G, 2000, AM J HUM GENET, V67, P504, DOI 10.1086/303017	35	60	64	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					209	215		10.1086/321267	http://dx.doi.org/10.1086/321267			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11389484	Green Published, Bronze			2022-12-18	WOS:000170108100021
J	Hanson, RL; Kobes, S; Lindsay, RS; Knowler, WC				Hanson, RL; Kobes, S; Lindsay, RS; Knowler, WC			Assessment of parent-of-origin effects in linkage analysis of quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSESSING GENETIC-LINKAGE; VARIANCE-COMPONENTS; DIABETES-MELLITUS; PEDIGREE ANALYSIS; SIB-PAIR; CHROMOSOME-18; ASSOCIATION; DISORDER; LOCI; RECOMBINATION	Methods are presented for incorporation of parent-of-origin effects into linkage analysis of quantitative traits. The estimated proportion of marker alleles shared identical by descent is first partitioned into a component derived from the mother and a component derived from the father. These parent-specific estimates of allele sharing are used in variance-components or Haseman-Elston methods of linkage analysis so that the effect of the quantitative-trait locus carried on the maternally derived chromosome is potentially different from the effect of the locus on the paternally derived chromosome. Statistics for linkage between trait and marker loci derived from either or both parents are then calculated, as are statistics for testing whether the effect of the maternally derived locus is equal to that of the paternally derived locus. Analyses of data simulated for 956 siblings from 263 nuclear families who had participated in a linkage study revealed that type I error rates for these statistics were generally similar to nominal values. Power to detect an imprinted locus was substantially increased when analyzed with a model allowing for parent-of-origin effects, compared with analyses that assumed equal effects; for example, for an imprinted locus accounting for 30% of the phenotypic variance, the expected LOD score was 4.5 when parent-of-origin effects were incorporated into the analysis, compared with 3.1 when these effects were ignored. The ability to include parent-of-origin effects within linkage analysis of quantitative traits will facilitate genetic dissection of complex traits.	NIDDKD, Diabet & Arthrit Epidemiol Sect, NIH, Phoenix, AZ 85014 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanson, RL (corresponding author), NIDDKD, Diabet & Arthrit Epidemiol Sect, NIH, 1550 E Indian Sch Rd, Phoenix, AZ 85014 USA.		Hanson, Robert L/O-3238-2015	Hanson, Robert L/0000-0002-4252-7068; Lindsay, Robert/0000-0002-9868-5217	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069028, ZIADK069028] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Amos CI, 1996, ANN HUM GENET, V60, P143, DOI 10.1111/j.1469-1809.1996.tb01184.x; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Fleiss J. L., 1981, STATISTICAL METHODS, P1; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; GRIGOROIUSERBANESCU M, 1995, ACTA PSYCHIAT SCAND, V92, P365, DOI 10.1111/j.1600-0447.1995.tb09598.x; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P419; LANGE K, 1976, ANN HUM GENET, V39, P485, DOI 10.1111/j.1469-1809.1976.tb00156.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lindsay RS, 2000, AM J HUM GENET, V67, P218; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; MARGARITTEJEANNIN P, 1995, AM J HUM GENET, V56, P1080; MEIERSHEIJBOER EJ, 1992, J MED GENET, V29, P853; Nothen MM, 1999, MOL PSYCHIATR, V4, P76, DOI 10.1038/sj.mp.4000454; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P54; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; Rice JP, 1995, GENET EPIDEMIOL, V12, P659, DOI 10.1002/gepi.1370120623; RUIZ RGG, 1992, CLIN EXP ALLERGY, V22, P762, DOI 10.1111/j.1365-2222.1992.tb02816.x; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SHIRE J G M, 1989, New Biologist, V1, P115; SMALLEY SL, 1993, AM J HUM GENET, V52, P210; STINE OC, 1995, AM J HUM GENET, V57, P1384; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; WILSON AF, 1993, GENET EPIDEMIOL, V10, P593, DOI 10.1002/gepi.1370100644	43	60	60	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					951	962		10.1086/319508	http://dx.doi.org/10.1086/319508			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254452	Bronze, Green Published			2022-12-18	WOS:000167666000017
J	Beales, PL; Katsanis, N; Lewis, RA; Ansley, SJ; Elcioglu, N; Raza, J; Woods, MO; Green, JS; Parfrey, PS; Davidson, WS; Lupski, JR				Beales, PL; Katsanis, N; Lewis, RA; Ansley, SJ; Elcioglu, N; Raza, J; Woods, MO; Green, JS; Parfrey, PS; Davidson, WS; Lupski, JR			Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME LOCUS; 5TH LOCUS; POPULATION; LINKAGE; HETEROGENEITY; FAMILIES; OBESITY; REGION; 11Q13	Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized primarily by obesity, polydactyly, retinal dystrophy, and renal disease. The significant genetic and clinical heterogeneity of this condition have substantially hindered efforts to positionally clone the numerous BBS genes, because the majority of available pedigrees are small and the disorder cannot be assigned to any of the six known BBS loci. Consequently, the delineation of critical BBS intervals, which would accelerate the discovery of the underlying genetic defect(s), becomes difficult, especially for loci with minor contributions to the syndrome. We have collected a cohort of 163 pedigrees from diverse ethnic backgrounds and have evaluated them for mutations in the recently discovered BBS6 gene (MKKS) on chromosome 20 and for potential assignment of the disorder to any of the other known BBS loci in the human genome. Using a combination of mutational and haplotype analysis, we describe the spectrum of BBS6 alterations that are likely to be pathogenic; propose substantially reduced critical intervals for BBS2, BBS3, and BBS5; and present evidence for the existence of at least one more BBS locus. Our data also suggest that BBS6 is a minor contributor to the syndrome and that some BBS6 alleles may act in conjunction with mutations at other BBS loci to cause or modify the BBS phenotype.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA; UCL, Inst Child Hlth, Mol Med Unit, London, England; Univ Hosp, Dept Pediat Genet, Istanbul, Turkey; Natl Inst Child Hlth, Karachi, Pakistan; Mem Univ Newfoundland, Fac Med, St John, NF, Canada; Simon Fraser Univ, Dept Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; Memorial University Newfoundland; Simon Fraser University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 609E,1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY012666] Funding Source: NIH RePORTER; NEI NIH HHS [EY12666] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, AM J MED GENET, V59, P199, DOI 10.1002/ajmg.1320590216; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; FARAG TI, 1989, CLIN GENET, V36, P463; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KLEIN D, 1969, J NEUROL SCI, V9, P479, DOI 10.1016/0022-510X(69)90091-4; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Woods MO, 1999, GENOMICS, V55, P2, DOI 10.1006/geno.1998.5626; Young TL, 1998, AM J MED GENET, V78, P461, DOI 10.1002/(SICI)1096-8628(19980806)78:5<461::AID-AJMG12>3.0.CO;2-D; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301; Young TL, 1999, AM J HUM GENET, V65, P1680, DOI 10.1086/302686	19	60	62	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					606	616		10.1086/318794	http://dx.doi.org/10.1086/318794			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179009	Green Published, Bronze			2022-12-18	WOS:000166994200006
J	Ringpfeil, F; Nakano, A; Uitto, J; Pulkkinen, L				Ringpfeil, F; Nakano, A; Uitto, J; Pulkkinen, L			Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSITIVE GEL-ELECTROPHORESIS; DUBIN-JOHNSON-SYNDROME; CHROMOSOME 16P13.1; PROTEIN GENE; RECOMBINATION; TRANSPORTER; DUPLICATION; FIBERS; CANCER; REGION	Pseudoxanthoma elasticum (PXE) is a systemic heritable disorder affecting the elastic structures in the skin, eyes, and cardiovascular system, with considerable morbidity and mortality. Recently, mutations in the ABCC6 gene (also referred to as "MRP6" or "eMOAT") encoding multidrug-resistance protein 6 (MRP6), a putative transmembrane ABC transporter protein of unknown function, have been disclosed. Most of the genetic lesions delineated thus far consist of single-base-pair substitutions resulting in nonsense, missense, or splice-site mutations. In this study, we examined four multiplex families with PXE inherited in an autosomal recessive pattern. In each family, the proband was a compound heterozygote for a single-base-pair-substitution mutation and a novel, similar to 16.5-kb deletion mutation spanning the site of the single-base-pair substitution in trans. The deletion mutation was shown to extend from intron 22 to intron 29, resulting in out-of-frame deletion of 1,213 nucleotides from the corresponding mRNA and causing elimination of 505 amino acids from the MRP6 polypeptide. The deletion breakpoints were precisely the same in all four families, which were of different ethnic backgrounds, and haplotype analysis by 13 microsatellite markers suggested that the deletion had occurred independently. Deletion breakpoints within introns 22 and 29 were embedded within AluSx repeat sequences, specifically in a 16-bp segment of DNA, suggesting Alu-mediated homologous recombination as a mechanism.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Pulkkinen, L (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR028450] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR028450, R01 AR28450] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN LK, 1974, ARCH INTERN MED, V134, P1048, DOI 10.1001/archinte.134.6.1048; BACCARANICONTRI M, 1996, AM J PATHOL, V148, P569; Bacchelli B, 1999, MODERN PATHOL, V12, P1112; Belinsky MG, 1999, BRIT J CANCER, V80, P1342, DOI 10.1038/sj.bjc.6690527; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Cai L, 2000, J MOL MED-JMM, V78, P36, DOI 10.1007/s001090000079; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1992, J INVEST DERMATOL, V99, P660, DOI 10.1111/1523-1747.ep12668156; DARIER J, 1896, MONATSSCHR PRAKT DER, V23, P609; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Germain DP, 2000, BIOCHEM BIOPH RES CO, V274, P297, DOI 10.1006/bbrc.2000.3101; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Konig J, 1999, HEPATOLOGY, V29, P1156, DOI 10.1002/hep.510290404; Kool M, 1999, CANCER RES, V59, P175; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Le Saux O, 1999, GENOMICS, V62, P1, DOI 10.1006/geno.1999.5925; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MARTINEZ.A, 1974, LAB INVEST, V31, P181; MCKUSICK VA, 1972, HERITABLE DISORDERS, P475; MENDELSOHN G, 1978, ARCH PATHOL LAB MED, V102, P298; Morgan NV, 1999, AM J HUM GENET, V65, P1330, DOI 10.1086/302627; Neldner K H, 1988, Clin Dermatol, V6, P1; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; POPE FM, 1975, BRIT J DERMATOL, V92, P493; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Ringpfeil F, 2000, P NATL ACAD SCI USA, V97, P6001, DOI 10.1073/pnas.100041297; Sherer DW, 1999, DERMATOLOGY, V199, P3, DOI 10.1159/000018195; STOPPALYONNET D, 1990, P NATL ACAD SCI USA, V87, P1551, DOI 10.1073/pnas.87.4.1551; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Struk B, 2000, J MOL MED, V78, P282, DOI 10.1007/s001090000114; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; Toh S, 1999, AM J HUM GENET, V64, P739, DOI 10.1086/302292; Uitto J, 2001, TRENDS MOL MED, V7, P13, DOI 10.1016/S1471-4914(00)01869-4; UITTO J, 1983, LAB INVEST, V49, P499; vanSoest S, 1997, GENOME RES, V7, P830, DOI 10.1101/gr.7.8.830; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203	38	60	60	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					642	652		10.1086/318807	http://dx.doi.org/10.1086/318807			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179012	Green Published, Bronze			2022-12-18	WOS:000166994200009
J	Zatkova, A; de Bernabe, DBV; Polakova, H; Zvarik, M; Ferakova, E; Bosak, V; Ferak, V; Kadasi, L; de Cordoba, SR				Zatkova, A; de Bernabe, DBV; Polakova, H; Zvarik, M; Ferakova, E; Bosak, V; Ferak, V; Kadasi, L; de Cordoba, SR			High frequency of alkaptonuria in Slovakia: Evidence for the appearance of multiple mutations in HGO involving different mutational hot spots	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOGENTISATE 1,2-DIOXYGENASE GENE; SMALL GEOGRAPHIC AREA	Alkaptonuria (AKU) is an autosomal recessive disorder caused by the deficiency of homogentisate 1,2 dioxygenase (HGO) activity. AKU shows a very low prevalence (1:100,000-250,000) in most ethnic groups. One notable exception is in Slovakia, where the incidence of AKU rises to 1:19,000, This high incidence is difficult to explain by a classical founder effect, because as many as 10 different AKU mutations have been identified in this relatively small country. We have determined the allelic associations of 11 HGO intragenic polymorphisms for 44 AKU chromosomes from 20 Slovak pedigrees, These data were compared to the HGO haplotype data available in our laboratory for >80 AKU chromosomes from different European and non-European countries, The results show that common European AKU chromosomes have had only a marginal contribution to the Slovak AKU gene pool. Six of the ten Slovak AKU mutations, including the prevalent G152fs, G161R, G270R, and P370fs mutations, most likely originated in Slovakia, Data available for 17 Slovak AKU pedigrees indicate that most of the AKU chromosomes have their origins in a single very small region in the Carpathian mountains, in the northwestern part of the country. Since all six Slovak AKU mutations are associated with HGO mutational hot spots, we suggest that an increased mutation rate at the HGO gene is responsible for the clustering of AKU mutations in such a small geographical region.	CSIC, Ctr Invest Biol, Dept Inmunol, E-28006 Madrid, Spain; Comenius Univ, Fac Nat Sci, Inst Mol Physiol & Genet, Bratislava, Slovakia; Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; Fdn Jimenez Diaz, Unidad Patol Mol, E-28040 Madrid, Spain; Fdn Jimenez Diaz, Unidad Invest, E-28040 Madrid, Spain; Res Inst Rheumat Dis, Piestany, Slovakia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava	de Cordoba, SR (corresponding author), CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain.		Zatkova, Andrea/E-8870-2018; de Cordoba, Santiago Rodriguez/K-6727-2014; Kadasi, Ludevit/A-4677-2013	Zatkova, Andrea/0000-0002-4105-3868; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; 				BACH G, 1993, AM J HUM GENET, V53, P330; COOPER DN, 1990, HUM GENET, V85, P55; de Bernabe DBV, 1999, AM J HUM GENET, V64, P1316, DOI 10.1086/302376; de Bernabe DBV, 1999, J MED GENET, V36, P922; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; Felbor U, 1999, BRIT J OPHTHALMOL, V83, P680, DOI 10.1136/bjo.83.6.680; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrod AE, 1902, LANCET, V2, P1616; Gehrig A, 1997, CYTOGENET CELL GENET, V76, P14, DOI 10.1159/000134501; Granadino B, 1997, GENOMICS, V43, P115, DOI 10.1006/geno.1997.4805; HEINISCH U, 1995, AM J HUM GENET, V56, P51; Higashino K, 1998, CLIN GENET, V53, P228; La Du BN, 1995, METABOLIC MOL BASES, P1371; LADU BN, 1958, J BIOL CHEM, V230, P251; Muller CR, 1999, EUR J HUM GENET, V7, P645, DOI 10.1038/sj.ejhg.5200343; Porfirio B, 2000, J MED GENET, V37, P309, DOI 10.1136/jmg.37.4.309; Ramos SM, 1998, AM J MED GENET, V78, P192, DOI 10.1002/(SICI)1096-8628(19980630)78:2<192::AID-AJMG20>3.3.CO;2-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; SRSEN S, 1978, AM J MED GENET, V2, P159, DOI 10.1002/ajmg.1320020207; SRSEN S, 1984, ALKAPTONURIA, P48; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Walter K, 1999, J MED GENET, V36, P645; Zatkova A, 2000, J MED GENET, V37, P539, DOI 10.1136/jmg.37.7.539	24	60	61	2	9	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1333	1339						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11017803				2022-12-18	WOS:000165091600031
J	Wijsman, EM; Peterson, D; Leutenegger, AL; Thomson, JB; Goddard, KAB; Hsu, L; Berninger, VW; Raskind, WH				Wijsman, EM; Peterson, D; Leutenegger, AL; Thomson, JB; Goddard, KAB; Hsu, L; Berninger, VW; Raskind, WH			Segregation analysis of phenotypic components of learning disabilities. I. Nonword memory and digit span	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; PHONOLOGICAL CODING DYSLEXIA; READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; FAMILY RESEMBLANCE; OLIGOGENIC TRAITS; LINKAGE ANALYSIS; CHROMOSOME 6P; BREAST-CANCER; LANGUAGE	Dyslexia is a common and complex disorder with evidence for a genetic component. Multiple loci (i.e., quantitative-trait loci [QTLs]) are likely to be involved, but the number is unknown. Diagnosis is complicated by the lack of a standard protocol, and many diagnostic measures have been proposed as understanding of the component processes has evolved. One or more genes may, in turn, influence these measures. To date, little work has been done to evaluate the mode of inheritance of individual component-as opposed to composite-phenotypes, beyond family or twin correlation studies that initially demonstrate evidence for a genetic basis of such components. Here we use two approaches to segregation analysis in 102 nuclear families to estimate genetic models for component phenotypes associated with dyslexia: digit span and a nonword-repetition task. Both measures are related to phonological skills, one of the key component processes in dyslexia. We use oligogenic-trait segregation analysis to estimate the number of QTLs contributing to each phenotype, and we use complex segregation analysis to identify the most parsimonious inheritance models. We provide evidence in support of both a major-gene mode of inheritance for the nonword-repetition task, with similar to 2.4 contributing QTLs, and for a genetic basis of digit span, with similar to 1.9 contributing QTLs. Results obtained by reciprocal adjustment of measures suggest that genes contributing to digit span may contribute to the nonword-repetition score but that there are additional QTLs involved in nonword repetition. Our study adds to existing studies of the genetic basis of composite phenotypes related to dyslexia, by providing evidence for major-gene modes of inheritance of these single-measure component phenotypes.	Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Educ Psychol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Wijsman, EM (corresponding author), Univ Washington, Dept Med, Div Med Genet, Box 357720, Seattle, WA 98195 USA.	wijsman@u.washington.edu	Leutenegger, Anne-Louise/B-5597-2009	Leutenegger, Anne-Louise/0000-0002-1302-4357	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655, P41 RR003655] Funding Source: Medline; PHS HHS [P50 33812] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1998, WOODCOCK READING MAS; BERNINGER V, IN PRESS SCI STUD RE; Berninger V.W, 1994, READING WRITING ACQU; BERNINGER VW, 1992, DEV MED CHILD NEUROL, V34, P198; BISGAARD ML, 1987, CLIN GENET, V32, P118; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; Daw EW, 1999, AM J HUM GENET, V64, P839, DOI 10.1086/302276; DECKER SN, 1981, DEV MED CHILD NEUROL, V23, P217; DEFRIES JC, 1987, NATURE, V329, P537, DOI 10.1038/329537a0; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Fagerheim T, 1999, J MED GENET, V36, P664; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; Fisher J. H., 1905, OPHTHALMIC REV, V24, P315; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; GILGER JW, 1994, BEHAV GENET, V24, P345, DOI 10.1007/BF01067536; Goddard KAB, 1995, GENET EPIDEMIOL, V12, P759, DOI 10.1002/gepi.1370120638; Greenberg DA, 1996, AM J HUM GENET, V58, P892; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hallgren B, 1950, ACTA PSYCH NEUROL SU, P1; Hammersley J.M., 1964, MONTE CARLO METHODS; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hinshelwood J, 1907, BRIT MED J, V1907, P1229; Hokanson JE, 1999, AM J HUM GENET, V64, P608, DOI 10.1086/302234; KAMHI AG, 1986, J SPEECH HEAR DISORD, V51, P337, DOI 10.1044/jshd.5104.337; Knoblauch H, 2000, AM J HUM GENET, V66, P157, DOI 10.1086/302704; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levy-Lahad E, 1998, J GERIATR PSYCH NEUR, V11, P42, DOI 10.1177/089198879801100202; LEWITTER FI, 1980, BEHAV GENET, V10, P9, DOI 10.1007/BF01067316; LIBERMAN U, 1984, THEOR POPUL BIOL, V25, P331, DOI 10.1016/0040-5809(84)90013-3; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEWMAN S, 1993, BRIT J EDUC PSYCHOL, V63, P287, DOI 10.1111/j.2044-8279.1993.tb01058.x; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; OLSON RK, 1991, READ WRIT, V3, P235, DOI 10.1007/BF00354960; OLSON RK, 1994, VARIETIES ORTHOGRAPH, V1, P27; PENNINGTON BF, 1987, ARCH NEUROL-CHICAGO, V44, P634, DOI 10.1001/archneur.1987.00520180054016; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; PENNINGTON BF, 1990, CHILD DEV, V61, P1753, DOI 10.1111/j.1467-8624.1990.tb03564.x; Petryshen TL, 2000, AM J HUM GENET, V66, P708, DOI 10.1086/302764; Petryshen TL, 1999, AM J HUM GENET, V65, pA32; Posner M.I., 1999, CONVERGING METHODS U; RASKIND W, IN PRESS BEHAV GENET; Richards TL, 2000, AM J NEURORADIOL, V21, P916; *SAGE, 1997, STAT AN GEN EP; Schellenberg G. D., 1994, American Journal of Human Genetics, V55, pA353; SCHELLENBERG GD, 1994, NEUROBIOL AGING, V15, pS149; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shaywitz SE, 1999, PEDIATRICS, V104, P1351, DOI 10.1542/peds.104.6.1351; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Stephenson S., 1907, OPHTHALMOSCOPE, V5, P482; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; Torgesen J.K., 2012, TEST WORD READING EF; Vellutino F.R., 1979, DYSLEXIA THEORY RES; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; Wagner R.W., 1999, COMPREHENSIVE TEST P; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; Wechsler D., 1992, WECHSLER INTELLIGENC; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; Wilkinson GS, 1993, WIDE RANGE ACHIEVEME; WOLFF PH, 1994, AM J MED GENET, V54, P122, DOI 10.1002/ajmg.1320540207; Woodcock R. W., 1990, WOODCOCK JOHNSON PSY; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	75	60	61	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					631	646		10.1086/303044	http://dx.doi.org/10.1086/303044			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	348TJ	10924405	Green Published, Bronze			2022-12-18	WOS:000089002300010
J	Zhang, WH; Bailey-Wilson, JE; Li, WD; Wang, XQ; Zhang, CL; Mao, XH; Liu, ZH; Zhou, CN; Wu, M				Zhang, WH; Bailey-Wilson, JE; Li, WD; Wang, XQ; Zhang, CL; Mao, XH; Liu, ZH; Zhou, CN; Wu, M			Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL AGGREGATION; SHANXI-PROVINCE; LINXIAN; STOMACH; TRIAL	In order to explore the mode of inheritance of esophageal cancer in a moderately high-incidence area of northern China, we conducted a pedigree survey on 225 patients affected by esophageal cancer in Yangquan, Shanxi Province. Segregation analysis was performed using the REGTL program of S.A.G.E. The results showed that Mendelian autosomal recessive inheritance of a major gene that influences susceptibility to esophageal cancer provided the best fit to the data. In the best-fitting recessive model, the frequency of the disease allele was .2039. There was a significant sex effect on susceptibility to the disease. The maximum cumulative probability of esophageal cancer among males with the AA genotype was 100%, but, among females, it was 63.5%. The mean age at onset for both men and women was 62 years. The age-dependent penetrances for males with the AA genotype by the ages of 60 and 80 years were 41.6% and 95.2%, respectively, whereas, for females, they were 26.4% and 60.5%, respectively. Incorporating environmental risk factors-such as cigarette smoking, pipe smoking, alcohol drinking, eating hot food, and eating pickled vegetables-into the models did not provide significant improvement of the fit of the models to these data. The results suggest a major locus underlying susceptibility to esophageal cancer with sex-specific penetrance.	Chinese Acad Med Sci, Inst Canc, Natl Lab Mol Oncol, Beijing 100021, Peoples R China; NHGRI, NIH, Baltimore, MD USA; Canc Inst Yangquan City, Yangquan City, Shanxi Province, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA)	Wu, M (corresponding author), Chinese Acad Med Sci, Inst Canc, Natl Lab Mol Oncol, Chaoyang Qu,POB 2258, Beijing 100021, Peoples R China.	wum@pubem.cicams.ac.cn		Li, Wei-Dong/0000-0003-0521-7412; Bailey-Wilson, Joan/0000-0002-9153-2920	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000074] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655, P41 RR003655] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CARTER CL, 1992, J NATL CANCER I, V84, P771, DOI 10.1093/jnci/84.10.771; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; Claus EB, 1995, CANCER SURV, V25, P13; DAY NE, 1994, CANCER SURV, V20, P43; DAYNE NE, 1982, CANC EPIDEMIOLOGY PR, P596; ELSTON RC, 1989, GENET EPIDEMIOL, V6, P217, DOI 10.1002/gepi.1370060138; GAO YT, 1994, INT J CANCER, V58, P197, DOI 10.1002/ijc.2910580209; GO RCP, 1978, AM J HUM GENET, V30, P28; GUO WD, 1994, INT J EPIDEMIOL, V23, P444, DOI 10.1093/ije/23.3.444; Hu N, 1999, CLIN CANCER RES, V5, P3476; HU N, 1992, INT J EPIDEMIOL, V21, P877, DOI 10.1093/ije/21.5.877; Kinjo Y, 1998, J Epidemiol, V8, P235; LI GH, 1986, GENES DIS, P43; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; LI JY, 1989, INT J CANCER, V43, P755, DOI 10.1002/ijc.2910430502; LI W, 1998, NATL MED J CHINA, V78, P203; Liu B, 1984, CARCINOMA ESOPHAGUS, P1; Montesano R, 1996, INT J CANCER, V69, P225, DOI 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6; *NAT CANC CONTR OF, 1980, INV CANC MORT CHIN, P65; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; WANG GQ, 1994, CANCER EPIDEM BIOMAR, V3, P161; WANG YP, 1992, CANCER CAUSE CONTROL, V3, P107, DOI 10.1007/BF00051650; WU M, 1989, GENETIC EPIDEMIOLOGY, P187; YANG GR, 1987, ENDOSCOPY, V19, P7, DOI 10.1055/s-2007-1018216; *YANGQ CANC CONTR, 1990, CANC PREV, V1, P1; [No title captured]	29	60	68	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					110	119		10.1086/302970	http://dx.doi.org/10.1086/302970			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	347JY	10841811	Green Published, Bronze			2022-12-18	WOS:000088926900014
J	Vincent, JB; Neves-Pereira, ML; Paterson, AD; Yamamoto, E; Parikh, SV; Macciardi, F; Gurling, HMD; Potkin, SG; Pato, CN; Macedo, A; Kovacs, M; Davies, M; Lieberman, JA; Meltzer, HY; Petronis, A; Kennedy, JL				Vincent, JB; Neves-Pereira, ML; Paterson, AD; Yamamoto, E; Parikh, SV; Macciardi, F; Gurling, HMD; Potkin, SG; Pato, CN; Macedo, A; Kovacs, M; Davies, M; Lieberman, JA; Meltzer, HY; Petronis, A; Kennedy, JL			An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion lotus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; EXPANDED CAG REPEATS; NO EVIDENCE; SCHIZOPHRENIA FAMILIES; RECEPTOR GENE; ASSOCIATION; GENOME; LOCI; ANTICIPATION; POPULATION	Larger CAG/CTG trinucleotide-repeat tracts in individuals affected with schizophrenia (SCZ) and bipolar affective disorder (BPAD) in comparison with control individuals have previously been reported, implying a possible etiological role for trinucleotide repeats in these diseases. Two unstable CAG/CTG repeats, SEF2-1B and ERDA1, have recently been cloned, and studies indicate that the majority of individuals with large repeats as detected by repeat-expansion detection (RED) hwe large repeat alleles at these loci. These repeats do not show association of large alleles with either BPAD or SCZ. Using RED, we have identified a BPAD individual with a very large CAG/CTG repeat that is not due to expansion at SEF2-1B or ERDA1. From this individual's DNA, we have cloned a highly polymorphic trinucleotide repeat consisting of (CTA)(n) (CTG)(n), which is very long (similar to 1,800 bp) in this patient. The repeat region localizes to chromosome 13q21, within 1.2 cM of fragile site FRA13C. Repeat alleles in our sample were unstable in 13 (5.4%) of 231 meioses. Large alleles (>100 repeats) were observed in 14 (1.25%) of 1,120 patients with psychosis, borderline personality disorder, or juvenile-onset depression and in 5 (.7%) of 710 healthy controls. Very large alleles were also detected for Centre d'Etude Polymorphisme Humaine (CEPH) reference family 1334. This triplet expansion has recently been reported to be the cause of spinocerebellar ataxia type 8 (SCA8); however, none of our large alleles above the disease threshold occurred in individuals either affected by SCA or with known family history of SCA. The high frequency of large alleles at this locus is inconsistent with the much rarer occurrence of SCA8. Thus, it seems unlikely that expansion alone causes SCA8; other genetic mechanisms may be necessary to explain SCA8 etiology.	Univ Toronto, Neurogenet Sect, Toronto, ON, Canada; Univ Toronto, Ctr Addict & Mental Hlth, Clarke Div, Bipolar Clin, Toronto, ON, Canada; UCL, Sch Med, Dept Psychiat & Behav Sci, Windeyer Inst Med Sci,Mol Psychiat Lab, London W1N 8AA, England; Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA; Univ Coimbra, Fac Med, Dept Psychiat, Coimbra, Portugal; Univ Coimbra, Ctr Neurosci, Coimbra, Portugal; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; Vanderbilt Univ, Dept Psychiat, Nashville, TN USA	University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of London; University College London; UCL Medical School; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade de Coimbra; Universidade de Coimbra; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University	Vincent, JB (corresponding author), Hosp Sick Children, Dept Genet, 555 Univ Ave,Room 9102, Toronto, ON M5G 1X8, Canada.	jvincent@genet.sickkids.on.ca	macedo, antónio/AFQ-1570-2022; macedo santos, antónio/M-5737-2013; Gurling, Hugh M/A-5029-2010; Lieberman, Jeffrey/AAY-8239-2020; Macciardi, Fabio/N-3768-2014; Petronis, Art/AAD-4491-2019; Paterson, Andrew D/A-4088-2011; macedo, antónio/AFQ-1571-2022; Meltzer, Herbert Y/E-8131-2013; Potkin, Steven G/A-2021-2013	macedo, antónio/0000-0003-2180-2718; macedo santos, antónio/0000-0003-2180-2718; Macciardi, Fabio/0000-0003-0537-4266; Paterson, Andrew D/0000-0002-9169-118X; macedo, antónio/0000-0003-2180-2718; Potkin, Steven/0000-0003-1028-1013	NIMH NIH HHS [MH33990, P01MH56193] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH033990, R37MH033990, P01MH056193] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barden N, 1998, Psychiatr Genet, V8, P93, DOI 10.1097/00041444-199800820-00013; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Bunzel R, 1998, MOL BRAIN RES, V59, P90, DOI 10.1016/S0169-328X(98)00146-6; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; GUTIERREZ B, 1995, LANCET, V346, P969, DOI 10.1016/S0140-6736(95)91590-7; Ikeuchi T, 1998, GENOMICS, V49, P321, DOI 10.1006/geno.1998.5266; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Laurent C, 1998, AM J MED GENET, V81, P342, DOI 10.1002/(SICI)1096-8628(19980710)81:4<342::AID-AJMG12>3.0.CO;2-L; Li T, 1998, BIOL PSYCHIAT, V44, P1160, DOI 10.1016/S0006-3223(97)00492-7; Lindblad K, 1998, MOL PSYCHIATR, V3, P405, DOI 10.1038/sj.mp.4000416; LINDBLAD K, 1995, NEUROBIOL DIS, V2, P55, DOI 10.1006/nbdi.1995.0006; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; McInnis MG, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P401; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; Nakamoto M, 1997, NAT GENET, V17, P385, DOI 10.1038/ng1297-385; ODonovan MC, 1996, PSYCHOL MED, V26, P1145, DOI 10.1017/S0033291700035868; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; Parikh SV, 1999, J AFFECT DISORDERS, V55, P221, DOI 10.1016/S0165-0327(98)00199-2; Paterson AD, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P413; Petronis A, 1996, AM J MED GENET, V67, P85, DOI 10.1002/(SICI)1096-8628(19960216)67:1<85::AID-AJMG15>3.0.CO;2-L; Petronis A, 1996, AM J HUM GENET, V59, P905; QUAN F, 1995, HUM MOL GENET, V4, P2411, DOI 10.1093/hmg/4.12.2411; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Sidransky E, 1998, AM J HUM GENET, V62, P1548, DOI 10.1086/301876; Sirugo G, 1997, AM J MED GENET, V74, P546, DOI 10.1002/(SICI)1096-8628(19970919)74:5<546::AID-AJMG19>3.0.CO;2-C; Stine OC, 1997, AM J MED GENET, V74, P263, DOI 10.1002/(SICI)1096-8628(19970531)74:3<263::AID-AJMG5>3.3.CO;2-S; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Vincent JB, 1999, AM J MED GENET, V88, P79, DOI 10.1002/(SICI)1096-8628(19990205)88:1<79::AID-AJMG14>3.0.CO;2-N; Vincent JB, 1999, MOL PSYCHIATR, V4, P229, DOI 10.1038/sj.mp.4000498; Vincent JB, 1998, HUM GENET, V103, P41, DOI 10.1007/s004390050780; Vincent JB, 1996, MOL PSYCHIATR, V1, P141; Williams J, 1996, LANCET, V347, P1294, DOI 10.1016/S0140-6736(96)90939-3; Zander C, 1998, AM J MED GENET, V81, P338, DOI 10.1002/(SICI)1096-8628(19980710)81:4<338::AID-AJMG11>3.0.CO;2-M	36	60	63	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					819	829		10.1086/302803	http://dx.doi.org/10.1086/302803			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712198	Green Published, Bronze			2022-12-18	WOS:000088373200006
J	Loughlin, J; Mustafa, Z; Irven, C; Smith, A; Carr, AJ; Sykes, B; Chapman, K				Loughlin, J; Mustafa, Z; Irven, C; Smith, A; Carr, AJ; Sykes, B; Chapman, K			Stratification analysis of an osteoarthritis genome screen - Suggestive linkage to chromosomes 4, 6, and 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MICE; DISEASE		Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England; Nuffield Orthopaed Ctr, Oxford OX3 7LD, England	University of Oxford; Nuffield Orthopaedic Centre	Loughlin, J (corresponding author), Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England.			Loughlin, John/0000-0003-2018-3361				Ayad S, 1994, EXTRACELLULAR MATRIX; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; COOPER C, 1994, J RHEUMATOL, V21, P307; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Kaprio J, 1996, BRIT MED J, V313, P232, DOI 10.1136/bmj.313.7051.232; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; LINDBERG H, 1986, CLIN ORTHOP RELAT R, P273; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291	12	60	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1795	1798		10.1086/302685	http://dx.doi.org/10.1086/302685			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577938	Bronze, Green Published			2022-12-18	WOS:000084282500039
J	Cabot, A; Rozet, JM; Gerber, S; Perrault, I; Ducroq, D; Smahi, A; Souied, E; Munnich, A; Kaplan, J				Cabot, A; Rozet, JM; Gerber, S; Perrault, I; Ducroq, D; Smahi, A; Souied, E; Munnich, A; Kaplan, J			A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOVEATION DYNAMICS	Congenital nystagmus (CN) is a common oculomotor disorder (frequency of 1/1,500 live births) characterized by bilateral uncontrollable ocular oscillations, with onset typically at birth or within the first few months of life. This condition is regarded as idiopathic, after exclusion of nervous and ocular diseases. X-linked, autosomal dominant, and autosomal recessive modes of inheritance have been reported, but X-linked inheritance is probably the most common. In this article, we report the mapping of a gene for X-linked dominant CN (NYS1) to the short arm of chromosome X, by showing close linkage of NYS1 to polymorphic markers on chromosome Xp11.4-p11.3 (maximum LOD score of 3.20, over locus DXS993). Because no candidate gene, by virtue of its function, has been found in this region of chromosome Xp, further studies are required, to reduce the genetic interval encompassing the NYS1 gene. It is hoped that the complete gene characterization will address the complex pathophysiology of CN.	Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kaplan, J (corresponding author), Hop Necker Enfants Malad, INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France.		ROZET, Jean-Michel/E-5737-2016; Smahi, Asma/J-4184-2017; perrault, isabelle/H-3047-2017	ROZET, Jean-Michel/0000-0001-7951-7886; Smahi, Asma/0000-0002-6002-0981; GERBER, Sylvie/0000-0002-6827-1769; perrault, isabelle/0000-0002-8560-1379				ADACHI M, 1973, ACTA NEUROPATHOL, V23, P300, DOI 10.1007/BF00687459; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; APKARIAN P, 1991, INVEST OPHTH VIS SCI, V32, P2653; Cogan D G, 1967, Can J Ophthalmol, V2, P4; DELLOSSO LF, 1993, NEUROLOGY, V43, P1741, DOI 10.1212/WNL.43.9.1741; DELLOSSO LF, 1992, DOC OPHTHALMOL, V79, P51, DOI 10.1007/BF00160132; DELLOSSO LF, 1992, DOC OPHTHALMOL, V79, P25, DOI 10.1007/BF00160131; DELLOSSO LF, 1992, DOC OPHTHALMOL, V79, P1, DOI 10.1007/BF00160130; DELLOSSO LF, 1974, ARCH OPHTHALMOL-CHIC, V92, P366, DOI 10.1001/archopht.1974.01010010378002; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FIELDER A R, 1988, Eye (London), V2, P628; FORSSMAN B, 1964, Acta Otolaryngol, V57, P427, DOI 10.3109/00016486409137104; FORSSMAN B, 1971, ANN HUM GENET, V35, P139, DOI 10.1111/j.1469-1809.1956.tb01386.x; GELBART SS, 1988, GRAEF ARCH CLIN EXP, V226, P178, DOI 10.1007/BF02173313; Hameb L M, 1995, Surv Ophthalmol, V40, P250, DOI 10.1016/S0039-6257(95)80037-9; HARCOURT B, 1970, Journal of Medical Genetics, V7, P253, DOI 10.1136/jmg.7.3.253; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kerrison JB, 1996, GENOMICS, V33, P523, DOI 10.1006/geno.1996.0229; Kestenbaum, 1961, CLIN METHODS NEUROOP; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MENCUCCI R, 1995, OPHTHALMOLOGICA, V209, P1, DOI 10.1159/000310564; Peng GH, 1998, OPHTHALMOLOGICA, V212, P1, DOI 10.1159/000027249; PEPIN B, 1980, J NEUROL SCI, V45, P191, DOI 10.1016/0022-510X(80)90165-3; WYBAR K, 1972, ISRAEL J MED SCI, V8, P1492	24	60	71	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1141	1146		10.1086/302324	http://dx.doi.org/10.1086/302324			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090899	Green Published, Bronze			2022-12-18	WOS:000079632900025
J	Reiss, J; Dorche, C; Stallmeyer, B; Mendel, RR; Cohen, N; Zabot, MT				Reiss, J; Dorche, C; Stallmeyer, B; Mendel, RR; Cohen, N; Zabot, MT			Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SULFITE OXIDASE; XANTHINE-OXIDASE; BIOSYNTHESIS; ENZYME; DEHYDROGENASE; EXPRESSION; CELLS; DNA; MO	Biosynthesis of the molybdenum cofactor (MoCo) can be divided into (1) the formation of a precursor and (2) the latter's subsequent conversion, by molybdopterin synthase, into the organic moiety of MoCo. These two steps are reflected by the complementation groups A and B and the two formally distinguished types of MoCo deficiency that have an identical phenotype. Both types of MoCo deficiency result in a pleiotropic loss of all molybdoenzyme activities and cause severe neurological damage. MOCS1 is defective in patients with group A deficiency and has been shown to encode two enzymes for early synthesis via a bicistronic transcript with two consecutive open reading frames (ORFs). MOCS2 encodes the small and large subunits of molybdopterin synthase via a single transcript with two overlapping reading frames. This gene was mapped to 5q and comprises seven exons. The coding sequence and all splice site-junction sequences were screened for mutations, in MoCo-deficient patients in whom a previous search for MoCS1 mutations had been negative. In seven of the eight patients whom we investigated, we identified MoCS2 mutations that, by their nature, are most likely responsible for the deficiency Three different frameshift mutations were observed, with one of them found on 7 of 14 identified alleles. Furthermore, a start-codon mutation and a missense mutation of a highly conserved amino acid residue were found. The locations of the mutations confirm the functional role of both ORFs. One of the patients with identified MOCS2 mutations had been classified as type B, in complementation studies. These findings support the hypothetical mechanism, for both forms of MoCo deficiency, that formerly had been established by cell-culture experiments.	Univ Gottingen, Inst Humangenet, D-37073 Gottingen, Germany; Hop Debrousse, Serv Biochim, Paris, France; Tech Univ Carolo Wilhelmina Braunschweig, Inst Bot, D-3300 Braunschweig, Germany; Technion Israel Inst Technol, Haifa, Israel	University of Gottingen; CHU Lyon; Braunschweig University of Technology; Technion Israel Institute of Technology	Reiss, J (corresponding author), Univ Gottingen, Inst Humangenet, Gosslerstr 12D, D-37073 Gottingen, Germany.	jreiss@gwdg.de	Stallmeyer, Birgit/AAE-3020-2020		FDA HHS [GENBANK/AF091871] Funding Source: Medline	FDA HHS		AMY CM, 1992, P NATL ACAD SCI USA, V89, P1105, DOI 10.1073/pnas.89.3.1105; BOLES RG, 1993, ANN NEUROL, V34, P742, DOI 10.1002/ana.410340520; Bonioli E, 1996, J INHERIT METAB DIS, V19, P700, DOI 10.1007/BF01799850; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; DAVIDSON JN, 1993, BIOESSAYS, V15, P157, DOI 10.1002/bies.950150303; DESJACQUES P, 1985, J INHERIT METAB DIS, V8, P117, DOI 10.1007/BF01811486; Duran M, 1978, J Inherit Metab Dis, V1, P175, DOI 10.1007/BF01805591; GARRETT RM, 1994, J BIOL CHEM, V269, P272; HUBER C, 1994, ARCH MICROBIOL, V162, P303, DOI 10.1007/BF00263776; Irreverre F, 1967, BIOCHEM MED, V1, P187; Johnson J.L, 1995, METABOLIC MOL BASES, V7th edition., P2271, DOI [10.1016/0168-9525(96)81407-7, DOI 10.1016/0168-9525(96)81407-7]; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; KRAWCZAK M, 1992, HUM GENET, V90, P41; LUDDEN PW, 1993, ACS SYM SER, V535, P196; Mendel RR, 1997, PLANTA, V203, P399, DOI 10.1007/s004250050206; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PICKART CM, 1994, J BIOL CHEM, V269, P7115; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Stallmeyer B, 1999, AM J HUM GENET, V64, P698, DOI 10.1086/302295; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Wolff JA, 1997, NEUROMUSCULAR DISORD, V7, P314, DOI 10.1016/S0960-8966(97)00055-2	26	60	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1999	64	3					706	711		10.1086/302296	http://dx.doi.org/10.1086/302296			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	177HN	10053004	Green Published, Bronze			2022-12-18	WOS:000079204700007
J	Oota, H; Saitou, N; Matsushita, T; Ueda, S				Oota, H; Saitou, N; Matsushita, T; Ueda, S			Molecular genetic analysis of remains of a 2,000-year-old human population in China - and its relevance for the origin of the modern Japanese population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL REGION; SEQUENCE; DIVERSITY; ANCIENT; DIFFERENTIATION; PURIFICATION; POLYMORPHISM; AMERINDS; DELETION	We extracted DNA from the human remains excavated from the Yixi site (similar to 2,000 years before the present) in the Shandong peninsula of China and, through PCR amplification, determined nucleotide sequences of their mitochondrial D-loop regions. Nucleotide diversity of the ancient Yixi people was similar to those of modern populations. Modern humans in Asia and the circum-Pacific region are divided into six radiation groups, on the basis of the phylogenetic network constructed by means of 414 mtDNA types from 1,298 individuals. We compared the ancient Yixi people with the modern Asian and the circum-Pacific populations, using two indices: frequency distribution of the radiation groups and genetic distances among populations, Both revealed that the closest genetic relatedness is between the ancient Yixi people and the modern Taiwan Han Chinese. The Yixi people show closer genetic affinity with Mongolians, mainland Japanese, and Koreans than with Ainu and Ryukyu Japanese and less genetic resemblance with Jomon people and Yayoi people, their predecessors and contemporaries, respectively, in ancient Japan.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Natl Inst Genet, Lab Evolut Genet, Mishima, Shizuoka 411, Japan; Doigahama Site Anthropol Museum, Houhoku, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ueda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BANDELT HJ, 1995, GENETICS, V141, P743; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Betty DJ, 1996, AM J HUM GENET, V58, P428; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Comas D, 1996, MOL BIOL EVOL, V13, P1067, DOI 10.1093/oxfordjournals.molbev.a025669; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1991, PHILOS T ROY SOC B, V333, P409, DOI 10.1098/rstb.1991.0091; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1989, P JPN ACAD B-PHYS, V65, P229, DOI 10.2183/pjab.65.229; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Imamura K., 1996, PREHISTORIC JAPAN NE; KANASEKI T, 1966, ORIGIN JAPANESE; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; KUROSAKI K, 1993, AM J HUM GENET, V53, P638; NEI M, 1995, RECENT ADV HUMAN BIO, V1, P71; Nei M., 1987, MOL EVOLUTIONARY GEN; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; OOTA H, 1995, AM J PHYS ANTHROPOL, V98, P133, DOI 10.1002/ajpa.1330980204; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SYKES B, 1995, AM J HUM GENET, V57, P1463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; *UNESCO IOC W PAC, 1995, WESTPAC PAL MAPS LAS; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; [No title captured]	31	60	62	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					250	258		10.1086/302197	http://dx.doi.org/10.1086/302197			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915964	Green Published, Bronze			2022-12-18	WOS:000078477400030
J	Gudmundsson, J; Johannesdottir, G; Arason, A; Bergthorsson, JT; Ingvarsson, S; Egilsson, V; Barkardottir, RB				Gudmundsson, J; Johannesdottir, G; Arason, A; Bergthorsson, JT; Ingvarsson, S; Egilsson, V; Barkardottir, RB			Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OVARIAN-CANCER; ENDOMETRIAL CANCER; RELATIVES	Cloning of a breast cancer-predisposing gene (BRCA2) on chromosome 13q12-14 has been reported recently. We analyzed seven large Icelandic breast cancer families with markers from the BRCA2 region. Five families showed strong evidence of linkage. The maximum two-point LOD scores for the five BRCA2-linked families ranged from 1.06 to 3.19. Haplotype analyses revealed a region with identical allele sizes between the families, suggesting that they have inherited the mutation from a common ancestor. Cancer types other than breast cancer occur in individuals, segregating the affected haplotype within these families. This suggests that mutations in the gene may also confer some risk of other malignancies in both males and females.	UNIV HOSP ICELAND,DEPT PATHOL,DIV CELL BIOL,CELL BIOL LAB,IS-101 REYKJAVIK,ICELAND	Landspitali National University Hospital			Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714; Bergthorsson, Jon Thor/0000-0002-0560-2639				ANDERSON KE, 1992, BRIT J CANCER, V66, P599, DOI 10.1038/bjc.1992.321; ARASON A, 1993, AM J HUM GENET, V52, P711; BARKARDOTTIR RB, 1995, ACTA ONCOL, V34, P657, DOI 10.3109/02841869509094044; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; BJARNASO.O, 1973, ANN HUM GENET, V36, P425, DOI 10.1111/j.1469-1809.1973.tb00606.x; CLAUS EB, 1991, AM J HUM GENET, V48, P232; COLLINS N, 1995, ONCOGENE, V10, P1673; DIB C, IN PRESS NATURE; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SELLERS TA, 1994, J NATL CANCER I, V86, P1860, DOI 10.1093/jnci/86.24.1860; THISSEN EU, 1974, CANCER, V34, P1102; TULINIUS H, 1992, BRIT MED J, V305, P855, DOI 10.1136/bmj.305.6858.855; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	23	60	63	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					749	756						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644738				2022-12-18	WOS:A1996UA38000012
J	CHANG, JG; JONG, YJ; HUANG, JM; WANG, WS; YANG, TY; CHANG, CP; CHEN, YJ; LIN, SP				CHANG, JG; JONG, YJ; HUANG, JM; WANG, WS; YANG, TY; CHANG, CP; CHEN, YJ; LIN, SP			MOLECULAR-BASIS OF SPINAL MUSCULAR-ATROPHY IN CHINESE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHILDHOOD; GENE		MACKAY MEM HOSP,DEPT PEDIAT,GENET SECT,TAIPEI,TAIWAN; KAOHSIUNG MED COLL,DEPT PEDIAT,NEUROL SECT,KAOHSIUNG,TAIWAN	Mackay Memorial Hospital; Kaohsiung Medical University	CHANG, JG (corresponding author), TAIPEI MUNICIPAL JEN AI HOSP,DEPT MOLEC MED,10,SECT 4,JEN AI RD,TAIPEI,TAIWAN.		Chang, Jan-Gowth/C-9544-2009; Jong, Yuh-Jyh/B-8782-2009	Chang, Chih-Peng/0000-0002-0212-5048				BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; CHIOU SS, 1993, BRIT J HAEMATOL, V83, P112, DOI 10.1111/j.1365-2141.1993.tb04640.x; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; HONGYO T, 1993, NUCLEIC ACIDS RES, V21, P3637, DOI 10.1093/nar/21.16.3637; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PEARN J, 1978, J NEUROL SCI, V37, P227, DOI 10.1016/0022-510X(78)90206-X; PEARN JH, 1973, J MED GENET, V10, P260, DOI 10.1136/jmg.10.3.260; PEARN JH, 1982, ADV NEUROL, P121; ROBERTS DF, 1970, ARCH DIS CHILD, V45, P33, DOI 10.1136/adc.45.239.33; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; [No title captured]	15	60	65	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1503	1505						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533782				2022-12-18	WOS:A1995TE65500030
J	ENGLE, EC; MARONDEL, I; HOUTMAN, WA; DEVRIES, B; LOEWENSTEIN, A; LAZAR, M; WARD, DC; KUCHERLAPATI, R; BEGGS, AH				ENGLE, EC; MARONDEL, I; HOUTMAN, WA; DEVRIES, B; LOEWENSTEIN, A; LAZAR, M; WARD, DC; KUCHERLAPATI, R; BEGGS, AH			CONGENITAL FIBROSIS OF THE EXTRAOCULAR-MUSCLES (AUTOSOMAL-DOMINANT CONGENITAL EXTERNAL OPHTHALMOPLEGIA) - GENETIC HOMOGENEITY, LINKAGE REFINEMENT, AND PHYSICAL MAPPING ON CHROMOSOME-12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU HYBRIDIZATION; CLONES; SEQUENCES; DNA	Congenital fibrosis of the extraocular muscles (CFEOM) is an autosomal dominant syndrome of congenital external ophthalmoplegia and bilateral ptosis. We previously reported linkage of this disorder in two unrelated families to an 8-cM region near the centromere of human chromosome 12. We now present refinement of linkage in the original two families, linkage analysis of five additional families, and a physical map of the critical region for the CFEOM gene. In each of the seven families the disease gene is linked to the pericentromeric region of chromosome 12. D12S345, D12S59, D12S331, and D12S1048 do not recombine with the disease gene and have combined lod scores of 35.7, 35.6, 16.0, and 31.4, respectively. AFM136xf6 and AFMb320wd9 flank the CFEOM locus, defining a critical region of 3 cM spanning the centromere of chromosome 12. These data support the concept that this may be a genetically homogeneous disorder. We also describe the generation of a YAC contig encompassing the critical region of the CFEOM locus. This interval has been assigned cytogenetically to 12p11.2-q12 and spans the centromere of chromosome 12. These results provide the basis for further molecular analyses of the structure and organization of the CFEOM locus and will help in the identification of candidate genes.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115; ALBERT EINSTEIN COLL MED,DEPT MOLEC GENET,BRONX,NY 10467; UNIV GRONINGEN HOSP,DEPT OPHTHALMOL,GRONINGEN,NETHERLANDS; ICHILOV HOSP,DEPT OPHTHALMOL,IL-64239 TEL AVIV,ISRAEL; YALE UNIV,SCH MED,NEW HAVEN,CT	Harvard University; Boston Children's Hospital; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; University of Groningen; Tel Aviv University; Yale University	ENGLE, EC (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,ENDERS 512,300 LONGWOOD AVE,BOSTON,MA 02115, USA.		Kucherlapati, Raju/ABC-8807-2021	Beggs, Alan/0000-0001-8818-0568	NATIONAL EYE INSTITUTE [K11EY000336] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000965] Funding Source: NIH RePORTER; NEI NIH HHS [PSA K11-EY00336-02] Funding Source: Medline; NHGRI NIH HHS [HG00965] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CIBIS GW, 1984, OPHTHALMIC PAED GEN, V4, P163, DOI 10.3109/13816818409006116; CIBIS GW, 1984, STRABISMUS, V2, P379; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; ENGLE EC, 1994, NAT GENET, V7, P69, DOI 10.1038/ng0594-69; FLIERINGA HJ, 1924, Z AUGENHEILKD, V52, P1; GYAPAY G, 1993, NAT GENET, V7, P246; HOUTMAN WA, 1986, OPHTHALMOLOGICA, V193, P207, DOI 10.1159/000309712; JONKERS G H, 1950, Ned Tijdschr Geneeskd, V94, P1471; JORDE LB, 1995, AM J HUM GENET, V56, P11; KRAUTER K, INPRESS NATURE; Kucherlapati R, 1994, Cytogenet Cell Genet, V67, P245, DOI 10.1159/000133868; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAUGHLIN RC, 1956, AM J OPHTHALMOL, V41, P432, DOI 10.1016/0002-9394(56)91259-4; LEBLANCSTRACESK.JM, 1994, GENOMICS, V19, P341; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LOOIJENGA LHJ, 1992, GENOMICS, V13, P1125, DOI 10.1016/0888-7543(92)90027-P; MATERA AG, 1992, HUM MOL GENET, V1, P535, DOI 10.1093/hmg/1.7.535; NEMET P, 1985, Metabolic Pediatric and Systemic Ophthalmology, V8, P172; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Traboulsi EI, 1993, AM ORTHOPT J, V43, P45; WU JS, 1990, AM J HUM GENET, V46, P624	24	60	69	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1086	1094						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485159				2022-12-18	WOS:A1995TA44900015
J	HOOK, EB; MUTTON, DE; IDE, R; ALBERMAN, E; BOBROW, M				HOOK, EB; MUTTON, DE; IDE, R; ALBERMAN, E; BOBROW, M			THE NATURAL-HISTORY OF DOWN-SYNDROME CONCEPTUSES DIAGNOSED PRENATALLY THAT ARE NOT ELECTIVELY TERMINATED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NATIONAL REGISTER; DOWNS-SYNDROME; FETUSES; ENGLAND; WALES	The pregnancy outcomes on cases of Down syndrome diagnosed prenatally in which the mother did not elect termination were evaluated in data reported to a comprehensive Register of Down syndrome for England and Wales for 1989-94. In the 168 cases in which placental biopsy was not used, the overall rare of spontaneous loss was 35%, but this figure masks considerable heterogeneity by gestational stage at ascertainment. Data on ages at diagnostic procedure and on pregnancy termination enabled a more precise survival analysis. The loss rates were similar to 50% for those fetuses ascertained at 15-17 completed wk, 43% at 18 wk, 31% at 19 wk, 25% at 20 wk, and then a leveling off at similar to 20%-25% for fetuses ascertained at 21-28 completed wk. For fetuses ascertained prior to 18 wk, there was no evidence that maternal age was associated with fetal loss, consistent with earlier reports. At 18 wk and after, however, maternal age was on the average similar to 3 years greater in fetuses that were lost. Comparison of successive gestational birth cohorts provided no evidence in these 168 cases that the diagnostic procedure itself had any effect on loss or that selective ascertainment of mothers in risk of loss had any effect on the results. In contrast, in the 21 cases in which placental biopsy had been undertaken, the overall loss rates were not only higher when appropriate comparisons could be made, but there was some evidence for selective ascertainment and/or procedure-associated losses. The total data here are >1.5-fold the previous number of cases in which the natural history of Down syndrome fetuses has been evaluated directly.	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; ST BARTHOLOMEWS HOSP,COLL MED,DEPT ENVIRONM & PREVENT MED,LONDON,ENGLAND; QMW,LONDON HOSP,COLL MED,DEPT EPIDEMIOL & MED STAT,LONDON,ENGLAND; UNITED MED & DENT SCH,DIV MED & MOLEC GENET,PAEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND	University of California System; University of California San Francisco; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; King's College London	HOOK, EB (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,304 WARREN HALL,BERKELEY,CA 94720, USA.							ARMITAGE P, 1973, STATISTICAL METHODS, P362; DIEM K, 1962, DOCUMENTA GEIGY SCI, P85; HALLIDAY GL, 1995, PRENAT DIAGN, V15, P455; HECHT CA, 1994, PRENATAL DIAG, V14, P729, DOI 10.1002/pd.1970140814; Hook E.B, 1992, PRENATAL DIAGNOSIS S, P351; HOOK EB, 1989, AM J HUM GENET, V45, P855; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; Morris J K, 1994, J Med Screen, V1, P233; MUTTON DE, 1991, BRIT MED J, V303, P1295, DOI 10.1136/bmj.303.6813.1295; MUTTON DE, 1993, BRIT MED J, V306, P431, DOI 10.1136/bmj.306.6875.431	10	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					875	881						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573049				2022-12-18	WOS:A1995RV79300019
J	GERBER, S; ROZET, JM; BONNEAU, D; SOUIED, E; CAMUZAT, A; DUFIER, JL; AMALRIC, P; WEISSENBACH, J; MUNNICH, A; KAPLAN, J				GERBER, S; ROZET, JM; BONNEAU, D; SOUIED, E; CAMUZAT, A; DUFIER, JL; AMALRIC, P; WEISSENBACH, J; MUNNICH, A; KAPLAN, J			A GENE FOR LATE-ONSET FUNDUS FLAVIMACULATUS WITH MACULAR DYSTROPHY MAPS TO CHROMOSOME 1P13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STARGARDTS-DISEASE; LINKAGE	Fundus flavimaculatus with macular dystrophy is an autosomal recessive disease responsible for a progressive loss of visual acuity in adulthood, with pigmentary changes of the macula, perimacular flecks, and atrophy of the retinal pigmentary epithelium. Since this condition shares several clinical features with Stargardt disease, which has been mapped to chromosome 1p21-p13, we tested the disease for linkage to chromosome 1p. We report here the mapping of the disease locus to chromosome 1p13-p21, in the genetic interval defined by loci D1S435 and D1S415, in four multiplex families (maximum lod score 4.79 at recombination fraction 0 for probe AFM217zb2 at locus D1S435). Thus, despite differences in the age at onset, clinical course, and severity, fundus flavimaculatus with macular dystrophy and Stargardt disease are probably allelic disorders. This result supports the view that allelic mutations produce a continuum of macular dystrophies, with onset in early childhood to late adulthood.	HOP NECKER ENFANTS MALAD,INSERM,U393,SERV GENET,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS,FRANCE; HOP LAENNEC,SERV OPHTALMOL,F-75340 PARIS,FRANCE; CONSULTAT OPHTALMOL,ALBI,FRANCE; GENETHON,EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP			ROZET, Jean-Michel/E-5737-2016	ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769				FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KUMARSINGH R, 1994, NUCLEIC ACIDS RES, V19, P5800; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MERIN S, 1978, METAB OPHTHALMOL, V2, P1991; MOLONEY JBM, 1983, AM J OPHTHALMOL, V96, P57, DOI 10.1016/0002-9394(83)90455-5; OTT J, 1985, ANAL HUMAN GENETIC L, P97; ROSEHR K, 1954, KLIN MONATSBL AUGENH, V124, P171; STARGARDT K, 1909, A VONGRAEFES ARCH OP, V71, P543; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELEBER RG, 1994, ARCH OPHTHALMOL-CHIC, V112, P752, DOI 10.1001/archopht.1994.01090180050033; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	16	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					396	399						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847373				2022-12-18	WOS:A1995QF42300006
J	LORENZETTI, D; PAREYSON, D; SGHIRLANZONI, A; ROA, BB; ABBAS, NE; PANDOLFO, M; DIDONATO, S; LUPSKI, JR				LORENZETTI, D; PAREYSON, D; SGHIRLANZONI, A; ROA, BB; ABBAS, NE; PANDOLFO, M; DIDONATO, S; LUPSKI, JR			A 1.5-MB DELETION IN 17P11.2-P12 IS FREQUENTLY OBSERVED IN ITALIAN FAMILIES WITH HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; POINT MUTATION; PMP22 GENE; DUPLICATION; CHROMOSOME-17; SEQUENCES; PMP-22; CMT1A; HNPP; MAPS	Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant disorder characterized by recurrent mononeuropathies. A 1.5-Mb deletion in chromosome 17p11.2-p12 has been associated with HNPP. Duplication of the same 1.5-Mb region is known to be associated with Charcot-Marie-Tooth disease type 1 (CMT1A), a more severe peripheral neuropathy characterized by symmetrically slowed nerve conduction velocity (NCV). The CMT1A duplication and HNPP deletion appear to be the reciprocal products of a recombination event involving a repeat element (CMT1A-REP) that hanks the 1.5-Mb region involved in the duplication/deletion. Patients from nine unrelated Italian families who were diagnosed with HNPP on the basis of clinical, electrophysiological, and histological evaluations were analyzed by molecular methods for DNA deletion on chromosome 17p. In all nine families, Southern analysis using a CMT1A-REP probe detected a reduced hybridization signal of a 6.0-kb EcoRI fragment mapping within the distal CMT1A-REP, indicating deletion of one copy of CMT1A-REP in these HNPP patients. Families were also typed with a polymorphic (CA)(n) repeat and with RFLPs corresponding to loci D17S122, D17S125, and D17S61, which all map within the deleted region. Lack of allelic transmission from affected parent to affected offspring was observed in four informative families, providing an independent indication for deletion. Furthermore, pulsed-field gel electrophoresis analysis of SacII-digested genomic DNA detected junction fragments specific to the 1.5-Mb HNPP deletion in seven of nine Italian families included in this study. These findings suggest that a 1.5-Mb deletion on 17p11.2-p12 is the most common mutation associated with HNPP.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN GENET,HOUSTON,TX 77030; IST NAZL NEUROL C BESTA,MILAN,ITALY	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; IRCCS Istituto Neurologico Besta			Pareyson, Davide/K-5890-2016; Pandolfo, Massimo/B-2853-2010; Di Donato, Stefano/B-9717-2012	Pareyson, Davide/0000-0001-6854-765X; 	NINDS NIH HHS [NS 27042] Funding Source: Medline; Telethon [560] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFORD RL, 1994, AM J HUM GENET, V55, P190; BEHSE F, 1972, BRAIN, V95, P777, DOI 10.1093/brain/95.4.777; BRADLEY WG, 1975, BRAIN, V98, P381, DOI 10.1093/brain/98.3.381; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; DAVIES DM, 1954, LANCET, V2, P266; DEBRUYNE J, 1980, J NEUROL SCI, V47, P385, DOI 10.1016/0022-510X(80)90091-X; Dyck P.J, 1993, PNP, P1094; DYCK PJ, 1981, ANN NEUROL, V10, P222, DOI 10.1002/ana.410100304; EARL CJ, 1964, Q J MED, V33, P481; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; IONASESCU VV, 1993, HUM MOL GENET, V2, P405; IONASESCU VV, 1993, MUSCLE NERVE, V16, P1232, DOI 10.1002/mus.880161114; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd; LEGUERN E, 1994, CYTOGENET CELL GENET, V65, P261, DOI 10.1159/000133643; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1994, JIKKEN IGAKU, V12, P109; MADRID R, 1975, J NEUROL SCI, V25, P415, DOI 10.1016/0022-510X(75)90263-4; MARAZZI R, 1988, ITAL J NEUROL SCI, V9, P355, DOI 10.1007/BF02333999; MARIMAN ECM, 1993, HUM GENET, V92, P87, DOI 10.1007/BF00216152; MATIMAN ECM, 1994, HUM GENET, V93, P151; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; McKusick V.A., 1992, MENDELIAN INHERITANC; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NELIS E, 1994, HUM MOL GENET, V3, P515; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PATEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483, DOI 10.1007/BF01534853; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REISECKER F, 1994, NEUROLOGY, V44, P753, DOI 10.1212/WNL.44.4.753; Roa B B, 1993, Prog Clin Biol Res, V384, P187; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; ROA BB, IN PRESS ADV HUM GEN; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VERHALLE D, 1994, ANN NEUROL, V35, P704, DOI 10.1002/ana.410350611; WISE CA, 1993, AM J HUM GENET, V53, P853; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YOSHIKAWA H, 1994, ANN NEUROL, V35, P445, DOI 10.1002/ana.410350412	50	60	61	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					91	98						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825607				2022-12-18	WOS:A1995QC10100012
J	TODA, T; IKEGAWA, S; OKUI, K; KONDO, E; SAITO, K; FUKUYAMA, Y; YOSHIOKA, M; KUMAGAI, T; SUZUMORI, K; KANAZAWA, I; NAKAMURA, Y				TODA, T; IKEGAWA, S; OKUI, K; KONDO, E; SAITO, K; FUKUYAMA, Y; YOSHIOKA, M; KUMAGAI, T; SUZUMORI, K; KANAZAWA, I; NAKAMURA, Y			REFINED MAPPING OF A GENE RESPONSIBLE FOR FUKUYAMA-TYPE CONGENITAL MUSCULAR-DYSTROPHY - EVIDENCE FOR STRONG LINKAGE DISEQUILIBRIUM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; MAP; LOCALIZATION; LOCUS; TISSUE; DNA	Fukuyama-type congenital muscular dystrophy (FCMD), the second most common form of childhood muscular dystrophy in Japan, is an autosomal recessive severe muscular dystrophy associated with an anomaly of the brain. After our initial mapping of the FCMD locus to chromosome 9q31-33, we further defined the locus within a region of similar to 5 cM between loci D9S127 and CA246, by homozygosity mapping in patients born to consanguineous marriages and by recombination analyses in other families. We also found evidence for strong linkage disequilibrium between FCMD and a polymorphic microsatelIite marker, mfd220, which showed no recombination and a lod score of (Z) 17.49. A ''111-bp'' allele for the mfd220 locus was observed in 22 (34%) of 64 FCMD chromosomes, but it was present in only 1 of 120 normal chromosomes. This allelic association with FCMD was highly significant (chi(2) = 50.7; P<.0001). Hence, we suspect that the FCMD gene could lie within a few hundred kilobases of the mfd220 locus.	UNIV TOKYO, INST CANC, DEPT BIOCHEM, TOKYO, JAPAN; UNIV TOKYO, DEPT NEUROL, TOKYO, JAPAN; TOKYO WOMENS MED COLL, DEPT PEDIAT, TOKYO 162, JAPAN; KOBE GEN HOSP, DEPT PEDIAT, KOBE, JAPAN; AICHI WELF CTR PERSONS DEV DISABIL, DEPT PEDIAT NEUROL, KASUGAI, AICHI, JAPAN; NAGOYA CITY UNIV, SCH MED, DEPT OBSTET & GYNECOL, NAGOYA, AICHI 467, JAPAN	University of Tokyo; University of Tokyo; Tokyo Women's Medical University; Kobe City Medical Center General Hospital; Nagoya City University	TODA, T (corresponding author), UNIV TOKYO, SCH INT HLTH, DEPT HUMAN GENET, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.			Saito, Kayoko/0000-0003-2632-0873				ATTWOOD J, 1994, GENOMICS, V19, P203, DOI 10.1006/geno.1994.1049; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FARRALL M, 1987, LANCET, V2, P156; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; FUKUYAMA Y, 1984, BRAIN DEV-JPN, V6, P373, DOI 10.1016/S0387-7604(84)80113-8; Fukuyama Y, 1960, PAEDIAT U TOKYO, V4, P5; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MATSUMURA K, 1993, LANCET, V341, P521, DOI 10.1016/0140-6736(93)90279-P; OSAWA M, 1978, J TOKYO WOMENS MED C, V48, P112; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; SAMBROOK J, 1989, MOL CLONINGS LABORAT; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R; WEBER JL, 1993, GENOME DATA BASE GDB; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	32	60	61	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					946	950						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977357				2022-12-18	WOS:A1994QB68200014
J	FARRER, LA; ARNOS, KS; ASHER, JH; BALDWIN, CT; DIEHL, SR; FRIEDMAN, TB; GREENBERG, J; GRUNDFAST, KM; HOTH, C; LALWANI, AK; LANDA, B; LEVERTON, K; MILUNSKY, A; MORELL, R; NANCE, WE; NEWTON, V; RAMESAR, R; RAO, VS; REYNOLDS, JE; SANAGUSTIN, TB; WILCOX, ER; WINSHIP, I; READ, AP				FARRER, LA; ARNOS, KS; ASHER, JH; BALDWIN, CT; DIEHL, SR; FRIEDMAN, TB; GREENBERG, J; GRUNDFAST, KM; HOTH, C; LALWANI, AK; LANDA, B; LEVERTON, K; MILUNSKY, A; MORELL, R; NANCE, WE; NEWTON, V; RAMESAR, R; RAO, VS; REYNOLDS, JE; SANAGUSTIN, TB; WILCOX, ER; WINSHIP, I; READ, AP			LOCUS HETEROGENEITY FOR WAARDENBURG SYNDROME IS PREDICTIVE OF CLINICAL SUBTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; FAMILIAL ALZHEIMERS-DISEASE; PLACENTAL ALKALINE-PHOSPHATASE; HUP2 PAIRED DOMAIN; PAX3 GENE; DINUCLEOTIDE REPEAT; FRAMESHIFT MUTATION; HUMAN HOMOLOG; MOUSE; SPLOTCH	Waardenburg syndrome (WS) is a dominantly inherited and clinically variable syndrome of deafness, pigmentary changes, and distinctive facial features. Clinically, WS type I(WS1) is differentiated from WS type II (WS2) by the high frequency of dystopia canthorum in the family. In some families, WS is caused by mutations in the PAX3 gene on chromosome 2q. We have typed microsatellite markers within and flanking PAX3 in 41 WS1 kindreds and 26 WS2 kindreds in order to estimate the proportion of families with probable mutations in PAX3 and to study the relationship between phenotypic and genotypic heterogeneity. Evaluation of heterogeneity in location scores obtained by multilocus analysis indicated that WS is linked to PAX3 in 60% of all WS families and in 100% of WS1 families. None of the WS2 families were linked. In those families in which equivocal lod scores (between -2 and +1) were found, PAX3 mutations have been identified in 5 of the 15 WS1 families but in none of the 4 WS2 families. Although preliminary studies do not suggest any association between the phenotype and the molecular pathology in 20 families with known PAX3 mutations and in four patients with chromosomal abnormalities in the vicinity of PAX3, the presence of dystopia in multiple family members is a reliable indicator for identifying families likely to have a defect in PAX3.	BOSTON UNIV, SCH MED, DEPT BIOSTAT & EPIDEMIOL, BOSTON, MA 02118 USA; BOSTON UNIV, SCH MED, CTR HUMAN GENET, BOSTON, MA 02118 USA; GALLAUDET UNIV, WASHINGTON, DC 20002 USA; MICHIGAN STATE UNIV, DEPT ZOOL, E LANSING, MI 48824 USA; MICHIGAN STATE UNIV, GRAD PROGRAM GENET, E LANSING, MI 48824 USA; NIDR, EPIDEMIOL & ORAL DIS PREVENT PROGRAM, MOLEC EPIDEMIOL & DIS INDICATORS BRANCH, BETHESDA, MD 20892 USA; NIDOCD, MOLEC OTOL LAB, BETHESDA, MD USA; UNIV CAPE TOWN, DEPT HUMAN GENET, CAPE TOWN 7925, SOUTH AFRICA; VIRGINIA COMMONWEALTH UNIV, DEPT HUMAN GENET, RICHMOND, VA USA; UNIV MANCHESTER, DEPT MED GENET, MANCHESTER, LANCS, ENGLAND; UNIV MANCHESTER, CTR AUDIOL, MANCHESTER, LANCS, ENGLAND	Boston University; Boston University; Michigan State University; Michigan State University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Cape Town; Virginia Commonwealth University; University of Manchester; University of Manchester	FARRER, LA (corresponding author), BOSTON UNIV, SCH MED, DEPT NEUROL, 80 E CONCORD ST, BOSTON, MA 02118 USA.		Farrer, Lindsay/AAS-1035-2020; Ramesar, Raj S/I-6941-2015; Winship, Ingrid M/D-7204-2016; Morell, Robert James/Q-2042-2019	Ramesar, Raj S/0000-0001-5688-1634; Farrer, Lindsay/0000-0001-5533-4225; Winship, Ingrid/0000-0001-8535-6003; Baldwin, Clinton/0000-0002-3275-9463; Milunsky, Aubrey/0000-0003-2114-4823; Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001160, R01DC001848] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00038, DC-01160, DC-01848] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission)		ARIAS S, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8a; ARIAS S, 1978, J GENET HUM, V26, P103; ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; BALDWIN CT, 1994, HUM MUTAT, V3, P205, DOI 10.1002/humu.1380030306; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARBER TD, 1993, HUM MOL GENET, V2, P88, DOI 10.1093/hmg/2.1.88; BECKMAN G, 1991, HUM HERED, V41, P122, DOI 10.1159/000153988; BUTT J, 1994, HUM MOL GENET, V3, P197, DOI 10.1093/hmg/3.1.197; COTTERMAN CW, 1951, AM J HUM GENET, V3, P254; DASILVA EO, 1991, AM J MED GENET, V40, P65, DOI 10.1002/ajmg.1320400113; EPSTEIN DJ, 1991, GENOMICS, V10, P89, DOI 10.1016/0888-7543(91)90488-Z; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; FARRER LA, 1992, AM J HUM GENET, V50, P902; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOY C, 1990, AM J HUM GENET, V46, P1017; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOODMAN RM, 1982, AM J MED GENET, V11, P425, DOI 10.1002/ajmg.1320110407; GOULDING M, 1993, GENOMICS, V17, P355, DOI 10.1006/geno.1993.1332; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; HOTH CF, 1993, AM J HUM GENET, V52, P455; HOTH CF, 1991, NUCLEIC ACIDS RES, V19, P6979, DOI 10.1093/nar/19.24.6979; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; KLEIN D, 1983, AM J MED GENET, V14, P231, DOI 10.1002/ajmg.1320140205; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARTIN D, 1987, NUCLEIC ACIDS RES, V15, P9104, DOI 10.1093/nar/15.21.9104; MORELL R, 1993, HUM MOL GENET, V2, P1487, DOI 10.1093/hmg/2.9.1487; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; MORTON NE, 1956, AM J HUM GENET, V8, P80; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; OTT J, 1986, GENET EPIDEMIOL, P251; Ott Jurg, ANAL HUMAN GENETIC L; PAKSTIS AJ, 1991, CYTOGENET CELL GENET, V58, P1871; PASTERIS NG, 1993, HUM MOL GENET, V2, P953, DOI 10.1093/hmg/2.7.953; READ AP, 1993, NAT GENET, V5, P8, DOI 10.1038/ng0993-8b; READ AP, 1991, AM J HUM GENET, V49, P6; REYNOLDS JE, 1993, THESIS VIRGINIA COMM; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Sokal R.R., 1981, BIOMETRY, V2nd ed.; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Tsukamoto Kazuhiro, 1992, Human Molecular Genetics, V1, P315, DOI 10.1093/hmg/1.5.315; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WILCOX ER, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215-a; WITKOP C, 1990, PRINCIPLES PRACTICE, P797; WU BL, 1993, CYTOGENET CELL GENET, V63, P29, DOI 10.1159/000133495; YAMAGATA Z, 1991, CYTOGENET CELL GENET, V58, P1874; 1992, SCIENCE, V258, P3	59	60	65	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					728	737						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942851				2022-12-18	WOS:A1994PJ02700016
J	HILDEBRANDT, F; SINGHSAWHNEY, I; SCHNIEDERS, B; CENTOFANTE, L; OMRAN, H; POHLMANN, A; SCHMALTZ, C; WEDEKIND, H; SCHUBOTZ, C; ANTIGNAC, C; WEBER, JL; BRANDIS, M				HILDEBRANDT, F; SINGHSAWHNEY, I; SCHNIEDERS, B; CENTOFANTE, L; OMRAN, H; POHLMANN, A; SCHMALTZ, C; WEDEKIND, H; SCHUBOTZ, C; ANTIGNAC, C; WEBER, JL; BRANDIS, M			MAPPING OF A GENE FOR FAMILIAL JUVENILE NEPHRONOPHTHISIS REFINING THE MAP AND DEFINING FLANKING MARKERS ON CHROMOSOME-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; DISEASE	Familial juvenile nephronophthisis (NPH) is an autosomal recessive kidney disease that leads to end-stage renal failure in adolescence and is associated with the formation of cysts at the cortico-medullary junction of the kidneys. NPH is responsible for about 15% of end-stage renal disease in children, as shown by Kleinknecht and Habib. NPH in combination with autosomal recessive retinitis pigmentosa is known as the Senior-Lerken syndrome (SLS) and exhibits renal pathology that is identical to NPH. We had excluded 40% of the human genome from linkage with a disease locus for NPH or SLS when Antignac et al. first demonstrated linkage for an NPH locus on chromosome 2. We present confirmation of linkage of an NPH locus to microsatellite markers on chromosome 2 in nine families with NPH. By linkage analysis with marker AFM262xb5 at locus D2S176, a maximum lod score of 5.05 at a theta(max) =.03 was obtained. In a large NPH family that yielded at D2S176 a maximum lod score of 2.66 at theta(max) =.0, markers AFM172xc3 and AFM016yc5, representing loci D2S135 and D2S110, respectively, were identified as flanking markers, thereby defining the interval for an NPH locus to a region of approximately 15 cM. Furthermore, the cytogenetic assignment of the NPH region was specified to 2p12-(2q13 or adjacent bands) by calculation of linkage between these flanking markers and markers with known unique cytogenetic assignment. The refined map may serve as a genetic framework for additional genetic and physical mapping of the region.	HOP NECKER ENFANTS MALAD,INSERM,U192,PARIS,FRANCE; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	HILDEBRANDT, F (corresponding author), UNIV FREIBURG,CHILDRENS HOSP,MATHILDENSTR 1,D-79106 FREIBURG,GERMANY.		ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; AVASTHI PS, 1976, ANN INTERN MED, V84, P157, DOI 10.7326/0003-4819-84-2-157; BOICHIS H, 1973, Q J MED, V42, P221; COHEN AH, 1986, LAB INVEST, V55, P564; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; GARDNER KD, 1971, ANN INTERN MED, V74, P47, DOI 10.7326/0003-4819-74-1-47; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HILDEBRANDT F, INRPESS COMPUT BIOME; KLEINKNECHT C, 1992, TXB CLIN NEPHROLOGY, P2188; LAFAGE M, 1989, BLOOD, V73, P104; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; MANIATIS T, 1987, MOL CLONING; MURRAY JC, 1993, COOPERATIVE HUM LINK, V1, P1; Ott J., 1991, ANAL HUMAN GENETIC L; POTTER DE, 1980, KIDNEY INT, V18, P103, DOI 10.1038/ki.1980.115; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; SMITH CH, 1945, AM J DIS CHILD, V69, P369; STEEL CM, 1977, NATURE, V270, P729, DOI 10.1038/270729a0; SUKATHME VP, 1985, J EXP MED, V161, P429; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	26	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1993	53	6					1256	1261						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MJ818	8250041				2022-12-18	WOS:A1993MJ81800012
J	GANGOPADHYAY, SB; SHERRATT, TG; HECKMATT, JZ; DUBOWITZ, V; MILLER, G; SHOKEIR, M; RAY, PN; STRONG, PN; WORTON, RG				GANGOPADHYAY, SB; SHERRATT, TG; HECKMATT, JZ; DUBOWITZ, V; MILLER, G; SHOKEIR, M; RAY, PN; STRONG, PN; WORTON, RG			DYSTROPHIN IN FRAMESHIFT DELETION PATIENTS WITH BECKER MUSCULAR-DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; MESSENGER-RNA; MOLECULAR-BASIS; POINT MUTATION; DMD GENE; DUCHENNE; TRANSCRIPTION; BREAKPOINT; TERMINUS	In a previous study we identified 14 cases with Duchenne muscular dystrophy (DMD) or its milder variant, Becker muscular dystrophy (BMD), with a deletion of exons 3-7, a deletion that would be expected to shift the translational reading frame of the mRNA and give a severe phenotype. We have examined dystrophin and its mRNA from muscle biopsies of seven cases with either mild or intermediate phenotypes. In all cases we detected slightly lower-molecular-weight dystrophin in 12%-15% abundance relative to the normal. By sequencing amplified mRNA we have found that exon 2 is spliced to exon 8, a splice that produces a frameshifted mRNA, and have found no evidence for alternative splicing that might be involved in restoration of dystrophin mRNA reading frame in the patients with a mild phenotype. Other transcriptional and posttranscriptional mechanisms such as cryptic promoter, ribosomal frameshifting, and reinitiation are suggested that might play some role in restoring the reading frame.	HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV SASKATCHEWAN HOSP,DEPT PEDIAT,DIV MED GENET,SASKATOON S7N 0W8,SASKATCHEWAN,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,JERRY LEWIS MUSCLE RES CTR,DEPT PEDIAT & NEONATAL MED,LONDON W12 0HS,ENGLAND; UNIV HOSP HERSHEY,PENN STATE COLL MED,DEPT PEDIAT,DIV NEUROL,HERSHEY,PA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Saskatchewan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Imperial College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health								ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BENNE R, 1990, TRENDS GENET, V6, P177, DOI 10.1016/0168-9525(90)90173-4; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BULMAN DE, 1991, AM J HUM GENET, V48, P295; CATTANEO R, 1989, TRENDS BIOCHEM SCI, V14, P165, DOI 10.1016/0968-0004(89)90266-1; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHEN SH, 1990, J BIOL CHEM, V265, P6811; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; DAUBAS P, 1985, NUCLEIC ACIDS RES, V13, P4623, DOI 10.1093/nar/13.13.4623; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; DUBOWITZ V, 1989, J CHILD NEUROL, V4, P240, DOI 10.1177/088307388900400402; EMERY AEH, 1987, OXFORD MONOGRAPHS ME; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MUNTONI F, 1989, FEBS LETT, V252, P95, DOI 10.1016/0014-5793(89)80896-8; PATEL K, 1988, J NEUROL SCI, V87, P315, DOI 10.1016/0022-510X(88)90256-0; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; THOMPSON MW, 1986, J MED GENET, V23, P548, DOI 10.1136/jmg.23.6.548; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WORTON RG, 1988, ANNU REV GENET, V22, P611; ZUBRZYCKAGAARN EE, 1991, EXP CELL RES, V192, P278, DOI 10.1016/0014-4827(91)90187-Y; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0; [No title captured]	34	60	64	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					562	570						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496988				2022-12-18	WOS:A1992JJ82800013
J	HARADA, N; OGAWA, H; SHOZU, M; YAMADA, K				HARADA, N; OGAWA, H; SHOZU, M; YAMADA, K			GENETIC-STUDIES TO CHARACTERIZE THE ORIGIN OF THE MUTATION IN PLACENTAL AROMATASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANDROSTENEDIONE; SEQUENCES; DNA; AROMATIZATION; TISSUE	Placental aromatase deficiency has recently been shown to be due to expression of RNA transcripts encoding abnormal aromatase molecules with 29 extra amino acids. To establish whether this aromatase deficiency is a hereditary or sporadic disease, we examined the genetic defect of the aromatase gene in the family of a patient. Direct sequencing of fragments of the aromatase gene prepared by PCR revealed that the splicing donor sequence (GT) of intron 6 in controls was mutated to GC in the patient, whereas the parents showed signals of both GT and GC. Subcloning of PCR products of the parents gave two different types of clones with GT and GC sequences in this site. Furthermore, for diagnosis of this deficiency, competitive-oligonucleotide-priming PCR of genomic DNA was performed in the presence of both normal and mutational oligonucleotide primers labeled with two kinds of fluorescent dyes, and the products were separated by agarose gel electrophoresis and were detected fluorometrically in the gel. Genomic DNA of the patient gave a PCR product primed only by the mutational primer, whereas that of controls gave a product primed only by the normal primer. The PCR products of the parents were primed by both primers. The results obtained by this fluorometric method were also confirmed by differential hybridizations with specific oligonucleotide probes. Thus these findings indicate that this deficiency is an autosomal hereditary disease and that the patient is a homozygote, while the parents are heterozygotes, for this mutation.	KANAZAWA UNIV,SCH MED,DEPT OBSTET & GYNECOL,KANAZAWA,ISHIKAWA 920,JAPAN	Kanazawa University	HARADA, N (corresponding author), FUJITA HLTH UNIV,INST COMPREHENS MED SCI,DIV MOLEC GENET,TOYOAKE,AICHI 47011,JAPAN.							CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; GIBBS RA, 1989, NUCLEIC ACIDS RES, V17, P2437, DOI 10.1093/nar/17.7.2437; HARADA N, 1992, J BIOL CHEM, V267, P4781; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; KEENAN BS, 1974, J CLIN ENDOCR METAB, V38, P1143, DOI 10.1210/jcem-38-6-1143; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; LONCOPE C, 1978, J CLIN ENDOCR METAB, V46, P146; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; MANGO D, 1978, EUR J OBSTET GYN R B, V8, P65, DOI 10.1016/0028-2243(78)90129-6; Maniatis T., 1982, MOL CLONING; MENDELSON CR, 1982, ENDOCRINOLOGY, V111, P1077, DOI 10.1210/endo-111-4-1077; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAFTOLIN F, 1972, ENDOCRINOLOGY, V90, P295, DOI 10.1210/endo-90-1-295; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; RYAN KJ, 1972, AM J OBSTET GYNECOL, V114, P454, DOI 10.1016/0002-9378(72)90204-9; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SCHINDLER AE, 1972, J CLIN ENDOCR METAB, V35, P627, DOI 10.1210/jcem-35-4-627; SCHWEIKERT HU, 1975, J CLIN ENDOCR METAB, V40, P413, DOI 10.1210/jcem-40-3-413; SHOZU M, 1991, J CLIN ENDOCR METAB, V72, P560, DOI 10.1210/jcem-72-3-560; SIITERI PK, 1976, J STEROID BIOCHEM, V7, P897, DOI 10.1016/0022-4731(76)90008-X; SMUK M, 1977, J CLIN ENDOCR METAB, V45, P1006; TAKANOYAMAMOTO T, 1990, P NATL ACAD SCI USA, V87, P2172, DOI 10.1073/pnas.87.6.2172	23	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					666	672						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496995				2022-12-18	WOS:A1992JJ82800024
J	TOMATSU, S; FUKUDA, S; SUKEGAWA, K; IKEDO, Y; YAMADA, S; YAMADA, Y; SASAKI, T; OKAMOTO, H; KUWAHARA, T; YAMAGUCHI, S; KIMAN, T; SHINTAKU, H; ISSHIKI, G; ORII, T				TOMATSU, S; FUKUDA, S; SUKEGAWA, K; IKEDO, Y; YAMADA, S; YAMADA, Y; SASAKI, T; OKAMOTO, H; KUWAHARA, T; YAMAGUCHI, S; KIMAN, T; SHINTAKU, H; ISSHIKI, G; ORII, T			MUCOPOLYSACCHARIDOSIS TYPE-VII - CHARACTERIZATION OF MUTATIONS AND MOLECULAR HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLUCURONIDASE; CDNA	We identified two different exonic point mutations causing beta-glucuronidase (beta-Gl) deficiency in two Japanese patients with mucopolysaccharidosis type VII (MPSVII). Enzyme assay of lysates of the lymphocytes and cultured fibroblasts showed little residual activity. The beta-Gl-specific mRNA levels were normal, as determined by northern blot analysis. Mutated cDNA clones, including the entire coding sequence, were isolated using the polymerase chain reaction (PCR) products derived from beta-Gl-deficient fibroblasts. Sequence analysis of the full-length mutated cDNAs showed C-->T transitions, which resulted in a single Ala 619--> Val change (case 1, a 24-year-old male) and a Arg382-->Cys change (case 2, a 7-year-old female). The former change was revealed by a loss of the cleavage site for the Fnu4HI in the mutated cDNA. On the basis of the loss of Fnu4HI restriction site, the patient (case 1) was a homozygote with this mutation. The mutational change in patient 2 was confirmed by direct sequencing and by demonstrating heterozygosity for the mutation in her parents. The Ala619-->Val and Arg382-->Cys mutations each disrupt a different domain which is highly conserved among human, rat, and Escherichia coli beta-Gls. Each of these two amino acid changes reduced the beta-Gl activity of the corresponding mutant beta-Gl expressed following transfection of COS cells with expression vectors harboring the mutated cDNAs.	KORIYAMA RYOIKUEN,KORIYAMA,JAPAN; OSAKA CITY UNIV,SCH MED,DEPT PEDIAT,OSAKA 545,JAPAN	Osaka Metropolitan University	TOMATSU, S (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,40 TSUKASA MACHI,GIFU 500,JAPAN.		Shintaku, Haruo/AAP-1196-2020					BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; GALLAGHER P M, 1988, Genomics, V2, P215, DOI 10.1016/0888-7543(88)90005-5; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; NISHIMURA Y, 1986, P NATL ACAD SCI USA, V83, P7292, DOI 10.1073/pnas.83.19.7292; OSHIMA A, 1987, P NATL ACAD SCI USA, V84, P685, DOI 10.1073/pnas.84.3.685; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SUKEGAWA K, 1985, J INHERIT METAB DIS, V8, P145, DOI 10.1007/BF01819300; TOMATSU S, 1990, GENE, V89, P283, DOI 10.1016/0378-1119(90)90019-N	10	60	63	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					89	96						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1702266				2022-12-18	WOS:A1991ET18800012
J	PARADIS, K; WEBER, A; SEIDMAN, EG; LAROCHELLE, J; GAREL, L; LENAERTS, C; ROY, CC				PARADIS, K; WEBER, A; SEIDMAN, EG; LAROCHELLE, J; GAREL, L; LENAERTS, C; ROY, CC			LIVER-TRANSPLANTATION FOR HEREDITARY TYROSINEMIA - THE QUEBEC EXPERIENCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP ST JUSTINE, DEPT RADIOL, MONTREAL H3T 1C5, QUEBEC, CANADA; HOP CHICOUTIMI, CHICOUTIMI, QUEBEC, CANADA; CHU AMIENS, F-80000 AMIENS, FRANCE	Universite de Montreal; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	PARADIS, K (corresponding author), HOP ST JUSTINE, DEPT PEDIAT, DIV GASTROENTEROL & NUTR, LIVER TRANSPLANT PROGRAM, GASTROENTEROL UNIT, MONTREAL H3T 1C5, QUEBEC, CANADA.							DAY DL, 1987, AM J ROENTGENOL, V149, P391, DOI 10.2214/ajr.149.2.391; DEBRAEKELEER M, 1989, MAY TYR UPD S; ESQUIVEL CO, 1988, GASTROENTEROL CLIN N, V17, P167; HODSON EM, 1983, J PEDIATR-US, V103, P735, DOI 10.1016/S0022-3476(83)80467-3; LAROCHELLE J, 1967, CAN MED ASSOC J, V97, P1051; LEUNISSEN KML, 1989, TRANSPLANTATION, V48, P590; MARGREITER R, 1988, TRANSPLANT P, V20, P522; MCDIARMID SV, 1989, TRANSPLANTATION, V47, P314, DOI 10.1097/00007890-198902000-00025; MCMAHON B, 1986, NOV AASLD PROGR COUR; MITCHELL G, 1990, NEW ENGL J MED, V322, P432, DOI 10.1056/NEJM199002153220704; RUSSO P, 1990, AM J HUM GENET, V47; STARZL TE, 1985, J PEDIATR-US, V106, P604, DOI 10.1016/S0022-3476(85)80081-0; TUCHMAN M, 1985, J INHERIT METAB DIS, V8, P21, DOI 10.1007/BF01805479; TUCHMAN M, 1987, J PEDIATR, V110, P339; VANSPRONSEN FJ, 1989, J INHERIT METAB DIS, V12, P339, DOI 10.1007/BF03335416; WEINBERG AG, 1976, J PEDIATR-US, V88, P434, DOI 10.1016/S0022-3476(76)80259-4	16	60	61	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					338	342						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378360				2022-12-18	WOS:A1990DT87100021
J	GESSLER, M; THOMAS, GH; COUILLIN, P; JUNIEN, C; MCGILLIVRAY, BC; HAYDEN, M; JASCHEK, G; BRUNS, GAP				GESSLER, M; THOMAS, GH; COUILLIN, P; JUNIEN, C; MCGILLIVRAY, BC; HAYDEN, M; JASCHEK, G; BRUNS, GAP			A DELETION MAP OF THE WAGR REGION ON CHROMOSOME-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; INSERM,F-75005 PARIS,FRANCE; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; KENNEDY INST,BALTIMORE,MD	Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University; University of British Columbia	GESSLER, M (corresponding author), CHILDRENS HOSP MED CTR,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115, USA.		Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Gessler, Manfred/0000-0002-7915-6045	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034988] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 24061] Funding Source: Medline; NIGMS NIH HHS [GM 34988] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; BRUNS G A P, 1984, American Journal of Human Genetics, V36, p25S; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; BRUNS GAP, 1987, CYTOGENET CELL GENET, V46, P588; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COMPTON D A, 1987, American Journal of Human Genetics, V41, pA162; COUILLIN P, UNPUB CHARACTERIZATI; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DEMARTINVILLE B, 1983, NATURE, V305, P641, DOI 10.1038/305641a0; DOUGLASS EC, 1985, CANCER GENET CYTOGEN, V14, P331, DOI 10.1016/0165-4608(85)90199-2; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERRELL RE, 1981, CYTOGENET CELL GENET, V31, P120, DOI 10.1159/000131636; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRISCHAUF AM, 1987, METHOD ENZYMOL, V153, P103; GESSLER M, 1988, GENOMICS, V3, P17; GESSLER M, UNPUB PHYSICAL MAP W; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HOUSMAN DE, 1985, CYTOGENET CELL GENET, V40, P655; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; JUNIEN C, 1983, CANCER GENET CYTOGEN, V7, P51; KANEKO Y, 1981, CANCER RES, V41, P4577; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; MOORE JW, 1986, HUM GENET, V72, P297, DOI 10.1007/BF00290952; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; ROGLER CE, 1985, SCIENCE, V230, P319, DOI 10.1126/science.2996131; RUSSELL L J, 1986, American Journal of Human Genetics, V39, pA78; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SHANNON RS, 1982, ARCH DIS CHILD, V57, P685, DOI 10.1136/adc.57.9.685; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; TURLEAU C, 1984, HUM GENET, V67, P455, DOI 10.1007/BF00291410; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205	38	60	60	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					486	495						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2539014				2022-12-18	WOS:A1989T810900007
J	WOO, SLC				WOO, SLC			COLLATION OF RFLP HAPLOTYPES AT THE HUMAN PHENYLALANINE-HYDROXYLASE (PAH) LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	Baylor College of Medicine	WOO, SLC (corresponding author), HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX, USA.							CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1986, LANCET, V1, P229; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; Folling A, 1934, H-S Z PHYSIOL CHEM, V227, P169, DOI 10.1515/bchm2.1934.227.1-4.169; GERVIS GA, 1947, J BIOL CHEM, V169, P651; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1987, J BIOL CHEM, V262, P2228; LEDLEY FD, 1985, SCIENCE, V228, P77, DOI 10.1126/science.3856322; LIDSKY AS, 1985, LANCET, V1, P549; LIDSKY AS, 1985, P NATL ACAD SCI USA, V82, P6221, DOI 10.1073/pnas.82.18.6221; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LIDSKY AS, 1984, AM J HUM GENET, V36, P527; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; ROBSON K, 1983, P NATL ACAD SCI US, V79, P4701; SCRIVER CR, 1980, ANNU REV GENET, V14, P179, DOI 10.1146/annurev.ge.14.120180.001143; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	17	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					781	783						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	2903669				2022-12-18	WOS:A1988Q933600028
J	COMINGS, DE; COMINGS, BG				COMINGS, DE; COMINGS, BG			A CONTROLLED-STUDY OF TOURETTE SYNDROME .2. CONDUCT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											COMINGS, DE (corresponding author), CITY HOPE NATL MED CTR,DEPT MED GENET,1500 E DUARTE RD,DUARTE,CA 91010, USA.							ABOUSALEH MT, 1983, BRIT J PSYCHIAT, V143, P527, DOI 10.1192/bjp.143.5.527; COHEN DJ, 1983, CLIN GUIDE CHILD PSY, P3; COMINGS DE, 1985, AM J HUM GENET, V37, P435; COMINGS DE, 1987, AM J HUM GENET, V41, P761; COMINGS DE, 1987, AM J HUM GENET, V41, P701; COMINGS DE, 1984, J AM ACAD CHILD PSY, V23, P138, DOI 10.1097/00004583-198403000-00004; COMINGS DE, 1984, AM J HUM GENET, V36, P586; GITTELMAN R, 1985, ARCH GEN PSYCHIAT, V42, P937; GOODNICK PJ, 1985, AM J PSYCHIATRY, V142, P759; JAGGER J, 1982, SCHIZOPHR B, V8, P367; Loney J., 1983, PROSPECTIVE STUDIES, P181; MOLDOFSKY H, 1974, J NERV MENT DIS, V159, P282, DOI 10.1097/00005053-197410000-00007; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PRINZ RJ, 1981, J ABNORM CHILD PSYCH, V9, P191, DOI 10.1007/BF00919114; Shapiro A. K., 1978, GILLES TOURETTE SYND; SHAPIRO AK, 1977, AM J PSYCHIAT, V134, P818; STEFL ME, 1984, AM J PUBLIC HEALTH, V74, P1310, DOI 10.2105/AJPH.74.12.1310; STEWART MA, 1981, J CHILD PSYCHOL PSYC, V22, P35, DOI 10.1111/j.1469-7610.1981.tb00529.x; TWITO TJ, 1982, NEUROPSYCHOBIOLOGY, V8, P144, DOI 10.1159/000117890; WILSON RS, 1982, GILLES TOURETTE SYND, P329; 1980, DIAGNOSTIC STATISTIC	21	60	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					742	760						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3479013				2022-12-18	WOS:A1987K936100002
J	BOWCOCK, AM; FARRER, LA; CAVALLISFORZA, LL; HEBERT, JM; KIDD, KK; FRYDMAN, M; BONNETAMIR, B				BOWCOCK, AM; FARRER, LA; CAVALLISFORZA, LL; HEBERT, JM; KIDD, KK; FRYDMAN, M; BONNETAMIR, B			MAPPING THE WILSON DISEASE LOCUS TO A CLUSTER OF LINKED POLYMORPHIC MARKERS ON CHROMOSOME-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06510; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,TEL AVIV,ISRAEL; HASHARON HOSP,DEPT PEDIAT,PETAH TIKVA,ISRAEL; HASHARON HOSP,DEPT BIOCHEM,PETAH TIKVA,ISRAEL	Yale University; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	BOWCOCK, AM (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.		Farrer, Lindsay/AAS-1035-2020	Bowcock, Anne/0000-0001-8691-9090; Farrer, Lindsay/0000-0001-5533-4225	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039239, R01MH039239, T32MH014235] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428] Funding Source: Medline; NIMH NIH HHS [MH39239, 2T32MH14235] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, IN PRESS CYTOGENET C; BUYS CHCM, 1985, CYTOGENET CELL GENET, V40, P597; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COX DW, 1972, AM J HUM GENET, V24, P646; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; FARRER LA, UNPUB PREDICTING GEN; FARRER LA, 1987, IN PRESS AM J HUM GE, V41; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; KRAMER PL, IN PRESS ADV NEUROL; KRAMER PL, 1986, GENET EPIDEMIOL S, V1, P153; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1986, AM J HUM GENET, V39, P425; MEYERS DA, 1986, AM J HUM GENET, V39, P539; OTT J, 1985, ANAL HUMAN GENETIC L; OTT J, 1974, AM J HUM GENET, V26, P773; PAKSTIS AJ, 1986, CYTOGENET CELL GENET, V41, P189, DOI 10.1159/000132226; PASSWELL J, 1977, ISRAEL J MED SCI, V13, P15; SCHEINBERG IH, 1982, LANCET, V1, P1469; Sokal Robert R., 1969, BIOMETRY; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT B, 1986, J MED GENET, V23, P417, DOI 10.1136/jmg.23.5.417; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P411; [No title captured]	31	60	62	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1987	41	1					27	35						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J0581	3474893				2022-12-18	WOS:A1987J058100003
J	BEATY, TH; BOUGHMAN, JA; YANG, P; ASTEMBORSKI, JA; SUZUKI, JB				BEATY, TH; BOUGHMAN, JA; YANG, P; ASTEMBORSKI, JA; SUZUKI, JB			GENETIC-ANALYSIS OF JUVENILE PERIODONTITIS IN FAMILIES ASCERTAINED THROUGH AN AFFECTED PROBAND	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MARYLAND,DIV HUMAN GENET,COLLEGE PK,MD 20742; UNIV MARYLAND,DEPT PERIODONT,COLLEGE PK,MD 20742	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	BEATY, TH (corresponding author), JOHNS HOPKINS UNIV,DEPT EPIDEMIOL,615 N WOLFE ST,BALTIMORE,MD 21205, USA.		Suzuki, Jon B./AAQ-9581-2020		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE007274] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE07274, DE07204] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BAER PN, 1974, PERIODONTAL DISEASE, P139; BEATY TH, 1986, AM J MED GENET, V24, P493, DOI 10.1002/ajmg.1320240312; CANNINGS C, 1977, CLIN GENET, V12, P208; CIANCIOLA LJ, 1977, NATURE, V265, P445, DOI 10.1038/265445a0; HASSTEDT SJ, 1981, 13 U UT DEP HUM GEN; LONG JC, 1986, IN PRESS GENET EPIDE; MELNICK M, 1976, ORAL SURG ORAL MED O, V42, P32, DOI 10.1016/0030-4220(76)90029-3; SAXEN L, 1984, CLIN GENET, V25, P332; SAXEN L, 1980, J CLIN PERIODONTOL, V7, P276, DOI 10.1111/j.1600-051X.1980.tb01970.x; SCHLOSSMAN M, 1986, J DENT RES, V65, P294; SLOTS J, 1982, J PERIODONTAL RES, V17, P447, DOI 10.1111/j.1600-0765.1982.tb02022.x; SUZUKI JB, 1984, J PERIODONTOL, V55, P461, DOI 10.1902/jop.1984.55.8.461; THOMPSON EA, 1981, BIOMETRICS, V37, P313, DOI 10.2307/2530420; VANDESTEEN GE, 1984, J PERIODONTOL, V55, P159, DOI 10.1902/jop.1984.55.3.159; VANDYKE TE, 1985, J PERIODONTAL RES, V20, P503; VINCENT JW, 1985, J PERIODONTOL, V56, P464, DOI 10.1902/jop.1985.56.8.464	16	60	62	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1987	40	5					443	452						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H5759	3578282				2022-12-18	WOS:A1987H575900006
J	FABBRO, D; DESNICK, RJ; GRABOWSKI, GA				FABBRO, D; DESNICK, RJ; GRABOWSKI, GA			GAUCHER DISEASE - GENETIC-HETEROGENEITY WITHIN AND AMONG THE SUBTYPES DETECTED BY IMMUNOBLOTTING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED GENET,5TH AVE 100TH ST,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K04DK001351, R01DK036729] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [K04 DK01351, R01-DK 36729] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 1984, P NATL ACAD SCI-BIOL, V81, P6506, DOI 10.1073/pnas.81.20.6506; BEUTLER E, 1985, AM J HUM GENET, V37, P1062; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRINN L, 1962, N Y State J Med, V62, P2346; CHAN SK, 1972, NATURE, V255, P240; CHOY FYM, 1984, HUM GENET, V67, P432, DOI 10.1007/BF00291405; DANIELS LB, 1982, CLIN CHEM, V28, P569; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; ERIKSON AH, 1985, J BIOL CHEM, V260, P14319; FABBRO D, UNPUB HUMAN ACID BET; Frederickson DS, 1972, METABOLIC BASIS INHE, P730; Fried K, 1958, B RES COUNCIL ISR B, V7B, P213; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GINNS EI, 1983, CLIN CHIM ACTA, V131, P283, DOI 10.1016/0009-8981(83)90097-9; GLEW RH, 1982, J NEUROPATH EXP NEUR, V41, P630, DOI 10.1097/00005072-198211000-00006; GRABOWSKI GA, 1984, ARCH BIOCHEM BIOPHYS, V231, P144, DOI 10.1016/0003-9861(84)90371-0; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; GRABOWSKI GA, 1986, IN PRESS ENZYMES LIP; GRAVES P, IN PRESS AM J HUM GE; HODSON P, 1979, ARCH DIS CHILD, V54, P707, DOI 10.1136/adc.54.9.707; Institute of Gaucher Disease, 2020, EP GAUCH DIS; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALONEY AFJ, 1960, J NEUROL NEUROSUR PS, V23, P207, DOI 10.1136/jnnp.23.3.207; MEDOFF AS, 1954, ANN INTERN MED, V40, P481, DOI 10.7326/0003-4819-40-3-481; OSIECKINEWMAN KM, 1986, ENZYME, V35, P147, DOI 10.1159/000469336; Parkin J, 1982, GAUCHER DISEASE CENT, P151; PATRICK DA, 1965, BIOCHEM J, V97, pC17; PENTCHEV PG, 1983, AM J HUM GENET, V35, P621; PIRRUCCELLO S, 1984, BIOCHEM MED METAB B, V31, P73, DOI 10.1016/0006-2944(84)90061-9; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJI S, 1986, J BIOL CHEM, V261, P50; Wenger D A, 1982, Prog Clin Biol Res, V95, P551	38	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1987	40	1					15	31						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G0618	3812484				2022-12-18	WOS:A1987G061800002
J	SMOUSE, PE; CHAKRABORTY, R				SMOUSE, PE; CHAKRABORTY, R			THE USE OF RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN PATERNITY ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,DIV BIOL SCI,ANN ARBOR,MI 48109; UNIV TEXAS,HLTH SCI CTR,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77225	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston	SMOUSE, PE (corresponding author), UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.				NIGMS NIH HHS [R01-GM-20293] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020293] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIRD M, 1984, American Journal of Human Genetics, V36, p161S; BALAZS I, 1984, American Journal of Human Genetics, V36, p161S; BAUR M P, 1985, Genetic Epidemiology, V2, P201, DOI 10.1002/gepi.1370020213; BAUR MP, 1976, Z IMMUNITATSFORSCH, V152, P209, DOI 10.1016/S0340-904X(76)80014-0; BECHHANSEN NT, 1983, P NATL ACAD SCI-BIOL, V80, P6952, DOI 10.1073/pnas.80.22.6952; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHAKRABO.R, 1974, AM J HUM GENET, V26, P477; CHAKRABORTY R, 1983, HUM HERED, V33, P13, DOI 10.1159/000153341; CHAKRABORTY R, 1982, FORENSIC SCI INT, V19, P113, DOI 10.1016/0379-0738(82)90038-X; CHAKRABORTY R, 1981, HUM HERED, V31, P363, DOI 10.1159/000153239; CHAKRAVARTI A, 1982, AM J HUM GENET, V34, P531; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHAKRAVARTI A, 1985, AM J HUM GENET, V37, P984; CHAKRAVARTI A, 1983, INCLUSION PROBABILIT, P411; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; FERRELL RE, 1983, ADV FAMILY LAW COURS, pR1; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LAMM LU, 1983, INCLUSION PROBABILIT, P381; MAYR WR, 1975, Z IMMUNITATSFORSCH, V150, P447; MAYR WR, 1972, Z IMMUNITATSFORSCH, V144, P18; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; MILLER WV, 1978, PATERNITY TESTING, P55; MOHRENWEISER HW, 1983, ISOZYMES-CURR T BIOL, V10, P51; MOHRENWEISER HW, 1983, UTILIZATION MAMMALIA, P55; MORGAN K, 1980, AM J HUM GENET, V32, P246; MORRIS JW, 1983, INCLUSION PROBABILIT, P267; MURRAY JC, 1984, P NATL ACAD SCI-BIOL, V81, P3486, DOI 10.1073/pnas.81.11.3486; NEEL IV, 1978, AM J HUM GENET, V41, P429; NEEL J V, 1971, Perspectives in Biology and Medicine, V14, P522; Neel JV, 1954, HUMAN HEREDITY; NEEL JV, 1983, UTILIZATION MAMMALIA, P71; NEEL JV, 1979, GENETIC DAMAGE MAN C, P29; NEI M, 1979, JPN J HUM GENET, V24, P131, DOI 10.1007/BF01888684; NEI M, 1977, 41ST P SESS INT STAT, P698; ROTHMAN ED, 1981, AM J HUM GENET, V33, P617; SALMON D, 1980, TRANSFUSION, V20, P684, DOI 10.1046/j.1537-2995.1980.20681057158.x; SCHUTZMAN F, 1983, INCLUSION PROBABILIT, P6; SELVIN S, 1980, American Journal of Human Genetics, V32, P276; SELVIN S, 1983, INCLUSION PROBABILIT, P77; SMOUSE PE, 1983, INCLUSION PROBABILIT, P397; WALKER RH, 1983, INCLUSION PROBABILIT, P25; Wiener AS, 1930, J IMMUNOL, V19, P259; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	45	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					918	939						22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014872				2022-12-18	WOS:A1986D392200015
J	BRANDRIFF, B; GORDON, L; ASHWORTH, LK; LITTMAN, V; WATCHMAKER, G; CARRANO, AV				BRANDRIFF, B; GORDON, L; ASHWORTH, LK; LITTMAN, V; WATCHMAKER, G; CARRANO, AV			CYTOGENETICS OF HUMAN-SPERM - MEIOTIC SEGREGATION IN 2 TRANSLOCATION CARRIERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	BRANDRIFF, B (corresponding author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,POB 5507 L-452,LIVERMORE,CA 94550, USA.							BALKAN W, 1983, HUM GENET, V63, P345, DOI 10.1007/BF00274760; BALKAN W, 1983, AM J MED GENET, V16, P169, DOI 10.1002/ajmg.1320160206; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; BRANDRIFF B, 1985, GAMETE RES, V11, P253, DOI 10.1002/mrd.1120110304; de Grouchy J., 1984, CLIN ATLAS HUMAN CHR; FORD CE, 1969, BRIT MED BULL, V25, P110, DOI 10.1093/oxfordjournals.bmb.a070659; GRELL RF, 1964, SCIENCE, V145, P66, DOI 10.1126/science.145.3627.66; JALBERT P, 1980, HUM GENET, V55, P209, DOI 10.1007/BF00291769; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; LIMADEFARIA A, 1983, MOL EVOLUTION ORG CH, P641; LINDENBAUM RH, 1975, J MED GENET, V12, P29, DOI 10.1136/jmg.12.1.29; MARTIN RH, 1984, CLIN GENET, V25, P357; NERI G, 1983, AM J MED GENET, V16, P535, DOI 10.1002/ajmg.1320160412; OIKAWA K, 1977, ARCH DIS CHILD, V52, P890, DOI 10.1136/adc.52.11.890; PETROSKY DL, 1984, AM J MED GENET, V19, P137, DOI 10.1002/ajmg.1320190115; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SUBRT I, 1980, HUM GENET, V55, P303, DOI 10.1007/BF00290208; WAUBENPENRIS PJJ, 1983, CYTOGENET CELL GENET, V36, P547, DOI 10.1159/000131971; WOLSTENHOLME J, 1983, HUM GENET, V63, P45, DOI 10.1007/BF00285396; YOUNG RS, 1984, CLIN GENET, V25, P522	22	60	61	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					197	208						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3946422				2022-12-18	WOS:A1986A311100008
J	SPRITZ, RA; FORGET, BG				SPRITZ, RA; FORGET, BG			THE THALASSEMIAS - MOLECULAR MECHANISMS OF HUMAN GENETIC-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									UNIV WISCONSIN, DEPT PEDIAT, GENET LAB, MADISON, WI 53706 USA; YALE UNIV, SCH MED, DEPT INTERNAL MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT HUMAN GENET, NEW HAVEN, CT 06510 USA	University of Wisconsin System; University of Wisconsin Madison; Yale University; Yale University	SPRITZ, RA (corresponding author), UNIV WISCONSIN, DEPT MED GENET, MADISON, WI 53706 USA.				NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM019482] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-19482, AM-28598] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUSIN A, 1979, J LAB CLIN MED, V93, P973; ADAMS JG, 1981, P NATL ACAD SCI-BIOL, V78, P469, DOI 10.1073/pnas.78.1.469; ADAMS JG, 1979, J CLIN INVEST, V63, P931, DOI 10.1172/JCI109393; ADAMS JG, 1981, AM J HUM GENET, V33, pA34; ADAMS JG, 1980, CLIN RES, V30, pA499; ALTER BP, 1976, NEW ENGL J MED, V295, P1437, DOI 10.1056/NEJM197612232952601; ANAGNOU N, 1981, BLOOD S, V58, pA52; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BAIRD M, 1981, J CLIN INVEST, V68, P560, DOI 10.1172/JCI110289; BAIRD M, 1981, P NATL ACAD SCI-BIOL, V78, P4218, DOI 10.1073/pnas.78.7.4218; BALSLEY JF, 1982, BLOOD, V59, P828; BANK A, 1980, HEMOGLOBIN, V4, P497, DOI 10.3109/03630268008996230; BARALLE FE, 1980, CELL, V21, P621, DOI 10.1016/0092-8674(80)90425-0; BELHANI M, 1980, HUM GENET, V54, P251, DOI 10.1007/BF00278980; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Benz E J Jr, 1975, Prog Hematol, V9, P107; BENZ EJ, 1981, J CLIN INVEST, V68, P1529, DOI 10.1172/JCI110407; BENZ EJ, 1981, J CLIN INVEST, V68, P118, DOI 10.1172/JCI110226; BENZ EJ, 1978, CELL, V14, P299, DOI 10.1016/0092-8674(78)90116-2; BENZ EJ, 1982, T ASS AM PHYSICIANS; BENZ EJ, 1981, BLOOD S, V58, pA52; BERNARDS R, 1979, GENE, V6, P265, DOI 10.1016/0378-1119(79)90062-3; BERNARDS R, 1980, NUCLEIC ACIDS RES, V8, P1521, DOI 10.1093/nar/8.7.1521; BEUTLER E, 1981, BLOOD, V57, P1132; BOWDEN DK, 1982, BRIT J HAEMATOL, V51, P243, DOI 10.1111/j.1365-2141.1982.tb08481.x; BRADLEY TB, 1975, CLIN RES, V23, pA131; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BRITTENHAM G, 1980, ACTA HAEMATOL-BASEL, V63, P44, DOI 10.1159/000207367; BUNN HF, 1975, P NATL ACAD SCI USA, V72, P3609, DOI 10.1073/pnas.72.9.3609; Bunn HF, 1977, HUMAN HEMOGLOBINS; BURNS AL, 1981, BLOOD, V57, P140; BUSSLINGER M, 1981, CELL, V27, P289, DOI 10.1016/0092-8674(81)90412-8; CATTERALL JF, 1978, NATURE, V275, P510, DOI 10.1038/275510a0; CHANG H, 1974, NEW ENGL J MED, V290, P1067, DOI 10.1056/NEJM197405092901909; CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; CHANG JC, 1981, LANCET, V2, P1127; CHANG JC, 1979, NATURE, V281, P602, DOI 10.1038/281602a0; CIVIDALLI GG, 1976, ISRAEL J MED SCI, V12, P1313; CLEGG JB, 1974, NATURE, V251, P245, DOI 10.1038/251245a0; CLEGG JB, 1971, NATURE, V234, P337, DOI 10.1038/234337a0; COMI P, 1977, EUR J BIOCHEM, V79, P617, DOI 10.1111/j.1432-1033.1977.tb11846.x; CONLEY CL, 1963, BLOOD, V21, P261, DOI 10.1182/blood.V21.3.261.261; CRAIK CS, 1980, P NATL ACAD SCI-BIOL, V77, P1384, DOI 10.1073/pnas.77.3.1384; CRAIK CS, 1981, NATURE, V291, P87, DOI 10.1038/291087a0; DAVIS JR, 1979, AM J HUM GENET, V31, P569; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; DEJONG WW, 1975, AM J HUM GENET, V27, P81; DELSENNO L, 1979, BIOCHEM BIOPH RES CO, V91, P548, DOI 10.1016/0006-291X(79)91557-2; DISEGNI G, 1978, ISRAEL J MED SCI, V14, P1116; DOVER GJ, 1981, SCIENCE, V211, P1441, DOI 10.1126/science.6162200; DOZY AM, 1979, JAMA-J AM MED ASSOC, V241, P1610, DOI 10.1001/jama.241.15.1610; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; DRISCOLL MC, 1981, BLOOD S, V58, pA53; DUNCAN C, 1979, P NATL ACAD SCI USA, V76, P5095, DOI 10.1073/pnas.76.10.5095; EATON WA, 1980, NATURE, V284, P183, DOI 10.1038/284183a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; EMBURY SH, 1979, J CLIN INVEST, V63, P1307, DOI 10.1172/JCI109426; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; ENGELS WR, 1981, P NATL ACAD SCI-BIOL, V78, P6329, DOI 10.1073/pnas.78.10.6329; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; FAIRWEATHER DVI, 1978, BRIT MED J, V1, P350, DOI 10.1136/bmj.1.6109.350; FELBER BK, 1982, CELL, V29, P895, DOI 10.1016/0092-8674(82)90451-2; FELDENZER J, 1979, J CLIN INVEST, V64, P751, DOI 10.1172/JCI109519; FESSAS P, 1962, NATURE, V195, P1215, DOI 10.1038/1951215a0; FITCH WM, 1974, ANN NY ACAD SCI, V241, P439, DOI 10.1111/j.1749-6632.1974.tb21900.x; FLATZ G, 1967, HUMANGENETIK, V3, P189, DOI 10.1007/BF00273124; FLATZ G, 1971, LANCET, V1, P732; FLAVELL RA, 1978, CELL, V15, P25, DOI 10.1016/0092-8674(78)90080-6; FLAVELL RA, 1979, NUCLEIC ACIDS RES, V6, P2749, DOI 10.1093/nar/6.8.2749; FOLDI J, 1980, EUR J BIOCHEM, V109, P463, DOI 10.1111/j.1432-1033.1980.tb04816.x; FORGET BG, 1975, P NATL ACAD SCI USA, V72, P3614, DOI 10.1073/pnas.72.9.3614; FORGET BG, 1974, NATURE, V247, P379, DOI 10.1038/247379a0; FORGET BG, 1976, CELL, V7, P323, DOI 10.1016/0092-8674(76)90161-6; FRIEDMAN S, 1976, NATURE, V259, P138, DOI 10.1038/259138a0; FRITSCH EF, 1979, NATURE, V279, P598, DOI 10.1038/279598a0; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; FUKUMAKI Y, 1982, CELL, V28, P585, DOI 10.1016/0092-8674(82)90213-6; GEEVER RF, 1981, P NATL ACAD SCI-BIOL, V78, P5081, DOI 10.1073/pnas.78.8.5081; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GILL F, 1972, SCIENCE, V178, P623, DOI 10.1126/science.178.4061.623; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; GOOSSENS M, 1982, NATURE, V296, P864, DOI 10.1038/296864a0; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; GORSKI J, 1982, J MOL BIOL, V154, P537, DOI 10.1016/S0022-2836(82)80012-0; GROSVELD GC, 1982, NATURE, V295, P120, DOI 10.1038/295120a0; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HAGENBUCHLE O, 1978, CELL, V13, P551, DOI 10.1016/0092-8674(78)90328-8; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HIGGS DR, 1981, P NATL ACAD SCI-BIOL, V78, P5833, DOI 10.1073/pnas.78.9.5833; HIGGS DR, 1979, LANCET, V2, P272; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; HIGGS DR, 1980, BRIT J HAEMATOL, V46, P387, DOI 10.1111/j.1365-2141.1980.tb05985.x; HIGGS DR, 1980, JOHNS HOPKINS MED J, V146, P300; HIGGS DR, 1979, J MED GENET, V16, P288, DOI 10.1136/jmg.16.4.288; HOBBINS JC, 1975, LANCET, V2, P107; HOBBINS JC, 1974, NEW ENGL J MED, V290, P1065, DOI 10.1056/NEJM197405092901908; HONIG GR, 1978, P NATL ACAD SCI USA, V75, P1475, DOI 10.1073/pnas.75.3.1475; HONIG GR, 1981, BLOOD, V57, P705; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; HOUSMAN D, 1973, P NATL ACAD SCI USA, V70, P1809, DOI 10.1073/pnas.70.6.1809; HUISMAN THJ, 1975, AM J HUM GENET, V27, P765; HUISMAN THJ, 1974, P NATL ACAD SCI USA, V71, P3270, DOI 10.1073/pnas.71.8.3270; HUISMAN THJ, 1974, ANN NY ACAD SCI, V232, P107, DOI 10.1111/j.1749-6632.1974.tb20576.x; HUISMAN THJ, 1972, ARCH BIOCHEM BIOPHYS, V153, P850, DOI 10.1016/0003-9861(72)90408-0; HUISMAN THJ, 1976, AM J HUM GENET, V28, P363; HUISMAN THJ, 1977, NATURE, V265, P63, DOI 10.1038/265063a0; HUISMAN THJ, 1981, BLOOD, V58, P491; HUMPHRIES RK, 1982, BLOOD, V60, pA54; HYLDIGNIELSEN JJ, 1982, NUCLEIC ACIDS RES, V10, P689, DOI 10.1093/nar/10.2.689; JAGADEESWARAN P, 1982, NATURE, V296, P469, DOI 10.1038/296469a0; JAGADEESWARAN P, 1982, COLD SPRING HARBOR S; JEFFREYS AJ, 1982, J MOL BIOL, V156, P487, DOI 10.1016/0022-2836(82)90262-5; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JEFFREYS AJ, 1979, NATURE, V281, P606, DOI 10.1038/281606a0; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; JENSEN M, 1978, EUR J PEDIATR, V127, P197, DOI 10.1007/BF00442061; JOHNSON CS, 1981, BLOOD S, V58, pA54; JONES RW, 1982, BRIT J HAEMATOL, V50, P415, DOI 10.1111/j.1365-2141.1982.tb01936.x; JONES RW, 1981, NUCLEIC ACIDS RES, V9, P6813, DOI 10.1093/nar/9.24.6813; JONES RW, 1981, NATURE, V291, P39, DOI 10.1038/291039a0; JUNG A, 1980, P NATL ACAD SCI-BIOL, V77, P5759, DOI 10.1073/pnas.77.10.5759; KACIAN DL, 1973, P NATL ACAD SCI USA, V70, P1886, DOI 10.1073/pnas.70.6.1886; KAN YW, 1979, BLOOD, V54, P1434; KAN YW, 1977, NEW ENGL J MED, V297, P1081, DOI 10.1056/NEJM197711172972002; KAN YW, 1975, NATURE, V255, P255, DOI 10.1038/255255a0; KAN YW, 1978, LANCET, V2, P910; KAN YW, 1977, LANCET, V1, P269; KAN YW, 1976, NEW ENGL J MED, V295, P1165, DOI 10.1056/NEJM197611182952104; KAN YW, 1980, SCIENCE, V209, P388, DOI 10.1126/science.7384810; KAN YW, 1980, NEW ENGL J MED, V302, P185, DOI 10.1056/NEJM198001243020401; KAN YW, 1975, P NATL ACAD SCI USA, V72, P5140, DOI 10.1073/pnas.72.12.5140; KAN YW, 1975, NATURE, V258, P162, DOI 10.1038/258162a0; KAN YW, 1975, NEW ENGL J MED, V292, P1096, DOI 10.1056/NEJM197505222922104; KAN YW, 1974, BRIT J HAEMATOL, V28, P103, DOI 10.1111/j.1365-2141.1974.tb06643.x; KANTOR JA, 1980, CELL, V21, P149, DOI 10.1016/0092-8674(80)90122-1; KATTAMIS C, 1980, BRIT MED J, V281, P268, DOI 10.1136/bmj.281.6235.268; KAZAZIAN HH, 1980, BLOOD, V56, P926; KINNIBURGH AJ, 1982, NUCLEIC ACIDS RES, V10, P5421, DOI 10.1093/nar/10.18.5421; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; LAWN RM, 1980, CELL, V21, P647, DOI 10.1016/0092-8674(80)90428-6; LEBO RV, 1979, P NATL ACAD SCI USA, V76, P5804, DOI 10.1073/pnas.76.11.5804; LEHMANN H, 1975, BRIT J HAEMATOL    S, V31, P119; LEWIN B, 1980, CELL, V22, P324, DOI 10.1016/0092-8674(80)90340-2; LEY TJ, 1982, P NATL ACAD SCI-BIOL, V79, P4775, DOI 10.1073/pnas.79.15.4775; LIEBHABER SA, 1981, J CLIN INVEST, V68, P439, DOI 10.1172/JCI110273; LIEBHABER SA, 1981, NATURE, V290, P26, DOI 10.1038/290026a0; LIEBHABER SA, 1980, P NATL ACAD SCI-BIOL, V77, P7054, DOI 10.1073/pnas.77.12.7054; LIEINJO LE, 1979, BLOOD, V54, P1407; LIEINJO LE, 1981, NUCLEIC ACIDS RES, V9, P3707, DOI 10.1093/nar/9.15.3707; LITTLE PFR, 1980, NATURE, V285, P144, DOI 10.1038/285144a0; MAQUAT LE, 1980, P NATL ACAD SCI-BIOL, V77, P4287, DOI 10.1073/pnas.77.7.4287; MAQUAT LE, 1981, CELL, V27, P543, DOI 10.1016/0092-8674(81)90396-2; MARTIN SL, 1983, J MOL BIOL; MARTIN SL, 1982, J CELL BIOCHEM, V6, P284; MARTINELL J, 1981, P NATL ACAD SCI-BIOL, V78, P5056, DOI 10.1073/pnas.78.8.5056; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; MEARS JG, 1978, P NATL ACAD SCI USA, V75, P1222, DOI 10.1073/pnas.75.3.1222; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; MICHELSON AM, 1980, CELL, V22, P371, DOI 10.1016/0092-8674(80)90347-5; MILNER PF, 1971, LANCET, V1, P729; MOSCHONAS N, 1981, NUCLEIC ACIDS RES, V9, P4391, DOI 10.1093/nar/9.17.4391; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NIENHUIS AW, 1977, P NATL ACAD SCI USA, V74, P3960, DOI 10.1073/pnas.74.9.3960; OHENEFREMPONG K, 1980, BLOOD, V56, P931; OHTA Y, 1980, HEMOGLOBIN, V4, P417, DOI 10.3109/03630268008996222; OHTA Y, 1971, BLOOD, V376, P706; OLD JM, 1982, SCIENCE, V215, P981, DOI 10.1126/science.6186021; OLD JM, 1978, CELL, V14, P289, DOI 10.1016/0092-8674(78)90115-0; ORKIN SH, 1980, NATURE, V286, P538, DOI 10.1038/286538a0; ORKIN SH, 1980, P NATL ACAD SCI-BIOL, V77, P3558, DOI 10.1073/pnas.77.6.3558; ORKIN SH, 1979, P NATL ACAD SCI USA, V76, P2400, DOI 10.1073/pnas.76.5.2400; ORKIN SH, 1979, J CLIN INVEST, V64, P866, DOI 10.1172/JCI109535; ORKIN SH, 1978, P NATL ACAD SCI USA, V75, P5950, DOI 10.1073/pnas.75.12.5950; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; ORKIN SH, 1981, P NATL ACAD SCI-BIOL, V78, P5041, DOI 10.1073/pnas.78.8.5041; ORKIN SH, 1981, J CLIN INVEST, V67, P878, DOI 10.1172/JCI110105; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; ORKIN SH, 1981, CELL, V24, P345, DOI 10.1016/0092-8674(81)90324-X; ORKIN SH, 1981, J BIOL CHEM, V256, P9782; ORKIN SH, 1979, CELL, V17, P33, DOI 10.1016/0092-8674(79)90292-7; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; ORKIN SH, 1978, NEW ENGL J MED, V299, P166, DOI 10.1056/NEJM197807272990403; OTTOLENGHI S, 1982, P NATL ACAD SCI-BIOL, V79, P2347, DOI 10.1073/pnas.79.7.2347; OTTOLENGHI S, 1974, NATURE, V251, P389, DOI 10.1038/251389a0; OTTOLENGHI S, 1979, NATURE, V278, P654, DOI 10.1038/278654a0; OTTOLENGHI S, 1976, CELL, V9, P71, DOI 10.1016/0092-8674(76)90053-2; OTTOLENGHI S, 1975, P NATL ACAD SCI USA, V72, P2294, DOI 10.1073/pnas.72.6.2294; OTTOLENGHI S, 1982, NATURE, V300, P770, DOI 10.1038/300770a0; OTTOLENGHI S, 1977, NATURE, V266, P231, DOI 10.1038/266231a0; OWERBACH D, 1980, NATURE, V286, P82, DOI 10.1038/286082a0; PAGNIER J, 1982, BRIT J HAEMATOL, V52, P115, DOI 10.1111/j.1365-2141.1982.tb03868.x; PAPAYANNOPOULOU T, 1982, BRIT J HAEMATOL, V50, P387, DOI 10.1111/j.1365-2141.1982.tb01934.x; PARKER CS, 1980, CLIN RES, V28, pA488; PERGOLIZZI R, 1981, NUCLEIC ACIDS RES, V9, P7065, DOI 10.1093/nar/9.24.7065; PHILLIPS JA, 1980, BLOOD, V55, P1066; PHILLIPS JA, 1979, BLOOD, V54, P1439; PONCZ M, 1982, J BIOL CHEM, V257, P5994; PRESSLEY L, 1980, NEW ENGL J MED, V303, P1383, DOI 10.1056/NEJM198012113032402; PRESSLEY L, 1980, NUCLEIC ACIDS RES, V8, P4889, DOI 10.1093/nar/8.21.4889; PRESSLEY L, 1980, P NATL ACAD SCI-BIOL, V77, P3586, DOI 10.1073/pnas.77.6.3586; PROUDFOOT NJ, 1980, CELL, V21, P537, DOI 10.1016/0092-8674(80)90491-2; PROUDFOOT NJ, 1980, SCIENCE, V209, P1329, DOI 10.1126/science.6158093; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; PROUDFOOT NJ, 1977, CELL, V11, P807, DOI 10.1016/0092-8674(77)90293-8; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; RAMIREZ F, 1976, NATURE, V263, P471, DOI 10.1038/263471a0; RAMIREZ F, 1978, BLOOD, V52, P735; RAMIREZ F, 1979, J CLIN INVEST, V63, P736, DOI 10.1172/JCI109357; RINGELHANN B, 1970, ACTA HAEMATOL-BASEL, V43, P100, DOI 10.1159/000208719; RITCHEY AK, 1981, BLOOD, V57, P788; ROBERTS AV, 1973, NATURE-NEW BIOL, V245, P23, DOI 10.1038/newbio245023a0; ROBERTS AV, 1972, BIOCHEM BIOPH RES CO, V47, P81, DOI 10.1016/S0006-291X(72)80013-5; SANCAR GB, 1980, JOHNS HOPKINS MED J, V146, P264; SANCAR GB, 1980, P NATL ACAD SCI-BIOL, V77, P6874, DOI 10.1073/pnas.77.11.6874; SANDERSHAIGH L, 1980, NATURE, V283, P683, DOI 10.1038/283683a0; SANGUANSERMSRI T, 1979, HEMOGLOBIN, V3, P161, DOI 10.3109/03630267908998911; SCHILIRO G, 1978, ACTA HAEMATOL-BASEL, V60, P193, DOI 10.1159/000207715; SCOTT AF, 1981, AM J HUM GENET, V33, P129; SEIDAKHAVAN M, 1976, P NATL ACAD SCI USA, V73, P882, DOI 10.1073/pnas.73.3.882; SEIF I, 1979, NUCLEIC ACIDS RES, V6, P3387, DOI 10.1093/nar/6.10.3387; SHEN SH, 1982, NUCLEIC ACIDS RES, V10, P7809, DOI 10.1093/nar/10.23.7809; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SICARD D, 1979, HUM GENET, V50, P327, DOI 10.1007/BF00399399; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; SOPHOCLEOUS T, 1981, BRIT J HAEMATOL, V47, P153, DOI 10.1111/j.1365-2141.1981.tb02770.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE SE, 1982, NUCLEIC ACIDS RES, V10, P1283, DOI 10.1093/nar/10.4.1283; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; SPRITZ RA, 1980, CELL, V21, P639, DOI 10.1016/0092-8674(80)90427-4; SPRITZ RA, 1982, NUCLEIC ACIDS RES, V10, P8025, DOI 10.1093/nar/10.24.8025; SURREY S, 1980, P NATL ACAD SCI-BIOL, V77, P4885, DOI 10.1073/pnas.77.8.4885; SURREY S, 1978, BIOCHEM BIOPH RES CO, V83, P1125, DOI 10.1016/0006-291X(78)91512-7; TABONE P, 1981, ACTA HAEMATOL-BASEL, V65, P26, DOI 10.1159/000207145; TAKESHITA K, 1982, CLIN RES, V30, pA500; TAM JWO, 1981, HEMOGLOBIN, V5, P209, DOI 10.3109/03630268108997545; TAYLOR JM, 1974, NATURE, V251, P392, DOI 10.1038/251392a0; TEMPLE GF, 1977, P NATL ACAD SCI USA, V74, P3047, DOI 10.1073/pnas.74.7.3047; THOMPSON RB, 1966, ACTA HAEMATOL-BASEL, V36, P412, DOI 10.1159/000209421; THOMPSON RB, 1965, ACTA HAEMATOL-BASEL, V33, P186, DOI 10.1159/000209527; THOMPSON RB, 1966, ACTA GENET STAT MED, V16, P340; THOMPSON RB, 1965, ACTA GENET STAT MED, V15, P190; TODD D, 1980, BRIT J HAEMATOL, V46, P557, DOI 10.1111/j.1365-2141.1980.tb06012.x; TOLSTOSHEV P, 1976, NATURE, V259, P95, DOI 10.1038/259095a0; TRAEGER J, 1980, NATURE, V288, P497, DOI 10.1038/288497a0; TRAEGER J, 1982, J CLIN INVEST, V69, P1050, DOI 10.1172/JCI110510; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; TRENT RJ, 1981, NUCLEIC ACIDS RES, V9, P6723, DOI 10.1093/nar/9.24.6723; TUAN D, 1979, NUCLEIC ACIDS RES, V6, P2519, DOI 10.1093/nar/6.7.2519; TUAN D, 1980, NATURE, V285, P335, DOI 10.1038/285335a0; VANDERPLOEG LHT, 1980, NATURE, V283, P637, DOI 10.1038/283637a0; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WEATHERALL DJ, 1978, BRIT J HAEMATOL, V38, P305, DOI 10.1111/j.1365-2141.1978.tb01049.x; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WENT LN, 1979, HEMOGLOBIN, V3, P117, DOI 10.3109/03630267908998908; WESTAWAY D, 1981, NUCLEIC ACIDS RES, V9, P1777, DOI 10.1093/nar/9.8.1777; WHITE JM, 1972, NATURE-NEW BIOL, V235, P208, DOI 10.1038/newbio235208a0; WHITNEY JB, 1981, P NATL ACAD SCI-BIOL, V78, P7644, DOI 10.1073/pnas.78.12.7644; WILLIAMSON R, 1981, LANCET, V2, P1125; WILSON JT, 1982, P NATL ACAD SCI-BIOL, V79, P3628, DOI 10.1073/pnas.79.11.3628; WILSON JT, 1981, BIOCHEM BIOPH RES CO, V99, P1035, DOI 10.1016/0006-291X(81)90722-1; WILSON JT, 1977, NUCLEIC ACIDS RES, V4, P2353, DOI 10.1093/nar/4.7.2353; WOOD WG, 1982, BRIT J HAEMATOL, V50, P401, DOI 10.1111/j.1365-2141.1982.tb01935.x; WOOD WG, 1978, CELL, V15, P437, DOI 10.1016/0092-8674(78)90013-2; WOOD WG, 1977, BRIT J HAEMATOL, V36, P461, DOI 10.1111/j.1365-2141.1977.tb00986.x; WOOD WG, 1976, NATURE, V264, P247, DOI 10.1038/264247a0; YASUKAWA M, 1980, BRIT J HAEMATOL, V46, P199, DOI 10.1111/j.1365-2141.1980.tb05958.x	270	60	61	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					333	361						29	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6407302				2022-12-18	WOS:A1983QS16000001
J	LEPENDU, J; LEMIEUX, RU; LAMBERT, F; DALIX, AM; ORIOL, R				LEPENDU, J; LEMIEUX, RU; LAMBERT, F; DALIX, AM; ORIOL, R			DISTRIBUTION OF H-TYPE-1 AND H-TYPE-2 ANTIGENIC DETERMINANTS IN HUMAN-SERA AND SALIVA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA	University of Alberta	LEPENDU, J (corresponding author), HOP BROUSSAIS,INST IMMUNO BIOL,F-75674 PARIS 14,FRANCE.		Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387				BERSON SA, 1968, CLIN CHIM ACTA, V22, P51, DOI 10.1016/0009-8981(68)90247-7; GRAHAM HA, 1977, HUMAN BLOOD GROUPS, P150; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HAKOMORI SI, 1974, ANTIGENS, V2, P112; HANFLAND P, 1981, ARCH BIOCHEM BIOPHYS, V210, P383, DOI 10.1016/0003-9861(81)90201-0; LEMIEUX RU, 1978, CHEM SOC REV, V7, P423, DOI 10.1039/cs9780700423; LEMIEUX RU, 1981, BIOCHEMISTRY-US, V20, P199, DOI 10.1021/bi00504a033; LEMIEUX RU, 1982, FRONTIERS CHEM; MARCUS DM, 1969, SCIENCE, V164, P553, DOI 10.1126/science.164.3879.553; MAYR WR, 1976, J IMMUNOGENET, V3, P367; MULET C, 1977, FEBS LETT, V84, P74, DOI 10.1016/0014-5793(77)81060-0; ORIOL R, 1980, HUM IMMUNOL, V1, P195, DOI 10.1016/0198-8859(80)90014-2; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1981, AM J HUM GENET, V33, P551; ORIOL R, 1980, TRANSPLANTATION, V29, P184, DOI 10.1097/00007890-198003000-00003; PEREIRA MEA, 1978, ARCH BIOCHEM BIOPHYS, V185, P108, DOI 10.1016/0003-9861(78)90149-2; PICARD J, 1978, J CLIN LAB IMMUNOL, V1, P119; PROHASKA R, 1978, EUR J BIOCHEM, V84, P161, DOI 10.1111/j.1432-1033.1978.tb12152.x; RACHKEWICH RA, 1978, J IMMUNOGENET, V5, P25; RAUVALA H, 1979, FEBS LETT, V97, P1, DOI 10.1016/0014-5793(79)80039-3; RENTON PH, 1962, VOX SANG, V7, P33, DOI 10.1111/j.1423-0410.1962.tb03226.x; ROUGER P, 1980, TRANSFUSION, V20, P536, DOI 10.1046/j.1537-2995.1980.20581034506.x; SHENKELBRUNNER H, 1972, EUR J BIOCH, V30, P269; SNEATH JS, 1955, NATURE, V176, P172, DOI 10.1038/176172a0; TILLEY CA, 1975, VOX SANG, V28, P25, DOI 10.1111/j.1423-0410.1975.tb02737.x; Watkins W M, 1980, Adv Hum Genet, V10, P1; YAZAWA S, 1980, J IMMUNOGENET, V7, P137	27	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					402	415						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	6177241				2022-12-18	WOS:A1982NR13300005
J	LISKER, R; GONZALEZ, B; DALTABUIT, M				LISKER, R; GONZALEZ, B; DALTABUIT, M			RECESSIVE INHERITANCE OF ADULT TYPE OF INTESTINAL LACTASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST NATL NUTR,DEPT GENET,SAN FERNANDO & VIADUCTO TLALPAN,MEXICO CITY 22,MEXICO				Lisker, Ruben/N-3094-2013	Lisker, Ruben/0000-0003-4272-5766				BAYLESS TM, 1968, GASTROENTEROLOGY, V54, P475; BOLIN TD, 1971, GASTROENTEROLOGY, V60, P432; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; FERGUSON A, 1967, LANCET, V2, P188; FLATZ G, 1969, NATURE, V224, P915, DOI 10.1038/224915a0; LISKER R, 1974, AM J CLIN NUTR, V27, P756, DOI 10.1093/ajcn/27.7.756; LISKER R, IN PRESS; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; MORRISON WJ, 1974, RADIOLOGY, V111, P513; SAHI T, 1973, LANCET, V2, P823	10	60	61	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					662	664						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	AR239	1163538				2022-12-18	WOS:A1975AR23900009
J	THELEN, TH; ABRAMS, DJ; FISCH, RO				THELEN, TH; ABRAMS, DJ; FISCH, RO			MULTIPLE ABNORMALITIES DUE TO POSSIBLE GENETIC INACTIVATION IN X AUTOSOME TRANSLOCATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ATKINS L, 1965, ANN HUM GENET, V29, P89, DOI 10.1111/j.1469-1809.1965.tb00503.x; ATKINS L, 1964, HEREDITAS, V51, P67; BAUGHMAN FA, 1968, AM J OBSTET GYNECOL, V102, P1065, DOI 10.1016/0002-9378(68)90393-1; BISHOP AUDREY M., 1966, J MED GENET, V3, P129, DOI 10.1136/jmg.3.2.129; CATTANACH B. M., 1965, Z VERERB, V96, P313, DOI 10.1007/BF00895048; Cenani A, 1969, Arch Kinderheilkd, V178, P266; COHEN MM, 1967, CYTOGENETICS, V6, P254, DOI 10.1159/000129946; ENGEL E, 1965, MEDICINE, V44, P135, DOI 10.1097/00005792-196503000-00002; EVANS HJ, 1965, NATURE, V206, P900, DOI 10.1038/206900a0; FISHER GW, 1965, J MENT DEFIC RES, V9, P39; FRACCARO M, 1966, ANN HUM GENET, V29, P281, DOI 10.1111/j.1469-1809.1966.tb00523.x; GERMAN J, 1967, 3 P INT C HUM GEN, P123; GUSTAVSSON I, 1968, NATURE, V218, P183, DOI 10.1038/218183a0; HSU LYF, 1970, PEDIATRICS, V45, P656; LAFOURCADE J, 1968, Union Medicale du Canada, V97, P936; LIE GW, 1964, CYTOGENETICS, V3, P427, DOI 10.1159/000129831; LINDSTEN J, 1962, LANCET, V1, P593; Lindsten j, 1963, NATURE ORIGIN X CHRO; LONDON DR, 1964, ACTA ENDOCRINOL-COP, V46, P341, DOI 10.1530/acta.0.0460341; LUBS HA, 1969, AM J HUM GENET, V21, P231; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; MILLER OJ, 1963, NATURE, V200, P918, DOI 10.1038/200918a0; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MUKERJEE D, 1966, NATURE, V212, P153, DOI 10.1038/212153a0; MULDAL S, 1963, LANCET, V1, P861; NEUHAUSER G, 1967, HUMANGENETIK, V3, P300; OHNO S., 1962, CYTOGENETICS, V1, P129, DOI 10.1159/000129725; PFEIFFER RA, 1964, NATURE, V204, P804, DOI 10.1038/204804b0; ROWLEY J, 1964, P NATL ACAD SCI USA, V51, P779, DOI 10.1073/pnas.51.5.779; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SCHMID W, 1965, HUMAN CHROMOSOME MET, P91; STEINBERGER EMIL, 1966, J MED GENET, V3, P226, DOI 10.1136/jmg.3.3.226; TAFT PD, 1963, LANCET, V2, P1069	33	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	4					410	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J8113	5097907				2022-12-18	WOS:A1971J811300009
J	PATAU, K; PICKEN, BF; THERMAN, E; SMITH, DW; INHORN, SL				PATAU, K; PICKEN, BF; THERMAN, E; SMITH, DW; INHORN, SL			PARTIAL-TRISOMY SYNDROMES .1. STURGE-WEBERS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BOEOEK JA, 1958, NATURE, V181, P1545; BUCKTON KE, 1961, LANCET, V1, P171; CARTER CO, 1960, LANCET, V2, P678; FRACCARO M, 1960, LANCET, V1, P724; Greenwald HM, 1936, AM J DIS CHILD, V51, P868; GUSTAVSON K, 1961, LANCET, V1, P559; HALL B, 1961, LANCET, V1, P559; HAYWARD MD, 1961, LANCET, V1, P558; HAYWARD MD, 1960, LANCET, V2, P844; LEHMANN O, 1960, LANCET, V2, P1450; MICHAELIS A, 1958, CHROMOSOMA, V9, P514, DOI 10.1007/BF02568091; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; PATAU K, 1961, LANCET, V1, P933; PATAU K, 1960, AM J HUM GENET, V12, P250; PENROSE LS, 1960, LANCET, V2, P409; POLANI PE, 1960, LANCET, V1, P721; THERMAN E, 1961, AM J HUM GENET, V13, P193	17	60	60	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	3					287	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2961A	13733242				2022-12-18	WOS:A19612961A00004
J	UCHIDA, IA; ROWE, RD				UCHIDA, IA; ROWE, RD			DISCORDANT HEART ANOMALIES IN TWINS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALZAMORA V, 1953, PEDIATRICS, V12, P259; ANDERSON RC, 1954, PEDIATRICS, V14, P143; BENESOVA D, 1954, J PATHOL BACTERIOL, V67, P367, DOI 10.1002/path.1700670210; BRODY H, 1950, AM J HUM GENET, V2, P371; CAMPBELL M, 1944, GUYS HOSP GAZ, V58, P228; CLAUSEN F, 1939, Z INDUKT ABSTAMM, V76, P14; DISSMANN E, 1932, FRANKFURT Z PATHOL, V43, P476; DOGRAMACI I, 1947, J PEDIATR, V30, P295, DOI 10.1016/S0022-3476(47)80164-7; FORSYTH CC, 1951, ARCH DIS CHILD, V26, P582, DOI 10.1136/adc.26.130.582; GEBBING M, 1936, DTSCH ARCH KLIN MED, V178, P472; Giustra FX, 1939, AM HEART J, V17, P249, DOI 10.1016/S0002-8703(39)90495-3; GLATZEL H, 1931, Z KLIN MED, V116, P632; GOLDMAN IR, 1952, AM HEART J, V44, P159, DOI 10.1016/0002-8703(52)90185-3; HOLMAN E, 1953, J THORAC SURG, V2, P111; JEUNE M, 1948, ARCH FRANC PEDIAT, V5, P252; Kean BH, 1942, J HERED, V33, P217, DOI 10.1093/oxfordjournals.jhered.a105172; KEMPTON J J, 1953, Proc R Soc Med, V46, P271; LAMY M, 1950, ANN PAEDIAT, V174, P65; MCALEESE JJ, 1952, AM J SURG, V83, P755, DOI 10.1016/0002-9610(52)90177-3; MCCLINTOCK K, 1945, ARCH DIS CHILD, V20, P47, DOI 10.1136/adc.20.101.47; MCKEOWN T, 1953, BRIT HEART J, V15, P273; MORISON JE, 1949, ARCH DIS CHILD, V24, P214, DOI 10.1136/adc.24.119.214; OSTERTAG M, 1936, Z MENSCHL VEREB, V19, P577; PAES ODO, 1956, AM HEART J, V52, P929; POLANI P. E., 1955, ANN HUMAN GENETICS, V19, P209, DOI 10.1111/j.1469-1809.1955.tb01345.x; PORTER WB, 1947, AM J MED SCI, V213, P178; PRICE B, 1950, AM J HUM GENET, V2, P293; RABL R, 1939, ARCH PATH ANAT, V305, P505; RECORD RG, 1953, BRIT HEART J, V15, P376; REITMAN H, 1953, JAMA-J AM MED ASSOC, V153, P1360, DOI 10.1001/jama.1953.02940320056010; ROSSLE R, 1936, VERH DEUT PATH GES, V29, P112; RUTSTEIN DD, 1952, AMA AM J DIS CHILD, V84, P199, DOI 10.1001/archpedi.1952.02050020063007; SCHILLER M, 1936, Z MENSCHL VERERB KON, V20, P284; Smith K S, 1929, Arch Dis Child, V4, P330; STADLER HE, 1956, J PEDIATR-US, V49, P450, DOI 10.1016/S0022-3476(56)80233-3; STARER F, 1953, BRIT MED J, V1, P971, DOI 10.1136/bmj.1.4817.971; STUCKEY D, 1956, BRIT HEART J, V18, P519; Taussig HB., 1947, CONGENITAL MALFORMAT; ULLRICH O., 1938, ZEITSCHR MENSCHL VERERBUNGSL U KONSTITUTIONSL, V21, P585; WADE G, 1952, BRIT HEART J, V14, P475; WEITZ W, 1936, VERERBUNG INNERER KR; WESSON HR, 1935, J TECH METHODS, V14, P86; YOUNG RJ, 1954, ARCH DIS CHILD, V29, P55, DOI 10.1136/adc.29.143.55	43	60	60	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	2					133	140						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA215	13444251				2022-12-18	WOS:A1957WA21500005
J	ITANO, HA				ITANO, HA			QUALITATIVE AND QUANTITATIVE CONTROL OF ADULT HEMOGLOBIN SYNTHESIS - A MULTIPLE ALLELE HYPOTHESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEET EA, 1949, ANN EUGENIC, V14, P279; GOODMAN M, 1952, IN PRESS BLOOD; ITANO HA, 1950, P NATL ACAD SCI USA, V36, P613, DOI 10.1073/pnas.36.11.613; ITANO HA, 1951, P NATL ACAD SCI USA, V37, P775, DOI 10.1073/pnas.37.12.775; ITANO HA, 1953, SCIENCE, V117, P89, DOI 10.1126/science.117.3031.89; KAPLAN E, 1951, BLOOD, V6, P1240, DOI 10.1182/blood.V6.12.1240.1240; LIQUORI AM, 1951, NATURE, V167, P950, DOI 10.1038/167950b0; NEEL JV, 1949, SCIENCE, V110, P64, DOI 10.1126/science.110.2846.64; NEEL JV, 1951, BLOOD, V6, P389, DOI 10.1182/blood.V6.5.389.389; NEEL JV, 1951, J CLIN INVEST, V30, P1120, DOI 10.1172/JCI102532; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; RICH A, 1952, P NATL ACAD SCI USA, V38, P187, DOI 10.1073/pnas.38.3.187; SANSONE G, 1950, Boll Soc Ital Biol Sper, V26, P1343; Sherman IJ, 1940, B JOHNS HOPKINS HOSP, V67, P309; SILVESTRONI E, 1952, BLOOD, V7, P429, DOI 10.1182/blood.V7.4.429.429; SINGER K, 1951, BLOOD, V6, P413, DOI 10.1182/blood.V6.5.413.413; SMITH CH, 1948, AM J DIS CHILD, V75, P505; Stern C, 1943, P NATL ACAD SCI USA, V29, P361, DOI 10.1073/pnas.29.11.361; STURGEON P, 1952, BLOOD, V7, P350, DOI 10.1182/blood.V7.3.350.350; Taliaferro WH, 1923, GENETICS, V8, P594; Valentine WN, 1944, ARCH INTERN MED, V74, P185, DOI 10.1001/archinte.1944.00210210032005; WELLS IC, 1951, J BIOL CHEM, V188, P65	22	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	1					34	45						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW629	13050608				2022-12-18	WOS:A1953XW62900003
J	MCKEOWN, T; MACMAHON, B; RECORD, RG				MCKEOWN, T; MACMAHON, B; RECORD, RG			AN INVESTIGATION OF 69 CASES OF EXOMPHALOS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Gross RE, 1940, SURG GYNECOL OBSTET, V71, P520; Hebert AF, 1928, AM J OBSTET GYNECOL, V15, P86, DOI 10.1016/S0002-9378(15)32688-0; HOLLENBERG HG, 1948, SURGERY, V23, P363; Jarcho J, 1937, SURG GYNECOL OBSTET, V65, P593; MCCRORY WW, 1947, J PEDIATR, V31, P456, DOI 10.1016/S0022-3476(47)80205-7; OLEARY CM, 1941, AM J SURG, V52, P38; Record RG, 1949, BR J SOC MED, V3, P183; SPECHT NW, 1943, SURG GYNECOL OBSTET, V77, P319; Stein JL, 1939, J PEDIATR-US, V14, P89, DOI 10.1016/S0022-3476(39)80122-6; WILLIAMS C, 1946, ANN SURG, V124, P1108, DOI 10.1097/00000658-194612000-00012	10	60	60	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1953	5	2					168	175						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XW630	13065264				2022-12-18	WOS:A1953XW63000006
J	AlDubayan, SH; Giannakis, M; Moore, ND; Han, GC; Reardon, B; Hamada, T; Mu, XJ; Nishihara, R; Qian, ZR; Liu, L; Yurgelun, MB; Syngal, S; Garraway, LA; Ogino, S; Fuchs, CS; Van Allen, EM				AlDubayan, Saud H.; Giannakis, Marios; Moore, Nathanael D.; Han, G. Celine; Reardon, Brendan; Hamada, Tsuyoshi; Mu, Xinmeng Jasmine; Nishihara, Reiko; Qian, Zhirong; Liu, Li; Yurgelun, Matthew B.; Syngal, Sapna; Garraway, Levi A.; Ogino, Shuji; Fuchs, Charles S.; Van Allen, Eliezer M.			Inherited DNA-Repair Defects in Colorectal Cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY GENE-MUTATIONS; METASTATIC PROSTATE-CANCER; NONPOLYPOSIS COLON-CANCER; ATAXIA-TELANGIECTASIA; PREDISPOSITION GENES; PANCREATIC-CANCER; LYNCH SYNDROME; CARRIERS; RISK; ASSOCIATION	Colorectal cancer (CRC) heritability has been estimated to be around 30%. However, mutations in the known CRC-susceptibility genes explain CRC risk in fewer than 10% of affected individuals. Germline mutations in DNA-repair genes (DRGs) have recently been reported in CRC, but their contribution to CRC risk is largely unknown. We evaluated the gene-level germline mutation enrichment of 40 DRGs in 680 unselected CRC individuals and 27,728 ancestry-matched cancer-free adults. Significant findings were then examined in independent cohorts of 1,661 unselected CRC individuals and 1,456 individuals with early-onset CRC. Of the 680 individuals in the discovery set, 31 (4.56%) individuals harbored germline pathogenic mutations in known CRC-susceptibility genes, and another 33 (4.85%) individuals had DRG mutations that have not been previously associated with CRC risk. Germline pathogenic mutations in ATM and PALB2 were enriched in both the discovery (OR = 2.81 and p = 0.035 for ATM and OR = 4.91 and p = 0.024 for PALB2) and validation (OR = 2.97 and adjusted p = 0.0013 for ATM and OR = 3.42 and adjusted p = 0.034 for PALB2) sets. Biallelic loss of ATM was evident in all individuals with matched tumor profiling. CRC individuals also had higher rates of actionable mutations in the HR pathway, which can substantially increase the risk of developing cancers other than CRC. Our analysis provides evidence for ATM and PALB2 as CRC-risk genes, underscoring the importance of the homologous recombination pathway in CRC. In addition, we identified frequent complete homologous recombination deficiency in CRC tumors, representing a unique opportunity to explore targeted therapeutic interventions such as poly-ADP ribose polymerase inhibitor (PARPi).	[AlDubayan, Saud H.; Giannakis, Marios; Moore, Nathanael D.; Han, G. Celine; Reardon, Brendan; Mu, Xinmeng Jasmine; Yurgelun, Matthew B.; Syngal, Sapna; Garraway, Levi A.; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [AlDubayan, Saud H.; Giannakis, Marios; Han, G. Celine; Reardon, Brendan; Hamada, Tsuyoshi; Mu, Xinmeng Jasmine; Nishihara, Reiko; Yurgelun, Matthew B.; Syngal, Sapna; Garraway, Levi A.; Ogino, Shuji; Van Allen, Eliezer M.] Harvard Med Sch, Boston, MA 02215 USA; [AlDubayan, Saud H.; Giannakis, Marios; Moore, Nathanael D.; Han, G. Celine; Reardon, Brendan; Mu, Xinmeng Jasmine; Garraway, Levi A.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [AlDubayan, Saud H.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [AlDubayan, Saud H.] King Saud bin Abdulaziz Univ Hlth Sci, Dept Med, Riyadh, Saudi Arabia; [Moore, Nathanael D.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Moore, Nathanael D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Hamada, Tsuyoshi; Nishihara, Reiko; Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Program Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA; [Hamada, Tsuyoshi; Qian, Zhirong; Liu, Li; Ogino, Shuji] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fuchs, Charles S.] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; King Saud Bin Abdulaziz University for Health Sciences; Indiana University System; Indiana University Bloomington; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Harvard University; Brigham & Women's Hospital	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Van Allen, EM (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	eliezerm_vanallen@dfci.harvard.edu	Giannakis, Marios/Z-4908-2019	Han, Celine/0000-0003-2004-8186; Ogino, Shuji/0000-0002-3909-2323	Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH National Center for Research Resources) [UL1 TR001102]; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard University; Damon Runyon Clinical Investigator Award; Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant [SU2C-AACR-DT22-17]; Project P Fund;  [KL2 TR001100];  [P01 CA87969];  [UM1 CA186107];  [P01 CA55075];  [UM1 CA167552];  [R35 CA197735];  [R01CA169141-04];  [R01CA118553-07];  [K08 CA188615-02]; NATIONAL CANCER INSTITUTE [UM1CA186107, R01CA169141, P01CA055075, R01CA118553, UM1CA167552, R37CA222574, R35CA197735, K08CA188615, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102, KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006492] Funding Source: NIH RePORTER	Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH National Center for Research Resources); Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); Harvard University; Damon Runyon Clinical Investigator Award; Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant; Project P Fund; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank all individuals who participated in this study. Drs. Van Allen, Ogino, Garraway, and Fuchs had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. This work was conducted with support from Harvard Catalyst, the Harvard Clinical and Translational Science Center (award UL1 TR001102 from the NIH National Center for Research Resources and National Center for Advancing Translational Sciences), and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the NIH. This work was also supported by K08 CA188615-02 (E.M.V.); the Damon Runyon Clinical Investigator Award (E.M.V.); KL2 TR001100 (M.G.); R01CA169141-04 (C.S.F.); R01CA118553-07 (C.S.F.); P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, and R35 CA197735 (S.O); the Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research Grant (grant SU2C-AACR-DT22-17 to M.G. and C.S.F.), and the Project P Fund. SU2C is a program of the Entertainment Industry Foundation, and the research grant is administered by the American Association for Cancer Research, a scientific partner of SU2C. N.D.M. is a Howard Hughes Medical Institute Medical Research Fellow. E.M.V.A. is an advisor to Genome Medical and consultant to Invitae. S.S. is a consultant to Myriad Genetics.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Barrett J.C., 2017, BIORXIV; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Ghazani AA, 2017, GENET MED, V19, P787, DOI 10.1038/gim.2016.191; Giannakis M, 2016, CELL REP, V17, P1206, DOI 10.1016/j.celrep.2016.10.009; Goldgar DE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2919; Gray SW, 2016, GENET MED, V18, P1011, DOI 10.1038/gim.2015.207; Guo MQ, 2001, ADV GENET, V42, P459; Helgason H, 2015, NAT GENET, V47, P906, DOI 10.1038/ng.3342; Iqbal J, 2012, BRIT J CANCER, V107, P2005, DOI 10.1038/bjc.2012.483; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Lee ASG, 2014, NEW ENGL J MED, V371, P1650, DOI [10.1056/NEJMc1410673, 10.1056/NEJMc1410673#SA1]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Mersha TB, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-014-0023-x; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; National Comprehensive Cancer Network, 2017, FAM GEN HIGH RISK AS, P96; Olsen JH, 2005, BRIT J CANCER, V93, P260, DOI 10.1038/sj.bjc.6602658; Pearlman R, 2017, JAMA ONCOL, V3, P464, DOI 10.1001/jamaoncol.2016.5194; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Susswein LR, 2016, GENET MED, V18, P823, DOI 10.1038/gim.2015.166; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Os NJH, 2016, CLIN GENET, V90, P105, DOI 10.1111/cge.12710; Wang C, 2017, TRANSL ONCOL, V10, P190, DOI 10.1016/j.tranon.2017.01.007; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Wang M, 2016, CANCER-AM CANCER SOC, V122, P1672, DOI 10.1002/cncr.29950; Yurgelun MB, 2017, J CLIN ONCOL, V35, P1086, DOI 10.1200/JCO.2016.71.0012; Yurgelun MB, 2015, GASTROENTEROLOGY, V149, P604, DOI 10.1053/j.gastro.2015.05.006; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054; Zhen DB, 2015, GENET MED, V17, P569, DOI 10.1038/gim.2014.153	50	59	61	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 1	2018	102	3					401	414		10.1016/j.ajhg.2018.01.018	http://dx.doi.org/10.1016/j.ajhg.2018.01.018			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FX9ZL	29478780	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000426469600012
J	Betts, JA; Marjaneh, MM; Al-Ejeh, F; Lim, YC; Shi, W; Sivakumaran, H; Tropee, R; Patch, AM; Clark, MB; Bartonicek, N; Wiegmans, AP; Hillman, KM; Kaufmann, S; Bain, AL; Gloss, BS; Crawford, J; Kazakoff, S; Wani, S; Wen, SW; Day, B; Moller, A; Cloonan, N; Pearson, J; Brown, MA; Mercer, TR; Waddell, N; Khanna, KK; Dray, E; Dinger, ME; Edwards, SL; French, JD				Betts, Joshua A.; Marjaneh, Mahdi Moradi; Al-Ejeh, Fares; Lim, Yi Chieh; Shi, Wei; Sivakumaran, Haran; Tropee, Romain; Patch, Ann-Marie; Clark, Michael B.; Bartonicek, Nenad; Wiegmans, Adrian P.; Hillman, Kristine M.; Kaufmann, Susanne; Bain, Amanda L.; Gloss, Brian S.; Crawford, Joanna; Kazakoff, Stephen; Wani, Shivangi; Wen, Shu W.; Day, Bryan; Moller, Andreas; Cloonan, Nicole; Pearson, John; Brown, Melissa A.; Mercer, Timothy R.; Waddell, Nicola; Khanna, Kum Kum; Dray, Eloise; Dinger, Marcel E.; Edwards, Stacey L.; French, Juliet D.			Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MUTATIONAL PROCESSES; SUSCEPTIBILITY LOCI; CYCLIN D1; GENE; QUANTIFICATION; STABILITY; VARIANTS	Breast cancer risk is strongly associated with an intergenic region on 11q13. We have previously shown that the strongest risk-associated SNPs fall within a distal enhancer that regulates CCND1. Here, we report that, in addition to regulating CCND1, this enhancer regulates two estrogen-regulated long noncoding RNAs, CUPID1 and CUPID2. We provide evidence that the risk-associated SNPs are associated with reduced chromatin looping between the enhancer and the CUPID1 and CUPID2 bidirectional promoter. We further show that CUPID1 and CUPID2 are predominantly expressed in hormone-receptor-positive breast tumors and play a role in modulating pathway choice for the repair of double-strand breaks. These data reveal a mechanism for the involvement of this region in breast cancer.	[Betts, Joshua A.; Marjaneh, Mahdi Moradi; Al-Ejeh, Fares; Lim, Yi Chieh; Shi, Wei; Sivakumaran, Haran; Patch, Ann-Marie; Wiegmans, Adrian P.; Hillman, Kristine M.; Kaufmann, Susanne; Bain, Amanda L.; Kazakoff, Stephen; Wani, Shivangi; Wen, Shu W.; Day, Bryan; Moller, Andreas; Cloonan, Nicole; Pearson, John; Waddell, Nicola; Khanna, Kum Kum; Edwards, Stacey L.; French, Juliet D.] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld 4006, Australia; [Betts, Joshua A.; Brown, Melissa A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Tropee, Romain; Dray, Eloise] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4102, Australia; [Clark, Michael B.] Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford OX1 2JD, England; [Clark, Michael B.; Bartonicek, Nenad; Gloss, Brian S.; Mercer, Timothy R.; Dinger, Marcel E.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Bartonicek, Nenad; Gloss, Brian S.; Mercer, Timothy R.; Dinger, Marcel E.] Univ New South Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Crawford, Joanna] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Cloonan, Nicole] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Queensland University of Technology (QUT); University of Oxford; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; Queensland University of Technology (QUT)	Edwards, SL; French, JD (corresponding author), QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld 4006, Australia.	stacey.edwards@qimrberghofer.edu.au; juliet.french@qimrberghofer.edu.au	Möller, Andreas/O-1063-2015; Brown, Melissa A/F-1451-2010; Day, Bryan/AAV-6170-2020; Patch, Ann-Marie/C-4201-2018; French, Juliet/AAV-4435-2020; Pearson, John/AAT-4211-2020; Dray, Eloise/AAD-5147-2021; Shi, Wei/AAX-6450-2021; Waddell, Nicola/H-4929-2015; Al-Ejeh, Fares/M-7032-2016; Dinger, Marcel/N-1398-2019; Crawford, Joanna/F-9135-2013; Pearson, John F/D-7428-2012; Mercer, Tim/AAK-5060-2020; Dray, Eloise/E-3938-2012	Möller, Andreas/0000-0002-8618-6998; Patch, Ann-Marie/0000-0001-6121-4019; French, Juliet/0000-0002-9770-0198; Shi, Wei/0000-0002-0378-8361; Waddell, Nicola/0000-0002-3950-2476; Al-Ejeh, Fares/0000-0002-1553-0077; Crawford, Joanna/0000-0003-0786-6889; Pearson, John F/0000-0001-5607-4517; Mercer, Tim/0000-0001-8780-894X; Lim, Yi Chieh/0000-0003-1261-5419; Dray, Eloise/0000-0001-6793-9838; Sivakumaran, Haran/0000-0002-4691-4989; Day, Bryan/0000-0002-8948-9089; Brown, Melissa/0000-0002-2830-9259; Dinger, Marcel/0000-0003-4423-934X; Khanna, Kum Kum/0000-0001-8650-5381; Clark, Michael/0000-0002-2903-9537; Tropee, Romain/0000-0003-1898-1057; Gloss, Brian/0000-0001-7695-4394	National Health and Medical Research Council of Australia (NHMRC) [1021731, 1058421]; Australian National Breast Cancer Foundation; Australian postgraduate scholarship; Australian Research Council [FT130101417]; NHMRC [APP1072662, APP1112113]; EMBO [ALTF 864-2013]; NHMRC; National Breast Cancer Foundation [ECF-12-04] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; Australian postgraduate scholarship(Australian Government); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EMBO(European Molecular Biology Organization (EMBO)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by grants (1021731 and 1058421) from the National Health and Medical Research Council of Australia (NHMRC). J.D.F., S.L.E., and A.P.W. were supported by fellowships from the Australian National Breast Cancer Foundation, J.A.B. was supported by an Australian postgraduate scholarship, F.A.-E. was supported by a Future Fellowship from the Australian Research Council (FT130101417), M.B.C. was supported by an NHMRC Early Career Fellowship (APP1072662) and EMBO Long-Term Fellowship (ALTF 864-2013), N.W. was supported by an NHMRC Career Development Fellowship (APP1112113), and K.K.K. was supported by an NHMRC Senior Principal Research Fellowship. The results published in this study are in part based on data generated by The Cancer Genome Atlas Research Network. The contents of the published material are solely the responsibility of the administering institution, a participating institution, or individual authors and do not reflect the views of the NHMRC.	Al-Ejeh F, 2014, ONCOTARGET, V5, P3145, DOI 10.18632/oncotarget.1865; Al-Ejeh F, 2014, J NUCL MED, V55, P772, DOI 10.2967/jnumed.113.130559; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Clark MB, 2015, NAT METHODS, V12, P339, DOI [10.1038/nmeth.3321, 10.1038/NMETH.3321]; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lim YC, 2014, MOL ONCOL, V8, P1603, DOI 10.1016/j.molonc.2014.06.012; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mercer TR, 2014, NAT PROTOC, V9, P989, DOI 10.1038/nprot.2014.058; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Parplys AC, 2015, NUCLEIC ACIDS RES, V43, P9817, DOI 10.1093/nar/gkv859; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Zhang YY, 2016, NAT STRUCT MOL BIOL, V23, P522, DOI 10.1038/nsmb.3211; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	34	59	59	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					255	266		10.1016/j.ajhg.2017.07.007	http://dx.doi.org/10.1016/j.ajhg.2017.07.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777932	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000406854800009
J	El Khouri, E; Thomas, L; Jeanson, L; Bequignon, E; Vallette, B; Duquesnoy, P; Montantin, G; Copin, B; Moal, FDL; Blanchon, S; Papon, JF; Lores, P; Yuan, L; Collot, N; Tissier, S; Faucon, C; Gacon, G; Patrat, C; Wolf, JP; Dulioust, E; Crestani, B; Escudier, E; Coste, A; Legendre, M; Toure, A; Amselem, S				El Khouri, Elma; Thomas, Lucie; Jeanson, Ludovic; Bequignon, Emilie; Vallette, Benoit; Duquesnoy, Philippe; Montantin, Guy; Copin, Bruno; Moal, Florence Dastot-Le; Blanchon, Sylvain; Papon, Jean Francois; Lores, Patrick; Yuan, Li; Collot, Nathalie; Tissier, Sylvie; Faucon, Catherine; Gacon, Gerard; Patrat, Catherine; Wolf, Jean Philippe; Dulioust, Emmanuel; Crestani, Bruno; Escudier, Estelle; Coste, Andre; Legendre, Marie; Toure, Aminata; Amselem, Serge			Mutations in DNAJB13, Encoding an HSP40 Family Member, Cause Primary Ciliary Dyskinesia and Male Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RADIAL-SPOKE; CENTRAL-COMPLEX; MOLECULAR-CLONING; PROTEIN; CHAPERONE; AXONEME; BINDING; HEAT-SHOCK-PROTEIN-40; SPERMATOZOA; FLAGELLUM	Primary ciliary dyskinesia (PCD) is an autosomal-recessive disease due to functional or ultra-structural defects of motile cilia. Affected individuals display recurrent respiratory-tract infections; most males are infertile as a result of sperm flagellar dysfunction. The great majority of the PCD-associated genes identified so far encode either components of dynein arms (DAs), which are multiprotein-ATPase complexes essential for ciliary motility, or proteins involved in DA assembly. To identify the molecular basis of a PCD phenotype characterized by central complex (CC) defects but normal DA structure, a phenotype found in similar to 15% of cases, we performed whole-exome sequencing in a male individual with PCD and unexplained CC defects. This analysis, combined with whole-genome SNP genotyping, identified a homozygous mutation in DNAJB13 (c.833T>G), a gene encoding a HSP40 co-chaperone whose ortholog in the flagellated alga Chlamydomonas localizes to the radial spokes. In vitro studies showed that this missense substitution (p.Met278Arg), which involves a highly conserved residue of several HSP40 family members, leads to protein instability and triggers proteasomal degradation, a result confirmed by the absence of endogenous DNAJB13 in cilia and sperm from this individual. Subsequent DNAJB13 analyses identified another homozygous mutation in a second family; the study of DNAJB13 transcripts obtained from airway cells showed that this mutation (c.68+1G>C) results in a splicing defect consistent with a loss-of-function mutation. Overall, this study, which establishes mutations in DNAJB13 as a cause of PCD, unveils the key role played by DNAJB13 in the proper formation and function of ciliary and flagellar axonemes in humans.	[El Khouri, Elma; Lores, Patrick; Gacon, Gerard; Toure, Aminata] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [El Khouri, Elma; Lores, Patrick; Gacon, Gerard; Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [El Khouri, Elma; Lores, Patrick; Gacon, Gerard; Wolf, Jean Philippe; Dulioust, Emmanuel; Toure, Aminata] Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France; [Thomas, Lucie; Jeanson, Ludovic; Vallette, Benoit; Duquesnoy, Philippe; Copin, Bruno; Moal, Florence Dastot-Le; Blanchon, Sylvain; Escudier, Estelle; Legendre, Marie; Amselem, Serge] Univ Paris 06, INSERM, UMR S933, F-75012 Paris, France; [Bequignon, Emilie; Papon, Jean Francois; Coste, Andre] Univ Paris Est, CNRS, Fac Med, Equipe 13,INSERM,UMR S955,ERL7240, F-94000 Creteil, France; [Bequignon, Emilie; Coste, Andre] Ctr Hosp Intercommunal Creteil, Serv ORL & Chirurg Cervicofaciale, F-94000 Creteil, France; [Bequignon, Emilie; Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, Assistance Publ Hop Paris, F-94000 Creteil, France; [Montantin, Guy; Copin, Bruno; Moal, Florence Dastot-Le; Collot, Nathalie; Tissier, Sylvie; Escudier, Estelle; Legendre, Marie; Amselem, Serge] Hop Armand Trousseau, Assistance Publ Hop Paris, Serv Genet & Embryol Med, F-75012 Paris, France; [Blanchon, Sylvain] Ctr Hosp Univ, Hop Enfants, Unite Pneumol & Allergol Pediat, F-31300 Toulouse, France; [Papon, Jean Francois] Hop Bicetre, Assistance Publ Hop Paris, Serv Otorhinolaryngol & Chirurg Cervicomaxillofac, F-94275 Le Kremlin Bicetre, France; [Yuan, Li] Univ Chinese Acad Sci, Savaid Sch Med, Beijing 100049, Peoples R China; [Yuan, Li] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Faucon, Catherine] Ctr Hosp Intercommunal Creteil, Serv Anatomopathol, Lab Microscopie Elect, F-94000 Creteil, France; [Patrat, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, Assistance Publ Hop Paris, Serv Biol Reprod,Hop Bichat, F-75018 Paris, France; [Wolf, Jean Philippe; Dulioust, Emmanuel] Grp Hosp Cochin Broca Hotel Dieu, Assistance Publ Hop Paris, Lab Histol Embryol Biol & Reprod, F-75014 Paris, France; [Crestani, Bruno] Hop Bicetre, Assistance Publ Hop Paris, Serv Pneumol A, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Toure, A (corresponding author), Inst Cochin, INSERM, U1016, F-75014 Paris, France.; Toure, A (corresponding author), CNRS, UMR8104, F-75014 Paris, France.; Toure, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, F-75014 Paris, France.	aminata.toure@inserm.fr	BEQUIGNON, Emilie/AAO-3221-2020; Blanchon, Sylvain/AAQ-2013-2020; Legendre, Marie/AAD-7018-2021; TOURE, Aminata/B-3236-2018; El Khouri, Elma/GRN-8601-2022	Blanchon, Sylvain/0000-0003-0284-9705; Legendre, Marie/0000-0003-2178-0846; TOURE, Aminata/0000-0001-5629-849X; COSTE, Andre/0000-0002-8386-3455; Lores, Patrick/0000-0002-3191-9488; THOMAS, Lucie/0000-0001-6998-590X; Papon, Jean Francois/0000-0002-2323-9239; BEQUIGNON, emilie/0000-0002-5193-5776	INSERM; Centre National de la Recherche Scientifique; Universite Paris Descartes; Universite Pierre et Marie Curie; Agence Nationale de la Recherche [MUCOFERTIL 12-BSV1-0011-01, MASFLAGELLA 14-CE15-0002-03]; Fondation pour la Recherche Medicale [DEQ20120323689]; Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Universite Pierre et Marie Curie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation	We thank all the individuals and their family for their cooperation, as well as all the referring physicians. We thank Baptiste Rode for critical reading of the manuscript. This work was supported by INSERM, the Centre National de la Recherche Scientifique, the Universite Paris Descartes, the Universite Pierre et Marie Curie, grants from the Agence Nationale de la Recherche (MUCOFERTIL 12-BSV1-0011-01 and MASFLAGELLA 14-CE15-0002-03), grants from the Fondation pour la Recherche Medicale (DEQ20120323689), the Legs Poix from the Chancellerie des Universites, and the Milena Carvajal ProKartagener Foundation.	AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; BLOCH MA, 1995, J CELL SCI, V108, P3541; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; CURRY AM, 1993, CELL MOTIL CYTOSKEL, V24, P224, DOI 10.1002/cm.970240403; Guan J, 2010, REPROD DOMEST ANIM, V45, P992, DOI 10.1111/j.1439-0531.2009.01473.x; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Jeanson L, 2015, AM J HUM GENET, V97, P153, DOI 10.1016/j.ajhg.2015.05.004; Kistler WS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005368; Knowles MR, 2014, AM J RESP CRIT CARE, V189, P707, DOI 10.1164/rccm.201311-2047OC; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Li WN, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0038-5; Liu G, 2004, ACTA BIOCH BIOPH SIN, V36, P93, DOI 10.1093/abbs/36.2.93; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Papon JF, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-78; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Seixas C, 2003, EXP CELL RES, V290, P303, DOI 10.1016/S0014-4827(03)00325-2; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Stephens RE, 1999, CELL MOTIL CYTOSKEL, V44, P274, DOI 10.1002/(SICI)1097-0169(199912)44:4<274::AID-CM5>3.0.CO;2-O; Tamalet A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e86; Teves ME, 2016, CYTOSKELETON, V73, P3, DOI 10.1002/cm.21271; Toure A, 2011, BIOL CHEM, V392, P799, DOI 10.1515/BC.2011.074; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; Yang HM, 2005, DNA SEQUENCE, V16, P166, DOI 10.1080/10425170500129736	36	59	60	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					489	500		10.1016/j.ajhg.2016.06.022	http://dx.doi.org/10.1016/j.ajhg.2016.06.022			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486783	Bronze, Green Published			2022-12-18	WOS:000381617200021
J	Tummala, H; Walne, AJ; Williams, M; Bockett, N; Collopy, L; Cardoso, S; Ellison, A; Wynn, R; Leblanc, T; Fitzgibbon, J; Kelsell, DP; van Heel, DA; Payne, E; Plagnol, V; Dokal, I; Vulliamy, T				Tummala, Hemanth; Walne, Amanda J.; Williams, Mike; Bockett, Nicholas; Collopy, Laura; Cardoso, Shirleny; Ellison, Alicia; Wynn, Rob; Leblanc, Thierry; Fitzgibbon, Jude; Kelsell, David P.; van Heel, David A.; Payne, Elspeth; Plagnol, Vincent; Dokal, Inderjeet; Vulliamy, Tom			DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHWACHMAN-DIAMOND-SYNDROME; BINDING-PROTEIN; BIOGENESIS; EBP1; JJJ1; RIBOSOMOPATHIES; CHAPERONES; PATHWAY; BIOLOGY; ANEMIA	A substantial number of individuals with bone marrow failure (BMF) present with one or more extra-hematopoietic abnormality. This suggests a constitutional or inherited basis, and yet many of them do not fit the diagnostic criteria of the known BMF syndromes. Through exome sequencing, we have now identified a subgroup of these individuals, defined by germline biallelic mutations in DNAJC21 (DNAJ homolog subfamily C member 21). They present with global BMF, and one individual developed a hematological cancer (acute myeloid leukemia) in childhood. We show that the encoded protein associates with rRNA and plays a highly conserved role in the maturation of the 60S ribosomal subunit. Lymphoblastoid cells obtained from an affected individual exhibit increased sensitivity to the transcriptional inhibitor actinomycin D and reduced amounts of rRNA. Characterization of mutations revealed impairment in interactions with cofactors (PA2G4, HSPA8, and ZNF622) involved in 60S maturation. DNAJC21 deficiency resulted in cytoplasmic accumulation of the 60S nuclear export factor PA2G4, aberrant ribosome profiles, and increased cell death. Collectively, these findings demonstrate that mutations in DNAJC21 cause a cancer-prone BMF syndrome due to corruption of early nuclear rRNA biogenesis and late cytoplasmic maturation of the 60S subunit.	[Tummala, Hemanth; Walne, Amanda J.; Bockett, Nicholas; Collopy, Laura; Cardoso, Shirleny; Ellison, Alicia; van Heel, David A.; Dokal, Inderjeet; Vulliamy, Tom] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Genom & Child Hlth, London E1 2AT, England; [Williams, Mike] Birmingham Childrens Hosp, Clin & Lab Haematol, Birmingham B4 6NH, W Midlands, England; [Wynn, Rob] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M13 9WL, Lancs, England; [Leblanc, Thierry] Hop Robert Debre, AP HP, Pediat Hematol, F-75019 Paris, France; [Fitzgibbon, Jude] Queen Mary Univ London, Barts & London Sch Med & Dent, Barts Canc Inst, London EC1M 6BQ, England; [Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cell Biol & Cutaneous Res, London E1 2AT, England; [Payne, Elspeth] UCL Canc Inst, 72 Huntley St, London WC1E 6DD, England; [Plagnol, Vincent] UCL Genet Inst, Gower Pl, London WC1E 6DD, England	University of London; Queen Mary University London; University of Birmingham; Royal Manchester Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; University College London; University of London; University College London	Vulliamy, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Genom & Child Hlth, London E1 2AT, England.	t.vulliamy@qmul.ac.uk	Tummala, Hemanth/ABC-8367-2020; Kelsell, David P/F-8767-2011	Tummala, Hemanth/0000-0002-1413-745X; Fitzgibbon, Jude/0000-0002-9069-1866; Kelsell, David/0000-0002-9910-7144; Romualdo Cardoso, Shirleny/0000-0001-5279-6424; Dokal, Inderjeet/0000-0003-4462-4782; Bockett, Nicholas/0000-0002-7630-7637; van Heel, David/0000-0002-0637-2265	Medical Research Council UK [MR/K000292/1]; Children with Cancer UK [2013/144]; Barts and The London Charity [845/1796]; Leukaemia Lymphoma Research/Bloodwise [14032]; Medical Research Council [MR/K000292/1] Funding Source: researchfish; MRC [MR/K000292/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Children with Cancer UK; Barts and The London Charity; Leukaemia Lymphoma Research/Bloodwise; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank all the families and clinicians who contributed to this research. This work was funded by The Medical Research Council UK (MR/K000292/1), Children with Cancer UK (2013/144), Barts and The London Charity (845/1796), and Leukaemia Lymphoma Research/Bloodwise (14032). The authors would like to thank Frederic Baleydier for providing case samples, Gary Warnes for support in FACS analysis, and staff at the Barts and The London Genome Centre for Sanger sequencing analysis.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; De Keersmaecker K, 2015, BLOOD, V125, P1377, DOI 10.1182/blood-2014-10-569616; Demoinet E, 2007, RNA, V13, P1570, DOI 10.1261/rna.585007; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; Dror Y, 2002, BRIT J HAEMATOL, V118, P701, DOI 10.1046/j.1365-2141.2002.03585.x; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Meyer AE, 2007, P NATL ACAD SCI USA, V104, P1558, DOI 10.1073/pnas.0610704104; Meyer AE, 2010, J BIOL CHEM, V285, P961, DOI 10.1074/jbc.M109.038349; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Pilipenko EV, 2000, GENE DEV, V14, P2028; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Shimamura A, 2006, SEMIN HEMATOL, V43, P178, DOI 10.1053/j.seminhematol.2006.04.006; Squatrito M, 2006, BIOCHEM BIOPH RES CO, V344, P859, DOI 10.1016/j.bbrc.2006.03.205; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Weis F, 2015, NAT STRUCT MOL BIOL, V22, P914, DOI 10.1038/nsmb.3112; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wong CC, 2011, BLOOD, V118, P4305, DOI 10.1182/blood-2011-06-353938; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075	34	59	67	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					115	124		10.1016/j.ajhg.2016.05.002	http://dx.doi.org/10.1016/j.ajhg.2016.05.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27346687	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000381616600009
J	Hempel, M; Cremer, K; Ockeloen, CW; Lichtenbelt, KD; Herkert, JC; Denecke, J; Haack, TB; Zink, AM; Becker, J; Wohlleber, E; Johannsen, J; Alhaddad, B; Pfundt, R; Fuchs, S; Wieczorek, D; Strom, TM; van Gassen, KLI; Kleefstra, T; Kubisch, C; Engels, H; Lessel, D				Hempel, Maja; Cremer, Kirsten; Ockeloen, Charlotte W.; Lichtenbelt, Klaske D.; Herkert, Johanna C.; Denecke, Jonas; Haack, Tobias B.; Zink, Alexander M.; Becker, Jessica; Wohlleber, Eva; Johannsen, Jessika; Alhaddad, Bader; Pfundt, Rolph; Fuchs, Sigrid; Wieczorek, Dagmar; Strom, Tim M.; van Gassen, Koen L. I.; Kleefstra, Tjitske; Kubisch, Christian; Engels, Hartmut; Lessel, Davor			De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KIF5C	CHAMP1 encodes a protein with a function in kinetochore-microtubule attachment and in the regulation of chromosome segregation, both of which are known to be important for neurodevelopment. By trio whole-exome sequencing, we have identified de novo deleterious mutations in CHAMP1 in five unrelated individuals affected by intellectual disability with severe speech impairment, motor developmental delay, muscular hypotonia, and similar dysmorphic features including short philtrum and a tented upper and everted lover lip. In addition to two frameshift and one nonsense mutations, we found an identical nonsense mutation, c.1192C>T (p.Arg398*), in two affected individuals. All mutations, if resulting in a stable protein, are predicted to lead to the loss of the functionally important zinc-finger domains in the C terminus of the protein, which regulate CHAMP1 localization to chromosomes and the mitotic spindle, thereby providing a mechanistic understanding for their pathogenicity. We thus establish deleterious de novo mutations in CHAMP1 as a cause of intellectual disability.	[Hempel, Maja; Fuchs, Sigrid; Kubisch, Christian; Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany; [Cremer, Kirsten; Zink, Alexander M.; Becker, Jessica; Wohlleber, Eva; Engels, Hartmut] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Ockeloen, Charlotte W.; Pfundt, Rolph; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Lichtenbelt, Klaske D.; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 GA Utrecht, Netherlands; [Herkert, Johanna C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Denecke, Jonas; Johannsen, Jessika] Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Haack, Tobias B.; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Haack, Tobias B.; Alhaddad, Bader; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Wieczorek, Dagmar] Univ Duisburg Essen, Univ Klinikum Essen, Inst Human Genet, D-45122 Essen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Duisburg Essen	Engels, H (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.	hartmut.engels@uni-bonn.de; d.lessel@uke.de	Kubisch, Christian/F-1893-2011; Lessel, Davor/ABD-6088-2021; , WaNgtJ/AAR-7045-2020; Ockeloen, Charlotte/P-5732-2015; Pfundt, Rolph/L-4576-2015; Kleefstra, Tjitske/G-2619-2012; Wieczorek, Dagmar/AAU-6008-2021; Alhaddad, Bader/AAJ-5504-2021	Kubisch, Christian/0000-0003-4220-0978; Ockeloen, Charlotte/0000-0003-0329-1520; Wieczorek, Dagmar/0000-0003-2812-6492; Alhaddad, Bader/0000-0003-4542-5267; van Gassen, Koen/0000-0001-7934-0662; Lessel, Davor/0000-0003-4496-244X	German Ministry of Research and Education (German Mental Retardation Network) as part of the National Genome Research Network [01GS08164, 01GS08167, 01GS08163]; Federal Ministry of Education and Research through a Juniorverbund in der Systemmedizin "mitOmics" [FKZ 01ZX1405C]	German Ministry of Research and Education (German Mental Retardation Network) as part of the National Genome Research Network; Federal Ministry of Education and Research through a Juniorverbund in der Systemmedizin "mitOmics"	We are thankful to the affected individuals and their family members for their participation. This work was supported in part by the German Ministry of Research and Education (grant nos. 01GS08164, 01GS08167, and 01GS08163; German Mental Retardation Network) as part of the National Genome Research Network. T.B.H. was supported by the Federal Ministry of Education and Research through a Juniorverbund in der Systemmedizin "mitOmics" (FKZ 01ZX1405C). We thank Ms. Jennifer Kaiser for excellent technical assistance.	de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deciphering Developmental Disorders Study, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Itoh G, 2011, EMBO J, V30, P130, DOI 10.1038/emboj.2010.276; Kirchhoff M, 2009, AM J MED GENET A, V149A, P894, DOI 10.1002/ajmg.a.32814; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Mirzaa GM, 2014, HUM GENET, V133, P1023, DOI 10.1007/s00439-014-1443-3; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Willemsen MH, 2014, J MED GENET, V51, P487, DOI 10.1136/jmedgenet-2013-102182	11	59	64	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					493	500		10.1016/j.ajhg.2015.08.003	http://dx.doi.org/10.1016/j.ajhg.2015.08.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26340335	Bronze, Green Published			2022-12-18	WOS:000361084700012
J	Meester, JAN; Southgate, L; Stittrich, AB; Venselaar, H; Beekmans, SJA; den Hollander, N; Bijlsma, EK; den Enden, AHV; Verheij, JBGM; Glusman, G; Roach, JC; Lehman, A; Patel, MS; de Vries, BBA; Ruivenkamp, C; Itin, P; Prescott, K; Clarke, S; Trembath, R; Zenker, M; Sukalo, M; Van Laer, L; Loeys, B; Wuyts, W				Meester, Josephina A. N.; Southgate, Laura; Stittrich, Anna-Barbara; Venselaar, Hanka; Beekmans, Sander J. A.; den Hollander, Nicolette; Bijlsma, Emilia K.; den Enden, Appolonia Helderman-van; Verheij, Joke B. G. M.; Glusman, Gustavo; Roach, Jared C.; Lehman, Anna; Patel, Millan S.; de Vries, Bert B. A.; Ruivenkamp, Claudia; Itin, Peter; Prescott, Katrina; Clarke, Sheila; Trembath, Richard; Zenker, Martin; Sukalo, Maja; Van Laer, Lut; Loeys, Bart; Wuyts, Wim			Heterozygous Loss-of-Function Mutations in DLL4 Cause Adams-Oliver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APLASIA-CUTIS-CONGENITA; DOCK6	Adams-Oliver syndrome (AOS) is a rare developmental disorder characterized by the presence of aplasia cutis congenita (ACC) of the scalp vertex and terminal limb-reduction defects. Cardiovascular anomalies are also frequently observed. Mutations in five genes have been identified as a cause for AOS prior to this report. Mutations in EOGT and DOCK6 cause autosomal-recessive AOS, whereas mutations in ARHGAP31, RBPJ, and NOTCH1 lead to autosomal-dominant AOS. Because REP]; NOTCH1, and EOGT are involved in NOTCH signaling, we hypothesized that mutations in other genes involved in this pathway might also be implicated in AOS pathogenesis. Using a candidate-gene-based approach, we prioritized DLL4, a critical NOTCH ligand, due to its essential role in vascular development in the context of cardiovascular features in AOS-affected individuals. Targeted resequencing of the DLL4 gene with a custom enrichment panel in 89 independent families resulted in the identification of seven mutations. A defect in DLL4 was also detected in two families via whole-exome or genome sequencing. In total, nine heterozygous mutations in DLL4 were identified, including two nonsense and seven missense variants, the latter encompassing four mutations that replace or create cysteine residues, which are most likely critical for maintaining structural integrity of the protein. Affected individuals with DLL4 mutations present with variable clinical expression with no emerging genotype-phenotype correlations. Our findings demonstrate that DLL4 mutations are an additional cause of autosomal-dominant AOS or isolated ACC and provide further evidence for a key role of NOTCH signaling in the etiology of this disorder.	[Meester, Josephina A. N.; Van Laer, Lut; Loeys, Bart; Wuyts, Wim] Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2650 Antwerp, Belgium; [Meester, Josephina A. N.; Van Laer, Lut; Loeys, Bart; Wuyts, Wim] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Southgate, Laura; Trembath, Richard] Queen Mary Univ London, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Stittrich, Anna-Barbara; Glusman, Gustavo; Roach, Jared C.] Inst Syst Biol, Seattle, WA USA; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Beekmans, Sander J. A.] VU Med Ctr Amsterdam, Dept Plast & Reconstruct Surg, NL-1081 HZ Amsterdam, Netherlands; [den Hollander, Nicolette; Bijlsma, Emilia K.; den Enden, Appolonia Helderman-van; Ruivenkamp, Claudia] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Genet, NL-9700 RB Groningen, Netherlands; [Verheij, Joke B. G. M.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Lehman, Anna; Patel, Millan S.] Child & Family Res Inst, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Lehman, Anna; Patel, Millan S.] Univ British Columbia, Vancouver, BC V6H 3N1, Canada; [de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Itin, Peter] Univ Basel Hosp, Dept Dermatol, CH-4031 Basel, Switzerland; [Prescott, Katrina] Chapel Allerton Hosp, Dept Clin Genet, Leeds LS7 4SA, W Yorkshire, England; [Clarke, Sheila] Chapel Allerton Hosp, Dept Dermatol, Leeds LS7 4SA, W Yorkshire, England; [Zenker, Martin; Sukalo, Maja] Univ Magdeburg, Inst Human Genet, Magdeburg, Germany; [Zenker, Martin; Sukalo, Maja] Univ Hosp Magdeburg, Magdeburg, Germany; [Loeys, Bart] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 GA Nijmegen, Netherlands	University of Antwerp; University of Antwerp; University of London; Queen Mary University London; Institute for Systems Biology (ISB); Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; Child & Family Research Institute; University of British Columbia; Radboud University Nijmegen; Radboud University Nijmegen; University of Basel; Chapel Allerton Hospital; Chapel Allerton Hospital; Otto von Guericke University; University Hospital Magdeburg; Radboud University Nijmegen	Loeys, B (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2650 Antwerp, Belgium.	bart.loeys@uantwerpen.be; wim.wuyts@uantwerpen.be	Southgate, Laura/H-7924-2019; Loeys, Bart/B-3236-2017; Loeys, B.L./L-4493-2015; Lehman, Anna/R-6706-2017; wuyts, wim/B-6262-2017; Venselaar, Hanka/D-2009-2016; Meester, Josephina/A-9577-2018	Southgate, Laura/0000-0002-2090-1450; Loeys, Bart/0000-0003-3703-9518; Lehman, Anna/0000-0003-0636-123X; wuyts, wim/0000-0002-4349-9038; Venselaar, Hanka/0000-0001-9824-6559; Meester, Josephina/0000-0001-8516-5856; /0000-0001-7061-6837; Glusman, Gustavo/0000-0001-8060-5955; Trembath, Richard/0000-0003-0550-3400	European Reseach Council; German Academic Exchange Service; German Research Foundation; Fund for Scientific Research, Flanders [G.0221.12]; Fondation Leducq; European Research Council, a Center for Systems Biology P50 grant (NIH) [GM076547]; Rare Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	European Reseach Council; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG)); Fund for Scientific Research, Flanders(FWO); Fondation Leducq(Leducq Foundation); European Research Council, a Center for Systems Biology P50 grant (NIH); Rare Disease Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the families who participated in this study. B.L.L. is a senior clinical investigator of the Fund for Scientific Research, Flanders and holds a European Reseach Council starting grant. J.A.N.M. is a predoctoral researcher of the Fund for Scientific Research, Flanders. A.B.S. was supported by the German Academic Exchange Service and the German Research Foundation. This research was supported by funding from the Fund for Scientific Research, Flanders (G.0221.12), the Fondation Leducq, and the European Research Council, a Center for Systems Biology P50 grant (GM076547, NIH), and the Rare Disease Foundation.	Adams Forrest H., 1945, JOUR HEREDITY, V36, P3; Algaze C, 2013, AM J MED GENET A, V161A, P1386, DOI 10.1002/ajmg.a.35864; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Itin PH, 2000, EUR J DERMATOL, V10, P181; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ogawa M, 2015, J BIOL CHEM, V290, P2137, DOI 10.1074/jbc.M114.598821; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shaheen R, 2011, AM J HUM GENET, V89, P328, DOI 10.1016/j.ajhg.2011.07.009; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Snape KMG, 2009, AM J MED GENET A, V149A, P1860, DOI 10.1002/ajmg.a.32708; Southgate L, 2015, CIRC CARDIOVASC GENE; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Sukalo M, 2015, HUM MUTAT, V36, P593, DOI 10.1002/humu.22795; Vandeweyer G, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0074-6	24	59	62	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 3	2015	97	3					475	482		10.1016/j.ajhg.2015.07.015	http://dx.doi.org/10.1016/j.ajhg.2015.07.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CR1KW	26299364	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000361084700010
J	Zech, M; Lam, DD; Francescatto, L; Schormair, B; Salminen, AV; Jochim, A; Wieland, T; Lichtner, P; Peters, A; Gieger, C; Lochmuller, H; Strom, TM; Haslinger, B; Katsanis, N; Winkelmann, J				Zech, Michael; Lam, Daniel D.; Francescatto, Ludmila; Schormair, Barbara; Salminen, Aaro V.; Jochim, Angela; Wieland, Thomas; Lichtner, Peter; Peters, Annette; Gieger, Christian; Lochmueller, Hanns; Strom, Tim M.; Haslinger, Bernhard; Katsanis, Nicholas; Winkelmann, Juliane			Recessive Mutations in the alpha 3 (VI) Collagen Gene COL6A3 Cause Early-Onset Isolated Dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRIMARY TORSION DYSTONIA; EXTRACELLULAR-MATRIX; ENDOGENOUS INHIBITOR; C5 DOMAIN; MYOPATHIES; BRAIN; CLASSIFICATION; IDENTIFICATION; PHENOMENOLOGY; HETEROGENEITY	Isolated dystonia is a disorder characterized by involuntary twisting postures arising from sustained muscle contractions. Although autosomal-dominant mutations in TOR1A, THAP1, and GNAL have been found in some cases, the molecular mechanisms underlying isolated dystonia are largely unknown. In addition, although emphasis has been placed on dominant isolated dystonia, the disorder is also transmitted as a recessive trait, for which no mutations have been defined. Using whole-exome sequencing in a recessive isolated dystonia-affected kindred, we identified disease-segregating compound heterozygous mutations in COL6A3, a collagen VI gene associated previously with muscular dystrophy. Genetic screening of a further 367 isolated dystonia subjects revealed two additional recessive pedigrees harboring compound heterozygous mutations in COL6A3. Strikingly, all affected individuals had at least one pathogenic allele in exon 41, including an exon-skipping mutation that induced an in-frame deletion. We tested the hypothesis that disruption of this exon is pathognomonic for isolated dystonia by inducing a series of in-frame deletions in zebrafish embryos. Consistent with our human genetics data, suppression of the exon 41 ortholog caused deficits in axonal outgrowth, whereas suppression of other exons phenocopied collagen deposition mutants. All recessive mutation carriers demonstrated early-onset segmental isolated dystonia without muscular disease. Finally, we show that Col6a3 is expressed in neurons, with relevant mRNA levels detectable throughout the adult mouse brain. Taken together, our data indicate that loss-of-function mutations affecting a specific region of COL6A3 cause recessive isolated dystonia with underlying neurodevelopmental deficits and highlight the brain extracellular matrix as a contributor to dystonia pathogenesis.	[Zech, Michael; Schormair, Barbara; Jochim, Angela; Haslinger, Bernhard; Winkelmann, Juliane] Tech Univ Munich, Neurol Klin & Poliklin, Klinikum Rechts Isar, D-81675 Munich, Germany; [Zech, Michael; Lam, Daniel D.; Winkelmann, Juliane] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Zech, Michael; Lam, Daniel D.; Winkelmann, Juliane] Stanford Univ, Sch Med, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA; [Zech, Michael; Schormair, Barbara; Salminen, Aaro V.; Wieland, Thomas; Lichtner, Peter; Strom, Tim M.; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Munich, Germany; [Francescatto, Ludmila; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Schormair, Barbara; Lichtner, Peter; Strom, Tim M.] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Munich, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Munich, Germany; [Lochmueller, Hanns] Newcastle Univ, John Walton Ctr Muscular Dystrophy Res, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Winkelmann, Juliane] SyNergy, Munich Cluster Syst Neurol, D-81377 Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Duke University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Newcastle University - UK	Winkelmann, J (corresponding author), Tech Univ Munich, Neurol Klin & Poliklin, Klinikum Rechts Isar, D-81675 Munich, Germany.	winkelmann@stanford.edu	Peters, Annette/A-6117-2011	Peters, Annette/0000-0001-6645-0985; Winkelmann, Juliane/0000-0003-2667-9691; Lam, Daniel/0000-0001-8593-3157; Gieger, Christian/0000-0001-6986-9554	Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; Center for Human Disease Modeling, Duke University; German Bundesministerium fur Bildung und Forschung (BMBF) [03.2007-02.2011 FKZ 01ET0713]; EU [305121, 305444]; Langmatz-Stiftung;  [P50 MH094268]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Technische Universitat Munchen; Helmholtz Zentrum Munchen, Munich, Germany; Center for Human Disease Modeling, Duke University; German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Langmatz-Stiftung; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all individuals with dystonia and their family members who participated in this study. We are gratefully indebted to Jelena Golic, Susanne Lindhof, Sybille Frischholz, and Regina Feldmann (Institut fur Humangenetik, Helmholtz Zentrum Munchen, Munich, Germany) and Melanie Plastini (Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, USA) for expert technical assistance, and our study nurses Silke Zwirner and Antje Lusebrink (Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany). We thank Dr. Kornelia Kreiser, Abteilung fur Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universitat Munchen (Munich, Germany) for the performance of muscle MRI. We thank Erik Tilch for help with CADD. This study was funded by in-house institutional funding from Technische Universitat Munchen and Helmholtz Zentrum Munchen, Munich, Germany, by seed funding from the Center for Human Disease Modeling, Duke University, and by P50 MH094268 to N.K. Recruitment of case and control cohorts was supported by institutional funding from Helmholtz Zentrum Munchen, Munich, Germany, and government funding from the German Bundesministerium fur Bildung und Forschung (BMBF, 03.2007-02.2011 FKZ 01ET0713). Fibroblasts were obtained from the Medical Research Council (MRC) Centre for Neuromuscular Diseases Biobank (Newcastle), which is part of EuroBioBank. The EU funded projects Neuromics (No. 305121) and RD-Connect (No. 305444). N.K. is a Distinguished Brumley Professor. M.Z. received intramural funding from the Langmatz-Stiftung.	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Balint B, 2014, CURR OPIN NEUROL, V27, P468, DOI 10.1097/WCO.0000000000000114; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Bovolenta M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-44; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Cheng IH, 2011, NEUROSCIENCE, V183, P178, DOI 10.1016/j.neuroscience.2011.03.057; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chouery E, 2008, NEUROGENETICS, V9, P287, DOI 10.1007/s10048-008-0142-4; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Dityatev A, 2010, TRENDS NEUROSCI, V33, P503, DOI 10.1016/j.tins.2010.08.003; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Fox MA, 2008, CURR OPIN CELL BIOL, V20, P508, DOI 10.1016/j.ceb.2008.05.003; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gimenez-Roldan S, 1988, Adv Neurol, V50, P73; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Karkheiran S, 2013, HUM GENET, V132, P275, DOI 10.1007/s00439-012-1248-1; Khan NL, 2003, NEUROLOGY, V61, P1801, DOI 10.1212/01.WNL.0000099076.17187.9A; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lohmann K, 2014, NEUROGENETICS, V15, P81, DOI 10.1007/s10048-014-0399-8; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moretti P, 2005, MOVEMENT DISORD, V20, P245, DOI 10.1002/mds.20228; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Niethammer M, 2011, NEUROBIOL DIS, V42, P202, DOI 10.1016/j.nbd.2010.10.010; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Paisan-Ruiz C, 2009, AM J MED GENET B, V150B, P993, DOI 10.1002/ajmg.b.30929; Quartarone A, 2013, MOVEMENT DISORD, V28, P958, DOI 10.1002/mds.25532; Quartarone A, 2011, NEUROBIOL DIS, V42, P162, DOI 10.1016/j.nbd.2010.12.011; Richards AJ, 2012, EUR J HUM GENET, V20, P552, DOI 10.1038/ejhg.2011.223; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Strekalova T, 2002, MOL CELL NEUROSCI, V21, P173, DOI 10.1006/mcne.2002.1172; TRUEB B, 1986, EMBO J, V5, P2815, DOI 10.1002/j.1460-2075.1986.tb04573.x; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	53	59	64	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					883	893		10.1016/j.ajhg.2015.04.010	http://dx.doi.org/10.1016/j.ajhg.2015.04.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CK0YH	26004199	Bronze, Green Published			2022-12-18	WOS:000355931200003
J	Brea-Calvo, G; Haack, TB; Karall, D; Ohtake, A; Invernizzi, F; Carrozzo, R; Kremer, L; Dusi, S; Fauth, C; Scholl-Burgi, S; Graf, E; Ahting, U; Resta, N; Laforgia, N; Verrigni, D; Okazaki, Y; Kohda, M; Martinelli, D; Freisinger, P; Strom, TM; Meitinger, T; Lamperti, C; Lacson, A; Navas, P; Mayr, JA; Bertini, E; Murayama, K; Zeviani, M; Prokisch, H; Ghezzi, D				Brea-Calvo, Gloria; Haack, Tobias B.; Karall, Daniela; Ohtake, Akira; Invernizzi, Federica; Carrozzo, Rosalba; Kremer, Laura; Dusi, Sabrina; Fauth, Christine; Scholl-Buergi, Sabine; Graf, Elisabeth; Ahting, Uwe; Resta, Nicoletta; Laforgia, Nicola; Verrigni, Daniela; Okazaki, Yasushi; Kohda, Masakazu; Martinelli, Diego; Freisinger, Peter; Strom, Tim M.; Meitinger, Thomas; Lamperti, Costanza; Lacson, Atilano; Navas, Placido; Mayr, Johannes A.; Bertini, Enrico; Murayama, Kei; Zeviani, Massimo; Prokisch, Holger; Ghezzi, Daniele			COQ4 Mutations Cause a Broad Spectrum of Mitochondrial Disorders Associated with CoQ(10) Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME Q(10) DEFICIENCY; NEPHROTIC SYNDROME; DILATED CARDIOMYOPATHY; CEREBELLAR-ATAXIA; DOUBLE-BLIND; BIOSYNTHESIS; CHAIN; COMPLEX; IDENTIFICATION; UBIQUINONE	Primary coenzyme Q10 (CoQ(10)) deficiencies are rare, clinically heterogeneous disorders caused by mutations in several genes encoding proteins involved in CoQ(10) biosynthesis. CoQ(10) is an essential component of the electron transport chain (ETC), where it shuttles electrons from complex I or II to complex III. By whole-exome sequencing, we identified five individuals carrying biallelic mutations in COQ4. The precise function of human COQ4 is not known, but it seems to play a structural role in stabilizing a multiheteromeric complex that contains most of the CoQ(10) biosynthetic enzymes. The clinical phenotypes of the five subjects varied widely, but four had a prenatal or perinatal onset with early fatal outcome. Two unrelated individuals presented with severe hypotonia, bradycardia, respiratory insufficiency, and heart failure; two sisters showed antenatal cerebellar hypoplasia, neonatal respiratory-distress syndrome, and epileptic encephalopathy. The fifth subject had an early-onset but slowly progressive clinical course dominated by neurological deterioration with hardly any involvement of other organs. All available specimens from affected subjects showed reduced amounts of CoQ(10) and often displayed a decrease in CoQ(10)-dependent ETC complex activities. The pathogenic role of all identified mutations was experimentally validated in a recombinant yeast model; oxidative growth, strongly impaired in strains lacking COQ4, was corrected by expression of human wild-type COQ4 cDNA but failed to be corrected by expression of COQ4 cDNAs with any of the mutations identified in affected subjects. COQ4 mutations are responsible for early-onset mitochondrial diseases with heterogeneous clinical presentations and associated with CoQ10 deficiency.	[Brea-Calvo, Gloria; Navas, Placido] Univ Pablo de Olavide, Consejo Super Invest Cient, Ctr Andaluz Biol Desarrollo, Junta de Andalucia, Seville 41013, Spain; [Brea-Calvo, Gloria; Navas, Placido] Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain; [Haack, Tobias B.; Kremer, Laura; Graf, Elisabeth; Ahting, Uwe; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Haack, Tobias B.; Kremer, Laura; Graf, Elisabeth; Ahting, Uwe; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Karall, Daniela; Scholl-Buergi, Sabine] Med Univ Innsbruck, Div Inherited Metab Disorders, Pediat Clin, A-6020 Innsbruck, Austria; [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama 3500495, Japan; [Invernizzi, Federica; Dusi, Sabrina; Lamperti, Costanza; Ghezzi, Daniele] Fdn Carlo Besta, Neurol Inst, Ist Ricovero & Cura Carettere Sci, Unit Mol Neurogenet, I-20126 Milan, Italy; [Carrozzo, Rosalba; Verrigni, Daniela; Bertini, Enrico] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carettere Sci, Mol Med Lab, Unit Neuromuscular & Neurodegenerat Disorders, I-00165 Rome, Italy; [Fauth, Christine] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Human Genet, A-6020 Innsbruck, Austria; [Resta, Nicoletta] Univ Bari Aldo Moro, Div Med Genet, Dept Biomed Sci & Human Oncol, I-70121 Bari, Italy; [Laforgia, Nicola] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Neonatol & Neonatal Intens Care Unit, I-70121 Bari, Italy; [Okazaki, Yasushi; Kohda, Masakazu] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Saitama 3501241, Japan; [Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama 3501241, Japan; [Martinelli, Diego] Bambino Gesu Pediat Hosp, Unit Metab, Ist Ricovero & Cura Carettere Sci, I-00165 Rome, Italy; [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Lacson, Atilano] Walter Mackenzie Hlth Sci Ctr, Edmonton, AB T6G 2B7, Canada; [Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan; [Murayama, Kei] Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan; [Zeviani, Massimo] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of Innsbruck; Saitama Medical University; IRCCS Istituto Neurologico Besta; Medical University of Innsbruck; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Saitama Medical University; University of Alberta; Paracelsus Private Medical University; Chiba Children's Hospital; Chiba Cancer Center	Prokisch, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, D-85764 Neuherberg, Germany.	prokisch@helmholtz-muenchen.de; dghezzi@istituto-besta.it	lamperti, costanza/J-8801-2016; Laforgia, Nicola/T-4088-2019; Zeviani, Massimo/AAU-2632-2021; Resta, Nicoletta/I-8424-2018; Carrozzo, Rosalba/A-2808-2014; Brea-Calvo, Gloria/N-4728-2014; Meitinger, Thomas/O-1318-2015; Bertini, Enrico/A-2284-2014; Ghezzi, Daniele/J-7873-2016; NAVAS, PLACIDO/R-5943-2019; Invernizzi, Federica/J-9849-2016; daniela, verrigni/K-3645-2014; Dusi, Sabrina/H-6561-2016; Bertini, Enrico/ABG-1278-2020	lamperti, costanza/0000-0002-2280-2253; Laforgia, Nicola/0000-0002-4610-1216; Zeviani, Massimo/0000-0002-9067-5508; Resta, Nicoletta/0000-0001-8640-5532; Carrozzo, Rosalba/0000-0002-3327-4054; Brea-Calvo, Gloria/0000-0001-5536-6868; Bertini, Enrico/0000-0001-9276-4590; Ghezzi, Daniele/0000-0002-6564-3766; NAVAS, PLACIDO/0000-0002-4115-7966; Invernizzi, Federica/0000-0001-8072-0152; daniela, verrigni/0000-0001-9532-9658; Dusi, Sabrina/0000-0002-4935-5174; Okazaki, Yasushi/0000-0003-3241-5502; Ohtake, Akira/0000-0003-1147-3113; Scholl-Burgi, Sabine/0000-0002-2529-4231; KOHDA, Masakazu/0000-0001-5970-2224; Mayr, Johannes/0000-0001-6970-336X; Meitinger, Thomas/0000-0002-8838-8403; Kremer, Laura/0000-0002-1647-7538; Prokisch, Holger/0000-0003-2379-6286	Fondazione Telethon [GGP11011]; Italian Ministry of Health [GR2010-2316392]; Fondazione CARIPLO [2011/0526]; Mariani Foundation; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); European Research Council [FP7-322424]; German Ministry of Education and Research through the E-Rare project GENOMIT [01GM1207, FWF I 920-B13, J41J11000420001]; German Network for mitochondrial disorders (mitoNET) [01GM1113C]; German Center for Heart Research by the German Research Foundation within the Munich Cluster for Systems Neurology [Z76010017300, Z56010015300, EXC-1010-SyNergy]; UK Medical Research Council; Spanish Instituto de Salud Carlos III [FIS-PI11-00078]; Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Bank of Muscle Tissue, Peripheral Nerve, DNA, and Cell Culture of the Telethon Network of Genetic Biobanks [GTB12001J]; Austrian Science Fund (FWF) [I 920] Funding Source: researchfish; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish; MRC [MC_UP_1002/1] Funding Source: UKRI	Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy); Fondazione CARIPLO(Fondazione Cariplo); Mariani Foundation; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); European Research Council(European Research Council (ERC)European Commission); German Ministry of Education and Research through the E-Rare project GENOMIT; German Network for mitochondrial disorders (mitoNET); German Center for Heart Research by the German Research Foundation within the Munich Cluster for Systems Neurology; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Bank of Muscle Tissue, Peripheral Nerve, DNA, and Cell Culture of the Telethon Network of Genetic Biobanks(Fondazione Telethon); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank the families for their collaboration. We thank Roberto Bellavia, Yoshihito Kishita, Yoshimi Tokuzawa, and Ana Sanchez-Cuesta for their technical support; Consolato Sergi for his help; and K. Muroya and M. Adachi for referral of subject materials. This work was supported by Fondazione Telethon (GGP11011), the Italian Ministry of Health (GR2010-2316392 [D.G.]; "Ricerca corrente" [E.B.]), Fondazione CARIPLO (2011/0526), the Mariani Foundation, the Italian Association of Mitochondrial Disease Patients and Families (Mitocon), the European Research Council Advanced Grant FP7-322424, the German Ministry of Education and Research through the E-Rare project GENOMIT (01GM1207 [T.M.; H.P.], FWF I 920-B13 [J.A.M.], J41J11000420001 [D.G.]), the German Network for mitochondrial disorders (mitoNET; 01GM1113C [T.M.; H.P.]), the German Center for Heart Research (Z76010017300; Z56010015300 [T.M.]) by the German Research Foundation within the Munich Cluster for Systems Neurology (EXC-1010-SyNergy), the UK Medical Research Council, the Spanish Instituto de Salud Carlos III (FIS-PI11-00078), the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology [Y.O.], Grants-in-Aid for the Research on Intractable Diseases (Mitochondrial Disease) from the Ministry of Health, Labour, and Welfare of Japan [A.O.; K.M.], and the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics [K.M.]. We also acknowledge the Cell Lines and DNA Bank of Paediatric Movement Disorders and Mitochondrial Diseases and the Bank of Muscle Tissue, Peripheral Nerve, DNA, and Cell Culture of the Telethon Network of Genetic Biobanks (grant GTB12001J) and the EurobiobanK Network.	ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; Aeby A, 2007, J INHERIT METAB DIS, V30, P827, DOI 10.1007/s10545-007-0612-0; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Casarin A, 2008, BIOCHEM BIOPH RES CO, V372, P35, DOI 10.1016/j.bbrc.2008.04.172; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; GHIRLANDA G, 1993, J CLIN PHARMACOL, V33, P226, DOI 10.1002/j.1552-4604.1993.tb03948.x; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; HANAKI Y, 1991, NEW ENGL J MED, V325, P814; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; LANGSJOEN PH, 1990, AM J CARDIOL, V65, P521, DOI 10.1016/0002-9149(90)90824-K; MANZOLI U, 1990, INT J TISSUE REACT, V12, P173; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Mignot C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-173; MILLER RW, 1969, CAN J BIOCHEM CELL B, V47, P725, DOI 10.1139/o69-110; MORTENSEN SA, 1984, DRUG EXP CLIN RES, V10, P497; Mortensen SA, 2014, JACC-HEART FAIL, V2, P641, DOI 10.1016/j.jchf.2014.06.008; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025; Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Salviati L, 2012, J MED GENET, V49, P187, DOI 10.1136/jmedgenet-2011-100394; Scalais E, 2013, EUR J PAEDIATR NEURO, V17, P625, DOI 10.1016/j.ejpn.2013.05.013; Schmelzer C, 2007, BIOFACTORS, V31, P211, DOI 10.1002/biof.5520310308; Silver MA, 2003, BIOFACTORS, V18, P125, DOI 10.1002/biof.5520180214; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Maldergem L, 2002, ANN NEUROL, V52, P750, DOI 10.1002/ana.10371; Yubero D, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0284-5; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	40	59	63	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					309	317		10.1016/j.ajhg.2014.12.023	http://dx.doi.org/10.1016/j.ajhg.2014.12.023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25658047	Green Published, hybrid			2022-12-18	WOS:000349276700013
J	Rainger, J; Pehlivan, D; Johansson, S; Bengani, H; Sanchez-Pulido, L; Williamson, KA; Ture, M; Barker, H; Rosendahl, K; Spranger, J; Horn, D; Meynert, A; Floyd, JAB; Prescott, T; Anderson, CA; Rainger, JK; Karaca, E; Gonzaga-Jauregui, C; Jhangiani, S; Muzny, DM; Seawright, A; Soares, DC; Kharbanda, M; Murday, V; Finch, A; Gibbs, RA; van Heyningen, V; Taylor, MS; Yakut, T; Knappskog, PM; Hurles, ME; Ponting, CP; Lupski, JR; Houge, G; FitzPatrick, DR				Rainger, Joe; Pehlivan, Davut; Johansson, Stefan; Bengani, Hemant; Sanchez-Pulido, Luis; Williamson, Kathleen A.; Ture, Mehmet; Barker, Heather; Rosendahl, Karen; Spranger, Juergen; Horn, Denise; Meynert, Alison; Floyd, James A. B.; Prescott, Trine; Anderson, Carl A.; Rainger, Jacqueline K.; Karaca, Ender; Gonzaga-Jauregui, Claudia; Jhangiani, Shalini; Muzny, Donna M.; Seawright, Anne; Soares, Dinesh C.; Kharbanda, Mira; Murday, Victoria; Finch, Andrew; Gibbs, Richard A.; van Heyningen, Veronica; Taylor, Martin S.; Yakut, Tahsin; Knappskog, Per M.; Hurles, Matthew E.; Ponting, Chris P.; Lupski, James R.; Houge, Gunnar; FitzPatrick, David R.		UK10K; Baylor-Hopkins Ctr Mendelian Genom	Monoallelic and Biallelic Mutations in MAB21L2 Cause a Spectrum of Major Eye Malformations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL HEART-DEFECTS; DIAPHRAGMATIC-HERNIA; MOUSE EMBRYOGENESIS; VISUAL IMPAIRMENT; NOONAN-SYNDROME; ANOPHTHALMIA; GENE; RNA; MICROPHTHALMIA; SYNTHETASE	We identified four different missense mutations in the single-exon gene MAB21L2 in eight individuals with bilateral eye malformations from five unrelated families via three independent exome sequencing projects. Three mutational events altered the same amino acid (Arg51), and two were identical de novo mutations (c.151C>T [p.Arg51Cys]) in unrelated children with bilateral anophthalmia, intellectual disability, and rhizomelic skeletal dysplasia. c.152G>A (p.Arg51His) segregated with autosomal-dominant bilateral colobomatous microphthalmia in a large multiplex family. The fourth heterozygous mutation (c.145G>A [p.Glu49Lys]) affected an amino acid within two residues of Arg51 in an adult male with bilateral colobomata. In a fifth family, a homozygous mutation (c.740G>A [p.Arg247Gln]) altering a different region of the protein was identified in two male siblings with bilateral retinal colobomata. In mouse embryos, Mab21l2 showed strong expression in the developing eye, pharyngeal arches, and limb bud. As predicted by structural homology, wild-type MAB21L2 bound single-stranded RNA, whereas this activity was lost in all altered forms of the protein. MAB21L2 had no detectable nucleotidyltransferase activity in vitro, and its function remains unknown. Induced expression of wild-type MAB21L2 in human embryonic kidney 293 cells increased phospho-ERK (pERK1/2) signaling. Compared to the wild-type and p.Arg247Gln proteins, the proteins with the Glu49 and Arg51 variants had increased stability. Abnormal persistence of pERK1/2 signaling in MAB21L2-expressing cells during development is a plausible pathogenic mechanism for the heterozygous mutations. The phenotype associated with the homozygous mutation might be a consequence of complete loss of MAB21L2 RNA binding, although the cellular function of this interaction remains unknown.	[Rainger, Joe; Bengani, Hemant; Williamson, Kathleen A.; Meynert, Alison; Rainger, Jacqueline K.; van Heyningen, Veronica; Taylor, Martin S.; FitzPatrick, David R.] Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Pehlivan, Davut; Karaca, Ender; Gonzaga-Jauregui, Claudia; Finch, Andrew; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jhangiani, Shalini; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Johansson, Stefan; Knappskog, Per M.; Houge, Gunnar] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Floyd, James A. B.; Anderson, Carl A.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, Oxford OX1 3PT, England; [Rosendahl, Karen] Haukeland Hosp, Dept Paediat Radiol, N-5021 Bergen, Norway; [Horn, Denise] Charite Campus Virchow Klinikum, Inst Med Genet, D-13353 Berlin, Germany; [Prescott, Trine] Oslo Univ Hosp, N-0424 Oslo, Norway; [Kharbanda, Mira; Murday, Victoria] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; [Finch, Andrew] Inst Genet & Mol Med, MRC, Edinburgh Canc Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Soares, Dinesh C.] Inst Genet & Mol Med, MRC, Ctr Genom & Expt Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Yakut, Tahsin] Uludag Univ, Dept Med Genet, TR-16120 Bursa, Turkey; [Johansson, Stefan; Knappskog, Per M.] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway	University of Edinburgh; Baylor College of Medicine; Baylor College of Medicine; University of Bergen; Haukeland University Hospital; Wellcome Trust Sanger Institute; University of Oxford; University of Bergen; Haukeland University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oslo; University of Glasgow; University of Edinburgh; University of Edinburgh; Uludag University; University of Bergen	FitzPatrick, DR (corresponding author), Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@igmm.ed.ac.uk	Taylor, Martin S/C-3825-2009; Gonzaga-Jauregui, Claudia/H-4752-2019; van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022; Pehlivan, Davut/I-3235-2019; Kharbanda, Mira/GPC-7884-2022; Soares, Dinesh C/A-4425-2012; Ponting, Chris/AAV-2621-2021; Schmidts, Miriam/A-3777-2012; Johansson, Stefan/C-4394-2011; Scambler, Peter/C-4998-2008	Taylor, Martin S/0000-0001-7656-330X; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; van Heyningen, Veronica/0000-0003-0359-0141; Kharbanda, Mira/0000-0001-7347-4176; Soares, Dinesh C/0000-0001-7557-0495; Schmidts, Miriam/0000-0002-1714-6749; Johansson, Stefan/0000-0002-2298-7008; Rainger, Joe/0000-0003-1091-5100; Scambler, Peter/0000-0002-1487-4628; Futema, Marta/0000-0002-2120-2088; Sanchez Pulido, Luis/0000-0002-2300-8502; Plagnol, Vincent/0000-0002-5597-9215; Mitchison, Hannah/0000-0002-3163-6293; Semple, Robert Kenneth/0000-0001-6539-3069; Anderson, Carl/0000-0003-1719-7009; FitzPatrick, David R./0000-0003-4861-969X; Walter, Klaudia/0000-0003-4448-0301; Ponting, Chris/0000-0003-0202-7816	Medical Research Council (MRC); Wellcome Trust [WT091310]; NIH National Human Genome Research Institute [U54 HG006542]; HelseVest grant [911744]; MRC [MC_PC_U127597124, MC_PC_U127527199, MC_U127527199, MC_UU_12021/1, MC_U137761446, MC_PC_U127561093] Funding Source: UKRI; Medical Research Council [MC_PC_U127561093, MC_UU_12021/1, MC_U127527199, MC_U137761446, MC_PC_U127527199, MC_PC_U127597124] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U54HG003273] Funding Source: NIH RePORTER	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); HelseVest grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	J.R., H.B., K.A.W., A.M., J.K.R., M.S.T., V.v.H., and D.R.F. are all supported by Medical Research Council (MRC) program grants awarded to the MRC Human Genetics Unit. Funding for UK10K was provided by the Wellcome Trust under award WT091310. Support for the Baylor-Hopkins Center for Mendelian Genomics was provided by the NIH National Human Genome Research Institute (U54 HG006542). G.H. is supported by HelseVest grant 911744. Thanks are given to Inge Jonassen and Kjell Petersen (Computational Biology Unit, Department of Informatics, University of Bergen, Norway) for providing IT infrastructure for the Norwegian next-generation sequencing data through the Elixir.no project and to the HudsonAlpha Institute for Biotechnology (Huntsville) for performing whole-exome sequencing in family 676.	Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bashir T, 2003, ADV CANCER RES, V88, P101, DOI 10.1016/S0065-230X(03)88305-7; Cederlund ML, 2011, DEV DYNAM, V240, P745, DOI 10.1002/dvdy.22573; Chassaing N, 2013, CLIN GENET; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Choy SW, 2007, BIOCHEM BIOPH RES CO, V358, P802, DOI 10.1016/j.bbrc.2007.04.194; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fares-Taie L, 2013, AM J HUM GENET, V92, P265, DOI 10.1016/j.ajhg.2012.12.003; Gerth-Kahlert C, 2013, MOL GENET GENOM MED, V1, P15, DOI 10.1002/mgg3.2; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Haddad MAO, 2007, J PEDIAT OPHTH STRAB, V44, P232, DOI 10.3928/01913913-20070701-04; Harima Y, 2013, CURR OPIN GENET DEV, V23, P484, DOI 10.1016/j.gde.2013.02.005; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hartmann R, 1998, J BIOL CHEM, V273, P3236, DOI 10.1074/jbc.273.6.3236; Haugarvoll K, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-1; Kennedy BN, 2004, DEV BIOL, V270, P336, DOI 10.1016/j.ydbio.2004.02.026; Krejci P, 2014, MUTAT RES-REV MUTAT, V759, P40, DOI 10.1016/j.mrrev.2013.11.001; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Le Goff C, 2012, AM J MED GENET C, V160C, P145, DOI 10.1002/ajmg.c.31337; Margolis RL, 1996, HUM MOL GENET, V5, P607, DOI 10.1093/hmg/5.5.607; Mariani M, 1998, MECH DEVELOP, V79, P131, DOI 10.1016/S0925-4773(98)00180-4; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Rudanko SL, 2004, OPHTHALMOLOGY, V111, P2307, DOI 10.1016/j.ophtha.2004.05.033; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Srour M, 2013, AM J HUM GENET, V93, P765, DOI 10.1016/j.ajhg.2013.08.014; Williamson KA, 2014, AM J HUM GENET, V94, P295, DOI 10.1016/j.ajhg.2014.01.001; Wong RLY, 1999, MECH DEVELOP, V87, P185, DOI 10.1016/S0925-4773(99)00127-6; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Yamada R, 2004, DEV BIOL, V274, P295, DOI 10.1016/j.ydbio.2004.07.016	37	59	62	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 5	2014	94	6					915	923		10.1016/j.ajhg.2014.05.005	http://dx.doi.org/10.1016/j.ajhg.2014.05.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AJ0HK	24906020	Green Published, Bronze			2022-12-18	WOS:000337331200012
J	Gong, J; Schumacher, F; Lim, U; Hindorff, LA; Haessler, J; Buyske, S; Carlson, CS; Rosse, S; Buzkova, P; Fornage, M; Gross, M; Pankratz, N; Pankow, JS; Schreiner, PJ; Cooper, R; Ehret, G; Gu, CC; Houston, D; Irvin, MR; Jackson, R; Kuller, L; Henderson, B; Cheng, I; Wilkens, L; Leppert, M; Lewis, CE; Li, RL; Nguyen, KDH; Goodloe, R; Farber-Eger, E; Boston, J; Dilks, HH; Ritchie, MD; Fowke, J; Pooler, L; Graff, M; Fernandez-Rhodes, L; Cochrane, B; Boerwinkle, E; Kooperberg, C; Matise, TC; Le Marchand, L; Crawford, DC; Haiman, CA; North, KE; Peters, U				Gong, Jian; Schumacher, Fredrick; Lim, Unhee; Hindorff, Lucia A.; Haessler, Jeff; Buyske, Steven; Carlson, Christopher S.; Rosse, Stephanie; Buzkova, Petra; Fornage, Myriam; Gross, Myron; Pankratz, Nathan; Pankow, James S.; Schreiner, Pamela J.; Cooper, Richard; Ehret, Georg; Gu, C. Charles; Houston, Denise; Irvin, Marguerite R.; Jackson, Rebecca; Kuller, Lew; Henderson, Brian; Cheng, Iona; Wilkens, Lynne; Leppert, Mark; Lewis, Cora E.; Li, Rongling; Nguyen, Khanh-Dung H.; Goodloe, Robert; Farber-Eger, Eric; Boston, Jonathan; Dilks, Holli H.; Ritchie, Marylyn D.; Fowke, Jay; Pooler, Loreall; Graff, Misa; Fernandez-Rhodes, Lindsay; Cochrane, Barbara; Boerwinkle, Eric; Kooperberg, Charles; Matise, Tara C.; Le Marchand, Loic; Crawford, Dana C.; Haiman, Christopher A.; North, Kari E.; Peters, Ulrike			Fine Mapping and Identification of BMI Loci in African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY PAGE; OBESITY; RELEVANCE; VARIANTS; TRAITS; DESIGN; RISK	Genome-wide association studies (GWASs) primarily performed in European-ancestry (EA) populations have identified numerous loci associated with body mass index (BMI). However, it is still unclear whether these GWAS loci can be generalized to other ethnic groups, such as African Americans (AAs). Furthermore, the putative functional variant or variants in these loci mostly remain under investigation. The overall lower linkage disequilibrium in AA compared to EA populations provides the opportunity to narrow in or fine-map these BMI-related loci. Therefore, we used the Metabochip to densely genotype and evaluate 21 BMI GWAS loci identified in EA studies in 29,151 AAs from the Population Architecture using Genomics and Epidemiology (PAGE) study. Eight of the 21 loci (SEC16B, TMEM18, ETV5, GNPDA2, TFAP2B, BDNF, FTO, and MC4R) were found to be associated with BMI in AAs at 5.8 x 10(-5). Within seven out of these eight loci, we found that, on average, a substantially smaller number of variants was correlated (r(2) > 0.5) with the most significant SNP in AA than in EA populations (16 versus 55). Conditional analyses revealed GNPDA2 harboring a potential additional independent signal. Moreover, Metabochip-wide discovery analyses revealed two BMI-related loci, BRE (rs116612809, p = 3.6 x 10(-8)) and DHX34 (rs4802349, p = 1.2 x 10(-7)), which were significant when adjustment was made for the total number of SNPs tested across the chip. These results demonstrate that fine mapping in AAs is a powerful approach for both narrowing in on the underlying causal variants in known loci and discovering BMI-related loci.	[Gong, Jian; Haessler, Jeff; Carlson, Christopher S.; Rosse, Stephanie; Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [Graff, Misa; Fernandez-Rhodes, Lindsay; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Buyske, Steven; Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Buyske, Steven] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ 08854 USA; [Jackson, Rebecca] Ohio State Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Kuller, Lew] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Lim, Unhee; Wilkens, Lynne; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96813 USA; [Schumacher, Fredrick; Henderson, Brian; Pooler, Loreall; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90089 USA; [Hindorff, Lucia A.; Li, Rongling] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Ehret, Georg; Nguyen, Khanh-Dung H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Ehret, Georg] Univ Hosp Geneva, Div Cardiol, CH-44041 Geneva, OH, Switzerland; [Cooper, Richard] Loyola Univ, Chicago, IL 60153 USA; [Lewis, Cora E.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Irvin, Marguerite R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Gu, C. Charles] Washington Univ, Dept Biostat, St Louis, MO 63110 USA; [Houston, Denise] Wake Forest Univ, Sch Med, Winston Salem, NC 27157 USA; [Buzkova, Petra] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ritchie, Marylyn D.] Penn State Univ, State Coll, PA 16801 USA; [Fowke, Jay] Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Goodloe, Robert; Farber-Eger, Eric; Boston, Jonathan; Dilks, Holli H.; Fowke, Jay; Crawford, Dana C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37203 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Gross, Myron; Pankratz, Nathan] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Pankow, James S.; Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Cochrane, Barbara] Baylor Coll Med, Houston, TX 77030 USA; [Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA 94538 USA	Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cancer Research Center of Hawaii; University of Hawaii System; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; University of Geneva; Loyola University Chicago; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Wake Forest University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Cancer Prevention Institute of California	Gong, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	jgong@fhcrc.org; upeters@fhcrc.org	Crawford, Dana/O-5578-2019; Lim, Unhee/AEA-8591-2022; EHRET, Georg B/A-9532-2009; Schumacher, Fredrick/R-6043-2019	Crawford, Dana/0000-0002-6437-6248; Lim, Unhee/0000-0001-6221-7190; EHRET, Georg B/0000-0002-5730-0675; Schumacher, Fredrick/0000-0002-3073-7463; Pankratz, Nathan/0000-0001-5958-693X; Schreiner, Pamela/0000-0002-9920-6257; Pankow, James/0000-0001-7076-483X; Buyske, Steven/0000-0001-8539-5416; Houston, Denise/0000-0002-3355-4304	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007416, U01HG004790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG007416, U01 HG004790] Funding Source: Medline; NICHD NIH HHS [R24 HD050924] Funding Source: Medline; NIDDK NIH HHS [P30 DK092986] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Connor Gorber S., 2010, OBESITY SILVER SPRIN, V18, P354; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Gu CH, 1998, FASEB J, V12, P1101, DOI 10.1096/fasebj.12.12.1101; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Miller Wendy M, 2005, Curr Cardiol Rep, V7, P465, DOI 10.1007/s11886-005-0065-8; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379	30	59	60	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					661	671		10.1016/j.ajhg.2013.08.012	http://dx.doi.org/10.1016/j.ajhg.2013.08.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24094743	Green Published, Bronze			2022-12-18	WOS:000326305600008
